archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,2.8267e-05,0.37482,0.39329,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,4.5779e-05,0.26399,0.29881,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0017696,0.23345,0.1917,1,1
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0172,0.16968,0.15484,1,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.045233,0.15438,0.091879,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0015882,0.088582,0.13856,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0172,-0.086193,-0.13495,1,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.023112,-0.095135,-0.18776,1,0
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.037377,-0.10996,-0.24695,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0080134,-0.11039,-0.27049,1,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.046961,-0.11548,-0.12635,1,0
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.024086,-0.12846,-0.18506,1,0
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.0040644,-0.12886,-0.19795,1,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.013834,-0.12954,-0.21845,1,0
1,GO HISTONE EXCHANGE,0.010572,-0.13825,-0.20609,1,0
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.013235,-0.14162,-0.1517,1,0
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.010101,-0.14221,-0.17266,1,0
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.016475,-0.15082,-0.20203,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0024341,-0.15186,-0.22683,1,0
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.00072571,-0.15616,-0.20479,1,0
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0011418,-0.16058,-0.18918,1,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0028457,-0.16139,-0.25039,1,0
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.00029789,-0.16833,-0.29757,1,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.0024341,-0.17081,-0.27406,1,0
1,GO QUINONE METABOLIC PROCESS,0.0013481,-0.17235,-0.22366,1,0
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.0172,-0.18344,-0.19913,1,0
1,GO DNA DEAMINATION,0.035953,-0.1836,-0.29326,1,0
1,GO RETINOL METABOLIC PROCESS,0.0020776,-0.18583,-0.26951,1,0
1,GO PROTEIN TARGETING,6.2007e-06,-0.18841,-0.2404,1,0
1,GO PEPTIDE BIOSYNTHETIC PROCESS,7.7514e-06,-0.18868,-0.24244,1,0
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.00096503,-0.19225,-0.22117,1,0
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00081392,-0.1942,-0.22323,1,0
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,6.4139e-05,-0.19588,-0.28599,1,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.0017696,-0.19732,-0.23978,1,0
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0010209,-0.1982,-0.25536,1,0
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00020554,-0.20208,-0.28408,1,0
1,GO SPERM EGG RECOGNITION,0.0042727,-0.20301,-0.20333,1,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.00076864,-0.2038,-0.28012,1,0
1,GO RIBOSOME BIOGENESIS,3.9936e-05,-0.20424,-0.25968,1,0
1,GO KERATINIZATION,0.052482,-0.20476,-0.17802,1,0
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0013481,-0.2058,-0.24971,1,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00012367,-0.20633,-0.30103,1,0
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.043559,-0.20818,-0.41448,1,0
1,GO HYPERSENSITIVITY,0.037377,-0.20957,-0.52225,1,0
1,GO RNA SURVEILLANCE,0.00017019,-0.20969,-0.30944,1,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.0010798,-0.21001,-0.29282,1,0
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.00086166,-0.21129,-0.28229,1,0
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0023095,-0.21379,-0.27752,1,0
1,GO T CELL MEDIATED CYTOTOXICITY,0.045233,-0.21519,-0.38974,1,0
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,1.2939e-05,-0.21528,-0.28707,1,0
1,GO RNA CATABOLIC PROCESS,7.7514e-06,-0.21624,-0.25133,1,0
1,GO SEQUESTERING OF METAL ION,0.026142,-0.21725,-0.22809,1,0
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.2907e-05,-0.21943,-0.28283,1,0
1,GO MATURATION OF LSU RRNA,0.0016767,-0.22019,-0.21711,1,0
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00017019,-0.2211,-0.26129,1,0
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00031664,-0.22171,-0.28892,1,0
1,GO FOREBRAIN REGIONALIZATION,0.016475,-0.2238,-0.35787,1,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.02951,-0.22409,-0.41727,1,0
1,GO RRNA METABOLIC PROCESS,1.4947e-05,-0.22735,-0.29878,1,0
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,1.9888e-05,-0.22944,-0.29168,1,0
1,GO TRNA WOBBLE BASE MODIFICATION,5.9985e-05,-0.23007,-0.34471,1,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.015104,-0.23042,-0.28335,1,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.019548,-0.2312,-0.2908,1,0
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,4.8997e-05,-0.2322,-0.29391,1,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.00057531,-0.23395,-0.25874,1,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.00045436,-0.2344,-0.25888,1,0
1,GO RRNA MODIFICATION,7.3279e-05,-0.23443,-0.32142,1,0
1,GO RETINAL METABOLIC PROCESS,0.033245,-0.23468,-0.30471,1,0
1,GO SPERM AXONEME ASSEMBLY,0.008797,-0.23728,-0.22807,1,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.031957,-0.23778,-0.38142,1,0
1,GO AMIDE BIOSYNTHETIC PROCESS,7.1973e-06,-0.2382,-0.2857,1,0
1,GO VIRAL BUDDING,9.5377e-05,-0.23837,-0.32007,1,0
1,GO PSEUDOURIDINE SYNTHESIS,0.0016767,-0.24034,-0.27468,1,0
1,GO RRNA METHYLATION,3.0304e-05,-0.24061,-0.33116,1,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.019548,-0.24069,-0.2444,1,0
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,7.8298e-05,-0.24149,-0.28764,1,0
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,9.6689e-06,-0.24159,-0.33593,1,0
1,GO CELL REDOX HOMEOSTASIS,5.2428e-05,-0.24193,-0.3524,1,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.00040321,-0.24211,-0.32222,1,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.0015041,-0.24268,-0.26386,1,0
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.00019306,-0.24273,-0.24486,1,0
1,GO SENSORY PERCEPTION OF TASTE,0.00033648,-0.24312,-0.32251,1,0
1,GO MUCUS SECRETION,0.045233,-0.24314,-0.22892,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0003797,-0.24317,-0.2509,1,0
1,GO PEPTIDE METABOLIC PROCESS,5.7533e-06,-0.24428,-0.28078,1,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.006955,-0.2444,-0.25233,1,0
1,GO STARTLE RESPONSE,0.015104,-0.24578,-0.36679,1,0
1,GO HISTONE MRNA METABOLIC PROCESS,8.9327e-05,-0.24587,-0.29055,1,0
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.015104,-0.24641,-0.23537,1,0
1,GO REGULATION OF FERTILIZATION,0.0034935,-0.24644,-0.2478,1,0
1,GO NCRNA PROCESSING,1.6059e-05,-0.24708,-0.31944,1,0
1,GO SENSORY PERCEPTION OF SMELL,0.00011593,-0.24954,-0.25177,1,0
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,3.0304e-05,-0.2505,-0.3056,1,0
1,GO REGULATION OF CILIUM MOVEMENT,0.0052065,-0.25115,-0.21764,1,0
1,GO RNA CAPPING,9.6689e-06,-0.25121,-0.32135,1,0
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,8.9327e-05,-0.25142,-0.30236,1,0
1,GO URONIC ACID METABOLIC PROCESS,0.00026348,-0.25175,-0.22375,1,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.0015882,-0.25502,-0.22958,1,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.0025648,-0.25599,-0.34347,1,0
1,GO GASTRIC ACID SECRETION,0.00057531,-0.26032,-0.28085,1,0
1,GO DRUG CATABOLIC PROCESS,0.0015041,-0.26055,-0.28752,1,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.0023095,-0.26166,-0.32101,1,0
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,3.7287e-05,-0.2635,-0.34288,1,0
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0042727,-0.26413,-0.46607,1,0
1,GO MULTIVESICULAR BODY ORGANIZATION,2.636e-05,-0.26504,-0.34225,1,0
1,GO POLYAMINE BIOSYNTHETIC PROCESS,8.9327e-05,-0.26561,-0.30034,1,0
1,GO VIRION ASSEMBLY,9.6689e-06,-0.26624,-0.3343,1,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0024341,-0.26692,-0.32621,1,0
1,GO MITOTIC CYTOKINETIC PROCESS,5.9985e-05,-0.26787,-0.37037,1,0
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.006955,-0.26828,-0.4508,1,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.0052065,-0.26839,-0.23134,1,0
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,3.9422e-06,-0.2688,-0.29995,1,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.00035748,-0.26965,-0.32855,1,0
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.0016767,-0.27023,-0.33943,1,0
1,GO POSITIVE REGULATION OF ACROSOME REACTION,0.012106,-0.27358,-0.25418,1,0
1,GO KETONE BODY METABOLIC PROCESS,0.0042727,-0.27403,-0.21673,1,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.018736,-0.27473,-0.33022,1,0
1,GO AMINE CATABOLIC PROCESS,0.00091199,-0.27644,-0.37447,1,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,0.016475,-0.27706,-0.25736,1,0
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,3.9422e-06,-0.27756,-0.31173,1,0
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.00076864,-0.27777,-0.3447,1,0
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0028457,-0.27889,-0.38801,1,0
1,GO REGULATION OF T CELL CHEMOTAXIS,0.035953,-0.27911,-0.42201,1,0
1,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.008797,-0.27951,-0.33622,1,0
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00045436,-0.27971,-0.37826,1,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.0014241,-0.27986,-0.30265,1,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,1.9888e-05,-0.2813,-0.31949,1,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,1.6059e-05,-0.28131,-0.32141,1,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,3.0304e-05,-0.28148,-0.31254,1,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00054254,-0.28159,-0.35654,1,0
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00019306,-0.28324,-0.31,1,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0031545,-0.2833,-0.41581,1,0
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,5.2428e-05,-0.28338,-0.35677,1,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.0024341,-0.28431,-0.34714,1,0
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,1.7249e-05,-0.28455,-0.32606,1,0
1,GO T CELL MEDIATED IMMUNITY,0.0029965,-0.28479,-0.46114,1,0
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,2.8267e-05,-0.28563,-0.2986,1,0
1,GO RESPONSE TO FOOD,0.0015882,-0.28767,-0.29393,1,0
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0034935,-0.28774,-0.28514,1,0
1,GO LIPOXYGENASE PATHWAY,0.037377,-0.28809,-0.24242,1,0
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,3.7287e-05,-0.28822,-0.3587,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.016475,-0.28859,-0.43926,1,0
1,GO PROTEIN NITROSYLATION,0.00015974,-0.29027,-0.36411,1,0
1,GO RESPONSE TO INSECTICIDE,0.0057394,-0.29186,-0.35847,1,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00014989,-0.29241,-0.31148,1,0
1,GO TONGUE DEVELOPMENT,3.0304e-05,-0.29303,-0.39362,1,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.00014989,-0.29319,-0.36342,1,0
1,GO TOLERANCE INDUCTION,0.028348,-0.29431,-0.59652,1,0
1,GO RETINA HOMEOSTASIS,8.9843e-06,-0.2944,-0.34083,1,0
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.00029789,-0.29469,-0.32294,1,0
1,GO TRNA METHYLATION,1.4947e-05,-0.29579,-0.37679,1,0
1,GO TRANSLESION SYNTHESIS,2.636e-05,-0.2963,-0.36879,1,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,1.8524e-05,-0.29659,-0.32641,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.013834,-0.29692,-0.38915,1,0
1,GO ETHANOL METABOLIC PROCESS,0.00064645,-0.29697,-0.4246,1,0
1,GO ZINC ION HOMEOSTASIS,0.00081392,-0.29785,-0.35162,1,0
1,GO INTERLEUKIN 5 PRODUCTION,0.030713,-0.29833,-0.36032,1,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.011574,-0.29854,-0.23408,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,7.1973e-06,-0.29862,-0.32719,1,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.9985e-05,-0.29954,-0.3866,1,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,9.5377e-05,-0.29991,-0.33895,1,0
1,GO V D J RECOMBINATION,0.0003797,-0.30029,-0.34628,1,0
1,GO PHOTOTRANSDUCTION,6.2007e-06,-0.30095,-0.36511,1,0
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00014989,-0.30105,-0.38457,1,0
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.2035e-05,-0.30132,-0.35594,1,0
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.008797,-0.3014,-0.32312,1,0
1,GO GTP METABOLIC PROCESS,2.636e-05,-0.30158,-0.33965,1,0
1,GO REGULATION OF FEEDING BEHAVIOR,3.0304e-05,-0.30161,-0.33911,1,0
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,8.3461e-06,-0.30164,-0.35094,1,0
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,5.2428e-05,-0.30205,-0.39721,1,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,0.0015041,-0.30218,-0.40673,1,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,0.0066311,-0.30271,-0.42264,1,0
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,2.2907e-05,-0.30271,-0.37732,1,0
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.00013188,-0.3033,-0.38314,1,0
1,GO NUCLEOSOME ASSEMBLY,0.00018128,-0.30362,-0.35081,1,0
1,GO DETOXIFICATION,0.00018128,-0.30406,-0.299,1,0
1,GO POSITIVE REGULATION OF CELL AGING,0.0010209,-0.30406,-0.26193,1,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0049572,-0.30478,-0.36307,1,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.0015882,-0.30482,-0.31895,1,0
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,1.6059e-05,-0.3049,-0.41916,1,0
1,GO POSITIVE REGULATION OF CELL KILLING,0.024086,-0.30519,-0.41368,1,0
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,2.1347e-05,-0.30541,-0.39477,1,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.0034935,-0.30624,-0.2996,1,0
1,GO CELL KILLING,0.0092139,-0.30627,-0.39062,1,0
1,GO HEPATOCYTE DIFFERENTIATION,0.0016767,-0.30641,-0.32462,1,0
1,GO NUCLEOSIDE METABOLIC PROCESS,1.2939e-05,-0.3065,-0.33117,1,0
1,GO SNRNA PROCESSING,0.00010866,-0.30675,-0.33894,1,0
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,3.4805e-05,-0.30677,-0.32641,1,0
1,GO CELLULAR AMIDE METABOLIC PROCESS,5.337e-06,-0.30725,-0.32705,1,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.0040644,-0.30754,-0.45607,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00035748,-0.30916,-0.30325,1,0
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00051151,-0.30918,-0.35698,1,0
1,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.00017019,-0.30931,-0.41428,1,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.0012071,-0.30958,-0.30874,1,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,7.1973e-06,-0.30993,-0.36044,1,0
1,GO OPSONIZATION,0.0029965,-0.31029,-0.47286,1,0
1,GO EMBRYONIC AXIS SPECIFICATION,1.7249e-05,-0.31032,-0.3827,1,0
1,GO NUCLEOSIDE CATABOLIC PROCESS,0.0012071,-0.3105,-0.33949,1,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,7.8298e-05,-0.31152,-0.36022,1,0
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,7.7514e-06,-0.31162,-0.38194,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.012106,-0.3118,-0.49125,1,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0029965,-0.31193,-0.35518,1,0
1,GO NUCLEOTIDE EXCISION REPAIR,1.3909e-05,-0.31241,-0.37956,1,0
1,GO PEPTIDYL ARGININE MODIFICATION,0.00015974,-0.31272,-0.3012,1,0
1,GO INTERLEUKIN 17 PRODUCTION,0.0027019,-0.31279,-0.51519,1,0
1,GO DNA REPLICATION INITIATION,0.00010181,-0.3131,-0.35462,1,0
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,1.4947e-05,-0.3133,-0.33654,1,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0015041,-0.31334,-0.26736,1,0
1,GO GLYCOSIDE METABOLIC PROCESS,0.00068502,-0.31409,-0.32103,1,0
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,6.8565e-05,-0.31412,-0.33839,1,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0016767,-0.31424,-0.36661,1,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,5.2428e-05,-0.31439,-0.36683,1,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,3.4805e-05,-0.31518,-0.30851,1,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.016475,-0.31535,-0.52249,1,0
1,GO PEROXISOME ORGANIZATION,1.2035e-05,-0.31553,-0.35708,1,0
1,GO MUSCLE FILAMENT SLIDING,0.00013188,-0.31606,-0.31922,1,0
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.00072571,-0.31646,-0.3757,1,0
1,GO DRUG METABOLIC PROCESS,1.2939e-05,-0.31709,-0.35625,1,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,7.7514e-06,-0.31715,-0.36213,1,0
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00014989,-0.31729,-0.38656,1,0
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.0304e-05,-0.31746,-0.42058,1,0
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,1.7249e-05,-0.31781,-0.41113,1,0
1,GO POLYAMINE METABOLIC PROCESS,3.7287e-05,-0.3183,-0.34729,1,0
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0031545,-0.3183,-0.29002,1,0
1,GO RESPONSE TO INTERLEUKIN 12,2.636e-05,-0.31837,-0.38107,1,0
1,GO SALIVA SECRETION,0.0083971,-0.31843,-0.2839,1,0
1,GO FEAR RESPONSE,4.2763e-05,-0.31859,-0.38619,1,0
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.006955,-0.31875,-0.4838,1,0
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.00091199,-0.3191,-0.37255,1,0
1,GO CELL CELL RECOGNITION,0.00024771,-0.31938,-0.33087,1,0
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,4.5779e-05,-0.31946,-0.36359,1,0
1,GO SKELETAL MUSCLE TISSUE REGENERATION,3.7287e-05,-0.3195,-0.44435,1,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.010101,-0.31957,-0.42088,1,0
1,GO NEPHRON TUBULE FORMATION,0.0019699,-0.31962,-0.29391,1,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,7.8298e-05,-0.3199,-0.3935,1,0
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.034576,-0.32003,-0.41395,1,0
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0096484,-0.3205,-0.49155,1,0
1,GO TONIC SMOOTH MUSCLE CONTRACTION,0.00054254,-0.32057,-0.42012,1,0
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,1.2035e-05,-0.32072,-0.39495,1,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,6.4139e-05,-0.32093,-0.38729,1,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.0020776,-0.32127,-0.28937,1,0
1,GO RNA INTERFERENCE,8.3641e-05,-0.32127,-0.38621,1,0
1,GO REGULATION OF CELL KILLING,0.0076456,-0.32146,-0.47641,1,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.0011418,-0.32238,-0.30897,1,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0020776,-0.32242,-0.40124,1,0
1,GO REGULATION OF CHROMOSOME SEPARATION,4.2763e-05,-0.32247,-0.41249,1,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00035748,-0.32258,-0.33517,1,0
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,8.3641e-05,-0.32269,-0.39266,1,0
1,GO NEURON FATE SPECIFICATION,0.024086,-0.32286,-0.40068,1,0
1,GO ALPHA BETA T CELL PROLIFERATION,0.011063,-0.32291,-0.53409,1,0
1,GO CELLULAR OXIDANT DETOXIFICATION,0.00013188,-0.32349,-0.31621,1,0
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,3.0304e-05,-0.32421,-0.28963,1,0
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.015104,-0.32464,-0.38542,1,0
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.01266,-0.32471,-0.50877,1,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.00014062,-0.32475,-0.38597,1,0
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,1.2035e-05,-0.32486,-0.409,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0020776,-0.32514,-0.39607,1,0
1,GO INTERLEUKIN 4 PRODUCTION,0.010572,-0.32557,-0.49188,1,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,1.2035e-05,-0.32619,-0.38769,1,0
1,GO ACROSOME REACTION,0.00072571,-0.32626,-0.39221,1,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.00019306,-0.32648,-0.39053,1,0
1,GO RESPONSE TO ZINC ION,5.6086e-05,-0.32697,-0.37224,1,0
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.00014062,-0.32747,-0.40255,1,0
1,GO NADPH REGENERATION,2.8267e-05,-0.32784,-0.43045,1,0
1,GO ESTROGEN METABOLIC PROCESS,2.4576e-05,-0.32821,-0.33307,1,0
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,1.2035e-05,-0.32884,-0.33219,1,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.034576,-0.32954,-0.41112,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00081392,-0.32959,-0.39104,1,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.00042807,-0.32997,-0.43005,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,1.7249e-05,-0.33003,-0.34675,1,0
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00017019,-0.33032,-0.32475,1,0
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00013188,-0.33036,-0.36111,1,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00040321,-0.33114,-0.30785,1,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,0.00035748,-0.33166,-0.36309,1,0
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0052065,-0.33195,-0.51967,1,0
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00024771,-0.33214,-0.40754,1,0
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,2.8267e-05,-0.3324,-0.40502,1,0
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0042727,-0.33241,-0.37554,1,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,4.2763e-05,-0.33284,-0.37448,1,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,4.2763e-05,-0.33385,-0.34552,1,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.00048214,-0.33387,-0.30694,1,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,6.8565e-05,-0.33389,-0.39137,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.006955,-0.3342,-0.4165,1,0
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,7.7514e-06,-0.33445,-0.3688,1,0
1,GO TRICARBOXYLIC ACID CYCLE,1.7249e-05,-0.33456,-0.38528,1,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,1.0403e-05,-0.33485,-0.37443,1,0
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,7.1973e-06,-0.33502,-0.42991,1,0
1,GO REGULATION OF TOLERANCE INDUCTION,0.030713,-0.3351,-0.58081,1,0
1,GO IMMUNE RESPONSE TO TUMOR CELL,0.0042727,-0.33539,-0.45644,1,0
1,GO PROTEIN ADP RIBOSYLATION,3.248e-05,-0.33572,-0.47808,1,0
1,GO PEROXISOMAL TRANSPORT,1.7249e-05,-0.33576,-0.35407,1,0
1,GO MITOCHONDRION ORGANIZATION,6.2007e-06,-0.3359,-0.37988,1,0
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00026348,-0.33596,-0.44702,1,0
1,GO MITOCHONDRIAL TRANSPORT,2.8267e-05,-0.3365,-0.37365,1,0
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,5.6086e-05,-0.33691,-0.31083,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,5.7533e-06,-0.33714,-0.43582,1,0
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,2.8267e-05,-0.33739,-0.44368,1,0
1,GO GERM CELL DEVELOPMENT,2.1347e-05,-0.33791,-0.38813,1,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,1.2939e-05,-0.3384,-0.3532,1,0
1,GO T CELL CYTOKINE PRODUCTION,0.0015041,-0.33847,-0.51844,1,0
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.012106,-0.33918,-0.38848,1,0
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.028348,-0.33992,-0.47895,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,5.9985e-05,-0.34069,-0.53388,1,0
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,1.0403e-05,-0.34072,-0.41273,1,0
1,GO PLASMA MEMBRANE FUSION,0.00026348,-0.34114,-0.36848,1,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,6.4139e-05,-0.34126,-0.33698,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.007293,-0.34132,-0.3497,1,0
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.016475,-0.34136,-0.34028,1,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.0015041,-0.34161,-0.33035,1,0
1,GO DETECTION OF LIGHT STIMULUS,5.337e-06,-0.34171,-0.37878,1,0
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.00068502,-0.34178,-0.39438,1,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.00045436,-0.34184,-0.39119,1,0
1,GO SPERMATID DIFFERENTIATION,3.4805e-05,-0.34197,-0.37131,1,0
1,GO INTERFERON GAMMA PRODUCTION,0.0052065,-0.34218,-0.51221,1,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.00045436,-0.34232,-0.4799,1,0
1,GO RESPONSE TO INTERFERON BETA,0.010101,-0.34238,-0.50761,1,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0025648,-0.3428,-0.35355,1,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,4.2763e-05,-0.34321,-0.38954,1,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,8.3461e-06,-0.34324,-0.38469,1,0
1,GO RESPONSE TO UV C,2.636e-05,-0.34412,-0.48307,1,0
1,GO INTERLEUKIN 13 PRODUCTION,0.013834,-0.34434,-0.45021,1,0
1,GO CELLULAR HORMONE METABOLIC PROCESS,5.9985e-05,-0.34458,-0.33778,1,0
1,GO SPERM CAPACITATION,0.0083971,-0.34514,-0.2401,1,0
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.00072571,-0.34539,-0.28989,1,0
1,GO BICARBONATE TRANSPORT,0.00015974,-0.34548,-0.37364,1,0
1,GO FEEDING BEHAVIOR,0.00018128,-0.34549,-0.3916,1,0
1,GO PREPULSE INHIBITION,0.0047188,-0.34559,-0.47726,1,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,1.7249e-05,-0.34643,-0.40406,1,0
1,GO PEPTIDYL ARGININE METHYLATION,5.2428e-05,-0.34668,-0.39786,1,0
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,6.4139e-05,-0.34715,-0.3574,1,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.030713,-0.34729,-0.5568,1,0
1,GO PH REDUCTION,8.3461e-06,-0.34752,-0.41937,1,0
1,GO NODAL SIGNALING PATHWAY,0.00054254,-0.34773,-0.3031,1,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00035748,-0.34816,-0.36574,1,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,3.248e-05,-0.34827,-0.38165,1,0
1,GO VIRAL TRANSLATION,3.7287e-05,-0.34827,-0.36515,1,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00029789,-0.3486,-0.45063,1,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,2.4576e-05,-0.34863,-0.38298,1,0
1,GO LIPID DIGESTION,0.030713,-0.34867,-0.29197,1,0
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.1191e-05,-0.34888,-0.36753,1,0
1,GO SECRETION BY TISSUE,9.5377e-05,-0.34892,-0.34119,1,0
1,GO TERPENOID METABOLIC PROCESS,5.6086e-05,-0.349,-0.36531,1,0
1,GO DENTATE GYRUS DEVELOPMENT,5.9985e-05,-0.35001,-0.39575,1,0
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0063209,-0.35021,-0.44861,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0016767,-0.35049,-0.38697,1,0
1,GO DETECTION OF VISIBLE LIGHT,4.5891e-06,-0.35065,-0.37957,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0052065,-0.35131,-0.42737,1,0
1,GO REGULATION OF BEHAVIOR,7.7514e-06,-0.35166,-0.43407,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,7.8298e-05,-0.35172,-0.38941,1,0
1,GO GLUTATHIONE METABOLIC PROCESS,5.2428e-05,-0.35247,-0.3332,1,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,5.6086e-05,-0.35259,-0.35656,1,0
1,GO EPOXYGENASE P450 PATHWAY,0.019548,-0.35275,-0.22756,1,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.00017019,-0.35314,-0.43649,1,0
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00035748,-0.3534,-0.50582,1,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.00332,-0.35344,-0.33007,1,0
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.00011593,-0.35345,-0.37671,1,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,2.636e-05,-0.35384,-0.49268,1,0
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.00029789,-0.35393,-0.39882,1,0
1,GO INTERLEUKIN 10 PRODUCTION,0.0076456,-0.35417,-0.52957,1,0
1,GO MUSCLE CELL FATE COMMITMENT,0.00010181,-0.35432,-0.40095,1,0
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0019699,-0.35478,-0.62401,1,0
1,GO ISOPRENOID METABOLIC PROCESS,5.9985e-05,-0.35519,-0.3489,1,0
1,GO INTERSTRAND CROSS LINK REPAIR,3.248e-05,-0.35519,-0.41836,1,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.00096503,-0.35578,-0.41804,1,0
1,GO ETHANOL OXIDATION,0.0057394,-0.35595,-0.45123,1,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.00014062,-0.35649,-0.46385,1,0
1,GO MACROPHAGE APOPTOTIC PROCESS,0.012106,-0.35664,-0.3107,1,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,3.7287e-05,-0.35735,-0.39331,1,0
1,GO AMINE METABOLIC PROCESS,2.1347e-05,-0.3574,-0.34564,1,0
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,1.1191e-05,-0.35766,-0.40182,1,0
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00013188,-0.35794,-0.50076,1,0
1,GO CHROMATIN SILENCING AT TELOMERE,0.00021879,-0.35811,-0.3742,1,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,5.6086e-05,-0.35813,-0.427,1,0
1,GO CELL CYCLE G2 M PHASE TRANSITION,9.6689e-06,-0.35856,-0.43054,1,0
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,3.7287e-05,-0.35921,-0.40544,1,0
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,6.6813e-06,-0.35923,-0.39922,1,0
1,GO KERATINOCYTE DIFFERENTIATION,0.00024771,-0.35984,-0.35907,1,0
1,GO HEART FIELD SPECIFICATION,0.00028019,-0.36004,-0.48913,1,0
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,7.3279e-05,-0.36022,-0.4398,1,0
1,GO SLEEP,3.9936e-05,-0.36027,-0.38682,1,0
1,GO ONE CARBON METABOLIC PROCESS,1.4947e-05,-0.36028,-0.37221,1,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0038653,-0.36034,-0.33176,1,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00068502,-0.36041,-0.46465,1,0
1,GO GLUTAMATE METABOLIC PROCESS,0.00011593,-0.36043,-0.40294,1,0
1,GO TRANSCRIPTION BY RNA POLYMERASE III,6.2007e-06,-0.36051,-0.41663,1,0
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0025648,-0.36112,-0.42759,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0047188,-0.36122,-0.56955,1,0
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,7.1973e-06,-0.36129,-0.42875,1,0
1,GO PROSTATE GLAND GROWTH,0.00086166,-0.36147,-0.2998,1,0
1,GO REGULATION OF ACROSOME REACTION,0.013235,-0.36154,-0.30387,1,0
1,GO NEGATIVE REGULATION OF DNA BINDING,1.2939e-05,-0.36183,-0.43581,1,0
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,8.3461e-06,-0.36206,-0.36797,1,0
1,GO EXPLORATION BEHAVIOR,0.00014989,-0.36227,-0.45627,1,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,9.5377e-05,-0.36291,-0.42508,1,0
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,4.2763e-05,-0.36332,-0.35725,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00026348,-0.36351,-0.34703,1,0
1,GO DNA PACKAGING,2.636e-05,-0.36371,-0.44455,1,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.00014989,-0.36388,-0.41586,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0057394,-0.36397,-0.4751,1,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00068502,-0.36479,-0.40255,1,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,7.7514e-06,-0.36485,-0.39618,1,0
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0076456,-0.36514,-0.50503,1,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,7.8298e-05,-0.36529,-0.34224,1,0
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0063209,-0.36555,-0.45748,1,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,2.1347e-05,-0.36607,-0.46071,1,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0042727,-0.36616,-0.4624,1,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,4.5779e-05,-0.36674,-0.42267,1,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0054671,-0.36679,-0.41305,1,0
1,GO PROTEIN LOCALIZATION TO ORGANELLE,4.5891e-06,-0.36711,-0.41511,1,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,4.8997e-05,-0.36741,-0.41386,1,0
1,GO NEURAL NUCLEUS DEVELOPMENT,7.8298e-05,-0.36749,-0.476,1,0
1,GO ICOSANOID METABOLIC PROCESS,9.5377e-05,-0.36757,-0.40373,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.012106,-0.36768,-0.64459,1,0
1,GO T CELL CHEMOTAXIS,0.019548,-0.36802,-0.51976,1,0
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0017696,-0.36819,-0.40656,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0027019,-0.36847,-0.55638,1,0
1,GO CELLULAR KETONE METABOLIC PROCESS,7.1973e-06,-0.36891,-0.39873,1,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,1.7249e-05,-0.36894,-0.53413,1,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,4.9495e-06,-0.369,-0.40758,1,0
1,GO ACID SECRETION,0.00028019,-0.36902,-0.35197,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0052065,-0.36923,-0.39092,1,0
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.012106,-0.36931,-0.47086,1,0
1,GO REGULATION OF RNA BINDING,9.6689e-06,-0.36951,-0.42679,1,0
1,GO PROTEIN AUTOPROCESSING,0.00057531,-0.36952,-0.34206,1,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.013235,-0.36977,-0.45085,1,0
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1.8524e-05,-0.37035,-0.41575,1,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,4.9495e-06,-0.37036,-0.41549,1,0
1,GO SINGLE FERTILIZATION,4.2763e-05,-0.37039,-0.35221,1,0
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,8.9843e-06,-0.37058,-0.37895,1,0
1,GO T CELL APOPTOTIC PROCESS,0.0015882,-0.37067,-0.47587,1,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,2.8267e-05,-0.37069,-0.4134,1,0
1,GO NUCLEOTIDE SALVAGE,0.00014062,-0.37075,-0.35987,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,9.6689e-06,-0.37105,-0.34614,1,0
1,GO INNATE IMMUNE RESPONSE,0.00019306,-0.37141,-0.50842,1,0
1,GO RESPONSE TO L GLUTAMATE,2.2907e-05,-0.3717,-0.43408,1,0
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0023095,-0.37193,-0.49405,1,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,5.2428e-05,-0.37194,-0.39679,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.010101,-0.37197,-0.49429,1,0
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,4.5891e-06,-0.37205,-0.45933,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.011063,-0.37212,-0.48671,1,0
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0076456,-0.37225,-0.53061,1,0
1,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.0049572,-0.37243,-0.58166,1,0
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,5.9985e-05,-0.37253,-0.42162,1,0
1,GO AMINO SUGAR CATABOLIC PROCESS,0.0029965,-0.37254,-0.48824,1,0
1,GO CILIUM MOVEMENT,0.00018128,-0.37262,-0.36615,1,0
1,GO TISSUE REGENERATION,4.5779e-05,-0.37289,-0.43147,1,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00020554,-0.37297,-0.40352,1,0
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0172,-0.37334,-0.48671,1,0
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,4.9495e-06,-0.37346,-0.38607,1,0
1,GO SPERM MOTILITY,6.8565e-05,-0.3735,-0.35948,1,0
1,GO MITOCHONDRION MORPHOGENESIS,9.6689e-06,-0.37353,-0.40368,1,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.7287e-05,-0.37353,-0.40213,1,0
1,GO NUCLEOSOME ORGANIZATION,2.4576e-05,-0.37405,-0.415,1,0
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00031664,-0.37418,-0.49875,1,0
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00011593,-0.37421,-0.36519,1,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,1.7249e-05,-0.37453,-0.41025,1,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,1.8524e-05,-0.37466,-0.41693,1,0
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0042727,-0.37551,-0.39797,1,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00060992,-0.37568,-0.37508,1,0
1,GO ACUTE PHASE RESPONSE,0.00028019,-0.37615,-0.46752,1,0
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,2.1347e-05,-0.37617,-0.40299,1,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,7.3279e-05,-0.37617,-0.45359,1,0
1,GO RESPONSE TO COPPER ION,0.0012758,-0.37642,-0.35765,1,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,1.2035e-05,-0.37645,-0.41687,1,0
1,GO REGULATION OF DNA CATABOLIC PROCESS,1.2035e-05,-0.37658,-0.40595,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,3.7287e-05,-0.37659,-0.40218,1,0
1,GO RESPONSE TO TOXIC SUBSTANCE,9.6689e-06,-0.37694,-0.39167,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.00013188,-0.37698,-0.39517,1,0
1,GO HEME METABOLIC PROCESS,1.9888e-05,-0.37743,-0.4124,1,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,3.7287e-05,-0.3776,-0.37713,1,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,8.9843e-06,-0.3776,-0.41053,1,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,4.9495e-06,-0.37788,-0.39521,1,0
1,GO REGULATION OF ATPASE ACTIVITY,8.9843e-06,-0.37803,-0.3707,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.8565e-05,-0.37803,-0.44205,1,0
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,5.337e-06,-0.37816,-0.42397,1,0
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,1.4947e-05,-0.37816,-0.44866,1,0
1,GO REGULATION OF OOGENESIS,7.1973e-06,-0.37819,-0.45551,1,0
1,GO ETHANOL CATABOLIC PROCESS,0.00035748,-0.3783,-0.40222,1,0
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,3.9422e-06,-0.37844,-0.48297,1,0
1,GO SECONDARY METABOLIC PROCESS,4.8997e-05,-0.37874,-0.36691,1,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0015041,-0.37883,-0.50421,1,0
1,GO MALE GAMETE GENERATION,1.0403e-05,-0.37905,-0.40582,1,0
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.00029789,-0.37912,-0.43238,1,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.00017019,-0.37939,-0.42218,1,0
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,1.3909e-05,-0.38012,-0.42362,1,0
1,GO OXIDATIVE DEMETHYLATION,2.1347e-05,-0.38015,-0.43979,1,0
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,7.3279e-05,-0.38017,-0.43019,1,0
1,GO RESPONSE TO INTERFERON GAMMA,0.0027019,-0.38038,-0.55562,1,0
1,GO PROSTANOID METABOLIC PROCESS,0.00021879,-0.38049,-0.43003,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0010798,-0.38059,-0.36809,1,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00023283,-0.38063,-0.45247,1,0
1,GO DIGESTION,4.8997e-05,-0.38095,-0.34738,1,0
1,GO NEUTROPHIL MIGRATION,0.007293,-0.3811,-0.47331,1,0
1,GO NCRNA TRANSCRIPTION,8.9843e-06,-0.38155,-0.4478,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0017696,-0.38169,-0.57069,1,0
1,GO EXTRACELLULAR VESICLE BIOGENESIS,1.4947e-05,-0.38174,-0.49031,1,0
1,GO FERTILIZATION,3.0304e-05,-0.38175,-0.36462,1,0
1,GO PROTEIN LOCALIZATION TO MEMBRANE,4.9495e-06,-0.38234,-0.39962,1,0
1,GO DETECTION OF STIMULUS,4.9495e-06,-0.38237,-0.38647,1,0
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,1.1191e-05,-0.3825,-0.4812,1,0
1,GO OXIDATION REDUCTION PROCESS,7.7514e-06,-0.38258,-0.38162,1,0
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0010209,-0.38267,-0.51167,1,0
1,GO RESPONSE TO MINERALOCORTICOID,2.636e-05,-0.38305,-0.47295,1,0
1,GO ALPHA AMINO ACID METABOLIC PROCESS,5.337e-06,-0.38326,-0.4097,1,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,6.6813e-06,-0.38341,-0.42705,1,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0013481,-0.38352,-0.43835,1,0
1,GO TETRAPYRROLE METABOLIC PROCESS,1.0403e-05,-0.38355,-0.41488,1,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.0015041,-0.38364,-0.31579,1,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,1.7249e-05,-0.38376,-0.41104,1,0
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,9.5377e-05,-0.38392,-0.46783,1,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,1.4947e-05,-0.38397,-0.46998,1,0
1,GO REGULATION OF STEM CELL DIFFERENTIATION,1.2035e-05,-0.38426,-0.40705,1,0
1,GO MYOBLAST MIGRATION,0.0017696,-0.38431,-0.36448,1,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,3.4805e-05,-0.38479,-0.36549,1,0
1,GO PYROPTOSIS,0.00064645,-0.38485,-0.39933,1,0
1,GO ACTIVATED T CELL PROLIFERATION,0.00019306,-0.38494,-0.51921,1,0
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00068502,-0.38528,-0.53619,1,0
1,GO INTRACILIARY TRANSPORT,0.00010181,-0.38621,-0.39397,1,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0019699,-0.38627,-0.39303,1,0
1,GO CHEMOSENSORY BEHAVIOR,3.7287e-05,-0.38658,-0.41131,1,0
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,6.4139e-05,-0.38683,-0.43214,1,0
1,GO FEMALE GAMETE GENERATION,5.7533e-06,-0.38713,-0.44649,1,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,9.6689e-06,-0.38719,-0.43126,1,0
1,GO REGULATION OF DOPAMINE SECRETION,0.0025648,-0.38725,-0.43877,1,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.00026348,-0.38742,-0.43827,1,0
1,GO APOPTOTIC DNA FRAGMENTATION,5.7533e-06,-0.38763,-0.41644,1,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,9.6689e-06,-0.38781,-0.43994,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.00013188,-0.38801,-0.5323,1,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,6.2007e-06,-0.3881,-0.41967,1,0
1,GO T CELL PROLIFERATION,0.00072571,-0.38815,-0.54601,1,0
1,GO DENDRITE SELF AVOIDANCE,9.5377e-05,-0.38838,-0.481,1,0
1,GO ATP TRANSPORT,3.248e-05,-0.3884,-0.46051,1,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,1.7249e-05,-0.38868,-0.37288,1,0
1,GO DEFENSE RESPONSE TO BACTERIUM,0.0016767,-0.38873,-0.40085,1,0
1,GO RESPONSE TO AMPHETAMINE,0.00068502,-0.38876,-0.3441,1,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,5.7533e-06,-0.38895,-0.44105,1,0
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.023112,-0.38895,-0.4707,1,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.9888e-05,-0.38933,-0.45017,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00026348,-0.38934,-0.56717,1,0
1,GO DNA DEPENDENT DNA REPLICATION,1.7249e-05,-0.38937,-0.44489,1,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.00028019,-0.38939,-0.40116,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0012758,-0.38963,-0.51046,1,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00021879,-0.38967,-0.42352,1,0
1,GO RESPONSE TO DIETARY EXCESS,0.00051151,-0.38972,-0.42733,1,0
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,5.2428e-05,-0.38973,-0.39097,1,0
1,GO HUMORAL IMMUNE RESPONSE,0.0066311,-0.38977,-0.41593,1,0
1,GO POSTSYNAPSE ASSEMBLY,0.0014241,-0.3901,-0.51484,1,0
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,5.337e-06,-0.3902,-0.40803,1,0
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00072571,-0.39042,-0.53728,1,0
1,GO NEURON FATE COMMITMENT,0.0019699,-0.39051,-0.43838,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00068502,-0.39066,-0.62557,1,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,2.8267e-05,-0.39066,-0.41721,1,0
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,1.4947e-05,-0.39072,-0.40525,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,1.3909e-05,-0.39102,-0.43197,1,0
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,5.2428e-05,-0.39127,-0.39728,1,0
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,1.1191e-05,-0.39148,-0.42303,1,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,3.9936e-05,-0.39152,-0.42302,1,0
1,GO MRNA SPLICE SITE SELECTION,9.5377e-05,-0.39167,-0.49535,1,0
1,GO RESPONSE TO BACTERIUM,0.00010181,-0.3917,-0.48839,1,0
1,GO FUCOSE METABOLIC PROCESS,1.2035e-05,-0.39184,-0.41599,1,0
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,3.4805e-05,-0.39229,-0.48248,1,0
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.00012367,-0.39252,-0.41041,1,0
1,GO SKELETAL MUSCLE CELL PROLIFERATION,2.636e-05,-0.39258,-0.42357,1,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,6.8565e-05,-0.39285,-0.45463,1,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,8.3641e-05,-0.39296,-0.41973,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00033648,-0.39307,-0.55211,1,0
1,GO CARDIOLIPIN METABOLIC PROCESS,7.1973e-06,-0.39308,-0.42995,1,0
1,GO INTRACELLULAR PROTEIN TRANSPORT,4.9495e-06,-0.3931,-0.42879,1,0
1,GO RESPONSE TO BIOTIC STIMULUS,3.9936e-05,-0.39337,-0.5004,1,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,2.8267e-05,-0.39351,-0.43032,1,0
1,GO INTERLEUKIN 1 PRODUCTION,0.00076864,-0.39352,-0.54078,1,0
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00332,-0.39355,-0.49468,1,0
1,GO TRANSPOSITION,6.4139e-05,-0.39357,-0.42021,1,0
1,GO RESPONSE TO CHEMOKINE,0.01266,-0.39432,-0.45102,1,0
1,GO RESPONSE TO FUNGUS,0.00064645,-0.3944,-0.3949,1,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,6.8565e-05,-0.39451,-0.42378,1,0
1,GO REGULATION OF T CELL MIGRATION,0.0017696,-0.39453,-0.51231,1,0
1,GO MANNOSYLATION,3.0304e-05,-0.39483,-0.44312,1,0
1,GO GENITALIA MORPHOGENESIS,0.00029789,-0.39488,-0.42234,1,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00011593,-0.39529,-0.38879,1,0
1,GO MITOTIC CELL CYCLE ARREST,6.8565e-05,-0.3956,-0.43306,1,0
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0083971,-0.39562,-0.46202,1,0
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,6.4139e-05,-0.39567,-0.43737,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00091199,-0.39586,-0.48157,1,0
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00064645,-0.39598,-0.58476,1,0
1,GO GLUTAMATE SECRETION,0.00031664,-0.39599,-0.50406,1,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,5.7533e-06,-0.39613,-0.42849,1,0
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0013481,-0.39639,-0.54422,1,0
1,GO ESTABLISHMENT OF TISSUE POLARITY,4.9495e-06,-0.39664,-0.46133,1,0
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00045436,-0.3967,-0.54257,1,0
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00076864,-0.39696,-0.5252,1,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,1.1191e-05,-0.39719,-0.45456,1,0
1,GO STEROID HORMONE SECRETION,0.00068502,-0.39726,-0.3819,1,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,1.0403e-05,-0.39766,-0.42131,1,0
1,GO LIPOPROTEIN METABOLIC PROCESS,9.6689e-06,-0.39766,-0.45237,1,0
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.00054254,-0.39801,-0.42952,1,0
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,9.6689e-06,-0.39812,-0.42924,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0014241,-0.39813,-0.55131,1,0
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00015974,-0.3992,-0.54841,1,0
1,GO REGULATION OF TRANSPOSITION,5.9985e-05,-0.39964,-0.44769,1,0
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,3.9422e-06,-0.39975,-0.40919,1,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,1.7249e-05,-0.39979,-0.45686,1,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,4.2763e-05,-0.40004,-0.43426,1,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0015882,-0.40049,-0.39693,1,0
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,3.9422e-06,-0.40063,-0.49138,1,0
1,GO RESPONSE TO CADMIUM ION,2.4576e-05,-0.40071,-0.43799,1,0
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,4.2763e-05,-0.40077,-0.37922,1,0
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00014062,-0.40083,-0.40548,1,0
1,GO REGULATION OF CHROMOSOME SEGREGATION,2.4576e-05,-0.40108,-0.46456,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,4.8997e-05,-0.40131,-0.49371,1,0
1,GO THYROID GLAND DEVELOPMENT,8.9327e-05,-0.40151,-0.53511,1,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,1.2035e-05,-0.40152,-0.43715,1,0
1,GO ZYMOGEN INHIBITION,0.0015041,-0.40153,-0.46746,1,0
1,GO SYMBIOTIC PROCESS,4.5891e-06,-0.40154,-0.42976,1,0
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00054254,-0.40169,-0.50767,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00054254,-0.40171,-0.53283,1,0
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00011593,-0.40177,-0.3437,1,0
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,5.6086e-05,-0.40227,-0.48549,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,3.9422e-06,-0.40249,-0.43435,1,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.00023283,-0.40267,-0.49168,1,0
1,GO RESPONSE TO INTERLEUKIN 1,3.0304e-05,-0.40277,-0.45259,1,0
1,GO RESPONSE TO VITAMIN A,7.7514e-06,-0.40287,-0.40551,1,0
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00017019,-0.40315,-0.54079,1,0
1,GO CELLULAR RESPONSE TO ALKALOID,1.0403e-05,-0.40317,-0.43316,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0013481,-0.4034,-0.4167,1,0
1,GO MYELOID LEUKOCYTE MIGRATION,0.00040321,-0.40343,-0.51978,1,0
1,GO VITAMIN METABOLIC PROCESS,7.1973e-06,-0.40368,-0.4214,1,0
1,GO NEURAL RETINA DEVELOPMENT,4.8997e-05,-0.40393,-0.45387,1,0
1,GO NUCLEOBASE METABOLIC PROCESS,6.2007e-06,-0.40396,-0.44128,1,0
1,GO ADHESION OF SYMBIONT TO HOST,0.0023095,-0.40427,-0.63493,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0015882,-0.40428,-0.48812,1,0
1,GO GAMETE GENERATION,7.1973e-06,-0.40429,-0.4313,1,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,3.0304e-05,-0.4043,-0.55139,1,0
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,6.2007e-06,-0.40438,-0.45418,1,0
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,3.7287e-05,-0.40452,-0.56866,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00020554,-0.40471,-0.43033,1,0
1,GO ETHER METABOLIC PROCESS,1.3909e-05,-0.40481,-0.46622,1,0
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,8.3461e-06,-0.40491,-0.44808,1,0
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00086166,-0.40507,-0.56682,1,0
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,7.8298e-05,-0.40527,-0.56745,1,0
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,6.2007e-06,-0.40537,-0.4585,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0096484,-0.40538,-0.46714,1,0
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00040321,-0.40539,-0.53892,1,0
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.00010866,-0.40545,-0.39289,1,0
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,5.337e-06,-0.40549,-0.44609,1,0
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.00014062,-0.40554,-0.43359,1,0
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,9.5377e-05,-0.40556,-0.43471,1,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,8.3641e-05,-0.40574,-0.4833,1,0
1,GO MITOTIC RECOMBINATION,1.3909e-05,-0.40585,-0.48526,1,0
1,GO NECROTIC CELL DEATH,4.2763e-05,-0.40589,-0.45886,1,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,2.2907e-05,-0.40595,-0.49857,1,0
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,7.7514e-06,-0.40623,-0.45555,1,0
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00021879,-0.40639,-0.47891,1,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.4064,-0.47516,1,0
1,GO PHAGOSOME ACIDIFICATION,2.1347e-05,-0.40674,-0.43621,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00072571,-0.40679,-0.55982,1,0
1,GO DENDRITIC CELL MIGRATION,0.0096484,-0.4068,-0.55608,1,0
1,GO HEART INDUCTION,0.0027019,-0.40699,-0.42013,1,0
1,GO LEUKOCYTE MEDIATED IMMUNITY,2.4576e-05,-0.40712,-0.53467,1,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,1.6059e-05,-0.40743,-0.50873,1,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,8.3641e-05,-0.40753,-0.424,1,0
1,GO FATTY ACID METABOLIC PROCESS,8.3461e-06,-0.40772,-0.42628,1,0
1,GO DEFENSE RESPONSE,3.248e-05,-0.40784,-0.52249,1,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0020776,-0.40818,-0.40233,1,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00013188,-0.40858,-0.39499,1,0
1,GO FAT CELL PROLIFERATION,0.00031664,-0.40869,-0.43542,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,7.8298e-05,-0.40892,-0.55238,1,0
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,1.6059e-05,-0.40892,-0.38473,1,0
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,2.4576e-05,-0.40905,-0.46091,1,0
1,GO REGULATION OF DENDRITE EXTENSION,0.00072571,-0.40929,-0.49668,1,0
1,GO REGULATION OF INNATE IMMUNE RESPONSE,8.3641e-05,-0.40935,-0.47235,1,0
1,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00057531,-0.40943,-0.54602,1,0
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,4.5891e-06,-0.40955,-0.44951,1,0
1,GO PROTEIN MANNOSYLATION,3.9936e-05,-0.40974,-0.46109,1,0
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00014062,-0.40975,-0.54891,1,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00015974,-0.40976,-0.49557,1,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,5.337e-06,-0.40982,-0.44419,1,0
1,GO SENSORY PERCEPTION,6.2007e-06,-0.41008,-0.40693,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0060238,-0.41014,-0.50312,1,0
1,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0024341,-0.41018,-0.46203,1,0
1,GO PIGMENT BIOSYNTHETIC PROCESS,4.9495e-06,-0.41019,-0.44328,1,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,1.2939e-05,-0.41021,-0.47407,1,0
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00040321,-0.41024,-0.54578,1,0
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00057531,-0.41029,-0.51239,1,0
1,GO CELLULAR DEFENSE RESPONSE,0.012106,-0.41071,-0.4818,1,0
1,GO DNA CONFORMATION CHANGE,1.1191e-05,-0.41072,-0.48005,1,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.00068502,-0.41081,-0.38692,1,0
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00015974,-0.41087,-0.57431,1,0
1,GO CYSTEINE METABOLIC PROCESS,5.9985e-05,-0.41117,-0.43172,1,0
1,GO NIK NF KAPPAB SIGNALING,1.9888e-05,-0.41134,-0.4674,1,0
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,2.1347e-05,-0.41134,-0.52664,1,0
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00017019,-0.41137,-0.59344,1,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,5.9985e-05,-0.41156,-0.3832,1,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,7.3279e-05,-0.41165,-0.41092,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00026348,-0.41174,-0.45938,1,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.0042727,-0.41181,-0.4654,1,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.5377e-05,-0.41189,-0.43726,1,0
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00017019,-0.41195,-0.5712,1,0
1,GO POSITIVE REGULATION OF TRANSLATION,3.9422e-06,-0.41207,-0.44604,1,0
1,GO PROTEIN FOLDING,8.3461e-06,-0.41225,-0.42729,1,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,3.4805e-05,-0.41241,-0.46499,1,0
1,GO GRANULOCYTE MIGRATION,0.0031545,-0.41255,-0.4952,1,0
1,GO HISTONE H2A UBIQUITINATION,8.9843e-06,-0.41256,-0.51194,1,0
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00091199,-0.41256,-0.4443,1,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00017019,-0.41266,-0.34838,1,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,2.8267e-05,-0.41276,-0.46598,1,0
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,5.337e-06,-0.41283,-0.44895,1,0
1,GO PROTEIN MONOUBIQUITINATION,8.3461e-06,-0.41287,-0.51087,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00042807,-0.41289,-0.5235,1,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,1.3909e-05,-0.41296,-0.42666,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0010209,-0.41297,-0.5223,1,0
1,GO ALPHA BETA T CELL ACTIVATION,0.00045436,-0.41306,-0.57732,1,0
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0012071,-0.41343,-0.58586,1,0
1,GO RESPONSE TO TUMOR CELL,0.00091199,-0.41345,-0.47349,1,0
1,GO T CELL TOLERANCE INDUCTION,0.031957,-0.41351,-0.57584,1,0
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.031957,-0.41366,-0.38576,1,0
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00018128,-0.41401,-0.55001,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,0.00042807,-0.41428,-0.42025,1,0
1,GO RESPONSE TO AMINE,0.00011593,-0.41431,-0.38598,1,0
1,GO IRON ION TRANSMEMBRANE TRANSPORT,1.7249e-05,-0.41448,-0.49319,1,0
1,GO MISMATCH REPAIR,1.0403e-05,-0.41448,-0.46808,1,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.01266,-0.41465,-0.6325,1,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,1.2035e-05,-0.41467,-0.43245,1,0
1,GO PHOTOPERIODISM,0.00013188,-0.4148,-0.41448,1,0
1,GO AXONEME ASSEMBLY,0.0029965,-0.41486,-0.34475,1,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,1.1191e-05,-0.41514,-0.44039,1,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,1.6059e-05,-0.41526,-0.40528,1,0
1,GO REGULATION OF MULTI ORGANISM PROCESS,6.6813e-06,-0.4153,-0.42309,1,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.00035748,-0.41553,-0.4295,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029789,-0.41579,-0.53703,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00076864,-0.41584,-0.43993,1,0
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0034935,-0.41596,-0.51701,1,0
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,8.3461e-06,-0.41614,-0.43979,1,0
1,GO GLYCEROL ETHER METABOLIC PROCESS,6.2007e-06,-0.41631,-0.48634,1,0
1,GO ORGANIC ACID CATABOLIC PROCESS,6.6813e-06,-0.41652,-0.43206,1,0
1,GO REGULATION OF T CELL ACTIVATION,0.00020554,-0.41662,-0.56118,1,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.050584,-0.41673,-0.29235,1,0
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,4.5891e-06,-0.41688,-0.44275,1,0
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,5.2428e-05,-0.41704,-0.53965,1,0
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00076864,-0.41742,-0.55635,1,0
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00048214,-0.41758,-0.48003,1,0
1,GO NEURON CELL CELL ADHESION,0.011063,-0.41764,-0.39659,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,3.4805e-05,-0.4177,-0.54737,1,0
1,GO INTERLEUKIN 2 PRODUCTION,0.00057531,-0.41777,-0.59648,1,0
1,GO TRANSITION METAL ION TRANSPORT,6.2007e-06,-0.41783,-0.4402,1,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,2.636e-05,-0.4179,-0.47287,1,0
1,GO SEXUAL REPRODUCTION,7.1973e-06,-0.41792,-0.42704,1,0
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,1.3909e-05,-0.418,-0.41232,1,0
1,GO ACUTE INFLAMMATORY RESPONSE,0.00015974,-0.41801,-0.47518,1,0
1,GO METHYLATION,4.5891e-06,-0.4181,-0.47183,1,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,9.5377e-05,-0.4185,-0.45419,1,0
1,GO ORGAN INDUCTION,4.5779e-05,-0.41868,-0.3956,1,0
1,GO T CELL SELECTION,0.0012758,-0.41876,-0.57554,1,0
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.4947e-05,-0.41917,-0.55051,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,7.7514e-06,-0.41938,-0.49111,1,0
1,GO EPIDERMAL CELL DIFFERENTIATION,4.8997e-05,-0.41944,-0.40903,1,0
1,GO ETHER BIOSYNTHETIC PROCESS,4.8997e-05,-0.41946,-0.50296,1,0
1,GO SMALL MOLECULE CATABOLIC PROCESS,6.6813e-06,-0.41946,-0.43639,1,0
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,6.6813e-06,-0.41947,-0.45158,1,0
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,5.2428e-05,-0.41969,-0.53531,1,0
1,GO HISTONE H2A ACETYLATION,8.3461e-06,-0.41975,-0.46858,1,0
1,GO RESPONSE TO PROTOZOAN,0.0063209,-0.41976,-0.53624,1,0
1,GO TRANSITION METAL ION HOMEOSTASIS,1.0403e-05,-0.41984,-0.43125,1,0
1,GO RECOMBINATIONAL REPAIR,1.4947e-05,-0.41986,-0.50844,1,0
1,GO REGULATION OF HISTONE UBIQUITINATION,5.7533e-06,-0.4199,-0.50019,1,0
1,GO DENDRITIC CELL CHEMOTAXIS,0.012106,-0.41998,-0.54692,1,0
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,2.4576e-05,-0.42012,-0.43074,1,0
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00010866,-0.42056,-0.57935,1,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,2.4576e-05,-0.4207,-0.50153,1,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,5.7533e-06,-0.42134,-0.4444,1,0
1,GO EPIDERMIS DEVELOPMENT,1.7249e-05,-0.42138,-0.45401,1,0
1,GO MONOSACCHARIDE CATABOLIC PROCESS,2.636e-05,-0.42144,-0.45308,1,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,4.5779e-05,-0.42161,-0.40166,1,0
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,1.2035e-05,-0.42168,-0.46606,1,0
1,GO MYELOID LEUKOCYTE ACTIVATION,1.9888e-05,-0.4219,-0.54177,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00048214,-0.42208,-0.52683,1,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0016767,-0.42221,-0.46927,1,0
1,GO LINOLEIC ACID METABOLIC PROCESS,7.8298e-05,-0.42252,-0.46842,1,0
1,GO POTASSIUM ION HOMEOSTASIS,7.1973e-06,-0.42269,-0.50196,1,0
1,GO NEUTROPHIL CHEMOTAXIS,0.0092139,-0.42274,-0.47787,1,0
1,GO REGULATION OF MRNA METABOLIC PROCESS,6.2007e-06,-0.4231,-0.46143,1,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.00013188,-0.42314,-0.45479,1,0
1,GO HORMONE METABOLIC PROCESS,5.2428e-05,-0.42335,-0.38319,1,0
1,GO THALAMUS DEVELOPMENT,0.0016767,-0.42341,-0.42306,1,0
1,GO INTERLEUKIN 1 BETA PRODUCTION,0.00048214,-0.42356,-0.57127,1,0
1,GO SYNAPTIC VESICLE TRANSPORT,8.3641e-05,-0.42371,-0.53062,1,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,3.4805e-05,-0.42395,-0.43179,1,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,1.9888e-05,-0.42399,-0.48787,1,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,7.1973e-06,-0.42417,-0.5011,1,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00018128,-0.42431,-0.43153,1,0
1,GO REGULATION OF DEFENSE RESPONSE,1.8524e-05,-0.42437,-0.50828,1,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00021879,-0.42438,-0.39432,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00042807,-0.42452,-0.4688,1,0
1,GO DOPAMINE METABOLIC PROCESS,7.8298e-05,-0.42473,-0.47076,1,0
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00091199,-0.42474,-0.55289,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00017019,-0.42477,-0.57082,1,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,6.2007e-06,-0.42481,-0.45398,1,0
1,GO RESPONSE TO INTERLEUKIN 18,0.00332,-0.42494,-0.58371,1,0
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.4947e-05,-0.42496,-0.4744,1,0
1,GO EMBRYONIC PATTERN SPECIFICATION,6.2007e-06,-0.42498,-0.46489,1,0
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00045436,-0.42498,-0.56118,1,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00040321,-0.42518,-0.57502,1,0
1,GO REGULATION OF STEROL TRANSPORT,1.7249e-05,-0.42518,-0.50818,1,0
1,GO BRAIN MORPHOGENESIS,1.3909e-05,-0.42534,-0.51274,1,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,6.6813e-06,-0.42535,-0.46502,1,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0011418,-0.4256,-0.4789,1,0
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00028019,-0.4257,-0.5097,1,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,6.2007e-06,-0.42588,-0.51243,1,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00021879,-0.42594,-0.48245,1,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0012758,-0.42601,-0.44085,1,0
1,GO MYOTUBE CELL DEVELOPMENT,8.9843e-06,-0.42614,-0.43854,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,3.0304e-05,-0.42618,-0.45559,1,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0024341,-0.42621,-0.56097,1,0
1,GO TONGUE MORPHOGENESIS,0.00081392,-0.42631,-0.36498,1,0
1,GO LEUKOCYTE PROLIFERATION,0.00033648,-0.42651,-0.56049,1,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.2539e-06,-0.42656,-0.4648,1,0
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,3.248e-05,-0.4266,-0.50898,1,0
1,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.034576,-0.42686,-0.63935,1,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00051151,-0.42688,-0.47892,1,0
1,GO PIGMENT METABOLIC PROCESS,7.1973e-06,-0.4269,-0.43517,1,0
1,GO MRNA MODIFICATION,3.4805e-05,-0.42698,-0.43874,1,0
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.00068502,-0.42699,-0.46859,1,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.00033648,-0.42701,-0.49497,1,0
1,GO SUPEROXIDE METABOLIC PROCESS,2.2907e-05,-0.42702,-0.52172,1,0
1,GO REGULATION OF MRNA CATABOLIC PROCESS,4.5891e-06,-0.42714,-0.44969,1,0
1,GO PRESYNAPSE ORGANIZATION,7.8298e-05,-0.42735,-0.50025,1,0
1,GO DOPAMINE TRANSPORT,0.0017696,-0.42738,-0.44257,1,0
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.4274,-0.48522,1,0
1,GO FRUCTOSE METABOLIC PROCESS,4.5779e-05,-0.4275,-0.50443,1,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.00029789,-0.42757,-0.47032,1,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,5.337e-06,-0.42766,-0.44951,1,0
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,4.9495e-06,-0.42769,-0.5095,1,0
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,3.9422e-06,-0.4277,-0.48841,1,0
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0024341,-0.42771,-0.52946,1,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,1.9888e-05,-0.42775,-0.44344,1,0
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,4.5891e-06,-0.42803,-0.45234,1,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,2.636e-05,-0.4282,-0.44709,1,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,6.6813e-06,-0.42821,-0.44247,1,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,1.0403e-05,-0.42825,-0.51403,1,0
1,GO CYTOKINETIC PROCESS,1.4947e-05,-0.42845,-0.47939,1,0
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00057531,-0.42846,-0.56813,1,0
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.020391,-0.4285,-0.48062,1,0
1,GO TYPE 2 IMMUNE RESPONSE,0.0018673,-0.42881,-0.53432,1,0
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00064645,-0.42885,-0.38061,1,0
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,1.1191e-05,-0.42917,-0.49361,1,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,2.2907e-05,-0.42935,-0.40528,1,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,3.248e-05,-0.4294,-0.44719,1,0
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0042727,-0.42943,-0.60734,1,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,2.2907e-05,-0.42961,-0.43297,1,0
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,1.0403e-05,-0.4299,-0.51367,1,0
1,GO LEUKOCYTE APOPTOTIC PROCESS,0.00017019,-0.43,-0.56065,1,0
1,GO LYMPHOCYTE CHEMOTAXIS,0.020391,-0.43016,-0.48296,1,0
1,GO REGULATION OF MESODERM DEVELOPMENT,1.4947e-05,-0.43024,-0.41517,1,0
1,GO EOSINOPHIL MIGRATION,0.038848,-0.43032,-0.48453,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0015041,-0.43033,-0.53179,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,8.9843e-06,-0.43036,-0.45761,1,0
1,GO LIVER REGENERATION,1.2035e-05,-0.43039,-0.43731,1,0
1,GO THYMIC T CELL SELECTION,0.0047188,-0.43054,-0.54885,1,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,7.1973e-06,-0.43082,-0.55613,1,0
1,GO T CELL ACTIVATION,0.00010866,-0.43084,-0.56945,1,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,9.6689e-06,-0.4309,-0.49591,1,0
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,6.6813e-06,-0.43097,-0.45331,1,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,6.6813e-06,-0.43122,-0.41695,1,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,3.7287e-05,-0.43128,-0.47427,1,0
1,GO REGULATION OF MRNA PROCESSING,1.1191e-05,-0.43137,-0.49696,1,0
1,GO CELLULAR LIPID CATABOLIC PROCESS,7.1973e-06,-0.43142,-0.4823,1,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.00012367,-0.43144,-0.34693,1,0
1,GO EXTRACELLULAR TRANSPORT,0.00035748,-0.43151,-0.42942,1,0
1,GO ACROSOME ASSEMBLY,0.00014989,-0.43167,-0.44541,1,0
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,6.4139e-05,-0.43198,-0.52857,1,0
1,GO CYTOKINE PRODUCTION,2.636e-05,-0.43203,-0.55417,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,6.8565e-05,-0.43207,-0.46888,1,0
1,GO REGULATION OF GTP BINDING,4.2763e-05,-0.43233,-0.47255,1,0
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,8.3461e-06,-0.43244,-0.46981,1,0
1,GO REGULATION OF RNA SPLICING,1.0403e-05,-0.4325,-0.47474,1,0
1,GO URETER DEVELOPMENT,8.9327e-05,-0.4325,-0.45811,1,0
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0054671,-0.43257,-0.53556,1,0
1,GO REGULATION OF PH,4.9495e-06,-0.43266,-0.48635,1,0
1,GO CATECHOLAMINE METABOLIC PROCESS,7.3279e-05,-0.43274,-0.45481,1,0
1,GO DNA METABOLIC PROCESS,7.1973e-06,-0.43277,-0.46482,1,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,6.6813e-06,-0.43283,-0.55313,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00040321,-0.43294,-0.58043,1,0
1,GO CARDIAC VENTRICLE FORMATION,0.00064645,-0.43312,-0.46119,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,5.337e-06,-0.43314,-0.44329,1,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,2.8267e-05,-0.43325,-0.41878,1,0
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0049572,-0.43326,-0.48648,1,0
1,GO TOXIN METABOLIC PROCESS,0.00026348,-0.43349,-0.39473,1,0
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,9.6689e-06,-0.43365,-0.44025,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.021265,-0.43371,-0.45557,1,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.1191e-05,-0.43372,-0.46745,1,0
1,GO SYNAPTIC SIGNALING,1.6059e-05,-0.43388,-0.52847,1,0
1,GO CRISTAE FORMATION,7.7514e-06,-0.434,-0.55277,1,0
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00332,-0.43403,-0.56809,1,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.00023283,-0.43434,-0.47943,1,0
1,GO DNA MODIFICATION,7.1973e-06,-0.4344,-0.44293,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,7.3279e-05,-0.43451,-0.58507,1,0
1,GO POSITIVE REGULATION OF RNA SPLICING,1.7249e-05,-0.43453,-0.47103,1,0
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00012367,-0.43459,-0.41749,1,0
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,1.2035e-05,-0.4346,-0.49372,1,0
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,2.2907e-05,-0.43475,-0.38555,1,0
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,1.0403e-05,-0.43504,-0.49689,1,0
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00010181,-0.43515,-0.57549,1,0
1,GO PIGMENT GRANULE LOCALIZATION,1.6059e-05,-0.43522,-0.43986,1,0
1,GO BLASTOCYST GROWTH,4.2539e-06,-0.43527,-0.49948,1,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,6.6813e-06,-0.4353,-0.45432,1,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.00096503,-0.43539,-0.5113,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,3.0304e-05,-0.43546,-0.43786,1,0
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,4.9495e-06,-0.43575,-0.4552,1,0
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0054671,-0.43576,-0.56053,1,0
1,GO ADAPTIVE IMMUNE RESPONSE,0.0015041,-0.43582,-0.58293,1,0
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.00042807,-0.43585,-0.38996,1,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.00096503,-0.43585,-0.49473,1,0
1,GO HISTONE UBIQUITINATION,7.7514e-06,-0.43604,-0.51552,1,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,2.636e-05,-0.43607,-0.44796,1,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00011593,-0.43643,-0.58557,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00054254,-0.43647,-0.60279,1,0
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.00015974,-0.43661,-0.45903,1,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,4.9495e-06,-0.43667,-0.48522,1,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,3.9422e-06,-0.43686,-0.49041,1,0
1,GO TUMOR NECROSIS FACTOR SECRETION,7.3279e-05,-0.43694,-0.50464,1,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,3.248e-05,-0.43706,-0.42415,1,0
1,GO INTERLEUKIN 12 PRODUCTION,0.0044907,-0.43707,-0.53204,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.8997e-05,-0.43709,-0.59441,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,3.4805e-05,-0.4371,-0.49303,1,0
1,GO REGULATION OF INFLAMMATORY RESPONSE,3.248e-05,-0.43715,-0.54163,1,0
1,GO DENDRITIC CELL DIFFERENTIATION,0.0092139,-0.43739,-0.56444,1,0
1,GO COPPER ION TRANSPORT,3.248e-05,-0.43792,-0.45212,1,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00014062,-0.43816,-0.41031,1,0
1,GO IMMUNE EFFECTOR PROCESS,2.2907e-05,-0.43823,-0.55017,1,0
1,GO RESPONSE TO VIRUS,0.00013188,-0.43823,-0.49668,1,0
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,7.1973e-06,-0.43826,-0.48349,1,0
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.2539e-06,-0.43828,-0.45488,1,0
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,1.1191e-05,-0.43828,-0.42605,1,0
1,GO LEARNING,8.3461e-06,-0.4383,-0.52106,1,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0017696,-0.43867,-0.44438,1,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,4.5891e-06,-0.43871,-0.50057,1,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,7.1973e-06,-0.43892,-0.44107,1,0
1,GO INTRACELLULAR TRANSPORT,4.9495e-06,-0.43894,-0.46872,1,0
1,GO PROTEIN N LINKED GLYCOSYLATION,9.6689e-06,-0.43901,-0.43834,1,0
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,1.7249e-05,-0.43904,-0.49057,1,0
1,GO SENSORY PERCEPTION OF PAIN,6.6813e-06,-0.43908,-0.49028,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.00019306,-0.43911,-0.54416,1,0
1,GO LEUKOCYTE CELL CELL ADHESION,0.00013188,-0.43942,-0.57943,1,0
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00014989,-0.43946,-0.56234,1,0
1,GO NEUROTRANSMITTER SECRETION,0.00020554,-0.43952,-0.54765,1,0
1,GO RESPONSE TO OXYGEN RADICAL,1.6059e-05,-0.43953,-0.43066,1,0
1,GO REGULATION OF IMMUNE RESPONSE,5.2428e-05,-0.44001,-0.55129,1,0
1,GO RRNA TRANSCRIPTION,8.9843e-06,-0.44004,-0.49547,1,0
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,4.2539e-06,-0.44015,-0.4929,1,0
1,GO FATTY ACID BIOSYNTHETIC PROCESS,8.9843e-06,-0.44031,-0.43602,1,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,8.3461e-06,-0.44032,-0.49374,1,0
1,GO POSITIVE REGULATION OF VIRAL PROCESS,3.9422e-06,-0.44032,-0.51602,1,0
1,GO IMMUNOGLOBULIN SECRETION,0.00051151,-0.44046,-0.50548,1,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00020554,-0.44051,-0.55927,1,0
1,GO DETECTION OF BIOTIC STIMULUS,0.0012758,-0.44052,-0.53321,1,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,4.8997e-05,-0.4407,-0.44139,1,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,8.3461e-06,-0.44079,-0.45513,1,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0016767,-0.44082,-0.42742,1,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0015882,-0.44095,-0.5208,1,0
1,GO CELL FATE SPECIFICATION,1.7249e-05,-0.44102,-0.48203,1,0
1,GO RESPONSE TO ALKALOID,6.6813e-06,-0.4413,-0.47194,1,0
1,GO CELLULAR IRON ION HOMEOSTASIS,1.3909e-05,-0.44134,-0.4404,1,0
1,GO NON CANONICAL WNT SIGNALING PATHWAY,5.337e-06,-0.44176,-0.5004,1,0
1,GO REGULATION OF TRANSLATIONAL TERMINATION,1.3909e-05,-0.44205,-0.46809,1,0
1,GO CYTOKINE METABOLIC PROCESS,5.9985e-05,-0.44236,-0.57074,1,0
1,GO CELLULAR COPPER ION HOMEOSTASIS,1.2939e-05,-0.44241,-0.51089,1,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,6.6813e-06,-0.4426,-0.48351,1,0
1,GO REGULATION OF SENSORY PERCEPTION,2.2907e-05,-0.44263,-0.41349,1,0
1,GO AXIS SPECIFICATION,7.1973e-06,-0.44307,-0.45376,1,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,4.5779e-05,-0.44314,-0.40431,1,0
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00081392,-0.44316,-0.45648,1,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,1.9888e-05,-0.44327,-0.46977,1,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00045436,-0.44344,-0.44714,1,0
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,5.7533e-06,-0.44351,-0.47248,1,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,2.2907e-05,-0.4441,-0.454,1,0
1,GO CELLULAR RESPONSE TO UV,4.9495e-06,-0.44423,-0.47769,1,0
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,4.8997e-05,-0.4443,-0.53101,1,0
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,6.2007e-06,-0.4444,-0.44661,1,0
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,4.9495e-06,-0.44441,-0.48953,1,0
1,GO DIGESTIVE SYSTEM PROCESS,2.8267e-05,-0.44443,-0.38338,1,0
1,GO CARNITINE METABOLIC PROCESS,0.00014062,-0.44455,-0.39855,1,0
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,9.6689e-06,-0.4447,-0.45039,1,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,8.3461e-06,-0.4447,-0.42419,1,0
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00014062,-0.44471,-0.59466,1,0
1,GO T CELL MIGRATION,0.0018673,-0.44481,-0.59239,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,6.4139e-05,-0.44489,-0.42933,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0034935,-0.44495,-0.50933,1,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00015974,-0.4451,-0.37385,1,0
1,GO CYTOKINE SECRETION,0.00010181,-0.44513,-0.5311,1,0
1,GO INTERACTION WITH SYMBIONT,2.636e-05,-0.44515,-0.45139,1,0
1,GO RENAL ABSORPTION,0.00033648,-0.44521,-0.52118,1,0
1,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.00014989,-0.44532,-0.44892,1,0
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00072571,-0.44549,-0.5805,1,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,3.9422e-06,-0.44553,-0.48665,1,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.9888e-05,-0.4456,-0.46139,1,0
1,GO DETECTION OF OTHER ORGANISM,0.0024341,-0.44581,-0.56133,1,0
1,GO LEUKOCYTE CHEMOTAXIS,0.00033648,-0.44594,-0.52878,1,0
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00018128,-0.44608,-0.56657,1,0
1,GO NAD BIOSYNTHETIC PROCESS,0.00024771,-0.44609,-0.47963,1,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,5.337e-06,-0.44615,-0.49262,1,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,1.3909e-05,-0.44617,-0.43882,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0066311,-0.44618,-0.53589,1,0
1,GO MICROTUBULE SEVERING,0.00010866,-0.44624,-0.4895,1,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,3.7287e-05,-0.4463,-0.48372,1,0
1,GO ORGANIC ACID METABOLIC PROCESS,5.337e-06,-0.44635,-0.44674,1,0
1,GO RESPONSE TO DEXAMETHASONE,8.9843e-06,-0.4464,-0.47623,1,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,4.5779e-05,-0.44645,-0.48265,1,0
1,GO RESPONSE TO LEAD ION,9.6689e-06,-0.44654,-0.51579,1,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,9.6689e-06,-0.44663,-0.49448,1,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,3.9422e-06,-0.44668,-0.48394,1,0
1,GO T CELL DIFFERENTIATION,5.9985e-05,-0.44724,-0.58785,1,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.00028019,-0.44729,-0.59189,1,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00033648,-0.44738,-0.59765,1,0
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,4.5891e-06,-0.44741,-0.47881,1,0
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,3.7287e-05,-0.44747,-0.53578,1,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,4.2539e-06,-0.4476,-0.4647,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0016767,-0.44775,-0.52287,1,0
1,GO NEGATIVE REGULATION OF CELL KILLING,0.0080134,-0.44778,-0.63237,1,0
1,GO DIOL BIOSYNTHETIC PROCESS,0.00021879,-0.44793,-0.47262,1,0
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,2.8267e-05,-0.44799,-0.55561,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,6.6813e-06,-0.44801,-0.49043,1,0
1,GO MYOBLAST DIFFERENTIATION,1.2035e-05,-0.44806,-0.49596,1,0
1,GO PANCREATIC JUICE SECRETION,0.00024771,-0.44808,-0.46125,1,0
1,GO REGULATION OF CILIUM ASSEMBLY,1.8524e-05,-0.4481,-0.49531,1,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,1.1191e-05,-0.44813,-0.41104,1,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.00091199,-0.44816,-0.6018,1,0
1,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00013188,-0.44825,-0.58113,1,0
1,GO G0 TO G1 TRANSITION,1.3909e-05,-0.44847,-0.50798,1,0
1,GO LYMPHOCYTE MIGRATION,0.0021907,-0.44847,-0.54771,1,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0003797,-0.44852,-0.51366,1,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,8.9843e-06,-0.44866,-0.47264,1,0
1,GO REGULATION OF LIPID TRANSPORT,1.4947e-05,-0.44869,-0.45451,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,3.0304e-05,-0.4487,-0.46336,1,0
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.44878,-0.50243,1,0
1,GO CELLULAR RESPONSE TO IRON ION,0.0003797,-0.44885,-0.49143,1,0
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,5.6086e-05,-0.44887,-0.49723,1,0
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,5.7533e-06,-0.44888,-0.47291,1,0
1,GO SHORT TERM MEMORY,0.00029789,-0.44896,-0.48884,1,0
1,GO LIPID OXIDATION,7.7514e-06,-0.44898,-0.44661,1,0
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00011593,-0.44907,-0.57314,1,0
1,GO REGULATION OF CELL CYCLE PROCESS,6.6813e-06,-0.44941,-0.48903,1,0
1,GO REFLEX,0.0042727,-0.44945,-0.4488,1,0
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,4.2539e-06,-0.44949,-0.47042,1,0
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,5.2428e-05,-0.44955,-0.54431,1,0
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00048214,-0.44969,-0.52027,1,0
1,GO LYMPHOCYTE ACTIVATION,3.9936e-05,-0.44974,-0.57922,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00029789,-0.44974,-0.55789,1,0
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,4.5891e-06,-0.44982,-0.52075,1,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,1.2939e-05,-0.44986,-0.45507,1,0
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,3.9422e-06,-0.45014,-0.49105,1,0
1,GO PROGRAMMED NECROTIC CELL DEATH,6.4139e-05,-0.45016,-0.50651,1,0
1,GO WALKING BEHAVIOR,5.9985e-05,-0.4503,-0.50489,1,0
1,GO AMINE TRANSPORT,0.00042807,-0.45043,-0.435,1,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,9.6689e-06,-0.4507,-0.45366,1,0
1,GO UV DAMAGE EXCISION REPAIR,7.7514e-06,-0.45071,-0.51745,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.00020554,-0.45073,-0.42784,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.00018128,-0.45081,-0.47098,1,0
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,7.3279e-05,-0.45082,-0.65229,1,0
1,GO MACROMOLECULE CATABOLIC PROCESS,4.2539e-06,-0.45086,-0.4755,1,0
1,GO T CELL LINEAGE COMMITMENT,0.00014062,-0.45087,-0.55368,1,0
1,GO DETECTION OF ABIOTIC STIMULUS,7.7514e-06,-0.45092,-0.45368,1,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,5.9985e-05,-0.45099,-0.5736,1,0
1,GO ZYMOGEN ACTIVATION,7.3279e-05,-0.45106,-0.53957,1,0
1,GO HISTONE MONOUBIQUITINATION,9.6689e-06,-0.45116,-0.52827,1,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,2.636e-05,-0.45119,-0.49511,1,0
1,GO REGULATION OF LYASE ACTIVITY,7.1973e-06,-0.45127,-0.46844,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00014062,-0.45129,-0.58271,1,0
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0010798,-0.45137,-0.59275,1,0
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,8.3641e-05,-0.45144,-0.52111,1,0
1,GO STEROL BIOSYNTHETIC PROCESS,5.6086e-05,-0.45144,-0.4343,1,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,3.9422e-06,-0.45178,-0.50826,1,0
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.5891e-06,-0.4519,-0.49093,1,0
1,GO RESPONSE TO CORTICOSTEROID,1.2035e-05,-0.45192,-0.49812,1,0
1,GO DNA REPLICATION,1.4947e-05,-0.4521,-0.47692,1,0
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,3.9422e-06,-0.45215,-0.47476,1,0
1,GO DOUBLE STRAND BREAK REPAIR,8.3461e-06,-0.45227,-0.51545,1,0
1,GO REGULATION OF CELL ACTIVATION,5.9985e-05,-0.45232,-0.58956,1,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,6.6813e-06,-0.45242,-0.51165,1,0
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,1.2939e-05,-0.45249,-0.52644,1,0
1,GO COCHLEA DEVELOPMENT,2.1347e-05,-0.45271,-0.49876,1,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,6.8565e-05,-0.45272,-0.53416,1,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,8.3461e-06,-0.45272,-0.51496,1,0
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,8.9843e-06,-0.45277,-0.53367,1,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0003797,-0.45282,-0.48953,1,0
1,GO STEROID METABOLIC PROCESS,1.2939e-05,-0.45292,-0.44664,1,0
1,GO REGULATION OF VIRAL TRANSCRIPTION,5.7533e-06,-0.45299,-0.48969,1,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.00014062,-0.45323,-0.43305,1,0
1,GO SULFUR COMPOUND METABOLIC PROCESS,6.6813e-06,-0.45331,-0.43624,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,1.1191e-05,-0.4534,-0.43191,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,7.8298e-05,-0.4534,-0.49427,1,0
1,GO BILE ACID METABOLIC PROCESS,1.6059e-05,-0.4534,-0.43936,1,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00023283,-0.45342,-0.50043,1,0
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,5.7533e-06,-0.45361,-0.49119,1,0
1,GO NEUROTRANSMITTER TRANSPORT,7.8298e-05,-0.45429,-0.53832,1,0
1,GO BLASTOCYST FORMATION,4.5891e-06,-0.45444,-0.48792,1,0
1,GO NUCLEAR PORE ORGANIZATION,2.1347e-05,-0.45451,-0.54279,1,0
1,GO REGULATION OF CELL MATURATION,1.7249e-05,-0.45453,-0.42307,1,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,7.7514e-06,-0.45467,-0.47866,1,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,1.1191e-05,-0.45491,-0.39927,1,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,8.9843e-06,-0.45491,-0.51778,1,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,6.2007e-06,-0.45491,-0.49836,1,0
1,GO SYNAPTIC MEMBRANE ADHESION,0.00014062,-0.45493,-0.58049,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,2.8267e-05,-0.45497,-0.48209,1,0
1,GO RESPONSE TO INTERLEUKIN 4,3.7287e-05,-0.45508,-0.5233,1,0
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00057531,-0.45508,-0.6246,1,0
1,GO IRON ION TRANSPORT,1.1191e-05,-0.45511,-0.47838,1,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00013188,-0.45514,-0.50524,1,0
1,GO PROTEIN O LINKED MANNOSYLATION,2.4576e-05,-0.45516,-0.4811,1,0
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0042727,-0.45528,-0.52503,1,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,3.9936e-05,-0.45528,-0.43748,1,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,5.337e-06,-0.45548,-0.47991,1,0
1,GO CELLULAR MACROMOLECULE LOCALIZATION,4.9495e-06,-0.45558,-0.48736,1,0
1,GO NADH METABOLIC PROCESS,5.9985e-05,-0.45565,-0.50469,1,0
1,GO MITOTIC SISTER CHROMATID COHESION,1.9888e-05,-0.45569,-0.49545,1,0
1,GO MRNA CLEAVAGE,1.1191e-05,-0.4557,-0.50409,1,0
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,6.2007e-06,-0.45572,-0.46605,1,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,3.7287e-05,-0.45576,-0.52066,1,0
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.037377,-0.4558,-0.43038,1,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,4.5779e-05,-0.45583,-0.48596,1,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,5.2428e-05,-0.45596,-0.46295,1,0
1,GO NERVOUS SYSTEM PROCESS,6.2007e-06,-0.45599,-0.47276,1,0
1,GO MULTI ORGANISM PROCESS,6.2007e-06,-0.4561,-0.45773,1,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,4.8997e-05,-0.45617,-0.39929,1,0
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.248e-05,-0.45629,-0.58972,1,0
1,GO PROTEIN TRIMERIZATION,3.4805e-05,-0.45633,-0.54341,1,0
1,GO MULTI ORGANISM LOCALIZATION,4.9495e-06,-0.45638,-0.49819,1,0
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.00010866,-0.4564,-0.50347,1,0
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,2.1347e-05,-0.45642,-0.43172,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,8.9327e-05,-0.45643,-0.55642,1,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,5.7533e-06,-0.45645,-0.45834,1,0
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,1.6059e-05,-0.45649,-0.48571,1,0
1,GO SUPEROXIDE ANION GENERATION,0.00014062,-0.45655,-0.53592,1,0
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.012106,-0.45657,-0.63837,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,6.8565e-05,-0.45679,-0.57456,1,0
1,GO MICROTUBULE BASED MOVEMENT,1.2939e-05,-0.45686,-0.48017,1,0
1,GO SARCOMERE ORGANIZATION,1.6059e-05,-0.45694,-0.43246,1,0
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,4.9495e-06,-0.45694,-0.50136,1,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,5.9985e-05,-0.45704,-0.45075,1,0
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0024341,-0.45705,-0.75725,1,0
1,GO INFLAMMATORY RESPONSE,3.4805e-05,-0.45714,-0.56109,1,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,4.2539e-06,-0.45715,-0.51683,1,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,7.7514e-06,-0.45727,-0.48874,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,5.7533e-06,-0.45753,-0.59958,1,0
1,GO TRANSCRIPTION BY RNA POLYMERASE I,5.337e-06,-0.45771,-0.49824,1,0
1,GO DIET INDUCED THERMOGENESIS,2.636e-05,-0.45784,-0.47625,1,0
1,GO REGULATION OF CENTRIOLE REPLICATION,1.4947e-05,-0.458,-0.52417,1,0
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,1.1191e-05,-0.45815,-0.51867,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION,8.3641e-05,-0.45817,-0.59086,1,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,6.2007e-06,-0.45817,-0.47429,1,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.00010181,-0.45837,-0.46222,1,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,1.8524e-05,-0.45849,-0.54302,1,0
1,GO NUCLEUS ORGANIZATION,6.6813e-06,-0.45859,-0.50329,1,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,5.337e-06,-0.4586,-0.48634,1,0
1,GO MACROPHAGE MIGRATION,0.00054254,-0.45861,-0.54468,1,0
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,6.4139e-05,-0.45874,-0.48457,1,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.5891e-06,-0.45879,-0.46305,1,0
1,GO RESPONSE TO ETHANOL,1.1191e-05,-0.45883,-0.42428,1,0
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.8267e-05,-0.45883,-0.52931,1,0
1,GO FLUID TRANSPORT,0.00014062,-0.459,-0.4905,1,0
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.2539e-06,-0.45929,-0.49153,1,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.7514e-06,-0.45933,-0.52028,1,0
1,GO PROTEIN MATURATION,9.6689e-06,-0.45951,-0.46943,1,0
1,GO FUCOSYLATION,8.3461e-06,-0.45955,-0.51321,1,0
1,GO MONOCYTE CHEMOTAXIS,0.023112,-0.45961,-0.45653,1,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.45969,-0.43698,1,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,4.9495e-06,-0.45975,-0.46137,1,0
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,4.8997e-05,-0.45976,-0.59307,1,0
1,GO PLASMINOGEN ACTIVATION,7.8298e-05,-0.45978,-0.58327,1,0
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,7.7514e-06,-0.45988,-0.53162,1,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.00013188,-0.45992,-0.57537,1,0
1,GO FATTY ACID CATABOLIC PROCESS,1.6059e-05,-0.45993,-0.44943,1,0
1,GO RESPONSE TO PARATHYROID HORMONE,4.2763e-05,-0.46008,-0.47888,1,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,1.8524e-05,-0.46021,-0.54701,1,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00019306,-0.46026,-0.3992,1,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,1.3909e-05,-0.46031,-0.4948,1,0
1,GO POSITIVE REGULATION OF CHEMOTAXIS,5.6086e-05,-0.46032,-0.57307,1,0
1,GO MECHANOSENSORY BEHAVIOR,0.0038653,-0.46037,-0.4639,1,0
1,GO DNA GEOMETRIC CHANGE,7.7514e-06,-0.46052,-0.50573,1,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,2.1347e-05,-0.46055,-0.49776,1,0
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0054671,-0.46073,-0.52022,1,0
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,1.4947e-05,-0.46073,-0.50791,1,0
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0010798,-0.46077,-0.54136,1,0
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.2539e-06,-0.4612,-0.49257,1,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,8.3461e-06,-0.46132,-0.47543,1,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,6.6813e-06,-0.46176,-0.47692,1,0
1,GO RESPONSE TO LITHIUM ION,0.00010866,-0.46181,-0.44857,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,3.248e-05,-0.46189,-0.45548,1,0
1,GO ACTIN NUCLEATION,6.6813e-06,-0.46193,-0.49937,1,0
1,GO KETONE BIOSYNTHETIC PROCESS,0.00013188,-0.46237,-0.44833,1,0
1,GO METENCEPHALON DEVELOPMENT,9.6689e-06,-0.46257,-0.52669,1,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,1.4947e-05,-0.46274,-0.56636,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,4.5779e-05,-0.46281,-0.60746,1,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,4.5891e-06,-0.46282,-0.50142,1,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0012071,-0.46288,-0.507,1,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00012367,-0.46289,-0.52174,1,0
1,GO HEART FORMATION,3.0304e-05,-0.46306,-0.49525,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00018128,-0.46318,-0.56328,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00020554,-0.46326,-0.48527,1,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,1.2035e-05,-0.46337,-0.51149,1,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,4.5891e-06,-0.46343,-0.46602,1,0
1,GO COPPER ION HOMEOSTASIS,7.7514e-06,-0.46359,-0.49805,1,0
1,GO MYOBLAST PROLIFERATION,3.0304e-05,-0.46383,-0.48559,1,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,4.5779e-05,-0.4639,-0.49047,1,0
1,GO DENDRITE EXTENSION,0.00024771,-0.46405,-0.50109,1,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.00076864,-0.46407,-0.37582,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00031664,-0.46421,-0.56265,1,0
1,GO RESPONSE TO NICOTINE,2.8267e-05,-0.46439,-0.46378,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00014989,-0.46443,-0.59205,1,0
1,GO DICARBOXYLIC ACID TRANSPORT,5.6086e-05,-0.46452,-0.47652,1,0
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,9.6689e-06,-0.46458,-0.5033,1,0
1,GO CELLULAR RESPONSE TO VIRUS,2.1347e-05,-0.46478,-0.52459,1,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,1.1191e-05,-0.46503,-0.51866,1,0
1,GO COCHLEA MORPHOGENESIS,1.3909e-05,-0.46512,-0.46762,1,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,6.4139e-05,-0.46517,-0.48616,1,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00013188,-0.46525,-0.58758,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION,4.5779e-05,-0.4653,-0.5085,1,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.010101,-0.46536,-0.44416,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,2.2907e-05,-0.46551,-0.49286,1,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,8.9843e-06,-0.46563,-0.49421,1,0
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,1.9888e-05,-0.46565,-0.53655,1,0
1,GO CELL CYCLE,6.2007e-06,-0.46569,-0.4974,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0020776,-0.46571,-0.60277,1,0
1,GO ARACHIDONIC ACID SECRETION,0.00010181,-0.46572,-0.43759,1,0
1,GO CELLULAR RESPONSE TO RADIATION,4.2539e-06,-0.4659,-0.46424,1,0
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,5.6086e-05,-0.46591,-0.49796,1,0
1,GO POTASSIUM ION TRANSPORT,2.2907e-05,-0.46592,-0.48946,1,0
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.6059e-05,-0.46598,-0.59643,1,0
1,GO SKIN DEVELOPMENT,1.9888e-05,-0.46601,-0.47629,1,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.8267e-05,-0.46605,-0.55885,1,0
1,GO NCRNA CATABOLIC PROCESS,8.3461e-06,-0.4661,-0.4733,1,0
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.2907e-05,-0.46614,-0.60997,1,0
1,GO REGULATION OF CELL CELL ADHESION,2.8267e-05,-0.46631,-0.59175,1,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,7.8298e-05,-0.46637,-0.5657,1,0
1,GO FEVER GENERATION,1.7249e-05,-0.46649,-0.49961,1,0
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,4.2539e-06,-0.46665,-0.50048,1,0
1,GO FOLIC ACID METABOLIC PROCESS,7.7514e-06,-0.46673,-0.47082,1,0
1,GO DETECTION OF CALCIUM ION,0.00051151,-0.46713,-0.42168,1,0
1,GO RESPONSE TO UV,5.337e-06,-0.46716,-0.5002,1,0
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00054254,-0.46736,-0.58845,1,0
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,1.2939e-05,-0.46737,-0.46018,1,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,8.3641e-05,-0.46741,-0.42264,1,0
1,GO CHLORIDE TRANSPORT,6.6813e-06,-0.46743,-0.48664,1,0
1,GO REGULATION OF PROTEIN ACETYLATION,5.337e-06,-0.46752,-0.50802,1,0
1,GO CHROMATIN REMODELING,9.6689e-06,-0.4677,-0.50599,1,0
1,GO CELLULAR PIGMENTATION,1.8524e-05,-0.46776,-0.42112,1,0
1,GO ALCOHOL CATABOLIC PROCESS,2.1347e-05,-0.46781,-0.46215,1,0
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.7533e-06,-0.46788,-0.50424,1,0
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,1.2035e-05,-0.46789,-0.56286,1,0
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,6.8565e-05,-0.46793,-0.55295,1,0
1,GO RESPONSE TO AUDITORY STIMULUS,0.0014241,-0.46803,-0.47386,1,0
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00010181,-0.46816,-0.58463,1,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,1.7249e-05,-0.46822,-0.46489,1,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,4.8997e-05,-0.46826,-0.49723,1,0
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,6.2007e-06,-0.46829,-0.50247,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.7249e-05,-0.46832,-0.54303,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.6813e-06,-0.46835,-0.45131,1,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,7.1973e-06,-0.46837,-0.55188,1,0
1,GO IMMUNOGLOBULIN PRODUCTION,1.4947e-05,-0.46852,-0.56838,1,0
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,4.5779e-05,-0.46862,-0.52149,1,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,1.4947e-05,-0.46864,-0.45265,1,0
1,GO MITOTIC CYTOKINESIS,8.9843e-06,-0.46867,-0.5201,1,0
1,GO REGULATION OF AMYLOID BETA CLEARANCE,4.8997e-05,-0.46877,-0.62512,1,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,6.4139e-05,-0.46878,-0.53883,1,0
1,GO IRON ION HOMEOSTASIS,1.2939e-05,-0.46882,-0.46679,1,0
1,GO STEROID BIOSYNTHETIC PROCESS,3.7287e-05,-0.46907,-0.42738,1,0
1,GO REGULATION OF HORMONE LEVELS,1.9888e-05,-0.46909,-0.45463,1,0
1,GO ORGANELLE ASSEMBLY,5.7533e-06,-0.46914,-0.49646,1,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,7.7514e-06,-0.46938,-0.53283,1,0
1,GO ALCOHOL METABOLIC PROCESS,6.2007e-06,-0.46948,-0.48825,1,0
1,GO ORGANELLE DISASSEMBLY,4.9495e-06,-0.46948,-0.51708,1,0
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00091199,-0.46958,-0.56667,1,0
1,GO MONONUCLEAR CELL MIGRATION,0.0038653,-0.46961,-0.51594,1,0
1,GO REGULATION OF DNA REPAIR,7.7514e-06,-0.46963,-0.516,1,0
1,GO C4 DICARBOXYLATE TRANSPORT,3.4805e-05,-0.4697,-0.45881,1,0
1,GO RESPONSE TO CAFFEINE,3.7287e-05,-0.46972,-0.46418,1,0
1,GO LYSINE METABOLIC PROCESS,0.00010866,-0.46973,-0.41362,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0028457,-0.46978,-0.52655,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0012071,-0.4698,-0.61528,1,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0015041,-0.46987,-0.52097,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,5.6086e-05,-0.46988,-0.52512,1,0
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.033245,-0.46992,-0.40575,1,0
1,GO ACTIVATION OF IMMUNE RESPONSE,2.8267e-05,-0.46993,-0.55826,1,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,8.9843e-06,-0.46995,-0.52998,1,0
1,GO RESPONSE TO X RAY,7.7514e-06,-0.47,-0.54744,1,0
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.9495e-06,-0.47013,-0.49888,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,3.7287e-05,-0.47018,-0.53507,1,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,6.2007e-06,-0.47043,-0.53902,1,0
1,GO LIPID CATABOLIC PROCESS,6.2007e-06,-0.47045,-0.48252,1,0
1,GO GRANULOCYTE CHEMOTAXIS,0.00332,-0.47054,-0.49602,1,0
1,GO PROTEIN TETRAMERIZATION,4.9495e-06,-0.47061,-0.48181,1,0
1,GO IMPORT INTO NUCLEUS,3.9422e-06,-0.47098,-0.50146,1,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,5.7533e-06,-0.47101,-0.47931,1,0
1,GO MITOCHONDRIAL FUSION,7.7514e-06,-0.47117,-0.5253,1,0
1,GO VIRAL RNA GENOME REPLICATION,1.0403e-05,-0.47123,-0.52011,1,0
1,GO NATURAL KILLER CELL ACTIVATION,0.00015974,-0.47129,-0.57491,1,0
1,GO PITUITARY GLAND DEVELOPMENT,0.00332,-0.4713,-0.41789,1,0
1,GO FEMALE GENITALIA DEVELOPMENT,9.6689e-06,-0.47133,-0.47076,1,0
1,GO HISTONE H3 K4 METHYLATION,1.2939e-05,-0.47136,-0.51863,1,0
1,GO POSITIVE REGULATION OF HEART RATE,5.9985e-05,-0.4714,-0.4547,1,0
1,GO SUCKLING BEHAVIOR,0.00020554,-0.47146,-0.56311,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00031664,-0.47158,-0.74513,1,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,9.6689e-06,-0.47161,-0.48872,1,0
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.00060992,-0.47165,-0.41324,1,0
1,GO ANIMAL ORGAN REGENERATION,6.2007e-06,-0.47169,-0.50375,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.5779e-05,-0.47185,-0.55712,1,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00021879,-0.47189,-0.52473,1,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,3.0304e-05,-0.47193,-0.49983,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,1.2939e-05,-0.47213,-0.47516,1,0
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,3.9422e-06,-0.47221,-0.48483,1,0
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,2.8267e-05,-0.4723,-0.54124,1,0
1,GO HEAT GENERATION,2.2907e-05,-0.47236,-0.49165,1,0
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.9888e-05,-0.4724,-0.52979,1,0
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0172,-0.47254,-0.61513,1,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.00060992,-0.47273,-0.49998,1,0
1,GO TRANSPORT ALONG MICROTUBULE,8.9843e-06,-0.47277,-0.53329,1,0
1,GO CELL ACTIVATION,9.6689e-06,-0.47295,-0.56682,1,0
1,GO DEVELOPMENTAL INDUCTION,3.7287e-05,-0.47299,-0.46613,1,0
1,GO PROTEIN POLYUBIQUITINATION,4.5891e-06,-0.473,-0.50465,1,0
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,4.5779e-05,-0.47302,-0.47258,1,0
1,GO DEFENSE RESPONSE TO VIRUS,0.00020554,-0.47306,-0.52999,1,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,8.3461e-06,-0.47346,-0.52516,1,0
1,GO LENS FIBER CELL DEVELOPMENT,3.0304e-05,-0.47353,-0.51867,1,0
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,4.9495e-06,-0.47356,-0.45794,1,0
1,GO REGULATION OF CELL CYCLE,5.337e-06,-0.47369,-0.5064,1,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,1.4947e-05,-0.47369,-0.47499,1,0
1,GO NADP METABOLIC PROCESS,9.6689e-06,-0.47372,-0.45806,1,0
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,4.9495e-06,-0.47401,-0.50764,1,0
1,GO PARTURITION,1.4947e-05,-0.47404,-0.47755,1,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,1.6059e-05,-0.47422,-0.53457,1,0
1,GO REGULATION OF AMINO ACID TRANSPORT,0.00021879,-0.47437,-0.49078,1,0
1,GO CELLULAR LIPID METABOLIC PROCESS,5.337e-06,-0.47457,-0.48593,1,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.5891e-06,-0.47467,-0.51338,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,1.3909e-05,-0.47467,-0.50087,1,0
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,5.7533e-06,-0.47493,-0.4951,1,0
1,GO LYMPHOCYTE DIFFERENTIATION,2.636e-05,-0.47493,-0.59745,1,0
1,GO SYNAPSE MATURATION,7.8298e-05,-0.47506,-0.59967,1,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.0024341,-0.47508,-0.35961,1,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,9.6689e-06,-0.47514,-0.5058,1,0
1,GO INTERFERON ALPHA PRODUCTION,3.9936e-05,-0.47524,-0.59036,1,0
1,GO RESPONSE TO LIGHT STIMULUS,4.9495e-06,-0.4753,-0.47554,1,0
1,GO POSITIVE REGULATION OF DNA REPAIR,7.7514e-06,-0.47534,-0.53446,1,0
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,2.4576e-05,-0.47558,-0.501,1,0
1,GO VAGINA DEVELOPMENT,0.00015974,-0.47569,-0.50186,1,0
1,GO ADULT LOCOMOTORY BEHAVIOR,0.00010181,-0.47586,-0.51334,1,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,2.2907e-05,-0.47591,-0.49226,1,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,3.9936e-05,-0.47595,-0.50582,1,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,1.7249e-05,-0.47601,-0.54392,1,0
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,4.2539e-06,-0.47605,-0.47611,1,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,1.7249e-05,-0.47614,-0.47063,1,0
1,GO CHEMOKINE PRODUCTION,0.00010181,-0.47626,-0.54506,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0018673,-0.4763,-0.55351,1,0
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00029789,-0.47638,-0.51793,1,0
1,GO SYNAPTIC VESICLE BUDDING,0.00023283,-0.47643,-0.52299,1,0
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,6.2007e-06,-0.47647,-0.49422,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.4576e-05,-0.47647,-0.62027,1,0
1,GO REGULATION OF PEPTIDASE ACTIVITY,1.0403e-05,-0.47664,-0.49388,1,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.4947e-05,-0.47673,-0.47385,1,0
1,GO NOTOCHORD DEVELOPMENT,0.00029789,-0.47675,-0.49849,1,0
1,GO EXECUTION PHASE OF APOPTOSIS,4.5891e-06,-0.47678,-0.49791,1,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,1.2939e-05,-0.47679,-0.48557,1,0
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0057394,-0.47679,-0.4987,1,0
1,GO MIDBRAIN DEVELOPMENT,4.9495e-06,-0.47701,-0.48645,1,0
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,6.8565e-05,-0.47721,-0.57028,1,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,2.4576e-05,-0.47723,-0.46091,1,0
1,GO INNER CELL MASS CELL PROLIFERATION,7.7514e-06,-0.47728,-0.56269,1,0
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,4.5891e-06,-0.47732,-0.51652,1,0
1,GO POLYOL BIOSYNTHETIC PROCESS,1.6059e-05,-0.47736,-0.473,1,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,8.9843e-06,-0.47745,-0.53933,1,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,3.248e-05,-0.47748,-0.51451,1,0
1,GO REGULATION OF LIPID LOCALIZATION,1.0403e-05,-0.47756,-0.49163,1,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0003797,-0.47766,-0.61517,1,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,1.2939e-05,-0.47768,-0.51225,1,0
1,GO PIGMENT GRANULE ORGANIZATION,2.636e-05,-0.47769,-0.45715,1,0
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00012367,-0.4777,-0.60587,1,0
1,GO APOPTOTIC SIGNALING PATHWAY,4.5891e-06,-0.47771,-0.50819,1,0
1,GO COGNITION,6.2007e-06,-0.47773,-0.50826,1,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,2.4576e-05,-0.47774,-0.4861,1,0
1,GO LIPID IMPORT INTO CELL,6.6813e-06,-0.47776,-0.5906,1,0
1,GO REGULATION OF CELLULAR PH,4.5891e-06,-0.47786,-0.50581,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0027019,-0.4779,-0.57149,1,0
1,GO WATER TRANSPORT,0.00017019,-0.47799,-0.5201,1,0
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00024771,-0.47802,-0.59215,1,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,5.7533e-06,-0.47802,-0.4857,1,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,3.4805e-05,-0.47825,-0.57916,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.00010181,-0.47831,-0.54201,1,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,8.3641e-05,-0.47832,-0.53139,1,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,9.6689e-06,-0.47844,-0.50808,1,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,5.2428e-05,-0.47845,-0.53816,1,0
1,GO PROTEIN K63 LINKED UBIQUITINATION,4.9495e-06,-0.4785,-0.51553,1,0
1,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,1.2035e-05,-0.47877,-0.49909,1,0
1,GO MICROTUBULE BASED PROCESS,8.9843e-06,-0.47879,-0.51163,1,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,8.3461e-06,-0.47882,-0.56753,1,0
1,GO T CELL HOMEOSTASIS,1.7249e-05,-0.47895,-0.49571,1,0
1,GO REGULATION OF SYMBIOTIC PROCESS,3.4805e-05,-0.47899,-0.50353,1,0
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.1191e-05,-0.47902,-0.54765,1,0
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,3.248e-05,-0.47912,-0.55342,1,0
1,GO SULFATION,3.4805e-05,-0.47928,-0.48959,1,0
1,GO MECHANORECEPTOR DIFFERENTIATION,1.0403e-05,-0.4793,-0.49909,1,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,2.2907e-05,-0.47936,-0.46544,1,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,3.9422e-06,-0.47942,-0.57297,1,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,1.3909e-05,-0.47951,-0.46769,1,0
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00028019,-0.47954,-0.57702,1,0
1,GO REGULATION OF DNA REPLICATION,1.2035e-05,-0.47955,-0.48944,1,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,3.4805e-05,-0.47962,-0.49878,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,2.1347e-05,-0.47974,-0.46851,1,0
1,GO REGULATION OF LIPASE ACTIVITY,1.3909e-05,-0.47975,-0.50903,1,0
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00014062,-0.47979,-0.53599,1,0
1,GO RESPONSE TO GAMMA RADIATION,6.6813e-06,-0.47982,-0.48804,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,1.2939e-05,-0.47997,-0.51475,1,0
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,4.9495e-06,-0.48006,-0.52774,1,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00021879,-0.4803,-0.59694,1,0
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.9495e-06,-0.4803,-0.50649,1,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,1.2035e-05,-0.48034,-0.59796,1,0
1,GO HETEROTYPIC CELL CELL ADHESION,2.4576e-05,-0.48035,-0.58324,1,0
1,GO POSITIVE REGULATION OF HEMOPOIESIS,1.0403e-05,-0.48037,-0.59747,1,0
1,GO RESPONSE TO UV B,8.3641e-05,-0.48041,-0.46497,1,0
1,GO LIPID METABOLIC PROCESS,5.7533e-06,-0.48045,-0.48923,1,0
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00024771,-0.48048,-0.60098,1,0
1,GO REGULATION OF MAST CELL ACTIVATION,1.3909e-05,-0.48051,-0.62389,1,0
1,GO NUCLEOTIDE PHOSPHORYLATION,7.1973e-06,-0.48052,-0.52471,1,0
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00023283,-0.4808,-0.61435,1,0
1,GO PORE COMPLEX ASSEMBLY,4.9495e-06,-0.48084,-0.53597,1,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,7.1973e-06,-0.48086,-0.45894,1,0
1,GO MESODERMAL CELL FATE COMMITMENT,1.9888e-05,-0.48089,-0.45225,1,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0012758,-0.48092,-0.48367,1,0
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,3.7287e-05,-0.48094,-0.62976,1,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,4.5779e-05,-0.48094,-0.55805,1,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,1.2035e-05,-0.481,-0.57102,1,0
1,GO LONG TERM SYNAPTIC DEPRESSION,1.8524e-05,-0.48103,-0.52173,1,0
1,GO BRANCH ELONGATION OF AN EPITHELIUM,4.2763e-05,-0.4811,-0.45216,1,0
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00020554,-0.48129,-0.69937,1,0
1,GO BROWN FAT CELL DIFFERENTIATION,1.2035e-05,-0.48131,-0.47574,1,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,5.337e-06,-0.48136,-0.50407,1,0
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,1.3909e-05,-0.48141,-0.54464,1,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0042727,-0.4816,-0.49179,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,1.2035e-05,-0.48168,-0.49584,1,0
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,3.7287e-05,-0.48175,-0.47651,1,0
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,2.636e-05,-0.48175,-0.46761,1,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00024771,-0.48177,-0.5532,1,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,5.7533e-06,-0.48192,-0.50629,1,0
1,GO POSITIVE T CELL SELECTION,0.0015882,-0.4821,-0.60536,1,0
1,GO BILE ACID AND BILE SALT TRANSPORT,1.2939e-05,-0.48212,-0.50272,1,0
1,GO CHEMOKINE SECRETION,0.00332,-0.48212,-0.55684,1,0
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.028348,-0.48222,-0.51263,1,0
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.5377e-05,-0.48222,-0.60531,1,0
1,GO MACROPHAGE CHEMOTAXIS,0.0011418,-0.48223,-0.52332,1,0
1,GO SYNAPSE ASSEMBLY,1.4947e-05,-0.48228,-0.57229,1,0
1,GO REGULATION OF SISTER CHROMATID COHESION,1.3909e-05,-0.48229,-0.55098,1,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,5.7533e-06,-0.48235,-0.48375,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,7.3279e-05,-0.48241,-0.56015,1,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,8.3461e-06,-0.48242,-0.56835,1,0
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,2.1347e-05,-0.48246,-0.56154,1,0
1,GO LIPID DROPLET ORGANIZATION,1.9888e-05,-0.48251,-0.4693,1,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.00028019,-0.48263,-0.48688,1,0
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,1.0403e-05,-0.48267,-0.51802,1,0
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,8.9843e-06,-0.48281,-0.52604,1,0
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,7.7514e-06,-0.48293,-0.50854,1,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,1.1191e-05,-0.48294,-0.49002,1,0
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,4.2539e-06,-0.48298,-0.49344,1,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,2.4576e-05,-0.48315,-0.45542,1,0
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,1.0403e-05,-0.48318,-0.55301,1,0
1,GO ASYMMETRIC CELL DIVISION,4.2539e-06,-0.4832,-0.54574,1,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,3.248e-05,-0.48321,-0.49919,1,0
1,GO DIOL METABOLIC PROCESS,0.00020554,-0.4833,-0.49679,1,0
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.3909e-05,-0.48331,-0.5748,1,0
1,GO RESPONSE TO WATER,0.00081392,-0.48345,-0.44749,1,0
1,GO NEUROMUSCULAR PROCESS,1.3909e-05,-0.48353,-0.55443,1,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.9888e-05,-0.48356,-0.55228,1,0
1,GO HYPOTONIC RESPONSE,1.3909e-05,-0.48378,-0.54779,1,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,6.6813e-06,-0.48392,-0.58269,1,0
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,4.5891e-06,-0.48394,-0.5023,1,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00096503,-0.48397,-0.58023,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.4805e-05,-0.48426,-0.6715,1,0
1,GO RESPONSE TO RADIATION,4.2539e-06,-0.48433,-0.48515,1,0
1,GO FC RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.48434,-0.5479,1,0
1,GO CILIUM ORGANIZATION,1.4947e-05,-0.48438,-0.49412,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,3.9936e-05,-0.48468,-0.6224,1,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,1.1191e-05,-0.4849,-0.52754,1,0
1,GO HEART TRABECULA FORMATION,0.00014062,-0.48507,-0.48914,1,0
1,GO ARGININE METABOLIC PROCESS,3.9422e-06,-0.48512,-0.53535,1,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,4.9495e-06,-0.48536,-0.48553,1,0
1,GO REGULATION OF MEMBRANE POTENTIAL,1.7249e-05,-0.48554,-0.5076,1,0
1,GO REGULATION OF ACTIN NUCLEATION,7.7514e-06,-0.48558,-0.51186,1,0
1,GO PEPTIDE HORMONE SECRETION,2.1347e-05,-0.48568,-0.49907,1,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,1.0403e-05,-0.48585,-0.53298,1,0
1,GO CALCIUM MEDIATED SIGNALING,7.1973e-06,-0.48597,-0.50555,1,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,1.7249e-05,-0.48623,-0.56205,1,0
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,4.5891e-06,-0.48644,-0.47442,1,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,1.2939e-05,-0.48645,-0.50479,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.48652,-0.48809,1,0
1,GO PURINE NUCLEOTIDE TRANSPORT,6.8565e-05,-0.48664,-0.46516,1,0
1,GO REGULATION OF HEART MORPHOGENESIS,1.2035e-05,-0.4868,-0.58684,1,0
1,GO HISTONE H2A MONOUBIQUITINATION,3.248e-05,-0.48682,-0.52058,1,0
1,GO HISTONE H4 DEACETYLATION,3.7287e-05,-0.487,-0.44225,1,0
1,GO RESPONSE TO CYTOKINE,1.0403e-05,-0.48704,-0.55775,1,0
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,4.5891e-06,-0.48704,-0.52546,1,0
1,GO SKELETAL MUSCLE CONTRACTION,9.6689e-06,-0.48741,-0.47965,1,0
1,GO CATECHOLAMINE SECRETION,0.00064645,-0.48743,-0.47405,1,0
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,6.8565e-05,-0.48749,-0.5932,1,0
1,GO INTERLEUKIN 8 PRODUCTION,0.00014062,-0.48758,-0.58914,1,0
1,GO LEUKOCYTE DIFFERENTIATION,1.3909e-05,-0.48758,-0.5967,1,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,4.9495e-06,-0.4876,-0.5013,1,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,5.7533e-06,-0.48761,-0.49285,1,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,1.0403e-05,-0.48762,-0.56886,1,0
1,GO TRNA TRANSPORT,9.6689e-06,-0.48767,-0.54131,1,0
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,8.3461e-06,-0.48787,-0.5388,1,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,7.7514e-06,-0.48795,-0.49406,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,1.7249e-05,-0.48801,-0.48294,1,0
1,GO EXOCYTIC PROCESS,1.8524e-05,-0.48809,-0.58421,1,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00011593,-0.48813,-0.59401,1,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,4.9495e-06,-0.48814,-0.518,1,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,2.2907e-05,-0.48819,-0.54196,1,0
1,GO APOPTOTIC PROCESS,4.5891e-06,-0.48822,-0.52276,1,0
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,4.5891e-06,-0.48825,-0.54006,1,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.00031664,-0.48842,-0.54728,1,0
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.48848,-0.54704,1,0
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,1.6059e-05,-0.48857,-0.51762,1,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,2.636e-05,-0.48859,-0.55956,1,0
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.00015974,-0.4886,-0.50872,1,0
1,GO BEHAVIOR,7.7514e-06,-0.48864,-0.52553,1,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,5.7533e-06,-0.48865,-0.52273,1,0
1,GO NCRNA EXPORT FROM NUCLEUS,8.9843e-06,-0.48866,-0.56191,1,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,1.2035e-05,-0.48866,-0.51432,1,0
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,6.2007e-06,-0.48875,-0.50039,1,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,1.0403e-05,-0.48878,-0.48088,1,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,2.1347e-05,-0.48897,-0.53054,1,0
1,GO CELLULAR COMPONENT DISASSEMBLY,3.9422e-06,-0.48904,-0.50692,1,0
1,GO ADULT BEHAVIOR,5.6086e-05,-0.48909,-0.51785,1,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,1.6059e-05,-0.48914,-0.51799,1,0
1,GO FATTY ACID TRANSPORT,4.5891e-06,-0.48935,-0.51603,1,0
1,GO PROTEIN AUTOUBIQUITINATION,7.1973e-06,-0.48942,-0.48877,1,0
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,1.6059e-05,-0.48949,-0.60092,1,0
1,GO STEROL METABOLIC PROCESS,8.9843e-06,-0.48968,-0.4937,1,0
1,GO RESPONSE TO OXIDATIVE STRESS,4.5891e-06,-0.48975,-0.50993,1,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,2.4576e-05,-0.48976,-0.52613,1,0
1,GO RESPONSE TO HYDROPEROXIDE,0.00010866,-0.48978,-0.55011,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.00026348,-0.48979,-0.54688,1,0
1,GO VASODILATION,2.2907e-05,-0.48999,-0.44444,1,0
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,4.9495e-06,-0.4901,-0.50852,1,0
1,GO TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.49021,-0.47729,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.2007e-06,-0.49028,-0.47731,1,0
1,GO WATER HOMEOSTASIS,3.248e-05,-0.49033,-0.48383,1,0
1,GO PROTEIN HOMOOLIGOMERIZATION,4.9495e-06,-0.49042,-0.50826,1,0
1,GO RESPONSE TO FATTY ACID,8.9843e-06,-0.49042,-0.50532,1,0
1,GO STEM CELL DIFFERENTIATION,3.9422e-06,-0.4906,-0.49866,1,0
1,GO CELLULAR HOMEOSTASIS,4.5891e-06,-0.49076,-0.50389,1,0
1,GO MICROTUBULE BASED TRANSPORT,1.1191e-05,-0.49082,-0.52165,1,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00081392,-0.49083,-0.58133,1,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,2.2907e-05,-0.49088,-0.49251,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00040321,-0.49097,-0.60739,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00012367,-0.49113,-0.50423,1,0
1,GO RIG I SIGNALING PATHWAY,1.6059e-05,-0.49119,-0.51168,1,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,6.6813e-06,-0.49138,-0.51088,1,0
1,GO RESPONSE TO CORTICOSTERONE,0.0010798,-0.49148,-0.4929,1,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.025096,-0.49151,-0.51776,1,0
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.2007e-06,-0.49159,-0.50246,1,0
1,GO POLYOL TRANSPORT,0.00013188,-0.49169,-0.50158,1,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,8.3461e-06,-0.49174,-0.51313,1,0
1,GO REPRODUCTION,6.2007e-06,-0.49174,-0.4828,1,0
1,GO DNA METHYLATION OR DEMETHYLATION,8.9843e-06,-0.49176,-0.48572,1,0
1,GO REGULATION OF DNA METABOLIC PROCESS,4.5891e-06,-0.49185,-0.51841,1,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,4.5779e-05,-0.49207,-0.46624,1,0
1,GO MODULATION BY HOST OF VIRAL PROCESS,8.9843e-06,-0.49208,-0.52666,1,0
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,5.337e-06,-0.49219,-0.51064,1,0
1,GO MAINTENANCE OF LOCATION IN CELL,5.337e-06,-0.49222,-0.52601,1,0
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.0403e-05,-0.49244,-0.53851,1,0
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,6.2007e-06,-0.49266,-0.50949,1,0
1,GO PONS DEVELOPMENT,0.023112,-0.49276,-0.44496,1,0
1,GO GLYCOSYLATION,7.7514e-06,-0.49276,-0.49409,1,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,4.9495e-06,-0.49278,-0.519,1,0
1,GO THYMOCYTE APOPTOTIC PROCESS,6.8565e-05,-0.49282,-0.55485,1,0
1,GO VITAMIN BIOSYNTHETIC PROCESS,2.2907e-05,-0.49285,-0.57638,1,0
1,GO WHITE FAT CELL DIFFERENTIATION,3.9422e-06,-0.49289,-0.53954,1,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,8.3461e-06,-0.49295,-0.49188,1,0
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,5.337e-06,-0.49298,-0.50379,1,0
1,GO PROTEIN PROCESSING,1.0403e-05,-0.49298,-0.50683,1,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,8.9843e-06,-0.49316,-0.56216,1,0
1,GO CELL CHEMOTAXIS,9.5377e-05,-0.49316,-0.55874,1,0
1,GO COPII COATED VESICLE BUDDING,5.7533e-06,-0.4932,-0.50779,1,0
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,6.6813e-06,-0.4932,-0.53447,1,0
1,GO ENDOCRINE PROCESS,9.6689e-06,-0.49326,-0.51162,1,0
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,7.1973e-06,-0.49339,-0.48242,1,0
1,GO FATTY ACID BETA OXIDATION,1.1191e-05,-0.49354,-0.47472,1,0
1,GO HORMONE TRANSPORT,1.6059e-05,-0.49356,-0.48504,1,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,1.0403e-05,-0.49362,-0.59726,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,5.337e-06,-0.49379,-0.53622,1,0
1,GO REGULATION OF B CELL DIFFERENTIATION,7.3279e-05,-0.49381,-0.67011,1,0
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00024771,-0.49395,-0.58595,1,0
1,GO NUCLEAR ENVELOPE ORGANIZATION,8.3461e-06,-0.49396,-0.54661,1,0
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,4.2539e-06,-0.49403,-0.53532,1,0
1,GO REGULATION OF PROTEIN FOLDING,1.2939e-05,-0.49406,-0.49238,1,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,1.0403e-05,-0.49408,-0.49634,1,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,7.1973e-06,-0.49446,-0.52444,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.337e-06,-0.49456,-0.53087,1,0
1,GO VESICLE BUDDING FROM MEMBRANE,6.2007e-06,-0.49488,-0.51028,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0063209,-0.49489,-0.52781,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,2.2907e-05,-0.49531,-0.49215,1,0
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,8.9843e-06,-0.49547,-0.49843,1,0
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,8.9843e-06,-0.49556,-0.47916,1,0
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,3.0304e-05,-0.49572,-0.544,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00048214,-0.49574,-0.57009,1,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,1.4947e-05,-0.49578,-0.49836,1,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,2.8267e-05,-0.49581,-0.52104,1,0
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,5.337e-06,-0.49582,-0.48991,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.9495e-06,-0.4959,-0.5062,1,0
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,8.9843e-06,-0.4959,-0.55127,1,0
1,GO REGULATION OF PEPTIDE TRANSPORT,4.9495e-06,-0.49594,-0.53114,1,0
1,GO REGULATION OF CELL FATE SPECIFICATION,6.4139e-05,-0.49597,-0.52917,1,0
1,GO NEGATIVE REGULATION OF TRANSPORT,4.2539e-06,-0.49598,-0.50707,1,0
1,GO LYMPHOCYTE COSTIMULATION,0.00031664,-0.49598,-0.60166,1,0
1,GO NEURON CELLULAR HOMEOSTASIS,2.4576e-05,-0.49613,-0.55098,1,0
1,GO BIOLOGICAL PHASE,0.00024771,-0.49617,-0.46638,1,0
1,GO CELL PROLIFERATION IN HINDBRAIN,1.6059e-05,-0.49632,-0.50624,1,0
1,GO AMINO SUGAR METABOLIC PROCESS,8.3461e-06,-0.49636,-0.52617,1,0
1,GO BLASTODERM SEGMENTATION,1.1191e-05,-0.49668,-0.48924,1,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,3.0304e-05,-0.49671,-0.49973,1,0
1,GO ENDOSOME ORGANIZATION,4.9495e-06,-0.49685,-0.5133,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,9.6689e-06,-0.49685,-0.56091,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.49685,-0.51884,1,0
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,5.6086e-05,-0.49686,-0.61241,1,0
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.49687,-0.53147,1,0
1,GO CELL RECOGNITION,9.6689e-06,-0.49694,-0.48403,1,0
1,GO REGULATION OF LEUKOCYTE MIGRATION,0.00013188,-0.49696,-0.57699,1,0
1,GO LOCOMOTORY BEHAVIOR,1.8524e-05,-0.49697,-0.55985,1,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,6.2007e-06,-0.49702,-0.51201,1,0
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00026348,-0.49706,-0.60914,1,0
1,GO REPRODUCTIVE BEHAVIOR,0.00015974,-0.49714,-0.4806,1,0
1,GO NEGATIVE REGULATION OF CELL DEATH,3.9422e-06,-0.49725,-0.51526,1,0
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,4.5891e-06,-0.49729,-0.51236,1,0
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,6.8565e-05,-0.49736,-0.45132,1,0
1,GO CATION TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.49741,-0.49575,1,0
1,GO POSITIVE REGULATION OF ORGAN GROWTH,5.337e-06,-0.49744,-0.54952,1,0
1,GO VIRAL GENOME REPLICATION,5.9985e-05,-0.49756,-0.51374,1,0
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,5.7533e-06,-0.49763,-0.53415,1,0
1,GO RESPONSE TO ALCOHOL,4.9495e-06,-0.49776,-0.52698,1,0
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.7514e-06,-0.49781,-0.53659,1,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,6.6813e-06,-0.4979,-0.5678,1,0
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.2907e-05,-0.4979,-0.58063,1,0
1,GO RESPONSE TO TYPE I INTERFERON,0.0028457,-0.49792,-0.59973,1,0
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,2.8267e-05,-0.49811,-0.50596,1,0
1,GO NEURAL TUBE PATTERNING,2.8267e-05,-0.49813,-0.49306,1,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,8.3461e-06,-0.49823,-0.51485,1,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,5.337e-06,-0.49826,-0.5963,1,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,1.1191e-05,-0.49831,-0.5293,1,0
1,GO REGULATION OF NECROTIC CELL DEATH,0.00014062,-0.49846,-0.47396,1,0
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,5.337e-06,-0.49858,-0.49664,1,0
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00017019,-0.49859,-0.52222,1,0
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,7.1973e-06,-0.49864,-0.47947,1,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,8.3461e-06,-0.49876,-0.59841,1,0
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,2.8267e-05,-0.49876,-0.59557,1,0
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.4947e-05,-0.49882,-0.56402,1,0
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,6.2007e-06,-0.49897,-0.51456,1,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,3.4805e-05,-0.49931,-0.52788,1,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00010181,-0.49937,-0.42288,1,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,2.8267e-05,-0.49947,-0.49895,1,0
1,GO T HELPER CELL LINEAGE COMMITMENT,0.0011418,-0.49949,-0.60362,1,0
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.010101,-0.49952,-0.47317,1,0
1,GO MATING BEHAVIOR,0.00040321,-0.49952,-0.45603,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,6.2007e-06,-0.4996,-0.53194,1,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00017019,-0.49962,-0.47647,1,0
1,GO INORGANIC ANION TRANSPORT,5.337e-06,-0.49973,-0.50212,1,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.00096503,-0.49974,-0.46549,1,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,1.3909e-05,-0.49974,-0.4554,1,0
1,GO MYOBLAST FUSION,5.2428e-05,-0.4998,-0.63673,1,0
1,GO PROSTATE GLAND DEVELOPMENT,1.4947e-05,-0.49981,-0.51916,1,0
1,GO REGULATION OF PROTEOLYSIS,4.9495e-06,-0.49988,-0.51839,1,0
1,GO REGULATION OF RESPONSE TO STRESS,3.9422e-06,-0.49991,-0.53772,1,0
1,GO PROTEIN KINASE A SIGNALING,8.9843e-06,-0.49995,-0.48346,1,0
1,GO NUCLEAR BODY ORGANIZATION,1.7249e-05,-0.50003,-0.52082,1,0
1,GO CATION TRANSPORT,7.1973e-06,-0.5001,-0.49048,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,9.5377e-05,-0.50011,-0.4664,1,0
1,GO SYNCYTIUM FORMATION,3.0304e-05,-0.50013,-0.60779,1,0
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,1.6059e-05,-0.50019,-0.69715,1,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.1191e-05,-0.50025,-0.50431,1,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,8.9843e-06,-0.50026,-0.53765,1,0
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00042807,-0.50037,-0.50914,1,0
1,GO O GLYCAN PROCESSING,8.9327e-05,-0.5004,-0.46445,1,0
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,3.9422e-06,-0.50047,-0.57043,1,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,4.2763e-05,-0.50048,-0.55071,1,0
1,GO T CELL RECEPTOR SIGNALING PATHWAY,5.9985e-05,-0.50057,-0.52991,1,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,3.0304e-05,-0.50059,-0.49134,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00028019,-0.50067,-0.60493,1,0
1,GO HORMONE MEDIATED SIGNALING PATHWAY,4.5891e-06,-0.50071,-0.51622,1,0
1,GO REGENERATION,5.337e-06,-0.50079,-0.52279,1,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,6.2007e-06,-0.50082,-0.49782,1,0
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,4.5779e-05,-0.50087,-0.48126,1,0
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0013481,-0.50096,-0.60061,1,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.00013188,-0.50118,-0.44472,1,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,7.3279e-05,-0.50129,-0.46924,1,0
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,7.7514e-06,-0.50134,-0.52567,1,0
1,GO ION TRANSMEMBRANE TRANSPORT,6.2007e-06,-0.50136,-0.49825,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00010181,-0.50138,-0.56818,1,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,9.6689e-06,-0.5014,-0.58982,1,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.00031664,-0.50143,-0.42951,1,0
1,GO HINDBRAIN MORPHOGENESIS,4.5891e-06,-0.50143,-0.56597,1,0
1,GO RELAXATION OF MUSCLE,1.3909e-05,-0.50161,-0.52193,1,0
1,GO TRANSFERRIN TRANSPORT,9.6689e-06,-0.50164,-0.48776,1,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,6.2007e-06,-0.50165,-0.51315,1,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,4.9495e-06,-0.50165,-0.55668,1,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,5.7533e-06,-0.50171,-0.56484,1,0
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.9495e-06,-0.50174,-0.50323,1,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,8.3461e-06,-0.50185,-0.52455,1,0
1,GO PROTEIN HOMOTETRAMERIZATION,7.1973e-06,-0.50191,-0.48414,1,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,5.337e-06,-0.50196,-0.51031,1,0
1,GO REGULATION OF GLIOGENESIS,5.7533e-06,-0.5021,-0.50982,1,0
1,GO NUCLEOTIDE TRANSPORT,1.2035e-05,-0.50212,-0.48951,1,0
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,1.9888e-05,-0.50215,-0.59918,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS,3.4805e-05,-0.50216,-0.54685,1,0
1,GO PROTEOLYSIS,4.9495e-06,-0.50221,-0.51424,1,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,2.636e-05,-0.50257,-0.56949,1,0
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,4.5891e-06,-0.50279,-0.52776,1,0
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,4.5779e-05,-0.50285,-0.58638,1,0
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,1.7249e-05,-0.50292,-0.50344,1,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.00018128,-0.50295,-0.46065,1,0
1,GO HISTONE H3 K9 TRIMETHYLATION,8.3461e-06,-0.50297,-0.5704,1,0
1,GO STEROL HOMEOSTASIS,6.2007e-06,-0.503,-0.54648,1,0
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00021879,-0.50302,-0.65772,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.1191e-05,-0.50312,-0.62147,1,0
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,9.6689e-06,-0.50322,-0.52837,1,0
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,1.6059e-05,-0.50327,-0.61572,1,0
1,GO CARBOHYDRATE HOMEOSTASIS,8.3461e-06,-0.5033,-0.51323,1,0
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0031545,-0.50341,-0.54977,1,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,1.3909e-05,-0.50344,-0.5093,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,8.9843e-06,-0.50346,-0.51701,1,0
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00051151,-0.50374,-0.47857,1,0
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.5039,-0.53423,1,0
1,GO FATTY ACYL COA METABOLIC PROCESS,7.3279e-05,-0.50391,-0.4723,1,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,6.2007e-06,-0.50396,-0.50082,1,0
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00023283,-0.504,-0.56576,1,0
1,GO GOLGI VESICLE BUDDING,6.2007e-06,-0.50403,-0.52595,1,0
1,GO GLIAL CELL PROLIFERATION,2.2907e-05,-0.50406,-0.5348,1,0
1,GO CELLULAR ION HOMEOSTASIS,5.337e-06,-0.50408,-0.50718,1,0
1,GO CARBOHYDRATE METABOLIC PROCESS,5.7533e-06,-0.5041,-0.51263,1,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.00015974,-0.50422,-0.53185,1,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00019306,-0.50431,-0.45545,1,0
1,GO METAL ION HOMEOSTASIS,5.7533e-06,-0.50431,-0.50864,1,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,3.9422e-06,-0.50435,-0.56022,1,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,7.7514e-06,-0.5044,-0.51993,1,0
1,GO ADAPTATION OF SIGNALING PATHWAY,8.3461e-06,-0.5045,-0.55899,1,0
1,GO INTERLEUKIN 6 PRODUCTION,3.9936e-05,-0.50469,-0.59006,1,0
1,GO AMYLOID BETA FORMATION,8.3461e-06,-0.50471,-0.55612,1,0
1,GO CYTOKINESIS,8.9843e-06,-0.50481,-0.52804,1,0
1,GO PROTEIN LOCALIZATION TO CILIUM,1.1191e-05,-0.5049,-0.52406,1,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,5.337e-06,-0.50491,-0.52375,1,0
1,GO PROTEIN METHYLATION,7.1973e-06,-0.50499,-0.54423,1,0
1,GO REGULATION OF HEMOPOIESIS,6.2007e-06,-0.50503,-0.56026,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.012106,-0.50508,-0.6548,1,0
1,GO REGULATION OF CELL DEATH,4.2539e-06,-0.50512,-0.52788,1,0
1,GO CARDIAC CHAMBER FORMATION,0.00012367,-0.50514,-0.5382,1,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.2035e-05,-0.50516,-0.51508,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.4139e-05,-0.50528,-0.62001,1,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,5.337e-06,-0.50533,-0.54575,1,0
1,GO CATECHOLAMINE UPTAKE,0.00040321,-0.50533,-0.49151,1,0
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,4.9495e-06,-0.50543,-0.58066,1,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,1.9888e-05,-0.50546,-0.50044,1,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,3.0304e-05,-0.50547,-0.57206,1,0
1,GO MAST CELL ACTIVATION,1.1191e-05,-0.50548,-0.61095,1,0
1,GO INSULIN SECRETION,1.6059e-05,-0.50556,-0.5078,1,0
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,3.0304e-05,-0.50557,-0.5633,1,0
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.4805e-05,-0.50558,-0.57545,1,0
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,5.7533e-06,-0.50561,-0.54667,1,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,3.0304e-05,-0.50562,-0.48666,1,0
1,GO CELL MATURATION,1.4947e-05,-0.50567,-0.49487,1,0
1,GO MACROPHAGE DIFFERENTIATION,3.0304e-05,-0.50571,-0.6746,1,0
1,GO CHOLESTEROL EFFLUX,7.1973e-06,-0.50572,-0.55251,1,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,1.1191e-05,-0.50587,-0.48733,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,1.2035e-05,-0.5059,-0.59617,1,0
1,GO REGULATION OF INSULIN SECRETION,1.3909e-05,-0.50596,-0.50275,1,0
1,GO INNER EAR MORPHOGENESIS,1.7249e-05,-0.506,-0.47145,1,0
1,GO SYNAPTIC VESICLE LOCALIZATION,3.7287e-05,-0.506,-0.58099,1,0
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00035748,-0.50602,-0.54147,1,0
1,GO STEROL TRANSPORT,5.337e-06,-0.50603,-0.56188,1,0
1,GO REGULATION OF HORMONE SECRETION,1.6059e-05,-0.50604,-0.47752,1,0
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00064645,-0.50613,-0.60811,1,0
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,4.9495e-06,-0.50626,-0.54861,1,0
1,GO RESPONSE TO CATECHOLAMINE,4.8997e-05,-0.50632,-0.50132,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,5.7533e-06,-0.50634,-0.54872,1,0
1,GO REGULATION OF VIRAL LIFE CYCLE,6.8565e-05,-0.50639,-0.51872,1,0
1,GO LIPID BIOSYNTHETIC PROCESS,6.2007e-06,-0.50646,-0.49303,1,0
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,5.7533e-06,-0.50655,-0.51757,1,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,3.9936e-05,-0.5067,-0.51376,1,0
1,GO NON RECOMBINATIONAL REPAIR,7.1973e-06,-0.50686,-0.51919,1,0
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00332,-0.50689,-0.5033,1,0
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,5.337e-06,-0.50689,-0.52139,1,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,5.337e-06,-0.50695,-0.49621,1,0
1,GO ERAD PATHWAY,4.5891e-06,-0.50698,-0.57357,1,0
1,GO GONADOTROPIN SECRETION,1.1191e-05,-0.50704,-0.50215,1,0
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00035748,-0.50741,-0.60352,1,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,5.337e-06,-0.50743,-0.54358,1,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,1.3909e-05,-0.50756,-0.50776,1,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,1.3909e-05,-0.50757,-0.46251,1,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,7.1973e-06,-0.50765,-0.52549,1,0
1,GO PROGESTERONE METABOLIC PROCESS,0.00031664,-0.50789,-0.47422,1,0
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,2.4576e-05,-0.5079,-0.51694,1,0
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,4.2539e-06,-0.50793,-0.57562,1,0
1,GO B CELL PROLIFERATION,0.00024771,-0.50797,-0.6377,1,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,7.3279e-05,-0.50807,-0.43409,1,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,3.0304e-05,-0.50813,-0.51614,1,0
1,GO PROTEIN STABILIZATION,4.2539e-06,-0.50828,-0.50285,1,0
1,GO MACROAUTOPHAGY,4.5891e-06,-0.50836,-0.54379,1,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,4.5779e-05,-0.50841,-0.54575,1,0
1,GO PIGMENT ACCUMULATION,4.2763e-05,-0.50844,-0.60973,1,0
1,GO T CELL DIFFERENTIATION IN THYMUS,1.9888e-05,-0.50866,-0.59281,1,0
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,1.4947e-05,-0.50876,-0.56756,1,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,9.6689e-06,-0.50877,-0.52905,1,0
1,GO NEURONAL ACTION POTENTIAL,5.9985e-05,-0.50877,-0.48192,1,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.3909e-05,-0.50882,-0.48923,1,0
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,5.6086e-05,-0.50885,-0.50395,1,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,4.9495e-06,-0.50886,-0.51804,1,0
1,GO TRANSMISSION OF NERVE IMPULSE,5.6086e-05,-0.50896,-0.49779,1,0
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,1.7249e-05,-0.50896,-0.51118,1,0
1,GO SIGNAL RELEASE,1.0403e-05,-0.50897,-0.51634,1,0
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,3.4805e-05,-0.50907,-0.6273,1,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0010209,-0.50908,-0.41853,1,0
1,GO PHOSPHOLIPID HOMEOSTASIS,1.8524e-05,-0.50913,-0.52353,1,0
1,GO RESPONSE TO IONIZING RADIATION,4.2539e-06,-0.50913,-0.52379,1,0
1,GO HOMEOSTATIC PROCESS,4.9495e-06,-0.50917,-0.5206,1,0
1,GO RECEPTOR BIOSYNTHETIC PROCESS,8.9843e-06,-0.50925,-0.55182,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0010798,-0.50934,-0.49753,1,0
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,1.8524e-05,-0.50944,-0.58178,1,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,4.2539e-06,-0.50957,-0.50107,1,0
1,GO GLUCOSE METABOLIC PROCESS,8.3461e-06,-0.50971,-0.53836,1,0
1,GO ENGULFMENT OF APOPTOTIC CELL,9.6689e-06,-0.50974,-0.62194,1,0
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,3.248e-05,-0.50979,-0.56307,1,0
1,GO REGULATION OF ATP METABOLIC PROCESS,4.2539e-06,-0.50981,-0.52063,1,0
1,GO LIVER MORPHOGENESIS,1.8524e-05,-0.50991,-0.57838,1,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,6.6813e-06,-0.50994,-0.53986,1,0
1,GO VESICLE TARGETING,5.7533e-06,-0.51012,-0.53103,1,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,3.7287e-05,-0.51013,-0.47972,1,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.248e-05,-0.51016,-0.53287,1,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00014062,-0.51022,-0.60651,1,0
1,GO ORGANELLE LOCALIZATION,5.337e-06,-0.51049,-0.55688,1,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,6.2007e-06,-0.51054,-0.54948,1,0
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,5.7533e-06,-0.5106,-0.59077,1,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.3909e-05,-0.51068,-0.53697,1,0
1,GO FOREBRAIN CELL MIGRATION,4.9495e-06,-0.51073,-0.58926,1,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,1.4947e-05,-0.51079,-0.52161,1,0
1,GO REGULATION OF PROTEIN STABILITY,4.5891e-06,-0.5108,-0.50669,1,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,2.1347e-05,-0.51082,-0.56225,1,0
1,GO ACIDIC AMINO ACID TRANSPORT,3.248e-05,-0.51087,-0.52851,1,0
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,1.1191e-05,-0.51088,-0.52969,1,0
1,GO TYPE I INTERFERON PRODUCTION,1.3909e-05,-0.51088,-0.56712,1,0
1,GO GENE SILENCING,5.7533e-06,-0.51091,-0.52588,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,1.9888e-05,-0.51106,-0.53532,1,0
1,GO SODIUM ION HOMEOSTASIS,3.0304e-05,-0.5111,-0.4746,1,0
1,GO ION HOMEOSTASIS,5.337e-06,-0.51119,-0.5106,1,0
1,GO REGULATION OF GLUCOSE IMPORT,6.2007e-06,-0.51126,-0.50413,1,0
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.51131,-0.54833,1,0
1,GO SYNAPTIC VESICLE DOCKING,0.0017696,-0.51143,-0.64323,1,0
1,GO REGULATION OF HEART RATE,1.8524e-05,-0.51153,-0.5096,1,0
1,GO REGULATION OF CYCLASE ACTIVITY,6.6813e-06,-0.51153,-0.49889,1,0
1,GO MEMBRANE DOCKING,8.3461e-06,-0.51168,-0.55217,1,0
1,GO REGULATION OF VIRAL GENOME REPLICATION,0.00014989,-0.51172,-0.50889,1,0
1,GO KIDNEY MESENCHYME DEVELOPMENT,1.7249e-05,-0.51183,-0.57123,1,0
1,GO PROTEIN DEPHOSPHORYLATION,4.5891e-06,-0.51194,-0.54665,1,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,5.337e-06,-0.512,-0.53755,1,0
1,GO THYMUS DEVELOPMENT,7.7514e-06,-0.51208,-0.5082,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,6.4139e-05,-0.51216,-0.61606,1,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,7.8298e-05,-0.51235,-0.58951,1,0
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,4.9495e-06,-0.51245,-0.57273,1,0
1,GO RESPONSE TO DOPAMINE,7.3279e-05,-0.51251,-0.49075,1,0
1,GO POSITIVE REGULATION OF PROTEOLYSIS,4.2539e-06,-0.51251,-0.55003,1,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,5.9985e-05,-0.51272,-0.61424,1,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,7.7514e-06,-0.51275,-0.52031,1,0
1,GO EPITHELIAL CELL MATURATION,8.3641e-05,-0.51289,-0.50943,1,0
1,GO REGULATION OF CHROMOSOME ORGANIZATION,8.3461e-06,-0.51321,-0.5287,1,0
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.1347e-05,-0.51322,-0.61821,1,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,2.4576e-05,-0.51334,-0.57446,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION,4.9495e-06,-0.51348,-0.54615,1,0
1,GO NEGATIVE REGULATION OF BINDING,4.9495e-06,-0.51363,-0.5284,1,0
1,GO LEUKOCYTE MIGRATION,3.0304e-05,-0.51372,-0.59893,1,0
1,GO REGULATION OF AMYLOID BETA FORMATION,1.0403e-05,-0.51373,-0.57278,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,1.9888e-05,-0.51375,-0.4413,1,0
1,GO B CELL APOPTOTIC PROCESS,3.4805e-05,-0.51389,-0.51758,1,0
1,GO RESPONSE TO DRUG,5.7533e-06,-0.51389,-0.51301,1,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,5.337e-06,-0.51404,-0.55224,1,0
1,GO SPLEEN DEVELOPMENT,8.9843e-06,-0.5141,-0.53645,1,0
1,GO REGULATION OF MYELINATION,4.9495e-06,-0.51418,-0.53698,1,0
1,GO SPINAL CORD DEVELOPMENT,9.6689e-06,-0.51419,-0.55995,1,0
1,GO RESPONSE TO ABIOTIC STIMULUS,4.2539e-06,-0.51423,-0.51113,1,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,4.2539e-06,-0.51424,-0.50231,1,0
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.0403e-05,-0.51433,-0.5356,1,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,4.9495e-06,-0.5144,-0.54455,1,0
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.51442,-0.53796,1,0
1,GO REGULATION OF PROTEIN TARGETING,4.5891e-06,-0.51453,-0.56043,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,5.9985e-05,-0.51454,-0.51737,1,0
1,GO REGULATION OF B CELL PROLIFERATION,0.00014062,-0.51456,-0.66372,1,0
1,GO TOR SIGNALING,5.337e-06,-0.51492,-0.56824,1,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,1.4947e-05,-0.51492,-0.51734,1,0
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,7.7514e-06,-0.51494,-0.56246,1,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,1.4947e-05,-0.51494,-0.47261,1,0
1,GO AUTOPHAGOSOME MATURATION,4.2539e-06,-0.51497,-0.56245,1,0
1,GO NEUROINFLAMMATORY RESPONSE,0.00010181,-0.51533,-0.66609,1,0
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.2035e-05,-0.51537,-0.5937,1,0
1,GO OSTEOBLAST DEVELOPMENT,1.8524e-05,-0.51542,-0.51723,1,0
1,GO HISTONE H3 ACETYLATION,4.5891e-06,-0.51548,-0.57679,1,0
1,GO MAINTENANCE OF LOCATION,4.9495e-06,-0.51552,-0.54087,1,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,1.4947e-05,-0.51564,-0.55713,1,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,4.2539e-06,-0.51576,-0.52694,1,0
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.51591,-0.52674,1,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,3.4805e-05,-0.51606,-0.55658,1,0
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,3.9936e-05,-0.5161,-0.55455,1,0
1,GO FIBROBLAST APOPTOTIC PROCESS,2.4576e-05,-0.51611,-0.53573,1,0
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,1.9888e-05,-0.51614,-0.49451,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00020554,-0.51622,-0.62362,1,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,1.2035e-05,-0.51637,-0.58597,1,0
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,3.9422e-06,-0.51645,-0.52442,1,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0019699,-0.51651,-0.53788,1,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,1.0403e-05,-0.51652,-0.54903,1,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,5.7533e-06,-0.51661,-0.49539,1,0
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,3.9422e-06,-0.51669,-0.56436,1,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,2.1347e-05,-0.51684,-0.53359,1,0
1,GO RESPIRATORY BURST,0.00010866,-0.51689,-0.59793,1,0
1,GO ION TRANSPORT,6.6813e-06,-0.517,-0.49409,1,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,1.2939e-05,-0.51708,-0.49927,1,0
1,GO NEUTROPHIL EXTRAVASATION,6.8565e-05,-0.51713,-0.6501,1,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,5.337e-06,-0.51716,-0.51391,1,0
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00017019,-0.51733,-0.65312,1,0
1,GO SODIUM ION TRANSPORT,1.2939e-05,-0.51747,-0.49384,1,0
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0027019,-0.51774,-0.58083,1,0
1,GO RESPONSE TO SALT STRESS,5.6086e-05,-0.51783,-0.45901,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0010798,-0.51806,-0.61683,1,0
1,GO SECRETION,5.337e-06,-0.51808,-0.53588,1,0
1,GO HORMONE BIOSYNTHETIC PROCESS,0.00024771,-0.51814,-0.43902,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0034935,-0.51816,-0.5714,1,0
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,6.6813e-06,-0.51816,-0.50778,1,0
1,GO DEPHOSPHORYLATION,4.5891e-06,-0.5182,-0.54431,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00014989,-0.51821,-0.5874,1,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,4.2539e-06,-0.51835,-0.55629,1,0
1,GO MANGANESE ION TRANSPORT,4.9495e-06,-0.51838,-0.50713,1,0
1,GO MAINTENANCE OF PROTEIN LOCATION,5.7533e-06,-0.51843,-0.51348,1,0
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.51849,-0.55586,1,0
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00035748,-0.51856,-0.51701,1,0
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,1.7249e-05,-0.51859,-0.60247,1,0
1,GO EPIDERMIS MORPHOGENESIS,0.00023283,-0.51872,-0.51454,1,0
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.4947e-05,-0.51881,-0.55508,1,0
1,GO CELLULAR RESPONSE TO X RAY,3.248e-05,-0.51888,-0.59049,1,0
1,GO PROTEIN POLYGLUTAMYLATION,0.00012367,-0.51894,-0.47907,1,0
1,GO VITAMIN TRANSPORT,2.636e-05,-0.51913,-0.47606,1,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,5.9985e-05,-0.5192,-0.57519,1,0
1,GO PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.51922,-0.54217,1,0
1,GO LIMBIC SYSTEM DEVELOPMENT,5.337e-06,-0.51931,-0.5233,1,0
1,GO POSTSYNAPSE ORGANIZATION,6.6813e-06,-0.51935,-0.58182,1,0
1,GO CHEMICAL HOMEOSTASIS,6.2007e-06,-0.51945,-0.51144,1,0
1,GO VIRAL LIFE CYCLE,6.6813e-06,-0.51955,-0.53963,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.0027019,-0.5196,-0.58073,1,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,1.7249e-05,-0.51964,-0.48728,1,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0018673,-0.51966,-0.54245,1,0
1,GO PROTEIN O LINKED GLYCOSYLATION,1.2035e-05,-0.51979,-0.50217,1,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,6.6813e-06,-0.51988,-0.50857,1,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,9.6689e-06,-0.51992,-0.58186,1,0
1,GO MALE GENITALIA DEVELOPMENT,8.9327e-05,-0.51996,-0.49064,1,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,4.5891e-06,-0.52002,-0.54477,1,0
1,GO RESPONSE TO ANTIBIOTIC,4.2539e-06,-0.52017,-0.50474,1,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,4.5779e-05,-0.52025,-0.50076,1,0
1,GO REGULATION OF COAGULATION,1.2939e-05,-0.52026,-0.61032,1,0
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.0403e-05,-0.52037,-0.56116,1,0
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,2.2907e-05,-0.5204,-0.57571,1,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,4.9495e-06,-0.52042,-0.55002,1,0
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.2907e-05,-0.52044,-0.56694,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,3.248e-05,-0.52052,-0.52489,1,0
1,GO RETINA LAYER FORMATION,0.00068502,-0.5206,-0.51653,1,0
1,GO GENITALIA DEVELOPMENT,6.2007e-06,-0.52061,-0.52454,1,0
1,GO TOXIN TRANSPORT,3.9422e-06,-0.52073,-0.57547,1,0
1,GO LONG TERM SYNAPTIC POTENTIATION,1.4947e-05,-0.52083,-0.54317,1,0
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,6.6813e-06,-0.5209,-0.49605,1,0
1,GO REGULATION OF PLATELET AGGREGATION,3.0304e-05,-0.52093,-0.61555,1,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,6.4139e-05,-0.52099,-0.59382,1,0
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00081392,-0.52105,-0.64814,1,0
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,4.5891e-06,-0.52113,-0.55818,1,0
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,1.6059e-05,-0.52113,-0.60069,1,0
1,GO T HELPER 1 CELL DIFFERENTIATION,0.0021907,-0.52122,-0.60621,1,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,1.8524e-05,-0.52124,-0.51291,1,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,6.6813e-06,-0.52144,-0.5855,1,0
1,GO POSITIVE REGULATION OF TRANSPORT,5.337e-06,-0.52152,-0.54482,1,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,5.7533e-06,-0.52157,-0.54084,1,0
1,GO RESPONSE TO OSMOTIC STRESS,5.7533e-06,-0.52158,-0.52783,1,0
1,GO REGULATION OF INTRACELLULAR TRANSPORT,4.2539e-06,-0.52159,-0.55504,1,0
1,GO PATTERN SPECIFICATION PROCESS,6.2007e-06,-0.52161,-0.53077,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,1.2035e-05,-0.52165,-0.50266,1,0
1,GO PROTEIN ACYLATION,6.2007e-06,-0.52167,-0.56538,1,0
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,3.9422e-06,-0.52176,-0.57729,1,0
1,GO PROTEIN ACETYLATION,4.9495e-06,-0.52176,-0.57009,1,0
1,GO EAR DEVELOPMENT,7.7514e-06,-0.52176,-0.49823,1,0
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,4.9495e-06,-0.5218,-0.53884,1,0
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00081392,-0.52181,-0.51235,1,0
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,4.5891e-06,-0.52186,-0.56063,1,0
1,GO CEREBRAL CORTEX CELL MIGRATION,1.3909e-05,-0.52189,-0.61552,1,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,9.6689e-06,-0.5219,-0.51677,1,0
1,GO SEROTONIN SECRETION,4.2763e-05,-0.52193,-0.51684,1,0
1,GO GRANULOCYTE DIFFERENTIATION,1.7249e-05,-0.5221,-0.63178,1,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,6.6813e-06,-0.52218,-0.52932,1,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,2.2907e-05,-0.52222,-0.5601,1,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,1.2939e-05,-0.52248,-0.56008,1,0
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,4.9495e-06,-0.52255,-0.52735,1,0
1,GO TISSUE HOMEOSTASIS,5.337e-06,-0.52257,-0.55225,1,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,1.8524e-05,-0.52266,-0.52712,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,1.1191e-05,-0.52278,-0.55064,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,7.7514e-06,-0.52286,-0.54513,1,0
1,GO DNA METHYLATION,8.9843e-06,-0.52294,-0.51013,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0024341,-0.52302,-0.51995,1,0
1,GO EXOCYTOSIS,4.5891e-06,-0.52305,-0.56398,1,0
1,GO CELL CELL SIGNALING,6.2007e-06,-0.52311,-0.52375,1,0
1,GO GLYCEROLIPID METABOLIC PROCESS,5.337e-06,-0.52312,-0.52918,1,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.52322,-0.51872,1,0
1,GO RESPONSE TO GLUCAGON,3.0304e-05,-0.52323,-0.53364,1,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,1.7249e-05,-0.52323,-0.54436,1,0
1,GO REGULATION OF ORGANELLE ASSEMBLY,4.2539e-06,-0.52323,-0.56776,1,0
1,GO ENDOCRINE HORMONE SECRETION,2.8267e-05,-0.52338,-0.48151,1,0
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,9.5377e-05,-0.52351,-0.61125,1,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,9.6689e-06,-0.52354,-0.54462,1,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,5.337e-06,-0.52356,-0.50537,1,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.0010798,-0.52383,-0.44146,1,0
1,GO METAL ION TRANSPORT,6.2007e-06,-0.52388,-0.50594,1,0
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,8.9327e-05,-0.52389,-0.64172,1,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,6.2007e-06,-0.52406,-0.5723,1,0
1,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.0016767,-0.52414,-0.54041,1,0
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,3.9422e-06,-0.52431,-0.5119,1,0
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,5.337e-06,-0.52442,-0.52157,1,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,3.9422e-06,-0.52454,-0.52443,1,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.5246,-0.52396,1,0
1,GO RESPONSE TO THYROID HORMONE,1.6059e-05,-0.52498,-0.55855,1,0
1,GO RESPONSE TO GONADOTROPIN,1.7249e-05,-0.52511,-0.52313,1,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,1.0403e-05,-0.52511,-0.49107,1,0
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,4.5891e-06,-0.52511,-0.5198,1,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,8.9843e-06,-0.52527,-0.49379,1,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,8.9843e-06,-0.52533,-0.56166,1,0
1,GO MICROTUBULE BUNDLE FORMATION,0.00010866,-0.52544,-0.45696,1,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.5255,-0.52997,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,4.2763e-05,-0.52551,-0.55258,1,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,5.7533e-06,-0.52554,-0.53162,1,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,4.5891e-06,-0.52571,-0.54438,1,0
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.6059e-05,-0.52575,-0.56727,1,0
1,GO ANTEROGRADE AXONAL TRANSPORT,7.7514e-06,-0.52577,-0.61335,1,0
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,1.1191e-05,-0.52578,-0.54417,1,0
1,GO HIPPOCAMPUS DEVELOPMENT,8.3461e-06,-0.52586,-0.52591,1,0
1,GO RESPONSE TO STARVATION,5.7533e-06,-0.52595,-0.53585,1,0
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,6.6813e-06,-0.52599,-0.56545,1,0
1,GO GOLGI LOCALIZATION,6.6813e-06,-0.52612,-0.49219,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,4.5891e-06,-0.52619,-0.56218,1,0
1,GO NEGATIVE REGULATION OF SECRETION,3.9422e-06,-0.52638,-0.51223,1,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,5.2428e-05,-0.52655,-0.48984,1,0
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,6.2007e-06,-0.52659,-0.52866,1,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,5.337e-06,-0.52667,-0.56096,1,0
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,9.5377e-05,-0.52679,-0.60919,1,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,4.5891e-06,-0.52682,-0.5511,1,0
1,GO MITOCHONDRION LOCALIZATION,8.9843e-06,-0.52684,-0.59643,1,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00068502,-0.52697,-0.6752,1,0
1,GO REGULATION OF B CELL ACTIVATION,5.2428e-05,-0.52703,-0.64754,1,0
1,GO HINDBRAIN DEVELOPMENT,8.9843e-06,-0.52706,-0.54089,1,0
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,2.8267e-05,-0.52711,-0.55848,1,0
1,GO ER NUCLEUS SIGNALING PATHWAY,7.1973e-06,-0.52713,-0.53736,1,0
1,GO REGULATION OF EXCRETION,6.4139e-05,-0.52726,-0.48928,1,0
1,GO REGULATION OF ION TRANSPORT,6.2007e-06,-0.52731,-0.51261,1,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,3.9936e-05,-0.52741,-0.50948,1,0
1,GO NEURON APOPTOTIC PROCESS,5.337e-06,-0.52745,-0.53335,1,0
1,GO MYOTUBE DIFFERENTIATION,1.0403e-05,-0.52747,-0.56804,1,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,5.337e-06,-0.52751,-0.56858,1,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.00048214,-0.52752,-0.49803,1,0
1,GO AMINO ACID TRANSPORT,1.3909e-05,-0.52753,-0.52933,1,0
1,GO REGULATION OF VESICLE FUSION,8.3641e-05,-0.52775,-0.6408,1,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,1.3909e-05,-0.52778,-0.52748,1,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.52785,-0.5288,1,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.0403e-05,-0.52785,-0.56037,1,0
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00019306,-0.52794,-0.66737,1,0
1,GO CELLULAR RESPONSE TO FATTY ACID,9.6689e-06,-0.528,-0.50221,1,0
1,GO CHROMATIN ORGANIZATION,6.2007e-06,-0.52813,-0.56552,1,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,7.7514e-06,-0.52825,-0.52411,1,0
1,GO ENDODERMAL CELL FATE COMMITMENT,3.4805e-05,-0.52828,-0.50167,1,0
1,GO REGULATION OF PROTEIN IMPORT,3.9422e-06,-0.52841,-0.55394,1,0
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,4.5891e-06,-0.52841,-0.54201,1,0
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.1191e-05,-0.52844,-0.54577,1,0
1,GO REGULATION OF PEPTIDE SECRETION,7.7514e-06,-0.52857,-0.53211,1,0
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,6.6813e-06,-0.52862,-0.51659,1,0
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,1.9888e-05,-0.52863,-0.45646,1,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,4.8997e-05,-0.52866,-0.60461,1,0
1,GO HISTONE METHYLATION,5.337e-06,-0.52885,-0.58752,1,0
1,GO ERK1 AND ERK2 CASCADE,8.9843e-06,-0.52886,-0.60596,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,2.4576e-05,-0.52887,-0.55372,1,0
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,5.6086e-05,-0.52889,-0.55898,1,0
1,GO RESPONSE TO AMINO ACID STARVATION,5.337e-06,-0.52892,-0.56872,1,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,4.5891e-06,-0.52894,-0.57487,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,4.9495e-06,-0.529,-0.547,1,0
1,GO CGMP MEDIATED SIGNALING,8.3461e-06,-0.52908,-0.56134,1,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,8.9843e-06,-0.52909,-0.62033,1,0
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,1.1191e-05,-0.52912,-0.58971,1,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.0403e-05,-0.52922,-0.54475,1,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,7.7514e-06,-0.52931,-0.61562,1,0
1,GO REGULATION OF CIRCADIAN RHYTHM,1.2035e-05,-0.52948,-0.53627,1,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,4.5891e-06,-0.52959,-0.5748,1,0
1,GO REGULATION OF GENE SILENCING,5.337e-06,-0.52985,-0.54259,1,0
1,GO ANION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.52991,-0.51621,1,0
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00033648,-0.52995,-0.62346,1,0
1,GO POSITIVE REGULATION OF SECRETION,7.1973e-06,-0.52996,-0.51339,1,0
1,GO HEART VALVE FORMATION,7.3279e-05,-0.53011,-0.58373,1,0
1,GO PHOSPHOLIPID CATABOLIC PROCESS,1.0403e-05,-0.53014,-0.58627,1,0
1,GO RESPONSE TO OXYGEN LEVELS,4.2539e-06,-0.5305,-0.52274,1,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.00018128,-0.53052,-0.51453,1,0
1,GO PALLIUM DEVELOPMENT,6.6813e-06,-0.53052,-0.56808,1,0
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,6.2007e-06,-0.53052,-0.52923,1,0
1,GO REGULATION OF MACROPHAGE MIGRATION,0.00014989,-0.53057,-0.60429,1,0
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,6.2007e-06,-0.53058,-0.5527,1,0
1,GO REGULATION OF CHROMATIN BINDING,6.2007e-06,-0.53064,-0.6103,1,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,3.7287e-05,-0.53069,-0.55655,1,0
1,GO MONOAMINE TRANSPORT,0.00015974,-0.53076,-0.49319,1,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,7.7514e-06,-0.53078,-0.54282,1,0
1,GO CALCINEURIN MEDIATED SIGNALING,3.9422e-06,-0.53079,-0.5773,1,0
1,GO SUBPALLIUM DEVELOPMENT,0.00015974,-0.5308,-0.5502,1,0
1,GO B CELL MEDIATED IMMUNITY,0.00031664,-0.53092,-0.62001,1,0
1,GO REGULATION OF METAL ION TRANSPORT,5.337e-06,-0.53092,-0.52872,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION,6.6813e-06,-0.53103,-0.51156,1,0
1,GO AMYLOID FIBRIL FORMATION,1.8524e-05,-0.53113,-0.61844,1,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,4.8997e-05,-0.53117,-0.51116,1,0
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,3.9422e-06,-0.53133,-0.54765,1,0
1,GO RNA POLYADENYLATION,6.2007e-06,-0.53134,-0.58513,1,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,2.2907e-05,-0.53135,-0.5146,1,0
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,1.4947e-05,-0.53138,-0.67055,1,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,4.2539e-06,-0.53143,-0.54773,1,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,2.2907e-05,-0.53148,-0.56947,1,0
1,GO MEMBRANE ORGANIZATION,4.9495e-06,-0.53161,-0.55759,1,0
1,GO CELLULAR RESPONSE TO RETINOIC ACID,1.0403e-05,-0.5318,-0.55141,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,7.3279e-05,-0.53182,-0.52046,1,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,2.4576e-05,-0.53193,-0.50211,1,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,1.8524e-05,-0.53195,-0.53755,1,0
1,GO REGULATION OF CYTOKINESIS,1.2939e-05,-0.53196,-0.54447,1,0
1,GO REGULATION OF PHAGOCYTOSIS,6.4139e-05,-0.53202,-0.64619,1,0
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,7.1973e-06,-0.5322,-0.54192,1,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,1.2035e-05,-0.53245,-0.67608,1,0
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,4.8997e-05,-0.53259,-0.6088,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,1.4947e-05,-0.53265,-0.57243,1,0
1,GO ASTROCYTE DIFFERENTIATION,8.3461e-06,-0.53296,-0.58097,1,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.00020554,-0.53302,-0.55544,1,0
1,GO SYNAPTIC VESICLE MATURATION,0.0012758,-0.5331,-0.58792,1,0
1,GO NERVE DEVELOPMENT,2.2907e-05,-0.53318,-0.59902,1,0
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00011593,-0.5333,-0.50504,1,0
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.0044907,-0.53336,-0.51604,1,0
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.00051151,-0.53341,-0.73774,1,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,5.337e-06,-0.53348,-0.49977,1,0
1,GO RESPONSE TO NITROGEN COMPOUND,4.5891e-06,-0.5335,-0.55159,1,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,1.0403e-05,-0.53368,-0.60669,1,0
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,3.9936e-05,-0.53383,-0.57065,1,0
1,GO PHAGOSOME MATURATION,6.6813e-06,-0.53389,-0.54373,1,0
1,GO RESPONSE TO LIPID,4.5891e-06,-0.53405,-0.54138,1,0
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,6.6813e-06,-0.53414,-0.52087,1,0
1,GO MUSCLE FIBER DEVELOPMENT,8.3461e-06,-0.53421,-0.54117,1,0
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00040321,-0.53424,-0.55418,1,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,2.8267e-05,-0.53429,-0.53121,1,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,8.9843e-06,-0.53437,-0.52472,1,0
1,GO RESPONSE TO REDOX STATE,0.00029789,-0.53451,-0.4916,1,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.00091199,-0.53451,-0.45551,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.53452,-0.54187,1,0
1,GO POSITIVE REGULATION OF CELL DEATH,4.5891e-06,-0.53452,-0.55716,1,0
1,GO SULFATE TRANSPORT,0.00045436,-0.5346,-0.45149,1,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.8524e-05,-0.53488,-0.6345,1,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,1.4947e-05,-0.53496,-0.54402,1,0
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,7.1973e-06,-0.53502,-0.52363,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,9.6689e-06,-0.5351,-0.5019,1,0
1,GO AXO DENDRITIC TRANSPORT,1.0403e-05,-0.5352,-0.62141,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.9422e-06,-0.53525,-0.59611,1,0
1,GO TELENCEPHALON DEVELOPMENT,4.9495e-06,-0.53534,-0.57181,1,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,4.8997e-05,-0.53539,-0.64092,1,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.0403e-05,-0.53547,-0.57501,1,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00012367,-0.53549,-0.70202,1,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,1.1191e-05,-0.53556,-0.51881,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,6.6813e-06,-0.53563,-0.52971,1,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,6.2007e-06,-0.53572,-0.5242,1,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,8.3461e-06,-0.53578,-0.59084,1,0
1,GO SERTOLI CELL DIFFERENTIATION,6.6813e-06,-0.53578,-0.62173,1,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,3.4805e-05,-0.53579,-0.50802,1,0
1,GO MEMORY,9.6689e-06,-0.53589,-0.52935,1,0
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,1.8524e-05,-0.53591,-0.63094,1,0
1,GO VITAMIN D METABOLIC PROCESS,3.9936e-05,-0.53616,-0.57253,1,0
1,GO SENSORY ORGAN MORPHOGENESIS,6.6813e-06,-0.5362,-0.53257,1,0
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.53623,-0.58224,1,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,6.2007e-06,-0.53631,-0.59778,1,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,4.2539e-06,-0.53663,-0.55218,1,0
1,GO LYMPHOCYTE HOMEOSTASIS,1.2035e-05,-0.53667,-0.57079,1,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,9.6689e-06,-0.53672,-0.56765,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,5.7533e-06,-0.53689,-0.57805,1,0
1,GO RESPONSE TO HYDROGEN PEROXIDE,6.2007e-06,-0.53696,-0.50939,1,0
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0015882,-0.53703,-0.57664,1,0
1,GO POSITIVE REGULATION OF CELL ADHESION,1.8524e-05,-0.53708,-0.62672,1,0
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,3.0304e-05,-0.53709,-0.66747,1,0
1,GO MELANOCYTE DIFFERENTIATION,3.9422e-06,-0.53714,-0.55931,1,0
1,GO CELLULAR RESPONSE TO LIPID,4.5891e-06,-0.53721,-0.55373,1,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.636e-05,-0.53723,-0.59483,1,0
1,GO REGULATION OF GLUCONEOGENESIS,6.2007e-06,-0.53727,-0.58953,1,0
1,GO POLYOL METABOLIC PROCESS,6.2007e-06,-0.53729,-0.52407,1,0
1,GO RESPONSE TO PAIN,1.0403e-05,-0.5373,-0.5393,1,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,4.2763e-05,-0.5373,-0.51491,1,0
1,GO LYTIC VACUOLE ORGANIZATION,4.9495e-06,-0.53739,-0.58889,1,0
1,GO AMELOGENESIS,1.2939e-05,-0.53742,-0.57667,1,0
1,GO AUTOPHAGY OF MITOCHONDRION,4.9495e-06,-0.53747,-0.55995,1,0
1,GO PHOSPHOLIPID TRANSPORT,6.2007e-06,-0.53749,-0.57571,1,0
1,GO VISUAL BEHAVIOR,7.1973e-06,-0.53752,-0.53139,1,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0017696,-0.53768,-0.52637,1,0
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00026348,-0.5377,-0.63112,1,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,3.7287e-05,-0.53774,-0.50903,1,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,1.6059e-05,-0.53777,-0.54966,1,0
1,GO POSITIVE REGULATION OF SIGNALING,4.5891e-06,-0.53783,-0.55104,1,0
1,GO RESPONSE TO ESTRADIOL,6.6813e-06,-0.5379,-0.53031,1,0
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0010209,-0.5379,-0.57855,1,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,5.7533e-06,-0.53807,-0.62122,1,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.0083971,-0.53811,-0.60531,1,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,7.1973e-06,-0.53836,-0.62457,1,0
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,4.2539e-06,-0.53839,-0.54086,1,0
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,1.9888e-05,-0.53842,-0.59706,1,0
1,GO CELLULAR RESPONSE TO ATP,6.6813e-06,-0.53847,-0.53835,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,9.6689e-06,-0.53851,-0.55724,1,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,1.6059e-05,-0.53854,-0.50401,1,0
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,4.2539e-06,-0.53858,-0.56541,1,0
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.2035e-05,-0.53865,-0.61067,1,0
1,GO RESPONSE TO STEROID HORMONE,4.9495e-06,-0.53877,-0.55423,1,0
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,8.9843e-06,-0.53878,-0.57099,1,0
1,GO RESPONSE TO PEPTIDOGLYCAN,0.00072571,-0.53891,-0.6033,1,0
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,4.5891e-06,-0.53892,-0.54099,1,0
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,1.3909e-05,-0.53897,-0.61187,1,0
1,GO COLLECTING DUCT DEVELOPMENT,0.00023283,-0.539,-0.53078,1,0
1,GO GLIAL CELL ACTIVATION,0.00028019,-0.53908,-0.67187,1,0
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,9.6689e-06,-0.53908,-0.56186,1,0
1,GO RESPONSE TO TEMPERATURE STIMULUS,4.5891e-06,-0.53911,-0.53813,1,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,1.8524e-05,-0.53913,-0.51965,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.010572,-0.5392,-0.67942,1,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.53921,-0.53986,1,0
1,GO ORGANELLE FUSION,6.2007e-06,-0.53934,-0.58763,1,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,2.4576e-05,-0.53937,-0.54606,1,0
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,3.9422e-06,-0.53938,-0.55937,1,0
1,GO PEPTIDYL LYSINE MODIFICATION,4.5891e-06,-0.5394,-0.57569,1,0
1,GO HISTONE H3 K14 ACETYLATION,8.9843e-06,-0.5394,-0.59782,1,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,6.2007e-06,-0.53952,-0.54513,1,0
1,GO REGULATION OF HEAT GENERATION,3.4805e-05,-0.53956,-0.51326,1,0
1,GO REGULATION OF TOR SIGNALING,4.9495e-06,-0.53956,-0.58963,1,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,2.636e-05,-0.53956,-0.51731,1,0
1,GO CELLULAR RESPONSE TO SALT STRESS,0.00029789,-0.53964,-0.54237,1,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2035e-05,-0.53964,-0.66759,1,0
1,GO RESPONSE TO MURAMYL DIPEPTIDE,1.4947e-05,-0.53983,-0.6914,1,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,4.5891e-06,-0.53983,-0.56053,1,0
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,3.7287e-05,-0.53992,-0.53905,1,0
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00035748,-0.53994,-0.6658,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00014989,-0.54015,-0.46351,1,0
1,GO CELLULAR RESPONSE TO CAMP,4.9495e-06,-0.54017,-0.51415,1,0
1,GO ANION TRANSPORT,6.2007e-06,-0.54022,-0.50802,1,0
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,1.0403e-05,-0.54033,-0.51432,1,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,5.337e-06,-0.54045,-0.65941,1,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,2.1347e-05,-0.54055,-0.58599,1,0
1,GO GOLGI VESICLE TRANSPORT,4.2539e-06,-0.54058,-0.57154,1,0
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,4.9495e-06,-0.54069,-0.58554,1,0
1,GO REGULATION OF CARDIAC CONDUCTION,1.7249e-05,-0.5407,-0.49651,1,0
1,GO GLIAL CELL FATE COMMITMENT,0.00033648,-0.5409,-0.50326,1,0
1,GO BODY FLUID SECRETION,4.9495e-06,-0.54097,-0.50033,1,0
1,GO HEAD DEVELOPMENT,4.9495e-06,-0.54104,-0.57269,1,0
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,4.5891e-06,-0.54105,-0.54447,1,0
1,GO MEMBRANE BIOGENESIS,9.6689e-06,-0.54106,-0.57655,1,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,6.2007e-06,-0.54108,-0.54767,1,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.00010866,-0.54112,-0.57022,1,0
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,3.4805e-05,-0.54121,-0.68546,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0021907,-0.54126,-0.52166,1,0
1,GO RESPONSE TO VITAMIN,5.337e-06,-0.54132,-0.59169,1,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,5.7533e-06,-0.54135,-0.56462,1,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.636e-05,-0.54137,-0.5509,1,0
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,1.4947e-05,-0.54153,-0.536,1,0
1,GO REGULATION OF CATABOLIC PROCESS,4.5891e-06,-0.54154,-0.54081,1,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,1.8524e-05,-0.54164,-0.51079,1,0
1,GO RESPONSE TO EPINEPHRINE,2.4576e-05,-0.54171,-0.52151,1,0
1,GO REGULATION OF ODONTOGENESIS,5.7533e-06,-0.54178,-0.56581,1,0
1,GO SOMITE DEVELOPMENT,5.337e-06,-0.5418,-0.54899,1,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,5.337e-06,-0.54181,-0.54428,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,9.6689e-06,-0.54183,-0.68069,1,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,4.8997e-05,-0.54186,-0.59444,1,0
1,GO STORE OPERATED CALCIUM ENTRY,1.4947e-05,-0.54188,-0.59409,1,0
1,GO PIGMENTATION,6.2007e-06,-0.5419,-0.48096,1,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.6059e-05,-0.54194,-0.49861,1,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,6.6813e-06,-0.54195,-0.5064,1,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00024771,-0.54212,-0.47515,1,0
1,GO OSTEOCLAST DIFFERENTIATION,9.6689e-06,-0.54216,-0.6321,1,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00018128,-0.54219,-0.51264,1,0
1,GO REGULATION OF CELLULAR LOCALIZATION,4.5891e-06,-0.54226,-0.57246,1,0
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.9495e-06,-0.54229,-0.54182,1,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,7.1973e-06,-0.54231,-0.6129,1,0
1,GO REGULATION OF HEART GROWTH,4.9495e-06,-0.54242,-0.53163,1,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,1.4947e-05,-0.54242,-0.57639,1,0
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,8.9843e-06,-0.54242,-0.60707,1,0
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00014989,-0.54243,-0.60331,1,0
1,GO AXONAL TRANSPORT,8.9843e-06,-0.5425,-0.63922,1,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,6.2007e-06,-0.54251,-0.55322,1,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,8.9843e-06,-0.54258,-0.539,1,0
1,GO ANION HOMEOSTASIS,4.5891e-06,-0.54265,-0.567,1,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00033648,-0.5427,-0.48114,1,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,5.7533e-06,-0.54271,-0.55671,1,0
1,GO REGULATION OF RECEPTOR BINDING,1.7249e-05,-0.54288,-0.63827,1,0
1,GO RESPONSE TO METAL ION,8.3461e-06,-0.5429,-0.48909,1,0
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,4.9495e-06,-0.54293,-0.53252,1,0
1,GO SULFUR COMPOUND CATABOLIC PROCESS,5.337e-06,-0.54302,-0.56,1,0
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,4.2539e-06,-0.54303,-0.54411,1,0
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.54309,-0.56477,1,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00014989,-0.54314,-0.52909,1,0
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,4.5891e-06,-0.54316,-0.52004,1,0
1,GO SENSORY ORGAN DEVELOPMENT,5.337e-06,-0.54321,-0.55304,1,0
1,GO INTERACTION WITH HOST,4.5891e-06,-0.54324,-0.5627,1,0
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,4.9495e-06,-0.54327,-0.58253,1,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,4.2763e-05,-0.5434,-0.50375,1,0
1,GO MICROVILLUS ORGANIZATION,1.1191e-05,-0.54341,-0.54428,1,0
1,GO MODULATION BY VIRUS OF HOST PROCESS,4.5891e-06,-0.54344,-0.56436,1,0
1,GO CEREBELLAR CORTEX FORMATION,1.2035e-05,-0.54349,-0.56521,1,0
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,4.5891e-06,-0.5435,-0.52719,1,0
1,GO AMYLOID BETA METABOLIC PROCESS,1.2035e-05,-0.54359,-0.55877,1,0
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,4.5891e-06,-0.54372,-0.55428,1,0
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,6.2007e-06,-0.54376,-0.52854,1,0
1,GO FIBROBLAST PROLIFERATION,6.6813e-06,-0.54382,-0.56852,1,0
1,GO MOTILE CILIUM ASSEMBLY,0.00011593,-0.54382,-0.52146,1,0
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,5.9985e-05,-0.54383,-0.6374,1,0
1,GO MEMBRANE INVAGINATION,1.7249e-05,-0.54409,-0.67785,1,0
1,GO SEGMENTATION,3.9422e-06,-0.54417,-0.55525,1,0
1,GO LIPID LOCALIZATION,6.6813e-06,-0.5443,-0.52324,1,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,7.7514e-06,-0.54436,-0.49683,1,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,2.2907e-05,-0.5444,-0.57821,1,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,5.9985e-05,-0.54453,-0.54984,1,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,5.2428e-05,-0.54474,-0.56214,1,0
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,2.636e-05,-0.54495,-0.55123,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.9936e-05,-0.54497,-0.5876,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.7249e-05,-0.54503,-0.46816,1,0
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,4.2539e-06,-0.54526,-0.57297,1,0
1,GO B CELL ACTIVATION,1.2939e-05,-0.54535,-0.61775,1,0
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,4.9495e-06,-0.5455,-0.5561,1,0
1,GO SECRETORY GRANULE ORGANIZATION,9.6689e-06,-0.54562,-0.54937,1,0
1,GO CLATHRIN COAT ASSEMBLY,0.00028019,-0.54565,-0.54337,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,3.7287e-05,-0.54581,-0.62384,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,4.2539e-06,-0.54587,-0.56465,1,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,1.2035e-05,-0.5459,-0.6352,1,0
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.9422e-06,-0.5459,-0.56193,1,0
1,GO REGULATION OF CHEMOTAXIS,1.3909e-05,-0.54595,-0.60082,1,0
1,GO REGULATION OF ORGANELLE ORGANIZATION,4.2539e-06,-0.54606,-0.56807,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,8.9843e-06,-0.54611,-0.57037,1,0
1,GO PEPTIDYL LYSINE METHYLATION,7.1973e-06,-0.54625,-0.58296,1,0
1,GO ACYLGLYCEROL HOMEOSTASIS,5.337e-06,-0.54648,-0.54198,1,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,1.7249e-05,-0.54655,-0.53761,1,0
1,GO CERAMIDE TRANSPORT,1.1191e-05,-0.54677,-0.5929,1,0
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,4.5891e-06,-0.54686,-0.55988,1,0
1,GO RESPONSE TO IRON ION,1.2035e-05,-0.54693,-0.53424,1,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,6.2007e-06,-0.54722,-0.51973,1,0
1,GO PSEUDOPODIUM ORGANIZATION,0.00024771,-0.54738,-0.57753,1,0
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,4.5891e-06,-0.54739,-0.55796,1,0
1,GO PEPTIDYL LYSINE ACETYLATION,5.337e-06,-0.54741,-0.58159,1,0
1,GO CELL AGGREGATION,0.00028019,-0.54751,-0.48085,1,0
1,GO MYELOID CELL APOPTOTIC PROCESS,4.5779e-05,-0.54753,-0.52852,1,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,7.1973e-06,-0.54755,-0.59335,1,0
1,GO LIPID GLYCOSYLATION,2.2907e-05,-0.54757,-0.59687,1,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.2939e-05,-0.54759,-0.61555,1,0
1,GO CELL PROJECTION ASSEMBLY,6.2007e-06,-0.5476,-0.55131,1,0
1,GO REGULATION OF CHOLESTEROL EFFLUX,1.0403e-05,-0.5477,-0.59725,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00010181,-0.54772,-0.49616,1,0
1,GO ORGANIC ANION TRANSPORT,7.1973e-06,-0.54777,-0.50597,1,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,4.5891e-06,-0.54778,-0.55087,1,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,6.6813e-06,-0.5479,-0.60305,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00072571,-0.54794,-0.5753,1,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,7.1973e-06,-0.54797,-0.56105,1,0
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,5.337e-06,-0.54798,-0.58958,1,0
1,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.00045436,-0.54799,-0.59515,1,0
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0040644,-0.54809,-0.57774,1,0
1,GO SEROTONIN TRANSPORT,1.9888e-05,-0.54811,-0.56292,1,0
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,2.636e-05,-0.54816,-0.53571,1,0
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,8.9843e-06,-0.54817,-0.55446,1,0
1,GO MACROPHAGE ACTIVATION,4.8997e-05,-0.5482,-0.66199,1,0
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,3.9422e-06,-0.54822,-0.55672,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,4.5891e-06,-0.54822,-0.56981,1,0
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,4.2539e-06,-0.54831,-0.55003,1,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,3.9422e-06,-0.54845,-0.5657,1,0
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,2.636e-05,-0.54847,-0.51675,1,0
1,GO LATERAL MESODERM DEVELOPMENT,3.9936e-05,-0.54851,-0.49493,1,0
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.2539e-06,-0.54853,-0.55843,1,0
1,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00028019,-0.54855,-0.57058,1,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,5.337e-06,-0.54856,-0.52912,1,0
1,GO SMOOTHENED SIGNALING PATHWAY,8.3461e-06,-0.54861,-0.55278,1,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,1.7249e-05,-0.54872,-0.58198,1,0
1,GO HISTONE H4 K5 ACETYLATION,2.636e-05,-0.5488,-0.59486,1,0
1,GO RESPONSE TO DSRNA,1.4947e-05,-0.5488,-0.54647,1,0
1,GO SEQUESTERING OF CALCIUM ION,1.2035e-05,-0.54884,-0.56981,1,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,8.3461e-06,-0.54939,-0.61196,1,0
1,GO SYNAPSE ORGANIZATION,5.337e-06,-0.54939,-0.60587,1,0
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,4.2539e-06,-0.54939,-0.54875,1,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.00011593,-0.54942,-0.63045,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,1.0403e-05,-0.54948,-0.54216,1,0
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.7533e-06,-0.54981,-0.56405,1,0
1,GO ENSHEATHMENT OF NEURONS,4.9495e-06,-0.54984,-0.55367,1,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,4.8997e-05,-0.54989,-0.55962,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,1.0403e-05,-0.54992,-0.51485,1,0
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.55,-0.58997,1,0
1,GO LIPID MODIFICATION,5.337e-06,-0.55006,-0.53185,1,0
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,4.5779e-05,-0.55014,-0.63892,1,0
1,GO HISTONE H4 ACETYLATION,6.2007e-06,-0.55018,-0.60445,1,0
1,GO PROTEIN SUMOYLATION,5.337e-06,-0.5502,-0.57923,1,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00028019,-0.55028,-0.51563,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,1.9888e-05,-0.5503,-0.65557,1,0
1,GO POSITIVE REGULATION OF VESICLE FUSION,2.636e-05,-0.55039,-0.5584,1,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,7.8298e-05,-0.55045,-0.53054,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0003797,-0.55046,-0.65431,1,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00014989,-0.55053,-0.61697,1,0
1,GO REGULATION OF TRANSPORT,5.337e-06,-0.55062,-0.53629,1,0
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,1.0403e-05,-0.55063,-0.58662,1,0
1,GO LEFT RIGHT AXIS SPECIFICATION,2.1347e-05,-0.55067,-0.58686,1,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,7.7514e-06,-0.55082,-0.55565,1,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,7.8298e-05,-0.55083,-0.47272,1,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00048214,-0.55083,-0.67505,1,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,6.2007e-06,-0.55083,-0.54827,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,5.2428e-05,-0.55089,-0.64239,1,0
1,GO RESPONSE TO KETONE,4.2539e-06,-0.55097,-0.55707,1,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,3.9422e-06,-0.55101,-0.63629,1,0
1,GO NEGATIVE REGULATION OF SIGNALING,4.5891e-06,-0.55106,-0.57262,1,0
1,GO FORELIMB MORPHOGENESIS,1.6059e-05,-0.55107,-0.53629,1,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,5.7533e-06,-0.55131,-0.58837,1,0
1,GO REGULATION OF TELOMERASE ACTIVITY,8.3461e-06,-0.55136,-0.51429,1,0
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,4.5891e-06,-0.55141,-0.5639,1,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,5.337e-06,-0.55147,-0.54933,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,4.9495e-06,-0.55151,-0.58352,1,0
1,GO RESPONSE TO FORSKOLIN,8.3641e-05,-0.55158,-0.62112,1,0
1,GO REGULATION OF HAIR CYCLE,1.8524e-05,-0.55168,-0.54732,1,0
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,4.9495e-06,-0.55169,-0.55544,1,0
1,GO REGULATION OF MACROAUTOPHAGY,4.5891e-06,-0.55173,-0.58689,1,0
1,GO ORGANELLE INHERITANCE,7.1973e-06,-0.55174,-0.53651,1,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,6.6813e-06,-0.55179,-0.52605,1,0
1,GO OLIGODENDROCYTE DEVELOPMENT,1.9888e-05,-0.55185,-0.54773,1,0
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0029965,-0.55188,-0.60418,1,0
1,GO ASSOCIATIVE LEARNING,8.9843e-06,-0.55188,-0.53358,1,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,7.7514e-06,-0.55189,-0.57009,1,0
1,GO RHYTHMIC BEHAVIOR,1.4947e-05,-0.55195,-0.54806,1,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,2.1347e-05,-0.55208,-0.53608,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,7.7514e-06,-0.55226,-0.58028,1,0
1,GO RESPONSE TO ATP,4.5891e-06,-0.5523,-0.5513,1,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,9.6689e-06,-0.55231,-0.5703,1,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00054254,-0.55253,-0.62587,1,0
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,2.636e-05,-0.55266,-0.53623,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00024771,-0.5527,-0.76238,1,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,4.2539e-06,-0.55274,-0.57235,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,3.9936e-05,-0.55277,-0.60592,1,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,8.9843e-06,-0.55297,-0.52527,1,0
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,4.5891e-06,-0.55329,-0.54329,1,0
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,6.4139e-05,-0.55335,-0.59881,1,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,4.5779e-05,-0.55336,-0.5145,1,0
1,GO CARDIOBLAST DIFFERENTIATION,1.1191e-05,-0.55353,-0.57619,1,0
1,GO LIPID HOMEOSTASIS,5.337e-06,-0.55367,-0.53582,1,0
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.0304e-05,-0.55369,-0.61972,1,0
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,8.9327e-05,-0.55375,-0.64345,1,0
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,6.8565e-05,-0.55375,-0.50058,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.6059e-05,-0.55389,-0.63648,1,0
1,GO REGULATION OF ORGAN GROWTH,4.5891e-06,-0.55397,-0.55141,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,4.2539e-06,-0.55402,-0.5574,1,0
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,7.7514e-06,-0.55406,-0.55683,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00018128,-0.5541,-0.57552,1,0
1,GO ACTIN MEDIATED CELL CONTRACTION,4.2539e-06,-0.55411,-0.5477,1,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,2.1347e-05,-0.55416,-0.48156,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,4.9495e-06,-0.55429,-0.57506,1,0
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,8.3461e-06,-0.55431,-0.64427,1,0
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,3.4805e-05,-0.55437,-0.64196,1,0
1,GO GLUCOSE IMPORT,4.5891e-06,-0.55445,-0.52417,1,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,4.2539e-06,-0.55452,-0.55883,1,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,7.1973e-06,-0.55455,-0.56484,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.2035e-05,-0.55455,-0.66226,1,0
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,4.2539e-06,-0.55456,-0.58457,1,0
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.008797,-0.5546,-0.53319,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,5.7533e-06,-0.55474,-0.56566,1,0
1,GO MICROTUBULE DEPOLYMERIZATION,1.7249e-05,-0.55474,-0.65715,1,0
1,GO VESICLE ORGANIZATION,4.9495e-06,-0.55478,-0.5655,1,0
1,GO REGULATION OF ENDOCRINE PROCESS,1.7249e-05,-0.55479,-0.49856,1,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,1.4947e-05,-0.55481,-0.56471,1,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.00076864,-0.55487,-0.57161,1,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,1.6059e-05,-0.55495,-0.59167,1,0
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,4.9495e-06,-0.55499,-0.6434,1,0
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,3.9422e-06,-0.55509,-0.55983,1,0
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,6.2007e-06,-0.55519,-0.57608,1,0
1,GO REGULATION OF ICOSANOID SECRETION,0.00014062,-0.55526,-0.4311,1,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,6.2007e-06,-0.55532,-0.56905,1,0
1,GO IMMUNE SYSTEM DEVELOPMENT,4.5891e-06,-0.55535,-0.57203,1,0
1,GO FOREBRAIN DEVELOPMENT,6.2007e-06,-0.55551,-0.56585,1,0
1,GO REGULATION OF ERAD PATHWAY,4.9495e-06,-0.55552,-0.58966,1,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,2.4576e-05,-0.55563,-0.52535,1,0
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.6059e-05,-0.55571,-0.5521,1,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,4.5891e-06,-0.55575,-0.58247,1,0
1,GO EPITHELIUM DEVELOPMENT,4.5891e-06,-0.55577,-0.54091,1,0
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.5558,-0.57607,1,0
1,GO REGULATION OF PHOSPHORYLATION,4.5891e-06,-0.55601,-0.57348,1,0
1,GO REGULATION OF DEPHOSPHORYLATION,4.5891e-06,-0.55601,-0.60112,1,0
1,GO ORGANELLE MEMBRANE FUSION,5.7533e-06,-0.55613,-0.61916,1,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,5.2428e-05,-0.55622,-0.57238,1,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,8.9843e-06,-0.55622,-0.51072,1,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,3.9422e-06,-0.55629,-0.60955,1,0
1,GO SNARE COMPLEX ASSEMBLY,1.2035e-05,-0.5563,-0.58772,1,0
1,GO ANATOMICAL STRUCTURE MATURATION,8.3461e-06,-0.55631,-0.54412,1,0
1,GO NEURON MIGRATION,9.6689e-06,-0.5564,-0.61762,1,0
1,GO REGULATION OF SECRETION,6.2007e-06,-0.55652,-0.52622,1,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,5.6086e-05,-0.5566,-0.65341,1,0
1,GO FOREGUT MORPHOGENESIS,3.248e-05,-0.55661,-0.57509,1,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,1.9888e-05,-0.55668,-0.67947,1,0
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.55675,-0.58457,1,0
1,GO NEGATIVE REGULATION OF DNA REPAIR,7.7514e-06,-0.55685,-0.54478,1,0
1,GO NEURONAL ION CHANNEL CLUSTERING,0.00011593,-0.55689,-0.58221,1,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,6.2007e-06,-0.55694,-0.58732,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,1.6059e-05,-0.55706,-0.54474,1,0
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,4.9495e-06,-0.55708,-0.56039,1,0
1,GO TRANSEPITHELIAL TRANSPORT,8.9843e-06,-0.55715,-0.55872,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,8.3461e-06,-0.55716,-0.53832,1,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,6.6813e-06,-0.5572,-0.55286,1,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,5.337e-06,-0.55733,-0.58518,1,0
1,GO LEUKOCYTE HOMEOSTASIS,8.3461e-06,-0.55734,-0.61308,1,0
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,5.7533e-06,-0.5574,-0.5338,1,0
1,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0080134,-0.55741,-0.78584,1,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,4.5891e-06,-0.55751,-0.59593,1,0
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.8524e-05,-0.55755,-0.62249,1,0
1,GO CIRCADIAN RHYTHM,7.1973e-06,-0.55756,-0.54923,1,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,4.8997e-05,-0.55758,-0.48964,1,0
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,4.8997e-05,-0.55773,-0.57763,1,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,6.2007e-06,-0.55779,-0.54782,1,0
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,6.6813e-06,-0.55786,-0.61441,1,0
1,GO POSITIVE REGULATION OF MYELINATION,8.9843e-06,-0.55796,-0.61442,1,0
1,GO CARTILAGE MORPHOGENESIS,6.2007e-06,-0.55806,-0.66999,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,6.2007e-06,-0.55812,-0.61374,1,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,1.4947e-05,-0.55814,-0.56274,1,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,5.337e-06,-0.55817,-0.55369,1,0
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,1.8524e-05,-0.55823,-0.61517,1,0
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,5.337e-06,-0.55834,-0.54469,1,0
1,GO MEMBRANE FISSION,4.8997e-05,-0.55844,-0.60611,1,0
1,GO POLYOL CATABOLIC PROCESS,3.9936e-05,-0.55854,-0.50138,1,0
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.1973e-06,-0.55862,-0.63992,1,0
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,4.2539e-06,-0.55874,-0.57946,1,0
1,GO NEUROBLAST PROLIFERATION,1.8524e-05,-0.55886,-0.56848,1,0
1,GO RESPONSE TO INTERLEUKIN 7,1.6059e-05,-0.55888,-0.60745,1,0
1,GO SYNAPSE PRUNING,0.0049572,-0.55893,-0.70313,1,0
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.55903,-0.60189,1,0
1,GO SYNAPTIC VESICLE RECYCLING,2.8267e-05,-0.55906,-0.60839,1,0
1,GO REGULATION OF TELOMERE MAINTENANCE,6.2007e-06,-0.55914,-0.54865,1,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0018673,-0.55914,-0.58566,1,0
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,1.1191e-05,-0.5592,-0.53872,1,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,7.1973e-06,-0.55927,-0.53677,1,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,4.5891e-06,-0.55957,-0.60287,1,0
1,GO DEVELOPMENTAL PIGMENTATION,3.9422e-06,-0.55966,-0.52098,1,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,1.2939e-05,-0.55972,-0.5239,1,0
1,GO DOSAGE COMPENSATION,1.2035e-05,-0.55972,-0.61984,1,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,6.2007e-06,-0.55974,-0.60954,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,8.3461e-06,-0.5598,-0.55345,1,0
1,GO ADAPTIVE THERMOGENESIS,5.337e-06,-0.55987,-0.55153,1,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00011593,-0.56009,-0.63051,1,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,5.2428e-05,-0.56013,-0.54541,1,0
1,GO POSITIVE CHEMOTAXIS,2.8267e-05,-0.56026,-0.54003,1,0
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,4.9495e-06,-0.56032,-0.58274,1,0
1,GO FOREBRAIN GENERATION OF NEURONS,6.8565e-05,-0.56038,-0.52269,1,0
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,6.2007e-06,-0.56045,-0.56069,1,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.0403e-05,-0.56046,-0.55233,1,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,6.6813e-06,-0.5605,-0.55308,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,3.7287e-05,-0.56061,-0.61795,1,0
1,GO REGULATION OF EXOCYTOSIS,9.6689e-06,-0.56061,-0.5862,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,3.9422e-06,-0.56077,-0.59769,1,0
1,GO RESPONSE TO ACETYLCHOLINE,8.3641e-05,-0.56077,-0.59135,1,0
1,GO NEGATIVE REGULATION OF CELL AGING,5.7533e-06,-0.56078,-0.55595,1,0
1,GO CERAMIDE METABOLIC PROCESS,1.2035e-05,-0.56082,-0.5643,1,0
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,9.5377e-05,-0.56087,-0.61778,1,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,5.337e-06,-0.56097,-0.55354,1,0
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,3.9422e-06,-0.56102,-0.57152,1,0
1,GO REGULATION OF RECEPTOR RECYCLING,3.9422e-06,-0.56104,-0.57775,1,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,5.7533e-06,-0.56115,-0.54772,1,0
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,5.2428e-05,-0.56119,-0.63739,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0080134,-0.56124,-0.56291,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.2539e-06,-0.56124,-0.57143,1,0
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,4.2539e-06,-0.56125,-0.55484,1,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,4.2539e-06,-0.5615,-0.57685,1,0
1,GO VESICLE DOCKING,8.3461e-06,-0.56176,-0.60896,1,0
1,GO PROTEIN DESTABILIZATION,5.337e-06,-0.56177,-0.59532,1,0
1,GO REGULATION OF HYDROLASE ACTIVITY,4.5891e-06,-0.56185,-0.56827,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,4.5891e-06,-0.5619,-0.58435,1,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,3.248e-05,-0.56207,-0.60018,1,0
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,6.6813e-06,-0.56208,-0.59314,1,0
1,GO VESICLE LOCALIZATION,4.9495e-06,-0.56218,-0.58476,1,0
1,GO MUSCLE ORGAN DEVELOPMENT,4.5891e-06,-0.5622,-0.5639,1,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,7.1973e-06,-0.56222,-0.53712,1,0
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,3.7287e-05,-0.56229,-0.70227,1,0
1,GO MITOCHONDRIAL FISSION,7.1973e-06,-0.5624,-0.58544,1,0
1,GO DENDRITIC SPINE MORPHOGENESIS,8.3461e-06,-0.56256,-0.61455,1,0
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,8.3461e-06,-0.56263,-0.6288,1,0
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,3.9422e-06,-0.56265,-0.62443,1,0
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,7.7514e-06,-0.56273,-0.54275,1,0
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,9.5377e-05,-0.56273,-0.58156,1,0
1,GO PROTEIN LOCALIZATION TO NUCLEUS,3.9422e-06,-0.56275,-0.55801,1,0
1,GO CALCIUM ION IMPORT,1.3909e-05,-0.56277,-0.54532,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,4.5891e-06,-0.56285,-0.57244,1,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,3.7287e-05,-0.56291,-0.53356,1,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,5.7533e-06,-0.56296,-0.60132,1,0
1,GO RESPONSE TO MONOSACCHARIDE,5.7533e-06,-0.56297,-0.54901,1,0
1,GO RESPONSE TO ORGANOPHOSPHORUS,5.7533e-06,-0.56301,-0.54129,1,0
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,4.9495e-06,-0.56301,-0.58128,1,0
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00012367,-0.56312,-0.44525,1,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,4.2539e-06,-0.56319,-0.51939,1,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,5.337e-06,-0.56319,-0.58007,1,0
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,4.5891e-06,-0.56319,-0.57289,1,0
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00029789,-0.56337,-0.53107,1,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.00010866,-0.56342,-0.53709,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,9.6689e-06,-0.56346,-0.54075,1,0
1,GO CELLULAR RESPONSE TO KETONE,5.337e-06,-0.56349,-0.55934,1,0
1,GO GENETIC IMPRINTING,6.4139e-05,-0.56351,-0.52683,1,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,7.1973e-06,-0.56355,-0.53626,1,0
1,GO FOAM CELL DIFFERENTIATION,1.9888e-05,-0.56387,-0.59066,1,0
1,GO RECEPTOR RECYCLING,4.5891e-06,-0.56393,-0.57283,1,0
1,GO HEART PROCESS,6.2007e-06,-0.5641,-0.52965,1,0
1,GO NEURON DEATH,4.9495e-06,-0.56419,-0.56856,1,0
1,GO PIGMENT CELL DIFFERENTIATION,3.9422e-06,-0.56427,-0.56555,1,0
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.5643,-0.55999,1,0
1,GO SKELETAL MUSCLE ADAPTATION,3.4805e-05,-0.56443,-0.51557,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00096503,-0.56446,-0.539,1,0
1,GO UTERUS DEVELOPMENT,4.2763e-05,-0.56446,-0.5115,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,9.6689e-06,-0.5646,-0.57101,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00035748,-0.56507,-0.62815,1,0
1,GO ECTODERM DEVELOPMENT,2.1347e-05,-0.5651,-0.46457,1,0
1,GO PEPTIDE SECRETION,7.1973e-06,-0.5651,-0.53857,1,0
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.9422e-06,-0.56518,-0.55729,1,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,5.2428e-05,-0.56519,-0.58893,1,0
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,5.7533e-06,-0.56522,-0.57394,1,0
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,5.337e-06,-0.56528,-0.54574,1,0
1,GO RHYTHMIC PROCESS,4.9495e-06,-0.56529,-0.56402,1,0
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.4576e-05,-0.56529,-0.58829,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,4.5891e-06,-0.56532,-0.57149,1,0
1,GO MESODERM DEVELOPMENT,4.9495e-06,-0.56551,-0.53708,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,6.2007e-06,-0.56559,-0.56272,1,0
1,GO REGULATION OF RESPONSE TO WOUNDING,4.9495e-06,-0.56575,-0.60646,1,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,5.337e-06,-0.56576,-0.55807,1,0
1,GO MIDGUT DEVELOPMENT,1.2035e-05,-0.56577,-0.58705,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,4.2539e-06,-0.5659,-0.58537,1,0
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,4.5891e-06,-0.56621,-0.56939,1,0
1,GO INTERMEMBRANE LIPID TRANSFER,4.2539e-06,-0.56622,-0.61304,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,4.5891e-06,-0.56636,-0.56363,1,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,4.9495e-06,-0.56641,-0.61225,1,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,0.0038653,-0.56665,-0.5432,1,0
1,GO NEGATIVE REGULATION OF WOUND HEALING,7.7514e-06,-0.56674,-0.61121,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,8.9843e-06,-0.56677,-0.60244,1,0
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,4.2539e-06,-0.56677,-0.58899,1,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,5.7533e-06,-0.56679,-0.56398,1,0
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,5.337e-06,-0.56686,-0.57152,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,1.2035e-05,-0.56686,-0.6103,1,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,5.337e-06,-0.56695,-0.59291,1,0
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,5.7533e-06,-0.56696,-0.57784,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,3.9422e-06,-0.56699,-0.63751,1,0
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,4.2539e-06,-0.56699,-0.58293,1,0
1,GO PRESYNAPTIC ENDOCYTOSIS,2.2907e-05,-0.56702,-0.61458,1,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,7.1973e-06,-0.56707,-0.59282,1,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.00017019,-0.56707,-0.50705,1,0
1,GO REGULATION OF SYNAPSE MATURATION,2.4576e-05,-0.56717,-0.65865,1,0
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,4.5891e-06,-0.56741,-0.61692,1,0
1,GO MOLTING CYCLE,1.1191e-05,-0.56744,-0.54402,1,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,4.2763e-05,-0.56768,-0.64144,1,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,7.7514e-06,-0.56781,-0.55242,1,0
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.00017019,-0.56802,-0.6345,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,1.3909e-05,-0.56809,-0.49313,1,0
1,GO PROTEIN POLYMERIZATION,4.2539e-06,-0.56813,-0.59658,1,0
1,GO COVALENT CHROMATIN MODIFICATION,4.5891e-06,-0.56815,-0.59267,1,0
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00045436,-0.56815,-0.75161,1,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,3.9422e-06,-0.56819,-0.58895,1,0
1,GO NEURON DIFFERENTIATION,6.6813e-06,-0.56841,-0.59073,1,0
1,GO RESPONSE TO PROSTAGLANDIN,3.0304e-05,-0.56842,-0.56393,1,0
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,3.248e-05,-0.56848,-0.64843,1,0
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,1.0403e-05,-0.56862,-0.60938,1,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,7.7514e-06,-0.56877,-0.57251,1,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,7.3279e-05,-0.56878,-0.53494,1,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,2.636e-05,-0.56888,-0.62594,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00072571,-0.56897,-0.58655,1,0
1,GO REGULATION OF NEURON DIFFERENTIATION,5.7533e-06,-0.56909,-0.61721,1,0
1,GO POSITIVE REGULATION OF WOUND HEALING,4.9495e-06,-0.56911,-0.60369,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,2.8267e-05,-0.56915,-0.58941,1,0
1,GO RESPONSE TO MISFOLDED PROTEIN,1.2035e-05,-0.56917,-0.63787,1,0
1,GO RESPONSE TO RETINOIC ACID,8.3461e-06,-0.56917,-0.5694,1,0
1,GO CELL CELL ADHESION,5.337e-06,-0.5692,-0.58968,1,0
1,GO GLIOGENESIS,6.2007e-06,-0.56922,-0.56468,1,0
1,GO ORGANIC ACID TRANSPORT,7.7514e-06,-0.56927,-0.51331,1,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,5.7533e-06,-0.56929,-0.61333,1,0
1,GO FEMALE SEX DIFFERENTIATION,4.2539e-06,-0.56946,-0.5256,1,0
1,GO ASTROCYTE DEVELOPMENT,1.8524e-05,-0.56954,-0.64579,1,0
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,4.9495e-06,-0.5696,-0.5739,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,8.3461e-06,-0.56962,-0.61463,1,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,1.4947e-05,-0.56965,-0.56742,1,0
1,GO CARDIAC MUSCLE CELL PROLIFERATION,5.337e-06,-0.56978,-0.57678,1,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,7.1973e-06,-0.5699,-0.59711,1,0
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,4.5891e-06,-0.5699,-0.57581,1,0
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,2.8267e-05,-0.56995,-0.56791,1,0
1,GO MAST CELL MEDIATED IMMUNITY,4.5891e-06,-0.56996,-0.67534,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,5.337e-06,-0.57,-0.54034,1,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.00010866,-0.57014,-0.57892,1,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,9.6689e-06,-0.57028,-0.55909,1,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,4.5891e-06,-0.57029,-0.57144,1,0
1,GO SOMITOGENESIS,4.5891e-06,-0.5703,-0.57494,1,0
1,GO ERBB2 SIGNALING PATHWAY,4.2539e-06,-0.57039,-0.55807,1,0
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,1.4947e-05,-0.5704,-0.63386,1,0
1,GO INTESTINAL ABSORPTION,0.00012367,-0.57042,-0.53558,1,0
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.4576e-05,-0.57055,-0.64847,1,0
1,GO AUTOPHAGY OF NUCLEUS,4.2539e-06,-0.5707,-0.59588,1,0
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,5.7533e-06,-0.57074,-0.59533,1,0
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,3.9422e-06,-0.57074,-0.62379,1,0
1,GO IMPORT INTO CELL,7.7514e-06,-0.57085,-0.54792,1,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,5.337e-06,-0.57091,-0.55377,1,0
1,GO INTESTINAL LIPID ABSORPTION,0.0034935,-0.571,-0.40569,1,0
1,GO REGULATION OF MRNA POLYADENYLATION,6.2007e-06,-0.57103,-0.63283,1,0
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,6.6813e-06,-0.57106,-0.57487,1,0
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,7.8298e-05,-0.57131,-0.61814,1,0
1,GO CELLULAR RESPONSE TO STARVATION,5.7533e-06,-0.57131,-0.55853,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.9422e-06,-0.57137,-0.56616,1,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,4.5891e-06,-0.57139,-0.5962,1,0
1,GO MYELOID CELL DIFFERENTIATION,3.9422e-06,-0.57142,-0.60531,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,4.9495e-06,-0.57148,-0.60545,1,0
1,GO RESPONSE TO LEPTIN,1.9888e-05,-0.57151,-0.52286,1,0
1,GO TELOMERE CAPPING,7.7514e-06,-0.57157,-0.5782,1,0
1,GO TEMPERATURE HOMEOSTASIS,5.337e-06,-0.57161,-0.55315,1,0
1,GO REGULATION OF FATTY ACID TRANSPORT,2.1347e-05,-0.57177,-0.51468,1,0
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,8.9327e-05,-0.57184,-0.72464,1,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,5.337e-06,-0.57187,-0.55051,1,0
1,GO ANIMAL ORGAN MORPHOGENESIS,4.9495e-06,-0.5719,-0.58134,1,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,6.2007e-06,-0.57209,-0.56468,1,0
1,GO REGULATION OF MRNA 3 END PROCESSING,5.7533e-06,-0.57213,-0.58959,1,0
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,4.5891e-06,-0.57222,-0.57396,1,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.5891e-06,-0.57238,-0.54206,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,5.337e-06,-0.57238,-0.58231,1,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,1.3909e-05,-0.57244,-0.58836,1,0
1,GO NEUROGENESIS,5.337e-06,-0.57249,-0.58666,1,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,4.2539e-06,-0.57265,-0.57724,1,0
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,7.1973e-06,-0.57279,-0.56667,1,0
1,GO REGULATION OF HISTONE MODIFICATION,4.9495e-06,-0.5729,-0.58551,1,0
1,GO REGULATION OF AUTOPHAGY,4.5891e-06,-0.57299,-0.58489,1,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,2.1347e-05,-0.573,-0.63819,1,0
1,GO CELL ADHESION MOLECULE PRODUCTION,0.00015974,-0.57303,-0.59418,1,0
1,GO RESPONSE TO AXON INJURY,1.2035e-05,-0.57306,-0.56443,1,0
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,8.3641e-05,-0.57306,-0.53229,1,0
1,GO OLFACTORY LOBE DEVELOPMENT,4.5779e-05,-0.57307,-0.57392,1,0
1,GO MIRNA METABOLIC PROCESS,6.2007e-06,-0.57321,-0.5987,1,0
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,4.2539e-06,-0.57322,-0.56896,1,0
1,GO RESPONSE TO VITAMIN D,2.1347e-05,-0.57326,-0.57355,1,0
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,7.1973e-06,-0.57326,-0.61598,1,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,7.1973e-06,-0.57331,-0.61063,1,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,7.7514e-06,-0.57337,-0.63588,1,0
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,4.5891e-06,-0.57338,-0.58975,1,0
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,3.7287e-05,-0.57348,-0.58661,1,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,4.5891e-06,-0.57353,-0.56147,1,0
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,3.248e-05,-0.57362,-0.66599,1,0
1,GO SEGMENT SPECIFICATION,3.248e-05,-0.5737,-0.51523,1,0
1,GO ORGANIC CATION TRANSPORT,2.636e-05,-0.57379,-0.5144,1,0
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,4.9495e-06,-0.57381,-0.5908,1,0
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.2007e-06,-0.57385,-0.54681,1,0
1,GO RESPONSE TO POTASSIUM ION,0.00020554,-0.57386,-0.54004,1,0
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,1.9888e-05,-0.57401,-0.60644,1,0
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,3.9422e-06,-0.5741,-0.66826,1,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,7.7514e-06,-0.57412,-0.54985,1,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.2035e-05,-0.57413,-0.60896,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,1.2035e-05,-0.57418,-0.5555,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,7.1973e-06,-0.57419,-0.59091,1,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,4.5891e-06,-0.57425,-0.57755,1,0
1,GO PROSTAGLANDIN SECRETION,4.5779e-05,-0.57433,-0.51696,1,0
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.57434,-0.60079,1,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,6.2007e-06,-0.57437,-0.60105,1,0
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.2539e-06,-0.57454,-0.57197,1,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,9.6689e-06,-0.57462,-0.6125,1,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,6.6813e-06,-0.5747,-0.58343,1,0
1,GO CYCLOOXYGENASE PATHWAY,0.0012071,-0.57498,-0.56109,1,0
1,GO HYPEROSMOTIC RESPONSE,1.2035e-05,-0.575,-0.56623,1,0
1,GO NEURON RECOGNITION,2.1347e-05,-0.57501,-0.59693,1,0
1,GO DISTAL TUBULE DEVELOPMENT,0.00017019,-0.57513,-0.67382,1,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00042807,-0.57515,-0.56901,1,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,1.0403e-05,-0.57542,-0.55315,1,0
1,GO ACTION POTENTIAL,8.3461e-06,-0.57556,-0.55126,1,0
1,GO RESPONSE TO HORMONE,4.5891e-06,-0.5756,-0.56177,1,0
1,GO NEUTRAL AMINO ACID TRANSPORT,7.1973e-06,-0.57569,-0.57415,1,0
1,GO INTEGRIN ACTIVATION,9.5377e-05,-0.57577,-0.69029,1,0
1,GO MEMBRANE HYPERPOLARIZATION,1.7249e-05,-0.57582,-0.55161,1,0
1,GO CARBOHYDRATE TRANSPORT,5.337e-06,-0.57587,-0.55123,1,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.3909e-05,-0.57593,-0.52811,1,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,5.337e-06,-0.57595,-0.58917,1,0
1,GO METANEPHROS DEVELOPMENT,8.9843e-06,-0.57604,-0.57995,1,0
1,GO MUSCLE TISSUE DEVELOPMENT,4.2539e-06,-0.57613,-0.56358,1,0
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,1.0403e-05,-0.57615,-0.64221,1,0
1,GO MUSCLE CELL PROLIFERATION,5.337e-06,-0.57628,-0.5991,1,0
1,GO VACUOLE ORGANIZATION,3.9422e-06,-0.57635,-0.59383,1,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,6.2007e-06,-0.57636,-0.56396,1,0
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.636e-05,-0.57642,-0.62919,1,0
1,GO MUSCLE SYSTEM PROCESS,4.9495e-06,-0.57658,-0.55852,1,0
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,2.636e-05,-0.57662,-0.54984,1,0
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,9.6689e-06,-0.57665,-0.5756,1,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,4.8997e-05,-0.57669,-0.49904,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0057394,-0.57677,-0.7163,1,0
1,GO HEART GROWTH,4.9495e-06,-0.57682,-0.55838,1,0
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,4.5891e-06,-0.57688,-0.63603,1,0
1,GO SPECIFICATION OF SYMMETRY,6.2007e-06,-0.57712,-0.5362,1,0
1,GO REGULATION OF MACROPHAGE ACTIVATION,4.2763e-05,-0.57713,-0.67608,1,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,2.1347e-05,-0.57717,-0.6288,1,0
1,GO SEQUESTERING OF TRIGLYCERIDE,7.1973e-06,-0.5772,-0.57495,1,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.6059e-05,-0.57723,-0.64897,1,0
1,GO CARBOHYDRATE PHOSPHORYLATION,1.2035e-05,-0.57725,-0.58334,1,0
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,4.9495e-06,-0.57729,-0.60006,1,0
1,GO REGULATION OF GROWTH,4.5891e-06,-0.57751,-0.5728,1,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,7.7514e-06,-0.57755,-0.62319,1,0
1,GO CHLORIDE ION HOMEOSTASIS,1.2939e-05,-0.57764,-0.57428,1,0
1,GO ENERGY RESERVE METABOLIC PROCESS,8.9843e-06,-0.57775,-0.53303,1,0
1,GO NEGATIVE T CELL SELECTION,0.010101,-0.57776,-0.57663,1,0
1,GO GLIAL CELL DIFFERENTIATION,6.6813e-06,-0.57779,-0.56185,1,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,7.7514e-06,-0.57795,-0.57249,1,0
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,6.2007e-06,-0.57803,-0.60362,1,0
1,GO NEGATIVE REGULATION OF COAGULATION,4.2763e-05,-0.57811,-0.61847,1,0
1,GO SPHINGOLIPID METABOLIC PROCESS,1.4947e-05,-0.57824,-0.55052,1,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,4.5891e-06,-0.5783,-0.58738,1,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.57831,-0.59017,1,0
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,7.3279e-05,-0.57833,-0.62617,1,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,4.5891e-06,-0.57838,-0.59354,1,0
1,GO REGULATION OF FIBRINOLYSIS,2.4576e-05,-0.57848,-0.60703,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,1.1191e-05,-0.57849,-0.58399,1,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,1.3909e-05,-0.5785,-0.57358,1,0
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,4.5891e-06,-0.57867,-0.58245,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,4.2539e-06,-0.57876,-0.56384,1,0
1,GO REGULATION OF MUSCLE CONTRACTION,5.337e-06,-0.57885,-0.52449,1,0
1,GO EMBRYO IMPLANTATION,7.1973e-06,-0.57887,-0.6498,1,0
1,GO REGULATION OF CALCIUM ION IMPORT,1.8524e-05,-0.57891,-0.59067,1,0
1,GO REGULATION OF SYSTEM PROCESS,5.7533e-06,-0.57892,-0.53573,1,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00018128,-0.57892,-0.56527,1,0
1,GO DENDRITE MORPHOGENESIS,7.7514e-06,-0.57909,-0.63172,1,0
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00042807,-0.57913,-0.65735,1,0
1,GO POSITIVE REGULATION OF CELL GROWTH,4.9495e-06,-0.57919,-0.6022,1,0
1,GO MAGNESIUM ION TRANSPORT,9.6689e-06,-0.57924,-0.59928,1,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,4.5891e-06,-0.57927,-0.58746,1,0
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,2.4576e-05,-0.57929,-0.63359,1,0
1,GO REGULATION OF TELOMERE CAPPING,8.3461e-06,-0.57938,-0.60287,1,0
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,2.2907e-05,-0.57939,-0.52831,1,0
1,GO MEMBRANE FUSION,5.7533e-06,-0.57939,-0.57954,1,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.2539e-06,-0.57942,-0.6224,1,0
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,6.2007e-06,-0.57945,-0.52057,1,0
1,GO DENDRITE DEVELOPMENT,6.2007e-06,-0.5795,-0.62371,1,0
1,GO NEURON DEVELOPMENT,6.6813e-06,-0.57951,-0.60825,1,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,8.9843e-06,-0.57954,-0.56537,1,0
1,GO MITOPHAGY,5.337e-06,-0.57964,-0.64981,1,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,3.9422e-06,-0.57991,-0.58372,1,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,1.2939e-05,-0.58003,-0.5629,1,0
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,5.337e-06,-0.5801,-0.5799,1,0
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0003797,-0.58012,-0.51866,1,0
1,GO LIPID STORAGE,6.2007e-06,-0.58014,-0.56923,1,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,3.9422e-06,-0.58023,-0.62589,1,0
1,GO RESPONSE TO COLD,1.8524e-05,-0.58046,-0.56748,1,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00010866,-0.58056,-0.63042,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,9.6689e-06,-0.58065,-0.63058,1,0
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,7.1973e-06,-0.58086,-0.55233,1,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.00048214,-0.58092,-0.49406,1,0
1,GO HETEROCHROMATIN ORGANIZATION,7.1973e-06,-0.58095,-0.59582,1,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,5.7533e-06,-0.58107,-0.63401,1,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,3.9422e-06,-0.58108,-0.60424,1,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,4.5779e-05,-0.58133,-0.66903,1,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,4.9495e-06,-0.58143,-0.59061,1,0
1,GO RESPONSE TO ENDOGENOUS STIMULUS,4.5891e-06,-0.58144,-0.57154,1,0
1,GO RECEPTOR METABOLIC PROCESS,4.2539e-06,-0.58148,-0.58829,1,0
1,GO MAINTENANCE OF CELL POLARITY,4.5779e-05,-0.5816,-0.52982,1,0
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.1191e-05,-0.58166,-0.62303,1,0
1,GO REGULATION OF MICROTUBULE BINDING,3.248e-05,-0.58177,-0.68558,1,0
1,GO RESPONSE TO HYPEROXIA,4.2539e-06,-0.58183,-0.61675,1,0
1,GO REGULATION OF COLLATERAL SPROUTING,6.8565e-05,-0.58191,-0.66103,1,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,8.3461e-06,-0.58197,-0.55438,1,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00024771,-0.58208,-0.61327,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,8.9843e-06,-0.58226,-0.5144,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,5.7533e-06,-0.58232,-0.54176,1,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,1.7249e-05,-0.58237,-0.61738,1,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,4.5779e-05,-0.58238,-0.52036,1,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,7.7514e-06,-0.58241,-0.56264,1,0
1,GO REGULATION OF DNA METHYLATION,1.1191e-05,-0.5825,-0.56469,1,0
1,GO GROWTH,4.5891e-06,-0.58257,-0.5793,1,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,8.9327e-05,-0.58273,-0.54253,1,0
1,GO KERATAN SULFATE METABOLIC PROCESS,1.2939e-05,-0.58279,-0.62888,1,0
1,GO NOTCH RECEPTOR PROCESSING,0.00018128,-0.58282,-0.56014,1,0
1,GO MUSCLE CONTRACTION,5.337e-06,-0.58286,-0.54948,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,2.8267e-05,-0.58305,-0.64347,1,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,4.5891e-06,-0.58319,-0.59619,1,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.337e-06,-0.58344,-0.60084,1,0
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,4.2539e-06,-0.58356,-0.53789,1,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,6.2007e-06,-0.58362,-0.58354,1,0
1,GO AUTOPHAGOSOME ORGANIZATION,4.2539e-06,-0.58375,-0.60544,1,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,4.2539e-06,-0.58383,-0.59728,1,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,3.4805e-05,-0.58388,-0.56469,1,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00015974,-0.58392,-0.58837,1,0
1,GO POSITIVE REGULATION OF COAGULATION,7.7514e-06,-0.58396,-0.61084,1,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,4.2539e-06,-0.58399,-0.60222,1,0
1,GO RESPONSE TO COCAINE,5.6086e-05,-0.58412,-0.52326,1,0
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.4947e-05,-0.58416,-0.64659,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.2007e-06,-0.58434,-0.55272,1,0
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,6.6813e-06,-0.58434,-0.56643,1,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,4.8997e-05,-0.58438,-0.57755,1,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,6.2007e-06,-0.58449,-0.56766,1,0
1,GO B CELL HOMEOSTASIS,5.7533e-06,-0.58451,-0.68219,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,8.3461e-06,-0.58457,-0.58134,1,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,4.2763e-05,-0.58464,-0.51092,1,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,4.9495e-06,-0.58466,-0.58036,1,0
1,GO RESPONSE TO CALCIUM ION,7.1973e-06,-0.58482,-0.5362,1,0
1,GO STRIATED MUSCLE CONTRACTION,6.6813e-06,-0.58487,-0.54027,1,0
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,4.2539e-06,-0.58492,-0.57127,1,0
1,GO PEPTIDYL AMINO ACID MODIFICATION,4.2539e-06,-0.58497,-0.57798,1,0
1,GO CARDIAC CONDUCTION,1.1191e-05,-0.58501,-0.54699,1,0
1,GO REGULATION OF WOUND HEALING,5.337e-06,-0.58521,-0.60167,1,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,4.5891e-06,-0.58528,-0.63017,1,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,4.9495e-06,-0.58529,-0.6018,1,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,4.2539e-06,-0.5853,-0.65535,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,1.0403e-05,-0.58538,-0.591,1,0
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.5891e-06,-0.58549,-0.5902,1,0
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,9.6689e-06,-0.58551,-0.65896,1,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,4.2539e-06,-0.58576,-0.62212,1,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,2.636e-05,-0.58577,-0.51603,1,0
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,6.2007e-06,-0.58581,-0.55536,1,0
1,GO MAGNESIUM ION HOMEOSTASIS,3.248e-05,-0.58585,-0.54957,1,0
1,GO MICROTUBULE POLYMERIZATION,8.3461e-06,-0.58587,-0.6259,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0031545,-0.58608,-0.55092,1,0
1,GO DEVELOPMENTAL GROWTH,4.2539e-06,-0.5861,-0.59579,1,0
1,GO HINDLIMB MORPHOGENESIS,8.3461e-06,-0.58612,-0.57541,1,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,4.9495e-06,-0.58614,-0.58109,1,0
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,6.6813e-06,-0.58641,-0.60749,1,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,4.5891e-06,-0.58645,-0.61963,1,0
1,GO NEGATIVE REGULATION OF GENE SILENCING,1.4947e-05,-0.58663,-0.55292,1,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,2.636e-05,-0.58665,-0.62281,1,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,7.7514e-06,-0.58677,-0.55676,1,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,5.7533e-06,-0.58687,-0.60914,1,0
1,GO RESPONSE TO ACID CHEMICAL,4.5891e-06,-0.58688,-0.56368,1,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.00026348,-0.58697,-0.62507,1,0
1,GO REGULATION OF WNT SIGNALING PATHWAY,4.9495e-06,-0.58703,-0.56418,1,0
1,GO REGULATION OF MAPK CASCADE,4.5891e-06,-0.58708,-0.60757,1,0
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.7249e-05,-0.58709,-0.52415,1,0
1,GO HISTONE H3 K9 MODIFICATION,4.2539e-06,-0.58724,-0.62478,1,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,4.5891e-06,-0.58726,-0.63247,1,0
1,GO REGULATION OF HORMONE METABOLIC PROCESS,9.5377e-05,-0.58726,-0.63966,1,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,8.9843e-06,-0.58733,-0.57242,1,0
1,GO NEUROTRANSMITTER UPTAKE,1.8524e-05,-0.58743,-0.50557,1,0
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,7.1973e-06,-0.58745,-0.58443,1,0
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,6.6813e-06,-0.5875,-0.60032,1,0
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,1.6059e-05,-0.58751,-0.60686,1,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,7.1973e-06,-0.58756,-0.60029,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.2007e-06,-0.58763,-0.58122,1,0
1,GO RESPONSE TO CAMP,6.2007e-06,-0.58768,-0.56418,1,0
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,5.337e-06,-0.58783,-0.6228,1,0
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,4.2539e-06,-0.58794,-0.55868,1,0
1,GO BONE MINERALIZATION,8.9843e-06,-0.58805,-0.59832,1,0
1,GO REGULATION OF SODIUM ION TRANSPORT,1.0403e-05,-0.58813,-0.53412,1,0
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,3.9422e-06,-0.58814,-0.60585,1,0
1,GO MEMBRANE DEPOLARIZATION,4.2763e-05,-0.58815,-0.55443,1,0
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,8.9843e-06,-0.58819,-0.60457,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.8267e-05,-0.58824,-0.69822,1,0
1,GO INTERFERON BETA PRODUCTION,1.0403e-05,-0.58832,-0.64041,1,0
1,GO GOLGI ORGANIZATION,4.2539e-06,-0.58836,-0.63801,1,0
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,2.4576e-05,-0.58857,-0.6194,1,0
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,4.2539e-06,-0.58863,-0.54042,1,0
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.9422e-06,-0.58869,-0.57058,1,0
1,GO NEUROTRANSMITTER REUPTAKE,2.2907e-05,-0.58871,-0.52489,1,0
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,3.248e-05,-0.58876,-0.62393,1,0
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,4.9495e-06,-0.58879,-0.58,1,0
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,6.6813e-06,-0.58881,-0.62839,1,0
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.2907e-05,-0.58883,-0.68056,1,0
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,1.2939e-05,-0.58891,-0.5489,1,0
1,GO B CELL DIFFERENTIATION,7.7514e-06,-0.58893,-0.64365,1,0
1,GO DETERMINATION OF ADULT LIFESPAN,2.4576e-05,-0.589,-0.57114,1,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.1973e-06,-0.58908,-0.55578,1,0
1,GO REGULATION OF BLOOD PRESSURE,5.7533e-06,-0.58917,-0.54851,1,0
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,1.2035e-05,-0.58923,-0.5893,1,0
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,8.3641e-05,-0.58931,-0.59593,1,0
1,GO CELL PART MORPHOGENESIS,4.5891e-06,-0.58938,-0.63644,1,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,1.3909e-05,-0.58955,-0.73576,1,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,4.5779e-05,-0.5896,-0.6546,1,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,2.636e-05,-0.58967,-0.58097,1,0
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,4.2539e-06,-0.58981,-0.59464,1,0
1,GO REGULATION OF HISTONE METHYLATION,6.2007e-06,-0.58984,-0.63097,1,0
1,GO HISTONE H3 K27 METHYLATION,4.5779e-05,-0.58994,-0.62922,1,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,1.4947e-05,-0.59,-0.58597,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,1.0403e-05,-0.59003,-0.5587,1,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,4.5891e-06,-0.59005,-0.55673,1,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,1.0403e-05,-0.59007,-0.58347,1,0
1,GO REGULATION OF PROTEIN MATURATION,5.337e-06,-0.59008,-0.58018,1,0
1,GO EMBRYO DEVELOPMENT,4.2539e-06,-0.59015,-0.5851,1,0
1,GO CELL FATE DETERMINATION,2.2907e-05,-0.59017,-0.53281,1,0
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,7.1973e-06,-0.59033,-0.63411,1,0
1,GO REGULATION OF MYOBLAST FUSION,0.0010798,-0.59043,-0.61249,1,0
1,GO AMINOGLYCAN METABOLIC PROCESS,6.2007e-06,-0.59051,-0.61518,1,0
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,5.7533e-06,-0.59054,-0.57061,1,0
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,6.2007e-06,-0.59072,-0.60157,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,4.2539e-06,-0.59074,-0.61795,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00076864,-0.5908,-0.52574,1,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.00010866,-0.59082,-0.57357,1,0
1,GO REGULATION OF GLIAL CELL MIGRATION,3.7287e-05,-0.59092,-0.7084,1,0
1,GO MOVEMENT IN HOST ENVIRONMENT,7.7514e-06,-0.59092,-0.57741,1,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,6.6813e-06,-0.59127,-0.6113,1,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,4.5891e-06,-0.59136,-0.64018,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,6.2007e-06,-0.59138,-0.57533,1,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00010866,-0.59146,-0.58486,1,0
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.0403e-05,-0.59146,-0.63556,1,0
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.2539e-06,-0.59152,-0.59108,1,0
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,5.337e-06,-0.59159,-0.60102,1,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,5.2428e-05,-0.59182,-0.50914,1,0
1,GO MATURE B CELL DIFFERENTIATION,2.4576e-05,-0.59187,-0.7405,1,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.0403e-05,-0.59207,-0.54185,1,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,4.5891e-06,-0.59218,-0.62078,1,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,1.6059e-05,-0.59224,-0.60305,1,0
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,8.3641e-05,-0.5924,-0.72215,1,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,8.9843e-06,-0.59246,-0.65945,1,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00031664,-0.59248,-0.50461,1,0
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,5.7533e-06,-0.59257,-0.62662,1,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,3.248e-05,-0.59258,-0.56966,1,0
1,GO COMPLEMENT ACTIVATION,0.0020776,-0.59261,-0.62208,1,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS,3.9422e-06,-0.59271,-0.59443,1,0
1,GO MACROMOLECULE DEACYLATION,5.7533e-06,-0.59273,-0.57358,1,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,6.6813e-06,-0.59274,-0.6113,1,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,5.6086e-05,-0.5928,-0.50416,1,0
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,2.1347e-05,-0.59305,-0.65578,1,0
1,GO PRIMARY MIRNA PROCESSING,2.1347e-05,-0.59305,-0.6158,1,0
1,GO CELL GROWTH,4.2539e-06,-0.59312,-0.60465,1,0
1,GO CELLULAR RESPONSE TO DRUG,4.9495e-06,-0.5932,-0.55415,1,0
1,GO POSITIVE REGULATION OF MAPK CASCADE,4.5891e-06,-0.59325,-0.60976,1,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,4.9495e-06,-0.59327,-0.54997,1,0
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,3.9422e-06,-0.59334,-0.60304,1,0
1,GO L AMINO ACID TRANSPORT,6.6813e-06,-0.59339,-0.54034,1,0
1,GO POSITIVE REGULATION OF URINE VOLUME,3.7287e-05,-0.5934,-0.56116,1,0
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,4.5891e-06,-0.59361,-0.60198,1,0
1,GO AXON DEVELOPMENT,4.5891e-06,-0.59374,-0.63389,1,0
1,GO POSITIVE REGULATION OF TISSUE REMODELING,3.0304e-05,-0.59385,-0.5865,1,0
1,GO IN UTERO EMBRYONIC DEVELOPMENT,4.2539e-06,-0.5939,-0.57292,1,0
1,GO PLACENTA DEVELOPMENT,4.9495e-06,-0.59393,-0.61026,1,0
1,GO CELLULAR RESPONSE TO DSRNA,3.7287e-05,-0.59396,-0.58268,1,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,7.1973e-06,-0.59401,-0.59141,1,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,6.2007e-06,-0.59408,-0.63842,1,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,0.00029789,-0.59409,-0.52689,1,0
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,4.9495e-06,-0.5942,-0.58985,1,0
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,4.2539e-06,-0.59424,-0.62613,1,0
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,5.337e-06,-0.59429,-0.62233,1,0
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,1.9888e-05,-0.59447,-0.62327,1,0
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,6.8565e-05,-0.59447,-0.64106,1,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,5.7533e-06,-0.5945,-0.64877,1,0
1,GO REGULATION OF CELL DEVELOPMENT,4.5891e-06,-0.59456,-0.60198,1,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,1.4947e-05,-0.59457,-0.58593,1,0
1,GO REGULATION OF BODY FLUID LEVELS,4.5891e-06,-0.59462,-0.59916,1,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0003797,-0.5947,-0.51706,1,0
1,GO ADIPOSE TISSUE DEVELOPMENT,8.3461e-06,-0.59481,-0.59327,1,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00010181,-0.59486,-0.56633,1,0
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,3.9422e-06,-0.59488,-0.59371,1,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,7.7514e-06,-0.59496,-0.55103,1,0
1,GO LYSOSOME LOCALIZATION,4.2539e-06,-0.59499,-0.63557,1,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,5.337e-06,-0.5955,-0.59231,1,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,4.9495e-06,-0.5955,-0.57782,1,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,5.7533e-06,-0.59552,-0.61626,1,0
1,GO AMYLOID BETA CLEARANCE,2.4576e-05,-0.59585,-0.68527,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,3.9422e-06,-0.59587,-0.61602,1,0
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00011593,-0.596,-0.5268,1,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,6.6813e-06,-0.59628,-0.61245,1,0
1,GO LONG TERM MEMORY,1.6059e-05,-0.59646,-0.57328,1,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,7.1973e-06,-0.59659,-0.62973,1,0
1,GO ENTRY INTO HOST,1.0403e-05,-0.59669,-0.60854,1,0
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,6.6813e-06,-0.59681,-0.56435,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,6.6813e-06,-0.59687,-0.62672,1,0
1,GO MESENCHYME DEVELOPMENT,4.9495e-06,-0.59702,-0.59978,1,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.2939e-05,-0.59705,-0.60123,1,0
1,GO CELL CELL SIGNALING BY WNT,4.5891e-06,-0.59715,-0.57557,1,0
1,GO POSITIVE REGULATION OF GROWTH,4.5891e-06,-0.5972,-0.60935,1,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,8.9843e-06,-0.59724,-0.57807,1,0
1,GO REGULATION OF LIPID STORAGE,4.5891e-06,-0.59731,-0.62575,1,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,1.3909e-05,-0.59737,-0.61596,1,0
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,3.0304e-05,-0.59747,-0.53931,1,0
1,GO SPINDLE LOCALIZATION,8.3461e-06,-0.59749,-0.60364,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.1973e-06,-0.59761,-0.56189,1,0
1,GO MEGAKARYOCYTE DIFFERENTIATION,4.2539e-06,-0.59767,-0.61896,1,0
1,GO CELLULAR HYPEROSMOTIC RESPONSE,4.5779e-05,-0.59773,-0.56877,1,0
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,4.2539e-06,-0.59774,-0.65638,1,0
1,GO BIOMINERALIZATION,7.7514e-06,-0.59779,-0.61026,1,0
1,GO GLAND DEVELOPMENT,5.337e-06,-0.59788,-0.58071,1,0
1,GO REGULATION OF CELL DIFFERENTIATION,4.5891e-06,-0.59797,-0.59233,1,0
1,GO RESPONSE TO WOUNDING,4.9495e-06,-0.59797,-0.62815,1,0
1,GO CELL PROLIFERATION IN FOREBRAIN,2.8267e-05,-0.59804,-0.61873,1,0
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,6.2007e-06,-0.59807,-0.6587,1,0
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,4.2539e-06,-0.59816,-0.61756,1,0
1,GO DEVELOPMENTAL MATURATION,7.7514e-06,-0.59822,-0.55799,1,0
1,GO REGULATION OF PROTEIN BINDING,4.5891e-06,-0.59828,-0.5953,1,0
1,GO MUSCLE CELL DEVELOPMENT,4.9495e-06,-0.59853,-0.55824,1,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,8.9843e-06,-0.59877,-0.5711,1,0
1,GO NEURON MATURATION,3.0304e-05,-0.5989,-0.58301,1,0
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,5.2428e-05,-0.59892,-0.62156,1,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,9.6689e-06,-0.59896,-0.53451,1,0
1,GO REGULATION OF BIOMINERALIZATION,7.7514e-06,-0.59907,-0.63361,1,0
1,GO PANCREAS DEVELOPMENT,7.7514e-06,-0.59923,-0.5896,1,0
1,GO INFLAMMATORY RESPONSE TO WOUNDING,7.8298e-05,-0.59928,-0.74947,1,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,4.9495e-06,-0.59931,-0.61717,1,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,4.9495e-06,-0.59932,-0.61396,1,0
1,GO INTRACELLULAR STEROL TRANSPORT,4.2539e-06,-0.59933,-0.63785,1,0
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,4.5891e-06,-0.59934,-0.58207,1,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,5.7533e-06,-0.59941,-0.58763,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,7.8298e-05,-0.59943,-0.64505,1,0
1,GO SENSORY SYSTEM DEVELOPMENT,4.5891e-06,-0.59948,-0.59947,1,0
1,GO SYNAPTIC VESICLE PRIMING,0.00026348,-0.5995,-0.63003,1,0
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,4.9495e-06,-0.59962,-0.57905,1,0
1,GO MORPHOGENESIS OF AN EPITHELIUM,4.5891e-06,-0.59962,-0.5926,1,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,0.00033648,-0.59963,-0.5794,1,0
1,GO OVULATION CYCLE PROCESS,3.9422e-06,-0.59971,-0.59869,1,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,4.9495e-06,-0.5998,-0.63138,1,0
1,GO LENS FIBER CELL DIFFERENTIATION,1.4947e-05,-0.59982,-0.55305,1,0
1,GO MYELOID CELL HOMEOSTASIS,4.2539e-06,-0.59989,-0.60077,1,0
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,6.6813e-06,-0.59995,-0.67287,1,0
1,GO CIRCULATORY SYSTEM PROCESS,4.9495e-06,-0.60007,-0.56389,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,5.7533e-06,-0.60007,-0.58129,1,0
1,GO REGULATION OF BLOOD CIRCULATION,7.1973e-06,-0.6003,-0.54982,1,0
1,GO GLIAL CELL DEVELOPMENT,6.2007e-06,-0.60032,-0.58412,1,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,7.1973e-06,-0.60042,-0.60914,1,0
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,1.0403e-05,-0.60045,-0.6256,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,7.1973e-06,-0.6005,-0.63926,1,0
1,GO CAMERA TYPE EYE DEVELOPMENT,4.5891e-06,-0.60054,-0.58957,1,0
1,GO HAIR CELL DIFFERENTIATION,1.0403e-05,-0.6006,-0.59048,1,0
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,7.1973e-06,-0.60068,-0.60088,1,0
1,GO DIVALENT METAL ION EXPORT,7.7514e-06,-0.60091,-0.62065,1,0
1,GO NEGATIVE REGULATION OF LIPID STORAGE,5.7533e-06,-0.60099,-0.62864,1,0
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,9.6689e-06,-0.6012,-0.63162,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,1.6059e-05,-0.60136,-0.55979,1,0
1,GO REGULATION OF KIDNEY DEVELOPMENT,9.6689e-06,-0.60169,-0.59793,1,0
1,GO MAINTENANCE OF CELL NUMBER,4.9495e-06,-0.60181,-0.56622,1,0
1,GO CELL PROJECTION ORGANIZATION,5.337e-06,-0.60196,-0.59017,1,0
1,GO CARDIAC MUSCLE CONTRACTION,6.6813e-06,-0.60198,-0.56555,1,0
1,GO POSITIVE REGULATION OF OSSIFICATION,1.2035e-05,-0.60202,-0.59654,1,0
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,4.9495e-06,-0.60216,-0.60772,1,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,5.7533e-06,-0.60227,-0.62282,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00060992,-0.60237,-0.65652,1,0
1,GO OSTEOBLAST DIFFERENTIATION,4.5891e-06,-0.60239,-0.59567,1,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,4.9495e-06,-0.60246,-0.59516,1,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,4.9495e-06,-0.60247,-0.63492,1,0
1,GO MEIOTIC SPINDLE ORGANIZATION,2.2907e-05,-0.60277,-0.63923,1,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,8.3461e-06,-0.60282,-0.60391,1,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,3.9422e-06,-0.60285,-0.602,1,0
1,GO LIPOPROTEIN LOCALIZATION,9.6689e-06,-0.60304,-0.62574,1,0
1,GO AXIS ELONGATION,1.4947e-05,-0.6031,-0.54725,1,0
1,GO RECEPTOR INTERNALIZATION,4.5891e-06,-0.60311,-0.59856,1,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,2.1347e-05,-0.60324,-0.59079,1,0
1,GO INNERVATION,0.00024771,-0.60331,-0.71012,1,0
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,3.9422e-06,-0.60337,-0.59629,1,0
1,GO EPITHELIAL CELL PROLIFERATION,4.9495e-06,-0.60347,-0.60425,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,7.8298e-05,-0.60353,-0.57851,1,0
1,GO PHAGOCYTOSIS,8.9843e-06,-0.60354,-0.67088,1,0
1,GO PLATELET DEGRANULATION,1.4947e-05,-0.60354,-0.64131,1,0
1,GO SERTOLI CELL DEVELOPMENT,7.7514e-06,-0.60362,-0.63226,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,8.9843e-06,-0.60362,-0.61287,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00072571,-0.60367,-0.58264,1,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,4.9495e-06,-0.60369,-0.62073,1,0
1,GO ODONTOGENESIS,6.2007e-06,-0.6037,-0.61158,1,0
1,GO REGULATION OF TUBE SIZE,7.7514e-06,-0.60372,-0.53695,1,0
1,GO VOCALIZATION BEHAVIOR,0.00029789,-0.60376,-0.52274,1,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,1.0403e-05,-0.60384,-0.64495,1,0
1,GO NOTCH SIGNALING PATHWAY,7.7514e-06,-0.60392,-0.60278,1,0
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.011063,-0.60397,-0.57249,1,0
1,GO RESPONSE TO CARBOHYDRATE,5.337e-06,-0.60407,-0.56102,1,0
1,GO RESPONSE TO INTERLEUKIN 15,0.00019306,-0.6041,-0.76376,1,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.00010866,-0.60413,-0.56808,1,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,4.5891e-06,-0.60439,-0.61396,1,0
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,4.2539e-06,-0.6044,-0.62788,1,0
1,GO DENDRITIC SPINE DEVELOPMENT,5.337e-06,-0.60442,-0.63123,1,0
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,5.7533e-06,-0.60443,-0.60945,1,0
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.8524e-05,-0.60465,-0.66367,1,0
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,8.9327e-05,-0.60487,-0.57569,1,0
1,GO T CELL EXTRAVASATION,0.00035748,-0.60495,-0.65435,1,0
1,GO GAMMA DELTA T CELL ACTIVATION,5.6086e-05,-0.60509,-0.67546,1,0
1,GO RESPONSE TO PEPTIDE,4.5891e-06,-0.60516,-0.59193,1,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,2.1347e-05,-0.60523,-0.56998,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.8524e-05,-0.60582,-0.61288,1,0
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,8.9843e-06,-0.60584,-0.57477,1,0
1,GO MUSCLE STRUCTURE DEVELOPMENT,4.5891e-06,-0.60586,-0.58148,1,0
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,7.7514e-06,-0.60606,-0.63505,1,0
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,4.5891e-06,-0.60633,-0.65306,1,0
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,7.1973e-06,-0.60649,-0.61982,1,0
1,GO REGULATION OF VACUOLE ORGANIZATION,4.5891e-06,-0.60666,-0.61136,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00040321,-0.60678,-0.5192,1,0
1,GO ORGAN GROWTH,4.5891e-06,-0.60688,-0.58004,1,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,4.9495e-06,-0.60693,-0.6075,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,8.9843e-06,-0.607,-0.61608,1,0
1,GO NEGATIVE REGULATION OF GROWTH,4.9495e-06,-0.60706,-0.58543,1,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,4.2539e-06,-0.60727,-0.68889,1,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,8.9843e-06,-0.6073,-0.64902,1,0
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,4.5891e-06,-0.60748,-0.58601,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,4.5891e-06,-0.60755,-0.58217,1,0
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00051151,-0.60755,-0.70599,1,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.2939e-05,-0.60759,-0.5771,1,0
1,GO CELLULAR RESPONSE TO PH,1.3909e-05,-0.6076,-0.57099,1,0
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,4.5891e-06,-0.60764,-0.59865,1,0
1,GO HYALURONAN CATABOLIC PROCESS,1.0403e-05,-0.60779,-0.61714,1,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,9.6689e-06,-0.60783,-0.71846,1,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,1.1191e-05,-0.60788,-0.5976,1,0
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,2.2907e-05,-0.60814,-0.66468,1,0
1,GO CANONICAL WNT SIGNALING PATHWAY,4.9495e-06,-0.60831,-0.57443,1,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,7.1973e-06,-0.60846,-0.61361,1,0
1,GO SMOOTH MUSCLE CELL PROLIFERATION,5.337e-06,-0.60849,-0.63641,1,0
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,3.4805e-05,-0.60871,-0.64219,1,0
1,GO RESPONSE TO PEPTIDE HORMONE,4.5891e-06,-0.60873,-0.57605,1,0
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,7.3279e-05,-0.60875,-0.6694,1,0
1,GO REGULATION OF PROTEIN DEACETYLATION,7.7514e-06,-0.6088,-0.59229,1,0
1,GO REGULATION OF ENDOCYTOSIS,4.5891e-06,-0.60895,-0.63688,1,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.00029789,-0.60914,-0.56825,1,0
1,GO RESPONSE TO INSULIN,4.9495e-06,-0.60922,-0.56815,1,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,1.0403e-05,-0.60934,-0.5861,1,0
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,6.2007e-06,-0.60941,-0.65475,1,0
1,GO EXCRETION,1.7249e-05,-0.60947,-0.51793,1,0
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,4.8997e-05,-0.60947,-0.57684,1,0
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,4.2539e-06,-0.60952,-0.58083,1,0
1,GO PROTEIN KINASE B SIGNALING,4.9495e-06,-0.61004,-0.59506,1,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,4.2539e-06,-0.61007,-0.63348,1,0
1,GO EMBRYONIC DIGIT MORPHOGENESIS,5.7533e-06,-0.61008,-0.5862,1,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,7.8298e-05,-0.61016,-0.54351,1,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,9.6689e-06,-0.61017,-0.61284,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,6.2007e-06,-0.61018,-0.62872,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,3.0304e-05,-0.61026,-0.66042,1,0
1,GO TISSUE MORPHOGENESIS,4.2539e-06,-0.61027,-0.59577,1,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,4.9495e-06,-0.61048,-0.60783,1,0
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0013481,-0.61057,-0.68858,1,0
1,GO GLYCINE TRANSPORT,0.00040321,-0.61061,-0.56627,1,0
1,GO BONE RESORPTION,6.2007e-06,-0.61071,-0.67873,1,0
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,4.9495e-06,-0.61072,-0.64696,1,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.00021879,-0.61079,-0.57184,1,0
1,GO NEURAL CREST FORMATION,0.0017696,-0.6109,-0.44106,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,6.2007e-06,-0.61101,-0.55218,1,0
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,6.6813e-06,-0.61105,-0.66314,1,0
1,GO OSSIFICATION,4.9495e-06,-0.61146,-0.6052,1,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,4.5891e-06,-0.61152,-0.58565,1,0
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,9.6689e-06,-0.61163,-0.64894,1,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,3.9422e-06,-0.61163,-0.69641,1,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,4.9495e-06,-0.61165,-0.67033,1,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,2.8267e-05,-0.61182,-0.621,1,0
1,GO ERYTHROCYTE HOMEOSTASIS,4.2539e-06,-0.61212,-0.59427,1,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00010181,-0.61214,-0.54575,1,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1347e-05,-0.61216,-0.60035,1,0
1,GO DEMETHYLATION,5.337e-06,-0.61221,-0.59618,1,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,5.7533e-06,-0.61224,-0.62244,1,0
1,GO DEVELOPMENTAL CELL GROWTH,4.5891e-06,-0.61227,-0.64258,1,0
1,GO COAGULATION,4.9495e-06,-0.61227,-0.63625,1,0
1,GO OVULATION,9.6689e-06,-0.61237,-0.60016,1,0
1,GO FIBRINOLYSIS,4.8997e-05,-0.61239,-0.64291,1,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,5.337e-06,-0.61242,-0.6221,1,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.00033648,-0.61255,-0.56725,1,0
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,7.7514e-06,-0.61259,-0.57402,1,0
1,GO AMINOGLYCAN CATABOLIC PROCESS,1.0403e-05,-0.6127,-0.63506,1,0
1,GO CELL MOTILITY,4.5891e-06,-0.61295,-0.61796,1,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00015974,-0.6131,-0.64121,1,0
1,GO MULTI ORGANISM CELLULAR PROCESS,1.2939e-05,-0.61318,-0.69807,1,0
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.0403e-05,-0.61332,-0.63708,1,0
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,1.1191e-05,-0.61332,-0.61248,1,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,4.9495e-06,-0.61341,-0.61767,1,0
1,GO NEURON REMODELING,5.6086e-05,-0.61375,-0.64364,1,0
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.0036751,-0.61386,-0.67207,1,0
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,2.1347e-05,-0.61404,-0.56523,1,0
1,GO ENDOSOMAL TRANSPORT,4.5891e-06,-0.61405,-0.58921,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00042807,-0.61412,-0.73901,1,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,3.0304e-05,-0.61412,-0.61566,1,0
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.2939e-05,-0.61421,-0.67839,1,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,5.7533e-06,-0.61421,-0.63445,1,0
1,GO RESPONSE TO GROWTH HORMONE,7.1973e-06,-0.61422,-0.57751,1,0
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,9.6689e-06,-0.61425,-0.68061,1,0
1,GO VACUOLAR TRANSPORT,4.2539e-06,-0.6144,-0.62984,1,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,4.5891e-06,-0.61454,-0.59761,1,0
1,GO LEFT RIGHT PATTERN FORMATION,9.6689e-06,-0.6146,-0.5626,1,0
1,GO WOUND HEALING,4.5891e-06,-0.6146,-0.65063,1,0
1,GO RESPONSE TO MECHANICAL STIMULUS,8.3461e-06,-0.61464,-0.60813,1,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,5.9985e-05,-0.61482,-0.53786,1,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,4.9495e-06,-0.61497,-0.61293,1,0
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.2939e-05,-0.61526,-0.67987,1,0
1,GO MUSCLE CELL MIGRATION,5.337e-06,-0.61529,-0.67734,1,0
1,GO CELLULAR EXTRAVASATION,2.8267e-05,-0.61538,-0.68248,1,0
1,GO CRANIAL NERVE MORPHOGENESIS,1.2035e-05,-0.61548,-0.6398,1,0
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,1.1191e-05,-0.61556,-0.53991,1,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,4.5891e-06,-0.6156,-0.63983,1,0
1,GO HISTONE H3 DEACETYLATION,1.2939e-05,-0.61569,-0.54939,1,0
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00015974,-0.61569,-0.745,1,0
1,GO I KAPPAB PHOSPHORYLATION,1.2035e-05,-0.61572,-0.68802,1,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,4.8997e-05,-0.6158,-0.621,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,2.1347e-05,-0.61582,-0.67889,1,0
1,GO LYMPH NODE DEVELOPMENT,8.9843e-06,-0.61585,-0.68362,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,3.9422e-06,-0.61604,-0.60244,1,0
1,GO MYOFIBRIL ASSEMBLY,5.337e-06,-0.6162,-0.6182,1,0
1,GO LOCALIZATION WITHIN MEMBRANE,6.6813e-06,-0.61622,-0.63728,1,0
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,4.2539e-06,-0.61624,-0.64112,1,0
1,GO SKIN EPIDERMIS DEVELOPMENT,1.1191e-05,-0.61637,-0.56857,1,0
1,GO NEURON PROJECTION EXTENSION,4.5891e-06,-0.6165,-0.66291,1,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,5.7533e-06,-0.61656,-0.62029,1,0
1,GO POSITIVE REGULATION OF LIPID STORAGE,9.6689e-06,-0.61658,-0.69198,1,0
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,7.1973e-06,-0.61659,-0.62264,1,0
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,6.2007e-06,-0.61685,-0.65913,1,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.00019306,-0.61694,-0.52927,1,0
1,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,1.1191e-05,-0.61703,-0.65007,1,0
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,2.8267e-05,-0.61716,-0.68166,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.00024771,-0.61721,-0.68976,1,0
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,3.9422e-06,-0.61725,-0.63447,1,0
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,4.9495e-06,-0.6173,-0.57413,1,0
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,7.1973e-06,-0.61735,-0.59698,1,0
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,5.337e-06,-0.61735,-0.60344,1,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,4.9495e-06,-0.61736,-0.65317,1,0
1,GO APICAL PROTEIN LOCALIZATION,3.0304e-05,-0.61744,-0.5704,1,0
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,4.5891e-06,-0.61747,-0.58171,1,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,4.2539e-06,-0.61753,-0.62739,1,0
1,GO REGULATION OF ANION TRANSPORT,8.9843e-06,-0.61754,-0.54191,1,0
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,5.337e-06,-0.61768,-0.62669,1,0
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.61791,-0.63099,1,0
1,GO RESPONSE TO ESTROGEN,6.2007e-06,-0.61809,-0.58608,1,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,8.9843e-06,-0.61811,-0.58131,1,0
1,GO METANEPHROS MORPHOGENESIS,1.6059e-05,-0.61816,-0.61358,1,0
1,GO CELLULAR RESPONSE TO NUTRIENT,9.6689e-06,-0.61826,-0.63052,1,0
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,4.2539e-06,-0.6183,-0.62551,1,0
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,4.9495e-06,-0.61876,-0.66146,1,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,4.5891e-06,-0.61881,-0.63654,1,0
1,GO NEURON PROJECTION REGENERATION,6.6813e-06,-0.61884,-0.63626,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.1191e-05,-0.61921,-0.58224,1,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,6.6813e-06,-0.61952,-0.59306,1,0
1,GO TRACHEA DEVELOPMENT,4.2539e-06,-0.61961,-0.68114,1,0
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,5.7533e-06,-0.61984,-0.63226,1,0
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,3.0304e-05,-0.62004,-0.583,1,0
1,GO RESPONSE TO INTERFERON ALPHA,0.0023095,-0.62008,-0.66278,1,0
1,GO LUNG EPITHELIUM DEVELOPMENT,3.248e-05,-0.62016,-0.5578,1,0
1,GO REGULATION OF ERBB SIGNALING PATHWAY,5.337e-06,-0.62021,-0.62605,1,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,7.7514e-06,-0.62033,-0.62587,1,0
1,GO EMBRYONIC MORPHOGENESIS,4.9495e-06,-0.62034,-0.60256,1,0
1,GO JNK CASCADE,4.2539e-06,-0.62105,-0.63677,1,0
1,GO CYTOSKELETON ORGANIZATION,4.2539e-06,-0.6211,-0.60488,1,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,4.2539e-06,-0.6212,-0.63005,1,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,4.5891e-06,-0.62143,-0.61535,1,0
1,GO PEPTIDYL SERINE MODIFICATION,4.2539e-06,-0.62149,-0.63288,1,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,6.6813e-06,-0.62152,-0.62212,1,0
1,GO REGULATION OF BONE MINERALIZATION,1.0403e-05,-0.62163,-0.63409,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,4.5891e-06,-0.62169,-0.61992,1,0
1,GO GLAND MORPHOGENESIS,7.1973e-06,-0.62187,-0.66516,1,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,4.5891e-06,-0.62188,-0.62769,1,0
1,GO REGULATION OF PLATELET ACTIVATION,4.5779e-05,-0.62201,-0.68859,1,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,5.9985e-05,-0.62201,-0.57028,1,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,4.9495e-06,-0.62206,-0.60568,1,0
1,GO RESPONSE TO PROGESTERONE,7.1973e-06,-0.6221,-0.63613,1,0
1,GO REGULATION OF RUFFLE ASSEMBLY,9.6689e-06,-0.62225,-0.59424,1,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,2.2907e-05,-0.62232,-0.58452,1,0
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,1.9888e-05,-0.62237,-0.74463,1,0
1,GO HEPARIN METABOLIC PROCESS,5.337e-06,-0.62257,-0.7014,1,0
1,GO MUSCLE CELL DIFFERENTIATION,4.5891e-06,-0.62257,-0.58476,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,5.337e-06,-0.62264,-0.67329,1,0
1,GO REGULATION OF OSSIFICATION,8.9843e-06,-0.62279,-0.60917,1,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,6.4139e-05,-0.62295,-0.56283,1,0
1,GO LUNG MORPHOGENESIS,1.0403e-05,-0.62304,-0.6353,1,0
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,5.337e-06,-0.62305,-0.63859,1,0
1,GO REGULATION OF GOLGI ORGANIZATION,5.337e-06,-0.62324,-0.66771,1,0
1,GO LAMELLIPODIUM ORGANIZATION,3.9422e-06,-0.62327,-0.61759,1,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,6.6813e-06,-0.62332,-0.64735,1,0
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,1.2939e-05,-0.62336,-0.61419,1,0
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,4.2539e-06,-0.6234,-0.62986,1,0
1,GO ENDOCYTOSIS,4.9495e-06,-0.62353,-0.62543,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,8.3461e-06,-0.62354,-0.61153,1,0
1,GO STRIATUM DEVELOPMENT,8.9843e-06,-0.62354,-0.59583,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE,4.2539e-06,-0.62365,-0.59979,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.00010866,-0.62372,-0.52289,1,0
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,4.2539e-06,-0.62376,-0.6183,1,0
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,5.337e-06,-0.62417,-0.67359,1,0
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,5.7533e-06,-0.62419,-0.64082,1,0
1,GO REGULATION OF ISOTYPE SWITCHING,7.1973e-06,-0.62441,-0.65147,1,0
1,GO RESPONSE TO STEROL DEPLETION,8.9843e-06,-0.62447,-0.62917,1,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,8.9843e-06,-0.62447,-0.57658,1,0
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,8.3641e-05,-0.62459,-0.5711,1,0
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,7.1973e-06,-0.62477,-0.63363,1,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,4.9495e-06,-0.62486,-0.66777,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00013188,-0.62488,-0.70663,1,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,2.4576e-05,-0.625,-0.57443,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,6.2007e-06,-0.62513,-0.60511,1,0
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,8.3461e-06,-0.62529,-0.62768,1,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,1.3909e-05,-0.62535,-0.59252,1,0
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,4.2539e-06,-0.62546,-0.615,1,0
1,GO LUNG CELL DIFFERENTIATION,0.00012367,-0.62549,-0.52191,1,0
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,4.9495e-06,-0.6255,-0.61708,1,0
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.7249e-05,-0.62555,-0.61982,1,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,7.7514e-06,-0.62561,-0.63864,1,0
1,GO RUFFLE ASSEMBLY,8.3461e-06,-0.62567,-0.60294,1,0
1,GO LOOP OF HENLE DEVELOPMENT,0.0003797,-0.62567,-0.61046,1,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,3.4805e-05,-0.62571,-0.60283,1,0
1,GO SULFUR COMPOUND TRANSPORT,1.2035e-05,-0.62596,-0.59785,1,0
1,GO ACTIN FILAMENT BASED MOVEMENT,4.2539e-06,-0.62612,-0.62231,1,0
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,4.5891e-06,-0.62638,-0.62571,1,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.2035e-05,-0.62665,-0.5938,1,0
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,6.2007e-06,-0.627,-0.68795,1,0
1,GO LEUKOCYTE AGGREGATION,0.00031664,-0.62711,-0.73257,1,0
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,1.9888e-05,-0.62715,-0.70805,1,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,4.5891e-06,-0.62716,-0.63511,1,0
1,GO CARDIAC SEPTUM MORPHOGENESIS,4.5891e-06,-0.62739,-0.65689,1,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,1.4947e-05,-0.62746,-0.62584,1,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.7249e-05,-0.62761,-0.7472,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,8.3641e-05,-0.62766,-0.67873,1,0
1,GO PROTEIN LOCALIZATION TO VACUOLE,4.9495e-06,-0.62766,-0.64,1,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,2.636e-05,-0.62767,-0.51088,1,0
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,1.9888e-05,-0.62773,-0.67151,1,0
1,GO NEURON PROJECTION GUIDANCE,4.9495e-06,-0.62773,-0.67419,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.636e-05,-0.62778,-0.66852,1,0
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,5.7533e-06,-0.62789,-0.66413,1,0
1,GO ASTROCYTE ACTIVATION,1.8524e-05,-0.62796,-0.69302,1,0
1,GO OLIGOPEPTIDE TRANSPORT,7.1973e-06,-0.62815,-0.61773,1,0
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,1.7249e-05,-0.62818,-0.71711,1,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,1.0403e-05,-0.62829,-0.62216,1,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,4.9495e-06,-0.62832,-0.6608,1,0
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00010866,-0.62841,-0.5731,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,3.9936e-05,-0.62842,-0.66145,1,0
1,GO PEPTIDYL TYROSINE MODIFICATION,4.2539e-06,-0.62843,-0.64983,1,0
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,4.9495e-06,-0.62857,-0.63157,1,0
1,GO CHAPERONE MEDIATED AUTOPHAGY,1.9888e-05,-0.62859,-0.53528,1,0
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,4.9495e-06,-0.62864,-0.60986,1,0
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,2.8267e-05,-0.6287,-0.66763,1,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,5.9985e-05,-0.6288,-0.66783,1,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,4.8997e-05,-0.62883,-0.75512,1,0
1,GO REGULATION OF CELL ADHESION,6.2007e-06,-0.62884,-0.65776,1,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,6.6813e-06,-0.62888,-0.59282,1,0
1,GO RESPONSE TO INTERLEUKIN 2,0.00011593,-0.62912,-0.69955,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,1.1191e-05,-0.62922,-0.56812,1,0
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,4.2539e-06,-0.62923,-0.59233,1,0
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,4.2539e-06,-0.62925,-0.64301,1,0
1,GO OPTIC NERVE DEVELOPMENT,0.00026348,-0.62936,-0.55656,1,0
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0003797,-0.62948,-0.6041,1,0
1,GO TRABECULA FORMATION,9.6689e-06,-0.6295,-0.64095,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.2539e-06,-0.62954,-0.61792,1,0
1,GO SCHWANN CELL DIFFERENTIATION,6.2007e-06,-0.62955,-0.62566,1,0
1,GO CARDIOCYTE DIFFERENTIATION,4.2539e-06,-0.6296,-0.60045,1,0
1,GO TAXIS,5.7533e-06,-0.63,-0.60552,1,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,4.5891e-06,-0.6301,-0.61996,1,0
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,4.2539e-06,-0.63015,-0.63654,1,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,4.9495e-06,-0.63029,-0.6263,1,0
1,GO PROSTAGLANDIN TRANSPORT,1.8524e-05,-0.63051,-0.59383,1,0
1,GO PHOSPHATE ION TRANSPORT,8.3461e-06,-0.63054,-0.61422,1,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,1.6059e-05,-0.63069,-0.62274,1,0
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,7.1973e-06,-0.63069,-0.59889,1,0
1,GO MEMBRANE RAFT ORGANIZATION,4.2763e-05,-0.63074,-0.66948,1,0
1,GO POSITIVE REGULATION OF NEURON DEATH,4.5891e-06,-0.63097,-0.60785,1,0
1,GO TUBE FORMATION,4.2539e-06,-0.63109,-0.58095,1,0
1,GO MESENCHYME MORPHOGENESIS,5.7533e-06,-0.63112,-0.67015,1,0
1,GO BIOLOGICAL ADHESION,4.9495e-06,-0.63127,-0.63731,1,0
1,GO RESPONSE TO MANGANESE ION,6.2007e-06,-0.63185,-0.60825,1,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,4.2539e-06,-0.63203,-0.58768,1,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,1.2035e-05,-0.63207,-0.60406,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,4.2539e-06,-0.63233,-0.64396,1,0
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,4.9495e-06,-0.63246,-0.6253,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.9422e-06,-0.63264,-0.6038,1,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,2.2907e-05,-0.63284,-0.60318,1,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.00010181,-0.63288,-0.73756,1,0
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,6.2007e-06,-0.63302,-0.55954,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,4.5891e-06,-0.63311,-0.58533,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,5.337e-06,-0.63348,-0.66723,1,0
1,GO ERBB SIGNALING PATHWAY,3.9422e-06,-0.63355,-0.61315,1,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,4.5779e-05,-0.63367,-0.55391,1,0
1,GO MUSCLE ADAPTATION,4.5891e-06,-0.63373,-0.64224,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,6.6813e-06,-0.63376,-0.61556,1,0
1,GO EPITHELIAL TUBE FORMATION,4.5891e-06,-0.63411,-0.57756,1,0
1,GO REGULATION OF FATTY ACID OXIDATION,1.2939e-05,-0.63415,-0.5701,1,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,7.7514e-06,-0.63416,-0.60024,1,0
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,4.5891e-06,-0.63417,-0.66111,1,0
1,GO RESPONSE TO ANGIOTENSIN,5.337e-06,-0.63431,-0.67086,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,7.7514e-06,-0.63432,-0.64599,1,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,9.6689e-06,-0.63433,-0.55613,1,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.1347e-05,-0.63438,-0.68785,1,0
1,GO INOSITOL LIPID MEDIATED SIGNALING,3.9422e-06,-0.63441,-0.65359,1,0
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,8.9843e-06,-0.63442,-0.69508,1,0
1,GO NEURON PROJECTION ORGANIZATION,4.9495e-06,-0.63447,-0.65614,1,0
1,GO POSITIVE REGULATION OF VASCULOGENESIS,8.3641e-05,-0.63481,-0.57644,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.00081392,-0.63484,-0.63685,1,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,3.9422e-06,-0.63498,-0.63227,1,0
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,1.8524e-05,-0.63498,-0.6379,1,0
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.011574,-0.635,-0.78934,1,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,3.7287e-05,-0.63516,-0.59749,1,0
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,5.7533e-06,-0.63524,-0.63739,1,0
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,4.9495e-06,-0.63526,-0.61197,1,0
1,GO RESPONSE TO INACTIVITY,6.2007e-06,-0.63546,-0.64982,1,0
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,4.9495e-06,-0.63558,-0.62768,1,0
1,GO FAT CELL DIFFERENTIATION,6.2007e-06,-0.63576,-0.59292,1,0
1,GO REGULATION OF AXONOGENESIS,4.5891e-06,-0.63579,-0.70263,1,0
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.2939e-05,-0.63582,-0.67521,1,0
1,GO POST ANAL TAIL MORPHOGENESIS,4.2539e-06,-0.63583,-0.66487,1,0
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,7.1973e-06,-0.63602,-0.63773,1,0
1,GO NEGATIVE REGULATION OF JNK CASCADE,3.9422e-06,-0.63622,-0.64314,1,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,5.7533e-06,-0.63625,-0.64387,1,0
1,GO STRIATED MUSCLE ADAPTATION,7.7514e-06,-0.63627,-0.62272,1,0
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,4.8997e-05,-0.63641,-0.55007,1,0
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.9422e-06,-0.63646,-0.64039,1,0
1,GO MEMBRANE REPOLARIZATION,1.0403e-05,-0.63648,-0.60653,1,0
1,GO CELLULAR COMPONENT MAINTENANCE,4.9495e-06,-0.63654,-0.64784,1,0
1,GO MITRAL VALVE DEVELOPMENT,8.9327e-05,-0.63697,-0.6592,1,0
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,4.2539e-06,-0.63707,-0.64719,1,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,1.0403e-05,-0.63709,-0.64978,1,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,8.3461e-06,-0.63724,-0.68907,1,0
1,GO OVULATION CYCLE,3.9422e-06,-0.63741,-0.62089,1,0
1,GO HYALURONAN METABOLIC PROCESS,5.337e-06,-0.63748,-0.6498,1,0
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,4.2539e-06,-0.63758,-0.68229,1,0
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,7.1973e-06,-0.63759,-0.63315,1,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,3.9936e-05,-0.63764,-0.59289,1,0
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,4.2539e-06,-0.63765,-0.63111,1,0
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.9888e-05,-0.63774,-0.59618,1,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,4.2539e-06,-0.63803,-0.63287,1,0
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.1347e-05,-0.63808,-0.66245,1,0
1,GO HISTONE DEACETYLATION,5.7533e-06,-0.63812,-0.60452,1,0
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,4.5891e-06,-0.63814,-0.64453,1,0
1,GO REGULATION OF ACTION POTENTIAL,4.2539e-06,-0.63824,-0.66072,1,0
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,3.9422e-06,-0.6383,-0.61956,1,0
1,GO REGULATION OF PROTEIN SUMOYLATION,6.2007e-06,-0.63836,-0.5996,1,0
1,GO HISTONE DEUBIQUITINATION,4.2539e-06,-0.63856,-0.7027,1,0
1,GO RESPONSE TO ACIDIC PH,2.2907e-05,-0.63866,-0.61345,1,0
1,GO COPII COATED VESICLE CARGO LOADING,4.9495e-06,-0.63903,-0.67179,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,1.8524e-05,-0.63904,-0.67384,1,0
1,GO ADRENAL GLAND DEVELOPMENT,9.5377e-05,-0.63911,-0.5696,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,5.337e-06,-0.63962,-0.68207,1,0
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.248e-05,-0.63974,-0.60045,1,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,1.7249e-05,-0.63978,-0.56106,1,0
1,GO CHROMATIN DISASSEMBLY,5.9985e-05,-0.63982,-0.59624,1,0
1,GO CARDIAC ATRIUM DEVELOPMENT,9.6689e-06,-0.6399,-0.67568,1,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,7.7514e-06,-0.63992,-0.71245,1,0
1,GO RUFFLE ORGANIZATION,6.2007e-06,-0.63994,-0.64227,1,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,4.9495e-06,-0.64028,-0.64767,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,6.6813e-06,-0.64028,-0.62214,1,0
1,GO LACTATION,3.9422e-06,-0.64031,-0.64569,1,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,4.9495e-06,-0.64053,-0.63396,1,0
1,GO PEPTIDYL LYSINE TRIMETHYLATION,4.5891e-06,-0.64083,-0.67698,1,0
1,GO SIALYLATION,8.9327e-05,-0.64089,-0.5585,1,0
1,GO SMOOTH MUSCLE CONTRACTION,5.337e-06,-0.64098,-0.57724,1,0
1,GO CARDIAC CHAMBER MORPHOGENESIS,4.9495e-06,-0.64115,-0.64899,1,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,2.8267e-05,-0.6414,-0.64515,1,0
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,4.2539e-06,-0.64145,-0.66937,1,0
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,5.7533e-06,-0.64159,-0.63418,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,3.248e-05,-0.64161,-0.54954,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.3909e-05,-0.64206,-0.56549,1,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,5.337e-06,-0.6421,-0.68079,1,0
1,GO REGULATION OF CELLULAR EXTRAVASATION,5.9985e-05,-0.64218,-0.67924,1,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,8.3461e-06,-0.64227,-0.62846,1,0
1,GO CELL JUNCTION ORGANIZATION,4.9495e-06,-0.64265,-0.64359,1,0
1,GO EXOCRINE SYSTEM DEVELOPMENT,6.2007e-06,-0.64266,-0.67538,1,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,4.9495e-06,-0.64276,-0.58934,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,7.7514e-06,-0.64279,-0.63744,1,0
1,GO REGULATION OF TORC1 SIGNALING,4.5891e-06,-0.64309,-0.66696,1,0
1,GO BRONCHUS DEVELOPMENT,7.8298e-05,-0.64315,-0.62916,1,0
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,4.9495e-06,-0.64357,-0.61315,1,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,5.7533e-06,-0.6436,-0.61585,1,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,2.2907e-05,-0.64381,-0.66275,1,0
1,GO RESPIRATORY SYSTEM PROCESS,4.9495e-06,-0.64391,-0.66907,1,0
1,GO NEUROBLAST DIVISION,4.2539e-06,-0.64392,-0.67729,1,0
1,GO KERATINOCYTE PROLIFERATION,8.3461e-06,-0.64397,-0.60535,1,0
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,6.6813e-06,-0.64464,-0.6117,1,0
1,GO REGULATION OF MEMBRANE INVAGINATION,0.00014062,-0.64471,-0.71875,1,0
1,GO TRANSCYTOSIS,6.6813e-06,-0.64487,-0.66765,1,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00010866,-0.64489,-0.70671,1,0
1,GO RECEPTOR CLUSTERING,7.1973e-06,-0.64498,-0.66444,1,0
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,4.2539e-06,-0.64512,-0.60916,1,0
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,4.5891e-06,-0.64516,-0.68748,1,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,7.8298e-05,-0.64517,-0.64063,1,0
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,4.9495e-06,-0.64519,-0.6421,1,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.2539e-06,-0.64521,-0.67147,1,0
1,GO SPINAL CORD PATTERNING,9.5377e-05,-0.64525,-0.62704,1,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,6.2007e-06,-0.64543,-0.65732,1,0
1,GO STRESS GRANULE ASSEMBLY,6.2007e-06,-0.64547,-0.63955,1,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,4.5891e-06,-0.6456,-0.63604,1,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,6.6813e-06,-0.64563,-0.63848,1,0
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.248e-05,-0.64564,-0.62551,1,0
1,GO CHOLESTEROL STORAGE,8.9843e-06,-0.64586,-0.70884,1,0
1,GO CAMP METABOLIC PROCESS,1.3909e-05,-0.64597,-0.65106,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,6.2007e-06,-0.64633,-0.66022,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,1.1191e-05,-0.64641,-0.6763,1,0
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,1.9888e-05,-0.64643,-0.63438,1,0
1,GO PROTEIN TARGETING TO VACUOLE,5.7533e-06,-0.64651,-0.66387,1,0
1,GO REGULATION OF VASCULOGENESIS,7.3279e-05,-0.64664,-0.58836,1,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,5.6086e-05,-0.64672,-0.58851,1,0
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.64682,-0.64574,1,0
1,GO REGULATION OF VASOCONSTRICTION,1.1191e-05,-0.6469,-0.63281,1,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,4.9495e-06,-0.64702,-0.60848,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,4.2763e-05,-0.64704,-0.62674,1,0
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.248e-05,-0.64721,-0.718,1,0
1,GO MESENCHYMAL CELL DIFFERENTIATION,6.2007e-06,-0.64725,-0.62239,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.3909e-05,-0.64731,-0.61427,1,0
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,4.9495e-06,-0.64755,-0.64496,1,0
1,GO POSITIVE REGULATION OF JNK CASCADE,4.9495e-06,-0.64757,-0.67552,1,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,8.9843e-06,-0.64774,-0.62166,1,0
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,4.2539e-06,-0.6481,-0.65795,1,0
1,GO NEGATIVE REGULATION OF CELL ADHESION,6.2007e-06,-0.64819,-0.66964,1,0
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,7.7514e-06,-0.64822,-0.71124,1,0
1,GO ACTIN CYTOSKELETON REORGANIZATION,3.9422e-06,-0.64826,-0.69179,1,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,5.7533e-06,-0.6483,-0.67549,1,0
1,GO CELL JUNCTION ASSEMBLY,4.9495e-06,-0.6484,-0.64254,1,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,4.5891e-06,-0.64841,-0.68669,1,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,1.0403e-05,-0.64843,-0.66587,1,0
1,GO EYE MORPHOGENESIS,4.5891e-06,-0.64853,-0.60777,1,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,6.6813e-06,-0.64871,-0.57012,1,0
1,GO UV PROTECTION,4.9495e-06,-0.64874,-0.61523,1,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.5891e-06,-0.64877,-0.65605,1,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,4.5891e-06,-0.649,-0.68683,1,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,1.9888e-05,-0.64915,-0.71866,1,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,4.9495e-06,-0.64918,-0.69765,1,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,6.4139e-05,-0.64924,-0.64919,1,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,9.6689e-06,-0.64951,-0.65905,1,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,8.3461e-06,-0.64965,-0.64319,1,0
1,GO POSITIVE REGULATION OF ERAD PATHWAY,4.2539e-06,-0.64974,-0.67402,1,0
1,GO CELL JUNCTION MAINTENANCE,3.0304e-05,-0.64994,-0.63954,1,0
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,4.9495e-06,-0.64995,-0.63134,1,0
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00015974,-0.65007,-0.66745,1,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.1191e-05,-0.65017,-0.68534,1,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.65023,-0.60502,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,4.5891e-06,-0.65024,-0.61256,1,0
1,GO CENTRIOLE CENTRIOLE COHESION,6.6813e-06,-0.65045,-0.7796,1,0
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,4.2539e-06,-0.65053,-0.63685,1,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,7.7514e-06,-0.65053,-0.66026,1,0
1,GO ESTROUS CYCLE,1.9888e-05,-0.65054,-0.63126,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,4.2539e-06,-0.65064,-0.65179,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,6.8565e-05,-0.65142,-0.69664,1,0
1,GO PROTEOGLYCAN METABOLIC PROCESS,4.5891e-06,-0.65143,-0.66374,1,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,6.2007e-06,-0.65157,-0.62465,1,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,4.2539e-06,-0.65171,-0.66001,1,0
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,4.5891e-06,-0.65186,-0.65623,1,0
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,1.2939e-05,-0.65196,-0.70501,1,0
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,1.2035e-05,-0.65197,-0.6613,1,0
1,GO PERICARDIUM DEVELOPMENT,9.6689e-06,-0.65198,-0.68968,1,0
1,GO MAMMARY GLAND MORPHOGENESIS,1.3909e-05,-0.65238,-0.67784,1,0
1,GO RESPONSE TO LIPOTEICHOIC ACID,0.00042807,-0.65246,-0.63784,1,0
1,GO RESPONSE TO PROSTAGLANDIN E,2.2907e-05,-0.65264,-0.62028,1,0
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,4.2539e-06,-0.65265,-0.65934,1,0
1,GO HAIR FOLLICLE MATURATION,3.9422e-06,-0.65287,-0.65135,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00045436,-0.65299,-0.59459,1,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,6.4139e-05,-0.65302,-0.56593,1,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,4.9495e-06,-0.65302,-0.62633,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,6.2007e-06,-0.65331,-0.61823,1,0
1,GO RNA DECAPPING,5.337e-06,-0.65335,-0.63228,1,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,8.3461e-06,-0.6534,-0.664,1,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,1.7249e-05,-0.65349,-0.63793,1,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,5.337e-06,-0.65349,-0.66642,1,0
1,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,8.9843e-06,-0.65356,-0.68012,1,0
1,GO CELL MORPHOGENESIS,4.2539e-06,-0.65357,-0.65505,1,0
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,4.5891e-06,-0.65358,-0.62354,1,0
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,4.2539e-06,-0.65363,-0.64262,1,0
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,3.9422e-06,-0.65366,-0.66927,1,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,6.6813e-06,-0.65367,-0.59949,1,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,6.2007e-06,-0.65377,-0.63725,1,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.636e-05,-0.65403,-0.66278,1,0
1,GO MEMBRANE PROTEIN PROTEOLYSIS,4.9495e-06,-0.65418,-0.70943,1,0
1,GO RENAL SYSTEM PROCESS,6.2007e-06,-0.65438,-0.62167,1,0
1,GO PROTEIN DEMANNOSYLATION,5.7533e-06,-0.65456,-0.70808,1,0
1,GO SKELETAL SYSTEM MORPHOGENESIS,4.5891e-06,-0.65462,-0.64685,1,0
1,GO REGULATION OF MUSCLE ADAPTATION,4.9495e-06,-0.6548,-0.6467,1,0
1,GO SELECTIVE AUTOPHAGY,5.337e-06,-0.65502,-0.61584,1,0
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,4.9495e-06,-0.65508,-0.62845,1,0
1,GO DISACCHARIDE METABOLIC PROCESS,4.9495e-06,-0.65511,-0.68433,1,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,1.1191e-05,-0.65529,-0.57679,1,0
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,1.0403e-05,-0.65541,-0.60133,1,0
1,GO REGULATION OF MAP KINASE ACTIVITY,4.9495e-06,-0.65542,-0.64689,1,0
1,GO MUSCLE ORGAN MORPHOGENESIS,4.5891e-06,-0.65571,-0.62207,1,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,4.9495e-06,-0.65572,-0.66509,1,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,1.3909e-05,-0.65572,-0.58756,1,0
1,GO REGULATION OF TISSUE REMODELING,7.1973e-06,-0.65578,-0.70268,1,0
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,4.5779e-05,-0.65599,-0.72647,1,0
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,7.7514e-06,-0.65602,-0.63532,1,0
1,GO PLATELET AGGREGATION,3.9422e-06,-0.65626,-0.70586,1,0
1,GO RENAL WATER HOMEOSTASIS,1.3909e-05,-0.65632,-0.63161,1,0
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,4.9495e-06,-0.65645,-0.63373,1,0
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,6.8565e-05,-0.65653,-0.75762,1,0
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,2.2907e-05,-0.65654,-0.69019,1,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.2539e-06,-0.6566,-0.67752,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,4.9495e-06,-0.6567,-0.63813,1,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,7.1973e-06,-0.65678,-0.72086,1,0
1,GO CELLULAR RESPONSE TO ALCOHOL,4.2539e-06,-0.65689,-0.68104,1,0
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,4.5891e-06,-0.65706,-0.6446,1,0
1,GO CORTICAL CYTOSKELETON ORGANIZATION,4.2539e-06,-0.65708,-0.67059,1,0
1,GO ENTRY OF BACTERIUM INTO HOST CELL,5.337e-06,-0.6571,-0.69277,1,0
1,GO NEGATIVE REGULATION OF MAPK CASCADE,4.5891e-06,-0.6572,-0.64918,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,9.6689e-06,-0.65722,-0.63515,1,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,6.6813e-06,-0.65726,-0.66985,1,0
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,4.5891e-06,-0.65727,-0.66541,1,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,6.2007e-06,-0.65771,-0.58243,1,0
1,GO AMEBOIDAL TYPE CELL MIGRATION,4.2539e-06,-0.65774,-0.66378,1,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,4.5891e-06,-0.65816,-0.61442,1,0
1,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.00013188,-0.65826,-0.65765,1,0
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,3.9422e-06,-0.65853,-0.59561,1,0
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00091199,-0.6586,-0.67252,1,0
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,1.8524e-05,-0.65875,-0.71538,1,0
1,GO HEART DEVELOPMENT,4.2539e-06,-0.65915,-0.62705,1,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.00021879,-0.65915,-0.54747,1,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,2.2907e-05,-0.65935,-0.54416,1,0
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,3.9422e-06,-0.65944,-0.69063,1,0
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,8.3461e-06,-0.65952,-0.64805,1,0
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,4.5891e-06,-0.65961,-0.62821,1,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,4.5891e-06,-0.66028,-0.64277,1,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,3.0304e-05,-0.66036,-0.60791,1,0
1,GO PROTEIN DEPOLYMERIZATION,4.5891e-06,-0.66065,-0.7048,1,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,8.3461e-06,-0.66078,-0.65934,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.6059e-05,-0.66121,-0.62816,1,0
1,GO MATERNAL PLACENTA DEVELOPMENT,5.337e-06,-0.66139,-0.69909,1,0
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.0403e-05,-0.66156,-0.64043,1,0
1,GO CELL VOLUME HOMEOSTASIS,8.3461e-06,-0.66204,-0.60392,1,0
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,4.2539e-06,-0.66222,-0.62386,1,0
1,GO RESPONSE TO INTERLEUKIN 6,1.8524e-05,-0.66231,-0.68739,1,0
1,GO GLIAL CELL MIGRATION,5.337e-06,-0.66258,-0.68148,1,0
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,4.5779e-05,-0.66264,-0.68283,1,0
1,GO CIRCULATORY SYSTEM DEVELOPMENT,4.2539e-06,-0.6627,-0.66571,1,0
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,3.9422e-06,-0.66272,-0.65533,1,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,4.9495e-06,-0.66291,-0.68195,1,0
1,GO MUSCLE HYPERTROPHY,4.5891e-06,-0.66296,-0.62971,1,0
1,GO RESPONSE TO GROWTH FACTOR,4.9495e-06,-0.66318,-0.63577,1,0
1,GO HISTONE H3 K9 METHYLATION,3.9422e-06,-0.66336,-0.68168,1,0
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,4.5891e-06,-0.6635,-0.60319,1,0
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,8.9843e-06,-0.66354,-0.71973,1,0
1,GO POST EMBRYONIC DEVELOPMENT,3.9422e-06,-0.66354,-0.65089,1,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,6.6813e-06,-0.66406,-0.64445,1,0
1,GO TUBE MORPHOGENESIS,4.5891e-06,-0.66421,-0.6713,1,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,1.1191e-05,-0.66439,-0.63448,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,6.6813e-06,-0.66458,-0.65178,1,0
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.00014989,-0.66503,-0.69499,1,0
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.8524e-05,-0.66533,-0.64852,1,0
1,GO REGULATION OF PLASMINOGEN ACTIVATION,6.4139e-05,-0.66537,-0.69303,1,0
1,GO PROTEIN LOCALIZATION TO AXON,0.00028019,-0.66543,-0.64846,1,0
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,7.7514e-06,-0.66553,-0.67682,1,0
1,GO PINOCYTOSIS,5.337e-06,-0.66558,-0.71189,1,0
1,GO ENAMEL MINERALIZATION,1.4947e-05,-0.66562,-0.7078,1,0
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,4.5891e-06,-0.66606,-0.71947,1,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,5.337e-06,-0.66627,-0.65321,1,0
1,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00031664,-0.6663,-0.58213,1,0
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,8.3461e-06,-0.66632,-0.70319,1,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,5.7533e-06,-0.66671,-0.71463,1,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,8.3461e-06,-0.66693,-0.58298,1,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,1.4947e-05,-0.66698,-0.60691,1,0
1,GO REGULATION OF CELL MORPHOGENESIS,4.2539e-06,-0.667,-0.67462,1,0
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,3.9422e-06,-0.66708,-0.70235,1,0
1,GO FIBROBLAST ACTIVATION,3.9422e-06,-0.66717,-0.72057,1,0
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,5.7533e-06,-0.6673,-0.74345,1,0
1,GO ATRIAL SEPTUM DEVELOPMENT,5.2428e-05,-0.6674,-0.62229,1,0
1,GO TUBE DEVELOPMENT,4.9495e-06,-0.66757,-0.64929,1,0
1,GO MITOCHONDRION DISTRIBUTION,1.1191e-05,-0.66762,-0.66634,1,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,3.9422e-06,-0.66773,-0.70808,1,0
1,GO MICROTUBULE ANCHORING,5.337e-06,-0.66794,-0.68232,1,0
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,5.337e-06,-0.66803,-0.65631,1,0
1,GO SPHINGOID METABOLIC PROCESS,7.1973e-06,-0.66843,-0.65798,1,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,5.7533e-06,-0.66851,-0.65318,1,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.2539e-06,-0.66857,-0.67962,1,0
1,GO REGULATION OF PODOSOME ASSEMBLY,4.2539e-06,-0.6688,-0.74889,1,0
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,5.337e-06,-0.66882,-0.75653,1,0
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.9888e-05,-0.66889,-0.62715,1,0
1,GO PROTEIN LOCALIZATION TO LYSOSOME,5.7533e-06,-0.66903,-0.66008,1,0
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,4.5891e-06,-0.66904,-0.665,1,0
1,GO NEPHRON DEVELOPMENT,5.7533e-06,-0.66924,-0.64543,1,0
1,GO APOPTOTIC CELL CLEARANCE,3.7287e-05,-0.66925,-0.72612,1,0
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,3.9422e-06,-0.66963,-0.68322,1,0
1,GO RETROGRADE AXONAL TRANSPORT,7.7514e-06,-0.66975,-0.73308,1,0
1,GO STEM CELL DIVISION,5.337e-06,-0.66985,-0.67945,1,0
1,GO ENDOTHELIAL CELL MIGRATION,4.2539e-06,-0.66985,-0.6852,1,0
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,8.9843e-06,-0.6699,-0.7321,1,0
1,GO TORC1 SIGNALING,4.5891e-06,-0.6702,-0.69358,1,0
1,GO INCLUSION BODY ASSEMBLY,3.9936e-05,-0.67076,-0.61529,1,0
1,GO HEART MORPHOGENESIS,3.9422e-06,-0.67079,-0.63509,1,0
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,5.7533e-06,-0.67101,-0.65154,1,0
1,GO HISTONE H3 K9 DEMETHYLATION,7.1973e-06,-0.67121,-0.71571,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,2.4576e-05,-0.67137,-0.65613,1,0
1,GO ACTIN FILAMENT ORGANIZATION,4.5891e-06,-0.67147,-0.64594,1,0
1,GO GLYCOLIPID CATABOLIC PROCESS,1.2035e-05,-0.6717,-0.71764,1,0
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,5.7533e-06,-0.67181,-0.66117,1,0
1,GO REVERSE CHOLESTEROL TRANSPORT,5.2428e-05,-0.67181,-0.70614,1,0
1,GO PEPTIDYL THREONINE MODIFICATION,4.5891e-06,-0.67187,-0.67393,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.2035e-05,-0.67196,-0.64523,1,0
1,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,6.4139e-05,-0.6722,-0.76661,1,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,6.6813e-06,-0.6722,-0.62305,1,0
1,GO RESPONSE TO STEROL,3.9422e-06,-0.67224,-0.75918,1,0
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,1.2035e-05,-0.67231,-0.6654,1,0
1,GO RELAXATION OF CARDIAC MUSCLE,2.636e-05,-0.67239,-0.6396,1,0
1,GO MESODERMAL CELL DIFFERENTIATION,4.9495e-06,-0.67242,-0.65128,1,0
1,GO COLLATERAL SPROUTING,7.7514e-06,-0.67249,-0.72939,1,0
1,GO ACTIVATION OF MAPK ACTIVITY,4.9495e-06,-0.67252,-0.62444,1,0
1,GO DECIDUALIZATION,8.3461e-06,-0.6726,-0.72041,1,0
1,GO PLATELET ACTIVATION,3.9422e-06,-0.67288,-0.71408,1,0
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00024771,-0.67298,-0.71483,1,0
1,GO LIPID PHOSPHORYLATION,3.9422e-06,-0.67333,-0.67734,1,0
1,GO REGULATION OF CELL SIZE,3.9422e-06,-0.67364,-0.6763,1,0
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,3.9422e-06,-0.67374,-0.68874,1,0
1,GO XENOBIOTIC TRANSPORT,6.6813e-06,-0.67383,-0.65459,1,0
1,GO BONE MATURATION,6.6813e-06,-0.67384,-0.65263,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00014062,-0.67387,-0.62966,1,0
1,GO REGULATION OF HISTONE DEACETYLATION,1.4947e-05,-0.6739,-0.58899,1,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,6.6813e-06,-0.67414,-0.62056,1,0
1,GO MULTICELLULAR ORGANISM GROWTH,4.9495e-06,-0.6749,-0.65681,1,0
1,GO LIPID TRANSLOCATION,7.7514e-06,-0.67501,-0.66081,1,0
1,GO CELLULAR RESPONSE TO ETHANOL,1.8524e-05,-0.67539,-0.73492,1,0
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,4.2539e-06,-0.67549,-0.64644,1,0
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,3.4805e-05,-0.67557,-0.66538,1,0
1,GO REGULATION OF BONE REMODELING,5.7533e-06,-0.6759,-0.70882,1,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.67593,-0.68612,1,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,9.6689e-06,-0.67596,-0.65111,1,0
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,3.9422e-06,-0.67621,-0.63903,1,0
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,9.6689e-06,-0.67643,-0.68436,1,0
1,GO CELL CELL JUNCTION MAINTENANCE,1.3909e-05,-0.67651,-0.72939,1,0
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,3.0304e-05,-0.67652,-0.65716,1,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.1191e-05,-0.67657,-0.75084,1,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,5.7533e-06,-0.6766,-0.63646,1,0
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.0403e-05,-0.67666,-0.67011,1,0
1,GO FILOPODIUM ASSEMBLY,4.5891e-06,-0.67677,-0.69245,1,0
1,GO TROPHOBLAST CELL MIGRATION,3.9422e-06,-0.67742,-0.68474,1,0
1,GO TISSUE MIGRATION,4.2539e-06,-0.67745,-0.68698,1,0
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,7.3279e-05,-0.67772,-0.62369,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,3.9422e-06,-0.67795,-0.73413,1,0
1,GO DENDRITIC TRANSPORT,3.7287e-05,-0.67807,-0.75851,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,1.2939e-05,-0.6781,-0.68104,1,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,8.9843e-06,-0.67818,-0.67858,1,0
1,GO PEPTIDE CROSS LINKING,0.00015974,-0.67843,-0.6137,1,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,4.2539e-06,-0.67896,-0.73316,1,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,1.6059e-05,-0.67899,-0.62441,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00042807,-0.67934,-0.59174,1,0
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,8.3461e-06,-0.67942,-0.67396,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,7.7514e-06,-0.68001,-0.68881,1,0
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,1.2939e-05,-0.68014,-0.65312,1,0
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,4.2539e-06,-0.68041,-0.66287,1,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,1.2035e-05,-0.68051,-0.58554,1,0
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,4.9495e-06,-0.68062,-0.67291,1,0
1,GO CELLULAR RESPONSE TO VITAMIN,1.6059e-05,-0.68075,-0.6261,1,0
1,GO MYELOID CELL DEVELOPMENT,3.9422e-06,-0.6809,-0.72584,1,0
1,GO ANIMAL ORGAN MATURATION,1.3909e-05,-0.68123,-0.60549,1,0
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,5.7533e-06,-0.68154,-0.68024,1,0
1,GO CARNITINE SHUTTLE,3.7287e-05,-0.6816,-0.57879,1,0
1,GO AXON EXTENSION,3.9422e-06,-0.68171,-0.70457,1,0
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,5.337e-06,-0.68234,-0.69753,1,0
1,GO BEHAVIORAL RESPONSE TO PAIN,7.7514e-06,-0.68241,-0.61761,1,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,4.2539e-06,-0.6826,-0.71875,1,0
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,4.9495e-06,-0.68281,-0.68836,1,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,2.1347e-05,-0.68295,-0.69296,1,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00013188,-0.68299,-0.661,1,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,4.9495e-06,-0.68357,-0.66081,1,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,4.5891e-06,-0.68365,-0.68792,1,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,4.2539e-06,-0.68378,-0.73746,1,0
1,GO HEMOGLOBIN METABOLIC PROCESS,2.1347e-05,-0.68395,-0.609,1,0
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,1.9888e-05,-0.684,-0.7331,1,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,6.8565e-05,-0.68409,-0.57506,1,0
1,GO LYSOSOMAL TRANSPORT,4.2539e-06,-0.6841,-0.69135,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,4.5891e-06,-0.68411,-0.66719,1,0
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,7.1973e-06,-0.68421,-0.6312,1,0
1,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00035748,-0.68426,-0.70795,1,0
1,GO POSITIVE REGULATION OF AUTOPHAGY,4.2539e-06,-0.68441,-0.6553,1,0
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.2939e-05,-0.68458,-0.74656,1,0
1,GO PROTEIN DEGLYCOSYLATION,4.5891e-06,-0.68484,-0.71366,1,0
1,GO RECEPTOR CATABOLIC PROCESS,3.9422e-06,-0.68494,-0.67691,1,0
1,GO POSITIVE REGULATION OF PROTEIN BINDING,4.5891e-06,-0.68578,-0.64454,1,0
1,GO REGULATION OF GASTRULATION,4.5891e-06,-0.68596,-0.66792,1,0
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,4.9495e-06,-0.68605,-0.69976,1,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,1.7249e-05,-0.6863,-0.71229,1,0
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,8.3461e-06,-0.68649,-0.75913,1,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,4.9495e-06,-0.68656,-0.6652,1,0
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.2539e-06,-0.68675,-0.68355,1,0
1,GO VASCULOGENESIS,6.6813e-06,-0.68683,-0.70185,1,0
1,GO VASCULATURE DEVELOPMENT,4.2539e-06,-0.68695,-0.71674,1,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.1973e-06,-0.68702,-0.67607,1,0
1,GO ACTIVATION OF MAPKK ACTIVITY,4.5891e-06,-0.68702,-0.72635,1,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,7.1973e-06,-0.68733,-0.64205,1,0
1,GO REGULATION OF BONE DEVELOPMENT,5.7533e-06,-0.68738,-0.73559,1,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,5.7533e-06,-0.68772,-0.67609,1,0
1,GO BONE MORPHOGENESIS,4.5891e-06,-0.68793,-0.691,1,0
1,GO PHAGOLYSOSOME ASSEMBLY,6.6813e-06,-0.68794,-0.70668,1,0
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,7.7514e-06,-0.68805,-0.713,1,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,6.2007e-06,-0.68813,-0.64209,1,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,4.8997e-05,-0.68824,-0.67432,1,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,6.6813e-06,-0.68862,-0.66345,1,0
1,GO HEART TRABECULA MORPHOGENESIS,4.5891e-06,-0.68871,-0.70777,1,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,7.3279e-05,-0.68875,-0.61373,1,0
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,5.7533e-06,-0.68878,-0.68036,1,0
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,4.5891e-06,-0.68921,-0.69674,1,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,4.2539e-06,-0.68935,-0.64339,1,0
1,GO MEMBRANE LIPID CATABOLIC PROCESS,8.3461e-06,-0.68939,-0.66945,1,0
1,GO GROWTH HORMONE SECRETION,0.00045436,-0.68982,-0.61094,1,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,8.9843e-06,-0.68982,-0.70125,1,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,4.9495e-06,-0.68984,-0.72545,1,0
1,GO CARDIAC CHAMBER DEVELOPMENT,4.5891e-06,-0.69028,-0.67294,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,8.9843e-06,-0.69029,-0.68617,1,0
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,9.6689e-06,-0.69085,-0.66872,1,0
1,GO RESPONSE TO HYDROXYUREA,1.0403e-05,-0.69092,-0.64036,1,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00060992,-0.691,-0.56793,1,0
1,GO OSTEOCLAST DEVELOPMENT,6.6813e-06,-0.69119,-0.76316,1,0
1,GO T HELPER 2 CELL DIFFERENTIATION,0.00068502,-0.69141,-0.63408,1,0
1,GO EPITHELIAL CELL DEVELOPMENT,5.337e-06,-0.69175,-0.66298,1,0
1,GO MOTOR NEURON AXON GUIDANCE,8.9843e-06,-0.69193,-0.64171,1,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,2.1347e-05,-0.69228,-0.6965,1,0
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,4.9495e-06,-0.69245,-0.64219,1,0
1,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.011574,-0.69246,-0.80205,1,0
1,GO REGULATION OF FAT CELL DIFFERENTIATION,8.3461e-06,-0.69248,-0.64359,1,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,6.6813e-06,-0.69252,-0.74283,1,0
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,6.2007e-06,-0.69266,-0.62499,1,0
1,GO TRABECULA MORPHOGENESIS,5.7533e-06,-0.69289,-0.74317,1,0
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,2.636e-05,-0.69291,-0.6846,1,0
1,GO REGULATION OF MITOPHAGY,5.337e-06,-0.69324,-0.71889,1,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,1.2035e-05,-0.69325,-0.66816,1,0
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,4.2539e-06,-0.69326,-0.67921,1,0
1,GO REGULATION OF VASCULATURE DEVELOPMENT,5.337e-06,-0.69331,-0.70623,1,0
1,GO ACTIN FILAMENT BASED PROCESS,4.2539e-06,-0.69336,-0.6564,1,0
1,GO CHONDROCYTE PROLIFERATION,4.9495e-06,-0.69435,-0.73312,1,0
1,GO ERYTHROCYTE MATURATION,7.1973e-06,-0.69463,-0.65771,1,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,1.0403e-05,-0.69469,-0.64916,1,0
1,GO HISTONE H3 K4 TRIMETHYLATION,6.2007e-06,-0.69491,-0.76965,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,5.337e-06,-0.69507,-0.67195,1,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,4.2539e-06,-0.6955,-0.69463,1,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,1.6059e-05,-0.69621,-0.66072,1,0
1,GO GASTRULATION,4.9495e-06,-0.69652,-0.68634,1,0
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,4.2539e-06,-0.69673,-0.68077,1,0
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,3.9422e-06,-0.69698,-0.71605,1,0
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,7.1973e-06,-0.69707,-0.68358,1,0
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,5.7533e-06,-0.6971,-0.68972,1,0
1,GO RESPONSE TO PH,1.1191e-05,-0.69742,-0.63715,1,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,4.5891e-06,-0.69753,-0.66923,1,0
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,8.3641e-05,-0.69762,-0.71601,1,0
1,GO BONE REMODELING,5.337e-06,-0.69797,-0.71338,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,8.3461e-06,-0.69807,-0.65541,1,0
1,GO SALIVARY GLAND DEVELOPMENT,4.2539e-06,-0.69834,-0.74065,1,0
1,GO EMBRYONIC BODY MORPHOGENESIS,6.2007e-06,-0.69842,-0.6957,1,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,5.7533e-06,-0.69874,-0.66805,1,0
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,2.1347e-05,-0.69875,-0.70064,1,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,4.2539e-06,-0.69882,-0.72845,1,0
1,GO ACTIN FILAMENT NETWORK FORMATION,1.6059e-05,-0.6992,-0.66929,1,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,6.6813e-06,-0.69951,-0.68783,1,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.9888e-05,-0.69957,-0.67471,1,0
1,GO RESPONSE TO ISCHEMIA,4.5891e-06,-0.69973,-0.70345,1,0
1,GO REGULATION OF CELL SHAPE,3.9422e-06,-0.69974,-0.7065,1,0
1,GO BARBED END ACTIN FILAMENT CAPPING,3.9422e-06,-0.70038,-0.70986,1,0
1,GO BLOOD VESSEL MORPHOGENESIS,4.5891e-06,-0.70081,-0.71603,1,0
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,4.5891e-06,-0.70086,-0.69827,1,0
1,GO NEURAL TUBE FORMATION,4.5891e-06,-0.7009,-0.63215,1,0
1,GO OUTFLOW TRACT MORPHOGENESIS,4.5891e-06,-0.70107,-0.67179,1,0
1,GO ENDOCARDIAL CUSHION FORMATION,4.5891e-06,-0.70131,-0.73873,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,4.9495e-06,-0.70149,-0.6908,1,0
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,5.7533e-06,-0.70175,-0.75275,1,0
1,GO REGULATION OF PINOCYTOSIS,4.9495e-06,-0.70188,-0.71326,1,0
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,1.0403e-05,-0.70259,-0.69446,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,4.9495e-06,-0.70264,-0.65719,1,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,2.1347e-05,-0.70312,-0.62869,1,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,3.7287e-05,-0.70336,-0.60326,1,0
1,GO RESPONSE TO LEUCINE,6.6813e-06,-0.70353,-0.74156,1,0
1,GO INTRACELLULAR MRNA LOCALIZATION,4.5891e-06,-0.70367,-0.6408,1,0
1,GO CARDIAC SEPTUM DEVELOPMENT,4.5891e-06,-0.70368,-0.70807,1,0
1,GO PROTEIN KINASE C SIGNALING,1.0403e-05,-0.70386,-0.6808,1,0
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,6.6813e-06,-0.70395,-0.72041,1,0
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,3.248e-05,-0.70401,-0.73997,1,0
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,4.2539e-06,-0.70487,-0.69416,1,0
1,GO BONE DEVELOPMENT,3.9422e-06,-0.70493,-0.70225,1,0
1,GO PEPTIDE CATABOLIC PROCESS,6.2007e-06,-0.70534,-0.66467,1,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,1.2035e-05,-0.70541,-0.65982,1,0
1,GO ENERGY HOMEOSTASIS,1.2939e-05,-0.70562,-0.61554,1,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,4.9495e-06,-0.70574,-0.64793,1,0
1,GO AROMATIC AMINO ACID TRANSPORT,9.6689e-06,-0.70592,-0.74527,1,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,5.337e-06,-0.706,-0.67007,1,0
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,6.6813e-06,-0.70648,-0.74062,1,0
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,4.9495e-06,-0.7071,-0.72732,1,0
1,GO METANEPHRIC NEPHRON DEVELOPMENT,6.2007e-06,-0.70735,-0.73248,1,0
1,GO ADHERENS JUNCTION ORGANIZATION,4.2539e-06,-0.70772,-0.73319,1,0
1,GO REGULATION OF GLOMERULAR FILTRATION,1.9888e-05,-0.70791,-0.74819,1,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,3.9422e-06,-0.7085,-0.70095,1,0
1,GO CELL CELL JUNCTION ORGANIZATION,5.337e-06,-0.70865,-0.64695,1,0
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,8.9843e-06,-0.7087,-0.67594,1,0
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,4.2539e-06,-0.70872,-0.69171,1,0
1,GO REGULATION OF CELL SUBSTRATE ADHESION,5.7533e-06,-0.70903,-0.74822,1,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,4.5891e-06,-0.70921,-0.70927,1,0
1,GO CELL SUBSTRATE ADHESION,4.5891e-06,-0.70932,-0.75762,1,0
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,5.7533e-06,-0.70949,-0.66856,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,4.2539e-06,-0.70966,-0.68315,1,0
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,1.6059e-05,-0.71008,-0.7016,1,0
1,GO MAMMARY GLAND DEVELOPMENT,4.5891e-06,-0.71015,-0.66335,1,0
1,GO CELL CELL JUNCTION ASSEMBLY,5.7533e-06,-0.71023,-0.61317,1,0
1,GO TRACHEA MORPHOGENESIS,4.2539e-06,-0.71048,-0.74885,1,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,5.7533e-06,-0.71057,-0.67462,1,0
1,GO ESTABLISHMENT OF CELL POLARITY,4.2539e-06,-0.7108,-0.69158,1,0
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,5.6086e-05,-0.71126,-0.7202,1,0
1,GO HISTONE H3 K36 METHYLATION,4.2539e-06,-0.71191,-0.77003,1,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,2.1347e-05,-0.71194,-0.80171,1,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,4.5891e-06,-0.71234,-0.68335,1,0
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,5.337e-06,-0.71251,-0.6805,1,0
1,GO GOLGI TO VACUOLE TRANSPORT,4.2539e-06,-0.71259,-0.75197,1,0
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,2.4576e-05,-0.71269,-0.64887,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,2.1347e-05,-0.71286,-0.63727,1,0
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,8.3461e-06,-0.71306,-0.66464,1,0
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,3.9422e-06,-0.71352,-0.74029,1,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,5.337e-06,-0.71361,-0.73266,1,0
1,GO PROTEIN TARGETING TO LYSOSOME,7.7514e-06,-0.71368,-0.6659,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,5.7533e-06,-0.71392,-0.69159,1,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,0.00010866,-0.71454,-0.61394,1,0
1,GO REGULATION OF JUN KINASE ACTIVITY,4.9495e-06,-0.7149,-0.69763,1,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,5.9985e-05,-0.715,-0.6425,1,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,5.337e-06,-0.71512,-0.75372,1,0
1,GO FORMATION OF PRIMARY GERM LAYER,4.9495e-06,-0.71524,-0.72217,1,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,8.3461e-06,-0.71551,-0.6883,1,0
1,GO TISSUE REMODELING,4.9495e-06,-0.71552,-0.73535,1,0
1,GO PHAGOCYTOSIS RECOGNITION,5.6086e-05,-0.71554,-0.67741,1,0
1,GO EMBRYONIC EYE MORPHOGENESIS,4.2539e-06,-0.71655,-0.73114,1,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,5.337e-06,-0.71686,-0.67147,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,3.9422e-06,-0.71775,-0.71278,1,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,4.5891e-06,-0.71836,-0.73663,1,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,5.7533e-06,-0.71862,-0.74333,1,0
1,GO NEGATIVE CHEMOTAXIS,4.9495e-06,-0.71874,-0.72721,1,0
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.5891e-06,-0.71923,-0.74274,1,0
1,GO RESPONSE TO BMP,5.7533e-06,-0.71925,-0.66969,1,0
1,GO INACTIVATION OF MAPK ACTIVITY,1.2939e-05,-0.71969,-0.63973,1,0
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,7.7514e-06,-0.71973,-0.76268,1,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,1.6059e-05,-0.71992,-0.71878,1,0
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,5.337e-06,-0.71996,-0.69079,1,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,8.9843e-06,-0.7203,-0.6872,1,0
1,GO ERYTHROCYTE DEVELOPMENT,3.9422e-06,-0.72058,-0.70482,1,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,4.9495e-06,-0.72101,-0.76021,1,0
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,8.9843e-06,-0.72123,-0.73327,1,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,4.5891e-06,-0.72129,-0.71531,1,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,6.6813e-06,-0.72229,-0.67466,1,0
1,GO ACTIN CROSSLINK FORMATION,7.1973e-06,-0.72301,-0.69556,1,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,7.1973e-06,-0.72321,-0.69277,1,0
1,GO ENDOTHELIAL CELL PROLIFERATION,4.2539e-06,-0.72397,-0.69541,1,0
1,GO REPLACEMENT OSSIFICATION,1.0403e-05,-0.7241,-0.68915,1,0
1,GO LAMELLIPODIUM MORPHOGENESIS,1.2939e-05,-0.72493,-0.63998,1,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,6.6813e-06,-0.72503,-0.70092,1,0
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,4.5891e-06,-0.7254,-0.76824,1,0
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,3.9422e-06,-0.72574,-0.69641,1,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,5.7533e-06,-0.72579,-0.70206,1,0
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,4.9495e-06,-0.72585,-0.69458,1,0
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,7.1973e-06,-0.72639,-0.67626,1,0
1,GO ACTIVATION OF JNKK ACTIVITY,4.5891e-06,-0.72669,-0.78564,1,0
1,GO CORPUS CALLOSUM DEVELOPMENT,5.337e-06,-0.72682,-0.72843,1,0
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,5.337e-06,-0.72753,-0.79933,1,0
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.7533e-06,-0.72753,-0.78841,1,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,2.1347e-05,-0.72768,-0.69073,1,0
1,GO PULMONARY VALVE DEVELOPMENT,4.9495e-06,-0.72831,-0.81117,1,0
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,4.5891e-06,-0.7284,-0.75633,1,0
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,4.9495e-06,-0.72851,-0.69724,1,0
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,2.2907e-05,-0.72949,-0.77046,1,0
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.4139e-05,-0.73011,-0.83712,1,0
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,7.1973e-06,-0.73049,-0.66148,1,0
1,GO REGULATION OF FIBROBLAST MIGRATION,4.2539e-06,-0.73053,-0.69465,1,0
1,GO REGULATION OF MIRNA METABOLIC PROCESS,4.5891e-06,-0.73098,-0.75594,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,2.2907e-05,-0.73108,-0.67829,1,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,6.2007e-06,-0.7311,-0.67527,1,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.1191e-05,-0.73118,-0.63519,1,0
1,GO REGULATION OF GTPASE ACTIVITY,4.2539e-06,-0.7313,-0.69224,1,0
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,3.9422e-06,-0.73222,-0.74078,1,0
1,GO GLYCOPROTEIN CATABOLIC PROCESS,5.7533e-06,-0.73233,-0.75363,1,0
1,GO PROTEIN AUTOPHOSPHORYLATION,3.9422e-06,-0.73234,-0.71547,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,6.2007e-06,-0.73248,-0.77202,1,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,1.3909e-05,-0.73358,-0.69209,1,0
1,GO KERATAN SULFATE CATABOLIC PROCESS,8.9327e-05,-0.7343,-0.76318,1,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,3.0304e-05,-0.73437,-0.70911,1,0
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.2539e-06,-0.73468,-0.73295,1,0
1,GO P38MAPK CASCADE,4.9495e-06,-0.73485,-0.74907,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,4.5891e-06,-0.73491,-0.68639,1,0
1,GO FIBROBLAST MIGRATION,3.9422e-06,-0.73518,-0.69067,1,0
1,GO PLASMA MEMBRANE ORGANIZATION,4.5891e-06,-0.73522,-0.70549,1,0
1,GO LEYDIG CELL DIFFERENTIATION,0.0010798,-0.7359,-0.55159,1,0
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,7.7514e-06,-0.73603,-0.66475,1,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,5.337e-06,-0.73634,-0.73591,1,0
1,GO REGULATION OF CELL MATRIX ADHESION,4.2539e-06,-0.73672,-0.76605,1,0
1,GO REGULATION OF BMP SIGNALING PATHWAY,5.337e-06,-0.73675,-0.70292,1,0
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,7.1973e-06,-0.73693,-0.70195,1,0
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,5.7533e-06,-0.73723,-0.75347,1,0
1,GO BLEB ASSEMBLY,5.2428e-05,-0.73735,-0.72409,1,0
1,GO BONE CELL DEVELOPMENT,3.9422e-06,-0.73761,-0.77537,1,0
1,GO CELL ADHESION MEDIATED BY INTEGRIN,1.7249e-05,-0.73768,-0.80933,1,0
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,1.2035e-05,-0.73783,-0.79502,1,0
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,8.3461e-06,-0.73798,-0.70822,1,0
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,4.5779e-05,-0.73814,-0.6155,1,0
1,GO REGULATION OF FATTY ACID BETA OXIDATION,6.2007e-06,-0.73839,-0.70118,1,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,7.7514e-06,-0.73841,-0.67514,1,0
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,4.2539e-06,-0.73845,-0.6973,1,0
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.3909e-05,-0.73889,-0.7183,1,0
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,6.6813e-06,-0.73898,-0.7812,1,0
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,7.7514e-06,-0.73941,-0.75537,1,0
1,GO LUTEINIZATION,6.2007e-06,-0.73944,-0.79383,1,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.2035e-05,-0.74054,-0.73017,1,0
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,3.9422e-06,-0.74125,-0.76095,1,0
1,GO PODOSOME ASSEMBLY,3.9422e-06,-0.74193,-0.81446,1,0
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.9422e-06,-0.74199,-0.72257,1,0
1,GO ALANINE TRANSPORT,1.1191e-05,-0.74201,-0.71663,1,0
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.74218,-0.77603,1,0
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,2.4576e-05,-0.74315,-0.72301,1,0
1,GO TUBULIN DEACETYLATION,6.6813e-06,-0.74361,-0.73484,1,0
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.4576e-05,-0.74379,-0.79252,1,0
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,4.9495e-06,-0.74426,-0.80644,1,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,5.337e-06,-0.74432,-0.66649,1,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,2.4576e-05,-0.74462,-0.75083,1,0
1,GO APICAL JUNCTION ASSEMBLY,1.4947e-05,-0.74463,-0.57971,1,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,1.1191e-05,-0.74492,-0.68728,1,0
1,GO CELL MATRIX ADHESION,3.9422e-06,-0.74561,-0.77531,1,0
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,4.2539e-06,-0.7465,-0.72552,1,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,4.5891e-06,-0.74678,-0.74932,1,0
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.2035e-05,-0.7471,-0.74202,1,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,1.4947e-05,-0.74792,-0.6865,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,4.5779e-05,-0.74933,-0.72251,1,0
1,GO RNA DESTABILIZATION,3.9422e-06,-0.74961,-0.75487,1,0
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,4.9495e-06,-0.75086,-0.72335,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,4.9495e-06,-0.75096,-0.67666,1,0
1,GO REGULATION OF VASCULAR PERMEABILITY,8.3461e-06,-0.75136,-0.66612,1,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.75153,-0.76462,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,4.2539e-06,-0.75203,-0.71148,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,4.5891e-06,-0.75261,-0.71165,1,0
1,GO ENDOTHELIUM DEVELOPMENT,4.9495e-06,-0.75273,-0.73264,1,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,3.9422e-06,-0.75325,-0.75428,1,0
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,4.5891e-06,-0.75342,-0.70234,1,0
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,6.2007e-06,-0.75361,-0.76914,1,0
1,GO ANATOMICAL STRUCTURE REGRESSION,7.3279e-05,-0.75409,-0.66002,1,0
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,4.2539e-06,-0.7548,-0.73853,1,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,5.9985e-05,-0.7548,-0.73556,1,0
1,GO PULMONARY VALVE MORPHOGENESIS,5.7533e-06,-0.75484,-0.79176,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,8.3461e-06,-0.75577,-0.70188,1,0
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,8.9843e-06,-0.75627,-0.6749,1,0
1,GO COLLAGEN CATABOLIC PROCESS,3.7287e-05,-0.7565,-0.73854,1,0
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.9495e-06,-0.75662,-0.72616,1,0
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,3.4805e-05,-0.75677,-0.69586,1,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,1.2035e-05,-0.75709,-0.78397,1,0
1,GO REGULATION OF CARTILAGE DEVELOPMENT,4.9495e-06,-0.75729,-0.70142,1,0
1,GO SPROUTING ANGIOGENESIS,4.2539e-06,-0.75733,-0.7491,1,0
1,GO KERATINOCYTE MIGRATION,4.2539e-06,-0.75737,-0.72676,1,0
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.0403e-05,-0.75778,-0.76665,1,0
1,GO REGULATION OF AXON GUIDANCE,4.5891e-06,-0.75852,-0.77073,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,3.9422e-06,-0.75923,-0.72128,1,0
1,GO HEART VALVE DEVELOPMENT,3.9422e-06,-0.75959,-0.77856,1,0
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,4.5891e-06,-0.75973,-0.69873,1,0
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00021879,-0.75993,-0.86572,1,0
1,GO PLATELET MORPHOGENESIS,3.9422e-06,-0.76025,-0.74533,1,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,8.3461e-06,-0.76062,-0.78489,1,0
1,GO CELLULAR RESPONSE TO CHOLESTEROL,4.5891e-06,-0.76068,-0.8051,1,0
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,4.9495e-06,-0.76091,-0.76449,1,0
1,GO STRESS FIBER ASSEMBLY,4.2539e-06,-0.76196,-0.70259,1,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.00096503,-0.76242,-0.59765,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,3.4805e-05,-0.76294,-0.67312,1,0
1,GO REGULATION OF NEURON MIGRATION,6.6813e-06,-0.76295,-0.75124,1,0
1,GO CORONARY VASCULATURE MORPHOGENESIS,5.337e-06,-0.76304,-0.79162,1,0
1,GO EPITHELIAL CELL MORPHOGENESIS,1.2939e-05,-0.76352,-0.73244,1,0
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,4.9495e-06,-0.76365,-0.74048,1,0
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,3.9422e-06,-0.76392,-0.75687,1,0
1,GO REGULATION OF STEM CELL DIVISION,1.1191e-05,-0.76428,-0.71993,1,0
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,4.5891e-06,-0.76487,-0.72704,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.7657,-0.71647,1,0
1,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.00076864,-0.7661,-0.65932,1,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,5.337e-06,-0.76669,-0.73675,1,0
1,GO ACTIVATION OF GTPASE ACTIVITY,4.9495e-06,-0.76729,-0.73438,1,0
1,GO MEGAKARYOCYTE DEVELOPMENT,3.9422e-06,-0.76735,-0.78911,1,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,1.3909e-05,-0.76766,-0.74578,1,0
1,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,5.6086e-05,-0.76817,-0.65044,1,0
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,4.2539e-06,-0.76859,-0.74136,1,0
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.2035e-05,-0.76859,-0.82418,1,0
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,5.337e-06,-0.76861,-0.74735,1,0
1,GO FACIAL NERVE MORPHOGENESIS,2.2907e-05,-0.76879,-0.74192,1,0
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,5.337e-06,-0.76888,-0.79872,1,0
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,3.9422e-06,-0.76954,-0.82527,1,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,7.1973e-06,-0.76956,-0.71335,1,0
1,GO RESPONSE TO MUSCLE STRETCH,5.6086e-05,-0.76981,-0.6962,1,0
1,GO CERAMIDE CATABOLIC PROCESS,7.7514e-06,-0.76993,-0.73572,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.8267e-05,-0.77038,-0.73152,1,0
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,5.7533e-06,-0.77066,-0.78881,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,2.1347e-05,-0.77132,-0.73682,1,0
1,GO GAP JUNCTION ASSEMBLY,0.00015974,-0.77271,-0.72565,1,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,9.6689e-06,-0.77297,-0.75301,1,0
1,GO REGULATION OF SPROUTING ANGIOGENESIS,4.5891e-06,-0.77311,-0.74678,1,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,5.7533e-06,-0.77319,-0.73964,1,0
1,GO GLOMERULUS DEVELOPMENT,4.5891e-06,-0.77377,-0.799,1,0
1,GO ACTIN FILAMENT BASED TRANSPORT,6.6813e-06,-0.7739,-0.76499,1,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,6.2007e-06,-0.77536,-0.75747,1,0
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,4.5891e-06,-0.77548,-0.75954,1,0
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,3.9422e-06,-0.77559,-0.78598,1,0
1,GO MYELIN MAINTENANCE,6.6813e-06,-0.77577,-0.69431,1,0
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.2539e-06,-0.77591,-0.75418,1,0
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,9.6689e-06,-0.77739,-0.77762,1,0
1,GO BASEMENT MEMBRANE ORGANIZATION,5.337e-06,-0.77764,-0.78603,1,0
1,GO ENDOCYTIC RECYCLING,4.2539e-06,-0.77876,-0.72033,1,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,3.9936e-05,-0.77945,-0.7818,1,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,1.3909e-05,-0.78044,-0.7742,1,0
1,GO ENDODERM DEVELOPMENT,5.337e-06,-0.78066,-0.79083,1,0
1,GO HIPPO SIGNALING,5.337e-06,-0.78114,-0.75705,1,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,5.337e-06,-0.78125,-0.75355,1,0
1,GO RESPONSE TO AMYLOID BETA,4.2539e-06,-0.78154,-0.78515,1,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,3.248e-05,-0.7823,-0.74882,1,0
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,6.2007e-06,-0.78237,-0.78062,1,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,6.8565e-05,-0.78329,-0.64753,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,6.2007e-06,-0.7833,-0.79255,1,0
1,GO PROTEIN ACTIVATION CASCADE,7.8298e-05,-0.78342,-0.6725,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,4.2763e-05,-0.78371,-0.84703,1,0
1,GO ARTERY MORPHOGENESIS,5.337e-06,-0.78437,-0.75781,1,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,5.7533e-06,-0.78457,-0.7438,1,0
1,GO SYNAPTIC VESICLE CLUSTERING,5.2428e-05,-0.78495,-0.7368,1,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,5.337e-06,-0.78531,-0.82528,1,0
1,GO GOLGI RIBBON FORMATION,5.7533e-06,-0.78554,-0.80722,1,0
1,GO LUNG ALVEOLUS DEVELOPMENT,7.7514e-06,-0.78628,-0.78088,1,0
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,7.1973e-06,-0.78743,-0.84469,1,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,4.9495e-06,-0.78813,-0.76458,1,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.9422e-06,-0.78818,-0.77223,1,0
1,GO BODY MORPHOGENESIS,4.5891e-06,-0.78847,-0.77576,1,0
1,GO REGULATION OF NEURON MATURATION,5.2428e-05,-0.78854,-0.5943,1,0
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,4.2539e-06,-0.78873,-0.80726,1,0
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,6.2007e-06,-0.78951,-0.80978,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,5.337e-06,-0.78953,-0.77013,1,0
1,GO LATERAL VENTRICLE DEVELOPMENT,8.3461e-06,-0.7903,-0.79303,1,0
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,4.5891e-06,-0.79048,-0.77108,1,0
1,GO NEUTROPHIL HOMEOSTASIS,3.9422e-06,-0.79157,-0.85263,1,0
1,GO COLLAGEN METABOLIC PROCESS,7.7514e-06,-0.7916,-0.82487,1,0
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,6.6813e-06,-0.79161,-0.77254,1,0
1,GO BLOOD VESSEL REMODELING,5.7533e-06,-0.79229,-0.78265,1,0
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,4.9495e-06,-0.79277,-0.81876,1,0
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,9.5377e-05,-0.79283,-0.71392,1,0
1,GO MACROPHAGE CYTOKINE PRODUCTION,1.1191e-05,-0.79379,-0.80921,1,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,4.9495e-06,-0.79407,-0.81628,1,0
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,4.5891e-06,-0.79421,-0.81732,1,0
1,GO MONONUCLEAR CELL DIFFERENTIATION,8.9843e-06,-0.79477,-0.77665,1,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,4.2539e-06,-0.7948,-0.77004,1,0
1,GO SOMATIC STEM CELL DIVISION,0.00020554,-0.79509,-0.66278,1,0
1,GO HEMIDESMOSOME ASSEMBLY,0.0029965,-0.79576,-0.61857,1,0
1,GO SEMI LUNAR VALVE DEVELOPMENT,3.9422e-06,-0.79617,-0.80288,1,0
1,GO MICROTUBULE NUCLEATION,7.7514e-06,-0.79751,-0.75232,1,0
1,GO REGULATION OF NEUTROPHIL ACTIVATION,5.2428e-05,-0.7977,-0.83358,1,0
1,GO FOCAL ADHESION ASSEMBLY,4.5891e-06,-0.79983,-0.80414,1,0
1,GO CORONARY VASCULATURE DEVELOPMENT,4.9495e-06,-0.80022,-0.77099,1,0
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,4.9495e-06,-0.80024,-0.75687,1,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.80075,-0.81262,1,0
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,4.9495e-06,-0.80165,-0.7599,1,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,1.2035e-05,-0.80309,-0.72083,1,0
1,GO VASCULAR WOUND HEALING,1.0403e-05,-0.80452,-0.79639,1,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,9.6689e-06,-0.80531,-0.74581,1,0
1,GO AORTIC VALVE DEVELOPMENT,3.9422e-06,-0.80779,-0.79801,1,0
1,GO EPIBOLY,3.9422e-06,-0.808,-0.78205,1,0
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,4.5891e-06,-0.80959,-0.7836,1,0
1,GO MRNA TRANSCRIPTION,4.9495e-06,-0.81072,-0.76623,1,0
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,3.9422e-06,-0.81139,-0.82052,1,0
1,GO FACE DEVELOPMENT,3.9422e-06,-0.81235,-0.81281,1,0
1,GO NEURON PROJECTION ARBORIZATION,5.337e-06,-0.81343,-0.80788,1,0
1,GO LYMPHANGIOGENESIS,7.1973e-06,-0.81586,-0.75059,1,0
1,GO TOOTH MINERALIZATION,8.9843e-06,-0.81815,-0.78462,1,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,6.2007e-06,-0.8191,-0.79962,1,0
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.9422e-06,-0.81925,-0.80809,1,0
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,4.9495e-06,-0.82102,-0.8462,1,0
1,GO RENAL FILTRATION,8.3461e-06,-0.82191,-0.87135,1,0
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,5.337e-06,-0.82381,-0.7953,1,0
1,GO PROTEIN DEMETHYLATION,5.337e-06,-0.82492,-0.77927,1,0
1,GO DERMATAN SULFATE METABOLIC PROCESS,1.7249e-05,-0.82609,-0.78288,1,0
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,4.5891e-06,-0.82673,-0.78494,1,0
1,GO ARTERY DEVELOPMENT,4.2539e-06,-0.82761,-0.77903,1,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,1.2939e-05,-0.82837,-0.75117,1,0
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,8.3461e-06,-0.82895,-0.8807,1,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,4.2539e-06,-0.8295,-0.90414,1,0
1,GO AORTA MORPHOGENESIS,4.5891e-06,-0.83074,-0.83012,1,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,3.0304e-05,-0.83205,-0.81208,1,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,5.337e-06,-0.83214,-0.78747,1,0
1,GO RESPONSE TO MAGNESIUM ION,2.636e-05,-0.83254,-0.71762,1,0
1,GO HEAD MORPHOGENESIS,4.5891e-06,-0.83643,-0.83265,1,0
1,GO POSITIVE REGULATION OF MITOPHAGY,4.5891e-06,-0.83661,-0.82286,1,0
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,5.7533e-06,-0.83899,-0.80782,1,0
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,4.9495e-06,-0.84009,-0.77599,1,0
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,4.2539e-06,-0.84085,-0.84279,1,0
1,GO AORTA DEVELOPMENT,3.9422e-06,-0.8413,-0.84837,1,0
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,4.9495e-06,-0.84219,-0.81273,1,0
1,GO COLLAGEN BIOSYNTHETIC PROCESS,5.337e-06,-0.84308,-0.87921,1,0
1,GO ACTIN FILAMENT SEVERING,7.7514e-06,-0.84336,-0.75795,1,0
1,GO SECRETORY GRANULE LOCALIZATION,9.6689e-06,-0.84367,-0.83168,1,0
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,5.337e-06,-0.84392,-0.83597,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,4.9495e-06,-0.84469,-0.79187,1,0
1,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,8.3461e-06,-0.84571,-0.8092,1,0
1,GO REGULATION OF KERATINOCYTE MIGRATION,3.9422e-06,-0.84584,-0.8404,1,0
1,GO RESPONSE TO FLUID SHEAR STRESS,4.2539e-06,-0.84676,-0.84496,1,0
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,8.3461e-06,-0.85048,-0.74664,1,0
1,GO LYMPH VESSEL MORPHOGENESIS,7.1973e-06,-0.85123,-0.78633,1,0
1,GO LOCOMOTOR RHYTHM,7.7514e-06,-0.85172,-0.80442,1,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,4.2539e-06,-0.85229,-0.78868,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,1.8524e-05,-0.85296,-0.77231,1,0
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.1191e-05,-0.85518,-0.8511,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,4.5891e-06,-0.85694,-0.80201,1,0
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,8.3461e-06,-0.85741,-0.74545,1,0
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.859,-0.83283,1,0
1,GO ENDODERM FORMATION,6.2007e-06,-0.86165,-0.84597,1,0
1,GO NUCLEAR MIGRATION,4.9495e-06,-0.86204,-0.85039,1,0
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,4.9495e-06,-0.86471,-0.79302,1,0
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,4.5891e-06,-0.86679,-0.80255,1,0
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,5.7533e-06,-0.86752,-0.8143,1,0
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,3.0304e-05,-0.87039,-0.82941,1,0
1,GO ENDOTHELIAL CELL DEVELOPMENT,4.5891e-06,-0.87074,-0.8192,1,0
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,3.9422e-06,-0.87519,-0.8207,1,0
1,GO EXTRACELLULAR MATRIX ASSEMBLY,6.2007e-06,-0.87593,-0.90861,1,0
1,GO DENSE CORE GRANULE TRANSPORT,7.3279e-05,-0.87745,-0.82685,1,0
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,8.9843e-06,-0.88187,-0.84717,1,0
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,4.9495e-06,-0.88511,-0.83822,1,0
1,GO PLASMA MEMBRANE TUBULATION,3.9422e-06,-0.8861,-0.8318,1,0
1,GO BASEMENT MEMBRANE ASSEMBLY,1.0403e-05,-0.88748,-0.84353,1,0
1,GO NUCLEUS LOCALIZATION,5.337e-06,-0.88833,-0.82596,1,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,4.5891e-06,-0.88962,-0.88419,1,0
1,GO MYELIN ASSEMBLY,5.7533e-06,-0.89118,-0.78658,1,0
1,GO CELL MIGRATION IN HINDBRAIN,2.4576e-05,-0.89268,-0.77661,1,0
1,GO COLLAGEN FIBRIL ORGANIZATION,6.6813e-06,-0.89278,-0.96117,1,0
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,1.2035e-05,-0.89721,-0.89054,1,0
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,6.2007e-06,-0.89995,-0.82521,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,3.9422e-06,-0.9042,-0.94446,1,0
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,8.3461e-06,-0.90669,-0.9124,1,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,5.7533e-06,-0.91214,-0.86549,1,0
1,GO POSITIVE REGULATION OF NEURON MIGRATION,3.9422e-06,-0.91511,-0.92234,1,0
1,GO ENDODERMAL CELL DIFFERENTIATION,5.337e-06,-0.9161,-0.93054,1,0
1,GO LYMPH VESSEL DEVELOPMENT,6.2007e-06,-0.91933,-0.83874,1,0
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00010866,-0.92291,-0.99863,1,0
1,GO BONE TRABECULA MORPHOGENESIS,7.8298e-05,-0.92476,-0.85409,1,0
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,1.7249e-05,-0.92506,-0.95161,1,0
1,GO HYALURONAN BIOSYNTHETIC PROCESS,4.9495e-06,-0.92603,-0.89323,1,0
1,GO ADHERENS JUNCTION ASSEMBLY,5.337e-06,-0.92618,-0.87721,1,0
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,3.9422e-06,-0.92655,-0.92373,1,0
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,7.1973e-06,-0.92879,-0.9716,1,0
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,5.337e-06,-0.93067,-0.87451,1,0
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,8.3641e-05,-0.93355,-0.89202,1,0
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,1.1191e-05,-0.93707,-0.84373,1,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,4.2539e-06,-0.93762,-0.87361,1,0
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,4.2539e-06,-0.93953,-0.9054,1,0
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,1.1191e-05,-0.94049,-0.97005,1,0
1,GO MACROPHAGE PROLIFERATION,5.2428e-05,-0.94062,-0.88075,1,0
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,5.7533e-06,-0.94297,-0.94619,1,0
1,GO DORSAL AORTA DEVELOPMENT,7.1973e-06,-0.94338,-0.84503,1,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,1.4947e-05,-0.95881,-0.84176,1,0
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,6.4139e-05,-0.95924,-0.79733,1,0
1,GO SKIN MORPHOGENESIS,8.9843e-06,-0.96257,-0.91253,1,0
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,4.9495e-06,-0.97458,-0.89019,1,0
1,GO ENDOTHELIAL CELL MORPHOGENESIS,5.7533e-06,-0.97533,-0.96018,1,0
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,6.2007e-06,-0.9843,-0.87976,1,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,8.9843e-06,-0.99135,-0.8693,1,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,5.337e-06,-1.0288,-1.0412,1,0
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,5.337e-06,-1.0302,-1.0591,1,0
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,5.337e-06,-1.0646,-0.96008,1,0
1,GO ELASTIC FIBER ASSEMBLY,1.0403e-05,-1.0784,-1.0383,1,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,4.2539e-06,-1.1525,-1.1533,1,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.091819,0.13768,0.086126,0,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.054439,0.14442,0.12896,0,0
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.18102,0.11873,0.04378,0,0
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.10811,0.1185,0.079637,0,0
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.10134,0.09617,0.095433,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.29248,0.088266,0.029721,0,0
1,GO OXYGEN TRANSPORT,0.65188,0.086736,-0.066425,0,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.27821,0.066894,0.019169,0,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.50109,0.054832,0.0060933,0,0
1,GO TRANSLATIONAL TERMINATION,0.51122,0.050554,-0.015039,0,0
1,GO REGULATION OF APPETITE,0.62923,0.046798,-0.1192,0,0
1,GO MITOCHONDRIAL TRANSLATION,0.76963,0.032666,-0.065235,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.69814,0.031164,0.067921,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.76963,0.030923,-0.043814,0,0
1,GO OXIDATIVE PHOSPHORYLATION,0.81845,0.029227,-0.020852,0,0
1,GO TRANSLATIONAL INITIATION,0.53179,0.0023127,0.032857,0,0
1,GO PROTEASOME ASSEMBLY,0.33029,-0.0081704,-0.10382,0,0
1,GO MITOCHONDRIAL GENE EXPRESSION,0.32248,-0.012501,-0.10628,0,0
1,GO XENOBIOTIC CATABOLIC PROCESS,0.52145,-0.018781,-0.094319,0,0
1,GO TRANSLATIONAL ELONGATION,0.53179,-0.019058,-0.068676,0,0
1,GO GAS TRANSPORT,0.33821,-0.01985,-0.16505,0,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.60692,-0.020305,-0.04752,0,0
1,GO PROTEIN NEDDYLATION,0.36271,-0.024538,-0.067986,0,0
1,GO PROTEIN TARGETING TO MEMBRANE,0.89296,-0.025854,-0.007756,0,0
1,GO CYTOPLASMIC TRANSLATION,0.32248,-0.030683,-0.040193,0,0
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.27821,-0.03324,-0.088737,0,0
1,GO GTP BIOSYNTHETIC PROCESS,0.28529,-0.035358,-0.09055,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.24463,-0.04311,-0.10006,0,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.37111,-0.043679,-0.077005,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.08588,-0.060854,-0.15244,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.1475,-0.061545,-0.1477,0,0
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.70989,-0.063905,-0.058636,0,0
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.17591,-0.067946,-0.14978,0,0
1,GO RIBOSOME ASSEMBLY,0.08881,-0.067994,-0.068351,0,0
1,GO VIRAL GENE EXPRESSION,0.098083,-0.070823,-0.055811,0,0
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0036751,-0.072602,-0.19366,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.10468,-0.072707,-0.11673,0,0
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.33821,-0.075498,-0.037737,0,0
1,GO PIRNA METABOLIC PROCESS,0.08881,-0.075898,-0.16574,0,0
1,GO UTP METABOLIC PROCESS,0.25111,-0.076824,-0.11159,0,0
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.069906,-0.07806,-0.13178,0,0
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.091819,-0.078448,-0.084043,0,0
1,GO RRNA 3 END PROCESSING,0.11894,-0.079117,-0.12558,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.15655,-0.094099,-0.11505,0,0
1,GO ELECTRON TRANSPORT CHAIN,0.054439,-0.10396,-0.11871,0,0
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.022172,-0.10664,-0.16038,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.062884,-0.10974,-0.070651,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.2259,-0.11228,-0.12954,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0028457,-0.11549,-0.20324,0,0
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.0063209,-0.11771,-0.2043,0,0
1,GO REGULATION OF RESPONSE TO FOOD,0.12662,-0.11899,-0.19595,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.046961,-0.12433,-0.15651,0,0
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.024086,-0.12493,-0.16504,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0052065,-0.12958,-0.19436,0,0
1,GO TRNA 5 LEADER REMOVAL,0.056456,-0.1313,-0.14005,0,0
1,GO CELLULAR RESPIRATION,0.018736,-0.1324,-0.15604,0,0
1,GO TRNA 5 END PROCESSING,0.02951,-0.13262,-0.15997,0,0
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.53179,-0.13838,-0.073621,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.037377,-0.13912,-0.15963,0,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.16602,-0.14226,-0.17803,0,0
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0063209,-0.14447,-0.24924,0,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.0010209,-0.14806,-0.2397,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0083971,-0.14988,-0.2194,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.27126,-0.15478,-0.23521,0,0
1,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.58498,-0.15709,-0.10483,0,0
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.17591,-0.15864,-0.22556,0,0
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0015041,-0.15882,-0.30844,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,9.6689e-06,-0.1594,-0.2008,0,0
1,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.0042727,-0.16102,-0.22622,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.11894,-0.16249,-0.28739,0,0
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00072571,-0.16258,-0.22147,0,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.056456,-0.16494,-0.26488,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.022172,-0.16792,-0.20414,0,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.072385,-0.16886,-0.18732,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.0042727,-0.17253,-0.24935,0,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.014457,-0.17265,-0.20427,0,0
1,GO OTIC VESICLE DEVELOPMENT,0.035953,-0.17519,-0.21115,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.13885,-0.17875,-0.3562,0,0
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00035748,-0.18511,-0.26795,0,0
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00051151,-0.18692,-0.18381,0,0
1,GO MIDBODY ABSCISSION,0.00091199,-0.18982,-0.29396,0,0
1,GO DNA LIGATION,0.0034935,-0.19033,-0.25995,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,3.7287e-05,-0.1906,-0.27889,0,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.0038653,-0.19171,-0.27283,0,0
1,GO PROTEIN DENEDDYLATION,0.01266,-0.19358,-0.21396,0,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.0080134,-0.19612,-0.20557,0,0
1,GO PENTOSE METABOLIC PROCESS,0.00024771,-0.19616,-0.30071,0,0
1,GO REGULATION OF GLUTAMATE SECRETION,0.010101,-0.20061,-0.41694,0,0
1,GO AEROBIC RESPIRATION,0.0031545,-0.20126,-0.20496,0,0
1,GO CYTIDINE TO URIDINE EDITING,0.069906,-0.20207,-0.34947,0,0
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00010181,-0.2046,-0.27378,0,0
1,GO CORNIFICATION,0.10134,-0.20461,-0.18233,0,0
1,GO GROOMING BEHAVIOR,0.045233,-0.20633,-0.25682,0,0
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00040321,-0.20787,-0.28835,0,0
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,7.8298e-05,-0.21036,-0.29814,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.007293,-0.21264,-0.21965,0,0
1,GO TRNA METABOLIC PROCESS,3.9936e-05,-0.21298,-0.31216,0,0
1,GO PROTEIN K11 LINKED UBIQUITINATION,5.2428e-05,-0.21638,-0.31131,0,0
1,GO TRNA PROCESSING,2.636e-05,-0.21964,-0.31231,0,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.00076864,-0.22305,-0.33098,0,0
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.074935,-0.22469,-0.36229,0,0
1,GO REGULATION OF TRANSLATIONAL ELONGATION,3.9936e-05,-0.2255,-0.27582,0,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.062884,-0.22571,-0.2246,0,0
1,GO MALE MEIOSIS I,0.015776,-0.22698,-0.33245,0,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.034576,-0.22838,-0.24579,0,0
1,GO KINETOCHORE ORGANIZATION,0.0027019,-0.22861,-0.33303,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.00010866,-0.22949,-0.27793,0,0
1,GO NUCLEOSIDE SALVAGE,0.00018128,-0.23012,-0.27613,0,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00026348,-0.23077,-0.32044,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.00081392,-0.23304,-0.23045,0,0
1,GO NCRNA 3 END PROCESSING,0.00015974,-0.2331,-0.27828,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,9.5377e-05,-0.23421,-0.30892,0,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,1.3909e-05,-0.23482,-0.30569,0,0
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.00026348,-0.23491,-0.36801,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,8.9327e-05,-0.23492,-0.32796,0,0
1,GO HISTONE SERINE PHOSPHORYLATION,0.00020554,-0.2352,-0.34102,0,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,9.5377e-05,-0.23605,-0.35128,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.00010866,-0.23615,-0.33941,0,0
1,GO TRNA MODIFICATION,1.8524e-05,-0.23885,-0.33885,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.00054254,-0.24073,-0.39106,0,0
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0012071,-0.24088,-0.22297,0,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.43329,-0.24241,-0.32138,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.0003797,-0.24253,-0.27605,0,0
1,GO PEPTIDYL ASPARAGINE MODIFICATION,3.4805e-05,-0.24262,-0.32857,0,0
1,GO STEROID ESTERIFICATION,0.0028457,-0.24378,-0.37076,0,0
1,GO TELOMERASE RNA LOCALIZATION,0.00020554,-0.24395,-0.26484,0,0
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,2.2907e-05,-0.24417,-0.30379,0,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,0.041938,-0.24482,-0.35658,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.00072571,-0.24645,-0.34287,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.00057531,-0.24834,-0.2363,0,0
1,GO UBIQUINONE METABOLIC PROCESS,0.0011418,-0.24836,-0.27596,0,0
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,8.9327e-05,-0.24859,-0.29765,0,0
1,GO LACTATE METABOLIC PROCESS,0.0010209,-0.24901,-0.27928,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,5.9985e-05,-0.2508,-0.30027,0,0
1,GO VIRAL LATENCY,0.00076864,-0.25243,-0.30094,0,0
1,GO RNA 5 END PROCESSING,0.00014062,-0.25253,-0.28323,0,0
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.00033648,-0.25388,-0.28649,0,0
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.00028019,-0.25494,-0.33762,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.00012367,-0.25562,-0.32621,0,0
1,GO SNORNA 3 END PROCESSING,0.00086166,-0.256,-0.29412,0,0
1,GO NCRNA METABOLIC PROCESS,1.0403e-05,-0.25646,-0.33111,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.058535,-0.25745,-0.17428,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,6.2007e-06,-0.2588,-0.3454,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.0092139,-0.2591,-0.27575,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.10811,-0.26196,-0.4118,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,4.5891e-06,-0.26236,-0.31497,0,0
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,3.248e-05,-0.26344,-0.39339,0,0
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.080256,-0.264,-0.22286,0,0
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.00060992,-0.26452,-0.35253,0,0
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.00017019,-0.26729,-0.27836,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,1.4947e-05,-0.26813,-0.35289,0,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.0013481,-0.27027,-0.30923,0,0
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.00028019,-0.27045,-0.34885,0,0
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00029789,-0.27562,-0.37628,0,0
1,GO POSTREPLICATION REPAIR,2.1347e-05,-0.27671,-0.35523,0,0
1,GO AMP METABOLIC PROCESS,0.00040321,-0.27835,-0.28401,0,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.00086166,-0.27854,-0.2956,0,0
1,GO KINETOCHORE ASSEMBLY,0.0012071,-0.27923,-0.36164,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.197,-0.27946,-0.41949,0,0
1,GO TRNA CATABOLIC PROCESS,0.00076864,-0.27951,-0.40048,0,0
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0049572,-0.281,-0.2014,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,8.3641e-05,-0.28483,-0.38735,0,0
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0003797,-0.28583,-0.32707,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,3.7287e-05,-0.28674,-0.34082,0,0
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.00024771,-0.29011,-0.30749,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,3.248e-05,-0.29036,-0.34178,0,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.0015041,-0.29092,-0.37142,0,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.00068502,-0.29095,-0.35911,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00076864,-0.29156,-0.27855,0,0
1,GO CYTOLYSIS,0.10134,-0.29287,-0.3397,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0013481,-0.29332,-0.36965,0,0
1,GO OOCYTE DIFFERENTIATION,4.8997e-05,-0.29436,-0.38007,0,0
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,7.7514e-06,-0.29466,-0.39422,0,0
1,GO AMINO ACID ACTIVATION,0.00010181,-0.29467,-0.34891,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.0025648,-0.29473,-0.27221,0,0
1,GO RNA MODIFICATION,7.1973e-06,-0.29523,-0.37676,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.0027019,-0.29683,-0.28949,0,0
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,6.8565e-05,-0.29787,-0.29879,0,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00021879,-0.29919,-0.34206,0,0
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,3.248e-05,-0.30088,-0.37383,0,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00014062,-0.30088,-0.33658,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.00013188,-0.30106,-0.31369,0,0
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.6059e-05,-0.30138,-0.32302,0,0
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.00011593,-0.30142,-0.39458,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,4.8997e-05,-0.30144,-0.32076,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.0025648,-0.30239,-0.31403,0,0
1,GO OOGENESIS,3.7287e-05,-0.30284,-0.37068,0,0
1,GO SNORNA METABOLIC PROCESS,7.8298e-05,-0.30682,-0.34629,0,0
1,GO HOMOLOGOUS RECOMBINATION,9.5377e-05,-0.30762,-0.40534,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00014062,-0.30787,-0.3335,0,0
1,GO METHIONINE METABOLIC PROCESS,0.00042807,-0.30795,-0.32849,0,0
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,8.3461e-06,-0.30908,-0.36009,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,4.5779e-05,-0.30969,-0.37269,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00010181,-0.31229,-0.33846,0,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.00060992,-0.31247,-0.38188,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.00332,-0.31275,-0.30131,0,0
1,GO MRNA METABOLIC PROCESS,6.6813e-06,-0.31354,-0.34804,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,1.7249e-05,-0.31393,-0.34829,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.008797,-0.31548,-0.30379,0,0
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,1.3909e-05,-0.3156,-0.32056,0,0
1,GO SNRNA METABOLIC PROCESS,4.5779e-05,-0.31566,-0.34187,0,0
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,1.8524e-05,-0.3157,-0.36675,0,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0049572,-0.31633,-0.25561,0,0
1,GO RNA METHYLATION,6.6813e-06,-0.31775,-0.4161,0,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.00010181,-0.31785,-0.40056,0,0
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0036751,-0.31818,-0.29522,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,1.9888e-05,-0.31819,-0.37416,0,0
1,GO MEIOTIC CELL CYCLE PROCESS,5.9985e-05,-0.31915,-0.4054,0,0
1,GO RESPONSE TO NITROSATIVE STRESS,0.00017019,-0.31918,-0.28342,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0015882,-0.32046,-0.28271,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.00086166,-0.32063,-0.37379,0,0
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00060992,-0.32207,-0.33065,0,0
1,GO REGULATION OF RELAXATION OF MUSCLE,0.0092139,-0.3231,-0.40706,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0018673,-0.32416,-0.35429,0,0
1,GO ATP METABOLIC PROCESS,3.248e-05,-0.32418,-0.32305,0,0
1,GO EATING BEHAVIOR,0.0015882,-0.32548,-0.34368,0,0
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,5.9985e-05,-0.32617,-0.36978,0,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.9936e-05,-0.32756,-0.36743,0,0
1,GO RRNA CATABOLIC PROCESS,4.8997e-05,-0.32763,-0.42742,0,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.00015974,-0.329,-0.38701,0,0
1,GO DNA STRAND ELONGATION,0.00014062,-0.32921,-0.37473,0,0
1,GO REGULATION OF PROTON TRANSPORT,3.248e-05,-0.32978,-0.3919,0,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,3.7287e-05,-0.33149,-0.37171,0,0
1,GO MITOCHONDRIAL DNA REPLICATION,9.6689e-06,-0.33313,-0.41042,0,0
1,GO REGULATION OF HELICASE ACTIVITY,0.00033648,-0.33387,-0.33573,0,0
1,GO MATURATION OF 5 8S RRNA,8.3641e-05,-0.33459,-0.33854,0,0
1,GO GLYCINE METABOLIC PROCESS,0.00017019,-0.3361,-0.35775,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0047188,-0.33643,-0.50255,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00021879,-0.33729,-0.36673,0,0
1,GO REGULATION OF LIGASE ACTIVITY,4.5779e-05,-0.33809,-0.39248,0,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,3.7287e-05,-0.33852,-0.35474,0,0
1,GO MIDDLE EAR MORPHOGENESIS,0.00015974,-0.33896,-0.37189,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,1.0403e-05,-0.33944,-0.35294,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,4.8997e-05,-0.33978,-0.41972,0,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00057531,-0.33991,-0.36501,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,3.248e-05,-0.34,-0.37148,0,0
1,GO MEIOTIC CELL CYCLE,2.1347e-05,-0.34184,-0.43641,0,0
1,GO SNRNA TRANSCRIPTION,9.6689e-06,-0.3425,-0.42411,0,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,4.8997e-05,-0.34254,-0.35745,0,0
1,GO METAPHASE PLATE CONGRESSION,5.6086e-05,-0.34306,-0.41526,0,0
1,GO NUCLEAR ENVELOPE REASSEMBLY,6.8565e-05,-0.34367,-0.40364,0,0
1,GO BASE EXCISION REPAIR,3.9936e-05,-0.34433,-0.37881,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,1.3909e-05,-0.34519,-0.39445,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,1.6059e-05,-0.34583,-0.3541,0,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,2.8267e-05,-0.3459,-0.43873,0,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,8.3461e-06,-0.34668,-0.36656,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,8.3641e-05,-0.34711,-0.3369,0,0
1,GO MATURATION OF SSU RRNA,8.3461e-06,-0.34796,-0.34366,0,0
1,GO NUCLEAR CHROMOSOME SEGREGATION,2.4576e-05,-0.3489,-0.4292,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,1.7249e-05,-0.34982,-0.43719,0,0
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,1.2939e-05,-0.35063,-0.39944,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,1.1191e-05,-0.35107,-0.38785,0,0
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,1.9888e-05,-0.35449,-0.39307,0,0
1,GO OOCYTE MATURATION,5.6086e-05,-0.3546,-0.40753,0,0
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00042807,-0.35472,-0.46347,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,3.0304e-05,-0.35564,-0.41121,0,0
1,GO RNA PROCESSING,7.1973e-06,-0.35576,-0.39569,0,0
1,GO RESPONSE TO SALT,0.00013188,-0.35581,-0.36757,0,0
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,2.4576e-05,-0.35587,-0.39396,0,0
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,5.337e-06,-0.35629,-0.37022,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0034935,-0.35696,-0.39214,0,0
1,GO CHROMOSOME SEGREGATION,2.4576e-05,-0.35757,-0.42771,0,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,1.8524e-05,-0.35835,-0.46184,0,0
1,GO REGULATION OF CELL PROJECTION SIZE,0.00021879,-0.35893,-0.41322,0,0
1,GO ZINC ION TRANSPORT,1.2939e-05,-0.35978,-0.38911,0,0
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00081392,-0.36036,-0.45016,0,0
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,2.8267e-05,-0.36169,-0.4324,0,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.040368,-0.36261,-0.2253,0,0
1,GO EXIT FROM MITOSIS,4.2763e-05,-0.36282,-0.44203,0,0
1,GO REGULATION OF CELLULAR RESPIRATION,4.8997e-05,-0.36327,-0.39091,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,7.1973e-06,-0.36438,-0.4328,0,0
1,GO REGULATION OF CENTROSOME DUPLICATION,1.1191e-05,-0.36508,-0.47509,0,0
1,GO REGULATION OF TRANSLATIONAL INITIATION,4.2539e-06,-0.36665,-0.45195,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.0304e-05,-0.36722,-0.4068,0,0
1,GO REGULATION OF MRNA BINDING,1.2939e-05,-0.36732,-0.40905,0,0
1,GO REGULATION OF NUCLEASE ACTIVITY,0.00076864,-0.36738,-0.37134,0,0
1,GO CHROMOSOME LOCALIZATION,2.8267e-05,-0.3681,-0.43755,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.0047188,-0.36815,-0.37415,0,0
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.2939e-05,-0.36837,-0.37559,0,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,5.2428e-05,-0.36902,-0.40892,0,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,2.8267e-05,-0.36947,-0.39585,0,0
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,5.7533e-06,-0.37024,-0.41055,0,0
1,GO RNA 3 END PROCESSING,1.1191e-05,-0.37036,-0.41044,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.00019306,-0.37305,-0.40004,0,0
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,6.6813e-06,-0.37498,-0.39109,0,0
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.00017019,-0.3753,-0.38818,0,0
1,GO CHRONIC INFLAMMATORY RESPONSE,0.080256,-0.37564,-0.3887,0,0
1,GO SISTER CHROMATID SEGREGATION,3.9936e-05,-0.37704,-0.43796,0,0
1,GO DNA CATABOLIC PROCESS,7.1973e-06,-0.37743,-0.43146,0,0
1,GO COENZYME A METABOLIC PROCESS,8.9843e-06,-0.37781,-0.43439,0,0
1,GO EOSINOPHIL CHEMOTAXIS,0.067497,-0.37798,-0.40896,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,6.4139e-05,-0.37863,-0.41514,0,0
1,GO MITOTIC SISTER CHROMATID SEGREGATION,4.8997e-05,-0.37897,-0.42998,0,0
1,GO HISTONE H3 K9 ACETYLATION,1.6059e-05,-0.37936,-0.44052,0,0
1,GO MESODERMAL CELL FATE SPECIFICATION,2.2907e-05,-0.3796,-0.43762,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00048214,-0.37996,-0.36543,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,1.4947e-05,-0.38033,-0.45088,0,0
1,GO NON MOTILE CILIUM ASSEMBLY,9.6689e-06,-0.38216,-0.4829,0,0
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,2.636e-05,-0.38293,-0.37951,0,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,2.2907e-05,-0.38394,-0.35651,0,0
1,GO INSEMINATION,0.00051151,-0.38478,-0.38325,0,0
1,GO HISTONE PHOSPHORYLATION,7.7514e-06,-0.38519,-0.49104,0,0
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,5.6086e-05,-0.38566,-0.41,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,5.9985e-05,-0.38599,-0.39648,0,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,8.9327e-05,-0.38623,-0.3539,0,0
1,GO ALDITOL METABOLIC PROCESS,0.0034935,-0.38648,-0.31646,0,0
1,GO REGULATION OF CENTROSOME CYCLE,1.0403e-05,-0.38695,-0.46528,0,0
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.8524e-05,-0.38805,-0.47096,0,0
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.00014989,-0.38891,-0.44478,0,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.019548,-0.3892,-0.34054,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,7.1973e-06,-0.38947,-0.43485,0,0
1,GO PEPTIDYL PROLINE MODIFICATION,2.8267e-05,-0.38981,-0.39193,0,0
1,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00014062,-0.39005,-0.34786,0,0
1,GO CHROMOSOME SEPARATION,2.8267e-05,-0.39079,-0.46326,0,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,5.2428e-05,-0.39155,-0.43727,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.0083971,-0.39272,-0.37609,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.00014989,-0.39396,-0.51955,0,0
1,GO RNA SPLICING,1.6059e-05,-0.395,-0.4122,0,0
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,5.2428e-05,-0.3955,-0.38685,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.0052065,-0.39588,-0.35882,0,0
1,GO REGULATION OF DNA BINDING,4.9495e-06,-0.39617,-0.47021,0,0
1,GO CHROMATIN SILENCING,1.3909e-05,-0.39648,-0.46315,0,0
1,GO CHROMOSOME CONDENSATION,7.3279e-05,-0.39725,-0.47892,0,0
1,GO HISTONE H2B UBIQUITINATION,5.7533e-06,-0.39798,-0.49346,0,0
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.00054254,-0.39924,-0.38376,0,0
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.00035748,-0.3994,-0.3785,0,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00029789,-0.39967,-0.33381,0,0
1,GO COBALAMIN METABOLIC PROCESS,3.0304e-05,-0.40001,-0.44101,0,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,1.9888e-05,-0.40145,-0.4128,0,0
1,GO CELL CYCLE DNA REPLICATION,7.3279e-05,-0.40171,-0.41448,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,6.2007e-06,-0.40189,-0.46626,0,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,7.7514e-06,-0.4032,-0.47995,0,0
1,GO HORMONE CATABOLIC PROCESS,0.00048214,-0.40324,-0.36576,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.00017019,-0.40435,-0.38655,0,0
1,GO MRNA PROCESSING,1.2035e-05,-0.40478,-0.43273,0,0
1,GO DNA REPAIR,8.9843e-06,-0.40487,-0.45747,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.00051151,-0.40729,-0.34003,0,0
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.0304e-05,-0.40781,-0.40316,0,0
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,3.9422e-06,-0.40838,-0.44306,0,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,2.4576e-05,-0.40909,-0.47114,0,0
1,GO DNA RECOMBINATION,6.2007e-06,-0.40992,-0.47372,0,0
1,GO BLASTOCYST DEVELOPMENT,5.337e-06,-0.41082,-0.42042,0,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,1.2035e-05,-0.41088,-0.44146,0,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0012071,-0.41124,-0.50167,0,0
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,9.6689e-06,-0.41195,-0.40923,0,0
1,GO ORGANELLE FISSION,1.1191e-05,-0.41361,-0.46862,0,0
1,GO DNA REPLICATION CHECKPOINT,6.4139e-05,-0.41381,-0.4464,0,0
1,GO CELL CYCLE PHASE TRANSITION,7.7514e-06,-0.41524,-0.45391,0,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.0019699,-0.41749,-0.40672,0,0
1,GO REGULATION OF GONAD DEVELOPMENT,1.1191e-05,-0.41771,-0.44752,0,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,4.5779e-05,-0.4178,-0.3935,0,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,1.3909e-05,-0.41793,-0.46454,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,2.8267e-05,-0.41805,-0.42407,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,2.8267e-05,-0.419,-0.42829,0,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,7.7514e-06,-0.4197,-0.43391,0,0
1,GO REGULATION OF REPRODUCTIVE PROCESS,6.6813e-06,-0.42032,-0.43842,0,0
1,GO THIOESTER METABOLIC PROCESS,1.1191e-05,-0.4204,-0.41085,0,0
1,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.00015974,-0.42141,-0.42047,0,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,7.8298e-05,-0.42181,-0.44884,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,1.3909e-05,-0.42329,-0.46912,0,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0025648,-0.42368,-0.45728,0,0
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0042727,-0.42446,-0.56437,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,2.4576e-05,-0.42502,-0.46933,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00014989,-0.42504,-0.4235,0,0
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,4.9495e-06,-0.4262,-0.47082,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.0010209,-0.42631,-0.3907,0,0
1,GO PROTEIN REFOLDING,5.9985e-05,-0.42669,-0.43203,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.00010181,-0.42679,-0.43581,0,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,6.8565e-05,-0.42738,-0.46841,0,0
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,5.337e-06,-0.4282,-0.44554,0,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0010209,-0.4284,-0.35826,0,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,1.2939e-05,-0.42889,-0.42155,0,0
1,GO REGULATION OF EXOSOMAL SECRETION,2.2907e-05,-0.43115,-0.51667,0,0
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,1.2035e-05,-0.43162,-0.48323,0,0
1,GO ACETYL COA METABOLIC PROCESS,3.9422e-06,-0.43274,-0.52368,0,0
1,GO GABAERGIC NEURON DIFFERENTIATION,0.08881,-0.43295,-0.4668,0,0
1,GO SISTER CHROMATID COHESION,1.7249e-05,-0.43299,-0.50473,0,0
1,GO CENTROSOME SEPARATION,4.2763e-05,-0.43312,-0.47212,0,0
1,GO DNA DEALKYLATION,3.248e-05,-0.43356,-0.42805,0,0
1,GO RNA LOCALIZATION,6.6813e-06,-0.43407,-0.4681,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.636e-05,-0.4345,-0.51965,0,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00013188,-0.43455,-0.46186,0,0
1,GO RESPONSE TO NITRIC OXIDE,4.5779e-05,-0.43509,-0.47625,0,0
1,GO MALE SEX DETERMINATION,0.00014062,-0.43561,-0.4569,0,0
1,GO VIRAL RELEASE FROM HOST CELL,1.2035e-05,-0.43586,-0.44779,0,0
1,GO MRNA 3 END PROCESSING,1.1191e-05,-0.43601,-0.46706,0,0
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00021879,-0.43684,-0.57466,0,0
1,GO RNA EXPORT FROM NUCLEUS,7.7514e-06,-0.43732,-0.47708,0,0
1,GO PROTEIN OXIDATION,0.00018128,-0.43791,-0.41928,0,0
1,GO GMP METABOLIC PROCESS,4.5891e-06,-0.43826,-0.45534,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,1.8524e-05,-0.43841,-0.45924,0,0
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,7.1973e-06,-0.43898,-0.46815,0,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,4.9495e-06,-0.43927,-0.49288,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,8.3461e-06,-0.43968,-0.49248,0,0
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00024771,-0.44012,-0.50181,0,0
1,GO REGULATION OF RIBOSOME BIOGENESIS,3.9422e-06,-0.44021,-0.51539,0,0
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,5.2428e-05,-0.44063,-0.45719,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00010866,-0.44116,-0.45961,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE,5.337e-06,-0.44235,-0.48927,0,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,1.2035e-05,-0.44296,-0.44493,0,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,3.7287e-05,-0.44405,-0.4292,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,4.2763e-05,-0.44409,-0.48805,0,0
1,GO PROTEIN K48 LINKED UBIQUITINATION,4.9495e-06,-0.4442,-0.49448,0,0
1,GO TELOMERE ORGANIZATION,8.3461e-06,-0.44423,-0.46475,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.00024771,-0.44523,-0.40319,0,0
1,GO DNA DEMETHYLATION,2.636e-05,-0.44635,-0.4586,0,0
1,GO CENTROSOME DUPLICATION,1.3909e-05,-0.44653,-0.53798,0,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.00068502,-0.44666,-0.44057,0,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,3.9422e-06,-0.44669,-0.47134,0,0
1,GO REGULATION OF NUCLEAR DIVISION,1.0403e-05,-0.44681,-0.46884,0,0
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,4.8997e-05,-0.44695,-0.43114,0,0
1,GO DORSAL VENTRAL PATTERN FORMATION,4.8997e-05,-0.44754,-0.46446,0,0
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,1.2939e-05,-0.44781,-0.56875,0,0
1,GO REGULATION OF MITOTIC CELL CYCLE,6.6813e-06,-0.44846,-0.48835,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,6.2007e-06,-0.44933,-0.49127,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,5.337e-06,-0.45151,-0.51971,0,0
1,GO POSITIVE REGULATION OF DNA BINDING,8.9843e-06,-0.45202,-0.47256,0,0
1,GO VACUOLAR ACIDIFICATION,1.0403e-05,-0.45272,-0.46664,0,0
1,GO CELL CYCLE PROCESS,7.7514e-06,-0.45289,-0.49337,0,0
1,GO CELL DIVISION,8.9843e-06,-0.45299,-0.48643,0,0
1,GO HISTAMINE SECRETION,0.00332,-0.45325,-0.38177,0,0
1,GO MITOTIC CELL CYCLE,7.7514e-06,-0.4534,-0.48966,0,0
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,4.8997e-05,-0.45411,-0.41456,0,0
1,GO REGULATION OF CELL AGING,7.7514e-06,-0.45534,-0.46509,0,0
1,GO IMP BIOSYNTHETIC PROCESS,0.00023283,-0.45576,-0.43348,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,5.337e-06,-0.45613,-0.48974,0,0
1,GO MRNA EXPORT FROM NUCLEUS,9.6689e-06,-0.4568,-0.49867,0,0
1,GO ESTABLISHMENT OF RNA LOCALIZATION,5.7533e-06,-0.45808,-0.49786,0,0
1,GO MATING,2.8267e-05,-0.45808,-0.45929,0,0
1,GO HEXOSE CATABOLIC PROCESS,1.9888e-05,-0.46022,-0.4987,0,0
1,GO IMP METABOLIC PROCESS,0.00015974,-0.46032,-0.43585,0,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0038653,-0.46055,-0.4795,0,0
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,4.5891e-06,-0.46121,-0.4825,0,0
1,GO REGULATION OF CELL CYCLE ARREST,8.9843e-06,-0.46189,-0.48421,0,0
1,GO MITOTIC NUCLEAR DIVISION,1.2035e-05,-0.46241,-0.49289,0,0
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.7533e-06,-0.4626,-0.4866,0,0
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,9.5377e-05,-0.46315,-0.51395,0,0
1,GO HYPOTHALAMUS DEVELOPMENT,9.5377e-05,-0.46332,-0.43516,0,0
1,GO DE NOVO PROTEIN FOLDING,2.4576e-05,-0.46472,-0.46652,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,1.2035e-05,-0.46475,-0.54663,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,1.4947e-05,-0.46551,-0.47802,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,6.2007e-06,-0.4657,-0.50332,0,0
1,GO ANIMAL ORGAN FORMATION,8.9843e-06,-0.46627,-0.50784,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,8.3461e-06,-0.46664,-0.49415,0,0
1,GO STEROID CATABOLIC PROCESS,0.00040321,-0.46675,-0.45341,0,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00014062,-0.46683,-0.3977,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE,7.1973e-06,-0.46746,-0.51318,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,1.4947e-05,-0.46773,-0.508,0,0
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,4.9495e-06,-0.46777,-0.52677,0,0
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,1.0403e-05,-0.46807,-0.44499,0,0
1,GO GLUTAMINE METABOLIC PROCESS,4.5891e-06,-0.46811,-0.52103,0,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.9495e-06,-0.46845,-0.45807,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,6.2007e-06,-0.46977,-0.5117,0,0
1,GO MRNA TRANSPORT,6.6813e-06,-0.47004,-0.51206,0,0
1,GO SINGLE STRAND BREAK REPAIR,3.7287e-05,-0.4705,-0.47035,0,0
1,GO CELL CYCLE CHECKPOINT,9.6689e-06,-0.47062,-0.50935,0,0
1,GO PENILE ERECTION,0.00026348,-0.4708,-0.5345,0,0
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,7.7514e-06,-0.47108,-0.47789,0,0
1,GO NUCLEAR TRANSPORT,4.2539e-06,-0.47167,-0.494,0,0
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,8.3641e-05,-0.47258,-0.46995,0,0
1,GO LIPID EXPORT FROM CELL,5.2428e-05,-0.47319,-0.41949,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,1.9888e-05,-0.4741,-0.50124,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,6.6813e-06,-0.47436,-0.48992,0,0
1,GO DNA BIOSYNTHETIC PROCESS,4.9495e-06,-0.47438,-0.48231,0,0
1,GO NAD METABOLIC PROCESS,1.2939e-05,-0.47539,-0.54159,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.00012367,-0.47598,-0.56001,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,5.337e-06,-0.47613,-0.51548,0,0
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,5.7533e-06,-0.47671,-0.49004,0,0
1,GO REPLICATION FORK PROCESSING,1.7249e-05,-0.47753,-0.5863,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,8.3461e-06,-0.47898,-0.49305,0,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,8.9843e-06,-0.47899,-0.54588,0,0
1,GO CHROMOSOME ORGANIZATION,7.7514e-06,-0.48103,-0.51645,0,0
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,6.6813e-06,-0.4816,-0.46877,0,0
1,GO RESPONSE TO ETHER,6.8565e-05,-0.48161,-0.43807,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,6.2007e-06,-0.48186,-0.50634,0,0
1,GO NUCLEAR EXPORT,5.337e-06,-0.48208,-0.51069,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,1.3909e-05,-0.48316,-0.50888,0,0
1,GO MITOTIC SPINDLE ORGANIZATION,1.9888e-05,-0.48368,-0.50389,0,0
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,4.8997e-05,-0.48496,-0.50065,0,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,1.3909e-05,-0.48508,-0.50951,0,0
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00026348,-0.48531,-0.39481,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,1.4947e-05,-0.48543,-0.47618,0,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,7.3279e-05,-0.48642,-0.388,0,0
1,GO CELL CYCLE G1 S PHASE TRANSITION,5.7533e-06,-0.48734,-0.49016,0,0
1,GO SPINDLE MIDZONE ASSEMBLY,2.8267e-05,-0.48755,-0.62583,0,0
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,7.1973e-06,-0.4884,-0.54339,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.8524e-05,-0.48934,-0.47908,0,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0017696,-0.48974,-0.40049,0,0
1,GO PARAXIAL MESODERM DEVELOPMENT,3.4805e-05,-0.49022,-0.48353,0,0
1,GO EAR MORPHOGENESIS,1.2035e-05,-0.49056,-0.46911,0,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,1.3909e-05,-0.49105,-0.50212,0,0
1,GO PROTEIN IMPORT,3.9422e-06,-0.49212,-0.49802,0,0
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,4.9495e-06,-0.49248,-0.53484,0,0
1,GO FATTY ACID HOMEOSTASIS,1.7249e-05,-0.49269,-0.5157,0,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,3.248e-05,-0.49288,-0.60546,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,1.0403e-05,-0.49302,-0.5384,0,0
1,GO SPINDLE ASSEMBLY,9.6689e-06,-0.49466,-0.52131,0,0
1,GO HISTAMINE TRANSPORT,0.0003797,-0.49495,-0.45126,0,0
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,6.6813e-06,-0.49585,-0.57464,0,0
1,GO CELLULAR SENESCENCE,5.337e-06,-0.49632,-0.4841,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,6.6813e-06,-0.49653,-0.5226,0,0
1,GO GANGLION DEVELOPMENT,0.00091199,-0.49705,-0.51646,0,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,0.17091,-0.49779,-0.40738,0,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00010866,-0.49801,-0.51469,0,0
1,GO NEGATIVE REGULATION OF DNA REPLICATION,1.4947e-05,-0.4984,-0.49122,0,0
1,GO MITOTIC CELL CYCLE CHECKPOINT,8.9843e-06,-0.49845,-0.51473,0,0
1,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,6.4139e-05,-0.49952,-0.54625,0,0
1,GO INTRA S DNA DAMAGE CHECKPOINT,1.3909e-05,-0.49955,-0.61977,0,0
1,GO DIENCEPHALON DEVELOPMENT,0.00020554,-0.49984,-0.46553,0,0
1,GO REGULATION OF STEM CELL PROLIFERATION,8.3461e-06,-0.50024,-0.52686,0,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.6059e-05,-0.50057,-0.53058,0,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00023283,-0.50108,-0.50992,0,0
1,GO CD40 SIGNALING PATHWAY,4.5779e-05,-0.5011,-0.60949,0,0
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.00035748,-0.50128,-0.44541,0,0
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,6.2007e-06,-0.50247,-0.51573,0,0
1,GO POSITIVE REGULATION OF BINDING,4.5891e-06,-0.50249,-0.53529,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00031664,-0.5026,-0.46977,0,0
1,GO AUTOPHAGIC CELL DEATH,2.2907e-05,-0.50332,-0.48212,0,0
1,GO CENTRIOLE ASSEMBLY,8.9843e-06,-0.50351,-0.5813,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0080134,-0.50371,-0.58901,0,0
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,3.9422e-06,-0.50483,-0.55638,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,5.337e-06,-0.50512,-0.52641,0,0
1,GO RESPONSE TO NUTRIENT,6.6813e-06,-0.50527,-0.54198,0,0
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,3.9422e-06,-0.5053,-0.51585,0,0
1,GO SPINDLE ORGANIZATION,1.4947e-05,-0.50531,-0.52541,0,0
1,GO DNA INTEGRITY CHECKPOINT,7.7514e-06,-0.50575,-0.52769,0,0
1,GO CELL CYCLE ARREST,4.5891e-06,-0.50603,-0.51996,0,0
1,GO RESPONSE TO ACTIVITY,6.2007e-06,-0.50605,-0.47584,0,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,2.636e-05,-0.50678,-0.53006,0,0
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,8.3461e-06,-0.50693,-0.50514,0,0
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,1.0403e-05,-0.50734,-0.47279,0,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,6.2007e-06,-0.50832,-0.52269,0,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00023283,-0.50861,-0.44884,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,6.2007e-06,-0.50863,-0.53125,0,0
1,GO COPULATION,9.5377e-05,-0.50868,-0.47609,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,3.248e-05,-0.50897,-0.48557,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,4.9495e-06,-0.50938,-0.51487,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,9.6689e-06,-0.51068,-0.51303,0,0
1,GO MULTICELLULAR ORGANISM AGING,1.6059e-05,-0.51118,-0.48249,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,1.4947e-05,-0.51124,-0.50979,0,0
1,GO GLUCOSE CATABOLIC PROCESS,5.2428e-05,-0.51206,-0.54776,0,0
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,2.8267e-05,-0.51255,-0.48119,0,0
1,GO REGULATION OF BINDING,4.5891e-06,-0.51304,-0.53768,0,0
1,GO ATP BIOSYNTHETIC PROCESS,4.2763e-05,-0.51394,-0.46768,0,0
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,4.9495e-06,-0.51405,-0.5592,0,0
1,GO HISTONE H4 K16 ACETYLATION,2.1347e-05,-0.5145,-0.56622,0,0
1,GO THYROID HORMONE METABOLIC PROCESS,0.00010181,-0.51566,-0.45715,0,0
1,GO REGULATION OF DNA RECOMBINATION,4.2539e-06,-0.51584,-0.5727,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,4.9495e-06,-0.51589,-0.55389,0,0
1,GO L GLUTAMATE IMPORT,4.2763e-05,-0.51615,-0.4349,0,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.6059e-05,-0.51748,-0.54463,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,4.9495e-06,-0.51853,-0.50033,0,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,6.4139e-05,-0.51895,-0.50076,0,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,2.636e-05,-0.5192,-0.50707,0,0
1,GO GLIAL CELL APOPTOTIC PROCESS,1.2035e-05,-0.51931,-0.59165,0,0
1,GO REGULATION OF CELL DIVISION,4.2539e-06,-0.52038,-0.54822,0,0
1,GO REGIONALIZATION,1.0403e-05,-0.52041,-0.51637,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,7.7514e-06,-0.52059,-0.52409,0,0
1,GO RNA STABILIZATION,4.9495e-06,-0.5206,-0.52129,0,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,5.337e-06,-0.52116,-0.52037,0,0
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,4.5891e-06,-0.52117,-0.53098,0,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,7.1973e-06,-0.52164,-0.56111,0,0
1,GO L SERINE METABOLIC PROCESS,3.4805e-05,-0.52171,-0.50078,0,0
1,GO MITOTIC CHROMOSOME CONDENSATION,4.8997e-05,-0.52235,-0.59296,0,0
1,GO CEREBRAL CORTEX DEVELOPMENT,6.2007e-06,-0.52362,-0.61873,0,0
1,GO STRIATED MUSCLE CELL PROLIFERATION,4.5891e-06,-0.52375,-0.54107,0,0
1,GO G2 DNA DAMAGE CHECKPOINT,9.6689e-06,-0.52632,-0.57393,0,0
1,GO CRANIAL NERVE DEVELOPMENT,2.8267e-05,-0.52672,-0.57265,0,0
1,GO MITOTIC DNA REPLICATION,0.00010181,-0.52678,-0.47971,0,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,7.7514e-06,-0.5268,-0.49244,0,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00012367,-0.52699,-0.44813,0,0
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,1.0403e-05,-0.52725,-0.5881,0,0
1,GO PYRUVATE METABOLIC PROCESS,6.6813e-06,-0.52726,-0.54809,0,0
1,GO REGULATION OF SPINDLE ORGANIZATION,1.3909e-05,-0.52818,-0.52056,0,0
1,GO SEX DIFFERENTIATION,4.9495e-06,-0.52868,-0.50667,0,0
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,4.9495e-06,-0.52872,-0.60021,0,0
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,6.2007e-06,-0.52925,-0.57332,0,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,4.8997e-05,-0.5296,-0.52756,0,0
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,7.7514e-06,-0.53052,-0.50398,0,0
1,GO SEX DETERMINATION,9.5377e-05,-0.53066,-0.47031,0,0
1,GO AGING,4.2539e-06,-0.53084,-0.53748,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,5.7533e-06,-0.53094,-0.51725,0,0
1,GO NOREPINEPHRINE TRANSPORT,0.00015974,-0.53153,-0.59628,0,0
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,9.6689e-06,-0.53174,-0.56423,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,4.5891e-06,-0.53176,-0.61217,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,3.4805e-05,-0.53237,-0.52023,0,0
1,GO RENAL SODIUM EXCRETION,6.4139e-05,-0.53237,-0.50331,0,0
1,GO AXONAL FASCICULATION,1.0403e-05,-0.53269,-0.64473,0,0
1,GO REGULATION OF HISTONE PHOSPHORYLATION,9.6689e-06,-0.53278,-0.54847,0,0
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,2.4576e-05,-0.53328,-0.49867,0,0
1,GO POSITIVE REGULATION OF DNA REPLICATION,1.3909e-05,-0.53396,-0.50973,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00064645,-0.53429,-0.45388,0,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,5.9985e-05,-0.53457,-0.50365,0,0
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,3.9422e-06,-0.53484,-0.58749,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.337e-06,-0.53542,-0.51328,0,0
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.00057531,-0.53549,-0.46473,0,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,7.7514e-06,-0.53632,-0.5037,0,0
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.2939e-05,-0.5365,-0.55307,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,4.9495e-06,-0.53653,-0.52214,0,0
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,1.3909e-05,-0.53965,-0.66958,0,0
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,1.8524e-05,-0.53983,-0.55116,0,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,5.337e-06,-0.5402,-0.56346,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,4.9495e-06,-0.54084,-0.56787,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,1.2939e-05,-0.54095,-0.53784,0,0
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,7.7514e-06,-0.54133,-0.58009,0,0
1,GO CELL AGING,5.337e-06,-0.54179,-0.5011,0,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,4.9495e-06,-0.54183,-0.53963,0,0
1,GO MRNA METHYLATION,5.7533e-06,-0.54221,-0.59695,0,0
1,GO MESONEPHROS DEVELOPMENT,2.1347e-05,-0.54244,-0.49993,0,0
1,GO REGULATION OF TRANSFERASE ACTIVITY,4.5891e-06,-0.54294,-0.5601,0,0
1,GO POSITIVE REGULATION OF CELL DIVISION,6.2007e-06,-0.54383,-0.52266,0,0
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,4.9495e-06,-0.54516,-0.5459,0,0
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,7.7514e-06,-0.54528,-0.5406,0,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00011593,-0.54564,-0.57803,0,0
1,GO RENAL TUBULE DEVELOPMENT,1.0403e-05,-0.54585,-0.55299,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00033648,-0.54794,-0.60397,0,0
1,GO CELL FATE COMMITMENT,7.1973e-06,-0.548,-0.52514,0,0
1,GO RESPONSE TO HEAT,3.9422e-06,-0.54896,-0.54158,0,0
1,GO INOSITOL METABOLIC PROCESS,0.00013188,-0.54933,-0.55094,0,0
1,GO VITAMIN D BIOSYNTHETIC PROCESS,9.5377e-05,-0.54982,-0.65345,0,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,9.6689e-06,-0.54995,-0.64034,0,0
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00024771,-0.55016,-0.66046,0,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,1.3909e-05,-0.55035,-0.50023,0,0
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,7.1973e-06,-0.55118,-0.53739,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,3.9422e-06,-0.55123,-0.59196,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.00019306,-0.55163,-0.47747,0,0
1,GO RENAL VESICLE DEVELOPMENT,1.0403e-05,-0.55209,-0.59411,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,1.6059e-05,-0.55212,-0.48621,0,0
1,GO MEMBRANE DISASSEMBLY,7.1973e-06,-0.55288,-0.63488,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,8.3641e-05,-0.5531,-0.56432,0,0
1,GO NOREPINEPHRINE SECRETION,0.00020554,-0.55403,-0.55469,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,1.9888e-05,-0.55478,-0.57127,0,0
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,8.3461e-06,-0.55494,-0.59295,0,0
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,6.6813e-06,-0.55522,-0.5579,0,0
1,GO MALE SEX DIFFERENTIATION,6.2007e-06,-0.55621,-0.54601,0,0
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,6.6813e-06,-0.55623,-0.56897,0,0
1,GO POSITIVE REGULATION OF HEART GROWTH,7.7514e-06,-0.5567,-0.52894,0,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,3.7287e-05,-0.55674,-0.53175,0,0
1,GO NATURAL KILLER CELL CHEMOTAXIS,0.19156,-0.55703,-0.40866,0,0
1,GO CGMP METABOLIC PROCESS,0.00045436,-0.55731,-0.52388,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,1.8524e-05,-0.55826,-0.61177,0,0
1,GO ER OVERLOAD RESPONSE,2.4576e-05,-0.55888,-0.49278,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,5.337e-06,-0.56109,-0.60955,0,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,1.7249e-05,-0.56175,-0.61542,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0012071,-0.56206,-0.55493,0,0
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,1.4947e-05,-0.56219,-0.61551,0,0
1,GO VESICLE CARGO LOADING,4.5891e-06,-0.56273,-0.59679,0,0
1,GO PROTEIN HYDROXYLATION,2.8267e-05,-0.5629,-0.56685,0,0
1,GO NEPHRON MORPHOGENESIS,1.3909e-05,-0.56305,-0.53563,0,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,1.3909e-05,-0.56487,-0.5317,0,0
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,4.5891e-06,-0.56513,-0.57793,0,0
1,GO PROTEIN PALMITOYLATION,4.8997e-05,-0.56658,-0.53715,0,0
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,3.9422e-06,-0.56667,-0.60152,0,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,4.2539e-06,-0.56679,-0.59254,0,0
1,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.023112,-0.56708,-0.74591,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,3.9936e-05,-0.5671,-0.62713,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,6.6813e-06,-0.56773,-0.55869,0,0
1,GO GERMINAL CENTER FORMATION,8.3641e-05,-0.56827,-0.78257,0,0
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00021879,-0.569,-0.57925,0,0
1,GO CELLULAR RESPONSE TO HEAT,4.2539e-06,-0.56921,-0.55352,0,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.3909e-05,-0.56921,-0.53421,0,0
1,GO LIMB BUD FORMATION,0.00024771,-0.56936,-0.55866,0,0
1,GO KIDNEY MORPHOGENESIS,1.6059e-05,-0.5697,-0.54139,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,8.9843e-06,-0.57053,-0.61042,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,1.8524e-05,-0.57187,-0.53685,0,0
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,9.6689e-06,-0.57216,-0.639,0,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,4.9495e-06,-0.57276,-0.58129,0,0
1,GO MODIFIED AMINO ACID TRANSPORT,1.4947e-05,-0.57434,-0.51723,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.8997e-05,-0.57478,-0.52608,0,0
1,GO REGULATION OF RESPIRATORY BURST,2.636e-05,-0.57493,-0.53631,0,0
1,GO POSITIVE REGULATION OF CELL MATURATION,3.7287e-05,-0.57662,-0.52183,0,0
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,4.8997e-05,-0.57753,-0.56334,0,0
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,6.6813e-06,-0.58036,-0.64287,0,0
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,4.5779e-05,-0.58139,-0.6051,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00096503,-0.58207,-0.4586,0,0
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,1.3909e-05,-0.58255,-0.65677,0,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,1.9888e-05,-0.58269,-0.56772,0,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,7.1973e-06,-0.58286,-0.59371,0,0
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,8.9843e-06,-0.58309,-0.59993,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,4.5779e-05,-0.58555,-0.54593,0,0
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,4.2539e-06,-0.58599,-0.54622,0,0
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,8.9843e-06,-0.5861,-0.57048,0,0
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,3.9422e-06,-0.58803,-0.6272,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,7.7514e-06,-0.58809,-0.58001,0,0
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,4.5891e-06,-0.5889,-0.588,0,0
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,1.2035e-05,-0.58991,-0.56721,0,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,8.9843e-06,-0.59005,-0.57022,0,0
1,GO REGULATION OF URINE VOLUME,1.6059e-05,-0.59006,-0.5472,0,0
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,4.2763e-05,-0.5913,-0.60163,0,0
1,GO PARENTAL BEHAVIOR,0.0029965,-0.59153,-0.50789,0,0
1,GO REGULATION OF TUBULIN DEACETYLATION,7.7514e-06,-0.5924,-0.64195,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,4.5891e-06,-0.59334,-0.62273,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,1.4947e-05,-0.59356,-0.64909,0,0
1,GO REGULATION OF ACTIN FILAMENT LENGTH,4.5891e-06,-0.59403,-0.61666,0,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.59516,-0.53523,0,0
1,GO RESPONSE TO TESTOSTERONE,4.5891e-06,-0.59684,-0.5275,0,0
1,GO NEURAL CREST CELL DIFFERENTIATION,4.5891e-06,-0.59792,-0.58938,0,0
1,GO REPLICATIVE SENESCENCE,3.9936e-05,-0.59799,-0.48024,0,0
1,GO MAINTENANCE OF ORGANELLE LOCATION,7.7514e-06,-0.59814,-0.62293,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,6.6813e-06,-0.59818,-0.62872,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0011418,-0.59838,-0.48658,0,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,2.8267e-05,-0.59931,-0.70058,0,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,7.1973e-06,-0.59962,-0.55029,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,4.9495e-06,-0.60128,-0.65444,0,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,1.9888e-05,-0.60181,-0.57034,0,0
1,GO PROSTATIC BUD FORMATION,5.2428e-05,-0.60195,-0.58845,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,1.2035e-05,-0.60221,-0.57479,0,0
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00021879,-0.60504,-0.56791,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0011418,-0.6053,-0.5188,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,1.3909e-05,-0.6078,-0.66347,0,0
1,GO CARDIAC CELL DEVELOPMENT,4.9495e-06,-0.6082,-0.55577,0,0
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,4.5891e-06,-0.60855,-0.59036,0,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,6.6813e-06,-0.61005,-0.5575,0,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,1.4947e-05,-0.61023,-0.7072,0,0
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,8.9843e-06,-0.61075,-0.59927,0,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,4.5891e-06,-0.61155,-0.61378,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00028019,-0.61172,-0.52774,0,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,1.9888e-05,-0.61315,-0.59267,0,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,6.2007e-06,-0.61552,-0.58767,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,1.1191e-05,-0.61611,-0.64459,0,0
1,GO STEM CELL PROLIFERATION,5.337e-06,-0.61704,-0.60153,0,0
1,GO MAST CELL MIGRATION,1.9888e-05,-0.61771,-0.64982,0,0
1,GO HOMOTYPIC CELL CELL ADHESION,4.5891e-06,-0.61861,-0.67365,0,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,5.7533e-06,-0.61927,-0.58976,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.00031664,-0.61934,-0.59637,0,0
1,GO PROSTATE GLAND MORPHOGENESIS,5.6086e-05,-0.61963,-0.56905,0,0
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,5.9985e-05,-0.62115,-0.7178,0,0
1,GO CYTOPLASM ORGANIZATION,1.2939e-05,-0.62118,-0.66168,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.00086166,-0.62415,-0.57121,0,0
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,3.9422e-06,-0.62487,-0.68537,0,0
1,GO GDP METABOLIC PROCESS,1.3909e-05,-0.62497,-0.52377,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,3.4805e-05,-0.62545,-0.60775,0,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,4.2539e-06,-0.62605,-0.63396,0,0
1,GO SCHWANN CELL DEVELOPMENT,6.2007e-06,-0.62802,-0.6416,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.9888e-05,-0.62813,-0.59912,0,0
1,GO MESENCHYMAL CELL PROLIFERATION,1.4947e-05,-0.62904,-0.64377,0,0
1,GO AMINO ACID IMPORT,9.6689e-06,-0.63019,-0.56199,0,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,8.3461e-06,-0.63075,-0.62112,0,0
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,4.2539e-06,-0.63129,-0.58908,0,0
1,GO INTRACELLULAR LIPID TRANSPORT,4.2539e-06,-0.63178,-0.62157,0,0
1,GO APPENDAGE DEVELOPMENT,4.5891e-06,-0.63331,-0.61719,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,8.9843e-06,-0.63349,-0.61127,0,0
1,GO GALACTOSE METABOLIC PROCESS,3.248e-05,-0.63569,-0.57344,0,0
1,GO NOSE DEVELOPMENT,0.00023283,-0.63668,-0.61958,0,0
1,GO NEURAL CREST CELL MIGRATION,5.7533e-06,-0.63818,-0.61972,0,0
1,GO APPENDAGE MORPHOGENESIS,5.7533e-06,-0.63821,-0.63198,0,0
1,GO LAMELLIPODIUM ASSEMBLY,3.9422e-06,-0.63906,-0.63392,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,1.0403e-05,-0.63926,-0.63687,0,0
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,2.4576e-05,-0.641,-0.5874,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,5.337e-06,-0.64149,-0.66163,0,0
1,GO EPITHELIAL CELL FATE COMMITMENT,2.1347e-05,-0.64183,-0.59925,0,0
1,GO CELLULAR RESPONSE TO VITAMIN D,7.3279e-05,-0.64245,-0.52207,0,0
1,GO ENDOCARDIUM DEVELOPMENT,1.1191e-05,-0.6437,-0.59453,0,0
1,GO REGULATION OF NEURON PROJECTION REGENERATION,6.2007e-06,-0.64411,-0.66728,0,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,5.2428e-05,-0.64412,-0.60037,0,0
1,GO NEGATIVE REGULATION OF OSSIFICATION,7.1973e-06,-0.64434,-0.62762,0,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.9888e-05,-0.6451,-0.69288,0,0
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,5.7533e-06,-0.64718,-0.6356,0,0
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,8.9843e-06,-0.64861,-0.70809,0,0
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,4.5891e-06,-0.64891,-0.64366,0,0
1,GO PRO B CELL DIFFERENTIATION,1.0403e-05,-0.64901,-0.68067,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00091199,-0.65021,-0.48007,0,0
1,GO MESODERM MORPHOGENESIS,5.337e-06,-0.65025,-0.60471,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,3.4805e-05,-0.65191,-0.55201,0,0
1,GO KERATINOCYTE DEVELOPMENT,5.9985e-05,-0.65246,-0.58559,0,0
1,GO SECONDARY PALATE DEVELOPMENT,7.1973e-06,-0.6536,-0.70797,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,6.2007e-06,-0.65364,-0.66444,0,0
1,GO AZOLE TRANSMEMBRANE TRANSPORT,2.1347e-05,-0.65386,-0.66217,0,0
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,3.9422e-06,-0.65515,-0.70868,0,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,7.1973e-06,-0.65579,-0.59929,0,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,5.6086e-05,-0.65587,-0.61197,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,5.337e-06,-0.6572,-0.61011,0,0
1,GO DETECTION OF MECHANICAL STIMULUS,1.0403e-05,-0.65804,-0.5882,0,0
1,GO MICROVILLUS ASSEMBLY,4.5891e-06,-0.65844,-0.63219,0,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,9.6689e-06,-0.66002,-0.61216,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,5.7533e-06,-0.66007,-0.6333,0,0
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,4.5891e-06,-0.66018,-0.64318,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,4.5891e-06,-0.66101,-0.65997,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,4.2763e-05,-0.66258,-0.62641,0,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,1.9888e-05,-0.66295,-0.64635,0,0
1,GO SKELETAL SYSTEM DEVELOPMENT,4.5891e-06,-0.66428,-0.64436,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,5.337e-06,-0.66567,-0.64225,0,0
1,GO DENDRITIC SPINE MAINTENANCE,5.7533e-06,-0.66681,-0.69542,0,0
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,2.636e-05,-0.66701,-0.65301,0,0
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,9.6689e-06,-0.66733,-0.64657,0,0
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,3.9422e-06,-0.66926,-0.64839,0,0
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00064645,-0.66979,-0.63567,0,0
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.4947e-05,-0.67312,-0.63926,0,0
1,GO CYTOSOLIC TRANSPORT,4.9495e-06,-0.67719,-0.68737,0,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,7.1973e-06,-0.67732,-0.61383,0,0
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00076864,-0.67781,-0.60404,0,0
1,GO CARTILAGE DEVELOPMENT,4.9495e-06,-0.6782,-0.66438,0,0
1,GO CELLULAR RESPONSE TO STEROL,4.5891e-06,-0.67861,-0.74026,0,0
1,GO REGULATION OF MUSCLE HYPERTROPHY,4.9495e-06,-0.67867,-0.63328,0,0
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,6.6813e-06,-0.67894,-0.63591,0,0
1,GO NEURAL TUBE DEVELOPMENT,5.337e-06,-0.67917,-0.62477,0,0
1,GO P BODY ASSEMBLY,4.2539e-06,-0.6803,-0.74793,0,0
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,6.2007e-06,-0.6845,-0.66529,0,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,1.3909e-05,-0.68474,-0.64857,0,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,4.2539e-06,-0.68539,-0.70846,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0027019,-0.68681,-0.50788,0,0
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,9.6689e-06,-0.68782,-0.71871,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,4.2539e-06,-0.68824,-0.65923,0,0
1,GO GANGLIOSIDE METABOLIC PROCESS,2.4576e-05,-0.68884,-0.62048,0,0
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,6.2007e-06,-0.69136,-0.76724,0,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,4.5891e-06,-0.69289,-0.70031,0,0
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,8.9843e-06,-0.69391,-0.63349,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,8.9843e-06,-0.69409,-0.62534,0,0
1,GO BASIC AMINO ACID TRANSPORT,5.6086e-05,-0.69834,-0.64574,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,9.6689e-06,-0.69869,-0.68174,0,0
1,GO CONNECTIVE TISSUE DEVELOPMENT,4.9495e-06,-0.69881,-0.66785,0,0
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,3.9422e-06,-0.69915,-0.73456,0,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,4.2539e-06,-0.7002,-0.68267,0,0
1,GO SMOOTH MUSCLE CELL MIGRATION,5.7533e-06,-0.70045,-0.73991,0,0
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.2035e-05,-0.70124,-0.68017,0,0
1,GO OSTEOBLAST PROLIFERATION,1.7249e-05,-0.70215,-0.67429,0,0
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,4.5891e-06,-0.70221,-0.71946,0,0
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,4.9495e-06,-0.70367,-0.67522,0,0
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,8.9843e-06,-0.70471,-0.748,0,0
1,GO CONVERGENT EXTENSION,1.4947e-05,-0.70526,-0.64463,0,0
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,6.6813e-06,-0.70597,-0.68265,0,0
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,4.5891e-06,-0.70597,-0.66108,0,0
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,1.0403e-05,-0.70849,-0.67224,0,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,1.3909e-05,-0.70913,-0.64788,0,0
1,GO EMBRYONIC HEMOPOIESIS,8.3461e-06,-0.71326,-0.70202,0,0
1,GO N GLYCAN PROCESSING,1.3909e-05,-0.71337,-0.68641,0,0
1,GO CELL JUNCTION DISASSEMBLY,5.2428e-05,-0.71469,-0.78748,0,0
1,GO REGULATION OF HIPPO SIGNALING,1.2035e-05,-0.71893,-0.6813,0,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,1.3909e-05,-0.7192,-0.76083,0,0
1,GO ENDOTHELIAL CELL CHEMOTAXIS,1.2035e-05,-0.72102,-0.66922,0,0
1,GO CHONDROCYTE DIFFERENTIATION,4.9495e-06,-0.72163,-0.73198,0,0
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,7.7514e-06,-0.7242,-0.7724,0,0
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,3.9422e-06,-0.72784,-0.73743,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,4.2539e-06,-0.72795,-0.69936,0,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,1.0403e-05,-0.72914,-0.61537,0,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,1.2939e-05,-0.72997,-0.6765,0,0
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,1.9888e-05,-0.73008,-0.66567,0,0
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,4.5891e-06,-0.73106,-0.77453,0,0
1,GO GOLGI TO ENDOSOME TRANSPORT,5.337e-06,-0.73321,-0.69825,0,0
1,GO ANOIKIS,8.9843e-06,-0.73805,-0.69679,0,0
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,4.5891e-06,-0.73858,-0.70923,0,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,6.4139e-05,-0.74249,-0.68,0,0
1,GO BONE GROWTH,7.1973e-06,-0.74557,-0.68579,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,8.9843e-06,-0.74614,-0.76185,0,0
1,GO NK T CELL DIFFERENTIATION,4.2763e-05,-0.75051,-0.72753,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,3.7287e-05,-0.75152,-0.75199,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,1.2035e-05,-0.75435,-0.69529,0,0
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,4.9495e-06,-0.75485,-0.75035,0,0
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,4.5891e-06,-0.75849,-0.69896,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,4.2539e-06,-0.75903,-0.76345,0,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,8.9327e-05,-0.75944,-0.66961,0,0
1,GO REGULATION OF ANOIKIS,1.3909e-05,-0.76024,-0.71521,0,0
1,GO CHONDROCYTE DEVELOPMENT,6.6813e-06,-0.76081,-0.77722,0,0
1,GO EPITHELIAL CELL CELL ADHESION,7.1973e-06,-0.7686,-0.78672,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,4.9495e-06,-0.77772,-0.71955,0,0
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,2.2907e-05,-0.78364,-0.80292,0,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,1.2939e-05,-0.79317,-0.73457,0,0
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,4.2539e-06,-0.79731,-0.79023,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,4.5891e-06,-0.79856,-0.77856,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.79945,-0.79305,0,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,4.5891e-06,-0.80482,-0.75971,0,0
1,GO DEFINITIVE HEMOPOIESIS,5.7533e-06,-0.82161,-0.79034,0,0
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,5.7533e-06,-0.82521,-0.86157,0,0
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,3.9422e-06,-0.86213,-0.78574,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.7514e-06,-0.86345,-0.75923,0,0
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,5.337e-06,-0.89113,-0.82292,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,6.2007e-06,-0.89294,-0.82067,0,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,6.6813e-06,-0.94111,-0.86766,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.4805e-05,-0.94764,-0.82382,0,0
1,GO PROTEIN LOCALIZATION TO ENDOSOME,6.2007e-06,-0.95664,-0.85341,0,0
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,4.5891e-06,-1.0297,-0.91087,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,7.7514e-06,-1.0345,-0.93999,0,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,7.3279e-05,1.2977,1.1402,1,1
2,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,8.9327e-05,1.287,1.1871,1,1
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,3.4805e-05,1.1916,1.0999,1,1
2,GO NATURAL KILLER CELL CHEMOTAXIS,0.00013188,1.1747,1.0656,1,1
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,7.8298e-05,1.159,1.1428,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,7.7514e-06,1.083,1.0356,1,1
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,1.3909e-05,1.046,0.9597,1,1
2,GO HYPERSENSITIVITY,7.8298e-05,1.0243,0.93678,1,1
2,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.00023283,1.0124,0.96197,1,1
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00020554,1.0119,0.84857,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,5.2428e-05,0.97628,0.92789,1,1
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,1.8524e-05,0.96856,1.0559,1,1
2,GO CHRONIC INFLAMMATORY RESPONSE,0.00011593,0.96459,0.88041,1,1
2,GO T CELL TOLERANCE INDUCTION,0.00023283,0.95887,0.89075,1,1
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,1.2035e-05,0.9572,0.96923,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,7.8298e-05,0.95685,0.83528,1,1
2,GO TOLERANCE INDUCTION,0.00017019,0.9471,0.89109,1,1
2,GO OPSONIZATION,5.337e-06,0.94565,0.88961,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00012367,0.9452,0.9179,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,7.3279e-05,0.94221,0.90396,1,1
2,GO DENDRITIC CELL MIGRATION,5.6086e-05,0.93513,0.80324,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00013188,0.9317,0.89542,1,1
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,1.6059e-05,0.93087,0.9363,1,1
2,GO SYNAPSE PRUNING,5.2428e-05,0.9221,0.95271,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.636e-05,0.90568,0.85932,1,1
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,2.636e-05,0.90358,0.85003,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,2.4576e-05,0.90011,0.86687,1,1
2,GO EOSINOPHIL MIGRATION,3.4805e-05,0.9,0.87883,1,1
2,GO EOSINOPHIL CHEMOTAXIS,3.9936e-05,0.8976,0.86568,1,1
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.00014989,0.89221,0.84231,1,1
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,9.6689e-06,0.89063,0.8873,1,1
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00017019,0.88867,0.88421,1,1
2,GO LYMPHOCYTE CHEMOTAXIS,3.7287e-05,0.88822,0.83099,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,3.248e-05,0.88753,0.88222,1,1
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,3.4805e-05,0.88663,0.88537,1,1
2,GO CYTOLYSIS,1.4947e-05,0.88616,0.93974,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,4.5779e-05,0.87797,0.87968,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00010866,0.87696,0.83059,1,1
2,GO LEUKOCYTE AGGREGATION,3.7287e-05,0.87645,0.89437,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,9.5377e-05,0.87568,0.77195,1,1
2,GO REGULATION OF TOLERANCE INDUCTION,0.00035748,0.87566,0.83325,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00014989,0.86873,0.7787,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,4.8997e-05,0.86615,0.78162,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,8.9843e-06,0.86317,0.92816,1,1
2,GO COMPLEMENT ACTIVATION,5.337e-06,0.86255,0.90822,1,1
2,GO NEGATIVE T CELL SELECTION,0.00019306,0.85332,0.85676,1,1
2,GO CHEMOKINE SECRETION,1.0403e-05,0.85202,0.87274,1,1
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,4.2763e-05,0.85091,0.84371,1,1
2,GO CYCLOOXYGENASE PATHWAY,1.2939e-05,0.84586,0.84636,1,1
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,2.8267e-05,0.84528,0.80707,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,6.8565e-05,0.84032,0.79787,1,1
2,GO IMMUNOGLOBULIN SECRETION,4.2763e-05,0.83883,0.64261,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,7.8298e-05,0.83651,0.74601,1,1
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,5.2428e-05,0.83452,0.77682,1,1
2,GO DENDRITIC CELL DIFFERENTIATION,7.3279e-05,0.83446,0.76737,1,1
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.2907e-05,0.83402,0.79781,1,1
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,2.2907e-05,0.83288,0.83981,1,1
2,GO INTERLEUKIN 10 PRODUCTION,4.2763e-05,0.83252,0.71145,1,1
2,GO NEGATIVE REGULATION OF CELL KILLING,9.5377e-05,0.83075,0.80437,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,3.0304e-05,0.83029,0.75036,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,5.9985e-05,0.82733,0.83291,1,1
2,GO ANTIBACTERIAL HUMORAL RESPONSE,1.3909e-05,0.82223,0.77197,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,7.8298e-05,0.82036,0.72003,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,3.0304e-05,0.81714,0.8178,1,1
2,GO MONOCYTE CHEMOTAXIS,1.1191e-05,0.8164,0.84889,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,3.248e-05,0.81453,0.85885,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,4.2763e-05,0.81423,0.76586,1,1
2,GO NEUTROPHIL CHEMOTAXIS,5.337e-06,0.81202,0.78418,1,1
2,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,1.9888e-05,0.81185,0.90688,1,1
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00010181,0.80958,0.74716,1,1
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,4.5891e-06,0.80557,0.85055,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,3.4805e-05,0.79997,0.75663,1,1
2,GO CELLULAR DEFENSE RESPONSE,7.3279e-05,0.79976,0.73841,1,1
2,GO RESPONSE TO CHEMOKINE,4.2763e-05,0.79839,0.74721,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,5.9985e-05,0.79617,0.70145,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,7.1973e-06,0.79002,0.80884,1,1
2,GO LYMPHOCYTE MIGRATION,4.2763e-05,0.78846,0.72825,1,1
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00017019,0.78757,0.76447,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,3.4805e-05,0.78736,0.76355,1,1
2,GO POSITIVE THYMIC T CELL SELECTION,0.00023283,0.78686,0.7716,1,1
2,GO RESPONSE TO PROTOZOAN,8.9327e-05,0.78541,0.71381,1,1
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.00028019,0.78024,0.72177,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00017019,0.77702,0.72062,1,1
2,GO DETECTION OF OTHER ORGANISM,9.5377e-05,0.77691,0.72456,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,3.9936e-05,0.77681,0.72478,1,1
2,GO NEUTROPHIL MIGRATION,1.1191e-05,0.77603,0.72828,1,1
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,5.2428e-05,0.77505,0.72055,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,3.0304e-05,0.77422,0.73673,1,1
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00015974,0.77056,0.6649,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,9.5377e-05,0.76955,0.67776,1,1
2,GO INTERLEUKIN 12 PRODUCTION,6.4139e-05,0.7685,0.70573,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,7.8298e-05,0.76442,0.69279,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00015974,0.76273,0.728,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,5.6086e-05,0.76058,0.6966,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00028019,0.76034,0.70512,1,1
2,GO T CELL MIGRATION,8.3641e-05,0.76019,0.70352,1,1
2,GO MONONUCLEAR CELL MIGRATION,1.1191e-05,0.75978,0.75591,1,1
2,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,7.3279e-05,0.75919,0.7573,1,1
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,3.7287e-05,0.75802,0.75095,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.9936e-05,0.7574,0.73623,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00011593,0.75674,0.66833,1,1
2,GO ADHESION OF SYMBIONT TO HOST,0.00033648,0.75625,0.64676,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.00015974,0.75462,0.67951,1,1
2,GO GLIAL CELL ACTIVATION,3.4805e-05,0.7537,0.74148,1,1
2,GO RESPONSE TO PEPTIDOGLYCAN,4.8997e-05,0.75301,0.74085,1,1
2,GO REGULATION OF NEUTROPHIL ACTIVATION,0.00020554,0.7521,0.7025,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,8.3641e-05,0.74866,0.683,1,1
2,GO NEGATIVE REGULATION OF BONE REMODELING,3.248e-05,0.747,0.71068,1,1
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00021879,0.74485,0.71871,1,1
2,GO INTERLEUKIN 4 PRODUCTION,2.8267e-05,0.73984,0.72922,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,6.4139e-05,0.73948,0.68019,1,1
2,GO INTERLEUKIN 2 PRODUCTION,3.9936e-05,0.73937,0.67056,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,5.6086e-05,0.73935,0.73128,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00014062,0.73834,0.69395,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,5.6086e-05,0.73691,0.66961,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,3.0304e-05,0.73662,0.78681,1,1
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,6.6813e-06,0.73662,0.85863,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00019306,0.7365,0.6777,1,1
2,GO POSITIVE T CELL SELECTION,0.00020554,0.73612,0.69005,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,1.4947e-05,0.73519,0.7305,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.9888e-05,0.73499,0.68283,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,0.00023283,0.73493,0.68786,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,1.9888e-05,0.73488,0.78188,1,1
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00014989,0.73337,0.68839,1,1
2,GO GRANULOCYTE CHEMOTAXIS,6.2007e-06,0.73296,0.72387,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,8.3641e-05,0.73105,0.6418,1,1
2,GO LEUKOCYTE TETHERING OR ROLLING,0.00011593,0.73056,0.63097,1,1
2,GO INTERLEUKIN 1 BETA PRODUCTION,2.2907e-05,0.73046,0.69905,1,1
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.00010181,0.7303,0.67699,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.00021879,0.73019,0.63624,1,1
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,1.8524e-05,0.72745,0.73961,1,1
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00023283,0.72725,0.64257,1,1
2,GO B CELL PROLIFERATION,0.00014062,0.7268,0.68632,1,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.2763e-05,0.72642,0.63573,1,1
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00010181,0.72578,0.69085,1,1
2,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,5.9985e-05,0.72336,0.82128,1,1
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,8.3461e-06,0.7228,0.76478,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,8.9327e-05,0.72213,0.7149,1,1
2,GO NEUROINFLAMMATORY RESPONSE,2.8267e-05,0.72135,0.6974,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00010181,0.72051,0.68299,1,1
2,GO GRANULOCYTE MIGRATION,1.0403e-05,0.7204,0.68468,1,1
2,GO RESPONSE TO INTERLEUKIN 18,0.00031664,0.71849,0.62905,1,1
2,GO T HELPER CELL LINEAGE COMMITMENT,0.00019306,0.71763,0.71052,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,1.9888e-05,0.71714,0.7112,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,7.3279e-05,0.71692,0.63481,1,1
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,7.1973e-06,0.71613,0.83012,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.5779e-05,0.71585,0.69805,1,1
2,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,2.636e-05,0.71568,0.75713,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00015974,0.71539,0.67173,1,1
2,GO THYMIC T CELL SELECTION,0.00033648,0.71527,0.66355,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00010866,0.7135,0.65285,1,1
2,GO REGULATION OF NEUTROPHIL MIGRATION,2.636e-05,0.71278,0.67286,1,1
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,3.4805e-05,0.71253,0.66714,1,1
2,GO REGULATION OF CELL KILLING,3.4805e-05,0.71231,0.6776,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,4.2763e-05,0.71191,0.63357,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00020554,0.70849,0.65885,1,1
2,GO T CELL CYTOKINE PRODUCTION,6.4139e-05,0.70838,0.63363,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,7.1973e-06,0.70607,0.87971,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,7.3279e-05,0.70606,0.70741,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.8298e-05,0.70535,0.60554,1,1
2,GO T CELL EXTRAVASATION,8.9327e-05,0.70425,0.64401,1,1
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00054254,0.70407,0.61282,1,1
2,GO DETECTION OF BIOTIC STIMULUS,3.4805e-05,0.70333,0.65511,1,1
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.3909e-05,0.7027,0.7697,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00020554,0.70213,0.6826,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00017019,0.70131,0.63727,1,1
2,GO INTERLEUKIN 13 PRODUCTION,2.4576e-05,0.70115,0.7434,1,1
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00019306,0.69991,0.65257,1,1
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,4.5779e-05,0.6994,0.72981,1,1
2,GO REGULATION OF PLATELET ACTIVATION,2.636e-05,0.69854,0.65279,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00019306,0.69829,0.66165,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,4.2763e-05,0.69498,0.66243,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00014062,0.69374,0.66847,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,4.5779e-05,0.69305,0.6824,1,1
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,3.7287e-05,0.69245,0.70348,1,1
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00015974,0.69227,0.63136,1,1
2,GO LYMPHOCYTE COSTIMULATION,0.00012367,0.69133,0.60307,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00013188,0.69071,0.63204,1,1
2,GO TYPE 2 IMMUNE RESPONSE,7.8298e-05,0.69067,0.69213,1,1
2,GO INTERFERON GAMMA PRODUCTION,5.2428e-05,0.69047,0.67455,1,1
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,2.4576e-05,0.68945,0.64917,1,1
2,GO MACROPHAGE PROLIFERATION,2.1347e-05,0.687,0.80935,1,1
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,1.4947e-05,0.68647,0.66268,1,1
2,GO RESPONSE TO INTERFERON GAMMA,4.2763e-05,0.68603,0.66653,1,1
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,1.3909e-05,0.68587,0.6924,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,4.2763e-05,0.68581,0.63756,1,1
2,GO INTERLEUKIN 1 PRODUCTION,2.2907e-05,0.68536,0.67395,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00010866,0.68532,0.63143,1,1
2,GO T CELL SELECTION,0.00019306,0.68513,0.64668,1,1
2,GO HUMORAL IMMUNE RESPONSE,4.9495e-06,0.68349,0.70316,1,1
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,2.4576e-05,0.68302,0.66712,1,1
2,GO MATURE B CELL DIFFERENTIATION,0.00010181,0.68118,0.66051,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.00014062,0.67848,0.59546,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.00017019,0.6781,0.69328,1,1
2,GO T CELL MEDIATED IMMUNITY,2.8267e-05,0.67676,0.61524,1,1
2,GO REGULATION OF B CELL PROLIFERATION,0.00017019,0.67553,0.64306,1,1
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00017019,0.67376,0.60935,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,4.8997e-05,0.6727,0.64636,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,0.00011593,0.67102,0.63377,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.2428e-05,0.67066,0.64202,1,1
2,GO PROTEIN ACTIVATION CASCADE,7.1973e-06,0.67041,0.72533,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00017019,0.67009,0.59759,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,5.2428e-05,0.66832,0.61942,1,1
2,GO REGULATION OF MYOBLAST FUSION,8.9843e-06,0.66781,0.7537,1,1
2,GO ELASTIC FIBER ASSEMBLY,0.00020554,0.66696,0.80502,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.9985e-05,0.66579,0.58612,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00015974,0.66461,0.6342,1,1
2,GO REGULATION OF PLASMINOGEN ACTIVATION,5.2428e-05,0.66449,0.66298,1,1
2,GO RESPONSE TO INTERLEUKIN 15,0.00051151,0.6639,0.64823,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,7.3279e-05,0.66361,0.59237,1,1
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,1.1191e-05,0.66295,0.63702,1,1
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00010181,0.66249,0.58906,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.8267e-05,0.66223,0.60997,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,4.5779e-05,0.66078,0.6037,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.00042807,0.6602,0.60444,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00021879,0.65962,0.60459,1,1
2,GO CELLULAR EXTRAVASATION,4.5779e-05,0.65926,0.60925,1,1
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00017019,0.65894,0.60434,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00011593,0.65832,0.65029,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00029789,0.65815,0.65446,1,1
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.8997e-05,0.65478,0.61818,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00021879,0.65402,0.65362,1,1
2,GO RESPONSE TO INTERFERON ALPHA,4.8997e-05,0.65242,0.68335,1,1
2,GO INTEGRIN ACTIVATION,9.5377e-05,0.65227,0.63922,1,1
2,GO RESPONSE TO INTERFERON BETA,6.4139e-05,0.65095,0.59771,1,1
2,GO FIBRINOLYSIS,1.3909e-05,0.64901,0.68348,1,1
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,2.8267e-05,0.64833,0.60331,1,1
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,6.4139e-05,0.64646,0.58415,1,1
2,GO REGULATION OF GLIAL CELL MIGRATION,0.00014062,0.6464,0.61274,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,4.8997e-05,0.64507,0.59135,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,2.8267e-05,0.64446,0.70232,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,8.3641e-05,0.64262,0.58448,1,1
2,GO MYELOID LEUKOCYTE MIGRATION,7.7514e-06,0.64202,0.61947,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,5.6086e-05,0.64175,0.6061,1,1
2,GO INTERLEUKIN 5 PRODUCTION,0.00010866,0.6414,0.65764,1,1
2,GO LEUKOCYTE CHEMOTAXIS,9.6689e-06,0.6411,0.63749,1,1
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,4.5779e-05,0.63939,0.72002,1,1
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,8.9327e-05,0.63691,0.58878,1,1
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00026348,0.63636,0.59219,1,1
2,GO ACUTE PHASE RESPONSE,1.9888e-05,0.63582,0.57257,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00021879,0.63575,0.60943,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00012367,0.63365,0.56167,1,1
2,GO PHAGOCYTOSIS RECOGNITION,1.6059e-05,0.6331,0.67198,1,1
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00014989,0.6321,0.58094,1,1
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,1.9888e-05,0.63007,0.6577,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,1.9888e-05,0.62942,0.60835,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00010181,0.62929,0.6022,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00015974,0.62789,0.61289,1,1
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00011593,0.62744,0.61591,1,1
2,GO REGULATION OF T CELL MIGRATION,0.00017019,0.62738,0.56801,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,3.4805e-05,0.62712,0.67925,1,1
2,GO CELL KILLING,3.4805e-05,0.6254,0.60747,1,1
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,2.1347e-05,0.62274,0.61106,1,1
2,GO INTERLEUKIN 17 PRODUCTION,0.00019306,0.62222,0.59149,1,1
2,GO REGULATION OF CELLULAR EXTRAVASATION,4.2763e-05,0.62211,0.64333,1,1
2,GO B CELL MEDIATED IMMUNITY,4.5779e-05,0.62064,0.63015,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,4.2763e-05,0.61958,0.62152,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00011593,0.61947,0.58818,1,1
2,GO PLASMINOGEN ACTIVATION,1.2939e-05,0.619,0.67323,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00014989,0.6187,0.64384,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.2428e-05,0.61752,0.57182,1,1
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,8.3641e-05,0.61744,0.66446,1,1
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00017019,0.61633,0.61137,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00023283,0.61577,0.59598,1,1
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.00020554,0.61558,0.62666,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.8298e-05,0.61539,0.58852,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,3.248e-05,0.61459,0.6293,1,1
2,GO LEUKOCYTE PROLIFERATION,5.2428e-05,0.61457,0.5817,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,5.2428e-05,0.61407,0.56208,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,3.248e-05,0.6135,0.6075,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,0.00028019,0.61342,0.63535,1,1
2,GO REGULATION OF B CELL DIFFERENTIATION,0.00045436,0.61327,0.54638,1,1
2,GO MACROPHAGE ACTIVATION,3.7287e-05,0.6123,0.64129,1,1
2,GO ETHANOL METABOLIC PROCESS,4.2763e-05,0.61216,0.6194,1,1
2,GO REGULATION OF MEMBRANE INVAGINATION,5.6086e-05,0.61129,0.6773,1,1
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.8267e-05,0.6098,0.6171,1,1
2,GO CYTOKINE METABOLIC PROCESS,3.4805e-05,0.60913,0.59448,1,1
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,3.0304e-05,0.60906,0.57149,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,3.4805e-05,0.60847,0.6272,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00031664,0.60826,0.57009,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,3.9936e-05,0.60722,0.62203,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.4805e-05,0.60672,0.55895,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,5.6086e-05,0.60524,0.58575,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,5.6086e-05,0.6047,0.6192,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00028019,0.60444,0.55445,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,5.2428e-05,0.60421,0.56534,1,1
2,GO RESPONSE TO LIPOTEICHOIC ACID,2.2907e-05,0.60421,0.68613,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,2.1347e-05,0.6034,0.59645,1,1
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.248e-05,0.60309,0.56347,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,5.6086e-05,0.60292,0.62595,1,1
2,GO ALPHA BETA T CELL ACTIVATION,0.00010181,0.60176,0.58644,1,1
2,GO APOPTOTIC CELL CLEARANCE,5.9985e-05,0.60121,0.61235,1,1
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00014989,0.60061,0.5208,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,1.2035e-05,0.59991,0.62554,1,1
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,4.5779e-05,0.59972,0.61308,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,5.2428e-05,0.59938,0.545,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,3.248e-05,0.59916,0.55673,1,1
2,GO INTERLEUKIN 8 PRODUCTION,4.5779e-05,0.59861,0.57793,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,5.2428e-05,0.59627,0.5355,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00029789,0.59615,0.54838,1,1
2,GO T CELL PROLIFERATION,5.9985e-05,0.59555,0.58341,1,1
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,3.4805e-05,0.59533,0.58693,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,1.2939e-05,0.59477,0.61487,1,1
2,GO REGULATION OF PHAGOCYTOSIS,4.2763e-05,0.59461,0.61123,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,3.4805e-05,0.59453,0.55593,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,6.4139e-05,0.59422,0.57112,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.00064645,0.59268,0.5658,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,3.9936e-05,0.59184,0.54727,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00021879,0.59067,0.56186,1,1
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,7.3279e-05,0.59067,0.55974,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,6.6813e-06,0.58979,0.65117,1,1
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,4.8997e-05,0.58965,0.67424,1,1
2,GO INTERLEUKIN 6 PRODUCTION,3.4805e-05,0.58953,0.53971,1,1
2,GO ALPHA BETA T CELL DIFFERENTIATION,0.00014989,0.58896,0.56785,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00023283,0.58895,0.53918,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.0304e-05,0.58756,0.5514,1,1
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,2.636e-05,0.58711,0.63701,1,1
2,GO DEFENSE RESPONSE TO FUNGUS,2.4576e-05,0.58537,0.54234,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00051151,0.58531,0.71798,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00010866,0.58504,0.54557,1,1
2,GO REGULATION OF LEUKOCYTE MIGRATION,2.8267e-05,0.58461,0.58179,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,3.0304e-05,0.58342,0.58358,1,1
2,GO REGULATION OF INTEGRIN ACTIVATION,8.3641e-05,0.58308,0.54789,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00020554,0.58193,0.58406,1,1
2,GO ASTROCYTE ACTIVATION,2.4576e-05,0.58173,0.56864,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.00028019,0.58136,0.54955,1,1
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,5.9985e-05,0.58107,0.61096,1,1
2,GO NEUTROPHIL HOMEOSTASIS,0.00010181,0.57974,0.55377,1,1
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,6.2007e-06,0.57962,0.6025,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,5.2428e-05,0.57891,0.60735,1,1
2,GO RESPONSE TO TYPE I INTERFERON,0.00020554,0.57852,0.5569,1,1
2,GO CYTOKINE SECRETION,3.248e-05,0.57802,0.53803,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,5.9985e-05,0.57754,0.55928,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,4.8997e-05,0.57743,0.5967,1,1
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,8.3461e-06,0.57559,0.57105,1,1
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00018128,0.57454,0.53238,1,1
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,1.2035e-05,0.57346,0.55064,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,7.3279e-05,0.57333,0.54457,1,1
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.00014989,0.57167,0.55615,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,6.4139e-05,0.57119,0.55079,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00021879,0.57045,0.56065,1,1
2,GO MACROPHAGE MIGRATION,1.6059e-05,0.56981,0.61994,1,1
2,GO ACUTE INFLAMMATORY RESPONSE,2.1347e-05,0.56961,0.54259,1,1
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,7.8298e-05,0.56936,0.55884,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,2.1347e-05,0.56877,0.57122,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00017019,0.56869,0.56049,1,1
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.00029789,0.56726,0.57611,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,5.9985e-05,0.56682,0.58692,1,1
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.00028019,0.56557,0.53755,1,1
2,GO LYMPH NODE DEVELOPMENT,0.00013188,0.56408,0.56576,1,1
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,2.8267e-05,0.56373,0.59899,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00031664,0.56175,0.54606,1,1
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,8.9327e-05,0.56173,0.56897,1,1
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,9.5377e-05,0.5615,0.595,1,1
2,GO REGULATION OF T CELL ACTIVATION,9.5377e-05,0.56145,0.53513,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.248e-05,0.56128,0.57567,1,1
2,GO REGULATION OF MACROPHAGE MIGRATION,3.7287e-05,0.5607,0.59038,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00010181,0.55987,0.56475,1,1
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00018128,0.55743,0.59504,1,1
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,4.5779e-05,0.5574,0.55872,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00014062,0.55597,0.52556,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.00064645,0.55596,0.52699,1,1
2,GO ETHANOL OXIDATION,0.00020554,0.55519,0.63144,1,1
2,GO ANTIMICROBIAL HUMORAL RESPONSE,6.2007e-06,0.55333,0.59942,1,1
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00020554,0.55324,0.58933,1,1
2,GO MAST CELL ACTIVATION,0.00010181,0.55323,0.50543,1,1
2,GO MACROPHAGE CHEMOTAXIS,1.4947e-05,0.55277,0.60357,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00010181,0.55183,0.52895,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00013188,0.55174,0.54183,1,1
2,GO CELL CHEMOTAXIS,1.7249e-05,0.55056,0.55709,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,9.5377e-05,0.55002,0.50816,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0010209,0.55001,0.48292,1,1
2,GO REGULATION OF B CELL ACTIVATION,0.00020554,0.54962,0.55501,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,3.4805e-05,0.54944,0.62038,1,1
2,GO AMYLOID BETA CLEARANCE,7.3279e-05,0.54899,0.54512,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00018128,0.54842,0.55355,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.4947e-05,0.5478,0.6436,1,1
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,1.9888e-05,0.5472,0.59201,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.8997e-05,0.54638,0.55586,1,1
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,3.7287e-05,0.54621,0.57834,1,1
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,1.8524e-05,0.54572,0.49745,1,1
2,GO DEFENSE RESPONSE TO BACTERIUM,7.7514e-06,0.54516,0.55515,1,1
2,GO REGULATION OF CELL ACTIVATION,6.8565e-05,0.54493,0.51153,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,8.9327e-05,0.54351,0.50754,1,1
2,GO T CELL APOPTOTIC PROCESS,7.3279e-05,0.54236,0.5342,1,1
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,8.9327e-05,0.54191,0.59579,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,6.4139e-05,0.54094,0.49208,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00019306,0.54091,0.51999,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00012367,0.54077,0.5528,1,1
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,1.4947e-05,0.54018,0.61849,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,6.4139e-05,0.53914,0.53561,1,1
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00014062,0.53905,0.53615,1,1
2,GO REGULATION OF PLATELET AGGREGATION,7.3279e-05,0.53895,0.49978,1,1
2,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00023283,0.53872,0.55113,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.636e-05,0.53839,0.55352,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,6.4139e-05,0.53796,0.54303,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,2.8267e-05,0.53724,0.51657,1,1
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.3909e-05,0.53708,0.56049,1,1
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00017019,0.53673,0.53984,1,1
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,6.4139e-05,0.53645,0.51025,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,3.9936e-05,0.53604,0.59757,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,4.5779e-05,0.53566,0.56753,1,1
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,4.5779e-05,0.53523,0.52249,1,1
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00012367,0.5346,0.54881,1,1
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,7.8298e-05,0.53432,0.49812,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,7.3279e-05,0.53356,0.52204,1,1
2,GO CHEMOKINE PRODUCTION,1.8524e-05,0.53308,0.55731,1,1
2,GO RESPIRATORY BURST,0.00013188,0.53273,0.5565,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,8.9327e-05,0.53071,0.52521,1,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,7.1973e-06,0.52916,0.56136,1,1
2,GO PEPTIDE CROSS LINKING,0.00020554,0.5289,0.51864,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00026348,0.52878,0.47941,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00012367,0.52877,0.54496,1,1
2,GO T CELL ACTIVATION,7.8298e-05,0.52811,0.51499,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,8.9327e-05,0.52728,0.54626,1,1
2,GO LEUKOCYTE MIGRATION,2.2907e-05,0.526,0.54942,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,9.5377e-05,0.52561,0.51077,1,1
2,GO GLYCINE TRANSPORT,0.008797,0.52275,0.33933,1,1
2,GO NAD BIOSYNTHETIC PROCESS,3.0304e-05,0.52233,0.49802,1,1
2,GO MEMBRANE RAFT ORGANIZATION,4.5779e-05,0.52139,0.55733,1,1
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,3.7287e-05,0.51996,0.52818,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.00054254,0.51952,0.55398,1,1
2,GO RESPONSE TO FUNGUS,1.2035e-05,0.51899,0.54838,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.4947e-05,0.5174,0.53867,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,5.2428e-05,0.51729,0.52109,1,1
2,GO RESPONSE TO HYDROPEROXIDE,0.00021879,0.51689,0.50263,1,1
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,3.9936e-05,0.51653,0.54582,1,1
2,GO REVERSE CHOLESTEROL TRANSPORT,7.3279e-05,0.51631,0.54242,1,1
2,GO SEROTONIN SECRETION,0.00010866,0.51629,0.50686,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,7.7514e-06,0.51629,0.64698,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,1.3909e-05,0.51517,0.56106,1,1
2,GO MAST CELL MEDIATED IMMUNITY,0.00012367,0.51495,0.48875,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,8.3641e-05,0.51427,0.5196,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,8.3641e-05,0.5137,0.50827,1,1
2,GO POSITIVE REGULATION OF CHEMOTAXIS,3.7287e-05,0.51319,0.50255,1,1
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0038653,0.51313,0.40978,1,1
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,5.2428e-05,0.51252,0.51797,1,1
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00013188,0.51242,0.5185,1,1
2,GO T CELL DIFFERENTIATION,0.00021879,0.50915,0.49199,1,1
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0003797,0.509,0.59838,1,1
2,GO SUPEROXIDE ANION GENERATION,5.6086e-05,0.50857,0.49548,1,1
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00040321,0.50789,0.48359,1,1
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00010866,0.5076,0.52581,1,1
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.00029789,0.50676,0.54144,1,1
2,GO BLEB ASSEMBLY,0.00048214,0.50645,0.52374,1,1
2,GO NATURAL KILLER CELL ACTIVATION,6.8565e-05,0.50498,0.53231,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00028019,0.50368,0.5002,1,1
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,2.8267e-05,0.50331,0.52489,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00045436,0.50297,0.45309,1,1
2,GO RESPONSE TO BACTERIUM,1.2939e-05,0.50229,0.52363,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,5.6086e-05,0.50107,0.50071,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.00072571,0.5002,0.47375,1,1
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00045436,0.49991,0.4416,1,1
2,GO NEGATIVE REGULATION OF COAGULATION,2.1347e-05,0.49977,0.54544,1,1
2,GO T CELL LINEAGE COMMITMENT,0.00020554,0.49934,0.51221,1,1
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,1.9888e-05,0.49922,0.47599,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.00012367,0.49913,0.46294,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,2.2907e-05,0.49818,0.50177,1,1
2,GO REGULATION OF IMMUNE RESPONSE,5.6086e-05,0.49795,0.48148,1,1
2,GO INFLAMMATORY RESPONSE,2.2907e-05,0.49779,0.51262,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00011593,0.4975,0.47865,1,1
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00013188,0.49725,0.51186,1,1
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00031664,0.49575,0.46338,1,1
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00015974,0.49381,0.42549,1,1
2,GO LEUKOCYTE HOMEOSTASIS,0.00010181,0.49176,0.47181,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00011593,0.4909,0.48917,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0016767,0.48927,0.47364,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,3.4805e-05,0.48923,0.4797,1,1
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00029789,0.48921,0.58777,1,1
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,1.4947e-05,0.4879,0.53733,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.3641e-05,0.48773,0.52209,1,1
2,GO REGULATION OF CELL CELL ADHESION,7.3279e-05,0.48692,0.47867,1,1
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00033648,0.48592,0.53995,1,1
2,GO MACROPHAGE DIFFERENTIATION,0.00026348,0.48584,0.48689,1,1
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00015974,0.48519,0.50637,1,1
2,GO HETEROTYPIC CELL CELL ADHESION,2.2907e-05,0.48443,0.49644,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00014062,0.48415,0.4709,1,1
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,5.9985e-05,0.4836,0.47966,1,1
2,GO INNATE IMMUNE RESPONSE,3.4805e-05,0.48281,0.4768,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011593,0.48232,0.49972,1,1
2,GO PHAGOCYTOSIS,5.2428e-05,0.48199,0.51502,1,1
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,4.2763e-05,0.48154,0.46077,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00023283,0.48136,0.46377,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION,6.8565e-05,0.47994,0.49427,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,0.00019306,0.47959,0.46408,1,1
2,GO ZYMOGEN ACTIVATION,5.7533e-06,0.4795,0.52937,1,1
2,GO REGULATION OF COAGULATION,1.7249e-05,0.47924,0.51941,1,1
2,GO PROTEIN CONTAINING COMPLEX REMODELING,3.248e-05,0.47923,0.47962,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,5.2428e-05,0.47904,0.46873,1,1
2,GO ACTIVATED T CELL PROLIFERATION,7.8298e-05,0.47739,0.45231,1,1
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,3.248e-05,0.47631,0.47455,1,1
2,GO FOAM CELL DIFFERENTIATION,5.2428e-05,0.476,0.49213,1,1
2,GO MYOBLAST FUSION,3.9936e-05,0.47488,0.50128,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0012758,0.47418,0.44292,1,1
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00018128,0.47364,0.4464,1,1
2,GO RESPONSE TO TUMOR CELL,0.00017019,0.47348,0.4722,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,5.2428e-05,0.47344,0.45081,1,1
2,GO ZYMOGEN INHIBITION,2.636e-05,0.47323,0.55431,1,1
2,GO RESPONSE TO INTERLEUKIN 2,0.0010209,0.47313,0.51965,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.00020554,0.47242,0.47559,1,1
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,6.4139e-05,0.47223,0.44636,1,1
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.8524e-05,0.47154,0.48796,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00040321,0.47108,0.49563,1,1
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,5.9985e-05,0.47053,0.50033,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.00021879,0.47025,0.4428,1,1
2,GO LYMPHOCYTE ACTIVATION,0.00011593,0.46945,0.47517,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,3.0304e-05,0.46922,0.45669,1,1
2,GO WATER TRANSPORT,5.6086e-05,0.46903,0.56277,1,1
2,GO TUMOR NECROSIS FACTOR SECRETION,1.4947e-05,0.46848,0.49785,1,1
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,3.4805e-05,0.46804,0.56271,1,1
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,9.5377e-05,0.46798,0.48647,1,1
2,GO LIPOXYGENASE PATHWAY,0.00010181,0.4679,0.51939,1,1
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,7.3279e-05,0.46784,0.43706,1,1
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,5.9985e-05,0.46687,0.45472,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00086166,0.46579,0.40304,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,6.8565e-05,0.46427,0.45906,1,1
2,GO MULTI ORGANISM CELLULAR PROCESS,6.8565e-05,0.46298,0.53477,1,1
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00026348,0.46183,0.47356,1,1
2,GO LEUKOCYTE MEDIATED IMMUNITY,3.248e-05,0.46039,0.46649,1,1
2,GO REGULATION OF AMYLOID BETA CLEARANCE,6.4139e-05,0.45953,0.51971,1,1
2,GO HEMIDESMOSOME ASSEMBLY,0.024086,0.45883,0.46391,1,1
2,GO OSTEOCLAST DIFFERENTIATION,4.2763e-05,0.45881,0.45213,1,1
2,GO RESPONSE TO PROSTAGLANDIN E,0.00018128,0.45879,0.44706,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,7.3279e-05,0.45847,0.45032,1,1
2,GO GAMMA DELTA T CELL ACTIVATION,0.00040321,0.45838,0.52942,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,5.2428e-05,0.45735,0.44892,1,1
2,GO KILLING OF CELLS OF OTHER ORGANISM,7.7514e-06,0.45653,0.46955,1,1
2,GO OSTEOCLAST DEVELOPMENT,0.00014062,0.45639,0.5386,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,1.9888e-05,0.45583,0.52714,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.0403e-05,0.45519,0.50496,1,1
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,5.9985e-05,0.45468,0.44226,1,1
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00024771,0.45388,0.48886,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.8298e-05,0.45374,0.48916,1,1
2,GO VITAMIN D METABOLIC PROCESS,0.00013188,0.45354,0.47933,1,1
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00031664,0.45353,0.43056,1,1
2,GO VAGINA DEVELOPMENT,0.00096503,0.45326,0.41483,1,1
2,GO RESPONSE TO PROSTAGLANDIN,0.00014062,0.45284,0.44552,1,1
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.00010866,0.45234,0.43933,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00010181,0.45195,0.42195,1,1
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00014989,0.44954,0.49935,1,1
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,4.2539e-06,0.4486,0.49585,1,1
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,5.2428e-05,0.44849,0.47882,1,1
2,GO ETHANOL CATABOLIC PROCESS,4.5779e-05,0.4484,0.55633,1,1
2,GO B CELL ACTIVATION,0.00017019,0.44685,0.47191,1,1
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00010181,0.44652,0.47217,1,1
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,3.7287e-05,0.44627,0.54152,1,1
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00064645,0.44618,0.49948,1,1
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,4.5779e-05,0.44579,0.45643,1,1
2,GO RESPONSE TO INTERLEUKIN 6,3.4805e-05,0.44543,0.47903,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,3.0304e-05,0.44338,0.46417,1,1
2,GO IMMUNOGLOBULIN PRODUCTION,0.00013188,0.44302,0.45704,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00035748,0.44293,0.49253,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.3641e-05,0.44226,0.46221,1,1
2,GO CYTOKINE PRODUCTION,3.7287e-05,0.44097,0.44861,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00012367,0.44078,0.45898,1,1
2,GO SYNCYTIUM FORMATION,3.9936e-05,0.44064,0.46503,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00035748,0.44057,0.43618,1,1
2,GO DEFENSE RESPONSE,3.248e-05,0.44041,0.43516,1,1
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,7.3279e-05,0.43997,0.47304,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00068502,0.4399,0.39112,1,1
2,GO FEVER GENERATION,0.00051151,0.43966,0.38902,1,1
2,GO TRANSCYTOSIS,5.9985e-05,0.43924,0.47776,1,1
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.00010181,0.43918,0.51963,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,3.0304e-05,0.43892,0.42912,1,1
2,GO REGULATION OF STEM CELL DIVISION,0.00060992,0.43881,0.48759,1,1
2,GO IMMUNE EFFECTOR PROCESS,3.9936e-05,0.43809,0.44884,1,1
2,GO CHOLESTEROL STORAGE,0.00013188,0.43756,0.49315,1,1
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,2.2907e-05,0.43732,0.51114,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.00040321,0.43674,0.45046,1,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00054254,0.4367,0.4494,1,1
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.00045436,0.43666,0.58741,1,1
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.7287e-05,0.43658,0.45917,1,1
2,GO ASTROCYTE DEVELOPMENT,0.00013188,0.43649,0.44701,1,1
2,GO BONE RESORPTION,5.6086e-05,0.43648,0.46066,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.00068502,0.43637,0.40976,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0019699,0.43489,0.43303,1,1
2,GO LEUKOCYTE DIFFERENTIATION,0.00010866,0.43419,0.44591,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,2.8267e-05,0.4336,0.45482,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.4805e-05,0.43344,0.44868,1,1
2,GO POSITIVE REGULATION OF COAGULATION,3.0304e-05,0.43343,0.49263,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00014062,0.43299,0.46522,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00026348,0.43257,0.45824,1,1
2,GO FLUID TRANSPORT,0.00011593,0.42969,0.48433,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00010181,0.42948,0.49888,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,6.8565e-05,0.42908,0.51463,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,5.9985e-05,0.42903,0.43412,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00091199,0.42877,0.50381,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00051151,0.42776,0.44851,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,8.3641e-05,0.4277,0.46514,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00014989,0.42743,0.55673,1,1
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00012367,0.42736,0.4599,1,1
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,6.8565e-05,0.42712,0.42284,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.00035748,0.42656,0.43523,1,1
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.00064645,0.42601,0.40521,1,1
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0054671,0.42573,0.40102,1,1
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,2.636e-05,0.42389,0.45361,1,1
2,GO CELL ADHESION MOLECULE PRODUCTION,0.00042807,0.42368,0.47119,1,1
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0025648,0.42365,0.35765,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,8.9327e-05,0.42284,0.44709,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00019306,0.42259,0.43098,1,1
2,GO REGULATION OF FIBRINOLYSIS,0.00021879,0.42189,0.52048,1,1
2,GO LYMPHOCYTE HOMEOSTASIS,0.00019306,0.42187,0.43807,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.8267e-05,0.42179,0.42866,1,1
2,GO B CELL HOMEOSTASIS,0.00054254,0.42107,0.41121,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,4.8997e-05,0.42094,0.54422,1,1
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.00051151,0.42077,0.45334,1,1
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0044907,0.42033,0.41359,1,1
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.0024341,0.41979,0.43068,1,1
2,GO REGULATION OF CHEMOTAXIS,5.2428e-05,0.41977,0.44016,1,1
2,GO ENTRY INTO HOST,5.9985e-05,0.4197,0.43031,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00020554,0.41948,0.43493,1,1
2,GO VASCULAR WOUND HEALING,0.00026348,0.41915,0.47915,1,1
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00010181,0.41861,0.45952,1,1
2,GO TRABECULA FORMATION,0.00024771,0.41841,0.43004,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.00012367,0.41831,0.53537,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00018128,0.41795,0.40931,1,1
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.00014989,0.41731,0.4623,1,1
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.9327e-05,0.41685,0.39381,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00076864,0.41674,0.45371,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,7.3279e-05,0.4166,0.45946,1,1
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,5.2428e-05,0.4165,0.44888,1,1
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00096503,0.41579,0.41295,1,1
2,GO DEFENSE RESPONSE TO VIRUS,0.00035748,0.41555,0.40843,1,1
2,GO MUCUS SECRETION,0.00010181,0.41455,0.45955,1,1
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00015974,0.41436,0.42607,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00013188,0.4141,0.43838,1,1
2,GO REGULATION OF BONE REMODELING,0.00014062,0.41395,0.41759,1,1
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.00023283,0.41362,0.5646,1,1
2,GO RESPONSE TO INTERLEUKIN 1,2.8267e-05,0.41361,0.37087,1,1
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00010181,0.41347,0.45764,1,1
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,6.4139e-05,0.41268,0.43847,1,1
2,GO I KAPPAB PHOSPHORYLATION,0.00035748,0.41211,0.45057,1,1
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00086166,0.41183,0.42107,1,1
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0023095,0.41147,0.37706,1,1
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00018128,0.41145,0.44494,1,1
2,GO PROSTANOID METABOLIC PROCESS,4.5779e-05,0.41078,0.41993,1,1
2,GO PLATELET DEGRANULATION,1.6059e-05,0.41072,0.50437,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,4.8997e-05,0.40984,0.43844,1,1
2,GO LIVER MORPHOGENESIS,0.00017019,0.4098,0.39989,1,1
2,GO XENOBIOTIC CATABOLIC PROCESS,0.025096,0.40977,0.25421,1,1
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.00021879,0.40955,0.46094,1,1
2,GO REGULATION OF TISSUE REMODELING,5.6086e-05,0.40828,0.43192,1,1
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.6059e-05,0.40815,0.48033,1,1
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.00028019,0.40735,0.4257,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,5.9985e-05,0.40664,0.46074,1,1
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0024341,0.40655,0.56303,1,1
2,GO T CELL DIFFERENTIATION IN THYMUS,0.00021879,0.40647,0.43475,1,1
2,GO AMYLOID FIBRIL FORMATION,6.8565e-05,0.40604,0.4398,1,1
2,GO GAP JUNCTION ASSEMBLY,0.00054254,0.40566,0.50168,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00024771,0.40491,0.42116,1,1
2,GO CELL ACTIVATION,4.8997e-05,0.40382,0.42459,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,8.9327e-05,0.40379,0.44505,1,1
2,GO MEMBRANE INVAGINATION,0.00013188,0.40374,0.46741,1,1
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.00068502,0.40162,0.44526,1,1
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0003797,0.40138,0.43446,1,1
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00091199,0.40136,0.36454,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,7.8298e-05,0.40022,0.43921,1,1
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0024341,0.39987,0.40129,1,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,6.8565e-05,0.39984,0.47976,1,1
2,GO PROTEIN TRIMERIZATION,0.00015974,0.39948,0.43632,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00023283,0.39884,0.44064,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.7249e-05,0.39814,0.46631,1,1
2,GO POSITIVE CHEMOTAXIS,2.636e-05,0.39712,0.42933,1,1
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00014062,0.39691,0.41429,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0021907,0.39685,0.41417,1,1
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,2.8267e-05,0.39667,0.41371,1,1
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00035748,0.39606,0.39475,1,1
2,GO B CELL DIFFERENTIATION,0.00033648,0.39509,0.43578,1,1
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00019306,0.39451,0.4353,1,1
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00019306,0.39363,0.40337,1,1
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00010866,0.39356,0.39003,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,0.00029789,0.39283,0.38913,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00040321,0.39245,0.40832,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.3279e-05,0.39236,0.41976,1,1
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0023095,0.39229,0.44379,1,1
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00012367,0.39166,0.51749,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00010866,0.39139,0.39339,1,1
2,GO REGULATION OF STEROL TRANSPORT,7.8298e-05,0.38989,0.3895,1,1
2,GO PROSTAGLANDIN TRANSPORT,7.8298e-05,0.38906,0.43826,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.9936e-05,0.38812,0.4073,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.00057531,0.38663,0.40954,1,1
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.00024771,0.38653,0.44803,1,1
2,GO RESPONSE TO FLUID SHEAR STRESS,0.00024771,0.38652,0.45582,1,1
2,GO RESPONSE TO ANGIOTENSIN,3.9936e-05,0.38579,0.38796,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,0.0011418,0.3853,0.40622,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00048214,0.38524,0.40228,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.0013481,0.38515,0.31732,1,1
2,GO NEGATIVE REGULATION OF WOUND HEALING,5.6086e-05,0.38491,0.4454,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00040321,0.38469,0.42541,1,1
2,GO COLLAGEN CATABOLIC PROCESS,0.0020776,0.38452,0.41996,1,1
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.00015974,0.38393,0.42085,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.00024771,0.38362,0.4337,1,1
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,5.9985e-05,0.38361,0.44632,1,1
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0040644,0.38328,0.37597,1,1
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,7.3279e-05,0.38284,0.46578,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.00019306,0.38229,0.40722,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00031664,0.38229,0.3908,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00031664,0.38184,0.43777,1,1
2,GO RESPONSE TO VIRUS,0.00024771,0.38112,0.38926,1,1
2,GO ERK1 AND ERK2 CASCADE,5.2428e-05,0.38074,0.42405,1,1
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.0019699,0.37963,0.46207,1,1
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.012106,0.37902,0.44574,1,1
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.0010209,0.37808,0.37466,1,1
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.00023283,0.3775,0.41745,1,1
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.00013188,0.3775,0.32374,1,1
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0013481,0.37741,0.37689,1,1
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00051151,0.37663,0.47018,1,1
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0014241,0.37555,0.38056,1,1
2,GO CELLULAR RESPONSE TO DSRNA,0.00010866,0.37547,0.41555,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00013188,0.37525,0.35686,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00018128,0.37521,0.41038,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.00028019,0.37515,0.41292,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,6.8565e-05,0.3749,0.46371,1,1
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.0028457,0.37488,0.39225,1,1
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,6.4139e-05,0.37424,0.4716,1,1
2,GO SUPEROXIDE METABOLIC PROCESS,5.9985e-05,0.37304,0.37157,1,1
2,GO REGULATION OF DEFENSE RESPONSE,5.9985e-05,0.3726,0.38505,1,1
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.00040321,0.37257,0.37189,1,1
2,GO REGULATION OF LIPASE ACTIVITY,0.00015974,0.37253,0.3675,1,1
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00026348,0.37218,0.32032,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00033648,0.37216,0.34798,1,1
2,GO GLYCOLIPID CATABOLIC PROCESS,0.00020554,0.37206,0.46274,1,1
2,GO RESPONSE TO CYTOKINE,7.3279e-05,0.3718,0.37611,1,1
2,GO COLLAGEN METABOLIC PROCESS,0.0010209,0.36988,0.42393,1,1
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,3.7287e-05,0.36956,0.42532,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00081392,0.36933,0.41768,1,1
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.00021879,0.3691,0.40037,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.8298e-05,0.36845,0.4183,1,1
2,GO HYALURONAN CATABOLIC PROCESS,2.2907e-05,0.3683,0.50051,1,1
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00018128,0.36761,0.46546,1,1
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00020554,0.36754,0.43466,1,1
2,GO REGULATION OF CALCIUM ION IMPORT,0.00014989,0.36729,0.38373,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,4.8997e-05,0.36583,0.37948,1,1
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.00035748,0.36543,0.35994,1,1
2,GO STEROL HOMEOSTASIS,5.2428e-05,0.36537,0.38703,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0031545,0.36532,0.3892,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00064645,0.36529,0.43061,1,1
2,GO REGULATION OF WOUND HEALING,6.4139e-05,0.36521,0.41177,1,1
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.00064645,0.36512,0.39382,1,1
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.0063209,0.36456,0.39047,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00028019,0.36426,0.35446,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0003797,0.3642,0.42516,1,1
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,9.5377e-05,0.36415,0.43964,1,1
2,GO RESPONSE TO MINERALOCORTICOID,0.0016767,0.36335,0.30371,1,1
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.00028019,0.36266,0.47521,1,1
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.00081392,0.36236,0.39231,1,1
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00028019,0.36211,0.35899,1,1
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0015041,0.36208,0.43466,1,1
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,3.4805e-05,0.36176,0.48198,1,1
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00033648,0.36167,0.36332,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,6.4139e-05,0.36138,0.37755,1,1
2,GO TRANSEPITHELIAL TRANSPORT,0.00057531,0.36129,0.36668,1,1
2,GO POSITIVE REGULATION OF URINE VOLUME,0.00028019,0.36078,0.39951,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00010181,0.36014,0.39657,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,3.248e-05,0.35994,0.38239,1,1
2,GO RENAL ABSORPTION,6.8565e-05,0.35979,0.49146,1,1
2,GO BONE CELL DEVELOPMENT,0.0010798,0.35919,0.37679,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,7.3279e-05,0.35904,0.37752,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00021879,0.35886,0.40163,1,1
2,GO PROSTAGLANDIN SECRETION,0.00031664,0.35885,0.40924,1,1
2,GO PLATELET ACTIVATION,0.00031664,0.3588,0.38683,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.3641e-05,0.35763,0.40888,1,1
2,GO REGULATION OF LYSOSOMAL LUMEN PH,3.4805e-05,0.35736,0.38331,1,1
2,GO SEQUESTERING OF METAL ION,0.00057531,0.35715,0.29692,1,1
2,GO CELLULAR RESPONSE TO IRON ION,0.0096484,0.35589,0.28779,1,1
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.00021879,0.35588,0.43135,1,1
2,GO CHOLESTEROL EFFLUX,0.00048214,0.35579,0.32547,1,1
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00031664,0.35549,0.41413,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00015974,0.35498,0.43692,1,1
2,GO P38MAPK CASCADE,0.00010866,0.35384,0.39066,1,1
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00040321,0.35352,0.35999,1,1
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.0025648,0.35333,0.2991,1,1
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.00023283,0.3532,0.40486,1,1
2,GO RESPONSE TO MANGANESE ION,3.4805e-05,0.35314,0.37089,1,1
2,GO BLOOD VESSEL REMODELING,0.0011418,0.35294,0.42416,1,1
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00033648,0.35283,0.319,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.00014062,0.35253,0.37872,1,1
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.00028019,0.352,0.35009,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,8.3641e-05,0.35187,0.38225,1,1
2,GO REGULATION OF CELL FATE SPECIFICATION,0.00010181,0.3515,0.44451,1,1
2,GO DIET INDUCED THERMOGENESIS,0.0020776,0.35072,0.32708,1,1
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.00051151,0.35008,0.45808,1,1
2,GO POSITIVE REGULATION OF WOUND HEALING,0.00012367,0.34996,0.3983,1,1
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00020554,0.34966,0.36154,1,1
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.00015974,0.34955,0.49063,1,1
2,GO RESPONSE TO CORTICOSTERONE,0.015776,0.34949,0.28931,1,1
2,GO RESPONSE TO THYROID HORMONE,0.00011593,0.34949,0.36356,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,6.4139e-05,0.34939,0.36937,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0021907,0.34901,0.34873,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00015974,0.34875,0.40728,1,1
2,GO RESPONSE TO PROGESTERONE,0.0003797,0.34873,0.35257,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00045436,0.34787,0.36294,1,1
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00040321,0.34697,0.41775,1,1
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00024771,0.34695,0.40376,1,1
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00015974,0.34667,0.43347,1,1
2,GO PINOCYTOSIS,0.00068502,0.34639,0.36188,1,1
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0047188,0.34501,0.37221,1,1
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.00024771,0.34483,0.45087,1,1
2,GO TRIGLYCERIDE CATABOLIC PROCESS,5.2428e-05,0.34477,0.33505,1,1
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00021879,0.34468,0.38089,1,1
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00014062,0.34455,0.38286,1,1
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,5.9985e-05,0.34337,0.40466,1,1
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.00015974,0.34182,0.40325,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00072571,0.34181,0.45393,1,1
2,GO RESPONSE TO VITAMIN D,0.0013481,0.34165,0.36363,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00023283,0.34147,0.36493,1,1
2,GO HYALURONAN METABOLIC PROCESS,6.4139e-05,0.34094,0.42532,1,1
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.0019699,0.34079,0.44488,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00024771,0.34072,0.43315,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00026348,0.34064,0.40799,1,1
2,GO PROGRAMMED NECROTIC CELL DEATH,7.3279e-05,0.34037,0.39534,1,1
2,GO RESPONSE TO DSRNA,0.00017019,0.34035,0.32911,1,1
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00048214,0.33988,0.39425,1,1
2,GO BONE REMODELING,0.00013188,0.33987,0.3964,1,1
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,7.3279e-05,0.33936,0.45048,1,1
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,2.8267e-05,0.33898,0.39957,1,1
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.00029789,0.33896,0.3735,1,1
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00026348,0.33895,0.37127,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00051151,0.33851,0.37674,1,1
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00018128,0.3384,0.36471,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,3.4805e-05,0.3384,0.37709,1,1
2,GO SEQUESTERING OF CALCIUM ION,0.00033648,0.33817,0.34158,1,1
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,4.8997e-05,0.33785,0.34383,1,1
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,5.2428e-05,0.33671,0.35509,1,1
2,GO THYMOCYTE APOPTOTIC PROCESS,0.0076456,0.33664,0.27476,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00014989,0.33566,0.37064,1,1
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.00017019,0.33408,0.36181,1,1
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.00029789,0.33377,0.41822,1,1
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.0012758,0.33365,0.37529,1,1
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.0025648,0.33353,0.40982,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,8.9327e-05,0.33316,0.42513,1,1
2,GO TISSUE REMODELING,6.4139e-05,0.33301,0.42713,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0040644,0.33255,0.31168,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0010798,0.33238,0.3484,1,1
2,GO HEART TRABECULA FORMATION,0.0020776,0.33205,0.3425,1,1
2,GO REGULATION OF CELL ADHESION,0.00012367,0.33196,0.40264,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00018128,0.33162,0.40757,1,1
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,8.9327e-05,0.33151,0.37113,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0019699,0.33082,0.40863,1,1
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00017019,0.33079,0.42586,1,1
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0016767,0.33049,0.42204,1,1
2,GO PLATELET AGGREGATION,0.00040321,0.33049,0.4007,1,1
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00020554,0.32997,0.36072,1,1
2,GO RETINAL METABOLIC PROCESS,0.00033648,0.32964,0.42576,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0042727,0.32936,0.37701,1,1
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00029789,0.3283,0.39018,1,1
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.0013481,0.32786,0.40964,1,1
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.00010866,0.32785,0.38597,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00091199,0.32771,0.35735,1,1
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00026348,0.32724,0.35,1,1
2,GO PHOSPHOLIPID HOMEOSTASIS,0.00014989,0.3268,0.36003,1,1
2,GO SEROTONIN TRANSPORT,0.0025648,0.32654,0.32364,1,1
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.00010866,0.32632,0.35244,1,1
2,GO LUNG MORPHOGENESIS,0.00086166,0.32625,0.35567,1,1
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00024771,0.32596,0.40356,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00060992,0.32549,0.40005,1,1
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00011593,0.32535,0.37027,1,1
2,GO REGULATION OF PROTEIN MATURATION,5.2428e-05,0.32532,0.35076,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,8.3641e-05,0.32521,0.40515,1,1
2,GO PULMONARY VALVE DEVELOPMENT,0.008797,0.32452,0.34395,1,1
2,GO POSITIVE REGULATION OF MYELINATION,0.0031545,0.32376,0.31168,1,1
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00014989,0.32358,0.316,1,1
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0019699,0.32357,0.2759,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,5.6086e-05,0.3233,0.35835,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00010181,0.32318,0.3405,1,1
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.00057531,0.32165,0.32276,1,1
2,GO SOMATIC STEM CELL DIVISION,0.024086,0.32162,0.33024,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0034935,0.32149,0.31143,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00029789,0.32104,0.34759,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0003797,0.32095,0.49168,1,1
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00018128,0.32077,0.36471,1,1
2,GO STORE OPERATED CALCIUM ENTRY,0.00332,0.32061,0.32753,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,7.3279e-05,0.32051,0.36316,1,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00064645,0.31986,0.41601,1,1
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0013481,0.31942,0.401,1,1
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.00064645,0.31917,0.33354,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0014241,0.31892,0.35763,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00010866,0.31887,0.34055,1,1
2,GO CELLULAR RESPONSE TO VIRUS,0.00068502,0.31866,0.34274,1,1
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,5.9985e-05,0.31857,0.38476,1,1
2,GO REGULATION OF CELL FATE COMMITMENT,0.00010866,0.31827,0.3617,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00068502,0.31689,0.33025,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.00014989,0.31679,0.38208,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.00015974,0.31663,0.33998,1,1
2,GO CELLULAR RESPONSE TO VITAMIN,0.0024341,0.31608,0.33837,1,1
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00014989,0.316,0.37787,1,1
2,GO SEQUESTERING OF TRIGLYCERIDE,0.00081392,0.31578,0.32698,1,1
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.00024771,0.31576,0.36367,1,1
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00086166,0.31544,0.33914,1,1
2,GO ARGININE METABOLIC PROCESS,0.00010866,0.31525,0.34023,1,1
2,GO INTERACTION WITH SYMBIONT,5.9985e-05,0.31469,0.32683,1,1
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00026348,0.31449,0.31691,1,1
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,9.5377e-05,0.31414,0.33382,1,1
2,GO TRABECULA MORPHOGENESIS,0.0012071,0.31406,0.34473,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00011593,0.31381,0.36099,1,1
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00051151,0.31339,0.39567,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0021907,0.31338,0.28936,1,1
2,GO RESPONSE TO AMYLOID BETA,0.0010209,0.31322,0.35109,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0024341,0.31286,0.34498,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0029965,0.3128,0.28917,1,1
2,GO NIK NF KAPPAB SIGNALING,0.00023283,0.31246,0.30345,1,1
2,GO REGULATION OF VASOCONSTRICTION,0.00035748,0.31206,0.3916,1,1
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.0017696,0.31203,0.31841,1,1
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0092139,0.31193,0.4005,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.7287e-05,0.31179,0.33396,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00091199,0.31177,0.39517,1,1
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00057531,0.31173,0.4341,1,1
2,GO REGULATION OF ODONTOGENESIS,0.0020776,0.31162,0.34837,1,1
2,GO REGULATION OF LIPID STORAGE,0.00033648,0.3109,0.34317,1,1
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0057394,0.31041,0.31537,1,1
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0010798,0.30988,0.2916,1,1
2,GO CARDIOBLAST DIFFERENTIATION,0.0020776,0.30966,0.32364,1,1
2,GO SULFATION,0.00096503,0.30958,0.36671,1,1
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00011593,0.30904,0.37781,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00048214,0.30902,0.30739,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00024771,0.30889,0.32214,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.4805e-05,0.30868,0.36396,1,1
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0031545,0.30823,0.38536,1,1
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.00023283,0.30812,0.39355,1,1
2,GO CALCIUM MEDIATED SIGNALING,0.00014062,0.30803,0.3401,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0010209,0.30692,0.30453,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.8298e-05,0.3063,0.32205,1,1
2,GO HEAT GENERATION,0.0018673,0.30588,0.30451,1,1
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.00023283,0.30585,0.27181,1,1
2,GO ICOSANOID METABOLIC PROCESS,4.2763e-05,0.30564,0.36407,1,1
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0031545,0.30531,0.27161,1,1
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0028457,0.30514,0.35418,1,1
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.00021879,0.30479,0.31991,1,1
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,5.6086e-05,0.30462,0.349,1,1
2,GO REGULATION OF BONE MINERALIZATION,0.00031664,0.30446,0.37277,1,1
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,3.9936e-05,0.304,0.32723,1,1
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00014989,0.30355,0.36522,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.00021879,0.30352,0.36594,1,1
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00028019,0.30331,0.3599,1,1
2,GO REGULATION OF GLOMERULAR FILTRATION,0.0021907,0.30329,0.43209,1,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00060992,0.30317,0.38595,1,1
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0024341,0.30314,0.37008,1,1
2,GO OVULATION,0.00091199,0.30312,0.36289,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00057531,0.30307,0.30168,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00020554,0.30301,0.31956,1,1
2,GO CARTILAGE MORPHOGENESIS,0.0034935,0.3028,0.30362,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00014989,0.30261,0.30998,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00076864,0.30254,0.34091,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0080134,0.30235,0.24778,1,1
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00017019,0.30171,0.31497,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0031545,0.30089,0.29159,1,1
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.00060992,0.30089,0.31131,1,1
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,8.3641e-05,0.30068,0.3286,1,1
2,GO COPPER ION TRANSPORT,0.00029789,0.30052,0.33064,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0010798,0.30041,0.35801,1,1
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0060238,0.30023,0.2823,1,1
2,GO CELLULAR RESPONSE TO NUTRIENT,0.00096503,0.30019,0.31916,1,1
2,GO RESPONSE TO SALT STRESS,0.0025648,0.30019,0.2675,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00086166,0.30009,0.34134,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00020554,0.29964,0.36121,1,1
2,GO ENDOCARDIAL CUSHION FORMATION,0.0021907,0.29926,0.35495,1,1
2,GO REGULATION OF ICOSANOID SECRETION,0.00017019,0.29891,0.33041,1,1
2,GO COAGULATION,0.00014989,0.29891,0.35483,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,9.5377e-05,0.2988,0.36619,1,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.014457,0.29876,0.28042,1,1
2,GO NECROTIC CELL DEATH,0.00020554,0.29862,0.31732,1,1
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00019306,0.29846,0.34421,1,1
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0003797,0.29845,0.38707,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0038653,0.29837,0.27268,1,1
2,GO KERATINOCYTE PROLIFERATION,0.0023095,0.29825,0.30366,1,1
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.0063209,0.2981,0.27531,1,1
2,GO RETINOIC ACID METABOLIC PROCESS,0.00086166,0.29778,0.32882,1,1
2,GO LYSOSOME LOCALIZATION,0.00068502,0.29774,0.30712,1,1
2,GO PROTEIN NITROSYLATION,0.00040321,0.29767,0.32015,1,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00026348,0.29628,0.34723,1,1
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00091199,0.29615,0.35743,1,1
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00031664,0.29596,0.34075,1,1
2,GO PEPTIDE CATABOLIC PROCESS,0.00014989,0.29586,0.38089,1,1
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00010181,0.29563,0.35253,1,1
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00015974,0.29551,0.36008,1,1
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00028019,0.29534,0.29586,1,1
2,GO RETINOL METABOLIC PROCESS,0.00042807,0.29531,0.3147,1,1
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0057394,0.29518,0.33345,1,1
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.0016767,0.29446,0.29933,1,1
2,GO DECIDUALIZATION,0.0015041,0.29445,0.37915,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00018128,0.29436,0.35164,1,1
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.00096503,0.29425,0.32245,1,1
2,GO RESPONSE TO LIPID,9.5377e-05,0.29417,0.298,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00086166,0.29404,0.25234,1,1
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.0034935,0.29398,0.38649,1,1
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0040644,0.29385,0.33809,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0013481,0.29312,0.34263,1,1
2,GO GLIAL CELL PROLIFERATION,0.0010798,0.2931,0.32931,1,1
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.00096503,0.29295,0.37375,1,1
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00014062,0.29291,0.39416,1,1
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00076864,0.29192,0.3146,1,1
2,GO REGULATION OF VASCULOGENESIS,0.0021907,0.29156,0.35124,1,1
2,GO POSITIVE REGULATION OF OSSIFICATION,0.00035748,0.29134,0.33602,1,1
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0063209,0.29129,0.28399,1,1
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00017019,0.29096,0.32042,1,1
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0010798,0.29081,0.35579,1,1
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00081392,0.29063,0.31622,1,1
2,GO REGULATION OF RESPONSE TO WOUNDING,0.00014062,0.29062,0.35525,1,1
2,GO RESPONSE TO EPINEPHRINE,0.033245,0.29036,0.23642,1,1
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00035748,0.29023,0.3206,1,1
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.0052065,0.29015,0.36398,1,1
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.00042807,0.29012,0.32934,1,1
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.013235,0.29011,0.31324,1,1
2,GO ENDOTHELIAL CELL MIGRATION,0.00040321,0.29002,0.34975,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0054671,0.28984,0.38407,1,1
2,GO PYROPTOSIS,0.0031545,0.2897,0.31789,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.00091199,0.28955,0.30978,1,1
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.00048214,0.28932,0.30377,1,1
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.00023283,0.28929,0.27611,1,1
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0083971,0.28831,0.25994,1,1
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00013188,0.28821,0.36406,1,1
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.0054671,0.2877,0.32545,1,1
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.0052065,0.28694,0.32514,1,1
2,GO GLIAL CELL MIGRATION,0.0060238,0.28685,0.2652,1,1
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00033648,0.28571,0.31588,1,1
2,GO REGULATION OF RECEPTOR BINDING,0.0028457,0.28569,0.31416,1,1
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.00026348,0.28568,0.36372,1,1
2,GO PROTEIN AUTOPROCESSING,0.00020554,0.28462,0.30108,1,1
2,GO REGULATION OF VIRAL LIFE CYCLE,0.00014062,0.28444,0.34584,1,1
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0024341,0.28365,0.29171,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.043559,0.28313,0.20622,1,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00054254,0.28231,0.37698,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00035748,0.28198,0.35681,1,1
2,GO AORTIC VALVE DEVELOPMENT,0.0083971,0.28185,0.35698,1,1
2,GO SALIVA SECRETION,0.0034935,0.28132,0.31468,1,1
2,GO POLYOL TRANSPORT,0.0038653,0.2807,0.33558,1,1
2,GO RESPONSE TO CORTICOSTEROID,9.5377e-05,0.2802,0.31683,1,1
2,GO FEMALE GENITALIA DEVELOPMENT,0.0021907,0.27986,0.2594,1,1
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.033245,0.27973,0.25854,1,1
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.00018128,0.27943,0.30054,1,1
2,GO EXOCYTOSIS,6.8565e-05,0.2791,0.30091,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.0080134,0.27908,0.30014,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00068502,0.27874,0.33743,1,1
2,GO CELLULAR RESPONSE TO LIPID,0.00011593,0.27872,0.29209,1,1
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.0040644,0.27865,0.30395,1,1
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00040321,0.27856,0.35321,1,1
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.02951,0.27824,0.2399,1,1
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0031545,0.27776,0.35238,1,1
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.0024341,0.27763,0.31354,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00060992,0.27754,0.30493,1,1
2,GO BICARBONATE TRANSPORT,0.0076456,0.27739,0.22116,1,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00019306,0.27712,0.30503,1,1
2,GO BRONCHUS DEVELOPMENT,0.0027019,0.27643,0.39365,1,1
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.00068502,0.27637,0.33604,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00064645,0.27607,0.28103,1,1
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.037377,0.27592,0.29372,1,1
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0003797,0.27522,0.30864,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00019306,0.27429,0.31628,1,1
2,GO REGULATION OF BODY FLUID LEVELS,0.00035748,0.27378,0.29669,1,1
2,GO RESPONSE TO PARATHYROID HORMONE,0.011063,0.27375,0.22294,1,1
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00033648,0.27342,0.31714,1,1
2,GO REGULATION OF FATTY ACID TRANSPORT,0.00024771,0.27325,0.32397,1,1
2,GO MYELOID CELL DEVELOPMENT,0.00096503,0.27253,0.32014,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0018673,0.27251,0.28995,1,1
2,GO WHITE FAT CELL DIFFERENTIATION,0.0025648,0.2722,0.30254,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0011418,0.27148,0.27295,1,1
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0027019,0.27101,0.26614,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.0076456,0.27098,0.24674,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.00332,0.27086,0.38433,1,1
2,GO REGULATION OF BIOMINERALIZATION,0.00054254,0.27074,0.33303,1,1
2,GO PLASMA MEMBRANE FUSION,0.00028019,0.27073,0.36801,1,1
2,GO ACYLGLYCEROL HOMEOSTASIS,0.00091199,0.27061,0.28063,1,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00072571,0.27043,0.35037,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.00024771,0.27018,0.30026,1,1
2,GO WOUND HEALING,0.00033648,0.27007,0.3378,1,1
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.0016767,0.27003,0.32329,1,1
2,GO NEURON REMODELING,0.010101,0.26996,0.3001,1,1
2,GO REGULATION OF CELL SHAPE,0.00054254,0.26967,0.31421,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00068502,0.26945,0.34079,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.00013188,0.26929,0.31181,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0020776,0.2692,0.36181,1,1
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00096503,0.26914,0.33826,1,1
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.00019306,0.26882,0.32145,1,1
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00096503,0.26869,0.36004,1,1
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.054439,0.26823,0.21245,1,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.0014241,0.26811,0.30873,1,1
2,GO MYOBLAST PROLIFERATION,0.0024341,0.26779,0.2748,1,1
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.00040321,0.26762,0.2979,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0031545,0.26719,0.29126,1,1
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00048214,0.26714,0.29665,1,1
2,GO RESPONSE TO ATP,0.0012071,0.2671,0.28905,1,1
2,GO MUSCLE CELL PROLIFERATION,0.00029789,0.26695,0.33183,1,1
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0016767,0.26692,0.35612,1,1
2,GO GLAND MORPHOGENESIS,0.0018673,0.26674,0.33097,1,1
2,GO RESPONSE TO RETINOIC ACID,0.00018128,0.26651,0.30909,1,1
2,GO REGULATION OF PEPTIDASE ACTIVITY,7.8298e-05,0.26648,0.29232,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00040321,0.26623,0.29,1,1
2,GO CELL SUBSTRATE ADHESION,0.0018673,0.26538,0.34319,1,1
2,GO HEAD MORPHOGENESIS,0.011063,0.26535,0.25739,1,1
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00096503,0.26518,0.29686,1,1
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.015104,0.26513,0.31332,1,1
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00017019,0.26511,0.28159,1,1
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.0014241,0.2649,0.32257,1,1
2,GO DRUG METABOLIC PROCESS,0.00060992,0.26474,0.28994,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00057531,0.26472,0.26074,1,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0083971,0.26461,0.27328,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.00081392,0.26454,0.27354,1,1
2,GO MATERNAL PLACENTA DEVELOPMENT,0.0036751,0.26427,0.28504,1,1
2,GO INTERACTION WITH HOST,0.00015974,0.26406,0.28885,1,1
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.023112,0.26402,0.26038,1,1
2,GO TAXIS,0.00029789,0.26399,0.30388,1,1
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00051151,0.26379,0.29459,1,1
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0044907,0.26307,0.25007,1,1
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0023095,0.263,0.34832,1,1
2,GO CELL REDOX HOMEOSTASIS,0.00020554,0.26298,0.28199,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,0.00042807,0.26291,0.31629,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.0063209,0.26259,0.27073,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,4.8997e-05,0.26245,0.31394,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0021907,0.26168,0.30626,1,1
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00072571,0.26113,0.33771,1,1
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0020776,0.26103,0.25146,1,1
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.00010866,0.26096,0.29071,1,1
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0010209,0.26084,0.3197,1,1
2,GO SALIVARY GLAND DEVELOPMENT,0.0029965,0.2608,0.34675,1,1
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00054254,0.26079,0.26858,1,1
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.043559,0.26018,0.22262,1,1
2,GO BONE MINERALIZATION,0.00020554,0.26017,0.32618,1,1
2,GO ARACHIDONIC ACID SECRETION,0.00068502,0.25993,0.28073,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00024771,0.2594,0.3087,1,1
2,GO ENDODERMAL CELL FATE COMMITMENT,0.0031545,0.25934,0.26619,1,1
2,GO REGULATION OF PINOCYTOSIS,0.0049572,0.25922,0.28688,1,1
2,GO MYELOID CELL DIFFERENTIATION,0.00051151,0.2589,0.2876,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0011418,0.25881,0.26465,1,1
2,GO PULMONARY VALVE MORPHOGENESIS,0.037377,0.25881,0.29324,1,1
2,GO POSITIVE REGULATION OF JNK CASCADE,0.00068502,0.25849,0.31865,1,1
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.013235,0.25848,0.21578,1,1
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00068502,0.2583,0.30211,1,1
2,GO RESPONSE TO INACTIVITY,0.017954,0.25829,0.22542,1,1
2,GO CERAMIDE CATABOLIC PROCESS,0.00072571,0.25823,0.3537,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,0.00051151,0.25796,0.30602,1,1
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0034935,0.25777,0.26703,1,1
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0023095,0.2577,0.29143,1,1
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0025648,0.25766,0.25375,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.0027019,0.25761,0.29238,1,1
2,GO RUFFLE ORGANIZATION,0.00014062,0.25725,0.33344,1,1
2,GO PROTEIN PROCESSING,2.8267e-05,0.25721,0.30839,1,1
2,GO RELAXATION OF CARDIAC MUSCLE,0.011574,0.2572,0.26703,1,1
2,GO EXPLORATION BEHAVIOR,0.0083971,0.25699,0.256,1,1
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00011593,0.25644,0.28959,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,2.2907e-05,0.25641,0.30508,1,1
2,GO SECRETION BY TISSUE,0.0016767,0.25615,0.24681,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.0018673,0.25604,0.28144,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0036751,0.25594,0.25349,1,1
2,GO BROWN FAT CELL DIFFERENTIATION,0.0017696,0.2558,0.25336,1,1
2,GO RESPONSE TO UV B,0.00051151,0.25547,0.29955,1,1
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0044907,0.25504,0.22818,1,1
2,GO TISSUE MIGRATION,0.0013481,0.25494,0.31878,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.00028019,0.25486,0.29706,1,1
2,GO ENGULFMENT OF APOPTOTIC CELL,0.0040644,0.25474,0.29701,1,1
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00014062,0.25462,0.30125,1,1
2,GO ZINC ION HOMEOSTASIS,0.022172,0.25356,0.21575,1,1
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00076864,0.25326,0.2984,1,1
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.050584,0.25303,0.19128,1,1
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0066311,0.25288,0.36191,1,1
2,GO ENDOTHELIAL CELL PROLIFERATION,0.00096503,0.25266,0.3107,1,1
2,GO RESPONSE TO CAMP,0.00040321,0.25264,0.30299,1,1
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00026348,0.25258,0.36318,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0057394,0.25253,0.32717,1,1
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0012071,0.25229,0.32611,1,1
2,GO RESPONSE TO MUSCLE STRETCH,0.0044907,0.2521,0.30902,1,1
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0083971,0.25196,0.26102,1,1
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00013188,0.25195,0.30489,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.0013481,0.25181,0.25232,1,1
2,GO NEPHRIC DUCT MORPHOGENESIS,0.01266,0.25139,0.27416,1,1
2,GO BIOMINERALIZATION,0.0010209,0.2511,0.28275,1,1
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.010572,0.25096,0.28172,1,1
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0017696,0.25065,0.25551,1,1
2,GO BLOOD VESSEL MORPHOGENESIS,0.00057531,0.25054,0.35538,1,1
2,GO TRACHEA MORPHOGENESIS,0.0014241,0.25015,0.38855,1,1
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.010572,0.25008,0.2892,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00026348,0.25006,0.27327,1,1
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0034935,0.24999,0.31964,1,1
2,GO REGULATION OF RUFFLE ASSEMBLY,0.00086166,0.24974,0.2665,1,1
2,GO RESPONSE TO DEXAMETHASONE,0.00081392,0.24933,0.25703,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.052482,0.24922,0.16407,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.015776,0.24881,0.25854,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.019548,0.24833,0.24876,1,1
2,GO LIPID STORAGE,0.00019306,0.2482,0.29538,1,1
2,GO REGULATION OF RECEPTOR RECYCLING,0.0011418,0.24795,0.25552,1,1
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.013235,0.24717,0.26736,1,1
2,GO DORSAL AORTA DEVELOPMENT,0.037377,0.24706,0.24186,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00064645,0.24698,0.29726,1,1
2,GO STEROID HORMONE SECRETION,0.023112,0.24663,0.23528,1,1
2,GO RENAL FILTRATION,0.013834,0.24662,0.32933,1,1
2,GO CELLULAR ION HOMEOSTASIS,0.00015974,0.24651,0.25772,1,1
2,GO REPLACEMENT OSSIFICATION,0.013235,0.24622,0.2747,1,1
2,GO ASTROCYTE DIFFERENTIATION,0.0014241,0.2462,0.28318,1,1
2,GO SPROUTING ANGIOGENESIS,0.0052065,0.24564,0.30718,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00068502,0.24561,0.25389,1,1
2,GO CELL CELL ADHESION,0.00048214,0.24516,0.30149,1,1
2,GO HEART INDUCTION,0.021265,0.24513,0.28939,1,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.012106,0.24481,0.23978,1,1
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.038848,0.24475,0.24517,1,1
2,GO EMBRYO IMPLANTATION,0.00042807,0.24459,0.33294,1,1
2,GO RESPONSE TO WOUNDING,0.00042807,0.24442,0.31091,1,1
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00014062,0.24425,0.26477,1,1
2,GO MAMMARY GLAND MORPHOGENESIS,0.0038653,0.2441,0.32514,1,1
2,GO RELAXATION OF MUSCLE,0.007293,0.24398,0.24004,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,3.4805e-05,0.24381,0.26217,1,1
2,GO HEART TRABECULA MORPHOGENESIS,0.0028457,0.24368,0.31155,1,1
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0063209,0.24331,0.28953,1,1
2,GO IRON ION HOMEOSTASIS,5.2428e-05,0.24318,0.30301,1,1
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0038653,0.24287,0.34344,1,1
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00060992,0.24268,0.31104,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.010101,0.24266,0.23421,1,1
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,9.5377e-05,0.24249,0.27409,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.0018673,0.24221,0.2471,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,6.4139e-05,0.24184,0.26379,1,1
2,GO KERATAN SULFATE METABOLIC PROCESS,0.0040644,0.2418,0.30177,1,1
2,GO RESPONSE TO FATTY ACID,0.00068502,0.24134,0.26933,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.0010798,0.24109,0.25457,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0029965,0.24098,0.22127,1,1
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0049572,0.24029,0.26567,1,1
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0044907,0.24023,0.28022,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00014062,0.24001,0.28702,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00023283,0.23988,0.25126,1,1
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.011574,0.23985,0.22795,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0013481,0.23961,0.28144,1,1
2,GO MYOTUBE DIFFERENTIATION,0.0034935,0.23952,0.25484,1,1
2,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.0092139,0.23931,0.31257,1,1
2,GO STEROL TRANSPORT,0.0003797,0.23906,0.2894,1,1
2,GO IMMUNE SYSTEM DEVELOPMENT,0.00031664,0.23882,0.30098,1,1
2,GO VASCULOGENESIS,0.0060238,0.23878,0.31187,1,1
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.048745,0.2386,0.35081,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00015974,0.23833,0.28564,1,1
2,GO METAL ION HOMEOSTASIS,0.00012367,0.23821,0.27779,1,1
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.00051151,0.23813,0.26947,1,1
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.0036751,0.23801,0.33724,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.01266,0.23791,0.24923,1,1
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0047188,0.23762,0.26325,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0044907,0.2375,0.26497,1,1
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.0011418,0.23733,0.30885,1,1
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.00057531,0.23716,0.31563,1,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0025648,0.23712,0.26185,1,1
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0020776,0.2369,0.37376,1,1
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.011574,0.23586,0.23156,1,1
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.0019699,0.23565,0.40366,1,1
2,GO REGULATION OF OSSIFICATION,0.00072571,0.23559,0.29444,1,1
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.00026348,0.23556,0.25054,1,1
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0016767,0.23502,0.25088,1,1
2,GO AMINOGLYCAN METABOLIC PROCESS,0.0023095,0.2349,0.28473,1,1
2,GO REGULATION OF ANION TRANSPORT,0.0020776,0.2343,0.2437,1,1
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.0076456,0.23394,0.25362,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0047188,0.23388,0.33056,1,1
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0023095,0.23363,0.27804,1,1
2,GO TISSUE REGENERATION,0.0013481,0.23314,0.22944,1,1
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0018673,0.23277,0.33132,1,1
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.007293,0.23276,0.25904,1,1
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0024341,0.23223,0.27058,1,1
2,GO REGULATION OF LIPID LOCALIZATION,0.00035748,0.23196,0.28346,1,1
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.00086166,0.23157,0.32801,1,1
2,GO INTERFERON BETA PRODUCTION,0.0019699,0.23135,0.31579,1,1
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0054671,0.23133,0.26189,1,1
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0024341,0.23129,0.32655,1,1
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00018128,0.23122,0.28552,1,1
2,GO DETOXIFICATION,3.7287e-05,0.23119,0.27014,1,1
2,GO PROTEIN KINASE B SIGNALING,0.00042807,0.23112,0.30905,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0019699,0.23104,0.23705,1,1
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.00096503,0.23041,0.24389,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.033245,0.2304,0.22858,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00033648,0.2304,0.25936,1,1
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0003797,0.23035,0.26508,1,1
2,GO MITOCHONDRIAL DEPOLARIZATION,0.00031664,0.23005,0.29986,1,1
2,GO ANIMAL ORGAN REGENERATION,8.3641e-05,0.22968,0.26943,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0013481,0.22863,0.22505,1,1
2,GO HEPARIN METABOLIC PROCESS,0.0083971,0.22819,0.2881,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.030713,0.22808,0.2078,1,1
2,GO ENDOCRINE PROCESS,0.00096503,0.22806,0.30215,1,1
2,GO ORGAN INDUCTION,0.0036751,0.22779,0.2464,1,1
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.010572,0.22777,0.25616,1,1
2,GO TRACHEA DEVELOPMENT,0.0036751,0.22682,0.32096,1,1
2,GO ION HOMEOSTASIS,0.00023283,0.2268,0.25094,1,1
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.010101,0.2266,0.24121,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00096503,0.22629,0.2524,1,1
2,GO INTRACELLULAR STEROL TRANSPORT,0.0038653,0.22624,0.2525,1,1
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.00031664,0.22615,0.28538,1,1
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,9.5377e-05,0.22601,0.25246,1,1
2,GO VASCULATURE DEVELOPMENT,0.0010209,0.22589,0.33217,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0013481,0.22584,0.25595,1,1
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.00028019,0.22574,0.23737,1,1
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0036751,0.22553,0.28509,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.00031664,0.2253,0.27529,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.00031664,0.22478,0.27057,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0021907,0.22467,0.25226,1,1
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00072571,0.22447,0.29293,1,1
2,GO REGULATION OF LIPID TRANSPORT,0.00054254,0.22446,0.27686,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,0.0024341,0.2244,0.2299,1,1
2,GO BASEMENT MEMBRANE ORGANIZATION,0.0060238,0.22387,0.31775,1,1
2,GO REGULATION OF MAPK CASCADE,0.00040321,0.22379,0.27676,1,1
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.023112,0.2237,0.23357,1,1
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0011418,0.22355,0.246,1,1
2,GO RESPONSE TO ESTROGEN,0.00029789,0.22336,0.29706,1,1
2,GO RESPONSE TO KETONE,0.00054254,0.22333,0.24643,1,1
2,GO KERATINOCYTE MIGRATION,0.0063209,0.22301,0.26564,1,1
2,GO TERPENOID METABOLIC PROCESS,0.0021907,0.22285,0.21555,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.0027019,0.22248,0.27262,1,1
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00057531,0.22202,0.27142,1,1
2,GO RESPONSE TO HYPEROXIA,0.00017019,0.22183,0.32553,1,1
2,GO CELLULAR RESPONSE TO CAMP,0.00081392,0.22156,0.25572,1,1
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0021907,0.22155,0.26034,1,1
2,GO EPOXYGENASE P450 PATHWAY,0.011574,0.22114,0.24409,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0029965,0.22111,0.2104,1,1
2,GO REGULATION OF AMYLOID BETA FORMATION,0.0029965,0.22106,0.2724,1,1
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.010101,0.22102,0.24498,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0172,0.22089,0.21559,1,1
2,GO MESENCHYME MORPHOGENESIS,0.0027019,0.22089,0.31499,1,1
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.016475,0.22061,0.23156,1,1
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.0092139,0.22057,0.29308,1,1
2,GO REGULATION OF TUBE SIZE,0.0015041,0.22044,0.27225,1,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.010572,0.22016,0.28484,1,1
2,GO CELLULAR RESPONSE TO ATP,0.0042727,0.22,0.25152,1,1
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.0012758,0.21981,0.24121,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0013481,0.21981,0.28212,1,1
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0012758,0.2197,0.27981,1,1
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.024086,0.21964,0.23094,1,1
2,GO CHONDROCYTE PROLIFERATION,0.041938,0.21914,0.24205,1,1
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0019699,0.21913,0.26524,1,1
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.00060992,0.21883,0.24386,1,1
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00060992,0.21859,0.24698,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0036751,0.21839,0.19271,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0040644,0.21837,0.26817,1,1
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0060238,0.21824,0.23178,1,1
2,GO FATTY ACID TRANSPORT,0.00020554,0.21727,0.26923,1,1
2,GO ESTROUS CYCLE,0.025096,0.21725,0.26396,1,1
2,GO ODONTOGENESIS,0.017954,0.21677,0.21828,1,1
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0019699,0.2159,0.27404,1,1
2,GO VIRAL GENOME REPLICATION,0.00068502,0.21557,0.28086,1,1
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.0066311,0.21512,0.22162,1,1
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.013834,0.21472,0.23757,1,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.015776,0.21466,0.22965,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.007293,0.21447,0.28898,1,1
2,GO SECRETION,0.00028019,0.21428,0.2516,1,1
2,GO DENDRITE SELF AVOIDANCE,0.040368,0.21397,0.20657,1,1
2,GO RESPONSE TO ALCOHOL,0.00060992,0.21379,0.23572,1,1
2,GO REGULATION OF EXCRETION,0.018736,0.2136,0.24001,1,1
2,GO MYELIN MAINTENANCE,0.0172,0.21344,0.25659,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00024771,0.21321,0.27279,1,1
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.046961,0.21291,0.27073,1,1
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.030713,0.21283,0.21966,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0034935,0.21277,0.30044,1,1
2,GO MAINTENANCE OF LOCATION IN CELL,0.00057531,0.21266,0.25011,1,1
2,GO SERTOLI CELL DEVELOPMENT,0.01266,0.21254,0.25736,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.00021879,0.21237,0.25672,1,1
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0019699,0.21225,0.28129,1,1
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0012758,0.21206,0.30156,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00028019,0.21179,0.27375,1,1
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.02951,0.21177,0.20143,1,1
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0010798,0.21117,0.26359,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.013834,0.21116,0.25281,1,1
2,GO VASODILATION,0.00076864,0.21094,0.26398,1,1
2,GO FIBROBLAST PROLIFERATION,0.0016767,0.21065,0.25136,1,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0076456,0.21055,0.2483,1,1
2,GO WATER HOMEOSTASIS,0.010572,0.21051,0.22456,1,1
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00024771,0.21042,0.24604,1,1
2,GO REGULATION OF MYELINATION,0.011574,0.21038,0.22742,1,1
2,GO VIRAL LIFE CYCLE,0.00028019,0.21019,0.26948,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00011593,0.21012,0.25935,1,1
2,GO ACTIVATION OF MAPK ACTIVITY,0.0012071,0.21003,0.2379,1,1
2,GO REGULATION OF GASTRULATION,0.0027019,0.20992,0.27625,1,1
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00064645,0.20991,0.20901,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0040644,0.20971,0.24822,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00057531,0.20926,0.25828,1,1
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.0040644,0.20916,0.26646,1,1
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.0010209,0.20898,0.24683,1,1
2,GO GENITALIA MORPHOGENESIS,0.025096,0.20898,0.26033,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.015104,0.20895,0.21155,1,1
2,GO ENDOTHELIUM DEVELOPMENT,0.0060238,0.20881,0.29579,1,1
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00086166,0.2087,0.28477,1,1
2,GO MESODERMAL CELL DIFFERENTIATION,0.0066311,0.20842,0.26943,1,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.0021907,0.20819,0.20188,1,1
2,GO INACTIVATION OF MAPK ACTIVITY,0.0027019,0.20787,0.26355,1,1
2,GO BIOLOGICAL ADHESION,0.0012071,0.20768,0.29605,1,1
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.0028457,0.20763,0.30202,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00042807,0.20753,0.23184,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0052065,0.20711,0.25338,1,1
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0024341,0.20703,0.24084,1,1
2,GO ESTROGEN METABOLIC PROCESS,0.00076864,0.20697,0.20845,1,1
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.007293,0.20679,0.28978,1,1
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0040644,0.20634,0.24472,1,1
2,GO HEART VALVE DEVELOPMENT,0.01266,0.20631,0.29142,1,1
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00068502,0.20623,0.29277,1,1
2,GO REGULATION OF TRANSPOSITION,0.01266,0.20539,0.19895,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.00015974,0.20496,0.24514,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00014062,0.2048,0.25646,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0083971,0.20428,0.22892,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.019548,0.20425,0.24478,1,1
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0038653,0.20422,0.23901,1,1
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00051151,0.20415,0.25888,1,1
2,GO MANGANESE ION TRANSPORT,0.0042727,0.2041,0.27104,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0027019,0.20407,0.29685,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.00051151,0.20353,0.2391,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.014457,0.20307,0.27101,1,1
2,GO LIPID CATABOLIC PROCESS,0.0003797,0.20297,0.22443,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00072571,0.20292,0.25764,1,1
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.0044907,0.20291,0.25838,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0042727,0.20279,0.27643,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00010866,0.20267,0.24561,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0044907,0.20257,0.2251,1,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0044907,0.20236,0.28228,1,1
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.0049572,0.20153,0.22259,1,1
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.013235,0.20139,0.20727,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,1.8524e-05,0.20138,0.24402,1,1
2,GO LIPID HOMEOSTASIS,0.0012758,0.20116,0.24253,1,1
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0021907,0.20115,0.21557,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0023095,0.20085,0.24423,1,1
2,GO COPPER ION HOMEOSTASIS,0.0012758,0.20074,0.21747,1,1
2,GO TUBE MORPHOGENESIS,0.00332,0.20048,0.2737,1,1
2,GO EPITHELIAL CELL PROLIFERATION,0.00072571,0.20004,0.26918,1,1
2,GO BONE MATURATION,0.0172,0.19917,0.25323,1,1
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0063209,0.19902,0.24776,1,1
2,GO TISSUE HOMEOSTASIS,0.00045436,0.19885,0.26605,1,1
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0063209,0.19881,0.24638,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0015882,0.19806,0.21597,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00015974,0.19796,0.23544,1,1
2,GO REGULATION OF NECROTIC CELL DEATH,0.00332,0.19786,0.23341,1,1
2,GO OSSIFICATION,0.0024341,0.1978,0.2434,1,1
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00072571,0.19768,0.27256,1,1
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00096503,0.19757,0.23392,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0044907,0.19754,0.22061,1,1
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.00048214,0.19705,0.22647,1,1
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0024341,0.19698,0.22112,1,1
2,GO PROTEIN MATURATION,0.00011593,0.19655,0.23557,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00051151,0.19609,0.22517,1,1
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0080134,0.19605,0.27775,1,1
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.0015041,0.19597,0.24128,1,1
2,GO CELL MOTILITY,0.00068502,0.19567,0.26325,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.010101,0.19556,0.25463,1,1
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0052065,0.19553,0.22507,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.010101,0.1955,0.23711,1,1
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0029965,0.19549,0.23798,1,1
2,GO PROTEIN DEMANNOSYLATION,0.025096,0.19538,0.23569,1,1
2,GO RENAL SYSTEM PROCESS,0.0036751,0.19528,0.25937,1,1
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.011574,0.19522,0.26364,1,1
2,GO RESPONSE TO GROWTH HORMONE,0.0042727,0.19445,0.22752,1,1
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00051151,0.1942,0.29975,1,1
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.00029789,0.19383,0.2492,1,1
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0016767,0.19375,0.24769,1,1
2,GO HYPOTONIC RESPONSE,0.022172,0.19367,0.21289,1,1
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.015104,0.19344,0.24378,1,1
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00024771,0.19332,0.25213,1,1
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.00054254,0.19329,0.22618,1,1
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0027019,0.19291,0.24092,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.019548,0.19283,0.16244,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.0172,0.19263,0.19493,1,1
2,GO REGULATION OF ENDOCRINE PROCESS,0.013834,0.19252,0.22633,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,8.9327e-05,0.19237,0.22947,1,1
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.026142,0.19232,0.26333,1,1
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00081392,0.19215,0.23821,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00054254,0.192,0.26761,1,1
2,GO DIGESTION,0.015776,0.19194,0.18198,1,1
2,GO SIALYLATION,0.040368,0.19194,0.23383,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.00072571,0.19138,0.22954,1,1
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00091199,0.19094,0.22859,1,1
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.010101,0.19046,0.24626,1,1
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.011063,0.19032,0.24668,1,1
2,GO HEART FORMATION,0.0083971,0.18983,0.2188,1,1
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.018736,0.18972,0.24343,1,1
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00057531,0.1897,0.22371,1,1
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0052065,0.18961,0.23011,1,1
2,GO PROTEIN KINASE A SIGNALING,0.028348,0.18959,0.16992,1,1
2,GO RIG I SIGNALING PATHWAY,0.010572,0.18948,0.20086,1,1
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00017019,0.18935,0.23343,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.018736,0.18862,0.20676,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0096484,0.18832,0.21527,1,1
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0021907,0.18821,0.25717,1,1
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00068502,0.18821,0.23849,1,1
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0040644,0.18789,0.17649,1,1
2,GO RENAL WATER HOMEOSTASIS,0.010101,0.18767,0.267,1,1
2,GO REGULATION OF PROTEOLYSIS,0.00031664,0.1872,0.22824,1,1
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0015882,0.18719,0.22503,1,1
2,GO ERBB SIGNALING PATHWAY,0.011063,0.18698,0.2123,1,1
2,GO REGULATION OF JUN KINASE ACTIVITY,0.008797,0.18639,0.23418,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.0031545,0.18635,0.1762,1,1
2,GO REGULATION OF PEPTIDE SECRETION,0.00072571,0.18614,0.23444,1,1
2,GO POSITIVE REGULATION OF SECRETION,0.00064645,0.18587,0.22439,1,1
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0040644,0.18584,0.25037,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,0.0052065,0.18554,0.17437,1,1
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.0010798,0.18547,0.23904,1,1
2,GO TRANSPOSITION,0.020391,0.18543,0.19315,1,1
2,GO VITAMIN TRANSPORT,0.00091199,0.18536,0.22791,1,1
2,GO MAINTENANCE OF LOCATION,0.00060992,0.18529,0.2371,1,1
2,GO BILE ACID METABOLIC PROCESS,0.0031545,0.18506,0.19446,1,1
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.0054671,0.18434,0.25183,1,1
2,GO PHAGOSOME MATURATION,0.0052065,0.1842,0.20654,1,1
2,GO NEGATIVE REGULATION OF SECRETION,0.0014241,0.18419,0.22178,1,1
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0040644,0.18415,0.21093,1,1
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.015104,0.18373,0.25909,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.00332,0.1837,0.21019,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.034576,0.18364,0.17592,1,1
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.018736,0.1836,0.19633,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0044907,0.18324,0.23741,1,1
2,GO ENDOCYTOSIS,0.0012071,0.18258,0.25519,1,1
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.020391,0.18256,0.17114,1,1
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0021907,0.18256,0.22646,1,1
2,GO OSTEOBLAST DIFFERENTIATION,0.0038653,0.18252,0.23131,1,1
2,GO SLEEP,0.006955,0.18247,0.19476,1,1
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0040644,0.18239,0.23064,1,1
2,GO REGULATION OF BLOOD PRESSURE,0.0015041,0.18186,0.24634,1,1
2,GO NEGATIVE REGULATION OF TRANSPORT,0.0017696,0.18179,0.19464,1,1
2,GO CELL VOLUME HOMEOSTASIS,0.011063,0.18147,0.24407,1,1
2,GO REGULATION OF RESPONSE TO STRESS,0.00060992,0.18088,0.23513,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.014457,0.18008,0.20156,1,1
2,GO CELL RECOGNITION,0.0024341,0.18006,0.21806,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.006955,0.18004,0.23454,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0066311,0.17956,0.24305,1,1
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0027019,0.1792,0.22986,1,1
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0052065,0.17913,0.23416,1,1
2,GO CHEMICAL HOMEOSTASIS,0.00051151,0.1788,0.22576,1,1
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.008797,0.17858,0.24006,1,1
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.0036751,0.17852,0.19795,1,1
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.040368,0.17821,0.16304,1,1
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00332,0.1782,0.22283,1,1
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0036751,0.17814,0.20918,1,1
2,GO CIRCULATORY SYSTEM PROCESS,0.0063209,0.1779,0.21106,1,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0018673,0.17783,0.21542,1,1
2,GO NEGATIVE REGULATION OF CELL DEATH,0.00091199,0.17752,0.20799,1,1
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.011063,0.17749,0.2003,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0017696,0.17719,0.21504,1,1
2,GO RESPONSE TO STEROID HORMONE,0.0031545,0.17703,0.21412,1,1
2,GO AMYLOID BETA FORMATION,0.0060238,0.17699,0.23371,1,1
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00096503,0.17698,0.22057,1,1
2,GO REGULATION OF HEAT GENERATION,0.020391,0.17625,0.24127,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0172,0.17596,0.24586,1,1
2,GO POSITIVE REGULATION OF NEURON DEATH,0.0060238,0.17582,0.21059,1,1
2,GO NEPHRON TUBULE FORMATION,0.019548,0.17553,0.20924,1,1
2,GO AMELOGENESIS,0.035953,0.17551,0.1881,1,1
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.0092139,0.17541,0.15312,1,1
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0040644,0.17517,0.30584,1,1
2,GO RESPONSE TO PH,0.014457,0.17489,0.21211,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.00057531,0.17456,0.21377,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.00057531,0.174,0.25664,1,1
2,GO BONE DEVELOPMENT,0.0092139,0.17326,0.25153,1,1
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0018673,0.17313,0.24267,1,1
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.020391,0.17293,0.16661,1,1
2,GO FAT CELL DIFFERENTIATION,0.0047188,0.17214,0.23275,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0034935,0.17208,0.17855,1,1
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0015882,0.17189,0.20686,1,1
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.050584,0.17187,0.2067,1,1
2,GO TUBE DEVELOPMENT,0.0060238,0.1718,0.24019,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.035953,0.17108,0.21811,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.0012071,0.17094,0.22345,1,1
2,GO BONE MORPHOGENESIS,0.0172,0.17051,0.24136,1,1
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.025096,0.17019,0.18918,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00048214,0.17006,0.23687,1,1
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0092139,0.16991,0.16194,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.00072571,0.1698,0.21726,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.020391,0.16909,0.24255,1,1
2,GO POSITIVE REGULATION OF TRANSPORT,0.0012758,0.16903,0.20859,1,1
2,GO POSITIVE REGULATION OF SIGNALING,0.0013481,0.169,0.21532,1,1
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0092139,0.16868,0.23192,1,1
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.006955,0.16839,0.21013,1,1
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.0063209,0.16823,0.29707,1,1
2,GO RESPONSE TO COPPER ION,0.038848,0.16798,0.17482,1,1
2,GO URONIC ACID METABOLIC PROCESS,0.0036751,0.16781,0.18305,1,1
2,GO LIVER REGENERATION,0.0012071,0.1676,0.22232,1,1
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0010798,0.16712,0.21404,1,1
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0038653,0.16711,0.21545,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0066311,0.1671,0.20421,1,1
2,GO ANIMAL ORGAN MATURATION,0.0172,0.16668,0.24611,1,1
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.045233,0.16665,0.22091,1,1
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.013834,0.16661,0.18991,1,1
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0066311,0.16654,0.30508,1,1
2,GO RUFFLE ASSEMBLY,0.00076864,0.16653,0.24396,1,1
2,GO FORMATION OF PRIMARY GERM LAYER,0.0038653,0.16613,0.27968,1,1
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.018736,0.16549,0.16685,1,1
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0083971,0.16537,0.22363,1,1
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0080134,0.16531,0.23232,1,1
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00332,0.16522,0.20814,1,1
2,GO JNK CASCADE,0.0054671,0.16384,0.2265,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0057394,0.16356,0.1891,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.022172,0.16351,0.19741,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0060238,0.16347,0.22261,1,1
2,GO ENDOCRINE HORMONE SECRETION,0.012106,0.16321,0.21921,1,1
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.020391,0.16316,0.21246,1,1
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0036751,0.16314,0.2318,1,1
2,GO PHAGOSOME ACIDIFICATION,0.024086,0.16293,0.13898,1,1
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.010101,0.16268,0.2034,1,1
2,GO REGULATION OF METAL ION TRANSPORT,0.0021907,0.16264,0.2029,1,1
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0027019,0.16259,0.21608,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0029965,0.16199,0.18365,1,1
2,GO POSITIVE REGULATION OF CELL DEATH,0.00076864,0.16188,0.22417,1,1
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.020391,0.16173,0.2015,1,1
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.00020554,0.16147,0.24296,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0052065,0.16144,0.19624,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0063209,0.1613,0.18514,1,1
2,GO REGULATION OF ORGAN GROWTH,0.011063,0.16126,0.19298,1,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0036751,0.16109,0.20626,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.030713,0.15995,0.16503,1,1
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.0015882,0.15983,0.20766,1,1
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0080134,0.15928,0.20488,1,1
2,GO REGULATION OF MUSCLE CONTRACTION,0.014457,0.15924,0.17877,1,1
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.0012071,0.15855,0.23109,1,1
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.010572,0.1585,0.1906,1,1
2,GO AMYLOID BETA METABOLIC PROCESS,0.0057394,0.1582,0.22034,1,1
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.018736,0.15799,0.23795,1,1
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.025096,0.15795,0.18198,1,1
2,GO PEPTIDE SECRETION,0.0027019,0.15792,0.21136,1,1
2,GO RESPONSE TO ESTRADIOL,0.0023095,0.15764,0.21479,1,1
2,GO ALCOHOL CATABOLIC PROCESS,0.01266,0.1575,0.1747,1,1
2,GO CALCIUM ION IMPORT,0.038848,0.15747,0.14941,1,1
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.035953,0.15694,0.15392,1,1
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.0036751,0.1568,0.20861,1,1
2,GO REGULATION OF PROTEIN IMPORT,0.007293,0.15646,0.17739,1,1
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.023112,0.15645,0.18293,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.040368,0.15642,0.15359,1,1
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0044907,0.15602,0.2144,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0054671,0.15563,0.20214,1,1
2,GO MUSCLE FILAMENT SLIDING,0.015104,0.15561,0.16145,1,1
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.0054671,0.15551,0.20515,1,1
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.030713,0.15505,0.1468,1,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0040644,0.15427,0.18954,1,1
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.024086,0.15407,0.1828,1,1
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0054671,0.15406,0.19999,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.0025648,0.15371,0.20576,1,1
2,GO RESPONSE TO CALCIUM ION,0.010101,0.15352,0.17439,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.013235,0.15305,0.20092,1,1
2,GO HORMONE METABOLIC PROCESS,0.0024341,0.15264,0.20653,1,1
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0066311,0.15249,0.2035,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.024086,0.15247,0.18828,1,1
2,GO RESPONSE TO CADMIUM ION,0.018736,0.15226,0.16963,1,1
2,GO LUNG EPITHELIUM DEVELOPMENT,0.025096,0.15198,0.2095,1,1
2,GO ORGANIC CATION TRANSPORT,0.043559,0.15155,0.17781,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0018673,0.15131,0.21417,1,1
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015041,0.15106,0.15087,1,1
2,GO PLACENTA DEVELOPMENT,0.0096484,0.15013,0.1996,1,1
2,GO ETHER METABOLIC PROCESS,0.008797,0.15007,0.17366,1,1
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.011574,0.14965,0.15331,1,1
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0027019,0.14935,0.19407,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.026142,0.14929,0.1578,1,1
2,GO REGULATION OF CELL DEATH,0.0012071,0.14922,0.20227,1,1
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0027019,0.14774,0.18168,1,1
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00096503,0.14744,0.22232,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0016767,0.1472,0.21154,1,1
2,GO HEME METABOLIC PROCESS,0.0040644,0.14683,0.16095,1,1
2,GO REGULATION OF HEART MORPHOGENESIS,0.046961,0.14612,0.19331,1,1
2,GO OVULATION CYCLE,0.034576,0.14611,0.19481,1,1
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0025648,0.14607,0.19445,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0042727,0.14603,0.18981,1,1
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.018736,0.14492,0.17324,1,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.0003797,0.14473,0.19858,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0013481,0.14465,0.1978,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.007293,0.14404,0.18233,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0028457,0.14363,0.18947,1,1
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.038848,0.14326,0.16985,1,1
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0049572,0.14318,0.19576,1,1
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.015104,0.14288,0.18436,1,1
2,GO RESPONSE TO ZINC ION,0.019548,0.14262,0.17808,1,1
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.006955,0.14215,0.18386,1,1
2,GO IRON ION TRANSPORT,0.0011418,0.14152,0.20547,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.019548,0.14151,0.13101,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0054671,0.14149,0.17694,1,1
2,GO REGULATION OF SENSORY PERCEPTION,0.038848,0.14133,0.15807,1,1
2,GO REGULATION OF HEART GROWTH,0.01266,0.14125,0.18732,1,1
2,GO GLYCOSIDE METABOLIC PROCESS,0.0020776,0.14098,0.17925,1,1
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0080134,0.14091,0.19627,1,1
2,GO BODY FLUID SECRETION,0.013235,0.14088,0.17153,1,1
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.007293,0.14085,0.18242,1,1
2,GO REGULATION OF HYDROLASE ACTIVITY,0.0024341,0.1406,0.2057,1,1
2,GO RESPONSE TO HORMONE,0.0042727,0.14028,0.19063,1,1
2,GO REGENERATION,0.0021907,0.14019,0.20708,1,1
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.035953,0.14014,0.14546,1,1
2,GO ER NUCLEUS SIGNALING PATHWAY,0.017954,0.13946,0.16413,1,1
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0080134,0.1394,0.17614,1,1
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.026142,0.13927,0.16622,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.030713,0.13856,0.14125,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0080134,0.13838,0.17621,1,1
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.010572,0.13826,0.16845,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0040644,0.13824,0.18832,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.016475,0.13817,0.26864,1,1
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.031957,0.13796,0.15855,1,1
2,GO CARBOHYDRATE TRANSPORT,0.0172,0.13672,0.16614,1,1
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.0036751,0.136,0.17352,1,1
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.022172,0.13562,0.25473,1,1
2,GO GASTRULATION,0.015776,0.1355,0.21485,1,1
2,GO TEMPERATURE HOMEOSTASIS,0.013235,0.1338,0.17349,1,1
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0044907,0.13281,0.17836,1,1
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.02951,0.13267,0.15047,1,1
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.027226,0.13163,0.14098,1,1
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.014457,0.13115,0.20231,1,1
2,GO REGULATION OF PROTEIN BINDING,0.023112,0.13108,0.17613,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0011418,0.131,0.1853,1,1
2,GO MUSCLE SYSTEM PROCESS,0.02951,0.13054,0.16694,1,1
2,GO ACTIN MEDIATED CELL CONTRACTION,0.048745,0.1303,0.15125,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.052482,0.13023,0.15939,1,1
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.015776,0.13011,0.17649,1,1
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.008797,0.12971,0.20316,1,1
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0042727,0.12951,0.18908,1,1
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0023095,0.12932,0.19143,1,1
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.015104,0.12913,0.17067,1,1
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.008797,0.12902,0.19233,1,1
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0049572,0.12891,0.20656,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.0063209,0.12859,0.16426,1,1
2,GO TRANSITION METAL ION TRANSPORT,0.0021907,0.12829,0.17683,1,1
2,GO MUSCLE CONTRACTION,0.052482,0.12827,0.15495,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0038653,0.12808,0.19979,1,1
2,GO CELLULAR HOMEOSTASIS,0.00091199,0.1277,0.20095,1,1
2,GO ANATOMICAL STRUCTURE MATURATION,0.037377,0.12567,0.15397,1,1
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00048214,0.12504,0.18533,1,1
2,GO REGULATION OF PHOSPHORYLATION,0.0060238,0.12464,0.18601,1,1
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0044907,0.12457,0.20168,1,1
2,GO NEGATIVE REGULATION OF SIGNALING,0.011574,0.12439,0.17009,1,1
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.024086,0.12388,0.13869,1,1
2,GO SYMBIOTIC PROCESS,0.0023095,0.12376,0.15886,1,1
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.023112,0.12314,0.2144,1,1
2,GO RESPONSE TO ETHANOL,0.0015041,0.12262,0.1874,1,1
2,GO HOMEOSTATIC PROCESS,0.0034935,0.12261,0.18668,1,1
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.013235,0.12237,0.1576,1,1
2,GO RESPONSE TO PEPTIDE,0.0083971,0.12209,0.17744,1,1
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0076456,0.12047,0.17734,1,1
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.025096,0.12044,0.1929,1,1
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0083971,0.11978,0.17768,1,1
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.021265,0.11977,0.15769,1,1
2,GO REGULATION OF ION TRANSPORT,0.033245,0.11771,0.1418,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0019699,0.11679,0.1592,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION,0.023112,0.11622,0.17274,1,1
2,GO CELLULAR RESPONSE TO PEPTIDE,0.011574,0.11622,0.17508,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.041938,0.11562,0.10415,1,1
2,GO CALCINEURIN MEDIATED SIGNALING,0.030713,0.11499,0.16129,1,1
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.025096,0.11489,0.16249,1,1
2,GO SMOOTH MUSCLE CONTRACTION,0.02951,0.11379,0.19341,1,1
2,GO AMINE METABOLIC PROCESS,0.0066311,0.11351,0.14104,1,1
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.046961,0.11319,0.13805,1,1
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.034576,0.11157,0.1643,1,1
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.011574,0.11156,0.15559,1,1
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.031957,0.11065,0.13104,1,1
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.040368,0.10984,0.12676,1,1
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0172,0.10978,0.15687,1,1
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.015104,0.10944,0.15865,1,1
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.013235,0.10926,0.17471,1,1
2,GO NEURON DEATH,0.054439,0.10918,0.14282,1,1
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0025648,0.10876,0.17909,1,1
2,GO REGULATION OF PEPTIDE TRANSPORT,0.01266,0.10859,0.16764,1,1
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.034576,0.10719,0.14705,1,1
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0044907,0.1071,0.15566,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.016475,0.10679,0.14092,1,1
2,GO RNA DECAPPING,0.050584,0.10665,0.16739,1,1
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.028348,0.10622,0.16239,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.0023095,0.10528,0.18138,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0076456,0.1052,0.18373,1,1
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0028457,0.10511,0.15614,1,1
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.038848,0.10509,0.15491,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0063209,0.10473,0.18968,1,1
2,GO PROTEIN HOMOTETRAMERIZATION,0.031957,0.10201,0.13599,1,1
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.021265,0.10184,0.16397,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.006955,0.10161,0.15228,1,1
2,GO CARDIOCYTE DIFFERENTIATION,0.027226,0.098261,0.17357,1,1
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.0080134,0.097133,0.18331,1,1
2,GO KETONE BIOSYNTHETIC PROCESS,0.020391,0.095709,0.15324,1,1
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.033245,0.093158,0.17147,1,1
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.040368,0.093072,0.12945,1,1
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.043559,0.092476,0.095079,1,1
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.033245,0.090535,0.15332,1,1
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.025096,0.090239,0.16973,1,1
2,GO PROTEIN DESTABILIZATION,0.019548,0.080523,0.16204,1,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.026142,0.078228,0.11872,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.054439,0.076876,0.12698,1,1
2,GO REGULATION OF ERAD PATHWAY,0.040368,0.067204,0.15846,1,1
2,GO T CELL CHEMOTAXIS,0.00040321,0.81635,0.70256,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0015041,0.71709,0.67616,1,0
2,GO AMINO SUGAR CATABOLIC PROCESS,5.2428e-05,0.67959,0.69175,1,0
2,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.0015041,0.67482,0.61623,1,0
2,GO ALPHA BETA T CELL PROLIFERATION,0.00018128,0.63107,0.64442,1,0
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00021879,0.58444,0.58714,1,0
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00045436,0.5815,0.63526,1,0
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.00064645,0.56821,0.57169,1,0
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00048214,0.55093,0.56515,1,0
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00048214,0.54579,0.60827,1,0
2,GO REGULATORY T CELL DIFFERENTIATION,0.0013481,0.5377,0.49782,1,0
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.00011593,0.53236,0.51618,1,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00018128,0.53167,0.5305,1,0
2,GO NEUTROPHIL EXTRAVASATION,0.00048214,0.51375,0.5102,1,0
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00033648,0.50542,0.46849,1,0
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00026348,0.50331,0.4733,1,0
2,GO REGULATION OF T CELL DIFFERENTIATION,0.00024771,0.49866,0.4895,1,0
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00014062,0.49214,0.5767,1,0
2,GO CYTIDINE TO URIDINE EDITING,0.0010798,0.47328,0.44736,1,0
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00024771,0.45139,0.50024,1,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00068502,0.43412,0.43625,1,0
2,GO INTERFERON ALPHA PRODUCTION,0.00035748,0.43198,0.46023,1,0
2,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00045436,0.43192,0.42443,1,0
2,GO MACROPHAGE APOPTOTIC PROCESS,0.00076864,0.42023,0.43486,1,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0013481,0.41082,0.3842,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00031664,0.40589,0.45966,1,0
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.0011418,0.38828,0.46904,1,0
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0020776,0.37832,0.46616,1,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0015882,0.37569,0.38605,1,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.00054254,0.36279,0.44718,1,0
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00086166,0.3625,0.39215,1,0
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0060238,0.3569,0.34121,1,0
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00057531,0.35586,0.37959,1,0
2,GO PODOSOME ASSEMBLY,0.0013481,0.35533,0.36068,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00076864,0.35048,0.33578,1,0
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.0092139,0.34672,0.37104,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.00031664,0.34459,0.34819,1,0
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0047188,0.34359,0.43327,1,0
2,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0003797,0.34242,0.35861,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0042727,0.34233,0.35439,1,0
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.007293,0.34173,0.35076,1,0
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.0083971,0.3393,0.3701,1,0
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.0012071,0.33904,0.35658,1,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00042807,0.33737,0.39343,1,0
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0011418,0.33607,0.41147,1,0
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00332,0.33567,0.30343,1,0
2,GO REGULATION OF PODOSOME ASSEMBLY,0.0028457,0.33322,0.33744,1,0
2,GO AMINE CATABOLIC PROCESS,0.0015882,0.33042,0.31677,1,0
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.020391,0.32141,0.42903,1,0
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00057531,0.32134,0.36254,1,0
2,GO DNA DEAMINATION,0.0021907,0.3193,0.31348,1,0
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00048214,0.31928,0.33438,1,0
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.0019699,0.31536,0.41631,1,0
2,GO T CELL HOMEOSTASIS,0.00026348,0.31517,0.35841,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00057531,0.31462,0.3269,1,0
2,GO URETER DEVELOPMENT,0.0080134,0.31183,0.28774,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0012071,0.3086,0.36042,1,0
2,GO RESPONSE TO INTERLEUKIN 4,0.00048214,0.30783,0.36274,1,0
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.037377,0.30293,0.33752,1,0
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0083971,0.29961,0.3388,1,0
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.02951,0.29885,0.35132,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00091199,0.29552,0.2937,1,0
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.0012758,0.29538,0.29224,1,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0021907,0.29261,0.32836,1,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.00033648,0.29109,0.34467,1,0
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00081392,0.29054,0.27777,1,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.020391,0.28754,0.25599,1,0
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0047188,0.28722,0.30466,1,0
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0054671,0.28596,0.29943,1,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00045436,0.2859,0.26504,1,0
2,GO SKIN MORPHOGENESIS,0.014457,0.28555,0.3365,1,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0014241,0.28508,0.30382,1,0
2,GO ACTIN FILAMENT SEVERING,0.0044907,0.28419,0.32201,1,0
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0040644,0.28033,0.34637,1,0
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.0040644,0.27908,0.28559,1,0
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.00054254,0.27729,0.30738,1,0
2,GO PSEUDOPODIUM ORGANIZATION,0.0023095,0.27567,0.33083,1,0
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0003797,0.27567,0.3677,1,0
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.0029965,0.27029,0.24434,1,0
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0080134,0.2698,0.34813,1,0
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.031957,0.26955,0.28313,1,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.0040644,0.26742,0.32051,1,0
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.00068502,0.26608,0.35287,1,0
2,GO RESPONSE TO INTERLEUKIN 7,0.00054254,0.26478,0.35447,1,0
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00076864,0.2645,0.34768,1,0
2,GO REGULATION OF HEMOPOIESIS,0.00028019,0.26362,0.32289,1,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.0024341,0.26289,0.30537,1,0
2,GO PHOSPHATE ION TRANSPORT,0.00031664,0.2561,0.33613,1,0
2,GO BONE TRABECULA MORPHOGENESIS,0.021265,0.25492,0.36019,1,0
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.00086166,0.25448,0.31518,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0012758,0.25218,0.3226,1,0
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.010101,0.25135,0.28324,1,0
2,GO CELLULAR RESPONSE TO X RAY,0.0060238,0.24891,0.26545,1,0
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.024086,0.24792,0.3506,1,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.010572,0.24679,0.35975,1,0
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.010101,0.24648,0.3058,1,0
2,GO B CELL APOPTOTIC PROCESS,0.0015882,0.2458,0.26626,1,0
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0076456,0.24515,0.27024,1,0
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.018736,0.2449,0.27842,1,0
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.0011418,0.24439,0.30261,1,0
2,GO PROSTATE GLAND DEVELOPMENT,0.0052065,0.24065,0.25833,1,0
2,GO LEYDIG CELL DIFFERENTIATION,0.045233,0.24048,0.25395,1,0
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00017019,0.23984,0.34808,1,0
2,GO RESPONSE TO MAGNESIUM ION,0.035953,0.23839,0.23771,1,0
2,GO CELL MATRIX ADHESION,0.0028457,0.238,0.33003,1,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.043559,0.23746,0.2317,1,0
2,GO STEM CELL DIVISION,0.041938,0.23719,0.22976,1,0
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00035748,0.23635,0.2602,1,0
2,GO RESPONSE TO ISCHEMIA,0.0021907,0.23601,0.27054,1,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0024341,0.23517,0.29252,1,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.020391,0.23476,0.21004,1,0
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0042727,0.23333,0.2541,1,0
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.0038653,0.23288,0.24562,1,0
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0023095,0.23191,0.31375,1,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.052482,0.23042,0.1855,1,0
2,GO INTESTINAL ABSORPTION,0.02951,0.22993,0.23956,1,0
2,GO MYOBLAST DIFFERENTIATION,0.0010798,0.22522,0.27247,1,0
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0076456,0.22489,0.29475,1,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0092139,0.22439,0.28056,1,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.0028457,0.22412,0.30174,1,0
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0015041,0.22378,0.29009,1,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.00045436,0.22303,0.27666,1,0
2,GO HEART FIELD SPECIFICATION,0.013235,0.22294,0.24559,1,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.00086166,0.22234,0.25698,1,0
2,GO PANCREATIC JUICE SECRETION,0.023112,0.21954,0.21918,1,0
2,GO ETHER BIOSYNTHETIC PROCESS,0.010572,0.21873,0.24203,1,0
2,GO FC RECEPTOR SIGNALING PATHWAY,0.00081392,0.21771,0.26083,1,0
2,GO BILE ACID AND BILE SALT TRANSPORT,0.010572,0.21587,0.24766,1,0
2,GO DRUG CATABOLIC PROCESS,0.00332,0.21574,0.22387,1,0
2,GO GENITALIA DEVELOPMENT,0.014457,0.21549,0.20514,1,0
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.012106,0.21155,0.25005,1,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.0066311,0.21056,0.24068,1,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.0066311,0.21047,0.29078,1,0
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.033245,0.21007,0.20674,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.020391,0.20959,0.23228,1,0
2,GO RESPONSE TO VITAMIN,0.0019699,0.20924,0.26463,1,0
2,GO CELL CELL RECOGNITION,0.0013481,0.20916,0.2241,1,0
2,GO GLOMERULUS DEVELOPMENT,0.023112,0.20831,0.29657,1,0
2,GO RESPONSE TO IRON ION,0.046961,0.20647,0.16963,1,0
2,GO EPIBOLY,0.008797,0.20478,0.26833,1,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.01266,0.20445,0.32794,1,0
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.031957,0.20394,0.24047,1,0
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.022172,0.20337,0.26807,1,0
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.027226,0.20275,0.26174,1,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.010572,0.20255,0.2179,1,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.011574,0.20179,0.24654,1,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.028348,0.2014,0.17219,1,0
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.018736,0.20028,0.27834,1,0
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.026142,0.19998,0.23323,1,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0063209,0.19933,0.2408,1,0
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.014457,0.19912,0.22102,1,0
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.019548,0.19861,0.19945,1,0
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0010798,0.19847,0.2321,1,0
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.030713,0.1983,0.28043,1,0
2,GO ENDODERM FORMATION,0.0028457,0.19761,0.368,1,0
2,GO RESPONSE TO MECHANICAL STIMULUS,0.0012071,0.19638,0.25798,1,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.037377,0.19567,0.25776,1,0
2,GO BARBED END ACTIN FILAMENT CAPPING,0.007293,0.19536,0.24435,1,0
2,GO TROPHOBLAST CELL MIGRATION,0.040368,0.19431,0.20842,1,0
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.040368,0.19329,0.2275,1,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.011063,0.19272,0.24654,1,0
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0172,0.19149,0.22532,1,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.022172,0.19138,0.2627,1,0
2,GO FACE DEVELOPMENT,0.010101,0.19076,0.25542,1,0
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.017954,0.19056,0.26316,1,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.040368,0.18903,0.19699,1,0
2,GO PERICARDIUM DEVELOPMENT,0.018736,0.18871,0.26456,1,0
2,GO MUSCLE CELL MIGRATION,0.0083971,0.18801,0.2515,1,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.008797,0.18775,0.27827,1,0
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.01266,0.18727,0.20022,1,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0060238,0.18712,0.22098,1,0
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.0015882,0.18651,0.21584,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00332,0.18592,0.25525,1,0
2,GO BEHAVIORAL RESPONSE TO PAIN,0.046961,0.18574,0.19735,1,0
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.013235,0.18532,0.21806,1,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.012106,0.18528,0.23103,1,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0063209,0.18473,0.18344,1,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.012106,0.18461,0.2486,1,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.023112,0.18453,0.30593,1,0
2,GO LIPID LOCALIZATION,0.0017696,0.18212,0.23583,1,0
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.046961,0.18193,0.23827,1,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.010101,0.18167,0.22334,1,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.019548,0.18155,0.2962,1,0
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0063209,0.18146,0.24242,1,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.019548,0.1801,0.20547,1,0
2,GO MUSCLE CELL FATE COMMITMENT,0.0076456,0.17956,0.30302,1,0
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0047188,0.17942,0.23319,1,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.046961,0.17938,0.2133,1,0
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.020391,0.17794,0.20448,1,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0028457,0.17769,0.23577,1,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.018736,0.1763,0.27845,1,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0076456,0.17597,0.23674,1,0
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.021265,0.17583,0.19825,1,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.0031545,0.17501,0.22641,1,0
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.045233,0.17491,0.20016,1,0
2,GO PHOSPHOLIPID TRANSPORT,0.015104,0.17411,0.20223,1,0
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0031545,0.17125,0.18823,1,0
2,GO METANEPHROS DEVELOPMENT,0.014457,0.17069,0.22048,1,0
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.034576,0.16974,0.2085,1,0
2,GO KERATINOCYTE DIFFERENTIATION,0.015104,0.16859,0.21448,1,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.022172,0.16817,0.24179,1,0
2,GO AXIS ELONGATION,0.015776,0.16775,0.227,1,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.020391,0.16773,0.24567,1,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.023112,0.16636,0.25477,1,0
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0057394,0.16624,0.20724,1,0
2,GO CGMP MEDIATED SIGNALING,0.030713,0.16592,0.19708,1,0
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.040368,0.16543,0.19321,1,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0172,0.16508,0.20439,1,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.011063,0.16459,0.17094,1,0
2,GO ARTERY MORPHOGENESIS,0.034576,0.16421,0.24061,1,0
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.025096,0.16382,0.21551,1,0
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0066311,0.16346,0.19988,1,0
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0060238,0.16324,0.22214,1,0
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.0018673,0.16309,0.21216,1,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.019548,0.16278,0.21618,1,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.014457,0.16228,0.22923,1,0
2,GO ENDODERM DEVELOPMENT,0.015104,0.1615,0.2696,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.020391,0.16099,0.22442,1,0
2,GO LYTIC VACUOLE ORGANIZATION,0.0027019,0.16079,0.21272,1,0
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00068502,0.16067,0.23415,1,0
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.028348,0.15993,0.24848,1,0
2,GO CERAMIDE TRANSPORT,0.019548,0.15959,0.23607,1,0
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.030713,0.15733,0.20852,1,0
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.0052065,0.15634,0.1808,1,0
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0025648,0.15605,0.25647,1,0
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.043559,0.15573,0.18216,1,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.046961,0.15563,0.20385,1,0
2,GO RESPONSE TO LITHIUM ION,0.010572,0.15547,0.22923,1,0
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.017954,0.15535,0.27258,1,0
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.041938,0.15429,0.22617,1,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.037377,0.15428,0.21175,1,0
2,GO MESENCHYME DEVELOPMENT,0.022172,0.15427,0.19791,1,0
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.0066311,0.15388,0.18173,1,0
2,GO VITAMIN METABOLIC PROCESS,0.0012071,0.15292,0.1901,1,0
2,GO CELLULAR RESPONSE TO KETONE,0.0060238,0.15227,0.19315,1,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0092139,0.15206,0.2039,1,0
2,GO RECEPTOR RECYCLING,0.037377,0.15188,0.17091,1,0
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0096484,0.15121,0.19829,1,0
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.012106,0.15098,0.21004,1,0
2,GO ACTIVATION OF MAPKK ACTIVITY,0.050584,0.14988,0.1905,1,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.045233,0.14915,0.14538,1,0
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.015776,0.14906,0.23882,1,0
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.025096,0.1488,0.20633,1,0
2,GO MYELOID CELL HOMEOSTASIS,0.0029965,0.14877,0.20581,1,0
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.02951,0.14855,0.17023,1,0
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.018736,0.14826,0.20208,1,0
2,GO CELLULAR RESPONSE TO FATTY ACID,0.0083971,0.14759,0.22024,1,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.025096,0.14744,0.20467,1,0
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.037377,0.14704,0.14678,1,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.028348,0.14675,0.15915,1,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.014457,0.14622,0.19576,1,0
2,GO MIDGUT DEVELOPMENT,0.054439,0.14619,0.22844,1,0
2,GO STEROL METABOLIC PROCESS,0.007293,0.14613,0.18118,1,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.040368,0.14608,0.19835,1,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.008797,0.14597,0.19482,1,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.023112,0.14593,0.18335,1,0
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.017954,0.14579,0.23371,1,0
2,GO PROGESTERONE METABOLIC PROCESS,0.048745,0.14573,0.20744,1,0
2,GO LINOLEIC ACID METABOLIC PROCESS,0.021265,0.14542,0.175,1,0
2,GO CELLULAR RESPONSE TO ALCOHOL,0.015104,0.14534,0.21625,1,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.020391,0.14399,0.17982,1,0
2,GO RECEPTOR CATABOLIC PROCESS,0.038848,0.14398,0.17728,1,0
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0042727,0.14355,0.19803,1,0
2,GO PARTURITION,0.02951,0.14263,0.21012,1,0
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.01266,0.14212,0.16573,1,0
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.02951,0.14169,0.33185,1,0
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.01266,0.14143,0.28763,1,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.028348,0.14096,0.17837,1,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.043559,0.14047,0.16407,1,0
2,GO INTERMEMBRANE LIPID TRANSFER,0.015776,0.13952,0.20532,1,0
2,GO DEVELOPMENTAL INDUCTION,0.054439,0.1395,0.15396,1,0
2,GO MESODERMAL CELL FATE COMMITMENT,0.033245,0.13781,0.13217,1,0
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.035953,0.13771,0.18905,1,0
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.007293,0.13727,0.16764,1,0
2,GO SKIN DEVELOPMENT,0.035953,0.13725,0.17588,1,0
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0024341,0.13692,0.1932,1,0
2,GO ADAPTIVE THERMOGENESIS,0.030713,0.13641,0.16501,1,0
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.048745,0.13634,0.18697,1,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.013834,0.13582,0.18435,1,0
2,GO APOPTOTIC SIGNALING PATHWAY,0.0014241,0.1357,0.18869,1,0
2,GO MUSCLE ADAPTATION,0.015104,0.13564,0.1991,1,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.015104,0.13535,0.19395,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.017954,0.13524,0.17581,1,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.024086,0.13515,0.17275,1,0
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0092139,0.13474,0.20872,1,0
2,GO GLIAL CELL DEVELOPMENT,0.033245,0.13444,0.17382,1,0
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.041938,0.1343,0.20751,1,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.027226,0.1342,0.15164,1,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.045233,0.13386,0.19288,1,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.014457,0.13384,0.1969,1,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.027226,0.13381,0.2228,1,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.013235,0.13358,0.17652,1,0
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.010572,0.13349,0.16757,1,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.025096,0.13293,0.22903,1,0
2,GO RESPONSE TO GAMMA RADIATION,0.0080134,0.1329,0.17604,1,0
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.016475,0.13287,0.19578,1,0
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.018736,0.13268,0.18587,1,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.023112,0.13231,0.22269,1,0
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0076456,0.13225,0.17623,1,0
2,GO REGULATION OF CELLULAR PH,0.021265,0.13203,0.14602,1,0
2,GO LAMELLIPODIUM ORGANIZATION,0.021265,0.13163,0.18585,1,0
2,GO RESPONSE TO METAL ION,0.006955,0.13159,0.16852,1,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.026142,0.13091,0.15034,1,0
2,GO REGULATION OF PH,0.0172,0.13019,0.14741,1,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.033245,0.12971,0.17875,1,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.026142,0.12904,0.19665,1,0
2,GO ANION HOMEOSTASIS,0.018736,0.12872,0.19213,1,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0052065,0.12863,0.21674,1,0
2,GO MUSCLE ORGAN MORPHOGENESIS,0.052482,0.12829,0.16399,1,0
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0052065,0.12708,0.15122,1,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.010101,0.12651,0.23994,1,0
2,GO STEROID METABOLIC PROCESS,0.00332,0.12548,0.17562,1,0
2,GO ERYTHROCYTE HOMEOSTASIS,0.022172,0.12512,0.16686,1,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.026142,0.12491,0.17216,1,0
2,GO FOLIC ACID METABOLIC PROCESS,0.0172,0.12441,0.15257,1,0
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.023112,0.12423,0.14478,1,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.040368,0.12412,0.14668,1,0
2,GO STEM CELL DIFFERENTIATION,0.023112,0.12388,0.14788,1,0
2,GO REGULATION OF GTPASE ACTIVITY,0.028348,0.12388,0.19161,1,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.02951,0.1232,0.17332,1,0
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.019548,0.12253,0.17917,1,0
2,GO PLATELET MORPHOGENESIS,0.052482,0.1222,0.20169,1,0
2,GO ACTIN FILAMENT ORGANIZATION,0.020391,0.12154,0.19258,1,0
2,GO NADP METABOLIC PROCESS,0.0092139,0.12099,0.16245,1,0
2,GO ERBB2 SIGNALING PATHWAY,0.038848,0.12094,0.16718,1,0
2,GO ALCOHOL METABOLIC PROCESS,0.0049572,0.12048,0.18352,1,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.011574,0.12037,0.15744,1,0
2,GO RESPONSE TO GROWTH FACTOR,0.028348,0.12028,0.18414,1,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.041938,0.12013,0.19014,1,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.052482,0.11996,0.14784,1,0
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.030713,0.11995,0.16094,1,0
2,GO REGULATION OF MUSCLE ADAPTATION,0.015104,0.11946,0.1899,1,0
2,GO REGULATION OF SECRETION,0.012106,0.11816,0.17113,1,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.021265,0.11809,0.15908,1,0
2,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.030713,0.11779,0.15733,1,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.014457,0.11778,0.15722,1,0
2,GO GLYCEROLIPID METABOLIC PROCESS,0.019548,0.11777,0.14929,1,0
2,GO APOPTOTIC PROCESS,0.00332,0.11764,0.18223,1,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0066311,0.11741,0.24334,1,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.022172,0.11695,0.19109,1,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.025096,0.11685,0.15695,1,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.015776,0.11659,0.16519,1,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.027226,0.11653,0.20142,1,0
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.018736,0.11559,0.16665,1,0
2,GO NEGATIVE REGULATION OF GROWTH,0.013834,0.11542,0.1774,1,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.050584,0.11529,0.2168,1,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.015776,0.11382,0.17463,1,0
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0017696,0.11317,0.17285,1,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.054439,0.113,0.16719,1,0
2,GO HEART GROWTH,0.052482,0.1129,0.16564,1,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.013235,0.11256,0.17989,1,0
2,GO EPIDERMAL CELL DIFFERENTIATION,0.033245,0.11156,0.16461,1,0
2,GO HEART MORPHOGENESIS,0.048745,0.11093,0.18736,1,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.033245,0.11087,0.1606,1,0
2,GO MUSCLE CELL DIFFERENTIATION,0.034576,0.1105,0.15716,1,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.054439,0.11045,0.16217,1,0
2,GO CELLULAR LIPID METABOLIC PROCESS,0.007293,0.11001,0.16711,1,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.017954,0.10953,0.17173,1,0
2,GO VESICLE BUDDING FROM MEMBRANE,0.024086,0.10952,0.14805,1,0
2,GO CELL FATE DETERMINATION,0.052482,0.10855,0.17586,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.012106,0.1084,0.15927,1,0
2,GO REGULATION OF ENDOCYTOSIS,0.013235,0.108,0.18403,1,0
2,GO PH REDUCTION,0.048745,0.10737,0.11456,1,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.052482,0.10735,0.19956,1,0
2,GO UV PROTECTION,0.037377,0.10713,0.20234,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.024086,0.10702,0.17161,1,0
2,GO ACTIN FILAMENT BASED PROCESS,0.040368,0.10685,0.17683,1,0
2,GO GLIOGENESIS,0.041938,0.10646,0.15819,1,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.033245,0.10568,0.15869,1,0
2,GO RESPONSE TO STEROL,0.027226,0.10564,0.22248,1,0
2,GO RESPONSE TO COLD,0.021265,0.10546,0.17633,1,0
2,GO RECEPTOR METABOLIC PROCESS,0.023112,0.1054,0.162,1,0
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.018736,0.10517,0.15748,1,0
2,GO LIPID METABOLIC PROCESS,0.0049572,0.10498,0.17005,1,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.017954,0.10473,0.22447,1,0
2,GO ORGAN GROWTH,0.020391,0.10473,0.18311,1,0
2,GO AUTOPHAGOSOME MATURATION,0.024086,0.10469,0.17657,1,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.037377,0.10456,0.20449,1,0
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.012106,0.10452,0.17199,1,0
2,GO HEMOGLOBIN METABOLIC PROCESS,0.040368,0.10418,0.16042,1,0
2,GO OLFACTORY LOBE DEVELOPMENT,0.054439,0.10401,0.18132,1,0
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.037377,0.10365,0.1461,1,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.054439,0.10338,0.18583,1,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.043559,0.10288,0.14244,1,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.045233,0.10191,0.16637,1,0
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.023112,0.10154,0.16178,1,0
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.020391,0.10148,0.16921,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.014457,0.10006,0.1425,1,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.043559,0.098427,0.14008,1,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.052482,0.097652,0.16146,1,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.02951,0.097127,0.16537,1,0
2,GO NEGATIVE REGULATION OF BINDING,0.054439,0.097012,0.14959,1,0
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.021265,0.095471,0.13212,1,0
2,GO REGULATION OF TRANSPORT,0.02951,0.094974,0.14779,1,0
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.046961,0.094876,0.18971,1,0
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.045233,0.094732,0.18295,1,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.035953,0.094259,0.14382,1,0
2,GO PROTEOLYSIS,0.015104,0.093251,0.1536,1,0
2,GO EPIDERMIS DEVELOPMENT,0.038848,0.093121,0.16408,1,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.046961,0.093006,0.16453,1,0
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.046961,0.092696,0.12129,1,0
2,GO LIPID BIOSYNTHETIC PROCESS,0.022172,0.091983,0.14054,1,0
2,GO RESPONSE TO DRUG,0.010572,0.091693,0.16957,1,0
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.046961,0.091535,0.14254,1,0
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.045233,0.090589,0.1343,1,0
2,GO CELLULAR PIGMENTATION,0.050584,0.089715,0.12695,1,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.010101,0.089334,0.1443,1,0
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.052482,0.08901,0.11368,1,0
2,GO REGULATION OF GLIOGENESIS,0.045233,0.088503,0.16245,1,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.035953,0.088179,0.15418,1,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.054439,0.087913,0.18313,1,0
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0172,0.087785,0.16103,1,0
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.030713,0.087648,0.15795,1,0
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.016475,0.087241,0.12005,1,0
2,GO STEROID BIOSYNTHETIC PROCESS,0.020391,0.087045,0.12553,1,0
2,GO RESPONSE TO OXYGEN LEVELS,0.012106,0.086098,0.15787,1,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.035953,0.085324,0.15113,1,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.031957,0.085009,0.15893,1,0
2,GO ORGANIC ANION TRANSPORT,0.033245,0.083988,0.14872,1,0
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.02951,0.083333,0.11213,1,0
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.045233,0.082405,0.12775,1,0
2,GO CELLULAR KETONE METABOLIC PROCESS,0.011574,0.08107,0.12722,1,0
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.018736,0.080956,0.16503,1,0
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.020391,0.080182,0.16002,1,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.026142,0.079505,0.15344,1,0
2,GO ORGANIC ACID METABOLIC PROCESS,0.016475,0.078887,0.13214,1,0
2,GO VACUOLE ORGANIZATION,0.048745,0.0753,0.14263,1,0
2,GO PROTEIN N LINKED GLYCOSYLATION,0.023112,0.074185,0.15376,1,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.045233,0.073295,0.14877,1,0
2,GO SARCOMERE ORGANIZATION,0.024086,0.069293,0.15195,1,0
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.015776,0.066626,0.14072,1,0
2,GO METAL ION TRANSPORT,0.048745,0.063105,0.13371,1,0
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.031957,0.062808,0.12215,1,0
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.054439,0.061795,0.11363,1,0
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.043559,-0.073094,-0.2405,1,0
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.031957,-0.074436,-0.10178,1,0
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.041938,-0.074603,-0.1044,1,0
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.030713,-0.078137,-0.10542,1,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.040368,-0.078434,-0.092625,1,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.050584,-0.078466,-0.20182,1,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.033245,-0.080485,-0.11048,1,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.030713,-0.085005,-0.13346,1,0
2,GO NUCLEOTIDE EXCISION REPAIR,0.028348,-0.08941,-0.10525,1,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.041938,-0.089962,-0.207,1,0
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.015776,-0.09074,-0.13947,1,0
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.040368,-0.093071,-0.11411,1,0
2,GO NUCLEAR BODY ORGANIZATION,0.054439,-0.10252,-0.065005,1,0
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0063209,-0.10298,-0.15676,1,0
2,GO REGULATION OF CYTOKINESIS,0.031957,-0.10416,-0.13494,1,0
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.041938,-0.10623,-0.12652,1,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.018736,-0.10669,-0.16927,1,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.0060238,-0.10747,-0.15135,1,0
2,GO PEPTIDYL ARGININE METHYLATION,0.033245,-0.11191,-0.14263,1,0
2,GO RNA CAPPING,0.045233,-0.11295,-0.097387,1,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.024086,-0.11749,-0.10568,1,0
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.046961,-0.12062,-0.10793,1,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.025096,-0.12143,-0.25728,1,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.048745,-0.122,-0.17792,1,0
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.050584,-0.12258,-0.09822,1,0
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.050584,-0.12381,-0.153,1,0
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.035953,-0.12505,-0.14001,1,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.024086,-0.12626,-0.14489,1,0
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.052482,-0.12818,-0.11656,1,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.035953,-0.12883,-0.11935,1,0
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.043559,-0.1325,-0.20199,1,0
2,GO REGULATION OF RNA BINDING,0.030713,-0.13566,-0.12929,1,0
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.045233,-0.13746,-0.19162,1,0
2,GO G0 TO G1 TRANSITION,0.046961,-0.13754,-0.16279,1,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.043559,-0.13903,-0.16551,1,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.031957,-0.1392,-0.21099,1,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.052482,-0.14064,-0.12277,1,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.022172,-0.14098,-0.133,1,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.045233,-0.14115,-0.19258,1,0
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.012106,-0.14119,-0.1569,1,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.028348,-0.1433,-0.10965,1,0
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.052482,-0.14336,-0.14105,1,0
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.043559,-0.14426,-0.12339,1,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.033245,-0.14601,-0.12661,1,0
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.014457,-0.14623,-0.23437,1,0
2,GO HISTONE H2A ACETYLATION,0.028348,-0.14757,-0.16915,1,0
2,GO HISTONE METHYLATION,0.054439,-0.14762,-0.11924,1,0
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.050584,-0.14792,-0.13478,1,0
2,GO CHROMATIN REMODELING,0.052482,-0.14931,-0.14152,1,0
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.020391,-0.14974,-0.15377,1,0
2,GO REGULATION OF MRNA PROCESSING,0.035953,-0.1498,-0.12271,1,0
2,GO PEPTIDYL LYSINE METHYLATION,0.050584,-0.15058,-0.12011,1,0
2,GO NEUROTRANSMITTER SECRETION,0.054439,-0.15123,-0.1317,1,0
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.027226,-0.15194,-0.14317,1,0
2,GO MISMATCH REPAIR,0.041938,-0.15345,-0.14741,1,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.046961,-0.1541,-0.10215,1,0
2,GO REGULATION OF RNA SPLICING,0.048745,-0.15547,-0.10052,1,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.034576,-0.15594,-0.16365,1,0
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.015104,-0.15622,-0.13295,1,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.0092139,-0.15752,-0.19622,1,0
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.054439,-0.15784,-0.17345,1,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.024086,-0.15957,-0.14406,1,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.050584,-0.15978,-0.16104,1,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.020391,-0.16076,-0.21739,1,0
2,GO HISTONE H3 K36 METHYLATION,0.048745,-0.16238,-0.16845,1,0
2,GO DNA CONFORMATION CHANGE,0.033245,-0.16311,-0.16847,1,0
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.024086,-0.16357,-0.18051,1,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.015776,-0.16449,-0.20483,1,0
2,GO OXIDATIVE DEMETHYLATION,0.045233,-0.16606,-0.13193,1,0
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0096484,-0.16712,-0.1576,1,0
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.017954,-0.16749,-0.20097,1,0
2,GO POSITIVE REGULATION OF RNA SPLICING,0.018736,-0.16775,-0.13058,1,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.017954,-0.16901,-0.18266,1,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.040368,-0.1721,-0.15445,1,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.052482,-0.17456,-0.16305,1,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.013235,-0.17477,-0.17444,1,0
2,GO DENDRITE EXTENSION,0.043559,-0.1754,-0.15804,1,0
2,GO REGULATION OF DOPAMINE SECRETION,0.050584,-0.17649,-0.16367,1,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.0172,-0.17847,-0.16544,1,0
2,GO MRNA SPLICE SITE SELECTION,0.023112,-0.1798,-0.22601,1,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.015104,-0.17992,-0.19099,1,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.035953,-0.18097,-0.17845,1,0
2,GO INTERSTRAND CROSS LINK REPAIR,0.013834,-0.18165,-0.21053,1,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.011063,-0.18217,-0.26542,1,0
2,GO DNA PACKAGING,0.019548,-0.18332,-0.20425,1,0
2,GO AXO DENDRITIC TRANSPORT,0.054439,-0.18353,-0.13707,1,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.023112,-0.18382,-0.16369,1,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.052482,-0.18391,-0.14859,1,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.0096484,-0.1853,-0.35681,1,0
2,GO EMBRYONIC BRAIN DEVELOPMENT,0.045233,-0.1863,-0.18423,1,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.019548,-0.18661,-0.28614,1,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.052482,-0.18662,-0.12277,1,0
2,GO NUCLEOSOME ASSEMBLY,0.019548,-0.18718,-0.22439,1,0
2,GO AXONAL TRANSPORT,0.041938,-0.18858,-0.14801,1,0
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.019548,-0.19011,-0.18058,1,0
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.052482,-0.1926,-0.14699,1,0
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.052482,-0.19736,-0.12701,1,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.013834,-0.19809,-0.18296,1,0
2,GO NUCLEOSOME ORGANIZATION,0.015104,-0.19968,-0.19484,1,0
2,GO HISTONE H4 K5 ACETYLATION,0.038848,-0.20105,-0.1621,1,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.045233,-0.20118,-0.20871,1,0
2,GO DNA REPLICATION INITIATION,0.015104,-0.20273,-0.28275,1,0
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.037377,-0.20276,-0.18192,1,0
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.052482,-0.20356,-0.17545,1,0
2,GO MICROTUBULE POLYMERIZATION,0.01266,-0.20589,-0.17485,1,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.01266,-0.20697,-0.18076,1,0
2,GO HISTONE EXCHANGE,0.0052065,-0.20757,-0.28613,1,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.019548,-0.20773,-0.21573,1,0
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.0172,-0.20842,-0.22179,1,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.02951,-0.21207,-0.17188,1,0
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.008797,-0.21215,-0.29329,1,0
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.025096,-0.21339,-0.17987,1,0
2,GO PROTEIN POLYGLUTAMYLATION,0.020391,-0.2155,-0.21419,1,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.021265,-0.21559,-0.16353,1,0
2,GO REGULATION OF RESPONSE TO FOOD,0.054439,-0.21724,-0.20105,1,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.041938,-0.21935,-0.16628,1,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.028348,-0.21943,-0.24131,1,0
2,GO SYNAPTIC VESICLE DOCKING,0.035953,-0.22147,-0.28698,1,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.043559,-0.22288,-0.25423,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.045233,-0.23722,-0.16363,1,0
2,GO HISTONE H3 K27 METHYLATION,0.034576,-0.23936,-0.20693,1,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.026142,-0.24101,-0.27417,1,0
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.019548,-0.24491,-0.21707,1,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.021265,-0.24615,-0.3211,1,0
2,GO SYNAPTIC VESICLE CLUSTERING,0.048745,-0.24785,-0.24126,1,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.0027019,-0.25788,-0.30127,1,0
2,GO SYNAPTIC VESICLE MATURATION,0.041938,-0.2608,-0.20999,1,0
2,GO MICROTUBULE NUCLEATION,0.0060238,-0.26581,-0.20296,1,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.023112,-0.26583,-0.25469,1,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.035953,-0.27994,-0.22555,1,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.023112,-0.28908,-0.24391,1,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.027226,-0.2916,-0.25471,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.035953,-0.30244,-0.25878,1,0
2,GO SYNAPTIC VESICLE PRIMING,0.02951,-0.33601,-0.21354,1,0
2,GO DENSE CORE GRANULE TRANSPORT,0.015104,-0.35353,-0.32684,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.013235,-0.35597,-0.32296,1,0
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.023112,-0.38124,-0.34127,1,0
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0063209,-0.38186,-0.42894,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.014457,-0.40276,-0.35881,1,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0096484,-0.40656,-0.37539,1,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.062884,0.26696,0.22833,0,1
2,GO REGULATION OF RELAXATION OF MUSCLE,0.062884,0.25046,0.2629,0,1
2,GO CORTICOSTEROID HORMONE SECRETION,0.058535,0.24204,0.19466,0,1
2,GO CELLULAR RESPONSE TO ZINC ION,0.11524,0.22203,0.1719,0,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.1306,0.22042,0.18412,0,1
2,GO DETERMINATION OF ADULT LIFESPAN,0.062884,0.21826,0.18012,0,1
2,GO IRON COORDINATION ENTITY TRANSPORT,0.077559,0.21481,0.19518,0,1
2,GO CELLULAR RESPONSE TO COPPER ION,0.15197,0.20997,0.16821,0,1
2,GO BASIC AMINO ACID TRANSPORT,0.20822,0.20107,0.15759,0,1
2,GO ENAMEL MINERALIZATION,0.069906,0.19804,0.20791,0,1
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.1475,0.19546,0.091474,0,1
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.072385,0.18738,0.24211,0,1
2,GO AMINE BIOSYNTHETIC PROCESS,0.16123,0.18643,0.12103,0,1
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.15655,0.17785,0.17229,0,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.062884,0.17454,0.16199,0,1
2,GO NOREPINEPHRINE METABOLIC PROCESS,0.098083,0.16858,0.1957,0,1
2,GO RETINAL CONE CELL DIFFERENTIATION,0.11163,0.16838,0.079195,0,1
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.065157,0.1649,0.17466,0,1
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.067497,0.16448,0.17483,0,1
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.072385,0.15647,0.2001,0,1
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.2259,0.15569,0.1597,0,1
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.197,0.15371,0.13772,0,1
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.060677,0.14871,0.19549,0,1
2,GO SODIUM ION HOMEOSTASIS,0.060677,0.14799,0.16964,0,1
2,GO PROSTATE GLAND GROWTH,0.074935,0.14605,0.14862,0,1
2,GO L GLUTAMATE IMPORT,0.10468,0.14406,0.14175,0,1
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.062884,0.14401,0.17831,0,1
2,GO REGULATION OF BLOOD CIRCULATION,0.077559,0.14397,0.13972,0,1
2,GO XENOBIOTIC TRANSPORT,0.069906,0.14285,0.18476,0,1
2,GO CELL MATURATION,0.11163,0.14151,0.13459,0,1
2,GO VITAMIN CATABOLIC PROCESS,0.2998,0.13844,0.096826,0,1
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.098083,0.13328,0.14972,0,1
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.11163,0.13093,0.19512,0,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.098083,0.13018,0.17583,0,1
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.16602,0.12522,0.13356,0,1
2,GO REGULATION OF FATTY ACID OXIDATION,0.074935,0.12497,0.17535,0,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.062884,0.12354,0.1419,0,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.08303,0.12058,0.16177,0,1
2,GO CARDIAC MUSCLE CONTRACTION,0.091819,0.11586,0.11912,0,1
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.12662,0.11569,0.13776,0,1
2,GO ACTIVATION OF JNKK ACTIVITY,0.15197,0.1149,0.14549,0,1
2,GO AROMATIC AMINO ACID TRANSPORT,0.5959,0.11382,0.078094,0,1
2,GO INTRACELLULAR LIPID TRANSPORT,0.080256,0.11195,0.15615,0,1
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.056456,0.10431,0.11879,0,1
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.15197,0.10378,0.076883,0,1
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.067497,0.09911,0.14215,0,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,0.065157,0.095728,0.11419,0,1
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.11524,0.095347,0.11009,0,1
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.10811,0.09493,0.11232,0,1
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.11163,0.094002,0.1861,0,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.065157,0.093419,0.14594,0,1
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.61803,0.091615,0.072135,0,1
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.30724,0.090971,0.10243,0,1
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.060677,0.090746,0.15512,0,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.197,0.090606,0.089029,0,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.065157,0.089207,0.15105,0,1
2,GO EPITHELIAL CELL DEVELOPMENT,0.08881,0.084877,0.16575,0,1
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.15655,0.082659,0.10082,0,1
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.13467,0.078315,0.10756,0,1
2,GO RESPONSE TO ACID CHEMICAL,0.08588,0.077664,0.11702,0,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.64051,0.077643,0.038279,0,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.17591,0.076614,0.094227,0,1
2,GO PROTEIN TETRAMERIZATION,0.058535,0.075632,0.12238,0,1
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.29248,0.072231,0.082746,0,1
2,GO FUCOSE METABOLIC PROCESS,0.23827,0.070396,0.09245,0,1
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.056456,0.068384,0.14403,0,1
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.26442,0.065741,0.11556,0,1
2,GO VESICLE CARGO LOADING,0.33821,0.059273,0.09932,0,1
2,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,5.9985e-05,1.2532,1.2321,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00014062,0.8606,0.83857,0,0
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00017019,0.81143,0.72352,0,0
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.00011593,0.70594,0.72451,0,0
2,GO GERMINAL CENTER FORMATION,0.00060992,0.63832,0.65766,0,0
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00028019,0.58708,0.60272,0,0
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.00019306,0.57882,0.59942,0,0
2,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.00054254,0.55961,0.48558,0,0
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00028019,0.54094,0.51888,0,0
2,GO NK T CELL DIFFERENTIATION,0.00091199,0.53618,0.54824,0,0
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00051151,0.52031,0.54495,0,0
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00019306,0.51209,0.50235,0,0
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00020554,0.51106,0.51207,0,0
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.00014989,0.50692,0.52465,0,0
2,GO CD40 SIGNALING PATHWAY,0.00023283,0.49535,0.50007,0,0
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00024771,0.46434,0.53053,0,0
2,GO CELL JUNCTION DISASSEMBLY,0.00014062,0.44476,0.61794,0,0
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.00029789,0.4092,0.45896,0,0
2,GO HISTAMINE SECRETION,0.0034935,0.40601,0.35068,0,0
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00054254,0.40031,0.37989,0,0
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.00072571,0.38614,0.38795,0,0
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00081392,0.37963,0.35772,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00051151,0.37723,0.39534,0,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00081392,0.37106,0.45196,0,0
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00040321,0.33905,0.42784,0,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0052065,0.33791,0.38075,0,0
2,GO NEGATIVE REGULATION OF ANOIKIS,0.010101,0.33582,0.31239,0,0
2,GO HISTAMINE TRANSPORT,0.0052065,0.31735,0.33031,0,0
2,GO HOMOTYPIC CELL CELL ADHESION,0.00091199,0.31697,0.3347,0,0
2,GO STEROID ESTERIFICATION,0.00096503,0.30384,0.30504,0,0
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0015882,0.30084,0.34165,0,0
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.015104,0.29896,0.31968,0,0
2,GO PROSTATIC BUD FORMATION,0.011063,0.2903,0.37117,0,0
2,GO STEROID CATABOLIC PROCESS,0.0016767,0.28961,0.31072,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.033245,0.28576,0.23701,0,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.015104,0.28386,0.25461,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.0066311,0.28349,0.28583,0,0
2,GO REGULATION OF RESPIRATORY BURST,0.0092139,0.28346,0.26409,0,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.0015041,0.28193,0.32436,0,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0172,0.27538,0.31523,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.060677,0.27238,0.2761,0,0
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.0066311,0.27218,0.30561,0,0
2,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.008797,0.27071,0.25568,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.062884,0.26519,0.19249,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0038653,0.26469,0.26389,0,0
2,GO REGULATION OF URINE VOLUME,0.0031545,0.26171,0.2995,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.0023095,0.26017,0.30503,0,0
2,GO OSTEOBLAST PROLIFERATION,0.0015882,0.2593,0.31512,0,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0019699,0.25634,0.2496,0,0
2,GO RESPONSE TO NITRIC OXIDE,0.0024341,0.25396,0.25071,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.022172,0.25373,0.26731,0,0
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0027019,0.25287,0.27283,0,0
2,GO RENAL VESICLE DEVELOPMENT,0.020391,0.25269,0.2237,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.022172,0.24787,0.24063,0,0
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.037377,0.24722,0.30104,0,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0028457,0.24421,0.3176,0,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0096484,0.24205,0.26234,0,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0080134,0.24138,0.24361,0,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.030713,0.23888,0.2313,0,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.18102,0.23857,0.15763,0,0
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0017696,0.23851,0.26128,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.0012071,0.23778,0.34153,0,0
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0076456,0.2331,0.31638,0,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.2259,0.23224,0.16353,0,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.014457,0.22857,0.32808,0,0
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.66333,0.22587,0.073179,0,0
2,GO LYMPHANGIOGENESIS,0.065157,0.22521,0.2818,0,0
2,GO REGULATION OF ANOIKIS,0.019548,0.22516,0.25355,0,0
2,GO MAST CELL MIGRATION,0.02951,0.22466,0.2487,0,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.056456,0.2246,0.20922,0,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.08588,0.223,0.25895,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.094909,0.22284,0.15553,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0049572,0.21762,0.27363,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.028348,0.21507,0.21128,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.033245,0.21435,0.24465,0,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.021265,0.21028,0.22772,0,0
2,GO LUTEINIZATION,0.056456,0.20916,0.22673,0,0
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.072385,0.20613,0.22273,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.017954,0.20484,0.29863,0,0
2,GO O GLYCAN PROCESSING,0.10134,0.20458,0.14389,0,0
2,GO ANIMAL ORGAN FORMATION,0.0047188,0.2019,0.24043,0,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,0.065157,0.20164,0.20231,0,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.058535,0.20096,0.20457,0,0
2,GO INSEMINATION,0.045233,0.19953,0.24278,0,0
2,GO NOTOCHORD DEVELOPMENT,0.1306,0.19911,0.15496,0,0
2,GO GAS TRANSPORT,0.065157,0.19674,0.23859,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.060677,0.19499,0.18367,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0092139,0.19465,0.20672,0,0
2,GO CARDIAC CELL FATE COMMITMENT,0.054439,0.19284,0.21894,0,0
2,GO SMOOTH MUSCLE CELL MIGRATION,0.0096484,0.19238,0.27719,0,0
2,GO LIPID EXPORT FROM CELL,0.0049572,0.19236,0.25618,0,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.013235,0.19212,0.20975,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.11524,0.19131,0.17137,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.080256,0.19105,0.21735,0,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.007293,0.19012,0.27936,0,0
2,GO GALACTOSE METABOLIC PROCESS,0.012106,0.18979,0.24799,0,0
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.43329,0.1896,0.13922,0,0
2,GO AMINO ACID IMPORT,0.0052065,0.18908,0.23448,0,0
2,GO RESPONSE TO NUTRIENT,0.0015041,0.1885,0.23744,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.056456,0.18785,0.25472,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0076456,0.18739,0.26338,0,0
2,GO BODY MORPHOGENESIS,0.058535,0.18673,0.19405,0,0
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0060238,0.1857,0.21714,0,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.069906,0.18568,0.22962,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.013235,0.18533,0.28738,0,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0092139,0.1827,0.23863,0,0
2,GO BIOLOGICAL PHASE,0.197,0.1825,0.14449,0,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,0.010101,0.18214,0.30958,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.022172,0.18208,0.29091,0,0
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.030713,0.18112,0.22342,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.072385,0.18097,0.19175,0,0
2,GO MITRAL VALVE DEVELOPMENT,0.12662,0.17987,0.1941,0,0
2,GO HIPPO SIGNALING,0.40594,0.17878,0.13136,0,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.11163,0.17861,0.17783,0,0
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.067497,0.17807,0.14451,0,0
2,GO HORMONE CATABOLIC PROCESS,0.028348,0.1778,0.23769,0,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.13467,0.17663,0.18466,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.020391,0.17601,0.24983,0,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.026142,0.17593,0.22064,0,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.010572,0.17593,0.27124,0,0
2,GO PARAXIAL MESODERM DEVELOPMENT,0.11524,0.1754,0.14743,0,0
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.069906,0.1745,0.187,0,0
2,GO GLIAL CELL APOPTOTIC PROCESS,0.0083971,0.17447,0.22472,0,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.060677,0.17392,0.22946,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.062884,0.17369,0.21972,0,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.046961,0.17363,0.15928,0,0
2,GO BONE GROWTH,0.074935,0.17257,0.20738,0,0
2,GO COPULATION,0.046961,0.17231,0.24073,0,0
2,GO CAMP METABOLIC PROCESS,0.091819,0.17048,0.19842,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.038848,0.17043,0.19752,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.010101,0.16941,0.25096,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.10134,0.169,0.2018,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.007293,0.16891,0.17854,0,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0080134,0.16852,0.32134,0,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.060677,0.16805,0.23858,0,0
2,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.022172,0.16734,0.15915,0,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.056456,0.16705,0.17372,0,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.030713,0.16605,0.19713,0,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.058535,0.16592,0.19939,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.058535,0.16501,0.26368,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0080134,0.16482,0.2719,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0049572,0.16432,0.27231,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.34626,0.16421,0.077069,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.013834,0.16387,0.21207,0,0
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.08588,0.16333,0.15572,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.035953,0.16293,0.24894,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.077559,0.16237,0.19564,0,0
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.08303,0.16216,0.18474,0,0
2,GO VACUOLAR ACIDIFICATION,0.0027019,0.16163,0.20711,0,0
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.10468,0.1615,0.20686,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.0092139,0.16112,0.21591,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.074935,0.1609,0.33624,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0092139,0.16032,0.20243,0,0
2,GO OSTEOBLAST DEVELOPMENT,0.062884,0.16025,0.1788,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.040368,0.1599,0.2457,0,0
2,GO MALE GENITALIA DEVELOPMENT,0.072385,0.15946,0.17139,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.33029,0.15911,0.15915,0,0
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.1475,0.15879,0.19342,0,0
2,GO RENAL SODIUM EXCRETION,0.040368,0.15802,0.19732,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.022172,0.15765,0.17731,0,0
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.2998,0.1569,0.14208,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.072385,0.15676,0.15989,0,0
2,GO LYMPH VESSEL DEVELOPMENT,0.10811,0.15613,0.25125,0,0
2,GO EMBRYONIC HEMOPOIESIS,0.011063,0.15538,0.25653,0,0
2,GO PROTEIN KINASE C SIGNALING,0.065157,0.15534,0.20782,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.14312,0.15531,0.16252,0,0
2,GO LATERAL VENTRICLE DEVELOPMENT,0.20822,0.15471,0.18557,0,0
2,GO AUTOPHAGIC CELL DEATH,0.0034935,0.15387,0.20405,0,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.091819,0.15335,0.19518,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.21989,0.15281,0.14065,0,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.11524,0.15128,0.15376,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.2577,0.15091,0.098976,0,0
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.14312,0.15064,0.1731,0,0
2,GO ECTODERM DEVELOPMENT,0.23827,0.14896,0.10684,0,0
2,GO MRNA TRANSCRIPTION,0.17591,0.14882,0.15984,0,0
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.091819,0.14874,0.12136,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.050584,0.14832,0.24864,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.062884,0.14827,0.16727,0,0
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.015104,0.14766,0.17281,0,0
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.18102,0.14747,0.18474,0,0
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.077559,0.14699,0.18993,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.074935,0.14637,0.29842,0,0
2,GO TOXIN METABOLIC PROCESS,0.2577,0.14612,0.093325,0,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.10134,0.14594,0.13999,0,0
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.12662,0.14544,0.12829,0,0
2,GO REGULATION OF HIPPO SIGNALING,0.61803,0.14543,0.087301,0,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.15655,0.14449,0.17629,0,0
2,GO LONG TERM SYNAPTIC DEPRESSION,0.47137,0.14433,0.075636,0,0
2,GO PROTEIN OXIDATION,0.023112,0.14411,0.16372,0,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.077559,0.14369,0.22914,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.024086,0.14366,0.23744,0,0
2,GO NEGATIVE CHEMOTAXIS,0.11524,0.14364,0.19501,0,0
2,GO ARTERY DEVELOPMENT,0.069906,0.14334,0.22498,0,0
2,GO OVULATION CYCLE PROCESS,0.067497,0.14332,0.16151,0,0
2,GO CELL PROLIFERATION IN HINDBRAIN,0.20256,0.14319,0.11574,0,0
2,GO MYOBLAST MIGRATION,0.16602,0.14303,0.12302,0,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.060677,0.14293,0.20895,0,0
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.072385,0.1427,0.12401,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.2259,0.14233,0.13501,0,0
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.041938,0.14224,0.16121,0,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.01266,0.14166,0.24545,0,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.08588,0.14155,0.17518,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.18102,0.13978,0.14694,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.094909,0.13897,0.1982,0,0
2,GO MESONEPHROS DEVELOPMENT,0.08588,0.1389,0.14179,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.2259,0.13887,0.11436,0,0
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.062884,0.13883,0.18139,0,0
2,GO DOPAMINE METABOLIC PROCESS,0.16123,0.13864,0.13724,0,0
2,GO MIDDLE EAR MORPHOGENESIS,0.048745,0.13853,0.12818,0,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.30724,0.13788,0.084466,0,0
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.067497,0.13776,0.12714,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.027226,0.13728,0.1658,0,0
2,GO LIPID OXIDATION,0.060677,0.13725,0.12709,0,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.054439,0.13695,0.18648,0,0
2,GO SIGNAL PEPTIDE PROCESSING,0.080256,0.13642,0.16304,0,0
2,GO FOREGUT MORPHOGENESIS,0.11524,0.13629,0.18631,0,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.060677,0.13623,0.19541,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.14312,0.13557,0.14793,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.0080134,0.1353,0.20145,0,0
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.012106,0.13512,0.21011,0,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.12662,0.13505,0.20354,0,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.045233,0.13502,0.16709,0,0
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.26442,0.13488,0.11984,0,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.18624,0.13472,0.13156,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.10468,0.13443,0.13054,0,0
2,GO REGULATION OF EXOSOMAL SECRETION,0.022172,0.13318,0.17406,0,0
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.037377,0.13294,0.16567,0,0
2,GO LIPID IMPORT INTO CELL,0.098083,0.13281,0.13658,0,0
2,GO CORNIFICATION,0.046961,0.13269,0.24028,0,0
2,GO NEPHRON DEVELOPMENT,0.12273,0.13192,0.16345,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.32248,0.13125,0.13057,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.214,0.13096,0.18893,0,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.15197,0.13071,0.14681,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.056456,0.13025,0.15928,0,0
2,GO GDP METABOLIC PROCESS,0.21989,0.12983,0.11892,0,0
2,GO RESPONSE TO X RAY,0.069906,0.12933,0.15698,0,0
2,GO METANEPHROS MORPHOGENESIS,0.19156,0.12845,0.15071,0,0
2,GO POSITIVE REGULATION OF CELL AGING,0.1306,0.12803,0.099485,0,0
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.18102,0.12783,0.14516,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.16123,0.12768,0.19492,0,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.12273,0.1275,0.16063,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.041938,0.12706,0.14005,0,0
2,GO TOOTH MINERALIZATION,0.16602,0.12644,0.14671,0,0
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.36271,0.12638,0.11179,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.050584,0.12637,0.20282,0,0
2,GO PROTEIN TARGETING TO LYSOSOME,0.08881,0.12635,0.17215,0,0
2,GO REGULATION OF CILIUM MOVEMENT,0.2577,0.12615,0.068737,0,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.030713,0.12613,0.18335,0,0
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.16602,0.12596,0.14296,0,0
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.10811,0.12546,0.19752,0,0
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.30724,0.12534,0.08686,0,0
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.040368,0.1252,0.14848,0,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.058535,0.12503,0.18375,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.077559,0.12479,0.15325,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.25111,0.12442,0.11448,0,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.12273,0.12438,0.19685,0,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.058535,0.12407,0.21181,0,0
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.060677,0.12364,0.13462,0,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.054439,0.12353,0.19409,0,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.37111,0.12337,0.13601,0,0
2,GO GLYCEROL ETHER METABOLIC PROCESS,0.065157,0.1231,0.1313,0,0
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.35442,0.12309,0.11461,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.18102,0.12268,0.18167,0,0
2,GO MULTICELLULAR ORGANISM AGING,0.11894,0.12251,0.13003,0,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.1475,0.12218,0.14578,0,0
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.25111,0.12197,0.12316,0,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.08588,0.12189,0.16838,0,0
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.18102,0.12178,0.13081,0,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.054439,0.12163,0.19246,0,0
2,GO DNA DEMETHYLATION,0.23827,0.1215,0.09139,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.08588,0.12143,0.18815,0,0
2,GO REGULATION OF HAIR CYCLE,0.18102,0.12139,0.15583,0,0
2,GO AORTA DEVELOPMENT,0.11524,0.1212,0.18877,0,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.30724,0.1208,0.1352,0,0
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.11894,0.1208,0.16014,0,0
2,GO MUSCLE HYPERTROPHY,0.1306,0.12075,0.14642,0,0
2,GO POSITIVE REGULATION OF HEART GROWTH,0.034576,0.12062,0.16987,0,0
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.11894,0.1206,0.13635,0,0
2,GO INTESTINAL LIPID ABSORPTION,0.13467,0.1203,0.17978,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.098083,0.11984,0.15505,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0066311,0.11961,0.16544,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,0.091819,0.11941,0.19476,0,0
2,GO LONG TERM MEMORY,0.27821,0.11941,0.11487,0,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.058535,0.11927,0.18054,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.08881,0.11904,0.16298,0,0
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.37964,0.1189,0.14475,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.067497,0.11883,0.21498,0,0
2,GO CARTILAGE DEVELOPMENT,0.013834,0.11858,0.22309,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.11894,0.11849,0.13039,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.056456,0.11849,0.14751,0,0
2,GO ALANINE TRANSPORT,0.1306,0.11843,0.18994,0,0
2,GO NEURON CELLULAR HOMEOSTASIS,0.44264,0.11827,0.077332,0,0
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.15197,0.11787,0.15586,0,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.13467,0.11786,0.14012,0,0
2,GO RESPONSE TO UV C,0.14312,0.11785,0.12737,0,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.17091,0.11766,0.14046,0,0
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.058535,0.11758,0.14167,0,0
2,GO AORTA MORPHOGENESIS,0.2577,0.11744,0.15384,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.11163,0.11738,0.14096,0,0
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0052065,0.11738,0.22038,0,0
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.012106,0.11722,0.19112,0,0
2,GO FIBROBLAST ACTIVATION,0.30724,0.11709,0.11191,0,0
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0044907,0.11702,0.21341,0,0
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.20256,0.11699,0.16992,0,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.025096,0.1166,0.23203,0,0
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.40594,0.11646,0.11767,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.12662,0.11624,0.18347,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.040368,0.11602,0.14176,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.094909,0.11596,0.17807,0,0
2,GO DEFINITIVE HEMOPOIESIS,0.15197,0.11559,0.19917,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.16123,0.11547,0.14006,0,0
2,GO FILOPODIUM ASSEMBLY,0.11894,0.11537,0.15187,0,0
2,GO FOCAL ADHESION ASSEMBLY,0.074935,0.11469,0.21732,0,0
2,GO REPLICATIVE SENESCENCE,0.18624,0.11466,0.12586,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.094909,0.11458,0.15813,0,0
2,GO RESPONSE TO BMP,0.11524,0.11429,0.17322,0,0
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.25111,0.11418,0.13631,0,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.20256,0.11406,0.12657,0,0
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.011574,0.11406,0.17661,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.20256,0.11393,0.13499,0,0
2,GO STRIATED MUSCLE CONTRACTION,0.14312,0.11359,0.096871,0,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.11524,0.11323,0.135,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.15655,0.11317,0.16024,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.027226,0.11297,0.19843,0,0
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.080256,0.11294,0.20051,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.074935,0.11277,0.21839,0,0
2,GO PROTEIN AUTOPHOSPHORYLATION,0.11524,0.11276,0.15861,0,0
2,GO MYOFIBRIL ASSEMBLY,0.060677,0.11274,0.18424,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.067497,0.1126,0.15509,0,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.26442,0.11257,0.091046,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.13885,0.11253,0.12747,0,0
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.16123,0.11236,0.16505,0,0
2,GO LAMELLIPODIUM ASSEMBLY,0.062884,0.11209,0.16194,0,0
2,GO SENSORY PERCEPTION OF PAIN,0.062884,0.11174,0.14833,0,0
2,GO OLIGOPEPTIDE TRANSPORT,0.13467,0.11173,0.15558,0,0
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.069906,0.1117,0.12338,0,0
2,GO OXYGEN TRANSPORT,0.26442,0.11169,0.14089,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.034576,0.11143,0.17199,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.054439,0.11115,0.15913,0,0
2,GO LUNG CELL DIFFERENTIATION,0.060677,0.11059,0.20276,0,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.098083,0.11053,0.15211,0,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.29248,0.11052,0.12367,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.28529,0.11051,0.14696,0,0
2,GO CATECHOLAMINE METABOLIC PROCESS,0.069906,0.11035,0.15312,0,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,0.42405,0.11027,0.11378,0,0
2,GO HEART PROCESS,0.18624,0.10978,0.10109,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.11524,0.1094,0.23338,0,0
2,GO EPITHELIAL CELL CELL ADHESION,0.24463,0.10924,0.16476,0,0
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.045233,0.10889,0.19472,0,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.13885,0.10859,0.12959,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.16123,0.10835,0.096967,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.37964,0.10834,0.091774,0,0
2,GO AGING,0.010572,0.10776,0.17097,0,0
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.091819,0.1074,0.16478,0,0
2,GO DNA DEALKYLATION,0.32248,0.1074,0.077196,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.01266,0.10738,0.1733,0,0
2,GO ENSHEATHMENT OF NEURONS,0.080256,0.10698,0.15577,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.24463,0.10642,0.10625,0,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.13467,0.10611,0.1239,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.098083,0.10611,0.15392,0,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.40594,0.10595,0.096536,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.16602,0.1055,0.13959,0,0
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.18624,0.10513,0.11797,0,0
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.11524,0.10509,0.12401,0,0
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.214,0.10505,0.10948,0,0
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.062884,0.10446,0.15836,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.08588,0.10429,0.20903,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.094909,0.10411,0.12388,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.15197,0.104,0.22733,0,0
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.11524,0.10383,0.12606,0,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.1475,0.10372,0.16583,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.10811,0.10336,0.14479,0,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.20822,0.10333,0.13711,0,0
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.12273,0.10317,0.14243,0,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.20822,0.10311,0.12469,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.44264,0.10307,0.11784,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.33029,0.10293,0.12501,0,0
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.056456,0.10282,0.19683,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.08881,0.10278,0.10552,0,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.21989,0.10273,0.15371,0,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.058535,0.10252,0.13588,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.197,0.10248,0.10932,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.16602,0.1024,0.17868,0,0
2,GO FIBROBLAST MIGRATION,0.072385,0.10219,0.17562,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.011574,0.10168,0.17418,0,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.062884,0.10163,0.16654,0,0
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.045233,0.1016,0.13561,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.17591,0.10142,0.099851,0,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.074935,0.10137,0.13658,0,0
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.1306,0.10121,0.12244,0,0
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.214,0.10119,0.11225,0,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.072385,0.10106,0.20839,0,0
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.11163,0.10099,0.14291,0,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.27126,0.10082,0.1159,0,0
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.10811,0.10076,0.17376,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.080256,0.10076,0.13963,0,0
2,GO REGULATION OF HORMONE LEVELS,0.11163,0.10041,0.12138,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.08588,0.10039,0.14978,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.33821,0.1002,0.1106,0,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.37111,0.10014,0.13347,0,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.32248,0.099905,0.14704,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.058535,0.099814,0.17283,0,0
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.056456,0.09965,0.13607,0,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.13885,0.099481,0.16588,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.065157,0.099407,0.18924,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.27821,0.099208,0.04011,0,0
2,GO HINDLIMB MORPHOGENESIS,0.098083,0.099174,0.16864,0,0
2,GO LIPID TRANSLOCATION,0.24463,0.099054,0.13697,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.21989,0.098971,0.17989,0,0
2,GO STRESS FIBER ASSEMBLY,0.08881,0.098619,0.20042,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.32248,0.098588,0.098763,0,0
2,GO ACTIN FILAMENT BASED TRANSPORT,0.43329,0.098495,0.1353,0,0
2,GO LATERAL MESODERM DEVELOPMENT,0.18102,0.098301,0.14324,0,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.49108,0.098248,0.097837,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.056456,0.098184,0.19435,0,0
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.062884,0.097869,0.18564,0,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.20822,0.097826,0.1249,0,0
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.1306,0.097599,0.13181,0,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,0.20822,0.097446,0.10803,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.080256,0.097424,0.19147,0,0
2,GO LIPID DIGESTION,0.2259,0.097182,0.16693,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.034576,0.097128,0.1952,0,0
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.08881,0.097124,0.12469,0,0
2,GO POLYAMINE METABOLIC PROCESS,0.15655,0.096981,0.065668,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.11524,0.096423,0.13056,0,0
2,GO KIDNEY MORPHOGENESIS,0.10468,0.096074,0.14307,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.10811,0.095908,0.15226,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.091819,0.095742,0.14925,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.14312,0.095448,0.12601,0,0
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.022172,0.095414,0.16959,0,0
2,GO MEMBRANE DEPOLARIZATION,0.28529,0.095148,0.072653,0,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.17591,0.095102,0.13469,0,0
2,GO MESODERMAL CELL FATE SPECIFICATION,0.26442,0.095057,0.080165,0,0
2,GO TONGUE DEVELOPMENT,0.28529,0.095024,0.094673,0,0
2,GO APICAL JUNCTION ASSEMBLY,0.077559,0.094872,0.16508,0,0
2,GO MEMBRANE FUSION,0.080256,0.094815,0.1224,0,0
2,GO MICROVILLUS ORGANIZATION,0.17091,0.094744,0.10781,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.058535,0.094521,0.1571,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.23203,0.094439,0.11185,0,0
2,GO ACTIN FILAMENT BASED MOVEMENT,0.072385,0.094426,0.15487,0,0
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.21989,0.094266,0.13492,0,0
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.16602,0.094207,0.1428,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.08303,0.094185,0.17165,0,0
2,GO RESPONSE TO ACIDIC PH,0.10468,0.094176,0.1793,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.12273,0.093904,0.13694,0,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.1475,0.093893,0.1522,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.55277,0.093841,0.072276,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.19156,0.093726,0.15841,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.15655,0.093711,0.13775,0,0
2,GO REGULATION OF BINDING,0.098083,0.09359,0.13538,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.20822,0.093479,0.11976,0,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.52145,0.093109,0.075416,0,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.28529,0.092901,0.10395,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.11524,0.092875,0.13118,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.058535,0.092795,0.12053,0,0
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.02951,0.092366,0.14693,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.11163,0.092091,0.187,0,0
2,GO NOREPINEPHRINE SECRETION,0.2577,0.092041,0.14346,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.13885,0.09176,0.17332,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.21989,0.091694,0.12138,0,0
2,GO ERYTHROCYTE DEVELOPMENT,0.077559,0.091662,0.16724,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.08881,0.09147,0.13659,0,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.41494,0.091405,0.076046,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.51122,0.091353,0.07827,0,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.11894,0.091221,0.16652,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.42405,0.091213,0.082205,0,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.12662,0.091211,0.086157,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.069906,0.091189,0.16146,0,0
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.47137,0.091125,0.091026,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.08588,0.091035,0.11922,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.25111,0.090952,0.10731,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.17091,0.090883,0.13371,0,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.12662,0.090704,0.2017,0,0
2,GO SIGNAL RELEASE,0.214,0.090466,0.11581,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.23203,0.090449,0.14265,0,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.10811,0.090309,0.17392,0,0
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.041938,0.090225,0.19221,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.11524,0.090051,0.13425,0,0
2,GO NADPH REGENERATION,0.091819,0.089984,0.10172,0,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.058535,0.089958,0.17858,0,0
2,GO MICROVILLUS ASSEMBLY,0.23203,0.089858,0.10964,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.065157,0.089839,0.14919,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.10134,0.089798,0.16081,0,0
2,GO POSITIVE REGULATION OF BINDING,0.17591,0.089773,0.11425,0,0
2,GO TELENCEPHALON REGIONALIZATION,0.99368,0.089472,-0.0057148,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.7336,0.089457,0.036681,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.46168,0.089365,0.074284,0,0
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.43329,0.089339,0.013985,0,0
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.065157,0.088902,0.14981,0,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.08303,0.088778,0.14962,0,0
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.36271,0.088688,0.1242,0,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.27821,0.088539,0.096539,0,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.027226,0.088481,0.1497,0,0
2,GO NEURON PROJECTION ARBORIZATION,0.51122,0.088401,0.13912,0,0
2,GO TISSUE MORPHOGENESIS,0.067497,0.088238,0.15266,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.23203,0.087787,0.12019,0,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.056456,0.087773,0.13543,0,0
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.28529,0.087765,0.098845,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.25111,0.087709,0.1341,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.37964,0.087553,0.18861,0,0
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.080256,0.087486,0.14156,0,0
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.098083,0.087457,0.12285,0,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.08881,0.087323,0.13619,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.11524,0.0872,0.14866,0,0
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.052482,0.087107,0.14594,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.069906,0.087087,0.13808,0,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.197,0.087063,0.14043,0,0
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.060677,0.086965,0.14951,0,0
2,GO RECEPTOR INTERNALIZATION,0.08303,0.086908,0.14828,0,0
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.074935,0.086762,0.12449,0,0
2,GO RESPONSE TO DIETARY EXCESS,0.12273,0.086725,0.13452,0,0
2,GO SPLEEN DEVELOPMENT,0.065157,0.086692,0.12751,0,0
2,GO GOLGI VESICLE BUDDING,0.074935,0.086396,0.13134,0,0
2,GO RESPONSE TO IONIZING RADIATION,0.20256,0.086253,0.092668,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.1475,0.086005,0.17534,0,0
2,GO SPHINGOLIPID METABOLIC PROCESS,0.067497,0.085769,0.13943,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.43329,0.085596,0.10203,0,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.050584,0.085592,0.1437,0,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.18624,0.085564,0.21583,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.080256,0.085477,0.11601,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.027226,0.085393,0.14593,0,0
2,GO MAMMARY GLAND DEVELOPMENT,0.12273,0.085276,0.17078,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.23203,0.085234,0.086204,0,0
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.15197,0.08523,0.1395,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.024086,0.085033,0.14693,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.11163,0.085024,0.2158,0,0
2,GO SECONDARY PALATE DEVELOPMENT,0.20256,0.084765,0.13294,0,0
2,GO SEGMENTATION,0.28529,0.084677,0.1121,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.20256,0.084567,0.14123,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.51122,0.084344,0.12506,0,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.069906,0.084247,0.1488,0,0
2,GO REGULATION OF HEART RATE,0.17591,0.084069,0.092599,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.30724,0.083937,0.099619,0,0
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.11894,0.083923,0.12887,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.27126,0.083904,0.11926,0,0
2,GO REGULATION OF BEHAVIOR,0.197,0.083677,0.095729,0,0
2,GO NEPHRON MORPHOGENESIS,0.13467,0.083538,0.13719,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.060677,0.083461,0.1469,0,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.19156,0.083395,0.14084,0,0
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.2998,0.083135,0.1057,0,0
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.10134,0.082885,0.14579,0,0
2,GO SELECTIVE AUTOPHAGY,0.10811,0.082844,0.1356,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.1475,0.08252,0.13232,0,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.056456,0.082232,0.14815,0,0
2,GO SEGMENT SPECIFICATION,0.1306,0.081989,0.16854,0,0
2,GO VIRAL RNA GENOME REPLICATION,0.24463,0.08195,0.10351,0,0
2,GO FOREBRAIN REGIONALIZATION,0.68646,0.081904,0.051687,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.21989,0.081863,0.15146,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.13885,0.081854,0.10116,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.056456,0.081821,0.12211,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.08881,0.081668,0.11965,0,0
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.11524,0.081614,0.15449,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.24463,0.081612,0.12446,0,0
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.23203,0.081495,0.12621,0,0
2,GO HEART DEVELOPMENT,0.065157,0.081472,0.1584,0,0
2,GO HYPEROSMOTIC RESPONSE,0.12273,0.081472,0.15895,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.197,0.081413,0.10933,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.214,0.081324,0.12227,0,0
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.12273,0.081185,0.12802,0,0
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.12273,0.080982,0.1186,0,0
2,GO SKELETAL MUSCLE CONTRACTION,0.11524,0.080775,0.098743,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.41494,0.080665,0.073389,0,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.3148,0.080605,0.16342,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.11163,0.080576,0.16518,0,0
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.30724,0.080551,0.15645,0,0
2,GO REGULATION OF SYSTEM PROCESS,0.13885,0.080535,0.12456,0,0
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.19156,0.080469,0.086914,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.46168,0.080412,0.045783,0,0
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.094909,0.080194,0.08113,0,0
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.28529,0.080022,0.10542,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.44264,0.079901,0.12652,0,0
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.3148,0.079853,0.12558,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.214,0.079744,0.11013,0,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.17591,0.07968,0.13305,0,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.060677,0.079665,0.15571,0,0
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.39705,0.079556,0.11057,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.15655,0.079497,0.11168,0,0
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.10468,0.079395,0.13047,0,0
2,GO COPII COATED VESICLE BUDDING,0.080256,0.079321,0.13475,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.080256,0.079226,0.19438,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.24463,0.079167,0.16469,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.10468,0.079112,0.17006,0,0
2,GO CONVERGENT EXTENSION,0.2998,0.079041,0.14299,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.072385,0.079003,0.15242,0,0
2,GO CELL CELL JUNCTION ORGANIZATION,0.27821,0.078962,0.12868,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.54223,0.078788,0.065135,0,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.41494,0.078711,0.098432,0,0
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.098083,0.07857,0.13158,0,0
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.32248,0.078467,0.11657,0,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.067497,0.078381,0.16241,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.1306,0.078329,0.099762,0,0
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.56341,0.078304,0.05145,0,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.67486,0.078016,0.048235,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.17091,0.07799,0.13581,0,0
2,GO PIGMENT GRANULE LOCALIZATION,0.14312,0.077841,0.080047,0,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.25111,0.077612,0.15243,0,0
2,GO MIDBODY ABSCISSION,0.26442,0.077501,0.059635,0,0
2,GO REGULATION OF WATER LOSS VIA SKIN,0.21989,0.07744,0.10739,0,0
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.17591,0.077381,0.15733,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.12662,0.077158,0.12601,0,0
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.10134,0.077153,0.14919,0,0
2,GO MESODERM MORPHOGENESIS,0.050584,0.076883,0.17613,0,0
2,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.39705,0.076688,0.058351,0,0
2,GO MESODERM DEVELOPMENT,0.060677,0.07664,0.14116,0,0
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.091819,0.076405,0.10706,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.20256,0.07639,0.12363,0,0
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.17591,0.076318,0.1608,0,0
2,GO GTP METABOLIC PROCESS,0.091819,0.07629,0.10491,0,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.4521,0.076238,0.098407,0,0
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.072385,0.076189,0.11714,0,0
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.14312,0.076143,0.062211,0,0
2,GO MAGNESIUM ION HOMEOSTASIS,0.88046,0.075736,0.015565,0,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.48117,0.075608,0.084645,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.53179,0.075527,0.05197,0,0
2,GO EPITHELIUM DEVELOPMENT,0.065157,0.075518,0.14196,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.24463,0.075226,0.10748,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.11894,0.075181,0.14165,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.1306,0.075162,0.19809,0,0
2,GO NEURAL CREST CELL MIGRATION,0.17091,0.07514,0.13773,0,0
2,GO EPITHELIAL CELL MORPHOGENESIS,0.33029,0.075093,0.14812,0,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.098083,0.074894,0.17573,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.37111,0.074889,0.089997,0,0
2,GO ORGANIC ACID TRANSPORT,0.069906,0.074857,0.13873,0,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.24463,0.074853,0.10987,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.11894,0.074823,0.1224,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.12662,0.074623,0.087862,0,0
2,GO REGULATION OF DNA BINDING,0.28529,0.07457,0.080759,0,0
2,GO NEURON APOPTOTIC PROCESS,0.16123,0.074506,0.10698,0,0
2,GO MEMBRANE BIOGENESIS,0.25111,0.074438,0.11128,0,0
2,GO GANGLION DEVELOPMENT,0.89296,0.073915,0.00095394,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.10468,0.073873,0.099163,0,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.11894,0.073847,0.11564,0,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.197,0.073818,0.10411,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.1475,0.073715,0.20184,0,0
2,GO RESPONSE TO AMINE,0.37111,0.073623,0.075469,0,0
2,GO CELL CELL JUNCTION ASSEMBLY,0.18624,0.073622,0.13479,0,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.14312,0.073583,0.10223,0,0
2,GO ORGANIC ACID CATABOLIC PROCESS,0.08303,0.073508,0.10765,0,0
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.50109,0.073138,0.057403,0,0
2,GO RESPONSE TO REDOX STATE,0.40594,0.072982,0.076046,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.21989,0.072947,0.10726,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.69814,0.072884,0.049038,0,0
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23827,0.072629,0.1096,0,0
2,GO CELL FATE COMMITMENT,0.20256,0.072449,0.12205,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.2259,0.072383,0.082068,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.058535,0.072284,0.13938,0,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.058535,0.071946,0.14448,0,0
2,GO PROTEIN IMPORT,0.40594,0.071647,0.073096,0,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.27126,0.0716,0.10008,0,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.65188,0.071362,0.075173,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.10468,0.071246,0.13445,0,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.39705,0.071146,0.08065,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.72171,0.071145,0.022294,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.20256,0.07056,0.11138,0,0
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.17091,0.070453,0.1463,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.052482,0.070428,0.14175,0,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.5959,0.070328,0.075085,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.098083,0.070201,0.13867,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.48117,0.070187,0.085343,0,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.069906,0.07017,0.17131,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.14312,0.070011,0.12763,0,0
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.20256,0.069857,0.10358,0,0
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.57414,0.069752,0.042666,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.16123,0.069564,0.16413,0,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.49108,0.069402,0.093745,0,0
2,GO HAIR FOLLICLE MATURATION,0.29248,0.069009,0.12483,0,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.10134,0.068907,0.13317,0,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.88046,0.068552,0.039437,0,0
2,GO ANDROGEN METABOLIC PROCESS,0.18624,0.068473,0.091092,0,0
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.12662,0.068131,0.11474,0,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.89296,0.068128,-0.019922,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.40594,0.068124,0.060101,0,0
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.20822,0.068059,0.12359,0,0
2,GO REGULATION OF EXOCYTOSIS,0.38829,0.067947,0.086973,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.18624,0.067946,0.20708,0,0
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.2998,0.067885,0.13465,0,0
2,GO ADRENAL GLAND DEVELOPMENT,0.66333,0.067828,0.089382,0,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.1475,0.067659,0.12711,0,0
2,GO INNER DYNEIN ARM ASSEMBLY,0.81845,0.067519,-0.057492,0,0
2,GO RENAL TUBULE DEVELOPMENT,0.24463,0.0675,0.11801,0,0
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.13885,0.067385,0.11511,0,0
2,GO LIPID MODIFICATION,0.15197,0.067314,0.11743,0,0
2,GO VESICLE TARGETING,0.1306,0.067038,0.11985,0,0
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.37111,0.066892,0.085665,0,0
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.074935,0.066871,0.1069,0,0
2,GO RESPONSE TO LEPTIN,0.50109,0.066805,0.092834,0,0
2,GO ANION TRANSPORT,0.062884,0.066577,0.13969,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.21989,0.066565,0.10876,0,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.76963,0.066446,0.025529,0,0
2,GO POLYOL BIOSYNTHETIC PROCESS,0.094909,0.066424,0.12077,0,0
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.18624,0.066315,0.10109,0,0
2,GO L AMINO ACID TRANSPORT,0.15197,0.066314,0.13098,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.33821,0.066309,0.12824,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.32248,0.066159,0.093371,0,0
2,GO ION TRANSPORT,0.072385,0.066102,0.12326,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.95582,0.065985,0.033138,0,0
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.12662,0.065938,0.12471,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.12273,0.065874,0.11229,0,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.1306,0.065803,0.10449,0,0
2,GO REGULATION OF CARDIAC CONDUCTION,0.30724,0.06562,0.08768,0,0
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.056456,0.065443,0.13861,0,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.18624,0.065219,0.11463,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.33821,0.065075,0.049656,0,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.1475,0.065043,0.13073,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.098083,0.064892,0.095495,0,0
2,GO PIGMENT GRANULE ORGANIZATION,0.14312,0.064883,0.13036,0,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.42405,0.064875,0.076337,0,0
2,GO CELLULAR RESPONSE TO STEROL,0.4521,0.06485,0.11355,0,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.16123,0.064801,0.081176,0,0
2,GO FATTY ACID BETA OXIDATION,0.42405,0.064767,0.072316,0,0
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.14312,0.064687,0.11333,0,0
2,GO TETRAPYRROLE METABOLIC PROCESS,0.17591,0.064626,0.10164,0,0
2,GO ERAD PATHWAY,0.14312,0.064581,0.11916,0,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.18102,0.064553,0.10941,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.16602,0.064492,0.073182,0,0
2,GO BLASTOCYST FORMATION,0.12662,0.064352,0.091353,0,0
2,GO INORGANIC ANION TRANSPORT,0.11894,0.0641,0.11965,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.34626,0.064053,0.13663,0,0
2,GO PIGMENT CELL DIFFERENTIATION,0.37111,0.063898,0.11085,0,0
2,GO NUCLEOTIDE SALVAGE,0.33029,0.063829,0.05879,0,0
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.2577,0.063828,0.067714,0,0
2,GO BLASTODERM SEGMENTATION,0.36271,0.063787,0.088033,0,0
2,GO RECEPTOR CLUSTERING,0.62923,0.063315,0.072828,0,0
2,GO STEM CELL PROLIFERATION,0.49108,0.063298,0.10861,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.2259,0.063079,0.10664,0,0
2,GO N GLYCAN PROCESSING,0.2259,0.062999,0.16559,0,0
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.42405,0.062717,0.089906,0,0
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.18102,0.062606,0.1049,0,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.17591,0.062576,0.11516,0,0
2,GO REGULATION OF APPETITE,0.27126,0.062501,0.079436,0,0
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.15197,0.062375,0.11044,0,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.12273,0.062198,0.13344,0,0
2,GO DEVELOPMENTAL MATURATION,0.26442,0.062161,0.096385,0,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.44264,0.062096,0.15208,0,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.36271,0.062053,0.087916,0,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.44264,0.062025,0.10897,0,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.21989,0.061987,0.073011,0,0
2,GO RESPONSE TO VITAMIN A,0.21989,0.061956,0.11197,0,0
2,GO RHYTHMIC BEHAVIOR,0.17091,0.061889,0.11594,0,0
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.23203,0.061888,0.1702,0,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.27821,0.061833,0.11573,0,0
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.08881,0.061689,0.11119,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.214,0.061558,0.055584,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.20822,0.061426,0.14208,0,0
2,GO CELL CELL SIGNALING,0.24463,0.061326,0.10162,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.38829,0.061158,0.082636,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.10811,0.061158,0.1308,0,0
2,GO RESPONSE TO TESTOSTERONE,0.40594,0.061033,0.079772,0,0
2,GO LOCOMOTOR RHYTHM,0.47137,0.060773,0.10284,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.13467,0.060757,0.095262,0,0
2,GO FACIAL NERVE MORPHOGENESIS,0.34626,0.060638,0.1379,0,0
2,GO POSITIVE REGULATION OF GROWTH,0.28529,0.06059,0.12151,0,0
2,GO VIRAL RELEASE FROM HOST CELL,0.11894,0.06023,0.10268,0,0
2,GO MOLTING CYCLE,0.30724,0.060219,0.11086,0,0
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.38829,0.060125,0.09704,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.23203,0.059772,0.07758,0,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.14312,0.059771,0.17104,0,0
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.28529,0.05974,0.15187,0,0
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.067497,0.059728,0.11398,0,0
2,GO RNA DESTABILIZATION,0.3148,0.059651,0.12955,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.20822,0.059623,0.1079,0,0
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.062884,0.059566,0.10644,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.25111,0.059504,0.082934,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.16602,0.059402,0.095456,0,0
2,GO PROTEIN HYDROXYLATION,0.41494,0.059258,0.079471,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.26442,0.059101,0.083648,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.17591,0.05907,0.10013,0,0
2,GO CERAMIDE METABOLIC PROCESS,0.098083,0.059005,0.12727,0,0
2,GO AZOLE TRANSMEMBRANE TRANSPORT,0.54223,0.058973,0.097373,0,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.52145,0.058878,0.055355,0,0
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.214,0.05872,0.11283,0,0
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.16602,0.058621,0.10667,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.1475,0.058559,0.1179,0,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.08588,0.05849,0.12369,0,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.47137,0.05821,0.10374,0,0
2,GO RESPONSE TO FORSKOLIN,0.27821,0.058191,0.1601,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.23827,0.05812,0.099295,0,0
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.18624,0.057969,0.12478,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.67486,0.057857,0.091257,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.08588,0.057662,0.12223,0,0
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.3148,0.05754,0.087151,0,0
2,GO ASYMMETRIC CELL DIVISION,0.65188,0.057511,0.040194,0,0
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.79394,0.057293,0.072647,0,0
2,GO NEUROBLAST DIVISION,0.62923,0.057182,0.076173,0,0
2,GO LIPID PHOSPHORYLATION,0.20822,0.057155,0.14302,0,0
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.20822,0.057121,0.094068,0,0
2,GO GLUCOSE IMPORT,0.36271,0.057097,0.077643,0,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.47137,0.057011,0.10137,0,0
2,GO CHLORIDE TRANSPORT,0.27126,0.056959,0.093997,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.23827,0.056843,0.10834,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.13467,0.056817,0.11928,0,0
2,GO REGULATION OF GLUCOSE IMPORT,0.27821,0.056792,0.084891,0,0
2,GO GLYCINE METABOLIC PROCESS,0.70989,0.056686,0.035379,0,0
2,GO ER OVERLOAD RESPONSE,0.24463,0.056591,0.10549,0,0
2,GO LACTATE METABOLIC PROCESS,0.33821,0.056536,0.068897,0,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.75756,0.05638,0.079429,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.3148,0.056319,0.10903,0,0
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.49108,0.056194,0.089051,0,0
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.40594,0.056114,0.055885,0,0
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.091819,0.056085,0.11106,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.4521,0.056049,0.0706,0,0
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.34626,0.056005,0.094201,0,0
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.08881,0.055859,0.12126,0,0
2,GO SPHINGOID METABOLIC PROCESS,0.24463,0.055745,0.13618,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.44264,0.055712,0.12532,0,0
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.074935,0.055658,0.12211,0,0
2,GO CATION TRANSPORT,0.08303,0.055649,0.11389,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.16602,0.055632,0.11539,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.21989,0.055532,0.16193,0,0
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.17591,0.055438,0.078292,0,0
2,GO KERATINOCYTE DEVELOPMENT,0.37111,0.055432,0.157,0,0
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.27821,0.055265,0.1478,0,0
2,GO MEMBRANE ORGANIZATION,0.11163,0.055128,0.12116,0,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.27821,0.05503,0.10212,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.16602,0.054832,0.10715,0,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.48117,0.054694,0.085892,0,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.26442,0.05465,0.091583,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.24463,0.054646,0.10606,0,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.24463,0.054447,0.086107,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.80618,0.054094,0.060692,0,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.74555,0.054067,0.061521,0,0
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.40594,0.054037,0.11534,0,0
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.48117,0.054023,0.092222,0,0
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.46168,0.053868,0.098255,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.17591,0.053826,0.12756,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.08303,0.053769,0.13812,0,0
2,GO CRANIAL NERVE DEVELOPMENT,0.55277,0.053637,0.070307,0,0
2,GO PENTOSE METABOLIC PROCESS,0.48117,0.053589,0.037522,0,0
2,GO NOTCH SIGNALING PATHWAY,0.2998,0.0534,0.10119,0,0
2,GO MEMBRANE REPOLARIZATION,0.40594,0.053277,0.089804,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.27821,0.053244,0.12036,0,0
2,GO REGULATION OF GROWTH,0.214,0.053188,0.12232,0,0
2,GO PEROXISOME ORGANIZATION,0.069906,0.053157,0.08367,0,0
2,GO SOMITOGENESIS,0.33821,0.053071,0.10144,0,0
2,GO OXIDATION REDUCTION PROCESS,0.065157,0.052988,0.098405,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.065157,0.052863,0.14139,0,0
2,GO EPITHELIAL CELL MATURATION,0.95582,0.052635,-0.010856,0,0
2,GO REGULATION OF CELL DIVISION,0.90549,0.05263,0.047791,0,0
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.065157,0.052612,0.091266,0,0
2,GO PEROXISOMAL TRANSPORT,0.072385,0.052406,0.093225,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.08588,0.052252,0.08845,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.34626,0.05177,0.1177,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.38829,0.051691,0.080916,0,0
2,GO EMBRYONIC MORPHOGENESIS,0.37111,0.05167,0.10595,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.43329,0.051643,0.04291,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.57414,0.051603,0.071653,0,0
2,GO FORELIMB MORPHOGENESIS,0.41494,0.0514,0.090473,0,0
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.37964,0.051228,0.036487,0,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.27126,0.051154,0.087316,0,0
2,GO VESICLE ORGANIZATION,0.12273,0.051153,0.11385,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.2259,0.051144,0.098064,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.64051,0.050881,0.08093,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.36271,0.050677,0.09163,0,0
2,GO RESPIRATORY SYSTEM PROCESS,0.2259,0.050584,0.13043,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.56341,0.050473,0.081309,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.33821,0.050331,0.074451,0,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.60692,0.050288,0.066562,0,0
2,GO ACTIVATION OF GTPASE ACTIVITY,0.23203,0.050154,0.15156,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.56341,0.049947,0.043813,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.41494,0.049911,0.10058,0,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.23203,0.049881,0.14755,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.64051,0.049581,0.064081,0,0
2,GO AUTOPHAGOSOME ORGANIZATION,0.14312,0.049508,0.13468,0,0
2,GO CELLULAR RESPONSE TO RADIATION,0.58498,0.049492,0.063553,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.49108,0.049331,0.071577,0,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.56341,0.049271,0.093162,0,0
2,GO ZINC ION TRANSPORT,0.47137,0.04916,0.044159,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.43329,0.049088,0.093914,0,0
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.53179,0.049061,0.072079,0,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,0.91805,0.049002,0.037473,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.17091,0.048979,0.10125,0,0
2,GO INTRACELLULAR MRNA LOCALIZATION,0.3148,0.048919,0.10839,0,0
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.062884,0.048721,0.1216,0,0
2,GO EXECUTION PHASE OF APOPTOSIS,0.69814,0.048641,0.054137,0,0
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.1306,0.048619,0.12334,0,0
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.25111,0.04859,0.10854,0,0
2,GO EXCRETION,0.23203,0.048497,0.12491,0,0
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.08303,0.04848,0.10376,0,0
2,GO ACID SECRETION,0.99368,0.048473,0.0025988,0,0
2,GO REGULATION OF CATABOLIC PROCESS,0.29248,0.04836,0.094949,0,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.54223,0.048052,0.074208,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.30724,0.048041,0.12505,0,0
2,GO ANOIKIS,0.28529,0.047909,0.13231,0,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.56341,0.047895,0.083801,0,0
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.38829,0.047883,0.058476,0,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.76963,0.047805,0.067248,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.21989,0.047651,0.064804,0,0
2,GO CELL AGGREGATION,0.95582,0.047542,-0.0019897,0,0
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.29248,0.047534,0.095835,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.56341,0.047453,0.11784,0,0
2,GO RESPONSE TO INSULIN,0.1475,0.04743,0.12267,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.37964,0.047411,0.060006,0,0
2,GO MITOTIC CYTOKINETIC PROCESS,0.32248,0.047329,0.053862,0,0
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.17591,0.04705,0.091734,0,0
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.16123,0.047,0.1202,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.58498,0.046886,0.060033,0,0
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.197,0.046779,0.10061,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.28529,0.046763,0.10284,0,0
2,GO RESPONSE TO NITROSATIVE STRESS,0.34626,0.046701,0.059029,0,0
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.51122,0.046295,0.075216,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.62923,0.046167,0.064101,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.48117,0.046018,0.093501,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.55277,0.046013,0.046723,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.49108,0.045948,0.08601,0,0
2,GO CARDIOLIPIN METABOLIC PROCESS,0.19156,0.045891,0.073517,0,0
2,GO ENDOCYTIC RECYCLING,0.48117,0.045815,0.10969,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.23203,0.04522,0.12878,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.86799,0.045154,0.067367,0,0
2,GO RESPONSE TO LEAD ION,0.41494,0.045143,0.078486,0,0
2,GO NUCLEOSIDE METABOLIC PROCESS,0.13467,0.04484,0.077001,0,0
2,GO REGULATION OF AXON GUIDANCE,0.38829,0.044617,0.12787,0,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.72171,0.044412,0.052428,0,0
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.98106,0.044044,-0.0064387,0,0
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.7336,0.043955,0.049735,0,0
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.056456,0.043861,0.11335,0,0
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.53179,0.043848,0.062106,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.79394,0.043839,0.076929,0,0
2,GO MITOCHONDRIAL FISSION,0.15197,0.043827,0.12025,0,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.68646,0.043746,0.062098,0,0
2,GO SKELETAL MUSCLE ADAPTATION,0.55277,0.043738,0.082159,0,0
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.37111,0.043619,0.078544,0,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.16602,0.043498,0.14226,0,0
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.69814,0.043496,0.060221,0,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.44264,0.043485,0.070616,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.43329,0.043469,0.11372,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.61803,0.04345,0.065408,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.17091,0.04335,0.097545,0,0
2,GO CELLULAR RESPONSE TO UV,0.43329,0.043264,0.06658,0,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.74555,0.043078,0.016022,0,0
2,GO PROTEIN POLYMERIZATION,0.41494,0.043059,0.09324,0,0
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.95582,0.043028,0.050694,0,0
2,GO SPERM CAPACITATION,0.25111,0.043027,0.11091,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.56341,0.042799,0.087908,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.32248,0.042768,0.12356,0,0
2,GO RESPONSE TO AXON INJURY,0.38829,0.042684,0.11484,0,0
2,GO CELL GROWTH,0.51122,0.042629,0.095222,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.62923,0.042512,0.072867,0,0
2,GO CELL CELL SIGNALING BY WNT,0.28529,0.042459,0.11603,0,0
2,GO RESPONSE TO GLUCAGON,0.56341,0.042321,0.042486,0,0
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.23203,0.042284,0.092784,0,0
2,GO EAR DEVELOPMENT,0.51122,0.042213,0.063227,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.84314,0.042203,0.015324,0,0
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.33029,0.042122,0.024287,0,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.36271,0.042088,0.093651,0,0
2,GO GMP METABOLIC PROCESS,0.91805,0.042061,0.027831,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.40594,0.042031,0.10063,0,0
2,GO RESPONSE TO MONOSACCHARIDE,0.53179,0.041998,0.076767,0,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.67486,0.041761,-0.1086,0,0
2,GO VIRION ASSEMBLY,0.056456,0.04155,0.090433,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.99368,0.041541,0.037999,0,0
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.3148,0.041474,0.079479,0,0
2,GO ACTIN NUCLEATION,0.08881,0.041445,0.12093,0,0
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.52145,0.041385,0.038155,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.1475,0.04093,0.08661,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.30724,0.040874,0.092807,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.11524,0.040749,0.12255,0,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.47137,0.040712,0.089114,0,0
2,GO ANATOMICAL STRUCTURE REGRESSION,0.64051,0.040676,0.080365,0,0
2,GO IMPORT INTO NUCLEUS,0.7336,0.040666,0.046576,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.74555,0.040638,0.051287,0,0
2,GO HORMONE TRANSPORT,0.54223,0.040596,0.071087,0,0
2,GO REGULATION OF LYASE ACTIVITY,0.40594,0.040477,0.057773,0,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.5959,0.040367,0.091072,0,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.098083,0.040281,0.18569,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.61803,0.040256,0.088931,0,0
2,GO MATING,0.33821,0.040198,0.10071,0,0
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.10811,0.040187,0.099369,0,0
2,GO ATP BIOSYNTHETIC PROCESS,0.2259,0.04018,0.10643,0,0
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.69814,0.040093,0.050867,0,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.46168,0.039954,0.087038,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.32248,0.039925,0.12296,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.37111,0.039581,0.083922,0,0
2,GO COGNITION,0.4521,0.039298,0.069363,0,0
2,GO EAR MORPHOGENESIS,0.94321,0.039258,0.021589,0,0
2,GO LYSOSOMAL TRANSPORT,0.46168,0.039245,0.10258,0,0
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.69814,0.039151,0.041624,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.60692,0.039135,0.090108,0,0
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.20256,0.039108,0.10522,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.42405,0.039044,0.094477,0,0
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.37111,0.038953,0.10126,0,0
2,GO REGULATION OF PROTEIN TARGETING,0.29248,0.03883,0.09148,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.55277,0.038667,0.073259,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.19156,0.038619,0.10748,0,0
2,GO RESPONSE TO AMPHETAMINE,0.4521,0.038438,0.060169,0,0
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.35442,0.038399,0.090207,0,0
2,GO VIRAL BUDDING,0.46168,0.038386,0.047495,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.55277,0.038371,0.10539,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.37964,0.03836,0.088193,0,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.25111,0.038276,0.12335,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.91805,0.038249,0.041685,0,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.85555,0.03822,0.0013441,0,0
2,GO CELLULAR RESPONSE TO STARVATION,0.38829,0.038154,0.09603,0,0
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.10811,0.03815,0.10849,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.214,0.037755,0.11595,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.99368,0.037752,0.014599,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.33029,0.037731,0.16049,0,0
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.27126,0.037663,0.11943,0,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.14312,0.037426,0.12747,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.12273,0.037384,0.12963,0,0
2,GO ELECTRON TRANSPORT CHAIN,0.27126,0.037346,0.0388,0,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.70989,0.037292,0.089889,0,0
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.48117,0.037263,0.047297,0,0
2,GO TOXIN TRANSPORT,0.42405,0.037253,0.085715,0,0
2,GO CELL JUNCTION ASSEMBLY,0.70989,0.037238,0.075265,0,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.43329,0.037139,0.054958,0,0
2,GO RESPONSE TO SALT,0.214,0.037007,0.10401,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.24463,0.036968,0.11231,0,0
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.50109,0.036937,0.095485,0,0
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.98106,0.036926,0.015393,0,0
2,GO CARDIAC CONDUCTION,0.78176,0.03687,0.036074,0,0
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.16123,0.036652,0.1089,0,0
2,GO EXTRACELLULAR TRANSPORT,0.61803,0.036555,0.041708,0,0
2,GO POSITIVE REGULATION OF TRANSLATION,0.37964,0.036473,0.064609,0,0
2,GO REGULATION OF HORMONE SECRETION,0.5959,0.036421,0.069973,0,0
2,GO PENILE ERECTION,0.36271,0.036279,0.094637,0,0
2,GO AUTOPHAGY OF NUCLEUS,0.56341,0.036194,0.088713,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.96843,0.036164,0.046592,0,0
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.19156,0.03607,0.084444,0,0
2,GO V D J RECOMBINATION,0.60692,0.036051,0.050041,0,0
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.53179,0.035965,0.068338,0,0
2,GO ENDOSOME ORGANIZATION,0.23203,0.035934,0.098869,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.86799,0.035874,0.085108,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.62923,0.035575,0.069674,0,0
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.74555,0.035481,0.078059,0,0
2,GO GROWTH,0.37964,0.035427,0.10453,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.40594,0.035317,0.084032,0,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.214,0.035297,0.1083,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.33029,0.035029,0.12388,0,0
2,GO RESPONSE TO CAFFEINE,0.55277,0.034999,0.053901,0,0
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.15655,0.034891,0.10316,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.53179,0.034828,0.059321,0,0
2,GO DIENCEPHALON DEVELOPMENT,0.95582,0.034806,0.039472,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.80618,0.034803,0.059755,0,0
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.26442,0.034616,0.097603,0,0
2,GO RESPONSE TO ABIOTIC STIMULUS,0.17091,0.034576,0.10531,0,0
2,GO SECRETORY GRANULE ORGANIZATION,0.55277,0.034446,0.086762,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.33821,0.034406,0.084366,0,0
2,GO GLAND DEVELOPMENT,0.2259,0.034309,0.13445,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.2998,0.034055,0.071133,0,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.34626,0.033723,0.062458,0,0
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.53179,0.033537,0.060543,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.72171,0.033367,0.043743,0,0
2,GO ONE CARBON METABOLIC PROCESS,0.67486,0.033366,0.025292,0,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.27126,0.033126,0.10514,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.19156,0.033057,0.10219,0,0
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.3148,0.032922,0.095531,0,0
2,GO REGULATION OF AUTOPHAGY,0.27821,0.032905,0.10615,0,0
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.47137,0.032816,0.081873,0,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.89296,0.032791,-0.017038,0,0
2,GO POLYOL METABOLIC PROCESS,0.46168,0.032766,0.080108,0,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.39705,0.032758,0.090289,0,0
2,GO APPENDAGE MORPHOGENESIS,0.65188,0.032737,0.091059,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.46168,0.032612,0.078889,0,0
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.54223,0.032372,0.069749,0,0
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.43329,0.032287,0.095266,0,0
2,GO DNA CATABOLIC PROCESS,0.53179,0.032045,0.054831,0,0
2,GO NUCLEOBASE METABOLIC PROCESS,0.4521,0.03168,0.052943,0,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.2259,0.03168,0.1225,0,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.42405,0.03155,0.090408,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.75756,0.031504,0.010524,0,0
2,GO REGULATION OF PROTEIN DEACETYLATION,0.38829,0.03119,0.094423,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.90549,0.031164,0.031473,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.89296,0.031064,0.024967,0,0
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.80618,0.030903,0.046711,0,0
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.21989,0.030903,0.060077,0,0
2,GO REGULATION OF GASTRIC ACID SECRETION,0.76963,0.030839,-0.0019251,0,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.53179,0.030578,0.10479,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.37111,0.030571,0.083071,0,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.52145,0.030104,0.094855,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.37111,0.02988,0.084384,0,0
2,GO ACTION POTENTIAL,0.79394,0.029782,0.03737,0,0
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.15197,0.02967,0.10783,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.5959,0.029655,0.053251,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.54223,0.029482,0.083668,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.47137,0.02936,0.10914,0,0
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.2998,0.029286,0.048447,0,0
2,GO SUBPALLIUM DEVELOPMENT,0.91805,0.029128,0.017092,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.2998,0.029038,0.081487,0,0
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.40594,0.029013,0.077594,0,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.2577,0.028972,0.1045,0,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.64051,0.028969,0.094754,0,0
2,GO RESPONSE TO GONADOTROPIN,0.69814,0.028968,0.057187,0,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.57414,0.028919,0.046406,0,0
2,GO MITOCHONDRION DISTRIBUTION,0.65188,0.028904,0.093766,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.70989,0.02888,0.064529,0,0
2,GO FRUCTOSE METABOLIC PROCESS,0.44264,0.028794,0.090187,0,0
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.15197,0.028558,0.11675,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.67486,0.028444,0.051823,0,0
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.25111,0.02832,0.10199,0,0
2,GO RESPONSE TO ETHER,0.11524,0.028241,0.16132,0,0
2,GO MOTILE CILIUM ASSEMBLY,0.66333,0.028188,-0.049615,0,0
2,GO SENSORY PERCEPTION OF BITTER TASTE,0.80618,0.028124,-0.0035569,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.88046,0.028,0.033823,0,0
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.62923,0.027804,0.071743,0,0
2,GO REGULATION OF OOGENESIS,0.78176,0.027789,0.03482,0,0
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.61803,0.02756,0.060083,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.65188,0.027437,0.078057,0,0
2,GO GONADOTROPIN SECRETION,0.64051,0.027417,0.055259,0,0
2,GO PORE COMPLEX ASSEMBLY,0.55277,0.027366,0.056248,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.76963,0.027301,0.06183,0,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.46168,0.027187,-0.078202,0,0
2,GO TUBE FORMATION,0.67486,0.027157,0.070983,0,0
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.10811,0.02715,0.13177,0,0
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.66333,0.027074,0.027007,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.37964,0.026975,0.08918,0,0
2,GO SHORT TERM MEMORY,0.37964,0.026911,0.11047,0,0
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.32248,0.026658,0.075713,0,0
2,GO STRIATED MUSCLE ADAPTATION,0.62923,0.026445,0.082523,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.54223,0.02624,0.082848,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.51122,0.026206,0.086025,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.37964,0.026174,0.082569,0,0
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.65188,0.026126,0.063478,0,0
2,GO GASTRIC ACID SECRETION,0.96843,0.02603,-0.010762,0,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.55277,0.026021,-0.012928,0,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.51122,0.025979,0.094862,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.47137,0.0259,0.11399,0,0
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.93062,0.02586,0.0017511,0,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.91805,0.025849,0.034493,0,0
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.26442,0.025845,0.07037,0,0
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.26442,0.025819,0.072879,0,0
2,GO REGULATION OF ACTIN NUCLEATION,0.38829,0.025795,0.086561,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.61803,0.025709,0.093677,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.85555,0.025552,-0.0044745,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.37111,0.02495,0.077904,0,0
2,GO CELLULAR SENESCENCE,0.36271,0.024917,0.067201,0,0
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.70989,0.024869,0.070212,0,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.62923,0.024753,0.081985,0,0
2,GO NOTCH RECEPTOR PROCESSING,0.79394,0.02467,-0.0058571,0,0
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.2577,0.024496,0.081673,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.4521,0.024448,0.083494,0,0
2,GO SECONDARY METABOLIC PROCESS,0.39705,0.024362,0.054656,0,0
2,GO REFLEX,0.98106,0.024321,0.032545,0,0
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.47137,0.024275,0.085863,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.54223,0.024201,0.07526,0,0
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.38829,0.024196,0.12852,0,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.214,0.024129,0.12169,0,0
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.4521,0.024028,0.089057,0,0
2,GO PIGMENTATION,0.60692,0.023842,0.064305,0,0
2,GO DIOL BIOSYNTHETIC PROCESS,0.78176,0.023613,0.0065582,0,0
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.57414,0.023512,0.032837,0,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.99368,0.023376,0.0051206,0,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.52145,0.023288,0.079865,0,0
2,GO DEVELOPMENTAL PIGMENTATION,0.4521,0.023184,0.093865,0,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.47137,0.023011,0.14961,0,0
2,GO THIOESTER METABOLIC PROCESS,0.23827,0.022765,0.085561,0,0
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.42405,0.022676,0.0802,0,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.84314,0.02265,0.018593,0,0
2,GO REGULATION OF CYCLASE ACTIVITY,0.61803,0.022564,0.042248,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.44264,0.022539,0.10106,0,0
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.53179,0.022425,0.053683,0,0
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.62923,0.022213,-0.094707,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.79394,0.022192,0.049623,0,0
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.88046,0.02215,-0.01824,0,0
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.46168,0.022042,0.10342,0,0
2,GO STRIATUM DEVELOPMENT,0.68646,0.022039,0.049578,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.53179,0.022016,0.076678,0,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.3148,0.021967,0.086472,0,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.83078,0.021857,0.006949,0,0
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.83078,0.021839,0.050286,0,0
2,GO ERYTHROCYTE MATURATION,0.41494,0.021785,0.087991,0,0
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.64051,0.021748,0.065577,0,0
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.54223,0.021732,0.082014,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.68646,0.021587,0.066224,0,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.70989,0.021571,0.098926,0,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.74555,0.021551,0.052803,0,0
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.98106,0.02153,0.025207,0,0
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.33029,0.021446,0.10342,0,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.91805,0.021424,0.063135,0,0
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.62923,0.021348,-0.089977,0,0
2,GO IMPORT INTO CELL,0.29248,0.021066,0.097499,0,0
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.78176,0.020936,0.069097,0,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.85555,0.020903,0.022165,0,0
2,GO CARBOHYDRATE METABOLIC PROCESS,0.27126,0.020794,0.09483,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.93062,0.020711,0.058085,0,0
2,GO DEPHOSPHORYLATION,0.55277,0.020686,0.073594,0,0
2,GO REGULATION OF TELOMERASE ACTIVITY,0.96843,0.020647,0.024835,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.78176,0.020556,0.034012,0,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.96843,0.020421,0.039194,0,0
2,GO CELL JUNCTION ORGANIZATION,0.85555,0.020403,0.061057,0,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.67486,0.02037,-0.089913,0,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.98106,0.020311,0.061076,0,0
2,GO CELL AGING,0.40594,0.020222,0.074335,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.67486,0.020173,0.069831,0,0
2,GO NEUROBLAST PROLIFERATION,0.83078,0.02008,0.055265,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.58498,0.019914,0.049208,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.62923,0.019879,0.085377,0,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.81845,0.019826,0.051251,0,0
2,GO REGULATION OF PROTEIN STABILITY,0.39705,0.019825,0.078706,0,0
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.58498,0.019638,0.089665,0,0
2,GO VACUOLAR TRANSPORT,0.46168,0.019593,0.093403,0,0
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.33821,0.019524,0.088215,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.64051,0.019445,0.078805,0,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.51122,0.01939,0.065944,0,0
2,GO REGULATION OF CELL DEVELOPMENT,0.98106,0.019364,0.065502,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.64051,0.019315,0.064761,0,0
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.89296,0.019221,0.043697,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.48117,0.019138,0.11,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.67486,0.01906,0.06399,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.88046,0.019051,0.054114,0,0
2,GO EPITHELIAL TUBE FORMATION,0.75756,0.019047,0.061202,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.81845,0.018847,0.027677,0,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.62923,0.01883,0.075891,0,0
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.37964,0.018627,0.078759,0,0
2,GO CARBOHYDRATE PHOSPHORYLATION,0.44264,0.018519,0.076266,0,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.57414,0.018499,0.03949,0,0
2,GO FATTY ACID CATABOLIC PROCESS,0.66333,0.018494,0.053804,0,0
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.98106,0.018454,0.03632,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.49108,0.018398,0.070405,0,0
2,GO LIPOPROTEIN METABOLIC PROCESS,0.3148,0.018248,0.094251,0,0
2,GO NAD METABOLIC PROCESS,0.60692,0.018221,0.073121,0,0
2,GO LACTATION,0.48117,0.018219,0.08795,0,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.76963,0.018187,-0.027726,0,0
2,GO MALE SEX DIFFERENTIATION,0.3148,0.017993,0.11508,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.79394,0.017953,0.03437,0,0
2,GO ACTIN CROSSLINK FORMATION,0.51122,0.017948,0.1036,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.88046,0.017863,0.011665,0,0
2,GO REPRODUCTION,0.85555,0.01777,0.050593,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.37111,0.017661,0.088876,0,0
2,GO UTERUS DEVELOPMENT,0.33821,0.017622,0.12026,0,0
2,GO DENDRITIC SPINE MAINTENANCE,0.42405,0.017622,0.11816,0,0
2,GO RESPONSE TO WATER,0.69814,0.017529,0.055704,0,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.4521,0.017508,0.092418,0,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.86799,0.017503,0.034756,0,0
2,GO THYROID GLAND DEVELOPMENT,0.96843,0.017453,0.023204,0,0
2,GO RESPONSE TO STARVATION,0.48117,0.017389,0.080394,0,0
2,GO ADAPTATION OF SIGNALING PATHWAY,0.62923,0.017301,0.053206,0,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.74555,0.0173,0.074994,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.81845,0.017288,-0.031889,0,0
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.37111,0.017276,0.1285,0,0
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.88046,0.017167,0.041251,0,0
2,GO SEX DIFFERENTIATION,0.49108,0.017112,0.089525,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.66333,0.016991,0.076697,0,0
2,GO MAINTENANCE OF CELL POLARITY,0.70989,0.016984,0.0568,0,0
2,GO MEMORY,0.61803,0.016858,0.058234,0,0
2,GO REGULATION OF CELL AGING,0.99368,0.016819,0.011707,0,0
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.90549,0.016775,0.0012299,0,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.43329,0.016752,0.077669,0,0
2,GO RETINA HOMEOSTASIS,0.50109,0.016574,0.039914,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.7336,0.01634,-0.040167,0,0
2,GO CELL MORPHOGENESIS,0.83078,0.016322,0.079128,0,0
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.56341,0.01595,0.058006,0,0
2,GO DEVELOPMENTAL GROWTH,0.69814,0.015774,0.076851,0,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.69814,0.015756,0.062996,0,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.56341,0.01563,0.081325,0,0
2,GO LIPID GLYCOSYLATION,0.56341,0.01542,0.085754,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.89296,0.015419,0.069449,0,0
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.53179,0.015316,0.085582,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.197,0.015312,0.14748,0,0
2,GO PIGMENT ACCUMULATION,0.48117,0.0152,0.11454,0,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.27821,0.01519,0.12323,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.96843,0.015071,0.034279,0,0
2,GO NEURONAL ACTION POTENTIAL,0.95582,0.014985,0.01508,0,0
2,GO RESPONSE TO ACTIVITY,0.30724,0.014887,0.087525,0,0
2,GO INNER EAR MORPHOGENESIS,0.88046,0.014759,0.0044329,0,0
2,GO RESPONSE TO MUSCLE ACTIVITY,0.72171,0.014621,0.050782,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.89296,0.014348,-0.041941,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.86799,0.014331,0.062031,0,0
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.26442,0.014276,0.090542,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.64051,0.014234,0.084,0,0
2,GO SENSORY PERCEPTION,0.83078,0.014051,0.034651,0,0
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.40594,0.014,0.095348,0,0
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.78176,0.01392,0.053369,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.29248,0.013863,0.07804,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.80618,0.013784,0.020331,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.51122,0.013759,0.084214,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.57414,0.013744,0.078543,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.38829,0.013547,-0.059037,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.85555,0.013519,0.0043863,0,0
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.37111,0.013497,0.069442,0,0
2,GO DETECTION OF STIMULUS,0.68646,0.012873,0.048207,0,0
2,GO COCHLEA MORPHOGENESIS,0.51122,0.012771,0.061873,0,0
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.69814,0.01275,0.0024861,0,0
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.20256,0.012733,0.10356,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,1,0.012726,-0.0025234,0,0
2,GO MULTI ORGANISM LOCALIZATION,0.89296,0.012611,0.032049,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.94321,0.012493,0.032804,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.83078,0.012332,0.025891,0,0
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.52145,0.012126,-0.069474,0,0
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.83078,0.011994,0.018716,0,0
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.76963,0.01183,0.070815,0,0
2,GO AXONAL FASCICULATION,0.76963,0.011804,-0.022226,0,0
2,GO RESPONSE TO HEAT,0.50109,0.011786,0.072193,0,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.48117,0.011717,0.092301,0,0
2,GO VESICLE LOCALIZATION,0.99368,0.011685,0.050633,0,0
2,GO NEURON PROJECTION REGENERATION,0.5959,0.011583,0.099779,0,0
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.89296,0.011516,0.024667,0,0
2,GO KERATINIZATION,0.17591,0.011492,0.16319,0,0
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.51122,0.011455,0.083065,0,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.76963,0.011444,-0.011891,0,0
2,GO REGULATION OF PROTEIN ACETYLATION,0.70989,0.01125,0.06401,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.7336,0.010983,0.033897,0,0
2,GO PROTEIN STABILIZATION,0.83078,0.010881,0.057947,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.96843,0.010842,0.052455,0,0
2,GO REGULATION OF FERTILIZATION,0.64051,0.010718,0.035425,0,0
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.98106,0.010635,0.041375,0,0
2,GO RESPONSE TO STEROL DEPLETION,0.58498,0.010608,0.09443,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.99368,0.0106,0.041996,0,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.60692,0.010259,0.080323,0,0
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.54223,0.010121,0.056786,0,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.46168,0.0099353,-0.12834,0,0
2,GO FEMALE SEX DIFFERENTIATION,0.34626,0.0099327,0.096641,0,0
2,GO FEAR RESPONSE,0.85555,0.0095364,0.0050518,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.80618,0.0094666,0.02778,0,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.94321,0.009428,0.057308,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,1,0.0091891,0.03601,0,0
2,GO NERVE DEVELOPMENT,0.80618,0.0089118,0.0087021,0,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.80618,0.008825,0.040485,0,0
2,GO RESPONSE TO UV,0.93062,0.0086689,0.03961,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.95582,0.0086423,0.037067,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.33029,0.0086178,0.09235,0,0
2,GO SPECIFICATION OF SYMMETRY,0.68646,0.0084647,0.068982,0,0
2,GO MACROMOLECULE CATABOLIC PROCESS,0.58498,0.0084379,0.064451,0,0
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.89296,0.0083833,0.011751,0,0
2,GO REGULATION OF ACTION POTENTIAL,0.58498,0.0083388,0.071215,0,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.78176,0.0081022,0.072339,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.75756,0.0080286,0.073626,0,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.5959,0.0078453,0.07936,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.93062,0.0077517,0.022706,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.74555,0.0076198,0.064392,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.55277,0.0074406,0.075289,0,0
2,GO REGULATION OF CELLULAR RESPIRATION,0.70989,0.0072686,0.040931,0,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,1,0.0071097,-0.005327,0,0
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.57414,0.0071095,0.055166,0,0
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.94321,0.0070804,0.0058772,0,0
2,GO CELLULAR RESPONSE TO HEAT,0.95582,0.0069702,0.046005,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.84314,0.0069585,0.032076,0,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.93062,0.0066698,0.033073,0,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.88046,0.0065428,0.03753,0,0
2,GO SPERM EGG RECOGNITION,0.91805,0.0065091,-0.0026708,0,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.60692,0.006468,-0.08323,0,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.75756,0.006443,0.060656,0,0
2,GO FATTY ACID HOMEOSTASIS,0.66333,0.0063395,0.066443,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.61803,0.0063044,0.05367,0,0
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.64051,0.0061948,0.050438,0,0
2,GO GOLGI VESICLE TRANSPORT,0.74555,0.0060924,0.067505,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.81845,0.0060863,0.040338,0,0
2,GO RHYTHMIC PROCESS,0.75756,0.0059582,0.061577,0,0
2,GO NERVOUS SYSTEM PROCESS,0.83078,0.0058884,0.036757,0,0
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.89296,0.0058392,0.0062124,0,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.67486,0.0057238,0.041218,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.54223,0.0057133,0.083806,0,0
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.7336,0.0056579,0.02743,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.2998,0.0054915,0.099395,0,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.91805,0.0053209,0.033676,0,0
2,GO PITUITARY GLAND DEVELOPMENT,0.90549,0.0051866,0.034661,0,0
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.5959,0.0047867,0.060894,0,0
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.95582,0.0047316,0.032715,0,0
2,GO GLUCOSE METABOLIC PROCESS,0.93062,0.0047121,0.045152,0,0
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.90549,0.004619,0.004933,0,0
2,GO REGULATION OF FEEDING BEHAVIOR,0.94321,0.0044963,-0.0069547,0,0
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.56341,0.0044956,0.066021,0,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.93062,0.0044767,0.054149,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.79394,0.0042612,0.086773,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.79394,0.0041668,0.062643,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.78176,0.0041508,0.060389,0,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.51122,0.0040787,0.091698,0,0
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.44264,0.0040497,0.050483,0,0
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.74555,0.0040282,0.037266,0,0
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.67486,0.0036591,0.047352,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.7336,0.0036419,0.058588,0,0
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.4521,0.0036102,0.083714,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.99368,0.003318,0.062446,0,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.96843,0.003001,-0.012588,0,0
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.94321,0.0029732,0.036308,0,0
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.79394,0.0028621,0.063399,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,0.95582,0.0027579,0.047106,0,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.90549,0.0025715,-0.011166,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.99368,0.0025659,0.026775,0,0
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.81845,0.002547,0.014401,0,0
2,GO NEURON PROJECTION GUIDANCE,0.81845,0.0023239,0.03537,0,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.46168,0.0022582,0.066563,0,0
2,GO DIVALENT METAL ION EXPORT,0.95582,0.002185,0.017467,0,0
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.93062,0.0021301,0.031395,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.98106,0.0019387,0.027051,0,0
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.61803,0.001797,0.056609,0,0
2,GO CYTOKINETIC PROCESS,0.85555,0.00168,-0.0032403,0,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.75756,0.0016616,0.072237,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.95582,0.0015356,0.055798,0,0
2,GO RESPONSE TO CATECHOLAMINE,0.90549,0.0013544,0.03142,0,0
2,GO MULTIVESICULAR BODY ORGANIZATION,0.58498,0.0012739,0.044039,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.94321,0.00090785,0.045821,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.91805,0.00081158,0.0086798,0,0
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.47137,0.0006587,-0.060347,0,0
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.90549,0.0006404,0.033179,0,0
2,GO RESPONSE TO AMINO ACID STARVATION,0.96843,0.00063981,0.042642,0,0
2,GO ASSOCIATIVE LEARNING,0.76963,0.00058754,0.0027839,0,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.96843,0.00037702,0.041744,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.76963,0.0003628,0.05729,0,0
2,GO RESPONSE TO ALKALOID,0.80618,0.00035449,0.015941,0,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.67486,0.0003386,0.039923,0,0
2,GO THYMUS DEVELOPMENT,0.83078,0.00021284,0.043178,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.90549,2.9116e-05,0.051913,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.62923,5.8627e-06,0.062884,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.95582,-9.1246e-05,0.040324,0,0
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.76963,-0.00020111,0.068962,0,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.88046,-0.00024368,0.04831,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.66333,-0.0004877,-0.031295,0,0
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.49108,-0.00068691,0.058223,0,0
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.72171,-0.0008341,0.049318,0,0
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.64051,-0.00091422,0.097282,0,0
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.64051,-0.00105,0.054969,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.94321,-0.0010601,0.041589,0,0
2,GO PRIMARY MIRNA PROCESSING,0.86799,-0.0010738,0.032656,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.53179,-0.0011081,0.10562,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.94321,-0.0011349,0.03828,0,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.98106,-0.0012531,0.011866,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.62923,-0.0013863,0.086499,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.42405,-0.0013933,-0.047818,0,0
2,GO PROTEIN CATABOLIC PROCESS,0.61803,-0.0014355,0.070555,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.93062,-0.0014523,0.044279,0,0
2,GO PEPTIDE METABOLIC PROCESS,0.65188,-0.0014978,0.030871,0,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.74555,-0.0017067,-0.023053,0,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.7336,-0.0017673,0.00089277,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.62923,-0.0017892,0.083913,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.78176,-0.002119,0.056066,0,0
2,GO VIRAL GENE EXPRESSION,0.89296,-0.0021958,-0.001229,0,0
2,GO HISTONE H3 K9 ACETYLATION,0.7336,-0.0022229,-0.029868,0,0
2,GO HEPATOCYTE DIFFERENTIATION,0.83078,-0.0022883,0.040842,0,0
2,GO NOREPINEPHRINE TRANSPORT,0.43329,-0.0023426,0.12303,0,0
2,GO NEUROTRANSMITTER REUPTAKE,0.98106,-0.0023753,0.018124,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.67486,-0.0028124,0.019551,0,0
2,GO PEPTIDYL SERINE MODIFICATION,0.96843,-0.002824,0.062753,0,0
2,GO PROTEIN POLYUBIQUITINATION,0.75756,-0.0028372,0.021875,0,0
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.65188,-0.0029144,0.037287,0,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.26442,-0.0031795,0.10773,0,0
2,GO PROTEIN TARGETING,0.84314,-0.0031818,0.022902,0,0
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.83078,-0.0032738,0.038061,0,0
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.83078,-0.0033199,0.011978,0,0
2,GO DIOL METABOLIC PROCESS,1,-0.0033363,0.020035,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.84314,-0.0033638,-0.0012762,0,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.86799,-0.0034021,-0.0097734,0,0
2,GO MULTI ORGANISM PROCESS,0.94321,-0.0036188,0.033288,0,0
2,GO REGULATION OF GONAD DEVELOPMENT,0.99368,-0.0041254,0.015944,0,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.72171,-0.0043127,0.084843,0,0
2,GO QUINONE METABOLIC PROCESS,0.80618,-0.0043275,-0.0032919,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.93062,-0.0045526,0.045843,0,0
2,GO MACROAUTOPHAGY,0.68646,-0.0045984,0.066995,0,0
2,GO AMP METABOLIC PROCESS,0.39705,-0.0046278,0.045928,0,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,1,-0.0046784,0.026888,0,0
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.94321,-0.0046899,0.039002,0,0
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.95582,-0.0046955,0.010665,0,0
2,GO APICAL PROTEIN LOCALIZATION,0.53179,-0.0047319,0.087846,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.65188,-0.0047456,0.038318,0,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.93062,-0.0050863,0.050934,0,0
2,GO REGULATION OF GLUTAMATE SECRETION,0.60692,-0.0052055,-0.059361,0,0
2,GO DNA BIOSYNTHETIC PROCESS,0.5959,-0.0052132,0.0096684,0,0
2,GO REGULATION OF ATP METABOLIC PROCESS,1,-0.0052629,0.035226,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.58498,-0.0053035,0.073101,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.5959,-0.0053165,0.073112,0,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.7336,-0.0054297,0.05381,0,0
2,GO CELLULAR RESPONSE TO PH,0.96843,-0.0054669,0.037927,0,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.98106,-0.0058203,0.043079,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.90549,-0.0058449,0.059175,0,0
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.93062,-0.0059255,0.024838,0,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.91805,-0.0059588,0.036355,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.84314,-0.0060712,0.013958,0,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.84314,-0.0061437,0.014286,0,0
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.99368,-0.0061743,0.042847,0,0
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.83078,-0.0062697,0.033262,0,0
2,GO BLASTOCYST GROWTH,0.85555,-0.0062697,0.0038424,0,0
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.51122,-0.0062736,-0.067297,0,0
2,GO COPII COATED VESICLE CARGO LOADING,0.67486,-0.0063837,0.084999,0,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.76963,-0.0066003,0.045668,0,0
2,GO REGULATION OF DNA METABOLIC PROCESS,0.68646,-0.006799,0.015431,0,0
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.85555,-0.0068309,0.016648,0,0
2,GO SCHWANN CELL DIFFERENTIATION,0.67486,-0.0068428,0.047147,0,0
2,GO TRANSFERRIN TRANSPORT,0.95582,-0.0068921,0.030355,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.72171,-0.0071995,-0.020936,0,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.96843,-0.0072316,0.03267,0,0
2,GO RESPONSE TO PAIN,0.86799,-0.0072453,0.027693,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.99368,-0.0073024,0.050596,0,0
2,GO PEPTIDE HORMONE SECRETION,0.93062,-0.007416,0.038273,0,0
2,GO REGULATION OF INSULIN SECRETION,1,-0.0075143,0.041844,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.91805,-0.0075484,0.050995,0,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.70989,-0.007719,0.02742,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.98106,-0.0077342,0.077373,0,0
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,1,-0.0078126,0.019873,0,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.7336,-0.0078321,0.066587,0,0
2,GO GOLGI LOCALIZATION,0.70989,-0.0079672,0.00013321,0,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.81845,-0.0080522,0.046071,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.75756,-0.0080552,-0.001121,0,0
2,GO CARDIAC CHAMBER FORMATION,0.61803,-0.0080704,-0.069131,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.94321,-0.0080782,0.050735,0,0
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.94321,-0.0080795,0.055596,0,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.84314,-0.008131,0.067819,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.80618,-0.0082631,0.053704,0,0
2,GO REGULATION OF ATPASE ACTIVITY,0.95582,-0.0083173,0.027393,0,0
2,GO PANCREAS DEVELOPMENT,0.96843,-0.0083688,0.044231,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.80618,-0.0085952,0.022578,0,0
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.72171,-0.0086568,0.068334,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.86799,-0.008659,0.021355,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.86799,-0.0086844,0.04239,0,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.83078,-0.0087283,0.027749,0,0
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.94321,-0.0089872,0.013612,0,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.69814,-0.0090354,-0.046219,0,0
2,GO RESPONSE TO FOOD,0.50109,-0.0090659,-0.0666,0,0
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.79394,-0.0091136,0.055931,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.67486,-0.0093215,-0.00078308,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.83078,-0.0094265,0.013656,0,0
2,GO PRO B CELL DIFFERENTIATION,0.84314,-0.009503,-0.0034392,0,0
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.78176,-0.0095102,-0.019505,0,0
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.88046,-0.0095777,0.0018571,0,0
2,GO MITOCHONDRION ORGANIZATION,0.74555,-0.0096803,0.013106,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.81845,-0.009745,0.014811,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.61803,-0.0098384,-0.012798,0,0
2,GO ACETYL COA METABOLIC PROCESS,0.5959,-0.0098822,0.079763,0,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.94321,-0.0099109,0.035255,0,0
2,GO APPENDAGE DEVELOPMENT,0.72171,-0.0099332,0.085285,0,0
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.95582,-0.0099873,0.050961,0,0
2,GO CELL FATE SPECIFICATION,0.72171,-0.010049,0.035916,0,0
2,GO DNA METHYLATION OR DEMETHYLATION,0.64051,-0.010267,-0.0090352,0,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.60692,-0.010313,-0.022879,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.32248,-0.010448,-0.11337,0,0
2,GO FUCOSYLATION,0.99368,-0.010471,0.0039001,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.83078,-0.010516,0.043104,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.89296,-0.010937,0.047418,0,0
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.42405,-0.011009,-0.052805,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.84314,-0.011073,0.065069,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.50109,-0.011099,0.085903,0,0
2,GO REGULATION OF DNA METHYLATION,0.94321,-0.01122,0.012527,0,0
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.78176,-0.011373,0.049219,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.94321,-0.011625,0.02588,0,0
2,GO CELL CYCLE ARREST,0.76963,-0.011802,0.012097,0,0
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.69814,-0.011842,0.0019757,0,0
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.99368,-0.01186,0.039964,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.55277,-0.012,-0.12794,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.54223,-0.012036,-0.028994,0,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.56341,-0.012095,0.077302,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.94321,-0.012355,0.038444,0,0
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.69814,-0.012368,0.054755,0,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.76963,-0.012527,0.06773,0,0
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.80618,-0.012674,0.032238,0,0
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.98106,-0.01272,0.011517,0,0
2,GO CELL PROLIFERATION IN FOREBRAIN,1,-0.012828,0.013893,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.54223,-0.013026,-0.021839,0,0
2,GO CILIUM MOVEMENT,0.90549,-0.013102,-0.018077,0,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.68646,-0.013166,0.079658,0,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.72171,-0.013215,0.0032297,0,0
2,GO AMMONIUM ION METABOLIC PROCESS,0.89296,-0.013248,0.026621,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.98106,-0.013351,0.037794,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.96843,-0.013419,0.018611,0,0
2,GO PIGMENT METABOLIC PROCESS,0.60692,-0.01342,0.057187,0,0
2,GO GLYCOSYLATION,0.44264,-0.013517,0.080801,0,0
2,GO HEXOSE CATABOLIC PROCESS,0.65188,-0.01353,0.012509,0,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.79394,-0.013974,0.066424,0,0
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.70989,-0.014,-0.012082,0,0
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.75756,-0.01419,0.051732,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.81845,-0.014322,0.0047457,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.7336,-0.014366,0.0062865,0,0
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.5959,-0.014514,-0.030892,0,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.89296,-0.014555,0.040624,0,0
2,GO ENDOSOMAL TRANSPORT,0.64051,-0.014581,0.076597,0,0
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.68646,-0.014603,0.014573,0,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.95582,-0.01464,0.02457,0,0
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.89296,-0.014656,0.031553,0,0
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.98106,-0.014762,0.050543,0,0
2,GO PROTEIN TARGETING TO MEMBRANE,0.54223,-0.014838,-0.0065369,0,0
2,GO NEURON RECOGNITION,0.98106,-0.014872,0.020403,0,0
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.81845,-0.014893,0.05806,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.61803,-0.015179,0.064764,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.67486,-0.015378,-0.010325,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.79394,-0.015608,-0.011017,0,0
2,GO ORGANELLE INHERITANCE,0.5959,-0.015753,-0.010622,0,0
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.89296,-0.015894,0.026914,0,0
2,GO TOR SIGNALING,0.72171,-0.01597,0.029684,0,0
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.93062,-0.016005,0.02935,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.98106,-0.016257,0.041681,0,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.88046,-0.016367,0.044991,0,0
2,GO RESPONSE TO RADIATION,0.98106,-0.016644,0.040828,0,0
2,GO PSEUDOURIDINE SYNTHESIS,0.78176,-0.016738,-0.0182,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.65188,-0.016791,-0.012208,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.81845,-0.016823,0.0066325,0,0
2,GO CYTOPLASMIC TRANSLATION,0.19156,-0.016839,-0.04746,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.52145,-0.016851,-0.026032,0,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.65188,-0.017005,0.017904,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.85555,-0.017023,-0.0021258,0,0
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.70989,-0.017039,0.058832,0,0
2,GO FOREBRAIN CELL MIGRATION,0.75756,-0.017048,0.0048904,0,0
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.61803,-0.017098,-0.027534,0,0
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.55277,-0.017108,-0.029691,0,0
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.55277,-0.017255,0.058409,0,0
2,GO NEUROTRANSMITTER UPTAKE,0.88046,-0.017347,0.042032,0,0
2,GO INTRACELLULAR TRANSPORT,0.86799,-0.017371,0.033793,0,0
2,GO SENSORY PERCEPTION OF TASTE,0.55277,-0.017397,0.031578,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.68646,-0.017409,0.027866,0,0
2,GO HISTONE H2B UBIQUITINATION,0.89296,-0.017498,0.0043849,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.83078,-0.017522,0.0061116,0,0
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.69814,-0.017681,-0.00023356,0,0
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.99368,-0.017947,0.029756,0,0
2,GO COCHLEA DEVELOPMENT,0.86799,-0.018001,0.0019885,0,0
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.49108,-0.018267,0.06059,0,0
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.98106,-0.018405,0.047308,0,0
2,GO REGULATION OF CENTROSOME DUPLICATION,0.26442,-0.018446,-0.081213,0,0
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.67486,-0.01853,-0.015001,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.84314,-0.018571,0.050597,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.85555,-0.018644,0.013314,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.61803,-0.018948,0.0029807,0,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.98106,-0.018952,0.026828,0,0
2,GO EMBRYO DEVELOPMENT,0.75756,-0.019169,0.07021,0,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.96843,-0.019326,0.030416,0,0
2,GO NUCLEOTIDE TRANSPORT,0.80618,-0.019452,0.016286,0,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.79394,-0.019712,0.016582,0,0
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.214,-0.019759,-0.13196,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.90549,-0.019874,0.043351,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.76963,-0.019901,0.024017,0,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.85555,-0.020027,0.012365,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.58498,-0.020099,-0.0024166,0,0
2,GO COBALAMIN METABOLIC PROCESS,0.57414,-0.020127,0.067489,0,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.75756,-0.020152,-0.0046796,0,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.86799,-0.020233,0.028982,0,0
2,GO CGMP METABOLIC PROCESS,0.72171,-0.020278,-0.028142,0,0
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.86799,-0.020457,0.041611,0,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.98106,-0.020617,0.02301,0,0
2,GO GOLGI ORGANIZATION,0.83078,-0.020813,0.06341,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.67486,-0.02083,-0.0028891,0,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.7336,-0.021051,-0.034151,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.7336,-0.021051,-0.018192,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.67486,-0.021262,-0.015252,0,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.79394,-0.021284,0.039633,0,0
2,GO NUCLEOSIDE SALVAGE,0.94321,-0.021312,0.013606,0,0
2,GO ORGANELLE LOCALIZATION,0.4521,-0.021339,-0.0090178,0,0
2,GO EXOCYTIC PROCESS,0.5959,-0.021346,0.017477,0,0
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.4521,-0.021385,-0.018535,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.19156,-0.021445,-0.14564,0,0
2,GO CRANIAL NERVE MORPHOGENESIS,0.94321,-0.021487,0.041561,0,0
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.78176,-0.021489,0.016859,0,0
2,GO MONOAMINE TRANSPORT,0.88046,-0.02149,0.020856,0,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.40594,-0.021619,-0.064196,0,0
2,GO VESICLE DOCKING,0.60692,-0.021649,0.022266,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.37964,-0.021678,-0.080215,0,0
2,GO REGULATION OF MEMBRANE POTENTIAL,0.56341,-0.021687,-0.0089093,0,0
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.62923,-0.021722,-0.011714,0,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.74555,-0.021739,0.0037391,0,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.64051,-0.021758,0.019271,0,0
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.43329,-0.021829,-0.012495,0,0
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.79394,-0.022037,0.037239,0,0
2,GO SOMITE DEVELOPMENT,0.66333,-0.022058,0.080978,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.66333,-0.022159,0.023501,0,0
2,GO AMINO ACID TRANSPORT,0.96843,-0.022281,0.036292,0,0
2,GO IMP METABOLIC PROCESS,0.49108,-0.022351,-0.043708,0,0
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.4521,-0.022412,-0.049007,0,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.7336,-0.022434,-0.017166,0,0
2,GO MALE SEX DETERMINATION,0.55277,-0.022497,-0.086189,0,0
2,GO BLASTOCYST DEVELOPMENT,0.37111,-0.022498,-0.01803,0,0
2,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.66333,-0.022592,-0.0060769,0,0
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.80618,-0.022777,-0.025429,0,0
2,GO MAINTENANCE OF CELL NUMBER,0.78176,-0.023015,0.04547,0,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.83078,-0.023027,0.019431,0,0
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.74555,-0.023192,0.078048,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.65188,-0.023261,-0.030109,0,0
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.67486,-0.023416,-0.002088,0,0
2,GO NEUROGENESIS,0.7336,-0.023438,0.029432,0,0
2,GO RNA SURVEILLANCE,0.26442,-0.023467,-0.069996,0,0
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.72171,-0.023617,-0.031363,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.85555,-0.023629,-0.0068912,0,0
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.62923,-0.023633,-0.044782,0,0
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.65188,-0.023638,0.0095711,0,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.48117,-0.02372,-0.066496,0,0
2,GO REGULATION OF CELL SIZE,0.93062,-0.023759,0.058291,0,0
2,GO LEARNING,0.68646,-0.023925,-0.026827,0,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.7336,-0.024016,-0.0020204,0,0
2,GO DENTATE GYRUS DEVELOPMENT,0.85555,-0.024048,-0.02984,0,0
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.90549,-0.024129,-0.0072073,0,0
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.89296,-0.024286,0.060604,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.99368,-0.024334,0.01953,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.81845,-0.024439,0.041337,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.86799,-0.024668,0.050395,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.96843,-0.024761,0.0067182,0,0
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.96843,-0.024882,0.03635,0,0
2,GO CYTOSOLIC TRANSPORT,0.91805,-0.024887,0.059862,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.26442,-0.02499,-0.038377,0,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.70989,-0.025019,-0.0099975,0,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.85555,-0.025073,0.032161,0,0
2,GO MIDBRAIN DEVELOPMENT,0.75756,-0.025174,0.030446,0,0
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.80618,-0.025336,0.027009,0,0
2,GO TRANSLATIONAL INITIATION,0.38829,-0.025361,-0.016745,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.99368,-0.025392,0.026516,0,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.86799,-0.025461,0.0599,0,0
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.69814,-0.025541,0.032704,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.91805,-0.025598,0.050047,0,0
2,GO REGULATION OF HISTONE MODIFICATION,0.55277,-0.025723,0.019047,0,0
2,GO INSULIN SECRETION,0.7336,-0.025781,0.019748,0,0
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.41494,-0.026096,-0.036999,0,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.67486,-0.02622,-0.0295,0,0
2,GO LIPID DROPLET ORGANIZATION,0.81845,-0.026228,0.019404,0,0
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.55277,-0.026277,-0.027081,0,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.64051,-0.026373,0.01521,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.88046,-0.026383,0.023449,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.68646,-0.026462,-0.014405,0,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.5959,-0.026613,0.046561,0,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.94321,-0.026704,0.031,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.95582,-0.026802,0.041842,0,0
2,GO VISUAL BEHAVIOR,0.5959,-0.026805,-0.0033328,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.62923,-0.026863,0.0079362,0,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.64051,-0.026985,0.003075,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.7336,-0.027233,0.00068827,0,0
2,GO POTASSIUM ION TRANSPORT,0.70989,-0.027237,-0.0033781,0,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.55277,-0.027328,0.00099707,0,0
2,GO RNA CATABOLIC PROCESS,0.48117,-0.027361,-0.012033,0,0
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.94321,-0.027573,0.042926,0,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.86799,-0.027618,0.038736,0,0
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.3148,-0.027723,-0.095647,0,0
2,GO NEURON MATURATION,0.94321,-0.027773,0.023518,0,0
2,GO ADHERENS JUNCTION ORGANIZATION,0.69814,-0.027945,0.030001,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.74555,-0.027964,-0.013878,0,0
2,GO TELENCEPHALON DEVELOPMENT,0.60692,-0.02797,-0.0015418,0,0
2,GO OPTIC NERVE DEVELOPMENT,0.99368,-0.02813,0.014139,0,0
2,GO REGULATION OF GLUCONEOGENESIS,0.88046,-0.028179,0.039232,0,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.37111,-0.028323,-0.043667,0,0
2,GO HISTONE H3 ACETYLATION,0.81845,-0.02833,0.025975,0,0
2,GO REGULATION OF TOR SIGNALING,0.57414,-0.028404,0.021487,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.79394,-0.028561,0.070659,0,0
2,GO ORGANELLE FUSION,0.93062,-0.028645,0.038944,0,0
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.80618,-0.028709,0.0064253,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.67486,-0.028872,-0.0060102,0,0
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.83078,-0.028915,0.0064639,0,0
2,GO GOLGI RIBBON FORMATION,0.90549,-0.028946,0.045299,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.5959,-0.029054,0.031161,0,0
2,GO SPERM MOTILITY,0.60692,-0.02921,-0.029732,0,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.83078,-0.029245,0.040035,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.53179,-0.029289,-0.026489,0,0
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.75756,-0.029296,0.018795,0,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.67486,-0.029361,0.00053132,0,0
2,GO REGULATION OF PROTEIN SUMOYLATION,0.81845,-0.02942,0.025769,0,0
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.75756,-0.029475,0.0099162,0,0
2,GO IMP BIOSYNTHETIC PROCESS,0.53179,-0.029552,-0.048969,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.34626,-0.029571,-0.075407,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.88046,-0.029628,0.020678,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.80618,-0.029637,0.004101,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.76963,-0.029684,0.016751,0,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.91805,-0.029726,0.033845,0,0
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.80618,-0.029732,0.046735,0,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.98106,-0.029816,0.020674,0,0
2,GO AXON EXTENSION,0.5959,-0.029872,0.010468,0,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.79394,-0.029889,0.0049757,0,0
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.65188,-0.029923,-0.021768,0,0
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.52145,-0.029984,-0.020798,0,0
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.79394,-0.030019,0.028785,0,0
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.51122,-0.030117,-0.01827,0,0
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.7336,-0.030206,-0.03447,0,0
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.65188,-0.030368,-0.019756,0,0
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.81845,-0.030384,0.030188,0,0
2,GO TORC1 SIGNALING,0.57414,-0.030409,0.01119,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.4521,-0.030447,-0.031734,0,0
2,GO PHOTOTRANSDUCTION,0.34626,-0.030637,-0.040587,0,0
2,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.72171,-0.030734,-0.017877,0,0
2,GO BEHAVIOR,0.99368,-0.030773,0.028191,0,0
2,GO RRNA METHYLATION,0.68646,-0.030926,-0.012339,0,0
2,GO REGIONALIZATION,0.66333,-0.031134,0.027589,0,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.72171,-0.031363,0.0051395,0,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.79394,-0.03143,0.037393,0,0
2,GO LEFT RIGHT AXIS SPECIFICATION,0.5959,-0.031613,-0.0065989,0,0
2,GO REGULATION OF GTP BINDING,0.86799,-0.031673,0.0035815,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.2998,-0.031801,-0.0077052,0,0
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.91805,-0.032069,0.036289,0,0
2,GO REGULATION OF NEURON DIFFERENTIATION,0.54223,-0.032121,0.0038357,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.4521,-0.032244,-0.011861,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.88046,-0.032306,-0.0071648,0,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.35442,-0.032366,-0.057678,0,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.38829,-0.032377,-0.018423,0,0
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.67486,-0.032402,0.019889,0,0
2,GO REGULATION OF CELL CYCLE ARREST,0.4521,-0.032644,-0.035833,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.75756,-0.03277,0.040848,0,0
2,GO AXONEME ASSEMBLY,0.51122,-0.03279,-0.082769,0,0
2,GO RESPONSE TO LEUCINE,0.79394,-0.033064,0.024726,0,0
2,GO CYSTEINE METABOLIC PROCESS,0.80618,-0.033152,0.025431,0,0
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.60692,-0.033233,-0.036254,0,0
2,GO SODIUM ION TRANSPORT,0.96843,-0.033318,0.028801,0,0
2,GO AMIDE BIOSYNTHETIC PROCESS,0.46168,-0.03342,-0.00031907,0,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.56341,-0.033424,-0.045916,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.58498,-0.033494,0.0094261,0,0
2,GO PROTEIN INSERTION INTO MEMBRANE,0.55277,-0.033557,-0.0074812,0,0
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.64051,-0.033664,-0.033352,0,0
2,GO MYELIN ASSEMBLY,0.98106,-0.033713,0.083865,0,0
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.56341,-0.033746,-0.05609,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.88046,-0.033816,0.035869,0,0
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.74555,-0.03405,0.002741,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.21989,-0.034232,-0.061649,0,0
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.46168,-0.034256,-0.043124,0,0
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.53179,-0.034268,-0.035626,0,0
2,GO REGULATION OF ACROSOME REACTION,0.95582,-0.034589,0.024286,0,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.56341,-0.034606,0.00013281,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.95582,-0.034717,0.078526,0,0
2,GO SYNAPTIC VESICLE TRANSPORT,0.51122,-0.034894,-0.047345,0,0
2,GO CIRCADIAN RHYTHM,0.89296,-0.035007,0.033544,0,0
2,GO RIBOSOME ASSEMBLY,0.26442,-0.035035,-0.050006,0,0
2,GO NUCLEAR TRANSPORT,0.51122,-0.035227,-0.012452,0,0
2,GO PROTEIN FOLDING,0.43329,-0.03531,0.0012476,0,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.81845,-0.035393,0.011582,0,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.64051,-0.035738,0.006673,0,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.62923,-0.035843,-0.011186,0,0
2,GO LIMBIC SYSTEM DEVELOPMENT,0.33029,-0.035861,-0.03224,0,0
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.50109,-0.035922,-0.013067,0,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.80618,-0.036022,-0.039718,0,0
2,GO RNA MODIFICATION,0.57414,-0.036093,-0.011177,0,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,0.49108,-0.036286,-0.083032,0,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.44264,-0.036333,-0.023782,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.43329,-0.036408,-0.024622,0,0
2,GO RRNA METABOLIC PROCESS,0.21989,-0.036616,-0.05092,0,0
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.40594,-0.03672,-0.017522,0,0
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.27821,-0.037084,-0.036969,0,0
2,GO RIBOSOME BIOGENESIS,0.26442,-0.037198,-0.047157,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.5959,-0.037303,-0.019472,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.37964,-0.037392,-0.037686,0,0
2,GO RESPONSE TO NICOTINE,0.84314,-0.037416,0.029218,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.37964,-0.037464,-0.013461,0,0
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.25111,-0.037477,-0.057665,0,0
2,GO MITOCHONDRIAL TRANSLATION,0.077559,-0.037478,-0.086089,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.27126,-0.037579,-0.054255,0,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.89296,-0.037611,0.030486,0,0
2,GO MATURATION OF LSU RRNA,0.41494,-0.037685,-0.04994,0,0
2,GO GROWTH HORMONE SECRETION,0.68646,-0.037706,-0.016529,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.37111,-0.037831,-0.0099294,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.66333,-0.038189,0.010731,0,0
2,GO MITOCHONDRIAL TRANSPORT,0.27126,-0.038306,-0.022719,0,0
2,GO CARNITINE METABOLIC PROCESS,0.99368,-0.038386,0.037822,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.54223,-0.03856,-0.012781,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.5959,-0.038577,0.021627,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.29248,-0.038761,-0.036284,0,0
2,GO NCRNA PROCESSING,0.214,-0.038771,-0.04901,0,0
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.2259,-0.038959,-0.054422,0,0
2,GO SNORNA METABOLIC PROCESS,0.46168,-0.039038,-0.061064,0,0
2,GO NEURON DIFFERENTIATION,0.53179,-0.039063,0.0060588,0,0
2,GO HEART VALVE FORMATION,0.67486,-0.039091,-0.0197,0,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.79394,-0.039215,0.036874,0,0
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.21989,-0.039312,-0.018571,0,0
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.56341,-0.039434,-0.018645,0,0
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.90549,-0.039495,0.042707,0,0
2,GO NEURAL TUBE PATTERNING,0.94321,-0.039567,-0.0001258,0,0
2,GO RESPONSE TO AUDITORY STIMULUS,0.55277,-0.039679,-0.033901,0,0
2,GO PATTERN SPECIFICATION PROCESS,0.76963,-0.039783,0.030464,0,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.52145,-0.039886,0.014946,0,0
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.69814,-0.039919,0.014632,0,0
2,GO STEROL BIOSYNTHETIC PROCESS,0.85555,-0.039939,0.028187,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.86799,-0.039962,0.050118,0,0
2,GO DEMETHYLATION,0.48117,-0.039976,-0.0019914,0,0
2,GO PYRUVATE METABOLIC PROCESS,0.42405,-0.039997,-0.001694,0,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.94321,-0.040196,0.057543,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.89296,-0.040327,0.095851,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.36271,-0.040385,-0.035333,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.094909,-0.040392,-0.1418,0,0
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.33029,-0.040442,-0.044299,0,0
2,GO DNA MODIFICATION,0.65188,-0.040601,-0.0092981,0,0
2,GO ALDITOL METABOLIC PROCESS,0.57414,-0.040882,-0.042937,0,0
2,GO SPERMATID DIFFERENTIATION,0.33821,-0.040882,-0.039168,0,0
2,GO HEAD DEVELOPMENT,0.52145,-0.040929,0.0039643,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.74555,-0.041055,0.026904,0,0
2,GO DNA RECOMBINATION,0.47137,-0.041225,-0.065904,0,0
2,GO LEFT RIGHT PATTERN FORMATION,0.53179,-0.041479,-0.011072,0,0
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.36271,-0.041552,-0.018463,0,0
2,GO NODAL SIGNALING PATHWAY,0.47137,-0.041613,-0.042851,0,0
2,GO DORSAL VENTRAL PATTERN FORMATION,0.65188,-0.041617,0.0091229,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.53179,-0.042315,-0.028952,0,0
2,GO CYTOSKELETON ORGANIZATION,0.99368,-0.042381,0.057631,0,0
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.53179,-0.042572,-0.01375,0,0
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.21989,-0.042694,-0.053419,0,0
2,GO EYE MORPHOGENESIS,0.75756,-0.042736,0.039938,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.10811,-0.042768,-0.19205,0,0
2,GO RRNA MODIFICATION,0.65188,-0.042793,-0.018898,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.49108,-0.043022,0.0078314,0,0
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.68646,-0.043063,0.017491,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.76963,-0.043164,-0.0090617,0,0
2,GO CELLULAR RESPIRATION,0.077559,-0.043215,-0.051962,0,0
2,GO REGULATION OF CELL CYCLE,0.27821,-0.043533,-0.027541,0,0
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.85555,-0.043573,0.0046783,0,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.4521,-0.043585,-0.034061,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.81845,-0.043638,0.016715,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.37964,-0.043793,-0.012296,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.88046,-0.043927,0.0051545,0,0
2,GO VIRAL TRANSLATION,0.33029,-0.043967,-0.033838,0,0
2,GO METHIONINE METABOLIC PROCESS,0.65188,-0.044126,-0.019992,0,0
2,GO FOREBRAIN DEVELOPMENT,0.56341,-0.044276,0.0044304,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.46168,-0.044331,-0.04626,0,0
2,GO TRANSLATIONAL TERMINATION,0.14312,-0.044534,-0.070176,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS,0.81845,-0.044552,-0.0047498,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.28529,-0.04457,-0.017434,0,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.69814,-0.044641,-0.0015893,0,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.98106,-0.044702,0.033492,0,0
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.15655,-0.044721,-0.050287,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.95582,-0.044736,0.018448,0,0
2,GO AXON DEVELOPMENT,0.62923,-0.044765,0.0036318,0,0
2,GO CELL PROJECTION ASSEMBLY,0.64051,-0.044886,0.01391,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.27821,-0.045174,-0.015571,0,0
2,GO RESPONSE TO DOPAMINE,0.54223,-0.045369,0.0038408,0,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.72171,-0.045703,-0.0018311,0,0
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.68646,-0.045868,-0.048546,0,0
2,GO NEURAL TUBE FORMATION,0.86799,-0.045903,0.059919,0,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.34626,-0.045983,-0.0042808,0,0
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.95582,-0.046103,0.020356,0,0
2,GO REGULATION OF MITOTIC CELL CYCLE,0.21989,-0.046364,-0.045849,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.23827,-0.04654,-0.02973,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.75756,-0.046719,-0.035384,0,0
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.24463,-0.046739,-0.029805,0,0
2,GO HISTONE PHOSPHORYLATION,0.46168,-0.046898,-0.046806,0,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.29248,-0.047052,-0.049418,0,0
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.094909,-0.047152,-0.1215,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.61803,-0.047365,-0.0066489,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.35442,-0.04739,-0.022575,0,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.39705,-0.047479,-0.0045135,0,0
2,GO MITOCHONDRIAL GENE EXPRESSION,0.08588,-0.047492,-0.082974,0,0
2,GO ENERGY HOMEOSTASIS,0.60692,-0.047515,0.020068,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.91805,-0.047535,0.013087,0,0
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.95582,-0.047577,0.050605,0,0
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.16602,-0.047688,-0.090521,0,0
2,GO GENETIC IMPRINTING,0.41494,-0.047877,-0.037197,0,0
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.40594,-0.047922,-0.03009,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.46168,-0.047929,-0.0023696,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.56341,-0.047994,0.038465,0,0
2,GO ACROSOME REACTION,0.34626,-0.048058,-0.047955,0,0
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.78176,-0.048223,0.028118,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.33821,-0.048224,-0.029532,0,0
2,GO CELL PROJECTION ORGANIZATION,0.65188,-0.04825,0.023484,0,0
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.21989,-0.048296,-0.062508,0,0
2,GO SEXUAL REPRODUCTION,0.40594,-0.048304,-0.019342,0,0
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.42405,-0.048507,-0.01324,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.78176,-0.048715,0.014428,0,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.99368,-0.048752,0.048584,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.27821,-0.049089,-0.034948,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.26442,-0.049096,-0.05345,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.20256,-0.049347,-0.072603,0,0
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.38829,-0.049557,-0.03584,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.16602,-0.049649,-0.04982,0,0
2,GO NEURAL TUBE DEVELOPMENT,0.99368,-0.049897,0.045311,0,0
2,GO NEURON DEVELOPMENT,0.54223,-0.04991,0.0064417,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.99368,-0.0501,-0.015626,0,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.56341,-0.050153,-0.018258,0,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.58498,-0.050283,0.0077042,0,0
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.50109,-0.050394,1.7882e-05,0,0
2,GO SUCKLING BEHAVIOR,0.76963,-0.050433,-0.0036475,0,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.75756,-0.050486,0.049464,0,0
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.10811,-0.050697,-0.084462,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.70989,-0.050933,-0.023324,0,0
2,GO TONGUE MORPHOGENESIS,0.5959,-0.050957,-0.056688,0,0
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.7336,-0.051047,-0.039396,0,0
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.55277,-0.051081,-0.005843,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.41494,-0.051215,-0.033064,0,0
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.44264,-0.05122,-0.031349,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.17591,-0.051412,-0.17113,0,0
2,GO REGULATION OF CELL MATURATION,0.35442,-0.05142,-0.034997,0,0
2,GO SNORNA 3 END PROCESSING,0.23827,-0.051476,-0.10333,0,0
2,GO NCRNA METABOLIC PROCESS,0.15655,-0.051889,-0.054835,0,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.33029,-0.0521,-0.050728,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.91805,-0.052243,0.052114,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.077559,-0.05226,-0.049557,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.49108,-0.052322,-0.05941,0,0
2,GO HINDBRAIN DEVELOPMENT,0.67486,-0.052336,0.0035022,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.46168,-0.052359,-0.03416,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.91805,-0.052435,-0.0060686,0,0
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.32248,-0.052663,-0.022511,0,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.51122,-0.052692,-0.011101,0,0
2,GO REGULATION OF TUBULIN DEACETYLATION,0.23203,-0.052857,-0.061364,0,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.25111,-0.052873,-0.084136,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.21989,-0.052936,-0.053493,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.34626,-0.053099,-0.021599,0,0
2,GO TRANSLATIONAL ELONGATION,0.037377,-0.053141,-0.07906,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.20822,-0.053252,-0.094765,0,0
2,GO FEMALE GAMETE GENERATION,0.41494,-0.053382,-0.025899,0,0
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.7336,-0.053389,-0.052633,0,0
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.4521,-0.053579,-0.01864,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.094909,-0.053749,-0.079946,0,0
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.44264,-0.05375,-0.059254,0,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.36271,-0.053792,-0.046269,0,0
2,GO ORGANELLE DISASSEMBLY,0.94321,-0.0538,0.036168,0,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.36271,-0.053801,-0.020656,0,0
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.58498,-0.053836,-0.005442,0,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.79394,-0.053892,0.026571,0,0
2,GO PRESYNAPTIC ENDOCYTOSIS,0.26442,-0.053947,-0.027609,0,0
2,GO MITOCHONDRIAL TRANSCRIPTION,0.20256,-0.054008,-0.087875,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.41494,-0.054055,-0.0033932,0,0
2,GO FAT CELL PROLIFERATION,0.56341,-0.054197,-0.042505,0,0
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.69814,-0.054324,0.038616,0,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.64051,-0.054424,0.00083835,0,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.5959,-0.054486,-0.061767,0,0
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.85555,-0.054535,0.0061092,0,0
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.44264,-0.054721,-0.0018401,0,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.41494,-0.054802,-0.074444,0,0
2,GO MATURATION OF 5 8S RRNA,0.28529,-0.054827,-0.070703,0,0
2,GO MEMBRANE DISASSEMBLY,0.37111,-0.055019,-0.10415,0,0
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.95582,-0.055221,0.050187,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.48117,-0.055236,-0.038518,0,0
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.33821,-0.055358,-0.0048374,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.47137,-0.055446,-0.043695,0,0
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.4521,-0.055536,0.0037243,0,0
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.54223,-0.055628,-0.045777,0,0
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.81845,-0.055661,-0.0027009,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.48117,-0.055668,-0.0014328,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.61803,-0.055671,0.013047,0,0
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.24463,-0.055913,-0.051031,0,0
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.88046,-0.056062,-0.0077429,0,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.50109,-0.056191,0.0031207,0,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,0.38829,-0.056207,-0.051074,0,0
2,GO TELOMERASE RNA LOCALIZATION,0.077559,-0.056494,-0.12894,0,0
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.32248,-0.056596,-0.009882,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.79394,-0.056648,0.032121,0,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.40594,-0.056685,-0.025066,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.60692,-0.057228,0.038953,0,0
2,GO MEMBRANE FISSION,0.68646,-0.057313,0.022718,0,0
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.046961,-0.057394,-0.16794,0,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.66333,-0.057398,0.016189,0,0
2,GO NEUROMUSCULAR PROCESS,0.41494,-0.057417,-0.044337,0,0
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.23203,-0.057458,-0.041419,0,0
2,GO REGULATION OF CELL CYCLE PROCESS,0.16602,-0.057602,-0.056742,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.33821,-0.057625,-0.023237,0,0
2,GO OOCYTE MATURATION,0.21989,-0.057627,-0.10536,0,0
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.55277,-0.057684,0.006034,0,0
2,GO WALKING BEHAVIOR,0.17091,-0.057695,-0.10191,0,0
2,GO RNA STABILIZATION,0.54223,-0.057782,-0.013545,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.42405,-0.057868,2.4305e-05,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.14312,-0.057921,-0.15331,0,0
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.56341,-0.058046,0.009973,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.76963,-0.05809,0.035848,0,0
2,GO CORPUS CALLOSUM DEVELOPMENT,0.58498,-0.058095,0.0042141,0,0
2,GO OOGENESIS,0.20822,-0.058502,-0.077493,0,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.33029,-0.058525,-0.027846,0,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.39705,-0.058642,0.0091891,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.58498,-0.058827,-0.0092635,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.76963,-0.058843,-0.043513,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.214,-0.058914,-0.053708,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.53179,-0.058988,-0.011378,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.56341,-0.05906,-0.022005,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.46168,-0.059198,-0.033985,0,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,0.79394,-0.059323,0.027061,0,0
2,GO PEPTIDYL THREONINE MODIFICATION,0.42405,-0.059378,0.007197,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.33029,-0.059408,-0.024978,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.30724,-0.059472,-0.053235,0,0
2,GO RESPONSE TO LIGHT STIMULUS,0.60692,-0.059542,0.0074896,0,0
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.10134,-0.05962,-0.072285,0,0
2,GO TRICARBOXYLIC ACID CYCLE,0.17091,-0.059646,-0.041232,0,0
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.95582,-0.059694,0.03132,0,0
2,GO AEROBIC RESPIRATION,0.062884,-0.059728,-0.059911,0,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.43329,-0.059829,-0.009852,0,0
2,GO OOCYTE DIFFERENTIATION,0.08303,-0.059869,-0.097042,0,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.27126,-0.059896,-0.058539,0,0
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.11163,-0.059981,-0.045419,0,0
2,GO PHOTOPERIODISM,0.50109,-0.060009,-0.010052,0,0
2,GO FATTY ACYL COA METABOLIC PROCESS,0.65188,-0.060013,0.025383,0,0
2,GO CYTOPLASM ORGANIZATION,0.52145,-0.060014,-0.033218,0,0
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.27126,-0.060096,-0.046075,0,0
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.11524,-0.060173,-0.044302,0,0
2,GO MALE GAMETE GENERATION,0.3148,-0.060197,-0.037996,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.20256,-0.060239,-0.04224,0,0
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.46168,-0.060391,0.012233,0,0
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.25111,-0.060455,-0.03543,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.48117,-0.060476,0.016933,0,0
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.60692,-0.060479,-0.015721,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.44264,-0.060493,-0.070965,0,0
2,GO OXIDATIVE PHOSPHORYLATION,0.048745,-0.060619,-0.082944,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.48117,-0.060764,-0.028188,0,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.58498,-0.060887,0.017627,0,0
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.81845,-0.060889,0.026878,0,0
2,GO RNA LOCALIZATION,0.1475,-0.061181,-0.061962,0,0
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.42405,-0.06139,-0.016388,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.20256,-0.061403,-0.073548,0,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.54223,-0.061444,-0.03881,0,0
2,GO GERM CELL DEVELOPMENT,0.23827,-0.06154,-0.053046,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.78176,-0.061543,0.021832,0,0
2,GO GLUTAMINE METABOLIC PROCESS,0.33029,-0.062036,-0.029747,0,0
2,GO GAMETE GENERATION,0.33029,-0.062134,-0.031949,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.60692,-0.062198,0.0034727,0,0
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.197,-0.062252,-0.049705,0,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.38829,-0.062588,-0.14268,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.49108,-0.0627,-0.010752,0,0
2,GO PROTEIN HETEROOLIGOMERIZATION,0.091819,-0.062714,-0.084592,0,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.51122,-0.062883,-0.0083274,0,0
2,GO TRNA 5 LEADER REMOVAL,0.10468,-0.063013,-0.090878,0,0
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.2998,-0.063283,-0.036083,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.2577,-0.063372,-0.028191,0,0
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.20256,-0.063631,-0.053328,0,0
2,GO SPERM AXONEME ASSEMBLY,0.33029,-0.063813,-0.068098,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.48117,-0.064285,-0.021767,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.44264,-0.064349,-0.03103,0,0
2,GO MITOTIC CYTOKINESIS,0.15655,-0.064473,-0.075305,0,0
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.15197,-0.064628,-0.06209,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.4521,-0.064882,0.0075214,0,0
2,GO POSTSYNAPSE ORGANIZATION,0.24463,-0.065013,-0.064285,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.32248,-0.06521,-0.072258,0,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.60692,-0.065312,-0.069382,0,0
2,GO COENZYME A METABOLIC PROCESS,0.23203,-0.065415,-0.039333,0,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.11524,-0.065466,-0.088207,0,0
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.7336,-0.065488,0.0088821,0,0
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.197,-0.06552,-0.044605,0,0
2,GO SULFATE TRANSPORT,0.3148,-0.065622,-0.05172,0,0
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.55277,-0.06589,-0.033057,0,0
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.50109,-0.066287,-0.076034,0,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.42405,-0.066584,-0.074945,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.091819,-0.066597,-0.088723,0,0
2,GO DEVELOPMENTAL CELL GROWTH,0.60692,-0.066706,0.0010463,0,0
2,GO LOCOMOTORY BEHAVIOR,0.53179,-0.066773,-0.012504,0,0
2,GO SINGLE FERTILIZATION,0.25111,-0.066773,-0.031771,0,0
2,GO VIRAL LATENCY,0.42405,-0.066847,-0.076756,0,0
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.058535,-0.067246,-0.085454,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.49108,-0.067375,-0.037676,0,0
2,GO DNA LIGATION,0.24463,-0.067577,-0.11422,0,0
2,GO MITOCHONDRIAL RNA PROCESSING,0.28529,-0.067595,-0.070213,0,0
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.94321,-0.068,0.019782,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.27821,-0.068387,-0.072238,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.18624,-0.068394,-0.12162,0,0
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.040368,-0.068399,-0.08309,0,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.53179,-0.068611,0.0034094,0,0
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.27821,-0.068858,-0.025306,0,0
2,GO REGULATION OF SPINDLE CHECKPOINT,0.13467,-0.068963,-0.18673,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.98106,-0.069016,0.020013,0,0
2,GO PROTEIN LOCALIZATION TO AXON,0.83078,-0.069021,0.0056835,0,0
2,GO NUCLEUS ORGANIZATION,0.2577,-0.069105,-0.038798,0,0
2,GO ATP METABOLIC PROCESS,0.13467,-0.069206,-0.036137,0,0
2,GO NOSE DEVELOPMENT,0.48117,-0.069476,-0.10658,0,0
2,GO NUCLEOTIDE PHOSPHORYLATION,0.29248,-0.069614,-0.01943,0,0
2,GO NEURON PROJECTION EXTENSION,0.47137,-0.069838,-0.011553,0,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.44264,-0.069853,-0.02577,0,0
2,GO PRESYNAPSE ORGANIZATION,0.57414,-0.070116,-0.038882,0,0
2,GO SNRNA PROCESSING,0.20822,-0.070241,-0.062741,0,0
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.50109,-0.070252,0.0021365,0,0
2,GO PROTEASOME ASSEMBLY,0.38829,-0.070275,-0.062882,0,0
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.26442,-0.070449,-0.046698,0,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.23203,-0.070488,-0.084345,0,0
2,GO L SERINE METABOLIC PROCESS,0.33821,-0.070506,-0.12135,0,0
2,GO MITOPHAGY,0.58498,-0.070631,0.017262,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.20256,-0.070778,-0.096004,0,0
2,GO REGULATION OF NEURON MIGRATION,0.38829,-0.070876,-0.07031,0,0
2,GO PROTEIN AUTOUBIQUITINATION,0.32248,-0.071007,-0.022514,0,0
2,GO PROTEIN MONOUBIQUITINATION,0.10134,-0.071083,-0.076244,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.3148,-0.071105,-0.047499,0,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.38829,-0.071381,-0.068501,0,0
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.025096,-0.07139,-0.11152,0,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.27821,-0.07159,-0.052486,0,0
2,GO TRNA 5 END PROCESSING,0.062884,-0.071749,-0.091981,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.43329,-0.07184,-0.033956,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.091819,-0.071922,-0.06955,0,0
2,GO POSTREPLICATION REPAIR,0.13885,-0.071976,-0.090962,0,0
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.41494,-0.072012,-0.016157,0,0
2,GO SYNAPTIC SIGNALING,0.33821,-0.07221,-0.046002,0,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.30724,-0.072253,-0.052087,0,0
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.37964,-0.072306,-0.051155,0,0
2,GO MATURATION OF SSU RRNA,0.17091,-0.072339,-0.073529,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.15197,-0.072491,-0.06522,0,0
2,GO CELL PART MORPHOGENESIS,0.43329,-0.072589,-0.011562,0,0
2,GO REGULATION OF DNA REPLICATION,0.12662,-0.072653,-0.092726,0,0
2,GO DNA METABOLIC PROCESS,0.20256,-0.073027,-0.057789,0,0
2,GO REGULATION OF NEURON MATURATION,0.40594,-0.073049,-0.00053381,0,0
2,GO TRNA PROCESSING,0.11894,-0.073093,-0.065722,0,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.60692,-0.073144,0.018114,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.41494,-0.073415,-0.016753,0,0
2,GO CELL CYCLE PHASE TRANSITION,0.13885,-0.073674,-0.070056,0,0
2,GO CELL CYCLE,0.24463,-0.07416,-0.047823,0,0
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.018736,-0.074314,-0.10777,0,0
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.10811,-0.074351,-0.09435,0,0
2,GO INCLUSION BODY ASSEMBLY,0.19156,-0.074378,-0.011041,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE,0.23827,-0.07438,-0.053573,0,0
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.41494,-0.075064,-0.055849,0,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,1,-0.075068,0.045931,0,0
2,GO DISTAL TUBULE DEVELOPMENT,0.48117,-0.075082,-0.12615,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.33029,-0.075116,-0.021807,0,0
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.080256,-0.075494,-0.15625,0,0
2,GO FERTILIZATION,0.36271,-0.075605,-0.026272,0,0
2,GO GOLGI TO VACUOLE TRANSPORT,0.81845,-0.075778,0.034108,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.48117,-0.075801,-0.0052867,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.077559,-0.075894,-0.049076,0,0
2,GO METENCEPHALON DEVELOPMENT,0.3148,-0.076166,-0.058148,0,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.12273,-0.076215,-0.053171,0,0
2,GO SYNAPTIC MEMBRANE ADHESION,0.62923,-0.076291,-0.072818,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.10811,-0.076301,-0.10079,0,0
2,GO BRAIN MORPHOGENESIS,0.35442,-0.076579,-0.057845,0,0
2,GO HISTONE DEACETYLATION,0.70989,-0.076623,0.014327,0,0
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.2998,-0.076966,-0.079187,0,0
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.40594,-0.077244,-0.053617,0,0
2,GO PIRNA METABOLIC PROCESS,0.2998,-0.07725,-0.046719,0,0
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.52145,-0.077531,-0.037188,0,0
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.37964,-0.077543,-0.070562,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.08588,-0.077547,-0.13125,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.33029,-0.077572,-0.034295,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.072385,-0.077711,-0.13973,0,0
2,GO METHYLATION,0.197,-0.077717,-0.051109,0,0
2,GO MANNOSYLATION,0.33821,-0.077782,-0.03557,0,0
2,GO REGULATION OF CENTROSOME CYCLE,0.10134,-0.077986,-0.12239,0,0
2,GO HAIR CELL DIFFERENTIATION,0.40594,-0.078197,-0.028983,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.08881,-0.078302,-0.083174,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.18624,-0.078306,-0.06596,0,0
2,GO TELOMERE CAPPING,0.37111,-0.078597,-0.03977,0,0
2,GO HISTONE H3 K14 ACETYLATION,0.42405,-0.078648,-0.026202,0,0
2,GO TRANSMISSION OF NERVE IMPULSE,0.57414,-0.07891,-0.030626,0,0
2,GO ATP TRANSPORT,0.3148,-0.07903,-0.025472,0,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.2998,-0.079082,-0.078879,0,0
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.20822,-0.079093,-0.0508,0,0
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.25111,-0.079636,-0.044074,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.28529,-0.079734,-0.043818,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.44264,-0.079777,0.013195,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.091819,-0.079921,-0.074699,0,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.26442,-0.079952,-0.023178,0,0
2,GO NON RECOMBINATIONAL REPAIR,0.18624,-0.080011,-0.072478,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.1475,-0.080246,-0.053385,0,0
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.23827,-0.080326,-0.092356,0,0
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.13467,-0.080441,-0.089843,0,0
2,GO GTP BIOSYNTHETIC PROCESS,0.37111,-0.080502,-0.035343,0,0
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.21989,-0.080521,-0.034637,0,0
2,GO CELL DIVISION,0.13467,-0.08054,-0.084659,0,0
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.41494,-0.080544,-0.028222,0,0
2,GO NEURAL NUCLEUS DEVELOPMENT,0.13467,-0.080626,-0.10647,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.44264,-0.080812,-0.041501,0,0
2,GO REGULATION OF HISTONE UBIQUITINATION,0.14312,-0.080836,-0.060611,0,0
2,GO RNA METHYLATION,0.27126,-0.080933,-0.049456,0,0
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.1475,-0.081002,-0.14229,0,0
2,GO PROTEIN PALMITOYLATION,0.39705,-0.081071,-0.044186,0,0
2,GO SYNAPTIC VESICLE RECYCLING,0.2998,-0.081122,-0.032157,0,0
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.056456,-0.081252,-0.090622,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.1475,-0.081651,-0.048359,0,0
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.3148,-0.081657,-0.055894,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.067497,-0.081757,-0.071342,0,0
2,GO RESPONSE TO HYDROXYUREA,0.1306,-0.08194,-0.11326,0,0
2,GO MICROTUBULE BUNDLE FORMATION,0.25111,-0.082366,-0.099199,0,0
2,GO REGULATION OF GENE SILENCING,0.33029,-0.08259,-0.019564,0,0
2,GO DNA DEPENDENT DNA REPLICATION,0.060677,-0.082678,-0.18946,0,0
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.3148,-0.082893,-0.030321,0,0
2,GO MITOCHONDRION LOCALIZATION,0.18102,-0.082941,-0.072984,0,0
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.74555,-0.083006,0.03238,0,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.16602,-0.083252,-0.11735,0,0
2,GO MITOTIC CELL CYCLE,0.10468,-0.083288,-0.077079,0,0
2,GO THALAMUS DEVELOPMENT,0.3148,-0.08332,-0.098872,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.065157,-0.08348,-0.10416,0,0
2,GO PEPTIDYL ARGININE MODIFICATION,0.24463,-0.083571,-0.060619,0,0
2,GO SNRNA METABOLIC PROCESS,0.14312,-0.083574,-0.070039,0,0
2,GO TRANSLESION SYNTHESIS,0.10468,-0.083594,-0.08882,0,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.39705,-0.083598,-0.028087,0,0
2,GO SENSORY PERCEPTION OF SMELL,0.13885,-0.083676,-0.07386,0,0
2,GO PROTEIN HETEROTETRAMERIZATION,0.16602,-0.083734,-0.084912,0,0
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.2259,-0.083973,-0.071237,0,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.37111,-0.084068,-0.05329,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.072385,-0.084161,-0.10449,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.2259,-0.084317,-0.038053,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.026142,-0.0849,-0.14731,0,0
2,GO RNA PROCESSING,0.067497,-0.084947,-0.078976,0,0
2,GO REGULATION OF CHROMATIN BINDING,0.44264,-0.08496,-0.051524,0,0
2,GO TRNA MODIFICATION,0.24463,-0.085011,-0.060661,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.1475,-0.085335,-0.0831,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.2998,-0.085412,-0.083749,0,0
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.5959,-0.085683,-0.039531,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.32248,-0.085816,-0.052677,0,0
2,GO MRNA METHYLATION,0.12662,-0.08591,-0.073374,0,0
2,GO CRISTAE FORMATION,0.1306,-0.086078,-0.081223,0,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.14312,-0.086272,-0.11022,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.47137,-0.086313,-0.03248,0,0
2,GO PROTEIN SUMOYLATION,0.16123,-0.086374,-0.05473,0,0
2,GO DETECTION OF VISIBLE LIGHT,0.080256,-0.086641,-0.085146,0,0
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.16602,-0.086684,-0.068406,0,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.091819,-0.086738,-0.065305,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.24463,-0.086874,-0.055875,0,0
2,GO NEURON FATE COMMITMENT,0.32248,-0.086905,-0.083989,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.43329,-0.086956,-0.076131,0,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.34626,-0.087415,-0.050263,0,0
2,GO SECRETORY GRANULE LOCALIZATION,0.23827,-0.087429,-0.088968,0,0
2,GO DE NOVO PROTEIN FOLDING,0.16602,-0.087493,-0.050679,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.44264,-0.087712,-0.014409,0,0
2,GO MITOTIC RECOMBINATION,0.16123,-0.087788,-0.10959,0,0
2,GO CATECHOLAMINE UPTAKE,0.27821,-0.087831,-0.1065,0,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.72171,-0.088033,0.023633,0,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.38829,-0.088078,-0.077143,0,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.20822,-0.088127,-0.1165,0,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.214,-0.088132,-0.062811,0,0
2,GO TRNA METABOLIC PROCESS,0.050584,-0.088177,-0.085359,0,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.33821,-0.088305,-0.061398,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.067497,-0.088523,-0.14956,0,0
2,GO NUCLEAR EXPORT,0.14312,-0.088532,-0.062551,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.074935,-0.088675,-0.12601,0,0
2,GO NCRNA CATABOLIC PROCESS,0.26442,-0.088708,-0.047987,0,0
2,GO CHROMOSOME LOCALIZATION,0.080256,-0.088725,-0.14557,0,0
2,GO HISTONE MRNA METABOLIC PROCESS,0.08588,-0.088851,-0.10071,0,0
2,GO PROTEIN ACYLATION,0.28529,-0.08886,-0.032997,0,0
2,GO CELL CYCLE PROCESS,0.12662,-0.088863,-0.071676,0,0
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.18624,-0.088897,-0.048795,0,0
2,GO DENDRITIC SPINE DEVELOPMENT,0.19156,-0.089118,-0.071258,0,0
2,GO SYNAPSE ORGANIZATION,0.41494,-0.089174,-0.03172,0,0
2,GO HISTONE H4 DEACETYLATION,0.26442,-0.089192,-0.059933,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.17091,-0.089218,-0.11513,0,0
2,GO NEURAL RETINA DEVELOPMENT,0.27126,-0.089227,-0.08972,0,0
2,GO MRNA TRANSPORT,0.12273,-0.0893,-0.074589,0,0
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.24463,-0.089448,-0.076226,0,0
2,GO HIPPOCAMPUS DEVELOPMENT,0.19156,-0.089708,-0.072545,0,0
2,GO TRNA WOBBLE BASE MODIFICATION,0.12662,-0.089828,-0.063922,0,0
2,GO SNRNA TRANSCRIPTION,0.1475,-0.090041,-0.058452,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.15655,-0.090069,-0.084103,0,0
2,GO RECOMBINATIONAL REPAIR,0.08303,-0.090103,-0.14557,0,0
2,GO SYNAPSE MATURATION,0.32248,-0.090181,-0.14424,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.3148,-0.090183,-0.048997,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.15197,-0.090189,-0.046368,0,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.68646,-0.09028,0.026691,0,0
2,GO PALLIUM DEVELOPMENT,0.23827,-0.090456,-0.056127,0,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.08881,-0.090635,-0.10843,0,0
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.25111,-0.09078,-0.052855,0,0
2,GO RNA 5 END PROCESSING,0.062884,-0.090866,-0.08571,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.094909,-0.090953,-0.16162,0,0
2,GO REGULATION OF AMINO ACID TRANSPORT,0.74555,-0.091035,-0.0017121,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.065157,-0.09112,-0.13746,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.091819,-0.091157,-0.045409,0,0
2,GO REGULATION OF AXONOGENESIS,0.33029,-0.091236,-0.03997,0,0
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.48117,-0.091275,-0.0019658,0,0
2,GO MITOCHONDRIAL DNA REPLICATION,0.20822,-0.091352,-0.086537,0,0
2,GO CYTOKINESIS,0.080256,-0.09152,-0.088647,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.16123,-0.091615,-0.096609,0,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.24463,-0.091636,-0.12869,0,0
2,GO CENTROSOME DUPLICATION,0.060677,-0.091652,-0.14286,0,0
2,GO PROTEIN ACETYLATION,0.28529,-0.091668,-0.028961,0,0
2,GO TUBULIN DEACETYLATION,0.30724,-0.091962,-0.044632,0,0
2,GO FEEDING BEHAVIOR,0.3148,-0.091978,-0.056152,0,0
2,GO MACROMOLECULE DEACYLATION,0.7336,-0.092092,0.013687,0,0
2,GO DETECTION OF CALCIUM ION,0.49108,-0.092369,-0.058959,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.20822,-0.092434,-0.033893,0,0
2,GO MITOCHONDRIAL FUSION,0.11894,-0.092646,-0.060923,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.36271,-0.092792,-0.019182,0,0
2,GO MRNA MODIFICATION,0.11524,-0.09282,-0.083997,0,0
2,GO ORGANELLE ASSEMBLY,0.2259,-0.092939,-0.038922,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.21989,-0.093045,-0.074991,0,0
2,GO SEX DETERMINATION,0.57414,-0.093117,-0.031413,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.046961,-0.093137,-0.16946,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.08303,-0.09352,-0.12722,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.11894,-0.09372,-0.07665,0,0
2,GO NEURON MIGRATION,0.36271,-0.093888,-0.053097,0,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.15655,-0.093926,-0.078958,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.23203,-0.094002,-0.14051,0,0
2,GO EATING BEHAVIOR,0.34626,-0.094048,-0.062776,0,0
2,GO POSITIVE REGULATION OF ACROSOME REACTION,0.25111,-0.094232,-0.075123,0,0
2,GO PARENTAL BEHAVIOR,0.7336,-0.094343,-0.056581,0,0
2,GO MRNA METABOLIC PROCESS,0.074935,-0.094502,-0.069655,0,0
2,GO NCRNA EXPORT FROM NUCLEUS,0.077559,-0.094733,-0.10367,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.08588,-0.094774,-0.17242,0,0
2,GO HISTONE H3 K9 MODIFICATION,0.17091,-0.094992,-0.077073,0,0
2,GO RNA INTERFERENCE,0.08303,-0.095236,-0.12955,0,0
2,GO P BODY ASSEMBLY,0.30724,-0.095462,-0.046239,0,0
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.56341,-0.095544,-0.047758,0,0
2,GO CEREBRAL CORTEX DEVELOPMENT,0.20822,-0.095731,-0.074309,0,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.27821,-0.096216,-0.063115,0,0
2,GO HISTONE H2A UBIQUITINATION,0.14312,-0.096411,-0.082569,0,0
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.11524,-0.096542,-0.075849,0,0
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.035953,-0.096547,-0.1253,0,0
2,GO PROTEIN NEDDYLATION,0.015104,-0.096574,-0.10688,0,0
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.10468,-0.096624,-0.090058,0,0
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.43329,-0.096971,-0.035748,0,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.23203,-0.097008,-0.098818,0,0
2,GO SYNAPTIC VESICLE LOCALIZATION,0.18624,-0.097011,-0.096441,0,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.1475,-0.097085,-0.07857,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.25111,-0.097557,-0.048983,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.214,-0.097835,-0.067815,0,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.5959,-0.097924,-0.01832,0,0
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.42405,-0.097926,-0.027874,0,0
2,GO REGULATION OF VESICLE FUSION,0.14312,-0.098229,-0.091416,0,0
2,GO CELL DIFFERENTIATION IN HINDBRAIN,0.5959,-0.098388,-0.041375,0,0
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.27821,-0.098494,-0.031198,0,0
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.10468,-0.098507,-0.11175,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.26442,-0.098834,-0.052286,0,0
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.27821,-0.098879,-0.072144,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.36271,-0.099314,-0.072176,0,0
2,GO MIRNA METABOLIC PROCESS,0.16123,-0.099423,-0.051992,0,0
2,GO NCRNA 3 END PROCESSING,0.050584,-0.09951,-0.096837,0,0
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.019548,-0.099609,-0.099742,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.026142,-0.099689,-0.14467,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.48117,-0.099799,-0.059671,0,0
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.20822,-0.099818,-0.072907,0,0
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.091819,-0.099828,-0.058565,0,0
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.197,-0.099917,-0.046985,0,0
2,GO GLIAL CELL FATE COMMITMENT,0.53179,-0.099939,-0.050382,0,0
2,GO TRNA TRANSPORT,0.062884,-0.10007,-0.11088,0,0
2,GO PREPULSE INHIBITION,0.1475,-0.10068,-0.20728,0,0
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.18624,-0.1007,-0.090222,0,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,0.080256,-0.10084,-0.12749,0,0
2,GO MAGNESIUM ION TRANSPORT,0.57414,-0.10085,-0.011877,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.15197,-0.10092,-0.052829,0,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.18102,-0.10101,-0.08595,0,0
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.14312,-0.10103,-0.081918,0,0
2,GO DOUBLE STRAND BREAK REPAIR,0.094909,-0.10127,-0.12204,0,0
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.1306,-0.10136,-0.11508,0,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.32248,-0.1014,-0.079163,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.15197,-0.1016,-0.10064,0,0
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.23827,-0.10169,-0.079029,0,0
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.52145,-0.10197,-0.072958,0,0
2,GO REGULATION OF NUCLEAR DIVISION,0.08303,-0.10209,-0.097358,0,0
2,GO NADH METABOLIC PROCESS,0.12662,-0.10215,-0.068566,0,0
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.37111,-0.1024,-0.078576,0,0
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.072385,-0.10245,-0.15474,0,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.37111,-0.10265,-0.046054,0,0
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.26442,-0.10272,-0.099784,0,0
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.037377,-0.10275,-0.2023,0,0
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.1306,-0.10279,-0.066151,0,0
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.20822,-0.10283,-0.16599,0,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.4521,-0.10309,-0.038393,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.47137,-0.10327,-0.077381,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.048745,-0.10342,-0.085584,0,0
2,GO DENDRITE DEVELOPMENT,0.23827,-0.10344,-0.057982,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.2259,-0.10355,-0.066688,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.33821,-0.1038,-0.078779,0,0
2,GO TRNA METHYLATION,0.17091,-0.10391,-0.068591,0,0
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.47137,-0.10397,-0.084388,0,0
2,GO HINDBRAIN MORPHOGENESIS,0.3148,-0.10451,-0.04942,0,0
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.1475,-0.10453,-0.054567,0,0
2,GO NEUROTRANSMITTER TRANSPORT,0.10468,-0.10454,-0.10396,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.072385,-0.10474,-0.089263,0,0
2,GO HISTONE MONOUBIQUITINATION,0.11163,-0.10521,-0.093438,0,0
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.054439,-0.10523,-0.091413,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.23827,-0.10543,-0.096859,0,0
2,GO AMINO ACID ACTIVATION,0.037377,-0.10548,-0.10171,0,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.61803,-0.10564,0.0067159,0,0
2,GO TELOMERE ORGANIZATION,0.08881,-0.10566,-0.10528,0,0
2,GO MEMBRANE DOCKING,0.10811,-0.10582,-0.076006,0,0
2,GO DNA METHYLATION,0.20256,-0.10595,-0.061159,0,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.33821,-0.10632,-0.095686,0,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.048745,-0.10644,-0.1803,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.2998,-0.10676,-0.025311,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.41494,-0.10676,-0.065739,0,0
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.38829,-0.10692,-0.074638,0,0
2,GO NCRNA TRANSCRIPTION,0.10134,-0.10695,-0.073594,0,0
2,GO MICROTUBULE BASED MOVEMENT,0.16602,-0.10702,-0.10016,0,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.24463,-0.10745,-0.056427,0,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.37111,-0.10757,-0.073943,0,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.12662,-0.10758,-0.12842,0,0
2,GO ACIDIC AMINO ACID TRANSPORT,0.28529,-0.10773,-0.035833,0,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.10134,-0.10775,-0.10368,0,0
2,GO PEPTIDYL LYSINE MODIFICATION,0.20256,-0.10788,-0.040771,0,0
2,GO POLYOL CATABOLIC PROCESS,0.08588,-0.10815,-0.095513,0,0
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.08881,-0.10828,-0.080212,0,0
2,GO AXIS SPECIFICATION,0.19156,-0.10836,-0.038903,0,0
2,GO MALE MEIOSIS I,0.26442,-0.1086,-0.095985,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.19156,-0.10881,-0.083099,0,0
2,GO GLUTAMATE SECRETION,0.16123,-0.10884,-0.086209,0,0
2,GO UTP METABOLIC PROCESS,0.080256,-0.10887,-0.099167,0,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.94321,-0.10903,0.075017,0,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.20822,-0.10918,-0.089832,0,0
2,GO GROOMING BEHAVIOR,0.18624,-0.10927,-0.16314,0,0
2,GO DNA REPAIR,0.048745,-0.10942,-0.12192,0,0
2,GO LOOP OF HENLE DEVELOPMENT,0.51122,-0.1097,-0.092806,0,0
2,GO ADULT LOCOMOTORY BEHAVIOR,0.20256,-0.11026,-0.068457,0,0
2,GO REPLICATION FORK PROCESSING,0.08588,-0.11035,-0.17258,0,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.18624,-0.11042,-0.073551,0,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.072385,-0.11047,-0.10826,0,0
2,GO RNA EXPORT FROM NUCLEUS,0.072385,-0.11052,-0.10918,0,0
2,GO DNA INTEGRITY CHECKPOINT,0.13885,-0.11069,-0.10423,0,0
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.13885,-0.11082,-0.04459,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.17591,-0.11106,-0.060445,0,0
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.17091,-0.11157,-0.10115,0,0
2,GO NEURON PROJECTION ORGANIZATION,0.197,-0.1117,-0.056163,0,0
2,GO REGULATION OF MRNA 3 END PROCESSING,0.08588,-0.11253,-0.084565,0,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.40594,-0.11271,-0.074473,0,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.16123,-0.11276,-0.07335,0,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.045233,-0.11296,-0.22283,0,0
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.10811,-0.11318,-0.14155,0,0
2,GO DOSAGE COMPENSATION,0.16602,-0.11345,-0.10118,0,0
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.20822,-0.1136,-0.12645,0,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.89296,-0.11377,0.029153,0,0
2,GO EXIT FROM MITOSIS,0.031957,-0.11385,-0.14237,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.3148,-0.11421,-0.047905,0,0
2,GO DNA REPLICATION,0.062884,-0.11446,-0.14819,0,0
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.25111,-0.11466,-0.056723,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.20256,-0.11491,-0.079121,0,0
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.043559,-0.11506,-0.19691,0,0
2,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.37964,-0.11588,-0.035244,0,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.49108,-0.11601,-0.083436,0,0
2,GO CELL MIGRATION IN HINDBRAIN,0.214,-0.11602,-0.066364,0,0
2,GO REPRODUCTIVE BEHAVIOR,0.54223,-0.11607,-0.044815,0,0
2,GO GENE SILENCING,0.17591,-0.1169,-0.051575,0,0
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.08588,-0.11705,-0.14652,0,0
2,GO SPINDLE LOCALIZATION,0.098083,-0.1171,-0.11675,0,0
2,GO HISTONE UBIQUITINATION,0.060677,-0.11727,-0.1042,0,0
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.08588,-0.11742,-0.11574,0,0
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.08588,-0.11743,-0.10924,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.42405,-0.11747,-0.035143,0,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.43329,-0.11759,-0.024632,0,0
2,GO HISTONE H3 K9 METHYLATION,0.098083,-0.1178,-0.10537,0,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.23203,-0.1179,-0.08284,0,0
2,GO RESPONSE TO POTASSIUM ION,0.33029,-0.11792,-0.13818,0,0
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.37111,-0.11792,-0.08713,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.1475,-0.11938,-0.13393,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.18102,-0.11939,-0.082148,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.20256,-0.11954,-0.06139,0,0
2,GO REGULATION OF MRNA BINDING,0.040368,-0.11969,-0.12145,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.067497,-0.12117,-0.14478,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.008797,-0.12117,-0.1637,0,0
2,GO MEIOTIC CELL CYCLE,0.02951,-0.12139,-0.16635,0,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.37964,-0.12164,-0.067969,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.48117,-0.12185,-0.055867,0,0
2,GO ACROSOME ASSEMBLY,0.16602,-0.12193,-0.087719,0,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.7336,-0.12194,0.010424,0,0
2,GO NEURAL CREST FORMATION,0.81845,-0.12218,-0.015873,0,0
2,GO CELL CYCLE CHECKPOINT,0.094909,-0.12251,-0.12054,0,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.197,-0.12263,-0.099048,0,0
2,GO CENTRIOLE ASSEMBLY,0.065157,-0.12283,-0.15199,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.080256,-0.12323,-0.18818,0,0
2,GO MITOTIC SISTER CHROMATID COHESION,0.15655,-0.12328,-0.14829,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.056456,-0.12369,-0.12064,0,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.069906,-0.12418,-0.13644,0,0
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.048745,-0.12496,-0.092848,0,0
2,GO RNA 3 END PROCESSING,0.02951,-0.12546,-0.12478,0,0
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.13467,-0.12588,-0.097009,0,0
2,GO MRNA EXPORT FROM NUCLEUS,0.043559,-0.12605,-0.11653,0,0
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.1475,-0.12606,-0.10575,0,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.23827,-0.12607,-0.11385,0,0
2,GO MATING BEHAVIOR,0.75756,-0.12701,-0.032314,0,0
2,GO GLUCOSE CATABOLIC PROCESS,0.15655,-0.12704,-0.07499,0,0
2,GO HISTONE SERINE PHOSPHORYLATION,0.098083,-0.12712,-0.16328,0,0
2,GO CILIUM ORGANIZATION,0.13885,-0.12721,-0.10575,0,0
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.1475,-0.12755,-0.12392,0,0
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.24463,-0.12831,-0.10108,0,0
2,GO RRNA TRANSCRIPTION,0.08588,-0.12856,-0.08199,0,0
2,GO PROTEIN DENEDDYLATION,0.098083,-0.12875,-0.073706,0,0
2,GO REGULATION OF SPINDLE ASSEMBLY,0.041938,-0.12939,-0.15491,0,0
2,GO VOCALIZATION BEHAVIOR,0.48117,-0.12945,-0.081445,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.056456,-0.12957,-0.10093,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.018736,-0.12959,-0.18389,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.056456,-0.12967,-0.097385,0,0
2,GO MICROTUBULE BASED PROCESS,0.074935,-0.12987,-0.11093,0,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.11163,-0.12997,-0.049072,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.015104,-0.13068,-0.1944,0,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.15655,-0.1307,-0.18706,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.014457,-0.13072,-0.22957,0,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.08303,-0.13075,-0.096745,0,0
2,GO REGULATION OF MITOPHAGY,0.32248,-0.13089,-0.0243,0,0
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.074935,-0.13127,-0.12887,0,0
2,GO REGULATION OF DNA REPAIR,0.08588,-0.13178,-0.10657,0,0
2,GO REGULATION OF EXIT FROM MITOSIS,0.035953,-0.132,-0.18732,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.028348,-0.13209,-0.11875,0,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.23827,-0.13288,-0.092522,0,0
2,GO METAPHASE PLATE CONGRESSION,0.046961,-0.13296,-0.17969,0,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.26442,-0.1331,-0.11414,0,0
2,GO MICROTUBULE BASED TRANSPORT,0.12662,-0.13313,-0.093514,0,0
2,GO MITOTIC DNA REPLICATION,0.13467,-0.13322,-0.2102,0,0
2,GO RESPONSE TO ACETYLCHOLINE,0.24463,-0.13359,-0.10053,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.2577,-0.13372,-0.052908,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.08881,-0.13389,-0.11468,0,0
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.18624,-0.13392,-0.073026,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.069906,-0.13397,-0.13991,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.12662,-0.13427,-0.13277,0,0
2,GO INNERVATION,0.39705,-0.13454,-0.06211,0,0
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.062884,-0.13492,-0.16316,0,0
2,GO HISTONE H4 ACETYLATION,0.18102,-0.13499,-0.05676,0,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.065157,-0.13502,-0.11968,0,0
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.1475,-0.13506,-0.074575,0,0
2,GO RNA POLYADENYLATION,0.08303,-0.13519,-0.088278,0,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.080256,-0.13539,-0.121,0,0
2,GO DENDRITE MORPHOGENESIS,0.15197,-0.13542,-0.088189,0,0
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.080256,-0.13583,-0.14694,0,0
2,GO DNA GEOMETRIC CHANGE,0.080256,-0.13652,-0.14157,0,0
2,GO NEURONAL ION CHANNEL CLUSTERING,0.34626,-0.13684,-0.099175,0,0
2,GO CHROMOSOME SEPARATION,0.030713,-0.13686,-0.21597,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.01266,-0.13692,-0.16598,0,0
2,GO RESPONSE TO COCAINE,0.15197,-0.13693,-0.11026,0,0
2,GO ORGANELLE FISSION,0.048745,-0.13728,-0.12961,0,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.70989,-0.13729,-0.11039,0,0
2,GO SYNAPSE ASSEMBLY,0.23827,-0.13816,-0.096829,0,0
2,GO NUCLEAR PORE ORGANIZATION,0.20256,-0.13829,-0.098837,0,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.013235,-0.13947,-0.23941,0,0
2,GO HISTONE H3 K4 METHYLATION,0.10811,-0.13954,-0.11947,0,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.12662,-0.13969,-0.15105,0,0
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.18624,-0.13999,-0.084251,0,0
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.034576,-0.14002,-0.14643,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.24463,-0.14008,-0.0066743,0,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.18102,-0.14045,-0.11636,0,0
2,GO PROTEIN DEMETHYLATION,0.094909,-0.14045,-0.08799,0,0
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.19156,-0.141,-0.096454,0,0
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.067497,-0.14115,-0.15972,0,0
2,GO COVALENT CHROMATIN MODIFICATION,0.15655,-0.14121,-0.058628,0,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.094909,-0.14161,-0.11501,0,0
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.08303,-0.14188,-0.078894,0,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.069906,-0.14204,-0.10136,0,0
2,GO RRNA 3 END PROCESSING,0.018736,-0.1425,-0.17314,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.197,-0.14282,-0.091033,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.42405,-0.14299,-0.073795,0,0
2,GO CARDIAC VENTRICLE FORMATION,0.21989,-0.14312,-0.15166,0,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.18624,-0.14315,-0.13619,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.33821,-0.14316,-0.12598,0,0
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.080256,-0.1433,-0.13642,0,0
2,GO GABAERGIC NEURON DIFFERENTIATION,0.27821,-0.14353,-0.054659,0,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.098083,-0.14368,-0.17964,0,0
2,GO OTIC VESICLE DEVELOPMENT,0.037377,-0.14433,-0.21668,0,0
2,GO BASE EXCISION REPAIR,0.015776,-0.1444,-0.17526,0,0
2,GO HISTONE DEUBIQUITINATION,0.19156,-0.14441,-0.074827,0,0
2,GO HETEROCHROMATIN ORGANIZATION,0.11524,-0.14452,-0.096556,0,0
2,GO RESPONSE TO L GLUTAMATE,0.10811,-0.14455,-0.13885,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.077559,-0.14457,-0.22155,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.08303,-0.14459,-0.11026,0,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.3148,-0.14466,-0.067167,0,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.15655,-0.14486,-0.11838,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.18624,-0.14488,-0.13781,0,0
2,GO PROTEIN REFOLDING,0.037377,-0.14523,-0.12256,0,0
2,GO CHROMOSOME SEGREGATION,0.033245,-0.14532,-0.18784,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.197,-0.14536,-0.090431,0,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.11524,-0.14539,-0.10444,0,0
2,GO PEPTIDYL METHIONINE MODIFICATION,0.069906,-0.14543,-0.106,0,0
2,GO MRNA 3 END PROCESSING,0.050584,-0.14579,-0.13105,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.060677,-0.14607,-0.12851,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.072385,-0.14643,-0.12919,0,0
2,GO MRNA CLEAVAGE,0.11163,-0.14655,-0.088965,0,0
2,GO CHEMOSENSORY BEHAVIOR,0.23827,-0.14708,-0.10252,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.26442,-0.14771,-0.11079,0,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.0052065,-0.14799,-0.24534,0,0
2,GO AMINE TRANSPORT,0.36271,-0.14804,-0.051154,0,0
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.18102,-0.14805,-0.19503,0,0
2,GO DENDRITIC SPINE MORPHOGENESIS,0.098083,-0.1482,-0.12465,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.060677,-0.14827,-0.13455,0,0
2,GO PROTEIN METHYLATION,0.058535,-0.14915,-0.10895,0,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.091819,-0.14956,-0.1116,0,0
2,GO POSITIVE REGULATION OF CELL MATURATION,0.18624,-0.14956,-0.095183,0,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.08588,-0.1497,-0.11416,0,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.08588,-0.14988,-0.12935,0,0
2,GO MRNA PROCESSING,0.038848,-0.15008,-0.11821,0,0
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.013834,-0.15026,-0.15247,0,0
2,GO ADULT BEHAVIOR,0.15197,-0.15052,-0.10722,0,0
2,GO MICROTUBULE SEVERING,0.10134,-0.15076,-0.13878,0,0
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.44264,-0.1508,-0.13214,0,0
2,GO MITOTIC NUCLEAR DIVISION,0.034576,-0.15099,-0.1539,0,0
2,GO CHROMATIN ORGANIZATION,0.098083,-0.15122,-0.082113,0,0
2,GO RNA SPLICING,0.037377,-0.15139,-0.11789,0,0
2,GO TRANSPORT ALONG MICROTUBULE,0.060677,-0.15151,-0.11701,0,0
2,GO STARTLE RESPONSE,0.1475,-0.15152,-0.14116,0,0
2,GO REGULATION OF SYNAPSE MATURATION,0.20256,-0.15181,-0.18245,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.27821,-0.15182,-0.11058,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.062884,-0.15187,-0.18971,0,0
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.069906,-0.15223,-0.12523,0,0
2,GO HISTONE H3 K4 TRIMETHYLATION,0.35442,-0.15226,-0.062441,0,0
2,GO CHROMOSOME ORGANIZATION,0.050584,-0.15238,-0.10715,0,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0080134,-0.1525,-0.26234,0,0
2,GO HISTONE H3 DEACETYLATION,0.27821,-0.15251,-0.054503,0,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.056456,-0.15275,-0.13658,0,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.030713,-0.15296,-0.19462,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.023112,-0.15298,-0.2528,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.017954,-0.15334,-0.1526,0,0
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.034576,-0.15372,-0.21638,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.10811,-0.15421,-0.082872,0,0
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.15655,-0.15426,-0.082743,0,0
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.025096,-0.15456,-0.13479,0,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.33029,-0.15475,-0.068026,0,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.41494,-0.15557,-0.042512,0,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.10134,-0.15626,-0.13276,0,0
2,GO RETINA LAYER FORMATION,0.10468,-0.15649,-0.17305,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.08303,-0.15687,-0.094602,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.007293,-0.15729,-0.17815,0,0
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.19156,-0.15732,-0.20226,0,0
2,GO CELL CYCLE DNA REPLICATION,0.035953,-0.15819,-0.23015,0,0
2,GO SISTER CHROMATID SEGREGATION,0.023112,-0.15835,-0.20669,0,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.015776,-0.15842,-0.27377,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.2998,-0.15849,-0.017373,0,0
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0044907,-0.15865,-0.16082,0,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.052482,-0.15938,-0.1243,0,0
2,GO REGULATION OF MRNA POLYADENYLATION,0.069906,-0.15949,-0.10136,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.026142,-0.15967,-0.15877,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.33029,-0.15983,-0.062193,0,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.060677,-0.16048,-0.16408,0,0
2,GO CATECHOLAMINE SECRETION,0.21989,-0.16088,-0.077696,0,0
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.1306,-0.16093,-0.11637,0,0
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.08881,-0.161,-0.13154,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.072385,-0.16134,-0.12317,0,0
2,GO MICROTUBULE ANCHORING,0.18624,-0.16202,-0.077277,0,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.067497,-0.16297,-0.16181,0,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.15197,-0.163,-0.122,0,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.66333,-0.16333,-0.048311,0,0
2,GO LIMB BUD FORMATION,0.27821,-0.16446,-0.13915,0,0
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.25111,-0.16458,-0.13875,0,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.019548,-0.16569,-0.21363,0,0
2,GO REGULATION OF SPINDLE ORGANIZATION,0.017954,-0.16643,-0.19482,0,0
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.16123,-0.16655,-0.10929,0,0
2,GO CARNITINE SHUTTLE,0.30724,-0.16659,-0.081462,0,0
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.11524,-0.16678,-0.10682,0,0
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.30724,-0.16706,-0.11472,0,0
2,GO REGULATION OF DENDRITE EXTENSION,0.058535,-0.16717,-0.16542,0,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.23203,-0.16718,-0.13981,0,0
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.12662,-0.16788,-0.10243,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.065157,-0.16886,-0.14879,0,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.29248,-0.16929,-0.083138,0,0
2,GO INOSITOL METABOLIC PROCESS,0.10134,-0.1694,-0.12652,0,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.11163,-0.16952,-0.12193,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.025096,-0.17,-0.19069,0,0
2,GO CHROMATIN SILENCING,0.023112,-0.17027,-0.1709,0,0
2,GO CEREBELLAR CORTEX FORMATION,0.30724,-0.17046,-0.083722,0,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.014457,-0.17066,-0.2203,0,0
2,GO NEURON CELL CELL ADHESION,0.1475,-0.17073,-0.17837,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.197,-0.17133,-0.080484,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.2577,-0.17193,-0.034617,0,0
2,GO RRNA CATABOLIC PROCESS,0.065157,-0.17203,-0.11072,0,0
2,GO NEURON FATE SPECIFICATION,0.15655,-0.17228,-0.1957,0,0
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.010572,-0.17397,-0.1762,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.094909,-0.1742,-0.10036,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.013834,-0.17433,-0.21439,0,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.34626,-0.17444,-0.10342,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.13885,-0.17476,-0.16714,0,0
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.094909,-0.17487,-0.15704,0,0
2,GO LYSINE METABOLIC PROCESS,0.15197,-0.17494,-0.10751,0,0
2,GO COLLATERAL SPROUTING,0.23827,-0.17556,-0.093788,0,0
2,GO SPINAL CORD DEVELOPMENT,0.10468,-0.17565,-0.13362,0,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.17091,-0.17576,-0.10189,0,0
2,GO INTRACILIARY TRANSPORT,0.08303,-0.17612,-0.15181,0,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.18102,-0.17635,-0.1947,0,0
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.017954,-0.17698,-0.19616,0,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.098083,-0.17703,-0.17338,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.030713,-0.17727,-0.26544,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.33029,-0.17731,-0.039578,0,0
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.12273,-0.17769,-0.13215,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.065157,-0.17857,-0.21123,0,0
2,GO SISTER CHROMATID COHESION,0.056456,-0.1788,-0.19446,0,0
2,GO TRNA CATABOLIC PROCESS,0.074935,-0.17914,-0.15361,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.20822,-0.17933,-0.098859,0,0
2,GO DOPAMINE TRANSPORT,0.069906,-0.17959,-0.14258,0,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.058535,-0.17965,-0.16026,0,0
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.16602,-0.17988,-0.1261,0,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.15655,-0.17997,-0.11937,0,0
2,GO PROTEIN MANNOSYLATION,0.1475,-0.1801,-0.094215,0,0
2,GO CHROMATIN DISASSEMBLY,0.060677,-0.18077,-0.12867,0,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.12662,-0.18127,-0.11657,0,0
2,GO SPINDLE ASSEMBLY,0.023112,-0.18313,-0.17731,0,0
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.16123,-0.18366,-0.094947,0,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.067497,-0.1837,-0.13154,0,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.098083,-0.18463,-0.16531,0,0
2,GO CELL JUNCTION MAINTENANCE,0.13467,-0.185,-0.11353,0,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.08881,-0.18621,-0.15826,0,0
2,GO STRESS GRANULE ASSEMBLY,0.072385,-0.18714,-0.098344,0,0
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.058535,-0.18718,-0.12923,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.030713,-0.18847,-0.27121,0,0
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.15655,-0.18918,-0.17385,0,0
2,GO MECHANOSENSORY BEHAVIOR,0.14312,-0.19065,-0.17117,0,0
2,GO DENDRITIC TRANSPORT,0.065157,-0.19155,-0.24905,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.056456,-0.19265,-0.13085,0,0
2,GO SPINDLE ORGANIZATION,0.021265,-0.19535,-0.18116,0,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.1306,-0.1961,-0.16169,0,0
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.065157,-0.19618,-0.14911,0,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.060677,-0.19657,-0.12929,0,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.056456,-0.19798,-0.16731,0,0
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.08588,-0.19858,-0.1195,0,0
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.072385,-0.1991,-0.13173,0,0
2,GO SPINAL CORD PATTERNING,0.10811,-0.19969,-0.16958,0,0
2,GO DNA STRAND ELONGATION,0.0066311,-0.20121,-0.32337,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.056456,-0.20154,-0.13767,0,0
2,GO RESPONSE TO INSECTICIDE,0.058535,-0.20325,-0.1874,0,0
2,GO DNA REPLICATION CHECKPOINT,0.0172,-0.20371,-0.29394,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.11524,-0.20587,-0.2153,0,0
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.030713,-0.20604,-0.15562,0,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.01266,-0.20627,-0.30832,0,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.42405,-0.20682,-0.042869,0,0
2,GO MICROTUBULE DEPOLYMERIZATION,0.056456,-0.20735,-0.22684,0,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.091819,-0.20818,-0.10869,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.007293,-0.21086,-0.39825,0,0
2,GO CENTROSOME SEPARATION,0.010572,-0.21095,-0.23821,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,0.056456,-0.21157,-0.16854,0,0
2,GO REGULATION OF MICROTUBULE BINDING,0.074935,-0.21346,-0.14563,0,0
2,GO CHROMOSOME CONDENSATION,0.021265,-0.21433,-0.28737,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.12273,-0.21447,-0.17559,0,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.0052065,-0.21496,-0.35459,0,0
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0076456,-0.21597,-0.22308,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.023112,-0.21764,-0.21756,0,0
2,GO NUCLEAR MIGRATION,0.197,-0.21892,-0.095546,0,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.0023095,-0.22022,-0.22711,0,0
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.023112,-0.22145,-0.30131,0,0
2,GO KINETOCHORE ASSEMBLY,0.010572,-0.22162,-0.34113,0,0
2,GO NUCLEUS LOCALIZATION,0.23827,-0.22164,-0.094671,0,0
2,GO POSTSYNAPSE ASSEMBLY,0.23203,-0.22182,-0.16575,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.052482,-0.22964,-0.16174,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.067497,-0.23198,-0.1775,0,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.072385,-0.23315,-0.17497,0,0
2,GO HISTONE H3 K9 DEMETHYLATION,0.074935,-0.23338,-0.13296,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0036751,-0.23354,-0.20468,0,0
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.074935,-0.23681,-0.21724,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.069906,-0.24685,-0.33782,0,0
2,GO RETROGRADE AXONAL TRANSPORT,0.058535,-0.24948,-0.18108,0,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0023095,-0.25455,-0.23977,0,0
2,GO KINETOCHORE ORGANIZATION,0.0096484,-0.25677,-0.38507,0,0
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.065157,-0.25712,-0.1903,0,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.08881,-0.25784,-0.30546,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.034576,-0.27188,-0.31751,0,0
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.16123,-0.27263,-0.1671,0,0
2,GO PONS DEVELOPMENT,0.091819,-0.28406,-0.30045,0,0
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.13467,-0.28821,-0.27069,0,0
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.023112,-0.34247,-0.22204,0,0
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.091819,-0.34263,-0.28865,0,0
3,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.0049572,0.91171,0.76767,1,1
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0038653,0.8531,0.70413,1,1
3,GO CHRONIC INFLAMMATORY RESPONSE,0.0012758,0.84183,0.69167,1,1
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00072571,0.83746,0.6421,1,1
3,GO TOLERANCE INDUCTION,0.010101,0.83538,0.62472,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0013481,0.82604,0.75201,1,1
3,GO T CELL TOLERANCE INDUCTION,0.0063209,0.82403,0.68378,1,1
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.01266,0.81714,0.63473,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0020776,0.80923,0.62339,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0014241,0.80661,0.65096,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00076864,0.79379,0.66391,1,1
3,GO REGULATION OF TOLERANCE INDUCTION,0.007293,0.79013,0.61347,1,1
3,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.013834,0.78283,0.54315,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0042727,0.76613,0.66245,1,1
3,GO T CELL CHEMOTAXIS,0.0015041,0.75891,0.61403,1,1
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0044907,0.75436,0.6027,1,1
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00054254,0.7346,0.75376,1,1
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0054671,0.73062,0.61186,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0014241,0.71583,0.57861,1,1
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0016767,0.71034,0.57287,1,1
3,GO SYNAPSE PRUNING,0.00332,0.70452,0.72554,1,1
3,GO LYMPHOCYTE CHEMOTAXIS,0.0044907,0.70193,0.54838,1,1
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00057531,0.69942,0.74723,1,1
3,GO RESPONSE TO PEPTIDOGLYCAN,0.00076864,0.69913,0.6145,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.9936e-05,0.68555,0.68228,1,1
3,GO T HELPER 2 CELL DIFFERENTIATION,0.00040321,0.68407,0.64795,1,1
3,GO NEGATIVE REGULATION OF CELL KILLING,0.0047188,0.68405,0.60179,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.0023095,0.67967,0.58767,1,1
3,GO T HELPER 1 CELL DIFFERENTIATION,0.00029789,0.67112,0.68545,1,1
3,GO RESPONSE TO CHEMOKINE,0.0027019,0.66759,0.48821,1,1
3,GO REGULATION OF T CELL CHEMOTAXIS,0.00096503,0.66378,0.57337,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0023095,0.66077,0.58885,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00081392,0.65966,0.58581,1,1
3,GO MONOCYTE CHEMOTAXIS,0.0040644,0.65835,0.53103,1,1
3,GO ETHANOL OXIDATION,2.636e-05,0.65455,0.78647,1,1
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0014241,0.64854,0.57765,1,1
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.008797,0.64668,0.50727,1,1
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.00081392,0.64549,0.62149,1,1
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.012106,0.64509,0.54952,1,1
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.0023095,0.63869,0.50346,1,1
3,GO MONONUCLEAR CELL MIGRATION,0.0019699,0.63787,0.50208,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00091199,0.63767,0.59136,1,1
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.00015974,0.63464,0.63676,1,1
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.015104,0.62676,0.57821,1,1
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0047188,0.62621,0.5731,1,1
3,GO DENDRITIC CELL MIGRATION,0.010572,0.62367,0.52591,1,1
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0028457,0.62173,0.5828,1,1
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00068502,0.61936,0.61378,1,1
3,GO RESPONSE TO PROTOZOAN,0.0028457,0.61758,0.54639,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0025648,0.61161,0.44773,1,1
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.010101,0.61138,0.48969,1,1
3,GO INTERLEUKIN 2 PRODUCTION,0.00081392,0.60862,0.54465,1,1
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0054671,0.60422,0.48672,1,1
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0015882,0.60414,0.48617,1,1
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0015041,0.6014,0.52546,1,1
3,GO DENDRITIC CELL CHEMOTAXIS,0.011574,0.59977,0.52761,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0047188,0.59885,0.48978,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.013834,0.59827,0.46308,1,1
3,GO T CELL CYTOKINE PRODUCTION,0.0029965,0.59551,0.46625,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.01266,0.59516,0.47194,1,1
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0054671,0.59507,0.47006,1,1
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0011418,0.58969,0.6452,1,1
3,GO RESPONSE TO TYPE I INTERFERON,0.0052065,0.58807,0.42928,1,1
3,GO T CELL MEDIATED CYTOTOXICITY,0.0019699,0.58727,0.54889,1,1
3,GO TYPE 2 IMMUNE RESPONSE,0.00060992,0.58687,0.5718,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0015041,0.5861,0.52696,1,1
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.01266,0.58447,0.53679,1,1
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0083971,0.58381,0.43272,1,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0010209,0.5838,0.5074,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0016767,0.58084,0.56662,1,1
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.0096484,0.57999,0.47267,1,1
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0054671,0.57972,0.4435,1,1
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00023283,0.57956,0.51713,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0044907,0.57931,0.52757,1,1
3,GO AMINO SUGAR CATABOLIC PROCESS,0.0080134,0.57905,0.45382,1,1
3,GO NEGATIVE T CELL SELECTION,0.007293,0.57864,0.58396,1,1
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0025648,0.57773,0.58246,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0020776,0.57615,0.47657,1,1
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.0012071,0.5757,0.53936,1,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0015882,0.57561,0.54046,1,1
3,GO CELLULAR DEFENSE RESPONSE,0.010101,0.57358,0.46927,1,1
3,GO INTERLEUKIN 10 PRODUCTION,0.0038653,0.57071,0.51159,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,5.6086e-05,0.57026,0.48787,1,1
3,GO POSITIVE T CELL SELECTION,0.022172,0.56977,0.42402,1,1
3,GO ETHANOL METABOLIC PROCESS,7.3279e-05,0.56957,0.57141,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00332,0.56879,0.497,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0018673,0.56843,0.5032,1,1
3,GO T CELL EXTRAVASATION,0.0040644,0.56487,0.45928,1,1
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00010866,0.56475,0.52253,1,1
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0029965,0.56333,0.46222,1,1
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.0015882,0.56319,0.52445,1,1
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0011418,0.56296,0.53909,1,1
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.016475,0.56142,0.465,1,1
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.008797,0.56036,0.50301,1,1
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0049572,0.55994,0.43925,1,1
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0014241,0.55871,0.4986,1,1
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00029789,0.55665,0.52537,1,1
3,GO T HELPER CELL LINEAGE COMMITMENT,0.010572,0.55448,0.47823,1,1
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.3279e-05,0.55447,0.58013,1,1
3,GO NEUTROPHIL MIGRATION,0.0054671,0.5539,0.43985,1,1
3,GO RESPONSE TO INTERFERON GAMMA,0.0049572,0.55359,0.46704,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.011574,0.55339,0.44795,1,1
3,GO CYCLOOXYGENASE PATHWAY,0.0012071,0.55302,0.51917,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.008797,0.55274,0.58397,1,1
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0018673,0.55205,0.50575,1,1
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0015882,0.55024,0.51833,1,1
3,GO RESPONSE TO INTERLEUKIN 15,0.0020776,0.55023,0.569,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00068502,0.54907,0.49584,1,1
3,GO NEUTROPHIL EXTRAVASATION,0.0016767,0.54806,0.47606,1,1
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,6.2007e-06,0.54677,0.58132,1,1
3,GO CHEMOKINE SECRETION,0.0049572,0.54596,0.45903,1,1
3,GO HEMIDESMOSOME ASSEMBLY,0.035953,0.5459,0.37685,1,1
3,GO REGULATION OF CELL KILLING,0.0049572,0.54316,0.44638,1,1
3,GO INTERLEUKIN 8 PRODUCTION,0.00060992,0.54248,0.47236,1,1
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0023095,0.54177,0.44002,1,1
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0034935,0.53831,0.4711,1,1
3,GO COMPLEMENT ACTIVATION,0.006955,0.53681,0.45917,1,1
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.016475,0.53674,0.4155,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0023095,0.53533,0.4781,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00051151,0.53179,0.47508,1,1
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00021879,0.53102,0.47846,1,1
3,GO OPSONIZATION,0.019548,0.53056,0.35673,1,1
3,GO THYMIC T CELL SELECTION,0.030713,0.53012,0.38884,1,1
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.015104,0.52963,0.46449,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00332,0.52824,0.40589,1,1
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0025648,0.52515,0.48793,1,1
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00024771,0.52499,0.5708,1,1
3,GO ALPHA BETA T CELL PROLIFERATION,0.021265,0.52437,0.40977,1,1
3,GO T CELL MEDIATED IMMUNITY,0.0029965,0.52432,0.44528,1,1
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.01266,0.52421,0.44546,1,1
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0076456,0.52308,0.45577,1,1
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0018673,0.52242,0.46368,1,1
3,GO INTERLEUKIN 13 PRODUCTION,0.0023095,0.52093,0.52739,1,1
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.0010209,0.52088,0.47072,1,1
3,GO RESPONSE TO INTERFERON BETA,0.0014241,0.52026,0.47554,1,1
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.0052065,0.51884,0.43545,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0066311,0.51875,0.41557,1,1
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0063209,0.51841,0.48034,1,1
3,GO POSITIVE REGULATION OF CELL KILLING,0.0063209,0.51579,0.45167,1,1
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.0036751,0.51521,0.41717,1,1
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.013235,0.515,0.41159,1,1
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0018673,0.51476,0.48366,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00019306,0.51234,0.53336,1,1
3,GO RESPONSE TO INTERLEUKIN 18,0.0015882,0.51151,0.51969,1,1
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00040321,0.51015,0.45705,1,1
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.0054671,0.50982,0.44463,1,1
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.01266,0.50945,0.40986,1,1
3,GO RESPONSE TO LIPOTEICHOIC ACID,0.0015882,0.50913,0.51546,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0023095,0.50912,0.51115,1,1
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00091199,0.5089,0.48919,1,1
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.017954,0.50867,0.40984,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0031545,0.50765,0.45254,1,1
3,GO INTERLEUKIN 1 PRODUCTION,0.0025648,0.50536,0.47038,1,1
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00023283,0.50469,0.53245,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.008797,0.50231,0.34818,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0034935,0.50211,0.40252,1,1
3,GO T CELL APOPTOTIC PROCESS,0.00096503,0.50206,0.43645,1,1
3,GO ADAPTIVE IMMUNE RESPONSE,0.008797,0.50178,0.44295,1,1
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0019699,0.50132,0.46923,1,1
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0027019,0.50014,0.44673,1,1
3,GO ALPHA BETA T CELL ACTIVATION,0.0063209,0.49895,0.43457,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00068502,0.49876,0.45997,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0023095,0.49726,0.41977,1,1
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0018673,0.49687,0.47772,1,1
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0092139,0.49676,0.40681,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0027019,0.49503,0.44943,1,1
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0028457,0.49498,0.44094,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0036751,0.49302,0.4311,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0044907,0.49289,0.47278,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0027019,0.49223,0.41896,1,1
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0047188,0.49079,0.46469,1,1
3,GO CYTOKINE METABOLIC PROCESS,0.0025648,0.49043,0.4087,1,1
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0015041,0.49026,0.45852,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0096484,0.48904,0.41271,1,1
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0029965,0.48862,0.43392,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.0092139,0.4885,0.46611,1,1
3,GO REGULATORY T CELL DIFFERENTIATION,0.022172,0.48571,0.4104,1,1
3,GO NAD BIOSYNTHETIC PROCESS,0.0010209,0.48485,0.38438,1,1
3,GO THYMOCYTE APOPTOTIC PROCESS,3.9936e-05,0.48473,0.46627,1,1
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0063209,0.48371,0.36806,1,1
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0066311,0.48355,0.40275,1,1
3,GO CELL AGGREGATION,0.0025648,0.48271,0.3565,1,1
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00045436,0.48196,0.49001,1,1
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0096484,0.48087,0.37927,1,1
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.015104,0.48032,0.3816,1,1
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0021907,0.47714,0.47226,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0049572,0.47693,0.4341,1,1
3,GO T CELL SELECTION,0.021265,0.47654,0.39333,1,1
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0063209,0.47545,0.42685,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0083971,0.4751,0.37051,1,1
3,GO B CELL PROLIFERATION,0.0096484,0.4749,0.41659,1,1
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.0057394,0.4747,0.3999,1,1
3,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.013834,0.47462,0.39831,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0028457,0.47453,0.4794,1,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0080134,0.47441,0.39224,1,1
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.023112,0.47413,0.43174,1,1
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0060238,0.47364,0.3978,1,1
3,GO MITRAL VALVE DEVELOPMENT,0.0014241,0.47337,0.42387,1,1
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0049572,0.46989,0.4402,1,1
3,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00014989,0.4688,0.53988,1,1
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0040644,0.46841,0.40237,1,1
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0096484,0.46777,0.40271,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0083971,0.46725,0.41052,1,1
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0063209,0.46598,0.40779,1,1
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0029965,0.46555,0.42625,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.01266,0.4653,0.3978,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.01266,0.46329,0.39843,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.0036751,0.45969,0.47538,1,1
3,GO INTERLEUKIN 4 PRODUCTION,0.020391,0.45912,0.39606,1,1
3,GO REGULATION OF B CELL PROLIFERATION,0.0092139,0.45831,0.4194,1,1
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.0066311,0.45825,0.40945,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0042727,0.45758,0.40071,1,1
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0013481,0.45597,0.39257,1,1
3,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.015104,0.45584,0.39237,1,1
3,GO MACROPHAGE ACTIVATION,0.0066311,0.45579,0.41125,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.00051151,0.45575,0.46505,1,1
3,GO APOPTOTIC CELL CLEARANCE,0.0038653,0.45514,0.4167,1,1
3,GO MACROPHAGE MIGRATION,0.0021907,0.45192,0.42474,1,1
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0010798,0.45101,0.40069,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0049572,0.45004,0.40301,1,1
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0063209,0.44997,0.36988,1,1
3,GO T CELL PROLIFERATION,0.0080134,0.44946,0.39502,1,1
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.00011593,0.4489,0.41067,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0052065,0.44874,0.41107,1,1
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0017696,0.44813,0.39716,1,1
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.0036751,0.44782,0.40767,1,1
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.006955,0.44625,0.35148,1,1
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0036751,0.44563,0.39247,1,1
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0083971,0.44538,0.4012,1,1
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00060992,0.44463,0.40225,1,1
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0025648,0.44368,0.38203,1,1
3,GO PROTEIN ACTIVATION CASCADE,0.0034935,0.44362,0.37698,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0038653,0.4434,0.30011,1,1
3,GO CYTIDINE TO URIDINE EDITING,0.0036751,0.44283,0.42818,1,1
3,GO BLEB ASSEMBLY,0.0029965,0.44212,0.4573,1,1
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.019548,0.44162,0.38306,1,1
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0042727,0.44062,0.44594,1,1
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.0080134,0.44016,0.47109,1,1
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00014989,0.43751,0.41172,1,1
3,GO LEUKOCYTE CELL CELL ADHESION,0.0080134,0.43621,0.38937,1,1
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.046961,0.43601,0.31854,1,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.007293,0.43579,0.39326,1,1
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.00076864,0.43505,0.45091,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0044907,0.43427,0.38287,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0096484,0.43388,0.35364,1,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0063209,0.43366,0.37338,1,1
3,GO DEFENSE RESPONSE TO VIRUS,0.0017696,0.43326,0.35418,1,1
3,GO REGULATION OF T CELL MIGRATION,0.0024341,0.43206,0.43909,1,1
3,GO I KAPPAB PHOSPHORYLATION,0.00086166,0.43205,0.41742,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0049572,0.432,0.36082,1,1
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.016475,0.43187,0.42724,1,1
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0083971,0.4316,0.37362,1,1
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00057531,0.43138,0.53344,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION,0.0057394,0.43014,0.38924,1,1
3,GO REGULATION OF MACROPHAGE MIGRATION,0.0021907,0.42967,0.42109,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0031545,0.42632,0.37582,1,1
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00020554,0.4254,0.44951,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0080134,0.42446,0.38594,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0066311,0.42399,0.38988,1,1
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0066311,0.42329,0.39057,1,1
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0019699,0.42304,0.36676,1,1
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.00040321,0.42255,0.47473,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.007293,0.42192,0.33138,1,1
3,GO PHAGOCYTOSIS RECOGNITION,0.0031545,0.42117,0.41904,1,1
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0096484,0.42082,0.39464,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00048214,0.42065,0.47816,1,1
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00035748,0.42043,0.45796,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.015104,0.42008,0.40846,1,1
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00096503,0.41912,0.35928,1,1
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00096503,0.41841,0.38758,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0066311,0.41841,0.37591,1,1
3,GO BONE TRABECULA MORPHOGENESIS,0.007293,0.41807,0.45685,1,1
3,GO MYOBLAST MIGRATION,0.00060992,0.41794,0.4273,1,1
3,GO AMINE CATABOLIC PROCESS,0.0023095,0.41781,0.32127,1,1
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00064645,0.41751,0.44214,1,1
3,GO ASTROCYTE ACTIVATION,0.0054671,0.41558,0.38458,1,1
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0063209,0.41513,0.39845,1,1
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.018736,0.41474,0.39523,1,1
3,GO MACROPHAGE CHEMOTAXIS,0.0023095,0.4143,0.41122,1,1
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.010572,0.41382,0.35207,1,1
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00031664,0.41379,0.40043,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.011063,0.41362,0.34811,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0025648,0.41322,0.31139,1,1
3,GO ACUTE PHASE RESPONSE,0.0019699,0.4125,0.37562,1,1
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0024341,0.41187,0.44668,1,1
3,GO REGULATION OF PHAGOCYTOSIS,0.006955,0.41175,0.38739,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00068502,0.41152,0.39461,1,1
3,GO REGULATION OF T CELL ACTIVATION,0.0080134,0.4115,0.37488,1,1
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0083971,0.41098,0.36827,1,1
3,GO IMMUNOLOGICAL MEMORY PROCESS,0.010101,0.40942,0.43766,1,1
3,GO LEUKOCYTE PROLIFERATION,0.0096484,0.40923,0.3738,1,1
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.020391,0.40864,0.35558,1,1
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0042727,0.40829,0.35254,1,1
3,GO REGULATION OF BONE DEVELOPMENT,0.0019699,0.40794,0.39674,1,1
3,GO B CELL MEDIATED IMMUNITY,0.008797,0.40775,0.41686,1,1
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.0042727,0.40752,0.368,1,1
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.012106,0.4074,0.35219,1,1
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.0015882,0.40686,0.44222,1,1
3,GO T CELL ACTIVATION,0.008797,0.40596,0.35982,1,1
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.033245,0.40507,0.34428,1,1
3,GO FEVER GENERATION,0.0038653,0.40448,0.31193,1,1
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.00021879,0.40416,0.39024,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.011063,0.40309,0.35313,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.0016767,0.40249,0.36458,1,1
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0029965,0.40217,0.40401,1,1
3,GO GAMMA DELTA T CELL ACTIVATION,0.017954,0.40188,0.39028,1,1
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0036751,0.40184,0.42243,1,1
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0092139,0.40175,0.40326,1,1
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00096503,0.40102,0.49943,1,1
3,GO RESPONSE TO INTERFERON ALPHA,0.0027019,0.40079,0.48226,1,1
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0049572,0.40026,0.39439,1,1
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0052065,0.39998,0.38509,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,1.9888e-05,0.3994,0.38992,1,1
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,2.1347e-05,0.39893,0.42875,1,1
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0080134,0.39874,0.36147,1,1
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0052065,0.3982,0.37981,1,1
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0044907,0.398,0.3845,1,1
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.0047188,0.39797,0.3768,1,1
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0023095,0.3967,0.41362,1,1
3,GO NEUTROPHIL HOMEOSTASIS,0.00031664,0.39631,0.46271,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0020776,0.39581,0.39634,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0020776,0.39563,0.4035,1,1
3,GO PEPTIDE CROSS LINKING,0.0092139,0.39512,0.35238,1,1
3,GO OSTEOBLAST DEVELOPMENT,0.0044907,0.39475,0.33372,1,1
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.0023095,0.39416,0.39486,1,1
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.011063,0.39376,0.35612,1,1
3,GO SOMATIC STEM CELL DIVISION,0.0049572,0.39372,0.38806,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0021907,0.39359,0.36626,1,1
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.00031664,0.39357,0.45684,1,1
3,GO CELLULAR EXTRAVASATION,0.0083971,0.39339,0.37487,1,1
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0042727,0.39179,0.4218,1,1
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00072571,0.39084,0.34357,1,1
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0023095,0.39051,0.32127,1,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00332,0.38895,0.35935,1,1
3,GO INTERFERON ALPHA PRODUCTION,0.0038653,0.38841,0.36847,1,1
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0047188,0.38838,0.37658,1,1
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0060238,0.38742,0.29965,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0060238,0.38709,0.3787,1,1
3,GO ETHER BIOSYNTHETIC PROCESS,0.0010798,0.38694,0.33647,1,1
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.006955,0.38674,0.35716,1,1
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0083971,0.38646,0.33984,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.010101,0.38602,0.37528,1,1
3,GO TUMOR NECROSIS FACTOR SECRETION,0.00051151,0.38468,0.3955,1,1
3,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.0047188,0.38449,0.28038,1,1
3,GO MACROPHAGE APOPTOTIC PROCESS,0.034576,0.3841,0.27261,1,1
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.0016767,0.38393,0.4324,1,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0013481,0.38386,0.38203,1,1
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0080134,0.38384,0.32797,1,1
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0031545,0.38382,0.37029,1,1
3,GO FIBRINOLYSIS,0.0047188,0.38323,0.38345,1,1
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.0015041,0.38269,0.36624,1,1
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.011063,0.3816,0.31182,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0066311,0.38127,0.38385,1,1
3,GO PLASMINOGEN ACTIVATION,0.013834,0.38107,0.32116,1,1
3,GO HUMORAL IMMUNE RESPONSE,0.015104,0.37933,0.34464,1,1
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.0020776,0.37895,0.39027,1,1
3,GO INNATE IMMUNE RESPONSE,0.0047188,0.37857,0.34594,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0049572,0.37836,0.35607,1,1
3,GO NATURAL KILLER CELL ACTIVATION,0.013834,0.37787,0.33516,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0015882,0.37779,0.36892,1,1
3,GO ETHANOL CATABOLIC PROCESS,0.0012758,0.37729,0.29901,1,1
3,GO ACTIVATED T CELL PROLIFERATION,0.020391,0.37688,0.27159,1,1
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.028348,0.37556,0.26875,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00332,0.37552,0.42307,1,1
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0042727,0.37219,0.34344,1,1
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.007293,0.3721,0.34582,1,1
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0047188,0.37143,0.3556,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00086166,0.37058,0.35901,1,1
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0031545,0.37045,0.3913,1,1
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0029965,0.36929,0.38277,1,1
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.00051151,0.36804,0.34967,1,1
3,GO CHEMOKINE PRODUCTION,0.0019699,0.36762,0.36979,1,1
3,GO RESPONSE TO VIRUS,0.0021907,0.3659,0.32748,1,1
3,GO OSTEOCLAST DEVELOPMENT,0.0034935,0.36587,0.39897,1,1
3,GO MYELOID CELL APOPTOTIC PROCESS,0.00091199,0.3653,0.35513,1,1
3,GO RESPONSE TO INTERLEUKIN 4,0.0014241,0.36493,0.32665,1,1
3,GO GRANULOCYTE DIFFERENTIATION,0.0057394,0.3628,0.32496,1,1
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.0021907,0.36269,0.4734,1,1
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0047188,0.36199,0.33278,1,1
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0012071,0.36144,0.40849,1,1
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.035953,0.36139,0.3343,1,1
3,GO CHONDROCYTE PROLIFERATION,0.0014241,0.36135,0.39671,1,1
3,GO STORE OPERATED CALCIUM ENTRY,0.0028457,0.36119,0.29637,1,1
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00033648,0.36103,0.35931,1,1
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0044907,0.36061,0.31829,1,1
3,GO T CELL DIFFERENTIATION,0.006955,0.36041,0.3628,1,1
3,GO BIOLOGICAL PHASE,0.011574,0.35923,0.33672,1,1
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00035748,0.35863,0.38777,1,1
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0049572,0.35862,0.32975,1,1
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.00040321,0.35813,0.43356,1,1
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00086166,0.35725,0.38843,1,1
3,GO LYMPHOCYTE ACTIVATION,0.0080134,0.35635,0.326,1,1
3,GO T CELL LINEAGE COMMITMENT,0.025096,0.35632,0.30844,1,1
3,GO PROSTATE GLAND GROWTH,0.0011418,0.35601,0.38682,1,1
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0025648,0.35589,0.36284,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0083971,0.35539,0.33349,1,1
3,GO RETINOL METABOLIC PROCESS,4.5779e-05,0.35533,0.34771,1,1
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0040644,0.35508,0.28536,1,1
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.0023095,0.35503,0.32544,1,1
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0047188,0.35475,0.30814,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00096503,0.35446,0.35096,1,1
3,GO ACUTE INFLAMMATORY RESPONSE,0.0060238,0.35433,0.31998,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0029965,0.35424,0.32692,1,1
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0049572,0.352,0.3542,1,1
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00064645,0.3519,0.39535,1,1
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.011063,0.35186,0.29262,1,1
3,GO CELLULAR RESPONSE TO X RAY,0.0019699,0.35179,0.37477,1,1
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.0031545,0.35154,0.37254,1,1
3,GO DEFENSE RESPONSE TO BACTERIUM,0.0042727,0.35149,0.33874,1,1
3,GO SEQUESTERING OF METAL ION,0.014457,0.35128,0.33423,1,1
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0018673,0.35096,0.35708,1,1
3,GO ZYMOGEN INHIBITION,0.0015882,0.35084,0.40271,1,1
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0023095,0.35076,0.33558,1,1
3,GO REGULATION OF IMMUNE RESPONSE,0.0060238,0.35065,0.33066,1,1
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0040644,0.35001,0.34347,1,1
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0052065,0.34996,0.29526,1,1
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00017019,0.34953,0.43701,1,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0012071,0.34923,0.36942,1,1
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0038653,0.3482,0.35099,1,1
3,GO TONGUE DEVELOPMENT,0.0038653,0.34816,0.25883,1,1
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.007293,0.34738,0.41405,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.025096,0.34726,0.26483,1,1
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0036751,0.34719,0.28447,1,1
3,GO FLUID TRANSPORT,0.00332,0.34711,0.33971,1,1
3,GO ELASTIC FIBER ASSEMBLY,0.017954,0.3468,0.40008,1,1
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.024086,0.34642,0.31418,1,1
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,6.4139e-05,0.34577,0.35558,1,1
3,GO HYPOTONIC RESPONSE,0.00332,0.34561,0.32863,1,1
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0011418,0.34556,0.36019,1,1
3,GO LYMPHOCYTE DIFFERENTIATION,0.006955,0.34463,0.34095,1,1
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0029965,0.34461,0.34641,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.0057394,0.34454,0.34593,1,1
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.008797,0.34448,0.31062,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0044907,0.34448,0.32899,1,1
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0038653,0.34434,0.32339,1,1
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00332,0.34398,0.24977,1,1
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0080134,0.34356,0.28731,1,1
3,GO SKELETAL MUSCLE TISSUE REGENERATION,5.9985e-05,0.34335,0.35902,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.010572,0.34309,0.32977,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0092139,0.34217,0.35809,1,1
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0066311,0.34194,0.30891,1,1
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00023283,0.34141,0.35121,1,1
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.012106,0.34093,0.37709,1,1
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00033648,0.34073,0.3356,1,1
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0015882,0.34036,0.45196,1,1
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00035748,0.33977,0.38781,1,1
3,GO PINOCYTOSIS,0.0034935,0.33954,0.32586,1,1
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0052065,0.33948,0.30264,1,1
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.0031545,0.33923,0.27397,1,1
3,GO RETINAL METABOLIC PROCESS,0.00060992,0.33901,0.37916,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.015104,0.33901,0.33991,1,1
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.0024341,0.33875,0.36706,1,1
3,GO PROSTANOID METABOLIC PROCESS,0.0010209,0.33863,0.32849,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0096484,0.33742,0.32495,1,1
3,GO COLLAGEN CATABOLIC PROCESS,0.0038653,0.33733,0.37085,1,1
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.013834,0.3373,0.24389,1,1
3,GO REGULATION OF FIBRINOLYSIS,0.0080134,0.33713,0.34654,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0028457,0.33652,0.32366,1,1
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.010101,0.3365,0.34786,1,1
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00332,0.33607,0.33426,1,1
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0029965,0.33593,0.38403,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0063209,0.33547,0.52859,1,1
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0019699,0.33508,0.30011,1,1
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.013235,0.3348,0.29712,1,1
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.014457,0.33408,0.43127,1,1
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00091199,0.33397,0.38723,1,1
3,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.022172,0.33389,0.25581,1,1
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.0057394,0.33308,0.31735,1,1
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0025648,0.33278,0.33134,1,1
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0034935,0.33136,0.30245,1,1
3,GO EPIDERMIS MORPHOGENESIS,0.0015041,0.33125,0.35108,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.048745,0.33054,0.29365,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0060238,0.33043,0.32418,1,1
3,GO DETERMINATION OF ADULT LIFESPAN,0.0172,0.33032,0.22071,1,1
3,GO LEFT RIGHT AXIS SPECIFICATION,0.011063,0.33005,0.25156,1,1
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.0031545,0.32965,0.32035,1,1
3,GO IMMUNOGLOBULIN PRODUCTION,0.0057394,0.32944,0.33098,1,1
3,GO SERTOLI CELL DEVELOPMENT,0.00091199,0.32941,0.34388,1,1
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00035748,0.32894,0.36076,1,1
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.0028457,0.32889,0.31751,1,1
3,GO ACTIVATION OF IMMUNE RESPONSE,0.0052065,0.32855,0.32169,1,1
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.0076456,0.32848,0.28159,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION,0.007293,0.32809,0.32284,1,1
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.0076456,0.328,0.25893,1,1
3,GO REGULATION OF STEM CELL DIVISION,0.012106,0.32652,0.30683,1,1
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0034935,0.326,0.26645,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0036751,0.3259,0.29545,1,1
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.00332,0.32409,0.35388,1,1
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.0015882,0.32395,0.33115,1,1
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0031545,0.32331,0.30505,1,1
3,GO ASTROCYTE DEVELOPMENT,0.0021907,0.3233,0.36,1,1
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00332,0.32293,0.31215,1,1
3,GO RESPONSE TO BACTERIUM,0.0060238,0.32238,0.3175,1,1
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0019699,0.32173,0.34416,1,1
3,GO B CELL ACTIVATION,0.011063,0.3215,0.31256,1,1
3,GO INTERACTION WITH SYMBIONT,7.3279e-05,0.32093,0.32605,1,1
3,GO REGULATION OF LIPASE ACTIVITY,0.0010209,0.31962,0.2953,1,1
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0060238,0.31938,0.3186,1,1
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.016475,0.31911,0.29381,1,1
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00051151,0.31902,0.34602,1,1
3,GO HETEROTYPIC CELL CELL ADHESION,0.013235,0.31875,0.27408,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0036751,0.31869,0.29881,1,1
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00096503,0.3185,0.39359,1,1
3,GO RESPONSE TO INTERLEUKIN 1,0.00064645,0.31797,0.30228,1,1
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0018673,0.31786,0.3958,1,1
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0020776,0.31777,0.30963,1,1
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.011574,0.31769,0.39888,1,1
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0038653,0.31768,0.32367,1,1
3,GO REGULATION OF CELL CELL ADHESION,0.010572,0.31741,0.31479,1,1
3,GO LEUKOCYTE DIFFERENTIATION,0.0076456,0.31676,0.32124,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0063209,0.31644,0.33312,1,1
3,GO LIPOPROTEIN LOCALIZATION,0.0018673,0.31608,0.33238,1,1
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0080134,0.31607,0.2921,1,1
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0036751,0.31563,0.35429,1,1
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00091199,0.31505,0.3502,1,1
3,GO CYTOKINE PRODUCTION,0.0042727,0.31477,0.31579,1,1
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0036751,0.31462,0.35254,1,1
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00031664,0.31409,0.37543,1,1
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.010101,0.31326,0.31819,1,1
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0054671,0.31304,0.35785,1,1
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0063209,0.31294,0.31559,1,1
3,GO PSEUDOPODIUM ORGANIZATION,0.0096484,0.31232,0.28851,1,1
3,GO RESPONSE TO PROSTAGLANDIN,0.014457,0.31165,0.26271,1,1
3,GO HEPATOCYTE DIFFERENTIATION,0.00072571,0.31161,0.31314,1,1
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0047188,0.31158,0.34246,1,1
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.006955,0.31149,0.32747,1,1
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0025648,0.31056,0.26492,1,1
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0063209,0.30978,0.34084,1,1
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.0038653,0.30975,0.295,1,1
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0019699,0.30962,0.33603,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.022172,0.30954,0.33546,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0044907,0.30916,0.31209,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0076456,0.30869,0.27112,1,1
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0010209,0.30842,0.32096,1,1
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.015776,0.30752,0.29156,1,1
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00068502,0.30713,0.29863,1,1
3,GO RESPONSE TO BIOTIC STIMULUS,0.0049572,0.30644,0.29558,1,1
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.0015882,0.30621,0.36129,1,1
3,GO O GLYCAN PROCESSING,0.012106,0.30591,0.22787,1,1
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.007293,0.30571,0.34394,1,1
3,GO MUSCLE CELL FATE COMMITMENT,0.00024771,0.30552,0.36306,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0044907,0.30488,0.25729,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0038653,0.30473,0.27989,1,1
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0063209,0.30459,0.34003,1,1
3,GO IMMUNE EFFECTOR PROCESS,0.0057394,0.3037,0.30616,1,1
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0060238,0.30347,0.33337,1,1
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.013235,0.30328,0.3986,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00057531,0.30268,0.26576,1,1
3,GO NIK NF KAPPAB SIGNALING,0.00081392,0.30213,0.27633,1,1
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0027019,0.30208,0.40765,1,1
3,GO REGULATION OF PODOSOME ASSEMBLY,0.0057394,0.30199,0.3362,1,1
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00029789,0.30145,0.35511,1,1
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0034935,0.30087,0.28596,1,1
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.014457,0.30064,0.22324,1,1
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0063209,0.30055,0.29373,1,1
3,GO CELLULAR RESPONSE TO SALT STRESS,0.00028019,0.30029,0.36664,1,1
3,GO RIG I SIGNALING PATHWAY,0.00064645,0.3,0.28623,1,1
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0054671,0.2999,0.32566,1,1
3,GO REGULATION OF VIRAL LIFE CYCLE,0.0017696,0.29938,0.29839,1,1
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.00051151,0.29873,0.29331,1,1
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.040368,0.29854,0.27813,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.021265,0.29833,0.24131,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.046961,0.29788,0.24114,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0021907,0.29739,0.45007,1,1
3,GO COLLAGEN METABOLIC PROCESS,0.0096484,0.29732,0.31708,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.0036751,0.29693,0.30884,1,1
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0017696,0.2966,0.29383,1,1
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.00060992,0.29645,0.28534,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0054671,0.29477,0.32607,1,1
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0080134,0.29451,0.19932,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0044907,0.29383,0.2822,1,1
3,GO REGULATION OF ODONTOGENESIS,0.0066311,0.29374,0.26492,1,1
3,GO LYMPHANGIOGENESIS,0.0036751,0.29308,0.34685,1,1
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.00068502,0.29271,0.31465,1,1
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0036751,0.29224,0.34095,1,1
3,GO ENTRY INTO HOST,0.0063209,0.2919,0.30561,1,1
3,GO NEGATIVE REGULATION OF COAGULATION,0.022172,0.29121,0.28008,1,1
3,GO PRIMARY MIRNA PROCESSING,0.00015974,0.29098,0.42004,1,1
3,GO ACTIN FILAMENT SEVERING,0.0076456,0.29034,0.36112,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.0092139,0.28935,0.29605,1,1
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.01266,0.28896,0.30717,1,1
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.013834,0.28894,0.28159,1,1
3,GO B CELL DIFFERENTIATION,0.006955,0.28888,0.31428,1,1
3,GO DEFENSE RESPONSE,0.0066311,0.28887,0.28908,1,1
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0042727,0.28879,0.36875,1,1
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.015104,0.2882,0.2741,1,1
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0021907,0.28789,0.3575,1,1
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.015776,0.28784,0.25633,1,1
3,GO PODOSOME ASSEMBLY,0.0066311,0.28768,0.33428,1,1
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.007293,0.28764,0.31547,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0031545,0.2874,0.31364,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0010798,0.28679,0.28431,1,1
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.027226,0.2865,0.29373,1,1
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0034935,0.28636,0.30843,1,1
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0036751,0.28612,0.26421,1,1
3,GO VAGINA DEVELOPMENT,0.033245,0.28606,0.23545,1,1
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0031545,0.28586,0.31409,1,1
3,GO LYMPH VESSEL DEVELOPMENT,0.0083971,0.28545,0.32629,1,1
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.014457,0.28535,0.29493,1,1
3,GO BARBED END ACTIN FILAMENT CAPPING,0.0019699,0.28504,0.28435,1,1
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0015041,0.28477,0.32233,1,1
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0012758,0.28475,0.33607,1,1
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0027019,0.28418,0.35313,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00081392,0.28401,0.28565,1,1
3,GO SKIN MORPHOGENESIS,0.033245,0.28393,0.30455,1,1
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0076456,0.28375,0.32442,1,1
3,GO BILE ACID AND BILE SALT TRANSPORT,0.0031545,0.28352,0.25818,1,1
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.031957,0.28343,0.3003,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0016767,0.28291,0.31971,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.043559,0.28277,0.26946,1,1
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.045233,0.28233,0.22827,1,1
3,GO RENAL ABSORPTION,0.0049572,0.28229,0.33453,1,1
3,GO GLIAL CELL PROLIFERATION,0.0015041,0.28227,0.31737,1,1
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.0057394,0.2818,0.26119,1,1
3,GO CELLULAR RESPONSE TO VIRUS,0.007293,0.2814,0.28055,1,1
3,GO GAP JUNCTION ASSEMBLY,0.038848,0.28096,0.30167,1,1
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.015776,0.28035,0.27792,1,1
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.008797,0.27971,0.34463,1,1
3,GO REGULATION OF SYMBIOTIC PROCESS,0.00086166,0.27968,0.27383,1,1
3,GO LEUKOTRIENE METABOLIC PROCESS,0.006955,0.27829,0.28316,1,1
3,GO REGULATION OF DEFENSE RESPONSE,0.0049572,0.27822,0.27206,1,1
3,GO HYALURONAN CATABOLIC PROCESS,0.0024341,0.27764,0.32305,1,1
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0034935,0.27755,0.29129,1,1
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.0015041,0.27575,0.30153,1,1
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.0054671,0.2753,0.32145,1,1
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.028348,0.27492,0.26373,1,1
3,GO CELL ADHESION MOLECULE PRODUCTION,0.0096484,0.27471,0.33432,1,1
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.043559,0.27414,0.28499,1,1
3,GO BONE CELL DEVELOPMENT,0.013235,0.2736,0.29689,1,1
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00332,0.27336,0.29687,1,1
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0054671,0.27334,0.28032,1,1
3,GO DNA DEAMINATION,0.0066311,0.27319,0.32329,1,1
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.0014241,0.27303,0.32694,1,1
3,GO COLLAGEN FIBRIL ORGANIZATION,0.017954,0.27279,0.39531,1,1
3,GO LAMELLIPODIUM MORPHOGENESIS,0.0018673,0.27273,0.30027,1,1
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0057394,0.27267,0.30871,1,1
3,GO REGULATION OF HEMOPOIESIS,0.00332,0.27265,0.28738,1,1
3,GO REGULATION OF ISOTYPE SWITCHING,0.0057394,0.27264,0.30604,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0066311,0.27241,0.27736,1,1
3,GO DIET INDUCED THERMOGENESIS,0.025096,0.27232,0.22518,1,1
3,GO TONGUE MORPHOGENESIS,0.033245,0.27228,0.22213,1,1
3,GO POSITIVE REGULATION OF COAGULATION,0.024086,0.27227,0.25779,1,1
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0010798,0.27184,0.30099,1,1
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0044907,0.27176,0.21875,1,1
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0020776,0.27165,0.31109,1,1
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.041938,0.27164,0.22048,1,1
3,GO SUPEROXIDE ANION GENERATION,0.027226,0.27146,0.26155,1,1
3,GO RESPONSE TO MANGANESE ION,0.0023095,0.27092,0.26647,1,1
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0063209,0.27018,0.30429,1,1
3,GO TERPENOID METABOLIC PROCESS,0.00024771,0.26987,0.2624,1,1
3,GO BEHAVIORAL RESPONSE TO PAIN,0.0096484,0.26974,0.27334,1,1
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0013481,0.26867,0.32508,1,1
3,GO RESPONSE TO CYTOKINE,0.0038653,0.26856,0.27881,1,1
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.00332,0.26831,0.33115,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.027226,0.26796,0.25404,1,1
3,GO TYPE I INTERFERON PRODUCTION,0.0021907,0.26792,0.28442,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.012106,0.26751,0.25868,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0011418,0.26731,0.3151,1,1
3,GO REGULATION OF DNA METHYLATION,0.0042727,0.26728,0.24863,1,1
3,GO TRACHEA DEVELOPMENT,0.0060238,0.26716,0.30743,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0036751,0.26707,0.3062,1,1
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.016475,0.26671,0.23247,1,1
3,GO ENDODERMAL CELL DIFFERENTIATION,0.0083971,0.26662,0.41194,1,1
3,GO SERTOLI CELL DIFFERENTIATION,0.0096484,0.26563,0.2648,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0024341,0.26554,0.30483,1,1
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0020776,0.26533,0.29053,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.013834,0.26533,0.24561,1,1
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.030713,0.26511,0.21742,1,1
3,GO PYROPTOSIS,0.008797,0.26503,0.31001,1,1
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.0038653,0.26455,0.26876,1,1
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00018128,0.26417,0.28824,1,1
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00045436,0.26382,0.31409,1,1
3,GO TRABECULA FORMATION,0.050584,0.26375,0.2381,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.011574,0.26371,0.23277,1,1
3,GO HIPPO SIGNALING,0.017954,0.26359,0.27417,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0028457,0.26351,0.3283,1,1
3,GO GLOMERULUS DEVELOPMENT,0.014457,0.26224,0.29811,1,1
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.0014241,0.26199,0.29315,1,1
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0042727,0.2619,0.28662,1,1
3,GO RESPONSE TO X RAY,0.00081392,0.26173,0.3136,1,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.012106,0.26155,0.26003,1,1
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0018673,0.26149,0.27403,1,1
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.034576,0.26137,0.30887,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.014457,0.26126,0.24481,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.025096,0.26125,0.26084,1,1
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0025648,0.26109,0.31903,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.012106,0.26103,0.27276,1,1
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0042727,0.26053,0.25257,1,1
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.034576,0.2605,0.32903,1,1
3,GO PROTEIN NITROSYLATION,0.0066311,0.26039,0.2663,1,1
3,GO MAMMARY GLAND MORPHOGENESIS,0.0038653,0.26034,0.31454,1,1
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.017954,0.26007,0.28119,1,1
3,GO REGULATION OF PROTEIN MATURATION,0.0021907,0.25961,0.25631,1,1
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0060238,0.25934,0.2362,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.008797,0.25917,0.27271,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.007293,0.25862,0.31908,1,1
3,GO INTERFERON BETA PRODUCTION,0.00332,0.25823,0.30888,1,1
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.023112,0.25744,0.27712,1,1
3,GO PROTEIN O LINKED GLYCOSYLATION,0.026142,0.25738,0.16692,1,1
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0076456,0.25714,0.28631,1,1
3,GO GLYCOLIPID CATABOLIC PROCESS,0.028348,0.25701,0.30351,1,1
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0052065,0.257,0.25776,1,1
3,GO REGULATION OF RECEPTOR BINDING,0.018736,0.25694,0.26706,1,1
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0027019,0.25605,0.2804,1,1
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.012106,0.25604,0.25945,1,1
3,GO HEPATOCYTE APOPTOTIC PROCESS,0.0066311,0.25589,0.27081,1,1
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0020776,0.25558,0.23242,1,1
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0025648,0.25549,0.29639,1,1
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0054671,0.25517,0.33158,1,1
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.011574,0.25515,0.3555,1,1
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0019699,0.25479,0.31588,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.046961,0.25441,0.22252,1,1
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.00024771,0.25383,0.30507,1,1
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.013834,0.25334,0.25533,1,1
3,GO B CELL APOPTOTIC PROCESS,0.0063209,0.25322,0.25884,1,1
3,GO ARTERY MORPHOGENESIS,0.0021907,0.25319,0.3412,1,1
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0049572,0.25315,0.28075,1,1
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.020391,0.25292,0.31176,1,1
3,GO RESPONSE TO DSRNA,0.0044907,0.2527,0.23867,1,1
3,GO STEM CELL DIVISION,0.015776,0.25247,0.26777,1,1
3,GO RESPONSE TO GROWTH HORMONE,0.00081392,0.25238,0.27083,1,1
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.00076864,0.25191,0.31171,1,1
3,GO FIBROBLAST APOPTOTIC PROCESS,0.0016767,0.2519,0.27401,1,1
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0012758,0.25188,0.35531,1,1
3,GO DECIDUALIZATION,0.015104,0.25173,0.28028,1,1
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0049572,0.25165,0.24703,1,1
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0040644,0.25092,0.26146,1,1
3,GO MYELOID CELL DEVELOPMENT,0.0036751,0.25089,0.28508,1,1
3,GO REGULATION OF CELL FATE COMMITMENT,0.007293,0.25031,0.25756,1,1
3,GO ARTERY DEVELOPMENT,0.0024341,0.25021,0.34436,1,1
3,GO MOVEMENT IN HOST ENVIRONMENT,0.0052065,0.25004,0.26986,1,1
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.0044907,0.24981,0.26386,1,1
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.011063,0.24976,0.27372,1,1
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.045233,0.24967,0.22744,1,1
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00086166,0.24962,0.27236,1,1
3,GO BRONCHUS DEVELOPMENT,0.035953,0.24894,0.24926,1,1
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0096484,0.24879,0.28897,1,1
3,GO ISOPRENOID METABOLIC PROCESS,0.00021879,0.24869,0.2304,1,1
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0016767,0.24715,0.25978,1,1
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.0036751,0.24698,0.29542,1,1
3,GO TROPHOBLAST CELL MIGRATION,0.00076864,0.24675,0.31043,1,1
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.023112,0.24662,0.23501,1,1
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0010798,0.24655,0.22882,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.011574,0.24643,0.25908,1,1
3,GO ODONTOGENESIS,0.007293,0.24606,0.23509,1,1
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0042727,0.246,0.26866,1,1
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.024086,0.24598,0.1907,1,1
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0049572,0.24589,0.27313,1,1
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.008797,0.24576,0.29696,1,1
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.011063,0.24575,0.23997,1,1
3,GO EPIBOLY,0.0047188,0.2455,0.28631,1,1
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0172,0.24549,0.29822,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.018736,0.24539,0.21154,1,1
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.016475,0.24538,0.24628,1,1
3,GO REGULATION OF CALCIUM ION IMPORT,0.006955,0.24537,0.26958,1,1
3,GO PANCREATIC JUICE SECRETION,0.037377,0.24519,0.22206,1,1
3,GO B CELL HOMEOSTASIS,0.012106,0.24473,0.31137,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0052065,0.24447,0.25379,1,1
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0096484,0.24415,0.26562,1,1
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.035953,0.24384,0.27745,1,1
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.0016767,0.24363,0.31372,1,1
3,GO KERATINOCYTE DIFFERENTIATION,0.028348,0.24305,0.18853,1,1
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.031957,0.24302,0.23489,1,1
3,GO FIBROBLAST ACTIVATION,0.014457,0.24247,0.26354,1,1
3,GO MRNA TRANSCRIPTION,0.0047188,0.24245,0.28687,1,1
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0060238,0.24228,0.30362,1,1
3,GO RESPONSE TO INTERLEUKIN 12,0.0076456,0.24228,0.21627,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0018673,0.24221,0.25276,1,1
3,GO PROSTATE GLAND DEVELOPMENT,0.006955,0.24191,0.28191,1,1
3,GO CHROMATIN DISASSEMBLY,0.020391,0.24155,0.21188,1,1
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0054671,0.24115,0.28685,1,1
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.010101,0.2411,0.25364,1,1
3,GO FC RECEPTOR SIGNALING PATHWAY,0.0057394,0.24072,0.22894,1,1
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.022172,0.2407,0.27706,1,1
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0060238,0.24069,0.24787,1,1
3,GO ENDOTHELIAL CELL MIGRATION,0.015776,0.24036,0.24036,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.019548,0.23982,0.20509,1,1
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0063209,0.23977,0.25472,1,1
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.023112,0.23976,0.25551,1,1
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.021265,0.23907,0.19335,1,1
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0063209,0.23894,0.26019,1,1
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0023095,0.2388,0.26548,1,1
3,GO ZYMOGEN ACTIVATION,0.015776,0.23849,0.25341,1,1
3,GO ENDODERM FORMATION,0.0047188,0.23799,0.37419,1,1
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0080134,0.2379,0.32901,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0029965,0.23754,0.2676,1,1
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.011574,0.23751,0.2084,1,1
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00023283,0.23686,0.24053,1,1
3,GO MESODERMAL CELL DIFFERENTIATION,0.0013481,0.23655,0.29512,1,1
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.034576,0.23631,0.24139,1,1
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0017696,0.23599,0.29225,1,1
3,GO RESPONSE TO UV C,0.01266,0.23559,0.21021,1,1
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0042727,0.23539,0.31635,1,1
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0025648,0.23524,0.24694,1,1
3,GO ERBB2 SIGNALING PATHWAY,0.0020776,0.2351,0.24724,1,1
3,GO KERATINOCYTE MIGRATION,0.034576,0.2348,0.22613,1,1
3,GO VIRAL GENOME REPLICATION,0.0023095,0.23426,0.2643,1,1
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.026142,0.23411,0.26465,1,1
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.015104,0.23395,0.21808,1,1
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.010572,0.23367,0.25488,1,1
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.021265,0.23327,0.23783,1,1
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.013235,0.23323,0.2336,1,1
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.010572,0.23288,0.28135,1,1
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0083971,0.23237,0.2331,1,1
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.0083971,0.23185,0.23363,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0038653,0.23142,0.35891,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0018673,0.23125,0.24182,1,1
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.015776,0.23117,0.24554,1,1
3,GO SYNCYTIUM FORMATION,0.0054671,0.23081,0.31667,1,1
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0018673,0.23078,0.29264,1,1
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.043559,0.23077,0.21134,1,1
3,GO LYMPH VESSEL MORPHOGENESIS,0.013834,0.23063,0.31176,1,1
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0034935,0.2303,0.29634,1,1
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0096484,0.23017,0.34002,1,1
3,GO TISSUE REGENERATION,0.0060238,0.23012,0.20364,1,1
3,GO RESPONSE TO FLUID SHEAR STRESS,0.0083971,0.22981,0.2962,1,1
3,GO BLOOD VESSEL MORPHOGENESIS,0.0096484,0.22979,0.26285,1,1
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.014457,0.22952,0.19766,1,1
3,GO ARGININE METABOLIC PROCESS,0.019548,0.22884,0.18111,1,1
3,GO STEROL HOMEOSTASIS,0.0060238,0.22882,0.24756,1,1
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0015041,0.22873,0.22905,1,1
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0092139,0.22843,0.236,1,1
3,GO DRUG METABOLIC PROCESS,0.0080134,0.22839,0.1741,1,1
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.00051151,0.22827,0.25885,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00048214,0.22811,0.2436,1,1
3,GO MANGANESE ION TRANSPORT,0.0063209,0.22785,0.20962,1,1
3,GO NOTOCHORD DEVELOPMENT,0.027226,0.22734,0.23076,1,1
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.040368,0.22719,0.22572,1,1
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.025096,0.2267,0.23114,1,1
3,GO ACTIN FILAMENT BASED TRANSPORT,0.031957,0.22652,0.24671,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.0052065,0.22625,0.28665,1,1
3,GO ASTROCYTE DIFFERENTIATION,0.0083971,0.2261,0.25601,1,1
3,GO OVULATION,0.008797,0.22599,0.24793,1,1
3,GO RESPONSE TO VITAMIN A,0.0034935,0.22597,0.24136,1,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0083971,0.2259,0.26135,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0024341,0.22581,0.25496,1,1
3,GO ERYTHROCYTE MATURATION,0.0042727,0.22506,0.27974,1,1
3,GO AORTA DEVELOPMENT,0.0023095,0.22485,0.34212,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.017954,0.22461,0.26188,1,1
3,GO AORTA MORPHOGENESIS,0.00332,0.2246,0.37241,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0063209,0.22429,0.22572,1,1
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0052065,0.22401,0.22114,1,1
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.0080134,0.22396,0.24151,1,1
3,GO PROTEIN ADP RIBOSYLATION,0.0020776,0.2239,0.24789,1,1
3,GO PROTEIN DEGLYCOSYLATION,0.016475,0.22363,0.22711,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0036751,0.22359,0.26576,1,1
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.007293,0.22308,0.22889,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00332,0.223,0.22115,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.013235,0.22294,0.2722,1,1
3,GO VASCULATURE DEVELOPMENT,0.0066311,0.22293,0.26035,1,1
3,GO REGULATION OF PINOCYTOSIS,0.025096,0.22275,0.24285,1,1
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.013235,0.22274,0.28903,1,1
3,GO IMMUNE SYSTEM DEVELOPMENT,0.0080134,0.22271,0.24641,1,1
3,GO LUNG MORPHOGENESIS,0.025096,0.22258,0.22165,1,1
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.0076456,0.22252,0.20139,1,1
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.02951,0.2224,0.23313,1,1
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.034576,0.22195,0.2362,1,1
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.015104,0.22187,0.27343,1,1
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00332,0.22155,0.22431,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.011063,0.22151,0.24569,1,1
3,GO PIGMENT GRANULE LOCALIZATION,0.0063209,0.22129,0.20079,1,1
3,GO PROTEIN TRIMERIZATION,0.027226,0.22103,0.27217,1,1
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.012106,0.22095,0.26049,1,1
3,GO BLASTODERM SEGMENTATION,0.00091199,0.22016,0.28007,1,1
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.013834,0.21989,0.26727,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.021265,0.21925,0.2373,1,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.017954,0.21916,0.23217,1,1
3,GO CELL CELL JUNCTION MAINTENANCE,0.013834,0.21843,0.27057,1,1
3,GO RESPONSE TO IONIZING RADIATION,0.00033648,0.21816,0.23928,1,1
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.018736,0.21784,0.21912,1,1
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.035953,0.21779,0.25142,1,1
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.010101,0.21742,0.26791,1,1
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.02951,0.21704,0.17979,1,1
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0049572,0.21694,0.33192,1,1
3,GO LIVER REGENERATION,0.00045436,0.21683,0.24307,1,1
3,GO SPROUTING ANGIOGENESIS,0.010101,0.21647,0.27795,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,0.054439,0.21633,0.1463,1,1
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.0076456,0.21547,0.21875,1,1
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.010572,0.21546,0.18553,1,1
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0025648,0.21526,0.25949,1,1
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0066311,0.21458,0.26846,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0023095,0.21439,0.26758,1,1
3,GO COCHLEA MORPHOGENESIS,0.013834,0.21401,0.20925,1,1
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.011063,0.21329,0.25512,1,1
3,GO RETINOIC ACID METABOLIC PROCESS,0.0036751,0.21322,0.28078,1,1
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.010101,0.21321,0.212,1,1
3,GO REGULATION OF GASTRULATION,0.0024341,0.21299,0.25559,1,1
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0052065,0.21293,0.22562,1,1
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.018736,0.21229,0.22262,1,1
3,GO REGULATION OF CELL SHAPE,0.0092139,0.21198,0.24912,1,1
3,GO ERYTHROCYTE DEVELOPMENT,0.0021907,0.21168,0.24382,1,1
3,GO SENSORY PERCEPTION OF TASTE,0.022172,0.21155,0.30358,1,1
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0040644,0.21105,0.19673,1,1
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0052065,0.21065,0.24237,1,1
3,GO SECRETION BY TISSUE,0.033245,0.21014,0.15833,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.008797,0.20975,0.25186,1,1
3,GO DRUG CATABOLIC PROCESS,0.045233,0.2096,0.15866,1,1
3,GO MATERNAL PLACENTA DEVELOPMENT,0.01266,0.20939,0.23769,1,1
3,GO RESPONSE TO DEXAMETHASONE,0.0054671,0.20908,0.20273,1,1
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0040644,0.20864,0.22136,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.052482,0.20853,0.2434,1,1
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0052065,0.2079,0.25472,1,1
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.013834,0.20764,0.17395,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0023095,0.20759,0.20443,1,1
3,GO REGULATION OF CELL ADHESION,0.0172,0.20754,0.26383,1,1
3,GO VIRAL LIFE CYCLE,0.0020776,0.2075,0.24006,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.011063,0.20736,0.2236,1,1
3,GO TISSUE MIGRATION,0.011574,0.20732,0.23081,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.006955,0.20725,0.199,1,1
3,GO P38MAPK CASCADE,0.013834,0.20724,0.25829,1,1
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.026142,0.2072,0.22161,1,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0092139,0.20719,0.22623,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.011574,0.20704,0.17856,1,1
3,GO RESPONSE TO GAMMA RADIATION,0.00028019,0.20692,0.25203,1,1
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.0054671,0.2067,0.22471,1,1
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0066311,0.20647,0.24625,1,1
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.035953,0.20624,0.23456,1,1
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.0020776,0.20621,0.25139,1,1
3,GO MYOBLAST FUSION,0.0080134,0.20614,0.32622,1,1
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.007293,0.20608,0.29302,1,1
3,GO FEMALE GENITALIA DEVELOPMENT,0.026142,0.20605,0.20287,1,1
3,GO MYELOID CELL DIFFERENTIATION,0.0049572,0.20533,0.24836,1,1
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.0042727,0.20503,0.26415,1,1
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0052065,0.2048,0.23711,1,1
3,GO RNA DECAPPING,0.0038653,0.20478,0.22429,1,1
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0044907,0.20478,0.2404,1,1
3,GO RESPONSE TO ESTROGEN,0.01266,0.20456,0.20647,1,1
3,GO NADPH REGENERATION,0.011063,0.20455,0.16495,1,1
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.0017696,0.20448,0.31687,1,1
3,GO CELL CELL RECOGNITION,0.0024341,0.20391,0.23381,1,1
3,GO MYOBLAST DIFFERENTIATION,0.010101,0.20376,0.21475,1,1
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.040368,0.20281,0.15491,1,1
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.01266,0.20271,0.18711,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.017954,0.20244,0.29112,1,1
3,GO REGULATION OF HAIR CYCLE,0.0092139,0.20228,0.23279,1,1
3,GO CELL MATRIX ADHESION,0.037377,0.2022,0.24011,1,1
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.016475,0.20208,0.21956,1,1
3,GO HEAT GENERATION,0.019548,0.2018,0.23203,1,1
3,GO EMBRYO IMPLANTATION,0.0060238,0.20177,0.26889,1,1
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.015776,0.2016,0.1611,1,1
3,GO GTP METABOLIC PROCESS,7.8298e-05,0.20102,0.22123,1,1
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.0054671,0.20091,0.24157,1,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0076456,0.20085,0.25583,1,1
3,GO INTERACTION WITH HOST,0.0034935,0.20082,0.23579,1,1
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0052065,0.20078,0.23992,1,1
3,GO EPOXYGENASE P450 PATHWAY,0.01266,0.20054,0.22623,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.017954,0.20005,0.23427,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.011063,0.20001,0.18597,1,1
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.0025648,0.19999,0.18967,1,1
3,GO NEUROBLAST DIVISION,0.017954,0.19971,0.24445,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.0018673,0.19955,0.16706,1,1
3,GO NEPHRON TUBULE FORMATION,0.0092139,0.19947,0.28553,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.048745,0.19921,0.1932,1,1
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.046961,0.19916,0.21133,1,1
3,GO HEMOGLOBIN METABOLIC PROCESS,0.0042727,0.19914,0.23228,1,1
3,GO BLASTOCYST GROWTH,0.023112,0.19912,0.15862,1,1
3,GO CARDIOLIPIN METABOLIC PROCESS,0.0019699,0.19889,0.21508,1,1
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.0047188,0.19881,0.20879,1,1
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.013834,0.1988,0.19273,1,1
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0012758,0.19878,0.22894,1,1
3,GO AMINO SUGAR METABOLIC PROCESS,0.0063209,0.19855,0.24911,1,1
3,GO WATER TRANSPORT,0.015104,0.19854,0.30813,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0015882,0.19841,0.28117,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.026142,0.19825,0.2017,1,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.034576,0.19803,0.16967,1,1
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.02951,0.19787,0.1833,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.015776,0.19725,0.19995,1,1
3,GO KERATAN SULFATE METABOLIC PROCESS,0.0049572,0.19661,0.27837,1,1
3,GO MIRNA METABOLIC PROCESS,0.046961,0.19657,0.17228,1,1
3,GO WHITE FAT CELL DIFFERENTIATION,0.024086,0.19654,0.18964,1,1
3,GO GLAND MORPHOGENESIS,0.014457,0.19649,0.25424,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.024086,0.19633,0.25226,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0096484,0.19617,0.1976,1,1
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0025648,0.19599,0.27201,1,1
3,GO POSITIVE REGULATION OF JNK CASCADE,0.024086,0.19559,0.2249,1,1
3,GO MALE GENITALIA DEVELOPMENT,0.026142,0.19554,0.22346,1,1
3,GO T CELL HOMEOSTASIS,0.027226,0.1955,0.22874,1,1
3,GO CELLULAR RESPONSE TO ATP,0.021265,0.19544,0.19239,1,1
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.026142,0.195,0.22959,1,1
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.030713,0.195,0.26734,1,1
3,GO ESTROUS CYCLE,0.035953,0.19494,0.26663,1,1
3,GO CELL SUBSTRATE ADHESION,0.034576,0.19475,0.24181,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.046961,0.19466,0.23311,1,1
3,GO LIVER MORPHOGENESIS,0.013235,0.19436,0.24043,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0083971,0.19412,0.20006,1,1
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0083971,0.19407,0.21389,1,1
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.018736,0.19405,0.29622,1,1
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.0038653,0.1938,0.21236,1,1
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.028348,0.19298,0.24214,1,1
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.007293,0.1927,0.27759,1,1
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.034576,0.19248,0.19293,1,1
3,GO REGULATION OF RECEPTOR RECYCLING,0.02951,0.19242,0.18032,1,1
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.043559,0.19216,0.17511,1,1
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.015776,0.19202,0.24164,1,1
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.010101,0.19112,0.23341,1,1
3,GO MUSCLE CELL PROLIFERATION,0.0054671,0.19111,0.23828,1,1
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.015776,0.19084,0.34761,1,1
3,GO POSITIVE REGULATION OF CELL AGING,0.024086,0.19082,0.17233,1,1
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0076456,0.19066,0.22044,1,1
3,GO BONE DEVELOPMENT,0.010101,0.19033,0.23864,1,1
3,GO REGULATION OF PROTEIN SUMOYLATION,0.035953,0.19026,0.17483,1,1
3,GO MRNA MODIFICATION,0.018736,0.19023,0.19827,1,1
3,GO INNER CELL MASS CELL PROLIFERATION,0.043559,0.18984,0.15173,1,1
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0017696,0.18977,0.17625,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0024341,0.18974,0.23812,1,1
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0092139,0.18927,0.19242,1,1
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.010572,0.18918,0.23529,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.030713,0.18903,0.19732,1,1
3,GO REGULATION OF PROTEIN IMPORT,0.00057531,0.18888,0.23963,1,1
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.025096,0.18888,0.25705,1,1
3,GO RNA DESTABILIZATION,0.023112,0.18863,0.21885,1,1
3,GO RESPONSE TO ANGIOTENSIN,0.010101,0.18857,0.24716,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.013235,0.18856,0.25496,1,1
3,GO TISSUE REMODELING,0.019548,0.18844,0.26846,1,1
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.013235,0.18822,0.20373,1,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.007293,0.18782,0.26405,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.043559,0.1877,0.20897,1,1
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.030713,0.18762,0.23343,1,1
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0076456,0.18758,0.22179,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.027226,0.18714,0.22309,1,1
3,GO PROTEIN DEMANNOSYLATION,0.052482,0.18707,0.19214,1,1
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.015776,0.1866,0.20755,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0052065,0.18649,0.27881,1,1
3,GO KERATINOCYTE PROLIFERATION,0.031957,0.18641,0.21414,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.015776,0.18632,0.21316,1,1
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.016475,0.18626,0.22033,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.012106,0.1861,0.21288,1,1
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.013235,0.18599,0.18017,1,1
3,GO REGULATION OF WOUND HEALING,0.045233,0.18586,0.2042,1,1
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.0036751,0.18546,0.18374,1,1
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00332,0.18512,0.25289,1,1
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.015104,0.18509,0.17373,1,1
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.00020554,0.18501,0.22757,1,1
3,GO RESPONSE TO VITAMIN,0.030713,0.18487,0.18811,1,1
3,GO ERBB SIGNALING PATHWAY,0.0047188,0.18476,0.22206,1,1
3,GO SKIN DEVELOPMENT,0.043559,0.18463,0.16407,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.011574,0.18417,0.18013,1,1
3,GO PERICARDIUM DEVELOPMENT,0.0049572,0.18399,0.32866,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.041938,0.18372,0.21146,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0031545,0.18353,0.23854,1,1
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.028348,0.1835,0.19904,1,1
3,GO REGULATION OF CELL MATRIX ADHESION,0.035953,0.18337,0.22771,1,1
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.0044907,0.18335,0.18414,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.016475,0.18326,0.22597,1,1
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.012106,0.18279,0.25659,1,1
3,GO HEME METABOLIC PROCESS,0.00035748,0.18278,0.20563,1,1
3,GO UTP METABOLIC PROCESS,0.045233,0.18209,0.13095,1,1
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.010101,0.18203,0.24527,1,1
3,GO TUBE MORPHOGENESIS,0.019548,0.18198,0.21497,1,1
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.013834,0.18195,0.22435,1,1
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0060238,0.18174,0.23898,1,1
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.01266,0.18166,0.17521,1,1
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.028348,0.18162,0.21258,1,1
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.013834,0.18155,0.23595,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.040368,0.18149,0.1771,1,1
3,GO PEPTIDYL TYROSINE MODIFICATION,0.011574,0.1814,0.237,1,1
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.045233,0.18139,0.21517,1,1
3,GO FIBROBLAST PROLIFERATION,0.0029965,0.18131,0.24078,1,1
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.008797,0.18125,0.29395,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.0172,0.18092,0.26746,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.038848,0.18086,0.19944,1,1
3,GO DNA METHYLATION,0.022172,0.18073,0.16103,1,1
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.011063,0.18066,0.19015,1,1
3,GO ENDODERM DEVELOPMENT,0.018736,0.18053,0.29826,1,1
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.011063,0.18053,0.17451,1,1
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.0076456,0.18019,0.18467,1,1
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.041938,0.17985,0.19884,1,1
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.026142,0.17929,0.174,1,1
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.010101,0.17911,0.19229,1,1
3,GO CELLULAR RESPONSE TO FATTY ACID,0.017954,0.17899,0.16891,1,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.040368,0.17873,0.20641,1,1
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0038653,0.17818,0.20581,1,1
3,GO BLOOD VESSEL REMODELING,0.037377,0.1778,0.28279,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.014457,0.17776,0.2266,1,1
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.0028457,0.17687,0.173,1,1
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.02951,0.17686,0.21838,1,1
3,GO MYELOID CELL HOMEOSTASIS,0.0047188,0.17682,0.21536,1,1
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.010101,0.17677,0.17809,1,1
3,GO RRNA MODIFICATION,0.0025648,0.17655,0.1432,1,1
3,GO AXIS ELONGATION,0.023112,0.17621,0.25126,1,1
3,GO ICOSANOID METABOLIC PROCESS,0.015104,0.17612,0.20391,1,1
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.043559,0.17592,0.26838,1,1
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.010572,0.17583,0.24992,1,1
3,GO AUTOPHAGOSOME MATURATION,0.0076456,0.17548,0.15351,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0080134,0.17539,0.23313,1,1
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.010572,0.17538,0.23465,1,1
3,GO LINOLEIC ACID METABOLIC PROCESS,0.025096,0.17535,0.19303,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.014457,0.17532,0.17936,1,1
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.014457,0.1752,0.16754,1,1
3,GO NEURAL TUBE FORMATION,0.052482,0.17394,0.1595,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.007293,0.17383,0.23421,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0013481,0.17317,0.20816,1,1
3,GO GENITALIA DEVELOPMENT,0.040368,0.17311,0.1896,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.030713,0.17309,0.15728,1,1
3,GO PORE COMPLEX ASSEMBLY,0.0054671,0.17298,0.19947,1,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.020391,0.17288,0.24879,1,1
3,GO REGULATION OF HEAT GENERATION,0.040368,0.17286,0.21436,1,1
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0018673,0.17223,0.16083,1,1
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.015776,0.17177,0.20593,1,1
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0028457,0.17162,0.21515,1,1
3,GO REGULATION OF LIPID STORAGE,0.023112,0.17158,0.22186,1,1
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0060238,0.17116,0.23358,1,1
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.015776,0.17115,0.22826,1,1
3,GO LAMELLIPODIUM ORGANIZATION,0.0049572,0.17073,0.21875,1,1
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0096484,0.17047,0.19809,1,1
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.01266,0.17037,0.20437,1,1
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0044907,0.17018,0.19749,1,1
3,GO MESODERMAL CELL FATE COMMITMENT,0.013834,0.1699,0.1634,1,1
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.037377,0.16941,0.15058,1,1
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.015776,0.16929,0.20178,1,1
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.031957,0.16887,0.17394,1,1
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.033245,0.1687,0.19329,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.014457,0.16863,0.22617,1,1
3,GO PROTEIN KINASE B SIGNALING,0.019548,0.16843,0.20466,1,1
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.052482,0.16821,0.17873,1,1
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0036751,0.16786,0.24181,1,1
3,GO RUFFLE ORGANIZATION,0.016475,0.16783,0.22278,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00086166,0.16762,0.22696,1,1
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.038848,0.1675,0.16237,1,1
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0049572,0.16742,0.21197,1,1
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0076456,0.1672,0.22306,1,1
3,GO PROTEIN HOMOTETRAMERIZATION,0.0015041,0.16695,0.22799,1,1
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.035953,0.16678,0.14302,1,1
3,GO GOLGI LOCALIZATION,0.0066311,0.16569,0.17936,1,1
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.011063,0.16548,0.22575,1,1
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.025096,0.16538,0.29324,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.046961,0.1653,0.16562,1,1
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.040368,0.16527,0.2034,1,1
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0080134,0.16474,0.22205,1,1
3,GO RESPONSE TO ATP,0.016475,0.16447,0.19664,1,1
3,GO CELLULAR RESPONSE TO CAMP,0.018736,0.16393,0.1729,1,1
3,GO CELLULAR OXIDANT DETOXIFICATION,0.008797,0.16373,0.16736,1,1
3,GO TISSUE HOMEOSTASIS,0.020391,0.1635,0.18547,1,1
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.037377,0.16341,0.22076,1,1
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.00332,0.16333,0.20647,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.026142,0.16319,0.20775,1,1
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.040368,0.163,0.20991,1,1
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.015104,0.163,0.15712,1,1
3,GO PHOSPHOLIPID HOMEOSTASIS,0.0066311,0.16288,0.26943,1,1
3,GO EPIDERMIS DEVELOPMENT,0.048745,0.16284,0.1569,1,1
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.035953,0.16265,0.20552,1,1
3,GO RESPONSE TO FATTY ACID,0.025096,0.1626,0.16953,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.043559,0.16244,0.229,1,1
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.030713,0.16244,0.25005,1,1
3,GO SYMBIOTIC PROCESS,0.0015041,0.16208,0.17642,1,1
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0044907,0.162,0.20519,1,1
3,GO FRUCTOSE METABOLIC PROCESS,0.013235,0.16168,0.19451,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0019699,0.16167,0.15913,1,1
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.035953,0.16113,0.19412,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.014457,0.16085,0.19768,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.010101,0.16076,0.1792,1,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0172,0.16072,0.31947,1,1
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.010101,0.16022,0.17514,1,1
3,GO SUPEROXIDE METABOLIC PROCESS,0.035953,0.16005,0.20112,1,1
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0027019,0.15988,0.18127,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.015776,0.15957,0.1729,1,1
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.035953,0.15919,0.20021,1,1
3,GO ERYTHROCYTE HOMEOSTASIS,0.0049572,0.15882,0.19906,1,1
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.054439,0.1588,0.13743,1,1
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.040368,0.15877,0.15989,1,1
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00029789,0.15831,0.26366,1,1
3,GO DNA METHYLATION OR DEMETHYLATION,0.018736,0.15812,0.15681,1,1
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.045233,0.15766,0.19334,1,1
3,GO V D J RECOMBINATION,0.022172,0.15763,0.19903,1,1
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.026142,0.15714,0.21982,1,1
3,GO CELLULAR RESPONSE TO LIPID,0.011063,0.15701,0.20527,1,1
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.017954,0.15689,0.25089,1,1
3,GO RESPONSE TO ANTIBIOTIC,0.010101,0.15679,0.18233,1,1
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.015104,0.15675,0.23066,1,1
3,GO REGULATION OF GENE SILENCING,0.011574,0.15661,0.16609,1,1
3,GO RRNA METHYLATION,0.0096484,0.15658,0.1471,1,1
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.033245,0.15651,0.11686,1,1
3,GO NUCLEOTIDE SALVAGE,0.033245,0.15643,0.16573,1,1
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.010101,0.1563,0.17944,1,1
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0083971,0.15627,0.1891,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0040644,0.15626,0.1445,1,1
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00332,0.15535,0.17188,1,1
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.013235,0.15517,0.18894,1,1
3,GO REGULATION OF AMYLOID BETA FORMATION,0.054439,0.15456,0.1985,1,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0172,0.15442,0.23545,1,1
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.038848,0.15441,0.20134,1,1
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0025648,0.15423,0.19019,1,1
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.048745,0.15414,0.1832,1,1
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.034576,0.15386,0.20222,1,1
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.010101,0.15328,0.17366,1,1
3,GO CELLULAR RESPONSE TO ALCOHOL,0.030713,0.15283,0.19764,1,1
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.026142,0.15248,0.16347,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0060238,0.15215,0.14985,1,1
3,GO MUSCLE CELL MIGRATION,0.0080134,0.15213,0.28443,1,1
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.016475,0.15192,0.22251,1,1
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0034935,0.15119,0.17489,1,1
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.008797,0.15058,0.17421,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.010572,0.1504,0.1774,1,1
3,GO STEROL METABOLIC PROCESS,0.026142,0.15034,0.15876,1,1
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.050584,0.15011,0.17696,1,1
3,GO FORMATION OF PRIMARY GERM LAYER,0.015104,0.1496,0.25115,1,1
3,GO SNRNA PROCESSING,0.041938,0.14931,0.15171,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.021265,0.14929,0.21581,1,1
3,GO ETHER METABOLIC PROCESS,0.0080134,0.14876,0.19557,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.054439,0.14825,0.12959,1,1
3,GO RESPONSE TO RETINOIC ACID,0.031957,0.14822,0.1838,1,1
3,GO BONE REMODELING,0.035953,0.14817,0.24521,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.016475,0.14775,0.13471,1,1
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.008797,0.14735,0.17298,1,1
3,GO CELLULAR RESPONSE TO UV,0.013235,0.1471,0.16118,1,1
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.046961,0.14693,0.21086,1,1
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.048745,0.14645,0.1878,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.0010798,0.14636,0.16579,1,1
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0027019,0.14634,0.1864,1,1
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.019548,0.14611,0.27834,1,1
3,GO REGULATION OF TELOMERASE ACTIVITY,0.00332,0.14607,0.16721,1,1
3,GO BONE MORPHOGENESIS,0.028348,0.14597,0.2324,1,1
3,GO TETRAPYRROLE METABOLIC PROCESS,0.0036751,0.14522,0.15756,1,1
3,GO PIGMENT GRANULE ORGANIZATION,0.007293,0.14499,0.23469,1,1
3,GO LIPID OXIDATION,0.041938,0.14477,0.12902,1,1
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.043559,0.14476,0.2274,1,1
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.013834,0.14465,0.15689,1,1
3,GO COPPER ION HOMEOSTASIS,0.052482,0.14418,0.1538,1,1
3,GO REGULATION OF PROTEOLYSIS,0.027226,0.14404,0.15943,1,1
3,GO WOUND HEALING,0.046961,0.14337,0.19599,1,1
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.024086,0.14336,0.16724,1,1
3,GO NCRNA CATABOLIC PROCESS,0.030713,0.14277,0.1586,1,1
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.043559,0.14275,0.12708,1,1
3,GO LIPID HOMEOSTASIS,0.021265,0.14202,0.17551,1,1
3,GO REGULATION OF ACTIN NUCLEATION,0.027226,0.14201,0.14359,1,1
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.016475,0.14198,0.18861,1,1
3,GO REGULATION OF RESPONSE TO WOUNDING,0.038848,0.14195,0.19294,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.041938,0.14178,0.16481,1,1
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.015776,0.14152,0.18778,1,1
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.010101,0.14123,0.14911,1,1
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.031957,0.14103,0.1941,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.011574,0.14078,0.12831,1,1
3,GO RNA INTERFERENCE,0.054439,0.14064,0.17359,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.033245,0.14046,0.11812,1,1
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.035953,0.14033,0.15928,1,1
3,GO FOLIC ACID METABOLIC PROCESS,0.024086,0.13995,0.13745,1,1
3,GO THYMUS DEVELOPMENT,0.008797,0.13984,0.17452,1,1
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0066311,0.13961,0.16903,1,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.028348,0.1392,0.13726,1,1
3,GO RESPONSE TO LIPID,0.028348,0.13914,0.17847,1,1
3,GO CELLULAR PIGMENTATION,0.021265,0.13902,0.16472,1,1
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.046961,0.13897,0.19564,1,1
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0092139,0.13855,0.25825,1,1
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0024341,0.13848,0.1412,1,1
3,GO CORONARY VASCULATURE DEVELOPMENT,0.02951,0.13813,0.24942,1,1
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.011574,0.13812,0.16922,1,1
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.020391,0.13785,0.25155,1,1
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.040368,0.13736,0.19924,1,1
3,GO AUTOPHAGY OF NUCLEUS,0.037377,0.137,0.15268,1,1
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.013834,0.13663,0.13396,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.023112,0.13634,0.18924,1,1
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.023112,0.13559,0.14527,1,1
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.054439,0.13556,0.16877,1,1
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.024086,0.13539,0.13451,1,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.046961,0.13519,0.14167,1,1
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.014457,0.13494,0.22532,1,1
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0172,0.13452,0.16312,1,1
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.023112,0.1344,0.21413,1,1
3,GO BLASTOCYST FORMATION,0.0020776,0.13382,0.18246,1,1
3,GO RETINA HOMEOSTASIS,0.015104,0.13371,0.12309,1,1
3,GO LATERAL MESODERM DEVELOPMENT,0.054439,0.13354,0.22879,1,1
3,GO ANIMAL ORGAN REGENERATION,0.0092139,0.13351,0.1858,1,1
3,GO REGULATION OF RESPONSE TO STRESS,0.018736,0.13343,0.17503,1,1
3,GO RESPONSE TO STEROL,0.024086,0.13336,0.22045,1,1
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.015776,0.13269,0.14929,1,1
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.030713,0.13248,0.13911,1,1
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.045233,0.13223,0.19637,1,1
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.052482,0.13212,0.17603,1,1
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.041938,0.13194,0.16152,1,1
3,GO FATTY ACID TRANSPORT,0.041938,0.13144,0.15739,1,1
3,GO RECEPTOR CATABOLIC PROCESS,0.043559,0.13081,0.19223,1,1
3,GO GASTRULATION,0.015776,0.13068,0.22827,1,1
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.020391,0.13026,0.15852,1,1
3,GO NCRNA PROCESSING,0.015104,0.13006,0.12725,1,1
3,GO NADP METABOLIC PROCESS,0.054439,0.12953,0.13617,1,1
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.028348,0.12928,0.13981,1,1
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.038848,0.12906,0.17166,1,1
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.023112,0.12788,0.21531,1,1
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0015882,0.12773,0.14785,1,1
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.028348,0.12763,0.2252,1,1
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.027226,0.12753,0.17242,1,1
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.019548,0.12735,0.16318,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.015104,0.12729,0.13638,1,1
3,GO OSTEOBLAST DIFFERENTIATION,0.052482,0.12719,0.16853,1,1
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0066311,0.1269,0.17561,1,1
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.01266,0.12678,0.12995,1,1
3,GO GENE SILENCING,0.041938,0.12651,0.13326,1,1
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.0080134,0.12591,0.13837,1,1
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.021265,0.12583,0.1212,1,1
3,GO RESPONSE TO OXIDATIVE STRESS,0.018736,0.12559,0.15876,1,1
3,GO FIBROBLAST MIGRATION,0.028348,0.12515,0.20343,1,1
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.023112,0.12494,0.14453,1,1
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.008797,0.12461,0.18714,1,1
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.031957,0.12455,0.11145,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.050584,0.12436,0.15833,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.012106,0.12431,0.17466,1,1
3,GO VIRAL RNA GENOME REPLICATION,0.052482,0.12351,0.14353,1,1
3,GO ESTROGEN METABOLIC PROCESS,0.015104,0.12343,0.13017,1,1
3,GO CELLULAR RESPONSE TO RADIATION,0.01266,0.12333,0.1502,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.012106,0.12326,0.14703,1,1
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.028348,0.12303,0.14262,1,1
3,GO VIRAL TRANSLATION,0.011574,0.12274,0.16336,1,1
3,GO NEGATIVE REGULATION OF CELL DEATH,0.011574,0.12229,0.16427,1,1
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.016475,0.12208,0.16563,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.021265,0.12188,0.13773,1,1
3,GO MITOTIC CELL CYCLE ARREST,0.045233,0.1215,0.17817,1,1
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.015104,0.12099,0.19734,1,1
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.046961,0.12092,0.1849,1,1
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.043559,0.1209,0.17345,1,1
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.013235,0.12012,0.16883,1,1
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.011574,0.12007,0.16565,1,1
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.048745,0.11977,0.14149,1,1
3,GO MAINTENANCE OF CELL NUMBER,0.02951,0.11967,0.17332,1,1
3,GO VITAMIN METABOLIC PROCESS,0.0080134,0.11908,0.15649,1,1
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.0015041,0.1185,0.17502,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.024086,0.11807,0.1428,1,1
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.011063,0.11771,0.13285,1,1
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.040368,0.11692,0.15302,1,1
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.054439,0.11601,0.16294,1,1
3,GO STEM CELL DIFFERENTIATION,0.027226,0.11542,0.16963,1,1
3,GO APOPTOTIC SIGNALING PATHWAY,0.040368,0.11528,0.13891,1,1
3,GO GLYCOSIDE METABOLIC PROCESS,0.0092139,0.11492,0.15858,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.02951,0.11448,0.16194,1,1
3,GO PLACENTA DEVELOPMENT,0.037377,0.11447,0.17474,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.010572,0.11444,0.17523,1,1
3,GO MULTI ORGANISM LOCALIZATION,0.0096484,0.11427,0.13792,1,1
3,GO SPERM EGG RECOGNITION,0.023112,0.11383,0.13627,1,1
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.028348,0.11356,0.15343,1,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.037377,0.11294,0.10668,1,1
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.016475,0.11289,0.13374,1,1
3,GO INTRACELLULAR MRNA LOCALIZATION,0.0040644,0.11218,0.20739,1,1
3,GO JNK CASCADE,0.052482,0.11174,0.16473,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0034935,0.11172,0.15644,1,1
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.037377,0.11136,0.15419,1,1
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.033245,0.11099,0.14647,1,1
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.037377,0.11083,0.16347,1,1
3,GO REGENERATION,0.033245,0.1104,0.15908,1,1
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.006955,0.10992,0.15775,1,1
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.054439,0.10944,0.18366,1,1
3,GO TRNA METHYLATION,0.048745,0.10923,0.13799,1,1
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.048745,0.10877,0.13097,1,1
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.045233,0.10835,0.12231,1,1
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.033245,0.10818,0.15242,1,1
3,GO PROTEIN TETRAMERIZATION,0.017954,0.10798,0.15762,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.048745,0.10763,0.094039,1,1
3,GO REGULATION OF CELL DEATH,0.024086,0.10755,0.15188,1,1
3,GO RNA CATABOLIC PROCESS,0.0049572,0.10744,0.10662,1,1
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0036751,0.10731,0.15703,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.040368,0.10727,0.25311,1,1
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.024086,0.10719,0.16697,1,1
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.034576,0.10708,0.12864,1,1
3,GO RIBOSOME BIOGENESIS,0.020391,0.10629,0.1083,1,1
3,GO FATTY ACID METABOLIC PROCESS,0.014457,0.10572,0.14664,1,1
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.023112,0.10373,0.15004,1,1
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.008797,0.10283,0.12666,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.035953,0.10254,0.11749,1,1
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.041938,0.10247,0.13814,1,1
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.043559,0.10222,0.17427,1,1
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.02951,0.10219,0.14556,1,1
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.045233,0.10162,0.14925,1,1
3,GO REGULATION OF FIBROBLAST MIGRATION,0.050584,0.10137,0.19258,1,1
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.030713,0.10123,0.17017,1,1
3,GO ALCOHOL METABOLIC PROCESS,0.038848,0.10069,0.14298,1,1
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0029965,0.10059,0.13805,1,1
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.035953,0.10045,0.10832,1,1
3,GO IMPORT INTO NUCLEUS,0.043559,0.10003,0.12762,1,1
3,GO NUCLEOBASE METABOLIC PROCESS,0.007293,0.099915,0.15435,1,1
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.052482,0.098073,0.15643,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.016475,0.098037,0.15196,1,1
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.031957,0.097487,0.15589,1,1
3,GO NUCLEOSIDE METABOLIC PROCESS,0.0057394,0.09626,0.13594,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.031957,0.095641,0.15986,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,0.041938,0.094574,0.14322,1,1
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.043559,0.09422,0.15109,1,1
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.0049572,0.092776,0.098507,1,1
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.030713,0.09277,0.1207,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,0.023112,0.092596,0.14502,1,1
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.050584,0.092561,0.12731,1,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.038848,0.092545,0.14502,1,1
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.023112,0.092265,0.12824,1,1
3,GO VIRAL GENE EXPRESSION,0.0096484,0.092033,0.099999,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.045233,0.0917,0.14159,1,1
3,GO CELLULAR KETONE METABOLIC PROCESS,0.022172,0.089858,0.11649,1,1
3,GO RRNA METABOLIC PROCESS,0.043559,0.089127,0.10286,1,1
3,GO APOPTOTIC PROCESS,0.054439,0.089103,0.13317,1,1
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.052482,0.087493,0.16953,1,1
3,GO ACTIN NUCLEATION,0.043559,0.087164,0.13496,1,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.027226,0.086674,0.13158,1,1
3,GO MATURATION OF LSU RRNA,0.045233,0.086655,0.12247,1,1
3,GO RESPONSE TO OXYGEN LEVELS,0.021265,0.086549,0.13849,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.040368,0.085715,0.14417,1,1
3,GO LIPID METABOLIC PROCESS,0.052482,0.084313,0.1309,1,1
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.040368,0.083113,0.16235,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.023112,0.080845,0.0806,1,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.020391,0.078433,0.14226,1,1
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0092139,0.073851,0.091068,1,1
3,GO REGULATION OF GLIOGENESIS,0.045233,0.071421,0.1573,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.027226,0.070135,0.076223,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.023112,0.069482,0.11294,1,1
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.048745,0.06642,0.11597,1,1
3,GO PEPTIDE METABOLIC PROCESS,0.033245,0.06307,0.074914,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.034576,0.061187,0.096183,1,1
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.021265,0.060656,0.084121,1,1
3,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.017954,0.96922,0.69435,1,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.012106,0.91068,0.70646,1,0
3,GO NATURAL KILLER CELL CHEMOTAXIS,0.013834,0.8031,0.69658,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0066311,0.74458,0.61256,1,0
3,GO HYPERSENSITIVITY,0.010572,0.72646,0.5671,1,0
3,GO EOSINOPHIL MIGRATION,0.052482,0.69021,0.44204,1,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0017696,0.65607,0.63602,1,0
3,GO EOSINOPHIL CHEMOTAXIS,0.038848,0.63613,0.4171,1,0
3,GO LEUKOCYTE AGGREGATION,0.0031545,0.62959,0.57015,1,0
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0060238,0.62002,0.49128,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.010101,0.58603,0.55228,1,0
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00072571,0.57729,0.57924,1,0
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0015041,0.57685,0.53416,1,0
3,GO DENDRITIC CELL DIFFERENTIATION,0.007293,0.5706,0.50479,1,0
3,GO POSITIVE THYMIC T CELL SELECTION,0.050584,0.57051,0.41769,1,0
3,GO NEUTROPHIL CHEMOTAXIS,0.0076456,0.57011,0.45241,1,0
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.012106,0.56514,0.46637,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.010101,0.56195,0.46309,1,0
3,GO CYTOLYSIS,0.0080134,0.54883,0.53774,1,0
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.008797,0.54785,0.44881,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0010798,0.54565,0.56138,1,0
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.0049572,0.54296,0.50802,1,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0017696,0.54255,0.55491,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0027019,0.53604,0.49114,1,0
3,GO INTERLEUKIN 12 PRODUCTION,0.015104,0.53293,0.43102,1,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00057531,0.53099,0.54351,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00091199,0.52946,0.54218,1,0
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.008797,0.52793,0.5631,1,0
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0066311,0.5174,0.477,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0036751,0.51722,0.48584,1,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0092139,0.51529,0.44498,1,0
3,GO DETECTION OF OTHER ORGANISM,0.007293,0.5137,0.48508,1,0
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0054671,0.51361,0.43789,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0049572,0.51036,0.4762,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0076456,0.50969,0.45488,1,0
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.008797,0.50837,0.49973,1,0
3,GO T CELL MIGRATION,0.0044907,0.50726,0.50082,1,0
3,GO LYMPHOCYTE MIGRATION,0.0083971,0.50091,0.43758,1,0
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.00332,0.50018,0.46196,1,0
3,GO DETECTION OF BIOTIC STIMULUS,0.0020776,0.49945,0.47905,1,0
3,GO GRANULOCYTE MIGRATION,0.0047188,0.49878,0.42214,1,0
3,GO GLIAL CELL ACTIVATION,0.0057394,0.49458,0.46571,1,0
3,GO REGULATION OF NEUTROPHIL ACTIVATION,0.022172,0.49425,0.41355,1,0
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.0038653,0.49158,0.42587,1,0
3,GO GRANULOCYTE CHEMOTAXIS,0.0040644,0.49114,0.43408,1,0
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.011574,0.49042,0.45472,1,0
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.043559,0.48983,0.33595,1,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0028457,0.4843,0.51115,1,0
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0029965,0.47928,0.48684,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0076456,0.47649,0.44436,1,0
3,GO INTERFERON GAMMA PRODUCTION,0.010101,0.47472,0.438,1,0
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.022172,0.47266,0.33981,1,0
3,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.014457,0.47069,0.50519,1,0
3,GO INTERLEUKIN 17 PRODUCTION,0.008797,0.46662,0.43421,1,0
3,GO REGULATION OF B CELL DIFFERENTIATION,0.0092139,0.46647,0.41335,1,0
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.026142,0.46111,0.34556,1,0
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0047188,0.45609,0.40777,1,0
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0015882,0.45563,0.50013,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.031957,0.45274,0.36677,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0063209,0.44985,0.4067,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0080134,0.44891,0.38284,1,0
3,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.013834,0.44831,0.43146,1,0
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.010101,0.44652,0.36562,1,0
3,GO NEUROINFLAMMATORY RESPONSE,0.0083971,0.44568,0.40816,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0029965,0.44333,0.39853,1,0
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.024086,0.44283,0.36364,1,0
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.023112,0.43767,0.50254,1,0
3,GO MATURE B CELL DIFFERENTIATION,0.01266,0.43555,0.3877,1,0
3,GO MYELOID LEUKOCYTE MIGRATION,0.0066311,0.43082,0.35952,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0057394,0.43041,0.37807,1,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0019699,0.42687,0.42552,1,0
3,GO CELL KILLING,0.011574,0.42402,0.34795,1,0
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0054671,0.42223,0.41833,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0049572,0.42198,0.3913,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0044907,0.42175,0.39783,1,0
3,GO NEGATIVE REGULATION OF BONE REMODELING,0.025096,0.42135,0.37071,1,0
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0052065,0.42128,0.39226,1,0
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0052065,0.42101,0.39536,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.006955,0.41684,0.37435,1,0
3,GO MACROPHAGE PROLIFERATION,0.020391,0.41497,0.41882,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0038653,0.41488,0.42107,1,0
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0042727,0.4106,0.37315,1,0
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.00332,0.40988,0.40358,1,0
3,GO LEUKOCYTE CHEMOTAXIS,0.0080134,0.40983,0.36219,1,0
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0025648,0.40554,0.39172,1,0
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0019699,0.40333,0.40669,1,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.007293,0.40047,0.40067,1,0
3,GO REGULATION OF B CELL ACTIVATION,0.013834,0.39882,0.37337,1,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0080134,0.39437,0.44287,1,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.0044907,0.39092,0.40514,1,0
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0052065,0.39024,0.47913,1,0
3,GO LYMPHOCYTE COSTIMULATION,0.023112,0.39018,0.35546,1,0
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.040368,0.38964,0.31635,1,0
3,GO IMMUNOGLOBULIN SECRETION,0.027226,0.38956,0.32346,1,0
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.010101,0.38642,0.34948,1,0
3,GO CYTOKINE SECRETION,0.0047188,0.38321,0.3515,1,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.015776,0.38279,0.45032,1,0
3,GO INTEGRIN ACTIVATION,0.018736,0.38004,0.35084,1,0
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0076456,0.37858,0.35529,1,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.021265,0.37754,0.39695,1,0
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.013834,0.37572,0.32333,1,0
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.026142,0.37541,0.37839,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0049572,0.37456,0.39602,1,0
3,GO INTERLEUKIN 6 PRODUCTION,0.0092139,0.37321,0.33405,1,0
3,GO VITAMIN D METABOLIC PROCESS,0.0080134,0.37169,0.32122,1,0
3,GO REGULATION OF CELL ACTIVATION,0.008797,0.36961,0.34679,1,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.040368,0.36661,0.31262,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.012106,0.36612,0.32352,1,0
3,GO MACROPHAGE DIFFERENTIATION,0.0063209,0.36179,0.35782,1,0
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.01266,0.35815,0.32228,1,0
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.0036751,0.35788,0.35666,1,0
3,GO AMYLOID BETA CLEARANCE,0.010101,0.3571,0.35047,1,0
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.013235,0.3557,0.38421,1,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0052065,0.3543,0.32706,1,0
3,GO RESPIRATORY BURST,0.038848,0.34451,0.29686,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.007293,0.34377,0.31616,1,0
3,GO INTERLEUKIN 5 PRODUCTION,0.019548,0.34213,0.36265,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0057394,0.34161,0.32011,1,0
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.031957,0.34143,0.30554,1,0
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0092139,0.33746,0.33072,1,0
3,GO LEUKOCYTE TETHERING OR ROLLING,0.026142,0.33597,0.30652,1,0
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.020391,0.3323,0.39726,1,0
3,GO CELL CHEMOTAXIS,0.008797,0.33035,0.33311,1,0
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0044907,0.32762,0.32012,1,0
3,GO RESPONSE TO INTERLEUKIN 2,0.046961,0.32537,0.32501,1,0
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.016475,0.32522,0.32139,1,0
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0052065,0.32063,0.33546,1,0
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.014457,0.31972,0.28554,1,0
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.027226,0.31912,0.31338,1,0
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.025096,0.31777,0.33611,1,0
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.010101,0.31192,0.30265,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.017954,0.31148,0.27871,1,0
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.048745,0.3106,0.23882,1,0
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.008797,0.30943,0.33154,1,0
3,GO LEUKOCYTE HOMEOSTASIS,0.0096484,0.30462,0.30741,1,0
3,GO RESPONSE TO TUMOR CELL,0.013235,0.30397,0.3243,1,0
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0049572,0.30224,0.32809,1,0
3,GO PHAGOCYTOSIS,0.0054671,0.30207,0.3416,1,0
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.010572,0.30092,0.29175,1,0
3,GO MUCUS SECRETION,0.011063,0.29921,0.29041,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.019548,0.2981,0.31644,1,0
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.007293,0.29783,0.29578,1,0
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.025096,0.29761,0.31064,1,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.0083971,0.29716,0.39988,1,0
3,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.037377,0.29673,0.29799,1,0
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.041938,0.2961,0.24409,1,0
3,GO MULTI ORGANISM CELLULAR PROCESS,0.011574,0.29453,0.32605,1,0
3,GO INFLAMMATORY RESPONSE,0.007293,0.29314,0.31011,1,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.011063,0.28725,0.34368,1,0
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.033245,0.28627,0.22012,1,0
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.007293,0.28459,0.32038,1,0
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0060238,0.28384,0.29914,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0092139,0.28158,0.3048,1,0
3,GO LYMPHOCYTE HOMEOSTASIS,0.013834,0.27781,0.28481,1,0
3,GO RESPONSE TO HYDROPEROXIDE,0.010101,0.27711,0.32622,1,0
3,GO MYELOID LEUKOCYTE ACTIVATION,0.008797,0.27624,0.29087,1,0
3,GO LEUKOCYTE MIGRATION,0.012106,0.27553,0.29871,1,0
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0052065,0.27543,0.31164,1,0
3,GO OSTEOCLAST DIFFERENTIATION,0.011063,0.27009,0.28745,1,0
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.021265,0.2693,0.27513,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.027226,0.26787,0.26813,1,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.010572,0.2675,0.29917,1,0
3,GO T CELL DIFFERENTIATION IN THYMUS,0.020391,0.26555,0.28964,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.048745,0.26386,0.26531,1,0
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.008797,0.26326,0.268,1,0
3,GO POSITIVE REGULATION OF CHEMOTAXIS,0.017954,0.26249,0.28665,1,0
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.038848,0.26145,0.28792,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0047188,0.26056,0.31239,1,0
3,GO ANTIMICROBIAL HUMORAL RESPONSE,0.052482,0.25981,0.2326,1,0
3,GO REGULATION OF INTEGRIN ACTIVATION,0.048745,0.25496,0.24656,1,0
3,GO PIGMENT ACCUMULATION,0.023112,0.25387,0.29817,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.01266,0.2512,0.26765,1,0
3,GO MEMBRANE INVAGINATION,0.019548,0.25117,0.29357,1,0
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.038848,0.2511,0.2882,1,0
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.034576,0.24944,0.31156,1,0
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.041938,0.24782,0.22909,1,0
3,GO REGULATION OF CHEMOTAXIS,0.010101,0.24562,0.27475,1,0
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.011063,0.24402,0.2535,1,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.021265,0.24327,0.29074,1,0
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.054439,0.24119,0.29158,1,0
3,GO REGULATION OF MYOBLAST FUSION,0.02951,0.23972,0.37895,1,0
3,GO CELL ACTIVATION,0.010101,0.23864,0.27212,1,0
3,GO CHOLESTEROL STORAGE,0.011574,0.23737,0.30981,1,0
3,GO REGULATION OF PLATELET ACTIVATION,0.026142,0.23677,0.32075,1,0
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.048745,0.2356,0.32567,1,0
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0031545,0.23473,0.34825,1,0
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.008797,0.23427,0.24194,1,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.021265,0.2333,0.24859,1,0
3,GO FOAM CELL DIFFERENTIATION,0.015776,0.22933,0.2744,1,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.035953,0.22742,0.28278,1,0
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.045233,0.22634,0.25864,1,0
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.014457,0.22454,0.21592,1,0
3,GO ERK1 AND ERK2 CASCADE,0.010101,0.2227,0.26772,1,0
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.01266,0.22263,0.27956,1,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.018736,0.22048,0.23438,1,0
3,GO MEMBRANE RAFT ORGANIZATION,0.050584,0.21526,0.27809,1,0
3,GO CELLULAR RESPONSE TO DSRNA,0.0172,0.21499,0.25189,1,0
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.011574,0.21209,0.24788,1,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.048745,0.21183,0.22012,1,0
3,GO POSITIVE CHEMOTAXIS,0.013235,0.21159,0.23512,1,0
3,GO PLATELET DEGRANULATION,0.043559,0.20972,0.23317,1,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.030713,0.20955,0.32906,1,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.054439,0.20937,0.24644,1,0
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.026142,0.20667,0.24351,1,0
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.046961,0.20634,0.2435,1,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.035953,0.20602,0.30058,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.019548,0.20391,0.26304,1,0
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.011574,0.20209,0.23159,1,0
3,GO FOREGUT MORPHOGENESIS,0.015104,0.2016,0.31584,1,0
3,GO DORSAL AORTA DEVELOPMENT,0.031957,0.20115,0.32891,1,0
3,GO REPLACEMENT OSSIFICATION,0.033245,0.20075,0.23717,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.031957,0.19929,0.20899,1,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0092139,0.19884,0.26575,1,0
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.014457,0.19797,0.2323,1,0
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.02951,0.19774,0.21203,1,0
3,GO REGULATION OF COAGULATION,0.034576,0.19773,0.24348,1,0
3,GO RESPONSE TO INTERLEUKIN 6,0.043559,0.19725,0.24608,1,0
3,GO REGULATION OF STEROL TRANSPORT,0.026142,0.19194,0.22846,1,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.045233,0.19131,0.23707,1,0
3,GO VASCULOGENESIS,0.0172,0.19057,0.28326,1,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0047188,0.19018,0.23926,1,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.02951,0.18937,0.22414,1,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.023112,0.18763,0.23185,1,0
3,GO COPPER ION TRANSPORT,0.023112,0.18386,0.20052,1,0
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0080134,0.17797,0.27446,1,0
3,GO GENITALIA MORPHOGENESIS,0.035953,0.17757,0.24195,1,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.038848,0.17508,0.20988,1,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.014457,0.17434,0.22003,1,0
3,GO ASYMMETRIC CELL DIVISION,0.019548,0.17424,0.20912,1,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.050584,0.17274,0.29879,1,0
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.013235,0.17241,0.26585,1,0
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.030713,0.17186,0.21254,1,0
3,GO TOXIN TRANSPORT,0.0080134,0.17085,0.18479,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.034576,0.17065,0.18328,1,0
3,GO BONE RESORPTION,0.035953,0.16962,0.26397,1,0
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.023112,0.16872,0.20869,1,0
3,GO PULMONARY VALVE DEVELOPMENT,0.034576,0.16659,0.30993,1,0
3,GO CELL REDOX HOMEOSTASIS,0.025096,0.16611,0.17167,1,0
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.02951,0.16555,0.13232,1,0
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.041938,0.16544,0.18289,1,0
3,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.030713,0.16462,0.18933,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.025096,0.16366,0.21663,1,0
3,GO OLIGOPEPTIDE TRANSPORT,0.041938,0.16347,0.19554,1,0
3,GO MIDGUT DEVELOPMENT,0.050584,0.15911,0.23267,1,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.027226,0.15882,0.21719,1,0
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.021265,0.15762,0.23458,1,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.026142,0.15705,0.27465,1,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.02951,0.15587,0.21177,1,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.045233,0.15411,0.18175,1,0
3,GO METANEPHROS DEVELOPMENT,0.023112,0.1532,0.20928,1,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.034576,0.15299,0.18819,1,0
3,GO RESPONSE TO VITAMIN D,0.035953,0.15265,0.21521,1,0
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.046961,0.15213,0.22906,1,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.022172,0.15108,0.22663,1,0
3,GO RESPONSE TO HYPEROXIA,0.026142,0.1508,0.18954,1,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.050584,0.14931,0.18197,1,0
3,GO PEPTIDE CATABOLIC PROCESS,0.043559,0.14747,0.20325,1,0
3,GO HYALURONAN METABOLIC PROCESS,0.048745,0.14338,0.198,1,0
3,GO GLUTATHIONE METABOLIC PROCESS,0.013834,0.14295,0.14567,1,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.013235,0.14279,0.26735,1,0
3,GO SALIVARY GLAND DEVELOPMENT,0.054439,0.14268,0.22343,1,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.0014241,0.14255,0.16957,1,0
3,GO NECROTIC CELL DEATH,0.02951,0.14193,0.18423,1,0
3,GO PROGRAMMED NECROTIC CELL DEATH,0.018736,0.13598,0.22442,1,0
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.041938,0.13532,0.17504,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.054439,0.13503,0.18298,1,0
3,GO IRON ION HOMEOSTASIS,0.023112,0.13441,0.17671,1,0
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.041938,0.13413,0.15604,1,0
3,GO DNA MODIFICATION,0.02951,0.13405,0.13728,1,0
3,GO CELLULAR IRON ION HOMEOSTASIS,0.054439,0.13139,0.15058,1,0
3,GO RNA SURVEILLANCE,0.041938,0.13133,0.11496,1,0
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.030713,0.12993,0.19972,1,0
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.026142,0.12838,0.17646,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.045233,0.1282,0.24163,1,0
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.033245,0.12799,0.18257,1,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.038848,0.12547,0.15748,1,0
3,GO MYOBLAST PROLIFERATION,0.018736,0.12275,0.25001,1,0
3,GO DETOXIFICATION,0.033245,0.12159,0.12827,1,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.038848,0.12004,0.16192,1,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.023112,0.11938,0.18075,1,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.037377,0.11526,0.18897,1,0
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.034576,0.11387,0.15849,1,0
3,GO TRANSITION METAL ION HOMEOSTASIS,0.017954,0.11216,0.16106,1,0
3,GO NEPHRON DEVELOPMENT,0.048745,0.11015,0.19408,1,0
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.020391,0.10433,0.18186,1,0
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.02951,0.10179,0.12161,1,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.024086,0.098716,0.18753,1,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.038848,0.09573,0.11668,1,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.040368,0.095467,0.12581,1,0
3,GO INTERMEMBRANE LIPID TRANSFER,0.022172,0.089056,0.20556,1,0
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.050584,0.088849,0.11871,1,0
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.040368,0.086045,0.090866,1,0
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.040368,0.084121,0.14024,1,0
3,GO REGULATION OF VACUOLE ORGANIZATION,0.035953,0.083534,0.12851,1,0
3,GO REGULATION OF ORGAN GROWTH,0.022172,0.077604,0.17839,1,0
3,GO PIGMENT METABOLIC PROCESS,0.035953,0.077379,0.1139,1,0
3,GO ORGANIC ACID METABOLIC PROCESS,0.050584,0.055624,0.11697,1,0
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.041938,-0.087977,-0.098482,1,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.045233,-0.095646,-0.094995,1,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.046961,-0.098174,-0.12706,1,0
3,GO ORGANELLE FUSION,0.045233,-0.10554,-0.046043,1,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.040368,-0.11293,-0.2305,1,0
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.054439,-0.11558,-0.09548,1,0
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.040368,-0.12022,-0.084746,1,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.052482,-0.124,-0.1051,1,0
3,GO ASSOCIATIVE LEARNING,0.045233,-0.1249,-0.11141,1,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.046961,-0.12963,-0.1087,1,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.038848,-0.13047,-0.12953,1,0
3,GO FEAR RESPONSE,0.033245,-0.13424,-0.14026,1,0
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.046961,-0.13653,-0.089411,1,0
3,GO REGULATION OF APPETITE,0.054439,-0.13783,-0.15764,1,0
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.046961,-0.14282,-0.097741,1,0
3,GO RESPONSE TO AMINE,0.041938,-0.14384,-0.11263,1,0
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.034576,-0.14498,-0.11203,1,0
3,GO TUBULIN DEACETYLATION,0.050584,-0.14521,-0.12671,1,0
3,GO NEUROTRANSMITTER UPTAKE,0.037377,-0.14536,-0.13025,1,0
3,GO SNARE COMPLEX ASSEMBLY,0.041938,-0.14609,-0.11856,1,0
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.050584,-0.1469,-0.11232,1,0
3,GO RESPONSE TO FOOD,0.037377,-0.148,-0.13871,1,0
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0092139,-0.14866,-0.1321,1,0
3,GO ACTION POTENTIAL,0.018736,-0.15015,-0.11407,1,0
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.045233,-0.15716,-0.1028,1,0
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.040368,-0.15716,-0.21624,1,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.035953,-0.15787,-0.14591,1,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.021265,-0.16329,-0.17526,1,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.040368,-0.16411,-0.14975,1,0
3,GO CARDIAC CONDUCTION,0.026142,-0.16558,-0.11758,1,0
3,GO REGULATION OF HORMONE SECRETION,0.041938,-0.16665,-0.094265,1,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0172,-0.16669,-0.17691,1,0
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.022172,-0.1672,-0.13663,1,0
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.02951,-0.17238,-0.11703,1,0
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.022172,-0.17478,-0.14187,1,0
3,GO HORMONE TRANSPORT,0.014457,-0.17622,-0.11406,1,0
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.027226,-0.17626,-0.18677,1,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.02951,-0.17704,-0.15706,1,0
3,GO MEMBRANE DEPOLARIZATION,0.01266,-0.17772,-0.14924,1,0
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.052482,-0.17786,-0.10805,1,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.050584,-0.1788,-0.14268,1,0
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.015104,-0.18043,-0.14826,1,0
3,GO SIGNAL RELEASE,0.037377,-0.18082,-0.083443,1,0
3,GO MAINTENANCE OF CELL POLARITY,0.038848,-0.18174,-0.16442,1,0
3,GO POTASSIUM ION TRANSPORT,0.011063,-0.18222,-0.15118,1,0
3,GO REGULATION OF EXOCYTOSIS,0.015776,-0.18313,-0.1276,1,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.017954,-0.18362,-0.15374,1,0
3,GO REGULATION OF INSULIN SECRETION,0.027226,-0.18401,-0.11563,1,0
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.041938,-0.18603,-0.18292,1,0
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.037377,-0.18663,-0.13312,1,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.033245,-0.18894,-0.17509,1,0
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.008797,-0.19238,-0.23126,1,0
3,GO FEEDING BEHAVIOR,0.0052065,-0.19424,-0.17642,1,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.011063,-0.19735,-0.21003,1,0
3,GO PROTEIN POLYGLUTAMYLATION,0.040368,-0.19856,-0.20179,1,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.024086,-0.19937,-0.18675,1,0
3,GO AMINO ACID TRANSPORT,0.0047188,-0.19951,-0.15169,1,0
3,GO LONG TERM SYNAPTIC DEPRESSION,0.046961,-0.20175,-0.1924,1,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.043559,-0.2024,-0.10064,1,0
3,GO GLUTAMATE METABOLIC PROCESS,0.018736,-0.20289,-0.15995,1,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0049572,-0.20385,-0.19933,1,0
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.034576,-0.20644,-0.13132,1,0
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.015776,-0.20731,-0.21103,1,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.020391,-0.20818,-0.16151,1,0
3,GO RESPONSE TO REDOX STATE,0.045233,-0.20865,-0.13846,1,0
3,GO NOTCH RECEPTOR PROCESSING,0.022172,-0.21005,-0.20097,1,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.033245,-0.21022,-0.15542,1,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.030713,-0.21124,-0.25515,1,0
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.041938,-0.21183,-0.19828,1,0
3,GO INSULIN SECRETION,0.010572,-0.21257,-0.14882,1,0
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0031545,-0.21311,-0.19184,1,0
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.033245,-0.21321,-0.1361,1,0
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0096484,-0.21413,-0.15549,1,0
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0034935,-0.21444,-0.23904,1,0
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.045233,-0.21561,-0.12862,1,0
3,GO REGULATION OF RESPONSE TO FOOD,0.040368,-0.21762,-0.2074,1,0
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.034576,-0.21872,-0.16266,1,0
3,GO REGULATION OF MEMBRANE POTENTIAL,0.0038653,-0.21886,-0.17582,1,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.015776,-0.22103,-0.23171,1,0
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0083971,-0.22172,-0.19484,1,0
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.048745,-0.22202,-0.15103,1,0
3,GO NEUROMUSCULAR PROCESS,0.040368,-0.22238,-0.15637,1,0
3,GO SYNAPTIC SIGNALING,0.0080134,-0.22333,-0.1946,1,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.022172,-0.22343,-0.19649,1,0
3,GO VESICLE DOCKING,0.0060238,-0.22387,-0.1603,1,0
3,GO RESPONSE TO NICOTINE,0.045233,-0.22461,-0.16108,1,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0060238,-0.22493,-0.17022,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0080134,-0.22526,-0.20443,1,0
3,GO LOCOMOTORY BEHAVIOR,0.027226,-0.22582,-0.15671,1,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.037377,-0.22622,-0.1373,1,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.018736,-0.22713,-0.20595,1,0
3,GO RESPONSE TO POTASSIUM ION,0.045233,-0.22728,-0.2481,1,0
3,GO SYNAPTIC VESICLE RECYCLING,0.0047188,-0.22828,-0.18621,1,0
3,GO RESPONSE TO COCAINE,0.0096484,-0.22871,-0.19015,1,0
3,GO MICROTUBULE DEPOLYMERIZATION,0.015104,-0.22994,-0.24589,1,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.010101,-0.23068,-0.21868,1,0
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.015104,-0.2311,-0.18864,1,0
3,GO RESPONSE TO CATECHOLAMINE,0.0044907,-0.23175,-0.15665,1,0
3,GO AMINE BIOSYNTHETIC PROCESS,0.013235,-0.23245,-0.16515,1,0
3,GO RESPONSE TO DOPAMINE,0.0036751,-0.23496,-0.17525,1,0
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.019548,-0.23515,-0.21678,1,0
3,GO PEPTIDE HORMONE SECRETION,0.0049572,-0.23566,-0.16994,1,0
3,GO MITOCHONDRION DISTRIBUTION,0.033245,-0.23593,-0.14604,1,0
3,GO CATECHOLAMINE METABOLIC PROCESS,0.0028457,-0.23644,-0.21375,1,0
3,GO ADRENAL GLAND DEVELOPMENT,0.043559,-0.23663,-0.19436,1,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.0025648,-0.23754,-0.1985,1,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0025648,-0.24277,-0.21316,1,0
3,GO SYNAPSE ASSEMBLY,0.046961,-0.24728,-0.18045,1,0
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.021265,-0.25054,-0.14992,1,0
3,GO PRESYNAPSE ORGANIZATION,0.034576,-0.25146,-0.16442,1,0
3,GO NEURON CELLULAR HOMEOSTASIS,0.035953,-0.25201,-0.21535,1,0
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.014457,-0.25253,-0.22507,1,0
3,GO OPTIC NERVE DEVELOPMENT,0.028348,-0.25489,-0.27086,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.022172,-0.25503,-0.22635,1,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.006955,-0.25702,-0.24422,1,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0029965,-0.25708,-0.29034,1,0
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0092139,-0.25779,-0.21295,1,0
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0047188,-0.25799,-0.1903,1,0
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.015104,-0.25843,-0.24305,1,0
3,GO DETECTION OF TEMPERATURE STIMULUS,0.0027019,-0.25849,-0.2456,1,0
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.0057394,-0.25962,-0.20538,1,0
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.017954,-0.26093,-0.20348,1,0
3,GO PRESYNAPTIC ENDOCYTOSIS,0.0029965,-0.26124,-0.21371,1,0
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0047188,-0.26261,-0.22672,1,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.037377,-0.26263,-0.17042,1,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.0036751,-0.26413,-0.26451,1,0
3,GO REPRODUCTIVE BEHAVIOR,0.008797,-0.26434,-0.23594,1,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.038848,-0.26498,-0.19036,1,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.031957,-0.2662,-0.20266,1,0
3,GO AMMONIUM ION METABOLIC PROCESS,0.0057394,-0.26653,-0.25179,1,0
3,GO SUCKLING BEHAVIOR,0.019548,-0.26874,-0.26688,1,0
3,GO MATING BEHAVIOR,0.010572,-0.27114,-0.22436,1,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0024341,-0.27162,-0.23501,1,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0027019,-0.2737,-0.20699,1,0
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00091199,-0.27492,-0.27155,1,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.010572,-0.27616,-0.27142,1,0
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0052065,-0.28165,-0.25059,1,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.027226,-0.28173,-0.20716,1,0
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.006955,-0.28214,-0.21422,1,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0060238,-0.28234,-0.23467,1,0
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0038653,-0.28527,-0.25921,1,0
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0019699,-0.28594,-0.28098,1,0
3,GO SYNAPTIC VESICLE LOCALIZATION,0.008797,-0.28706,-0.21898,1,0
3,GO DOPAMINE METABOLIC PROCESS,0.0013481,-0.28826,-0.2683,1,0
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0010209,-0.28894,-0.30026,1,0
3,GO NEURAL NUCLEUS DEVELOPMENT,0.0015882,-0.29251,-0.23851,1,0
3,GO DETECTION OF CALCIUM ION,0.0017696,-0.29265,-0.27998,1,0
3,GO SECRETORY GRANULE LOCALIZATION,0.0063209,-0.29455,-0.26579,1,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0080134,-0.29763,-0.22353,1,0
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.010572,-0.29846,-0.22879,1,0
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.0044907,-0.29895,-0.2606,1,0
3,GO EXOCYTIC PROCESS,0.0016767,-0.30083,-0.23477,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.011574,-0.30204,-0.25138,1,0
3,GO ACIDIC AMINO ACID TRANSPORT,0.0017696,-0.30278,-0.23599,1,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0017696,-0.30445,-0.2764,1,0
3,GO ADULT BEHAVIOR,0.0052065,-0.30447,-0.2248,1,0
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.022172,-0.30527,-0.30471,1,0
3,GO HEART FIELD SPECIFICATION,0.022172,-0.30658,-0.25217,1,0
3,GO SPINAL CORD PATTERNING,0.022172,-0.30988,-0.25792,1,0
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.048745,-0.31056,-0.24882,1,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.01266,-0.31357,-0.23634,1,0
3,GO THALAMUS DEVELOPMENT,0.015776,-0.31456,-0.23744,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.0025648,-0.31701,-0.28885,1,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0028457,-0.31742,-0.23649,1,0
3,GO DENDRITIC TRANSPORT,0.011574,-0.31989,-0.2932,1,0
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.013834,-0.32197,-0.22157,1,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.024086,-0.32314,-0.22393,1,0
3,GO NEURONAL ACTION POTENTIAL,0.00096503,-0.32327,-0.29704,1,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.033245,-0.32474,-0.2257,1,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.01266,-0.32597,-0.23428,1,0
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0054671,-0.32636,-0.33554,1,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0025648,-0.3281,-0.34747,1,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.0076456,-0.32862,-0.25796,1,0
3,GO SYNAPTIC MEMBRANE ADHESION,0.041938,-0.33165,-0.24259,1,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.0011418,-0.33429,-0.30866,1,0
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0096484,-0.33599,-0.29988,1,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.008797,-0.33631,-0.28481,1,0
3,GO REGULATION OF VESICLE FUSION,0.00054254,-0.33653,-0.33761,1,0
3,GO TELENCEPHALON REGIONALIZATION,0.0076456,-0.34476,-0.34521,1,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.0013481,-0.34511,-0.32698,1,0
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.054439,-0.34633,-0.17317,1,0
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0076456,-0.34811,-0.22624,1,0
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.02951,-0.34942,-0.33029,1,0
3,GO REGULATION OF MICROTUBULE BINDING,0.006955,-0.35074,-0.26101,1,0
3,GO REGULATION OF AMINO ACID TRANSPORT,0.00060992,-0.35146,-0.2995,1,0
3,GO RESPONSE TO ACETYLCHOLINE,0.0060238,-0.35195,-0.29034,1,0
3,GO NEURON FATE COMMITMENT,0.0040644,-0.35368,-0.2771,1,0
3,GO REFLEX,0.012106,-0.3555,-0.27154,1,0
3,GO FOREBRAIN REGIONALIZATION,0.0015041,-0.36005,-0.33416,1,0
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00020554,-0.36284,-0.32579,1,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.00096503,-0.36761,-0.32015,1,0
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0020776,-0.36802,-0.34804,1,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0044907,-0.36805,-0.33084,1,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.038848,-0.36857,-0.24215,1,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0028457,-0.3724,-0.33846,1,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.014457,-0.37411,-0.32435,1,0
3,GO SYNAPSE MATURATION,0.0054671,-0.37775,-0.3587,1,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00060992,-0.38684,-0.35096,1,0
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00081392,-0.3882,-0.30287,1,0
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.00054254,-0.38888,-0.37691,1,0
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0012071,-0.39034,-0.36101,1,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0024341,-0.39039,-0.33642,1,0
3,GO POSTSYNAPSE ASSEMBLY,0.01266,-0.39151,-0.2439,1,0
3,GO GLIAL CELL FATE COMMITMENT,0.037377,-0.39277,-0.28998,1,0
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00051151,-0.39745,-0.3418,1,0
3,GO TRANSMISSION OF NERVE IMPULSE,0.00048214,-0.39849,-0.3451,1,0
3,GO RESPONSE TO INSECTICIDE,0.00019306,-0.40062,-0.37537,1,0
3,GO NEUROTRANSMITTER TRANSPORT,0.00051151,-0.40177,-0.33969,1,0
3,GO MECHANOSENSORY BEHAVIOR,0.033245,-0.40709,-0.26553,1,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0010209,-0.40953,-0.41299,1,0
3,GO DENDRITE EXTENSION,0.00033648,-0.4184,-0.37771,1,0
3,GO NEURONAL ION CHANNEL CLUSTERING,0.00086166,-0.42056,-0.41397,1,0
3,GO RESPONSE TO FORSKOLIN,0.035953,-0.42068,-0.23198,1,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00045436,-0.423,-0.41002,1,0
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0017696,-0.42387,-0.32873,1,0
3,GO NEUROTRANSMITTER SECRETION,0.00026348,-0.42426,-0.38435,1,0
3,GO GLUTAMATE SECRETION,0.00023283,-0.42892,-0.38658,1,0
3,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00029789,-0.42942,-0.40524,1,0
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0013481,-0.44026,-0.39843,1,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.034576,-0.44378,-0.28224,1,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.00011593,-0.44701,-0.40841,1,0
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00028019,-0.44769,-0.41389,1,0
3,GO CATECHOLAMINE UPTAKE,0.0013481,-0.44924,-0.37995,1,0
3,GO GROWTH HORMONE SECRETION,0.0012758,-0.458,-0.39427,1,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.008797,-0.46118,-0.39964,1,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0021907,-0.46203,-0.40936,1,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0054671,-0.46317,-0.38358,1,0
3,GO MONOAMINE TRANSPORT,0.00040321,-0.46839,-0.37839,1,0
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0015882,-0.47558,-0.36857,1,0
3,GO PITUITARY GLAND DEVELOPMENT,0.0018673,-0.48333,-0.35796,1,0
3,GO INNERVATION,0.007293,-0.4834,-0.39425,1,0
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.00068502,-0.48914,-0.40463,1,0
3,GO AMINE TRANSPORT,8.3641e-05,-0.49057,-0.40701,1,0
3,GO STARTLE RESPONSE,0.0023095,-0.49493,-0.40094,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00028019,-0.49968,-0.52963,1,0
3,GO PROTEIN LOCALIZATION TO AXON,0.00057531,-0.50146,-0.49421,1,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0029965,-0.50487,-0.39261,1,0
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.012106,-0.50499,-0.33326,1,0
3,GO REGULATION OF DENDRITE EXTENSION,0.00014062,-0.50716,-0.47619,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0083971,-0.50925,-0.32201,1,0
3,GO DOPAMINE TRANSPORT,8.3641e-05,-0.5141,-0.49308,1,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.0019699,-0.51416,-0.39492,1,0
3,GO SYNAPTIC VESICLE PRIMING,0.00029789,-0.51616,-0.42585,1,0
3,GO NEURON CELL CELL ADHESION,0.007293,-0.51855,-0.35946,1,0
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0010798,-0.52114,-0.42418,1,0
3,GO SYNAPTIC VESICLE CLUSTERING,0.0076456,-0.52494,-0.41319,1,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.00060992,-0.53414,-0.44371,1,0
3,GO REGULATION OF DOPAMINE SECRETION,6.8565e-05,-0.53856,-0.53567,1,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.022172,-0.53878,-0.3079,1,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0028457,-0.55628,-0.42765,1,0
3,GO DENSE CORE GRANULE TRANSPORT,0.00057531,-0.55929,-0.52089,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.0034935,-0.55952,-0.43448,1,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.00017019,-0.56013,-0.49114,1,0
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00024771,-0.56048,-0.52813,1,0
3,GO PREPULSE INHIBITION,0.00091199,-0.56419,-0.47198,1,0
3,GO CATECHOLAMINE SECRETION,5.9985e-05,-0.56476,-0.50166,1,0
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,9.5377e-05,-0.58476,-0.51288,1,0
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,7.3279e-05,-0.58694,-0.50963,1,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00035748,-0.58886,-0.50884,1,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00015974,-0.59,-0.52119,1,0
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00014989,-0.59413,-0.53186,1,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0012071,-0.6,-0.53509,1,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00024771,-0.60006,-0.51383,1,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00028019,-0.60568,-0.53079,1,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0010209,-0.60839,-0.49887,1,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.00081392,-0.61231,-0.54586,1,0
3,GO NEURON FATE SPECIFICATION,0.00048214,-0.63169,-0.46784,1,0
3,GO SYNAPTIC VESICLE DOCKING,8.9327e-05,-0.64847,-0.65948,1,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,5.2428e-05,-0.67662,-0.62993,1,0
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.00010866,-0.68633,-0.65087,1,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,6.4139e-05,-0.71744,-0.68837,1,0
3,GO SYNAPTIC VESICLE MATURATION,4.5779e-05,-0.74896,-0.66227,1,0
3,GO PONS DEVELOPMENT,0.00014062,-0.7903,-0.72409,1,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,7.3279e-05,-0.80132,-0.73392,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,4.8997e-05,-0.83857,-0.79362,1,0
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.00010866,-0.84042,-0.75533,1,0
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.4139e-05,-1.057,-0.90825,1,0
3,GO ADHESION OF SYMBIONT TO HOST,0.13885,0.41689,0.26334,0,1
3,GO LIMB BUD FORMATION,0.065157,0.36296,0.36228,0,1
3,GO CORNIFICATION,0.080256,0.31237,0.17476,0,1
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.062884,0.3113,0.22943,0,1
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.20822,0.30794,0.1919,0,1
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.072385,0.30394,0.29391,0,1
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.08588,0.29238,0.17859,0,1
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.074935,0.28543,0.1945,0,1
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.18102,0.28058,0.26142,0,1
3,GO CYTOPLASM ORGANIZATION,0.091819,0.27429,0.26182,0,1
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.065157,0.27296,0.22741,0,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.11163,0.27021,0.2086,0,1
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.060677,0.26427,0.26501,0,1
3,GO GAMMA DELTA T CELL DIFFERENTIATION,0.058535,0.25898,0.28427,0,1
3,GO PRO B CELL DIFFERENTIATION,0.067497,0.24021,0.2049,0,1
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.12273,0.22872,0.20714,0,1
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.17091,0.22793,0.13529,0,1
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.16123,0.2257,0.16117,0,1
3,GO REGULATION OF HIPPO SIGNALING,0.098083,0.22483,0.18241,0,1
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.077559,0.22316,0.25271,0,1
3,GO ENDODERMAL CELL FATE COMMITMENT,0.056456,0.2213,0.17476,0,1
3,GO TRANSEPITHELIAL TRANSPORT,0.067497,0.21874,0.17993,0,1
3,GO L SERINE METABOLIC PROCESS,0.056456,0.21816,0.18076,0,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.094909,0.21467,0.20851,0,1
3,GO SULFATION,0.10134,0.21305,0.16775,0,1
3,GO TRABECULA MORPHOGENESIS,0.08881,0.21196,0.22007,0,1
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.077559,0.20677,0.23633,0,1
3,GO ACYLGLYCEROL HOMEOSTASIS,0.056456,0.20622,0.17422,0,1
3,GO AMELOGENESIS,0.060677,0.20283,0.22826,0,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.08303,0.20254,0.1337,0,1
3,GO ECTODERM DEVELOPMENT,0.23203,0.20203,0.080598,0,1
3,GO REGULATION OF GASTRIC ACID SECRETION,0.069906,0.19974,0.27623,0,1
3,GO HEPARIN METABOLIC PROCESS,0.077559,0.19793,0.27157,0,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.056456,0.19509,0.21063,0,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.065157,0.19502,0.19095,0,1
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.077559,0.19432,0.25015,0,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.08881,0.19356,0.19453,0,1
3,GO BONE MATURATION,0.17091,0.19262,0.17294,0,1
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.062884,0.1906,0.20619,0,1
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.14312,0.18906,0.15954,0,1
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.080256,0.18896,0.18053,0,1
3,GO INTRACELLULAR STEROL TRANSPORT,0.067497,0.18692,0.17131,0,1
3,GO NEURAL CREST FORMATION,0.15197,0.1869,0.19352,0,1
3,GO RESPONSE TO NITRIC OXIDE,0.08303,0.18667,0.15483,0,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.077559,0.18518,0.19293,0,1
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.08588,0.18497,0.12089,0,1
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.18624,0.18486,0.14518,0,1
3,GO VASCULAR WOUND HEALING,0.23203,0.18425,0.16115,0,1
3,GO NEURAL TUBE PATTERNING,0.18624,0.18229,0.1299,0,1
3,GO SALIVA SECRETION,0.15197,0.18227,0.1606,0,1
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.080256,0.18101,0.1378,0,1
3,GO ENDOCARDIUM DEVELOPMENT,0.18102,0.17971,0.16381,0,1
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.094909,0.17882,0.21053,0,1
3,GO PARAXIAL MESODERM DEVELOPMENT,0.080256,0.17851,0.18113,0,1
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.12273,0.17799,0.16096,0,1
3,GO RESPONSE TO PROGESTERONE,0.08588,0.1779,0.18049,0,1
3,GO NEURAL TUBE DEVELOPMENT,0.08881,0.17704,0.15143,0,1
3,GO TRNA CATABOLIC PROCESS,0.098083,0.17474,0.18135,0,1
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.060677,0.17425,0.17512,0,1
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.072385,0.17244,0.17456,0,1
3,GO RECEPTOR RECYCLING,0.074935,0.17217,0.15784,0,1
3,GO LIPID IMPORT INTO CELL,0.060677,0.17146,0.16982,0,1
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.214,0.17113,0.17999,0,1
3,GO BICARBONATE TRANSPORT,0.23827,0.16879,0.10586,0,1
3,GO CERAMIDE TRANSPORT,0.14312,0.16835,0.15095,0,1
3,GO SPINDLE MIDZONE ASSEMBLY,0.214,0.16794,0.15071,0,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.11163,0.16737,0.16863,0,1
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.13885,0.16731,0.24234,0,1
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.08881,0.16719,0.17625,0,1
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.094909,0.16635,0.12321,0,1
3,GO RESPONSE TO MINERALOCORTICOID,0.18624,0.16554,0.13231,0,1
3,GO BILE ACID METABOLIC PROCESS,0.060677,0.16512,0.12709,0,1
3,GO TRANSCYTOSIS,0.094909,0.16512,0.21946,0,1
3,GO REGULATION OF PLATELET AGGREGATION,0.11524,0.16409,0.19236,0,1
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.056456,0.16403,0.17016,0,1
3,GO LABYRINTHINE LAYER MORPHOGENESIS,0.27126,0.16398,0.10524,0,1
3,GO PLASMA MEMBRANE FUSION,0.060677,0.16278,0.16934,0,1
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.098083,0.16273,0.1233,0,1
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.11894,0.16265,0.10727,0,1
3,GO FACE DEVELOPMENT,0.062884,0.16191,0.23659,0,1
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.16123,0.16149,0.10779,0,1
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.098083,0.16144,0.14417,0,1
3,GO STEROL TRANSPORT,0.08303,0.16061,0.15843,0,1
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.094909,0.16038,0.18861,0,1
3,GO CERAMIDE CATABOLIC PROCESS,0.062884,0.16036,0.2299,0,1
3,GO REGULATION OF WATER LOSS VIA SKIN,0.37111,0.15946,0.056949,0,1
3,GO PEPTIDYL ARGININE MODIFICATION,0.08303,0.15856,0.13713,0,1
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.08588,0.15823,0.22687,0,1
3,GO REGULATION OF RUFFLE ASSEMBLY,0.058535,0.15754,0.16602,0,1
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.058535,0.15623,0.193,0,1
3,GO POSITIVE REGULATION OF WOUND HEALING,0.067497,0.15587,0.17655,0,1
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.08588,0.15574,0.14442,0,1
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.094909,0.1547,0.14686,0,1
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.091819,0.1524,0.15133,0,1
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.08303,0.1507,0.15119,0,1
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.14312,0.15048,0.17559,0,1
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.074935,0.14911,0.17098,0,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.056456,0.14897,0.15275,0,1
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.13885,0.14858,0.1409,0,1
3,GO INTRACELLULAR LIPID TRANSPORT,0.091819,0.1478,0.14586,0,1
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.098083,0.14746,0.18253,0,1
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.065157,0.14734,0.17308,0,1
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.065157,0.14706,0.14128,0,1
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.13467,0.14498,0.13203,0,1
3,GO GLIAL CELL APOPTOTIC PROCESS,0.065157,0.1448,0.16831,0,1
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.16123,0.14385,0.16076,0,1
3,GO PROTEIN AUTOPHOSPHORYLATION,0.058535,0.14358,0.18135,0,1
3,GO EPITHELIAL TUBE FORMATION,0.062884,0.14353,0.14773,0,1
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.060677,0.14352,0.158,0,1
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.072385,0.14349,0.16753,0,1
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.10134,0.14304,0.15082,0,1
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.10811,0.14267,0.12198,0,1
3,GO MYOTUBE DIFFERENTIATION,0.074935,0.14177,0.17125,0,1
3,GO COAGULATION,0.08303,0.1404,0.17634,0,1
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.058535,0.14015,0.15001,0,1
3,GO HISTONE SERINE PHOSPHORYLATION,0.10134,0.14006,0.1765,0,1
3,GO GASTRIC ACID SECRETION,0.10134,0.13978,0.15989,0,1
3,GO CELL PROLIFERATION IN HINDBRAIN,0.3148,0.13949,0.090055,0,1
3,GO AMYLOID BETA FORMATION,0.056456,0.1392,0.17745,0,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.10811,0.13873,0.16116,0,1
3,GO GLYCINE METABOLIC PROCESS,0.094909,0.13822,0.13493,0,1
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.060677,0.13781,0.1604,0,1
3,GO PHOSPHATE ION TRANSPORT,0.13467,0.13771,0.16116,0,1
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.10811,0.1377,0.12683,0,1
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.060677,0.1372,0.16666,0,1
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.11163,0.13715,0.15301,0,1
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.065157,0.13612,0.15194,0,1
3,GO NUCLEAR PORE ORGANIZATION,0.08303,0.13557,0.12275,0,1
3,GO TUBE FORMATION,0.056456,0.13542,0.15052,0,1
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.11524,0.13537,0.16174,0,1
3,GO ALDITOL METABOLIC PROCESS,0.062884,0.13502,0.1051,0,1
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.065157,0.13488,0.16233,0,1
3,GO RESPONSE TO ISCHEMIA,0.077559,0.13411,0.18723,0,1
3,GO TUBE DEVELOPMENT,0.065157,0.13409,0.17677,0,1
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.12662,0.13326,0.12078,0,1
3,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.11894,0.1331,0.1106,0,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.23203,0.13275,0.084526,0,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.077559,0.13234,0.16133,0,1
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.060677,0.13198,0.19192,0,1
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.33029,0.13182,0.12013,0,1
3,GO RESPONSE TO STEROID HORMONE,0.12662,0.13177,0.13425,0,1
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.091819,0.13175,0.1585,0,1
3,GO ENDOCRINE PROCESS,0.077559,0.13107,0.15092,0,1
3,GO TRANSPOSITION,0.18102,0.1307,0.11154,0,1
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.058535,0.1302,0.14335,0,1
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.58498,0.12992,0.05697,0,1
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.16123,0.12945,0.11116,0,1
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.08588,0.12942,0.17887,0,1
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.10134,0.12854,0.27577,0,1
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.094909,0.12615,0.14693,0,1
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.077559,0.12587,0.13525,0,1
3,GO ENDOTHELIAL CELL PROLIFERATION,0.056456,0.12547,0.19749,0,1
3,GO SNRNA METABOLIC PROCESS,0.1306,0.1251,0.1081,0,1
3,GO FILOPODIUM ASSEMBLY,0.074935,0.12487,0.16397,0,1
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.098083,0.12428,0.15437,0,1
3,GO MICROVILLUS ASSEMBLY,0.08303,0.12421,0.13584,0,1
3,GO NCRNA 3 END PROCESSING,0.091819,0.12415,0.098648,0,1
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.091819,0.12414,0.14827,0,1
3,GO REGULATION OF MYELINATION,0.091819,0.124,0.20348,0,1
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.08588,0.12348,0.15508,0,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.062884,0.12344,0.15445,0,1
3,GO REGULATION OF JUN KINASE ACTIVITY,0.1306,0.12329,0.16039,0,1
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.094909,0.12268,0.25227,0,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.058535,0.12221,0.16319,0,1
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.1475,0.12168,0.091519,0,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.10811,0.12154,0.13853,0,1
3,GO REGULATION OF TRANSPOSITION,0.214,0.12132,0.12005,0,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.077559,0.12101,0.12299,0,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.15197,0.12045,0.088214,0,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.17591,0.12,0.084568,0,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.08588,0.11912,0.15163,0,1
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.080256,0.1187,0.20444,0,1
3,GO DENDRITIC SPINE MAINTENANCE,0.08303,0.11775,0.18246,0,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.060677,0.11767,0.13455,0,1
3,GO MUSCLE ADAPTATION,0.069906,0.11755,0.15624,0,1
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.056456,0.11751,0.16878,0,1
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.11524,0.1174,0.14863,0,1
3,GO RUFFLE ASSEMBLY,0.058535,0.11726,0.15765,0,1
3,GO TRNA 5 LEADER REMOVAL,0.27126,0.11697,0.055095,0,1
3,GO CELLULAR RESPONSE TO KETONE,0.11524,0.11679,0.1334,0,1
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.062884,0.1164,0.15709,0,1
3,GO CELL CELL ADHESION,0.069906,0.11572,0.17985,0,1
3,GO RESPONSE TO WOUNDING,0.091819,0.11558,0.17342,0,1
3,GO REGULATION OF LIPID LOCALIZATION,0.080256,0.1154,0.15391,0,1
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.091819,0.11505,0.1753,0,1
3,GO STEROID METABOLIC PROCESS,0.060677,0.11493,0.12285,0,1
3,GO RNA 5 END PROCESSING,0.062884,0.11406,0.109,0,1
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.16602,0.11402,0.093152,0,1
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.08881,0.11392,0.099292,0,1
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.16602,0.11372,0.13125,0,1
3,GO AUTOPHAGOSOME ORGANIZATION,0.072385,0.11341,0.1242,0,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.058535,0.11286,0.13158,0,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.080256,0.11265,0.13879,0,1
3,GO LIPID CATABOLIC PROCESS,0.065157,0.11231,0.13043,0,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.065157,0.11227,0.18802,0,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.08881,0.11216,0.13164,0,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.056456,0.11192,0.10538,0,1
3,GO REGULATION OF MAP KINASE ACTIVITY,0.10468,0.11131,0.15505,0,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.10468,0.11112,0.12956,0,1
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.056456,0.11108,0.1642,0,1
3,GO MOTOR NEURON AXON GUIDANCE,0.43329,0.11104,0.097817,0,1
3,GO PROTEIN MATURATION,0.098083,0.11088,0.11855,0,1
3,GO QUINONE METABOLIC PROCESS,0.16123,0.11043,0.062922,0,1
3,GO RESPONSE TO NUTRIENT,0.058535,0.11002,0.16014,0,1
3,GO RESPONSE TO OSMOTIC STRESS,0.065157,0.10987,0.14013,0,1
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.062884,0.10969,0.12552,0,1
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.13467,0.10933,0.10013,0,1
3,GO BIOLOGICAL ADHESION,0.08588,0.10866,0.1831,0,1
3,GO POSITIVE REGULATION OF CELL DEATH,0.058535,0.1086,0.1536,0,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.10468,0.10756,0.13308,0,1
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.065157,0.10752,0.14787,0,1
3,GO NCRNA EXPORT FROM NUCLEUS,0.060677,0.10743,0.12815,0,1
3,GO CELL MOTILITY,0.12662,0.10634,0.1607,0,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.08303,0.10624,0.11488,0,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.1306,0.10604,0.13586,0,1
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.067497,0.10561,0.1233,0,1
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.091819,0.10537,0.14183,0,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.091819,0.10522,0.086949,0,1
3,GO ACTIN FILAMENT ORGANIZATION,0.072385,0.10505,0.16089,0,1
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.32248,0.10466,0.088526,0,1
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.058535,0.10451,0.14984,0,1
3,GO FAT CELL DIFFERENTIATION,0.074935,0.10438,0.1602,0,1
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.098083,0.10425,0.18501,0,1
3,GO REGULATION OF MUSCLE ADAPTATION,0.16602,0.10151,0.13436,0,1
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.20822,0.10134,0.12156,0,1
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.20822,0.10072,0.12479,0,1
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.056456,0.10035,0.14384,0,1
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.058535,0.10022,0.12014,0,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.062884,0.099557,0.14877,0,1
3,GO MALE SEX DIFFERENTIATION,0.077559,0.099439,0.13471,0,1
3,GO REGULATION OF ANOIKIS,0.20822,0.099429,0.15196,0,1
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.25111,0.09938,0.12723,0,1
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.062884,0.099336,0.11521,0,1
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.28529,0.099285,0.11101,0,1
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.18624,0.099219,0.085585,0,1
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.072385,0.098809,0.15589,0,1
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.10811,0.09869,0.11186,0,1
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.12273,0.098575,0.091584,0,1
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.077559,0.098031,0.10207,0,1
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.058535,0.097745,0.12718,0,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.27126,0.097478,0.089604,0,1
3,GO RESPONSE TO SALT STRESS,0.19156,0.097287,0.12275,0,1
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.13885,0.096845,0.10579,0,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.08303,0.095895,0.12484,0,1
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.062884,0.095568,0.13455,0,1
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.37111,0.095094,0.08696,0,1
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.069906,0.095091,0.14092,0,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.16123,0.095039,0.090355,0,1
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.1306,0.094793,0.12788,0,1
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.12273,0.094716,0.13838,0,1
3,GO MATURATION OF 5 8S RRNA,0.072385,0.094673,0.11429,0,1
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.11894,0.094398,0.12662,0,1
3,GO LIPID LOCALIZATION,0.1475,0.094341,0.13029,0,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.14312,0.09419,0.13361,0,1
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.067497,0.094057,0.10358,0,1
3,GO REGULATION OF CELL AGING,0.074935,0.093982,0.10592,0,1
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.13885,0.093748,0.14672,0,1
3,GO PROTEIN HYDROXYLATION,0.17591,0.093699,0.10852,0,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.11163,0.093656,0.07963,0,1
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.12662,0.093205,0.1535,0,1
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.08303,0.092642,0.13676,0,1
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.077559,0.092381,0.12386,0,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.10811,0.091802,0.10292,0,1
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.058535,0.091594,0.17019,0,1
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.067497,0.09146,0.11592,0,1
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.2998,0.091268,0.088706,0,1
3,GO CORPUS CALLOSUM DEVELOPMENT,0.2998,0.091066,0.13459,0,1
3,GO RESPONSE TO KETONE,0.10811,0.090749,0.14045,0,1
3,GO FOCAL ADHESION ASSEMBLY,0.067497,0.090371,0.22477,0,1
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.1475,0.090084,0.11601,0,1
3,GO REGULATION OF LIPID TRANSPORT,0.11894,0.089089,0.12941,0,1
3,GO REGULATION OF HYDROLASE ACTIVITY,0.080256,0.088979,0.14331,0,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.077559,0.08888,0.14111,0,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.13885,0.088632,0.10876,0,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.074935,0.088242,0.14709,0,1
3,GO PENTOSE METABOLIC PROCESS,0.08881,0.08806,0.1363,0,1
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.27821,0.087725,0.11275,0,1
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.12662,0.087495,0.11239,0,1
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.10468,0.087004,0.1142,0,1
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.13885,0.086951,0.12814,0,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.2577,0.086441,0.11184,0,1
3,GO RESPONSE TO TESTOSTERONE,0.16123,0.08622,0.11163,0,1
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.14312,0.085906,0.12863,0,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.19156,0.085212,0.10708,0,1
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.098083,0.084958,0.16235,0,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.19156,0.084603,0.10205,0,1
3,GO TRNA TRANSPORT,0.08881,0.084336,0.1115,0,1
3,GO TRNA 5 END PROCESSING,0.36271,0.084183,0.03077,0,1
3,GO GOLGI VESICLE BUDDING,0.074935,0.083308,0.11417,0,1
3,GO TRANSITION METAL ION TRANSPORT,0.16123,0.083009,0.09409,0,1
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.49108,0.082863,0.055705,0,1
3,GO AGING,0.058535,0.082182,0.13905,0,1
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.49108,0.082152,0.062485,0,1
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.20822,0.081866,0.12044,0,1
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.08881,0.081041,0.11804,0,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.42405,0.079914,0.061482,0,1
3,GO LIPID BIOSYNTHETIC PROCESS,0.065157,0.079693,0.11993,0,1
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.067497,0.079625,0.14539,0,1
3,GO PROTEOLYSIS,0.069906,0.0794,0.12305,0,1
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.067497,0.079165,0.074457,0,1
3,GO BASE EXCISION REPAIR,0.29248,0.078673,0.069819,0,1
3,GO CELL AGING,0.065157,0.078602,0.13215,0,1
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.11524,0.078434,0.10865,0,1
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.12273,0.077662,0.14577,0,1
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.15655,0.075532,0.12856,0,1
3,GO MITOCHONDRIAL TRANSLATION,0.20256,0.074699,0.054738,0,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.08303,0.074451,0.1289,0,1
3,GO HISTONE PHOSPHORYLATION,0.20822,0.072836,0.11357,0,1
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.48117,0.072415,0.071469,0,1
3,GO CELLULAR COMPONENT DISASSEMBLY,0.08303,0.072151,0.099616,0,1
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.08303,0.07163,0.11578,0,1
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.14312,0.071227,0.11011,0,1
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.19156,0.07121,0.09827,0,1
3,GO UTERUS DEVELOPMENT,0.27126,0.070227,0.082052,0,1
3,GO PROTEIN DESTABILIZATION,0.1475,0.06758,0.10755,0,1
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.060677,0.066992,0.1043,0,1
3,GO RIBOSOME ASSEMBLY,0.098083,0.066868,0.066649,0,1
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.18624,0.065936,0.11111,0,1
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.1306,0.065367,0.12604,0,1
3,GO TISSUE MORPHOGENESIS,0.077559,0.065091,0.14815,0,1
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.14312,0.064833,0.15471,0,1
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.11894,0.06394,0.11026,0,1
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.08303,0.059911,0.14637,0,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.15197,0.059857,0.12085,0,1
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.13885,0.058713,0.12554,0,1
3,GO MITOCHONDRIAL GENE EXPRESSION,0.19156,0.05406,0.056874,0,1
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.40594,0.053651,0.087832,0,1
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.094909,0.052248,0.078987,0,1
3,GO OXIDATION REDUCTION PROCESS,0.098083,0.051627,0.086681,0,1
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.067497,0.04947,0.080081,0,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.27821,0.045277,0.10762,0,1
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.4521,0.023216,0.047665,0,1
3,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.0057394,1.0507,0.85696,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0044907,0.67936,0.62594,0,0
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0057394,0.66022,0.50377,0,0
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.014457,0.51355,0.45337,0,0
3,GO GERMINAL CENTER FORMATION,0.012106,0.47091,0.43306,0,0
3,GO CD40 SIGNALING PATHWAY,0.0020776,0.46371,0.41173,0,0
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0096484,0.43695,0.40467,0,0
3,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.020391,0.42785,0.35485,0,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.14312,0.42424,0.26259,0,0
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.023112,0.42033,0.34961,0,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0076456,0.41111,0.35337,0,0
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.008797,0.40911,0.39816,0,0
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.010101,0.4033,0.36509,0,0
3,GO CELL JUNCTION DISASSEMBLY,0.0060238,0.36551,0.46822,0,0
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.013235,0.34529,0.34975,0,0
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.026142,0.34409,0.28464,0,0
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.065157,0.34104,0.31255,0,0
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.021265,0.33712,0.3358,0,0
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.065157,0.33673,0.16876,0,0
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.0076456,0.3326,0.34009,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.08303,0.32049,0.26929,0,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.011574,0.31894,0.28185,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.058535,0.289,0.2098,0,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.035953,0.28804,0.25851,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.08588,0.28665,0.19216,0,0
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.18624,0.28289,0.23648,0,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.24463,0.27828,0.15415,0,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0049572,0.27212,0.33592,0,0
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.034576,0.24752,0.23985,0,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.018736,0.2466,0.21677,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.13467,0.24647,0.1868,0,0
3,GO RESPONSE TO PROSTAGLANDIN E,0.077559,0.24545,0.22388,0,0
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.094909,0.23989,0.2466,0,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.069906,0.23833,0.23508,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.074935,0.23736,0.30782,0,0
3,GO GAS TRANSPORT,0.067497,0.23652,0.23526,0,0
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.12273,0.23295,0.1974,0,0
3,GO EPITHELIAL CELL CELL ADHESION,0.058535,0.23239,0.24242,0,0
3,GO HISTONE H3 K4 TRIMETHYLATION,0.065157,0.2315,0.24564,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.077559,0.23068,0.3663,0,0
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.069906,0.22705,0.20922,0,0
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.10468,0.22523,0.23084,0,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.056456,0.2251,0.26793,0,0
3,GO URETER DEVELOPMENT,0.10811,0.22284,0.12293,0,0
3,GO STEROID ESTERIFICATION,0.11524,0.22155,0.14831,0,0
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.056456,0.21853,0.22151,0,0
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.10134,0.21595,0.2019,0,0
3,GO REGULATION OF MAST CELL ACTIVATION,0.065157,0.21528,0.24222,0,0
3,GO KERATINIZATION,0.1306,0.21429,0.097961,0,0
3,GO AORTIC VALVE DEVELOPMENT,0.065157,0.21353,0.25818,0,0
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.074935,0.21275,0.20464,0,0
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.043559,0.21153,0.18587,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.15197,0.20821,0.19369,0,0
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.017954,0.20684,0.23703,0,0
3,GO LYMPH NODE DEVELOPMENT,0.13885,0.19779,0.20855,0,0
3,GO DISTAL TUBULE DEVELOPMENT,0.14312,0.1958,0.25904,0,0
3,GO NK T CELL DIFFERENTIATION,0.24463,0.19565,0.19692,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.18102,0.19492,0.14665,0,0
3,GO PROSTATIC BUD FORMATION,0.034576,0.19475,0.22858,0,0
3,GO RESPONSE TO FUNGUS,0.080256,0.19418,0.21762,0,0
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.027226,0.19383,0.26532,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.056456,0.19215,0.19007,0,0
3,GO REGULATION OF NUCLEASE ACTIVITY,0.015776,0.192,0.19167,0,0
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.19156,0.18909,0.22233,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.10468,0.18871,0.20104,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.02951,0.18866,0.23002,0,0
3,GO HISTONE H4 DEACETYLATION,0.065157,0.18663,0.12956,0,0
3,GO OXIDATIVE DEMETHYLATION,0.11163,0.18481,0.12756,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.091819,0.18437,0.16157,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.008797,0.18359,0.20928,0,0
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.35442,0.18325,0.095856,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.26442,0.18291,0.1483,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.072385,0.18143,0.23727,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.10134,0.1813,0.16955,0,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.058535,0.18121,0.15403,0,0
3,GO REPLICATION FORK PROCESSING,0.34626,0.1788,0.094086,0,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.1475,0.17771,0.20651,0,0
3,GO MAST CELL ACTIVATION,0.197,0.17768,0.16265,0,0
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.2259,0.17608,0.14692,0,0
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.091819,0.17596,0.27171,0,0
3,GO G0 TO G1 TRANSITION,0.23203,0.17561,0.10012,0,0
3,GO NEURON REMODELING,0.11894,0.17484,0.19527,0,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.11524,0.17427,0.17993,0,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.11894,0.17233,0.15646,0,0
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.027226,0.17233,0.25928,0,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.016475,0.17206,0.22822,0,0
3,GO IMP BIOSYNTHETIC PROCESS,0.011063,0.1716,0.17469,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.11163,0.17091,0.12947,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,0.18102,0.17079,0.13964,0,0
3,GO STEROID CATABOLIC PROCESS,0.15655,0.17064,0.14837,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.20822,0.16937,0.11194,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0049572,0.16818,0.18233,0,0
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.015776,0.16757,0.19586,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.11163,0.16742,0.15741,0,0
3,GO AMINOGLYCAN METABOLIC PROCESS,0.060677,0.16656,0.18738,0,0
3,GO HISTONE H2B UBIQUITINATION,0.028348,0.16652,0.14649,0,0
3,GO MAST CELL MEDIATED IMMUNITY,0.2259,0.16499,0.15404,0,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.27821,0.16386,0.1305,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.17591,0.16283,0.12887,0,0
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.10468,0.16037,0.199,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.2259,0.16031,0.15373,0,0
3,GO OTIC VESICLE DEVELOPMENT,0.072385,0.15985,0.2787,0,0
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.08303,0.15974,0.19593,0,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.011574,0.15966,0.16207,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.098083,0.15927,0.22807,0,0
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.010101,0.15842,0.17101,0,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.2259,0.15781,0.17693,0,0
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.08881,0.15765,0.23646,0,0
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.074935,0.15754,0.17406,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.077559,0.15751,0.26657,0,0
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.074935,0.15734,0.15521,0,0
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.011063,0.15728,0.18955,0,0
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.069906,0.15712,0.23688,0,0
3,GO REVERSE CHOLESTEROL TRANSPORT,0.16123,0.15676,0.20284,0,0
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.17091,0.15595,0.1276,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.14312,0.15592,0.19243,0,0
3,GO P BODY ASSEMBLY,0.13467,0.15535,0.14436,0,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.13467,0.15511,0.16346,0,0
3,GO OSTEOBLAST PROLIFERATION,0.10468,0.15499,0.19397,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.65188,0.15487,0.013508,0,0
3,GO GOLGI TO VACUOLE TRANSPORT,0.11163,0.15471,0.17177,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.13467,0.15468,0.19775,0,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.08588,0.1546,0.20744,0,0
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.13467,0.15428,0.21383,0,0
3,GO GLUTAMINE METABOLIC PROCESS,0.0172,0.15407,0.16361,0,0
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.033245,0.15327,0.13761,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.10134,0.15323,0.2338,0,0
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.094909,0.15269,0.12091,0,0
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.08881,0.15218,0.17366,0,0
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.091819,0.1515,0.1488,0,0
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.25111,0.15135,0.13236,0,0
3,GO RESPONSE TO INACTIVITY,0.16123,0.15078,0.14814,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.10811,0.15048,0.17399,0,0
3,GO IMP METABOLIC PROCESS,0.015776,0.15019,0.16629,0,0
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.11163,0.14994,0.14305,0,0
3,GO AMYLOID FIBRIL FORMATION,0.08588,0.14953,0.19745,0,0
3,GO SEQUESTERING OF CALCIUM ION,0.10811,0.14899,0.16367,0,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.39705,0.14897,0.18695,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.098083,0.14876,0.2395,0,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.015104,0.14838,0.17146,0,0
3,GO DEFENSE RESPONSE TO FUNGUS,0.214,0.14801,0.14685,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.08588,0.1479,0.18967,0,0
3,GO VESICLE CARGO LOADING,0.033245,0.14787,0.14456,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.056456,0.14773,0.21268,0,0
3,GO REGULATION OF TISSUE REMODELING,0.08881,0.14742,0.20412,0,0
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.010101,0.1474,0.15989,0,0
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.11524,0.14737,0.18926,0,0
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.069906,0.14674,0.13095,0,0
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.1475,0.14631,0.12122,0,0
3,GO SEQUESTERING OF TRIGLYCERIDE,0.1306,0.14618,0.16308,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.062884,0.14611,0.21064,0,0
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.034576,0.14607,0.17349,0,0
3,GO REGULATION OF GTP BINDING,0.23827,0.14598,0.099435,0,0
3,GO CELLULAR RESPONSE TO STEROL,0.098083,0.1448,0.1741,0,0
3,GO BONE GROWTH,0.11894,0.14392,0.1863,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.08303,0.14371,0.21072,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.34626,0.14364,0.11939,0,0
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.10134,0.14338,0.24176,0,0
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.17591,0.14283,0.14288,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.13467,0.1425,0.14624,0,0
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.17091,0.14222,0.17848,0,0
3,GO TRNA MODIFICATION,0.031957,0.14201,0.13477,0,0
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.11894,0.14184,0.13279,0,0
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.20256,0.14167,0.18617,0,0
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.15655,0.14135,0.10531,0,0
3,GO HAIR FOLLICLE MATURATION,0.074935,0.14126,0.16166,0,0
3,GO ACTIVATION OF JNKK ACTIVITY,0.197,0.14082,0.14986,0,0
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.34626,0.14044,0.17624,0,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.16123,0.14005,0.13229,0,0
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.08881,0.13981,0.22831,0,0
3,GO HISTONE H3 K4 METHYLATION,0.18102,0.1394,0.11083,0,0
3,GO LAMELLIPODIUM ASSEMBLY,0.025096,0.13937,0.18693,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.058535,0.13798,0.25637,0,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.35442,0.13778,0.097563,0,0
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.08303,0.13738,0.14302,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.069906,0.13714,0.29219,0,0
3,GO COBALAMIN METABOLIC PROCESS,0.11524,0.13687,0.13355,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.12662,0.13686,0.17464,0,0
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.050584,0.13653,0.17287,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.1475,0.13651,0.15652,0,0
3,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.098083,0.13651,0.14516,0,0
3,GO CHLORIDE ION HOMEOSTASIS,0.18624,0.13651,0.13701,0,0
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.26442,0.13605,0.1191,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.1475,0.13529,0.184,0,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.2577,0.13518,0.095287,0,0
3,GO TRNA PROCESSING,0.041938,0.13511,0.11933,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.074935,0.13419,0.17578,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.1306,0.13417,0.1617,0,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.026142,0.13395,0.2009,0,0
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.15655,0.1339,0.1543,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.058535,0.13381,0.18554,0,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.13467,0.13376,0.20069,0,0
3,GO TRNA WOBBLE BASE MODIFICATION,0.072385,0.13372,0.11097,0,0
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.11524,0.1336,0.17073,0,0
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.08588,0.13337,0.16806,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.10468,0.1331,0.20864,0,0
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.26442,0.13309,0.094269,0,0
3,GO EXTRACELLULAR TRANSPORT,0.39705,0.13258,0.067497,0,0
3,GO CALCIUM MEDIATED SIGNALING,0.069906,0.1324,0.17463,0,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.23203,0.13226,0.10398,0,0
3,GO MRNA METHYLATION,0.13885,0.13225,0.12401,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.2259,0.13195,0.14048,0,0
3,GO PEPTIDYL METHIONINE MODIFICATION,0.046961,0.13189,0.1597,0,0
3,GO HISTONE H3 K9 ACETYLATION,0.080256,0.13184,0.14445,0,0
3,GO PROTEIN PROCESSING,0.074935,0.13176,0.14106,0,0
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.058535,0.13174,0.14698,0,0
3,GO TOOTH MINERALIZATION,0.072385,0.13142,0.24034,0,0
3,GO ZINC ION HOMEOSTASIS,0.15197,0.13042,0.14007,0,0
3,GO MICROVILLUS ORGANIZATION,0.056456,0.13039,0.14862,0,0
3,GO ACTIVATION OF MAPKK ACTIVITY,0.23827,0.13004,0.13174,0,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.11524,0.12948,0.12587,0,0
3,GO RESPONSE TO THYROID HORMONE,0.20822,0.12935,0.13702,0,0
3,GO ENDOCYTIC RECYCLING,0.1475,0.12863,0.14848,0,0
3,GO POLYOL TRANSPORT,0.57414,0.12827,0.081734,0,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.10468,0.1277,0.17848,0,0
3,GO ENAMEL MINERALIZATION,0.056456,0.12769,0.26846,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.058535,0.12759,0.15745,0,0
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.10134,0.12745,0.11349,0,0
3,GO SEROTONIN SECRETION,0.83078,0.12721,0.012684,0,0
3,GO PROSTAGLANDIN TRANSPORT,0.25111,0.12709,0.12266,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.42405,0.12699,0.10547,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.060677,0.12669,0.14474,0,0
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.15655,0.12598,0.19531,0,0
3,GO VIRAL RELEASE FROM HOST CELL,0.023112,0.12597,0.13465,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.091819,0.12589,0.22633,0,0
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.11894,0.12539,0.1777,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.62923,0.12536,0.049329,0,0
3,GO REGULATION OF CELL FATE SPECIFICATION,0.18102,0.12518,0.15816,0,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.32248,0.12475,0.094285,0,0
3,GO REGULATION OF NECROTIC CELL DEATH,0.197,0.12471,0.11282,0,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.37964,0.12407,0.08474,0,0
3,GO DNA RECOMBINATION,0.17091,0.12389,0.094662,0,0
3,GO REGULATION OF BONE REMODELING,0.11524,0.12378,0.1952,0,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.16123,0.1236,0.14921,0,0
3,GO TAXIS,0.098083,0.12356,0.17126,0,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.16602,0.12301,0.097186,0,0
3,GO HISTONE H3 ACETYLATION,0.091819,0.12277,0.12965,0,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.056456,0.12233,0.18351,0,0
3,GO PARTURITION,0.47137,0.12227,0.079071,0,0
3,GO HEART VALVE DEVELOPMENT,0.08881,0.12226,0.2401,0,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.62923,0.12209,0.039624,0,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.1306,0.12153,0.213,0,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.2577,0.1212,0.12818,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.08881,0.1211,0.20202,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.11894,0.12107,0.16858,0,0
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.12273,0.12101,0.10814,0,0
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.60692,0.12052,0.048053,0,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.080256,0.12045,0.21184,0,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.11163,0.12037,0.1598,0,0
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.028348,0.12022,0.15657,0,0
3,GO INTERSTRAND CROSS LINK REPAIR,0.42405,0.12013,0.060499,0,0
3,GO TRNA METABOLIC PROCESS,0.052482,0.12009,0.11285,0,0
3,GO REGULATION OF TELOMERE MAINTENANCE,0.069906,0.12006,0.13632,0,0
3,GO CELL VOLUME HOMEOSTASIS,0.062884,0.12006,0.18198,0,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.23827,0.11983,0.2167,0,0
3,GO SELECTIVE AUTOPHAGY,0.077559,0.11952,0.13102,0,0
3,GO CHOLESTEROL EFFLUX,0.15655,0.11936,0.15663,0,0
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.08303,0.11879,0.15988,0,0
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.19156,0.11878,0.1325,0,0
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0015882,0.11869,0.16315,0,0
3,GO MEGAKARYOCYTE DEVELOPMENT,0.11524,0.11843,0.18205,0,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.060677,0.11824,0.18814,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.11163,0.11799,0.11024,0,0
3,GO POSITIVE REGULATION OF HEART GROWTH,0.033245,0.11793,0.20559,0,0
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.13885,0.11792,0.14301,0,0
3,GO DISACCHARIDE METABOLIC PROCESS,0.072385,0.11789,0.20241,0,0
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.12662,0.11786,0.15625,0,0
3,GO LEFT RIGHT PATTERN FORMATION,0.3148,0.11778,0.076149,0,0
3,GO PROTEIN TARGETING TO LYSOSOME,0.23827,0.11774,0.12634,0,0
3,GO AUTOPHAGIC CELL DEATH,0.060677,0.1177,0.12868,0,0
3,GO RNA MODIFICATION,0.011063,0.11745,0.14417,0,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.20256,0.11726,0.053525,0,0
3,GO HISTONE H3 K14 ACETYLATION,0.33821,0.11716,0.081615,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.074935,0.11714,0.11952,0,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.33029,0.11691,0.079931,0,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.4521,0.11666,0.072647,0,0
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.36271,0.11661,0.094768,0,0
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.27126,0.11651,0.15757,0,0
3,GO INTESTINAL ABSORPTION,0.20822,0.11639,0.15419,0,0
3,GO ER NUCLEUS SIGNALING PATHWAY,0.12662,0.11624,0.12181,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.15197,0.11597,0.11586,0,0
3,GO AMINO ACID ACTIVATION,0.060677,0.11581,0.11241,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0020776,0.11569,0.14597,0,0
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.074935,0.11559,0.18551,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.20822,0.11544,0.11959,0,0
3,GO OSSIFICATION,0.16602,0.11543,0.14114,0,0
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.08303,0.11536,0.12696,0,0
3,GO RNA METHYLATION,0.046961,0.11526,0.13278,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.1306,0.11523,0.18353,0,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.10811,0.11522,0.13564,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.069906,0.11522,0.24163,0,0
3,GO NCRNA METABOLIC PROCESS,0.031957,0.11498,0.11441,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.08881,0.11479,0.12549,0,0
3,GO REGULATION OF HISTONE DEACETYLATION,0.1475,0.1147,0.12784,0,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.10468,0.11458,0.11157,0,0
3,GO POSITIVE REGULATION OF MYELINATION,0.11524,0.11438,0.20551,0,0
3,GO HISTONE DEACETYLATION,0.18102,0.11422,0.10491,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.10811,0.11406,0.162,0,0
3,GO RESPONSE TO SALT,0.069906,0.11388,0.11509,0,0
3,GO HISTONE H3 K9 MODIFICATION,0.24463,0.11378,0.090724,0,0
3,GO URONIC ACID METABOLIC PROCESS,0.077559,0.11377,0.09475,0,0
3,GO MOLTING CYCLE,0.08303,0.11351,0.14998,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.12662,0.11339,0.20149,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.067497,0.11323,0.21103,0,0
3,GO RRNA TRANSCRIPTION,0.10811,0.11312,0.11765,0,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.20822,0.11308,0.16588,0,0
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.21989,0.11305,0.10842,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.10811,0.11302,0.16369,0,0
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.17091,0.11295,0.15997,0,0
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.12273,0.11286,0.12224,0,0
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.16602,0.11242,0.14519,0,0
3,GO HEAD MORPHOGENESIS,0.17091,0.11124,0.19618,0,0
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.12662,0.11093,0.11366,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.20256,0.11084,0.11632,0,0
3,GO UV DAMAGE EXCISION REPAIR,0.37964,0.1107,0.074967,0,0
3,GO PROTEIN POLYUBIQUITINATION,0.077559,0.11056,0.1105,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.11163,0.11051,0.085309,0,0
3,GO ACETYL COA METABOLIC PROCESS,0.026142,0.11024,0.17594,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.41494,0.11019,0.075807,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.016475,0.11003,0.15786,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.11524,0.11003,0.18597,0,0
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.11894,0.10988,0.1445,0,0
3,GO DNA DEMETHYLATION,0.072385,0.10985,0.16244,0,0
3,GO PROTEIN IMPORT,0.041938,0.10978,0.12848,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.14312,0.10967,0.10296,0,0
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.13467,0.10955,0.136,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.098083,0.10951,0.099211,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.14312,0.10951,0.12096,0,0
3,GO DEMETHYLATION,0.12662,0.10944,0.12162,0,0
3,GO SMOOTH MUSCLE CELL MIGRATION,0.028348,0.10943,0.25585,0,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.12273,0.10939,0.13525,0,0
3,GO RNA 3 END PROCESSING,0.197,0.10938,0.087715,0,0
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.08303,0.10892,0.15399,0,0
3,GO SEGMENTATION,0.19156,0.10876,0.12145,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.197,0.10852,0.086426,0,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.077559,0.10851,0.14845,0,0
3,GO VITAMIN TRANSPORT,0.14312,0.10832,0.13028,0,0
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.50109,0.10826,0.067364,0,0
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.098083,0.10806,0.22892,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.046961,0.10785,0.11594,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.015776,0.10764,0.13053,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.28529,0.10744,0.079768,0,0
3,GO CARDIAC SEPTUM DEVELOPMENT,0.08588,0.10731,0.18788,0,0
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.040368,0.10731,0.12217,0,0
3,GO PROGESTERONE METABOLIC PROCESS,0.077559,0.10725,0.18508,0,0
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.42405,0.1072,0.15314,0,0
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.069906,0.10687,0.10646,0,0
3,GO BODY FLUID SECRETION,0.15197,0.10681,0.11189,0,0
3,GO REGULATION OF RESPIRATORY BURST,0.54223,0.10674,0.045179,0,0
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.072385,0.1067,0.18731,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.077559,0.10625,0.20114,0,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.34626,0.10611,0.10511,0,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.33821,0.1061,0.16937,0,0
3,GO REGULATION OF GTPASE ACTIVITY,0.12662,0.10604,0.15232,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.15655,0.10602,0.13105,0,0
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.24463,0.10563,0.081449,0,0
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.098083,0.10559,0.14643,0,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.11894,0.10556,0.1427,0,0
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.13885,0.10551,0.14903,0,0
3,GO ARACHIDONIC ACID SECRETION,0.17091,0.10543,0.12051,0,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.065157,0.10531,0.20572,0,0
3,GO ACTIN FILAMENT BASED PROCESS,0.13885,0.10523,0.14311,0,0
3,GO GOLGI RIBBON FORMATION,0.11524,0.10466,0.15079,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.16602,0.10455,0.20321,0,0
3,GO DIGESTION,0.2577,0.10453,0.08361,0,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.33821,0.10445,0.10538,0,0
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.13885,0.10436,0.13353,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.1475,0.10425,0.11367,0,0
3,GO LIPID MODIFICATION,0.15197,0.10422,0.11252,0,0
3,GO RESPONSE TO GONADOTROPIN,0.15197,0.10415,0.13306,0,0
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.091819,0.10404,0.10699,0,0
3,GO ANIMAL ORGAN MATURATION,0.33029,0.10395,0.11542,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.19156,0.1039,0.18913,0,0
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.077559,0.10373,0.094808,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.2259,0.10366,0.13314,0,0
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.42405,0.1036,0.085483,0,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.15655,0.10344,0.12553,0,0
3,GO CARTILAGE DEVELOPMENT,0.050584,0.10342,0.20885,0,0
3,GO TELOMERE ORGANIZATION,0.15655,0.10334,0.10277,0,0
3,GO METHYLATION,0.17591,0.10314,0.09112,0,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.26442,0.10312,0.092811,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.17091,0.10302,0.09686,0,0
3,GO CYSTEINE METABOLIC PROCESS,0.28529,0.10291,0.09471,0,0
3,GO FATTY ACID BETA OXIDATION,0.25111,0.10289,0.091732,0,0
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.17091,0.10286,0.14677,0,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.10811,0.10281,0.19009,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.20256,0.10278,0.14625,0,0
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.24463,0.10246,0.10964,0,0
3,GO RESPONSE TO WATER,0.1306,0.10243,0.15015,0,0
3,GO RESPONSE TO UV,0.065157,0.10238,0.1257,0,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.2577,0.10234,0.087474,0,0
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.18102,0.10225,0.1276,0,0
3,GO EPITHELIAL CELL PROLIFERATION,0.12273,0.10221,0.1483,0,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.35442,0.10191,0.121,0,0
3,GO REGULATION OF DNA RECOMBINATION,0.08588,0.10188,0.14613,0,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.11894,0.10185,0.14574,0,0
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.20822,0.10176,0.15212,0,0
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.54223,0.10171,0.074929,0,0
3,GO RNA PROCESSING,0.16123,0.10166,0.091217,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.014457,0.10156,0.12764,0,0
3,GO PROTEIN KINASE A SIGNALING,0.35442,0.10143,0.082582,0,0
3,GO PROTEIN AUTOUBIQUITINATION,0.27821,0.10142,0.071903,0,0
3,GO ENDOTHELIUM DEVELOPMENT,0.16123,0.10142,0.16911,0,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.065157,0.10141,0.17204,0,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.016475,0.10123,0.18393,0,0
3,GO HISTONE MONOUBIQUITINATION,0.18102,0.10117,0.09912,0,0
3,GO REGULATION OF OSSIFICATION,0.11524,0.10087,0.1593,0,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.197,0.10079,0.14048,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.058535,0.10073,0.11241,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.42405,0.10044,0.11471,0,0
3,GO MITOTIC DNA REPLICATION,0.72171,0.10037,0.051893,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.13467,0.10036,0.11851,0,0
3,GO POSITIVE REGULATION OF HEART RATE,0.197,0.1003,0.10206,0,0
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.197,0.10025,0.14148,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.24463,0.10021,0.12594,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.080256,0.10016,0.097147,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.98106,0.10009,-0.013262,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.52145,0.10006,0.049039,0,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.2577,0.10005,0.092281,0,0
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.1306,0.099946,0.15485,0,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.08588,0.099832,0.15703,0,0
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.33821,0.099803,0.11175,0,0
3,GO CHROMATIN SILENCING,0.75756,0.099753,0.036958,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.27126,0.099579,0.12049,0,0
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.08303,0.099561,0.163,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.16602,0.099375,0.09261,0,0
3,GO REGULATION OF MAPK CASCADE,0.056456,0.099245,0.1744,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.29248,0.099041,0.059846,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.024086,0.098806,0.11882,0,0
3,GO REGULATION OF CELL MATURATION,0.18624,0.098628,0.089933,0,0
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.2998,0.098553,0.1538,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.14312,0.098445,0.15127,0,0
3,GO PLATELET AGGREGATION,0.074935,0.098368,0.21795,0,0
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.29248,0.098145,0.1306,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.30724,0.097732,0.09273,0,0
3,GO RNA SPLICING,0.58498,0.097717,0.050092,0,0
3,GO HISTONE H3 K27 METHYLATION,0.89296,0.097697,0.023854,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.08303,0.097663,0.093992,0,0
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.29248,0.09763,0.086275,0,0
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.1475,0.097525,0.13498,0,0
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.27821,0.097287,0.10214,0,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.46168,0.097141,0.09113,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.23203,0.09705,0.17944,0,0
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.08588,0.096944,0.15282,0,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.08303,0.096876,0.19153,0,0
3,GO HISTONE H3 K9 DEMETHYLATION,0.85555,0.096872,0.041619,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.18102,0.096786,0.23073,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.080256,0.096726,0.15791,0,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.27126,0.096624,0.12442,0,0
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.11894,0.096402,0.21851,0,0
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.098083,0.096362,0.12597,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.12662,0.096361,0.068095,0,0
3,GO ANIMAL ORGAN FORMATION,0.13467,0.096254,0.16004,0,0
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.13885,0.09624,0.082007,0,0
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.060677,0.095893,0.16841,0,0
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.024086,0.095877,0.16831,0,0
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.14312,0.095875,0.14773,0,0
3,GO PROTEIN SUMOYLATION,0.072385,0.095777,0.13308,0,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.41494,0.095594,0.067889,0,0
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.040368,0.095558,0.10545,0,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.1306,0.095323,0.12074,0,0
3,GO RESPONSE TO MUSCLE ACTIVITY,0.21989,0.095179,0.09084,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.16602,0.095057,0.09013,0,0
3,GO RESPONSE TO UV B,0.2577,0.095052,0.098953,0,0
3,GO ER OVERLOAD RESPONSE,0.17591,0.095044,0.10847,0,0
3,GO MESENCHYME MORPHOGENESIS,0.15655,0.094778,0.16784,0,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.58498,0.094773,0.089432,0,0
3,GO EMBRYONIC HEMOPOIESIS,0.11894,0.094561,0.17859,0,0
3,GO ACTIVATION OF MAPK ACTIVITY,0.20822,0.094499,0.13554,0,0
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.2577,0.094489,0.091772,0,0
3,GO MESODERM MORPHOGENESIS,0.037377,0.09446,0.18247,0,0
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.13885,0.094322,0.1646,0,0
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.08588,0.09423,0.089885,0,0
3,GO VESICLE BUDDING FROM MEMBRANE,0.12662,0.093961,0.10851,0,0
3,GO HOMOTYPIC CELL CELL ADHESION,0.16602,0.093942,0.18122,0,0
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.1306,0.093829,0.1353,0,0
3,GO LATERAL VENTRICLE DEVELOPMENT,0.28529,0.093791,0.1761,0,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.08303,0.093743,0.12285,0,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.49108,0.093429,0.086917,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.27821,0.0934,0.13808,0,0
3,GO DIGESTIVE SYSTEM PROCESS,0.14312,0.09325,0.10541,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.16123,0.093217,0.079554,0,0
3,GO EYE MORPHOGENESIS,0.37111,0.093073,0.10923,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.077559,0.093039,0.10938,0,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.43329,0.092972,0.085717,0,0
3,GO EMBRYONIC PLACENTA DEVELOPMENT,0.094909,0.09271,0.16211,0,0
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.20256,0.09264,0.11897,0,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.197,0.092547,0.15051,0,0
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.20822,0.092537,0.15825,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.19156,0.092477,0.16695,0,0
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.1306,0.092469,0.16356,0,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.16123,0.092422,0.15429,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.17091,0.092319,0.15978,0,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.14312,0.092186,0.096456,0,0
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.08881,0.092026,0.15404,0,0
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.062884,0.092003,0.16695,0,0
3,GO GENETIC IMPRINTING,0.3148,0.091961,0.10199,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.12273,0.091531,0.12021,0,0
3,GO RESPONSE TO CADMIUM ION,0.11524,0.091488,0.13352,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.15655,0.091461,0.11923,0,0
3,GO MRNA TRANSPORT,0.18102,0.091459,0.10017,0,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.16602,0.091423,0.1914,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.16602,0.091305,0.095523,0,0
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.15655,0.091282,0.13079,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.17091,0.09121,0.19864,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.40594,0.091153,0.064133,0,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.14312,0.091134,0.1052,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.10811,0.090973,0.1113,0,0
3,GO N GLYCAN PROCESSING,0.5959,0.090959,0.081318,0,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.11894,0.090849,0.11369,0,0
3,GO MAINTENANCE OF LOCATION IN CELL,0.10811,0.090828,0.14042,0,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.10811,0.090824,0.16918,0,0
3,GO COPII COATED VESICLE CARGO LOADING,0.12273,0.090671,0.12192,0,0
3,GO THIOESTER METABOLIC PROCESS,0.043559,0.090659,0.13787,0,0
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.34626,0.09,0.056457,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.51122,0.089981,0.0397,0,0
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.1475,0.089836,0.12306,0,0
3,GO GDP METABOLIC PROCESS,0.19156,0.089684,0.13291,0,0
3,GO RNA EXPORT FROM NUCLEUS,0.23827,0.089422,0.095754,0,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.2577,0.089388,0.083188,0,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.056456,0.08927,0.19759,0,0
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.091819,0.089186,0.23069,0,0
3,GO COPII COATED VESICLE BUDDING,0.077559,0.088978,0.11266,0,0
3,GO LIPID DIGESTION,0.37111,0.088846,0.10822,0,0
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.13467,0.088703,0.1159,0,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.13885,0.088605,0.17019,0,0
3,GO CONVERGENT EXTENSION,0.24463,0.088526,0.14698,0,0
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.11163,0.088232,0.10587,0,0
3,GO PROTEIN STABILIZATION,0.091819,0.08803,0.10146,0,0
3,GO DNA DEALKYLATION,0.11894,0.088026,0.13655,0,0
3,GO RESPONSE TO CORTICOSTEROID,0.065157,0.088008,0.15377,0,0
3,GO HISTONE DEUBIQUITINATION,0.19156,0.087859,0.13148,0,0
3,GO GLIAL CELL MIGRATION,0.13467,0.087847,0.17848,0,0
3,GO HISTONE H3 K9 METHYLATION,0.46168,0.087819,0.066897,0,0
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.24463,0.087635,0.076782,0,0
3,GO REGULATION OF PROTEIN BINDING,0.34626,0.087556,0.1109,0,0
3,GO NCRNA TRANSCRIPTION,0.36271,0.087555,0.06583,0,0
3,GO PHOSPHOLIPID TRANSPORT,0.16123,0.087513,0.13087,0,0
3,GO REGULATION OF PROTEIN STABILITY,0.074935,0.08741,0.10734,0,0
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.067497,0.087189,0.11302,0,0
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.072385,0.087053,0.11472,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.64051,0.087017,0.059427,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.046961,0.086765,0.13534,0,0
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.069906,0.086662,0.15695,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.13467,0.086458,0.095571,0,0
3,GO GTP BIOSYNTHETIC PROCESS,0.017954,0.086323,0.1427,0,0
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.18102,0.086244,0.11461,0,0
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.13467,0.086136,0.15655,0,0
3,GO SNRNA TRANSCRIPTION,0.29248,0.086027,0.071115,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.1306,0.085863,0.15105,0,0
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.2998,0.085774,0.16138,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.13885,0.085755,0.13591,0,0
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.10134,0.085658,0.11276,0,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.10811,0.085648,0.092123,0,0
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.53179,0.085566,0.12146,0,0
3,GO SNORNA METABOLIC PROCESS,0.12273,0.085443,0.091991,0,0
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.1306,0.08541,0.12381,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.098083,0.085388,0.15291,0,0
3,GO GOLGI TO ENDOSOME TRANSPORT,0.058535,0.085318,0.15406,0,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.11894,0.085069,0.14007,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.10811,0.085001,0.12548,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.44264,0.084999,0.067978,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.35442,0.084801,0.088916,0,0
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.197,0.084732,0.080357,0,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.30724,0.084695,0.15208,0,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.39705,0.084346,0.078656,0,0
3,GO ANOIKIS,0.20822,0.084287,0.13198,0,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.25111,0.084267,0.13568,0,0
3,GO RNA STABILIZATION,0.050584,0.084188,0.13002,0,0
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.65188,0.084138,0.037854,0,0
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.42405,0.084134,0.065364,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION,0.33029,0.084077,0.089536,0,0
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.20822,0.083911,0.063623,0,0
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.64051,0.083889,0.04361,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.44264,0.083682,0.10723,0,0
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.2259,0.083679,0.09493,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.1475,0.083556,0.16876,0,0
3,GO RNA LOCALIZATION,0.094909,0.083424,0.10837,0,0
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.014457,0.08326,0.12581,0,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.37111,0.083254,0.1488,0,0
3,GO RESPONSE TO CORTICOSTERONE,0.69814,0.083113,0.056333,0,0
3,GO SENSORY PERCEPTION OF SMELL,0.54223,0.082957,0.037037,0,0
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.56341,0.082913,0.074007,0,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.18102,0.082698,0.10249,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.33029,0.082621,0.076649,0,0
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.67486,0.0826,0.057242,0,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.19156,0.082504,0.24525,0,0
3,GO PLATELET MORPHOGENESIS,0.058535,0.082444,0.21092,0,0
3,GO PROTEIN OXIDATION,0.24463,0.082419,0.13915,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.16602,0.082353,0.09539,0,0
3,GO NODAL SIGNALING PATHWAY,0.15197,0.082337,0.08658,0,0
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.35442,0.082218,0.11952,0,0
3,GO HEART MORPHOGENESIS,0.18624,0.082063,0.14386,0,0
3,GO MRNA 3 END PROCESSING,0.34626,0.082025,0.079841,0,0
3,GO XENOBIOTIC TRANSPORT,0.29248,0.082009,0.12502,0,0
3,GO DNA GEOMETRIC CHANGE,0.40594,0.081993,0.070545,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.19156,0.081778,0.14025,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.15197,0.081622,0.18541,0,0
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.18102,0.081394,0.087285,0,0
3,GO SNORNA 3 END PROCESSING,0.091819,0.081256,0.10789,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.23203,0.081252,0.13589,0,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.2577,0.08118,0.12074,0,0
3,GO NEPHRON MORPHOGENESIS,0.041938,0.080751,0.16724,0,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.15655,0.080712,0.12929,0,0
3,GO HISTONE H2A UBIQUITINATION,0.33029,0.080703,0.075249,0,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.27821,0.080692,0.15388,0,0
3,GO MRNA CLEAVAGE,0.094909,0.080579,0.13433,0,0
3,GO CARDIOBLAST DIFFERENTIATION,0.2577,0.080567,0.1303,0,0
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.70989,0.080445,0.048507,0,0
3,GO PROTEIN MONOUBIQUITINATION,0.24463,0.080426,0.075608,0,0
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.1306,0.080253,0.13656,0,0
3,GO LIPID PHOSPHORYLATION,0.26442,0.080239,0.11378,0,0
3,GO DE NOVO PROTEIN FOLDING,0.27821,0.080213,0.074006,0,0
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.045233,0.080155,0.098455,0,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.33029,0.080073,0.15566,0,0
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.15655,0.079908,0.10586,0,0
3,GO GALACTOSE METABOLIC PROCESS,0.18102,0.079696,0.12388,0,0
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.29248,0.079596,0.068892,0,0
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.027226,0.079434,0.10852,0,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.094909,0.079377,0.15555,0,0
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.34626,0.079328,0.08161,0,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.55277,0.079316,0.093136,0,0
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.08588,0.079143,0.13276,0,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.25111,0.079109,0.16046,0,0
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.1306,0.079086,0.1115,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.24463,0.079077,0.15388,0,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.11524,0.078987,0.11011,0,0
3,GO PIGMENTATION,0.13885,0.078934,0.10329,0,0
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.27821,0.078879,0.15073,0,0
3,GO MRNA PROCESSING,0.56341,0.078863,0.051625,0,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.062884,0.078848,0.13706,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.15655,0.078783,0.13482,0,0
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.25111,0.078657,0.096545,0,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.098083,0.078618,0.11293,0,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.08303,0.078552,0.18111,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.23203,0.078479,0.13381,0,0
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.40594,0.078354,0.090181,0,0
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.30724,0.078167,0.13198,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.27821,0.078126,0.13183,0,0
3,GO ENDOSOMAL TRANSPORT,0.20822,0.078094,0.093186,0,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.19156,0.078001,0.12188,0,0
3,GO PROTEIN DEMETHYLATION,0.37111,0.077959,0.1138,0,0
3,GO RENAL TUBULE DEVELOPMENT,0.067497,0.077951,0.17172,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.19156,0.077905,0.15805,0,0
3,GO PIGMENT CELL DIFFERENTIATION,0.33821,0.077883,0.14721,0,0
3,GO RESPONSE TO RADIATION,0.15655,0.077797,0.09682,0,0
3,GO DNA INTEGRITY CHECKPOINT,0.25111,0.077666,0.092919,0,0
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.038848,0.077502,0.091706,0,0
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.14312,0.077373,0.11908,0,0
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.32248,0.077278,0.13253,0,0
3,GO NUCLEAR EXPORT,0.15655,0.077193,0.10286,0,0
3,GO NUCLEAR TRANSPORT,0.094909,0.077173,0.10608,0,0
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.19156,0.077165,0.16171,0,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.25111,0.077134,0.099048,0,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.21989,0.077128,0.089968,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.12662,0.077119,0.10868,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.17591,0.077038,0.10055,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.08881,0.076774,0.18602,0,0
3,GO FACIAL NERVE MORPHOGENESIS,0.38829,0.076768,0.1484,0,0
3,GO RESPONSE TO HORMONE,0.2259,0.076727,0.11632,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.17091,0.07671,0.12405,0,0
3,GO VIRAL LATENCY,0.24463,0.07662,0.089527,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.197,0.076615,0.14352,0,0
3,GO POSITIVE REGULATION OF CELL MATURATION,0.25111,0.07645,0.14383,0,0
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.18624,0.076441,0.073971,0,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.16602,0.076358,0.092479,0,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.32248,0.076198,0.11884,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.24463,0.076103,0.096714,0,0
3,GO CHROMOSOME SEPARATION,0.86799,0.07604,0.031863,0,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.41494,0.076015,0.072509,0,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.79394,0.075984,0.034627,0,0
3,GO GOLGI ORGANIZATION,0.30724,0.075888,0.084836,0,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.65188,0.075884,0.063119,0,0
3,GO CELLULAR RESPONSE TO IRON ION,0.14312,0.075849,0.1784,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.36271,0.075623,0.077623,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.35442,0.075585,0.081407,0,0
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.29248,0.075547,0.12305,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.67486,0.075503,0.055824,0,0
3,GO STRESS FIBER ASSEMBLY,0.16602,0.075444,0.15991,0,0
3,GO NEGATIVE REGULATION OF TRANSPORT,0.23203,0.075363,0.10716,0,0
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.12273,0.075284,0.11897,0,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.64051,0.07528,0.048523,0,0
3,GO GLYCOSYLATION,0.48117,0.075251,0.074432,0,0
3,GO HISTONE UBIQUITINATION,0.23203,0.075177,0.08015,0,0
3,GO SKELETAL SYSTEM DEVELOPMENT,0.041938,0.075124,0.20336,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.38829,0.074766,0.049691,0,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.19156,0.074435,0.082603,0,0
3,GO PROSTAGLANDIN SECRETION,0.44264,0.074393,0.094726,0,0
3,GO REGULATION OF CATABOLIC PROCESS,0.08588,0.074337,0.1113,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.13885,0.074244,0.17235,0,0
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.18102,0.074132,0.084802,0,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.29248,0.074103,0.14333,0,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.13467,0.074064,0.12819,0,0
3,GO NEGATIVE REGULATION OF SECRETION,0.2259,0.074055,0.11701,0,0
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.197,0.073983,0.27662,0,0
3,GO ORGAN INDUCTION,0.47137,0.073901,0.083858,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.214,0.073871,0.062689,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.3148,0.073814,0.082227,0,0
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.33821,0.073557,0.10631,0,0
3,GO GOLGI VESICLE TRANSPORT,0.19156,0.073543,0.086073,0,0
3,GO MACROMOLECULE CATABOLIC PROCESS,0.077559,0.073332,0.10133,0,0
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.15197,0.07326,0.12044,0,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.2259,0.073247,0.10334,0,0
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.16602,0.073175,0.095867,0,0
3,GO ENDOTHELIAL CELL CHEMOTAXIS,0.38829,0.073116,0.14828,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.098083,0.073108,0.079666,0,0
3,GO CELLULAR RESPONSE TO COPPER ION,0.88046,0.072935,0.026699,0,0
3,GO MITOTIC CYTOKINESIS,0.50109,0.072879,0.046111,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.40594,0.072829,0.060305,0,0
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.098083,0.07277,0.12954,0,0
3,GO REGULATION OF MRNA BINDING,0.75756,0.07264,0.043761,0,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.11163,0.072594,0.13869,0,0
3,GO HORMONE METABOLIC PROCESS,0.33029,0.07259,0.078556,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.21989,0.072509,0.075287,0,0
3,GO ANDROGEN METABOLIC PROCESS,0.18102,0.072437,0.082852,0,0
3,GO HETEROCHROMATIN ORGANIZATION,0.26442,0.072424,0.10994,0,0
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.34626,0.072223,0.16141,0,0
3,GO PROTEIN REFOLDING,0.30724,0.072155,0.063159,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.18624,0.072129,0.17275,0,0
3,GO MITOPHAGY,0.35442,0.072025,0.086656,0,0
3,GO LACTATION,0.61803,0.071922,0.074739,0,0
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.34626,0.071918,0.12099,0,0
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.15197,0.071782,0.15592,0,0
3,GO MATURATION OF SSU RRNA,0.0172,0.071776,0.12267,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.3148,0.071771,0.08563,0,0
3,GO REGULATION OF CELL DIVISION,0.37964,0.071744,0.085515,0,0
3,GO CELL RECOGNITION,0.18624,0.071727,0.1247,0,0
3,GO CRANIAL NERVE MORPHOGENESIS,0.35442,0.071642,0.13205,0,0
3,GO ENDOCYTOSIS,0.19156,0.071554,0.13049,0,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.91805,0.07155,0.023961,0,0
3,GO KIDNEY MORPHOGENESIS,0.10468,0.071506,0.13703,0,0
3,GO MESENCHYME DEVELOPMENT,0.29248,0.071426,0.14449,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.1475,0.071274,0.13749,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.84314,0.071266,0.019566,0,0
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.19156,0.071144,0.13037,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.23203,0.071095,0.13031,0,0
3,GO POSITIVE REGULATION OF NEURON DEATH,0.18102,0.070961,0.13209,0,0
3,GO CHROMATIN REMODELING,0.4521,0.070787,0.066687,0,0
3,GO NEGATIVE REGULATION OF ANOIKIS,0.43329,0.070753,0.13322,0,0
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.37964,0.070686,0.082889,0,0
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.08881,0.070673,0.11364,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.2998,0.07062,0.080891,0,0
3,GO AMP METABOLIC PROCESS,0.08303,0.070522,0.11017,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.027226,0.07046,0.22487,0,0
3,GO ALCOHOL CATABOLIC PROCESS,0.34626,0.070451,0.073653,0,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.13885,0.070447,0.11606,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.2577,0.070307,0.088075,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.38829,0.070248,0.087873,0,0
3,GO MACROMOLECULE DEACYLATION,0.36271,0.070211,0.083181,0,0
3,GO MRNA METABOLIC PROCESS,0.15197,0.070171,0.07621,0,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.15197,0.070169,0.15751,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.41494,0.070103,0.068719,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.15655,0.070018,0.10664,0,0
3,GO LABYRINTHINE LAYER DEVELOPMENT,0.37964,0.069954,0.093974,0,0
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.16602,0.069952,0.12865,0,0
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.55277,0.069946,0.08916,0,0
3,GO SEGMENT SPECIFICATION,0.35442,0.069907,0.094021,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.38829,0.069872,0.1516,0,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.25111,0.069846,0.069117,0,0
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.20256,0.069686,0.098489,0,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.61803,0.069666,0.030357,0,0
3,GO MAMMARY GLAND DEVELOPMENT,0.10468,0.069647,0.16727,0,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.17591,0.069578,0.17251,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.70989,0.069418,-0.032665,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.48117,0.06939,0.083872,0,0
3,GO VACUOLAR ACIDIFICATION,0.2577,0.069308,0.085461,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.23203,0.069226,0.14194,0,0
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.20256,0.069192,0.079851,0,0
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.056456,0.069157,0.12059,0,0
3,GO CELLULAR SENESCENCE,0.080256,0.069108,0.1172,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.39705,0.069016,0.061677,0,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.214,0.069002,0.082463,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.18102,0.068985,0.15331,0,0
3,GO NON RECOMBINATIONAL REPAIR,0.42405,0.068891,0.077094,0,0
3,GO MANNOSYLATION,0.55277,0.06887,0.043505,0,0
3,GO RRNA 3 END PROCESSING,0.7336,0.068774,0.030997,0,0
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.23827,0.068725,0.12393,0,0
3,GO RESPONSE TO NITROSATIVE STRESS,0.091819,0.068669,0.099473,0,0
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.24463,0.068651,0.09901,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.28529,0.068612,0.060537,0,0
3,GO SULFUR COMPOUND TRANSPORT,0.214,0.068541,0.095885,0,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.25111,0.068522,0.11097,0,0
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.18624,0.068445,0.07358,0,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.20822,0.068416,0.12136,0,0
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.2259,0.068305,0.10129,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.21989,0.068123,0.093848,0,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.93062,0.068101,0.027331,0,0
3,GO LUNG ALVEOLUS DEVELOPMENT,0.58498,0.068057,0.11161,0,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.15655,0.067945,0.16144,0,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.11894,0.067944,0.13156,0,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.24463,0.067933,0.12121,0,0
3,GO EPITHELIUM DEVELOPMENT,0.21989,0.067916,0.10769,0,0
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.25111,0.067818,0.11518,0,0
3,GO REGULATION OF CELLULAR PH,0.3148,0.067787,0.084957,0,0
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.18624,0.067784,0.11946,0,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.24463,0.06777,0.10254,0,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.56341,0.067673,0.068607,0,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.11894,0.067383,0.10313,0,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.4521,0.067305,0.16286,0,0
3,GO FATTY ACID CATABOLIC PROCESS,0.34626,0.067263,0.079004,0,0
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.32248,0.067207,0.074576,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.32248,0.066995,0.064886,0,0
3,GO REGULATION OF VASOCONSTRICTION,0.36271,0.066967,0.10667,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.27821,0.066869,0.1386,0,0
3,GO RESPONSE TO AMYLOID BETA,0.15197,0.066863,0.18913,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.86799,0.066771,0.034186,0,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.16123,0.066765,0.10326,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.058535,0.066628,0.13638,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.21989,0.06658,0.12495,0,0
3,GO RRNA CATABOLIC PROCESS,0.40594,0.06657,0.079838,0,0
3,GO VACUOLE ORGANIZATION,0.20822,0.066553,0.097241,0,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.42405,0.066477,0.050115,0,0
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.214,0.066403,0.092835,0,0
3,GO RECEPTOR METABOLIC PROCESS,0.25111,0.066361,0.10881,0,0
3,GO DEFINITIVE HEMOPOIESIS,0.23827,0.066346,0.15853,0,0
3,GO MESONEPHROS DEVELOPMENT,0.37964,0.066257,0.089282,0,0
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.34626,0.066126,0.10856,0,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.13885,0.066117,0.1271,0,0
3,GO EXOCYTOSIS,0.17591,0.066114,0.13302,0,0
3,GO PROTEIN CATABOLIC PROCESS,0.21989,0.066103,0.091573,0,0
3,GO REGULATION OF BODY FLUID LEVELS,0.18624,0.066065,0.13971,0,0
3,GO CARDIOCYTE DIFFERENTIATION,0.2259,0.066013,0.12502,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.2577,0.066009,0.14226,0,0
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.197,0.065965,0.082906,0,0
3,GO RENAL FILTRATION,0.46168,0.065949,0.14339,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.33029,0.065938,0.024813,0,0
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.4521,0.065874,0.067138,0,0
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.091819,0.065817,0.1431,0,0
3,GO POST ANAL TAIL MORPHOGENESIS,0.51122,0.065806,0.071887,0,0
3,GO CALCINEURIN MEDIATED SIGNALING,0.1475,0.065724,0.13418,0,0
3,GO RECOMBINATIONAL REPAIR,0.67486,0.065368,0.053335,0,0
3,GO AUTOPHAGY OF MITOCHONDRION,0.50109,0.06533,0.06574,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.46168,0.065319,0.059598,0,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.80618,0.065286,0.043491,0,0
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.197,0.065222,0.11905,0,0
3,GO PLATELET ACTIVATION,0.1475,0.06515,0.17995,0,0
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.08881,0.065102,0.13007,0,0
3,GO GMP METABOLIC PROCESS,0.29248,0.065102,0.084167,0,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.214,0.065011,0.055474,0,0
3,GO PROTEASOME ASSEMBLY,0.41494,0.064938,0.044372,0,0
3,GO REGULATION OF PHOSPHORYLATION,0.1475,0.064849,0.12415,0,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.10811,0.064827,0.10903,0,0
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.30724,0.064753,0.11778,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.19156,0.064636,0.18183,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.17591,0.06458,0.117,0,0
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.64051,0.064568,0.055807,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.49108,0.064531,0.13226,0,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.27126,0.064496,0.098621,0,0
3,GO STEROID BIOSYNTHETIC PROCESS,0.12662,0.064485,0.098402,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.1306,0.064469,0.13824,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.4521,0.06443,0.067166,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.30724,0.064255,0.096472,0,0
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.11163,0.064244,0.1494,0,0
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.2259,0.064244,0.10427,0,0
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.23203,0.064203,0.10869,0,0
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.37964,0.064038,0.067944,0,0
3,GO AMYLOID BETA METABOLIC PROCESS,0.24463,0.063954,0.11647,0,0
3,GO VESICLE TARGETING,0.19156,0.063944,0.093455,0,0
3,GO REGULATION OF RNA BINDING,0.57414,0.063835,0.044556,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.11163,0.063824,0.11582,0,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.17591,0.063579,0.091474,0,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.62923,0.063538,0.049375,0,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.80618,0.063482,0.030163,0,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.18102,0.063468,0.11213,0,0
3,GO FEMALE GAMETE GENERATION,0.44264,0.063336,0.049114,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.30724,0.063313,0.13557,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.30724,0.063306,0.097656,0,0
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.2998,0.0633,0.10743,0,0
3,GO MRNA EXPORT FROM NUCLEUS,0.3148,0.063238,0.082151,0,0
3,GO HINDLIMB MORPHOGENESIS,0.53179,0.063229,0.093307,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.2577,0.063191,0.10628,0,0
3,GO POSITIVE REGULATION OF BINDING,0.72171,0.063153,0.069164,0,0
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.23827,0.063109,0.075505,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.214,0.063087,0.16754,0,0
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.17591,0.062986,0.12793,0,0
3,GO RESPONSE TO DRUG,0.23827,0.062927,0.11304,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.41494,0.06291,0.05615,0,0
3,GO LIPID STORAGE,0.15655,0.062883,0.14596,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.13467,0.062843,0.13104,0,0
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.19156,0.06278,0.080185,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.55277,0.062775,0.045066,0,0
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.36271,0.062584,0.051586,0,0
3,GO RESPONSE TO HEAT,0.17591,0.062563,0.097229,0,0
3,GO RESPONSE TO OXYGEN RADICAL,0.42405,0.062482,0.069505,0,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.11894,0.062479,0.20926,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.5959,0.062191,0.07244,0,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.18624,0.062155,0.092457,0,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.24463,0.062099,0.077681,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.091819,0.062097,0.16661,0,0
3,GO MACROAUTOPHAGY,0.17591,0.062059,0.082116,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.47137,0.061919,0.04671,0,0
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.23827,0.061825,0.097252,0,0
3,GO DOUBLE STRAND BREAK REPAIR,0.49108,0.061732,0.059698,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.27126,0.061715,0.06667,0,0
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.1475,0.061712,0.082179,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.21989,0.061624,0.10048,0,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.43329,0.061611,0.077259,0,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.21989,0.061435,0.10584,0,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.24463,0.061337,0.083961,0,0
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.2998,0.061263,0.10443,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.37964,0.061131,0.049696,0,0
3,GO DNA DEPENDENT DNA REPLICATION,0.62923,0.061086,0.056329,0,0
3,GO RESPONSE TO IRON ION,0.72171,0.061076,0.069163,0,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.84314,0.06104,0.035422,0,0
3,GO RESPONSE TO PEPTIDE,0.2998,0.06087,0.11101,0,0
3,GO PEPTIDYL THREONINE MODIFICATION,0.38829,0.060833,0.10331,0,0
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.43329,0.060707,0.059067,0,0
3,GO MUSCLE CELL DIFFERENTIATION,0.33821,0.060679,0.10363,0,0
3,GO DNA CONFORMATION CHANGE,0.67486,0.060613,0.045096,0,0
3,GO REGULATION OF METAL ION TRANSPORT,0.30724,0.060548,0.095471,0,0
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.2577,0.060482,0.075601,0,0
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.42405,0.060408,0.12523,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.56341,0.060387,0.062846,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.57414,0.06036,0.080206,0,0
3,GO ANION HOMEOSTASIS,0.10134,0.060233,0.14719,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.36271,0.060186,0.053532,0,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.37111,0.060141,0.065073,0,0
3,GO RESPONSE TO PEPTIDE HORMONE,0.32248,0.059989,0.099077,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.214,0.059964,0.12751,0,0
3,GO OVULATION CYCLE,0.42405,0.059828,0.10677,0,0
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.42405,0.05982,0.05127,0,0
3,GO DNA STRAND ELONGATION,0.83078,0.059753,0.035794,0,0
3,GO SPLEEN DEVELOPMENT,0.17091,0.059736,0.11431,0,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.17091,0.059677,0.11937,0,0
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.20256,0.059672,0.11696,0,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.35442,0.059664,0.07493,0,0
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.23203,0.05966,0.092508,0,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.53179,0.059631,0.065003,0,0
3,GO DNA METABOLIC PROCESS,0.35442,0.059596,0.070364,0,0
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.70989,0.059557,0.031595,0,0
3,GO BRAIN MORPHOGENESIS,0.93062,0.059509,0.010256,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.098083,0.05939,0.06998,0,0
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.33029,0.059252,0.1187,0,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.033245,0.059232,0.18953,0,0
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.20822,0.059079,0.12151,0,0
3,GO MESODERMAL CELL FATE SPECIFICATION,0.27126,0.059009,0.063471,0,0
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.10468,0.05898,0.079586,0,0
3,GO ORGAN GROWTH,0.10134,0.058892,0.15254,0,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.094909,0.05876,0.15866,0,0
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.30724,0.058746,0.10504,0,0
3,GO ACTIVATION OF GTPASE ACTIVITY,0.27821,0.058741,0.13494,0,0
3,GO LACTATE METABOLIC PROCESS,0.61803,0.058686,0.046278,0,0
3,GO DENTATE GYRUS DEVELOPMENT,0.43329,0.058584,0.030819,0,0
3,GO BODY MORPHOGENESIS,0.23203,0.058461,0.16522,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.29248,0.058454,0.056738,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.197,0.058436,0.12789,0,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.29248,0.058434,0.080031,0,0
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.38829,0.058247,0.056382,0,0
3,GO REGULATION OF LIGASE ACTIVITY,0.84314,0.058226,0.016662,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.21989,0.058192,0.12906,0,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.3148,0.058069,0.077892,0,0
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.1475,0.058056,0.1487,0,0
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.29248,0.058008,0.07374,0,0
3,GO RESPONSE TO ESTRADIOL,0.35442,0.057779,0.10131,0,0
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.60692,0.057649,0.058483,0,0
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.27821,0.057646,0.12697,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.16123,0.057624,0.098166,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.41494,0.057613,0.089469,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.10811,0.057467,0.13359,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.33029,0.057309,0.098713,0,0
3,GO REGULATION OF AUTOPHAGY,0.2998,0.05728,0.091271,0,0
3,GO MAINTENANCE OF LOCATION,0.14312,0.057226,0.13048,0,0
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.091819,0.057224,0.11676,0,0
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.40594,0.057192,0.10135,0,0
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.30724,0.057121,0.09237,0,0
3,GO CELLULAR RESPONSE TO PH,0.79394,0.057072,0.035236,0,0
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.72171,0.056869,0.041284,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.214,0.056714,0.20586,0,0
3,GO CELL CYCLE CHECKPOINT,0.37111,0.056699,0.074554,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.27821,0.05663,0.11596,0,0
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.3148,0.056542,0.10718,0,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.57414,0.056499,0.078712,0,0
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.23203,0.056384,0.13924,0,0
3,GO REGULATION OF BINDING,0.3148,0.056293,0.093013,0,0
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.16602,0.056184,0.10333,0,0
3,GO CENTRIOLE CENTRIOLE COHESION,0.68646,0.056126,0.067031,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.065157,0.056103,0.10554,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.20256,0.056008,0.070416,0,0
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.12662,0.055958,0.15632,0,0
3,GO CELLULAR RESPONSE TO HEAT,0.13467,0.055935,0.09964,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.93062,0.055933,0.029349,0,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.41494,0.055907,0.082329,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.28529,0.055725,0.064671,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.33029,0.05562,0.11545,0,0
3,GO HOMEOSTATIC PROCESS,0.23203,0.055583,0.10402,0,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.85555,0.055567,0.027945,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.49108,0.05553,0.056756,0,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.26442,0.055428,0.10862,0,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.36271,0.055425,0.089992,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.2577,0.055423,0.094315,0,0
3,GO REGULATION OF PROTEIN DEACETYLATION,0.49108,0.05542,0.070976,0,0
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.17591,0.055358,0.13967,0,0
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.1475,0.055329,0.1341,0,0
3,GO PROTEIN N LINKED GLYCOSYLATION,0.20256,0.055315,0.089743,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.18102,0.055296,0.099858,0,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.037377,0.055202,0.12238,0,0
3,GO IRON ION TRANSPORT,0.20822,0.055133,0.10539,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.1306,0.055101,0.12948,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.39705,0.055099,0.085982,0,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.27126,0.055091,0.10661,0,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.4521,0.05502,0.0573,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.27821,0.055,0.085855,0,0
3,GO REGULATION OF SPINDLE CHECKPOINT,0.89296,0.054914,0.015845,0,0
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.36271,0.054909,0.11449,0,0
3,GO SYNAPTIC VESICLE BUDDING,0.51122,0.054888,0.086156,0,0
3,GO HORMONE BIOSYNTHETIC PROCESS,0.214,0.054714,0.086723,0,0
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.23203,0.0547,0.090859,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.058535,0.054607,0.093883,0,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.41494,0.054535,0.10829,0,0
3,GO MULTIVESICULAR BODY ORGANIZATION,0.32248,0.054534,0.055178,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.67486,0.054533,-0.057646,0,0
3,GO CANONICAL WNT SIGNALING PATHWAY,0.4521,0.054381,0.096502,0,0
3,GO OOGENESIS,0.83078,0.054363,-0.019043,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.20822,0.054286,0.085369,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.51122,0.054213,0.11683,0,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.81845,0.054197,0.017835,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.55277,0.054184,0.10219,0,0
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.30724,0.05412,0.10832,0,0
3,GO LYSOSOME LOCALIZATION,0.72171,0.054037,0.060325,0,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.33821,0.053924,0.14386,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.2259,0.05368,0.12326,0,0
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.35442,0.053633,0.069839,0,0
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.23203,0.053605,0.12041,0,0
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.44264,0.053578,0.08791,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.25111,0.053563,0.14739,0,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.15655,0.053545,0.19205,0,0
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.1475,0.053479,0.14356,0,0
3,GO HAIR CELL DIFFERENTIATION,0.93062,0.053476,0.02838,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.10134,0.053435,0.07767,0,0
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.24463,0.053399,0.096322,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.29248,0.053338,0.14253,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.72171,0.053338,-0.03849,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.5959,0.053251,0.045579,0,0
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.25111,0.053212,0.11165,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.66333,0.053189,0.035491,0,0
3,GO REGULATION OF DNA BINDING,0.48117,0.053101,0.057188,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.28529,0.053015,0.090958,0,0
3,GO REGULATION OF CELL CYCLE PROCESS,0.40594,0.052977,0.057408,0,0
3,GO PEPTIDYL ARGININE METHYLATION,0.67486,0.052949,0.029965,0,0
3,GO RESPONSE TO ALCOHOL,0.33029,0.052915,0.10044,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.98106,0.052881,0.032982,0,0
3,GO REGULATION OF CELL DIFFERENTIATION,0.32248,0.052822,0.10439,0,0
3,GO GPI ANCHOR METABOLIC PROCESS,0.5959,0.052791,0.033852,0,0
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.38829,0.052674,0.067699,0,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.42405,0.05252,0.069866,0,0
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.41494,0.052503,0.068958,0,0
3,GO RESPONSE TO ABIOTIC STIMULUS,0.20822,0.052469,0.092363,0,0
3,GO NUCLEUS LOCALIZATION,0.7336,0.052452,0.073296,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.57414,0.052337,0.051608,0,0
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.44264,0.052318,0.094924,0,0
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.26442,0.052196,0.088887,0,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.41494,0.052117,0.069266,0,0
3,GO LYSOSOMAL TRANSPORT,0.39705,0.051943,0.092392,0,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.41494,0.051885,0.11017,0,0
3,GO REGULATION OF CELL CYCLE,0.55277,0.051733,0.053633,0,0
3,GO REGULATION OF GONAD DEVELOPMENT,0.26442,0.05168,0.093607,0,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.74555,0.051623,0.03849,0,0
3,GO OXYGEN TRANSPORT,0.60692,0.051597,0.043139,0,0
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.13885,0.051597,0.10446,0,0
3,GO PYRUVATE METABOLIC PROCESS,0.40594,0.051417,0.079243,0,0
3,GO RESPONSE TO GROWTH FACTOR,0.41494,0.051371,0.10829,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.67486,0.051319,0.018802,0,0
3,GO CHROMOSOME SEGREGATION,0.99368,0.051276,0.0028598,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.20256,0.051193,0.16347,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.57414,0.051161,0.081926,0,0
3,GO CYTOPLASMIC TRANSLATION,0.23203,0.051136,0.03737,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.29248,0.051114,0.081329,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.42405,0.051113,0.072501,0,0
3,GO ADAPTIVE THERMOGENESIS,0.49108,0.051065,0.082763,0,0
3,GO HORMONE CATABOLIC PROCESS,0.66333,0.05103,0.044681,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.197,0.050975,0.1099,0,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.20822,0.050885,0.10503,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.17591,0.050833,0.091362,0,0
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.33029,0.050774,0.11729,0,0
3,GO INORGANIC ANION TRANSPORT,0.90549,0.050682,0.043682,0,0
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.58498,0.050502,0.075524,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.40594,0.050413,0.038614,0,0
3,GO REGULATION OF RNA SPLICING,0.83078,0.050388,0.031663,0,0
3,GO NEGATIVE REGULATION OF CELL AGING,0.44264,0.050359,0.11316,0,0
3,GO RESPONSE TO CAMP,0.214,0.050358,0.11874,0,0
3,GO REGULATION OF TELOMERE CAPPING,0.42405,0.050356,0.081074,0,0
3,GO HISTONE H3 DEACETYLATION,0.68646,0.050309,0.045833,0,0
3,GO PROTEIN NEDDYLATION,0.74555,0.050246,0.023571,0,0
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.66333,0.05023,0.038956,0,0
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.37111,0.050043,0.1001,0,0
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.29248,0.050008,0.092241,0,0
3,GO SPHINGOID METABOLIC PROCESS,0.98106,0.049971,0.029119,0,0
3,GO MACROMOLECULE DEPALMITOYLATION,0.098083,0.049946,0.089391,0,0
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.23203,0.049931,0.098233,0,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.23203,0.049804,0.11621,0,0
3,GO HISTONE MRNA METABOLIC PROCESS,0.077559,0.049753,0.10733,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.15655,0.049726,0.22079,0,0
3,GO CYTOKINETIC PROCESS,0.43329,0.049708,0.050492,0,0
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.29248,0.049703,0.11635,0,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.34626,0.049629,0.067511,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.30724,0.049538,0.060211,0,0
3,GO RESPONSE TO TOXIC SUBSTANCE,0.33029,0.049358,0.076525,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.78176,0.04931,0.045486,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.54223,0.049256,0.040864,0,0
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.42405,0.049246,0.069795,0,0
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.56341,0.049238,0.051521,0,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.25111,0.049229,0.21311,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.28529,0.049206,0.081923,0,0
3,GO NEGATIVE REGULATION OF DNA BINDING,0.48117,0.049169,0.056347,0,0
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.14312,0.049155,0.1013,0,0
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.29248,0.049137,0.049168,0,0
3,GO ORGANELLE DISASSEMBLY,0.5959,0.049134,0.047559,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.5959,0.049084,0.049042,0,0
3,GO REGULATION OF EXOSOMAL SECRETION,0.83078,0.048951,0.037799,0,0
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.88046,0.048904,0.04452,0,0
3,GO REGULATION OF ATP METABOLIC PROCESS,0.38829,0.048846,0.074871,0,0
3,GO MUSCLE HYPERTROPHY,0.38829,0.048809,0.11517,0,0
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.34626,0.048791,0.065639,0,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,0.2998,0.048749,0.066212,0,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.66333,0.048626,0.038226,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.15197,0.048513,0.158,0,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.46168,0.048487,0.07089,0,0
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.41494,0.048482,0.099972,0,0
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.41494,0.048453,0.092947,0,0
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.53179,0.04843,0.07084,0,0
3,GO TEMPERATURE HOMEOSTASIS,0.39705,0.048187,0.094543,0,0
3,GO REGULATION OF HISTONE UBIQUITINATION,0.44264,0.047956,0.058252,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.23827,0.047844,0.10263,0,0
3,GO CHROMOSOME ORGANIZATION,0.64051,0.047817,0.047471,0,0
3,GO PROTEIN TARGETING TO VACUOLE,0.36271,0.047676,0.10462,0,0
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.5959,0.047637,0.11973,0,0
3,GO REPLICATIVE SENESCENCE,0.33821,0.047637,0.10871,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.4521,0.047611,0.0851,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.16123,0.047611,0.15923,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.197,0.047564,0.16621,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.17591,0.047546,0.085662,0,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.55277,0.047506,0.080485,0,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.86799,0.047471,0.034485,0,0
3,GO BLASTOCYST DEVELOPMENT,0.33821,0.047455,0.05385,0,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.2259,0.047323,0.11039,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.3148,0.047274,0.089073,0,0
3,GO DEVELOPMENTAL PIGMENTATION,0.37111,0.047226,0.11492,0,0
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.67486,0.047171,0.050769,0,0
3,GO REGULATION OF VASCULOGENESIS,0.26442,0.047062,0.13506,0,0
3,GO DNA REPLICATION,0.62923,0.047056,0.044981,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.13467,0.047032,0.11413,0,0
3,GO PEPTIDYL LYSINE METHYLATION,0.48117,0.046982,0.057771,0,0
3,GO ACTIN FILAMENT BASED MOVEMENT,0.35442,0.046924,0.11325,0,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.52145,0.046883,0.075599,0,0
3,GO APPENDAGE MORPHOGENESIS,0.2998,0.046854,0.12906,0,0
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.08303,0.046782,0.10573,0,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.83078,0.046721,-2.9e-05,0,0
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.37111,0.046703,0.090409,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.86799,0.046305,0.0032952,0,0
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.2577,0.046275,0.10484,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.51122,0.046235,0.10771,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.24463,0.046212,0.15002,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.4521,0.046187,0.11468,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.25111,0.04616,0.16621,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.65188,0.046105,0.074659,0,0
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.24463,0.045953,0.10324,0,0
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.17591,0.04579,0.15346,0,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.68646,0.0457,0.058584,0,0
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.33029,0.045699,0.14034,0,0
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.2577,0.045693,0.10513,0,0
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.37111,0.045657,0.071407,0,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.4521,0.04556,0.057989,0,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.80618,0.045414,-0.0054581,0,0
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.29248,0.045377,0.057215,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.39705,0.045377,0.048197,0,0
3,GO STEROL BIOSYNTHETIC PROCESS,0.30724,0.04535,0.095011,0,0
3,GO CARBOHYDRATE TRANSPORT,0.5959,0.045315,0.071631,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.18102,0.045296,0.11391,0,0
3,GO REGULATION OF ENDOCYTOSIS,0.37964,0.045154,0.098817,0,0
3,GO BIOMINERALIZATION,0.34626,0.045134,0.11422,0,0
3,GO CELL CYCLE ARREST,0.57414,0.045027,0.061922,0,0
3,GO HEXOSE CATABOLIC PROCESS,0.54223,0.044982,0.079522,0,0
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.13467,0.044901,0.096913,0,0
3,GO REGULATION OF PH,0.39705,0.044862,0.073031,0,0
3,GO ATP BIOSYNTHETIC PROCESS,0.41494,0.044759,0.076335,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.50109,0.044679,0.041869,0,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.55277,0.044672,0.067248,0,0
3,GO CENTROSOME SEPARATION,0.74555,0.044593,0.032595,0,0
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.56341,0.044561,0.028659,0,0
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.37964,0.044538,0.055969,0,0
3,GO SPHINGOLIPID METABOLIC PROCESS,0.83078,0.044418,0.059933,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.51122,0.04441,0.067277,0,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.98106,0.044383,0.019443,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.99368,0.044341,0.016286,0,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.34626,0.044223,0.10083,0,0
3,GO DNA REPAIR,0.60692,0.044223,0.043794,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.99368,0.044124,0.0056786,0,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.48117,0.044121,0.11998,0,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.83078,0.044001,0.017843,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.7336,0.043962,0.055038,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.4521,0.043924,0.10157,0,0
3,GO VITAMIN CATABOLIC PROCESS,0.58498,0.043895,0.065642,0,0
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.23827,0.043813,0.088801,0,0
3,GO POSITIVE REGULATION OF SIGNALING,0.214,0.043733,0.11497,0,0
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.5959,0.043699,0.060994,0,0
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.64051,0.043584,0.066944,0,0
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.64051,0.043548,0.056434,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.27821,0.043462,0.086625,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.34626,0.043418,0.062192,0,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.13467,0.043418,0.13066,0,0
3,GO RNA POLYADENYLATION,0.4521,0.043346,0.08341,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.34626,0.04332,0.077824,0,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.48117,0.043309,0.074838,0,0
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.17091,0.0433,0.084073,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.23203,0.043262,0.12331,0,0
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.48117,0.043234,0.083957,0,0
3,GO MEMBRANE DISASSEMBLY,0.57414,0.04323,0.07787,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.80618,0.04312,0.044337,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.93062,0.043091,0.037766,0,0
3,GO EMBRYONIC EYE MORPHOGENESIS,0.15197,0.043041,0.23214,0,0
3,GO REGULATION OF HISTONE METHYLATION,0.46168,0.043031,0.077295,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.51122,0.043021,0.075311,0,0
3,GO REGULATION OF MACROAUTOPHAGY,0.33029,0.043004,0.074085,0,0
3,GO EXTRACELLULAR VESICLE BIOGENESIS,0.52145,0.042886,0.066092,0,0
3,GO MIDBRAIN DEVELOPMENT,0.48117,0.042855,0.063559,0,0
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.37964,0.042754,0.095334,0,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.32248,0.042528,0.12397,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.34626,0.042472,0.051967,0,0
3,GO ENDOSOME ORGANIZATION,0.23827,0.042372,0.079743,0,0
3,GO MESODERM DEVELOPMENT,0.2577,0.042352,0.10259,0,0
3,GO REGULATION OF DNA REPLICATION,0.78176,0.04231,0.031636,0,0
3,GO CARBOHYDRATE METABOLIC PROCESS,0.26442,0.042293,0.091446,0,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.3148,0.042239,0.13552,0,0
3,GO VACUOLAR TRANSPORT,0.40594,0.042078,0.081617,0,0
3,GO COVALENT CHROMATIN MODIFICATION,0.47137,0.041973,0.067585,0,0
3,GO REGULATION OF NEURON MATURATION,0.65188,0.041822,0.10184,0,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.14312,0.041707,0.14389,0,0
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.48117,0.041514,0.095169,0,0
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.37964,0.041489,0.060458,0,0
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.27821,0.041386,0.10075,0,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.61803,0.041283,0.058866,0,0
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.4521,0.041215,0.081148,0,0
3,GO DNA LIGATION,0.29248,0.041212,0.080077,0,0
3,GO VIRION ASSEMBLY,0.094909,0.041191,0.088609,0,0
3,GO POST EMBRYONIC DEVELOPMENT,0.46168,0.041163,0.092843,0,0
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.33821,0.04075,0.068052,0,0
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.26442,0.040737,0.06911,0,0
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.38829,0.040681,0.091475,0,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.79394,0.040681,0.0064613,0,0
3,GO MAGNESIUM ION TRANSPORT,0.51122,0.04067,0.032026,0,0
3,GO REGULATION OF HISTONE MODIFICATION,0.49108,0.040476,0.061042,0,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.20256,0.040451,0.12489,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.58498,0.040378,0.054127,0,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.78176,0.040326,-0.018212,0,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.94321,0.040325,0.014726,0,0
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.49108,0.040294,0.070363,0,0
3,GO REGULATION OF CENTROSOME DUPLICATION,0.84314,0.040267,0.01073,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.46168,0.040266,0.082714,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.64051,0.040102,0.069057,0,0
3,GO INTESTINAL LIPID ABSORPTION,0.57414,0.039856,0.080314,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.28529,0.039827,0.087911,0,0
3,GO NEGATIVE REGULATION OF SIGNALING,0.37111,0.03975,0.095849,0,0
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.76963,0.039631,0.056196,0,0
3,GO APICAL JUNCTION ASSEMBLY,0.67486,0.039208,0.067456,0,0
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.52145,0.039088,0.08872,0,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.74555,0.038994,0.043414,0,0
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.41494,0.03877,0.10072,0,0
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.55277,0.038699,0.079653,0,0
3,GO INNER EAR MORPHOGENESIS,0.66333,0.038637,0.042648,0,0
3,GO PROTEIN HETEROOLIGOMERIZATION,0.94321,0.038462,0.02184,0,0
3,GO TRANSLATIONAL INITIATION,0.13885,0.038363,0.057804,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.53179,0.038254,0.064921,0,0
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.28529,0.038201,0.1241,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.47137,0.0382,0.071397,0,0
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.43329,0.038179,0.082689,0,0
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.29248,0.038164,0.092834,0,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.54223,0.038077,0.066055,0,0
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.53179,0.037592,0.068839,0,0
3,GO REGULATION OF URINE VOLUME,0.15655,0.037499,0.18069,0,0
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.20256,0.037425,0.092305,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.57414,0.037424,0.07292,0,0
3,GO EMBRYONIC BRAIN DEVELOPMENT,0.65188,0.037393,0.082988,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.56341,0.037292,0.053307,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.68646,0.037274,0.067802,0,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.53179,0.037188,0.078386,0,0
3,GO EXIT FROM MITOSIS,0.93062,0.037006,0.001548,0,0
3,GO NEGATIVE REGULATION OF GROWTH,0.52145,0.036984,0.089529,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.28529,0.036854,0.15245,0,0
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.5959,0.036845,0.086547,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.34626,0.03677,0.073993,0,0
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.16123,0.036753,0.081934,0,0
3,GO NUCLEAR MIGRATION,0.88046,0.036749,0.058923,0,0
3,GO REGULATION OF HEART GROWTH,0.091819,0.036683,0.15561,0,0
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.49108,0.03667,0.037048,0,0
3,GO RESPONSE TO ACID CHEMICAL,0.37111,0.036589,0.091699,0,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.95582,0.036532,0.041524,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.64051,0.036486,0.045022,0,0
3,GO MITOTIC CELL CYCLE,0.52145,0.036439,0.055332,0,0
3,GO TELOMERASE RNA LOCALIZATION,0.13467,0.036349,0.077792,0,0
3,GO TRICARBOXYLIC ACID CYCLE,0.50109,0.036273,0.054383,0,0
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.52145,0.036194,0.06539,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.90549,0.036087,0.02729,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.49108,0.035959,0.051102,0,0
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.40594,0.035835,0.056465,0,0
3,GO REGULATION OF CHROMATIN BINDING,0.53179,0.035795,0.072887,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.33029,0.035742,0.11434,0,0
3,GO LYSINE METABOLIC PROCESS,0.55277,0.035713,0.048794,0,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.60692,0.03571,0.11487,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.37964,0.035601,0.14597,0,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.25111,0.035547,0.089754,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.91805,0.035487,0.028227,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.33029,0.035364,0.10747,0,0
3,GO SISTER CHROMATID COHESION,0.69814,0.035156,-0.014505,0,0
3,GO REGULATION OF MITOPHAGY,0.74555,0.034931,0.061102,0,0
3,GO REGULATION OF AXON GUIDANCE,0.34626,0.034921,0.16927,0,0
3,GO REGULATION OF CENTROSOME CYCLE,0.78176,0.034913,0.016516,0,0
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.40594,0.034861,0.10391,0,0
3,GO CELL CYCLE PROCESS,0.5959,0.034693,0.049031,0,0
3,GO WATER HOMEOSTASIS,0.85555,0.034683,0.038528,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.52145,0.034639,0.085587,0,0
3,GO GONADOTROPIN SECRETION,0.69814,0.034591,0.054882,0,0
3,GO KETONE BIOSYNTHETIC PROCESS,0.40594,0.034549,0.069201,0,0
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.54223,0.034536,0.051293,0,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.49108,0.034511,0.095341,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.83078,0.03451,0.063485,0,0
3,GO REGULATION OF FERTILIZATION,0.42405,0.034498,0.044549,0,0
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.33029,0.034497,0.091236,0,0
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.32248,0.03446,0.06073,0,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.60692,0.034357,0.072647,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.42405,0.034191,0.11701,0,0
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.23203,0.034177,0.078362,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.67486,0.033822,0.04562,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.61803,0.033822,0.068488,0,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.98106,0.033702,0.0064677,0,0
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.36271,0.033623,0.12627,0,0
3,GO TRACHEA MORPHOGENESIS,0.13467,0.033459,0.19595,0,0
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.30724,0.033429,0.093746,0,0
3,GO RESPONSE TO STEROL DEPLETION,0.13467,0.033412,0.15857,0,0
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.4521,0.033362,0.087987,0,0
3,GO OOCYTE MATURATION,0.84314,0.033256,-0.014723,0,0
3,GO DETECTION OF STIMULUS,0.40594,0.033181,0.062952,0,0
3,GO ORGANIC ACID CATABOLIC PROCESS,0.20256,0.033121,0.09027,0,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.93062,0.033106,-0.0039066,0,0
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.5959,0.033097,0.054906,0,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.80618,0.033097,0.013375,0,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.88046,0.033013,-0.011105,0,0
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.35442,0.032987,0.097493,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.42405,0.032943,0.090954,0,0
3,GO NEURAL CREST CELL MIGRATION,0.44264,0.032928,0.15494,0,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,0.7336,0.032849,0.0017805,0,0
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.68646,0.032838,0.018623,0,0
3,GO TRANSLATIONAL TERMINATION,0.44264,0.03282,0.031731,0,0
3,GO CELL CELL JUNCTION ASSEMBLY,0.70989,0.032707,0.075324,0,0
3,GO POSTREPLICATION REPAIR,0.58498,0.032674,0.051045,0,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.49108,0.03267,0.06801,0,0
3,GO CHROMATIN ORGANIZATION,0.56341,0.032565,0.051591,0,0
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.69814,0.032444,0.049176,0,0
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.68646,0.032396,0.038416,0,0
3,GO UV PROTECTION,0.38829,0.032357,0.10807,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE,0.53179,0.032334,0.09378,0,0
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.72171,0.032316,0.051743,0,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.79394,0.032032,0.0092057,0,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.39705,0.031885,0.11943,0,0
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.41494,0.031849,0.054751,0,0
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.44264,0.031818,0.078207,0,0
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.21989,0.031813,0.086532,0,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.40594,0.031811,0.051042,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.86799,0.031676,0.053749,0,0
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.69814,0.031548,0.054616,0,0
3,GO DEPHOSPHORYLATION,0.57414,0.0315,0.066856,0,0
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.10134,0.031342,0.1014,0,0
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.74555,0.03133,0.059816,0,0
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.46168,0.0312,0.097157,0,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.58498,0.031159,0.14923,0,0
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.66333,0.031108,0.026638,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.5959,0.031085,0.1132,0,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.58498,0.031076,0.063282,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.72171,0.030985,0.07462,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.36271,0.030983,0.098004,0,0
3,GO RESPONSE TO ACTIVITY,0.20822,0.030951,0.10318,0,0
3,GO PROTEIN POLYMERIZATION,0.78176,0.03095,0.064552,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.37964,0.030937,0.14426,0,0
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.62923,0.030916,0.087151,0,0
3,GO CERAMIDE METABOLIC PROCESS,0.54223,0.030823,0.074935,0,0
3,GO PEPTIDYL SERINE MODIFICATION,0.65188,0.030803,0.070743,0,0
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.65188,0.030677,0.054292,0,0
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.78176,0.030636,0.097738,0,0
3,GO ONE CARBON METABOLIC PROCESS,0.28529,0.0305,0.069478,0,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.2577,0.030465,0.15205,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.54223,0.030418,0.13729,0,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.69814,0.030408,0.040348,0,0
3,GO RESPONSE TO HYDROXYUREA,0.93062,0.030178,0.039167,0,0
3,GO EAR MORPHOGENESIS,0.66333,0.030163,0.04036,0,0
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.49108,0.030156,0.062967,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.33029,0.030147,0.078192,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.39705,0.030051,0.093373,0,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.68646,0.030042,-0.042856,0,0
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.49108,0.030017,0.051924,0,0
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.34626,0.029989,0.060488,0,0
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.65188,0.029942,0.060416,0,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.70989,0.02978,0.054704,0,0
3,GO SENSORY ORGAN MORPHOGENESIS,0.44264,0.029746,0.078124,0,0
3,GO RENAL SYSTEM PROCESS,0.69814,0.029644,0.083615,0,0
3,GO RESPONSE TO COPPER ION,0.81845,0.029558,0.040394,0,0
3,GO HISTONE METHYLATION,0.65188,0.029468,0.046469,0,0
3,GO PEROXISOMAL TRANSPORT,0.27821,0.029215,0.067298,0,0
3,GO LIPID EXPORT FROM CELL,0.29248,0.029175,0.089699,0,0
3,GO NUCLEOTIDE EXCISION REPAIR,0.89296,0.029055,0.027518,0,0
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.58498,0.028969,0.062544,0,0
3,GO CELL DIVISION,0.61803,0.028939,0.042773,0,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.56341,0.028906,0.050787,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.46168,0.028851,0.090472,0,0
3,GO POSITIVE REGULATION OF FERTILIZATION,0.40594,0.028771,0.061623,0,0
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.58498,0.028754,0.047281,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.7336,0.028705,0.058623,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.46168,0.028665,0.079918,0,0
3,GO SPECIFICATION OF SYMMETRY,0.79394,0.028623,0.049404,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.57414,0.028592,0.035602,0,0
3,GO INTRACELLULAR TRANSPORT,0.72171,0.028525,0.045545,0,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.62923,0.028434,0.044034,0,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.49108,0.028368,0.086356,0,0
3,GO ESTABLISHMENT OF CELL POLARITY,0.23203,0.028349,0.11894,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.74555,0.028302,0.03816,0,0
3,GO SEX DIFFERENTIATION,0.51122,0.02826,0.070668,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.64051,0.02824,0.062262,0,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.7336,0.028185,0.068708,0,0
3,GO REGULATION OF DNA REPAIR,0.86799,0.027959,0.040699,0,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.88046,0.027952,0.0026049,0,0
3,GO NAD METABOLIC PROCESS,0.37964,0.027617,0.09352,0,0
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.80618,0.027617,0.044858,0,0
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.70989,0.027582,0.070863,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.47137,0.027571,0.097526,0,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.40594,0.027569,0.043462,0,0
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.51122,0.027535,0.071365,0,0
3,GO MITOCHONDRIAL TRANSPORT,0.85555,0.027471,0.034905,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.197,0.02746,0.054647,0,0
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.66333,0.027347,0.060383,0,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.26442,0.027309,0.094686,0,0
3,GO PEROXISOME ORGANIZATION,0.17091,0.02728,0.077716,0,0
3,GO PHAGOSOME MATURATION,0.67486,0.027183,0.067854,0,0
3,GO DNA PACKAGING,0.93062,0.027013,0.0073442,0,0
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.44264,0.026947,0.075713,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.42405,0.026926,0.13463,0,0
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.55277,0.026846,0.078515,0,0
3,GO NUCLEOSIDE SALVAGE,0.3148,0.026829,0.05276,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.86799,0.026516,0.047808,0,0
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.81845,0.026359,0.053832,0,0
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.75756,0.026343,0.030982,0,0
3,GO CYTOSKELETON ORGANIZATION,0.68646,0.026296,0.068168,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.55277,0.026289,0.11809,0,0
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.74555,0.026271,0.040446,0,0
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.54223,0.02627,0.062405,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.57414,0.026269,0.064694,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.47137,0.026241,0.0838,0,0
3,GO STRESS GRANULE ASSEMBLY,0.69814,0.026196,0.052821,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.88046,0.026193,0.034978,0,0
3,GO GROWTH,0.79394,0.026184,0.072661,0,0
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.81845,0.026178,0.094162,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.2998,0.026089,0.15638,0,0
3,GO REGULATION OF ERAD PATHWAY,0.48117,0.026067,0.077979,0,0
3,GO PHOTOTRANSDUCTION,0.30724,0.026003,0.033315,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.95582,0.025937,0.0095808,0,0
3,GO VESICLE LOCALIZATION,0.85555,0.025661,0.046422,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.57414,0.025608,0.098575,0,0
3,GO CELLULAR HOMEOSTASIS,0.40594,0.025593,0.073532,0,0
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.68646,0.025588,0.002237,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.62923,0.025577,0.066955,0,0
3,GO CELL CYCLE DNA REPLICATION,0.89296,0.025535,0.024556,0,0
3,GO EMBRYO DEVELOPMENT,0.20822,0.025505,0.11737,0,0
3,GO SECRETION,0.41494,0.025494,0.097096,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.52145,0.025433,0.1063,0,0
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.84314,0.025379,0.025981,0,0
3,GO REGULATION OF NUCLEAR DIVISION,0.95582,0.025308,0.026204,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.48117,0.025108,0.084572,0,0
3,GO RESPONSE TO LIGHT STIMULUS,0.70989,0.0251,0.041784,0,0
3,GO MUSCLE ORGAN MORPHOGENESIS,0.64051,0.024865,0.06792,0,0
3,GO MITOTIC RECOMBINATION,0.58498,0.024665,0.071714,0,0
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.78176,0.024567,0.05406,0,0
3,GO CENTRIOLE ASSEMBLY,0.72171,0.024532,0.036725,0,0
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.26442,0.024529,0.13801,0,0
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.2577,0.024505,0.11916,0,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.21989,0.024431,0.15466,0,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.98106,0.024416,0.016996,0,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.55277,0.024349,0.053897,0,0
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.80618,0.024289,0.026316,0,0
3,GO GLUCOSE CATABOLIC PROCESS,0.99368,0.024254,0.036196,0,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.60692,0.024208,0.042539,0,0
3,GO FUCOSE METABOLIC PROCESS,0.89296,0.024191,0.0020287,0,0
3,GO REGULATION OF MRNA PROCESSING,0.94321,0.02404,0.017657,0,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.37111,0.023908,0.075188,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.48117,0.023849,0.077317,0,0
3,GO PROTEIN HOMOOLIGOMERIZATION,0.61803,0.023795,0.055393,0,0
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.88046,0.023761,0.016559,0,0
3,GO CHEMOSENSORY BEHAVIOR,0.89296,0.023536,0.010651,0,0
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.4521,0.023523,0.058148,0,0
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.65188,0.023441,0.065643,0,0
3,GO RESPONSE TO NITROGEN COMPOUND,0.55277,0.023424,0.074975,0,0
3,GO PROTEIN METHYLATION,0.66333,0.023367,0.040758,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.54223,0.02335,0.068516,0,0
3,GO SOMITOGENESIS,0.72171,0.023324,0.049869,0,0
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.33029,0.023276,0.18154,0,0
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.84314,0.023245,-0.012608,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.68646,0.023219,0.056864,0,0
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.28529,0.023136,0.092933,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.99368,0.023094,-0.014348,0,0
3,GO NEGATIVE CHEMOTAXIS,0.64051,0.02309,0.13093,0,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.80618,0.022881,0.030586,0,0
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.32248,0.022833,0.087491,0,0
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.80618,0.022746,-0.0014403,0,0
3,GO CELL CYCLE,0.62923,0.022745,0.048438,0,0
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.84314,0.022713,0.051602,0,0
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.46168,0.022675,0.068582,0,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.62923,0.022632,0.050508,0,0
3,GO REPRODUCTION,0.78176,0.022585,0.046647,0,0
3,GO HEART DEVELOPMENT,0.27821,0.022554,0.12072,0,0
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.93062,0.022541,0.0097852,0,0
3,GO ENGULFMENT OF APOPTOTIC CELL,0.44264,0.02249,0.083868,0,0
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.61803,0.022353,0.057008,0,0
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.69814,0.022314,0.075255,0,0
3,GO SIGNAL PEPTIDE PROCESSING,0.85555,0.02226,0.012846,0,0
3,GO MITOTIC CYTOKINETIC PROCESS,0.75756,0.022176,0.029485,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.50109,0.02215,0.090384,0,0
3,GO UBIQUINONE METABOLIC PROCESS,0.90549,0.022047,0.0052129,0,0
3,GO EMBRYONIC MORPHOGENESIS,0.2577,0.021978,0.13059,0,0
3,GO SPERMATID DIFFERENTIATION,0.70989,0.021969,-0.024809,0,0
3,GO ACTIN MEDIATED CELL CONTRACTION,0.67486,0.021911,0.064655,0,0
3,GO CELLULAR ION HOMEOSTASIS,0.47137,0.021764,0.084909,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.2998,0.021558,0.089486,0,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.62923,0.021411,0.052184,0,0
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.36271,0.021409,0.18838,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.61803,0.021288,0.024668,0,0
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.90549,0.021219,0.037358,0,0
3,GO CARNITINE SHUTTLE,0.58498,0.021169,0.060524,0,0
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.79394,0.020966,0.018111,0,0
3,GO CELL PROJECTION ASSEMBLY,0.75756,0.020708,0.046163,0,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.48117,0.020536,-0.054738,0,0
3,GO SINGLE STRAND BREAK REPAIR,0.90549,0.020291,-0.0034665,0,0
3,GO CELL PROLIFERATION IN FOREBRAIN,0.84314,0.020089,0.025726,0,0
3,GO L GLUTAMATE IMPORT,0.70989,0.01986,0.045983,0,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.91805,0.019781,0.019476,0,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.61803,0.01963,0.067048,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.65188,0.019556,0.036533,0,0
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.64051,0.019555,0.084789,0,0
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.83078,0.019457,0.054598,0,0
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.98106,0.019399,0.034009,0,0
3,GO BROWN FAT CELL DIFFERENTIATION,0.37964,0.019248,0.087633,0,0
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.84314,0.019241,0.049591,0,0
3,GO PROTEIN AUTOPROCESSING,0.66333,0.019189,0.036653,0,0
3,GO REGULATION OF SENSORY PERCEPTION,0.68646,0.019107,0.037874,0,0
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.72171,0.019086,0.041507,0,0
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.76963,0.019084,0.061544,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.40594,0.018984,0.16565,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.7336,0.018976,0.021745,0,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.80618,0.018916,-0.030477,0,0
3,GO NUCLEOSOME ORGANIZATION,0.98106,0.01878,0.0088366,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.48117,0.018617,0.081156,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.84314,0.018609,0.03276,0,0
3,GO TRANSLATIONAL ELONGATION,0.96843,0.018592,-0.00084403,0,0
3,GO CELL CELL SIGNALING BY WNT,0.5959,0.018242,0.079188,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION,0.66333,0.018239,0.076176,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.93062,0.018071,0.029312,0,0
3,GO REGULATION OF PROTON TRANSPORT,0.60692,0.018063,0.051691,0,0
3,GO POLYOL BIOSYNTHETIC PROCESS,0.44264,0.018024,0.087348,0,0
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.85555,0.018018,0.023439,0,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.81845,0.017816,0.078322,0,0
3,GO ION HOMEOSTASIS,0.4521,0.017793,0.082318,0,0
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.84314,0.01774,0.046768,0,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.47137,0.017671,0.12718,0,0
3,GO CYTOSOLIC TRANSPORT,0.70989,0.017585,0.05114,0,0
3,GO SARCOMERE ORGANIZATION,0.38829,0.017513,0.093978,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.70989,0.017508,-0.00023797,0,0
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.81845,0.017507,0.042918,0,0
3,GO REGULATION OF GLUCONEOGENESIS,0.85555,0.017495,0.033976,0,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.2577,0.017445,0.10833,0,0
3,GO RESPONSE TO INSULIN,0.41494,0.017395,0.091948,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.56341,0.017355,0.061368,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.60692,0.017296,0.12141,0,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.85555,0.017241,0.06225,0,0
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.47137,0.017216,0.11384,0,0
3,GO SISTER CHROMATID SEGREGATION,0.79394,0.017119,0.00035542,0,0
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.66333,0.017057,0.076142,0,0
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.98106,0.016982,-0.0042157,0,0
3,GO REGULATION OF SPINDLE ASSEMBLY,0.91805,0.016968,0.027044,0,0
3,GO DNA REPLICATION CHECKPOINT,0.99368,0.016968,0.027415,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.93062,0.016962,0.013734,0,0
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.81845,0.016892,-0.0044803,0,0
3,GO FATTY ACYL COA METABOLIC PROCESS,0.69814,0.016833,0.059601,0,0
3,GO REGULATION OF PROTEIN TARGETING,0.90549,0.016719,0.048871,0,0
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.57414,0.016669,0.12762,0,0
3,GO SENSORY PERCEPTION,0.99368,0.016598,0.026438,0,0
3,GO AEROBIC RESPIRATION,0.80618,0.016527,0.0054611,0,0
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.75756,0.016364,0.062293,0,0
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.80618,0.016357,0.052892,0,0
3,GO MODIFIED AMINO ACID TRANSPORT,0.58498,0.016049,0.067102,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.84314,0.015901,0.053852,0,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.79394,0.015858,0.00263,0,0
3,GO DNA REPLICATION INITIATION,0.93062,0.015752,0.023388,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.58498,0.015663,0.068577,0,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.60692,0.015649,-0.0079584,0,0
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.62923,0.015609,0.081178,0,0
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.85555,0.015586,0.03141,0,0
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.53179,0.01545,0.059522,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.84314,0.015441,0.031326,0,0
3,GO MELANOCYTE DIFFERENTIATION,0.80618,0.015432,0.11053,0,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.99368,0.015395,0.015118,0,0
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.27126,0.015229,0.079953,0,0
3,GO GANGLIOSIDE METABOLIC PROCESS,0.60692,0.015198,0.081075,0,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.56341,0.015188,0.065027,0,0
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.69814,0.015175,0.032398,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.86799,0.015078,0.015746,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.40594,0.01503,0.06507,0,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.58498,0.015006,0.074877,0,0
3,GO COLLECTING DUCT DEVELOPMENT,0.94321,0.014935,-0.0048492,0,0
3,GO REGULATION OF CYTOKINESIS,0.80618,0.014876,0.0033303,0,0
3,GO REGULATION OF GLUCOSE IMPORT,0.84314,0.014853,0.030539,0,0
3,GO EPITHELIAL CELL DEVELOPMENT,0.64051,0.014812,0.098122,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.85555,0.014732,0.031546,0,0
3,GO ANIMAL ORGAN MORPHOGENESIS,0.32248,0.014712,0.11031,0,0
3,GO RNA CAPPING,0.94321,0.014555,0.016835,0,0
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.70989,0.014425,0.061605,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.85555,0.014368,0.014491,0,0
3,GO PROTEIN MANNOSYLATION,0.90549,0.014142,-0.01049,0,0
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.89296,0.014099,0.043122,0,0
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.72171,0.013975,0.00062209,0,0
3,GO NUCLEUS ORGANIZATION,0.74555,0.013798,0.032902,0,0
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.83078,0.013778,0.059802,0,0
3,GO AZOLE TRANSMEMBRANE TRANSPORT,0.81845,0.013749,0.044953,0,0
3,GO ELECTRON TRANSPORT CHAIN,0.62923,0.013736,0.015812,0,0
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.43329,0.013715,0.090249,0,0
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.54223,0.013669,0.041571,0,0
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.86799,0.013633,0.032572,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.69814,0.01346,0.012559,0,0
3,GO REGULATION OF TOR SIGNALING,0.7336,0.013455,0.053996,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.89296,0.013366,0.065633,0,0
3,GO SPINDLE ASSEMBLY,0.94321,0.01335,0.00085221,0,0
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.61803,0.013306,0.072349,0,0
3,GO PLASMA MEMBRANE TUBULATION,0.5959,0.013075,0.096192,0,0
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.2577,0.013066,0.081151,0,0
3,GO PROTEIN TARGETING,0.84314,0.012786,0.019486,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.43329,0.012769,0.094722,0,0
3,GO MITOCHONDRION ORGANIZATION,0.90549,0.012565,0.033943,0,0
3,GO RESPONSE TO MUSCLE STRETCH,0.86799,0.012366,0.02131,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.32248,0.012319,0.17684,0,0
3,GO ANION TRANSMEMBRANE TRANSPORT,0.74555,0.012135,0.021765,0,0
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.76963,0.012046,0.065415,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.49108,0.011923,0.13079,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.95582,0.011917,0.053844,0,0
3,GO CELLULAR RESPONSE TO STARVATION,0.95582,0.011664,0.039262,0,0
3,GO MIDBODY ABSCISSION,0.95582,0.011503,-0.0028812,0,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.79394,0.011395,0.038034,0,0
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.86799,0.011376,0.030698,0,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.85555,0.011262,0.062479,0,0
3,GO METAL ION HOMEOSTASIS,0.4521,0.011246,0.086757,0,0
3,GO STRIATED MUSCLE ADAPTATION,0.66333,0.011199,0.06351,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.56341,0.011189,0.097114,0,0
3,GO CELL CELL JUNCTION ORGANIZATION,0.81845,0.011032,0.082918,0,0
3,GO PH REDUCTION,0.90549,0.010862,0.0023272,0,0
3,GO RECEPTOR INTERNALIZATION,0.96843,0.010683,0.052044,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.65188,0.010652,-0.010468,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.94321,0.010627,0.033493,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.57414,0.010594,0.12617,0,0
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.36271,0.010366,0.048526,0,0
3,GO POSITIVE REGULATION OF MITOPHAGY,0.75756,0.010341,0.058495,0,0
3,GO MULTI ORGANISM PROCESS,0.88046,0.010323,0.03326,0,0
3,GO NUCLEOTIDE PHOSPHORYLATION,0.5959,0.01027,0.063941,0,0
3,GO GLIOGENESIS,0.44264,0.010236,0.093158,0,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.44264,0.010219,0.10123,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.54223,0.010055,0.09568,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.65188,0.0099045,-0.031821,0,0
3,GO LIPID DROPLET ORGANIZATION,0.98106,0.009896,0.011819,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.52145,0.0098609,0.087087,0,0
3,GO SLEEP,0.79394,0.0097961,0.026975,0,0
3,GO CENTROSOME DUPLICATION,0.88046,0.0097791,0.0072902,0,0
3,GO ORGANELLE ASSEMBLY,1,0.0097308,0.016837,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.66333,0.0096802,0.10481,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.99368,0.0096466,0.013392,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.98106,0.0096121,0.0068617,0,0
3,GO GERM CELL DEVELOPMENT,0.75756,0.0094922,-0.025645,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.5959,0.0093097,-0.019112,0,0
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.56341,0.0092863,0.063563,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.93062,0.0092425,0.072562,0,0
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.85555,0.0092229,0.016281,0,0
3,GO MEMBRANE ORGANIZATION,0.84314,0.0091544,0.057163,0,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.75756,0.0091487,0.0018959,0,0
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.36271,0.0091289,0.15168,0,0
3,GO SECONDARY METABOLIC PROCESS,0.99368,0.0090669,0.013607,0,0
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.43329,0.0090287,0.061297,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.94321,0.0090211,0.024865,0,0
3,GO MYOFIBRIL ASSEMBLY,0.42405,0.008992,0.092543,0,0
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.69814,0.0088272,0.063426,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.34626,0.0087647,0.081166,0,0
3,GO POSITIVE REGULATION OF TRANSPORT,0.52145,0.0087509,0.080681,0,0
3,GO GLAND DEVELOPMENT,0.4521,0.0087407,0.10044,0,0
3,GO REGULATION OF CELLULAR LOCALIZATION,0.96843,0.0084656,0.050798,0,0
3,GO REGULATION OF CELL CYCLE ARREST,0.88046,0.0084655,0.026586,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.81845,0.0084301,0.035691,0,0
3,GO GLIAL CELL DEVELOPMENT,0.41494,0.0084286,0.095259,0,0
3,GO RESPONSE TO ETHER,0.55277,0.0083856,0.052802,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.84314,0.0081478,0.066884,0,0
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,1,0.0080686,0.0059468,0,0
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.55277,0.0079809,0.041174,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.80618,0.0077811,0.042141,0,0
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.47137,0.0077064,0.066683,0,0
3,GO EAR DEVELOPMENT,0.93062,0.0076241,0.030054,0,0
3,GO APPENDAGE DEVELOPMENT,0.38829,0.0075953,0.10965,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.69814,0.0074512,0.020587,0,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.69814,0.0073762,0.048518,0,0
3,GO MOTILE CILIUM ASSEMBLY,0.52145,0.007109,-0.10246,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.60692,0.0071013,0.087749,0,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.61803,0.0070684,-0.04237,0,0
3,GO HEART VALVE FORMATION,0.2998,0.0070299,0.15853,0,0
3,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.99368,0.0069104,0.022802,0,0
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.64051,0.0069087,0.099614,0,0
3,GO AMINE METABOLIC PROCESS,0.96843,0.0069066,0.022478,0,0
3,GO MULTICELLULAR ORGANISM AGING,1,0.0067841,0.031782,0,0
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.50109,0.006651,0.076303,0,0
3,GO GLUCOSE IMPORT,0.64051,0.0065238,0.055957,0,0
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.66333,0.0064713,-0.015756,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.79394,0.0064471,0.055161,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.70989,0.0064123,0.066081,0,0
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.94321,0.0062992,0.036089,0,0
3,GO REGIONALIZATION,0.91805,0.0061049,0.033543,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.80618,0.0060927,0.010949,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.85555,0.0060687,0.047015,0,0
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.57414,0.0060084,-0.038752,0,0
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.83078,0.0059972,0.043109,0,0
3,GO AXONAL FASCICULATION,0.98106,0.0059331,0.018998,0,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.64051,0.0058784,-0.027664,0,0
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.41494,0.0058547,0.099795,0,0
3,GO HISTONE H3 K36 METHYLATION,0.66333,0.0058084,0.054807,0,0
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.57414,0.0057713,0.094753,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.91805,0.0056682,0.048818,0,0
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.98106,0.0056521,0.041579,0,0
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.58498,0.0055249,0.075146,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.74555,0.005469,0.059562,0,0
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.46168,0.0054463,0.056309,0,0
3,GO APICAL PROTEIN LOCALIZATION,0.81845,0.005359,0.037112,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.85555,0.0052963,-0.0096287,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.57414,0.0052709,0.087754,0,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.75756,0.0050297,-0.015197,0,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.67486,0.0049661,0.054561,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.66333,0.0047608,0.038859,0,0
3,GO ERAD PATHWAY,0.41494,0.0047331,0.075332,0,0
3,GO ACTIN CROSSLINK FORMATION,0.67486,0.0045245,-0.0053396,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.39705,0.0045047,0.089984,0,0
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.39705,0.0044503,0.068129,0,0
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.50109,0.0041137,-0.019782,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.88046,0.0041021,0.043454,0,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.99368,0.0040916,0.028964,0,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.57414,0.0040478,-0.0086272,0,0
3,GO SOMITE DEVELOPMENT,0.96843,0.0040352,0.028618,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.81845,0.0039931,0.020458,0,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,1,0.0039776,0.040319,0,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.95582,0.0038802,0.043248,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.83078,0.0038466,0.0087653,0,0
3,GO CILIUM MOVEMENT,0.67486,0.003799,-0.051067,0,0
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.76963,0.0036706,0.039865,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.86799,0.0035924,0.026377,0,0
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.99368,0.0033415,0.053865,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.66333,0.0033154,0.067699,0,0
3,GO CIRCULATORY SYSTEM PROCESS,0.95582,0.0033,0.042431,0,0
3,GO REGULATION OF CELLULAR RESPIRATION,0.70989,0.0031919,0.011877,0,0
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.50109,0.0030124,0.074979,0,0
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.70989,0.0027533,-0.0061841,0,0
3,GO POSITIVE REGULATION OF RNA SPLICING,0.50109,0.0027499,-0.029409,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.68646,0.002658,0.070256,0,0
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.94321,0.0025105,0.041743,0,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.46168,0.0024915,0.099009,0,0
3,GO TELOMERE CAPPING,0.75756,0.0022173,0.048065,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.7336,0.0021515,0.049468,0,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.46168,0.002125,0.12192,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.53179,0.0019945,0.031203,0,0
3,GO MITOCHONDRIAL DEPOLARIZATION,0.56341,0.0018706,0.078711,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.83078,0.0018199,0.039726,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.38829,0.0017873,-0.050377,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.72171,0.0016749,0.050558,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.74555,0.0016688,0.063287,0,0
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.85555,0.0016031,0.034041,0,0
3,GO OVULATION CYCLE PROCESS,0.68646,0.0015402,0.061697,0,0
3,GO REGULATION OF BLOOD PRESSURE,0.74555,0.0013987,0.05809,0,0
3,GO HISTONE H4 ACETYLATION,0.93062,0.0013217,0.023074,0,0
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.79394,0.0012887,0.057915,0,0
3,GO RENAL WATER HOMEOSTASIS,0.89296,0.0012341,0.059297,0,0
3,GO MECHANORECEPTOR DIFFERENTIATION,0.43329,0.001185,-0.027674,0,0
3,GO FATTY ACID HOMEOSTASIS,0.98106,0.0011131,0.0062498,0,0
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.7336,0.0011016,0.00063953,0,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.99368,0.0010448,0.089129,0,0
3,GO REGULATION OF PEPTIDE TRANSPORT,0.78176,0.00060989,0.061758,0,0
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.7336,0.00060115,0.0073323,0,0
3,GO PROTEIN HETEROTETRAMERIZATION,0.62923,0.00052807,0.044511,0,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.69814,0.00043791,0.080312,0,0
3,GO CHEMICAL HOMEOSTASIS,0.61803,0.00038401,0.071068,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.47137,0.00023533,0.104,0,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.50109,0.00016253,0.10628,0,0
3,GO TRANSLESION SYNTHESIS,0.69814,0.00014662,0.044374,0,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.81845,-0.00020845,0.034416,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.69814,-0.00036785,0.068948,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.98106,-0.00050459,0.0126,0,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.68646,-0.0006638,0.0091458,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.79394,-0.0008071,0.048257,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.52145,-0.00082567,0.073246,0,0
3,GO RESPONSE TO MECHANICAL STIMULUS,0.61803,-0.0010062,0.084995,0,0
3,GO MUSCLE SYSTEM PROCESS,0.98106,-0.0010908,0.044027,0,0
3,GO NEUTRAL AMINO ACID TRANSPORT,0.67486,-0.0011684,0.005943,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.83078,-0.0011813,-0.019389,0,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.79394,-0.0012268,0.030458,0,0
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.99368,-0.0012615,0.039798,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.81845,-0.0012669,0.063751,0,0
3,GO BONE MINERALIZATION,0.60692,-0.0012964,0.095408,0,0
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.48117,-0.0013141,0.0078745,0,0
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.98106,-0.0014114,0.040626,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.68646,-0.0014286,0.084134,0,0
3,GO VIRAL BUDDING,0.88046,-0.0014842,0.02066,0,0
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.89296,-0.001494,0.011053,0,0
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.62923,-0.001507,0.083588,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.98106,-0.0015634,0.046203,0,0
3,GO CHROMOSOME LOCALIZATION,0.57414,-0.0017064,-0.018305,0,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.86799,-0.001723,0.049808,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.62923,-0.0018352,0.069205,0,0
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.5959,-0.001839,-0.033109,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.64051,-0.0020064,0.064049,0,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.90549,-0.002007,0.04249,0,0
3,GO NEURON APOPTOTIC PROCESS,0.93062,-0.0020509,0.046555,0,0
3,GO LOOP OF HENLE DEVELOPMENT,0.65188,-0.0022569,0.059437,0,0
3,GO REGULATION OF FATTY ACID TRANSPORT,0.70989,-0.0022866,0.066369,0,0
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.42405,-0.0023175,0.10504,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.7336,-0.0023613,0.0056615,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.74555,-0.0024418,0.06507,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.4521,-0.0024435,0.078464,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.78176,-0.0025018,0.08243,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.95582,-0.0025093,0.027896,0,0
3,GO REGULATION OF TORC1 SIGNALING,0.70989,-0.002587,0.0057218,0,0
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.32248,-0.0026686,0.10624,0,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.95582,-0.0026993,0.031275,0,0
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.88046,-0.0028149,0.0060809,0,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.37964,-0.0028647,-0.06301,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.76963,-0.0029549,0.0028494,0,0
3,GO DENDRITE SELF AVOIDANCE,0.78176,-0.0030481,0.041757,0,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.27821,-0.0031377,-0.092846,0,0
3,GO NOTCH SIGNALING PATHWAY,0.93062,-0.0031466,0.031009,0,0
3,GO ENDOCRINE HORMONE SECRETION,0.62923,-0.0032639,0.059525,0,0
3,GO SPINDLE ORGANIZATION,0.55277,-0.003349,-0.024359,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.90549,-0.0033828,0.034001,0,0
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.99368,-0.0034357,0.015311,0,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.55277,-0.0036212,-0.046717,0,0
3,GO ORGANELLE FISSION,0.7336,-0.0037847,0.0015318,0,0
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.84314,-0.0038337,0.019061,0,0
3,GO REGULATION OF CILIUM MOVEMENT,0.72171,-0.003915,-0.044443,0,0
3,GO OOCYTE DIFFERENTIATION,0.5959,-0.0039156,-0.031568,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.98106,-0.0040698,-0.0044475,0,0
3,GO REGULATION OF NEURON MIGRATION,0.70989,-0.0041068,-0.025236,0,0
3,GO MISMATCH REPAIR,0.98106,-0.0041775,0.022197,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.58498,-0.0041905,0.080513,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.46168,-0.004277,-0.04331,0,0
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.55277,-0.0045324,0.055508,0,0
3,GO PROTEIN ACETYLATION,0.99368,-0.0045622,0.028111,0,0
3,GO POSITIVE REGULATION OF CELL GROWTH,0.83078,-0.004563,0.030216,0,0
3,GO TOR SIGNALING,0.72171,-0.0046947,0.056696,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.84314,-0.0047848,0.023243,0,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.7336,-0.0048517,-0.0015981,0,0
3,GO STEM CELL PROLIFERATION,0.89296,-0.0048779,0.045318,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.76963,-0.0048818,-0.01523,0,0
3,GO LIPOPROTEIN METABOLIC PROCESS,0.72171,-0.0049019,0.052831,0,0
3,GO RESPONSE TO ZINC ION,0.57414,-0.0049638,0.053352,0,0
3,GO EXECUTION PHASE OF APOPTOSIS,0.95582,-0.0050215,0.03219,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.44264,-0.0050583,-0.015169,0,0
3,GO GLUCOSE METABOLIC PROCESS,0.91805,-0.0050634,0.037996,0,0
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.80618,-0.0052842,0.030175,0,0
3,GO TORC1 SIGNALING,0.91805,-0.0054722,0.031621,0,0
3,GO REGULATION OF GROWTH,0.99368,-0.0054778,0.058485,0,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.75756,-0.0055018,0.079241,0,0
3,GO GAMETE GENERATION,0.84314,-0.0055928,0.0026508,0,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.62923,-0.005596,0.063271,0,0
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.67486,-0.0058315,0.013974,0,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.5959,-0.0058403,0.10362,0,0
3,GO AMINO ACID IMPORT,0.80618,-0.005971,0.01751,0,0
3,GO MULTICELLULAR ORGANISM REPRODUCTION,1,-0.006064,0.025272,0,0
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.93062,-0.0061755,0.014287,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.70989,-0.0062652,0.15146,0,0
3,GO HISTONE H2A ACETYLATION,0.80618,-0.0062779,0.030553,0,0
3,GO MICROTUBULE NUCLEATION,0.50109,-0.0063242,-0.014159,0,0
3,GO PATTERN SPECIFICATION PROCESS,0.99368,-0.006424,0.030613,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.66333,-0.0068378,0.050101,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.86799,-0.0069669,0.0048258,0,0
3,GO METANEPHROS MORPHOGENESIS,0.69814,-0.0072068,0.022177,0,0
3,GO REGULATION OF MRNA POLYADENYLATION,0.89296,-0.007266,0.014883,0,0
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.96843,-0.0073348,0.0093702,0,0
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.7336,-0.0074585,0.047485,0,0
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.68646,-0.007568,0.092333,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE,0.88046,-0.0076456,0.036627,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.93062,-0.0076984,0.019017,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.75756,-0.0077092,0.098113,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.94321,-0.0077882,0.025023,0,0
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.70989,-0.0078196,0.077365,0,0
3,GO ANATOMICAL STRUCTURE MATURATION,0.76963,-0.0078942,0.030714,0,0
3,GO MALE GAMETE GENERATION,0.83078,-0.0080104,-0.0072372,0,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.98106,-0.0080831,0.026655,0,0
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.86799,-0.0084294,0.029196,0,0
3,GO DETECTION OF LIGHT STIMULUS,0.95582,-0.0084673,-0.014932,0,0
3,GO METAPHASE PLATE CONGRESSION,0.70989,-0.0085721,-0.0052861,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.79394,-0.0086443,0.053097,0,0
3,GO RESPONSE TO ETHANOL,0.95582,-0.0087223,0.038648,0,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.83078,-0.0087651,0.019663,0,0
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.68646,-0.0087685,0.023233,0,0
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.72171,-0.0088792,-0.014391,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.79394,-0.0090277,0.054337,0,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.83078,-0.0091372,0.080868,0,0
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.62923,-0.0092145,0.01253,0,0
3,GO HEART GROWTH,0.25111,-0.0096951,0.1122,0,0
3,GO MICROTUBULE SEVERING,0.65188,-0.0096994,-0.030983,0,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.79394,-0.0097136,0.033191,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.78176,-0.0097607,0.026343,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.95582,-0.0097816,0.055674,0,0
3,GO NEURON DEATH,0.79394,-0.0097907,0.062016,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.96843,-0.0098063,0.038695,0,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.74555,-0.0098195,0.068999,0,0
3,GO REGULATION OF SPINDLE ORGANIZATION,0.67486,-0.0099181,-0.0060536,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.58498,-0.010107,0.10649,0,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.84314,-0.010111,0.020979,0,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.78176,-0.010354,0.02027,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.80618,-0.010538,-0.0016553,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.88046,-0.010552,0.068518,0,0
3,GO MULTICELLULAR ORGANISM GROWTH,0.44264,-0.01093,0.0017576,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.88046,-0.011,0.037686,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.89296,-0.011001,0.031506,0,0
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.64051,-0.011057,0.092209,0,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.64051,-0.011433,-0.011765,0,0
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.76963,-0.011528,0.069409,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.61803,-0.011595,0.090022,0,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.74555,-0.01184,-0.0082973,0,0
3,GO REGULATION OF ACROSOME REACTION,0.7336,-0.012035,-0.012362,0,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.80618,-0.012195,0.01243,0,0
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.96843,-0.012196,0.01405,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.80618,-0.01227,-0.01599,0,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.89296,-0.012479,0.027338,0,0
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.85555,-0.012628,0.042888,0,0
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.83078,-0.013069,0.0047793,0,0
3,GO DENDRITIC SPINE MORPHOGENESIS,0.58498,-0.01308,-0.030406,0,0
3,GO CARNITINE METABOLIC PROCESS,0.88046,-0.013089,0.039597,0,0
3,GO RESPONSE TO EPINEPHRINE,0.58498,-0.013113,0.076861,0,0
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.56341,-0.013173,-0.0091748,0,0
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.95582,-0.013222,0.038272,0,0
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.64051,-0.013283,0.0052343,0,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.94321,-0.01339,0.017589,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.52145,-0.013417,-0.0046144,0,0
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.79394,-0.013492,0.0064434,0,0
3,GO FERTILIZATION,0.7336,-0.0136,-0.0081738,0,0
3,GO PROTEIN O LINKED MANNOSYLATION,0.89296,-0.01365,-0.0081707,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.29248,-0.013837,-0.068437,0,0
3,GO VESICLE ORGANIZATION,0.76963,-0.013963,0.033396,0,0
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.75756,-0.013972,0.056523,0,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.33029,-0.013981,0.12562,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.60692,-0.014226,0.017239,0,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.86799,-0.014238,0.034344,0,0
3,GO HISTAMINE SECRETION,0.84314,-0.014256,-0.013832,0,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.91805,-0.014293,0.011957,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.72171,-0.014403,0.05875,0,0
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.76963,-0.014426,0.0066971,0,0
3,GO ATP METABOLIC PROCESS,0.69814,-0.014576,0.013409,0,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.76963,-0.014789,0.084123,0,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.7336,-0.014955,-0.022292,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.61803,-0.014985,0.087826,0,0
3,GO CALCIUM ION IMPORT,0.88046,-0.015136,0.028465,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.67486,-0.015207,-0.040797,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.90549,-0.015219,0.037249,0,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.79394,-0.015266,0.019671,0,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.84314,-0.015369,0.033463,0,0
3,GO DENDRITIC SPINE DEVELOPMENT,0.79394,-0.015471,0.00056995,0,0
3,GO ENERGY RESERVE METABOLIC PROCESS,0.65188,-0.015574,-0.0062666,0,0
3,GO ORGANIC ANION TRANSPORT,0.90549,-0.015705,0.036769,0,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.94321,-0.015734,0.015761,0,0
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.86799,-0.01579,0.0030166,0,0
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.49108,-0.015819,-0.015186,0,0
3,GO CELLULAR RESPIRATION,0.44264,-0.015876,-0.013481,0,0
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.83078,-0.015965,0.13268,0,0
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.66333,-0.016038,-0.032307,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.70989,-0.01604,-0.012679,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.68646,-0.016092,0.0078497,0,0
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.58498,-0.016187,0.067546,0,0
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.96843,-0.016354,0.038567,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.79394,-0.016491,-0.008027,0,0
3,GO LYTIC VACUOLE ORGANIZATION,0.68646,-0.016562,0.066598,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.60692,-0.016598,0.019982,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.90549,-0.016947,0.019855,0,0
3,GO POLYOL METABOLIC PROCESS,0.98106,-0.016975,0.038094,0,0
3,GO PHAGOLYSOSOME ASSEMBLY,0.94321,-0.016987,0.05045,0,0
3,GO DEVELOPMENTAL GROWTH,0.98106,-0.017019,0.05265,0,0
3,GO MUSCLE CELL DEVELOPMENT,0.89296,-0.017218,0.044016,0,0
3,GO KINETOCHORE ASSEMBLY,0.96843,-0.017226,-0.013982,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.61803,-0.01734,0.19625,0,0
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.4521,-0.017362,0.095979,0,0
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.37964,-0.01778,-0.031221,0,0
3,GO CYTOKINESIS,0.64051,-0.01793,-0.0079895,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.56341,-0.018215,-0.014507,0,0
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.91805,-0.018399,0.039204,0,0
3,GO RELAXATION OF CARDIAC MUSCLE,0.98106,-0.018456,0.025894,0,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.89296,-0.018485,0.00042372,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.79394,-0.018487,0.012711,0,0
3,GO POSITIVE REGULATION OF DNA REPAIR,0.80618,-0.018547,0.013881,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.99368,-0.018889,-0.0073934,0,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.50109,-0.019266,0.073282,0,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.67486,-0.019642,-0.0089609,0,0
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.33029,-0.019666,0.098901,0,0
3,GO SENSORY ORGAN DEVELOPMENT,0.90549,-0.019735,0.045297,0,0
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.67486,-0.019739,0.11051,0,0
3,GO MEIOTIC CELL CYCLE,0.40594,-0.019741,-0.043006,0,0
3,GO NADH METABOLIC PROCESS,0.86799,-0.019804,0.017692,0,0
3,GO CHROMOSOME CONDENSATION,0.60692,-0.019915,-0.011411,0,0
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.65188,-0.020295,-0.012569,0,0
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.61803,-0.020325,0.009584,0,0
3,GO RESPONSE TO PARATHYROID HORMONE,0.55277,-0.02039,0.07233,0,0
3,GO ANION TRANSPORT,0.94321,-0.020551,0.035723,0,0
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.94321,-0.020587,0.036214,0,0
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.89296,-0.020727,0.034989,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.85555,-0.02078,0.057118,0,0
3,GO SPINDLE LOCALIZATION,0.98106,-0.020849,0.033863,0,0
3,GO ADIPOSE TISSUE DEVELOPMENT,0.65188,-0.020911,0.0071489,0,0
3,GO CARBOHYDRATE PHOSPHORYLATION,0.96843,-0.020952,0.051399,0,0
3,GO HYPEROSMOTIC RESPONSE,0.70989,-0.020987,0.013211,0,0
3,GO REGULATION OF ICOSANOID SECRETION,0.86799,-0.021,0.017271,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.56341,-0.021011,0.018057,0,0
3,GO RESPONSE TO STARVATION,0.49108,-0.021269,0.013678,0,0
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.80618,-0.021394,0.026551,0,0
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.95582,-0.021454,0.039714,0,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.88046,-0.021608,0.007552,0,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.93062,-0.021789,0.028787,0,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.83078,-0.021816,0.023681,0,0
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.96843,-0.021831,0.037654,0,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.66333,-0.021916,-0.041903,0,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.49108,-0.022281,-0.042141,0,0
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.85555,-0.022435,-0.013525,0,0
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.64051,-0.022526,-0.022304,0,0
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.88046,-0.022563,0.035276,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.86799,-0.022634,0.015198,0,0
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.86799,-0.022765,-0.014929,0,0
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.3148,-0.022806,-0.07388,0,0
3,GO POSITIVE REGULATION OF GROWTH,0.7336,-0.022812,0.042367,0,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.93062,-0.022942,0.055427,0,0
3,GO MICROTUBULE BASED MOVEMENT,0.33029,-0.023147,-0.068735,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.94321,-0.023244,0.052104,0,0
3,GO POLYAMINE METABOLIC PROCESS,0.85555,-0.023371,0.03307,0,0
3,GO ORGANELLE LOCALIZATION,0.56341,-0.023596,-0.00058684,0,0
3,GO MITOCHONDRIAL FISSION,0.62923,-0.023604,0.029945,0,0
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.37964,-0.023747,0.11456,0,0
3,GO REGULATION OF ENDOCRINE PROCESS,0.62923,-0.023797,0.069776,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.74555,-0.023841,0.026557,0,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.76963,-0.023924,-0.020816,0,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.61803,-0.023967,-0.03529,0,0
3,GO SMOOTH MUSCLE CONTRACTION,0.78176,-0.02398,0.032364,0,0
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,1,-0.024007,0.039562,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.78176,-0.024032,0.0062118,0,0
3,GO MICROTUBULE BASED PROCESS,0.46168,-0.024106,-0.042289,0,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.96843,-0.024209,0.033461,0,0
3,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.75756,-0.024709,-0.0019804,0,0
3,GO CELL FATE COMMITMENT,0.7336,-0.024768,0.029212,0,0
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.91805,-0.025174,0.027747,0,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.84314,-0.025202,0.065374,0,0
3,GO PHOTOPERIODISM,0.86799,-0.025236,-0.0020422,0,0
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.69814,-0.025255,0.025121,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.64051,-0.025358,0.12922,0,0
3,GO DETECTION OF VISIBLE LIGHT,0.61803,-0.02539,-0.032865,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.88046,-0.025513,0.01318,0,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.62923,-0.02578,0.065074,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.7336,-0.025797,0.060902,0,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.34626,-0.02592,-0.040004,0,0
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.40594,-0.025951,-0.020976,0,0
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.47137,-0.026133,-0.023785,0,0
3,GO PROTEIN FOLDING,0.18624,-0.026407,-0.0082336,0,0
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.65188,-0.026626,-0.0084813,0,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.58498,-0.026717,0.080451,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.94321,-0.026911,0.038957,0,0
3,GO MRNA SPLICE SITE SELECTION,0.36271,-0.026924,-0.090899,0,0
3,GO CILIUM ORGANIZATION,0.53179,-0.027047,-0.046993,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.62923,-0.027499,0.022289,0,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.83078,-0.027599,-0.0084756,0,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.76963,-0.027642,-0.021658,0,0
3,GO PROTEIN TARGETING TO MEMBRANE,0.60692,-0.027811,-0.021763,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.68646,-0.028209,-0.0081276,0,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.48117,-0.028347,-0.027946,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.89296,-0.028366,0.033086,0,0
3,GO REGULATION OF TRANSPORT,0.72171,-0.028504,0.036692,0,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.50109,-0.028659,-0.021396,0,0
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.95582,-0.02869,0.05054,0,0
3,GO AXIS SPECIFICATION,0.93062,-0.028717,0.0077662,0,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.96843,-0.028846,0.054382,0,0
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.85555,-0.02919,0.00010791,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.83078,-0.029198,0.078423,0,0
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.86799,-0.0292,0.047599,0,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.79394,-0.029216,0.033626,0,0
3,GO MAST CELL MIGRATION,0.53179,-0.029388,-0.036603,0,0
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.90549,-0.029517,0.026691,0,0
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.85555,-0.02977,0.036436,0,0
3,GO CELL GROWTH,0.81845,-0.029858,0.039979,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.89296,-0.029914,0.046743,0,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.88046,-0.029917,0.0024758,0,0
3,GO LIPOXYGENASE PATHWAY,0.42405,-0.029951,0.10551,0,0
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,1,-0.029982,0.0054129,0,0
3,GO SEXUAL REPRODUCTION,0.68646,-0.030038,-0.0059525,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.40594,-0.030088,-0.021761,0,0
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.61803,-0.030115,0.086724,0,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.95582,-0.030216,0.029317,0,0
3,GO SINGLE FERTILIZATION,0.53179,-0.030266,-0.017074,0,0
3,GO REGULATION OF PEPTIDE SECRETION,0.94321,-0.030271,0.044104,0,0
3,GO METAL ION TRANSPORT,0.48117,-0.030418,0.0052698,0,0
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.93062,-0.030518,0.059026,0,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.85555,-0.030699,0.027257,0,0
3,GO PHAGOSOME ACIDIFICATION,1,-0.030856,0.011193,0,0
3,GO TRANSMEMBRANE TRANSPORT,0.56341,-0.030948,0.011151,0,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.76963,-0.030999,-0.002639,0,0
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.93062,-0.031005,0.037072,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.95582,-0.031169,0.053437,0,0
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.7336,-0.031311,0.012918,0,0
3,GO SPERM AXONEME ASSEMBLY,0.5959,-0.031465,-0.052239,0,0
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.34626,-0.031868,0.0037104,0,0
3,GO DNA CATABOLIC PROCESS,0.53179,-0.031942,0.0030912,0,0
3,GO RESPONSE TO ACIDIC PH,0.99368,-0.032142,0.045253,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.93062,-0.032226,0.070973,0,0
3,GO RHYTHMIC PROCESS,0.62923,-0.032251,0.019534,0,0
3,GO SPERM CAPACITATION,0.47137,-0.032318,-0.058442,0,0
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,1,-0.032321,0.001784,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.69814,-0.032462,0.10213,0,0
3,GO REGULATION OF BEHAVIOR,0.67486,-0.032531,-0.0082649,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.80618,-0.032542,-0.0039246,0,0
3,GO MICROTUBULE ANCHORING,0.93062,-0.032606,0.017122,0,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.70989,-0.032698,0.076355,0,0
3,GO RELAXATION OF MUSCLE,0.94321,-0.032956,0.010192,0,0
3,GO CARDIAC MUSCLE CONTRACTION,0.64051,-0.032957,0.0034404,0,0
3,GO ADHERENS JUNCTION ORGANIZATION,0.95582,-0.033372,0.050054,0,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.55277,-0.033531,-0.065443,0,0
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.47137,-0.03365,-0.010716,0,0
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.39705,-0.034148,-0.007152,0,0
3,GO GLIAL CELL DIFFERENTIATION,0.75756,-0.03423,0.069852,0,0
3,GO POSITIVE REGULATION OF ACROSOME REACTION,0.93062,-0.034233,-0.0082656,0,0
3,GO CHLORIDE TRANSPORT,0.40594,-0.034257,-0.021677,0,0
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.89296,-0.034786,0.024597,0,0
3,GO LOCOMOTOR RHYTHM,0.95582,-0.034822,0.043969,0,0
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.79394,-0.034914,0.031417,0,0
3,GO ADAPTATION OF SIGNALING PATHWAY,0.75756,-0.035053,-0.016295,0,0
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.76963,-0.035093,0.019198,0,0
3,GO RESPONSE TO COLD,0.46168,-0.035097,-0.0013127,0,0
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.91805,-0.035146,-0.0077453,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.44264,-0.035201,-0.0073172,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.98106,-0.035223,0.031813,0,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.60692,-0.035345,-0.015519,0,0
3,GO APOPTOTIC DNA FRAGMENTATION,0.4521,-0.035382,-0.0062621,0,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.46168,-0.035559,-0.053872,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.51122,-0.035763,8.7257e-05,0,0
3,GO CARDIAC VENTRICLE FORMATION,0.89296,-0.035822,0.083347,0,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.98106,-0.035837,0.044003,0,0
3,GO MEMBRANE FUSION,0.4521,-0.036136,0.0068927,0,0
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.89296,-0.036158,0.03223,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,1,-0.036318,0.0015568,0,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.60692,-0.036338,0.066334,0,0
3,GO SPERM MOTILITY,0.72171,-0.036417,-0.031382,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.40594,-0.036537,-0.053854,0,0
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.65188,-0.036603,0.028615,0,0
3,GO REGULATION OF LYASE ACTIVITY,0.46168,-0.036699,-0.046134,0,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.70989,-0.036713,-0.0018347,0,0
3,GO CARDIAC CELL FATE COMMITMENT,0.81845,-0.03677,-0.030769,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.47137,-0.036944,-0.064562,0,0
3,GO CELL MATURATION,0.48117,-0.037006,0.0090656,0,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.96843,-0.037068,0.030542,0,0
3,GO LIPID GLYCOSYLATION,0.83078,-0.037309,0.0059074,0,0
3,GO ALANINE TRANSPORT,0.62923,-0.03743,-0.016887,0,0
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.70989,-0.03752,0.0012819,0,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.4521,-0.037706,-0.019377,0,0
3,GO DOSAGE COMPENSATION,0.93062,-0.037725,0.019183,0,0
3,GO RESPONSE TO BMP,0.62923,-0.037897,0.090474,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.33821,-0.037918,-0.049179,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.98106,-0.03813,0.012981,0,0
3,GO ORGANELLE INHERITANCE,0.83078,-0.038314,0.033246,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.86799,-0.038327,-0.0024219,0,0
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.98106,-0.038572,0.047817,0,0
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.70989,-0.038697,-0.018105,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.70989,-0.038856,0.023897,0,0
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.95582,-0.039101,0.024393,0,0
3,GO REGULATION OF CELL SIZE,0.99368,-0.039114,0.059011,0,0
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.99368,-0.039597,0.02795,0,0
3,GO NEURON PROJECTION ARBORIZATION,0.78176,-0.039684,0.02109,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.57414,-0.039708,0.078599,0,0
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.53179,-0.039715,0.0017081,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.35442,-0.040055,-0.053305,0,0
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.4521,-0.040297,-0.0027875,0,0
3,GO ENSHEATHMENT OF NEURONS,0.67486,-0.040335,0.086126,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.72171,-0.040483,0.026104,0,0
3,GO REGULATION OF EXCRETION,0.62923,-0.040508,-0.027348,0,0
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.38829,-0.040654,-0.0079555,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.39705,-0.0407,-0.02234,0,0
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.55277,-0.040801,0.020134,0,0
3,GO ACID SECRETION,0.61803,-0.040869,-0.011431,0,0
3,GO SMOOTHENED SIGNALING PATHWAY,0.91805,-0.040918,0.027264,0,0
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.55277,-0.040976,-0.025887,0,0
3,GO REGULATION OF HEART RATE,0.50109,-0.041011,-0.019582,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.65188,-0.041057,-0.059819,0,0
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.84314,-0.041138,0.031316,0,0
3,GO NUCLEOSOME ASSEMBLY,0.54223,-0.041268,-0.035159,0,0
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.33029,-0.041351,-0.034937,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.67486,-0.041539,0.11996,0,0
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.44264,-0.041614,-0.018273,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.61803,-0.041684,-0.0060496,0,0
3,GO CARDIAC CELL DEVELOPMENT,0.7336,-0.041802,0.055774,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.74555,-0.042053,0.019131,0,0
3,GO REGULATION OF SODIUM ION TRANSPORT,0.75756,-0.042079,0.021249,0,0
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.2577,-0.042132,-0.044525,0,0
3,GO LUNG EPITHELIUM DEVELOPMENT,0.25111,-0.042184,-0.061263,0,0
3,GO SULFATE TRANSPORT,0.58498,-0.042233,-0.025635,0,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.35442,-0.042432,-0.05108,0,0
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.75756,-0.042508,-0.0088388,0,0
3,GO REGULATION OF CELL DEVELOPMENT,0.74555,-0.042565,0.026804,0,0
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.4521,-0.042647,-0.014114,0,0
3,GO ATP TRANSPORT,0.44264,-0.042839,-0.013476,0,0
3,GO PROTEIN ACYLATION,0.5959,-0.042968,-0.0094118,0,0
3,GO ZINC ION TRANSPORT,0.56341,-0.043059,0.0036652,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.47137,-0.043259,-0.020545,0,0
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.39705,-0.043297,-0.0017064,0,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.33821,-0.043326,-0.034612,0,0
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.64051,-0.043362,-0.064038,0,0
3,GO EXCRETION,0.75756,-0.043423,0.000364,0,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.91805,-0.04389,0.10532,0,0
3,GO PLASMA MEMBRANE ORGANIZATION,0.55277,-0.044076,0.01909,0,0
3,GO CHROMATIN SILENCING AT TELOMERE,0.33029,-0.044309,-0.064622,0,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.79394,-0.044404,0.024466,0,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.69814,-0.044584,-0.0022158,0,0
3,GO MICROTUBULE BASED TRANSPORT,0.46168,-0.044889,-0.043391,0,0
3,GO EMBRYONIC AXIS SPECIFICATION,0.48117,-0.045212,-0.039329,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.76963,-0.045277,0.049731,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.50109,-0.045298,-0.061554,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.95582,-0.045316,0.022285,0,0
3,GO HISTONE EXCHANGE,0.46168,-0.0454,-0.041755,0,0
3,GO FORELIMB MORPHOGENESIS,0.81845,-0.045693,0.0029921,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.90549,-0.045722,0.046446,0,0
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.93062,-0.045774,0.018095,0,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.88046,-0.045812,0.037547,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.91805,-0.046076,0.062269,0,0
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.47137,-0.046226,-0.024338,0,0
3,GO CARDIAC CHAMBER FORMATION,0.95582,-0.046392,0.09977,0,0
3,GO DIOL BIOSYNTHETIC PROCESS,0.42405,-0.046532,-0.031315,0,0
3,GO PIRNA METABOLIC PROCESS,0.83078,-0.046611,-0.027369,0,0
3,GO MYOTUBE CELL DEVELOPMENT,0.62923,-0.046666,-0.024624,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.60692,-0.046839,0.017557,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.61803,-0.047092,-0.043873,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.21989,-0.04764,-0.083942,0,0
3,GO ION TRANSPORT,0.4521,-0.047766,0.0050124,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.55277,-0.047959,-0.014279,0,0
3,GO SPHINGOMYELIN METABOLIC PROCESS,0.30724,-0.048215,-0.051428,0,0
3,GO RESPONSE TO MISFOLDED PROTEIN,0.25111,-0.048361,-0.012,0,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.38829,-0.048449,-0.057878,0,0
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.68646,-0.048474,0.017634,0,0
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.27821,-0.048515,-0.030236,0,0
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.79394,-0.048771,0.01727,0,0
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.99368,-0.048807,0.0403,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.99368,-0.048899,0.071812,0,0
3,GO THYROID GLAND DEVELOPMENT,0.5959,-0.049006,0.0076838,0,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.78176,-0.049065,0.033969,0,0
3,GO REGULATION OF TUBE SIZE,0.91805,-0.049334,0.027163,0,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.37111,-0.049357,-0.046065,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.34626,-0.049555,-0.0016349,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.84314,-0.049605,0.047984,0,0
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.4521,-0.050373,-0.055882,0,0
3,GO WALKING BEHAVIOR,0.42405,-0.050415,-0.04085,0,0
3,GO SEROTONIN TRANSPORT,0.34626,-0.050453,-0.073955,0,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.34626,-0.050575,-0.038265,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,1,-0.050772,0.05175,0,0
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.84314,-0.050851,-0.00015356,0,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.49108,-0.050906,-0.092671,0,0
3,GO KERATINOCYTE DEVELOPMENT,0.98106,-0.051119,0.026174,0,0
3,GO MUSCLE CONTRACTION,0.54223,-0.051223,0.003983,0,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.4521,-0.05147,-0.085292,0,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.98106,-0.051491,-0.04133,0,0
3,GO MUSCLE FILAMENT SLIDING,0.95582,-0.051833,0.019254,0,0
3,GO FAT CELL PROLIFERATION,0.28529,-0.052172,-0.061968,0,0
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.47137,-0.052554,-0.023533,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.64051,-0.052944,-0.019672,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.53179,-0.052969,0.0099068,0,0
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.18102,-0.053103,-0.058106,0,0
3,GO CELL MORPHOGENESIS,0.67486,-0.053157,0.028468,0,0
3,GO SODIUM ION HOMEOSTASIS,0.41494,-0.053177,-0.035635,0,0
3,GO HEART TRABECULA FORMATION,0.86799,-0.05332,0.01386,0,0
3,GO RENAL SODIUM EXCRETION,0.57414,-0.053337,-0.040054,0,0
3,GO SODIUM ION TRANSPORT,0.20256,-0.053404,-0.047838,0,0
3,GO INSEMINATION,0.41494,-0.053615,-0.086524,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.61803,-0.053692,-0.003282,0,0
3,GO TRANSFERRIN TRANSPORT,0.39705,-0.05385,-0.018448,0,0
3,GO REGULATION OF VASCULAR PERMEABILITY,0.79394,-0.053967,0.044876,0,0
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.28529,-0.05397,-0.087198,0,0
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.60692,-0.054188,-0.022933,0,0
3,GO HISTAMINE TRANSPORT,0.56341,-0.054253,-0.050727,0,0
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.42405,-0.054588,-0.045405,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.79394,-0.05465,-0.0096206,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.88046,-0.054956,0.059473,0,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.72171,-0.05506,-0.00074842,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.68646,-0.055163,-0.0054432,0,0
3,GO RESPONSE TO L GLUTAMATE,0.93062,-0.055186,0.0042625,0,0
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.5959,-0.05534,-0.0077427,0,0
3,GO EPITHELIAL CELL MORPHOGENESIS,0.43329,-0.05542,-0.013671,0,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.53179,-0.055491,0.006281,0,0
3,GO INTRACILIARY TRANSPORT,0.40594,-0.0555,-0.10315,0,0
3,GO CATION TRANSPORT,0.27821,-0.055928,-0.012928,0,0
3,GO HINDBRAIN MORPHOGENESIS,0.81845,-0.056059,0.021572,0,0
3,GO REGULATION OF ION TRANSPORT,0.36271,-0.056203,-0.010798,0,0
3,GO RESPIRATORY SYSTEM PROCESS,0.88046,-0.056259,0.062632,0,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.94321,-0.05636,0.073775,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.94321,-0.056505,0.038023,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.65188,-0.056605,0.011493,0,0
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.95582,-0.056733,0.023056,0,0
3,GO IRON COORDINATION ENTITY TRANSPORT,0.85555,-0.057294,-0.020627,0,0
3,GO REGULATION OF CYCLASE ACTIVITY,0.34626,-0.057296,-0.051575,0,0
3,GO VASODILATION,0.58498,-0.057369,-0.026419,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.077559,-0.05761,-0.045246,0,0
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.78176,-0.057861,0.061038,0,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.52145,-0.058229,-0.058052,0,0
3,GO LIPID TRANSLOCATION,0.68646,-0.05856,0.020847,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.26442,-0.05862,-0.049384,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.39705,-0.058957,-0.036941,0,0
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.67486,-0.058981,-0.0037915,0,0
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.080256,-0.059076,-0.057346,0,0
3,GO MYELIN ASSEMBLY,0.16123,-0.059162,-0.066234,0,0
3,GO ORGANIC ACID TRANSPORT,0.44264,-0.059476,0.001657,0,0
3,GO CELLULAR RESPONSE TO ALKALOID,0.30724,-0.059573,-0.029594,0,0
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.16123,-0.059745,-0.013656,0,0
3,GO OXIDATIVE PHOSPHORYLATION,0.15197,-0.059762,-0.044699,0,0
3,GO DIOL METABOLIC PROCESS,0.21989,-0.059767,-0.075425,0,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.47137,-0.060004,0.0047086,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.52145,-0.060084,0.016105,0,0
3,GO RESPONSE TO METAL ION,0.51122,-0.0602,0.017824,0,0
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.51122,-0.060519,-0.037872,0,0
3,GO RESPONSE TO LEAD ION,0.91805,-0.060572,0.03031,0,0
3,GO METHIONINE METABOLIC PROCESS,0.94321,-0.060763,0.0038612,0,0
3,GO SCHWANN CELL DIFFERENTIATION,0.91805,-0.061122,0.083103,0,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.51122,-0.061124,-0.03499,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.47137,-0.061353,-0.0391,0,0
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.28529,-0.061617,-0.015136,0,0
3,GO PURINE NUCLEOTIDE TRANSPORT,0.23203,-0.061642,-0.02836,0,0
3,GO NEURON PROJECTION ORGANIZATION,0.61803,-0.061665,-0.0063511,0,0
3,GO RESPONSE TO PH,0.94321,-0.061721,0.048752,0,0
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.1475,-0.061828,-0.076833,0,0
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.10811,-0.062161,-0.089934,0,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.2259,-0.062211,-0.1195,0,0
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.51122,-0.062305,0.015375,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.56341,-0.062616,-0.0036353,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.61803,-0.062942,-0.035995,0,0
3,GO STEROID HORMONE SECRETION,0.58498,-0.063122,-0.019467,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.65188,-0.063148,-0.024708,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.48117,-0.06317,-0.091162,0,0
3,GO RESPONSE TO AMINO ACID STARVATION,0.24463,-0.063294,-0.027934,0,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.85555,-0.063381,-0.022215,0,0
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.17091,-0.063482,-0.055548,0,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.56341,-0.063565,0.008408,0,0
3,GO ION TRANSMEMBRANE TRANSPORT,0.2259,-0.063616,-0.02222,0,0
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.42405,-0.063881,-0.046869,0,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.55277,-0.063921,0.0031986,0,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.5959,-0.063966,-0.035741,0,0
3,GO NEUROBLAST PROLIFERATION,0.43329,-0.064086,-0.049741,0,0
3,GO PENILE ERECTION,0.74555,-0.064154,-0.064851,0,0
3,GO CRISTAE FORMATION,0.49108,-0.064386,-0.0025007,0,0
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.85555,-0.064846,0.008678,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.42405,-0.064929,-0.07007,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.12662,-0.064969,-0.074074,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.72171,-0.065013,0.014199,0,0
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.48117,-0.065014,-0.036923,0,0
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.20256,-0.06502,-0.11883,0,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.95582,-0.065064,0.056284,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.96843,-0.065326,0.014329,0,0
3,GO CLATHRIN COAT ASSEMBLY,0.17591,-0.065431,-0.040754,0,0
3,GO NEURON PROJECTION REGENERATION,0.93062,-0.065575,0.033732,0,0
3,GO REGULATION OF HORMONE LEVELS,0.16602,-0.065882,-0.03605,0,0
3,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.7336,-0.065956,-0.013327,0,0
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.33821,-0.066158,-0.047706,0,0
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.32248,-0.066249,-0.056519,0,0
3,GO CELL JUNCTION ASSEMBLY,0.69814,-0.066403,0.022256,0,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.64051,-0.066419,-0.010396,0,0
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.99368,-0.066446,0.042411,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.30724,-0.066717,-0.011303,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.47137,-0.06681,-0.03361,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.39705,-0.067172,-0.030935,0,0
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.20256,-0.067207,-0.092732,0,0
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.2998,-0.067391,-0.010835,0,0
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.39705,-0.067497,-0.054232,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.74555,-0.067512,0.033938,0,0
3,GO REGULATION OF BLOOD CIRCULATION,0.24463,-0.067628,-0.03065,0,0
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.056456,-0.06772,-0.093057,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.48117,-0.068127,-0.0073822,0,0
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.79394,-0.068483,0.074059,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.51122,-0.068631,0.0060402,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.4521,-0.068866,-0.020806,0,0
3,GO NEURON PROJECTION GUIDANCE,0.53179,-0.069028,1.7205e-05,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.50109,-0.069028,-0.005525,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.32248,-0.069225,-0.030042,0,0
3,GO AXON EXTENSION,0.64051,-0.069461,0.010971,0,0
3,GO SEX DETERMINATION,0.61803,-0.06981,-0.043826,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.65188,-0.069816,0.029609,0,0
3,GO POTASSIUM ION HOMEOSTASIS,0.53179,-0.070067,-0.027494,0,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.3148,-0.070238,-0.1115,0,0
3,GO HEART PROCESS,0.30724,-0.070402,-0.026537,0,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.12273,-0.070971,-0.081002,0,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.62923,-0.071204,0.015921,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.68646,-0.071315,-0.0076461,0,0
3,GO CATION TRANSMEMBRANE TRANSPORT,0.214,-0.071745,-0.028703,0,0
3,GO REGULATION OF ACTION POTENTIAL,0.24463,-0.071863,-0.063034,0,0
3,GO MITOCHONDRIAL TRANSCRIPTION,0.62923,-0.072055,-0.0030951,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.20822,-0.072059,-0.10369,0,0
3,GO CELL PROJECTION ORGANIZATION,0.57414,-0.072099,-0.0026383,0,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.11163,-0.072129,-0.066647,0,0
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.47137,-0.072153,-0.0422,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.70989,-0.072228,0.013272,0,0
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.44264,-0.072333,-0.013744,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.4521,-0.072614,-0.0046152,0,0
3,GO BASIC AMINO ACID TRANSPORT,0.44264,-0.07276,-0.036388,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.47137,-0.073012,-0.045584,0,0
3,GO STRIATED MUSCLE CONTRACTION,0.37111,-0.073162,-0.019588,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.32248,-0.073191,-0.01989,0,0
3,GO VISUAL BEHAVIOR,0.13885,-0.073491,-0.075732,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.197,-0.073548,-0.099692,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.85555,-0.073728,0.059476,0,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.42405,-0.073915,-0.0078433,0,0
3,GO CIRCADIAN RHYTHM,0.23203,-0.073938,-0.018883,0,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.20256,-0.074022,-0.071709,0,0
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.50109,-0.074418,-0.010287,0,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.33029,-0.074904,-0.054042,0,0
3,GO PROTEIN DENEDDYLATION,0.53179,-0.074911,-0.017576,0,0
3,GO REGULATION OF CELL PROJECTION SIZE,0.39705,-0.075037,-0.15657,0,0
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.66333,-0.075067,0.0040916,0,0
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.42405,-0.075234,-0.053984,0,0
3,GO HIPPOCAMPUS DEVELOPMENT,0.69814,-0.075445,0.005062,0,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.81845,-0.075456,0.015436,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.29248,-0.075841,-0.023719,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.78176,-0.075861,0.0076754,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.10811,-0.075958,-0.081831,0,0
3,GO COENZYME A METABOLIC PROCESS,0.214,-0.076016,-0.037112,0,0
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.84314,-0.07617,0.024216,0,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.15655,-0.076248,-0.10947,0,0
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.4521,-0.076257,-0.075328,0,0
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.41494,-0.076375,-0.0052856,0,0
3,GO RETROGRADE AXONAL TRANSPORT,0.37111,-0.076492,-0.088869,0,0
3,GO CELL JUNCTION ORGANIZATION,0.50109,-0.076493,-0.0038694,0,0
3,GO MALE SEX DETERMINATION,0.4521,-0.076569,-0.083767,0,0
3,GO POSITIVE REGULATION OF SECRETION,0.62923,-0.076805,0.0089351,0,0
3,GO PEPTIDE SECRETION,0.67486,-0.076897,0.015569,0,0
3,GO RESPONSE TO CARBOHYDRATE,0.28529,-0.077043,-0.0090124,0,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.70989,-0.077717,-0.014231,0,0
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.40594,-0.077994,-0.022345,0,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.93062,-0.078134,0.027617,0,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.78176,-0.078239,0.0013323,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.61803,-0.078588,0.015901,0,0
3,GO L AMINO ACID TRANSPORT,0.34626,-0.078612,-0.029316,0,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.53179,-0.078645,-0.0037211,0,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.61803,-0.078932,0.027569,0,0
3,GO FUCOSYLATION,0.39705,-0.078971,-0.039018,0,0
3,GO TELENCEPHALON DEVELOPMENT,0.38829,-0.079024,-0.031452,0,0
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.35442,-0.079119,-0.027545,0,0
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.17091,-0.079235,-0.033823,0,0
3,GO CARBOHYDRATE HOMEOSTASIS,0.16123,-0.079404,-0.023609,0,0
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.23827,-0.079765,-0.028994,0,0
3,GO NUCLEAR BODY ORGANIZATION,0.33029,-0.079784,-0.04927,0,0
3,GO NUCLEOTIDE TRANSPORT,0.40594,-0.08042,-0.0067364,0,0
3,GO RESPONSE TO CAFFEINE,0.37111,-0.081276,-0.042905,0,0
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.4521,-0.081393,-0.031963,0,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.3148,-0.0814,-0.058223,0,0
3,GO NERVOUS SYSTEM PROCESS,0.214,-0.08145,-0.030665,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.12273,-0.081665,-0.043562,0,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.68646,-0.081736,-0.033857,0,0
3,GO AXON DEVELOPMENT,0.47137,-0.081811,-0.016639,0,0
3,GO ACTIN FILAMENT NETWORK FORMATION,0.214,-0.081883,-0.098366,0,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.41494,-0.081949,-0.03311,0,0
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.28529,-0.082008,-0.08874,0,0
3,GO RESPONSE TO AXON INJURY,0.5959,-0.082325,0.0063281,0,0
3,GO MITOCHONDRIAL FUSION,0.197,-0.082601,-0.021766,0,0
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.33821,-0.082886,-0.03236,0,0
3,GO CELL CELL SIGNALING,0.20822,-0.08364,-0.020568,0,0
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.55277,-0.083678,0.0015641,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.80618,-0.083885,0.014546,0,0
3,GO KINETOCHORE ORGANIZATION,0.43329,-0.084077,-0.074102,0,0
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.069906,-0.084151,-0.078138,0,0
3,GO RESPONSE TO ALKALOID,0.08303,-0.084408,-0.05741,0,0
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.24463,-0.085133,-0.06674,0,0
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.18102,-0.085323,-0.047696,0,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.32248,-0.085403,-0.058243,0,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.33821,-0.085436,-0.051898,0,0
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.72171,-0.085498,-0.0015536,0,0
3,GO NEUROGENESIS,0.33821,-0.085652,-0.01352,0,0
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.40594,-0.085953,-0.02524,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.43329,-0.086014,-0.062072,0,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.70989,-0.086129,0.017045,0,0
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.045233,-0.086243,-0.082646,0,0
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.08881,-0.086925,-0.085929,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.10134,-0.087138,-0.041312,0,0
3,GO ALDEHYDE CATABOLIC PROCESS,0.065157,-0.087439,-0.099184,0,0
3,GO ENERGY HOMEOSTASIS,0.20822,-0.088014,-0.057981,0,0
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.39705,-0.08823,-0.0025656,0,0
3,GO SCHWANN CELL DEVELOPMENT,0.72171,-0.088373,0.019398,0,0
3,GO TRANSPORT ALONG MICROTUBULE,0.3148,-0.088393,-0.060916,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.35442,-0.088473,-0.078211,0,0
3,GO IMPORT INTO CELL,0.2577,-0.088508,-0.030882,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.51122,-0.088562,-0.01114,0,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.10811,-0.088809,-0.12887,0,0
3,GO MICROTUBULE BUNDLE FORMATION,0.094909,-0.089001,-0.16114,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.53179,-0.089073,0.0010802,0,0
3,GO CRANIAL NERVE DEVELOPMENT,0.57414,-0.089371,-0.032362,0,0
3,GO ORGANELLE MEMBRANE FUSION,0.065157,-0.089395,-0.048356,0,0
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.17591,-0.089453,-0.10969,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.32248,-0.089476,-0.049298,0,0
3,GO REGULATION OF AXONOGENESIS,0.58498,-0.089779,-0.01568,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.67486,-0.089794,0.014554,0,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.81845,-0.089827,0.03454,0,0
3,GO SKELETAL MUSCLE CONTRACTION,0.33821,-0.090152,-0.029522,0,0
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.11524,-0.090212,-0.09583,0,0
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.08881,-0.090215,-0.051384,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.34626,-0.090227,-0.018135,0,0
3,GO INOSITOL METABOLIC PROCESS,0.16602,-0.090572,-0.10543,0,0
3,GO HEART FORMATION,0.57414,-0.090649,-0.005415,0,0
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.1475,-0.090722,-0.080682,0,0
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.66333,-0.091156,0.017619,0,0
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.197,-0.091426,-0.065839,0,0
3,GO MEMBRANE REPOLARIZATION,0.28529,-0.091469,-0.03292,0,0
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.34626,-0.092209,-0.060059,0,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.12662,-0.092778,-0.068807,0,0
3,GO DEVELOPMENTAL INDUCTION,0.53179,-0.09312,-0.030852,0,0
3,GO COCHLEA DEVELOPMENT,0.41494,-0.094519,-0.042528,0,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.5959,-0.095065,0.0018304,0,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.65188,-0.095192,-0.047736,0,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.60692,-0.095264,-0.0053402,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.19156,-0.095775,-0.082705,0,0
3,GO DETECTION OF MECHANICAL STIMULUS,0.25111,-0.09603,-0.038171,0,0
3,GO POSTSYNAPSE ORGANIZATION,0.21989,-0.096061,-0.061463,0,0
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.27126,-0.096219,-0.027626,0,0
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.29248,-0.096522,-0.02809,0,0
3,GO REGULATION OF CIRCADIAN RHYTHM,0.15197,-0.096719,-0.05108,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.49108,-0.096857,-0.018656,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.25111,-0.097066,-0.11246,0,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.25111,-0.097356,-0.036419,0,0
3,GO INNER DYNEIN ARM ASSEMBLY,0.36271,-0.097474,-0.17922,0,0
3,GO CARTILAGE MORPHOGENESIS,0.72171,-0.097814,0.077448,0,0
3,GO RESPONSE TO CALCIUM ION,0.51122,-0.098037,-0.0005401,0,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.18624,-0.098082,-0.051003,0,0
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.5959,-0.098131,-0.013217,0,0
3,GO REGULATION OF ANION TRANSPORT,0.39705,-0.098578,-0.020557,0,0
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.197,-0.098717,-0.052324,0,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.27126,-0.099056,-0.042262,0,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.20822,-0.09906,-0.079413,0,0
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.44264,-0.099075,-0.0087053,0,0
3,GO CORTICOSTEROID HORMONE SECRETION,0.094909,-0.099299,-0.15836,0,0
3,GO DETECTION OF ABIOTIC STIMULUS,0.069906,-0.099955,-0.069329,0,0
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.48117,-0.099976,-0.040391,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.44264,-0.1002,-0.033257,0,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.29248,-0.10033,-0.067385,0,0
3,GO MEMBRANE DOCKING,0.15655,-0.10043,-0.072058,0,0
3,GO COGNITION,0.20256,-0.10048,-0.059014,0,0
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.15655,-0.10061,-0.1153,0,0
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.20256,-0.10072,-0.059852,0,0
3,GO RESPONSE TO MONOSACCHARIDE,0.14312,-0.10104,-0.031305,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.49108,-0.10156,-0.019352,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.13467,-0.10212,-0.087027,0,0
3,GO LUNG CELL DIFFERENTIATION,0.15197,-0.10224,-0.14673,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.077559,-0.10261,-0.055231,0,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.32248,-0.10302,-0.064648,0,0
3,GO DIVALENT METAL ION EXPORT,0.23203,-0.10307,-0.09917,0,0
3,GO DEVELOPMENTAL CELL GROWTH,0.32248,-0.10315,-0.038565,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.33029,-0.10365,-0.039244,0,0
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.3148,-0.10418,-0.040279,0,0
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.11163,-0.10425,-0.044847,0,0
3,GO SENSORY PERCEPTION OF PAIN,0.1306,-0.10432,-0.05895,0,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.65188,-0.10447,0.0035877,0,0
3,GO REGULATION OF SYSTEM PROCESS,0.197,-0.10458,-0.032725,0,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.4521,-0.10466,-0.039844,0,0
3,GO SECONDARY PALATE DEVELOPMENT,0.7336,-0.10469,0.0020395,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.1306,-0.10486,-0.09587,0,0
3,GO CAMP METABOLIC PROCESS,0.54223,-0.10496,0.0073152,0,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.57414,-0.10496,0.04896,0,0
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.26442,-0.10511,-0.055915,0,0
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.19156,-0.10513,-0.059638,0,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.2998,-0.10531,-0.072304,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.11894,-0.10548,-0.06548,0,0
3,GO NEURON DIFFERENTIATION,0.29248,-0.10573,-0.035211,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.13467,-0.10623,-0.075441,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.29248,-0.10626,-0.023709,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.08303,-0.1065,-0.074624,0,0
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.17091,-0.10664,-0.06507,0,0
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.11163,-0.10693,-0.091074,0,0
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.214,-0.10717,-0.093646,0,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.39705,-0.1074,-0.046579,0,0
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.42405,-0.10754,-0.058246,0,0
3,GO REGULATION OF SECRETION,0.36271,-0.10757,-0.0092674,0,0
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.19156,-0.10795,-0.065293,0,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.47137,-0.10804,-0.0024922,0,0
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.094909,-0.10812,-0.071478,0,0
3,GO MUSCLE FIBER DEVELOPMENT,0.18624,-0.10876,-0.065841,0,0
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.12662,-0.10891,-0.085611,0,0
3,GO RESPONSE TO DIETARY EXCESS,0.072385,-0.10916,-0.10952,0,0
3,GO REGULATION OF NEURON DIFFERENTIATION,0.2998,-0.11015,-0.033509,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.19156,-0.1107,-0.075072,0,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.32248,-0.11089,-0.072233,0,0
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.20256,-0.1109,-0.12838,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.3148,-0.11109,-0.048452,0,0
3,GO DENDRITE DEVELOPMENT,0.20822,-0.11137,-0.06416,0,0
3,GO INCLUSION BODY ASSEMBLY,0.13467,-0.11166,-0.056188,0,0
3,GO MICROTUBULE POLYMERIZATION,0.072385,-0.11174,-0.12398,0,0
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.25111,-0.112,-0.039969,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.2259,-0.11229,-0.10539,0,0
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.67486,-0.1125,0.032429,0,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.37111,-0.11299,-0.048019,0,0
3,GO HEAD DEVELOPMENT,0.23203,-0.11299,-0.043753,0,0
3,GO EXPLORATION BEHAVIOR,0.48117,-0.1133,-0.051846,0,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.1475,-0.11494,-0.076092,0,0
3,GO RECEPTOR CLUSTERING,0.36271,-0.11499,-0.046279,0,0
3,GO CELL PART MORPHOGENESIS,0.23827,-0.11509,-0.047962,0,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.27821,-0.11529,-0.038964,0,0
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.61803,-0.11571,-0.038904,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.15655,-0.1165,-0.073291,0,0
3,GO BRANCHING MORPHOGENESIS OF A NERVE,0.53179,-0.1167,-0.029041,0,0
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.214,-0.11757,-0.069567,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.17091,-0.1176,-0.060062,0,0
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.91805,-0.11786,0.035582,0,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.11894,-0.11823,-0.083796,0,0
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.32248,-0.11827,-0.079777,0,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.17591,-0.11872,-0.043148,0,0
3,GO DORSAL VENTRAL PATTERN FORMATION,0.056456,-0.11904,-0.14998,0,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.072385,-0.11963,-0.08284,0,0
3,GO REGULATION OF OOGENESIS,0.08303,-0.11968,-0.10411,0,0
3,GO NEURON DEVELOPMENT,0.197,-0.12029,-0.048143,0,0
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.074935,-0.12031,-0.10999,0,0
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.18624,-0.1212,-0.13959,0,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.33029,-0.12147,-0.039924,0,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.20256,-0.12157,-0.051996,0,0
3,GO MEMBRANE FISSION,0.13885,-0.1219,-0.064805,0,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.11163,-0.12191,-0.1205,0,0
3,GO ORGANIC CATION TRANSPORT,0.13467,-0.12212,-0.087189,0,0
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.4521,-0.12212,-0.051633,0,0
3,GO SIALYLATION,0.78176,-0.12227,0.094328,0,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.08588,-0.12236,-0.080066,0,0
3,GO STRIATUM DEVELOPMENT,0.50109,-0.12269,-0.023577,0,0
3,GO FOREBRAIN CELL MIGRATION,0.2998,-0.12271,-0.066178,0,0
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.13885,-0.12296,-0.076322,0,0
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.1306,-0.12321,-0.090189,0,0
3,GO REGULATION OF DENDRITE MORPHOGENESIS,0.17591,-0.12351,-0.085674,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.2259,-0.12358,-0.12584,0,0
3,GO CELL FATE SPECIFICATION,0.098083,-0.12386,-0.11453,0,0
3,GO LIMBIC SYSTEM DEVELOPMENT,0.39705,-0.12431,-0.022422,0,0
3,GO NEURON PROJECTION EXTENSION,0.26442,-0.12452,-0.054033,0,0
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.13885,-0.12483,-0.11132,0,0
3,GO METENCEPHALON DEVELOPMENT,0.08881,-0.12493,-0.11315,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.30724,-0.12499,-0.11311,0,0
3,GO SKELETAL MUSCLE ADAPTATION,0.49108,-0.125,-0.028886,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.32248,-0.12506,-0.052702,0,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.12662,-0.1251,-0.1295,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.33029,-0.12526,-0.074648,0,0
3,GO COPULATION,0.49108,-0.12545,-0.0689,0,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.10468,-0.12576,-0.22499,0,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.37111,-0.12605,-0.081675,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.08588,-0.12617,-0.09264,0,0
3,GO RESPONSE TO PAIN,0.2998,-0.1265,-0.079919,0,0
3,GO PALLIUM DEVELOPMENT,0.25111,-0.12716,-0.053682,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.12273,-0.12725,-0.1008,0,0
3,GO RHYTHMIC BEHAVIOR,0.39705,-0.12773,-0.022871,0,0
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.28529,-0.12787,-0.08629,0,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.14312,-0.12809,-0.19121,0,0
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.12273,-0.12837,-0.1414,0,0
3,GO DEVELOPMENTAL MATURATION,0.10468,-0.12884,-0.063466,0,0
3,GO SECRETORY GRANULE ORGANIZATION,0.13467,-0.12886,-0.1019,0,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.20822,-0.12914,-0.065065,0,0
3,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.30724,-0.12998,-0.090518,0,0
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.072385,-0.13003,-0.14982,0,0
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.091819,-0.1305,-0.07696,0,0
3,GO RESPONSE TO GLUCAGON,0.067497,-0.13098,-0.10607,0,0
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.39705,-0.13109,-0.019765,0,0
3,GO POLYOL CATABOLIC PROCESS,0.15197,-0.13115,-0.086559,0,0
3,GO DENDRITE MORPHOGENESIS,0.17591,-0.13115,-0.094809,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.88046,-0.13117,0.14513,0,0
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.27821,-0.13136,-0.062438,0,0
3,GO ACROSOME REACTION,0.062884,-0.13226,-0.10888,0,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.25111,-0.13257,-0.072554,0,0
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.08588,-0.13273,-0.1359,0,0
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.12273,-0.13343,-0.086618,0,0
3,GO FOREBRAIN DEVELOPMENT,0.17591,-0.13363,-0.065667,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.53179,-0.13386,-0.017184,0,0
3,GO AXONAL TRANSPORT,0.077559,-0.13388,-0.12159,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.57414,-0.1344,-0.039309,0,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.214,-0.1345,-0.12377,0,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.34626,-0.13457,-0.077658,0,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.12273,-0.13463,-0.11112,0,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.056456,-0.13488,-0.11593,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.17091,-0.1352,-0.12175,0,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.08881,-0.1365,-0.087216,0,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.197,-0.13705,-0.1189,0,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.20256,-0.13721,-0.13519,0,0
3,GO LEARNING,0.060677,-0.13796,-0.12963,0,0
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.067497,-0.13798,-0.09517,0,0
3,GO EPITHELIAL CELL MATURATION,0.062884,-0.13808,-0.19272,0,0
3,GO MALE MEIOSIS I,0.023112,-0.1381,-0.16077,0,0
3,GO EPITHELIAL CELL FATE COMMITMENT,0.38829,-0.13941,-0.03206,0,0
3,GO HINDBRAIN DEVELOPMENT,0.17091,-0.14046,-0.07288,0,0
3,GO SPINAL CORD DEVELOPMENT,0.27821,-0.14072,-0.08159,0,0
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.16602,-0.14107,-0.109,0,0
3,GO ACROSOME ASSEMBLY,0.23203,-0.14152,-0.13114,0,0
3,GO MATING,0.094909,-0.14221,-0.10603,0,0
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.074935,-0.14225,-0.086672,0,0
3,GO PANCREAS DEVELOPMENT,0.08303,-0.14269,-0.096212,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.36271,-0.14291,-0.044412,0,0
3,GO MITOCHONDRION LOCALIZATION,0.056456,-0.14471,-0.11515,0,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.2259,-0.14528,-0.040442,0,0
3,GO SYNAPTIC TRANSMISSION GABAERGIC,0.074935,-0.14593,-0.1287,0,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.080256,-0.14598,-0.15683,0,0
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.23203,-0.14649,-0.070832,0,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.30724,-0.14649,-0.085054,0,0
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.28529,-0.14736,-0.052727,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.072385,-0.14763,-0.15062,0,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.23827,-0.14808,-0.051975,0,0
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.10134,-0.14816,-0.12075,0,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.16602,-0.14825,-0.11823,0,0
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.18624,-0.14883,-0.062308,0,0
3,GO BEHAVIOR,0.08303,-0.14946,-0.09477,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.17091,-0.14965,-0.095546,0,0
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.058535,-0.1503,-0.10831,0,0
3,GO AXONEME ASSEMBLY,0.080256,-0.15051,-0.20391,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.098083,-0.15088,-0.086741,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.08303,-0.15147,-0.12748,0,0
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.11163,-0.15183,-0.099101,0,0
3,GO REGULATION OF COLLATERAL SPROUTING,0.46168,-0.15198,-0.072467,0,0
3,GO RESPONSE TO MAGNESIUM ION,0.214,-0.15222,-0.095607,0,0
3,GO MEMORY,0.065157,-0.15268,-0.10529,0,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.11894,-0.15297,-0.14503,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.11163,-0.15318,-0.10826,0,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.15197,-0.15328,-0.11013,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.11524,-0.15357,-0.21978,0,0
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.065157,-0.15391,-0.068038,0,0
3,GO PROTEIN KINASE C SIGNALING,0.10134,-0.15403,-0.083341,0,0
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.20822,-0.15406,-0.089323,0,0
3,GO AXO DENDRITIC TRANSPORT,0.08303,-0.15408,-0.12282,0,0
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.13467,-0.15414,-0.094038,0,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.11163,-0.15427,-0.067697,0,0
3,GO RESPONSE TO LITHIUM ION,0.197,-0.15458,-0.070451,0,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.2259,-0.15486,-0.12941,0,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.067497,-0.15525,-0.16741,0,0
3,GO LONG TERM MEMORY,0.11524,-0.15569,-0.11914,0,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.29248,-0.15605,-0.097294,0,0
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.18624,-0.15651,-0.10553,0,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.55277,-0.15672,-0.027237,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.16123,-0.15728,-0.10526,0,0
3,GO ANATOMICAL STRUCTURE REGRESSION,0.17091,-0.15797,-0.1222,0,0
3,GO EXCITATORY SYNAPSE ASSEMBLY,0.15197,-0.15868,-0.1016,0,0
3,GO REGULATION OF CARDIAC CONDUCTION,0.056456,-0.15895,-0.098855,0,0
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.065157,-0.15934,-0.13822,0,0
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.08881,-0.15934,-0.086609,0,0
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.10468,-0.16029,-0.13599,0,0
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.214,-0.16081,-0.089091,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.13467,-0.1609,-0.099356,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.069906,-0.16102,-0.14211,0,0
3,GO GLYCINE TRANSPORT,0.24463,-0.16108,-0.13292,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.15655,-0.1611,-0.11359,0,0
3,GO MEMBRANE BIOGENESIS,0.18102,-0.16267,-0.060478,0,0
3,GO SYNAPSE ORGANIZATION,0.08588,-0.16288,-0.10717,0,0
3,GO NEUROTRANSMITTER REUPTAKE,0.10468,-0.16424,-0.13346,0,0
3,GO TOXIN METABOLIC PROCESS,0.18624,-0.16468,-0.089659,0,0
3,GO RESPONSE TO AMPHETAMINE,0.065157,-0.16504,-0.12479,0,0
3,GO LUTEINIZATION,0.37964,-0.16512,-0.062767,0,0
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.24463,-0.16526,-0.10187,0,0
3,GO NERVE DEVELOPMENT,0.12273,-0.16557,-0.12457,0,0
3,GO NEURAL RETINA DEVELOPMENT,0.08303,-0.16561,-0.14341,0,0
3,GO RESPONSE TO IMMOBILIZATION STRESS,0.077559,-0.16617,-0.11673,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.34626,-0.16645,-0.092538,0,0
3,GO MEMBRANE HYPERPOLARIZATION,0.26442,-0.16669,-0.093627,0,0
3,GO NEURON MIGRATION,0.12662,-0.16685,-0.11515,0,0
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.098083,-0.16695,-0.11097,0,0
3,GO SHORT TERM MEMORY,0.12273,-0.16701,-0.1377,0,0
3,GO CELL JUNCTION MAINTENANCE,0.077559,-0.16752,-0.14368,0,0
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.30724,-0.16834,-0.087931,0,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.069906,-0.16855,-0.19493,0,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.08881,-0.16955,-0.10942,0,0
3,GO CEREBELLAR CORTEX FORMATION,0.077559,-0.17081,-0.14139,0,0
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.060677,-0.1717,-0.13416,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.1475,-0.17172,-0.069711,0,0
3,GO CGMP MEDIATED SIGNALING,0.20822,-0.17228,-0.091356,0,0
3,GO RETINA LAYER FORMATION,0.1306,-0.17314,-0.17702,0,0
3,GO OUTER DYNEIN ARM ASSEMBLY,0.098083,-0.17326,-0.25996,0,0
3,GO TELENCEPHALON GLIAL CELL MIGRATION,0.28529,-0.17391,-0.076318,0,0
3,GO MYELIN MAINTENANCE,0.2998,-0.17464,-0.059251,0,0
3,GO COLLATERAL SPROUTING,0.34626,-0.17499,-0.070837,0,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.16602,-0.17508,-0.090677,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.035953,-0.17591,-0.15051,0,0
3,GO RESPONSE TO LEUCINE,0.091819,-0.17725,-0.16893,0,0
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.10811,-0.17732,-0.11425,0,0
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.098083,-0.18051,-0.11373,0,0
3,GO CELL FATE DETERMINATION,0.19156,-0.18057,-0.076456,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.11524,-0.18225,-0.10185,0,0
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.26442,-0.18358,-0.11009,0,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.08588,-0.1842,-0.12324,0,0
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.20256,-0.18474,-0.18984,0,0
3,GO REGULATION OF SYNAPSE MATURATION,0.069906,-0.187,-0.23427,0,0
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.11524,-0.18857,-0.11301,0,0
3,GO RESPONSE TO LEPTIN,0.37964,-0.19021,-0.017223,0,0
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.08881,-0.19189,-0.13941,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.15655,-0.19306,-0.14554,0,0
3,GO REGULATION OF TUBULIN DEACETYLATION,0.033245,-0.19333,-0.1629,0,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.33029,-0.1953,-0.097272,0,0
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.072385,-0.19531,-0.13537,0,0
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.10134,-0.19593,-0.14488,0,0
3,GO AROMATIC AMINO ACID TRANSPORT,0.12662,-0.20262,-0.11263,0,0
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.098083,-0.20285,-0.1634,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.13885,-0.20355,-0.11243,0,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.11894,-0.20367,-0.11193,0,0
3,GO LEYDIG CELL DIFFERENTIATION,0.08881,-0.20397,-0.20091,0,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.39705,-0.20452,-0.096677,0,0
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.10811,-0.20552,-0.17108,0,0
3,GO NEURON MATURATION,0.056456,-0.20565,-0.12997,0,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.019548,-0.20782,-0.14318,0,0
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.1475,-0.20885,-0.11417,0,0
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.21989,-0.20911,-0.10453,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.33029,-0.20961,-0.090809,0,0
3,GO OLIGODENDROCYTE DEVELOPMENT,0.12662,-0.21107,-0.099502,0,0
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.2577,-0.21114,-0.0524,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.098083,-0.21293,-0.13489,0,0
3,GO NEURON RECOGNITION,0.14312,-0.21308,-0.11444,0,0
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.20256,-0.21458,-0.14191,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.0083971,-0.21646,-0.22317,0,0
3,GO FOREBRAIN NEURON DEVELOPMENT,0.11524,-0.21739,-0.13309,0,0
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.037377,-0.21932,-0.22185,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.36271,-0.22104,-0.043347,0,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.214,-0.22352,-0.066758,0,0
3,GO CELL MIGRATION IN HINDBRAIN,0.42405,-0.22482,-0.017883,0,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.12273,-0.22823,-0.15691,0,0
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.13467,-0.22889,-0.22032,0,0
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.20256,-0.22934,-0.15764,0,0
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.091819,-0.23019,-0.17152,0,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.20256,-0.23725,-0.13925,0,0
3,GO HYPOTHALAMUS DEVELOPMENT,0.037377,-0.2373,-0.14738,0,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.056456,-0.2434,-0.15154,0,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.197,-0.25746,-0.13137,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.031957,-0.25993,-0.20516,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.024086,-0.26224,-0.22071,0,0
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.080256,-0.26249,-0.13492,0,0
3,GO REGULATION OF RECEPTOR CLUSTERING,0.19156,-0.26274,-0.11209,0,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.094909,-0.26321,-0.14854,0,0
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.098083,-0.2639,-0.11345,0,0
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.011574,-0.26514,-0.18115,0,0
3,GO EATING BEHAVIOR,0.0052065,-0.27518,-0.21852,0,0
3,GO HEART INDUCTION,0.069906,-0.27526,-0.16766,0,0
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.28529,-0.2759,-0.13392,0,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.11894,-0.27993,-0.17471,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.08303,-0.28002,-0.16124,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.00031664,-0.28788,-0.27538,0,0
3,GO PROTEIN PALMITOYLATION,0.00332,-0.29459,-0.25715,0,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.067497,-0.29484,-0.16123,0,0
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.008797,-0.29963,-0.2232,0,0
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.08881,-0.29997,-0.15803,0,0
3,GO GROOMING BEHAVIOR,0.00064645,-0.30175,-0.3,0,0
3,GO DIENCEPHALON DEVELOPMENT,0.006955,-0.30655,-0.23985,0,0
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.013834,-0.31482,-0.20516,0,0
3,GO PARENTAL BEHAVIOR,0.0063209,-0.32448,-0.40216,0,0
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.077559,-0.3333,-0.2543,0,0
3,GO NOREPINEPHRINE SECRETION,0.0042727,-0.33344,-0.30567,0,0
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.046961,-0.3451,-0.24288,0,0
3,GO GANGLION DEVELOPMENT,0.013834,-0.36003,-0.27549,0,0
3,GO CGMP METABOLIC PROCESS,0.0010209,-0.36269,-0.34713,0,0
3,GO NOSE DEVELOPMENT,0.022172,-0.36509,-0.29546,0,0
3,GO VOCALIZATION BEHAVIOR,0.091819,-0.36775,-0.20561,0,0
3,GO REGULATION OF RELAXATION OF MUSCLE,0.11524,-0.39231,-0.22208,0,0
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.017954,-0.39899,-0.29935,0,0
3,GO NOREPINEPHRINE TRANSPORT,0.00332,-0.40278,-0.34001,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.023112,-0.40844,-0.27831,0,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.028348,-0.47625,-0.26895,0,0
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00015974,-0.52402,-0.48292,0,0
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.00028019,-0.59778,-0.58374,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.00013188,-0.61497,-0.57091,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.00076864,-0.69161,-0.56818,0,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.013834,-0.77752,-0.47443,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.00051151,-0.82073,-0.72789,0,0
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00040321,0.70811,0.60504,1,1
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00014989,0.69761,0.58521,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,7.8298e-05,0.69542,0.70655,1,1
4,GO REGULATION OF SYNAPSE MATURATION,2.636e-05,0.69329,0.6735,1,1
4,GO SYNAPTIC MEMBRANE ADHESION,0.00010866,0.67727,0.59749,1,1
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0054671,0.6618,0.49041,1,1
4,GO COMMISSURAL NEURON AXON GUIDANCE,2.2907e-05,0.65709,0.60368,1,1
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.00048214,0.63061,0.54297,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,4.2539e-06,0.6233,0.72331,1,1
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,7.3279e-05,0.62128,0.62977,1,1
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00013188,0.61163,0.53791,1,1
4,GO RESPONSE TO POTASSIUM ION,0.0011418,0.59738,0.44234,1,1
4,GO POSITIVE REGULATION OF NEURON MIGRATION,5.9985e-05,0.58915,0.61787,1,1
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.00028019,0.5875,0.55627,1,1
4,GO PREPULSE INHIBITION,9.5377e-05,0.57503,0.57759,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.00020554,0.57378,0.51728,1,1
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.013235,0.5734,0.45056,1,1
4,GO SYNAPSE MATURATION,7.8298e-05,0.55784,0.59539,1,1
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00054254,0.55783,0.45075,1,1
4,GO POSTSYNAPSE ASSEMBLY,0.00010181,0.5444,0.54077,1,1
4,GO TELENCEPHALON REGIONALIZATION,0.00026348,0.54383,0.49972,1,1
4,GO DISTAL TUBULE DEVELOPMENT,0.0042727,0.54273,0.45889,1,1
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.00054254,0.53569,0.49576,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.00014989,0.53229,0.51512,1,1
4,GO REGULATION OF NEURON MIGRATION,4.8997e-05,0.52481,0.54966,1,1
4,GO CELL PROLIFERATION IN HINDBRAIN,0.00021879,0.52263,0.43697,1,1
4,GO CENTRIOLE CENTRIOLE COHESION,5.9985e-05,0.51596,0.5284,1,1
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.00060992,0.51378,0.5628,1,1
4,GO FOREBRAIN REGIONALIZATION,3.4805e-05,0.51261,0.55526,1,1
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0019699,0.50008,0.5539,1,1
4,GO CARDIAC VENTRICLE FORMATION,0.00045436,0.49437,0.50545,1,1
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00012367,0.49121,0.41526,1,1
4,GO VOCALIZATION BEHAVIOR,0.00035748,0.48652,0.45257,1,1
4,GO MICROTUBULE DEPOLYMERIZATION,0.00014989,0.47855,0.46884,1,1
4,GO OPTIC NERVE DEVELOPMENT,0.0044907,0.4781,0.45363,1,1
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00035748,0.47424,0.49101,1,1
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,5.6086e-05,0.47302,0.43336,1,1
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.025096,0.47042,0.35755,1,1
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.0023095,0.46574,0.39276,1,1
4,GO SYNAPTIC VESICLE CLUSTERING,0.00045436,0.46333,0.51353,1,1
4,GO DENDRITIC TRANSPORT,0.00051151,0.45911,0.48817,1,1
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0012758,0.45704,0.38282,1,1
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00042807,0.456,0.44737,1,1
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00026348,0.45544,0.41171,1,1
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0016767,0.45537,0.39487,1,1
4,GO SPINAL CORD PATTERNING,0.00051151,0.45295,0.48665,1,1
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00014989,0.44893,0.46283,1,1
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.00096503,0.44666,0.41388,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00042807,0.44646,0.42091,1,1
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.00035748,0.44296,0.44362,1,1
4,GO PROTEIN LOCALIZATION TO AXON,0.00054254,0.44268,0.46204,1,1
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00029789,0.43943,0.4514,1,1
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00057531,0.43877,0.41406,1,1
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,7.3279e-05,0.43471,0.51609,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.00021879,0.42958,0.41162,1,1
4,GO NEURONAL ION CHANNEL CLUSTERING,0.00014062,0.42886,0.47088,1,1
4,GO CARDIAC CHAMBER FORMATION,0.0025648,0.42092,0.40837,1,1
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00060992,0.41781,0.41797,1,1
4,GO CEREBELLAR CORTEX DEVELOPMENT,3.9936e-05,0.41768,0.40023,1,1
4,GO CEREBELLAR CORTEX MORPHOGENESIS,4.2763e-05,0.41019,0.42292,1,1
4,GO REGULATION OF CENTRIOLE REPLICATION,0.00048214,0.41009,0.35954,1,1
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.0023095,0.40982,0.38219,1,1
4,GO ANATOMICAL STRUCTURE REGRESSION,0.0011418,0.4088,0.40857,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00086166,0.40825,0.35631,1,1
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0027019,0.40807,0.40193,1,1
4,GO HISTONE H3 K9 DEMETHYLATION,9.5377e-05,0.40693,0.42517,1,1
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00060992,0.40559,0.37363,1,1
4,GO CYSTEINE METABOLIC PROCESS,0.033245,0.40277,0.23285,1,1
4,GO NEURON FATE SPECIFICATION,0.0012071,0.40182,0.42452,1,1
4,GO DENTATE GYRUS DEVELOPMENT,0.00068502,0.40161,0.48953,1,1
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0003797,0.4016,0.40468,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031664,0.40008,0.41451,1,1
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0025648,0.39922,0.45385,1,1
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.0057394,0.39872,0.32489,1,1
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,5.6086e-05,0.39854,0.47298,1,1
4,GO CELL PROLIFERATION IN FOREBRAIN,0.0013481,0.39394,0.38633,1,1
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.0018673,0.39374,0.32697,1,1
4,GO GROWTH HORMONE SECRETION,0.00054254,0.39209,0.42023,1,1
4,GO REGULATION OF COLLATERAL SPROUTING,0.0014241,0.39101,0.36428,1,1
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.00045436,0.39089,0.41401,1,1
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00024771,0.39042,0.42004,1,1
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00076864,0.39034,0.34591,1,1
4,GO FORELIMB MORPHOGENESIS,0.00072571,0.38895,0.37548,1,1
4,GO NEURON CELL CELL ADHESION,0.0012071,0.38702,0.48221,1,1
4,GO HISTONE H3 K27 METHYLATION,0.0014241,0.38685,0.36844,1,1
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0027019,0.38679,0.29927,1,1
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.00096503,0.38619,0.33854,1,1
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.00064645,0.38596,0.42306,1,1
4,GO MATING BEHAVIOR,0.00051151,0.38559,0.34615,1,1
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.0015041,0.38409,0.36654,1,1
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00086166,0.38384,0.37771,1,1
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,7.8298e-05,0.38113,0.49622,1,1
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0027019,0.37922,0.3196,1,1
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0083971,0.37915,0.48881,1,1
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0040644,0.37755,0.38633,1,1
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00042807,0.37718,0.4047,1,1
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0014241,0.37592,0.35808,1,1
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0020776,0.37579,0.35354,1,1
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0027019,0.37535,0.41355,1,1
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0003797,0.37415,0.36076,1,1
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00051151,0.37256,0.38627,1,1
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0019699,0.37149,0.39542,1,1
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.00042807,0.37117,0.50219,1,1
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00020554,0.37057,0.40787,1,1
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0013481,0.36865,0.36101,1,1
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.00332,0.36854,0.37571,1,1
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00033648,0.36793,0.35062,1,1
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00010181,0.36732,0.40915,1,1
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.0044907,0.36508,0.30593,1,1
4,GO EPITHELIAL CELL MATURATION,0.007293,0.36385,0.29058,1,1
4,GO STARTLE RESPONSE,0.00017019,0.36335,0.45381,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.2763e-05,0.36294,0.42168,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.0021907,0.36266,0.33903,1,1
4,GO REGULATION OF NEUROBLAST PROLIFERATION,0.00051151,0.36249,0.34308,1,1
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0076456,0.36236,0.28438,1,1
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00057531,0.36227,0.38739,1,1
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0019699,0.36126,0.41229,1,1
4,GO MEIOTIC CHROMOSOME SEPARATION,0.00072571,0.36057,0.41723,1,1
4,GO CRANIAL NERVE MORPHOGENESIS,0.012106,0.35979,0.29759,1,1
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.0057394,0.35952,0.27907,1,1
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0015882,0.35867,0.31872,1,1
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.00031664,0.3581,0.43926,1,1
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0017696,0.35617,0.31697,1,1
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.0017696,0.35445,0.28746,1,1
4,GO METENCEPHALON DEVELOPMENT,6.8565e-05,0.35443,0.35022,1,1
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0017696,0.35423,0.41607,1,1
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00096503,0.35419,0.36369,1,1
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.0029965,0.35347,0.30535,1,1
4,GO HISTONE H3 K9 METHYLATION,0.00072571,0.35306,0.34772,1,1
4,GO NEURAL TUBE PATTERNING,0.0021907,0.353,0.28568,1,1
4,GO CORPUS CALLOSUM DEVELOPMENT,0.00060992,0.35251,0.373,1,1
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00064645,0.35202,0.33871,1,1
4,GO CEREBELLAR CORTEX FORMATION,0.00026348,0.35171,0.38723,1,1
4,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0012758,0.35098,0.35202,1,1
4,GO RESPONSE TO L GLUTAMATE,7.8298e-05,0.35062,0.35859,1,1
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00033648,0.35062,0.35648,1,1
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.00076864,0.35041,0.35312,1,1
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00057531,0.34886,0.33235,1,1
4,GO RESPONSE TO COCAINE,0.00024771,0.34764,0.34935,1,1
4,GO NUCLEUS LOCALIZATION,0.00035748,0.34699,0.41567,1,1
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00018128,0.34625,0.37059,1,1
4,GO MAGNESIUM ION HOMEOSTASIS,0.0038653,0.34504,0.34996,1,1
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0010798,0.34194,0.35297,1,1
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00086166,0.34157,0.34631,1,1
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00096503,0.33998,0.34357,1,1
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.0010209,0.33871,0.33337,1,1
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0012071,0.33763,0.34965,1,1
4,GO REGULATION OF SPINDLE CHECKPOINT,0.00014989,0.33636,0.34914,1,1
4,GO PROTEIN POLYGLUTAMYLATION,0.0038653,0.33441,0.31365,1,1
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00020554,0.33429,0.37891,1,1
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0063209,0.33427,0.29015,1,1
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.00015974,0.33316,0.33611,1,1
4,GO ACROSOME ASSEMBLY,0.0047188,0.33291,0.29312,1,1
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0012758,0.33262,0.3096,1,1
4,GO CARTILAGE MORPHOGENESIS,0.013834,0.33217,0.30668,1,1
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.00091199,0.3314,0.33471,1,1
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0015041,0.33111,0.27936,1,1
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013834,0.33064,0.28649,1,1
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.00081392,0.33053,0.30579,1,1
4,GO POSTSYNAPSE ORGANIZATION,0.00035748,0.32943,0.33309,1,1
4,GO DENDRITE MORPHOGENESIS,0.00029789,0.32889,0.35861,1,1
4,GO URETER DEVELOPMENT,0.024086,0.32827,0.39695,1,1
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.0018673,0.32744,0.34739,1,1
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0014241,0.32652,0.38694,1,1
4,GO DENDRITIC SPINE MORPHOGENESIS,0.00026348,0.32592,0.38192,1,1
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0063209,0.32578,0.28856,1,1
4,GO RESPONSE TO NICOTINE,0.00068502,0.32547,0.34052,1,1
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.00026348,0.32451,0.3157,1,1
4,GO PROTEIN LOCALIZATION TO CILIUM,0.0013481,0.32411,0.30863,1,1
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00060992,0.32375,0.34801,1,1
4,GO INNERVATION,0.0040644,0.32308,0.45515,1,1
4,GO FACIAL NERVE MORPHOGENESIS,0.050584,0.32191,0.26078,1,1
4,GO BRAIN MORPHOGENESIS,0.00072571,0.3219,0.31469,1,1
4,GO EMBRYONIC BRAIN DEVELOPMENT,0.0036751,0.32075,0.29271,1,1
4,GO MEMBRANE HYPERPOLARIZATION,0.015104,0.31985,0.33992,1,1
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00014062,0.31844,0.36642,1,1
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.0014241,0.31752,0.2952,1,1
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0027019,0.31696,0.29305,1,1
4,GO FOREBRAIN NEURON DEVELOPMENT,0.0029965,0.31663,0.30344,1,1
4,GO NEURAL RETINA DEVELOPMENT,0.00042807,0.31641,0.34402,1,1
4,GO NUCLEAR MIGRATION,0.00060992,0.31598,0.41547,1,1
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00040321,0.31561,0.31275,1,1
4,GO RESPONSE TO AUDITORY STIMULUS,0.011063,0.31518,0.3381,1,1
4,GO PRESYNAPSE ORGANIZATION,0.00057531,0.3151,0.35321,1,1
4,GO NEURAL CREST FORMATION,0.0083971,0.31478,0.35053,1,1
4,GO RESPONSE TO INSECTICIDE,0.0083971,0.31469,0.27655,1,1
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0080134,0.31427,0.26601,1,1
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.0010798,0.31426,0.39089,1,1
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0172,0.31422,0.28561,1,1
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.00072571,0.31421,0.3705,1,1
4,GO POSITIVE REGULATION OF BEHAVIOR,0.0044907,0.31418,0.27644,1,1
4,GO CATECHOLAMINE UPTAKE,0.00081392,0.31404,0.36716,1,1
4,GO SECRETORY GRANULE LOCALIZATION,0.0019699,0.31377,0.36166,1,1
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.0010798,0.31242,0.28334,1,1
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00086166,0.31233,0.34987,1,1
4,GO MEIOTIC SPINDLE ORGANIZATION,0.0023095,0.31093,0.35744,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0031545,0.31026,0.34593,1,1
4,GO HEART VALVE FORMATION,0.0038653,0.30842,0.42054,1,1
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0003797,0.30817,0.34647,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.018736,0.30805,0.3396,1,1
4,GO REGULATION OF RESPONSE TO FOOD,0.0017696,0.30774,0.35926,1,1
4,GO AXONEME ASSEMBLY,0.031957,0.30728,0.22514,1,1
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.0015041,0.30714,0.29624,1,1
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.040368,0.30636,0.27505,1,1
4,GO CHROMATIN SILENCING AT TELOMERE,0.00014989,0.30584,0.3316,1,1
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0014241,0.30538,0.32007,1,1
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0060238,0.30535,0.28099,1,1
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00086166,0.30526,0.27979,1,1
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.00048214,0.30512,0.324,1,1
4,GO SPINAL CORD DEVELOPMENT,0.00014062,0.30481,0.38779,1,1
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0016767,0.3045,0.2984,1,1
4,GO NEURON MIGRATION,7.3279e-05,0.3036,0.40087,1,1
4,GO CARNITINE SHUTTLE,0.00042807,0.3034,0.32291,1,1
4,GO MICROTUBULE BUNDLE FORMATION,0.0044907,0.3032,0.25957,1,1
4,GO RETINAL ROD CELL DIFFERENTIATION,0.022172,0.30316,0.23418,1,1
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.0010209,0.30274,0.31955,1,1
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.00031664,0.30238,0.3434,1,1
4,GO ADULT BEHAVIOR,0.0003797,0.3022,0.33728,1,1
4,GO THALAMUS DEVELOPMENT,0.0052065,0.30155,0.33078,1,1
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.023112,0.30103,0.25755,1,1
4,GO ASYMMETRIC CELL DIVISION,0.010101,0.30083,0.24585,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0012071,0.30038,0.3451,1,1
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.0049572,0.30004,0.34709,1,1
4,GO SUCKLING BEHAVIOR,0.0066311,0.29927,0.31724,1,1
4,GO RESPONSE TO LEUCINE,0.0019699,0.29891,0.35624,1,1
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0018673,0.29783,0.28251,1,1
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00081392,0.29774,0.32505,1,1
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00096503,0.29766,0.31734,1,1
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0015041,0.29752,0.32203,1,1
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.00057531,0.29745,0.33533,1,1
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0049572,0.29744,0.31566,1,1
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.015104,0.29722,0.26817,1,1
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0013481,0.29698,0.26231,1,1
4,GO EXCITATORY SYNAPSE ASSEMBLY,0.0019699,0.29683,0.3562,1,1
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.00096503,0.29641,0.32157,1,1
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0047188,0.29627,0.34325,1,1
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.025096,0.29517,0.26331,1,1
4,GO NEUROTRANSMITTER SECRETION,0.00091199,0.29435,0.32642,1,1
4,GO REGULATION OF CHROMATIN BINDING,0.00072571,0.29423,0.33113,1,1
4,GO DENDRITE DEVELOPMENT,0.00029789,0.29394,0.33372,1,1
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.006955,0.29388,0.27886,1,1
4,GO DENDRITIC SPINE DEVELOPMENT,0.00023283,0.29377,0.34665,1,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00068502,0.29257,0.33739,1,1
4,GO MITOTIC SISTER CHROMATID COHESION,0.00031664,0.29224,0.3285,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00048214,0.29217,0.34352,1,1
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.00051151,0.29138,0.33383,1,1
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.011574,0.29135,0.27509,1,1
4,GO ANTEROGRADE AXONAL TRANSPORT,0.00096503,0.29122,0.3104,1,1
4,GO HIPPOCAMPUS DEVELOPMENT,6.8565e-05,0.28914,0.31494,1,1
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.0003797,0.28896,0.3002,1,1
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0080134,0.28884,0.30363,1,1
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0016767,0.28828,0.27664,1,1
4,GO MICROTUBULE BASED MOVEMENT,0.00086166,0.28824,0.27037,1,1
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00051151,0.28756,0.33385,1,1
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.00042807,0.28709,0.30618,1,1
4,GO HISTONE H3 K4 TRIMETHYLATION,0.013235,0.28642,0.30835,1,1
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.01266,0.28605,0.26314,1,1
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.00021879,0.2859,0.33741,1,1
4,GO TRANSPORT ALONG MICROTUBULE,0.00045436,0.28575,0.28475,1,1
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.043559,0.28545,0.25213,1,1
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.01266,0.28503,0.20093,1,1
4,GO MICROTUBULE POLYMERIZATION,0.00076864,0.28403,0.32533,1,1
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.00086166,0.28367,0.33433,1,1
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.0015041,0.2832,0.32003,1,1
4,GO G0 TO G1 TRANSITION,0.0012758,0.28283,0.2958,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.00054254,0.28241,0.33033,1,1
4,GO CEREBRAL CORTEX CELL MIGRATION,0.0021907,0.28229,0.31422,1,1
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0013481,0.28203,0.30885,1,1
4,GO PEPTIDYL LYSINE METHYLATION,0.00076864,0.28139,0.30889,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00019306,0.28112,0.3264,1,1
4,GO INTERSTRAND CROSS LINK REPAIR,0.00060992,0.28043,0.2956,1,1
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.0016767,0.28017,0.43052,1,1
4,GO REGULATION OF AXONOGENESIS,0.0012071,0.27998,0.33567,1,1
4,GO RESPONSE TO FOOD,0.0012071,0.27987,0.28344,1,1
4,GO RESPONSE TO VITAMIN A,0.0083971,0.27979,0.2048,1,1
4,GO NEURON RECOGNITION,0.0057394,0.27975,0.28287,1,1
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.00014062,0.2796,0.31193,1,1
4,GO HINDBRAIN MORPHOGENESIS,0.00019306,0.27843,0.31613,1,1
4,GO NEUROBLAST PROLIFERATION,0.00086166,0.27812,0.30321,1,1
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.00031664,0.27774,0.29169,1,1
4,GO NEURON FATE COMMITMENT,0.0020776,0.27573,0.32454,1,1
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.0047188,0.27523,0.28996,1,1
4,GO RESPONSE TO HYDROXYUREA,0.0027019,0.27504,0.27046,1,1
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.0057394,0.27467,0.35868,1,1
4,GO HISTONE METHYLATION,0.00068502,0.27464,0.3065,1,1
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.025096,0.27449,0.2359,1,1
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.0047188,0.27444,0.25806,1,1
4,GO HISTONE H3 K9 MODIFICATION,0.0014241,0.27395,0.29644,1,1
4,GO LEARNING,0.00048214,0.27227,0.31788,1,1
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0017696,0.27179,0.27419,1,1
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0028457,0.27177,0.28302,1,1
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.026142,0.27162,0.27829,1,1
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.00057531,0.27151,0.40657,1,1
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.00042807,0.27086,0.31106,1,1
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.0044907,0.27071,0.29502,1,1
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.0011418,0.27052,0.30663,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.0025648,0.27004,0.28575,1,1
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.00064645,0.26995,0.30081,1,1
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.007293,0.26982,0.29219,1,1
4,GO CELL FATE SPECIFICATION,0.00332,0.26963,0.25928,1,1
4,GO MICROTUBULE BASED TRANSPORT,0.0012758,0.26898,0.27123,1,1
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.018736,0.26838,0.29458,1,1
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0040644,0.26685,0.3035,1,1
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.0023095,0.26674,0.32159,1,1
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.0014241,0.26664,0.30443,1,1
4,GO SMOOTHENED SIGNALING PATHWAY,0.00060992,0.26621,0.27493,1,1
4,GO MICROTUBULE BASED PROCESS,0.00040321,0.26614,0.27165,1,1
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0016767,0.26567,0.28703,1,1
4,GO SYNAPSE ORGANIZATION,0.0012758,0.26551,0.29623,1,1
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0023095,0.26524,0.28282,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0076456,0.26436,0.30112,1,1
4,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.007293,0.26425,0.26315,1,1
4,GO UTERUS DEVELOPMENT,0.0047188,0.26361,0.34531,1,1
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00096503,0.26346,0.31384,1,1
4,GO PROTEIN METHYLATION,0.00068502,0.26323,0.28244,1,1
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.0021907,0.26301,0.31583,1,1
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0010209,0.2624,0.29184,1,1
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.016475,0.26236,0.20929,1,1
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.0023095,0.25973,0.23996,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00040321,0.25947,0.2652,1,1
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.00029789,0.25881,0.31166,1,1
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.007293,0.25871,0.37091,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.01266,0.25832,0.22139,1,1
4,GO RECEPTOR CLUSTERING,0.0042727,0.25793,0.29709,1,1
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.052482,0.25754,0.24969,1,1
4,GO MICROTUBULE NUCLEATION,0.0036751,0.25715,0.30474,1,1
4,GO PROTEIN DEMETHYLATION,0.0015882,0.25571,0.31667,1,1
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.00332,0.25557,0.32776,1,1
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.037377,0.25515,0.2477,1,1
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0017696,0.25509,0.25335,1,1
4,GO HISTONE H2A UBIQUITINATION,0.0036751,0.25507,0.2384,1,1
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0003797,0.25501,0.32341,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0036751,0.25493,0.27603,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0047188,0.25474,0.25488,1,1
4,GO NEUROTRANSMITTER TRANSPORT,0.0014241,0.25466,0.29549,1,1
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0020776,0.25355,0.27254,1,1
4,GO MISMATCH REPAIR,0.00023283,0.25335,0.27502,1,1
4,GO HISTONE EXCHANGE,0.00064645,0.25332,0.29442,1,1
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.00068502,0.25308,0.23515,1,1
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.0015882,0.25292,0.3369,1,1
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.00031664,0.25264,0.27117,1,1
4,GO FEEDING BEHAVIOR,0.0066311,0.2525,0.21937,1,1
4,GO SYNAPTIC SIGNALING,0.0012758,0.25238,0.27937,1,1
4,GO NEURON PROJECTION GUIDANCE,0.0020776,0.25214,0.31253,1,1
4,GO AXONAL TRANSPORT,0.0011418,0.25176,0.31034,1,1
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.013834,0.25164,0.25184,1,1
4,GO EXPLORATION BEHAVIOR,0.040368,0.25161,0.20143,1,1
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00014989,0.25152,0.33033,1,1
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00060992,0.25104,0.27176,1,1
4,GO NEURON PROJECTION ARBORIZATION,0.0044907,0.25015,0.32886,1,1
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.007293,0.24983,0.26421,1,1
4,GO HISTONE H3 K4 METHYLATION,0.00057531,0.2498,0.29841,1,1
4,GO REGULATION OF SISTER CHROMATID COHESION,0.00086166,0.24901,0.32839,1,1
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.00096503,0.2485,0.25185,1,1
4,GO CHROMATIN REMODELING,0.00064645,0.24849,0.27047,1,1
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0092139,0.24773,0.27472,1,1
4,GO REGULATION OF MRNA POLYADENYLATION,0.0012758,0.24762,0.27365,1,1
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.015104,0.24718,0.20501,1,1
4,GO HISTONE H2A MONOUBIQUITINATION,0.0017696,0.24667,0.27644,1,1
4,GO RECOMBINATIONAL REPAIR,0.00091199,0.2459,0.27227,1,1
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.024086,0.24588,0.20264,1,1
4,GO HINDBRAIN DEVELOPMENT,0.00040321,0.24539,0.27815,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING,0.00017019,0.24523,0.26542,1,1
4,GO LENS FIBER CELL DIFFERENTIATION,0.011574,0.24518,0.22196,1,1
4,GO REGULATION OF FEEDING BEHAVIOR,0.00064645,0.24506,0.25289,1,1
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.040368,0.24447,0.19254,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.008797,0.24398,0.25377,1,1
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.00010181,0.24385,0.34376,1,1
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.017954,0.24342,0.23784,1,1
4,GO DNA DEPENDENT DNA REPLICATION,0.0013481,0.24325,0.26842,1,1
4,GO STRESS GRANULE ASSEMBLY,0.00051151,0.24315,0.29847,1,1
4,GO APICAL PROTEIN LOCALIZATION,0.015776,0.24313,0.21182,1,1
4,GO LEFT RIGHT AXIS SPECIFICATION,0.0083971,0.24262,0.267,1,1
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0052065,0.24256,0.26071,1,1
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.00010181,0.24255,0.30361,1,1
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0003797,0.24244,0.2525,1,1
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.0036751,0.24227,0.25121,1,1
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0015882,0.24181,0.2792,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.007293,0.24178,0.24519,1,1
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0024341,0.24169,0.28721,1,1
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.0040644,0.24133,0.27408,1,1
4,GO REGULATION OF CYTOKINESIS,0.0015041,0.24095,0.26442,1,1
4,GO MYOBLAST MIGRATION,0.052482,0.23964,0.20767,1,1
4,GO ECTODERM DEVELOPMENT,0.0024341,0.2389,0.24164,1,1
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0024341,0.2389,0.2937,1,1
4,GO NEUROTRANSMITTER REUPTAKE,0.0040644,0.23863,0.26013,1,1
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0013481,0.23862,0.30924,1,1
4,GO POST ANAL TAIL MORPHOGENESIS,0.0034935,0.23859,0.28882,1,1
4,GO NEURON PROJECTION ORGANIZATION,0.0019699,0.23712,0.30603,1,1
4,GO NUCLEOSOME ORGANIZATION,0.00057531,0.2366,0.27707,1,1
4,GO REGULATION OF BEHAVIOR,0.00332,0.23622,0.22057,1,1
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.014457,0.23583,0.27871,1,1
4,GO NON RECOMBINATIONAL REPAIR,0.0011418,0.23583,0.23718,1,1
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0003797,0.23578,0.24163,1,1
4,GO REGULATION OF CIRCADIAN RHYTHM,0.00064645,0.23536,0.26033,1,1
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0027019,0.23496,0.25156,1,1
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.00040321,0.23496,0.27025,1,1
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00057531,0.23475,0.27471,1,1
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.010572,0.23444,0.28595,1,1
4,GO REGULATION OF HISTONE METHYLATION,0.00057531,0.23423,0.29776,1,1
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0029965,0.2339,0.27638,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0023095,0.2337,0.25394,1,1
4,GO DNA REPLICATION,0.00064645,0.23364,0.26841,1,1
4,GO LOCOMOTORY BEHAVIOR,0.00091199,0.23226,0.30879,1,1
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0052065,0.2321,0.27008,1,1
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.015776,0.23198,0.31519,1,1
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0012758,0.23193,0.27176,1,1
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.00021879,0.23189,0.29094,1,1
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.045233,0.23182,0.16315,1,1
4,GO SPINDLE LOCALIZATION,0.0031545,0.23181,0.24368,1,1
4,GO PALLIUM DEVELOPMENT,0.00031664,0.23181,0.28666,1,1
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0015041,0.23061,0.26377,1,1
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00072571,0.23033,0.33673,1,1
4,GO INCLUSION BODY ASSEMBLY,0.0054671,0.23009,0.25918,1,1
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0016767,0.22952,0.29219,1,1
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0020776,0.22936,0.23313,1,1
4,GO SPERM MOTILITY,0.0049572,0.22929,0.19725,1,1
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.0038653,0.22918,0.26941,1,1
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0066311,0.22909,0.27042,1,1
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0080134,0.22905,0.21104,1,1
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0020776,0.22897,0.27359,1,1
4,GO REGULATION OF MRNA 3 END PROCESSING,0.0018673,0.22838,0.23955,1,1
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0020776,0.22831,0.25823,1,1
4,GO HISTONE H4 DEACETYLATION,0.0076456,0.22767,0.19898,1,1
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0016767,0.22654,0.2751,1,1
4,GO DNA CONFORMATION CHANGE,0.00081392,0.2254,0.27446,1,1
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.020391,0.22488,0.22642,1,1
4,GO REGULATION OF APPETITE,0.043559,0.22392,0.17449,1,1
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.00051151,0.22343,0.2902,1,1
4,GO REGULATION OF NEURON DIFFERENTIATION,0.00096503,0.22311,0.27851,1,1
4,GO DNA REPLICATION INITIATION,0.0052065,0.22304,0.2335,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0024341,0.223,0.29901,1,1
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0076456,0.22279,0.26391,1,1
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00332,0.22256,0.24898,1,1
4,GO TORC1 SIGNALING,0.0015882,0.22207,0.28478,1,1
4,GO REGULATION OF TORC1 SIGNALING,0.0021907,0.22199,0.27017,1,1
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0017696,0.22148,0.2295,1,1
4,GO CILIUM MOVEMENT,0.014457,0.22102,0.19729,1,1
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.024086,0.22087,0.24455,1,1
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.0092139,0.22066,0.26513,1,1
4,GO NUCLEOSOME ASSEMBLY,0.0011418,0.21929,0.30024,1,1
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.038848,0.21831,0.15521,1,1
4,GO MIDGUT DEVELOPMENT,0.046961,0.21804,0.18829,1,1
4,GO ACTIVATION OF JNKK ACTIVITY,0.052482,0.21726,0.20639,1,1
4,GO REGULATION OF CHROMOSOME SEPARATION,0.00011593,0.21675,0.28403,1,1
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0013481,0.21659,0.27029,1,1
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0019699,0.21658,0.2543,1,1
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0052065,0.21597,0.20277,1,1
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00096503,0.21583,0.21659,1,1
4,GO POSITIVE REGULATION OF DNA REPAIR,0.0015041,0.21561,0.23423,1,1
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.022172,0.2156,0.2245,1,1
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.010572,0.21555,0.21865,1,1
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.00096503,0.21377,0.22077,1,1
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0021907,0.21309,0.23415,1,1
4,GO GOLGI RIBBON FORMATION,0.0025648,0.21278,0.30808,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.013235,0.21225,0.25839,1,1
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0024341,0.21224,0.23927,1,1
4,GO HETEROCHROMATIN ORGANIZATION,0.0029965,0.21213,0.24297,1,1
4,GO DNA PACKAGING,0.00054254,0.21178,0.29377,1,1
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0011418,0.21155,0.24873,1,1
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0060238,0.21121,0.19198,1,1
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0040644,0.21083,0.28762,1,1
4,GO METANEPHROS MORPHOGENESIS,0.025096,0.21034,0.22118,1,1
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0044907,0.21029,0.16074,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.028348,0.21014,0.19418,1,1
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.02951,0.21001,0.26274,1,1
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00086166,0.20985,0.27462,1,1
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0049572,0.20958,0.24881,1,1
4,GO NEGATIVE CHEMOTAXIS,0.028348,0.20928,0.23815,1,1
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0016767,0.20862,0.2252,1,1
4,GO DNA GEOMETRIC CHANGE,0.0014241,0.20862,0.26159,1,1
4,GO TELENCEPHALON DEVELOPMENT,0.0003797,0.20854,0.27866,1,1
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00031664,0.20806,0.26084,1,1
4,GO MEMBRANE DOCKING,0.0038653,0.20784,0.22346,1,1
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.013235,0.20738,0.23523,1,1
4,GO MOTOR NEURON AXON GUIDANCE,0.0080134,0.20712,0.26192,1,1
4,GO DOUBLE STRAND BREAK REPAIR,0.0014241,0.2069,0.24777,1,1
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00015974,0.20605,0.27782,1,1
4,GO ONE CARBON METABOLIC PROCESS,0.033245,0.20579,0.15175,1,1
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0023095,0.20524,0.28687,1,1
4,GO POSITIVE REGULATION OF RNA SPLICING,0.0036751,0.20469,0.22867,1,1
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0027019,0.20436,0.18666,1,1
4,GO RNA POLYADENYLATION,0.0052065,0.20334,0.22034,1,1
4,GO ACTIN FILAMENT BASED TRANSPORT,0.045233,0.20319,0.22579,1,1
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0010798,0.20293,0.20857,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.0029965,0.20284,0.19481,1,1
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.0014241,0.20275,0.21402,1,1
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.026142,0.20249,0.18743,1,1
4,GO HISTONE MONOUBIQUITINATION,0.011574,0.20202,0.19975,1,1
4,GO LOCALIZATION WITHIN MEMBRANE,0.019548,0.20172,0.21748,1,1
4,GO REGULATION OF OOGENESIS,0.035953,0.20059,0.15127,1,1
4,GO ASSOCIATIVE LEARNING,0.00068502,0.20046,0.26233,1,1
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.013834,0.20007,0.19905,1,1
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.00086166,0.19995,0.22874,1,1
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0031545,0.19846,0.24605,1,1
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.0028457,0.19835,0.22765,1,1
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0018673,0.19827,0.24639,1,1
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0010798,0.1979,0.26525,1,1
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.012106,0.1975,0.21626,1,1
4,GO FOREBRAIN DEVELOPMENT,0.00035748,0.19679,0.28001,1,1
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.0096484,0.19608,0.18181,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.028348,0.196,0.19731,1,1
4,GO HISTONE UBIQUITINATION,0.0057394,0.19584,0.2142,1,1
4,GO FUCOSYLATION,0.024086,0.19507,0.18522,1,1
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00332,0.19486,0.25119,1,1
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.0044907,0.19418,0.29342,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.046961,0.19394,0.146,1,1
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0036751,0.19354,0.2151,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.022172,0.19229,0.19482,1,1
4,GO LIMBIC SYSTEM DEVELOPMENT,0.00064645,0.1911,0.2513,1,1
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.016475,0.19102,0.22133,1,1
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.02951,0.19029,0.22976,1,1
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.011063,0.19007,0.21476,1,1
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0080134,0.18999,0.16194,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.046961,0.18975,0.28597,1,1
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.017954,0.18944,0.22679,1,1
4,GO NUCLEAR PORE ORGANIZATION,0.011574,0.18898,0.25804,1,1
4,GO PROTEIN MONOUBIQUITINATION,0.0044907,0.18808,0.20917,1,1
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0012758,0.18742,0.23323,1,1
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0060238,0.18702,0.23617,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.024086,0.1856,0.18013,1,1
4,GO PROTEIN TARGETING TO LYSOSOME,0.028348,0.18552,0.19141,1,1
4,GO PITUITARY GLAND DEVELOPMENT,0.011574,0.1852,0.28364,1,1
4,GO DETECTION OF VISIBLE LIGHT,0.0014241,0.18483,0.16439,1,1
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0044907,0.18396,0.23148,1,1
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.00096503,0.1836,0.22244,1,1
4,GO FUCOSE METABOLIC PROCESS,0.0042727,0.1834,0.20463,1,1
4,GO METHYLATION,0.0016767,0.18316,0.19978,1,1
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.0049572,0.18305,0.19127,1,1
4,GO ATP TRANSPORT,0.031957,0.18275,0.1588,1,1
4,GO CARNITINE METABOLIC PROCESS,0.033245,0.18226,0.15822,1,1
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.0013481,0.18179,0.19786,1,1
4,GO FATTY ACID BETA OXIDATION,0.037377,0.18168,0.12614,1,1
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0017696,0.1812,0.23432,1,1
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.00332,0.18051,0.22814,1,1
4,GO REGULATION OF DNA REPLICATION,0.0013481,0.18016,0.23747,1,1
4,GO CHAPERONE MEDIATED AUTOPHAGY,0.037377,0.17923,0.18293,1,1
4,GO DNA METABOLIC PROCESS,0.0042727,0.17884,0.1779,1,1
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.0036751,0.17723,0.21632,1,1
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.007293,0.17697,0.2612,1,1
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.027226,0.1767,0.2502,1,1
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.007293,0.17643,0.22992,1,1
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.013235,0.17581,0.20369,1,1
4,GO MULTICELLULAR ORGANISM GROWTH,0.0034935,0.17537,0.23508,1,1
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.050584,0.17489,0.17127,1,1
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.0019699,0.17443,0.22081,1,1
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0018673,0.1743,0.23425,1,1
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0044907,0.17386,0.21043,1,1
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0057394,0.17374,0.2004,1,1
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0054671,0.1731,0.20266,1,1
4,GO NCRNA TRANSCRIPTION,0.0025648,0.17273,0.17507,1,1
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.048745,0.17226,0.13785,1,1
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.012106,0.17207,0.20182,1,1
4,GO REGULATION OF CELL CYCLE PROCESS,0.0012758,0.17014,0.20746,1,1
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0038653,0.1698,0.16033,1,1
4,GO NUCLEAR BODY ORGANIZATION,0.0057394,0.1688,0.18938,1,1
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0034935,0.16879,0.29643,1,1
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.018736,0.16766,0.19165,1,1
4,GO ORGANELLE LOCALIZATION,0.010101,0.16726,0.17777,1,1
4,GO SNARE COMPLEX ASSEMBLY,0.031957,0.16692,0.15472,1,1
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.024086,0.16677,0.17495,1,1
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.0066311,0.16554,0.23542,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.023112,0.16542,0.24905,1,1
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0080134,0.16489,0.13107,1,1
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0028457,0.16403,0.20987,1,1
4,GO NEGATIVE REGULATION OF CELL AGING,0.0052065,0.16402,0.23249,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.023112,0.1634,0.20628,1,1
4,GO PROTEIN SUMOYLATION,0.0031545,0.16312,0.21261,1,1
4,GO REGULATION OF RNA BINDING,0.011063,0.16279,0.16221,1,1
4,GO RNA SURVEILLANCE,0.020391,0.16243,0.12057,1,1
4,GO DEMETHYLATION,0.00332,0.16218,0.22227,1,1
4,GO RRNA TRANSCRIPTION,0.0031545,0.16213,0.18292,1,1
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.052482,0.16207,0.18411,1,1
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.021265,0.16143,0.1745,1,1
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.0172,0.16143,0.18209,1,1
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.024086,0.16135,0.2242,1,1
4,GO MITOCHONDRION DISTRIBUTION,0.0092139,0.16089,0.24439,1,1
4,GO REGULATION OF PROTEIN SUMOYLATION,0.026142,0.16064,0.18174,1,1
4,GO FOREBRAIN GENERATION OF NEURONS,0.024086,0.15963,0.19632,1,1
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0034935,0.15899,0.17021,1,1
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0096484,0.15893,0.20445,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.031957,0.1582,0.19293,1,1
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.020391,0.15777,0.21344,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.035953,0.15718,0.25274,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.033245,0.15697,0.22188,1,1
4,GO DNA METHYLATION OR DEMETHYLATION,0.0076456,0.15528,0.16964,1,1
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0063209,0.15474,0.14418,1,1
4,GO OVULATION CYCLE PROCESS,0.052482,0.15351,0.16327,1,1
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0054671,0.15321,0.16213,1,1
4,GO RHYTHMIC BEHAVIOR,0.021265,0.15276,0.18637,1,1
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.040368,0.15174,0.097996,1,1
4,GO DNA METHYLATION,0.010572,0.15149,0.17274,1,1
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0044907,0.15145,0.20708,1,1
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.0029965,0.15114,0.18459,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0060238,0.1508,0.24211,1,1
4,GO NCRNA EXPORT FROM NUCLEUS,0.0080134,0.1505,0.20666,1,1
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0040644,0.15042,0.15843,1,1
4,GO RNA DESTABILIZATION,0.035953,0.14909,0.19579,1,1
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.046961,0.14903,0.1185,1,1
4,GO DETECTION OF LIGHT STIMULUS,0.006955,0.14815,0.1232,1,1
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.020391,0.14787,0.17186,1,1
4,GO TRNA TRANSPORT,0.010101,0.14713,0.18688,1,1
4,GO LYSOSOMAL TRANSPORT,0.046961,0.14709,0.17179,1,1
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.031957,0.14643,0.20799,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.0080134,0.14588,0.21762,1,1
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0083971,0.1456,0.15354,1,1
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.034576,0.14523,0.16578,1,1
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.013834,0.14411,0.22808,1,1
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0018673,0.1441,0.23822,1,1
4,GO PROTEIN TARGETING TO VACUOLE,0.027226,0.14352,0.18621,1,1
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.020391,0.14351,0.10861,1,1
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.033245,0.14244,0.14211,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.007293,0.14175,0.1751,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.015776,0.14148,0.14515,1,1
4,GO SNRNA PROCESSING,0.045233,0.14116,0.10012,1,1
4,GO REGULATION OF HISTONE UBIQUITINATION,0.0029965,0.13989,0.21064,1,1
4,GO RESPONSE TO AMINO ACID STARVATION,0.007293,0.13968,0.19952,1,1
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.007293,0.13948,0.15621,1,1
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0031545,0.13915,0.14051,1,1
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.015104,0.13889,0.22224,1,1
4,GO APOPTOTIC DNA FRAGMENTATION,0.012106,0.13847,0.16847,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.0063209,0.13798,0.12778,1,1
4,GO MRNA CLEAVAGE,0.016475,0.13774,0.19899,1,1
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.021265,0.13759,0.27784,1,1
4,GO MAINTENANCE OF CELL NUMBER,0.013834,0.13571,0.17277,1,1
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.0057394,0.13571,0.16744,1,1
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.01266,0.13463,0.16257,1,1
4,GO FEMALE SEX DIFFERENTIATION,0.011063,0.13335,0.19916,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.012106,0.13318,0.14931,1,1
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.023112,0.13223,0.14153,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0049572,0.13192,0.17211,1,1
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.011063,0.1311,0.12167,1,1
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.031957,0.13099,0.11446,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.033245,0.12975,0.1321,1,1
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.052482,0.12915,0.12925,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.023112,0.12783,0.13588,1,1
4,GO PHOTOTRANSDUCTION,0.01266,0.1277,0.10656,1,1
4,GO TRANSLESION SYNTHESIS,0.012106,0.12564,0.14726,1,1
4,GO INTRACELLULAR MRNA LOCALIZATION,0.021265,0.12431,0.17459,1,1
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.043559,0.12351,0.1411,1,1
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.011063,0.12092,0.13524,1,1
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.015776,0.1209,0.16385,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.034576,0.1205,0.10532,1,1
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0044907,0.12043,0.1796,1,1
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.0096484,0.1191,0.16315,1,1
4,GO DNA MODIFICATION,0.0172,0.1181,0.1406,1,1
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.007293,0.1177,0.12578,1,1
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.018736,0.11331,0.098429,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.034576,0.11322,0.13734,1,1
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.052482,0.11026,0.11456,1,1
4,GO MULTI ORGANISM LOCALIZATION,0.040368,0.10948,0.12097,1,1
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.025096,0.10946,0.16034,1,1
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.045233,0.10629,0.099641,1,1
4,GO IMPORT INTO NUCLEUS,0.028348,0.10585,0.14062,1,1
4,GO ESTABLISHMENT OF CELL POLARITY,0.027226,0.10277,0.18784,1,1
4,GO HISTONE MRNA METABOLIC PROCESS,0.007293,0.10102,0.13372,1,1
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.017954,0.099082,0.14197,1,1
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.054439,0.098208,0.10904,1,1
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.026142,0.093265,0.17142,1,1
4,GO RESPONSE TO STARVATION,0.050584,0.091299,0.14611,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.041938,0.068612,0.0871,1,1
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0012071,0.50596,0.49549,1,0
4,GO SYNAPTIC VESICLE DOCKING,0.012106,0.43395,0.37204,1,0
4,GO HISTONE H3 K36 METHYLATION,0.00045436,0.40106,0.43288,1,0
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0080134,0.38625,0.38961,1,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0019699,0.37311,0.41883,1,0
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00040321,0.35586,0.343,1,0
4,GO DENSE CORE GRANULE TRANSPORT,0.0042727,0.35542,0.40747,1,0
4,GO LOOP OF HENLE DEVELOPMENT,0.015104,0.34772,0.33686,1,0
4,GO RETROGRADE AXONAL TRANSPORT,0.00060992,0.33901,0.42939,1,0
4,GO MRNA SPLICE SITE SELECTION,0.00031664,0.3199,0.38518,1,0
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0015882,0.31946,0.41776,1,0
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.007293,0.31888,0.31688,1,0
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0031545,0.31313,0.33954,1,0
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0021907,0.31191,0.31528,1,0
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0011418,0.3095,0.35901,1,0
4,GO REPRODUCTIVE BEHAVIOR,0.0013481,0.30949,0.31746,1,0
4,GO LONG TERM SYNAPTIC DEPRESSION,0.013235,0.30854,0.26506,1,0
4,GO SYNAPTIC VESICLE PRIMING,0.014457,0.30781,0.2779,1,0
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0029965,0.30511,0.39527,1,0
4,GO MICROTUBULE ANCHORING,0.00033648,0.30028,0.35538,1,0
4,GO COLLATERAL SPROUTING,0.0034935,0.29853,0.3221,1,0
4,GO NEURON CELLULAR HOMEOSTASIS,0.0080134,0.2957,0.31791,1,0
4,GO RESPONSE TO ACETYLCHOLINE,0.00091199,0.29479,0.38556,1,0
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.013235,0.29228,0.24803,1,0
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.048745,0.29186,0.23698,1,0
4,GO RETINA LAYER FORMATION,0.0021907,0.29087,0.37751,1,0
4,GO REGULATION OF CILIUM ASSEMBLY,0.0025648,0.28774,0.27955,1,0
4,GO REGULATION OF MICROTUBULE BINDING,0.0012071,0.28744,0.39495,1,0
4,GO DIVALENT METAL ION EXPORT,0.0066311,0.287,0.33321,1,0
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.026142,0.28659,0.36713,1,0
4,GO NERVE DEVELOPMENT,0.0042727,0.28342,0.33359,1,0
4,GO SYNAPSE ASSEMBLY,0.0011418,0.28215,0.33406,1,0
4,GO INTRACILIARY TRANSPORT,0.0012758,0.28129,0.31439,1,0
4,GO MICROTUBULE SEVERING,0.0047188,0.27924,0.27597,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0028457,0.27834,0.30636,1,0
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0017696,0.27503,0.33029,1,0
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.0013481,0.2735,0.30638,1,0
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.046961,0.2728,0.21389,1,0
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0014241,0.27279,0.32212,1,0
4,GO SYNAPTIC VESICLE LOCALIZATION,0.0042727,0.26934,0.28939,1,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.0024341,0.26861,0.34666,1,0
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.0025648,0.26398,0.26699,1,0
4,GO FEAR RESPONSE,0.0034935,0.26317,0.24934,1,0
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0034935,0.26259,0.27922,1,0
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0028457,0.26082,0.3451,1,0
4,GO MUSCLE FIBER DEVELOPMENT,0.0038653,0.25947,0.24534,1,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0092139,0.25743,0.33761,1,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.038848,0.25565,0.21808,1,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0063209,0.25317,0.32646,1,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.00051151,0.25311,0.27401,1,0
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0080134,0.25309,0.38023,1,0
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0010209,0.25291,0.31392,1,0
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0019699,0.25277,0.30547,1,0
4,GO DOSAGE COMPENSATION,0.0042727,0.25271,0.28776,1,0
4,GO MECHANOSENSORY BEHAVIOR,0.030713,0.2516,0.36202,1,0
4,GO SIALYLATION,0.0027019,0.2494,0.30791,1,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.00045436,0.24907,0.32988,1,0
4,GO TUBULIN DEACETYLATION,0.025096,0.24825,0.2341,1,0
4,GO REGULATION OF MRNA PROCESSING,0.0013481,0.24813,0.24937,1,0
4,GO CILIUM ORGANIZATION,0.0015041,0.24729,0.26526,1,0
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0044907,0.24324,0.27902,1,0
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0021907,0.24206,0.24311,1,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0017696,0.24205,0.26899,1,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0028457,0.23982,0.32072,1,0
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.02951,0.23881,0.17524,1,0
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.015104,0.23673,0.2438,1,0
4,GO HISTONE H4 K5 ACETYLATION,0.0052065,0.23501,0.24655,1,0
4,GO CELL PART MORPHOGENESIS,0.0020776,0.23409,0.29139,1,0
4,GO HISTONE H3 K9 TRIMETHYLATION,0.0021907,0.23376,0.27626,1,0
4,GO MYELIN MAINTENANCE,0.022172,0.23264,0.25429,1,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.02951,0.23031,0.25173,1,0
4,GO GLIAL CELL FATE COMMITMENT,0.014457,0.22891,0.28157,1,0
4,GO AXON DEVELOPMENT,0.0019699,0.2285,0.29602,1,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0042727,0.2284,0.26609,1,0
4,GO MITOCHONDRION LOCALIZATION,0.0015041,0.22825,0.27497,1,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0023095,0.22821,0.30981,1,0
4,GO AXO DENDRITIC TRANSPORT,0.0034935,0.22813,0.28676,1,0
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0025648,0.2264,0.26426,1,0
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.012106,0.22592,0.2796,1,0
4,GO CELL JUNCTION MAINTENANCE,0.030713,0.22575,0.25139,1,0
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.0044907,0.22478,0.30669,1,0
4,GO RESPONSE TO GLUCAGON,0.045233,0.22297,0.21142,1,0
4,GO TONGUE DEVELOPMENT,0.020391,0.22278,0.19192,1,0
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0028457,0.22155,0.29355,1,0
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.045233,0.22143,0.25544,1,0
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.054439,0.22086,0.24122,1,0
4,GO NEURON MATURATION,0.006955,0.21895,0.25549,1,0
4,GO NEUROMUSCULAR PROCESS,0.0034935,0.21861,0.2777,1,0
4,GO HIPPO SIGNALING,0.020391,0.21789,0.24525,1,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0076456,0.21755,0.27121,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0049572,0.21615,0.30185,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0063209,0.21527,0.26314,1,0
4,GO MITOTIC RECOMBINATION,0.0040644,0.21433,0.25842,1,0
4,GO EMBRYONIC AXIS SPECIFICATION,0.0010798,0.21371,0.24863,1,0
4,GO BEHAVIOR,0.0024341,0.21366,0.24848,1,0
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0015882,0.21357,0.27004,1,0
4,GO MYOTUBE CELL DEVELOPMENT,0.022172,0.2135,0.18438,1,0
4,GO HISTONE DEUBIQUITINATION,0.010572,0.21309,0.25853,1,0
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.0049572,0.2129,0.23309,1,0
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0096484,0.21276,0.29355,1,0
4,GO REGULATION OF CYCLASE ACTIVITY,0.0063209,0.21232,0.23276,1,0
4,GO CELL MIGRATION IN HINDBRAIN,0.017954,0.21224,0.27991,1,0
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.0028457,0.21143,0.27048,1,0
4,GO FOREBRAIN CELL MIGRATION,0.00086166,0.21111,0.31204,1,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.038848,0.21093,0.22966,1,0
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.0049572,0.20898,0.23926,1,0
4,GO LATERAL VENTRICLE DEVELOPMENT,0.041938,0.20836,0.25843,1,0
4,GO V D J RECOMBINATION,0.008797,0.20824,0.24149,1,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.026142,0.20785,0.26664,1,0
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0031545,0.20642,0.29428,1,0
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.007293,0.20555,0.22263,1,0
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0083971,0.20513,0.22318,1,0
4,GO AXON EXTENSION,0.0063209,0.2041,0.27542,1,0
4,GO NEURON PROJECTION EXTENSION,0.0060238,0.20383,0.26128,1,0
4,GO REGULATION OF DNA REPAIR,0.0019699,0.20313,0.23334,1,0
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0052065,0.20028,0.19502,1,0
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.02951,0.19836,0.22863,1,0
4,GO NEURON DIFFERENTIATION,0.0014241,0.19791,0.26083,1,0
4,GO SYNAPTIC VESICLE TRANSPORT,0.034576,0.19769,0.1949,1,0
4,GO NEURON DEVELOPMENT,0.0018673,0.19677,0.2608,1,0
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0083971,0.19629,0.26675,1,0
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.0015041,0.19626,0.25417,1,0
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.023112,0.19496,0.26922,1,0
4,GO EMBRYONIC BODY MORPHOGENESIS,0.024086,0.19483,0.22106,1,0
4,GO CYTOKINESIS,0.0019699,0.19443,0.20921,1,0
4,GO HINDLIMB MORPHOGENESIS,0.031957,0.19415,0.20643,1,0
4,GO HISTONE H3 DEACETYLATION,0.0080134,0.19403,0.23444,1,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.028348,0.19381,0.21874,1,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.045233,0.19347,0.35253,1,0
4,GO REGULATION OF DOPAMINE SECRETION,0.045233,0.1931,0.21702,1,0
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0021907,0.19249,0.24277,1,0
4,GO SPERMATID DIFFERENTIATION,0.0052065,0.19242,0.17666,1,0
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.017954,0.19235,0.26097,1,0
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.019548,0.19214,0.24887,1,0
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.010572,0.19128,0.23799,1,0
4,GO COLLECTING DUCT DEVELOPMENT,0.0083971,0.1912,0.33644,1,0
4,GO REGULATION OF RNA SPLICING,0.0027019,0.19091,0.22229,1,0
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.0044907,0.19091,0.21148,1,0
4,GO PROTEIN ACYLATION,0.0049572,0.19058,0.21831,1,0
4,GO DOPAMINE TRANSPORT,0.0172,0.19056,0.25859,1,0
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.040368,0.19055,0.22897,1,0
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0172,0.19035,0.22175,1,0
4,GO CELLULAR COMPONENT MAINTENANCE,0.022172,0.18991,0.23165,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0028457,0.18837,0.22192,1,0
4,GO PANCREAS DEVELOPMENT,0.006955,0.18814,0.25592,1,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.045233,0.18788,0.32469,1,0
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.006955,0.18733,0.20636,1,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.011063,0.18727,0.18947,1,0
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.021265,0.18635,0.22668,1,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.043559,0.18621,0.23885,1,0
4,GO CELL PROJECTION ORGANIZATION,0.00332,0.18596,0.22465,1,0
4,GO COVALENT CHROMATIN MODIFICATION,0.0016767,0.18576,0.25365,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0052065,0.1856,0.25319,1,0
4,GO POTASSIUM ION HOMEOSTASIS,0.020391,0.18468,0.19596,1,0
4,GO DEVELOPMENTAL CELL GROWTH,0.012106,0.18445,0.23204,1,0
4,GO HEAD DEVELOPMENT,0.0015041,0.1839,0.24501,1,0
4,GO ACTIN CROSSLINK FORMATION,0.010572,0.18371,0.28689,1,0
4,GO REGULATION OF MITOPHAGY,0.015776,0.18326,0.22372,1,0
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.0096484,0.18279,0.19212,1,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.0040644,0.18276,0.17551,1,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0024341,0.18204,0.22999,1,0
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.01266,0.18154,0.21566,1,0
4,GO CHEMOSENSORY BEHAVIOR,0.019548,0.18137,0.17459,1,0
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.011574,0.18058,0.20705,1,0
4,GO HISTONE H4 ACETYLATION,0.0066311,0.18051,0.22351,1,0
4,GO CHROMATIN ORGANIZATION,0.0014241,0.18018,0.25605,1,0
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.0063209,0.17957,0.23648,1,0
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.0063209,0.17923,0.26169,1,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0096484,0.1789,0.23168,1,0
4,GO ADULT LOCOMOTORY BEHAVIOR,0.017954,0.1785,0.21744,1,0
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.037377,0.17821,0.17989,1,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.015104,0.17739,0.25132,1,0
4,GO NEUROGENESIS,0.0020776,0.17617,0.23784,1,0
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.037377,0.17608,0.14934,1,0
4,GO REGULATION OF CELL SIZE,0.016475,0.17607,0.22843,1,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.01266,0.17576,0.21491,1,0
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.010572,0.17545,0.21533,1,0
4,GO LONG TERM SYNAPTIC POTENTIATION,0.025096,0.17507,0.21569,1,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.012106,0.17481,0.22233,1,0
4,GO WALKING BEHAVIOR,0.0080134,0.17414,0.22572,1,0
4,GO LONG TERM MEMORY,0.040368,0.17372,0.21447,1,0
4,GO SYNAPTIC VESICLE RECYCLING,0.0076456,0.17369,0.22855,1,0
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0172,0.17306,0.23162,1,0
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0044907,0.17291,0.2566,1,0
4,GO ORGANELLE ASSEMBLY,0.0040644,0.17285,0.19019,1,0
4,GO COGNITION,0.0066311,0.1727,0.2006,1,0
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.046961,0.17174,0.24088,1,0
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.015776,0.17171,0.24207,1,0
4,GO PROTEIN ACETYLATION,0.0036751,0.17159,0.2184,1,0
4,GO NEUROTRANSMITTER UPTAKE,0.013834,0.17123,0.19206,1,0
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.0083971,0.17109,0.20865,1,0
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.0049572,0.17104,0.21106,1,0
4,GO SCHWANN CELL DIFFERENTIATION,0.014457,0.17072,0.22397,1,0
4,GO PATTERN SPECIFICATION PROCESS,0.007293,0.17067,0.20194,1,0
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.035953,0.17035,0.18999,1,0
4,GO REGULATION OF TRANSPOSITION,0.028348,0.17027,0.17938,1,0
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.037377,0.17011,0.27907,1,0
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.010572,0.16987,0.19878,1,0
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.018736,0.16936,0.22142,1,0
4,GO POST EMBRYONIC DEVELOPMENT,0.0172,0.16925,0.21099,1,0
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.040368,0.16913,0.15608,1,0
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0024341,0.1688,0.23202,1,0
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.024086,0.16843,0.28246,1,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.010572,0.16822,0.21938,1,0
4,GO REGULATION OF ACTION POTENTIAL,0.022172,0.16736,0.20164,1,0
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.008797,0.16721,0.20529,1,0
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.018736,0.16717,0.18053,1,0
4,GO PEPTIDYL LYSINE MODIFICATION,0.0025648,0.16687,0.22153,1,0
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.0010798,0.16654,0.22115,1,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0019699,0.16551,0.26362,1,0
4,GO ATRIAL SEPTUM DEVELOPMENT,0.034576,0.16494,0.24466,1,0
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.016475,0.16483,0.21622,1,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.035953,0.16469,0.26674,1,0
4,GO ORGANIC CATION TRANSPORT,0.041938,0.16461,0.20221,1,0
4,GO HISTONE H2A ACETYLATION,0.0034935,0.16422,0.21365,1,0
4,GO REGULATION OF NEURON MATURATION,0.021265,0.1642,0.24558,1,0
4,GO DENDRITE EXTENSION,0.011574,0.16409,0.22531,1,0
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.022172,0.16359,0.20807,1,0
4,GO REGULATION OF CELL CYCLE,0.0023095,0.16324,0.19571,1,0
4,GO MALE GAMETE GENERATION,0.0018673,0.16268,0.18654,1,0
4,GO SOMITE DEVELOPMENT,0.015776,0.16247,0.18983,1,0
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0063209,0.16191,0.22486,1,0
4,GO PEPTIDYL LYSINE ACETYLATION,0.0044907,0.16144,0.22642,1,0
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.0019699,0.16137,0.2228,1,0
4,GO TRANSMISSION OF NERVE IMPULSE,0.0063209,0.16132,0.25712,1,0
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.010101,0.16118,0.18047,1,0
4,GO SHORT TERM MEMORY,0.052482,0.16103,0.19173,1,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0066311,0.16101,0.21732,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.017954,0.16044,0.16798,1,0
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.035953,0.15943,0.22106,1,0
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.017954,0.15925,0.22623,1,0
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.0028457,0.15909,0.21494,1,0
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0092139,0.15872,0.19529,1,0
4,GO SEXUAL REPRODUCTION,0.0025648,0.15857,0.17761,1,0
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00332,0.15846,0.18373,1,0
4,GO EMBRYONIC PATTERN SPECIFICATION,0.00072571,0.15782,0.21109,1,0
4,GO REGULATION OF TOR SIGNALING,0.023112,0.15758,0.181,1,0
4,GO UV DAMAGE EXCISION REPAIR,0.014457,0.15734,0.21145,1,0
4,GO TELOMERE CAPPING,0.040368,0.15732,0.17928,1,0
4,GO COCHLEA DEVELOPMENT,0.017954,0.1573,0.26235,1,0
4,GO GERM CELL DEVELOPMENT,0.0016767,0.15717,0.20704,1,0
4,GO ADHERENS JUNCTION ORGANIZATION,0.022172,0.15692,0.22317,1,0
4,GO TUBE FORMATION,0.028348,0.15662,0.18073,1,0
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.043559,0.15587,0.21716,1,0
4,GO CELL CYCLE,0.0027019,0.15567,0.19463,1,0
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.02951,0.15548,0.25171,1,0
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.0021907,0.15512,0.22072,1,0
4,GO PRESYNAPTIC ENDOCYTOSIS,0.0066311,0.15471,0.23419,1,0
4,GO POSITIVE REGULATION OF MITOPHAGY,0.025096,0.15471,0.21932,1,0
4,GO OXIDATIVE DEMETHYLATION,0.048745,0.15454,0.1371,1,0
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.02951,0.15419,0.20301,1,0
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.015776,0.15312,0.15257,1,0
4,GO GAMETE GENERATION,0.0016767,0.15299,0.1897,1,0
4,GO GENE SILENCING,0.010572,0.15295,0.17728,1,0
4,GO CAMERA TYPE EYE DEVELOPMENT,0.0063209,0.15279,0.22052,1,0
4,GO MEMORY,0.019548,0.15187,0.19002,1,0
4,GO EPITHELIAL TUBE FORMATION,0.041938,0.1515,0.1708,1,0
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.030713,0.15077,0.18041,1,0
4,GO CIRCADIAN RHYTHM,0.006955,0.15071,0.19889,1,0
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.014457,0.15046,0.21789,1,0
4,GO MITOTIC CYTOKINESIS,0.0083971,0.15005,0.17161,1,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.025096,0.14963,0.18533,1,0
4,GO REGULATION OF MEMBRANE POTENTIAL,0.010101,0.1489,0.20271,1,0
4,GO SOMITOGENESIS,0.033245,0.14881,0.1713,1,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.012106,0.14821,0.1601,1,0
4,GO LENS FIBER CELL DEVELOPMENT,0.045233,0.14779,0.19709,1,0
4,GO REGULATION OF LYASE ACTIVITY,0.008797,0.14713,0.19798,1,0
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.014457,0.14638,0.23142,1,0
4,GO TOR SIGNALING,0.023112,0.1456,0.1748,1,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.025096,0.14549,0.15377,1,0
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.043559,0.14452,0.12819,1,0
4,GO REGULATION OF TELOMERE MAINTENANCE,0.024086,0.14448,0.17503,1,0
4,GO CELL JUNCTION ORGANIZATION,0.019548,0.14443,0.20996,1,0
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.045233,0.14344,0.17019,1,0
4,GO REGULATION OF CELL DEVELOPMENT,0.0080134,0.14332,0.20863,1,0
4,GO PROTEIN DEPOLYMERIZATION,0.0063209,0.1429,0.24234,1,0
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.028348,0.14205,0.20747,1,0
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.017954,0.14174,0.17989,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.028348,0.14156,0.24125,1,0
4,GO LATERAL MESODERM DEVELOPMENT,0.045233,0.14133,0.18162,1,0
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.012106,0.14122,0.20214,1,0
4,GO CATECHOLAMINE SECRETION,0.011063,0.1411,0.25855,1,0
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.021265,0.14078,0.17364,1,0
4,GO CELL MORPHOGENESIS,0.01266,0.1406,0.21792,1,0
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.037377,0.14058,0.17731,1,0
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.013235,0.14056,0.16853,1,0
4,GO RESPONSE TO DOPAMINE,0.027226,0.14053,0.17505,1,0
4,GO SEGMENTATION,0.02951,0.14001,0.17818,1,0
4,GO RESPONSE TO UV,0.016475,0.13955,0.17105,1,0
4,GO HISTONE H3 K14 ACETYLATION,0.013235,0.13913,0.22823,1,0
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.0076456,0.13846,0.17403,1,0
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.048745,0.13833,0.16719,1,0
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.010101,0.13822,0.21514,1,0
4,GO MONOAMINE TRANSPORT,0.024086,0.13804,0.22192,1,0
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0066311,0.13675,0.18263,1,0
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.012106,0.13635,0.1588,1,0
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.043559,0.13574,0.18336,1,0
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.034576,0.1353,0.14586,1,0
4,GO NUCLEUS ORGANIZATION,0.015104,0.13529,0.1541,1,0
4,GO PEPTIDE HORMONE SECRETION,0.0049572,0.13515,0.20217,1,0
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0066311,0.13502,0.16814,1,0
4,GO PEPTIDYL SERINE MODIFICATION,0.025096,0.13499,0.17301,1,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.045233,0.1345,0.18022,1,0
4,GO REGULATION OF HISTONE MODIFICATION,0.0066311,0.13405,0.20195,1,0
4,GO NERVOUS SYSTEM PROCESS,0.028348,0.134,0.15391,1,0
4,GO REGULATION OF CELL MATURATION,0.0028457,0.13396,0.17829,1,0
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.019548,0.13381,0.16688,1,0
4,GO ACIDIC AMINO ACID TRANSPORT,0.020391,0.1336,0.19961,1,0
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.050584,0.13269,0.21093,1,0
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.0066311,0.1321,0.18086,1,0
4,GO REGULATION OF CELL MORPHOGENESIS,0.022172,0.13198,0.20633,1,0
4,GO TRANSPOSITION,0.014457,0.13174,0.17471,1,0
4,GO FERTILIZATION,0.0076456,0.13161,0.15281,1,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.023112,0.13127,0.17082,1,0
4,GO AXIS SPECIFICATION,0.0057394,0.13114,0.1883,1,0
4,GO DEVELOPMENTAL GROWTH,0.024086,0.13093,0.18546,1,0
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.040368,0.13092,0.17288,1,0
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0047188,0.1308,0.18533,1,0
4,GO RESPIRATORY SYSTEM PROCESS,0.038848,0.13064,0.20464,1,0
4,GO VISUAL BEHAVIOR,0.011063,0.13023,0.1894,1,0
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.021265,0.13004,0.15322,1,0
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.027226,0.12999,0.17478,1,0
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.027226,0.12967,0.20114,1,0
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.025096,0.12964,0.17476,1,0
4,GO MITOPHAGY,0.043559,0.12884,0.17621,1,0
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.012106,0.12884,0.1702,1,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.0047188,0.12882,0.15472,1,0
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.021265,0.12739,0.18415,1,0
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.024086,0.12728,0.19182,1,0
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.0049572,0.12725,0.20766,1,0
4,GO CELL PROJECTION ASSEMBLY,0.020391,0.12711,0.17789,1,0
4,GO MACROMOLECULE DEACYLATION,0.023112,0.12642,0.17918,1,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.023112,0.12594,0.14963,1,0
4,GO NEURAL NUCLEUS DEVELOPMENT,0.050584,0.12551,0.19455,1,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.015104,0.12545,0.15337,1,0
4,GO HISTONE DEACETYLATION,0.022172,0.12495,0.20145,1,0
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.050584,0.12395,0.17074,1,0
4,GO AMINE TRANSPORT,0.013834,0.12362,0.21642,1,0
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0066311,0.1236,0.18641,1,0
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.024086,0.12303,0.16682,1,0
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.038848,0.12125,0.16694,1,0
4,GO HAIR CELL DIFFERENTIATION,0.028348,0.12077,0.20051,1,0
4,GO RHYTHMIC PROCESS,0.008797,0.11897,0.19042,1,0
4,GO POLYOL CATABOLIC PROCESS,0.024086,0.11868,0.15469,1,0
4,GO RESPONSE TO LIGHT STIMULUS,0.010572,0.11838,0.15612,1,0
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.022172,0.11831,0.22426,1,0
4,GO SINGLE FERTILIZATION,0.0076456,0.11817,0.15113,1,0
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.033245,0.11617,0.15584,1,0
4,GO RESPONSE TO ALKALOID,0.041938,0.11603,0.14753,1,0
4,GO SENSORY SYSTEM DEVELOPMENT,0.022172,0.11568,0.19301,1,0
4,GO EMBRYONIC EYE MORPHOGENESIS,0.035953,0.11546,0.21605,1,0
4,GO SPECIFICATION OF SYMMETRY,0.017954,0.11485,0.17039,1,0
4,GO RNA INTERFERENCE,0.013235,0.11482,0.17836,1,0
4,GO MECHANORECEPTOR DIFFERENTIATION,0.0038653,0.11474,0.21316,1,0
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0080134,0.11457,0.18622,1,0
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.021265,0.11378,0.13458,1,0
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.040368,0.11157,0.10827,1,0
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0083971,0.11128,0.20526,1,0
4,GO FEMALE GAMETE GENERATION,0.010101,0.11119,0.16927,1,0
4,GO OLFACTORY LOBE DEVELOPMENT,0.038848,0.11115,0.2103,1,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.041938,0.11017,0.19657,1,0
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.040368,0.11006,0.18348,1,0
4,GO PROTEIN LOCALIZATION TO ORGANELLE,0.01266,0.10929,0.11811,1,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.025096,0.10908,0.16917,1,0
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.038848,0.10878,0.18104,1,0
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.024086,0.10852,0.13048,1,0
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.024086,0.10849,0.1369,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.048745,0.10749,0.18058,1,0
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.052482,0.10696,0.17671,1,0
4,GO MULTI ORGANISM PROCESS,0.023112,0.10687,0.13704,1,0
4,GO CELLULAR RESPONSE TO UV,0.046961,0.1067,0.14129,1,0
4,GO INTRACELLULAR TRANSPORT,0.040368,0.10643,0.11328,1,0
4,GO INNER EAR MORPHOGENESIS,0.021265,0.10554,0.21376,1,0
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.045233,0.10484,0.17786,1,0
4,GO CYTOSKELETON ORGANIZATION,0.022172,0.1044,0.1757,1,0
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.031957,0.10376,0.15698,1,0
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.028348,0.10356,0.1466,1,0
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.027226,0.10355,0.12813,1,0
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.018736,0.10329,0.17153,1,0
4,GO POTASSIUM ION TRANSPORT,0.030713,0.10228,0.18119,1,0
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.046961,0.10215,0.17062,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.052482,0.10208,0.1865,1,0
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.046961,0.10178,0.1474,1,0
4,GO REGULATION OF DNA METABOLIC PROCESS,0.019548,0.10151,0.15214,1,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.034576,0.10122,0.12764,1,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0172,0.10119,0.11964,1,0
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.012106,0.10044,0.17147,1,0
4,GO SENSORY ORGAN MORPHOGENESIS,0.038848,0.10037,0.17456,1,0
4,GO SENSORY ORGAN DEVELOPMENT,0.013235,0.10024,0.19087,1,0
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.028348,0.099279,0.15083,1,0
4,GO REGULATION OF HORMONE SECRETION,0.050584,0.098791,0.14775,1,0
4,GO REGULATION OF PROTEIN ACETYLATION,0.054439,0.098582,0.14491,1,0
4,GO ACTION POTENTIAL,0.038848,0.098497,0.15627,1,0
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.043559,0.098452,0.1028,1,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.011574,0.097543,0.18419,1,0
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.046961,0.096569,0.17342,1,0
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.052482,0.095974,0.19374,1,0
4,GO INSULIN SECRETION,0.012106,0.095316,0.19192,1,0
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.046961,0.095028,0.14119,1,0
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.037377,0.094902,0.159,1,0
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.048745,0.093787,0.13858,1,0
4,GO RESPONSE TO RADIATION,0.045233,0.093678,0.12693,1,0
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.046961,0.092706,0.16099,1,0
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.040368,0.092694,0.14533,1,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.035953,0.092056,0.12536,1,0
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.046961,0.09066,0.13219,1,0
4,GO REPRODUCTION,0.037377,0.0902,0.14069,1,0
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.038848,0.090198,0.18611,1,0
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.011574,0.087098,0.11705,1,0
4,GO VESICLE DOCKING,0.054439,0.086485,0.15838,1,0
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.054439,0.08532,0.1321,1,0
4,GO REGULATION OF INSULIN SECRETION,0.01266,0.08431,0.18684,1,0
4,GO LIPID DROPLET ORGANIZATION,0.040368,0.081614,0.1355,1,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.02951,0.081126,0.11377,1,0
4,GO NUCLEOTIDE PHOSPHORYLATION,0.050584,0.077857,0.14114,1,0
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.041938,0.076789,0.15929,1,0
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.052482,0.075188,0.17915,1,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.048745,0.074174,0.090021,1,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.013235,0.071918,0.16501,1,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.034576,0.069522,0.17334,1,0
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.038848,0.069286,0.17442,1,0
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.052482,0.065263,0.13884,1,0
4,GO PRIMARY MIRNA PROCESSING,0.025096,0.060502,0.17701,1,0
4,GO EAR DEVELOPMENT,0.033245,0.051053,0.17757,1,0
4,GO POLYAMINE METABOLIC PROCESS,0.043559,-0.094253,-0.059618,1,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.026142,-0.09864,-0.070739,1,0
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.022172,-0.10098,-0.11859,1,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.050584,-0.10287,-0.047103,1,0
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.052482,-0.10477,-0.084971,1,0
4,GO GLUTATHIONE METABOLIC PROCESS,0.023112,-0.10853,-0.12174,1,0
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.030713,-0.11091,-0.078908,1,0
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.02951,-0.11376,-0.087285,1,0
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.034576,-0.11564,-0.072662,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.046961,-0.11659,-0.091751,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.037377,-0.13317,-0.074049,1,0
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.052482,-0.13578,-0.089608,1,0
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.045233,-0.13621,-0.097023,1,0
4,GO ARACHIDONIC ACID SECRETION,0.054439,-0.13916,-0.10168,1,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.052482,-0.1436,-0.093443,1,0
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.037377,-0.15441,-0.16749,1,0
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.041938,-0.1592,-0.1318,1,0
4,GO CELL REDOX HOMEOSTASIS,0.033245,-0.16177,-0.15271,1,0
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.011063,-0.16638,-0.16786,1,0
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.043559,-0.17168,-0.16515,1,0
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.048745,-0.17295,-0.1472,1,0
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.041938,-0.18197,-0.17052,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.043559,-0.18431,-0.18024,1,0
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.048745,-0.18484,-0.11891,1,0
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.033245,-0.18774,-0.12519,1,0
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.02951,-0.18878,-0.10087,1,0
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.043559,-0.19109,-0.17317,1,0
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.038848,-0.19274,-0.11936,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0172,-0.19342,-0.10298,1,0
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.052482,-0.19494,-0.22088,1,0
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.048745,-0.19618,-0.21159,1,0
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.013834,-0.19705,-0.20752,1,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.020391,-0.19724,-0.21302,1,0
4,GO ETHER BIOSYNTHETIC PROCESS,0.046961,-0.19992,-0.17541,1,0
4,GO FRUCTOSE METABOLIC PROCESS,0.043559,-0.20023,-0.11858,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.048745,-0.20291,-0.25616,1,0
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.033245,-0.20396,-0.21002,1,0
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.01266,-0.20432,-0.1172,1,0
4,GO T CELL MEDIATED IMMUNITY,0.048745,-0.20576,-0.27115,1,0
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0036751,-0.20763,-0.22103,1,0
4,GO RESPONSE TO BACTERIUM,0.052482,-0.20847,-0.18987,1,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.021265,-0.20987,-0.17941,1,0
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.054439,-0.21096,-0.12569,1,0
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0172,-0.21188,-0.16782,1,0
4,GO CELL CELL RECOGNITION,0.045233,-0.21301,-0.11869,1,0
4,GO PROSTANOID METABOLIC PROCESS,0.012106,-0.21384,-0.23902,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.045233,-0.2149,-0.24037,1,0
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.046961,-0.21513,-0.19026,1,0
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.045233,-0.21932,-0.28263,1,0
4,GO COPPER ION TRANSPORT,0.01266,-0.21961,-0.19819,1,0
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.040368,-0.22338,-0.16942,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.037377,-0.22417,-0.20541,1,0
4,GO ICOSANOID METABOLIC PROCESS,0.019548,-0.22613,-0.18828,1,0
4,GO LIPID DIGESTION,0.052482,-0.22651,-0.22252,1,0
4,GO REGULATION OF T CELL CHEMOTAXIS,0.052482,-0.23083,-0.3428,1,0
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.043559,-0.23117,-0.25601,1,0
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.041938,-0.23163,-0.20927,1,0
4,GO PLASMA MEMBRANE FUSION,0.02951,-0.23167,-0.2339,1,0
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.027226,-0.23531,-0.18793,1,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0054671,-0.23753,-0.1909,1,0
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.045233,-0.2391,-0.22704,1,0
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.020391,-0.24122,-0.16965,1,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.0021907,-0.24155,-0.26969,1,0
4,GO ACUTE INFLAMMATORY RESPONSE,0.043559,-0.24189,-0.21147,1,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0057394,-0.24218,-0.29325,1,0
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.023112,-0.24305,-0.21583,1,0
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.022172,-0.24315,-0.36523,1,0
4,GO ACUTE PHASE RESPONSE,0.028348,-0.24361,-0.21462,1,0
4,GO RESPONSE TO INTERFERON BETA,0.050584,-0.24436,-0.28191,1,0
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.046961,-0.24463,-0.16965,1,0
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.010101,-0.2453,-0.16352,1,0
4,GO INTERLEUKIN 1 PRODUCTION,0.043559,-0.24561,-0.25821,1,0
4,GO INTERLEUKIN 8 PRODUCTION,0.040368,-0.24564,-0.24076,1,0
4,GO REGULATION OF PROSTAGLANDIN SECRETION,0.046961,-0.24586,-0.18406,1,0
4,GO TROPHOBLAST CELL MIGRATION,0.041938,-0.24603,-0.13955,1,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.052482,-0.25043,-0.26838,1,0
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.031957,-0.25103,-0.17952,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.020391,-0.25321,-0.22548,1,0
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.050584,-0.25372,-0.16573,1,0
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0096484,-0.25429,-0.23963,1,0
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.050584,-0.2564,-0.22172,1,0
4,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.033245,-0.25735,-0.24401,1,0
4,GO CELL KILLING,0.043559,-0.25852,-0.25869,1,0
4,GO ARACHIDONIC ACID METABOLIC PROCESS,0.028348,-0.25892,-0.18644,1,0
4,GO ACTIN FILAMENT SEVERING,0.026142,-0.26123,-0.211,1,0
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.052482,-0.26231,-0.22967,1,0
4,GO EMBRYO IMPLANTATION,0.028348,-0.26324,-0.18075,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.052482,-0.26397,-0.28621,1,0
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.038848,-0.26541,-0.2496,1,0
4,GO POSITIVE REGULATION OF COAGULATION,0.022172,-0.26573,-0.21601,1,0
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.054439,-0.26598,-0.29344,1,0
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.034576,-0.26657,-0.17194,1,0
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.040368,-0.26684,-0.24034,1,0
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.046961,-0.26875,-0.25371,1,0
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.052482,-0.26883,-0.25403,1,0
4,GO RESPIRATORY BURST,0.028348,-0.27,-0.29415,1,0
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.021265,-0.27077,-0.29993,1,0
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.02951,-0.27153,-0.20592,1,0
4,GO PLASMINOGEN ACTIVATION,0.0057394,-0.27465,-0.31498,1,0
4,GO CHEMOKINE PRODUCTION,0.048745,-0.27482,-0.21381,1,0
4,GO PROSTAGLANDIN TRANSPORT,0.034576,-0.27548,-0.18102,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.024086,-0.27569,-0.18843,1,0
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.031957,-0.27582,-0.21581,1,0
4,GO RETINAL METABOLIC PROCESS,0.043559,-0.27665,-0.19553,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.050584,-0.27671,-0.30604,1,0
4,GO ZYMOGEN ACTIVATION,0.033245,-0.27855,-0.2085,1,0
4,GO IMMUNOGLOBULIN SECRETION,0.030713,-0.27878,-0.28164,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.033245,-0.27963,-0.25948,1,0
4,GO RESPONSE TO FUNGUS,0.0172,-0.27971,-0.25437,1,0
4,GO EPOXYGENASE P450 PATHWAY,0.018736,-0.28357,-0.23887,1,0
4,GO INTERLEUKIN 17 PRODUCTION,0.0083971,-0.28547,-0.36215,1,0
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.026142,-0.28675,-0.23966,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.021265,-0.28814,-0.29489,1,0
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.048745,-0.28931,-0.23613,1,0
4,GO LEUKOCYTE CHEMOTAXIS,0.031957,-0.28942,-0.26652,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.041938,-0.28972,-0.20649,1,0
4,GO MYELOID LEUKOCYTE MIGRATION,0.013235,-0.29062,-0.28851,1,0
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.021265,-0.29188,-0.32718,1,0
4,GO SEQUESTERING OF METAL ION,0.0066311,-0.29194,-0.26242,1,0
4,GO REGULATION OF NEUTROPHIL MIGRATION,0.030713,-0.29215,-0.31852,1,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.052482,-0.29253,-0.25781,1,0
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.016475,-0.29499,-0.25772,1,0
4,GO REGULATION OF COAGULATION,0.014457,-0.29526,-0.25171,1,0
4,GO RESPONSE TO INTERFERON ALPHA,0.052482,-0.29552,-0.25714,1,0
4,GO MACROPHAGE MIGRATION,0.028348,-0.29564,-0.26132,1,0
4,GO VASODILATION,0.0057394,-0.29844,-0.21359,1,0
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.026142,-0.29861,-0.24107,1,0
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.007293,-0.29985,-0.33682,1,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.035953,-0.30079,-0.25493,1,0
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.030713,-0.30185,-0.18932,1,0
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.041938,-0.30339,-0.28088,1,0
4,GO XENOBIOTIC CATABOLIC PROCESS,0.00332,-0.30386,-0.32731,1,0
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.035953,-0.30437,-0.24353,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.034576,-0.30533,-0.30411,1,0
4,GO LEUKOTRIENE METABOLIC PROCESS,0.034576,-0.30608,-0.20988,1,0
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.015104,-0.30655,-0.31019,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.033245,-0.30677,-0.2797,1,0
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.038848,-0.30775,-0.30043,1,0
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.01266,-0.31019,-0.24159,1,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.0172,-0.31079,-0.27167,1,0
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.016475,-0.31112,-0.30502,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.019548,-0.31311,-0.22628,1,0
4,GO VITAMIN D METABOLIC PROCESS,0.025096,-0.31355,-0.2478,1,0
4,GO T CELL MEDIATED CYTOTOXICITY,0.024086,-0.31376,-0.37525,1,0
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.054439,-0.31391,-0.25557,1,0
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.015104,-0.31695,-0.31783,1,0
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.054439,-0.3172,-0.38951,1,0
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.021265,-0.31752,-0.27524,1,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.035953,-0.3181,-0.3363,1,0
4,GO MACROPHAGE CHEMOTAXIS,0.023112,-0.31866,-0.25914,1,0
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.02951,-0.3202,-0.29852,1,0
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0042727,-0.32627,-0.28775,1,0
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.02951,-0.32773,-0.22876,1,0
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.013834,-0.32793,-0.32655,1,0
4,GO NEUTROPHIL MIGRATION,0.018736,-0.3283,-0.33548,1,0
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.021265,-0.32885,-0.38316,1,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.048745,-0.32966,-0.28717,1,0
4,GO REGULATION OF BONE DEVELOPMENT,0.026142,-0.33039,-0.25092,1,0
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.013235,-0.33244,-0.3198,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.020391,-0.33258,-0.281,1,0
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.028348,-0.33609,-0.3427,1,0
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.040368,-0.33668,-0.28729,1,0
4,GO REGULATION OF MACROPHAGE MIGRATION,0.026142,-0.33676,-0.27203,1,0
4,GO INFLAMMATORY RESPONSE TO WOUNDING,0.024086,-0.33838,-0.32695,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.040368,-0.33851,-0.26795,1,0
4,GO DEFENSE RESPONSE TO BACTERIUM,0.01266,-0.33932,-0.26256,1,0
4,GO TYPE 2 IMMUNE RESPONSE,0.034576,-0.33933,-0.33153,1,0
4,GO FIBRINOLYSIS,0.011063,-0.33935,-0.32457,1,0
4,GO PROTEIN ACTIVATION CASCADE,0.031957,-0.33937,-0.25104,1,0
4,GO REGULATION OF T CELL MIGRATION,0.023112,-0.33947,-0.3064,1,0
4,GO GRANULOCYTE CHEMOTAXIS,0.010572,-0.34255,-0.34781,1,0
4,GO GRANULOCYTE MIGRATION,0.01266,-0.34306,-0.33317,1,0
4,GO RESPONSE TO CHEMOKINE,0.026142,-0.34745,-0.33255,1,0
4,GO INTERLEUKIN 4 PRODUCTION,0.037377,-0.34954,-0.32504,1,0
4,GO ANTIMICROBIAL HUMORAL RESPONSE,0.011574,-0.35017,-0.26901,1,0
4,GO CELL ADHESION MEDIATED BY INTEGRIN,0.034576,-0.35052,-0.27966,1,0
4,GO DENDRITIC CELL DIFFERENTIATION,0.054439,-0.35109,-0.34363,1,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.0052065,-0.35111,-0.26541,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.050584,-0.35177,-0.32164,1,0
4,GO PEPTIDE CROSS LINKING,0.0092139,-0.35229,-0.33861,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.034576,-0.35419,-0.24803,1,0
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.052482,-0.3542,-0.27677,1,0
4,GO REGULATION OF MYOBLAST FUSION,0.033245,-0.35446,-0.30959,1,0
4,GO NEGATIVE REGULATION OF COAGULATION,0.017954,-0.35461,-0.26672,1,0
4,GO INTESTINAL LIPID ABSORPTION,0.050584,-0.35463,-0.23884,1,0
4,GO DEFENSE RESPONSE TO FUNGUS,0.0017696,-0.35469,-0.34773,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.037377,-0.35587,-0.34723,1,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.027226,-0.35689,-0.27792,1,0
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.018736,-0.35725,-0.3386,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.027226,-0.35865,-0.34096,1,0
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.026142,-0.35887,-0.32744,1,0
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.014457,-0.35952,-0.2702,1,0
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.017954,-0.35969,-0.34777,1,0
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.018736,-0.3613,-0.36416,1,0
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.019548,-0.36132,-0.30691,1,0
4,GO NEUTROPHIL CHEMOTAXIS,0.014457,-0.36261,-0.36049,1,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.018736,-0.36288,-0.3813,1,0
4,GO T CELL MIGRATION,0.038848,-0.36811,-0.30629,1,0
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.030713,-0.36915,-0.2787,1,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.034576,-0.36938,-0.26625,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.038848,-0.37014,-0.343,1,0
4,GO COLLAGEN CATABOLIC PROCESS,0.045233,-0.37083,-0.23268,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.010572,-0.37589,-0.32225,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.014457,-0.37769,-0.3528,1,0
4,GO HUMORAL IMMUNE RESPONSE,0.015776,-0.3794,-0.30368,1,0
4,GO ETHANOL OXIDATION,0.01266,-0.38078,-0.35853,1,0
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.015776,-0.38099,-0.31974,1,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.037377,-0.38199,-0.36599,1,0
4,GO REGULATION OF FIBRINOLYSIS,0.013834,-0.3835,-0.31072,1,0
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.006955,-0.38405,-0.29068,1,0
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.033245,-0.38406,-0.33096,1,0
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.020391,-0.38756,-0.26756,1,0
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.008797,-0.38977,-0.39491,1,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.034576,-0.39032,-0.36935,1,0
4,GO REGULATION OF PLATELET ACTIVATION,0.018736,-0.39161,-0.3137,1,0
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.040368,-0.39285,-0.37995,1,0
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.02951,-0.39754,-0.34776,1,0
4,GO CELLULAR DEFENSE RESPONSE,0.046961,-0.40191,-0.33522,1,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0096484,-0.40764,-0.38206,1,0
4,GO INTERLEUKIN 10 PRODUCTION,0.013834,-0.40807,-0.38807,1,0
4,GO LIPOXYGENASE PATHWAY,0.0034935,-0.41284,-0.3731,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0063209,-0.4146,-0.36292,1,0
4,GO CHEMOKINE SECRETION,0.016475,-0.4153,-0.39006,1,0
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.020391,-0.4154,-0.38907,1,0
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0172,-0.42144,-0.39907,1,0
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.054439,-0.42444,-0.20451,1,0
4,GO REGULATION OF MEMBRANE INVAGINATION,0.027226,-0.42614,-0.31063,1,0
4,GO MONONUCLEAR CELL MIGRATION,0.0042727,-0.42631,-0.42334,1,0
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.010572,-0.42738,-0.37126,1,0
4,GO HYPERSENSITIVITY,0.0172,-0.4282,-0.47934,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0083971,-0.42911,-0.36941,1,0
4,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.011574,-0.43551,-0.38186,1,0
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.014457,-0.43664,-0.3628,1,0
4,GO LYMPHOCYTE CHEMOTAXIS,0.028348,-0.43994,-0.38702,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0080134,-0.44239,-0.42671,1,0
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.020391,-0.44402,-0.38296,1,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.023112,-0.44836,-0.34941,1,0
4,GO RESPONSE TO LIPOTEICHOIC ACID,0.016475,-0.4653,-0.35355,1,0
4,GO KERATAN SULFATE CATABOLIC PROCESS,0.014457,-0.46997,-0.36018,1,0
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.016475,-0.47253,-0.46725,1,0
4,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.012106,-0.47565,-0.43766,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.011574,-0.47598,-0.50715,1,0
4,GO REGULATION OF NEUTROPHIL ACTIVATION,0.038848,-0.48242,-0.37672,1,0
4,GO CYCLOOXYGENASE PATHWAY,0.011574,-0.48743,-0.41571,1,0
4,GO ADHESION OF SYMBIONT TO HOST,0.0080134,-0.49288,-0.44094,1,0
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0076456,-0.4939,-0.4381,1,0
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.038848,-0.49402,-0.46015,1,0
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.011063,-0.49625,-0.45544,1,0
4,GO INTERLEUKIN 5 PRODUCTION,0.008797,-0.50513,-0.37893,1,0
4,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.015104,-0.51668,-0.44781,1,0
4,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.011063,-0.51694,-0.55447,1,0
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.030713,-0.52762,-0.36053,1,0
4,GO CHRONIC INFLAMMATORY RESPONSE,0.021265,-0.53273,-0.47315,1,0
4,GO MONOCYTE CHEMOTAXIS,0.0017696,-0.53439,-0.51909,1,0
4,GO COMPLEMENT ACTIVATION,0.0080134,-0.53561,-0.41313,1,0
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.018736,-0.53646,-0.39562,1,0
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0031545,-0.53755,-0.46997,1,0
4,GO INTERLEUKIN 13 PRODUCTION,0.0066311,-0.54071,-0.45181,1,0
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0044907,-0.5425,-0.52852,1,0
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.010572,-0.54273,-0.42232,1,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.020391,-0.54366,-0.49492,1,0
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.0027019,-0.54444,-0.46564,1,0
4,GO MUCUS SECRETION,0.00019306,-0.55501,-0.46544,1,0
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0092139,-0.56105,-0.41927,1,0
4,GO RESPONSE TO PEPTIDOGLYCAN,0.0015882,-0.5631,-0.49299,1,0
4,GO EOSINOPHIL MIGRATION,0.0076456,-0.57549,-0.54416,1,0
4,GO SYNAPSE PRUNING,0.0092139,-0.59144,-0.59996,1,0
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.015776,-0.59255,-0.52413,1,0
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0040644,-0.59807,-0.57315,1,0
4,GO EOSINOPHIL CHEMOTAXIS,0.0060238,-0.64433,-0.548,1,0
4,GO DENDRITIC CELL APOPTOTIC PROCESS,0.006955,-0.66433,-0.63674,1,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0027019,-0.66633,-0.61137,1,0
4,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.015776,-0.7085,-0.66111,1,0
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.016475,-0.73532,-0.63907,1,0
4,GO TONGUE MORPHOGENESIS,0.091819,0.26564,0.1583,0,1
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.098083,0.26556,0.22859,0,1
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.12662,0.26249,0.19858,0,1
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.094909,0.25188,0.23938,0,1
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.16123,0.21458,0.17737,0,1
4,GO SKELETAL MUSCLE ADAPTATION,0.1475,0.20954,0.12842,0,1
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.08588,0.19804,0.20141,0,1
4,GO BICARBONATE TRANSPORT,0.27126,0.19491,0.11713,0,1
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.077559,0.19204,0.13708,0,1
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.11894,0.18938,0.15397,0,1
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.08588,0.18818,0.1824,0,1
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.16602,0.18687,0.19636,0,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.13467,0.18365,0.14252,0,1
4,GO GANGLION DEVELOPMENT,0.12273,0.18337,0.16591,0,1
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.26442,0.18298,0.10228,0,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.11524,0.17965,0.16031,0,1
4,GO PEPTIDYL METHIONINE MODIFICATION,0.069906,0.17835,0.14901,0,1
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.11894,0.17783,0.12299,0,1
4,GO COCHLEA MORPHOGENESIS,0.060677,0.17668,0.20636,0,1
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.13467,0.1718,0.14375,0,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.16123,0.17165,0.15508,0,1
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.33029,0.16826,0.05313,0,1
4,GO PORE COMPLEX ASSEMBLY,0.11163,0.16392,0.10425,0,1
4,GO RECEPTOR RECYCLING,0.12273,0.16389,0.1367,0,1
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.12662,0.16039,0.13245,0,1
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.24463,0.15738,0.13233,0,1
4,GO RESPONSE TO INACTIVITY,0.20822,0.15714,0.12701,0,1
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.077559,0.15159,0.2015,0,1
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.069906,0.15057,0.16163,0,1
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.062884,0.1502,0.19874,0,1
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.094909,0.14999,0.19102,0,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.51122,0.14853,0.064181,0,1
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.065157,0.14725,0.18381,0,1
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.080256,0.14656,0.10933,0,1
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.10811,0.14605,0.12754,0,1
4,GO AMMONIUM ION METABOLIC PROCESS,0.28529,0.14568,0.12092,0,1
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.83078,0.14527,0.018691,0,1
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.15197,0.1437,0.14244,0,1
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.28529,0.14361,0.094802,0,1
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.1306,0.14314,0.20042,0,1
4,GO UV PROTECTION,0.062884,0.13993,0.19956,0,1
4,GO VIRAL RNA GENOME REPLICATION,0.067497,0.13972,0.15285,0,1
4,GO DENDRITIC SPINE MAINTENANCE,0.214,0.13917,0.12964,0,1
4,GO PROSTATE GLAND GROWTH,0.056456,0.1377,0.14316,0,1
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.13467,0.1369,0.11421,0,1
4,GO REGULATION OF RECEPTOR RECYCLING,0.20256,0.13365,0.12005,0,1
4,GO RNA DECAPPING,0.16123,0.13261,0.13263,0,1
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.098083,0.13144,0.16102,0,1
4,GO TOXIN TRANSPORT,0.20256,0.12728,0.096358,0,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.058535,0.12687,0.18826,0,1
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.094909,0.12597,0.11278,0,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.16123,0.12247,0.085503,0,1
4,GO NEPHRIC DUCT MORPHOGENESIS,0.2577,0.12226,0.13121,0,1
4,GO ALDITOL METABOLIC PROCESS,0.33821,0.12166,0.090176,0,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.077559,0.1213,0.11354,0,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.058535,0.12031,0.12182,0,1
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.098083,0.11967,0.11435,0,1
4,GO ACETYL COA METABOLIC PROCESS,0.15197,0.11922,0.081193,0,1
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.080256,0.11854,0.11209,0,1
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.19156,0.11811,0.09569,0,1
4,GO MIRNA METABOLIC PROCESS,0.094909,0.11776,0.13403,0,1
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.37111,0.11757,0.10378,0,1
4,GO NEPHRON TUBULE FORMATION,0.37111,0.11734,0.083073,0,1
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.10811,0.11679,0.098893,0,1
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.11524,0.11676,0.20983,0,1
4,GO MESENCHYMAL CELL PROLIFERATION,0.20256,0.11591,0.15083,0,1
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.074935,0.11489,0.16452,0,1
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.077559,0.11473,0.1274,0,1
4,GO OVULATION CYCLE,0.091819,0.11426,0.16515,0,1
4,GO MATURATION OF SSU RRNA,0.098083,0.11395,0.090723,0,1
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.10811,0.11389,0.14799,0,1
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.11894,0.11286,0.11046,0,1
4,GO PYRUVATE METABOLIC PROCESS,0.074935,0.11197,0.13187,0,1
4,GO PROTEIN IMPORT,0.08303,0.11153,0.10599,0,1
4,GO NUCLEOTIDE TRANSPORT,0.27126,0.11094,0.086901,0,1
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.11524,0.11071,0.070089,0,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.27126,0.10877,0.080265,0,1
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.098083,0.10706,0.19818,0,1
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.069906,0.10627,0.13127,0,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.08588,0.10451,0.14452,0,1
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.10468,0.10174,0.069749,0,1
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.214,0.10053,0.079687,0,1
4,GO NEGATIVE REGULATION OF CELL DIVISION,0.15197,0.099875,0.16355,0,1
4,GO SNORNA METABOLIC PROCESS,0.10468,0.099066,0.084915,0,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.065157,0.097327,0.1069,0,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.25111,0.097219,0.089468,0,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.10468,0.097089,0.18381,0,1
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.056456,0.096446,0.10507,0,1
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.2259,0.095788,0.082468,0,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.14312,0.095608,0.090657,0,1
4,GO CORONARY VASCULATURE DEVELOPMENT,0.13467,0.095212,0.18013,0,1
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.20822,0.093911,0.12465,0,1
4,GO SNORNA 3 END PROCESSING,0.16123,0.093361,0.089465,0,1
4,GO MATURATION OF LSU RRNA,0.197,0.092975,0.063623,0,1
4,GO RRNA METABOLIC PROCESS,0.11524,0.091161,0.075701,0,1
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.33821,0.084074,0.023969,0,1
4,GO RIBOSOME BIOGENESIS,0.15655,0.082287,0.06462,0,1
4,GO CLATHRIN COAT ASSEMBLY,0.1306,0.079936,0.11845,0,1
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.32248,0.078362,0.134,0,1
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.4521,0.078149,0.058151,0,1
4,GO NUCLEOBASE METABOLIC PROCESS,0.30724,0.076517,0.044035,0,1
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.13467,0.076274,0.078063,0,1
4,GO CYTOPLASMIC TRANSLATION,0.3148,0.073716,0.042215,0,1
4,GO NUCLEOSIDE SALVAGE,0.17091,0.073079,0.094533,0,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.24463,0.072909,0.099769,0,1
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.20256,0.072277,0.10735,0,1
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.08881,0.072076,0.1004,0,1
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.13885,0.069805,0.068094,0,1
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.1475,0.065816,0.1461,0,1
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.52145,0.065365,0.05107,0,1
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.65188,0.062126,0.031214,0,1
4,GO VIRAL TRANSLATION,0.15655,0.061989,0.079893,0,1
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.1475,0.056359,0.071388,0,1
4,GO PROTEIN TARGETING TO MEMBRANE,0.16123,0.056292,0.026862,0,1
4,GO REGULATION OF ERAD PATHWAY,0.68646,0.054299,0.03723,0,1
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.41494,0.052306,0.038272,0,1
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.33029,0.042784,0.071157,0,1
4,GO VIRAL GENE EXPRESSION,0.48117,0.041705,0.020387,0,1
4,GO NUCLEOSIDE METABOLIC PROCESS,0.40594,0.037857,0.033284,0,1
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.00072571,0.41375,0.44284,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.0014241,0.40615,0.43271,0,0
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0036751,0.38682,0.39132,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0049572,0.36398,0.33283,0,0
4,GO LIMB BUD FORMATION,0.011063,0.34693,0.33784,0,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.0010209,0.34373,0.39915,0,0
4,GO AXONAL FASCICULATION,0.00086166,0.34125,0.38977,0,0
4,GO PENILE ERECTION,0.030713,0.32683,0.26033,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.045233,0.32266,0.35023,0,0
4,GO CENTRIOLE ASSEMBLY,0.00057531,0.318,0.34007,0,0
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.00064645,0.31782,0.5001,0,0
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.080256,0.3106,0.23297,0,0
4,GO INNER DYNEIN ARM ASSEMBLY,0.1475,0.30633,0.29317,0,0
4,GO KINETOCHORE ORGANIZATION,0.00057531,0.30063,0.38639,0,0
4,GO MALE SEX DETERMINATION,0.025096,0.29294,0.28321,0,0
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.0016767,0.29178,0.25413,0,0
4,GO NOREPINEPHRINE SECRETION,0.015776,0.2906,0.26577,0,0
4,GO REGULATION OF RECEPTOR CLUSTERING,0.067497,0.29049,0.23472,0,0
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00086166,0.28938,0.28298,0,0
4,GO NOREPINEPHRINE TRANSPORT,0.010572,0.28789,0.31801,0,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.0010798,0.28435,0.35975,0,0
4,GO MITOTIC CHROMOSOME CONDENSATION,0.00060992,0.28385,0.4274,0,0
4,GO KINETOCHORE ASSEMBLY,0.0023095,0.28262,0.33845,0,0
4,GO OUTER DYNEIN ARM ASSEMBLY,0.1475,0.28155,0.21575,0,0
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.00332,0.27816,0.30709,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.00057531,0.27756,0.31884,0,0
4,GO DNA STRAND ELONGATION,0.0024341,0.27708,0.26722,0,0
4,GO REPLICATION FORK PROCESSING,0.0016767,0.27407,0.36228,0,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.00054254,0.27306,0.32993,0,0
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.0042727,0.27263,0.2649,0,0
4,GO INOSITOL METABOLIC PROCESS,0.013834,0.26923,0.27205,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0036751,0.26895,0.28139,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.00033648,0.26767,0.31046,0,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0083971,0.26361,0.28792,0,0
4,GO FOREBRAIN NEURON FATE COMMITMENT,0.16602,0.2631,0.27524,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.18624,0.26014,0.24457,0,0
4,GO CENTROSOME DUPLICATION,0.0010798,0.25922,0.28792,0,0
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0096484,0.25836,0.33328,0,0
4,GO NOSE DEVELOPMENT,0.021265,0.25515,0.30813,0,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.031957,0.25404,0.26085,0,0
4,GO OTIC VESICLE DEVELOPMENT,0.027226,0.25328,0.23718,0,0
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.00096503,0.25317,0.3397,0,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.00035748,0.24931,0.29598,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.00332,0.24907,0.25113,0,0
4,GO DNA REPLICATION CHECKPOINT,0.0028457,0.24906,0.28488,0,0
4,GO NON MOTILE CILIUM ASSEMBLY,0.00332,0.24822,0.26395,0,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.00048214,0.2459,0.29438,0,0
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.060677,0.24524,0.29663,0,0
4,GO CHROMATIN SILENCING,0.00091199,0.24317,0.25213,0,0
4,GO PARENTAL BEHAVIOR,0.065157,0.24299,0.27786,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.094909,0.24239,0.16418,0,0
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.040368,0.24232,0.23541,0,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0044907,0.24191,0.21793,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.0019699,0.24178,0.27785,0,0
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0047188,0.24053,0.27608,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.037377,0.23801,0.24515,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.0066311,0.23733,0.2146,0,0
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.024086,0.23714,0.30943,0,0
4,GO REGULATION OF CENTROSOME DUPLICATION,0.0028457,0.23678,0.22666,0,0
4,GO P BODY ASSEMBLY,0.0044907,0.23561,0.29107,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.0014241,0.2352,0.26374,0,0
4,GO CEREBRAL CORTEX DEVELOPMENT,0.00072571,0.23499,0.30572,0,0
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00035748,0.23319,0.28047,0,0
4,GO SPINDLE ORGANIZATION,0.00072571,0.23311,0.27578,0,0
4,GO REGULATION OF CENTROSOME CYCLE,0.0020776,0.23114,0.23727,0,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.00011593,0.23079,0.29897,0,0
4,GO CELL CYCLE DNA REPLICATION,0.0018673,0.23039,0.28026,0,0
4,GO PROSTATE GLAND MORPHOGENESIS,0.043559,0.23003,0.23886,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.0010798,0.22972,0.2722,0,0
4,GO REGULATION OF CELL PROJECTION SIZE,0.067497,0.22911,0.25651,0,0
4,GO CHROMOSOME SEPARATION,0.00024771,0.2288,0.30993,0,0
4,GO PROTEIN PALMITOYLATION,0.015776,0.22854,0.22502,0,0
4,GO CENTROMERE COMPLEX ASSEMBLY,0.0010209,0.22827,0.32536,0,0
4,GO GROOMING BEHAVIOR,0.031957,0.22807,0.19684,0,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0063209,0.22797,0.2815,0,0
4,GO CHROMATIN REMODELING AT CENTROMERE,0.0013481,0.22571,0.32455,0,0
4,GO REGULATION OF GLUTAMATE SECRETION,0.10468,0.2252,0.23802,0,0
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.065157,0.22498,0.19587,0,0
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.00057531,0.22485,0.2712,0,0
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.060677,0.22484,0.209,0,0
4,GO SPINDLE ASSEMBLY,0.0016767,0.22449,0.25817,0,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0057394,0.22438,0.28004,0,0
4,GO CHROMOSOME SEGREGATION,0.00096503,0.22437,0.26424,0,0
4,GO NOTOCHORD DEVELOPMENT,0.056456,0.22317,0.2022,0,0
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.00068502,0.22309,0.26611,0,0
4,GO HISTONE H4 K16 ACETYLATION,0.0027019,0.22249,0.26525,0,0
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.008797,0.22177,0.2971,0,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.011574,0.22101,0.19191,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.0012758,0.22093,0.27873,0,0
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.074935,0.22017,0.18908,0,0
4,GO CHROMOSOME CONDENSATION,0.0010209,0.22004,0.32599,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.18624,0.21829,0.1425,0,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.14312,0.21775,0.15532,0,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0063209,0.21646,0.23023,0,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.0015041,0.21622,0.24915,0,0
4,GO MEMBRANE DISASSEMBLY,0.020391,0.21525,0.22719,0,0
4,GO CGMP METABOLIC PROCESS,0.098083,0.21443,0.1612,0,0
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.058535,0.21439,0.20702,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.031957,0.21431,0.26263,0,0
4,GO MITOTIC DNA REPLICATION,0.020391,0.21281,0.22429,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.067497,0.21242,0.22115,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.022172,0.21238,0.27244,0,0
4,GO SISTER CHROMATID SEGREGATION,0.00051151,0.21129,0.26979,0,0
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0023095,0.21118,0.26003,0,0
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.00013188,0.21084,0.29861,0,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.0010209,0.21051,0.25352,0,0
4,GO G2 DNA DAMAGE CHECKPOINT,0.0076456,0.21003,0.25183,0,0
4,GO MITOTIC NUCLEAR DIVISION,0.00057531,0.20979,0.25017,0,0
4,GO MATING,0.0036751,0.20954,0.22867,0,0
4,GO CRANIAL NERVE DEVELOPMENT,0.0172,0.20953,0.28426,0,0
4,GO MRNA 3 END PROCESSING,0.0023095,0.20939,0.22303,0,0
4,GO REGULATION OF HELICASE ACTIVITY,0.010572,0.20837,0.18985,0,0
4,GO REGULATION OF TUBULIN DEACETYLATION,0.024086,0.20738,0.22757,0,0
4,GO MEIOTIC CELL CYCLE,0.00064645,0.20547,0.25724,0,0
4,GO SINGLE STRAND BREAK REPAIR,0.0066311,0.20524,0.21674,0,0
4,GO PRO B CELL DIFFERENTIATION,0.010572,0.2028,0.29188,0,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0054671,0.20129,0.25489,0,0
4,GO RRNA 3 END PROCESSING,0.0029965,0.20092,0.17476,0,0
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.069906,0.20057,0.18175,0,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.016475,0.20038,0.24333,0,0
4,GO DNA RECOMBINATION,0.007293,0.20028,0.20291,0,0
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.01266,0.19975,0.28292,0,0
4,GO HOMOLOGOUS RECOMBINATION,0.0013481,0.19947,0.2896,0,0
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.0080134,0.19892,0.24928,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.021265,0.19808,0.25039,0,0
4,GO ORGANELLE FISSION,0.0011418,0.19683,0.22069,0,0
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0028457,0.19671,0.30161,0,0
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.013834,0.19656,0.19856,0,0
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.010101,0.1965,0.22653,0,0
4,GO DORSAL VENTRAL PATTERN FORMATION,0.0024341,0.1963,0.27281,0,0
4,GO SISTER CHROMATID COHESION,0.00091199,0.19557,0.29213,0,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.006955,0.19503,0.24603,0,0
4,GO EPITHELIAL CELL CELL ADHESION,0.18102,0.19441,0.17594,0,0
4,GO STEM CELL DIVISION,0.12662,0.19366,0.17155,0,0
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.069906,0.19282,0.24676,0,0
4,GO MEIOTIC CELL CYCLE PROCESS,0.00064645,0.19188,0.25059,0,0
4,GO SEX DETERMINATION,0.094909,0.19132,0.16014,0,0
4,GO CHROMOSOME LOCALIZATION,0.0015882,0.19128,0.22478,0,0
4,GO CHROMOSOME ORGANIZATION,0.0011418,0.19083,0.24005,0,0
4,GO METAPHASE PLATE CONGRESSION,0.0012071,0.19073,0.23185,0,0
4,GO GANGLIOSIDE METABOLIC PROCESS,0.015776,0.19025,0.23206,0,0
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0052065,0.19004,0.25519,0,0
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.0025648,0.18981,0.26516,0,0
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0018673,0.18963,0.2252,0,0
4,GO MALE MEIOSIS I,0.01266,0.1889,0.2217,0,0
4,GO OOCYTE MATURATION,0.010101,0.18876,0.25623,0,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.077559,0.18867,0.23221,0,0
4,GO NEURAL TUBE DEVELOPMENT,0.017954,0.18865,0.20722,0,0
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.54223,0.18858,0.070045,0,0
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.11524,0.18841,0.32885,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.28529,0.18838,0.12812,0,0
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00332,0.18714,0.22791,0,0
4,GO REGULATION OF HIPPO SIGNALING,0.080256,0.18666,0.21046,0,0
4,GO DNA INTEGRITY CHECKPOINT,0.0052065,0.18532,0.23415,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.035953,0.18524,0.24519,0,0
4,GO MRNA METHYLATION,0.0076456,0.18425,0.24065,0,0
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.013235,0.18391,0.2332,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.15197,0.18361,0.19202,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.056456,0.18355,0.26724,0,0
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.098083,0.18351,0.14424,0,0
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0040644,0.18277,0.2383,0,0
4,GO HEMIDESMOSOME ASSEMBLY,0.54223,0.18266,0.092104,0,0
4,GO RNA EXPORT FROM NUCLEUS,0.0063209,0.18147,0.19572,0,0
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.08303,0.18064,0.21953,0,0
4,GO DNA REPAIR,0.0013481,0.18031,0.21927,0,0
4,GO MRNA PROCESSING,0.0029965,0.18006,0.20525,0,0
4,GO CELL DIVISION,0.0012758,0.17945,0.21312,0,0
4,GO LACTATION,0.056456,0.17933,0.16203,0,0
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.056456,0.17896,0.21457,0,0
4,GO EPITHELIAL CELL FATE COMMITMENT,0.018736,0.17894,0.23758,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.038848,0.1788,0.18204,0,0
4,GO REGULATION OF AXON GUIDANCE,0.060677,0.17823,0.20776,0,0
4,GO RENAL VESICLE DEVELOPMENT,0.035953,0.1779,0.22385,0,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,0.017954,0.17767,0.24716,0,0
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.08881,0.17754,0.19294,0,0
4,GO SCHWANN CELL DEVELOPMENT,0.011574,0.17628,0.2491,0,0
4,GO METHIONINE METABOLIC PROCESS,0.041938,0.17622,0.1868,0,0
4,GO REGULATION OF STEM CELL PROLIFERATION,0.013834,0.17422,0.21764,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.11163,0.17344,0.26962,0,0
4,GO RNA 3 END PROCESSING,0.0044907,0.17299,0.17726,0,0
4,GO CELL CYCLE CHECKPOINT,0.00332,0.17227,0.23623,0,0
4,GO SOMATIC STEM CELL DIVISION,0.18624,0.17205,0.2004,0,0
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.007293,0.17146,0.21394,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.0042727,0.17095,0.24127,0,0
4,GO REGULATION OF NUCLEAR DIVISION,0.00096503,0.17077,0.20967,0,0
4,GO MRNA EXPORT FROM NUCLEUS,0.0040644,0.17061,0.21188,0,0
4,GO ADHERENS JUNCTION ASSEMBLY,0.065157,0.17026,0.22677,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.007293,0.17014,0.24303,0,0
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.050584,0.16895,0.1561,0,0
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.017954,0.16805,0.21036,0,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0029965,0.16727,0.2005,0,0
4,GO EXIT FROM MITOSIS,0.00332,0.16712,0.21925,0,0
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.0010209,0.16676,0.25153,0,0
4,GO MOTILE CILIUM ASSEMBLY,0.067497,0.16648,0.20783,0,0
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.065157,0.16597,0.18283,0,0
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.214,0.16569,0.18528,0,0
4,GO APPENDAGE MORPHOGENESIS,0.0080134,0.16558,0.23542,0,0
4,GO FAT CELL PROLIFERATION,0.197,0.16538,0.12774,0,0
4,GO REGULATION OF MRNA BINDING,0.024086,0.16516,0.13896,0,0
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.0054671,0.16493,0.17911,0,0
4,GO DIENCEPHALON DEVELOPMENT,0.0057394,0.16473,0.26516,0,0
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.0063209,0.16437,0.22679,0,0
4,GO REGULATION OF CELL DIVISION,0.0172,0.16422,0.17258,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0047188,0.16317,0.21137,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.28529,0.16295,0.12819,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0047188,0.16264,0.17261,0,0
4,GO OXYGEN TRANSPORT,0.41494,0.16259,0.15998,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.0023095,0.16159,0.20148,0,0
4,GO RNA SPLICING,0.0029965,0.16143,0.19879,0,0
4,GO THYROID HORMONE METABOLIC PROCESS,0.197,0.16139,0.14666,0,0
4,GO HISTONE PHOSPHORYLATION,0.0057394,0.16019,0.19483,0,0
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.52145,0.16004,0.077339,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.0024341,0.16002,0.22689,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.012106,0.16002,0.20456,0,0
4,GO CELL CYCLE PROCESS,0.0016767,0.15991,0.20835,0,0
4,GO DNA DEMETHYLATION,0.012106,0.15931,0.18353,0,0
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.2998,0.15888,0.13985,0,0
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.2577,0.15888,0.11381,0,0
4,GO NEURAL TUBE FORMATION,0.056456,0.15844,0.17258,0,0
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.022172,0.15831,0.19269,0,0
4,GO AZOLE TRANSMEMBRANE TRANSPORT,0.58498,0.1574,0.082051,0,0
4,GO NUCLEAR EXPORT,0.0047188,0.15728,0.18826,0,0
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.056456,0.15711,0.15864,0,0
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.060677,0.15621,0.18726,0,0
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.028348,0.15577,0.17725,0,0
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.0063209,0.15549,0.17668,0,0
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.012106,0.15526,0.25769,0,0
4,GO RRNA CATABOLIC PROCESS,0.040368,0.15525,0.1457,0,0
4,GO NEURONAL ACTION POTENTIAL,0.08303,0.15504,0.14313,0,0
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.0096484,0.15455,0.21117,0,0
4,GO MAINTENANCE OF CELL POLARITY,0.058535,0.15412,0.19847,0,0
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.0027019,0.15398,0.23412,0,0
4,GO CELLULAR RESPONSE TO STEROL,0.037377,0.15387,0.2137,0,0
4,GO GENITALIA MORPHOGENESIS,0.08588,0.15361,0.21802,0,0
4,GO CHROMATIN DISASSEMBLY,0.062884,0.15351,0.19295,0,0
4,GO MITOTIC CELL CYCLE,0.0018673,0.15253,0.19683,0,0
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.027226,0.15245,0.17334,0,0
4,GO SNRNA TRANSCRIPTION,0.0063209,0.15188,0.16018,0,0
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.012106,0.15181,0.21545,0,0
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.18624,0.15105,0.09656,0,0
4,GO KERATINOCYTE DEVELOPMENT,0.060677,0.15102,0.25,0,0
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.11163,0.1509,0.19523,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE,0.0054671,0.15032,0.1778,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.11163,0.15023,0.19693,0,0
4,GO OOGENESIS,0.0025648,0.14979,0.20955,0,0
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.019548,0.1495,0.20115,0,0
4,GO SALIVA SECRETION,0.14312,0.14849,0.16026,0,0
4,GO DNA CATABOLIC PROCESS,0.0096484,0.14789,0.16301,0,0
4,GO REGULATION OF CILIUM MOVEMENT,0.094909,0.14735,0.11148,0,0
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.010572,0.1468,0.181,0,0
4,GO CELL CYCLE ARREST,0.0031545,0.14667,0.1931,0,0
4,GO DNA LIGATION,0.031957,0.14642,0.1462,0,0
4,GO REGIONALIZATION,0.013235,0.14641,0.1914,0,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.214,0.14619,0.099114,0,0
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.17091,0.14603,0.15418,0,0
4,GO TELOMERE ORGANIZATION,0.0057394,0.14583,0.17906,0,0
4,GO MRNA TRANSPORT,0.0054671,0.14573,0.19416,0,0
4,GO SEX DIFFERENTIATION,0.014457,0.14539,0.17209,0,0
4,GO OOCYTE DIFFERENTIATION,0.033245,0.14529,0.14505,0,0
4,GO REGULATION OF CELL CYCLE ARREST,0.00086166,0.14464,0.21571,0,0
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0052065,0.1445,0.18409,0,0
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.1475,0.14442,0.17153,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.16123,0.14423,0.17909,0,0
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.60692,0.14403,0.10202,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.0038653,0.14384,0.17722,0,0
4,GO RESPONSE TO SALT,0.067497,0.1436,0.12863,0,0
4,GO LACTATE METABOLIC PROCESS,0.027226,0.14344,0.14515,0,0
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.067497,0.14344,0.2212,0,0
4,GO CELLULAR RESPONSE TO VITAMIN D,0.17591,0.14337,0.15386,0,0
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0020776,0.14294,0.20075,0,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.15655,0.1428,0.13298,0,0
4,GO STEM CELL PROLIFERATION,0.026142,0.14275,0.19644,0,0
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0076456,0.1425,0.16076,0,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0031545,0.1418,0.18863,0,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.13885,0.14105,0.14495,0,0
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.15197,0.14098,0.18925,0,0
4,GO CELL CYCLE PHASE TRANSITION,0.0027019,0.14074,0.18243,0,0
4,GO REGULATION OF MITOTIC CELL CYCLE,0.0027019,0.13999,0.18182,0,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.031957,0.13999,0.15202,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.010572,0.13984,0.21454,0,0
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.022172,0.13961,0.20846,0,0
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.12273,0.13945,0.21773,0,0
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.17591,0.13926,0.17388,0,0
4,GO DENDRITE SELF AVOIDANCE,0.23827,0.13857,0.12431,0,0
4,GO SYNAPTIC VESICLE MATURATION,0.08303,0.13851,0.25113,0,0
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.0060238,0.13805,0.23679,0,0
4,GO CENTROSOME SEPARATION,0.0063209,0.13804,0.22819,0,0
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.021265,0.13788,0.1472,0,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.094909,0.13733,0.16752,0,0
4,GO NEURAL CREST CELL MIGRATION,0.045233,0.13712,0.19465,0,0
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.37111,0.137,0.099451,0,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.014457,0.13694,0.16365,0,0
4,GO REGULATION OF DNA RECOMBINATION,0.056456,0.13694,0.15463,0,0
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.2577,0.13649,0.11414,0,0
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.011574,0.13638,0.16279,0,0
4,GO POSTREPLICATION REPAIR,0.0096484,0.13589,0.14912,0,0
4,GO WHITE FAT CELL DIFFERENTIATION,0.17091,0.13574,0.12733,0,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.072385,0.13535,0.17123,0,0
4,GO REGULATION OF EXIT FROM MITOSIS,0.007293,0.13522,0.26858,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0063209,0.13522,0.16432,0,0
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.033245,0.1352,0.16765,0,0
4,GO REGULATION OF DNA BINDING,0.0036751,0.13509,0.19778,0,0
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.10811,0.13408,0.16148,0,0
4,GO EATING BEHAVIOR,0.023112,0.13365,0.20442,0,0
4,GO LEFT RIGHT PATTERN FORMATION,0.10134,0.13353,0.15097,0,0
4,GO POSITIVE REGULATION OF ACROSOME REACTION,0.08303,0.1329,0.14068,0,0
4,GO ACTIVATION OF MAPKK ACTIVITY,0.1306,0.13274,0.16446,0,0
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.069906,0.13212,0.18546,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.040368,0.13199,0.13624,0,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.072385,0.13162,0.13637,0,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.035953,0.13154,0.18855,0,0
4,GO REGULATION OF CELL AGING,0.056456,0.13083,0.15815,0,0
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.0172,0.13068,0.16119,0,0
4,GO SPINDLE MIDZONE ASSEMBLY,0.10468,0.13059,0.18582,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.35442,0.13045,0.098158,0,0
4,GO REGULATION OF GTP BINDING,0.36271,0.13027,0.096138,0,0
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.08588,0.13011,0.10786,0,0
4,GO GOLGI LOCALIZATION,0.080256,0.12995,0.10785,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.030713,0.12956,0.11751,0,0
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.1306,0.12938,0.14348,0,0
4,GO NUCLEAR TRANSPORT,0.007293,0.12898,0.16562,0,0
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.062884,0.12874,0.13777,0,0
4,GO APPENDAGE DEVELOPMENT,0.016475,0.12857,0.2079,0,0
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.026142,0.12843,0.14977,0,0
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.20822,0.12817,0.1006,0,0
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.094909,0.12809,0.1238,0,0
4,GO NEUROBLAST DIVISION,0.065157,0.12802,0.18281,0,0
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.24463,0.12711,0.16648,0,0
4,GO EXTRACELLULAR TRANSPORT,0.091819,0.12707,0.1686,0,0
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.062884,0.12703,0.16692,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.1306,0.12694,0.21808,0,0
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.067497,0.1269,0.16065,0,0
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.10468,0.12672,0.12562,0,0
4,GO CELL JUNCTION ASSEMBLY,0.062884,0.12669,0.18434,0,0
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0057394,0.12666,0.19985,0,0
4,GO REGULATION OF GONAD DEVELOPMENT,0.011063,0.12642,0.2158,0,0
4,GO RESPONSE TO PARATHYROID HORMONE,0.11894,0.12606,0.15887,0,0
4,GO DNA DEALKYLATION,0.033245,0.12576,0.14844,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.016475,0.12571,0.1358,0,0
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.091819,0.12529,0.15698,0,0
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.065157,0.12509,0.20122,0,0
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.10811,0.12475,0.11736,0,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.14312,0.12475,0.14393,0,0
4,GO RNA LOCALIZATION,0.013834,0.1247,0.15353,0,0
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.065157,0.12403,0.17555,0,0
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.060677,0.12398,0.21832,0,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.056456,0.12394,0.14223,0,0
4,GO PROSTATIC BUD FORMATION,0.197,0.12376,0.14227,0,0
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.16123,0.12352,0.19379,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.28529,0.12338,0.10732,0,0
4,GO EMBRYONIC HEMOPOIESIS,0.11524,0.12316,0.16579,0,0
4,GO POSITIVE REGULATION OF DNA BINDING,0.0172,0.123,0.1708,0,0
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.11524,0.12275,0.16516,0,0
4,GO PROTEIN HETEROOLIGOMERIZATION,0.062884,0.12249,0.13302,0,0
4,GO DORSAL AORTA DEVELOPMENT,0.4521,0.12227,0.11993,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.077559,0.12207,0.11393,0,0
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.11524,0.12187,0.1687,0,0
4,GO MRNA MODIFICATION,0.056456,0.12186,0.1369,0,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.056456,0.12103,0.12911,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.52145,0.12068,0.075463,0,0
4,GO POSITIVE REGULATION OF CELL MATURATION,0.13467,0.12035,0.15902,0,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.069906,0.12004,0.22705,0,0
4,GO MEMBRANE FISSION,0.058535,0.11964,0.16349,0,0
4,GO ACROSOME REACTION,0.10468,0.11907,0.15155,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.065157,0.11884,0.15574,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.39705,0.11882,0.12814,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.010572,0.11875,0.19208,0,0
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.1475,0.11841,0.15251,0,0
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.11524,0.11826,0.20615,0,0
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.11524,0.11824,0.12994,0,0
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.030713,0.11797,0.13807,0,0
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.065157,0.11788,0.16519,0,0
4,GO RNA PROCESSING,0.010101,0.11787,0.15002,0,0
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.058535,0.1178,0.16177,0,0
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.1306,0.11778,0.12695,0,0
4,GO TRNA CATABOLIC PROCESS,0.056456,0.11774,0.18745,0,0
4,GO MEMBRANE BIOGENESIS,0.072385,0.11771,0.17236,0,0
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.017954,0.11763,0.159,0,0
4,GO DEFINITIVE HEMOPOIESIS,0.098083,0.11754,0.20598,0,0
4,GO COPULATION,0.21989,0.11735,0.13724,0,0
4,GO BASIC AMINO ACID TRANSPORT,0.23827,0.11724,0.1435,0,0
4,GO REGULATION OF SENSORY PERCEPTION,0.056456,0.1172,0.15086,0,0
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.33029,0.11713,0.095486,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.030713,0.11667,0.13823,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.27126,0.11658,0.08018,0,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.043559,0.11651,0.13319,0,0
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.12273,0.11649,0.22238,0,0
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.27126,0.11627,0.1355,0,0
4,GO POSITIVE REGULATION OF BINDING,0.050584,0.11623,0.12556,0,0
4,GO DETERMINATION OF ADULT LIFESPAN,0.37111,0.11597,0.10612,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.080256,0.11593,0.13918,0,0
4,GO BASE EXCISION REPAIR,0.0024341,0.11592,0.18977,0,0
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.49108,0.11589,0.065362,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.022172,0.11551,0.15122,0,0
4,GO IRON COORDINATION ENTITY TRANSPORT,0.214,0.11547,0.1364,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.18624,0.11546,0.19822,0,0
4,GO EYE MORPHOGENESIS,0.058535,0.11524,0.18203,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0054671,0.11522,0.14986,0,0
4,GO SPERM AXONEME ASSEMBLY,0.12662,0.11494,0.16181,0,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.25111,0.11477,0.13453,0,0
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.077559,0.11464,0.15408,0,0
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.080256,0.1143,0.13907,0,0
4,GO MELANOCYTE DIFFERENTIATION,0.08588,0.11427,0.14711,0,0
4,GO PLASMA MEMBRANE TUBULATION,0.12662,0.11426,0.15933,0,0
4,GO FATTY ACID CATABOLIC PROCESS,0.13885,0.11399,0.10168,0,0
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.060677,0.11393,0.1745,0,0
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.067497,0.1139,0.18398,0,0
4,GO CELL AGGREGATION,0.32248,0.11368,0.084705,0,0
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.13885,0.11364,0.19713,0,0
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.10811,0.11362,0.15128,0,0
4,GO CARDIAC ATRIUM DEVELOPMENT,0.18102,0.11341,0.17797,0,0
4,GO CELLULAR RESPONSE TO PH,0.14312,0.11319,0.1415,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.38829,0.11311,0.084938,0,0
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.214,0.11298,0.13748,0,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.08588,0.11297,0.1423,0,0
4,GO MRNA METABOLIC PROCESS,0.0040644,0.11282,0.15422,0,0
4,GO SULFATION,0.30724,0.11274,0.11113,0,0
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.020391,0.11266,0.14965,0,0
4,GO ENDOCYTIC RECYCLING,0.11524,0.11225,0.16434,0,0
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.072385,0.11215,0.13133,0,0
4,GO MRNA TRANSCRIPTION,0.30724,0.11206,0.12118,0,0
4,GO REGULATION OF TELOMERE CAPPING,0.10134,0.11205,0.15976,0,0
4,GO RNA METHYLATION,0.027226,0.1119,0.14255,0,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.058535,0.11164,0.14617,0,0
4,GO INTRACELLULAR LIPID TRANSPORT,0.050584,0.11148,0.16822,0,0
4,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.50109,0.11144,0.06166,0,0
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.060677,0.11124,0.13722,0,0
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.11524,0.11104,0.11875,0,0
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.15197,0.11089,0.11311,0,0
4,GO PERICARDIUM DEVELOPMENT,0.080256,0.11067,0.18667,0,0
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.15655,0.11064,0.18179,0,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.17591,0.1106,0.10621,0,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,0.2259,0.11058,0.12858,0,0
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.2259,0.11044,0.10973,0,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.12662,0.11036,0.16569,0,0
4,GO HISTONE H3 ACETYLATION,0.058535,0.11015,0.15416,0,0
4,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.34626,0.10955,0.12282,0,0
4,GO MYOBLAST PROLIFERATION,0.14312,0.1093,0.10129,0,0
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.077559,0.10923,0.14182,0,0
4,GO LIPID PHOSPHORYLATION,0.094909,0.1092,0.16178,0,0
4,GO LIPOPROTEIN LOCALIZATION,0.55277,0.10918,0.064579,0,0
4,GO CELL FATE COMMITMENT,0.014457,0.10908,0.18247,0,0
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.080256,0.10888,0.12752,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.013834,0.10872,0.15915,0,0
4,GO OSTEOBLAST DEVELOPMENT,0.27126,0.1087,0.10408,0,0
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.077559,0.10866,0.15304,0,0
4,GO REGULATION OF EXOCYTOSIS,0.060677,0.10845,0.1542,0,0
4,GO PONS DEVELOPMENT,0.19156,0.10841,0.27007,0,0
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.55277,0.10832,0.060032,0,0
4,GO PEPTIDYL THREONINE MODIFICATION,0.058535,0.10804,0.17014,0,0
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.36271,0.10794,0.091291,0,0
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.17091,0.10792,0.23189,0,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.10811,0.1078,0.17607,0,0
4,GO PROTEIN KINASE C SIGNALING,0.2259,0.10769,0.17723,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.12273,0.10733,0.20496,0,0
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.13467,0.10709,0.1235,0,0
4,GO FIBROBLAST APOPTOTIC PROCESS,0.1475,0.10704,0.13136,0,0
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.065157,0.10702,0.16326,0,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.12273,0.10683,0.17725,0,0
4,GO RNA MODIFICATION,0.045233,0.10642,0.10393,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.058535,0.10635,0.12576,0,0
4,GO MANNOSYLATION,0.11524,0.10622,0.12518,0,0
4,GO GOLGI ORGANIZATION,0.11524,0.10615,0.11581,0,0
4,GO MATURATION OF 5 8S RRNA,0.17591,0.10599,0.08453,0,0
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.08303,0.10597,0.11085,0,0
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.53179,0.10578,0.10411,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.037377,0.10565,0.15217,0,0
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.2998,0.10562,0.14729,0,0
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.056456,0.1053,0.20156,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.15197,0.10525,0.12895,0,0
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.17591,0.10517,0.09461,0,0
4,GO TRACHEA DEVELOPMENT,0.25111,0.10481,0.15194,0,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.098083,0.10473,0.15034,0,0
4,GO HYPEROSMOTIC RESPONSE,0.12273,0.10467,0.17492,0,0
4,GO SNRNA METABOLIC PROCESS,0.022172,0.10433,0.12017,0,0
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.069906,0.10413,0.15954,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.020391,0.10398,0.1131,0,0
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.12273,0.10387,0.12564,0,0
4,GO LIPID OXIDATION,0.34626,0.10385,0.073946,0,0
4,GO MITOCHONDRIAL RNA PROCESSING,0.69814,0.10382,0.024546,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.040368,0.10308,0.12717,0,0
4,GO AROMATIC AMINO ACID TRANSPORT,0.214,0.10274,0.17766,0,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.018736,0.1026,0.21743,0,0
4,GO POSITIVE REGULATION OF CELL DIVISION,0.094909,0.10248,0.13053,0,0
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.072385,0.10246,0.1808,0,0
4,GO RNA STABILIZATION,0.011063,0.1021,0.18088,0,0
4,GO GMP METABOLIC PROCESS,0.046961,0.10199,0.14164,0,0
4,GO ERYTHROCYTE MATURATION,0.16123,0.10194,0.15227,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.28529,0.10187,0.1514,0,0
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.080256,0.10183,0.12209,0,0
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.08588,0.1018,0.17343,0,0
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.08588,0.10176,0.15219,0,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.64051,0.10109,0.070037,0,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.14312,0.10072,0.12008,0,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.011063,0.10065,0.18267,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.46168,0.10056,0.11078,0,0
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.33821,0.10053,0.11234,0,0
4,GO GENETIC IMPRINTING,0.10134,0.1002,0.1684,0,0
4,GO VIRAL LATENCY,0.054439,0.10014,0.12598,0,0
4,GO COENZYME A METABOLIC PROCESS,0.12662,0.099866,0.12706,0,0
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.12662,0.099826,0.093325,0,0
4,GO ENERGY HOMEOSTASIS,0.13467,0.099812,0.15502,0,0
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.077559,0.099724,0.17037,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.077559,0.099655,0.12445,0,0
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.058535,0.099305,0.18522,0,0
4,GO NCRNA 3 END PROCESSING,0.065157,0.099161,0.086037,0,0
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.21989,0.09898,0.08085,0,0
4,GO PURINE NUCLEOTIDE TRANSPORT,0.23203,0.098708,0.087869,0,0
4,GO THYROID GLAND DEVELOPMENT,0.08303,0.098202,0.2127,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.52145,0.097821,0.061475,0,0
4,GO BLASTOCYST GROWTH,0.32248,0.097771,0.088531,0,0
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.17591,0.097589,0.14719,0,0
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.36271,0.09758,0.089776,0,0
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.42405,0.097535,0.062562,0,0
4,GO PARTURITION,0.24463,0.097279,0.11205,0,0
4,GO VACUOLAR TRANSPORT,0.11163,0.097191,0.12883,0,0
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.098083,0.097056,0.15033,0,0
4,GO RRNA MODIFICATION,0.37111,0.096789,0.05958,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.11894,0.096622,0.13824,0,0
4,GO HISTONE H2B UBIQUITINATION,0.19156,0.09659,0.11443,0,0
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.35442,0.09643,0.12675,0,0
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.30724,0.096352,0.16383,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.1475,0.096239,0.12227,0,0
4,GO REGULATION OF FIBROBLAST MIGRATION,0.25111,0.096229,0.13133,0,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.14312,0.096102,0.10951,0,0
4,GO MULTICELLULAR ORGANISM AGING,0.46168,0.09609,0.074272,0,0
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.38829,0.096062,0.096117,0,0
4,GO REGULATION OF ATP METABOLIC PROCESS,0.094909,0.096058,0.11442,0,0
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.32248,0.096031,0.068421,0,0
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.17591,0.096011,0.14394,0,0
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.067497,0.095869,0.15672,0,0
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.27821,0.095826,0.095876,0,0
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.23827,0.095659,0.112,0,0
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.067497,0.095531,0.1464,0,0
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.060677,0.09546,0.14433,0,0
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.08881,0.095432,0.12421,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.10468,0.095375,0.14594,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0066311,0.095136,0.18337,0,0
4,GO LIPOPROTEIN METABOLIC PROCESS,0.21989,0.09506,0.086052,0,0
4,GO REGULATION OF DNA METHYLATION,0.32248,0.094933,0.08105,0,0
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.17091,0.094685,0.090681,0,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.060677,0.094681,0.083295,0,0
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.048745,0.094578,0.10015,0,0
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.08588,0.094502,0.13997,0,0
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.056456,0.094462,0.11838,0,0
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.056456,0.094456,0.168,0,0
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.094909,0.094333,0.15659,0,0
4,GO GOLGI TO VACUOLE TRANSPORT,0.24463,0.094119,0.14512,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.69814,0.094072,0.041059,0,0
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.10811,0.093925,0.10279,0,0
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.29248,0.093925,0.11926,0,0
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.058535,0.093916,0.098093,0,0
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.29248,0.093912,0.084821,0,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.62923,0.093838,0.060613,0,0
4,GO BLASTOCYST DEVELOPMENT,0.031957,0.093821,0.10777,0,0
4,GO PROTEIN NEDDYLATION,0.26442,0.093653,0.063553,0,0
4,GO REGULATION OF PROTEIN DEACETYLATION,0.10468,0.09356,0.14486,0,0
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.08303,0.09353,0.13668,0,0
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.067497,0.093369,0.12971,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.36271,0.093268,0.12633,0,0
4,GO REFLEX,0.69814,0.093065,-0.020926,0,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.197,0.092982,0.11126,0,0
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.15197,0.092956,0.20126,0,0
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.10134,0.092849,0.12039,0,0
4,GO REGULATION OF RELAXATION OF MUSCLE,0.50109,0.092726,0.049728,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.2259,0.092481,0.1568,0,0
4,GO ESTROUS CYCLE,0.21989,0.092326,0.15881,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.2577,0.092169,0.11349,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.15197,0.091972,0.16469,0,0
4,GO MITOCHONDRIAL TRANSCRIPTION,0.098083,0.091941,0.11005,0,0
4,GO TRNA METHYLATION,0.072385,0.091408,0.11624,0,0
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.13467,0.091407,0.13152,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.2259,0.091315,0.12765,0,0
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.37111,0.091198,0.15408,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.17091,0.090828,0.087607,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.091819,0.090826,0.095549,0,0
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.18624,0.090784,0.14329,0,0
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.080256,0.090746,0.1238,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.013834,0.090686,0.14528,0,0
4,GO MOLTING CYCLE,0.15655,0.09017,0.13235,0,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.074935,0.090083,0.10418,0,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.18624,0.090075,0.11164,0,0
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.060677,0.089959,0.17014,0,0
4,GO STRIATED MUSCLE ADAPTATION,0.080256,0.089818,0.16538,0,0
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.23827,0.089609,0.12017,0,0
4,GO THIOESTER METABOLIC PROCESS,0.35442,0.08957,0.043778,0,0
4,GO EAR MORPHOGENESIS,0.040368,0.089557,0.1879,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.18624,0.089473,0.089548,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.35442,0.089452,0.066524,0,0
4,GO PIRNA METABOLIC PROCESS,0.2577,0.089144,0.056838,0,0
4,GO HISTONE H3 K9 ACETYLATION,0.062884,0.089092,0.13553,0,0
4,GO NEURAL CREST CELL DIFFERENTIATION,0.13467,0.088893,0.1596,0,0
4,GO SKIN EPIDERMIS DEVELOPMENT,0.11894,0.088629,0.14202,0,0
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.11894,0.088436,0.12795,0,0
4,GO PROTEIN REFOLDING,0.20256,0.08822,0.12242,0,0
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.12662,0.088193,0.12632,0,0
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.32248,0.088176,0.12515,0,0
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.53179,0.088171,0.092774,0,0
4,GO CANONICAL WNT SIGNALING PATHWAY,0.1306,0.088168,0.13644,0,0
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.13467,0.08816,0.11576,0,0
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.36271,0.087675,0.13776,0,0
4,GO SMOOTH MUSCLE CONTRACTION,0.13885,0.087647,0.12748,0,0
4,GO RESPONSE TO ACTIVITY,0.18624,0.087506,0.098939,0,0
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.34626,0.087422,0.082691,0,0
4,GO GLIAL CELL DIFFERENTIATION,0.15655,0.087418,0.14654,0,0
4,GO VESICLE LOCALIZATION,0.08881,0.087157,0.1281,0,0
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.11163,0.087029,0.12053,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,0.13467,0.086965,0.10731,0,0
4,GO LYMPH VESSEL MORPHOGENESIS,0.46168,0.086606,0.11351,0,0
4,GO CRISTAE FORMATION,0.17091,0.086569,0.11206,0,0
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.34626,0.086494,0.1185,0,0
4,GO DEVELOPMENTAL MATURATION,0.077559,0.086485,0.1571,0,0
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.080256,0.086377,0.19279,0,0
4,GO HORMONE TRANSPORT,0.060677,0.086356,0.14531,0,0
4,GO MIDBRAIN DEVELOPMENT,0.069906,0.08629,0.13831,0,0
4,GO CELL CELL SIGNALING,0.065157,0.086188,0.14393,0,0
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.077559,0.085901,0.13515,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.27821,0.085804,0.077893,0,0
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.11894,0.085704,0.12168,0,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.32248,0.085546,0.068706,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.51122,0.085545,0.024185,0,0
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.58498,0.085527,0.10924,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.040368,0.085427,0.11773,0,0
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.065157,0.085193,0.14251,0,0
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.52145,0.085165,0.079162,0,0
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.30724,0.085137,0.13142,0,0
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.008797,0.084786,0.1976,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.29248,0.08447,0.087916,0,0
4,GO AXIS ELONGATION,0.40594,0.08442,0.099258,0,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.48117,0.084154,0.048976,0,0
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.61803,0.084138,0.070686,0,0
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.18624,0.083941,0.12158,0,0
4,GO CELLULAR RESPONSE TO STARVATION,0.056456,0.083801,0.14714,0,0
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.30724,0.0837,0.14652,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.094909,0.083659,0.15768,0,0
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.08303,0.083464,0.15667,0,0
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.49108,0.083412,0.11751,0,0
4,GO SEGMENT SPECIFICATION,0.2259,0.083359,0.098306,0,0
4,GO RESPONSE TO OXYGEN RADICAL,0.25111,0.083299,0.0823,0,0
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.33821,0.083124,0.10467,0,0
4,GO GLUTAMATE SECRETION,0.1306,0.083092,0.18087,0,0
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.015104,0.083017,0.16711,0,0
4,GO SENSORY PERCEPTION,0.08881,0.082948,0.1008,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.11163,0.082898,0.13211,0,0
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.42405,0.082582,0.083706,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.23827,0.082533,0.13177,0,0
4,GO RESPONSE TO MISFOLDED PROTEIN,0.08588,0.082394,0.16935,0,0
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.34626,0.082218,0.11886,0,0
4,GO REGULATION OF NUCLEASE ACTIVITY,0.74555,0.082082,0.038868,0,0
4,GO CELL CELL SIGNALING BY WNT,0.10811,0.082073,0.13991,0,0
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.48117,0.082038,0.039782,0,0
4,GO MITOCHONDRIAL TRANSPORT,0.12273,0.081993,0.082506,0,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.19156,0.081864,0.1572,0,0
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.19156,0.081661,0.21257,0,0
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.44264,0.081602,0.073307,0,0
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.69814,0.081435,0.064124,0,0
4,GO RESPONSE TO IRON ION,0.83078,0.081381,0.055427,0,0
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.067497,0.081089,0.10611,0,0
4,GO PROTEIN MANNOSYLATION,0.094909,0.081008,0.13879,0,0
4,GO RESPONSE TO CATECHOLAMINE,0.12662,0.080949,0.13418,0,0
4,GO DNA BIOSYNTHETIC PROCESS,0.021265,0.080793,0.12968,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.12273,0.080725,0.14696,0,0
4,GO MAGNESIUM ION TRANSPORT,0.058535,0.080627,0.13445,0,0
4,GO CELLULAR RESPONSE TO IRON ION,0.61803,0.080581,0.062455,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.050584,0.080509,0.097951,0,0
4,GO BLASTODERM SEGMENTATION,0.1306,0.08028,0.13037,0,0
4,GO CYTOSOLIC TRANSPORT,0.13467,0.080252,0.14323,0,0
4,GO REGULATION OF DENDRITE EXTENSION,0.065157,0.080249,0.19217,0,0
4,GO CELLULAR RESPONSE TO RADIATION,0.077559,0.080153,0.11484,0,0
4,GO NCRNA PROCESSING,0.094909,0.079791,0.081511,0,0
4,GO NADH METABOLIC PROCESS,0.19156,0.07971,0.10875,0,0
4,GO REGULATION OF GTPASE ACTIVITY,0.43329,0.079504,0.12354,0,0
4,GO POSITIVE REGULATION OF HEART GROWTH,0.42405,0.0795,0.089846,0,0
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.11524,0.07934,0.14997,0,0
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.18624,0.079007,0.13601,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.10811,0.078903,0.16224,0,0
4,GO N GLYCAN PROCESSING,0.197,0.078796,0.20213,0,0
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.68646,0.078789,0.096444,0,0
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.08303,0.078668,0.14448,0,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.1475,0.078628,0.15166,0,0
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.70989,0.078607,0.070707,0,0
4,GO MYELIN ASSEMBLY,0.15655,0.07854,0.17538,0,0
4,GO BILE ACID METABOLIC PROCESS,0.47137,0.078527,0.056158,0,0
4,GO REGULATION OF PROTON TRANSPORT,0.14312,0.078421,0.090964,0,0
4,GO BONE GROWTH,0.48117,0.078358,0.1124,0,0
4,GO ENERGY RESERVE METABOLIC PROCESS,0.11163,0.078297,0.1253,0,0
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.26442,0.078173,0.1245,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.069906,0.078071,0.12017,0,0
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.062884,0.078004,0.099662,0,0
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.18102,0.077798,0.080909,0,0
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.15655,0.077741,0.087131,0,0
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.17091,0.077601,0.11819,0,0
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.7336,0.077563,0.031916,0,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.072385,0.077242,0.14502,0,0
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.13885,0.077219,0.11259,0,0
4,GO SODIUM ION TRANSPORT,0.069906,0.077134,0.13829,0,0
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.091819,0.077128,0.16924,0,0
4,GO UBIQUINONE METABOLIC PROCESS,0.17091,0.077126,0.061685,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.040368,0.077085,0.15382,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.18624,0.07695,0.10873,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.074935,0.076813,0.10086,0,0
4,GO NCRNA CATABOLIC PROCESS,0.27126,0.076794,0.074428,0,0
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.18624,0.076681,0.19551,0,0
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.054439,0.076571,0.12357,0,0
4,GO REGULATION OF GENE SILENCING,0.056456,0.076491,0.13158,0,0
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.55277,0.076487,0.062177,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.08881,0.075877,0.17473,0,0
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.20256,0.075796,0.13202,0,0
4,GO REGULATION OF BINDING,0.17591,0.075708,0.12337,0,0
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.16602,0.075676,0.13122,0,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.38829,0.075517,0.081055,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.33821,0.075508,0.11438,0,0
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.32248,0.075487,0.11658,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.4521,0.075407,0.1026,0,0
4,GO MYOBLAST DIFFERENTIATION,0.50109,0.075279,0.083551,0,0
4,GO CHLORIDE TRANSPORT,0.1475,0.075246,0.1106,0,0
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.094909,0.0751,0.12951,0,0
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.3148,0.074928,0.084887,0,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.48117,0.074927,0.031957,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.16602,0.074766,0.12575,0,0
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.30724,0.074665,0.15138,0,0
4,GO REGULATION OF DEPHOSPHORYLATION,0.08303,0.074664,0.14094,0,0
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.11524,0.074639,0.11018,0,0
4,GO STRIATUM DEVELOPMENT,0.36271,0.074597,0.094814,0,0
4,GO RESPONSE TO CAFFEINE,0.35442,0.074562,0.07362,0,0
4,GO PROTEIN CATABOLIC PROCESS,0.17591,0.074535,0.099979,0,0
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.072385,0.074348,0.13932,0,0
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.35442,0.074337,0.11527,0,0
4,GO EXECUTION PHASE OF APOPTOSIS,0.11163,0.074281,0.11184,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.13467,0.074162,0.13879,0,0
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.067497,0.074159,0.15751,0,0
4,GO INSEMINATION,0.62923,0.074157,0.028568,0,0
4,GO REGULATION OF HEART GROWTH,0.37964,0.074081,0.081656,0,0
4,GO CARDIAC CELL DEVELOPMENT,0.08881,0.07405,0.13692,0,0
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.19156,0.073887,0.1342,0,0
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.4521,0.073747,0.058766,0,0
4,GO DEPHOSPHORYLATION,0.12273,0.073715,0.11111,0,0
4,GO DETECTION OF ABIOTIC STIMULUS,0.072385,0.073713,0.10558,0,0
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.16123,0.07356,0.1084,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.72171,0.073486,0.043998,0,0
4,GO PROTEIN DEPHOSPHORYLATION,0.065157,0.073454,0.12039,0,0
4,GO GOLGI VESICLE TRANSPORT,0.23827,0.073435,0.093774,0,0
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.39705,0.073322,0.047841,0,0
4,GO INTRACELLULAR STEROL TRANSPORT,0.36271,0.073314,0.11558,0,0
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.197,0.073263,0.14311,0,0
4,GO ENDOSOMAL TRANSPORT,0.14312,0.073182,0.11415,0,0
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.12273,0.073162,0.11258,0,0
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.18102,0.07299,0.062514,0,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.41494,0.072983,0.072818,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.32248,0.07289,0.12599,0,0
4,GO POLYOL METABOLIC PROCESS,0.27821,0.072754,0.10401,0,0
4,GO ODONTOGENESIS,0.53179,0.072655,0.094576,0,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.072385,0.072582,0.15367,0,0
4,GO MACROMOLECULE CATABOLIC PROCESS,0.17091,0.072556,0.089305,0,0
4,GO PROTEIN ADP RIBOSYLATION,0.81845,0.072453,0.028986,0,0
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.23203,0.072363,0.15367,0,0
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.067497,0.072184,0.12477,0,0
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.08881,0.072031,0.1745,0,0
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.33029,0.072015,0.14577,0,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.18624,0.071894,0.09943,0,0
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.36271,0.071867,0.13471,0,0
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.28529,0.071718,0.10982,0,0
4,GO REGULATION OF GLUCOSE IMPORT,0.1475,0.071644,0.11714,0,0
4,GO REGULATION OF SYSTEM PROCESS,0.08881,0.071632,0.14609,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.15655,0.071598,0.10006,0,0
4,GO CARDIAC CONDUCTION,0.080256,0.071549,0.15896,0,0
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.14312,0.071498,0.10071,0,0
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.48117,0.071439,0.070052,0,0
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.28529,0.071432,0.099253,0,0
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.11163,0.071402,0.12919,0,0
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.11894,0.071366,0.14403,0,0
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.18624,0.071268,0.12859,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.29248,0.071066,0.12007,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.16123,0.071038,0.13703,0,0
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.098083,0.070972,0.11038,0,0
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.2998,0.070969,0.098118,0,0
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.094909,0.070958,0.12451,0,0
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.069906,0.070729,0.098837,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.66333,0.070615,0.03724,0,0
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.16123,0.070432,0.10165,0,0
4,GO EPITHELIAL CELL MORPHOGENESIS,0.51122,0.070425,0.11675,0,0
4,GO ENAMEL MINERALIZATION,0.34626,0.070318,0.11473,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.20822,0.070312,0.099613,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.20256,0.070305,0.11694,0,0
4,GO AUTOPHAGY OF NUCLEUS,0.37111,0.070287,0.082741,0,0
4,GO NEPHRIC DUCT DEVELOPMENT,0.20822,0.070257,0.15801,0,0
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.40594,0.070194,0.12992,0,0
4,GO NEURON APOPTOTIC PROCESS,0.15655,0.070174,0.11852,0,0
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.17091,0.069871,0.1106,0,0
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.52145,0.069809,0.087013,0,0
4,GO NCRNA METABOLIC PROCESS,0.091819,0.069282,0.081996,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.3148,0.069266,0.15594,0,0
4,GO GENITALIA DEVELOPMENT,0.46168,0.069239,0.086448,0,0
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.17091,0.06913,0.1386,0,0
4,GO SIGNAL RELEASE,0.11894,0.069097,0.12353,0,0
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.214,0.069054,0.12028,0,0
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.2259,0.068967,0.10244,0,0
4,GO VITAMIN CATABOLIC PROCESS,0.23203,0.068718,0.19065,0,0
4,GO NEGATIVE REGULATION OF BINDING,0.12662,0.068668,0.13214,0,0
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.13885,0.068441,0.14069,0,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.29248,0.068395,0.15603,0,0
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.16602,0.068337,0.12093,0,0
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.23203,0.068299,0.096312,0,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.33029,0.068178,0.097425,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.38829,0.068111,0.1068,0,0
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.21989,0.067961,0.22112,0,0
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.08881,0.0679,0.099001,0,0
4,GO SERTOLI CELL DEVELOPMENT,0.214,0.067744,0.1472,0,0
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.27126,0.06761,0.10827,0,0
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.17091,0.067556,0.15414,0,0
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.17091,0.067555,0.12619,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.10811,0.067337,0.087612,0,0
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.16602,0.067321,0.14039,0,0
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.41494,0.067253,0.046504,0,0
4,GO TRNA PROCESSING,0.17091,0.066983,0.072238,0,0
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.53179,0.066843,0.070697,0,0
4,GO RNA CAPPING,0.12273,0.066831,0.080236,0,0
4,GO ACTIVATION OF GTPASE ACTIVITY,0.1306,0.066646,0.1625,0,0
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.33821,0.066506,0.11549,0,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.10134,0.066489,0.13763,0,0
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.32248,0.066391,0.1126,0,0
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.091819,0.066384,0.10689,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.49108,0.066278,0.071815,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.14312,0.066156,0.11378,0,0
4,GO NEUROTRANSMITTER METABOLIC PROCESS,0.53179,0.066107,0.085789,0,0
4,GO GLUTAMATE METABOLIC PROCESS,0.11894,0.066076,0.12198,0,0
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.10468,0.066019,0.12943,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.094909,0.065934,0.12391,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.47137,0.065681,0.069003,0,0
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.16123,0.065658,0.12251,0,0
4,GO TRNA MODIFICATION,0.10811,0.065608,0.094981,0,0
4,GO CALCINEURIN MEDIATED SIGNALING,0.08881,0.065586,0.15552,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.26442,0.065555,0.10429,0,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.91805,0.065477,-0.049656,0,0
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.17091,0.065064,0.1119,0,0
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.41494,0.065056,0.10522,0,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.66333,0.065005,0.04236,0,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.23827,0.06494,0.16215,0,0
4,GO RRNA METHYLATION,0.41494,0.064897,0.04822,0,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.41494,0.06489,0.022127,0,0
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.23203,0.064882,0.11036,0,0
4,GO PROTEIN STABILIZATION,0.15197,0.064731,0.097033,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.35442,0.064559,0.073029,0,0
4,GO ORGANIC ACID CATABOLIC PROCESS,0.48117,0.064488,0.058722,0,0
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.10468,0.064164,0.13914,0,0
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.39705,0.064128,0.087688,0,0
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.197,0.063996,0.11103,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.52145,0.063981,0.036807,0,0
4,GO CELLULAR RESPONSE TO HEAT,0.14312,0.063915,0.10139,0,0
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.52145,0.063896,0.069162,0,0
4,GO RESPONSE TO IONIZING RADIATION,0.29248,0.063776,0.086897,0,0
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.55277,0.063716,0.10135,0,0
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.214,0.063699,0.13256,0,0
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.60692,0.063636,0.093695,0,0
4,GO REGULATION OF MACROAUTOPHAGY,0.24463,0.063383,0.10022,0,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.13885,0.063316,0.10088,0,0
4,GO CELL FATE DETERMINATION,0.32248,0.063267,0.10595,0,0
4,GO ENSHEATHMENT OF NEURONS,0.197,0.063265,0.12543,0,0
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.12662,0.063231,0.20848,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.19156,0.063229,0.15345,0,0
4,GO LYSINE METABOLIC PROCESS,0.23203,0.063215,0.11274,0,0
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.44264,0.063214,0.086716,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.10468,0.06315,0.11207,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.37111,0.063127,0.10712,0,0
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.54223,0.063031,0.06625,0,0
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.37964,0.063006,0.093113,0,0
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.4521,0.06299,0.050516,0,0
4,GO MALE SEX DIFFERENTIATION,0.25111,0.062949,0.11984,0,0
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.24463,0.062871,0.11323,0,0
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.51122,0.062779,0.078322,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.17591,0.062634,0.1247,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.20822,0.062584,0.089867,0,0
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.08588,0.062519,0.13332,0,0
4,GO POSITIVE REGULATION OF CELL AGING,0.84314,0.062331,0.0013497,0,0
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.2577,0.06226,0.089723,0,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.056456,0.062186,0.11041,0,0
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.077559,0.062114,0.11251,0,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.1475,0.062049,0.11321,0,0
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.10134,0.062016,0.18463,0,0
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.19156,0.062004,0.12457,0,0
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.20822,0.061779,0.082696,0,0
4,GO MACROAUTOPHAGY,0.27821,0.061764,0.08605,0,0
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.17591,0.061743,0.109,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.65188,0.06172,0.10016,0,0
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.094909,0.061674,0.12244,0,0
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.33821,0.061461,0.10571,0,0
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.11163,0.061375,0.11705,0,0
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.19156,0.061259,0.13795,0,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.72171,0.061229,0.10654,0,0
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.2259,0.061189,0.15258,0,0
4,GO REGULATION OF CATABOLIC PROCESS,0.3148,0.06116,0.08777,0,0
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.30724,0.061158,0.10609,0,0
4,GO DNA DEAMINATION,0.98106,0.060875,-0.0026448,0,0
4,GO REGULATION OF CELLULAR LOCALIZATION,0.24463,0.060756,0.10874,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.75756,0.06075,0.065195,0,0
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.46168,0.060747,0.081312,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.19156,0.060505,0.12925,0,0
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.30724,0.060461,0.099536,0,0
4,GO REGULATION OF AMINO ACID TRANSPORT,0.2577,0.060156,0.12793,0,0
4,GO DEVELOPMENTAL INDUCTION,0.44264,0.06008,0.07761,0,0
4,GO DOPAMINE METABOLIC PROCESS,0.41494,0.060049,0.099843,0,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.90549,0.059859,0.0085842,0,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.35442,0.059396,0.059457,0,0
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.47137,0.05934,0.09923,0,0
4,GO MANGANESE ION TRANSPORT,0.81845,0.059275,0.03568,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.18102,0.059232,0.10951,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.23203,0.059213,0.095417,0,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.28529,0.059201,0.10975,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.3148,0.059197,0.096448,0,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.094909,0.059187,0.089219,0,0
4,GO SENSORY PERCEPTION OF PAIN,0.28529,0.059078,0.099478,0,0
4,GO PIGMENT ACCUMULATION,0.7336,0.059071,0.048234,0,0
4,GO RESPONSE TO AMINE,0.29248,0.059045,0.07751,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.065157,0.058979,0.15342,0,0
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.34626,0.058953,0.10139,0,0
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.46168,0.058914,0.10107,0,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.40594,0.058865,0.074845,0,0
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.34626,0.058818,0.069613,0,0
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.17591,0.058767,0.10161,0,0
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.32248,0.058616,0.077478,0,0
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.44264,0.058581,0.11718,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.11163,0.058527,0.12984,0,0
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.18624,0.058451,0.072936,0,0
4,GO EXOCYTIC PROCESS,0.23827,0.058409,0.11954,0,0
4,GO LIPID TRANSLOCATION,0.33029,0.058375,0.13305,0,0
4,GO LOCOMOTOR RHYTHM,0.19156,0.058307,0.19516,0,0
4,GO NEURON DEATH,0.19156,0.0583,0.112,0,0
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.21989,0.058255,0.15992,0,0
4,GO GLIOGENESIS,0.34626,0.058019,0.12041,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.72171,0.057915,0.024615,0,0
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.12662,0.05787,0.085428,0,0
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.26442,0.057842,0.073947,0,0
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.17091,0.057648,0.12769,0,0
4,GO REGULATION OF VASCULOGENESIS,0.55277,0.057574,0.080617,0,0
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.37964,0.057456,0.055666,0,0
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.37964,0.057453,0.11969,0,0
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.1475,0.057429,0.15505,0,0
4,GO MAMMARY GLAND MORPHOGENESIS,0.79394,0.057362,0.077944,0,0
4,GO CELLULAR SENESCENCE,0.20256,0.057117,0.1032,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.64051,0.056941,0.070572,0,0
4,GO LIPID MODIFICATION,0.29248,0.056902,0.094288,0,0
4,GO RECEPTOR INTERNALIZATION,0.25111,0.056815,0.12072,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.27126,0.056657,0.12068,0,0
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.76963,0.056652,0.026201,0,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.56341,0.056577,0.055466,0,0
4,GO GROWTH,0.10811,0.056528,0.13865,0,0
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.68646,0.056517,0.1014,0,0
4,GO EXCRETION,0.2259,0.056448,0.12544,0,0
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.26442,0.056081,0.11179,0,0
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.62923,0.055788,0.065344,0,0
4,GO DICARBOXYLIC ACID TRANSPORT,0.19156,0.055752,0.13426,0,0
4,GO FATTY ACYL COA METABOLIC PROCESS,0.35442,0.055725,0.066676,0,0
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.23203,0.055607,0.11608,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.12273,0.055601,0.14533,0,0
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.11524,0.055592,0.20704,0,0
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.61803,0.055587,0.10126,0,0
4,GO NODAL SIGNALING PATHWAY,0.18102,0.055529,0.11581,0,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.42405,0.055487,0.090729,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.20256,0.055392,0.089372,0,0
4,GO RESPONSE TO BMP,0.44264,0.055279,0.12962,0,0
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.094909,0.055101,0.1322,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.33821,0.055079,0.059277,0,0
4,GO ORGANELLE DISASSEMBLY,0.26442,0.054846,0.087765,0,0
4,GO CELLULAR RESPONSE TO ALKALOID,0.21989,0.05472,0.10694,0,0
4,GO HEART MORPHOGENESIS,0.36271,0.054711,0.12976,0,0
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.7336,0.054644,0.044774,0,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.23203,0.054542,0.10447,0,0
4,GO PROSTATE GLAND DEVELOPMENT,0.46168,0.054496,0.083478,0,0
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.197,0.054421,0.21128,0,0
4,GO DETECTION OF CALCIUM ION,0.39705,0.054344,0.077188,0,0
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.2998,0.054234,0.088829,0,0
4,GO SECRETORY GRANULE ORGANIZATION,0.41494,0.054013,0.099325,0,0
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.27126,0.053889,0.099564,0,0
4,GO ERBB2 SIGNALING PATHWAY,0.64051,0.053882,0.070046,0,0
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.40594,0.053827,0.098439,0,0
4,GO AUTOPHAGY OF MITOCHONDRION,0.29248,0.053714,0.097364,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.61803,0.053549,0.077399,0,0
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.60692,0.053214,0.050282,0,0
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.1306,0.053198,0.11512,0,0
4,GO REGULATION OF ATPASE ACTIVITY,0.2259,0.053188,0.063763,0,0
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.4521,0.053173,0.083039,0,0
4,GO REGULATION OF SODIUM ION TRANSPORT,0.14312,0.053066,0.13988,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.54223,0.053055,0.18731,0,0
4,GO REGULATION OF HEAT GENERATION,0.37111,0.053035,0.11751,0,0
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.40594,0.052951,0.092187,0,0
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.43329,0.05293,0.099919,0,0
4,GO REGULATION OF GLUCONEOGENESIS,0.20822,0.052759,0.11687,0,0
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.2577,0.05269,0.083803,0,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.54223,0.052629,0.04559,0,0
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.17091,0.052537,0.12595,0,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,0.38829,0.052506,0.051137,0,0
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.26442,0.052442,0.10877,0,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.47137,0.052069,0.10688,0,0
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.3148,0.051997,0.085836,0,0
4,GO EMBRYO DEVELOPMENT,0.077559,0.051907,0.14436,0,0
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.2577,0.051859,0.13717,0,0
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.53179,0.05185,0.076821,0,0
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.17591,0.051813,0.11878,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.18102,0.051676,0.14425,0,0
4,GO SECONDARY PALATE DEVELOPMENT,0.2998,0.051394,0.13647,0,0
4,GO REGULATION OF CELL DIFFERENTIATION,0.29248,0.051385,0.12745,0,0
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.61803,0.051308,0.066446,0,0
4,GO REGULATION OF HORMONE LEVELS,0.23827,0.051034,0.092743,0,0
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.27126,0.050906,0.10196,0,0
4,GO ESCRT COMPLEX DISASSEMBLY,0.52145,0.050905,0.028868,0,0
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.4521,0.050791,0.070931,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.2259,0.050756,0.11472,0,0
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.17591,0.05072,0.070027,0,0
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.20822,0.050647,0.08688,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.43329,0.050638,0.056595,0,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.3148,0.050584,0.10033,0,0
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.2259,0.050524,0.13053,0,0
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.34626,0.050417,0.10036,0,0
4,GO ROOF OF MOUTH DEVELOPMENT,0.17591,0.050238,0.14206,0,0
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.52145,0.050139,0.12428,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.40594,0.050132,0.085134,0,0
4,GO GLIAL CELL DEVELOPMENT,0.34626,0.050098,0.1139,0,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.2577,0.050063,0.14488,0,0
4,GO REGULATION OF AUTOPHAGY,0.2998,0.050061,0.091445,0,0
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.69814,0.049881,-0.017344,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.61803,0.049806,0.027431,0,0
4,GO STEM CELL DIFFERENTIATION,0.41494,0.049668,0.089457,0,0
4,GO ENDODERMAL CELL FATE COMMITMENT,0.85555,0.049666,0.018858,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.48117,0.049611,0.083002,0,0
4,GO PYROPTOSIS,0.4521,0.049568,0.075321,0,0
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.33029,0.049501,0.068109,0,0
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.93062,0.049323,0.010483,0,0
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.51122,0.049297,0.076089,0,0
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.58498,0.049255,0.09224,0,0
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.46168,0.049089,0.061882,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.48117,0.049089,0.091835,0,0
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.54223,0.049062,0.076169,0,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.37111,0.048973,0.082747,0,0
4,GO ANIMAL ORGAN MATURATION,0.48117,0.048822,0.1077,0,0
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.2577,0.048759,0.078688,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.51122,0.048745,0.045858,0,0
4,GO RESPONSE TO IMMOBILIZATION STRESS,0.78176,0.04873,0.022782,0,0
4,GO MUSCLE ORGAN MORPHOGENESIS,0.54223,0.048706,0.089201,0,0
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.39705,0.048702,0.07773,0,0
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.48117,0.04851,0.07353,0,0
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.2577,0.048492,0.11768,0,0
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.26442,0.048429,0.10237,0,0
4,GO PIGMENTATION,0.37964,0.048156,0.073392,0,0
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.1475,0.048068,0.14105,0,0
4,GO MAMMARY GLAND DEVELOPMENT,0.25111,0.048064,0.13808,0,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.08588,0.047905,0.16642,0,0
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.16602,0.047885,0.12147,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION,0.30724,0.0477,0.093683,0,0
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.51122,0.047538,0.12133,0,0
4,GO TRNA METABOLIC PROCESS,0.18624,0.047362,0.072395,0,0
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.60692,0.047342,0.055206,0,0
4,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.197,0.047233,0.12445,0,0
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.20256,0.047117,0.14212,0,0
4,GO REGULATION OF LIGASE ACTIVITY,0.25111,0.047081,0.069559,0,0
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.33029,0.047047,0.091722,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.08303,0.047006,0.073125,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.27126,0.046982,0.13022,0,0
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.197,0.046976,0.11941,0,0
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.32248,0.046954,0.09965,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.38829,0.046923,0.082359,0,0
4,GO PHOTOPERIODISM,0.069906,0.046877,0.14863,0,0
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.27821,0.046838,0.096162,0,0
4,GO RESPONSE TO MONOSACCHARIDE,0.18102,0.046834,0.1139,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.18624,0.046746,0.11792,0,0
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.197,0.046743,0.11243,0,0
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.75756,0.046673,0.046057,0,0
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.40594,0.046669,0.11367,0,0
4,GO PROTEIN FOLDING,0.39705,0.046607,0.054934,0,0
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.4521,0.046588,0.096231,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.20256,0.046586,0.13806,0,0
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.56341,0.046528,0.10281,0,0
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.2259,0.046455,0.13848,0,0
4,GO GOLGI TO ENDOSOME TRANSPORT,0.3148,0.046344,0.10352,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.17091,0.046315,0.12924,0,0
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.40594,0.046098,0.089953,0,0
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.47137,0.045594,0.063619,0,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.067497,0.045583,0.073131,0,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.60692,0.04557,0.062189,0,0
4,GO LUNG MORPHOGENESIS,0.75756,0.045528,0.076807,0,0
4,GO THYMUS DEVELOPMENT,0.062884,0.045415,0.15767,0,0
4,GO CELL GROWTH,0.25111,0.045361,0.12727,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.37964,0.045331,0.12456,0,0
4,GO LYMPHANGIOGENESIS,0.94321,0.045216,0.032356,0,0
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.33029,0.045162,0.086297,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.29248,0.04514,0.078849,0,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.080256,0.045121,0.095918,0,0
4,GO BASEMENT MEMBRANE ASSEMBLY,0.70989,0.044833,0.079478,0,0
4,GO PEPTIDYL ARGININE METHYLATION,0.68646,0.044804,0.039486,0,0
4,GO POSITIVE REGULATION OF GROWTH,0.23203,0.044799,0.13358,0,0
4,GO EMBRYONIC MORPHOGENESIS,0.16602,0.044757,0.14042,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.43329,0.044657,0.089998,0,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.43329,0.044575,0.11757,0,0
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.16123,0.044502,0.081638,0,0
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.46168,0.044474,0.072383,0,0
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.38829,0.044167,0.079533,0,0
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.49108,0.044138,0.07596,0,0
4,GO CARBOHYDRATE HOMEOSTASIS,0.15197,0.044108,0.10781,0,0
4,GO MEMBRANE DEPOLARIZATION,0.52145,0.044013,0.077029,0,0
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.53179,0.043807,0.075182,0,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.47137,0.043774,0.035129,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.197,0.043746,0.11358,0,0
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.2577,0.043624,0.12237,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION,0.19156,0.043523,0.10613,0,0
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.37964,0.043353,0.11739,0,0
4,GO BONE MORPHOGENESIS,0.46168,0.04335,0.10802,0,0
4,GO NEURON PROJECTION REGENERATION,0.19156,0.043309,0.1837,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.99368,0.043298,0.023313,0,0
4,GO FATTY ACID HOMEOSTASIS,0.27821,0.043286,0.11508,0,0
4,GO ALDEHYDE CATABOLIC PROCESS,0.57414,0.043249,0.031761,0,0
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.80618,0.043206,0.058021,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.30724,0.043105,0.046088,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.26442,0.043093,0.10262,0,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.94321,0.043049,0.016097,0,0
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.61803,0.043024,0.10509,0,0
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.67486,0.042978,0.083237,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.28529,0.042917,0.096779,0,0
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.98106,0.042822,-0.006825,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.40594,0.0428,0.071606,0,0
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.29248,0.042746,0.12995,0,0
4,GO AMINO ACID TRANSPORT,0.2577,0.042624,0.11315,0,0
4,GO DETECTION OF MECHANICAL STIMULUS,0.53179,0.042552,0.092319,0,0
4,GO MUSCLE HYPERTROPHY,0.40594,0.042541,0.10865,0,0
4,GO BLASTOCYST FORMATION,0.21989,0.042504,0.07483,0,0
4,GO PROTEIN HOMOOLIGOMERIZATION,0.27126,0.04233,0.10266,0,0
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.41494,0.042328,0.080288,0,0
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.30724,0.0423,0.097916,0,0
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.17091,0.042285,0.071414,0,0
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.40594,0.042247,0.084797,0,0
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.66333,0.042134,0.081698,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.20256,0.041898,0.062038,0,0
4,GO CARDIAC SEPTUM DEVELOPMENT,0.47137,0.041896,0.11931,0,0
4,GO TRANSLATIONAL INITIATION,0.54223,0.041811,0.019965,0,0
4,GO AMIDE BIOSYNTHETIC PROCESS,0.13467,0.041742,0.054596,0,0
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.47137,0.041669,0.094013,0,0
4,GO ORGANELLE FUSION,0.42405,0.041601,0.082681,0,0
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.42405,0.041575,0.10653,0,0
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.78176,0.041563,0.087501,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.50109,0.041416,0.097238,0,0
4,GO LUNG CELL DIFFERENTIATION,0.23203,0.041378,0.15623,0,0
4,GO ENDOSOME ORGANIZATION,0.52145,0.041352,0.04783,0,0
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.26442,0.04121,0.10111,0,0
4,GO REGULATION OF HISTONE DEACETYLATION,0.52145,0.041203,0.10164,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.17591,0.041178,0.11431,0,0
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.40594,0.041165,0.10612,0,0
4,GO RESPONSE TO CALCIUM ION,0.66333,0.040926,0.065551,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.7336,0.040873,0.019863,0,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.36271,0.0408,0.053338,0,0
4,GO REGULATION OF GOLGI ORGANIZATION,0.4521,0.040785,0.095247,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS,0.7336,0.040775,0.071527,0,0
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.40594,0.040769,0.0846,0,0
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.37964,0.040765,0.077816,0,0
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.36271,0.040715,0.09454,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.68646,0.040678,0.060536,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.15655,0.040627,0.1229,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.24463,0.040422,0.11381,0,0
4,GO RECEPTOR METABOLIC PROCESS,0.33821,0.040394,0.098411,0,0
4,GO MESODERM DEVELOPMENT,0.46168,0.040372,0.078864,0,0
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.35442,0.040342,0.062402,0,0
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.81845,0.040293,0.066458,0,0
4,GO RESPONSE TO COLD,0.98106,0.040275,0.024678,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.048745,0.040213,0.058275,0,0
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.30724,0.040031,0.11384,0,0
4,GO TRNA WOBBLE BASE MODIFICATION,0.18102,0.039706,0.090179,0,0
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.48117,0.039513,0.075001,0,0
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.42405,0.039449,0.11332,0,0
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.24463,0.039437,0.10279,0,0
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.44264,0.039335,0.088532,0,0
4,GO GDP METABOLIC PROCESS,0.30724,0.039171,0.11708,0,0
4,GO MAST CELL MIGRATION,0.29248,0.039171,0.11684,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.26442,0.039123,0.1174,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.38829,0.039044,0.06651,0,0
4,GO FIBROBLAST MIGRATION,0.53179,0.039039,0.10647,0,0
4,GO HEPARIN METABOLIC PROCESS,0.39705,0.039007,0.088654,0,0
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.14312,0.039005,0.14855,0,0
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20256,0.038957,0.11702,0,0
4,GO AUTOPHAGOSOME ORGANIZATION,0.64051,0.038899,0.070208,0,0
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.80618,0.038888,0.038324,0,0
4,GO REGULATION OF HAIR CYCLE,0.41494,0.038879,0.087431,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.41494,0.038801,0.094957,0,0
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.95582,0.03877,0.0061789,0,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.43329,0.038742,0.085469,0,0
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.61803,0.038691,0.090761,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.27821,0.038615,0.095691,0,0
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.18102,0.038412,0.059192,0,0
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.61803,0.038216,0.062917,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.5959,0.038204,0.064815,0,0
4,GO REGULATION OF PROTEIN IMPORT,0.75756,0.038104,0.054701,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.66333,0.037983,0.065481,0,0
4,GO HEART FORMATION,0.50109,0.037976,0.089031,0,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.18624,0.037744,0.071216,0,0
4,GO T CELL DIFFERENTIATION IN THYMUS,0.94321,0.03763,0.027274,0,0
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.15655,0.037576,0.1521,0,0
4,GO L AMINO ACID TRANSPORT,0.83078,0.037472,0.043223,0,0
4,GO CELLULAR RESPONSE TO ALCOHOL,0.86799,0.037456,0.075864,0,0
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.15655,0.037178,0.10028,0,0
4,GO REPLACEMENT OSSIFICATION,0.79394,0.037097,0.019391,0,0
4,GO ANOIKIS,0.57414,0.037039,0.095821,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.79394,0.036912,0.0080917,0,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.64051,0.036847,0.068806,0,0
4,GO VAGINA DEVELOPMENT,0.37964,0.036837,0.1257,0,0
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.214,0.036836,0.11615,0,0
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.44264,0.036806,0.10847,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.72171,0.036761,0.028088,0,0
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.23203,0.036758,0.12574,0,0
4,GO REGULATION OF VESICLE FUSION,0.214,0.036653,0.15206,0,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.50109,0.036506,0.033685,0,0
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.34626,0.036492,0.040583,0,0
4,GO HEAT GENERATION,0.76963,0.036418,0.052509,0,0
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.2577,0.036352,0.12784,0,0
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.35442,0.036315,0.16238,0,0
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.61803,0.035944,0.11109,0,0
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.53179,0.035901,0.095342,0,0
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.44264,0.035871,0.085268,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.57414,0.035868,0.025617,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.60692,0.035862,0.060819,0,0
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.49108,0.035815,0.10543,0,0
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.49108,0.035758,0.068206,0,0
4,GO CHLORIDE ION HOMEOSTASIS,0.2998,0.035642,0.13935,0,0
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.44264,0.035464,0.13111,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.58498,0.035445,-0.05276,0,0
4,GO REGULATION OF PROTEIN TARGETING,0.33029,0.035433,0.089882,0,0
4,GO SPLEEN DEVELOPMENT,0.57414,0.03543,0.067673,0,0
4,GO GLAND DEVELOPMENT,0.2259,0.035179,0.12364,0,0
4,GO SUBPALLIUM DEVELOPMENT,0.83078,0.035162,0.053064,0,0
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.78176,0.035106,0.09174,0,0
4,GO RNA CATABOLIC PROCESS,0.08303,0.03507,0.073727,0,0
4,GO PROTEIN AUTOPHOSPHORYLATION,0.37111,0.034942,0.11846,0,0
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.65188,0.03488,0.041609,0,0
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.52145,0.034768,0.10336,0,0
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.49108,0.034756,0.07347,0,0
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.56341,0.034697,0.084184,0,0
4,GO ION TRANSMEMBRANE TRANSPORT,0.27126,0.034624,0.10222,0,0
4,GO CELL AGING,0.27126,0.034545,0.089463,0,0
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.80618,0.034536,0.043798,0,0
4,GO KERATINOCYTE PROLIFERATION,0.74555,0.034344,0.06882,0,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.53179,0.034328,0.063886,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.4521,0.034319,0.13358,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.65188,0.034246,0.063634,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.32248,0.034242,0.083049,0,0
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.39705,0.034151,0.092038,0,0
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.80618,0.03406,0.049584,0,0
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.52145,0.034055,0.060981,0,0
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.34626,0.034032,0.1089,0,0
4,GO IMPORT INTO CELL,0.2577,0.033885,0.11408,0,0
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.81845,0.033865,0.024307,0,0
4,GO RESPONSE TO HEAT,0.46168,0.033846,0.077678,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.72171,0.03376,-0.05941,0,0
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.42405,0.033756,0.072223,0,0
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.69814,0.033738,0.052365,0,0
4,GO PEROXISOME ORGANIZATION,0.74555,0.033732,0.016193,0,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.12662,0.033632,0.10777,0,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.74555,0.0334,0.048708,0,0
4,GO RESPONSE TO AXON INJURY,0.48117,0.033333,0.12399,0,0
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.80618,0.033301,0.033906,0,0
4,GO ENDOCARDIAL CUSHION FORMATION,0.95582,0.033168,0.043207,0,0
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.35442,0.033062,0.12292,0,0
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,1,0.033033,0.046099,0,0
4,GO REGULATION OF PROTEIN STABILITY,0.41494,0.033011,0.071192,0,0
4,GO COBALAMIN METABOLIC PROCESS,0.67486,0.032752,0.033354,0,0
4,GO MUSCLE ORGAN DEVELOPMENT,0.33029,0.032741,0.10814,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.74555,0.032697,0.032712,0,0
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.52145,0.032556,0.10601,0,0
4,GO LAMELLIPODIUM ASSEMBLY,0.52145,0.032481,0.089553,0,0
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.52145,0.032468,0.10251,0,0
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.35442,0.03241,0.10221,0,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.60692,0.032391,0.037274,0,0
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.72171,0.032358,0.02757,0,0
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.60692,0.032321,0.087918,0,0
4,GO HEART DEVELOPMENT,0.33029,0.032318,0.12366,0,0
4,GO RETINA HOMEOSTASIS,0.29248,0.0323,0.059322,0,0
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.29248,0.032264,0.11722,0,0
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.7336,0.032109,0.05505,0,0
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.55277,0.032063,0.089518,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.72171,0.032053,0.039573,0,0
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.89296,0.032031,0.024726,0,0
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.46168,0.031955,0.10784,0,0
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.75756,0.031917,0.056777,0,0
4,GO SODIUM ION HOMEOSTASIS,0.61803,0.031914,0.065215,0,0
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.38829,0.031742,0.055395,0,0
4,GO PROTEIN KINASE A SIGNALING,0.56341,0.031615,0.077283,0,0
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.55277,0.031447,0.054674,0,0
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.4521,0.031324,0.058981,0,0
4,GO MITRAL VALVE DEVELOPMENT,0.27126,0.031319,0.14776,0,0
4,GO L GLUTAMATE IMPORT,0.35442,0.031091,0.093002,0,0
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.74555,0.03108,0.078741,0,0
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.75756,0.031026,0.10952,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.25111,0.030861,0.10711,0,0
4,GO MUSCLE CELL DEVELOPMENT,0.27126,0.030696,0.10938,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.60692,0.03063,0.06423,0,0
4,GO GLAND MORPHOGENESIS,0.84314,0.030578,0.07155,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.80618,0.030479,0.037202,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.83078,0.030471,0.065785,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.49108,0.030454,0.083954,0,0
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.37964,0.03045,0.098726,0,0
4,GO RIBOSOME ASSEMBLY,0.43329,0.030398,0.028233,0,0
4,GO GLYCOSYLATION,0.65188,0.030308,0.058179,0,0
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.55277,0.030303,0.085642,0,0
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.46168,0.030279,-0.10075,0,0
4,GO TOOTH MINERALIZATION,0.67486,0.030269,0.11238,0,0
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.62923,0.030121,0.070816,0,0
4,GO GLUCOSE IMPORT,0.43329,0.030097,0.078609,0,0
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.49108,0.03008,0.11273,0,0
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.75756,0.029895,0.062239,0,0
4,GO BROWN FAT CELL DIFFERENTIATION,0.86799,0.029894,0.041196,0,0
4,GO HEART GROWTH,0.61803,0.029869,0.07363,0,0
4,GO REGULATION OF PEPTIDE TRANSPORT,0.64051,0.02974,0.072055,0,0
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.91805,0.029707,0.016534,0,0
4,GO COPII COATED VESICLE CARGO LOADING,0.34626,0.029699,0.11949,0,0
4,GO UTP METABOLIC PROCESS,0.96843,0.029631,-0.0049038,0,0
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.49108,0.029403,0.10307,0,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.89296,0.029247,0.017903,0,0
4,GO VASCULOGENESIS,0.50109,0.029209,0.11272,0,0
4,GO ERYTHROCYTE HOMEOSTASIS,0.74555,0.029206,0.067881,0,0
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.90549,0.029053,0.026742,0,0
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.75756,0.029051,0.066714,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.18102,0.029047,0.079962,0,0
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.58498,0.029005,0.10033,0,0
4,GO FEMALE GENITALIA DEVELOPMENT,0.61803,0.02897,0.065857,0,0
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.72171,0.028933,0.049816,0,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,0.18624,0.028932,0.048615,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.40594,0.028899,0.047315,0,0
4,GO RESPONSE TO STEROL,0.49108,0.028831,0.11518,0,0
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.53179,0.028808,0.070767,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.35442,0.028792,0.075113,0,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.4521,0.028751,0.081068,0,0
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.37964,0.028685,0.10333,0,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.38829,0.028641,0.057009,0,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.5959,0.028593,-0.05656,0,0
4,GO ERYTHROCYTE DEVELOPMENT,0.79394,0.02858,0.061412,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.60692,0.028479,0.099356,0,0
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.37964,0.028277,0.11283,0,0
4,GO PROTEIN POLYMERIZATION,0.38829,0.02826,0.10783,0,0
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.49108,0.028075,0.10685,0,0
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.57414,0.028016,0.063241,0,0
4,GO CELL CELL JUNCTION ORGANIZATION,0.49108,0.027959,0.10874,0,0
4,GO ANION TRANSMEMBRANE TRANSPORT,0.3148,0.027875,0.091087,0,0
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.66333,0.027671,0.056516,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.96843,0.027608,0.026626,0,0
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.32248,0.027591,0.096968,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.5959,0.027587,0.087595,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.69814,0.027522,0.054445,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.3148,0.027518,0.08985,0,0
4,GO GLUCOSE CATABOLIC PROCESS,0.37111,0.02735,0.096532,0,0
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.47137,0.027302,0.031827,0,0
4,GO RESPONSE TO NITROSATIVE STRESS,0.7336,0.027193,0.017811,0,0
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.58498,0.027183,0.084167,0,0
4,GO SYNAPTIC VESICLE BUDDING,0.58498,0.027061,0.076315,0,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.90549,0.026963,0.050479,0,0
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.61803,0.026347,0.032967,0,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.42405,0.026279,0.11231,0,0
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.98106,0.026217,0.022269,0,0
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.86799,0.026163,0.065801,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.49108,0.025945,0.095641,0,0
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.95582,0.025944,-0.0027466,0,0
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.51122,0.025939,0.098632,0,0
4,GO REGULATION OF JUN KINASE ACTIVITY,0.74555,0.025817,0.092936,0,0
4,GO CELLULAR AMIDE METABOLIC PROCESS,0.58498,0.025804,0.035141,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.54223,0.025789,0.11561,0,0
4,GO RESPONSE TO MUSCLE ACTIVITY,0.61803,0.025788,0.054803,0,0
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.62923,0.025786,0.082321,0,0
4,GO CELL MATURATION,0.33821,0.025781,0.10819,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.66333,0.025741,0.098911,0,0
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.7336,0.025738,0.078657,0,0
4,GO SEROTONIN TRANSPORT,0.20256,0.025724,0.15317,0,0
4,GO INORGANIC ANION TRANSPORT,0.52145,0.025722,0.078093,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.93062,0.025533,0.024042,0,0
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.53179,0.02529,0.073685,0,0
4,GO PROTEIN TETRAMERIZATION,0.52145,0.025278,0.056868,0,0
4,GO DE NOVO PROTEIN FOLDING,0.57414,0.025242,0.070415,0,0
4,GO REGULATION OF CELLULAR RESPIRATION,0.81845,0.025176,0.032643,0,0
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.53179,0.025175,0.040126,0,0
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.76963,0.025171,0.06893,0,0
4,GO CARDIOCYTE DIFFERENTIATION,0.53179,0.02511,0.0948,0,0
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.43329,0.025066,0.081219,0,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.7336,0.02505,0.07562,0,0
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.88046,0.024986,0.016353,0,0
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.47137,0.024964,0.11938,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.55277,0.024923,0.10385,0,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.89296,0.024807,0.033041,0,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.48117,0.024794,0.059533,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.84314,0.02451,0.03097,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.72171,0.024493,0.047416,0,0
4,GO MESENCHYME DEVELOPMENT,0.56341,0.024443,0.088538,0,0
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.72171,0.024422,0.051251,0,0
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.54223,0.024363,0.08825,0,0
4,GO CYTOKINETIC PROCESS,0.74555,0.023934,0.055222,0,0
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.4521,0.023902,0.092211,0,0
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.37964,0.023884,0.063632,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.95582,0.023808,0.0057019,0,0
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.23203,0.023744,0.11876,0,0
4,GO RESPONSE TO TESTOSTERONE,0.65188,0.023535,0.059282,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.57414,0.023467,0.093586,0,0
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,1,0.023379,0.057217,0,0
4,GO VESICLE ORGANIZATION,0.79394,0.023344,0.059285,0,0
4,GO REGULATION OF ORGAN GROWTH,0.37111,0.023152,0.094941,0,0
4,GO ORGANELLE MEMBRANE FUSION,0.54223,0.022993,0.076281,0,0
4,GO REGULATION OF TRANSPORT,0.57414,0.022912,0.081904,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.36271,0.022813,0.089107,0,0
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.65188,0.022801,0.039773,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.65188,0.022787,0.080858,0,0
4,GO TELOMERASE RNA LOCALIZATION,0.28529,0.022692,0.053215,0,0
4,GO HEART PROCESS,0.23203,0.022627,0.097547,0,0
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.64051,0.022625,0.092135,0,0
4,GO RESPONSE TO CARBOHYDRATE,0.29248,0.022547,0.10065,0,0
4,GO MITOTIC CELL CYCLE ARREST,0.47137,0.022488,0.083698,0,0
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.43329,0.022214,0.13374,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.76963,0.022132,0.025239,0,0
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.70989,0.022131,0.040351,0,0
4,GO VESICLE TARGETING,0.95582,0.022111,0.038183,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.58498,0.022107,0.093028,0,0
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.32248,0.02205,0.12218,0,0
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.70989,0.021966,0.070969,0,0
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.57414,0.021865,0.049274,0,0
4,GO RENAL TUBULE DEVELOPMENT,0.43329,0.021798,0.098894,0,0
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.7336,0.021726,0.069001,0,0
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.25111,0.021527,0.10876,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.37964,0.021502,0.16353,0,0
4,GO PROTEIN TARGETING,0.15197,0.021365,0.047644,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.99368,0.021365,0.0093871,0,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.65188,0.021325,0.051486,0,0
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.90549,0.021319,0.06664,0,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.50109,0.02122,0.082607,0,0
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.16123,0.021206,0.057139,0,0
4,GO PIGMENT CELL DIFFERENTIATION,0.27821,0.021131,0.11159,0,0
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.81845,0.021063,-0.039559,0,0
4,GO KIDNEY MORPHOGENESIS,0.16602,0.020935,0.14745,0,0
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.2998,0.020933,0.10076,0,0
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.2998,0.020877,0.10273,0,0
4,GO LAMELLIPODIUM ORGANIZATION,0.89296,0.020834,0.063549,0,0
4,GO RESPONSE TO UV C,0.49108,0.020811,0.077442,0,0
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.83078,0.020801,0.046508,0,0
4,GO REGULATION OF BLOOD CIRCULATION,0.33821,0.02078,0.096222,0,0
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.84314,0.020668,0.012445,0,0
4,GO MICROVILLUS ASSEMBLY,0.46168,0.020471,0.087852,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.64051,0.02047,0.071671,0,0
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.90549,0.020465,0.064758,0,0
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.48117,0.020396,0.095491,0,0
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.76963,0.020364,0.069472,0,0
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.62923,0.020316,0.072426,0,0
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.36271,0.020257,0.099699,0,0
4,GO CELLULAR KETONE METABOLIC PROCESS,0.53179,0.020142,0.041085,0,0
4,GO GLUTAMINE METABOLIC PROCESS,0.61803,0.020113,0.0603,0,0
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.84314,0.020099,0.064188,0,0
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.99368,0.020085,0.0042244,0,0
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.69814,0.020065,0.054055,0,0
4,GO MUSCLE CELL MIGRATION,0.89296,0.020044,0.043912,0,0
4,GO TRANSMEMBRANE TRANSPORT,0.47137,0.020024,0.075231,0,0
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.41494,0.019946,0.10226,0,0
4,GO ATP METABOLIC PROCESS,0.39705,0.019938,0.054467,0,0
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.54223,0.019853,-0.088699,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.37964,0.019834,0.077076,0,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.48117,0.019823,0.089612,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.88046,0.019756,0.0441,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.23827,0.019726,0.23311,0,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.62923,0.019552,0.058107,0,0
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.44264,0.019505,0.098146,0,0
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.57414,0.01948,0.068124,0,0
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.94321,0.019372,0.056921,0,0
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.40594,0.019248,0.070583,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.64051,0.019191,0.019338,0,0
4,GO ENDOCRINE HORMONE SECRETION,0.99368,0.019151,0.02571,0,0
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.89296,0.019139,0.013334,0,0
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.64051,0.019123,0.056117,0,0
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.88046,0.018997,0.045299,0,0
4,GO CATION TRANSMEMBRANE TRANSPORT,0.29248,0.018965,0.10375,0,0
4,GO SKELETAL MUSCLE CONTRACTION,0.55277,0.018933,0.055099,0,0
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.41494,0.018713,0.10943,0,0
4,GO CELLULAR RESPONSE TO X RAY,0.80618,0.018671,0.073885,0,0
4,GO REGULATION OF VASCULAR PERMEABILITY,0.93062,0.018593,0.069356,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.85555,0.018574,0.015426,0,0
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.23203,0.018545,0.12678,0,0
4,GO REGULATION OF PROTEIN BINDING,0.58498,0.01853,0.086042,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.57414,0.018513,0.12827,0,0
4,GO DEVELOPMENTAL PIGMENTATION,0.40594,0.018435,0.090302,0,0
4,GO REGULATION OF HEART MORPHOGENESIS,0.58498,0.018174,0.097948,0,0
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.33029,0.018155,0.076964,0,0
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.42405,0.01806,0.087596,0,0
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.60692,0.018055,0.031276,0,0
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.51122,0.018022,0.086717,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.85555,0.018002,0.024247,0,0
4,GO PEROXISOMAL TRANSPORT,0.91805,0.017945,0.0074571,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.24463,0.017921,0.081004,0,0
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.54223,0.017845,0.042325,0,0
4,GO FOREGUT MORPHOGENESIS,0.17591,0.017755,0.15275,0,0
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.74555,0.01771,0.088508,0,0
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.68646,0.017673,0.069906,0,0
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.62923,0.017567,0.085218,0,0
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.56341,0.01756,0.087711,0,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.36271,0.017464,0.09001,0,0
4,GO NEGATIVE REGULATION OF SIGNALING,0.54223,0.017265,0.087216,0,0
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.99368,0.017244,0.032058,0,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.93062,0.017197,0.035091,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.62923,0.017195,0.1049,0,0
4,GO RECEPTOR CATABOLIC PROCESS,0.95582,0.017193,0.044081,0,0
4,GO POSITIVE REGULATION OF CELL GROWTH,0.37964,0.017169,0.10275,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.7336,0.01688,0.014631,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.60692,0.016859,0.090464,0,0
4,GO GLUCOSE METABOLIC PROCESS,0.60692,0.016731,0.076681,0,0
4,GO CARDIOBLAST DIFFERENTIATION,0.51122,0.01673,0.083812,0,0
4,GO GOLGI VESICLE BUDDING,0.89296,0.016687,0.021669,0,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,0.85555,0.016534,0.038422,0,0
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.69814,0.016514,-0.017319,0,0
4,GO NOTCH SIGNALING PATHWAY,0.42405,0.016438,0.09385,0,0
4,GO ANIMAL ORGAN MORPHOGENESIS,0.20822,0.016352,0.13531,0,0
4,GO BONE MATURATION,0.48117,0.016249,0.11208,0,0
4,GO CARBOHYDRATE METABOLIC PROCESS,0.60692,0.01618,0.06294,0,0
4,GO ALANINE TRANSPORT,0.62923,0.015975,0.079378,0,0
4,GO IMP METABOLIC PROCESS,0.75756,0.015755,-0.00046179,0,0
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.66333,0.015697,0.079829,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.62923,0.015602,0.065768,0,0
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.70989,0.015596,0.049171,0,0
4,GO LIPID HOMEOSTASIS,0.96843,0.015428,0.028141,0,0
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.53179,0.015281,0.095002,0,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.98106,0.015131,0.033349,0,0
4,GO NEPHRON MORPHOGENESIS,0.19156,0.015109,0.1346,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.91805,0.015079,0.035932,0,0
4,GO MITOCHONDRIAL FUSION,0.36271,0.015011,0.082808,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.88046,0.014991,0.014322,0,0
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.98106,0.014903,0.05656,0,0
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.91805,0.014857,0.032924,0,0
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.66333,0.014727,0.074704,0,0
4,GO PROTEIN DESTABILIZATION,0.91805,0.014681,0.055031,0,0
4,GO VIRAL GENOME REPLICATION,0.99368,0.014562,0.017497,0,0
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.53179,0.014522,0.092984,0,0
4,GO INTERFERON BETA PRODUCTION,0.89296,0.014459,0.023921,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.89296,0.014421,0.019005,0,0
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.49108,0.014168,0.11541,0,0
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.95582,0.014096,0.032588,0,0
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.74555,0.013873,0.077093,0,0
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.74555,0.013857,0.042371,0,0
4,GO RESPONSE TO ACIDIC PH,0.96843,0.013738,0.021515,0,0
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.66333,0.013693,0.093447,0,0
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.28529,0.01369,0.11477,0,0
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.65188,0.013496,0.06725,0,0
4,GO MEMBRANE ORGANIZATION,0.58498,0.013477,0.073676,0,0
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.80618,0.013468,0.042357,0,0
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.39705,0.013335,0.042221,0,0
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.96843,0.013216,0.024675,0,0
4,GO PIGMENT GRANULE ORGANIZATION,0.89296,0.013145,0.032475,0,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.57414,0.013094,0.064465,0,0
4,GO REGULATION OF MUSCLE ADAPTATION,0.61803,0.013014,0.10151,0,0
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.4521,0.012962,0.092046,0,0
4,GO MUSCLE TISSUE DEVELOPMENT,0.60692,0.012838,0.088549,0,0
4,GO REGULATION OF MUSCLE CONTRACTION,0.84314,0.012789,0.045318,0,0
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.69814,0.012718,0.04246,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.42405,0.012502,0.10624,0,0
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.36271,0.012392,0.04166,0,0
4,GO STEROL METABOLIC PROCESS,0.85555,0.012358,0.0098212,0,0
4,GO MITOCHONDRION ORGANIZATION,0.46168,0.012356,0.055758,0,0
4,GO AMINO ACID ACTIVATION,0.74555,0.012295,0.028287,0,0
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.28529,0.012267,0.10569,0,0
4,GO HYPOTHALAMUS DEVELOPMENT,0.55277,0.012235,0.082699,0,0
4,GO BODY FLUID SECRETION,0.85555,0.012229,0.052341,0,0
4,GO TISSUE MORPHOGENESIS,0.38829,0.012172,0.1101,0,0
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.74555,0.012061,0.075902,0,0
4,GO ERBB SIGNALING PATHWAY,0.90549,0.012036,0.041681,0,0
4,GO CAMP METABOLIC PROCESS,0.56341,0.01203,0.1017,0,0
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.94321,0.012027,0.050246,0,0
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.99368,0.011858,0.058027,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,1,0.011421,0.059006,0,0
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.89296,0.011296,0.022094,0,0
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.80618,0.011112,0.065022,0,0
4,GO EPITHELIAL CELL DEVELOPMENT,0.34626,0.011084,0.12856,0,0
4,GO HEART VALVE DEVELOPMENT,0.55277,0.011032,0.12014,0,0
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.93062,0.011018,0.047619,0,0
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.85555,0.010565,-0.0047913,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.84314,0.010394,0.052364,0,0
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.89296,0.010209,0.048389,0,0
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.94321,0.010171,0.047922,0,0
4,GO TRACHEA MORPHOGENESIS,0.40594,0.010098,0.13883,0,0
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.69814,0.0099644,0.076517,0,0
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.64051,0.009939,0.058219,0,0
4,GO LYMPH VESSEL DEVELOPMENT,0.80618,0.0098215,0.072711,0,0
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.99368,0.0096937,0.023483,0,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.93062,0.0095459,0.069533,0,0
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.99368,0.0094813,0.018366,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.62923,0.0094429,0.098224,0,0
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.81845,0.0094061,0.072752,0,0
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.89296,0.0093961,0.051013,0,0
4,GO REGULATION OF ACROSOME REACTION,0.49108,0.0091627,0.072032,0,0
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.37111,0.009145,0.08213,0,0
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.37964,0.0091272,0.11035,0,0
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.50109,0.0090689,0.090249,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.25111,0.0090442,0.077025,0,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.40594,0.0089683,0.11698,0,0
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.96843,0.0089472,0.032605,0,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.41494,0.0089044,0.094148,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.58498,0.0088858,0.07245,0,0
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.95582,0.0088607,0.0065902,0,0
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.91805,0.0087538,0.010193,0,0
4,GO REGULATION OF GROWTH,0.34626,0.0087333,0.11855,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.94321,0.0086945,0.064164,0,0
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.64051,0.008667,-0.0085404,0,0
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.65188,0.0086522,0.041601,0,0
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.96843,0.0086365,0.043212,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.58498,0.0086266,0.087355,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.93062,0.0085804,0.029734,0,0
4,GO RESPONSE TO INSULIN,0.58498,0.0084783,0.078248,0,0
4,GO FOCAL ADHESION ASSEMBLY,0.67486,0.0084315,0.11234,0,0
4,GO VIRAL RELEASE FROM HOST CELL,1,0.0083826,0.02527,0,0
4,GO REGULATION OF PHOSPHORYLATION,0.89296,0.0083182,0.069069,0,0
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.83078,0.0082982,0.080784,0,0
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.52145,0.0081352,0.092646,0,0
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.74555,0.0080026,0.031321,0,0
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.76963,0.0079023,-0.0029812,0,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.86799,0.0078819,0.040312,0,0
4,GO PSEUDOURIDINE SYNTHESIS,0.89296,0.0078496,0.010083,0,0
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.7336,0.0078421,0.084802,0,0
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.81845,0.007735,0.0381,0,0
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.91805,0.0076942,0.061887,0,0
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.64051,0.0076184,0.11794,0,0
4,GO REGULATION OF PODOSOME ASSEMBLY,0.89296,0.0075688,0.049693,0,0
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.46168,0.0075634,0.094749,0,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.74555,0.0075091,0.065513,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.62923,0.0075017,-0.053532,0,0
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.75756,0.0073815,0.057178,0,0
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.5959,0.0072872,0.083786,0,0
4,GO SYMBIOTIC PROCESS,0.91805,0.0072214,0.021338,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.98106,0.0071765,0.034174,0,0
4,GO POSITIVE REGULATION OF TRANSLATION,0.91805,0.0068775,0.028873,0,0
4,GO CARDIAC CHAMBER DEVELOPMENT,0.67486,0.0067769,0.094243,0,0
4,GO ERAD PATHWAY,1,0.006716,0.042181,0,0
4,GO SKIN MORPHOGENESIS,0.99368,0.006672,0.060717,0,0
4,GO FILOPODIUM ASSEMBLY,0.66333,0.0066026,0.08863,0,0
4,GO REGULATION OF HYDROLASE ACTIVITY,0.93062,0.0065643,0.048604,0,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.98106,0.0064277,0.071122,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.40594,0.0063758,0.07778,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.93062,0.0062412,0.036563,0,0
4,GO VACUOLE ORGANIZATION,0.90549,0.0061852,0.055379,0,0
4,GO POSITIVE REGULATION OF JNK CASCADE,0.84314,0.0061605,0.034994,0,0
4,GO LUNG EPITHELIUM DEVELOPMENT,0.85555,0.0061024,0.082012,0,0
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.90549,0.0060769,0.03744,0,0
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.25111,0.0059871,0.12427,0,0
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.81845,0.0059028,0.03142,0,0
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.89296,0.0057564,0.063529,0,0
4,GO SARCOMERE ORGANIZATION,0.75756,0.0056499,0.042531,0,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.65188,0.0056364,0.073853,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.84314,0.0056123,-0.012275,0,0
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.44264,0.005568,0.070185,0,0
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.81845,0.0055555,0.041067,0,0
4,GO SULFATE TRANSPORT,0.38829,0.0055327,0.08504,0,0
4,GO RESPONSE TO ACID CHEMICAL,0.54223,0.005485,0.080041,0,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.96843,0.0054552,0.03766,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.85555,0.0054437,0.0061141,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.96843,0.0053842,0.041263,0,0
4,GO SLEEP,0.67486,0.0053209,-0.029745,0,0
4,GO NATURAL KILLER CELL ACTIVATION,0.43329,0.0052466,-0.097568,0,0
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.96843,0.0051256,0.028917,0,0
4,GO ADAPTATION OF SIGNALING PATHWAY,0.51122,0.0051054,0.083688,0,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.80618,0.0050644,-0.012107,0,0
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.75756,0.0049807,0.053975,0,0
4,GO RESPONSE TO GAMMA RADIATION,0.93062,0.0049241,0.032259,0,0
4,GO SELECTIVE AUTOPHAGY,0.48117,0.0048131,0.088208,0,0
4,GO STEROL HOMEOSTASIS,0.69814,0.0047955,-0.022519,0,0
4,GO ACTIN FILAMENT BASED MOVEMENT,0.60692,0.0047868,0.089043,0,0
4,GO MESONEPHROS DEVELOPMENT,0.27126,0.0047827,0.1108,0,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.94321,0.0047563,0.037158,0,0
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.39705,0.0047027,0.11836,0,0
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.85555,0.004678,0.068159,0,0
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.84314,0.004615,-0.0061477,0,0
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.37111,0.0045267,0.10094,0,0
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.95582,0.0042278,0.021116,0,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.98106,0.0041426,0.057897,0,0
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.37964,0.0039651,0.061435,0,0
4,GO MONOSACCHARIDE METABOLIC PROCESS,0.90549,0.0038612,0.048508,0,0
4,GO CELLULAR LIPID CATABOLIC PROCESS,0.96843,0.0037837,0.020353,0,0
4,GO RESPONSE TO PEPTIDE HORMONE,0.67486,0.0037832,0.079969,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.85555,0.0037512,0.0010255,0,0
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.89296,0.0037426,0.015205,0,0
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.98106,0.0037155,0.031962,0,0
4,GO REGULATION OF SECRETION,0.60692,0.0037137,0.080335,0,0
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.27821,0.0036922,0.10858,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.75756,0.0036576,0.077678,0,0
4,GO EPIDERMIS DEVELOPMENT,0.80618,0.0036284,0.045614,0,0
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.84314,0.0035959,0.016796,0,0
4,GO CATECHOLAMINE METABOLIC PROCESS,0.56341,0.0035215,0.081989,0,0
4,GO SEROTONIN SECRETION,0.5959,0.0035109,0.057085,0,0
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.5959,0.0034015,0.083431,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.74555,0.00327,0.052281,0,0
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.64051,0.0032657,0.048656,0,0
4,GO ENDOCARDIUM DEVELOPMENT,0.56341,0.0032013,0.10801,0,0
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.62923,0.0025378,0.077251,0,0
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.98106,0.0025148,0.069677,0,0
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.56341,0.0024748,0.075422,0,0
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.48117,0.0023618,0.063393,0,0
4,GO POSITIVE REGULATION OF ERAD PATHWAY,0.49108,0.0023465,-0.018481,0,0
4,GO INTERMEMBRANE LIPID TRANSFER,0.94321,0.0022427,0.050095,0,0
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.80618,0.0021278,0.031786,0,0
4,GO CARDIAC MUSCLE CONTRACTION,0.69814,0.0018509,0.058025,0,0
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.43329,0.0017673,0.10452,0,0
4,GO MITOCHONDRION MORPHOGENESIS,0.81845,0.001732,0.04033,0,0
4,GO REPLICATIVE SENESCENCE,0.86799,0.0016884,0.0046027,0,0
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.81845,0.0016588,0.004932,0,0
4,GO POSITIVE REGULATION OF ANION TRANSPORT,0.76963,0.0016292,0.053178,0,0
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.88046,0.0015452,-0.0033695,0,0
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.60692,0.0013896,-0.012256,0,0
4,GO DIOL BIOSYNTHETIC PROCESS,0.91805,0.0013774,0.058835,0,0
4,GO CELLULAR RESPONSE TO PEPTIDE,0.49108,0.001346,0.091435,0,0
4,GO GAS TRANSPORT,0.69814,0.0013265,0.079851,0,0
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.78176,0.0013251,0.0096397,0,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.84314,0.0013195,0.030906,0,0
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.74555,0.0013105,0.0070059,0,0
4,GO ORGAN GROWTH,0.64051,0.0012891,0.093857,0,0
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.81845,0.0011802,0.027554,0,0
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.51122,0.0011265,0.090312,0,0
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.66333,0.0010278,0.063272,0,0
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.80618,0.00095471,0.11166,0,0
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.49108,0.0009111,0.084934,0,0
4,GO MYELOID CELL HOMEOSTASIS,1,0.00082089,0.046069,0,0
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.81845,0.00079577,0.017066,0,0
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.95582,0.00071912,0.042975,0,0
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.85555,0.00065158,0.023757,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.3148,0.00024531,0.10345,0,0
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.74555,0.00017883,0.0826,0,0
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.49108,6.617e-05,0.08432,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.62923,-2.1733e-05,0.040287,0,0
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.64051,-6.5107e-05,0.1012,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.79394,-9.825e-05,0.023731,0,0
4,GO RESPONSE TO ABIOTIC STIMULUS,0.79394,-0.00010496,0.059419,0,0
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.53179,-0.00012366,0.099726,0,0
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.80618,-0.00031662,0.056302,0,0
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.68646,-0.00032354,0.079663,0,0
4,GO CELL VOLUME HOMEOSTASIS,0.41494,-0.00060176,0.10883,0,0
4,GO REGULATION OF MYELINATION,0.7336,-0.00068484,0.048131,0,0
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.85555,-0.00069708,0.061099,0,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.81845,-0.0007003,0.096892,0,0
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.86799,-0.00071562,0.041114,0,0
4,GO COPII COATED VESICLE BUDDING,0.89296,-0.00080993,0.016356,0,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.62923,-0.00082709,-0.020228,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.95582,-0.00087788,0.040761,0,0
4,GO JNK CASCADE,0.91805,-0.00088155,0.051092,0,0
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.68646,-0.00090345,0.062259,0,0
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.76963,-0.00090349,0.074646,0,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.78176,-0.0009087,0.034718,0,0
4,GO LIPID BIOSYNTHETIC PROCESS,0.80618,-0.00095912,0.024515,0,0
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.60692,-0.0011685,0.062042,0,0
4,GO MIDBODY ABSCISSION,0.61803,-0.0012863,-0.024762,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.51122,-0.0013445,0.11253,0,0
4,GO REGULATION OF FERTILIZATION,0.52145,-0.0013656,0.055406,0,0
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.95582,-0.0013772,0.036311,0,0
4,GO DOPAMINE BIOSYNTHETIC PROCESS,0.30724,-0.0015881,0.13654,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.74555,-0.0016469,0.030352,0,0
4,GO AMELOGENESIS,0.85555,-0.0017628,0.047022,0,0
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.7336,-0.0017639,0.084874,0,0
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.60692,-0.0017786,-0.06492,0,0
4,GO STEROL BIOSYNTHETIC PROCESS,0.96843,-0.0019492,0.029733,0,0
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.90549,-0.0020316,0.039995,0,0
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.72171,-0.0021614,0.10212,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.70989,-0.0022444,0.057461,0,0
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.86799,-0.0022848,0.028269,0,0
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.62923,-0.0025214,0.091926,0,0
4,GO GLIAL CELL MIGRATION,0.93062,-0.0025321,0.040101,0,0
4,GO CELLULAR PIGMENTATION,0.90549,-0.0025737,0.0072329,0,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.91805,-0.00274,0.0154,0,0
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.67486,-0.0027935,0.049251,0,0
4,GO ALCOHOL METABOLIC PROCESS,0.80618,-0.0028802,0.016343,0,0
4,GO GAMMA DELTA T CELL ACTIVATION,0.57414,-0.002907,-0.069862,0,0
4,GO AORTA DEVELOPMENT,0.84314,-0.0029452,0.08746,0,0
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.7336,-0.0031173,0.032419,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.70989,-0.0031556,0.1016,0,0
4,GO ER OVERLOAD RESPONSE,0.91805,-0.0031815,0.03293,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.78176,-0.003189,-0.027297,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.7336,-0.0032244,0.059537,0,0
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.96843,-0.0032416,0.053649,0,0
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.52145,-0.0033154,0.090451,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.68646,-0.0034001,-0.023686,0,0
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.50109,-0.003512,0.11123,0,0
4,GO OSTEOBLAST DIFFERENTIATION,0.93062,-0.003519,0.046744,0,0
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.79394,-0.0035621,-0.0043247,0,0
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.70989,-0.0035889,0.044403,0,0
4,GO ACID SECRETION,0.41494,-0.0036153,0.075296,0,0
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.70989,-0.003634,0.00016446,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.96843,-0.0041416,0.030386,0,0
4,GO ION TRANSPORT,0.61803,-0.0041628,0.070717,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.86799,-0.0042087,0.057579,0,0
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.49108,-0.0042508,0.093645,0,0
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.5959,-0.0042949,-0.010646,0,0
4,GO REGULATION OF GLIOGENESIS,0.64051,-0.0044473,0.07212,0,0
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.75756,-0.0045049,0.029903,0,0
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.51122,-0.0046853,0.051163,0,0
4,GO CYTOPLASM ORGANIZATION,0.65188,-0.0047848,0.070885,0,0
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.88046,-0.0047856,0.0476,0,0
4,GO IMMUNE SYSTEM DEVELOPMENT,0.70989,-0.0047936,0.00087926,0,0
4,GO GPI ANCHOR METABOLIC PROCESS,0.81845,-0.0048089,0.026974,0,0
4,GO CHOLESTEROL STORAGE,0.67486,-0.0049082,-0.017687,0,0
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.94321,-0.0049193,0.078225,0,0
4,GO REGULATION OF PEPTIDE SECRETION,0.96843,-0.0049291,0.047357,0,0
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.33821,-0.0049981,0.10167,0,0
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.75756,-0.0052184,-0.0049624,0,0
4,GO DETECTION OF STIMULUS,0.89296,-0.0052609,0.03597,0,0
4,GO PODOSOME ASSEMBLY,0.84314,-0.0053387,0.062847,0,0
4,GO PEPTIDE METABOLIC PROCESS,0.60692,-0.0053935,0.031458,0,0
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.96843,-0.0055006,0.020145,0,0
4,GO MITOCHONDRIAL FISSION,0.78176,-0.0055276,0.03221,0,0
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.64051,-0.0056573,0.072396,0,0
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.85555,-0.0057723,0.090743,0,0
4,GO LIVER REGENERATION,0.91805,-0.0058532,0.016098,0,0
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.94321,-0.0059235,0.02921,0,0
4,GO RESPONSE TO WATER,0.81845,-0.0059336,0.0035986,0,0
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,1,-0.0059912,0.043953,0,0
4,GO RESPONSE TO INTERLEUKIN 12,0.48117,-0.0060757,-0.044641,0,0
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.99368,-0.0060865,0.035055,0,0
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.75756,-0.006213,0.058649,0,0
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.95582,-0.0062816,0.062401,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.85555,-0.0063613,0.044643,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,0.58498,-0.0063672,0.13829,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.84314,-0.006376,0.077724,0,0
4,GO REGULATION OF PROTEIN FOLDING,0.93062,-0.0064005,0.035613,0,0
4,GO SEQUESTERING OF ACTIN MONOMERS,0.69814,-0.0064598,0.032698,0,0
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.98106,-0.0065112,0.059691,0,0
4,GO CELLULAR RESPONSE TO DSRNA,0.7336,-0.0066154,-0.0012549,0,0
4,GO CELLULAR COMPONENT DISASSEMBLY,0.99368,-0.0066278,0.04733,0,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.72171,-0.0068615,0.045102,0,0
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.78176,-0.0070256,0.089833,0,0
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.93062,-0.0071457,0.041618,0,0
4,GO CARBOHYDRATE PHOSPHORYLATION,0.76963,-0.0071583,0.068661,0,0
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.84314,-0.0072133,0.02948,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.53179,-0.0072608,-0.054877,0,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.68646,-0.0074009,0.10201,0,0
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.50109,-0.0074177,0.079846,0,0
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.62923,-0.0074601,0.098019,0,0
4,GO NEGATIVE REGULATION OF GROWTH,0.7336,-0.007467,0.076014,0,0
4,GO CELLULAR RESPONSE TO VIRUS,0.68646,-0.0074838,-0.024039,0,0
4,GO PIGMENT GRANULE LOCALIZATION,0.78176,-0.0075097,0.041009,0,0
4,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,1,-0.0076012,0.020481,0,0
4,GO PENTOSE METABOLIC PROCESS,0.57414,-0.0076142,0.087771,0,0
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.90549,-0.0076436,0.035588,0,0
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.93062,-0.0076789,-0.00037743,0,0
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.60692,-0.0077427,0.07456,0,0
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.98106,-0.007916,0.058557,0,0
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.85555,-0.0079221,0.0054696,0,0
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.86799,-0.007988,0.029263,0,0
4,GO CELLULAR RESPONSE TO FATTY ACID,0.85555,-0.0079929,0.051301,0,0
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.94321,-0.0080282,0.029695,0,0
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.89296,-0.0080313,0.049006,0,0
4,GO REGULATION OF GASTRIC ACID SECRETION,0.96843,-0.008077,0.0096712,0,0
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.47137,-0.0081364,0.1108,0,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.89296,-0.0081766,0.019113,0,0
4,GO MYOFIBRIL ASSEMBLY,0.89296,-0.0082173,0.033464,0,0
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.48117,-0.0083007,-0.019158,0,0
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.86799,-0.0083515,0.065937,0,0
4,GO MALE GENITALIA DEVELOPMENT,0.70989,-0.0083823,-0.027731,0,0
4,GO RESPONSE TO ESTRADIOL,0.55277,-0.008534,0.078828,0,0
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.57414,-0.0085856,-0.028146,0,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.69814,-0.0086326,0.022306,0,0
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.90549,-0.0086362,0.04072,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.64051,-0.0086658,-0.032313,0,0
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.84314,-0.0087704,0.080193,0,0
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.39705,-0.0088838,-0.084908,0,0
4,GO SPHINGOID METABOLIC PROCESS,0.74555,-0.0089273,0.075157,0,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.66333,-0.0090851,-0.036508,0,0
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.58498,-0.0090912,-0.038965,0,0
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.64051,-0.0091849,0.00065267,0,0
4,GO APOPTOTIC PROCESS,0.98106,-0.0092444,0.043703,0,0
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.91805,-0.0093318,0.040306,0,0
4,GO LIPID METABOLIC PROCESS,0.67486,-0.0094006,0.019951,0,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.98106,-0.0094374,0.070686,0,0
4,GO NEPHRON DEVELOPMENT,0.79394,-0.0094933,0.075535,0,0
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.37111,-0.0095438,0.099266,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.83078,-0.0096876,0.078639,0,0
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.83078,-0.0097661,0.014052,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.78176,-0.0098108,0.058168,0,0
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.68646,-0.0098162,0.013185,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.68646,-0.0098392,0.090276,0,0
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.46168,-0.0098584,0.12562,0,0
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.79394,-0.0099204,0.026222,0,0
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.65188,-0.010123,0.067941,0,0
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.94321,-0.010134,0.012629,0,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.61803,-0.010142,0.018177,0,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.56341,-0.010176,-0.061804,0,0
4,GO EPITHELIAL CELL PROLIFERATION,0.96843,-0.010194,0.058241,0,0
4,GO MITOTIC CYTOKINETIC PROCESS,0.52145,-0.010273,-0.012254,0,0
4,GO EPITHELIUM DEVELOPMENT,0.56341,-0.010294,0.086391,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.80618,-0.010312,0.054404,0,0
4,GO STRIATED MUSCLE CONTRACTION,0.5959,-0.010334,0.060838,0,0
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.88046,-0.010362,0.045466,0,0
4,GO METANEPHROS DEVELOPMENT,0.58498,-0.010366,0.087253,0,0
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.94321,-0.010397,0.044106,0,0
4,GO REGULATION OF PINOCYTOSIS,0.93062,-0.0104,0.057261,0,0
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.7336,-0.010431,-0.037329,0,0
4,GO NAD METABOLIC PROCESS,0.76963,-0.010436,0.06533,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.38829,-0.010455,0.087593,0,0
4,GO RESPONSE TO NITROGEN COMPOUND,0.91805,-0.010727,0.061164,0,0
4,GO RESPONSE TO DRUG,0.96843,-0.010729,0.049126,0,0
4,GO TYPE I INTERFERON PRODUCTION,0.74555,-0.010813,-0.0085167,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.84314,-0.01082,0.02102,0,0
4,GO REGULATION OF ENDOCYTOSIS,0.94321,-0.011127,0.064656,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION,0.75756,-0.011239,0.064281,0,0
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.98106,-0.011379,0.027427,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.91805,-0.011442,0.072262,0,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.68646,-0.011661,0.059876,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.95582,-0.011735,0.053782,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.72171,-0.011844,-0.022227,0,0
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.64051,-0.011929,0.019105,0,0
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.93062,-0.011946,0.031199,0,0
4,GO AUTOPHAGOSOME MATURATION,0.69814,-0.011985,0.01058,0,0
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.98106,-0.012013,0.028783,0,0
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.60692,-0.012221,0.010739,0,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.74555,-0.01233,0.0076749,0,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.56341,-0.012427,0.069952,0,0
4,GO HEXOSE CATABOLIC PROCESS,0.88046,-0.012499,0.049005,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.75756,-0.012504,0.024317,0,0
4,GO RESPONSE TO OSMOTIC STRESS,0.90549,-0.012541,0.036367,0,0
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.84314,-0.012552,0.089689,0,0
4,GO CELLULAR LIPID METABOLIC PROCESS,0.64051,-0.012728,0.015345,0,0
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.65188,-0.012775,0.077684,0,0
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.70989,-0.012775,0.071822,0,0
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.95582,-0.012804,0.035546,0,0
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.53179,-0.012929,0.069763,0,0
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.99368,-0.012938,0.04557,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.7336,-0.012953,-0.021215,0,0
4,GO CATION TRANSPORT,0.55277,-0.013037,0.080568,0,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.5959,-0.0131,0.059638,0,0
4,GO POSITIVE REGULATION OF SIGNALING,0.95582,-0.013121,0.049585,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.93062,-0.013382,0.04159,0,0
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.61803,-0.01339,0.002284,0,0
4,GO CELL CELL JUNCTION ASSEMBLY,0.79394,-0.013392,0.083027,0,0
4,GO SPERM CAPACITATION,0.75756,-0.013425,0.0456,0,0
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.85555,-0.013448,0.01124,0,0
4,GO PSEUDOPODIUM ORGANIZATION,0.88046,-0.013466,0.011301,0,0
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.24463,-0.013473,-0.046956,0,0
4,GO ENGULFMENT OF APOPTOTIC CELL,0.94321,-0.013598,0.017335,0,0
4,GO ANATOMICAL STRUCTURE MATURATION,0.54223,-0.013672,0.10026,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.95582,-0.013735,0.045023,0,0
4,GO HOMEOSTATIC PROCESS,0.84314,-0.013764,0.036742,0,0
4,GO ATP BIOSYNTHETIC PROCESS,0.39705,-0.013861,-0.062464,0,0
4,GO LIPID CATABOLIC PROCESS,0.61803,-0.013889,0.0042647,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.94321,-0.013933,0.055716,0,0
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.98106,-0.014003,0.03314,0,0
4,GO MUSCLE SYSTEM PROCESS,0.79394,-0.014006,0.057429,0,0
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.56341,-0.01402,0.079428,0,0
4,GO GLYCEROLIPID METABOLIC PROCESS,0.76963,-0.014068,0.028869,0,0
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.76963,-0.014092,0.023055,0,0
4,GO VESICLE CARGO LOADING,0.80618,-0.014191,0.056928,0,0
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.53179,-0.01424,-0.057174,0,0
4,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.81845,-0.014275,0.0054148,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.55277,-0.014328,0.065818,0,0
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.43329,-0.014411,-0.054717,0,0
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.5959,-0.014519,0.091584,0,0
4,GO RESPONSE TO STEROL DEPLETION,0.85555,-0.014676,0.017858,0,0
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.90549,-0.014706,0.039877,0,0
4,GO TRICARBOXYLIC ACID CYCLE,0.58498,-0.014917,-0.010121,0,0
4,GO RESPONSE TO CADMIUM ION,0.88046,-0.014924,0.04072,0,0
4,GO EPIDERMAL CELL DIFFERENTIATION,0.94321,-0.014942,0.0062913,0,0
4,GO AMINE CATABOLIC PROCESS,0.7336,-0.015177,-0.029352,0,0
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.83078,-0.015215,0.068029,0,0
4,GO RESPONSE TO ETHER,0.75756,-0.015221,0.05553,0,0
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.94321,-0.015334,0.083221,0,0
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.40594,-0.015532,-0.00395,0,0
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.79394,-0.015547,0.014995,0,0
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.69814,-0.015647,0.013374,0,0
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.67486,-0.015699,0.072301,0,0
4,GO CERAMIDE METABOLIC PROCESS,0.72171,-0.016077,0.074605,0,0
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.76963,-0.016107,0.005182,0,0
4,GO SKELETAL SYSTEM DEVELOPMENT,0.60692,-0.016117,0.087519,0,0
4,GO L SERINE METABOLIC PROCESS,0.47137,-0.016172,0.086167,0,0
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.66333,-0.01629,-0.011618,0,0
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.74555,-0.016296,-0.073562,0,0
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.79394,-0.016366,0.0068641,0,0
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.93062,-0.016367,0.057319,0,0
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.74555,-0.016374,0.01997,0,0
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.90549,-0.01638,0.085794,0,0
4,GO ASTROCYTE DIFFERENTIATION,0.91805,-0.016577,0.045153,0,0
4,GO QUINONE METABOLIC PROCESS,0.79394,-0.016648,0.06598,0,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.68646,-0.016702,-0.11572,0,0
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.91805,-0.016796,0.042699,0,0
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,1,-0.01682,0.054866,0,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.80618,-0.016959,0.057035,0,0
4,GO ORGANIC ACID METABOLIC PROCESS,0.70989,-0.01696,0.016495,0,0
4,GO REGULATION OF EXOSOMAL SECRETION,0.79394,-0.016969,0.01227,0,0
4,GO STRESS FIBER ASSEMBLY,0.7336,-0.017038,0.10108,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.89296,-0.017072,0.040257,0,0
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.74555,-0.017122,-0.018257,0,0
4,GO CONVERGENT EXTENSION,0.60692,-0.017185,0.088414,0,0
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.99368,-0.017191,0.043581,0,0
4,GO APICAL JUNCTION ASSEMBLY,0.85555,-0.017207,0.064944,0,0
4,GO NUCLEOTIDE SALVAGE,0.33029,-0.017222,-0.040393,0,0
4,GO KERATINOCYTE MIGRATION,0.96843,-0.017243,0.05079,0,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.78176,-0.0174,0.058047,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.94321,-0.017438,0.024149,0,0
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.75756,-0.017518,0.0054423,0,0
4,GO ANION HOMEOSTASIS,0.79394,-0.017628,0.070793,0,0
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.94321,-0.017662,0.026427,0,0
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.65188,-0.017704,-0.033804,0,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.24463,-0.017773,-0.036219,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.79394,-0.017841,0.023579,0,0
4,GO NEGATIVE REGULATION OF CELL DEATH,0.74555,-0.018048,0.025629,0,0
4,GO METAL ION TRANSPORT,0.61803,-0.018054,0.075049,0,0
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.89296,-0.018142,0.068097,0,0
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.66333,-0.018303,0.0017001,0,0
4,GO CHONDROCYTE PROLIFERATION,0.84314,-0.018391,0.048718,0,0
4,GO REGULATION OF CARDIAC CONDUCTION,0.60692,-0.018507,0.073594,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.7336,-0.018771,0.081409,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.65188,-0.01879,0.025224,0,0
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.75756,-0.018957,0.023398,0,0
4,GO PROTEOLYSIS,0.79394,-0.018962,0.037445,0,0
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.34626,-0.019399,-0.026679,0,0
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.85555,-0.019475,0.02735,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.67486,-0.019486,-0.014508,0,0
4,GO RESPONSE TO GROWTH FACTOR,0.79394,-0.019624,0.083053,0,0
4,GO INTERFERON ALPHA PRODUCTION,0.56341,-0.019659,-0.064746,0,0
4,GO REGULATION OF ION TRANSPORT,0.62923,-0.02003,0.076453,0,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.67486,-0.020198,0.045135,0,0
4,GO STEROID METABOLIC PROCESS,0.42405,-0.020276,-0.012389,0,0
4,GO DIOL METABOLIC PROCESS,0.93062,-0.020424,0.050627,0,0
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.90549,-0.020434,0.036813,0,0
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.78176,-0.020561,0.069364,0,0
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.99368,-0.020675,0.028665,0,0
4,GO HORMONE BIOSYNTHETIC PROCESS,0.66333,-0.02069,0.0092333,0,0
4,GO ORGANELLE INHERITANCE,0.56341,-0.020789,0.073551,0,0
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.94321,-0.020801,0.030399,0,0
4,GO IMP BIOSYNTHETIC PROCESS,0.70989,-0.020821,-0.021982,0,0
4,GO MUSCLE CONTRACTION,0.80618,-0.020878,0.055884,0,0
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.67486,-0.020905,-0.022548,0,0
4,GO SECONDARY METABOLIC PROCESS,0.79394,-0.020942,0.024261,0,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.52145,-0.021233,-0.02747,0,0
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.90549,-0.021352,0.00024249,0,0
4,GO PHOSPHOLIPID METABOLIC PROCESS,0.74555,-0.021464,0.0245,0,0
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.60692,-0.021834,-0.048246,0,0
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.86799,-0.021924,0.027185,0,0
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.99368,-0.022176,0.046507,0,0
4,GO VIRAL BUDDING,0.50109,-0.022181,-0.027903,0,0
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.78176,-0.022234,0.0098395,0,0
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.90549,-0.022292,0.024715,0,0
4,GO SPHINGOLIPID METABOLIC PROCESS,0.80618,-0.02256,0.058012,0,0
4,GO PROTEIN HOMOTETRAMERIZATION,0.86799,-0.02261,0.017381,0,0
4,GO CHONDROCYTE DEVELOPMENT,0.91805,-0.022821,0.043338,0,0
4,GO REGULATION OF ENDOCRINE PROCESS,0.7336,-0.022834,-0.0037221,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.72171,-0.023033,0.062571,0,0
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.55277,-0.02306,-0.014715,0,0
4,GO ANIMAL ORGAN FORMATION,0.72171,-0.02318,0.055727,0,0
4,GO REGULATION OF ORGANIC ACID TRANSPORT,0.93062,-0.023204,0.052863,0,0
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.91805,-0.023276,0.046519,0,0
4,GO RESPONSE TO UV B,0.89296,-0.023373,0.025759,0,0
4,GO AMYLOID BETA FORMATION,0.89296,-0.023467,0.045633,0,0
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.76963,-0.023521,0.02651,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.54223,-0.023523,-0.013057,0,0
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.83078,-0.023582,0.074157,0,0
4,GO RESPONSE TO AMPHETAMINE,0.54223,-0.023586,0.058377,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.86799,-0.0237,0.036887,0,0
4,GO SECRETION BY TISSUE,0.52145,-0.023719,-0.038202,0,0
4,GO CARDIOLIPIN METABOLIC PROCESS,0.18624,-0.023752,-0.057484,0,0
4,GO AMYLOID BETA METABOLIC PROCESS,0.76963,-0.023758,0.025215,0,0
4,GO NIK NF KAPPAB SIGNALING,0.37111,-0.023943,-0.057075,0,0
4,GO MITOCHONDRIAL GENE EXPRESSION,0.25111,-0.023958,-0.034434,0,0
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.52145,-0.024046,0.015068,0,0
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.30724,-0.024051,-0.067851,0,0
4,GO PROTEIN N LINKED GLYCOSYLATION,0.34626,-0.024096,-0.019126,0,0
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.74555,-0.02411,0.015419,0,0
4,GO RESPONSE TO PAIN,0.78176,-0.024257,0.058343,0,0
4,GO ANION TRANSPORT,0.95582,-0.024274,0.053357,0,0
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.72171,-0.024485,0.04947,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.96843,-0.024806,0.022418,0,0
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.57414,-0.024843,-0.082778,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.81845,-0.025114,0.010946,0,0
4,GO NK T CELL DIFFERENTIATION,0.65188,-0.025176,-0.055091,0,0
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.70989,-0.025224,-0.0098722,0,0
4,GO CELLULAR RESPONSE TO ATP,0.81845,-0.025228,0.0022227,0,0
4,GO REGULATION OF HEART RATE,0.88046,-0.025425,0.036449,0,0
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.88046,-0.02561,0.038393,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.94321,-0.025847,0.031292,0,0
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.54223,-0.026063,0.0035788,0,0
4,GO POLYOL BIOSYNTHETIC PROCESS,0.95582,-0.026066,0.040079,0,0
4,GO AORTA MORPHOGENESIS,0.96843,-0.026152,0.041623,0,0
4,GO REGULATION OF VIRAL TRANSCRIPTION,0.62923,-0.026239,0.01157,0,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.69814,-0.026279,-0.0047968,0,0
4,GO MUSCLE ADAPTATION,0.94321,-0.026321,0.062327,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.90549,-0.026384,0.042751,0,0
4,GO POSITIVE REGULATION OF NEURON DEATH,0.83078,-0.026464,0.067386,0,0
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.40594,-0.026484,-0.050496,0,0
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.89296,-0.026564,0.040563,0,0
4,GO TRANSLATIONAL ELONGATION,0.37964,-0.026606,-0.020649,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.72171,-0.026644,0.01624,0,0
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.74555,-0.026829,0.013215,0,0
4,GO REGULATION OF HEMOPOIESIS,0.65188,-0.026836,-0.01307,0,0
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.85555,-0.026893,0.044042,0,0
4,GO BONE DEVELOPMENT,0.95582,-0.027092,0.063204,0,0
4,GO CYTIDINE TO URIDINE EDITING,0.70989,-0.027154,-0.024961,0,0
4,GO PLACENTA DEVELOPMENT,0.96843,-0.027214,0.049236,0,0
4,GO CELLULAR HOMEOSTASIS,0.61803,-0.0273,0.018178,0,0
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.197,-0.027307,-0.060204,0,0
4,GO MEMBRANE FUSION,0.76963,-0.027313,0.033399,0,0
4,GO MULTIVESICULAR BODY ORGANIZATION,0.47137,-0.027413,-0.031912,0,0
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.93062,-0.027509,0.03974,0,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.98106,-0.027522,0.062911,0,0
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.42405,-0.027584,-0.026064,0,0
4,GO FAT CELL DIFFERENTIATION,0.81845,-0.027589,0.048204,0,0
4,GO TEMPERATURE HOMEOSTASIS,0.72171,-0.027605,0.047067,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.55277,-0.027647,-0.016037,0,0
4,GO MESODERM MORPHOGENESIS,0.78176,-0.027703,0.034462,0,0
4,GO ZINC ION TRANSPORT,0.99368,-0.027715,0.039931,0,0
4,GO PLASMA MEMBRANE ORGANIZATION,0.81845,-0.027761,0.082926,0,0
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.64051,-0.027851,0.022448,0,0
4,GO REGULATION OF AMYLOID BETA FORMATION,1,-0.028014,0.042013,0,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.76963,-0.028166,0.026353,0,0
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.78176,-0.028327,0.039166,0,0
4,GO MEMBRANE REPOLARIZATION,1,-0.028497,0.040962,0,0
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.91805,-0.028763,0.053568,0,0
4,GO BODY MORPHOGENESIS,0.80618,-0.028799,0.042645,0,0
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.89296,-0.028808,0.026659,0,0
4,GO LYTIC VACUOLE ORGANIZATION,0.65188,-0.028843,0.017752,0,0
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.95582,-0.02885,0.03967,0,0
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.76963,-0.028875,0.082784,0,0
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.91805,-0.02888,0.064145,0,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.75756,-0.02895,0.012109,0,0
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.60692,-0.02898,-0.0081492,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.78176,-0.029039,0.0077092,0,0
4,GO VIRAL LIFE CYCLE,0.42405,-0.029071,-0.020361,0,0
4,GO REGULATION OF CELL DEATH,0.78176,-0.029113,0.033139,0,0
4,GO FEVER GENERATION,0.91805,-0.029322,-0.0024336,0,0
4,GO GASTRIC ACID SECRETION,0.57414,-0.029342,0.05856,0,0
4,GO NEGATIVE REGULATION OF SECRETION,0.91805,-0.029342,0.048333,0,0
4,GO OXIDATION REDUCTION PROCESS,0.57414,-0.029362,0.0015179,0,0
4,GO PIGMENT METABOLIC PROCESS,0.68646,-0.029408,0.0055887,0,0
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.91805,-0.029505,0.02966,0,0
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.58498,-0.029622,0.07831,0,0
4,GO DIET INDUCED THERMOGENESIS,0.46168,-0.029665,-0.06609,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.90549,-0.029685,0.018763,0,0
4,GO PROTEIN O LINKED MANNOSYLATION,0.70989,-0.02975,0.063886,0,0
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.66333,-0.029815,0.017599,0,0
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.85555,-0.02983,0.022684,0,0
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.91805,-0.029856,0.015678,0,0
4,GO RESPONSE TO ANTIBIOTIC,0.52145,-0.029918,-0.0021803,0,0
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.53179,-0.029931,0.020601,0,0
4,GO CIRCULATORY SYSTEM PROCESS,0.96843,-0.030091,0.049802,0,0
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.89296,-0.030276,0.0045529,0,0
4,GO FC RECEPTOR SIGNALING PATHWAY,0.42405,-0.030433,-0.032841,0,0
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.67486,-0.03045,0.027764,0,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.95582,-0.030522,0.055158,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.85555,-0.030562,0.078468,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.94321,-0.03065,0.034951,0,0
4,GO BRONCHUS DEVELOPMENT,0.78176,-0.030713,0.088564,0,0
4,GO REGULATION OF RESPONSE TO STRESS,0.50109,-0.030775,0.0061155,0,0
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.86799,-0.030817,0.084522,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.81845,-0.030907,0.043048,0,0
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.78176,-0.030923,0.061768,0,0
4,GO REGULATION OF STEROID METABOLIC PROCESS,0.3148,-0.030953,-0.010798,0,0
4,GO MUSCLE CELL DIFFERENTIATION,0.68646,-0.031035,0.087421,0,0
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.95582,-0.031067,0.042092,0,0
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.98106,-0.031074,0.036437,0,0
4,GO RESPONSE TO PH,0.76963,-0.031194,0.059913,0,0
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.94321,-0.031215,0.041124,0,0
4,GO PEPTIDE SECRETION,0.83078,-0.031266,0.056102,0,0
4,GO EPIDERMIS MORPHOGENESIS,0.90549,-0.031309,0.019851,0,0
4,GO MYELOID CELL DIFFERENTIATION,0.65188,-0.031332,0.010033,0,0
4,GO ACTIN FILAMENT BASED PROCESS,0.76963,-0.031622,0.087124,0,0
4,GO MUSCLE FILAMENT SLIDING,0.55277,-0.031656,-0.029329,0,0
4,GO CELLULAR RESPONSE TO DRUG,0.80618,-0.031692,0.030316,0,0
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.54223,-0.031725,-0.015186,0,0
4,GO CHONDROCYTE DIFFERENTIATION,0.94321,-0.031847,0.060647,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.64051,-0.031895,0.063302,0,0
4,GO CELL MOTILITY,0.69814,-0.031972,0.039868,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.95582,-0.031973,0.016665,0,0
4,GO FATTY ACID METABOLIC PROCESS,0.47137,-0.031999,-0.0073716,0,0
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.94321,-0.032026,0.047383,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.34626,-0.032029,-0.065913,0,0
4,GO REGULATION OF MAPK CASCADE,0.52145,-0.032031,0.014719,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.80618,-0.03218,0.027746,0,0
4,GO NADPH REGENERATION,0.80618,-0.032294,0.00025248,0,0
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.38829,-0.032296,0.021247,0,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.94321,-0.032379,0.025871,0,0
4,GO RESPONSE TO PEPTIDE,0.95582,-0.032389,0.060426,0,0
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.57414,-0.032417,-0.029787,0,0
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.99368,-0.032451,0.03526,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.7336,-0.032603,-0.021837,0,0
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.65188,-0.032645,0.123,0,0
4,GO CELLULAR RESPIRATION,0.56341,-0.032657,-0.014887,0,0
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.98106,-0.032755,0.042044,0,0
4,GO PHOSPHOLIPID TRANSPORT,0.79394,-0.032791,0.030482,0,0
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.43329,-0.032814,-0.10096,0,0
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.84314,-0.032986,0.025029,0,0
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.88046,-0.03315,0.025762,0,0
4,GO LAMELLIPODIUM MORPHOGENESIS,0.84314,-0.033337,0.041209,0,0
4,GO STEROID BIOSYNTHETIC PROCESS,0.24463,-0.033437,-0.021174,0,0
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.49108,-0.033467,-0.018143,0,0
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.54223,-0.033699,-0.024219,0,0
4,GO CELLULAR OXIDANT DETOXIFICATION,0.47137,-0.033705,-0.041481,0,0
4,GO PROTEIN AUTOPROCESSING,0.98106,-0.033985,0.014836,0,0
4,GO GTP METABOLIC PROCESS,0.52145,-0.033996,-0.012524,0,0
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.4521,-0.034078,-0.023416,0,0
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.52145,-0.034088,-0.035479,0,0
4,GO CORTICOSTEROID HORMONE SECRETION,0.75756,-0.034156,-0.03005,0,0
4,GO RESPONSE TO TOXIC SUBSTANCE,0.70989,-0.034272,0.011269,0,0
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.99368,-0.03435,0.049464,0,0
4,GO MODIFIED AMINO ACID TRANSPORT,0.65188,-0.034419,0.0054485,0,0
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.43329,-0.034423,-0.029058,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.57414,-0.034431,-0.01692,0,0
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.81845,-0.034511,0.022234,0,0
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.67486,-0.034615,0.023146,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.58498,-0.034621,0.012546,0,0
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.93062,-0.034974,0.061202,0,0
4,GO RESPONSE TO DIETARY EXCESS,0.61803,-0.034979,-0.017363,0,0
4,GO RESPONSE TO FORSKOLIN,0.48117,-0.035167,0.12074,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.47137,-0.035181,-0.049641,0,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.61803,-0.035191,0.014336,0,0
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.36271,-0.035203,-0.050879,0,0
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.76963,-0.035599,0.089417,0,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.51122,-0.035656,0.10199,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.3148,-0.035819,-0.018057,0,0
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.86799,-0.035823,0.053195,0,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.72171,-0.035894,0.13056,0,0
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.90549,-0.036165,0.047958,0,0
4,GO HEPATOCYTE DIFFERENTIATION,0.83078,-0.036499,-0.025165,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.49108,-0.036513,0.010482,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.26442,-0.036533,-0.062686,0,0
4,GO RESPONSE TO METAL ION,0.74555,-0.036785,0.024906,0,0
4,GO ENDOTHELIUM DEVELOPMENT,0.76963,-0.036788,0.038286,0,0
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.95582,-0.036862,0.030457,0,0
4,GO SKIN DEVELOPMENT,0.95582,-0.036874,0.02421,0,0
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.95582,-0.03696,0.059561,0,0
4,GO REGULATION OF CELL SHAPE,0.85555,-0.036978,0.044986,0,0
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.38829,-0.037005,-0.039234,0,0
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.64051,-0.037013,-0.011311,0,0
4,GO RESPONSE TO X RAY,0.91805,-0.037033,0.047062,0,0
4,GO REGULATION OF SYMBIOTIC PROCESS,0.32248,-0.037243,-0.041611,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.80618,-0.037249,0.048529,0,0
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.74555,-0.037255,0.07136,0,0
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.40594,-0.037454,-0.05322,0,0
4,GO REGULATION OF MAP KINASE ACTIVITY,0.80618,-0.037459,0.045153,0,0
4,GO RENAL SYSTEM PROCESS,0.85555,-0.037675,0.051778,0,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.60692,-0.037804,0.015811,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.94321,-0.037814,0.01858,0,0
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.88046,-0.037865,0.032234,0,0
4,GO CALCIUM ION IMPORT,0.90549,-0.038024,0.044268,0,0
4,GO ACTIN FILAMENT ORGANIZATION,0.96843,-0.038088,0.061142,0,0
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.33821,-0.038215,-0.046078,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.55277,-0.038282,-0.039285,0,0
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.66333,-0.03848,0.039655,0,0
4,GO NEGATIVE REGULATION OF TRANSPORT,0.93062,-0.038551,0.039569,0,0
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.37111,-0.038629,-0.056254,0,0
4,GO RESPONSE TO VIRUS,0.4521,-0.038681,-0.064606,0,0
4,GO WATER HOMEOSTASIS,0.89296,-0.038708,0.020899,0,0
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.69814,-0.038815,0.00011145,0,0
4,GO ACTIN MEDIATED CELL CONTRACTION,0.91805,-0.038916,0.041778,0,0
4,GO LIPID GLYCOSYLATION,0.7336,-0.038955,0.093938,0,0
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.61803,-0.038992,0.02635,0,0
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.90549,-0.039024,0.048492,0,0
4,GO MITOCHONDRIAL TRANSLATION,0.08303,-0.039072,-0.053857,0,0
4,GO ARGININE METABOLIC PROCESS,0.99368,-0.039205,0.023602,0,0
4,GO RENAL SODIUM EXCRETION,0.83078,-0.039331,0.0076294,0,0
4,GO DRUG CATABOLIC PROCESS,0.78176,-0.039338,-0.046957,0,0
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.50109,-0.039409,-0.04469,0,0
4,GO GONADOTROPIN SECRETION,0.81845,-0.039479,0.017064,0,0
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.89296,-0.039481,0.061093,0,0
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.86799,-0.039638,0.024718,0,0
4,GO MEGAKARYOCYTE DEVELOPMENT,0.81845,-0.039679,0.04678,0,0
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.50109,-0.039686,-0.03999,0,0
4,GO PROTON TRANSMEMBRANE TRANSPORT,0.55277,-0.039719,-0.013746,0,0
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.76963,-0.039745,0.03829,0,0
4,GO CELLULAR RESPONSE TO NUTRIENT,0.72171,-0.039853,0.0072051,0,0
4,GO KETONE BIOSYNTHETIC PROCESS,0.74555,-0.039892,0.0037839,0,0
4,GO ORGANIC ANION TRANSPORT,0.84314,-0.039916,0.037253,0,0
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.67486,-0.039946,0.02703,0,0
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.57414,-0.040534,-0.0062473,0,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.30724,-0.040585,-0.03241,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.81845,-0.040609,-0.013254,0,0
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.40594,-0.040707,-0.014353,0,0
4,GO AGING,0.67486,-0.040789,0.026218,0,0
4,GO TETRAPYRROLE METABOLIC PROCESS,0.54223,-0.040943,-0.0099034,0,0
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.78176,-0.040944,0.011738,0,0
4,GO REGULATION OF PH,0.55277,-0.041064,0.013916,0,0
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.5959,-0.04109,-0.023562,0,0
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.40594,-0.041136,-0.0087813,0,0
4,GO RESPONSE TO STEROID HORMONE,0.91805,-0.041231,0.04477,0,0
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.72171,-0.041254,0.0073933,0,0
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.7336,-0.041307,0.044622,0,0
4,GO ACTIVATION OF MAPK ACTIVITY,0.85555,-0.04136,0.053532,0,0
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.80618,-0.041446,-0.00941,0,0
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.80618,-0.041623,0.051785,0,0
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.76963,-0.041698,0.0086822,0,0
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.30724,-0.041911,-0.026027,0,0
4,GO TRABECULA MORPHOGENESIS,0.80618,-0.041944,0.020214,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.88046,-0.042,0.07371,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.94321,-0.042065,0.031371,0,0
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.49108,-0.042133,-0.04919,0,0
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.83078,-0.042147,0.031808,0,0
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.20822,-0.042233,-0.04596,0,0
4,GO MAINTENANCE OF LOCATION,0.48117,-0.042295,0.0046745,0,0
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.52145,-0.042493,-0.00020242,0,0
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.43329,-0.04255,-0.036303,0,0
4,GO HEART TRABECULA MORPHOGENESIS,0.94321,-0.042793,0.049012,0,0
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.98106,-0.042863,0.026591,0,0
4,GO CARTILAGE DEVELOPMENT,0.64051,-0.04292,0.032821,0,0
4,GO RESPONSE TO DEXAMETHASONE,0.35442,-0.043012,-0.029757,0,0
4,GO PROTEIN MATURATION,0.3148,-0.043268,-0.012229,0,0
4,GO RNA 5 END PROCESSING,0.44264,-0.04351,-0.020538,0,0
4,GO GLIAL CELL PROLIFERATION,0.84314,-0.043531,0.038831,0,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.69814,-0.043802,0.0093356,0,0
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.79394,-0.044054,0.043457,0,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.96843,-0.044221,0.051781,0,0
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.47137,-0.04461,-0.067487,0,0
4,GO GASTRULATION,0.5959,-0.044625,0.024824,0,0
4,GO NOTCH RECEPTOR PROCESSING,0.99368,-0.044649,0.025039,0,0
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.53179,-0.044745,0.023255,0,0
4,GO REGULATION OF EXCRETION,0.76963,-0.044771,-0.007079,0,0
4,GO STEROL TRANSPORT,0.7336,-0.044782,0.009904,0,0
4,GO PROTEIN DEGLYCOSYLATION,0.47137,-0.044824,-0.020264,0,0
4,GO REGULATION OF PROTEOLYSIS,0.37111,-0.04504,-0.0035727,0,0
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.78176,-0.045076,0.052889,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.33821,-0.045168,-0.076041,0,0
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.75756,-0.045244,-0.041224,0,0
4,GO RESPONSE TO SALT STRESS,0.7336,-0.045312,0.055728,0,0
4,GO PROTEIN NITROSYLATION,0.23203,-0.045411,-0.10568,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.56341,-0.045445,0.033974,0,0
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.83078,-0.045505,0.074801,0,0
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.52145,-0.045531,0.002279,0,0
4,GO PEPTIDYL PROLINE MODIFICATION,0.3148,-0.045572,-0.014839,0,0
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.74555,-0.045611,0.0069708,0,0
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.62923,-0.045759,0.026997,0,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.98106,-0.045963,0.049277,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.46168,-0.046384,-0.081891,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.57414,-0.046497,0.016365,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.65188,-0.046528,0.092634,0,0
4,GO RESPONSE TO ESTROGEN,0.43329,-0.046623,-0.013522,0,0
4,GO HORMONE METABOLIC PROCESS,0.67486,-0.046708,0.0029978,0,0
4,GO ETHANOL CATABOLIC PROCESS,0.53179,-0.04672,-0.088297,0,0
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.70989,-0.046916,-0.0047591,0,0
4,GO B CELL DIFFERENTIATION,0.48117,-0.04701,-0.054694,0,0
4,GO AMINO SUGAR METABOLIC PROCESS,0.37964,-0.047047,-0.033781,0,0
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.33821,-0.047192,-0.072618,0,0
4,GO FOLIC ACID METABOLIC PROCESS,0.43329,-0.04736,-0.012983,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.86799,-0.047431,0.011404,0,0
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.61803,-0.047555,0.0067981,0,0
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.69814,-0.04758,0.025168,0,0
4,GO LUNG ALVEOLUS DEVELOPMENT,0.67486,-0.047613,0.050263,0,0
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.74555,-0.047616,0.03172,0,0
4,GO RESPONSE TO CORTICOSTERONE,0.76963,-0.047645,0.038358,0,0
4,GO HYPOTONIC RESPONSE,0.88046,-0.047781,0.054981,0,0
4,GO CELLULAR RESPONSE TO KETONE,0.93062,-0.048027,0.053949,0,0
4,GO REGULATION OF VIRAL LIFE CYCLE,0.39705,-0.048102,-0.045605,0,0
4,GO MIDDLE EAR MORPHOGENESIS,0.95582,-0.048117,-0.013982,0,0
4,GO POSITIVE REGULATION OF TRANSPORT,0.83078,-0.048237,0.032191,0,0
4,GO HEART FIELD SPECIFICATION,0.80618,-0.048326,0.091626,0,0
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.069906,-0.048518,-0.072362,0,0
4,GO RELAXATION OF MUSCLE,0.51122,-0.048846,-0.033055,0,0
4,GO RENAL FILTRATION,0.99368,-0.048858,0.07428,0,0
4,GO SULFUR COMPOUND TRANSPORT,0.95582,-0.048935,0.05604,0,0
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.61803,-0.04909,0.040521,0,0
4,GO REGULATION OF VASOCONSTRICTION,0.86799,-0.049229,0.052494,0,0
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.42405,-0.049303,-0.01121,0,0
4,GO TRNA 5 LEADER REMOVAL,0.08303,-0.049495,-0.076731,0,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.35442,-0.049571,-0.058745,0,0
4,GO REGULATION OF ANION TRANSPORT,0.85555,-0.049829,0.018668,0,0
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.40594,-0.049838,-0.095326,0,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.94321,-0.05018,-0.0047162,0,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.52145,-0.050203,-0.01014,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.74555,-0.050208,0.0035036,0,0
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.32248,-0.05024,-0.074236,0,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.80618,-0.050242,0.034919,0,0
4,GO ADAPTIVE THERMOGENESIS,0.86799,-0.050267,0.047646,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.47137,-0.050403,-0.0050403,0,0
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.16602,-0.050522,-0.053205,0,0
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.2577,-0.050575,-0.079152,0,0
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.27126,-0.050677,-0.067488,0,0
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.36271,-0.051126,-0.022755,0,0
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.84314,-0.051227,0.0081106,0,0
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.86799,-0.051327,0.08733,0,0
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.81845,-0.051477,0.043943,0,0
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.84314,-0.05152,0.03156,0,0
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.99368,-0.051551,0.06655,0,0
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.98106,-0.051559,0.029587,0,0
4,GO RESPONSE TO NITRIC OXIDE,0.65188,-0.052058,-0.018946,0,0
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.4521,-0.052168,-0.054242,0,0
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.42405,-0.052244,-0.058645,0,0
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.39705,-0.052363,-0.021575,0,0
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.23203,-0.052383,-0.079498,0,0
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.65188,-0.052428,0.0041941,0,0
4,GO ENDOCYTOSIS,0.72171,-0.052448,0.030408,0,0
4,GO POSITIVE REGULATION OF CELL DEATH,0.69814,-0.052553,0.035837,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.4521,-0.052599,-0.0052933,0,0
4,GO CHEMICAL HOMEOSTASIS,0.62923,-0.052628,0.018295,0,0
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.83078,-0.052633,0.063461,0,0
4,GO REGULATION OF GASTRULATION,0.44264,-0.052643,-0.02187,0,0
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.55277,-0.052668,0.074363,0,0
4,GO PULMONARY VALVE MORPHOGENESIS,0.90549,-0.052716,0.024373,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.90549,-0.052728,0.045761,0,0
4,GO TUBE DEVELOPMENT,0.85555,-0.052778,0.056535,0,0
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.27821,-0.052791,-0.10535,0,0
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.43329,-0.052854,-0.016898,0,0
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.25111,-0.052969,-0.036586,0,0
4,GO REGULATION OF CELLULAR PH,0.48117,-0.053009,0.0094491,0,0
4,GO RESPONSE TO HORMONE,0.91805,-0.053113,0.049962,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.62923,-0.053206,0.0093351,0,0
4,GO PROTEIN O LINKED GLYCOSYLATION,0.4521,-0.053392,-0.030647,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.81845,-0.053428,0.034423,0,0
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.29248,-0.053455,-0.12053,0,0
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.54223,-0.053456,-0.0075097,0,0
4,GO RESPONSE TO DSRNA,0.38829,-0.053467,-0.043265,0,0
4,GO RESPONSE TO ETHANOL,0.94321,-0.053526,0.04372,0,0
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.99368,-0.053549,0.061619,0,0
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.20822,-0.053729,-0.034014,0,0
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.46168,-0.053861,-0.07917,0,0
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.7336,-0.053919,0.020036,0,0
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.4521,-0.053993,-0.042926,0,0
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.46168,-0.054426,-0.037309,0,0
4,GO TRANSEPITHELIAL TRANSPORT,0.69814,-0.054465,-0.018478,0,0
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.85555,-0.054575,0.04869,0,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.68646,-0.054595,0.03321,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.61803,-0.054836,0.0051562,0,0
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.68646,-0.054937,0.0011305,0,0
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,1,-0.055131,0.032156,0,0
4,GO TUBE MORPHOGENESIS,0.81845,-0.055148,0.05415,0,0
4,GO VESICLE BUDDING FROM MEMBRANE,0.50109,-0.055169,0.00070114,0,0
4,GO HYALURONAN CATABOLIC PROCESS,0.62923,-0.055204,-0.032882,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.49108,-0.055269,0.003294,0,0
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.79394,-0.055278,0.013698,0,0
4,GO REGULATION OF METAL ION TRANSPORT,0.72171,-0.055295,0.025168,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.46168,-0.055612,-0.015735,0,0
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.53179,-0.055629,-0.020915,0,0
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.68646,-0.055649,0.0051545,0,0
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.50109,-0.055726,-0.028586,0,0
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.65188,-0.055792,-0.018093,0,0
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.81845,-0.055808,0.07446,0,0
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.38829,-0.055816,-0.020899,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.55277,-0.055835,-0.00023328,0,0
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.56341,-0.05586,-0.011647,0,0
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.37964,-0.056281,0.0044055,0,0
4,GO CELL CELL ADHESION,0.76963,-0.056548,0.029321,0,0
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.57414,-0.056637,-0.019626,0,0
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.49108,-0.056651,0.011125,0,0
4,GO CELLULAR RESPONSE TO LIPID,0.53179,-0.056668,0.0049637,0,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.26442,-0.056737,-0.031235,0,0
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.85555,-0.056797,0.054159,0,0
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.23203,-0.056914,-0.013219,0,0
4,GO RESPONSE TO GONADOTROPIN,0.46168,-0.057141,-0.028185,0,0
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.41494,-0.057181,-0.014491,0,0
4,GO INACTIVATION OF MAPK ACTIVITY,0.44264,-0.057195,-0.013185,0,0
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.30724,-0.057407,-0.031532,0,0
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.39705,-0.057752,-0.054849,0,0
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.83078,-0.058495,0.0075782,0,0
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.90549,-0.058825,0.026739,0,0
4,GO REGULATION OF CELL MATRIX ADHESION,0.57414,-0.058895,0.04179,0,0
4,GO REGULATION OF INNATE IMMUNE RESPONSE,0.33029,-0.058926,-0.080153,0,0
4,GO PROTEIN DEMANNOSYLATION,0.4521,-0.059004,-0.014923,0,0
4,GO OVULATION,0.28529,-0.059028,-0.065485,0,0
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.94321,-0.059088,0.024392,0,0
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.98106,-0.059144,0.059972,0,0
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.54223,-0.059169,-0.019301,0,0
4,GO I KAPPAB PHOSPHORYLATION,0.30724,-0.059224,-0.089281,0,0
4,GO T CELL DIFFERENTIATION,0.5959,-0.059461,-0.069506,0,0
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.43329,-0.059544,-0.061436,0,0
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.23203,-0.059597,-0.0074975,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.46168,-0.059781,-0.058841,0,0
4,GO LUTEINIZATION,0.94321,-0.059842,0.048726,0,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,0.23827,-0.059953,-0.062271,0,0
4,GO DEFENSE RESPONSE TO VIRUS,0.47137,-0.06031,-0.062766,0,0
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.96843,-0.060328,0.03937,0,0
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.25111,-0.060474,-0.0097889,0,0
4,GO TRNA 5 END PROCESSING,0.069906,-0.060543,-0.051846,0,0
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.74555,-0.060551,0.00518,0,0
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.21989,-0.060591,-0.040277,0,0
4,GO RESPONSE TO NUTRIENT,0.40594,-0.06061,-0.0091528,0,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.96843,-0.060618,0.015724,0,0
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.42405,-0.060628,0.003134,0,0
4,GO HAIR FOLLICLE MATURATION,0.80618,-0.060646,0.048286,0,0
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.80618,-0.060662,-0.023081,0,0
4,GO ACTIN NUCLEATION,0.23827,-0.060718,-0.030242,0,0
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.93062,-0.06072,0.029961,0,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.47137,-0.060723,-0.041616,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.81845,-0.060752,0.032818,0,0
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.38829,-0.060764,-0.035908,0,0
4,GO CELL SUBSTRATE ADHESION,0.49108,-0.060886,0.019739,0,0
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.7336,-0.061104,0.012131,0,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.20822,-0.061192,-0.046695,0,0
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.37964,-0.061261,-0.074073,0,0
4,GO APOPTOTIC SIGNALING PATHWAY,0.2998,-0.061272,-0.0092215,0,0
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.29248,-0.0613,-0.13952,0,0
4,GO ENDOTHELIAL CELL PROLIFERATION,0.65188,-0.061313,0.029101,0,0
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.2577,-0.061385,-0.076063,0,0
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.93062,-0.061391,0.041929,0,0
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.40594,-0.061525,-0.085045,0,0
4,GO RESPONSE TO INORGANIC SUBSTANCE,0.57414,-0.061711,0.011015,0,0
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.89296,-0.061757,0.036122,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.49108,-0.061855,-0.010909,0,0
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.35442,-0.061945,-0.017677,0,0
4,GO THYMOCYTE APOPTOTIC PROCESS,0.39705,-0.061965,-0.073401,0,0
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.51122,-0.062077,-0.025337,0,0
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.38829,-0.062103,-0.044359,0,0
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.27821,-0.062127,-0.042181,0,0
4,GO RESPONSE TO VITAMIN D,0.7336,-0.062155,-0.0047884,0,0
4,GO LYMPHOCYTE DIFFERENTIATION,0.57414,-0.062167,-0.058388,0,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,0.85555,-0.062546,0.01045,0,0
4,GO GLIAL CELL APOPTOTIC PROCESS,0.58498,-0.06261,-0.016836,0,0
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.46168,-0.062938,-0.0045744,0,0
4,GO STEROID ESTERIFICATION,0.38829,-0.063005,-0.071461,0,0
4,GO CELLULAR ION HOMEOSTASIS,0.4521,-0.063018,-0.012308,0,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.51122,-0.063084,-0.022882,0,0
4,GO TISSUE REGENERATION,0.52145,-0.063103,-0.011101,0,0
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,1,-0.063105,0.025635,0,0
4,GO ORGANIC ACID TRANSPORT,0.79394,-0.063302,0.02607,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.34626,-0.06335,-0.024586,0,0
4,GO HEAD MORPHOGENESIS,0.47137,-0.063411,0.0033862,0,0
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.58498,-0.063427,-0.0035084,0,0
4,GO GTP BIOSYNTHETIC PROCESS,0.67486,-0.063518,-0.062678,0,0
4,GO ION HOMEOSTASIS,0.55277,-0.063567,0.0022003,0,0
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.93062,-0.063688,0.060334,0,0
4,GO RIG I SIGNALING PATHWAY,0.60692,-0.063796,-0.024386,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.55277,-0.063825,-0.05337,0,0
4,GO REGULATION OF WATER LOSS VIA SKIN,0.46168,-0.06392,-0.031852,0,0
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.61803,-0.063948,-0.0021345,0,0
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.68646,-0.063986,0.0018836,0,0
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.2998,-0.064114,-0.015621,0,0
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.46168,-0.064315,-0.017289,0,0
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.35442,-0.064318,-0.04318,0,0
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.15655,-0.064429,-0.037415,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.70989,-0.064458,0.037967,0,0
4,GO RENAL WATER HOMEOSTASIS,0.91805,-0.064484,0.090419,0,0
4,GO SECRETION,0.46168,-0.064498,-0.0032031,0,0
4,GO REGULATION OF TUBE SIZE,0.55277,-0.064592,0.00060646,0,0
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.74555,-0.064617,-0.038121,0,0
4,GO RETINOIC ACID METABOLIC PROCESS,1,-0.064729,-0.0075102,0,0
4,GO CELL MATRIX ADHESION,0.48117,-0.064883,0.017379,0,0
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.74555,-0.065008,0.00030747,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.41494,-0.065017,-0.0011504,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.93062,-0.065166,0.050705,0,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.28529,-0.065391,-0.019645,0,0
4,GO TOXIN METABOLIC PROCESS,0.35442,-0.065434,-0.046488,0,0
4,GO KERATINOCYTE DIFFERENTIATION,0.58498,-0.065435,-0.041225,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.68646,-0.065452,0.020958,0,0
4,GO SMOOTH MUSCLE CELL MIGRATION,0.52145,-0.065462,0.01116,0,0
4,GO RESPONSE TO ZINC ION,0.69814,-0.065583,-0.00078093,0,0
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.67486,-0.065602,0.024286,0,0
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.26442,-0.06575,-0.084878,0,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1,-0.066053,0.033543,0,0
4,GO RESPONSE TO LEAD ION,0.89296,-0.066142,0.026361,0,0
4,GO PROTEIN KINASE B SIGNALING,0.53179,-0.06623,-0.0050046,0,0
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.24463,-0.066589,0.0068867,0,0
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.40594,-0.066617,-0.049811,0,0
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.39705,-0.066623,-0.062885,0,0
4,GO REGENERATION,0.62923,-0.066685,0.023495,0,0
4,GO RESPONSE TO OXIDATIVE STRESS,0.30724,-0.06684,-0.0097005,0,0
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.2259,-0.0669,-0.052144,0,0
4,GO RESPONSE TO ALCOHOL,0.80618,-0.067044,0.036742,0,0
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.47137,-0.067126,-0.017292,0,0
4,GO TRANSLATIONAL TERMINATION,0.035953,-0.067197,-0.067763,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.93062,-0.067234,0.058192,0,0
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.20822,-0.067374,0.0042928,0,0
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.84314,-0.067587,-0.031482,0,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.48117,-0.0676,0.0088493,0,0
4,GO FATTY ACID TRANSPORT,0.26442,-0.067613,-0.038714,0,0
4,GO REGULATION OF OSSIFICATION,0.65188,-0.067625,0.026719,0,0
4,GO KERATINIZATION,0.27821,-0.067747,-0.087039,0,0
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.46168,-0.067761,-0.0027138,0,0
4,GO REGULATION OF BLOOD PRESSURE,0.35442,-0.067797,-0.015037,0,0
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.4521,-0.067862,-0.053397,0,0
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.55277,-0.068172,0.011244,0,0
4,GO METAL ION HOMEOSTASIS,0.46168,-0.068193,-0.012525,0,0
4,GO REGULATION OF RESPIRATORY BURST,0.36271,-0.068219,-0.054933,0,0
4,GO REGULATION OF ISOTYPE SWITCHING,0.79394,-0.068362,0.0035138,0,0
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.90549,-0.068473,0.010792,0,0
4,GO REGULATION OF ACTIN NUCLEATION,0.42405,-0.068543,-0.028396,0,0
4,GO AMINO ACID IMPORT,0.52145,-0.068602,-0.0077614,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.68646,-0.068782,0.00717,0,0
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.197,-0.068958,-0.078986,0,0
4,GO REGULATION OF LIPID STORAGE,0.33029,-0.068999,-0.037174,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.33821,-0.069002,-0.012981,0,0
4,GO SENSORY PERCEPTION OF TASTE,0.76963,-0.069027,-0.020052,0,0
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.38829,-0.069047,0.10293,0,0
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.64051,-0.069058,-0.0050064,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.44264,-0.069125,-0.075951,0,0
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.57414,-0.069169,-0.031701,0,0
4,GO TISSUE HOMEOSTASIS,0.34626,-0.069371,-0.011976,0,0
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.42405,-0.069456,0.0039273,0,0
4,GO REGULATION OF PLATELET AGGREGATION,0.35442,-0.069533,-0.091514,0,0
4,GO MESODERMAL CELL DIFFERENTIATION,0.60692,-0.069714,-0.0019424,0,0
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.80618,-0.069779,0.0013693,0,0
4,GO VIRION ASSEMBLY,0.18102,-0.069959,-0.034544,0,0
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.78176,-0.069963,0.010534,0,0
4,GO ALCOHOL CATABOLIC PROCESS,0.96843,-0.069994,0.026038,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.2577,-0.070019,-0.064279,0,0
4,GO LIPID STORAGE,0.43329,-0.070135,-0.0033935,0,0
4,GO BONE MINERALIZATION,0.214,-0.070318,-0.031029,0,0
4,GO REGULATION OF VACUOLE ORGANIZATION,0.2998,-0.07034,0.0023517,0,0
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.43329,-0.070402,-0.054288,0,0
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.46168,-0.070518,0.0098731,0,0
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.29248,-0.070605,-0.048306,0,0
4,GO SALIVARY GLAND DEVELOPMENT,0.75756,-0.070718,0.040969,0,0
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.78176,-0.070731,0.04327,0,0
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.39705,-0.070991,-0.045043,0,0
4,GO CELL RECOGNITION,0.91805,-0.071105,0.032906,0,0
4,GO PEPTIDYL ARGININE MODIFICATION,0.98106,-0.071119,0.035606,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.76963,-0.071176,-0.002464,0,0
4,GO REGULATION OF URINE VOLUME,0.57414,-0.071187,-0.024693,0,0
4,GO CHOLESTEROL EFFLUX,0.4521,-0.071189,-0.044154,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.43329,-0.07119,-0.035299,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.72171,-0.071259,0.0070314,0,0
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.56341,-0.071305,-0.028478,0,0
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.4521,-0.071322,-0.055442,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.54223,-0.071446,0.0089629,0,0
4,GO RESPONSE TO ANGIOTENSIN,0.37111,-0.071497,-0.046697,0,0
4,GO BIOMINERALIZATION,0.38829,-0.071507,-0.0042579,0,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.38829,-0.07165,-0.032988,0,0
4,GO BEHAVIORAL RESPONSE TO PAIN,0.93062,-0.071701,0.05378,0,0
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.74555,-0.071897,0.027277,0,0
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.47137,-0.072264,-0.056577,0,0
4,GO NEURON REMODELING,0.35442,-0.072268,-0.09266,0,0
4,GO SPERM EGG RECOGNITION,0.4521,-0.0723,-0.025053,0,0
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.197,-0.072314,-0.049278,0,0
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.2998,-0.072318,-0.13111,0,0
4,GO XENOBIOTIC TRANSPORT,0.5959,-0.072482,0.082691,0,0
4,GO AEROBIC RESPIRATION,0.10134,-0.0725,-0.041096,0,0
4,GO HEME METABOLIC PROCESS,0.18102,-0.072649,-0.051317,0,0
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.68646,-0.072688,0.013488,0,0
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.94321,-0.0728,-0.0085561,0,0
4,GO POSITIVE REGULATION OF OSSIFICATION,0.47137,-0.072865,0.0072617,0,0
4,GO FIBROBLAST PROLIFERATION,0.76963,-0.07287,0.044854,0,0
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.23827,-0.072878,-0.053829,0,0
4,GO AMEBOIDAL TYPE CELL MIGRATION,0.67486,-0.073094,0.02477,0,0
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.44264,-0.073151,-0.019711,0,0
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.78176,-0.073258,0.0049806,0,0
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.2259,-0.073421,-0.071661,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.32248,-0.073526,-0.1111,0,0
4,GO OLIGOPEPTIDE TRANSPORT,0.44264,-0.073577,-0.012366,0,0
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.75756,-0.073612,0.010211,0,0
4,GO RESPONSE TO OXYGEN LEVELS,0.40594,-0.073695,-0.00035345,0,0
4,GO SEQUESTERING OF TRIGLYCERIDE,0.61803,-0.073788,-0.012736,0,0
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.29248,-0.073856,-0.033867,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.25111,-0.07413,-0.070715,0,0
4,GO VITAMIN METABOLIC PROCESS,0.214,-0.074153,-0.039301,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.62923,-0.074414,0.0044891,0,0
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.64051,-0.074641,-0.018846,0,0
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.49108,-0.074728,-0.014044,0,0
4,GO MACROMOLECULE DEPALMITOYLATION,0.10811,-0.074769,-0.075037,0,0
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.42405,-0.0748,0.0036064,0,0
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.19156,-0.075065,-0.070088,0,0
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.47137,-0.075113,-0.088328,0,0
4,GO EPIBOLY,0.5959,-0.075165,0.039223,0,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.67486,-0.075297,0.011708,0,0
4,GO MAINTENANCE OF LOCATION IN CELL,0.33821,-0.075507,-0.029732,0,0
4,GO NEGATIVE REGULATION OF ANOIKIS,0.35442,-0.075518,-0.053178,0,0
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.067497,-0.075609,-0.036817,0,0
4,GO REGULATION OF B CELL DIFFERENTIATION,0.37111,-0.075645,-0.13905,0,0
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.3148,-0.075723,-0.13559,0,0
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.94321,-0.075749,0.04517,0,0
4,GO RESPONSE TO TUMOR CELL,0.35442,-0.075752,-0.10271,0,0
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.33029,-0.075773,-0.014623,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.53179,-0.075938,0.011153,0,0
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.13885,-0.075974,-0.071377,0,0
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.2998,-0.076207,-0.040704,0,0
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.62923,-0.076238,0.017496,0,0
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.4521,-0.076496,-0.065419,0,0
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.74555,-0.076521,0.028459,0,0
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.21989,-0.076539,-0.052753,0,0
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.42405,-0.076564,-0.013694,0,0
4,GO CARBOHYDRATE TRANSPORT,0.38829,-0.07671,-0.0015344,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.61803,-0.076717,-0.047259,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.32248,-0.07677,-0.0033012,0,0
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.37111,-0.076804,-0.022854,0,0
4,GO PEPTIDYL TYROSINE MODIFICATION,0.46168,-0.076896,0.0019953,0,0
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.94321,-0.076952,0.05092,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.64051,-0.077111,0.030056,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.69814,-0.077216,0.034704,0,0
4,GO RESPONSE TO COPPER ION,0.47137,-0.077295,-0.010936,0,0
4,GO REGULATION OF CELL FATE SPECIFICATION,0.50109,-0.077402,-0.044691,0,0
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.214,-0.077792,-0.17757,0,0
4,GO ACYLGLYCEROL HOMEOSTASIS,0.27126,-0.077968,-0.098002,0,0
4,GO RESPONSE TO MECHANICAL STIMULUS,0.35442,-0.078074,-0.0037152,0,0
4,GO OUTFLOW TRACT MORPHOGENESIS,0.99368,-0.078098,0.054288,0,0
4,GO ARTERY DEVELOPMENT,0.98106,-0.078116,0.057417,0,0
4,GO SPROUTING ANGIOGENESIS,0.98106,-0.078146,0.05978,0,0
4,GO INTERACTION WITH HOST,0.24463,-0.078296,-0.045873,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.39705,-0.078398,-0.0071205,0,0
4,GO POSITIVE REGULATION OF SECRETION,0.66333,-0.078472,0.012447,0,0
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.47137,-0.078627,-0.0065173,0,0
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.41494,-0.07882,-0.018684,0,0
4,GO ISOPRENOID METABOLIC PROCESS,0.4521,-0.07902,-0.025148,0,0
4,GO PROTEIN OXIDATION,0.054439,-0.079095,-0.14007,0,0
4,GO HYALURONAN METABOLIC PROCESS,0.42405,-0.079467,-0.028675,0,0
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.58498,-0.079497,-0.034906,0,0
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.30724,-0.079647,-0.083526,0,0
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.35442,-0.079691,-0.0068982,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.37111,-0.079691,-0.12387,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.18624,-0.079692,-0.025281,0,0
4,GO PARAXIAL MESODERM DEVELOPMENT,0.4521,-0.079699,-0.041875,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.1306,-0.079831,-0.06549,0,0
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.29248,-0.080242,-0.079536,0,0
4,GO OSSIFICATION,0.50109,-0.080348,0.018178,0,0
4,GO LYSOSOME LOCALIZATION,0.52145,-0.080378,-0.020779,0,0
4,GO RESPONSE TO MUSCLE STRETCH,0.29248,-0.080584,-0.055709,0,0
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.11163,-0.080592,-0.05839,0,0
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.27821,-0.080734,-0.021162,0,0
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.32248,-0.080865,-0.020962,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.29248,-0.080875,-0.059422,0,0
4,GO DETOXIFICATION,0.40594,-0.080945,-0.027041,0,0
4,GO TERPENOID METABOLIC PROCESS,0.48117,-0.080981,-0.029275,0,0
4,GO ACTIN FILAMENT NETWORK FORMATION,0.78176,-0.080987,0.022727,0,0
4,GO AMINOGLYCAN METABOLIC PROCESS,0.53179,-0.081227,-0.0070607,0,0
4,GO MESENCHYME MORPHOGENESIS,0.76963,-0.081493,0.016294,0,0
4,GO TRANSFERRIN TRANSPORT,0.4521,-0.08159,-0.0025126,0,0
4,GO BIOLOGICAL ADHESION,0.57414,-0.081702,0.020505,0,0
4,GO URONIC ACID METABOLIC PROCESS,0.056456,-0.0818,-0.087678,0,0
4,GO SERTOLI CELL DIFFERENTIATION,0.7336,-0.082002,0.01741,0,0
4,GO RETINOL METABOLIC PROCESS,0.12273,-0.082115,-0.1286,0,0
4,GO GLYCINE METABOLIC PROCESS,0.53179,-0.08213,-0.042667,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.4521,-0.082268,-0.00098141,0,0
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.2577,-0.082271,-0.014002,0,0
4,GO LONG CHAIN FATTY ACID TRANSPORT,0.35442,-0.082274,-0.023552,0,0
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.66333,-0.082362,-0.014285,0,0
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.36271,-0.082413,-0.07179,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.85555,-0.08255,0.045244,0,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.26442,-0.082585,-0.029373,0,0
4,GO AMINE METABOLIC PROCESS,0.54223,-0.082602,-0.013602,0,0
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.18624,-0.082971,-0.091411,0,0
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.62923,-0.083316,0.020773,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.20256,-0.083371,-0.012402,0,0
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.19156,-0.083404,-0.056471,0,0
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.2259,-0.083676,-0.057752,0,0
4,GO REGULATION OF ANOIKIS,0.30724,-0.083839,-0.026936,0,0
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.43329,-0.084009,-0.028323,0,0
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.36271,-0.084079,-0.0027178,0,0
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.27821,-0.08413,-0.041326,0,0
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.68646,-0.084179,-0.029739,0,0
4,GO FACE DEVELOPMENT,0.40594,-0.084229,0.0041919,0,0
4,GO AMP METABOLIC PROCESS,0.14312,-0.084349,-0.070147,0,0
4,GO POSITIVE REGULATION OF URINE VOLUME,0.3148,-0.084467,-0.065293,0,0
4,GO RESPONSE TO THYROID HORMONE,0.28529,-0.084529,-0.07372,0,0
4,GO REGULATION OF STEM CELL DIVISION,0.48117,-0.084538,-0.056935,0,0
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.42405,-0.084713,-0.025664,0,0
4,GO PROTEASOME ASSEMBLY,0.050584,-0.084744,-0.0887,0,0
4,GO RESPONSE TO LIPID,0.38829,-0.08486,-0.016156,0,0
4,GO TAXIS,0.74555,-0.084866,0.037081,0,0
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.99368,-0.084887,0.028736,0,0
4,GO DIGESTION,0.62923,-0.084951,-0.012373,0,0
4,GO GRANULOCYTE DIFFERENTIATION,0.43329,-0.085029,-0.078922,0,0
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.93062,-0.085195,0.054199,0,0
4,GO RESPONSE TO MURAMYL DIPEPTIDE,0.55277,-0.085207,-0.024318,0,0
4,GO PEPTIDE CATABOLIC PROCESS,0.42405,-0.085268,-0.039683,0,0
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.080256,-0.085307,-0.11389,0,0
4,GO TISSUE MIGRATION,0.44264,-0.085447,-0.0087366,0,0
4,GO P38MAPK CASCADE,0.54223,-0.085521,0.016079,0,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.44264,-0.085622,-0.032257,0,0
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.61803,-0.085756,-0.02347,0,0
4,GO LEUKOCYTE DIFFERENTIATION,0.51122,-0.085757,-0.064489,0,0
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.86799,-0.085992,-0.02483,0,0
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.58498,-0.086646,-0.04419,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.29248,-0.086676,-0.056555,0,0
4,GO B CELL HOMEOSTASIS,0.41494,-0.086691,-0.074321,0,0
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.37964,-0.0867,-0.029648,0,0
4,GO PHOSPHOLIPID HOMEOSTASIS,0.70989,-0.086996,-0.0046619,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.84314,-0.087112,0.044548,0,0
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.40594,-0.087116,-0.051487,0,0
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.29248,-0.087207,-0.046138,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.47137,-0.087377,-0.019412,0,0
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.56341,-0.087772,-0.02542,0,0
4,GO REGULATORY T CELL DIFFERENTIATION,0.39705,-0.087797,-0.15696,0,0
4,GO CELLULAR RESPONSE TO CAMP,0.57414,-0.087844,-0.0039359,0,0
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.1475,-0.087906,-0.065491,0,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.33821,-0.087963,-0.025426,0,0
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.55277,-0.087965,0.001987,0,0
4,GO COPPER ION HOMEOSTASIS,0.214,-0.088132,-0.046482,0,0
4,GO KETONE BODY METABOLIC PROCESS,0.83078,-0.088148,-0.015701,0,0
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.70989,-0.088156,-0.026348,0,0
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.050584,-0.088239,-0.076726,0,0
4,GO BLOOD VESSEL MORPHOGENESIS,0.37111,-0.088443,-0.0015023,0,0
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.15655,-0.088495,-0.10592,0,0
4,GO PROTEIN HYDROXYLATION,0.10468,-0.08861,-0.092495,0,0
4,GO OXIDATIVE PHOSPHORYLATION,0.11163,-0.088612,-0.052511,0,0
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.47137,-0.088692,-0.025859,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.214,-0.08886,-0.12911,0,0
4,GO ER NUCLEUS SIGNALING PATHWAY,0.18624,-0.088965,-0.030768,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.67486,-0.088976,0.027088,0,0
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.10468,-0.089083,-0.033126,0,0
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.35442,-0.089135,-0.044532,0,0
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.78176,-0.089295,-0.0013957,0,0
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.3148,-0.089319,-0.025896,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.56341,-0.089377,-0.035989,0,0
4,GO MYOTUBE DIFFERENTIATION,0.60692,-0.089411,-0.0040795,0,0
4,GO EXOCYTOSIS,0.28529,-0.089478,-0.047027,0,0
4,GO PINOCYTOSIS,0.68646,-0.089678,-0.0056345,0,0
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.70989,-0.089713,0.018857,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.30724,-0.089875,-0.0008316,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.57414,-0.089925,-0.026725,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.197,-0.089989,-0.058901,0,0
4,GO DIGESTIVE SYSTEM PROCESS,0.46168,-0.090126,-0.01884,0,0
4,GO PANCREATIC JUICE SECRETION,0.53179,-0.090264,-0.030479,0,0
4,GO AUTOPHAGIC CELL DEATH,0.17591,-0.090317,-0.050798,0,0
4,GO FIBROBLAST ACTIVATION,0.1306,-0.090353,-0.086225,0,0
4,GO RESPONSE TO MAGNESIUM ION,0.32248,-0.090371,-0.080686,0,0
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.60692,-0.090415,0.012125,0,0
4,GO DRUG METABOLIC PROCESS,0.12273,-0.090578,-0.12392,0,0
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.18624,-0.090894,-0.058512,0,0
4,GO RESPONSE TO VITAMIN,0.39705,-0.091037,-0.021153,0,0
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.46168,-0.091071,-0.01457,0,0
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.54223,-0.091124,-0.025554,0,0
4,GO VASCULATURE DEVELOPMENT,0.42405,-0.091147,0.0092024,0,0
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.42405,-0.091249,-0.01877,0,0
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.94321,-0.091433,-0.004598,0,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,0.33029,-0.091469,-0.052355,0,0
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.89296,-0.09168,0.053311,0,0
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.35442,-0.091696,-0.034309,0,0
4,GO RESPONSE TO WOUNDING,0.39705,-0.091984,-0.011557,0,0
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.27126,-0.091994,-0.042217,0,0
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.58498,-0.092032,0.0055312,0,0
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.30724,-0.092041,-0.090721,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.90549,-0.092085,0.054568,0,0
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.18102,-0.092242,-0.057401,0,0
4,GO LIPID LOCALIZATION,0.48117,-0.092405,-0.0062191,0,0
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.34626,-0.09257,-0.037051,0,0
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.95582,-0.092782,0.04582,0,0
4,GO MULTI ORGANISM CELLULAR PROCESS,0.48117,-0.092846,-0.0468,0,0
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.060677,-0.092947,-0.057082,0,0
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.17091,-0.093193,-0.10706,0,0
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.30724,-0.093308,-0.032759,0,0
4,GO TUMOR NECROSIS FACTOR SECRETION,0.2998,-0.093506,-0.082835,0,0
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.27126,-0.093537,-0.082205,0,0
4,GO RESPONSE TO KETONE,0.51122,-0.093555,0.017634,0,0
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.2577,-0.093561,-0.046082,0,0
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.72171,-0.093572,0.015138,0,0
4,GO MITOCHONDRIAL DEPOLARIZATION,0.32248,-0.093614,-0.066834,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION,0.4521,-0.093685,-0.093095,0,0
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.85555,-0.093691,0.043968,0,0
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.38829,-0.093828,-0.034842,0,0
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.41494,-0.094146,-0.0394,0,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.2998,-0.094182,-0.052371,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.197,-0.094249,-0.091434,0,0
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.23827,-0.094365,-0.044138,0,0
4,GO REGULATION OF FATTY ACID TRANSPORT,0.4521,-0.094383,-0.036089,0,0
4,GO ZINC ION HOMEOSTASIS,0.38829,-0.09455,-0.033042,0,0
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.85555,-0.094565,0.016842,0,0
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.47137,-0.095027,-0.014686,0,0
4,GO TRANSITION METAL ION TRANSPORT,0.26442,-0.095049,-0.033099,0,0
4,GO BASEMENT MEMBRANE ORGANIZATION,0.36271,-0.095279,-0.024664,0,0
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.64051,-0.095304,-0.046089,0,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.56341,-0.09554,-0.046805,0,0
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.08303,-0.095563,-0.075092,0,0
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.20822,-0.09579,-0.048063,0,0
4,GO REGULATION OF RESPONSE TO WOUNDING,0.20256,-0.096066,-0.064225,0,0
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.75756,-0.096125,0.0056714,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.12662,-0.09623,-0.010076,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.43329,-0.09682,-0.073801,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.18624,-0.097246,-0.11114,0,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.25111,-0.097248,-0.07622,0,0
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.16123,-0.09754,-0.051627,0,0
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.16602,-0.097807,-0.062319,0,0
4,GO REGULATION OF RECEPTOR BINDING,0.54223,-0.098016,-0.0016521,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.11894,-0.098022,-0.092791,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.2998,-0.09827,-0.077089,0,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.074935,-0.098381,-0.07015,0,0
4,GO ANIMAL ORGAN REGENERATION,0.12273,-0.098632,-0.049009,0,0
4,GO RELAXATION OF CARDIAC MUSCLE,0.13885,-0.098946,-0.10298,0,0
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.3148,-0.099103,-0.081837,0,0
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.4521,-0.099141,-0.048623,0,0
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.47137,-0.0992,-0.014978,0,0
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.41494,-0.099385,-0.030314,0,0
4,GO RESPONSE TO MINERALOCORTICOID,0.43329,-0.099398,-0.017394,0,0
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.18624,-0.099666,-0.17181,0,0
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.23827,-0.099668,-0.053544,0,0
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.37964,-0.099677,-0.03176,0,0
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.75756,-0.09972,-0.0055446,0,0
4,GO ELECTRON TRANSPORT CHAIN,0.050584,-0.10006,-0.082666,0,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.37111,-0.10014,-0.069551,0,0
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.25111,-0.10046,-0.13912,0,0
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.11163,-0.10047,-0.12883,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.42405,-0.10055,-0.0085975,0,0
4,GO PH REDUCTION,0.37964,-0.10059,-0.019959,0,0
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.32248,-0.10073,-0.099333,0,0
4,GO RESPONSE TO ATP,0.61803,-0.10087,-0.020673,0,0
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.57414,-0.10108,-0.031703,0,0
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.28529,-0.10121,-0.077743,0,0
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.16602,-0.10122,-0.16955,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.35442,-0.10131,-0.044495,0,0
4,GO T CELL LINEAGE COMMITMENT,0.40594,-0.10134,-0.10677,0,0
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.55277,-0.10151,-0.023844,0,0
4,GO RESPONSE TO FATTY ACID,0.40594,-0.10154,-0.012025,0,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.37964,-0.10158,-0.01957,0,0
4,GO LINOLEIC ACID METABOLIC PROCESS,0.080256,-0.1016,-0.10487,0,0
4,GO HOMOTYPIC CELL CELL ADHESION,0.38829,-0.10167,-0.03276,0,0
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.17591,-0.10171,-0.049949,0,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.098083,-0.10183,-0.089956,0,0
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.40594,-0.10211,-0.12398,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.83078,-0.10212,-0.0035774,0,0
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.40594,-0.10246,-0.030595,0,0
4,GO RESPONSE TO RETINOIC ACID,0.40594,-0.10251,-0.016528,0,0
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.3148,-0.10251,-0.045408,0,0
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.38829,-0.10252,-0.056212,0,0
4,GO RESPONSE TO CORTICOSTEROID,0.42405,-0.10274,-0.01232,0,0
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.3148,-0.10275,-0.075813,0,0
4,GO ESTROGEN METABOLIC PROCESS,0.25111,-0.1029,-0.072639,0,0
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.37111,-0.10293,-0.040834,0,0
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.16602,-0.10302,-0.086502,0,0
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.65188,-0.10315,0.0001539,0,0
4,GO STEROID HORMONE SECRETION,0.4521,-0.10318,-0.033275,0,0
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.52145,-0.10325,-0.024665,0,0
4,GO CORNIFICATION,0.214,-0.10327,-0.11763,0,0
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.33821,-0.10336,-0.093669,0,0
4,GO REGULATION OF ICOSANOID SECRETION,0.18624,-0.10341,-0.079009,0,0
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.38829,-0.10349,-0.072868,0,0
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.42405,-0.10353,0.00010184,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.61803,-0.10356,-0.014489,0,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.32248,-0.10363,-0.050859,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.66333,-0.10393,0.1062,0,0
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.23827,-0.10394,-0.1622,0,0
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.3148,-0.10457,-0.096959,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.26442,-0.10464,-0.1538,0,0
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.23203,-0.10467,-0.10903,0,0
4,GO REGULATION OF PROTEIN MATURATION,0.40594,-0.1047,-0.014295,0,0
4,GO LYMPHOCYTE ACTIVATION,0.38829,-0.10479,-0.094631,0,0
4,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.53179,-0.10489,-0.018625,0,0
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.214,-0.1049,-0.046935,0,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.33029,-0.10511,-0.052668,0,0
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.39705,-0.10513,-0.054859,0,0
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.23827,-0.10514,-0.1919,0,0
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.25111,-0.10518,-0.023044,0,0
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.065157,-0.10522,-0.06783,0,0
4,GO ALPHA BETA T CELL ACTIVATION,0.39705,-0.10527,-0.13446,0,0
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.60692,-0.10527,0.013085,0,0
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.13467,-0.1053,-0.033774,0,0
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.25111,-0.10534,-0.095981,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.12662,-0.10536,-0.1155,0,0
4,GO LIVER MORPHOGENESIS,0.42405,-0.10542,-0.042199,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.33029,-0.10546,-0.023631,0,0
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.26442,-0.10575,-0.11127,0,0
4,GO ENDODERM DEVELOPMENT,0.66333,-0.10578,0.022102,0,0
4,GO MICROVILLUS ORGANIZATION,0.25111,-0.10583,-0.053268,0,0
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.32248,-0.10584,-0.0030762,0,0
4,GO AMINE BIOSYNTHETIC PROCESS,0.17091,-0.1059,-0.088665,0,0
4,GO PROTEIN DENEDDYLATION,0.37111,-0.10592,-0.036506,0,0
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.39705,-0.10598,-0.085694,0,0
4,GO TRANSITION METAL ION HOMEOSTASIS,0.08881,-0.10599,-0.060992,0,0
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.28529,-0.10628,-0.047274,0,0
4,GO CELLULAR RESPONSE TO SALT STRESS,0.69814,-0.10633,-0.014777,0,0
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.3148,-0.10638,-0.074699,0,0
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.79394,-0.10639,0.0044048,0,0
4,GO WOUND HEALING,0.33821,-0.10665,-0.031235,0,0
4,GO REGULATION OF RUFFLE ASSEMBLY,0.08881,-0.10681,-0.074367,0,0
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.35442,-0.10729,-0.025317,0,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.33029,-0.10739,-0.052119,0,0
4,GO LYMPHOCYTE HOMEOSTASIS,0.2998,-0.10752,-0.09497,0,0
4,GO RESPONSE TO CYTOKINE,0.15655,-0.10762,-0.099764,0,0
4,GO RESPONSE TO FLUID SHEAR STRESS,0.35442,-0.10772,-0.032044,0,0
4,GO FORMATION OF PRIMARY GERM LAYER,0.27821,-0.10781,-0.01763,0,0
4,GO HEART TRABECULA FORMATION,0.28529,-0.108,-0.096639,0,0
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.21989,-0.10806,-0.074832,0,0
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.1306,-0.10844,-0.11415,0,0
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.2577,-0.10846,-0.17296,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.33821,-0.10854,-0.11638,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.077559,-0.10863,-0.087131,0,0
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.074935,-0.10864,-0.068918,0,0
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.2577,-0.10885,-0.181,0,0
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.54223,-0.10898,-0.061419,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.26442,-0.10901,-0.047305,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.067497,-0.1092,-0.092346,0,0
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.2998,-0.10925,-0.087856,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.33029,-0.10927,-0.034383,0,0
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.27821,-0.10927,-0.14189,0,0
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.29248,-0.10999,-0.05629,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.7336,-0.11006,-0.020652,0,0
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.4521,-0.11025,-0.0099129,0,0
4,GO RESPONSE TO INTERLEUKIN 7,0.23203,-0.11047,-0.084886,0,0
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.72171,-0.11053,-0.021751,0,0
4,GO IRON ION TRANSPORT,0.11894,-0.11061,-0.050941,0,0
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.30724,-0.11062,-0.052818,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.80618,-0.11066,0.0071321,0,0
4,GO GERMINAL CENTER FORMATION,0.11163,-0.11069,-0.26651,0,0
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.89296,-0.11084,0.030753,0,0
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.28529,-0.11097,-0.072069,0,0
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.16602,-0.11116,-0.21534,0,0
4,GO REGULATION OF BONE MINERALIZATION,0.2577,-0.11122,-0.05056,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.36271,-0.11126,-0.028985,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.33029,-0.11134,-0.034944,0,0
4,GO REGULATION OF DEFENSE RESPONSE,0.20822,-0.1115,-0.10118,0,0
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.27821,-0.11154,-0.078096,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.23827,-0.11159,-0.18802,0,0
4,GO T CELL APOPTOTIC PROCESS,0.1306,-0.11165,-0.19038,0,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.43329,-0.11168,-0.013611,0,0
4,GO RESPONSE TO PROSTAGLANDIN,0.58498,-0.1117,-0.04205,0,0
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.39705,-0.11175,-0.1395,0,0
4,GO FLUID TRANSPORT,0.27821,-0.11179,-0.11122,0,0
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.37111,-0.11201,-0.03502,0,0
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.12662,-0.11213,-0.086758,0,0
4,GO VACUOLAR ACIDIFICATION,0.10468,-0.11216,-0.072979,0,0
4,GO HORMONE CATABOLIC PROCESS,0.89296,-0.11238,-0.0070878,0,0
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.37111,-0.11277,-0.06335,0,0
4,GO T CELL HOMEOSTASIS,0.55277,-0.11291,-0.050402,0,0
4,GO RESPONSE TO PROGESTERONE,0.37964,-0.11304,-0.021409,0,0
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.53179,-0.11304,-0.0012142,0,0
4,GO CELL CELL JUNCTION MAINTENANCE,0.38829,-0.11306,-0.045273,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.29248,-0.1132,-0.084532,0,0
4,GO POSITIVE REGULATION OF MYELINATION,0.43329,-0.11322,-0.063988,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.61803,-0.11328,-0.071684,0,0
4,GO REGULATION OF NECROTIC CELL DEATH,0.11894,-0.11348,-0.073274,0,0
4,GO REGULATION OF BIOMINERALIZATION,0.30724,-0.11357,-0.028232,0,0
4,GO MYELOID CELL APOPTOTIC PROCESS,0.30724,-0.11385,-0.085343,0,0
4,GO POSITIVE CHEMOTAXIS,0.36271,-0.11403,-0.049643,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.33821,-0.11404,-0.097781,0,0
4,GO RESPONSE TO CAMP,0.37964,-0.11413,-0.0040351,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.10811,-0.11418,-0.21753,0,0
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.37111,-0.11426,-0.0169,0,0
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.197,-0.11437,-0.089643,0,0
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.38829,-0.11438,-0.029343,0,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.10134,-0.11466,-0.10619,0,0
4,GO CGMP MEDIATED SIGNALING,0.2998,-0.11492,-0.070052,0,0
4,GO CELLULAR RESPONSE TO COPPER ION,0.80618,-0.11495,0.033679,0,0
4,GO LIPID IMPORT INTO CELL,0.2259,-0.11497,-0.0347,0,0
4,GO REGULATION OF BODY FLUID LEVELS,0.33029,-0.11499,-0.026178,0,0
4,GO NADP METABOLIC PROCESS,0.16602,-0.115,-0.061971,0,0
4,GO SPHINGOMYELIN METABOLIC PROCESS,0.32248,-0.11506,-0.049109,0,0
4,GO PROTEIN PROCESSING,0.10468,-0.11516,-0.059829,0,0
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.23827,-0.11529,-0.18203,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.20822,-0.11567,-0.052407,0,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.25111,-0.11586,-0.10374,0,0
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.35442,-0.11605,-0.089582,0,0
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.2998,-0.1161,-0.026698,0,0
4,GO PLATELET MORPHOGENESIS,0.51122,-0.11622,-0.01415,0,0
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.30724,-0.11629,-0.077753,0,0
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.2998,-0.11636,-0.085015,0,0
4,GO NECROTIC CELL DEATH,0.10134,-0.11658,-0.08128,0,0
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.53179,-0.11674,-0.062335,0,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.40594,-0.11698,-0.097424,0,0
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.17091,-0.11737,-0.10374,0,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.25111,-0.11807,-0.052313,0,0
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.16123,-0.11814,-0.12088,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.214,-0.11831,-0.10132,0,0
4,GO MYELOID CELL DEVELOPMENT,0.27821,-0.11833,-0.039429,0,0
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.40594,-0.11845,-0.065798,0,0
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.40594,-0.11849,-0.11132,0,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.88046,-0.11855,0.017824,0,0
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.17091,-0.11869,-0.116,0,0
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.5959,-0.11887,-0.0079301,0,0
4,GO RESPONSE TO ISCHEMIA,0.68646,-0.11888,0.0069906,0,0
4,GO BONE TRABECULA MORPHOGENESIS,0.72171,-0.11893,-0.00064929,0,0
4,GO AORTIC VALVE DEVELOPMENT,0.95582,-0.1192,0.030867,0,0
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.37964,-0.11938,-0.067932,0,0
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.094909,-0.11943,-0.11366,0,0
4,GO PROGRAMMED NECROTIC CELL DEATH,0.13885,-0.1195,-0.084834,0,0
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.16602,-0.12004,-0.050877,0,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.23827,-0.12009,-0.10278,0,0
4,GO ARTERY MORPHOGENESIS,0.67486,-0.12029,0.0099599,0,0
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.32248,-0.1204,-0.048045,0,0
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.68646,-0.12053,-0.012287,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.33821,-0.12056,-0.089819,0,0
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.26442,-0.12064,-0.023673,0,0
4,GO REVERSE CHOLESTEROL TRANSPORT,0.79394,-0.12075,-0.0064295,0,0
4,GO RUFFLE ASSEMBLY,0.20822,-0.12096,-0.031071,0,0
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.75756,-0.121,0.012455,0,0
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.27126,-0.12126,-0.04995,0,0
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.33821,-0.12144,-0.03317,0,0
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.35442,-0.12163,-0.05913,0,0
4,GO RESPONSE TO GROWTH HORMONE,0.16602,-0.12174,-0.043377,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.29248,-0.12194,-0.051627,0,0
4,GO OSTEOBLAST PROLIFERATION,0.20822,-0.12227,-0.039083,0,0
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.2998,-0.12227,-0.028927,0,0
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.69814,-0.12239,-0.011623,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.27821,-0.12242,-0.12697,0,0
4,GO REGULATION OF LIPID LOCALIZATION,0.41494,-0.12244,-0.030123,0,0
4,GO ANDROGEN METABOLIC PROCESS,0.046961,-0.12248,-0.097605,0,0
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.38829,-0.12249,-0.02563,0,0
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.33821,-0.12258,-0.021433,0,0
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.12273,-0.12264,-0.097425,0,0
4,GO MUSCLE CELL PROLIFERATION,0.37964,-0.12266,-0.018644,0,0
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.20256,-0.12285,-0.062192,0,0
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.72171,-0.12304,0.0079773,0,0
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.197,-0.12338,-0.065046,0,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.29248,-0.12338,-0.073602,0,0
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.55277,-0.12344,-0.030732,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.2998,-0.12363,-0.11686,0,0
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.12273,-0.12363,-0.071995,0,0
4,GO IRON ION HOMEOSTASIS,0.1306,-0.12374,-0.078919,0,0
4,GO CELLULAR RESPONSE TO ZINC ION,0.96843,-0.12417,0.079385,0,0
4,GO CALCIUM MEDIATED SIGNALING,0.66333,-0.12455,-0.032065,0,0
4,GO REGULATION OF STEROL TRANSPORT,0.36271,-0.12456,-0.050052,0,0
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.080256,-0.12471,-0.11986,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.48117,-0.12493,-0.12342,0,0
4,GO OPSONIZATION,0.26442,-0.12503,-0.21821,0,0
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.40594,-0.12503,-0.08115,0,0
4,GO PULMONARY VALVE DEVELOPMENT,0.72171,-0.1251,0.0013206,0,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.17591,-0.12517,-0.063297,0,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.15197,-0.12529,-0.096699,0,0
4,GO REGULATION OF METANEPHROS DEVELOPMENT,0.32248,-0.1255,-0.068182,0,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.20822,-0.12557,-0.10586,0,0
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.17591,-0.12569,-0.10834,0,0
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.21989,-0.12571,-0.14525,0,0
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.20256,-0.12601,-0.036384,0,0
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.48117,-0.12608,0.10304,0,0
4,GO T CELL ACTIVATION,0.36271,-0.12645,-0.11814,0,0
4,GO MAST CELL MEDIATED IMMUNITY,0.2259,-0.12713,-0.13709,0,0
4,GO MACROPHAGE APOPTOTIC PROCESS,0.37964,-0.12733,-0.10612,0,0
4,GO GLYCOSIDE METABOLIC PROCESS,0.21989,-0.12789,-0.0041327,0,0
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.20256,-0.12806,-0.035997,0,0
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.058535,-0.12823,-0.073457,0,0
4,GO ENDOTHELIAL CELL MIGRATION,0.27126,-0.1285,-0.039413,0,0
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.16123,-0.12885,-0.075721,0,0
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.24463,-0.12914,-0.1083,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.32248,-0.12916,-0.041891,0,0
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.80618,-0.12917,-0.020259,0,0
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.27126,-0.1296,-0.10951,0,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.26442,-0.12963,-0.055127,0,0
4,GO RESPONSE TO PROSTAGLANDIN E,0.67486,-0.12966,-0.025587,0,0
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.15197,-0.13,-0.067344,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.32248,-0.13005,-0.042005,0,0
4,GO MONOCARBOXYLIC ACID TRANSPORT,0.36271,-0.13009,-0.02191,0,0
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.43329,-0.13029,-0.051395,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.094909,-0.131,-0.08453,0,0
4,GO B CELL ACTIVATION,0.32248,-0.13118,-0.10217,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.3148,-0.13128,-0.057256,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.062884,-0.13133,-0.13169,0,0
4,GO GLYCOPROTEIN CATABOLIC PROCESS,0.24463,-0.13137,-0.05368,0,0
4,GO CELLULAR RESPONSE TO ETHANOL,0.23827,-0.13143,-0.11373,0,0
4,GO DEFENSE RESPONSE,0.17091,-0.13148,-0.12209,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.33029,-0.13169,-0.02096,0,0
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.42405,-0.13174,-0.0091972,0,0
4,GO ORGAN INDUCTION,0.44264,-0.13175,-0.036593,0,0
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.077559,-0.1318,-0.13324,0,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.21989,-0.13183,-0.067272,0,0
4,GO CYTOKINE PRODUCTION,0.197,-0.13183,-0.12277,0,0
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.35442,-0.132,-0.03667,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.2998,-0.13212,-0.079253,0,0
4,GO INTERACTION WITH SYMBIONT,0.1475,-0.13214,-0.078205,0,0
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.42405,-0.13217,-0.031002,0,0
4,GO CELL ACTIVATION,0.25111,-0.13217,-0.10401,0,0
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.64051,-0.13241,0.019907,0,0
4,GO CERAMIDE TRANSPORT,0.2998,-0.13258,-0.081507,0,0
4,GO BILE ACID AND BILE SALT TRANSPORT,0.1306,-0.13269,-0.12317,0,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.214,-0.13273,-0.12399,0,0
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.35442,-0.13283,-0.03374,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.28529,-0.13319,-0.082708,0,0
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.28529,-0.1333,-0.049895,0,0
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.2998,-0.13331,-0.049513,0,0
4,GO DISACCHARIDE METABOLIC PROCESS,0.16602,-0.13353,-0.051975,0,0
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.38829,-0.13354,-0.05501,0,0
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.29248,-0.13356,-0.032164,0,0
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.17091,-0.13412,-0.22001,0,0
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.15197,-0.1342,-0.12603,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.15197,-0.13442,-0.10871,0,0
4,GO MACROPHAGE DIFFERENTIATION,0.28529,-0.13448,-0.11922,0,0
4,GO HEMOGLOBIN METABOLIC PROCESS,0.062884,-0.13451,-0.079444,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.34626,-0.13457,-0.14096,0,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.48117,-0.13482,-0.11183,0,0
4,GO ERK1 AND ERK2 CASCADE,0.30724,-0.13515,-0.068681,0,0
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.29248,-0.13527,-0.0678,0,0
4,GO COAGULATION,0.23203,-0.13547,-0.06338,0,0
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.27126,-0.13548,-0.043812,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.41494,-0.13569,-0.072334,0,0
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.36271,-0.13585,-0.092986,0,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.86799,-0.13593,-0.00092373,0,0
4,GO CD40 SIGNALING PATHWAY,0.10811,-0.13597,-0.21352,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.058535,-0.13624,-0.16094,0,0
4,GO REGULATION OF LIPID TRANSPORT,0.56341,-0.13642,-0.020776,0,0
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.11524,-0.13672,-0.18121,0,0
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.41494,-0.13679,-0.052389,0,0
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.18102,-0.13685,-0.095873,0,0
4,GO MAST CELL ACTIVATION,0.28529,-0.13689,-0.12227,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.36271,-0.13698,-0.051312,0,0
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.30724,-0.13701,-0.039669,0,0
4,GO RESPONSE TO BIOTIC STIMULUS,0.15655,-0.13711,-0.12397,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.27821,-0.13723,-0.10647,0,0
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.51122,-0.13741,-0.037383,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.38829,-0.13762,-0.036957,0,0
4,GO REGULATION OF ODONTOGENESIS,0.33029,-0.1377,-0.076245,0,0
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.33029,-0.13791,-0.061948,0,0
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.1306,-0.13797,-0.11359,0,0
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.29248,-0.13809,-0.067799,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.2577,-0.13823,-0.05808,0,0
4,GO RESPONSE TO MANGANESE ION,0.197,-0.13841,-0.05905,0,0
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.14312,-0.13857,-0.12193,0,0
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.13885,-0.13858,-0.099983,0,0
4,GO POSITIVE REGULATION OF HEART CONTRACTION,0.08881,-0.13863,-0.092599,0,0
4,GO SUPEROXIDE METABOLIC PROCESS,0.214,-0.13871,-0.065235,0,0
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.28529,-0.13872,-0.17139,0,0
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.12273,-0.13874,-0.14711,0,0
4,GO SEQUESTERING OF CALCIUM ION,0.214,-0.13905,-0.086996,0,0
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.26442,-0.13927,-0.10513,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.16602,-0.13939,-0.18936,0,0
4,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.3148,-0.13957,-0.10477,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.66333,-0.13996,-0.012309,0,0
4,GO POLYOL TRANSPORT,0.2259,-0.14015,-0.088582,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.08881,-0.14028,-0.098067,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.016475,-0.14078,-0.11753,0,0
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.098083,-0.14099,-0.13856,0,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.24463,-0.14139,-0.042846,0,0
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.20822,-0.14212,-0.11844,0,0
4,GO CELLULAR IRON ION HOMEOSTASIS,0.098083,-0.14223,-0.089427,0,0
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.37111,-0.14263,-0.13042,0,0
4,GO MUSCLE CELL FATE COMMITMENT,0.12273,-0.1427,-0.14448,0,0
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.48117,-0.14272,-0.051361,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.50109,-0.14272,-0.031719,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.23827,-0.14301,-0.073224,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.11894,-0.14304,-0.13468,0,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,0.058535,-0.14349,-0.10571,0,0
4,GO POSITIVE REGULATION OF WOUND HEALING,0.17591,-0.1437,-0.093356,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.1475,-0.1438,-0.15128,0,0
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.58498,-0.14385,-0.01545,0,0
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.2259,-0.14396,-0.10746,0,0
4,GO PHAGOSOME ACIDIFICATION,0.091819,-0.14423,-0.082121,0,0
4,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.38829,-0.14463,-0.12565,0,0
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.2259,-0.14485,-0.14649,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.18624,-0.14524,-0.072824,0,0
4,GO LEUKOCYTE TETHERING OR ROLLING,0.214,-0.14548,-0.18591,0,0
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.33029,-0.14562,-0.15015,0,0
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.16602,-0.14579,-0.071995,0,0
4,GO IMMUNE EFFECTOR PROCESS,0.17091,-0.14589,-0.13354,0,0
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.37964,-0.14593,-0.053662,0,0
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.094909,-0.14595,-0.10294,0,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.3148,-0.1461,-0.032421,0,0
4,GO POSITIVE REGULATION OF HEART RATE,0.10811,-0.14613,-0.1369,0,0
4,GO ENDOCRINE PROCESS,0.11163,-0.14661,-0.087069,0,0
4,GO PHAGOSOME MATURATION,0.14312,-0.14671,-0.064937,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.2577,-0.1471,-0.1792,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.21989,-0.14759,-0.074446,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.18624,-0.14786,-0.11955,0,0
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.4521,-0.14791,-0.047188,0,0
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.3148,-0.148,-0.09881,0,0
4,GO GLOMERULUS DEVELOPMENT,0.54223,-0.1482,-0.015965,0,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.11163,-0.14826,-0.15293,0,0
4,GO RESPONSE TO REDOX STATE,0.19156,-0.14828,-0.10655,0,0
4,GO REGULATION OF GLIAL CELL MIGRATION,0.214,-0.14843,-0.17394,0,0
4,GO PROGESTERONE METABOLIC PROCESS,0.14312,-0.14851,-0.038182,0,0
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.29248,-0.14861,-0.073468,0,0
4,GO ASTROCYTE DEVELOPMENT,0.53179,-0.14861,-0.044784,0,0
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.13467,-0.14867,-0.17636,0,0
4,GO INNATE IMMUNE RESPONSE,0.14312,-0.14876,-0.15873,0,0
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.11163,-0.14885,-0.096171,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.37111,-0.149,-0.1403,0,0
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.20822,-0.14926,-0.12619,0,0
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.43329,-0.1493,-0.052438,0,0
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.28529,-0.14933,-0.071064,0,0
4,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.44264,-0.14952,-0.038149,0,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.38829,-0.14979,-0.075471,0,0
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.20256,-0.15029,-0.066467,0,0
4,GO T HELPER CELL LINEAGE COMMITMENT,0.214,-0.15065,-0.23007,0,0
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.48117,-0.15076,-0.011795,0,0
4,GO REGULATION OF CELL ADHESION,0.30724,-0.15086,-0.057371,0,0
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.16602,-0.15089,-0.10977,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.19156,-0.15092,-0.092346,0,0
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.42405,-0.15095,-0.067948,0,0
4,GO REGULATION OF GLOMERULAR FILTRATION,0.33821,-0.15146,-0.080875,0,0
4,GO RESPONSE TO HYPEROXIA,0.10811,-0.15164,-0.078823,0,0
4,GO PHAGOCYTOSIS RECOGNITION,0.42405,-0.15213,-0.09611,0,0
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.28529,-0.15222,-0.052139,0,0
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.077559,-0.15234,-0.18503,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.33029,-0.1524,-0.062854,0,0
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.23203,-0.15244,-0.055291,0,0
4,GO RESPONSE TO AMYLOID BETA,0.39705,-0.1526,-0.018415,0,0
4,GO TONIC SMOOTH MUSCLE CONTRACTION,0.12273,-0.15261,-0.14796,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.28529,-0.15262,-0.091696,0,0
4,GO IMMUNOGLOBULIN PRODUCTION,0.2577,-0.15269,-0.11877,0,0
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.26442,-0.15281,-0.089781,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.34626,-0.15297,-0.049345,0,0
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.17591,-0.15319,-0.11695,0,0
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.1306,-0.15329,-0.093265,0,0
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.15197,-0.15329,-0.10632,0,0
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.17091,-0.15398,-0.04055,0,0
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.32248,-0.15416,-0.059579,0,0
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.11163,-0.15428,-0.098853,0,0
4,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.08588,-0.15449,-0.21305,0,0
4,GO HEART INDUCTION,0.40594,-0.15463,-0.054176,0,0
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.3148,-0.1547,-0.12023,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.17091,-0.15473,-0.13418,0,0
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.30724,-0.15478,-0.073152,0,0
4,GO LEUKOCYTE HOMEOSTASIS,0.27821,-0.15511,-0.10343,0,0
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.11524,-0.15542,-0.21489,0,0
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.23827,-0.15549,-0.060413,0,0
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.64051,-0.15562,-0.021526,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.40594,-0.15586,-0.064735,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.08303,-0.15601,-0.087299,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.054439,-0.1565,-0.12068,0,0
4,GO REGULATION OF CELL CELL ADHESION,0.2998,-0.15664,-0.11318,0,0
4,GO RESPONSE TO INTERLEUKIN 1,0.074935,-0.15672,-0.14078,0,0
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.11894,-0.15715,-0.10271,0,0
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.11163,-0.15802,-0.10986,0,0
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.15655,-0.15828,-0.14156,0,0
4,GO O GLYCAN PROCESSING,0.11894,-0.15837,-0.11072,0,0
4,GO DETOXIFICATION OF INORGANIC COMPOUND,1,-0.1585,0.13416,0,0
4,GO BIOLOGICAL PHASE,0.39705,-0.15855,-0.094901,0,0
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.23203,-0.15876,-0.059912,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.10811,-0.15886,-0.11784,0,0
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.098083,-0.15908,-0.22929,0,0
4,GO RESPONSE TO INTERLEUKIN 2,0.33029,-0.15915,-0.13125,0,0
4,GO LEUKOCYTE AGGREGATION,0.23827,-0.15935,-0.23946,0,0
4,GO NEUTRAL AMINO ACID TRANSPORT,0.072385,-0.15936,-0.088222,0,0
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.28529,-0.15973,-0.13962,0,0
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.094909,-0.16024,-0.09838,0,0
4,GO ACTIVATION OF IMMUNE RESPONSE,0.17091,-0.16032,-0.13138,0,0
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.36271,-0.16039,-0.12925,0,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.4521,-0.16063,-0.16298,0,0
4,GO MOVEMENT IN HOST ENVIRONMENT,0.11163,-0.1608,-0.10468,0,0
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.14312,-0.16117,-0.15251,0,0
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.214,-0.16129,-0.11325,0,0
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.091819,-0.16139,-0.12186,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.33029,-0.16217,-0.096145,0,0
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.42405,-0.16218,-0.10442,0,0
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.43329,-0.16221,-0.048232,0,0
4,GO PLATELET ACTIVATION,0.24463,-0.16288,-0.068429,0,0
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.60692,-0.16299,-0.057206,0,0
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.098083,-0.16323,-0.1578,0,0
4,GO BONE CELL DEVELOPMENT,0.19156,-0.16333,-0.078247,0,0
4,GO STORE OPERATED CALCIUM ENTRY,0.4521,-0.16359,-0.058794,0,0
4,GO RESPONSE TO LEPTIN,0.21989,-0.16388,-0.065638,0,0
4,GO NEUTROPHIL EXTRAVASATION,0.28529,-0.16396,-0.14191,0,0
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.15655,-0.16396,-0.089588,0,0
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.2577,-0.16403,-0.082459,0,0
4,GO TRANSCYTOSIS,0.08881,-0.16426,-0.1541,0,0
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.13467,-0.16477,-0.1917,0,0
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.18102,-0.16493,-0.12702,0,0
4,GO REGULATION OF LIPASE ACTIVITY,0.18102,-0.16511,-0.092938,0,0
4,GO RESPONSE TO INTERLEUKIN 4,0.12662,-0.16514,-0.14252,0,0
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.214,-0.1652,-0.082086,0,0
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.098083,-0.16556,-0.091196,0,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.20822,-0.16561,-0.080434,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.11163,-0.16593,-0.16809,0,0
4,GO RUFFLE ORGANIZATION,0.10468,-0.16658,-0.086847,0,0
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.46168,-0.16717,-0.046192,0,0
4,GO REGULATION OF TISSUE REMODELING,0.15655,-0.16724,-0.086506,0,0
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.2998,-0.16738,-0.066231,0,0
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.080256,-0.16744,-0.13502,0,0
4,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.24463,-0.16747,-0.1596,0,0
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.074935,-0.16778,-0.27611,0,0
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.46168,-0.16782,-0.06269,0,0
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.058535,-0.16796,-0.15576,0,0
4,GO ETHER METABOLIC PROCESS,0.056456,-0.16808,-0.10937,0,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.13467,-0.1681,-0.12976,0,0
4,GO REGULATION OF T CELL ACTIVATION,0.24463,-0.16863,-0.15541,0,0
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.13467,-0.16866,-0.18374,0,0
4,GO HETEROTYPIC CELL CELL ADHESION,0.13467,-0.16868,-0.12844,0,0
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.34626,-0.16889,-0.040669,0,0
4,GO KERATAN SULFATE METABOLIC PROCESS,0.080256,-0.16891,-0.10824,0,0
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.14312,-0.16924,-0.059064,0,0
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.11894,-0.16937,-0.17742,0,0
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.056456,-0.16965,-0.11987,0,0
4,GO RESPONSE TO LITHIUM ION,0.062884,-0.16977,-0.098983,0,0
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.27126,-0.17019,-0.10491,0,0
4,GO OSTEOCLAST DIFFERENTIATION,0.29248,-0.17029,-0.079936,0,0
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.1306,-0.17049,-0.10018,0,0
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.28529,-0.17073,-0.1336,0,0
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.15197,-0.17092,-0.14506,0,0
4,GO MATERNAL PLACENTA DEVELOPMENT,0.21989,-0.17154,-0.063539,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.1306,-0.17166,-0.18333,0,0
4,GO INTERLEUKIN 6 PRODUCTION,0.11163,-0.1718,-0.17793,0,0
4,GO REGULATION OF WOUND HEALING,0.08588,-0.17193,-0.1196,0,0
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.23827,-0.17211,-0.1881,0,0
4,GO VASCULAR WOUND HEALING,0.17591,-0.17218,-0.083685,0,0
4,GO NEUTROPHIL HOMEOSTASIS,0.18102,-0.17227,-0.13286,0,0
4,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.32248,-0.1729,-0.21456,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.42405,-0.17305,-0.0091487,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.13885,-0.17308,-0.070065,0,0
4,GO FOAM CELL DIFFERENTIATION,0.15197,-0.17341,-0.11907,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.1475,-0.17358,-0.19312,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.4521,-0.17362,-0.092138,0,0
4,GO B CELL APOPTOTIC PROCESS,0.056456,-0.17377,-0.13408,0,0
4,GO LIPID EXPORT FROM CELL,0.1475,-0.17413,-0.091079,0,0
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.14312,-0.17489,-0.16269,0,0
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.19156,-0.17502,-0.098122,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.38829,-0.17516,-0.098553,0,0
4,GO MEMBRANE RAFT ORGANIZATION,0.16602,-0.17527,-0.16262,0,0
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.056456,-0.17532,-0.17961,0,0
4,GO RESPONSE TO INTERLEUKIN 6,0.214,-0.17559,-0.093432,0,0
4,GO INFLAMMATORY RESPONSE,0.10134,-0.1762,-0.16123,0,0
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.19156,-0.1771,-0.16278,0,0
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.098083,-0.17738,-0.11673,0,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.20822,-0.17782,-0.13557,0,0
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.080256,-0.178,-0.11159,0,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.27126,-0.17805,-0.115,0,0
4,GO REGULATION OF IMMUNE RESPONSE,0.18624,-0.17825,-0.14407,0,0
4,GO PHOSPHATE ION TRANSPORT,0.08588,-0.17835,-0.10761,0,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.077559,-0.17926,-0.16684,0,0
4,GO MEMBRANE LIPID CATABOLIC PROCESS,0.13885,-0.18014,-0.10637,0,0
4,GO ALPHA BETA T CELL PROLIFERATION,0.19156,-0.1803,-0.21052,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.197,-0.18034,-0.089822,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.37964,-0.18049,-0.1485,0,0
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.16123,-0.18058,-0.1654,0,0
4,GO PROTEIN TRIMERIZATION,0.10811,-0.18156,-0.15593,0,0
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.67486,-0.18163,-0.018243,0,0
4,GO AMINO SUGAR CATABOLIC PROCESS,0.065157,-0.18164,-0.27853,0,0
4,GO REGULATION OF CELL ACTIVATION,0.23203,-0.18215,-0.14832,0,0
4,GO BARBED END ACTIN FILAMENT CAPPING,0.069906,-0.18259,-0.12389,0,0
4,GO TISSUE REMODELING,0.16602,-0.18268,-0.090962,0,0
4,GO BONE REMODELING,0.20256,-0.18275,-0.066604,0,0
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.16602,-0.18298,-0.14057,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.08588,-0.18361,-0.20553,0,0
4,GO MYELOID LEUKOCYTE ACTIVATION,0.094909,-0.18502,-0.16894,0,0
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.20822,-0.18511,-0.08852,0,0
4,GO TRABECULA FORMATION,0.24463,-0.18563,-0.094485,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.89296,-0.18623,0.013473,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.13467,-0.18666,-0.10448,0,0
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.37111,-0.18686,-0.050883,0,0
4,GO POSITIVE T CELL SELECTION,0.48117,-0.18719,-0.14976,0,0
4,GO RESPONSE TO INTERLEUKIN 18,0.1306,-0.18772,-0.20561,0,0
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.08303,-0.18805,-0.17323,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.23203,-0.18836,-0.17185,0,0
4,GO T CELL CYTOKINE PRODUCTION,0.069906,-0.1885,-0.25652,0,0
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.27126,-0.18902,-0.16487,0,0
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.18624,-0.18912,-0.15427,0,0
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.16602,-0.18917,-0.11602,0,0
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.2577,-0.18948,-0.075068,0,0
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.072385,-0.1896,-0.16534,0,0
4,GO ENDODERM FORMATION,0.26442,-0.19036,-0.064607,0,0
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.062884,-0.19062,-0.12593,0,0
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.1306,-0.19071,-0.18826,0,0
4,GO THYMIC T CELL SELECTION,0.51122,-0.1911,-0.14732,0,0
4,GO RESPONSE TO EPINEPHRINE,0.214,-0.19136,-0.088579,0,0
4,GO T CELL SELECTION,0.49108,-0.19155,-0.14308,0,0
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.058535,-0.19188,-0.16753,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.214,-0.19199,-0.17203,0,0
4,GO GAP JUNCTION ASSEMBLY,0.10134,-0.19204,-0.21176,0,0
4,GO NAD BIOSYNTHETIC PROCESS,0.2998,-0.19246,-0.10487,0,0
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.49108,-0.19252,-0.082228,0,0
4,GO ENTRY INTO HOST,0.11894,-0.19262,-0.1292,0,0
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.36271,-0.19263,-0.13592,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.12273,-0.1927,-0.23637,0,0
4,GO REGULATION OF CALCIUM ION IMPORT,0.056456,-0.19271,-0.13664,0,0
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.007293,-0.19287,-0.20192,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.24463,-0.19304,-0.083458,0,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.16602,-0.19309,-0.17878,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.12273,-0.19324,-0.17162,0,0
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.197,-0.19326,-0.1263,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.43329,-0.19362,-0.14961,0,0
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.15197,-0.19387,-0.094514,0,0
4,GO CELLULAR EXTRAVASATION,0.16123,-0.19399,-0.1781,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.44264,-0.19425,-0.096211,0,0
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.32248,-0.19437,-0.086558,0,0
4,GO CYTOKINE SECRETION,0.14312,-0.19464,-0.15775,0,0
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.1475,-0.1953,-0.16649,0,0
4,GO POSITIVE REGULATION OF CELL ADHESION,0.19156,-0.19531,-0.13389,0,0
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.13467,-0.1959,-0.15939,0,0
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.23827,-0.1966,-0.094734,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.10811,-0.1969,-0.11782,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.197,-0.19697,-0.16969,0,0
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.15197,-0.19747,-0.15081,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.21989,-0.19823,-0.16861,0,0
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.080256,-0.19832,-0.17897,0,0
4,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.49108,-0.19871,-0.045179,0,0
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.098083,-0.19875,-0.19866,0,0
4,GO STEROID CATABOLIC PROCESS,0.11163,-0.19889,-0.15749,0,0
4,GO CERAMIDE CATABOLIC PROCESS,0.11894,-0.19972,-0.093167,0,0
4,GO GLYCINE TRANSPORT,0.10811,-0.19985,-0.17431,0,0
4,GO LEUKOCYTE MEDIATED IMMUNITY,0.091819,-0.19994,-0.17604,0,0
4,GO ACTIVATED T CELL PROLIFERATION,0.077559,-0.20043,-0.18111,0,0
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.12662,-0.20138,-0.108,0,0
4,GO ETHANOL METABOLIC PROCESS,0.077559,-0.20172,-0.21773,0,0
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.15655,-0.20246,-0.24489,0,0
4,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.091819,-0.20275,-0.24203,0,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.2577,-0.20317,-0.14922,0,0
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.19156,-0.20318,-0.1672,0,0
4,GO AMYLOID FIBRIL FORMATION,0.27126,-0.20362,-0.081691,0,0
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.091819,-0.20432,-0.085756,0,0
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.077559,-0.20452,-0.12328,0,0
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.11163,-0.20496,-0.14036,0,0
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.017954,-0.20522,-0.15337,0,0
4,GO REGULATION OF MAST CELL ACTIVATION,0.091819,-0.2053,-0.19072,0,0
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.077559,-0.20567,-0.14832,0,0
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.11894,-0.20586,-0.22887,0,0
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.16123,-0.20636,-0.18531,0,0
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.27821,-0.20648,-0.069574,0,0
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.15197,-0.20677,-0.25082,0,0
4,GO PHAGOLYSOSOME ASSEMBLY,0.26442,-0.20766,-0.044348,0,0
4,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.197,-0.20773,-0.23066,0,0
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.13467,-0.20783,-0.20507,0,0
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.35442,-0.20867,-0.19065,0,0
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.062884,-0.20868,-0.17488,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.23827,-0.20904,-0.1343,0,0
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.10811,-0.20911,-0.1323,0,0
4,GO RETINAL CONE CELL DIFFERENTIATION,0.10811,-0.20919,-0.078664,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.10468,-0.20963,-0.09357,0,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.214,-0.21,-0.15722,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.24463,-0.21031,-0.11064,0,0
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.098083,-0.2105,-0.1743,0,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.16123,-0.21098,-0.1695,0,0
4,GO REGULATION OF CHEMOTAXIS,0.12273,-0.21142,-0.124,0,0
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.062884,-0.21224,-0.17906,0,0
4,GO CYTOKINE METABOLIC PROCESS,0.08881,-0.21226,-0.21124,0,0
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.17091,-0.21226,-0.16223,0,0
4,GO AMYLOID BETA CLEARANCE,0.080256,-0.2123,-0.18764,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.11894,-0.21232,-0.22858,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.11894,-0.21245,-0.13791,0,0
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.08881,-0.21269,-0.16966,0,0
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.091819,-0.21347,-0.21253,0,0
4,GO REGULATION OF PHAGOCYTOSIS,0.10134,-0.21419,-0.20765,0,0
4,GO LEUKOCYTE CELL CELL ADHESION,0.20256,-0.21466,-0.17547,0,0
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.16602,-0.21493,-0.085892,0,0
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.17091,-0.21554,-0.19692,0,0
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.13885,-0.2166,-0.18501,0,0
4,GO MEMBRANE INVAGINATION,0.13467,-0.21667,-0.14996,0,0
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.094909,-0.21672,-0.26779,0,0
4,GO REGULATION OF BONE REMODELING,0.12662,-0.21685,-0.11619,0,0
4,GO REGULATION OF B CELL ACTIVATION,0.1306,-0.21717,-0.20446,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.15655,-0.21735,-0.22264,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.08588,-0.21812,-0.17212,0,0
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.080256,-0.21903,-0.17531,0,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.15655,-0.21905,-0.15007,0,0
4,GO T HELPER 1 CELL DIFFERENTIATION,0.12662,-0.21923,-0.25437,0,0
4,GO PLATELET AGGREGATION,0.21989,-0.21943,-0.088156,0,0
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.08881,-0.21949,-0.31192,0,0
4,GO GALACTOSE METABOLIC PROCESS,0.038848,-0.22011,-0.15886,0,0
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.098083,-0.2206,-0.19535,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.08881,-0.22112,-0.13136,0,0
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.041938,-0.22184,-0.23115,0,0
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.15197,-0.22241,-0.085577,0,0
4,GO SYNCYTIUM FORMATION,0.072385,-0.22313,-0.15187,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.067497,-0.2239,-0.23744,0,0
4,GO ADRENAL GLAND DEVELOPMENT,0.25111,-0.22397,-0.070117,0,0
4,GO LYMPHOCYTE COSTIMULATION,0.214,-0.22418,-0.18758,0,0
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.1306,-0.22422,-0.14232,0,0
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.35442,-0.22444,-0.048045,0,0
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.074935,-0.22466,-0.25278,0,0
4,GO ENDODERMAL CELL DIFFERENTIATION,0.11894,-0.22527,-0.13048,0,0
4,GO RESPONSE TO TYPE I INTERFERON,0.214,-0.22561,-0.15593,0,0
4,GO MYOBLAST FUSION,0.067497,-0.22562,-0.17678,0,0
4,GO BLEB ASSEMBLY,0.23827,-0.22573,-0.11216,0,0
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.12662,-0.22603,-0.1949,0,0
4,GO ASTROCYTE ACTIVATION,0.1475,-0.22639,-0.17118,0,0
4,GO WATER TRANSPORT,0.38829,-0.22657,-0.11205,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.1306,-0.22716,-0.19996,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.077559,-0.22727,-0.18859,0,0
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.25111,-0.22739,-0.18895,0,0
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.062884,-0.22745,-0.21823,0,0
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.094909,-0.22755,-0.14792,0,0
4,GO BONE RESORPTION,0.094909,-0.2278,-0.14997,0,0
4,GO T CELL EXTRAVASATION,0.197,-0.22805,-0.1888,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.12273,-0.22825,-0.23465,0,0
4,GO T CELL PROLIFERATION,0.12273,-0.22838,-0.20699,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.08881,-0.22882,-0.15064,0,0
4,GO LEUKOCYTE PROLIFERATION,0.12662,-0.22961,-0.19647,0,0
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.067497,-0.22967,-0.21398,0,0
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.12273,-0.23114,-0.18647,0,0
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.12662,-0.23205,-0.20773,0,0
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.19156,-0.23246,-0.20664,0,0
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.12662,-0.23279,-0.16306,0,0
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.214,-0.23307,-0.17443,0,0
4,GO LEUKOCYTE MIGRATION,0.069906,-0.23324,-0.19494,0,0
4,GO RESPONSE TO INTERFERON GAMMA,0.077559,-0.23375,-0.26422,0,0
4,GO VITAMIN TRANSPORT,0.069906,-0.23463,-0.10745,0,0
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.17091,-0.23546,-0.19039,0,0
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.12273,-0.23583,-0.15369,0,0
4,GO NEGATIVE REGULATION OF BONE REMODELING,0.10468,-0.23623,-0.23355,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.16602,-0.23671,-0.14489,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.062884,-0.23773,-0.23268,0,0
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.098083,-0.23791,-0.22685,0,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.098083,-0.2382,-0.15194,0,0
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.072385,-0.23858,-0.22032,0,0
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.17091,-0.23972,-0.18776,0,0
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.27126,-0.24,-0.13384,0,0
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.10134,-0.24021,-0.19488,0,0
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.058535,-0.24106,-0.17024,0,0
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.080256,-0.24111,-0.21637,0,0
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.072385,-0.24173,-0.2539,0,0
4,GO CELL CHEMOTAXIS,0.062884,-0.24234,-0.20639,0,0
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.16602,-0.24294,-0.12615,0,0
4,GO RENAL ABSORPTION,0.1475,-0.24388,-0.12702,0,0
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.08303,-0.24446,-0.20924,0,0
4,GO B CELL PROLIFERATION,0.11894,-0.24518,-0.24721,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.13467,-0.2453,-0.2564,0,0
4,GO LEYDIG CELL DIFFERENTIATION,0.2577,-0.24568,-0.10086,0,0
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.069906,-0.24693,-0.2705,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.11894,-0.24736,-0.1978,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.16602,-0.24743,-0.20296,0,0
4,GO ZYMOGEN INHIBITION,0.056456,-0.2475,-0.21765,0,0
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.094909,-0.24809,-0.20509,0,0
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.067497,-0.24818,-0.21583,0,0
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.072385,-0.24877,-0.30523,0,0
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.11163,-0.24904,-0.21287,0,0
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.28529,-0.25118,-0.080889,0,0
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.069906,-0.25135,-0.18964,0,0
4,GO PHAGOCYTOSIS,0.10811,-0.25153,-0.15623,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.17591,-0.25187,-0.17153,0,0
4,GO GLYCOLIPID CATABOLIC PROCESS,0.098083,-0.25253,-0.16144,0,0
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.10468,-0.2528,-0.30543,0,0
4,GO CELL ADHESION MOLECULE PRODUCTION,0.23203,-0.2529,-0.13105,0,0
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.11894,-0.25373,-0.13078,0,0
4,GO PROSTAGLANDIN SECRETION,0.074935,-0.25658,-0.16852,0,0
4,GO REGULATION OF INTEGRIN ACTIVATION,0.08881,-0.25668,-0.19822,0,0
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.17591,-0.2569,-0.18379,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.058535,-0.25728,-0.17078,0,0
4,GO POSITIVE REGULATION OF CELL KILLING,0.11524,-0.25729,-0.24613,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.11894,-0.25765,-0.15019,0,0
4,GO SUPEROXIDE ANION GENERATION,0.08303,-0.25801,-0.20053,0,0
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.060677,-0.25804,-0.19511,0,0
4,GO NEGATIVE T CELL SELECTION,0.34626,-0.25805,-0.22459,0,0
4,GO NEGATIVE REGULATION OF CELL KILLING,0.098083,-0.2587,-0.30148,0,0
4,GO ADAPTIVE IMMUNE RESPONSE,0.1306,-0.25902,-0.2445,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.11524,-0.25905,-0.25687,0,0
4,GO RESPONSE TO INTERLEUKIN 15,0.17091,-0.2593,-0.23764,0,0
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.094909,-0.25939,-0.24921,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.12662,-0.26092,-0.27443,0,0
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.20822,-0.26103,-0.20801,0,0
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.11894,-0.26159,-0.18608,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.080256,-0.26169,-0.22594,0,0
4,GO HISTAMINE TRANSPORT,0.027226,-0.26201,-0.24434,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0034935,-0.26208,-0.20936,0,0
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.2259,-0.2621,-0.10809,0,0
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.10468,-0.26252,-0.23178,0,0
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.11524,-0.26267,-0.21064,0,0
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.094909,-0.26286,-0.23999,0,0
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.056456,-0.26326,-0.343,0,0
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.060677,-0.26329,-0.16836,0,0
4,GO COLLAGEN BIOSYNTHETIC PROCESS,0.08881,-0.26422,-0.15387,0,0
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.10468,-0.26452,-0.22394,0,0
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.056456,-0.26503,-0.23209,0,0
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.098083,-0.26569,-0.2727,0,0
4,GO INTESTINAL ABSORPTION,0.065157,-0.26647,-0.19452,0,0
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.074935,-0.26673,-0.22445,0,0
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.060677,-0.26674,-0.26824,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.10134,-0.26676,-0.19565,0,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.08588,-0.2674,-0.22003,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.080256,-0.26741,-0.23409,0,0
4,GO DETECTION OF BIOTIC STIMULUS,0.091819,-0.26793,-0.21727,0,0
4,GO BLOOD VESSEL REMODELING,0.1475,-0.2697,-0.12663,0,0
4,GO OSTEOCLAST DEVELOPMENT,0.098083,-0.27088,-0.18938,0,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.197,-0.27253,-0.19867,0,0
4,GO NEUROINFLAMMATORY RESPONSE,0.10134,-0.27438,-0.23124,0,0
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.47137,-0.27535,-0.11936,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.40594,-0.27548,-0.1155,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.13885,-0.27574,-0.18837,0,0
4,GO MATURE B CELL DIFFERENTIATION,0.11894,-0.27683,-0.23754,0,0
4,GO REGULATION OF CELL KILLING,0.074935,-0.27684,-0.26876,0,0
4,GO INTERLEUKIN 2 PRODUCTION,0.065157,-0.27756,-0.26045,0,0
4,GO MACROPHAGE ACTIVATION,0.11894,-0.27885,-0.22594,0,0
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.058535,-0.28092,-0.25806,0,0
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.17091,-0.28131,-0.14048,0,0
4,GO ELASTIC FIBER ASSEMBLY,0.11163,-0.28133,-0.2387,0,0
4,GO RESPONSE TO PROTOZOAN,0.11163,-0.28189,-0.27196,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.080256,-0.28224,-0.17146,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.11894,-0.28233,-0.2734,0,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.08588,-0.28343,-0.22963,0,0
4,GO INTERFERON GAMMA PRODUCTION,0.080256,-0.28412,-0.25276,0,0
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.074935,-0.2848,-0.24215,0,0
4,GO REGULATION OF B CELL PROLIFERATION,0.065157,-0.28561,-0.27773,0,0
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.069906,-0.28583,-0.23976,0,0
4,GO PLATELET DEGRANULATION,0.060677,-0.28594,-0.17564,0,0
4,GO SIGNAL PEPTIDE PROCESSING,0.00045436,-0.28631,-0.27452,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.08588,-0.28688,-0.20237,0,0
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.10468,-0.28764,-0.22209,0,0
4,GO GLIAL CELL ACTIVATION,0.094909,-0.28782,-0.24867,0,0
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.062884,-0.28805,-0.23216,0,0
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.060677,-0.28922,-0.17363,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.065157,-0.2902,-0.31626,0,0
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.065157,-0.29202,-0.23813,0,0
4,GO POSITIVE THYMIC T CELL SELECTION,0.43329,-0.29261,-0.19339,0,0
4,GO LYMPH NODE DEVELOPMENT,0.13467,-0.29269,-0.19161,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.069906,-0.293,-0.25014,0,0
4,GO COLLAGEN METABOLIC PROCESS,0.069906,-0.29379,-0.16157,0,0
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.08881,-0.29676,-0.30683,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.069906,-0.297,-0.29501,0,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.072385,-0.29705,-0.23833,0,0
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.11524,-0.29783,-0.26951,0,0
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.031957,-0.29832,-0.2981,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.14312,-0.30121,-0.30166,0,0
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.18102,-0.30379,-0.26574,0,0
4,GO DENDRITIC CELL MIGRATION,0.077559,-0.30472,-0.32239,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.094909,-0.30699,-0.26384,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.072385,-0.30954,-0.2823,0,0
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.17091,-0.3104,-0.21161,0,0
4,GO INTERLEUKIN 12 PRODUCTION,0.098083,-0.3104,-0.28317,0,0
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.074935,-0.31052,-0.24356,0,0
4,GO INTEGRIN ACTIVATION,0.058535,-0.31268,-0.26248,0,0
4,GO COLLAGEN FIBRIL ORGANIZATION,0.056456,-0.31397,-0.24779,0,0
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.067497,-0.31536,-0.24394,0,0
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.058535,-0.31644,-0.18613,0,0
4,GO B CELL MEDIATED IMMUNITY,0.080256,-0.31981,-0.24123,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.069906,-0.32093,-0.26405,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.091819,-0.32325,-0.30544,0,0
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.077559,-0.32382,-0.30124,0,0
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.056456,-0.32413,-0.31725,0,0
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.067497,-0.32489,-0.24979,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.18102,-0.32559,-0.24717,0,0
4,GO DECIDUALIZATION,0.094909,-0.32616,-0.17297,0,0
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.080256,-0.3265,-0.26437,0,0
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.045233,-0.32771,-0.26851,0,0
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.067497,-0.32815,-0.21195,0,0
4,GO LYMPHOCYTE MIGRATION,0.056456,-0.32933,-0.29428,0,0
4,GO APOPTOTIC CELL CLEARANCE,0.077559,-0.33152,-0.23012,0,0
4,GO DETECTION OF OTHER ORGANISM,0.077559,-0.33366,-0.28159,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.13885,-0.33506,-0.21338,0,0
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.10134,-0.33684,-0.26525,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.069906,-0.33691,-0.3158,0,0
4,GO T CELL CHEMOTAXIS,0.065157,-0.3425,-0.34761,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.098083,-0.34768,-0.22955,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.12273,-0.35216,-0.26622,0,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.062884,-0.35933,-0.39241,0,0
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.10811,-0.36452,-0.2904,0,0
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.18624,-0.37069,-0.27905,0,0
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.060677,-0.37098,-0.31352,0,0
4,GO DENDRITIC CELL CHEMOTAXIS,0.062884,-0.37236,-0.3509,0,0
4,GO CELL JUNCTION DISASSEMBLY,0.037377,-0.37621,-0.30279,0,0
4,GO MACROPHAGE PROLIFERATION,0.1475,-0.38234,-0.23507,0,0
4,GO T HELPER 2 CELL DIFFERENTIATION,0.077559,-0.39043,-0.28432,0,0
4,GO HISTAMINE SECRETION,0.0042727,-0.39527,-0.35647,0,0
4,GO TOLERANCE INDUCTION,0.08303,-0.41953,-0.3997,0,0
4,GO T CELL TOLERANCE INDUCTION,0.17591,-0.42115,-0.33106,0,0
4,GO CYTOLYSIS,0.062884,-0.4423,-0.36966,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.046961,-0.44907,-0.4087,0,0
4,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.18102,-0.45078,-0.39133,0,0
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.074935,-0.455,-0.35919,0,0
4,GO REGULATION OF TOLERANCE INDUCTION,0.10134,-0.46376,-0.37935,0,0
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.060677,-0.49633,-0.3114,0,0
4,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.040368,-0.62367,-0.58702,0,0
4,GO NATURAL KILLER CELL CHEMOTAXIS,0.062884,-0.75458,-0.4782,0,0
5,GO OUTER DYNEIN ARM ASSEMBLY,0.0042727,0.72927,0.55721,1,1
5,GO LOOP OF HENLE DEVELOPMENT,0.00010866,0.65891,0.58751,1,1
5,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00086166,0.62543,0.62029,1,1
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0036751,0.62443,0.49293,1,1
5,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.00068502,0.62205,0.70374,1,1
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0018673,0.58271,0.50879,1,1
5,GO INNER DYNEIN ARM ASSEMBLY,0.0092139,0.57842,0.46801,1,1
5,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0047188,0.57552,0.48063,1,1
5,GO DISTAL TUBULE DEVELOPMENT,0.007293,0.56769,0.42324,1,1
5,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0054671,0.56534,0.43859,1,1
5,GO DENSE CORE GRANULE TRANSPORT,0.00019306,0.55827,0.61589,1,1
5,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00064645,0.55692,0.56118,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,3.4805e-05,0.54966,0.77858,1,1
5,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0015882,0.54636,0.54885,1,1
5,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.00051151,0.54355,0.4966,1,1
5,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00051151,0.53949,0.51005,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00029789,0.53284,0.65425,1,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,5.2428e-05,0.52838,0.6408,1,1
5,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0014241,0.5246,0.47168,1,1
5,GO PONS DEVELOPMENT,8.9327e-05,0.51956,0.61447,1,1
5,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.00033648,0.50673,0.6922,1,1
5,GO ADHESION OF SYMBIONT TO HOST,0.011574,0.50612,0.45454,1,1
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00040321,0.50422,0.50611,1,1
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0023095,0.49926,0.5192,1,1
5,GO SYNAPTIC VESICLE DOCKING,0.00048214,0.4991,0.65805,1,1
5,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.00028019,0.49538,0.53641,1,1
5,GO MICROTUBULE ANCHORING AT CENTROSOME,0.0014241,0.49116,0.43881,1,1
5,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.00010866,0.48856,0.65877,1,1
5,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0057394,0.48659,0.37692,1,1
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,4.8997e-05,0.48406,0.51759,1,1
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.00010866,0.48173,0.42606,1,1
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.012106,0.48149,0.35686,1,1
5,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.00076864,0.47692,0.51556,1,1
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00024771,0.47665,0.49735,1,1
5,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.0018673,0.47566,0.41286,1,1
5,GO AXONEME ASSEMBLY,0.0018673,0.47422,0.43104,1,1
5,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0015882,0.47317,0.46473,1,1
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0013481,0.47171,0.43961,1,1
5,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0012071,0.46652,0.50278,1,1
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.00060992,0.46629,0.43672,1,1
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.00023283,0.46491,0.37878,1,1
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00010866,0.45689,0.61409,1,1
5,GO EXTRACELLULAR TRANSPORT,0.00091199,0.45244,0.42976,1,1
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00076864,0.44991,0.40718,1,1
5,GO DETECTION OF CALCIUM ION,0.00031664,0.44883,0.4309,1,1
5,GO MOTILE CILIUM ASSEMBLY,0.0042727,0.44865,0.36018,1,1
5,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00042807,0.44793,0.40456,1,1
5,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00024771,0.44568,0.51603,1,1
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,8.9327e-05,0.44381,0.52318,1,1
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,9.5377e-05,0.44301,0.59358,1,1
5,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0010798,0.4427,0.4463,1,1
5,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0012758,0.44107,0.46912,1,1
5,GO CELL JUNCTION MAINTENANCE,0.00023283,0.44008,0.40313,1,1
5,GO MICROTUBULE BUNDLE FORMATION,0.00076864,0.43937,0.40023,1,1
5,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,3.248e-05,0.43717,0.68607,1,1
5,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0025648,0.43439,0.39709,1,1
5,GO SECRETORY GRANULE LOCALIZATION,0.00076864,0.43179,0.45268,1,1
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,7.3279e-05,0.42911,0.4312,1,1
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,3.9936e-05,0.42887,0.56986,1,1
5,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0092139,0.42661,0.45343,1,1
5,GO LIPID DIGESTION,0.00020554,0.42629,0.48049,1,1
5,GO DENDRITIC TRANSPORT,0.008797,0.4259,0.34954,1,1
5,GO CENTRIOLE CENTRIOLE COHESION,0.014457,0.4255,0.32776,1,1
5,GO RESPONSE TO FORSKOLIN,0.00014989,0.42501,0.48962,1,1
5,GO NEURON REMODELING,0.00026348,0.42272,0.47612,1,1
5,GO INTESTINAL LIPID ABSORPTION,0.00010181,0.42125,0.50741,1,1
5,GO VOCALIZATION BEHAVIOR,0.0010798,0.41997,0.41953,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00013188,0.41988,0.56169,1,1
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.00054254,0.41895,0.50663,1,1
5,GO IRON COORDINATION ENTITY TRANSPORT,0.00048214,0.41659,0.40266,1,1
5,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.018736,0.41647,0.34116,1,1
5,GO STARTLE RESPONSE,0.00091199,0.41521,0.39074,1,1
5,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00014989,0.4148,0.44946,1,1
5,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.00048214,0.4134,0.67439,1,1
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,9.5377e-05,0.41325,0.51404,1,1
5,GO COLLECTING DUCT DEVELOPMENT,0.0003797,0.40933,0.45297,1,1
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0049572,0.40892,0.43333,1,1
5,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,2.1347e-05,0.40627,0.60794,1,1
5,GO NEURON MATURATION,0.00018128,0.40525,0.38112,1,1
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0031545,0.40383,0.36548,1,1
5,GO PREPULSE INHIBITION,0.00332,0.40379,0.45112,1,1
5,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0003797,0.40341,0.40113,1,1
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0040644,0.40278,0.41352,1,1
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00051151,0.40206,0.43007,1,1
5,GO MEMBRANE DEPOLARIZATION,2.8267e-05,0.40087,0.44025,1,1
5,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00042807,0.39815,0.62174,1,1
5,GO PROTEIN LOCALIZATION TO SYNAPSE,0.00033648,0.3975,0.41047,1,1
5,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0018673,0.3961,0.39208,1,1
5,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00020554,0.3952,0.52081,1,1
5,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0060238,0.39425,0.37889,1,1
5,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00010866,0.39227,0.45755,1,1
5,GO PROTEIN POLYGLUTAMYLATION,0.00019306,0.39094,0.39725,1,1
5,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00081392,0.3906,0.46276,1,1
5,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0010798,0.39032,0.41106,1,1
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00021879,0.39007,0.38341,1,1
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0034935,0.38933,0.37647,1,1
5,GO SEGMENT SPECIFICATION,0.0054671,0.3887,0.33741,1,1
5,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00021879,0.38696,0.39201,1,1
5,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0054671,0.38668,0.37008,1,1
5,GO REFLEX,0.00013188,0.38451,0.47279,1,1
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.00040321,0.38443,0.44622,1,1
5,GO INTERLEUKIN 5 PRODUCTION,0.018736,0.38369,0.33166,1,1
5,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.024086,0.38343,0.33364,1,1
5,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00013188,0.38295,0.46662,1,1
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,6.8565e-05,0.38288,0.41465,1,1
5,GO CALCIUM ION REGULATED EXOCYTOSIS,3.4805e-05,0.38272,0.56671,1,1
5,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0016767,0.37992,0.39696,1,1
5,GO NEURONAL ACTION POTENTIAL,0.00012367,0.37887,0.46567,1,1
5,GO LUTEINIZATION,0.0034935,0.37876,0.40257,1,1
5,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0013481,0.37805,0.42804,1,1
5,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00057531,0.37796,0.43593,1,1
5,GO LIPOXYGENASE PATHWAY,0.028348,0.37795,0.24651,1,1
5,GO POSTSYNAPSE ASSEMBLY,0.0044907,0.37788,0.4211,1,1
5,GO NEURONAL ION CHANNEL CLUSTERING,0.0018673,0.3776,0.39973,1,1
5,GO MICROTUBULE DEPOLYMERIZATION,0.0076456,0.37755,0.32986,1,1
5,GO FEAR RESPONSE,0.0031545,0.37717,0.27011,1,1
5,GO REGULATION OF CILIUM ASSEMBLY,0.0014241,0.37638,0.32125,1,1
5,GO LEYDIG CELL DIFFERENTIATION,0.00040321,0.37372,0.48252,1,1
5,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0080134,0.37347,0.35698,1,1
5,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00054254,0.37325,0.35261,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00076864,0.37323,0.33601,1,1
5,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00045436,0.37308,0.42303,1,1
5,GO SYNAPTIC MEMBRANE ADHESION,0.0052065,0.37269,0.38493,1,1
5,GO MICROTUBULE ANCHORING,0.0015882,0.37238,0.36332,1,1
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00040321,0.37131,0.32579,1,1
5,GO NEURON CELLULAR HOMEOSTASIS,0.013834,0.37081,0.29065,1,1
5,GO NEPHRIC DUCT DEVELOPMENT,0.0076456,0.37031,0.31065,1,1
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.00014989,0.3696,0.39641,1,1
5,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00024771,0.36938,0.45557,1,1
5,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0011418,0.36937,0.35218,1,1
5,GO EXCITATORY SYNAPSE ASSEMBLY,0.00028019,0.36923,0.48532,1,1
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0029965,0.36865,0.30388,1,1
5,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00054254,0.36835,0.34248,1,1
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.0025648,0.36715,0.3445,1,1
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00019306,0.36604,0.38124,1,1
5,GO HISTONE H3 K27 METHYLATION,0.0024341,0.36582,0.38235,1,1
5,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0013481,0.36568,0.37488,1,1
5,GO DOPAMINE BIOSYNTHETIC PROCESS,0.00096503,0.36485,0.38612,1,1
5,GO RETINA LAYER FORMATION,0.0034935,0.36464,0.41461,1,1
5,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.00015974,0.36453,0.32435,1,1
5,GO MEMBRANE HYPERPOLARIZATION,0.0034935,0.36395,0.30603,1,1
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0015041,0.36358,0.39781,1,1
5,GO ADRENAL GLAND DEVELOPMENT,0.00048214,0.36316,0.39071,1,1
5,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.010101,0.36313,0.34703,1,1
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.00091199,0.36132,0.40073,1,1
5,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.00051151,0.36042,0.39385,1,1
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,9.5377e-05,0.36003,0.40955,1,1
5,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.00086166,0.35952,0.37828,1,1
5,GO SYNAPTIC VESICLE BUDDING,0.00010181,0.35843,0.39793,1,1
5,GO SYNAPTIC VESICLE CLUSTERING,0.0010209,0.3581,0.49213,1,1
5,GO GLUTAMATE SECRETION,0.00068502,0.35757,0.36494,1,1
5,GO SYNAPSE MATURATION,0.015776,0.35721,0.32432,1,1
5,GO DERMATAN SULFATE METABOLIC PROCESS,0.0016767,0.35716,0.42559,1,1
5,GO NEUROTRANSMITTER SECRETION,0.00017019,0.3555,0.43084,1,1
5,GO NODAL SIGNALING PATHWAY,0.0012758,0.35492,0.33059,1,1
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.022172,0.35443,0.34658,1,1
5,GO SYNAPTIC VESICLE PRIMING,0.00028019,0.3538,0.53532,1,1
5,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.0014241,0.35303,0.35967,1,1
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.00021879,0.35294,0.43907,1,1
5,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.7287e-05,0.35259,0.38831,1,1
5,GO HISTONE H3 K9 DEMETHYLATION,0.0028457,0.35237,0.33507,1,1
5,GO SYNAPTIC VESICLE LOCALIZATION,8.9327e-05,0.35199,0.4044,1,1
5,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00014062,0.35179,0.46283,1,1
5,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00031664,0.35132,0.41663,1,1
5,GO SYNAPTIC VESICLE MATURATION,0.00028019,0.35107,0.52246,1,1
5,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0019699,0.34977,0.31052,1,1
5,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0013481,0.34876,0.34877,1,1
5,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0047188,0.34725,0.379,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0012758,0.34688,0.36859,1,1
5,GO LONG TERM SYNAPTIC DEPRESSION,0.0012758,0.34665,0.3602,1,1
5,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,9.5377e-05,0.34634,0.42152,1,1
5,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00076864,0.34621,0.46579,1,1
5,GO ATRIAL SEPTUM DEVELOPMENT,0.0028457,0.34573,0.34345,1,1
5,GO RESPONSE TO AUDITORY STIMULUS,0.0021907,0.34489,0.3463,1,1
5,GO CILIUM MOVEMENT,0.00086166,0.34348,0.36477,1,1
5,GO SKELETAL MUSCLE ADAPTATION,0.00033648,0.34306,0.37157,1,1
5,GO REGULATION OF DOPAMINE SECRETION,4.5779e-05,0.3425,0.52154,1,1
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00021879,0.34236,0.3572,1,1
5,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0047188,0.3419,0.31857,1,1
5,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0018673,0.34095,0.39477,1,1
5,GO MRNA SPLICE SITE SELECTION,0.014457,0.3405,0.27404,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0013481,0.34039,0.38851,1,1
5,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0034935,0.33979,0.28756,1,1
5,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0015882,0.33934,0.35554,1,1
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.0057394,0.33908,0.29776,1,1
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.00033648,0.33847,0.39141,1,1
5,GO COLLATERAL SPROUTING,0.00057531,0.33838,0.40331,1,1
5,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0023095,0.33753,0.3201,1,1
5,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0029965,0.33713,0.38497,1,1
5,GO ADULT BEHAVIOR,0.00057531,0.33672,0.33433,1,1
5,GO RECEPTOR CLUSTERING,0.0015882,0.33661,0.34381,1,1
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,6.8565e-05,0.33645,0.37873,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.012106,0.3358,0.32493,1,1
5,GO REGULATION OF COLLATERAL SPROUTING,0.0023095,0.33374,0.37647,1,1
5,GO LEARNING,0.0010798,0.33369,0.31692,1,1
5,GO SENSORY PERCEPTION OF TASTE,0.00014062,0.33266,0.32553,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00035748,0.33208,0.33198,1,1
5,GO DOPAMINE TRANSPORT,9.5377e-05,0.3312,0.46268,1,1
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00045436,0.33063,0.38192,1,1
5,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00018128,0.33047,0.33552,1,1
5,GO SYNAPSE ASSEMBLY,0.00019306,0.33038,0.41719,1,1
5,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.00028019,0.33016,0.40789,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00054254,0.32817,0.39957,1,1
5,GO O GLYCAN PROCESSING,0.00051151,0.32729,0.33487,1,1
5,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00035748,0.32723,0.35798,1,1
5,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00068502,0.32714,0.39175,1,1
5,GO NEUROTRANSMITTER TRANSPORT,0.00014989,0.32714,0.40406,1,1
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0015882,0.32703,0.37957,1,1
5,GO MICROTUBULE POLYMERIZATION,0.00033648,0.32668,0.33742,1,1
5,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00021879,0.32644,0.42236,1,1
5,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00068502,0.32593,0.39985,1,1
5,GO REGULATION OF VESICLE FUSION,0.00015974,0.32567,0.41437,1,1
5,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0012071,0.32564,0.38907,1,1
5,GO RETROGRADE AXONAL TRANSPORT,0.0034935,0.32525,0.36588,1,1
5,GO EPITHELIAL CELL MORPHOGENESIS,0.00023283,0.32509,0.36678,1,1
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0031545,0.32489,0.28663,1,1
5,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.00081392,0.32482,0.34813,1,1
5,GO SHORT TERM MEMORY,0.008797,0.32473,0.32972,1,1
5,GO REGULATION OF NEURON MIGRATION,0.006955,0.32438,0.34981,1,1
5,GO MECHANOSENSORY BEHAVIOR,0.0028457,0.32428,0.36617,1,1
5,GO PROTEIN DEMETHYLATION,0.0012071,0.32424,0.37176,1,1
5,GO DENDRITIC SPINE MORPHOGENESIS,0.00072571,0.32409,0.36158,1,1
5,GO MICROTUBULE SEVERING,0.0066311,0.32325,0.28989,1,1
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.010572,0.3222,0.33959,1,1
5,GO TYPE B PANCREATIC CELL PROLIFERATION,0.00086166,0.32178,0.34221,1,1
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00023283,0.32115,0.38971,1,1
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0012758,0.32089,0.38618,1,1
5,GO LOCOMOTOR RHYTHM,0.00014989,0.3204,0.42697,1,1
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.025096,0.32002,0.31563,1,1
5,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0025648,0.31963,0.27952,1,1
5,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0011418,0.31882,0.42447,1,1
5,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00011593,0.31871,0.40065,1,1
5,GO POSITIVE REGULATION OF VESICLE FUSION,0.00081392,0.31865,0.37828,1,1
5,GO RESPONSE TO GLUCAGON,0.0018673,0.3183,0.27615,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0010798,0.31767,0.39838,1,1
5,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0031545,0.31762,0.42622,1,1
5,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,8.3641e-05,0.3176,0.33982,1,1
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00054254,0.31707,0.37611,1,1
5,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0020776,0.31682,0.31162,1,1
5,GO REGULATION OF CHOLESTEROL EFFLUX,0.0020776,0.31674,0.31958,1,1
5,GO AXO DENDRITIC TRANSPORT,0.00028019,0.31657,0.33946,1,1
5,GO DOPAMINE METABOLIC PROCESS,0.00068502,0.31651,0.32856,1,1
5,GO PANCREATIC JUICE SECRETION,0.01266,0.31646,0.26056,1,1
5,GO RESPONSE TO MAGNESIUM ION,0.01266,0.31607,0.30611,1,1
5,GO FOREBRAIN NEURON DEVELOPMENT,0.0044907,0.31599,0.30179,1,1
5,GO CEREBRAL CORTEX CELL MIGRATION,0.0010798,0.31549,0.34399,1,1
5,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0003797,0.31547,0.41517,1,1
5,GO BRAIN MORPHOGENESIS,0.00033648,0.31546,0.34309,1,1
5,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.040368,0.31544,0.27649,1,1
5,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.00086166,0.31541,0.29909,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0012071,0.31537,0.29929,1,1
5,GO REGULATION OF MICROTUBULE BINDING,0.00054254,0.31507,0.35668,1,1
5,GO DRUG CATABOLIC PROCESS,0.021265,0.31499,0.23716,1,1
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,4.5779e-05,0.31493,0.35199,1,1
5,GO TUBULIN DEACETYLATION,0.0016767,0.31378,0.36591,1,1
5,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0013481,0.31341,0.33585,1,1
5,GO CGMP MEDIATED SIGNALING,0.0013481,0.31275,0.35086,1,1
5,GO SYNAPTIC VESICLE TRANSPORT,3.7287e-05,0.31257,0.38051,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00024771,0.31247,0.42192,1,1
5,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.033245,0.31235,0.26637,1,1
5,GO DENDRITE MORPHOGENESIS,0.00086166,0.31219,0.33641,1,1
5,GO CILIUM ORGANIZATION,0.00096503,0.31218,0.29885,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00332,0.31206,0.27458,1,1
5,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0020776,0.31183,0.41171,1,1
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0014241,0.31163,0.31703,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00091199,0.31145,0.41749,1,1
5,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.023112,0.31122,0.29027,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,8.9327e-05,0.3112,0.46168,1,1
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00018128,0.31118,0.35236,1,1
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.0038653,0.31109,0.29059,1,1
5,GO RETINAL GANGLION CELL AXON GUIDANCE,0.0018673,0.31101,0.35554,1,1
5,GO POSITIVE REGULATION OF EXOCYTOSIS,3.9936e-05,0.31071,0.34855,1,1
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0047188,0.3102,0.33683,1,1
5,GO DIVALENT METAL ION EXPORT,0.0076456,0.31012,0.287,1,1
5,GO ACTION POTENTIAL,0.00017019,0.30982,0.37611,1,1
5,GO ASSOCIATIVE LEARNING,0.0027019,0.30977,0.30773,1,1
5,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0015041,0.30975,0.35139,1,1
5,GO TRANSCYTOSIS,0.0049572,0.30944,0.30416,1,1
5,GO NEURON PROJECTION ORGANIZATION,0.00045436,0.30912,0.33593,1,1
5,GO LONG TERM MEMORY,0.0015882,0.30874,0.34454,1,1
5,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0042727,0.30853,0.28738,1,1
5,GO RESPONSE TO REDOX STATE,0.00018128,0.30837,0.39,1,1
5,GO SECONDARY HEART FIELD SPECIFICATION,0.0038653,0.30837,0.37782,1,1
5,GO NEURON PROJECTION EXTENSION,0.00011593,0.30835,0.36496,1,1
5,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00057531,0.30825,0.29482,1,1
5,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.0054671,0.30782,0.27438,1,1
5,GO SYNAPTIC SIGNALING,0.00014989,0.30755,0.36234,1,1
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0021907,0.30745,0.34806,1,1
5,GO POSTSYNAPSE ORGANIZATION,0.00086166,0.30744,0.31605,1,1
5,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,3.248e-05,0.30743,0.36536,1,1
5,GO REGULATION OF GOLGI ORGANIZATION,0.00033648,0.30702,0.35963,1,1
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.00076864,0.30641,0.33273,1,1
5,GO ADHERENS JUNCTION ORGANIZATION,0.00020554,0.30631,0.34643,1,1
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,3.9936e-05,0.30629,0.38098,1,1
5,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0003797,0.30624,0.39412,1,1
5,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,3.9936e-05,0.30618,0.36231,1,1
5,GO WATER HOMEOSTASIS,0.00035748,0.30613,0.31303,1,1
5,GO AXONAL TRANSPORT,0.00054254,0.30612,0.32788,1,1
5,GO CHEMOSENSORY BEHAVIOR,0.00029789,0.30608,0.3921,1,1
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.033245,0.30584,0.33884,1,1
5,GO ANTEROGRADE AXONAL TRANSPORT,0.00091199,0.30582,0.32794,1,1
5,GO RESPONSE TO DIETARY EXCESS,0.0029965,0.30573,0.32057,1,1
5,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.0028457,0.30567,0.2696,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.017954,0.30537,0.283,1,1
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0066311,0.30499,0.3251,1,1
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.00057531,0.30489,0.30949,1,1
5,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.023112,0.30468,0.25656,1,1
5,GO CAMP METABOLIC PROCESS,0.00048214,0.3034,0.36953,1,1
5,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.011574,0.30308,0.27196,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00033648,0.30306,0.37028,1,1
5,GO ALANINE TRANSPORT,0.012106,0.30258,0.30674,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00060992,0.30244,0.35443,1,1
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.00017019,0.30223,0.41691,1,1
5,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00081392,0.30222,0.35916,1,1
5,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.007293,0.30204,0.23152,1,1
5,GO MICROTUBULE BASED MOVEMENT,0.0003797,0.30182,0.31109,1,1
5,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00023283,0.3012,0.37316,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.0029965,0.30111,0.30917,1,1
5,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.010101,0.3011,0.27338,1,1
5,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.00051151,0.30042,0.32988,1,1
5,GO LIPID TRANSLOCATION,0.00035748,0.30042,0.35357,1,1
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0015041,0.3001,0.39036,1,1
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00051151,0.29991,0.36169,1,1
5,GO RESPONSE TO ACETYLCHOLINE,0.0029965,0.29989,0.32871,1,1
5,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00010181,0.29963,0.51675,1,1
5,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.0044907,0.29933,0.33354,1,1
5,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0054671,0.2993,0.36858,1,1
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00031664,0.29922,0.38707,1,1
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0023095,0.29921,0.34597,1,1
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.014457,0.29919,0.27269,1,1
5,GO SYNAPTIC VESICLE RECYCLING,3.4805e-05,0.29899,0.41665,1,1
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0024341,0.29889,0.29288,1,1
5,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0014241,0.29887,0.32964,1,1
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.00026348,0.29854,0.38003,1,1
5,GO UV DAMAGE EXCISION REPAIR,0.0054671,0.29839,0.26327,1,1
5,GO GOLGI RIBBON FORMATION,0.0063209,0.29833,0.31961,1,1
5,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0049572,0.29824,0.28561,1,1
5,GO CHOLESTEROL EFFLUX,0.014457,0.29808,0.22869,1,1
5,GO ACTIVATION OF JNKK ACTIVITY,0.014457,0.29778,0.27219,1,1
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00014062,0.29674,0.36243,1,1
5,GO POSITIVE REGULATION OF AXONOGENESIS,0.00042807,0.29636,0.35215,1,1
5,GO LATERAL VENTRICLE DEVELOPMENT,0.0042727,0.29628,0.3362,1,1
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0014241,0.2961,0.31564,1,1
5,GO PRESYNAPTIC ENDOCYTOSIS,6.8565e-05,0.29597,0.4088,1,1
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0015882,0.29596,0.29744,1,1
5,GO DIOL METABOLIC PROCESS,7.8298e-05,0.2959,0.3342,1,1
5,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.0047188,0.29577,0.30102,1,1
5,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0017696,0.29571,0.26463,1,1
5,GO NEURON CELL CELL ADHESION,0.00091199,0.29557,0.47305,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0012071,0.29557,0.38943,1,1
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013834,0.29552,0.26185,1,1
5,GO INTRACILIARY TRANSPORT,0.0049572,0.29539,0.26256,1,1
5,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0014241,0.29513,0.38848,1,1
5,GO SYNAPSE ORGANIZATION,0.00042807,0.29508,0.35239,1,1
5,GO AXON EXTENSION,0.0003797,0.29437,0.35245,1,1
5,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00048214,0.29421,0.32258,1,1
5,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00057531,0.29411,0.31698,1,1
5,GO FAT CELL PROLIFERATION,0.0040644,0.29392,0.26005,1,1
5,GO MEMORY,0.00026348,0.29374,0.33834,1,1
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0011418,0.2937,0.30782,1,1
5,GO BEHAVIORAL RESPONSE TO COCAINE,0.006955,0.29345,0.29234,1,1
5,GO GENETIC IMPRINTING,0.00045436,0.29341,0.33963,1,1
5,GO DENDRITE DEVELOPMENT,0.00060992,0.29338,0.30855,1,1
5,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.0031545,0.29327,0.39154,1,1
5,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0080134,0.29312,0.28873,1,1
5,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.00010866,0.29293,0.31706,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0023095,0.29205,0.34011,1,1
5,GO PIGMENT ACCUMULATION,0.0080134,0.29166,0.27553,1,1
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0076456,0.29158,0.33098,1,1
5,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.00020554,0.29143,0.41552,1,1
5,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0010209,0.29132,0.3779,1,1
5,GO GOLGI TO VACUOLE TRANSPORT,0.00020554,0.29131,0.3644,1,1
5,GO ACROSOME REACTION,0.00011593,0.29127,0.29611,1,1
5,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.035953,0.29124,0.26031,1,1
5,GO POTASSIUM ION TRANSPORT,7.3279e-05,0.29097,0.34915,1,1
5,GO NEURON PROJECTION ARBORIZATION,0.0017696,0.29084,0.33371,1,1
5,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0028457,0.2904,0.34257,1,1
5,GO INTRACILIARY RETROGRADE TRANSPORT,0.0060238,0.29039,0.31327,1,1
5,GO NEURAL RETINA DEVELOPMENT,0.011574,0.29035,0.21908,1,1
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00017019,0.2899,0.3713,1,1
5,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.0021907,0.28974,0.34032,1,1
5,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,5.2428e-05,0.28973,0.35205,1,1
5,GO DIET INDUCED THERMOGENESIS,0.013834,0.28944,0.26057,1,1
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.00068502,0.28942,0.28699,1,1
5,GO SPERM MOTILITY,0.0010798,0.2893,0.29987,1,1
5,GO HISTONE METHYLATION,0.0024341,0.2886,0.28008,1,1
5,GO GROWTH HORMONE SECRETION,0.0096484,0.28852,0.33453,1,1
5,GO TRANSMISSION OF NERVE IMPULSE,0.0010798,0.28764,0.35235,1,1
5,GO POTASSIUM ION HOMEOSTASIS,0.00028019,0.28753,0.32117,1,1
5,GO REGULATION OF TELOMERE CAPPING,0.0027019,0.28752,0.27115,1,1
5,GO PROTEIN O LINKED GLYCOSYLATION,7.8298e-05,0.28705,0.33557,1,1
5,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0015041,0.28667,0.29891,1,1
5,GO CELL PART MORPHOGENESIS,0.00033648,0.28643,0.31225,1,1
5,GO CELLULAR COMPONENT MAINTENANCE,0.00031664,0.28641,0.31549,1,1
5,GO POSITIVE REGULATION OF LIPID STORAGE,0.0172,0.28622,0.27556,1,1
5,GO LYSINE METABOLIC PROCESS,0.0012071,0.28608,0.31132,1,1
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00031664,0.28605,0.33664,1,1
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0040644,0.286,0.31829,1,1
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00021879,0.28569,0.32549,1,1
5,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0034935,0.28554,0.33451,1,1
5,GO REGULATION OF DENDRITE DEVELOPMENT,0.00048214,0.2855,0.31243,1,1
5,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.013235,0.28542,0.31874,1,1
5,GO LOCALIZATION WITHIN MEMBRANE,0.0016767,0.28488,0.30587,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0028457,0.28477,0.32037,1,1
5,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.011063,0.28474,0.26147,1,1
5,GO MYOTUBE CELL DEVELOPMENT,0.0076456,0.28423,0.22599,1,1
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00035748,0.28395,0.31956,1,1
5,GO CELLULAR COMPONENT MORPHOGENESIS,0.00028019,0.28389,0.30843,1,1
5,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00051151,0.28382,0.31087,1,1
5,GO PROTEIN LOCALIZATION TO CILIUM,0.0031545,0.28373,0.29402,1,1
5,GO HAIR CELL DIFFERENTIATION,5.9985e-05,0.28362,0.35941,1,1
5,GO PEPTIDYL ARGININE METHYLATION,4.5779e-05,0.28355,0.32664,1,1
5,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00086166,0.28352,0.31228,1,1
5,GO CARDIAC ATRIUM DEVELOPMENT,0.0083971,0.28296,0.28613,1,1
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.015104,0.28286,0.27661,1,1
5,GO REGULATION OF MITOPHAGY,6.8565e-05,0.28263,0.41043,1,1
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00035748,0.28261,0.29414,1,1
5,GO ADULT LOCOMOTORY BEHAVIOR,0.00064645,0.28255,0.29301,1,1
5,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0036751,0.28254,0.31067,1,1
5,GO PEPTIDYL LYSINE METHYLATION,0.00332,0.28238,0.27926,1,1
5,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00060992,0.28216,0.31388,1,1
5,GO HISTONE H4 K5 ACETYLATION,0.00086166,0.28208,0.29235,1,1
5,GO NEURON RECOGNITION,0.0031545,0.28197,0.33748,1,1
5,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0092139,0.28162,0.25711,1,1
5,GO HISTONE H3 K9 MODIFICATION,0.008797,0.28145,0.27158,1,1
5,GO MEMBRANE DOCKING,0.00031664,0.28133,0.27468,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00096503,0.28103,0.32187,1,1
5,GO NEURON PROJECTION GUIDANCE,0.00086166,0.28066,0.32002,1,1
5,GO NEUROMUSCULAR PROCESS,0.00096503,0.28005,0.31087,1,1
5,GO TRANSPORT ALONG MICROTUBULE,0.00064645,0.27988,0.27668,1,1
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0063209,0.27949,0.27759,1,1
5,GO MICROTUBULE BASED TRANSPORT,0.00042807,0.27948,0.30031,1,1
5,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00096503,0.27878,0.30581,1,1
5,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0034935,0.27868,0.30761,1,1
5,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0044907,0.27862,0.25074,1,1
5,GO REGULATION OF ACTION POTENTIAL,0.00068502,0.27827,0.36318,1,1
5,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0013481,0.2781,0.3146,1,1
5,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.0080134,0.27789,0.29304,1,1
5,GO MONOAMINE TRANSPORT,0.00026348,0.27778,0.35796,1,1
5,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.017954,0.2776,0.30334,1,1
5,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0038653,0.27759,0.35378,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0040644,0.27754,0.35197,1,1
5,GO EXPLORATION BEHAVIOR,0.0052065,0.27734,0.3059,1,1
5,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0014241,0.27703,0.29972,1,1
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.0049572,0.27647,0.26589,1,1
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.00033648,0.2764,0.34293,1,1
5,GO CHROMATIN SILENCING AT TELOMERE,0.014457,0.27637,0.2288,1,1
5,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0057394,0.27634,0.23271,1,1
5,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0038653,0.27621,0.28292,1,1
5,GO FUCOSYLATION,0.00010866,0.27619,0.35191,1,1
5,GO BASEMENT MEMBRANE ASSEMBLY,0.00051151,0.27609,0.46015,1,1
5,GO DEVELOPMENTAL CELL GROWTH,0.00010866,0.27549,0.33621,1,1
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0020776,0.27547,0.30575,1,1
5,GO DENDRITE EXTENSION,6.4139e-05,0.27543,0.44921,1,1
5,GO DOSAGE COMPENSATION,0.006955,0.2754,0.28114,1,1
5,GO POSITIVE REGULATION OF AXON EXTENSION,0.00054254,0.27535,0.33525,1,1
5,GO CELL PROJECTION ORGANIZATION,0.00031664,0.27509,0.28594,1,1
5,GO REGULATION OF RESPONSE TO FOOD,0.0028457,0.27502,0.32516,1,1
5,GO POSITIVE REGULATION OF ACROSOME REACTION,0.00040321,0.27484,0.27851,1,1
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0038653,0.27465,0.27744,1,1
5,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.00072571,0.27445,0.32913,1,1
5,GO POSITIVE REGULATION OF HAIR CYCLE,0.043559,0.27441,0.2506,1,1
5,GO NEURON DEVELOPMENT,0.00029789,0.27413,0.30255,1,1
5,GO FACIAL NERVE MORPHOGENESIS,0.050584,0.2739,0.25126,1,1
5,GO SPHINGOMYELIN METABOLIC PROCESS,6.4139e-05,0.2735,0.33352,1,1
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,7.8298e-05,0.27306,0.31219,1,1
5,GO ADHERENS JUNCTION ASSEMBLY,0.00060992,0.273,0.35621,1,1
5,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0083971,0.2729,0.29968,1,1
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00040321,0.27283,0.35366,1,1
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.00072571,0.27274,0.43002,1,1
5,GO NOTCH RECEPTOR PROCESSING,0.00096503,0.27271,0.38229,1,1
5,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0020776,0.27271,0.34701,1,1
5,GO THYROID GLAND DEVELOPMENT,0.0019699,0.27259,0.26579,1,1
5,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.0049572,0.27248,0.27072,1,1
5,GO MICROTUBULE BASED PROCESS,0.0013481,0.27238,0.25325,1,1
5,GO RESPONSE TO COCAINE,0.0025648,0.27228,0.28438,1,1
5,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0010209,0.27216,0.4272,1,1
5,GO NEUROTRANSMITTER REUPTAKE,0.00096503,0.27193,0.31842,1,1
5,GO LONG TERM SYNAPTIC POTENTIATION,0.00096503,0.27188,0.34204,1,1
5,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0003797,0.27171,0.2877,1,1
5,GO POSITIVE REGULATION OF MITOPHAGY,0.00033648,0.27166,0.42648,1,1
5,GO CELL MIGRATION IN HINDBRAIN,0.0016767,0.27163,0.33936,1,1
5,GO HINDBRAIN DEVELOPMENT,0.0021907,0.27151,0.24822,1,1
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0054671,0.27139,0.30739,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0014241,0.27125,0.32046,1,1
5,GO NEGATIVE CHEMOTAXIS,0.00068502,0.27119,0.37823,1,1
5,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.046961,0.27113,0.20845,1,1
5,GO MITOCHONDRION LOCALIZATION,0.0012758,0.27108,0.29225,1,1
5,GO VISUAL BEHAVIOR,0.00010181,0.27105,0.33028,1,1
5,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0172,0.2709,0.24451,1,1
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.00048214,0.27084,0.31513,1,1
5,GO REGULATION OF AXON GUIDANCE,0.0013481,0.27075,0.36588,1,1
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00042807,0.27053,0.31731,1,1
5,GO REGULATION OF SYNAPSE ASSEMBLY,0.00057531,0.27053,0.3657,1,1
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0012758,0.2704,0.39229,1,1
5,GO REGULATION OF DENDRITE EXTENSION,5.9985e-05,0.27035,0.53516,1,1
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0012758,0.26986,0.33656,1,1
5,GO REGULATION OF AMINO ACID TRANSPORT,0.0083971,0.26976,0.25013,1,1
5,GO SPECIFICATION OF SYMMETRY,0.0010209,0.26931,0.27966,1,1
5,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.012106,0.26886,0.29132,1,1
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0060238,0.26868,0.29508,1,1
5,GO BEHAVIOR,0.0010209,0.26827,0.2748,1,1
5,GO CELL VOLUME HOMEOSTASIS,0.00048214,0.26815,0.31248,1,1
5,GO REPRODUCTIVE BEHAVIOR,0.035953,0.26807,0.20129,1,1
5,GO BASE EXCISION REPAIR AP SITE FORMATION,0.0018673,0.26792,0.24092,1,1
5,GO REGULATION OF MRNA POLYADENYLATION,0.0016767,0.26786,0.30056,1,1
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.00028019,0.26785,0.31341,1,1
5,GO REGULATION OF APPETITE,0.0049572,0.26754,0.33882,1,1
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00018128,0.26729,0.33749,1,1
5,GO MICROTUBULE NUCLEATION,0.0029965,0.26601,0.29938,1,1
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,8.3641e-05,0.266,0.36839,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,3.248e-05,0.26565,0.27798,1,1
5,GO HEART FIELD SPECIFICATION,0.0023095,0.26561,0.31009,1,1
5,GO ACIDIC AMINO ACID TRANSPORT,0.0003797,0.2653,0.315,1,1
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00033648,0.26514,0.29641,1,1
5,GO CATECHOLAMINE SECRETION,0.00010181,0.26354,0.41713,1,1
5,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0012071,0.26332,0.30208,1,1
5,GO HISTONE H3 K9 TRIMETHYLATION,0.0047188,0.26311,0.29133,1,1
5,GO OLIGODENDROCYTE DEVELOPMENT,0.00010866,0.26302,0.29332,1,1
5,GO REGULATION OF AXONOGENESIS,0.0014241,0.26257,0.32942,1,1
5,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.0066311,0.26233,0.28772,1,1
5,GO CATECHOLAMINE METABOLIC PROCESS,0.00040321,0.26228,0.31259,1,1
5,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0028457,0.26224,0.33061,1,1
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00020554,0.26175,0.38854,1,1
5,GO REGULATION OF SYNAPTIC PLASTICITY,0.00026348,0.26127,0.373,1,1
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0015882,0.26123,0.27242,1,1
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00014989,0.26117,0.33507,1,1
5,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0096484,0.26114,0.26146,1,1
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.006955,0.26109,0.29036,1,1
5,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,6.8565e-05,0.26076,0.31227,1,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.012106,0.26057,0.28268,1,1
5,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.0019699,0.26039,0.27876,1,1
5,GO AXON DEVELOPMENT,0.00054254,0.26027,0.30347,1,1
5,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0015041,0.2599,0.29879,1,1
5,GO CARDIAC MYOFIBRIL ASSEMBLY,0.00064645,0.25982,0.36602,1,1
5,GO RESPONSE TO INACTIVITY,0.012106,0.25973,0.24444,1,1
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00081392,0.25968,0.31941,1,1
5,GO CLATHRIN COAT ASSEMBLY,0.00332,0.25966,0.32534,1,1
5,GO HISTONE H3 K9 METHYLATION,0.011063,0.25965,0.28607,1,1
5,GO SOMITOGENESIS,0.006955,0.25945,0.2323,1,1
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00028019,0.25938,0.32924,1,1
5,GO AMINE BIOSYNTHETIC PROCESS,0.0015882,0.25921,0.25076,1,1
5,GO EXPORT ACROSS PLASMA MEMBRANE,0.00019306,0.25903,0.33221,1,1
5,GO BASEMENT MEMBRANE ORGANIZATION,0.0018673,0.25897,0.36158,1,1
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.041938,0.25894,0.2353,1,1
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00012367,0.25891,0.28532,1,1
5,GO MONOVALENT INORGANIC CATION TRANSPORT,4.5779e-05,0.25889,0.31196,1,1
5,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0044907,0.25886,0.30215,1,1
5,GO REGULATION OF EXTENT OF CELL GROWTH,0.0011418,0.25876,0.33086,1,1
5,GO SODIUM ION TRANSPORT,4.8997e-05,0.25876,0.35032,1,1
5,GO REGULATION OF JUN KINASE ACTIVITY,0.0031545,0.25864,0.28961,1,1
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0024341,0.25862,0.29264,1,1
5,GO LOCOMOTORY BEHAVIOR,0.00091199,0.25854,0.30651,1,1
5,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.00033648,0.25834,0.31552,1,1
5,GO HISTONE DEUBIQUITINATION,0.0047188,0.25829,0.27258,1,1
5,GO SUBPALLIUM DEVELOPMENT,0.0036751,0.25812,0.30108,1,1
5,GO NEURON DIFFERENTIATION,0.00040321,0.25798,0.28186,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0047188,0.25758,0.28476,1,1
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,4.2763e-05,0.2575,0.35891,1,1
5,GO FIBROBLAST ACTIVATION,0.0031545,0.25743,0.26278,1,1
5,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.013834,0.25741,0.26919,1,1
5,GO CARDIAC CONDUCTION,0.00035748,0.25733,0.3412,1,1
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00086166,0.25733,0.35521,1,1
5,GO PROTEIN METHYLATION,0.0044907,0.25726,0.25148,1,1
5,GO ACTIVATION OF MAPKKK ACTIVITY,0.0044907,0.25726,0.31783,1,1
5,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.0021907,0.2571,0.33354,1,1
5,GO RESPONSE TO PAIN,0.00054254,0.257,0.36562,1,1
5,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.0044907,0.25698,0.36167,1,1
5,GO TELOMERE CAPPING,0.0016767,0.25692,0.2578,1,1
5,GO DENDRITIC SPINE DEVELOPMENT,0.0015041,0.25689,0.30923,1,1
5,GO SPHINGOID METABOLIC PROCESS,0.00019306,0.25675,0.3393,1,1
5,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00040321,0.25662,0.35326,1,1
5,GO THALAMUS DEVELOPMENT,0.015776,0.2562,0.25066,1,1
5,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0027019,0.25594,0.33164,1,1
5,GO REGULATION OF MRNA PROCESSING,0.013834,0.2557,0.20282,1,1
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00018128,0.25535,0.36519,1,1
5,GO REGULATION OF MEMBRANE REPOLARIZATION,0.00028019,0.25528,0.39709,1,1
5,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.00051151,0.25527,0.36037,1,1
5,GO OSTEOCLAST DEVELOPMENT,0.034576,0.25482,0.25784,1,1
5,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0028457,0.2548,0.31622,1,1
5,GO DIOL BIOSYNTHETIC PROCESS,5.9985e-05,0.25471,0.30425,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.030713,0.25466,0.21729,1,1
5,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0013481,0.25456,0.27616,1,1
5,GO POLYOL CATABOLIC PROCESS,0.00064645,0.25424,0.30411,1,1
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,3.9936e-05,0.25392,0.33925,1,1
5,GO SMOOTHENED SIGNALING PATHWAY,0.0027019,0.2539,0.24822,1,1
5,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0034935,0.25376,0.24643,1,1
5,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0024341,0.25375,0.34063,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.026142,0.25358,0.20057,1,1
5,GO CELL JUNCTION ASSEMBLY,0.00014062,0.25326,0.32445,1,1
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.01266,0.25317,0.23196,1,1
5,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00028019,0.25316,0.31233,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0044907,0.25308,0.31225,1,1
5,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0034935,0.25306,0.33489,1,1
5,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0092139,0.25295,0.23045,1,1
5,GO STRIATED MUSCLE ADAPTATION,0.00033648,0.25269,0.34732,1,1
5,GO RESPONSE TO LEAD ION,0.00024771,0.25266,0.29906,1,1
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.0020776,0.25259,0.28957,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0076456,0.2525,0.2208,1,1
5,GO SENSORY PERCEPTION OF SMELL,0.00029789,0.2522,0.24147,1,1
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.01266,0.25203,0.27746,1,1
5,GO AMMONIUM ION METABOLIC PROCESS,0.0044907,0.25188,0.31286,1,1
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0019699,0.25154,0.29142,1,1
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0027019,0.25128,0.26031,1,1
5,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0029965,0.25125,0.3742,1,1
5,GO REGULATION OF METANEPHROS DEVELOPMENT,0.017954,0.25109,0.28166,1,1
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00042807,0.25101,0.32499,1,1
5,GO REGULATION OF LYASE ACTIVITY,0.0029965,0.25083,0.23044,1,1
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.046961,0.25071,0.17721,1,1
5,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.033245,0.25054,0.24755,1,1
5,GO EMBRYONIC BODY MORPHOGENESIS,0.0040644,0.25034,0.32779,1,1
5,GO NEURON MIGRATION,0.0076456,0.25034,0.263,1,1
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,9.5377e-05,0.25026,0.26857,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00068502,0.25024,0.3458,1,1
5,GO PROTEIN HETEROOLIGOMERIZATION,0.00068502,0.24991,0.27463,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0038653,0.24979,0.27043,1,1
5,GO TORC1 SIGNALING,0.0017696,0.24963,0.29934,1,1
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0012071,0.24957,0.27803,1,1
5,GO MAINTENANCE OF CELL POLARITY,0.0044907,0.24953,0.27403,1,1
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0028457,0.24945,0.2812,1,1
5,GO EXTRACELLULAR MATRIX ASSEMBLY,0.010572,0.24943,0.36152,1,1
5,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.0036751,0.24928,0.25249,1,1
5,GO BODY MORPHOGENESIS,0.0021907,0.24926,0.30652,1,1
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0015041,0.24921,0.31013,1,1
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.00072571,0.24917,0.30144,1,1
5,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0018673,0.24903,0.23741,1,1
5,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.014457,0.24896,0.30249,1,1
5,GO REGULATION OF HORMONE SECRETION,0.00031664,0.24879,0.26526,1,1
5,GO HISTONE H3 K4 METHYLATION,0.0063209,0.24875,0.24612,1,1
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0019699,0.24825,0.23327,1,1
5,GO RESPONSE TO NERVE GROWTH FACTOR,0.00054254,0.24819,0.29097,1,1
5,GO PHOSPHATE ION TRANSPORT,0.006955,0.24793,0.24872,1,1
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00054254,0.24788,0.31058,1,1
5,GO MICROVILLUS ORGANIZATION,0.0092139,0.24776,0.22437,1,1
5,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00076864,0.24751,0.31521,1,1
5,GO PEPTIDE HORMONE SECRETION,0.00011593,0.24749,0.29939,1,1
5,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.0012758,0.24738,0.26625,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.033245,0.24725,0.24131,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.00086166,0.24709,0.36873,1,1
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00033648,0.24701,0.36496,1,1
5,GO LEFT RIGHT PATTERN FORMATION,0.0057394,0.24678,0.26125,1,1
5,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0083971,0.24654,0.28744,1,1
5,GO REGULATION OF WATER LOSS VIA SKIN,0.0034935,0.24643,0.23066,1,1
5,GO NEUROGENESIS,0.00045436,0.24623,0.26877,1,1
5,GO SPERM AXONEME ASSEMBLY,0.007293,0.24606,0.23609,1,1
5,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.006955,0.24596,0.36493,1,1
5,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,5.9985e-05,0.24589,0.33959,1,1
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.041938,0.24555,0.20873,1,1
5,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.0066311,0.24554,0.31378,1,1
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0013481,0.24532,0.29648,1,1
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.00064645,0.24529,0.33384,1,1
5,GO CELL CELL JUNCTION MAINTENANCE,0.0080134,0.245,0.30703,1,1
5,GO CELL PROJECTION ASSEMBLY,0.00096503,0.24474,0.26298,1,1
5,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00045436,0.24469,0.39303,1,1
5,GO PROTEIN DEPOLYMERIZATION,0.00060992,0.24453,0.29809,1,1
5,GO DEVELOPMENTAL MATURATION,0.00040321,0.24441,0.28317,1,1
5,GO LUNG ALVEOLUS DEVELOPMENT,0.0010798,0.24438,0.35123,1,1
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.00033648,0.24364,0.33702,1,1
5,GO MEMBRANE BIOGENESIS,0.00045436,0.24363,0.34765,1,1
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.00045436,0.24362,0.31605,1,1
5,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.037377,0.24355,0.22869,1,1
5,GO REGULATION OF MICROTUBULE BASED PROCESS,0.0024341,0.24354,0.23874,1,1
5,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0076456,0.24346,0.24623,1,1
5,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0042727,0.2434,0.35516,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0060238,0.2433,0.37071,1,1
5,GO REGULATION OF HEART RATE,0.00048214,0.24311,0.31595,1,1
5,GO INTERMEDIATE FILAMENT BASED PROCESS,0.0029965,0.24309,0.23372,1,1
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00029789,0.24306,0.31012,1,1
5,GO RESPONSE TO ALKALOID,0.0015041,0.24292,0.2326,1,1
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00015974,0.24271,0.30338,1,1
5,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0011418,0.24268,0.28717,1,1
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.0060238,0.24253,0.23809,1,1
5,GO REGULATION OF RNA SPLICING,0.0092139,0.24252,0.20665,1,1
5,GO REGULATION OF CYCLASE ACTIVITY,0.00332,0.24235,0.23788,1,1
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00028019,0.24228,0.30672,1,1
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0066311,0.24206,0.2665,1,1
5,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.00023283,0.24187,0.37141,1,1
5,GO PARTURITION,0.0020776,0.24185,0.28165,1,1
5,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.037377,0.24163,0.21758,1,1
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00012367,0.24159,0.31671,1,1
5,GO REGULATION OF NEURON DIFFERENTIATION,0.00086166,0.24141,0.27782,1,1
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0023095,0.24139,0.24142,1,1
5,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.0025648,0.24136,0.29393,1,1
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.0049572,0.24132,0.26194,1,1
5,GO NEURAL NUCLEUS DEVELOPMENT,0.00011593,0.24121,0.30956,1,1
5,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.0080134,0.24099,0.23276,1,1
5,GO CELL JUNCTION ORGANIZATION,0.00023283,0.24086,0.31686,1,1
5,GO PEPTIDYL LYSINE MODIFICATION,0.0038653,0.24067,0.22725,1,1
5,GO KERATAN SULFATE METABOLIC PROCESS,0.006955,0.24052,0.28485,1,1
5,GO MEMBRANE REPOLARIZATION,0.00045436,0.24028,0.35711,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.00035748,0.24025,0.33136,1,1
5,GO PANCREAS DEVELOPMENT,0.0029965,0.24016,0.26862,1,1
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0038653,0.24004,0.23915,1,1
5,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00014989,0.23993,0.31626,1,1
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.01266,0.23992,0.23898,1,1
5,GO GLIAL CELL FATE COMMITMENT,0.025096,0.23988,0.26046,1,1
5,GO MITOCHONDRION DISTRIBUTION,0.0028457,0.23975,0.30653,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0010798,0.23969,0.25407,1,1
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0010798,0.23968,0.28335,1,1
5,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.0017696,0.23931,0.26075,1,1
5,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.00091199,0.23927,0.25975,1,1
5,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0092139,0.23926,0.23149,1,1
5,GO METENCEPHALON DEVELOPMENT,0.0040644,0.2392,0.25213,1,1
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00040321,0.23904,0.31241,1,1
5,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0052065,0.239,0.26092,1,1
5,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.0024341,0.23898,0.32655,1,1
5,GO NEUROTRANSMITTER UPTAKE,0.0016767,0.23891,0.25853,1,1
5,GO COGNITION,0.0012758,0.23879,0.27321,1,1
5,GO BILE ACID AND BILE SALT TRANSPORT,0.0057394,0.23874,0.23993,1,1
5,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0016767,0.23862,0.24611,1,1
5,GO REGULATION OF MEMBRANE POTENTIAL,0.00010866,0.23858,0.33646,1,1
5,GO CARDIAC MUSCLE CELL CONTRACTION,0.0019699,0.23852,0.32797,1,1
5,GO REGULATION OF ACTIN NUCLEATION,0.00028019,0.2382,0.27857,1,1
5,GO REGULATION OF TORC1 SIGNALING,0.0028457,0.23818,0.27509,1,1
5,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,9.5377e-05,0.23803,0.41053,1,1
5,GO RENAL WATER HOMEOSTASIS,0.0015882,0.23775,0.29078,1,1
5,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.024086,0.23761,0.19167,1,1
5,GO MULTICELLULAR ORGANISMAL SIGNALING,0.00033648,0.23748,0.33782,1,1
5,GO INSULIN SECRETION,0.00010181,0.23743,0.30088,1,1
5,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.00019306,0.2374,0.3119,1,1
5,GO NERVOUS SYSTEM PROCESS,0.00019306,0.23738,0.26884,1,1
5,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00086166,0.2373,0.30061,1,1
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0015882,0.23729,0.29081,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00081392,0.23724,0.27511,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00332,0.23711,0.28187,1,1
5,GO RESPONSE TO DOPAMINE,0.00019306,0.23708,0.26905,1,1
5,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.00010181,0.23702,0.35243,1,1
5,GO ORGANELLE LOCALIZATION,0.00026348,0.23699,0.2437,1,1
5,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.043559,0.23694,0.24137,1,1
5,GO HISTONE H3 K36 METHYLATION,0.015776,0.23688,0.2998,1,1
5,GO NEGATIVE REGULATION OF JNK CASCADE,0.00028019,0.23685,0.27606,1,1
5,GO FOREBRAIN CELL MIGRATION,0.00332,0.2367,0.26816,1,1
5,GO MITOPHAGY,0.00023283,0.23667,0.31671,1,1
5,GO MIRNA METABOLIC PROCESS,0.00029789,0.23645,0.28575,1,1
5,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.031957,0.23637,0.27048,1,1
5,GO WALKING BEHAVIOR,0.0092139,0.23634,0.25818,1,1
5,GO PLASMA MEMBRANE ORGANIZATION,0.0010798,0.23627,0.29851,1,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0015882,0.23626,0.28,1,1
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0036751,0.2362,0.30716,1,1
5,GO OLFACTORY LOBE DEVELOPMENT,0.031957,0.23619,0.2351,1,1
5,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0019699,0.23607,0.33065,1,1
5,GO REGULATION OF PROTEIN DEACETYLATION,0.0015882,0.23605,0.27786,1,1
5,GO MYELIN ASSEMBLY,0.0011418,0.23602,0.34462,1,1
5,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00031664,0.2358,0.29633,1,1
5,GO REGULATION OF EXOCYTOSIS,0.00026348,0.23567,0.3182,1,1
5,GO REGULATION OF CARDIAC CONDUCTION,0.00068502,0.23564,0.3192,1,1
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00096503,0.23553,0.35778,1,1
5,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.022172,0.23553,0.2168,1,1
5,GO LENS FIBER CELL DEVELOPMENT,0.0080134,0.23539,0.23258,1,1
5,GO PLASMA MEMBRANE TUBULATION,0.0015041,0.23527,0.29726,1,1
5,GO PRESYNAPSE ORGANIZATION,0.0016767,0.23504,0.344,1,1
5,GO PEPTIDYL LYSINE ACETYLATION,0.0031545,0.23487,0.23314,1,1
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00045436,0.23486,0.28947,1,1
5,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0066311,0.23479,0.25354,1,1
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00064645,0.23427,0.25819,1,1
5,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.011574,0.23419,0.26588,1,1
5,GO MACROMOLECULE DEACYLATION,0.0019699,0.23419,0.25312,1,1
5,GO SOMITE DEVELOPMENT,0.0047188,0.23415,0.23035,1,1
5,GO MEGAKARYOCYTE DEVELOPMENT,0.0034935,0.2341,0.2981,1,1
5,GO HEART INDUCTION,0.027226,0.23363,0.24749,1,1
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.0034935,0.23357,0.24004,1,1
5,GO ACTIN FILAMENT NETWORK FORMATION,0.0020776,0.23355,0.31413,1,1
5,GO ENDOCYTIC RECYCLING,0.00051151,0.23351,0.30607,1,1
5,GO HORMONE TRANSPORT,0.00020554,0.23344,0.26959,1,1
5,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0024341,0.23342,0.29077,1,1
5,GO HYPEROSMOTIC RESPONSE,0.0066311,0.23337,0.2556,1,1
5,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0054671,0.23337,0.25733,1,1
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00091199,0.23316,0.25859,1,1
5,GO NEGATIVE REGULATION OF WOUND HEALING,0.041938,0.23282,0.21992,1,1
5,GO PIGMENT GRANULE LOCALIZATION,0.00086166,0.2327,0.28452,1,1
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.013834,0.23265,0.23636,1,1
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.016475,0.23263,0.24017,1,1
5,GO REGULATION OF HISTONE DEACETYLATION,0.0016767,0.23263,0.26544,1,1
5,GO PLATELET MORPHOGENESIS,0.0040644,0.23244,0.28999,1,1
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.00064645,0.23238,0.28627,1,1
5,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.024086,0.23226,0.21581,1,1
5,GO PROTEIN O LINKED MANNOSYLATION,0.00021879,0.2321,0.28793,1,1
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0044907,0.23208,0.29589,1,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0003797,0.23208,0.29938,1,1
5,GO RESPONSE TO CATECHOLAMINE,0.00012367,0.23198,0.28532,1,1
5,GO FOREGUT MORPHOGENESIS,0.052482,0.23184,0.19601,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0038653,0.23182,0.2705,1,1
5,GO LENS FIBER CELL DIFFERENTIATION,0.011063,0.23173,0.20442,1,1
5,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0012071,0.23163,0.26502,1,1
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00042807,0.23155,0.28466,1,1
5,GO SEXUAL REPRODUCTION,0.00332,0.23144,0.2007,1,1
5,GO SPERMATID DIFFERENTIATION,0.0016767,0.23127,0.22435,1,1
5,GO DIGESTIVE SYSTEM DEVELOPMENT,0.0052065,0.23124,0.24914,1,1
5,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.023112,0.23124,0.18921,1,1
5,GO PROTEIN LOCALIZATION TO VACUOLE,0.00040321,0.23115,0.26728,1,1
5,GO IMPORT INTO CELL,0.00042807,0.23104,0.27046,1,1
5,GO PROTEIN MANNOSYLATION,0.0034935,0.23094,0.22801,1,1
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0025648,0.23092,0.25941,1,1
5,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.012106,0.23091,0.19831,1,1
5,GO OLIGOPEPTIDE TRANSPORT,0.0049572,0.23088,0.25697,1,1
5,GO METHYLATION,0.0066311,0.23084,0.19521,1,1
5,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.0096484,0.23075,0.27798,1,1
5,GO VENTRAL SPINAL CORD DEVELOPMENT,0.040368,0.23074,0.17777,1,1
5,GO SPERM CAPACITATION,0.0038653,0.23073,0.25129,1,1
5,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.0013481,0.23069,0.3055,1,1
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.0012758,0.23067,0.25495,1,1
5,GO MITOTIC RECOMBINATION,0.0172,0.23064,0.22472,1,1
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0003797,0.2304,0.31917,1,1
5,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.006955,0.23031,0.26116,1,1
5,GO REGULATION OF TUBE SIZE,0.0044907,0.23018,0.22145,1,1
5,GO HISTONE H4 DEACETYLATION,0.019548,0.23012,0.17821,1,1
5,GO HISTONE DEACETYLATION,0.0034935,0.23006,0.25619,1,1
5,GO SPINDLE LOCALIZATION,0.0027019,0.22995,0.24278,1,1
5,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0044907,0.22995,0.30817,1,1
5,GO GLUCOCORTICOID METABOLIC PROCESS,0.0044907,0.2299,0.25536,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.0017696,0.22986,0.24935,1,1
5,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00051151,0.22964,0.29596,1,1
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0047188,0.2294,0.24342,1,1
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.00068502,0.22927,0.27202,1,1
5,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0047188,0.22924,0.25523,1,1
5,GO CELLULAR RESPONSE TO AMYLOID BETA,0.052482,0.22919,0.21948,1,1
5,GO CHROMATIN DISASSEMBLY,0.012106,0.22912,0.23956,1,1
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0034935,0.22906,0.21828,1,1
5,GO BONE CELL DEVELOPMENT,0.0057394,0.22884,0.27679,1,1
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.00051151,0.22865,0.2519,1,1
5,GO COVALENT CHROMATIN MODIFICATION,0.0066311,0.22852,0.2385,1,1
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0010798,0.2285,0.27713,1,1
5,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0042727,0.22845,0.29128,1,1
5,GO AMINE TRANSPORT,0.00060992,0.2284,0.31705,1,1
5,GO REGULATION OF ACROSOME REACTION,0.0014241,0.2284,0.23904,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00024771,0.22825,0.27354,1,1
5,GO EPIDERMAL CELL DIFFERENTIATION,0.0018673,0.22811,0.21525,1,1
5,GO PROTEIN ACYLATION,0.0017696,0.22797,0.23828,1,1
5,GO CHLORIDE ION HOMEOSTASIS,0.0012071,0.22783,0.30246,1,1
5,GO REGULATION OF ORGANELLE ASSEMBLY,0.0029965,0.22766,0.21762,1,1
5,GO CARDIAC SEPTUM MORPHOGENESIS,0.011063,0.22745,0.23819,1,1
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0029965,0.22736,0.24052,1,1
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0047188,0.22717,0.23338,1,1
5,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.00076864,0.22694,0.34083,1,1
5,GO CELLULAR RESPONSE TO PH,0.0020776,0.22675,0.26707,1,1
5,GO PEPTIDYL THREONINE MODIFICATION,0.00018128,0.2267,0.30015,1,1
5,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.0042727,0.22656,0.22768,1,1
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.00054254,0.22649,0.31342,1,1
5,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0028457,0.22637,0.33211,1,1
5,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.025096,0.22636,0.22219,1,1
5,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0017696,0.22627,0.21207,1,1
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0042727,0.22613,0.17551,1,1
5,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.006955,0.226,0.24536,1,1
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.00332,0.22589,0.29751,1,1
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0021907,0.22583,0.26036,1,1
5,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.00017019,0.2258,0.21966,1,1
5,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.019548,0.2258,0.26711,1,1
5,GO MELANOCYTE DIFFERENTIATION,0.0054671,0.2257,0.24886,1,1
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.0020776,0.22566,0.22974,1,1
5,GO REGULATION OF CELL SIZE,0.00045436,0.22564,0.30439,1,1
5,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.00033648,0.22557,0.31378,1,1
5,GO PURINE NUCLEOTIDE TRANSPORT,0.00026348,0.22547,0.24113,1,1
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00096503,0.22542,0.2944,1,1
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.00028019,0.2251,0.2358,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0029965,0.22497,0.2563,1,1
5,GO POSITIVE REGULATION OF TOR SIGNALING,0.00096503,0.22487,0.24604,1,1
5,GO EXOCYTIC PROCESS,7.8298e-05,0.22485,0.33994,1,1
5,GO STRIATED MUSCLE CONTRACTION,0.00096503,0.2248,0.29613,1,1
5,GO CRANIAL NERVE MORPHOGENESIS,0.035953,0.2247,0.22807,1,1
5,GO ACTIN CROSSLINK FORMATION,0.025096,0.2245,0.23793,1,1
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00017019,0.22446,0.29794,1,1
5,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.015104,0.22431,0.23556,1,1
5,GO REGULATION OF FILOPODIUM ASSEMBLY,0.0027019,0.22413,0.24913,1,1
5,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.026142,0.22408,0.20909,1,1
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00017019,0.22405,0.31878,1,1
5,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.0040644,0.22375,0.22964,1,1
5,GO HEAD DEVELOPMENT,0.00072571,0.22366,0.24869,1,1
5,GO CELL MATURATION,0.0003797,0.22363,0.24589,1,1
5,GO METANEPHROS MORPHOGENESIS,0.0080134,0.22352,0.25179,1,1
5,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0034935,0.2235,0.24314,1,1
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0057394,0.2235,0.23429,1,1
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00076864,0.22347,0.31657,1,1
5,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.045233,0.22328,0.19689,1,1
5,GO REGULATION OF INSULIN SECRETION,0.00011593,0.2232,0.29869,1,1
5,GO DETECTION OF VISIBLE LIGHT,0.00048214,0.2231,0.20802,1,1
5,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0015882,0.22306,0.25073,1,1
5,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0011418,0.22301,0.30363,1,1
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.00033648,0.22289,0.26712,1,1
5,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.038848,0.22247,0.19691,1,1
5,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0014241,0.22245,0.29904,1,1
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.00091199,0.22232,0.3093,1,1
5,GO MUSCLE FIBER DEVELOPMENT,0.010101,0.22221,0.22904,1,1
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.00064645,0.2222,0.28916,1,1
5,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00096503,0.2222,0.29674,1,1
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.00042807,0.22218,0.28548,1,1
5,GO PHOTORECEPTOR CELL MAINTENANCE,0.0012071,0.22205,0.27957,1,1
5,GO HISTONE H3 DEACETYLATION,0.0028457,0.22203,0.27813,1,1
5,GO RESPONSE TO ISCHEMIA,0.038848,0.22187,0.20011,1,1
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00029789,0.22186,0.31175,1,1
5,GO RNA POLYADENYLATION,0.0042727,0.22176,0.24301,1,1
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00086166,0.2217,0.25365,1,1
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0080134,0.22166,0.24268,1,1
5,GO HISTONE H3 K14 ACETYLATION,0.0031545,0.22165,0.30661,1,1
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00033648,0.22165,0.37434,1,1
5,GO SULFUR COMPOUND CATABOLIC PROCESS,0.0036751,0.22159,0.254,1,1
5,GO SEGMENTATION,0.010101,0.22155,0.20084,1,1
5,GO TRANSFERRIN TRANSPORT,7.8298e-05,0.22132,0.28506,1,1
5,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.021265,0.22122,0.26141,1,1
5,GO REGULATION OF BLOOD CIRCULATION,0.00057531,0.22117,0.28494,1,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.024086,0.22117,0.29197,1,1
5,GO RESPONSE TO IRON ION,0.012106,0.22109,0.21972,1,1
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.031957,0.22101,0.20804,1,1
5,GO SENSORY PERCEPTION,0.00023283,0.22099,0.233,1,1
5,GO CELL MORPHOGENESIS,0.00054254,0.22092,0.28146,1,1
5,GO AMINOGLYCAN METABOLIC PROCESS,0.0024341,0.2208,0.27992,1,1
5,GO SECRETORY GRANULE ORGANIZATION,0.0054671,0.22055,0.24813,1,1
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.0076456,0.22047,0.21778,1,1
5,GO REGULATION OF GTP BINDING,0.020391,0.22046,0.21846,1,1
5,GO SENSORY PERCEPTION OF PAIN,0.00332,0.22035,0.21254,1,1
5,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.052482,0.22034,0.19539,1,1
5,GO RESPONSE TO IMMOBILIZATION STRESS,0.0023095,0.22021,0.28062,1,1
5,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.0042727,0.22015,0.22836,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00042807,0.22008,0.27903,1,1
5,GO ATRIAL SEPTUM MORPHOGENESIS,0.028348,0.22001,0.27999,1,1
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0083971,0.21986,0.21176,1,1
5,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.015104,0.21976,0.20614,1,1
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.030713,0.21965,0.19274,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS,0.013235,0.21951,0.28009,1,1
5,GO HISTONE H3 ACETYLATION,0.008797,0.21934,0.19999,1,1
5,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.0014241,0.2193,0.28685,1,1
5,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00017019,0.21928,0.25881,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0024341,0.2191,0.28809,1,1
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0038653,0.219,0.22731,1,1
5,GO SPLEEN DEVELOPMENT,0.0042727,0.21888,0.24307,1,1
5,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00019306,0.21886,0.25209,1,1
5,GO REGULATION OF PINOCYTOSIS,0.030713,0.21876,0.2622,1,1
5,GO POSITIVE REGULATION OF RNA SPLICING,0.011574,0.21874,0.18638,1,1
5,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0015882,0.21867,0.38745,1,1
5,GO CALCINEURIN MEDIATED SIGNALING,0.0042727,0.21863,0.23912,1,1
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.019548,0.21859,0.23032,1,1
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0052065,0.21849,0.24449,1,1
5,GO HISTONE H4 ACETYLATION,0.0023095,0.21847,0.2523,1,1
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0096484,0.21846,0.22472,1,1
5,GO RNA DESTABILIZATION,0.012106,0.21844,0.2505,1,1
5,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.015776,0.21837,0.19592,1,1
5,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.0052065,0.21833,0.24103,1,1
5,GO REGULATION OF ENDOCYTIC RECYCLING,0.015104,0.21824,0.25328,1,1
5,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.0019699,0.21819,0.25797,1,1
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.00332,0.21815,0.25016,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0024341,0.21813,0.32874,1,1
5,GO PROTEIN KINASE A SIGNALING,0.0057394,0.21805,0.2294,1,1
5,GO ERYTHROCYTE MATURATION,0.023112,0.21799,0.25487,1,1
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.019548,0.21793,0.24007,1,1
5,GO RESPONSE TO AMPHETAMINE,0.012106,0.21782,0.21721,1,1
5,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0025648,0.21755,0.22042,1,1
5,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.012106,0.21738,0.35449,1,1
5,GO REGULATION OF GLUCONEOGENESIS,0.0029965,0.21723,0.2808,1,1
5,GO HEAD MORPHOGENESIS,0.008797,0.2172,0.30384,1,1
5,GO PROTEIN ACETYLATION,0.0036751,0.21719,0.22107,1,1
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00017019,0.21714,0.22974,1,1
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.028348,0.21702,0.19888,1,1
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.046961,0.21684,0.17591,1,1
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0036751,0.21678,0.27114,1,1
5,GO MYOTUBE DIFFERENTIATION,0.013235,0.21657,0.22303,1,1
5,GO REGULATION OF HISTONE METHYLATION,0.0038653,0.21648,0.25115,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0040644,0.21645,0.22802,1,1
5,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.022172,0.21629,0.24164,1,1
5,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.00091199,0.21618,0.20672,1,1
5,GO IMPORT ACROSS PLASMA MEMBRANE,0.0013481,0.21597,0.25471,1,1
5,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00086166,0.21582,0.21682,1,1
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0044907,0.21579,0.23438,1,1
5,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0011418,0.21561,0.27105,1,1
5,GO GAMETE GENERATION,0.0036751,0.21548,0.20215,1,1
5,GO NUCLEOTIDE TRANSPORT,0.00051151,0.21547,0.22143,1,1
5,GO DETECTION OF LIGHT STIMULUS,0.00045436,0.21546,0.20599,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00045436,0.21544,0.26727,1,1
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00045436,0.21543,0.31046,1,1
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00096503,0.21542,0.26203,1,1
5,GO OXIDATIVE DEMETHYLATION,0.00072571,0.21539,0.33928,1,1
5,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.017954,0.21538,0.25489,1,1
5,GO SECONDARY METABOLIC PROCESS,7.3279e-05,0.21533,0.26322,1,1
5,GO AXIS SPECIFICATION,0.00096503,0.21532,0.21567,1,1
5,GO SENSORY SYSTEM DEVELOPMENT,0.0012758,0.21526,0.24926,1,1
5,GO REGULATION OF HISTONE H4 ACETYLATION,0.01266,0.21522,0.18137,1,1
5,GO PEPTIDYL LYSINE DIMETHYLATION,0.0096484,0.21522,0.26229,1,1
5,GO ACTIVATION OF GTPASE ACTIVITY,0.0016767,0.2152,0.30932,1,1
5,GO AMINOGLYCAN CATABOLIC PROCESS,0.031957,0.2152,0.21953,1,1
5,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00057531,0.215,0.28011,1,1
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.007293,0.21484,0.27467,1,1
5,GO REGULATION OF PROTEIN POLYMERIZATION,0.00014062,0.21483,0.27213,1,1
5,GO PHOSPHOLIPID TRANSPORT,0.0031545,0.21467,0.2398,1,1
5,GO REGULATION OF HISTONE MODIFICATION,0.0042727,0.21458,0.22075,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.019548,0.21454,0.24477,1,1
5,GO SIGNAL RELEASE,0.00048214,0.21436,0.26604,1,1
5,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.0020776,0.21435,0.28797,1,1
5,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0096484,0.21428,0.26674,1,1
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.007293,0.21408,0.29244,1,1
5,GO LYSOSOME LOCALIZATION,0.041938,0.21399,0.1971,1,1
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00013188,0.21391,0.26579,1,1
5,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.014457,0.21377,0.25673,1,1
5,GO CAMERA TYPE EYE DEVELOPMENT,0.0024341,0.21374,0.23849,1,1
5,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.0096484,0.21367,0.26142,1,1
5,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00060992,0.21352,0.24667,1,1
5,GO RESPIRATORY SYSTEM PROCESS,0.0019699,0.21343,0.31289,1,1
5,GO HINDLIMB MORPHOGENESIS,0.0096484,0.21332,0.24223,1,1
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00026348,0.21324,0.30606,1,1
5,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00020554,0.21319,0.27858,1,1
5,GO ENERGY HOMEOSTASIS,0.00081392,0.21317,0.29429,1,1
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00023283,0.21305,0.29862,1,1
5,GO ADAPTATION OF SIGNALING PATHWAY,0.0076456,0.21291,0.30531,1,1
5,GO REGULATION OF FEEDING BEHAVIOR,0.007293,0.21276,0.21801,1,1
5,GO NERVE DEVELOPMENT,0.024086,0.21276,0.23075,1,1
5,GO AROMATIC AMINO ACID TRANSPORT,0.045233,0.21242,0.23881,1,1
5,GO REGULATION OF CHROMATIN ORGANIZATION,0.006955,0.21222,0.21216,1,1
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.00060992,0.21217,0.27925,1,1
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0017696,0.21201,0.30089,1,1
5,GO PROTEIN HOMOOLIGOMERIZATION,0.00086166,0.21191,0.23979,1,1
5,GO SULFATE TRANSPORT,0.0096484,0.21185,0.21441,1,1
5,GO AMINO ACID TRANSPORT,0.00028019,0.21171,0.26771,1,1
5,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.007293,0.21164,0.27116,1,1
5,GO CHLORIDE TRANSPORT,0.00051151,0.21147,0.29784,1,1
5,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0017696,0.2113,0.27559,1,1
5,GO GOLGI VESICLE BUDDING,0.00033648,0.211,0.24573,1,1
5,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00068502,0.21083,0.20919,1,1
5,GO ORGANELLE ASSEMBLY,0.00091199,0.21081,0.2208,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.031957,0.21078,0.29435,1,1
5,GO LIPID GLYCOSYLATION,0.0057394,0.21075,0.27983,1,1
5,GO PROTEIN KINASE C SIGNALING,0.015104,0.21074,0.28046,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.006955,0.21059,0.31731,1,1
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0013481,0.21051,0.24929,1,1
5,GO DEVELOPMENTAL PIGMENTATION,0.0019699,0.21047,0.24858,1,1
5,GO RESPONSE TO LITHIUM ION,0.0018673,0.21016,0.27021,1,1
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0013481,0.21014,0.25226,1,1
5,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.010101,0.2101,0.20176,1,1
5,GO CELLULAR PIGMENTATION,0.00028019,0.21001,0.25503,1,1
5,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.027226,0.21001,0.20536,1,1
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0028457,0.20992,0.24501,1,1
5,GO CARDIAC CHAMBER MORPHOGENESIS,0.0057394,0.2099,0.23543,1,1
5,GO NUCLEAR BODY ORGANIZATION,0.0024341,0.20989,0.24659,1,1
5,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0054671,0.20981,0.30419,1,1
5,GO DICARBOXYLIC ACID TRANSPORT,0.00029789,0.20947,0.2736,1,1
5,GO REGULATION OF BODY FLUID LEVELS,0.0172,0.20941,0.20659,1,1
5,GO COPII COATED VESICLE BUDDING,0.00033648,0.20941,0.2454,1,1
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0016767,0.20937,0.35742,1,1
5,GO PEPTIDE CATABOLIC PROCESS,0.006955,0.20935,0.24904,1,1
5,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0011418,0.20934,0.26684,1,1
5,GO PROTEIN AUTOUBIQUITINATION,0.0011418,0.20934,0.2359,1,1
5,GO RESPONSE TO FOOD,0.0172,0.20914,0.1918,1,1
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.043559,0.20913,0.181,1,1
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0031545,0.20888,0.27743,1,1
5,GO AXONAL TRANSPORT OF MITOCHONDRION,0.038848,0.20885,0.18787,1,1
5,GO REGULATION OF PROTEIN TARGETING,0.00029789,0.20879,0.24392,1,1
5,GO DEMETHYLATION,0.00031664,0.20876,0.28673,1,1
5,GO RECEPTOR RECYCLING,0.023112,0.20857,0.1999,1,1
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0172,0.20811,0.18336,1,1
5,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.0049572,0.20793,0.26665,1,1
5,GO FATTY ACID BETA OXIDATION,0.0010209,0.20791,0.24096,1,1
5,GO ALCOHOL CATABOLIC PROCESS,0.0020776,0.20783,0.20931,1,1
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.00040321,0.20761,0.32589,1,1
5,GO CALCIUM ION IMPORT,0.0015041,0.20733,0.30666,1,1
5,GO OVARIAN FOLLICLE DEVELOPMENT,0.035953,0.20694,0.17626,1,1
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00332,0.20688,0.22922,1,1
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.010101,0.20681,0.28977,1,1
5,GO PHOTOTRANSDUCTION,0.00072571,0.20675,0.17825,1,1
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0031545,0.20672,0.34901,1,1
5,GO FEEDING BEHAVIOR,0.0057394,0.2067,0.22465,1,1
5,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.006955,0.20649,0.21358,1,1
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00076864,0.20647,0.23394,1,1
5,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0042727,0.20639,0.26692,1,1
5,GO MECHANORECEPTOR DIFFERENTIATION,0.00033648,0.20628,0.30046,1,1
5,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.006955,0.20627,0.2492,1,1
5,GO HEART PROCESS,0.00091199,0.20622,0.27079,1,1
5,GO CARDIAC SEPTUM DEVELOPMENT,0.013834,0.20613,0.25526,1,1
5,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.022172,0.20602,0.29306,1,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0019699,0.20594,0.19594,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00076864,0.20578,0.25725,1,1
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.052482,0.20564,0.1776,1,1
5,GO PALLIUM DEVELOPMENT,0.007293,0.20552,0.21267,1,1
5,GO ACTIN MEDIATED CELL CONTRACTION,0.0012758,0.20552,0.27296,1,1
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0076456,0.20541,0.20162,1,1
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.0015041,0.20536,0.24203,1,1
5,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.0060238,0.20526,0.22091,1,1
5,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.021265,0.2052,0.20047,1,1
5,GO NOTCH SIGNALING PATHWAY,0.00018128,0.2051,0.29318,1,1
5,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0042727,0.20498,0.30696,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0038653,0.20494,0.26512,1,1
5,GO ORGANIC CATION TRANSPORT,0.017954,0.20493,0.21286,1,1
5,GO EMBRYONIC AXIS SPECIFICATION,0.0016767,0.20489,0.22526,1,1
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0013481,0.20461,0.26596,1,1
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.0028457,0.2046,0.20451,1,1
5,GO REGULATION OF DEACETYLASE ACTIVITY,0.00045436,0.20459,0.30893,1,1
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0066311,0.20457,0.26658,1,1
5,GO BONE MATURATION,0.025096,0.20439,0.2265,1,1
5,GO FEMALE GAMETE GENERATION,0.0076456,0.20435,0.1905,1,1
5,GO REGULATION OF ION TRANSPORT,0.00051151,0.20426,0.27054,1,1
5,GO REGULATION OF DEVELOPMENTAL GROWTH,0.00028019,0.20418,0.27715,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.020391,0.20414,0.21999,1,1
5,GO REGULATION OF CELL DEVELOPMENT,0.00091199,0.20411,0.2451,1,1
5,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.012106,0.20409,0.27654,1,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0015882,0.20401,0.19383,1,1
5,GO FILOPODIUM ASSEMBLY,0.0042727,0.20389,0.24378,1,1
5,GO LIPID PHOSPHORYLATION,0.0060238,0.20377,0.2265,1,1
5,GO ANATOMICAL STRUCTURE MATURATION,0.00086166,0.20371,0.24645,1,1
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.011574,0.20365,0.27177,1,1
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0029965,0.20359,0.2752,1,1
5,GO CATION TRANSMEMBRANE TRANSPORT,0.00019306,0.20356,0.27208,1,1
5,GO INTESTINAL ABSORPTION,0.028348,0.20351,0.23868,1,1
5,GO NEGATIVE REGULATION OF AXONOGENESIS,0.007293,0.2035,0.31172,1,1
5,GO CARDIAC CHAMBER DEVELOPMENT,0.00332,0.20346,0.25168,1,1
5,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0076456,0.20344,0.22087,1,1
5,GO DISACCHARIDE METABOLIC PROCESS,0.0042727,0.2034,0.33452,1,1
5,GO CARDIAC MUSCLE CONTRACTION,0.0012071,0.2032,0.2891,1,1
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0054671,0.2032,0.26971,1,1
5,GO RESPONSE TO MUSCLE STRETCH,0.019548,0.20288,0.32006,1,1
5,GO REGULATION OF TOR SIGNALING,0.00072571,0.20288,0.24102,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.0042727,0.20283,0.22392,1,1
5,GO MALE GAMETE GENERATION,0.0036751,0.2028,0.19711,1,1
5,GO POSITIVE REGULATION OF HEART CONTRACTION,0.00060992,0.20279,0.34468,1,1
5,GO REGULATION OF DEPHOSPHORYLATION,0.0021907,0.20264,0.22814,1,1
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00054254,0.20262,0.2931,1,1
5,GO RESPONSE TO ELECTRICAL STIMULUS,0.048745,0.20252,0.16511,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.0028457,0.20252,0.21618,1,1
5,GO CRISTAE FORMATION,0.00048214,0.20247,0.23696,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00051151,0.20241,0.25182,1,1
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.034576,0.20215,0.19378,1,1
5,GO REGULATION OF HORMONE LEVELS,0.00021879,0.20211,0.24226,1,1
5,GO RESPONSE TO CALCIUM ION,0.00014062,0.20205,0.29852,1,1
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.0023095,0.20197,0.25141,1,1
5,GO PROTEIN POLYUBIQUITINATION,0.0015041,0.20193,0.19897,1,1
5,GO 3 UTR MEDIATED MRNA STABILIZATION,0.015104,0.20177,0.2252,1,1
5,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.0047188,0.20117,0.22235,1,1
5,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0060238,0.20104,0.27191,1,1
5,GO PIGMENTATION,0.00035748,0.20097,0.26899,1,1
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.0042727,0.20084,0.20483,1,1
5,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.0036751,0.20083,0.23753,1,1
5,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.0016767,0.20082,0.24351,1,1
5,GO POSITIVE REGULATION OF FERTILIZATION,0.0016767,0.20066,0.23331,1,1
5,GO ORGANELLE MEMBRANE FUSION,0.00021879,0.20044,0.29042,1,1
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00064645,0.19999,0.30425,1,1
5,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.015104,0.19997,0.24197,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.054439,0.1999,0.17219,1,1
5,GO GLUTAMATE METABOLIC PROCESS,0.00017019,0.19986,0.2617,1,1
5,GO GERM CELL DEVELOPMENT,0.0036751,0.19986,0.20636,1,1
5,GO KERATINIZATION,0.0038653,0.19967,0.2142,1,1
5,GO PHOTOPERIODISM,0.0010798,0.19966,0.23227,1,1
5,GO CELLULAR RESPONSE TO ALKALOID,0.012106,0.19939,0.18993,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0054671,0.19933,0.24102,1,1
5,GO CARDIAC VENTRICLE DEVELOPMENT,0.00086166,0.1991,0.25934,1,1
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,6.8565e-05,0.19908,0.30652,1,1
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0011418,0.19907,0.24066,1,1
5,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.00057531,0.19897,0.3121,1,1
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00033648,0.19885,0.2787,1,1
5,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.026142,0.19861,0.2183,1,1
5,GO SCHWANN CELL DIFFERENTIATION,0.011574,0.19855,0.23307,1,1
5,GO CERAMIDE BIOSYNTHETIC PROCESS,0.00012367,0.19847,0.26771,1,1
5,GO VENTRICULAR SEPTUM DEVELOPMENT,0.0031545,0.19842,0.26346,1,1
5,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0040644,0.1983,0.20287,1,1
5,GO SECOND MESSENGER MEDIATED SIGNALING,0.011574,0.19828,0.20897,1,1
5,GO FOCAL ADHESION ASSEMBLY,0.008797,0.19812,0.27249,1,1
5,GO XENOBIOTIC TRANSPORT,0.011063,0.19811,0.25861,1,1
5,GO CELL SUBSTRATE ADHESION,0.022172,0.19806,0.25073,1,1
5,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00072571,0.19792,0.28041,1,1
5,GO CHAPERONE MEDIATED AUTOPHAGY,0.021265,0.19792,0.21656,1,1
5,GO ACTIN FILAMENT SEVERING,0.035953,0.19779,0.27088,1,1
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0010209,0.19779,0.24195,1,1
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0011418,0.19773,0.29711,1,1
5,GO SEQUESTERING OF CALCIUM ION,0.038848,0.19771,0.20986,1,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.007293,0.1977,0.30466,1,1
5,GO POSITIVE REGULATION OF HEART RATE,0.0096484,0.19764,0.24261,1,1
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.0024341,0.1976,0.2207,1,1
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.0047188,0.19757,0.2185,1,1
5,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.00081392,0.19735,0.24072,1,1
5,GO RESPONSE TO AMINE,0.014457,0.19728,0.20524,1,1
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.00033648,0.19724,0.24359,1,1
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.0003797,0.19722,0.2404,1,1
5,GO REGULATION OF SYSTEM PROCESS,0.00057531,0.19717,0.25611,1,1
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.007293,0.19711,0.19688,1,1
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00064645,0.19706,0.25111,1,1
5,GO VESICLE LOCALIZATION,4.5779e-05,0.19699,0.29539,1,1
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0092139,0.19696,0.30618,1,1
5,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0011418,0.19676,0.25581,1,1
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.008797,0.19669,0.23654,1,1
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0076456,0.19654,0.19519,1,1
5,GO REGULATION OF CELL MORPHOGENESIS,0.0014241,0.19651,0.26239,1,1
5,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.027226,0.1965,0.19082,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0092139,0.19649,0.2024,1,1
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0014241,0.19637,0.24956,1,1
5,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.00068502,0.19632,0.29469,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0014241,0.1963,0.23424,1,1
5,GO CHROMATIN ORGANIZATION,0.0083971,0.19629,0.22356,1,1
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00013188,0.19621,0.28075,1,1
5,GO PROGESTERONE METABOLIC PROCESS,0.02951,0.19609,0.18872,1,1
5,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.016475,0.19608,0.24,1,1
5,GO REGULATION OF KERATINOCYTE MIGRATION,0.006955,0.19582,0.31626,1,1
5,GO CARBOHYDRATE HOMEOSTASIS,0.00012367,0.19579,0.23311,1,1
5,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00019306,0.19561,0.25005,1,1
5,GO ACTIN FILAMENT BASED PROCESS,0.0016767,0.19551,0.25275,1,1
5,GO POLYSACCHARIDE METABOLIC PROCESS,0.00011593,0.1955,0.27136,1,1
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.030713,0.19543,0.19272,1,1
5,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.010101,0.19537,0.20608,1,1
5,GO RESPONSE TO LIGHT STIMULUS,0.0010798,0.19537,0.21322,1,1
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.015104,0.19524,0.26441,1,1
5,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0063209,0.19515,0.1784,1,1
5,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0010798,0.19507,0.19472,1,1
5,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.0023095,0.19506,0.22317,1,1
5,GO MYOFIBRIL ASSEMBLY,0.0018673,0.19505,0.26193,1,1
5,GO NEUTRAL AMINO ACID TRANSPORT,0.0034935,0.19504,0.23012,1,1
5,GO REGULATION OF MEIOTIC CELL CYCLE,0.0020776,0.19495,0.21731,1,1
5,GO HISTONE H2A UBIQUITINATION,0.0060238,0.19491,0.22872,1,1
5,GO POSITIVE REGULATION OF CELL GROWTH,0.00017019,0.19462,0.2798,1,1
5,GO OLIGODENDROCYTE DIFFERENTIATION,0.0010798,0.19457,0.21806,1,1
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.011574,0.19429,0.25533,1,1
5,GO CELLULAR RESPONSE TO SALT STRESS,0.014457,0.19422,0.22288,1,1
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.022172,0.19415,0.20759,1,1
5,GO REGULATION OF VASCULAR PERMEABILITY,0.0063209,0.19414,0.25311,1,1
5,GO POST EMBRYONIC DEVELOPMENT,0.0010798,0.19404,0.26437,1,1
5,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.030713,0.1939,0.18874,1,1
5,GO NEURON PROJECTION REGENERATION,0.00076864,0.19389,0.28392,1,1
5,GO DIACYLGLYCEROL METABOLIC PROCESS,0.00091199,0.19376,0.3228,1,1
5,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.0016767,0.19374,0.18803,1,1
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0036751,0.19373,0.29548,1,1
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,4.8997e-05,0.19358,0.23898,1,1
5,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0015041,0.19355,0.27442,1,1
5,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0015882,0.19341,0.27494,1,1
5,GO PROTEIN COMPLEX OLIGOMERIZATION,0.00064645,0.19335,0.23618,1,1
5,GO CELL CELL SIGNALING,0.00051151,0.19329,0.25421,1,1
5,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0092139,0.19311,0.25921,1,1
5,GO RECEPTOR CATABOLIC PROCESS,0.0014241,0.19299,0.24881,1,1
5,GO POSITIVE REGULATION OF SECRETION,0.0040644,0.19285,0.217,1,1
5,GO BIOLOGICAL ADHESION,0.015776,0.19276,0.22938,1,1
5,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0024341,0.19273,0.21954,1,1
5,GO PEPTIDYL SERINE MODIFICATION,0.00072571,0.1926,0.25055,1,1
5,GO REGULATION OF NEURON MATURATION,0.015776,0.19259,0.2466,1,1
5,GO MULTICELLULAR ORGANISM GROWTH,0.00091199,0.19247,0.2677,1,1
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.0015882,0.19245,0.22089,1,1
5,GO REGULATION OF ENDOCRINE PROCESS,0.031957,0.19225,0.17998,1,1
5,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0015041,0.19216,0.2663,1,1
5,GO ION TRANSMEMBRANE TRANSPORT,0.00015974,0.19199,0.27198,1,1
5,GO CYTOSKELETON ORGANIZATION,0.0010798,0.19193,0.24164,1,1
5,GO DEVELOPMENTAL GROWTH,0.00086166,0.19179,0.2532,1,1
5,GO CARDIAC ATRIUM MORPHOGENESIS,0.030713,0.19166,0.24119,1,1
5,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.00048214,0.19159,0.24323,1,1
5,GO REGULATION OF FERTILIZATION,0.00086166,0.19156,0.2017,1,1
5,GO STRIATUM DEVELOPMENT,0.0029965,0.19155,0.27857,1,1
5,GO VENTRICULAR SYSTEM DEVELOPMENT,0.0028457,0.19143,0.27205,1,1
5,GO REGULATION OF PHOSPHATASE ACTIVITY,0.0034935,0.19143,0.22654,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION,0.0018673,0.19142,0.21049,1,1
5,GO TOXIN TRANSPORT,0.0021907,0.19124,0.24646,1,1
5,GO ORGANELLE FUSION,0.00014062,0.19112,0.26975,1,1
5,GO SALIVARY GLAND DEVELOPMENT,0.020391,0.19102,0.25294,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.033245,0.19099,0.18473,1,1
5,GO CELL CELL JUNCTION ORGANIZATION,0.00029789,0.19097,0.27177,1,1
5,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.015776,0.19094,0.23417,1,1
5,GO PIGMENT CELL DIFFERENTIATION,0.0038653,0.19088,0.24587,1,1
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0066311,0.19082,0.31615,1,1
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0019699,0.19068,0.25214,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0054671,0.19067,0.20672,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0034935,0.19056,0.23856,1,1
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0021907,0.19051,0.25598,1,1
5,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00060992,0.19048,0.31761,1,1
5,GO ATP TRANSPORT,0.0021907,0.19032,0.20742,1,1
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.00060992,0.19029,0.27791,1,1
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.00096503,0.19028,0.24823,1,1
5,GO NOREPINEPHRINE METABOLIC PROCESS,0.045233,0.19028,0.2476,1,1
5,GO WOUND HEALING,0.054439,0.19027,0.20404,1,1
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0018673,0.19026,0.25236,1,1
5,GO REGULATION OF CILIUM MOVEMENT,0.024086,0.19022,0.20125,1,1
5,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.0054671,0.19016,0.28315,1,1
5,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.016475,0.19015,0.24232,1,1
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.017954,0.19003,0.19858,1,1
5,GO CAMERA TYPE EYE MORPHOGENESIS,0.0017696,0.18998,0.26742,1,1
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.018736,0.18998,0.22856,1,1
5,GO ENDODERM DEVELOPMENT,0.025096,0.18988,0.24331,1,1
5,GO PEPTIDYL CYSTEINE MODIFICATION,0.0012758,0.18977,0.21247,1,1
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.00068502,0.18975,0.21661,1,1
5,GO LUNG CELL DIFFERENTIATION,0.045233,0.18968,0.23893,1,1
5,GO DNA MODIFICATION,0.0021907,0.18961,0.18941,1,1
5,GO MEMBRANE FUSION,0.00014989,0.18937,0.26583,1,1
5,GO PULMONARY VALVE MORPHOGENESIS,0.052482,0.18936,0.24574,1,1
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0003797,0.18932,0.23474,1,1
5,GO VESICLE DOCKING,0.00011593,0.18909,0.33097,1,1
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0083971,0.18904,0.20597,1,1
5,GO SELECTIVE AUTOPHAGY,0.0011418,0.189,0.25317,1,1
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0024341,0.18897,0.21522,1,1
5,GO SNARE COMPLEX ASSEMBLY,0.007293,0.18896,0.30185,1,1
5,GO STRESS FIBER ASSEMBLY,0.00086166,0.18883,0.2755,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0052065,0.18878,0.25011,1,1
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0040644,0.1887,0.25188,1,1
5,GO TISSUE MIGRATION,0.037377,0.18858,0.21214,1,1
5,GO AMYLOID BETA METABOLIC PROCESS,0.0027019,0.18857,0.25581,1,1
5,GO REGULATION OF RECEPTOR INTERNALIZATION,0.0044907,0.18855,0.2193,1,1
5,GO GLUTATHIONE METABOLIC PROCESS,0.0076456,0.18841,0.17265,1,1
5,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0066311,0.18841,0.21253,1,1
5,GO PATTERN SPECIFICATION PROCESS,0.0060238,0.18837,0.20202,1,1
5,GO EMBRYO DEVELOPMENT,0.0029965,0.18833,0.2115,1,1
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00042807,0.18817,0.25739,1,1
5,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0044907,0.18806,0.23075,1,1
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0049572,0.18799,0.23397,1,1
5,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0092139,0.18791,0.23521,1,1
5,GO CELL MATRIX ADHESION,0.020391,0.1879,0.2586,1,1
5,GO CARDIAC VENTRICLE MORPHOGENESIS,0.0010209,0.18788,0.25345,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.027226,0.18785,0.2192,1,1
5,GO GLIAL CELL DEVELOPMENT,0.013834,0.18773,0.19173,1,1
5,GO MANNOSYLATION,0.0044907,0.18772,0.18813,1,1
5,GO HISTONE H2A MONOUBIQUITINATION,0.0049572,0.18765,0.27075,1,1
5,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0172,0.18763,0.23065,1,1
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00017019,0.18756,0.25145,1,1
5,GO RESPONSE TO STEROL DEPLETION,0.0013481,0.18745,0.26234,1,1
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0040644,0.18732,0.27869,1,1
5,GO REGULATION OF PROTEIN BINDING,0.0023095,0.18723,0.21779,1,1
5,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0020776,0.1871,0.27999,1,1
5,GO NADH METABOLIC PROCESS,0.0057394,0.1871,0.20676,1,1
5,GO SKELETAL MUSCLE CONTRACTION,0.0019699,0.187,0.31093,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0015041,0.18697,0.25171,1,1
5,GO GLUCOSE METABOLIC PROCESS,0.00051151,0.18688,0.21631,1,1
5,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0012758,0.18633,0.26947,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.014457,0.18632,0.26599,1,1
5,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0015041,0.18629,0.21958,1,1
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00045436,0.18624,0.28013,1,1
5,GO DETECTION OF ABIOTIC STIMULUS,8.3641e-05,0.18621,0.23923,1,1
5,GO JNK CASCADE,0.0083971,0.18618,0.22844,1,1
5,GO POSITIVE REGULATION OF MYELINATION,0.040368,0.18617,0.2395,1,1
5,GO KERATINOCYTE MIGRATION,0.013235,0.18612,0.24439,1,1
5,GO RESPONSE TO AXON INJURY,0.00051151,0.18608,0.25083,1,1
5,GO ERBB SIGNALING PATHWAY,0.0057394,0.18602,0.22605,1,1
5,GO TOOTH MINERALIZATION,0.0027019,0.18595,0.35839,1,1
5,GO SENSORY ORGAN DEVELOPMENT,0.0047188,0.18585,0.21327,1,1
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.010101,0.18585,0.21754,1,1
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.020391,0.18582,0.21399,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0029965,0.18575,0.27691,1,1
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.013235,0.18574,0.22913,1,1
5,GO REGULATION OF DNA REPAIR,0.0096484,0.18572,0.19909,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0010798,0.18567,0.23382,1,1
5,GO PEPTIDE SECRETION,0.0066311,0.18567,0.21327,1,1
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0015882,0.18566,0.23137,1,1
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.0003797,0.18561,0.27599,1,1
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00024771,0.18556,0.29624,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0052065,0.18551,0.22907,1,1
5,GO MULTI ORGANISM PROCESS,0.0025648,0.18546,0.19002,1,1
5,GO APICAL JUNCTION ASSEMBLY,0.0017696,0.18533,0.23628,1,1
5,GO VESICLE BUDDING FROM MEMBRANE,0.00015974,0.18517,0.24015,1,1
5,GO DEPHOSPHORYLATION,0.00064645,0.18514,0.2411,1,1
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0015041,0.18506,0.28149,1,1
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0020776,0.18489,0.33192,1,1
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0066311,0.18488,0.23882,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0012758,0.18487,0.25634,1,1
5,GO GOLGI ORGANIZATION,0.0012071,0.18483,0.273,1,1
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0042727,0.18482,0.30292,1,1
5,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.033245,0.18475,0.26484,1,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.019548,0.18474,0.21398,1,1
5,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.006955,0.18455,0.19512,1,1
5,GO POSITIVE REGULATION OF DNA REPAIR,0.0063209,0.1845,0.22719,1,1
5,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00332,0.18448,0.17492,1,1
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0014241,0.18428,0.28254,1,1
5,GO EYE MORPHOGENESIS,0.0015041,0.18426,0.2697,1,1
5,GO CERAMIDE METABOLIC PROCESS,0.00015974,0.18404,0.25194,1,1
5,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.031957,0.18385,0.23929,1,1
5,GO SPHINGOLIPID METABOLIC PROCESS,0.00010181,0.1836,0.24725,1,1
5,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0015041,0.18355,0.24606,1,1
5,GO RESPONSE TO LEPTIN,0.00072571,0.18345,0.29761,1,1
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0049572,0.18335,0.23565,1,1
5,GO HISTONE UBIQUITINATION,0.0080134,0.1833,0.21908,1,1
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.014457,0.18321,0.30591,1,1
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00033648,0.18316,0.25829,1,1
5,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.012106,0.18314,0.2277,1,1
5,GO ACTIVATION OF MAPKK ACTIVITY,0.0092139,0.18312,0.27954,1,1
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.015104,0.18309,0.19549,1,1
5,GO RESPONSE TO MISFOLDED PROTEIN,0.00051151,0.18301,0.27449,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0023095,0.18298,0.23928,1,1
5,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.00024771,0.18297,0.22311,1,1
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.006955,0.18297,0.20961,1,1
5,GO HISTONE MONOUBIQUITINATION,0.0092139,0.18288,0.22556,1,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.00086166,0.18274,0.32002,1,1
5,GO RESPONSE TO WOUNDING,0.043559,0.18271,0.20131,1,1
5,GO TRANSMEMBRANE TRANSPORT,0.00019306,0.18254,0.24189,1,1
5,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.010101,0.1825,0.19174,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.010101,0.18248,0.25533,1,1
5,GO RESPONSE TO GONADOTROPIN,0.010101,0.18246,0.19811,1,1
5,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.01266,0.18233,0.22273,1,1
5,GO RESPONSE TO UV,0.017954,0.1823,0.16449,1,1
5,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0021907,0.18225,0.25191,1,1
5,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.00029789,0.18223,0.27957,1,1
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00010181,0.18196,0.22508,1,1
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.025096,0.1819,0.20733,1,1
5,GO ERYTHROCYTE DEVELOPMENT,0.021265,0.18185,0.20992,1,1
5,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.027226,0.18182,0.18939,1,1
5,GO PROTEIN DEPHOSPHORYLATION,0.00076864,0.1817,0.22545,1,1
5,GO PEPTIDYL ARGININE MODIFICATION,0.0076456,0.18167,0.14651,1,1
5,GO REGULATION OF ORGANELLE ORGANIZATION,0.00091199,0.1816,0.21374,1,1
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.017954,0.18158,0.20476,1,1
5,GO VESICLE TARGETING,0.00014989,0.1815,0.24979,1,1
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,7.3279e-05,0.18148,0.24099,1,1
5,GO POSITIVE REGULATION OF GROWTH,0.00060992,0.1814,0.26289,1,1
5,GO REGULATION OF CELLULAR LOCALIZATION,0.00064645,0.18139,0.23577,1,1
5,GO GONADOTROPIN SECRETION,0.0029965,0.18136,0.23655,1,1
5,GO ACTIN FILAMENT BASED MOVEMENT,0.0015041,0.18133,0.27429,1,1
5,GO CATION TRANSPORT,0.00026348,0.18132,0.25462,1,1
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.030713,0.1813,0.19239,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0172,0.18128,0.17372,1,1
5,GO CEREBELLAR CORTEX DEVELOPMENT,0.008797,0.18127,0.22938,1,1
5,GO REGULATION OF ENDOCYTOSIS,0.0040644,0.1812,0.24341,1,1
5,GO LIPID DROPLET ORGANIZATION,0.00042807,0.18102,0.22445,1,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0021907,0.18092,0.26973,1,1
5,GO TOR SIGNALING,0.00064645,0.18083,0.22791,1,1
5,GO RESPONSE TO MONOSACCHARIDE,0.00018128,0.18074,0.24487,1,1
5,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0013481,0.18074,0.23082,1,1
5,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.021265,0.18072,0.23049,1,1
5,GO RHYTHMIC PROCESS,0.0021907,0.18069,0.21396,1,1
5,GO ACID SECRETION,0.00040321,0.18046,0.24178,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0096484,0.18028,0.23269,1,1
5,GO MEMBRANE FISSION,0.0029965,0.1802,0.2956,1,1
5,GO ORGANIC ACID TRANSPORT,0.00051151,0.18,0.22531,1,1
5,GO DIGESTION,0.0076456,0.17994,0.1854,1,1
5,GO NEPHRON DEVELOPMENT,0.017954,0.17993,0.23099,1,1
5,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0012758,0.17991,0.22476,1,1
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0044907,0.17985,0.20997,1,1
5,GO NEURAL TUBE FORMATION,0.0076456,0.1798,0.22318,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0015882,0.1796,0.27267,1,1
5,GO AORTA MORPHOGENESIS,0.012106,0.17929,0.30789,1,1
5,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.00060992,0.17913,0.2813,1,1
5,GO COCHLEA DEVELOPMENT,0.010572,0.179,0.20175,1,1
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00054254,0.17886,0.24407,1,1
5,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0010209,0.17879,0.25111,1,1
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0172,0.17857,0.18913,1,1
5,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.019548,0.17855,0.15676,1,1
5,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.019548,0.17844,0.16248,1,1
5,GO REGULATION OF CELLULAR PH,0.0020776,0.17841,0.20714,1,1
5,GO ION HOMEOSTASIS,0.0172,0.17834,0.18571,1,1
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.045233,0.17828,0.21706,1,1
5,GO CELLULAR RESPONSE TO NUTRIENT,0.034576,0.17811,0.22825,1,1
5,GO HEART FORMATION,0.008797,0.17811,0.22674,1,1
5,GO CELL CELL JUNCTION ASSEMBLY,0.00024771,0.17803,0.2683,1,1
5,GO MUSCLE CONTRACTION,0.0027019,0.17791,0.23795,1,1
5,GO OUTFLOW TRACT MORPHOGENESIS,0.037377,0.17783,0.19462,1,1
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.033245,0.17774,0.17064,1,1
5,GO POLYOL METABOLIC PROCESS,0.00010866,0.17772,0.24826,1,1
5,GO CELLULAR RESPONSE TO CALCIUM ION,0.00014989,0.17768,0.29912,1,1
5,GO ENDOCYTOSIS,0.0060238,0.17766,0.23186,1,1
5,GO REGULATION OF HAIR CYCLE,0.011574,0.17762,0.22342,1,1
5,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.020391,0.17759,0.185,1,1
5,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0020776,0.17746,0.33551,1,1
5,GO GLIAL CELL DIFFERENTIATION,0.0076456,0.1772,0.19288,1,1
5,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0049572,0.17713,0.28021,1,1
5,GO SODIUM ION HOMEOSTASIS,0.015104,0.17703,0.23181,1,1
5,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0092139,0.1769,0.20805,1,1
5,GO PROTEIN POLYMERIZATION,0.00035748,0.17679,0.24445,1,1
5,GO PROTEIN AUTOPHOSPHORYLATION,0.01266,0.17676,0.23493,1,1
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0066311,0.1767,0.19743,1,1
5,GO RESPONSE TO AMYLOID BETA,0.050584,0.17667,0.23413,1,1
5,GO TRNA WOBBLE BASE MODIFICATION,0.013834,0.17662,0.16028,1,1
5,GO LIPID MODIFICATION,0.0015041,0.17659,0.2368,1,1
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.008797,0.17655,0.19185,1,1
5,GO REGULATION OF PROTEIN ACETYLATION,0.0047188,0.17651,0.19608,1,1
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00015974,0.17641,0.25392,1,1
5,GO LYSOSOMAL TRANSPORT,0.00031664,0.17625,0.30288,1,1
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0016767,0.17615,0.20706,1,1
5,GO ACTIN FILAMENT ORGANIZATION,0.0020776,0.17605,0.23762,1,1
5,GO CIRCADIAN RHYTHM,0.00096503,0.17574,0.21886,1,1
5,GO METAL ION TRANSPORT,0.00042807,0.17573,0.25963,1,1
5,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.016475,0.17572,0.22499,1,1
5,GO REGULATION OF PEPTIDE SECRETION,0.008797,0.1757,0.20196,1,1
5,GO INORGANIC ANION TRANSPORT,0.00040321,0.17568,0.26528,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0038653,0.17556,0.21198,1,1
5,GO NEUTRAL LIPID METABOLIC PROCESS,0.0052065,0.17535,0.20983,1,1
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00064645,0.17532,0.27315,1,1
5,GO FACE DEVELOPMENT,0.011063,0.1751,0.27063,1,1
5,GO POSITIVE REGULATION OF ION TRANSPORT,0.0040644,0.17504,0.21271,1,1
5,GO TRIGLYCERIDE CATABOLIC PROCESS,0.030713,0.17485,0.18677,1,1
5,GO REGULATION OF TELOMERE MAINTENANCE,0.016475,0.17479,0.18927,1,1
5,GO EXCRETION,0.0066311,0.17467,0.23868,1,1
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0003797,0.17464,0.23189,1,1
5,GO SUBSTANTIA NIGRA DEVELOPMENT,0.0052065,0.17454,0.18036,1,1
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00033648,0.17452,0.26656,1,1
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.008797,0.17446,0.2281,1,1
5,GO RENAL SYSTEM PROCESS,0.0092139,0.17445,0.23013,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.018736,0.17445,0.18614,1,1
5,GO CERAMIDE TRANSPORT,0.019548,0.17443,0.284,1,1
5,GO HIPPOCAMPUS DEVELOPMENT,0.0172,0.17431,0.18002,1,1
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0021907,0.17415,0.19246,1,1
5,GO GLYCOSYLATION,0.00015974,0.17415,0.24868,1,1
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0044907,0.17406,0.21993,1,1
5,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0028457,0.17405,0.18691,1,1
5,GO LIPID OXIDATION,0.0028457,0.17375,0.21114,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00064645,0.1737,0.27574,1,1
5,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0092139,0.17352,0.26927,1,1
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.023112,0.1735,0.17802,1,1
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.021265,0.1734,0.22902,1,1
5,GO SENSORY ORGAN MORPHOGENESIS,0.0038653,0.17326,0.21768,1,1
5,GO BARBED END ACTIN FILAMENT CAPPING,0.023112,0.17302,0.22072,1,1
5,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0023095,0.17293,0.19572,1,1
5,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.0066311,0.17289,0.19508,1,1
5,GO CELLULAR ION HOMEOSTASIS,0.024086,0.17276,0.17435,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0017696,0.17266,0.25478,1,1
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.00040321,0.17264,0.23743,1,1
5,GO CIRCULATORY SYSTEM PROCESS,0.0017696,0.17262,0.24705,1,1
5,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0036751,0.17261,0.18875,1,1
5,GO REGULATION OF SODIUM ION TRANSPORT,0.00019306,0.17253,0.30741,1,1
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0020776,0.17246,0.22168,1,1
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.013834,0.17243,0.18756,1,1
5,GO RESPONSE TO CARBOHYDRATE,0.00035748,0.17242,0.224,1,1
5,GO METAL ION HOMEOSTASIS,0.026142,0.17236,0.17706,1,1
5,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.027226,0.17232,0.18645,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00017019,0.17231,0.23933,1,1
5,GO REGULATION OF ERBB SIGNALING PATHWAY,0.014457,0.1723,0.20465,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.046961,0.1722,0.18002,1,1
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.00076864,0.17215,0.27913,1,1
5,GO HEART MORPHOGENESIS,0.0092139,0.17212,0.21926,1,1
5,GO REGULATION OF SECRETION,0.0024341,0.17212,0.22554,1,1
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00091199,0.17205,0.22139,1,1
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.024086,0.17204,0.15422,1,1
5,GO CELL GROWTH,0.00026348,0.172,0.25362,1,1
5,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0080134,0.17195,0.21072,1,1
5,GO REGULATION OF HORMONE METABOLIC PROCESS,0.045233,0.17192,0.18891,1,1
5,GO RESPONSE TO PH,0.0042727,0.17189,0.2597,1,1
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.041938,0.17189,0.23564,1,1
5,GO AMEBOIDAL TYPE CELL MIGRATION,0.019548,0.17176,0.21567,1,1
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.01266,0.17174,0.18806,1,1
5,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.011063,0.17172,0.25267,1,1
5,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0027019,0.17167,0.25015,1,1
5,GO INACTIVATION OF MAPK ACTIVITY,0.010572,0.17165,0.23526,1,1
5,GO REGULATION OF LIPID STORAGE,0.026142,0.17162,0.21372,1,1
5,GO CARBOHYDRATE PHOSPHORYLATION,0.0066311,0.17156,0.21241,1,1
5,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.016475,0.17148,0.23324,1,1
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0083971,0.17143,0.21852,1,1
5,GO PROTEIN TARGETING TO VACUOLE,0.0010209,0.1714,0.25146,1,1
5,GO MIDBRAIN DEVELOPMENT,0.00057531,0.17138,0.19222,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00096503,0.1712,0.27201,1,1
5,GO VASODILATION,0.018736,0.1711,0.20278,1,1
5,GO REGULATION OF BLOOD PRESSURE,0.00332,0.17096,0.22651,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.021265,0.17094,0.18752,1,1
5,GO REGULATION OF RUFFLE ASSEMBLY,0.006955,0.17091,0.22803,1,1
5,GO CHEMICAL HOMEOSTASIS,0.0038653,0.17089,0.20231,1,1
5,GO NEGATIVE REGULATION OF MAPK CASCADE,0.010572,0.17067,0.21983,1,1
5,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0010209,0.17061,0.17253,1,1
5,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.030713,0.17045,0.25295,1,1
5,GO RESPONSE TO INORGANIC SUBSTANCE,0.0015041,0.17013,0.19979,1,1
5,GO UV PROTECTION,0.010101,0.17012,0.23276,1,1
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.02951,0.17006,0.18677,1,1
5,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.010572,0.17004,0.2256,1,1
5,GO REPRODUCTION,0.0020776,0.17002,0.19357,1,1
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.00057531,0.16976,0.24488,1,1
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.048745,0.16972,0.22261,1,1
5,GO CELL DIFFERENTIATION IN HINDBRAIN,0.026142,0.16971,0.20909,1,1
5,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0027019,0.16962,0.21731,1,1
5,GO INNER EAR MORPHOGENESIS,0.013834,0.1696,0.18898,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.010101,0.16958,0.25214,1,1
5,GO REGULATION OF CIRCADIAN RHYTHM,0.0031545,0.16943,0.21915,1,1
5,GO VACUOLAR TRANSPORT,0.00018128,0.16941,0.27823,1,1
5,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00086166,0.16937,0.36087,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00096503,0.16936,0.26497,1,1
5,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.011574,0.16933,0.20087,1,1
5,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.006955,0.16931,0.26063,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0012758,0.16929,0.33663,1,1
5,GO REGULATION OF TRANSPORT,0.0015041,0.16919,0.2281,1,1
5,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.007293,0.16917,0.17342,1,1
5,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.008797,0.16899,0.19631,1,1
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0047188,0.16899,0.1879,1,1
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00021879,0.16886,0.24857,1,1
5,GO CEREBELLAR CORTEX FORMATION,0.0052065,0.16885,0.27605,1,1
5,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.006955,0.16876,0.18316,1,1
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0049572,0.16849,0.2276,1,1
5,GO MUSCLE ORGAN DEVELOPMENT,0.007293,0.16848,0.20359,1,1
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.043559,0.16833,0.21257,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.025096,0.16824,0.15836,1,1
5,GO EPITHELIAL TUBE FORMATION,0.0096484,0.16823,0.20557,1,1
5,GO RESPONSE TO WATER,0.0036751,0.16816,0.23251,1,1
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0092139,0.16809,0.19898,1,1
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0015882,0.16806,0.19087,1,1
5,GO REGULATION OF PH,0.0029965,0.16797,0.19779,1,1
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.0036751,0.16795,0.23646,1,1
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0038653,0.16792,0.27658,1,1
5,GO HEMOGLOBIN METABOLIC PROCESS,0.0018673,0.16789,0.22407,1,1
5,GO REGULATION OF TRANSPORTER ACTIVITY,0.0010209,0.16774,0.2871,1,1
5,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00026348,0.16772,0.23412,1,1
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.0076456,0.16766,0.28057,1,1
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.0025648,0.16764,0.31153,1,1
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0028457,0.16735,0.27123,1,1
5,GO CELL CELL ADHESION,0.046961,0.16728,0.19593,1,1
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.00014062,0.16725,0.21721,1,1
5,GO NEPHRON EPITHELIUM DEVELOPMENT,0.010101,0.16719,0.21796,1,1
5,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.01266,0.16704,0.1905,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0034935,0.16694,0.24944,1,1
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.022172,0.16676,0.13956,1,1
5,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0031545,0.16662,0.18587,1,1
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.00091199,0.16658,0.19048,1,1
5,GO MUSCLE SYSTEM PROCESS,0.0042727,0.16658,0.22232,1,1
5,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.0012071,0.16647,0.21823,1,1
5,GO REGULATION OF MUSCLE CONTRACTION,0.0023095,0.16638,0.22027,1,1
5,GO EMBRYONIC PATTERN SPECIFICATION,0.0063209,0.16637,0.2213,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0040644,0.16637,0.25412,1,1
5,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.030713,0.16634,0.18932,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00096503,0.16629,0.18997,1,1
5,GO L AMINO ACID TRANSPORT,0.02951,0.16615,0.16964,1,1
5,GO DETECTION OF STIMULUS,0.00020554,0.1661,0.19605,1,1
5,GO ACTIN NUCLEATION,0.00057531,0.16598,0.22945,1,1
5,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0015041,0.16588,0.23377,1,1
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.024086,0.16579,0.24033,1,1
5,GO ION TRANSPORT,0.00026348,0.16561,0.24888,1,1
5,GO GLYCOPROTEIN METABOLIC PROCESS,0.0011418,0.1656,0.22826,1,1
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0024341,0.16549,0.20792,1,1
5,GO CIRCULATORY SYSTEM DEVELOPMENT,0.024086,0.16547,0.20196,1,1
5,GO ANION TRANSMEMBRANE TRANSPORT,0.00023283,0.16542,0.24979,1,1
5,GO TRANSCRIPTION BY RNA POLYMERASE I,0.013834,0.16541,0.18114,1,1
5,GO IRON ION TRANSPORT,0.0017696,0.16538,0.20798,1,1
5,GO PROTEIN K63 LINKED UBIQUITINATION,0.0047188,0.16534,0.18916,1,1
5,GO LIPID HOMEOSTASIS,0.022172,0.16521,0.17461,1,1
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0172,0.1651,0.1731,1,1
5,GO CELLULAR LIPID CATABOLIC PROCESS,0.0012071,0.16497,0.21008,1,1
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.016475,0.16469,0.2009,1,1
5,GO PROTON TRANSMEMBRANE TRANSPORT,0.00023283,0.16468,0.20953,1,1
5,GO LACTATION,0.013235,0.16465,0.22612,1,1
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00048214,0.16464,0.19051,1,1
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.012106,0.16447,0.20193,1,1
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.00045436,0.16447,0.2236,1,1
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0047188,0.16436,0.22924,1,1
5,GO REGULATION OF CATABOLIC PROCESS,0.0016767,0.16427,0.19204,1,1
5,GO FATTY ACID CATABOLIC PROCESS,0.00076864,0.16414,0.22693,1,1
5,GO MUSCLE HYPERTROPHY,0.0047188,0.16413,0.23237,1,1
5,GO GROWTH,0.00076864,0.16402,0.22115,1,1
5,GO ANION TRANSPORT,0.00020554,0.16397,0.23876,1,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.025096,0.16387,0.27444,1,1
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0054671,0.16386,0.32272,1,1
5,GO LIPOPROTEIN METABOLIC PROCESS,0.00072571,0.16362,0.19594,1,1
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0014241,0.16343,0.20097,1,1
5,GO NON RECOMBINATIONAL REPAIR,0.017954,0.16331,0.17185,1,1
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.014457,0.1633,0.19135,1,1
5,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.00023283,0.16326,0.21521,1,1
5,GO NUCLEAR ENVELOPE ORGANIZATION,0.0044907,0.163,0.19667,1,1
5,GO PHOSPHOLIPID METABOLIC PROCESS,0.0027019,0.163,0.21978,1,1
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0066311,0.16277,0.16199,1,1
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.017954,0.16266,0.2128,1,1
5,GO DEVELOPMENTAL INDUCTION,0.016475,0.16234,0.19828,1,1
5,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0011418,0.16233,0.2092,1,1
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0063209,0.16226,0.24028,1,1
5,GO RESPONSE TO BMP,0.014457,0.16196,0.23109,1,1
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.00024771,0.16187,0.21656,1,1
5,GO ORGANIC ANION TRANSPORT,0.00040321,0.16185,0.22113,1,1
5,GO NUCLEUS ORGANIZATION,0.0027019,0.16182,0.19828,1,1
5,GO CARBOHYDRATE TRANSPORT,0.0013481,0.16174,0.23135,1,1
5,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.00042807,0.16172,0.21604,1,1
5,GO OVULATION CYCLE,0.041938,0.16169,0.22219,1,1
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.033245,0.16159,0.22239,1,1
5,GO KIDNEY EPITHELIUM DEVELOPMENT,0.019548,0.16155,0.19766,1,1
5,GO SARCOMERE ORGANIZATION,0.0029965,0.16144,0.20559,1,1
5,GO REGULATION OF CELLULAR COMPONENT SIZE,0.00045436,0.16136,0.25899,1,1
5,GO STEROL METABOLIC PROCESS,0.00332,0.16136,0.19514,1,1
5,GO REGULATION OF MAP KINASE ACTIVITY,0.014457,0.16122,0.20815,1,1
5,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00040321,0.16115,0.19761,1,1
5,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0015882,0.1611,0.20867,1,1
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.0023095,0.16093,0.22281,1,1
5,GO REGULATION OF METAL ION TRANSPORT,0.0063209,0.16092,0.23083,1,1
5,GO RECEPTOR INTERNALIZATION,0.017954,0.1609,0.20446,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0076456,0.16078,0.234,1,1
5,GO MOLTING CYCLE,0.010101,0.16074,0.2098,1,1
5,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.013834,0.16072,0.2682,1,1
5,GO TELENCEPHALON DEVELOPMENT,0.0092139,0.16063,0.20837,1,1
5,GO FERTILIZATION,0.00057531,0.16059,0.18769,1,1
5,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0019699,0.16055,0.18436,1,1
5,GO KETONE BODY METABOLIC PROCESS,0.0052065,0.16052,0.225,1,1
5,GO AUTOPHAGOSOME MATURATION,0.0025648,0.16052,0.25843,1,1
5,GO HORMONE METABOLIC PROCESS,0.0034935,0.16034,0.18488,1,1
5,GO MAGNESIUM ION TRANSPORT,0.0076456,0.16033,0.27935,1,1
5,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.0029965,0.16007,0.2683,1,1
5,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0023095,0.15979,0.2082,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.006955,0.15974,0.19145,1,1
5,GO DIGESTIVE SYSTEM PROCESS,0.025096,0.15963,0.16672,1,1
5,GO PROTEIN CATABOLIC PROCESS,0.00081392,0.15954,0.19298,1,1
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0010798,0.15952,0.22573,1,1
5,GO LIPID CATABOLIC PROCESS,0.0020776,0.15934,0.19183,1,1
5,GO C21 STEROID HORMONE METABOLIC PROCESS,0.014457,0.15933,0.17699,1,1
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0023095,0.15932,0.22957,1,1
5,GO LIPID LOCALIZATION,0.0038653,0.15931,0.21231,1,1
5,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0028457,0.15925,0.21856,1,1
5,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0172,0.15908,0.22458,1,1
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.034576,0.15904,0.17684,1,1
5,GO ANIMAL ORGAN MATURATION,0.041938,0.15902,0.21181,1,1
5,GO TUBE FORMATION,0.013834,0.15883,0.19857,1,1
5,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.00057531,0.15876,0.19905,1,1
5,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0038653,0.15875,0.22273,1,1
5,GO EXOCRINE SYSTEM DEVELOPMENT,0.018736,0.15873,0.25702,1,1
5,GO RESPONSE TO EPINEPHRINE,0.045233,0.15865,0.27159,1,1
5,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0060238,0.15859,0.18451,1,1
5,GO CYTOKINESIS,0.0038653,0.15841,0.20466,1,1
5,GO SECRETION,0.016475,0.15824,0.17954,1,1
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0040644,0.15822,0.23891,1,1
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.006955,0.15817,0.18241,1,1
5,GO GLYCEROLIPID METABOLIC PROCESS,0.0028457,0.15817,0.22383,1,1
5,GO RESPONSE TO CAMP,0.020391,0.15813,0.17698,1,1
5,GO ERAD PATHWAY,0.0024341,0.15795,0.21694,1,1
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0042727,0.15794,0.25116,1,1
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0013481,0.15791,0.2627,1,1
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.01266,0.15789,0.20135,1,1
5,GO POSITIVE REGULATION OF TRANSPORT,0.0076456,0.15769,0.19711,1,1
5,GO VESICLE ORGANIZATION,0.00021879,0.15763,0.24912,1,1
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.023112,0.15753,0.17639,1,1
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.020391,0.15747,0.21613,1,1
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.0040644,0.15739,0.18696,1,1
5,GO MESENCHYME DEVELOPMENT,0.0076456,0.15636,0.21636,1,1
5,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0031545,0.15634,0.25852,1,1
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.0010209,0.15631,0.2141,1,1
5,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00086166,0.1562,0.23222,1,1
5,GO RESPONSE TO MECHANICAL STIMULUS,0.019548,0.15618,0.20334,1,1
5,GO ESTABLISHMENT OF CELL POLARITY,0.0020776,0.15617,0.24624,1,1
5,GO RESPONSE TO METAL ION,0.00060992,0.15609,0.20981,1,1
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.026142,0.15608,0.15703,1,1
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.022172,0.15606,0.20852,1,1
5,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00096503,0.15598,0.18722,1,1
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0096484,0.15585,0.2219,1,1
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.037377,0.15584,0.14547,1,1
5,GO MESENCHYMAL CELL DIFFERENTIATION,0.015776,0.15572,0.21531,1,1
5,GO MEMBRANE LIPID METABOLIC PROCESS,0.00012367,0.15563,0.23208,1,1
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.017954,0.15559,0.19673,1,1
5,GO HAIR FOLLICLE MATURATION,0.025096,0.15558,0.23353,1,1
5,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.023112,0.15554,0.27058,1,1
5,GO GOLGI VESICLE TRANSPORT,0.00024771,0.15542,0.24536,1,1
5,GO RESPONSE TO RADIATION,0.0029965,0.15537,0.17808,1,1
5,GO ESCRT COMPLEX DISASSEMBLY,0.011574,0.1553,0.17631,1,1
5,GO SPERM EGG RECOGNITION,0.00051151,0.15526,0.16047,1,1
5,GO MUSCLE CELL DIFFERENTIATION,0.0034935,0.15518,0.2286,1,1
5,GO REGULATION OF GTPASE ACTIVITY,0.007293,0.15516,0.24526,1,1
5,GO HORMONE BIOSYNTHETIC PROCESS,0.0019699,0.15515,0.18819,1,1
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0047188,0.15508,0.21959,1,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0011418,0.15473,0.20491,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.015776,0.15466,0.22604,1,1
5,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0054671,0.15464,0.21102,1,1
5,GO EMBRYONIC MORPHOGENESIS,0.014457,0.15463,0.20197,1,1
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00096503,0.15463,0.20177,1,1
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0096484,0.15459,0.24173,1,1
5,GO AUTOPHAGY OF MITOCHONDRION,0.00051151,0.15446,0.23754,1,1
5,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0044907,0.15446,0.18003,1,1
5,GO ENDOSOMAL TRANSPORT,0.00033648,0.1544,0.24692,1,1
5,GO REGULATION OF GROWTH,0.00051151,0.15413,0.21972,1,1
5,GO EPITHELIUM DEVELOPMENT,0.0020776,0.15409,0.20946,1,1
5,GO RESPONSE TO STEROID HORMONE,0.019548,0.15402,0.18186,1,1
5,GO LIMBIC SYSTEM DEVELOPMENT,0.010572,0.15394,0.18897,1,1
5,GO CARDIOLIPIN METABOLIC PROCESS,0.054439,0.15386,0.12453,1,1
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.025096,0.15383,0.20371,1,1
5,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0044907,0.15383,0.23076,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0017696,0.15381,0.22858,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0012071,0.1536,0.19888,1,1
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00045436,0.15351,0.23359,1,1
5,GO PEPTIDYL AMINO ACID MODIFICATION,0.0036751,0.15335,0.20546,1,1
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0036751,0.15335,0.22917,1,1
5,GO HEART DEVELOPMENT,0.0034935,0.15325,0.22595,1,1
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0042727,0.15318,0.2318,1,1
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0049572,0.15299,0.24461,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0057394,0.1529,0.24042,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.013235,0.15289,0.192,1,1
5,GO RESPONSE TO HORMONE,0.0092139,0.15285,0.18766,1,1
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.016475,0.15271,0.20873,1,1
5,GO STEROL TRANSPORT,0.008797,0.15262,0.22713,1,1
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.019548,0.15247,0.21437,1,1
5,GO NEGATIVE REGULATION OF GROWTH,0.0031545,0.15241,0.1997,1,1
5,GO MUSCLE STRUCTURE DEVELOPMENT,0.0052065,0.15214,0.21543,1,1
5,GO DIVALENT INORGANIC CATION TRANSPORT,0.0092139,0.15212,0.21293,1,1
5,GO LYTIC VACUOLE ORGANIZATION,0.0021907,0.15205,0.23394,1,1
5,GO FAT CELL DIFFERENTIATION,0.017954,0.15203,0.18942,1,1
5,GO REGULATION OF ANION TRANSPORT,0.015104,0.15197,0.18514,1,1
5,GO REGULATION OF MESODERM DEVELOPMENT,0.013834,0.15194,0.20061,1,1
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.0083971,0.15192,0.19406,1,1
5,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0063209,0.15164,0.17884,1,1
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.00096503,0.15163,0.23064,1,1
5,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.00081392,0.15162,0.21789,1,1
5,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.028348,0.15159,0.24276,1,1
5,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0018673,0.15157,0.1977,1,1
5,GO REGULATION OF MACROAUTOPHAGY,0.00068502,0.15157,0.22876,1,1
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0017696,0.15155,0.22345,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0052065,0.15149,0.1847,1,1
5,GO STRESS GRANULE ASSEMBLY,0.014457,0.15148,0.21111,1,1
5,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.00019306,0.15135,0.20723,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0027019,0.15124,0.21122,1,1
5,GO STEROL BIOSYNTHETIC PROCESS,0.0042727,0.15109,0.17064,1,1
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.050584,0.15104,0.19452,1,1
5,GO MACROMOLECULE DEPALMITOYLATION,0.0042727,0.15095,0.16818,1,1
5,GO PHAGOSOME ACIDIFICATION,0.0019699,0.15094,0.2066,1,1
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0036751,0.15083,0.20868,1,1
5,GO NEGATIVE REGULATION OF NEURON DEATH,0.0063209,0.15072,0.20145,1,1
5,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.00086166,0.15059,0.21132,1,1
5,GO PLASMA MEMBRANE FUSION,0.035953,0.15054,0.21852,1,1
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.019548,0.15049,0.23804,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.017954,0.15046,0.19565,1,1
5,GO RESPONSE TO ORGANOPHOSPHORUS,0.031957,0.15046,0.1625,1,1
5,GO CELLULAR RESPONSE TO KETONE,0.018736,0.15031,0.1653,1,1
5,GO AUTOPHAGOSOME ORGANIZATION,0.00081392,0.15013,0.24443,1,1
5,GO ORGANELLE DISASSEMBLY,0.00076864,0.15009,0.21811,1,1
5,GO TOXIN METABOLIC PROCESS,0.038848,0.15007,0.19037,1,1
5,GO RESPONSE TO PEPTIDE HORMONE,0.0049572,0.15005,0.19433,1,1
5,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0076456,0.15,0.18399,1,1
5,GO RESPONSE TO ESTRADIOL,0.026142,0.15,0.16584,1,1
5,GO MEMBRANE ORGANIZATION,0.0010798,0.14969,0.21649,1,1
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.028348,0.14965,0.20424,1,1
5,GO BODY FLUID SECRETION,0.0063209,0.14956,0.19414,1,1
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0080134,0.14954,0.21725,1,1
5,GO PHAGOSOME MATURATION,0.0029965,0.1494,0.23604,1,1
5,GO RETINA HOMEOSTASIS,0.00068502,0.14931,0.2318,1,1
5,GO MACROAUTOPHAGY,0.0010798,0.14929,0.21218,1,1
5,GO CELLULAR MACROMOLECULE LOCALIZATION,0.00064645,0.14924,0.19323,1,1
5,GO RESPONSE TO AMINO ACID STARVATION,0.0021907,0.1492,0.20177,1,1
5,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.007293,0.14912,0.15251,1,1
5,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0172,0.14911,0.24622,1,1
5,GO RESPONSE TO GROWTH FACTOR,0.0023095,0.14905,0.23101,1,1
5,GO CELLULAR COMPONENT DISASSEMBLY,0.00057531,0.14891,0.1821,1,1
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.027226,0.14869,0.20366,1,1
5,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0028457,0.14861,0.18629,1,1
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0092139,0.14858,0.24204,1,1
5,GO EPOXYGENASE P450 PATHWAY,0.050584,0.14851,0.20684,1,1
5,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.052482,0.14848,0.21404,1,1
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.006955,0.14836,0.19058,1,1
5,GO REGULATION OF CELL MATURATION,0.01266,0.14835,0.17247,1,1
5,GO CELL MOTILITY,0.027226,0.14833,0.19614,1,1
5,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0080134,0.14824,0.18018,1,1
5,GO HISTONE H2A ACETYLATION,0.0096484,0.14809,0.22421,1,1
5,GO GPI ANCHOR METABOLIC PROCESS,0.0038653,0.1478,0.18157,1,1
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0020776,0.14759,0.2321,1,1
5,GO TUBE DEVELOPMENT,0.026142,0.14757,0.20065,1,1
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0040644,0.14757,0.23874,1,1
5,GO ORGANELLE INHERITANCE,0.0042727,0.14728,0.17531,1,1
5,GO MUSCLE ADAPTATION,0.011574,0.14719,0.2039,1,1
5,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.0066311,0.14719,0.16639,1,1
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.01266,0.14706,0.20326,1,1
5,GO RADIAL GLIAL CELL DIFFERENTIATION,0.043559,0.14704,0.19865,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.050584,0.14704,0.14653,1,1
5,GO HEART GROWTH,0.0049572,0.14696,0.21482,1,1
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0076456,0.1469,0.1986,1,1
5,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.048745,0.14679,0.13718,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.010572,0.14679,0.18182,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION,0.0016767,0.14677,0.20062,1,1
5,GO RESPONSE TO INSULIN,0.0042727,0.14665,0.19632,1,1
5,GO REGULATION OF CALCIUM ION TRANSPORT,0.027226,0.14659,0.2145,1,1
5,GO REGULATION OF MRNA 3 END PROCESSING,0.017954,0.14652,0.19901,1,1
5,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.037377,0.14647,0.23553,1,1
5,GO RESPONSE TO NITROGEN COMPOUND,0.0028457,0.14642,0.19608,1,1
5,GO INTRACELLULAR TRANSPORT,0.00051151,0.14641,0.1875,1,1
5,GO NEURON DEATH,0.0057394,0.14639,0.20231,1,1
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0044907,0.14638,0.17066,1,1
5,GO ENDOCRINE HORMONE SECRETION,0.035953,0.14632,0.16402,1,1
5,GO RRNA TRANSCRIPTION,0.021265,0.1463,0.17187,1,1
5,GO OVULATION CYCLE PROCESS,0.043559,0.14621,0.22754,1,1
5,GO ALCOHOL METABOLIC PROCESS,0.0014241,0.14598,0.20601,1,1
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.026142,0.14589,0.21054,1,1
5,GO NUCLEOTIDE PHOSPHORYLATION,0.0047188,0.14582,0.18008,1,1
5,GO REGULATION OF ORGANIC ACID TRANSPORT,0.010101,0.14579,0.19354,1,1
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.054439,0.14571,0.20452,1,1
5,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00033648,0.14544,0.22043,1,1
5,GO PEROXISOMAL MEMBRANE TRANSPORT,0.00096503,0.14543,0.23638,1,1
5,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0017696,0.14538,0.16801,1,1
5,GO ADAPTIVE THERMOGENESIS,0.016475,0.14535,0.18018,1,1
5,GO CELL CELL SIGNALING BY WNT,0.0014241,0.14533,0.21425,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0092139,0.14508,0.21512,1,1
5,GO ACTIVATION OF MAPK ACTIVITY,0.018736,0.14494,0.2101,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0044907,0.14493,0.22129,1,1
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.0029965,0.14479,0.19906,1,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0057394,0.14464,0.21018,1,1
5,GO CARNITINE METABOLIC PROCESS,0.010101,0.14457,0.22037,1,1
5,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00020554,0.14457,0.24099,1,1
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0025648,0.14447,0.18327,1,1
5,GO VIRAL BUDDING,0.0025648,0.14416,0.16141,1,1
5,GO CELLULAR RESPONSE TO MANGANESE ION,0.0054671,0.14414,0.21459,1,1
5,GO HOMEOSTATIC PROCESS,0.0054671,0.14378,0.18438,1,1
5,GO MONOSACCHARIDE METABOLIC PROCESS,0.00081392,0.14376,0.192,1,1
5,GO CARBOHYDRATE CATABOLIC PROCESS,0.006955,0.14373,0.16943,1,1
5,GO MODULATION BY VIRUS OF HOST PROCESS,0.0083971,0.14372,0.17617,1,1
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00096503,0.1436,0.22124,1,1
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0063209,0.14357,0.18147,1,1
5,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00033648,0.14354,0.21459,1,1
5,GO NEGATIVE REGULATION OF BINDING,0.015776,0.14341,0.16642,1,1
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.0042727,0.14338,0.18885,1,1
5,GO MUSCLE TISSUE DEVELOPMENT,0.0083971,0.14313,0.20323,1,1
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.013235,0.14299,0.20457,1,1
5,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.046961,0.14295,0.14891,1,1
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.017954,0.14255,0.16453,1,1
5,GO LIPOSACCHARIDE METABOLIC PROCESS,0.00045436,0.14253,0.20565,1,1
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0016767,0.14252,0.20479,1,1
5,GO REGULATION OF CYTOKINESIS,0.016475,0.14229,0.18475,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0036751,0.14204,0.1828,1,1
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00021879,0.14203,0.22705,1,1
5,GO HYALURONAN METABOLIC PROCESS,0.031957,0.14199,0.24505,1,1
5,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0038653,0.14157,0.17391,1,1
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.008797,0.14156,0.18215,1,1
5,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.0066311,0.14155,0.21403,1,1
5,GO PROTEOGLYCAN METABOLIC PROCESS,0.0029965,0.14148,0.2574,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.013834,0.14143,0.20223,1,1
5,GO RECEPTOR METABOLIC PROCESS,0.01266,0.14135,0.19866,1,1
5,GO CELLULAR HOMEOSTASIS,0.013235,0.14117,0.16905,1,1
5,GO REGULATION OF PEPTIDE TRANSPORT,0.0049572,0.14116,0.19168,1,1
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.0052065,0.14115,0.21919,1,1
5,GO NEGATIVE REGULATION OF CELL GROWTH,0.0034935,0.14103,0.21793,1,1
5,GO REGULATION OF FATTY ACID OXIDATION,0.048745,0.14093,0.19021,1,1
5,GO IN UTERO EMBRYONIC DEVELOPMENT,0.00332,0.14093,0.19681,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0044907,0.14091,0.20198,1,1
5,GO REGULATION OF PROTEIN FOLDING,0.0060238,0.14079,0.19836,1,1
5,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.0040644,0.14074,0.24622,1,1
5,GO RESPONSE TO PEPTIDE,0.0063209,0.14059,0.19332,1,1
5,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0031545,0.14059,0.15525,1,1
5,GO REGULATION OF CELL CYCLE,0.011063,0.14058,0.16598,1,1
5,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.0023095,0.14058,0.19769,1,1
5,GO PIGMENT BIOSYNTHETIC PROCESS,0.0010209,0.14045,0.15455,1,1
5,GO POLYOL BIOSYNTHETIC PROCESS,0.0013481,0.14044,0.19494,1,1
5,GO PROTEIN MATURATION,0.010572,0.14042,0.15679,1,1
5,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.011574,0.14041,0.17018,1,1
5,GO CELL RECOGNITION,0.018736,0.14041,0.18476,1,1
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.016475,0.14035,0.19835,1,1
5,GO REGULATION OF AUTOPHAGY,0.0010798,0.14019,0.22639,1,1
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0015041,0.14002,0.18469,1,1
5,GO ANIMAL ORGAN MORPHOGENESIS,0.0080134,0.13982,0.20643,1,1
5,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.00081392,0.13975,0.17853,1,1
5,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.019548,0.13959,0.1577,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.041938,0.13959,0.14471,1,1
5,GO NEGATIVE REGULATION OF SIGNALING,0.0040644,0.13933,0.20646,1,1
5,GO SMALL MOLECULE CATABOLIC PROCESS,0.00091199,0.1393,0.17936,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.010572,0.13922,0.19095,1,1
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.022172,0.13918,0.19255,1,1
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0019699,0.13909,0.21586,1,1
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00040321,0.13892,0.20542,1,1
5,GO MUSCLE CELL DEVELOPMENT,0.0025648,0.13874,0.2262,1,1
5,GO OSSIFICATION,0.031957,0.13868,0.18275,1,1
5,GO PROTEIN TETRAMERIZATION,0.017954,0.13839,0.16554,1,1
5,GO KETONE BIOSYNTHETIC PROCESS,0.0066311,0.13814,0.20472,1,1
5,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0052065,0.13803,0.19062,1,1
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.025096,0.13777,0.13747,1,1
5,GO POSITIVE REGULATION OF URINE VOLUME,0.034576,0.13774,0.2315,1,1
5,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.022172,0.13765,0.19993,1,1
5,GO C4 DICARBOXYLATE TRANSPORT,0.0063209,0.13765,0.17802,1,1
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.020391,0.13744,0.173,1,1
5,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.01266,0.13741,0.27956,1,1
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.013235,0.13738,0.18273,1,1
5,GO GLUCOSE IMPORT,0.0083971,0.13733,0.19172,1,1
5,GO RESPONSE TO MANGANESE ION,0.031957,0.13726,0.18054,1,1
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.040368,0.13726,0.14788,1,1
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.011574,0.13707,0.13514,1,1
5,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.00068502,0.13699,0.17983,1,1
5,GO REGULATION OF WNT SIGNALING PATHWAY,0.0054671,0.13679,0.19684,1,1
5,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0057394,0.13674,0.2708,1,1
5,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0040644,0.1367,0.19123,1,1
5,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.021265,0.13665,0.15173,1,1
5,GO PROTEIN TARGETING TO MITOCHONDRION,0.0044907,0.13655,0.12487,1,1
5,GO METANEPHROS DEVELOPMENT,0.048745,0.13653,0.18683,1,1
5,GO LONG CHAIN FATTY ACID TRANSPORT,0.020391,0.1365,0.16144,1,1
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.0013481,0.13631,0.19796,1,1
5,GO CELL FATE DETERMINATION,0.008797,0.13627,0.21809,1,1
5,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.035953,0.13618,0.16862,1,1
5,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.006955,0.13607,0.26907,1,1
5,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.016475,0.13603,0.16717,1,1
5,GO IRON SULFUR CLUSTER ASSEMBLY,0.0054671,0.13601,0.15408,1,1
5,GO MUSCLE ORGAN MORPHOGENESIS,0.018736,0.13579,0.21401,1,1
5,GO SULFUR COMPOUND TRANSPORT,0.0010209,0.13566,0.23409,1,1
5,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0015882,0.13557,0.18835,1,1
5,GO ALDEHYDE CATABOLIC PROCESS,0.027226,0.13555,0.11548,1,1
5,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.00076864,0.13549,0.1804,1,1
5,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.038848,0.13527,0.15229,1,1
5,GO REGULATION OF BEHAVIOR,0.017954,0.13495,0.16,1,1
5,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00035748,0.13495,0.22111,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0010798,0.13478,0.18673,1,1
5,GO CARDIAC MUSCLE CELL PROLIFERATION,0.019548,0.13472,0.2001,1,1
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00057531,0.13464,0.2204,1,1
5,GO PROTEOLYSIS,0.0027019,0.13462,0.18904,1,1
5,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.043559,0.13458,0.16193,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0052065,0.13457,0.21077,1,1
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0060238,0.13454,0.18981,1,1
5,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00076864,0.13445,0.20386,1,1
5,GO REGULATION OF ATP METABOLIC PROCESS,0.008797,0.13442,0.16245,1,1
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.008797,0.13437,0.1983,1,1
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0083971,0.13431,0.26443,1,1
5,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0023095,0.13419,0.18632,1,1
5,GO COPII COATED VESICLE CARGO LOADING,0.013235,0.13419,0.23302,1,1
5,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.0010798,0.13403,0.19438,1,1
5,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.046961,0.13399,0.15841,1,1
5,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0052065,0.13395,0.23802,1,1
5,GO LINOLEIC ACID METABOLIC PROCESS,0.011063,0.13392,0.23048,1,1
5,GO CARBOHYDRATE METABOLIC PROCESS,0.00035748,0.13389,0.20225,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0049572,0.13388,0.20672,1,1
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0034935,0.13382,0.19653,1,1
5,GO NEURON APOPTOTIC PROCESS,0.0044907,0.13377,0.19451,1,1
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0031545,0.13369,0.1531,1,1
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.037377,0.13369,0.20926,1,1
5,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0014241,0.13365,0.16315,1,1
5,GO MAMMARY GLAND DEVELOPMENT,0.010572,0.13353,0.22577,1,1
5,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.013834,0.13334,0.14322,1,1
5,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.028348,0.13333,0.12007,1,1
5,GO REGULATION OF MRNA METABOLIC PROCESS,0.013834,0.13313,0.15704,1,1
5,GO STEROID BIOSYNTHETIC PROCESS,0.0020776,0.1331,0.16252,1,1
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0040644,0.13304,0.18815,1,1
5,GO ENSHEATHMENT OF NEURONS,0.0096484,0.13296,0.20329,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE,0.0054671,0.13288,0.19955,1,1
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.043559,0.13275,0.25078,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0021907,0.13275,0.18364,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.045233,0.13266,0.18107,1,1
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.010572,0.13255,0.19609,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0028457,0.13253,0.18231,1,1
5,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.024086,0.1324,0.17851,1,1
5,GO RESPONSE TO COLD,0.048745,0.13223,0.19861,1,1
5,GO RESPONSE TO TOXIC SUBSTANCE,0.007293,0.13222,0.15262,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0052065,0.13202,0.23367,1,1
5,GO REGULATION OF BMP SIGNALING PATHWAY,0.026142,0.13184,0.23267,1,1
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.0054671,0.13181,0.20528,1,1
5,GO GASTRIC ACID SECRETION,0.052482,0.13176,0.11343,1,1
5,GO VACUOLE ORGANIZATION,0.00064645,0.1317,0.23653,1,1
5,GO RESPONSE TO ACIDIC PH,0.026142,0.13169,0.2522,1,1
5,GO ENAMEL MINERALIZATION,0.013235,0.13163,0.32203,1,1
5,GO MAINTENANCE OF LOCATION,0.020391,0.13163,0.18351,1,1
5,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.012106,0.13158,0.16006,1,1
5,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.012106,0.13156,0.17769,1,1
5,GO GLIOGENESIS,0.025096,0.13148,0.18566,1,1
5,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.027226,0.13124,0.1838,1,1
5,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0076456,0.13124,0.20493,1,1
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00096503,0.13079,0.21624,1,1
5,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.031957,0.13077,0.11527,1,1
5,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.011574,0.1307,0.16518,1,1
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0020776,0.13061,0.23068,1,1
5,GO EMBRYONIC EYE MORPHOGENESIS,0.01266,0.13057,0.24348,1,1
5,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0044907,0.13036,0.19816,1,1
5,GO SINGLE FERTILIZATION,0.0010209,0.12998,0.17478,1,1
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0172,0.12986,0.18828,1,1
5,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.02951,0.12972,0.15206,1,1
5,GO FEMALE SEX DIFFERENTIATION,0.031957,0.12965,0.16677,1,1
5,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0096484,0.12947,0.21062,1,1
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0172,0.129,0.17146,1,1
5,GO REGULATION OF GLUCOSE IMPORT,0.027226,0.12886,0.17622,1,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.023112,0.1288,0.13554,1,1
5,GO EXECUTION PHASE OF APOPTOSIS,0.0076456,0.12873,0.17392,1,1
5,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0025648,0.12862,0.15638,1,1
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.048745,0.12859,0.17118,1,1
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.0020776,0.12859,0.19221,1,1
5,GO TRIGLYCERIDE METABOLIC PROCESS,0.031957,0.12857,0.1649,1,1
5,GO REGULATION OF PROTEIN STABILITY,0.0020776,0.12817,0.16322,1,1
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0080134,0.12814,0.19462,1,1
5,GO CARDIOCYTE DIFFERENTIATION,0.013834,0.12802,0.20972,1,1
5,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.016475,0.128,0.14216,1,1
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0038653,0.12792,0.19225,1,1
5,GO MAINTENANCE OF LOCATION IN CELL,0.026142,0.1279,0.17929,1,1
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.017954,0.12775,0.16253,1,1
5,GO PHAGOLYSOSOME ASSEMBLY,0.041938,0.12767,0.25598,1,1
5,GO EAR DEVELOPMENT,0.013235,0.12763,0.17761,1,1
5,GO POSITIVE REGULATION OF SIGNALING,0.016475,0.1276,0.17863,1,1
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.052482,0.12722,0.12779,1,1
5,GO PH REDUCTION,0.019548,0.12714,0.15186,1,1
5,GO EPITHELIAL CELL DEVELOPMENT,0.0040644,0.12701,0.23588,1,1
5,GO INTERMEMBRANE LIPID TRANSFER,0.030713,0.12694,0.18731,1,1
5,GO QUINONE METABOLIC PROCESS,0.020391,0.12664,0.098749,1,1
5,GO MITOCHONDRIAL FUSION,0.0029965,0.12643,0.19293,1,1
5,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0066311,0.12643,0.19535,1,1
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00091199,0.12627,0.18555,1,1
5,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.048745,0.12622,0.14969,1,1
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0031545,0.12611,0.23167,1,1
5,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.027226,0.12605,0.15914,1,1
5,GO NADP METABOLIC PROCESS,0.019548,0.12592,0.14457,1,1
5,GO ORGANIC ACID CATABOLIC PROCESS,0.00076864,0.12564,0.19204,1,1
5,GO RESPONSE TO CAFFEINE,0.026142,0.12561,0.23579,1,1
5,GO INTRACELLULAR PROTEIN TRANSPORT,0.00081392,0.12557,0.16548,1,1
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.031957,0.12551,0.18611,1,1
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.008797,0.12547,0.17214,1,1
5,GO TISSUE MORPHOGENESIS,0.0092139,0.12542,0.19793,1,1
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0031545,0.12539,0.19753,1,1
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0025648,0.12528,0.15825,1,1
5,GO REGULATION OF MITOCHONDRIAL FISSION,0.0054671,0.12526,0.22811,1,1
5,GO LIPID IMPORT INTO CELL,0.037377,0.1252,0.18074,1,1
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.010572,0.12505,0.2189,1,1
5,GO CANONICAL WNT SIGNALING PATHWAY,0.0044907,0.12503,0.20562,1,1
5,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0060238,0.12486,0.17548,1,1
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0172,0.12481,0.16782,1,1
5,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.011063,0.1248,0.14912,1,1
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.024086,0.12473,0.16053,1,1
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0027019,0.12448,0.18179,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.046961,0.12443,0.19006,1,1
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.010101,0.12437,0.17167,1,1
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0028457,0.12423,0.18768,1,1
5,GO SULFUR COMPOUND METABOLIC PROCESS,0.00068502,0.12413,0.18615,1,1
5,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0024341,0.12404,0.15093,1,1
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.021265,0.12403,0.17295,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.0052065,0.12379,0.17559,1,1
5,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0011418,0.12362,0.15884,1,1
5,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.015104,0.12356,0.13427,1,1
5,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0042727,0.12336,0.17701,1,1
5,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.012106,0.12317,0.14097,1,1
5,GO MONOSACCHARIDE CATABOLIC PROCESS,0.013834,0.12315,0.1585,1,1
5,GO REGULATION OF CHROMOSOME ORGANIZATION,0.024086,0.123,0.17075,1,1
5,GO PEROXISOME ORGANIZATION,0.0016767,0.12294,0.18001,1,1
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.010101,0.12282,0.17722,1,1
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.008797,0.1227,0.16738,1,1
5,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.0054671,0.1226,0.14219,1,1
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0092139,0.12256,0.17994,1,1
5,GO SKIN EPIDERMIS DEVELOPMENT,0.028348,0.12251,0.18916,1,1
5,GO MACROMOLECULE CATABOLIC PROCESS,0.0029965,0.1225,0.15274,1,1
5,GO CELLULAR HORMONE METABOLIC PROCESS,0.043559,0.12249,0.13079,1,1
5,GO PROTEIN LOCALIZATION TO MEMBRANE,0.00051151,0.12243,0.16562,1,1
5,GO NON CANONICAL WNT SIGNALING PATHWAY,0.006955,0.12241,0.18074,1,1
5,GO EPITHELIAL TUBE MORPHOGENESIS,0.019548,0.1224,0.20099,1,1
5,GO MITOCHONDRIAL DEPOLARIZATION,0.041938,0.12234,0.1923,1,1
5,GO REGULATION OF MUSCLE ADAPTATION,0.024086,0.1223,0.18272,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0172,0.12226,0.16542,1,1
5,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0060238,0.12204,0.21017,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.020391,0.12198,0.19935,1,1
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00040321,0.12125,0.23146,1,1
5,GO RETINAL CONE CELL DIFFERENTIATION,0.027226,0.12105,0.17283,1,1
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.010101,0.12081,0.18089,1,1
5,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00086166,0.1207,0.17,1,1
5,GO REGULATION OF ATPASE ACTIVITY,0.0066311,0.12066,0.13514,1,1
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.011574,0.12057,0.17254,1,1
5,GO NEGATIVE REGULATION OF TRANSPORT,0.027226,0.12034,0.15891,1,1
5,GO REGULATION OF LIPID CATABOLIC PROCESS,0.019548,0.12022,0.18559,1,1
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0031545,0.1202,0.22892,1,1
5,GO TETRAPYRROLE METABOLIC PROCESS,0.011574,0.12011,0.13736,1,1
5,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0020776,0.12006,0.16188,1,1
5,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.01266,0.12,0.12098,1,1
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.024086,0.11981,0.14925,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.025096,0.1198,0.17453,1,1
5,GO MONOCARBOXYLIC ACID TRANSPORT,0.010572,0.11978,0.18978,1,1
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.048745,0.11968,0.16351,1,1
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0052065,0.11954,0.19292,1,1
5,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.00332,0.11945,0.14635,1,1
5,GO MORPHOGENESIS OF AN EPITHELIUM,0.017954,0.11931,0.1923,1,1
5,GO FATTY ACID METABOLIC PROCESS,0.0027019,0.11926,0.18131,1,1
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0063209,0.11914,0.14839,1,1
5,GO ENDOSOME ORGANIZATION,0.0024341,0.11893,0.18597,1,1
5,GO REGULATION OF CELL DIFFERENTIATION,0.0096484,0.11891,0.19783,1,1
5,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0066311,0.11886,0.23386,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.023112,0.11872,0.18612,1,1
5,GO MULTIVESICULAR BODY ORGANIZATION,0.008797,0.11869,0.13852,1,1
5,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.025096,0.11866,0.17176,1,1
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0047188,0.11841,0.14419,1,1
5,GO REGULATION OF CARTILAGE DEVELOPMENT,0.038848,0.11821,0.21173,1,1
5,GO MITOCHONDRIAL TRANSPORT,0.00332,0.1181,0.13685,1,1
5,GO STEROID METABOLIC PROCESS,0.0042727,0.11801,0.18046,1,1
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.025096,0.11801,0.15554,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.022172,0.11782,0.19502,1,1
5,GO TRANSITION METAL ION TRANSPORT,0.0025648,0.11778,0.17742,1,1
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.0017696,0.11768,0.18515,1,1
5,GO RESPONSE TO ABIOTIC STIMULUS,0.0028457,0.11721,0.16441,1,1
5,GO CELLULAR LIPID METABOLIC PROCESS,0.0025648,0.11715,0.19664,1,1
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.015776,0.11702,0.17541,1,1
5,GO REGULATION OF STEROID METABOLIC PROCESS,0.019548,0.11688,0.15746,1,1
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.019548,0.11677,0.19592,1,1
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.013834,0.11668,0.18744,1,1
5,GO FATTY ACYL COA METABOLIC PROCESS,0.0060238,0.11659,0.16818,1,1
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.02951,0.11648,0.24301,1,1
5,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.013235,0.11633,0.237,1,1
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0092139,0.11632,0.17236,1,1
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.010572,0.11628,0.22466,1,1
5,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.008797,0.11619,0.17686,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0049572,0.11618,0.19099,1,1
5,GO ANION HOMEOSTASIS,0.0096484,0.11606,0.20175,1,1
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.030713,0.11579,0.1461,1,1
5,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.0018673,0.11564,0.16492,1,1
5,GO MITOTIC CYTOKINESIS,0.027226,0.11555,0.16433,1,1
5,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0011418,0.11546,0.15394,1,1
5,GO REGULATION OF DNA METABOLIC PROCESS,0.030713,0.11545,0.15255,1,1
5,GO NUCLEOTIDE EXCISION REPAIR,0.016475,0.11523,0.13607,1,1
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.028348,0.11452,0.20434,1,1
5,GO CELL CYCLE,0.012106,0.1145,0.16714,1,1
5,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.052482,0.11427,0.16421,1,1
5,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0036751,0.11427,0.12148,1,1
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0052065,0.11402,0.18989,1,1
5,GO CELLULAR RESPONSE TO STARVATION,0.0019699,0.11376,0.19604,1,1
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0096484,0.11339,0.18904,1,1
5,GO REGULATION OF PHOSPHORYLATION,0.015776,0.11295,0.18372,1,1
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.01266,0.11267,0.18503,1,1
5,GO MITOCHONDRION MORPHOGENESIS,0.0054671,0.11255,0.16655,1,1
5,GO TRICARBOXYLIC ACID CYCLE,0.02951,0.1122,0.11071,1,1
5,GO FATTY ACID TRANSPORT,0.046961,0.11206,0.15188,1,1
5,GO PEROXISOMAL TRANSPORT,0.0012758,0.11202,0.16377,1,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0019699,0.11171,0.20108,1,1
5,GO RESPONSE TO DRUG,0.010101,0.11136,0.17283,1,1
5,GO REGULATION OF HEART GROWTH,0.023112,0.11133,0.17565,1,1
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00060992,0.11096,0.18705,1,1
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.02951,0.11074,0.17765,1,1
5,GO MESODERM DEVELOPMENT,0.0172,0.1107,0.16921,1,1
5,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.017954,0.11059,0.16673,1,1
5,GO VITAMIN TRANSPORT,0.041938,0.11049,0.17007,1,1
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.045233,0.10974,0.17252,1,1
5,GO RNA CAPPING,0.015776,0.10964,0.1173,1,1
5,GO PROTEIN STABILIZATION,0.019548,0.10945,0.13805,1,1
5,GO LIPID BIOSYNTHETIC PROCESS,0.0010798,0.10944,0.19282,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.014457,0.10934,0.19892,1,1
5,GO ORGAN GROWTH,0.01266,0.10901,0.20169,1,1
5,GO PROTEIN DESTABILIZATION,0.0019699,0.109,0.19135,1,1
5,GO REGULATION OF VACUOLE ORGANIZATION,0.0044907,0.10878,0.22152,1,1
5,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0049572,0.10833,0.17707,1,1
5,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.02951,0.10823,0.23379,1,1
5,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0011418,0.10808,0.16566,1,1
5,GO RESPONSE TO STARVATION,0.0019699,0.10808,0.18861,1,1
5,GO RESPONSE TO TEMPERATURE STIMULUS,0.0080134,0.10785,0.16042,1,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.016475,0.10773,0.19421,1,1
5,GO REGULATION OF HYDROLASE ACTIVITY,0.018736,0.10741,0.18332,1,1
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.0080134,0.10682,0.21993,1,1
5,GO MITOCHONDRION ORGANIZATION,0.00086166,0.10643,0.13651,1,1
5,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.024086,0.1062,0.14473,1,1
5,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0092139,0.10614,0.13516,1,1
5,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.035953,0.10611,0.1336,1,1
5,GO LIPID METABOLIC PROCESS,0.0023095,0.10607,0.19431,1,1
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00332,0.10562,0.17838,1,1
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.011063,0.10406,0.18168,1,1
5,GO TEMPERATURE HOMEOSTASIS,0.015776,0.10398,0.17342,1,1
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.011063,0.10349,0.18902,1,1
5,GO RHYTHMIC BEHAVIOR,0.020391,0.10335,0.16897,1,1
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.02951,0.10304,0.17692,1,1
5,GO PROTEIN LOCALIZATION TO ORGANELLE,0.0066311,0.10239,0.1342,1,1
5,GO REGENERATION,0.025096,0.1019,0.1742,1,1
5,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0024341,0.10121,0.11996,1,1
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0021907,0.10109,0.16702,1,1
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0036751,0.10074,0.17329,1,1
5,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.020391,0.10056,0.1405,1,1
5,GO MAINTENANCE OF PROTEIN LOCATION,0.0027019,0.099979,0.17034,1,1
5,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.022172,0.099428,0.12853,1,1
5,GO MITOCHONDRIAL FISSION,0.0025648,0.099331,0.21542,1,1
5,GO PROTEIN FOLDING,0.0038653,0.099096,0.13787,1,1
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00091199,0.098965,0.16651,1,1
5,GO CYTOCHROME COMPLEX ASSEMBLY,0.0172,0.098679,0.09805,1,1
5,GO REGULATION OF MULTI ORGANISM PROCESS,0.037377,0.098408,0.12998,1,1
5,GO ENERGY RESERVE METABOLIC PROCESS,0.0029965,0.098219,0.21742,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.028348,0.097749,0.17261,1,1
5,GO MUSCLE CELL APOPTOTIC PROCESS,0.030713,0.097566,0.16293,1,1
5,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.048745,0.097067,0.21267,1,1
5,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0044907,0.096519,0.14064,1,1
5,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.037377,0.096178,0.14602,1,1
5,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0096484,0.096137,0.18259,1,1
5,GO GLAND DEVELOPMENT,0.013235,0.095996,0.1946,1,1
5,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0042727,0.095717,0.1316,1,1
5,GO CYTOKINETIC PROCESS,0.0076456,0.094584,0.174,1,1
5,GO REGULATION OF ORGAN GROWTH,0.017954,0.094495,0.18594,1,1
5,GO ALPHA AMINO ACID METABOLIC PROCESS,0.0034935,0.094264,0.15034,1,1
5,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.011063,0.093783,0.1514,1,1
5,GO ORGANIC ACID METABOLIC PROCESS,0.0015041,0.093762,0.16764,1,1
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.017954,0.093458,0.191,1,1
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0031545,0.093457,0.14936,1,1
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.025096,0.093265,0.16525,1,1
5,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00072571,0.093208,0.13905,1,1
5,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.010572,0.092337,0.21233,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.017954,0.092203,0.18709,1,1
5,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0027019,0.091126,0.1312,1,1
5,GO MITOTIC CYTOKINETIC PROCESS,0.014457,0.089865,0.12859,1,1
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.037377,0.08978,0.14074,1,1
5,GO PROTEIN N LINKED GLYCOSYLATION,0.013235,0.089595,0.12877,1,1
5,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.050584,0.089166,0.22928,1,1
5,GO PIGMENT METABOLIC PROCESS,0.0049572,0.088762,0.14057,1,1
5,GO POLYAMINE METABOLIC PROCESS,0.030713,0.088431,0.12,1,1
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.031957,0.087166,0.13689,1,1
5,GO REGULATION OF ERAD PATHWAY,0.041938,0.085793,0.14908,1,1
5,GO POSITIVE REGULATION OF NEURON DEATH,0.052482,0.083969,0.16391,1,1
5,GO OXIDATION REDUCTION PROCESS,0.0018673,0.083907,0.14755,1,1
5,GO VIRION ASSEMBLY,0.0034935,0.081266,0.12591,1,1
5,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.028348,0.079651,0.18975,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.034576,0.078992,0.14327,1,1
5,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0027019,0.07596,0.13532,1,1
5,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0080134,0.074723,0.13669,1,1
5,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.033245,0.074023,0.16535,1,1
5,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.027226,0.067969,0.10605,1,1
5,GO RESPONSE TO ACID CHEMICAL,0.033245,0.060573,0.17371,1,1
5,GO PROTEIN TARGETING,0.0047188,0.045098,0.081353,1,1
5,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00040321,0.4052,0.62566,1,0
5,GO RESPONSE TO POTASSIUM ION,0.0036751,0.40378,0.43563,1,0
5,GO HEMIDESMOSOME ASSEMBLY,0.034576,0.37171,0.31672,1,0
5,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0036751,0.33752,0.32445,1,0
5,GO GLYCINE TRANSPORT,0.019548,0.33678,0.29847,1,0
5,GO CELL AGGREGATION,0.013235,0.32724,0.29134,1,0
5,GO REGULATION OF SYNAPSE MATURATION,0.038848,0.32634,0.26567,1,0
5,GO HISTONE H3 K4 TRIMETHYLATION,0.0042727,0.31508,0.36294,1,0
5,GO CARDIAC CHAMBER FORMATION,0.028348,0.30527,0.24199,1,0
5,GO REGULATION OF GROWTH HORMONE SECRETION,0.027226,0.29916,0.32598,1,0
5,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.033245,0.27083,0.23988,1,0
5,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.027226,0.26584,0.24946,1,0
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.048745,0.26504,0.27247,1,0
5,GO NUCLEUS LOCALIZATION,0.0014241,0.2643,0.40265,1,0
5,GO NUCLEAR MIGRATION,0.0013481,0.25848,0.40264,1,0
5,GO REGULATION OF CHROMATIN ASSEMBLY,0.010101,0.2569,0.2582,1,0
5,GO POSITIVE REGULATION OF BEHAVIOR,0.0172,0.25443,0.22077,1,0
5,GO CARDIAC VENTRICLE FORMATION,0.052482,0.25166,0.20654,1,0
5,GO INNERVATION,0.031957,0.25129,0.31723,1,0
5,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0092139,0.25113,0.29933,1,0
5,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.048745,0.24992,0.21987,1,0
5,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.011574,0.245,0.27344,1,0
5,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.013834,0.24496,0.28038,1,0
5,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.016475,0.24307,0.23324,1,0
5,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.050584,0.24115,0.23669,1,0
5,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0029965,0.23635,0.31965,1,0
5,GO RESPONSE TO CORTICOSTERONE,0.015104,0.23342,0.24114,1,0
5,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0063209,0.23179,0.29281,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.031957,0.22922,0.24096,1,0
5,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.0012071,0.22904,0.34475,1,0
5,GO CATECHOLAMINE UPTAKE,0.0060238,0.22727,0.35793,1,0
5,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.038848,0.22511,0.25832,1,0
5,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.015776,0.22294,0.23996,1,0
5,GO MRNA TRANSCRIPTION,0.028348,0.21986,0.22517,1,0
5,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.0080134,0.21761,0.30825,1,0
5,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0031545,0.21704,0.30413,1,0
5,GO DNA METHYLATION,0.0080134,0.21678,0.20444,1,0
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.041938,0.2122,0.19259,1,0
5,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.02951,0.20818,0.17862,1,0
5,GO RESPONSE TO INSECTICIDE,0.038848,0.20767,0.23095,1,0
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.046961,0.20645,0.20354,1,0
5,GO EPIDERMIS DEVELOPMENT,0.006955,0.20605,0.19164,1,0
5,GO MUSCLE CELL FATE COMMITMENT,0.043559,0.20501,0.22387,1,0
5,GO MEIOTIC SPINDLE ORGANIZATION,0.017954,0.20435,0.24803,1,0
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0025648,0.20416,0.21744,1,0
5,GO ESTROUS CYCLE,0.048745,0.19986,0.20523,1,0
5,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.02951,0.19855,0.20027,1,0
5,GO HIPPO SIGNALING,0.033245,0.19848,0.23147,1,0
5,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.0066311,0.19797,0.29308,1,0
5,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.016475,0.19795,0.23385,1,0
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0060238,0.19678,0.26664,1,0
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.052482,0.1952,0.1875,1,0
5,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.011574,0.19469,0.2441,1,0
5,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0019699,0.19435,0.29743,1,0
5,GO SPINAL CORD DEVELOPMENT,0.013834,0.19364,0.24402,1,0
5,GO MAGNESIUM ION HOMEOSTASIS,0.017954,0.19304,0.3107,1,0
5,GO REGULATION OF WOUND HEALING,0.052482,0.19192,0.18817,1,0
5,GO LYMPH VESSEL DEVELOPMENT,0.033245,0.19088,0.28783,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0028457,0.19073,0.24836,1,0
5,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.023112,0.19044,0.22558,1,0
5,GO NEURAL TUBE PATTERNING,0.046961,0.19015,0.18994,1,0
5,GO SKIN DEVELOPMENT,0.0057394,0.1891,0.20485,1,0
5,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.015776,0.18792,0.24274,1,0
5,GO MYELOID CELL DEVELOPMENT,0.0172,0.18792,0.22794,1,0
5,GO REGULATION OF NECROTIC CELL DEATH,0.046961,0.18741,0.15901,1,0
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0096484,0.18638,0.24287,1,0
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.050584,0.18638,0.22663,1,0
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.026142,0.18618,0.28173,1,0
5,GO SPERMATID NUCLEUS DIFFERENTIATION,0.035953,0.18579,0.18354,1,0
5,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.050584,0.18549,0.23751,1,0
5,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.054439,0.18492,0.24269,1,0
5,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.008797,0.18458,0.23741,1,0
5,GO ENDODERMAL CELL DIFFERENTIATION,0.052482,0.18454,0.29143,1,0
5,GO ARACHIDONIC ACID SECRETION,0.021265,0.18425,0.16882,1,0
5,GO BEHAVIORAL RESPONSE TO PAIN,0.045233,0.18322,0.22469,1,0
5,GO KERATINOCYTE DIFFERENTIATION,0.010572,0.18275,0.17651,1,0
5,GO HETEROCHROMATIN ORGANIZATION,0.0092139,0.18139,0.24029,1,0
5,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.024086,0.17996,0.23919,1,0
5,GO FUCOSE METABOLIC PROCESS,0.0063209,0.1793,0.22287,1,0
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.013834,0.17706,0.2645,1,0
5,GO CHROMATIN REMODELING,0.020391,0.17651,0.19456,1,0
5,GO LIPOPROTEIN LOCALIZATION,0.054439,0.17531,0.21027,1,0
5,GO TISSUE REGENERATION,0.026142,0.17488,0.18251,1,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.019548,0.17421,0.17161,1,0
5,GO GENE SILENCING,0.0096484,0.17399,0.18817,1,0
5,GO FOREBRAIN DEVELOPMENT,0.0047188,0.1733,0.22382,1,0
5,GO ECTODERM DEVELOPMENT,0.030713,0.17266,0.1709,1,0
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.015104,0.17215,0.20307,1,0
5,GO MOTOR NEURON AXON GUIDANCE,0.028348,0.17212,0.23371,1,0
5,GO HEART TRABECULA MORPHOGENESIS,0.045233,0.17145,0.19629,1,0
5,GO ARTERY MORPHOGENESIS,0.0172,0.17058,0.25186,1,0
5,GO AORTA DEVELOPMENT,0.012106,0.17048,0.27749,1,0
5,GO RESPONSE TO STEROL,0.020391,0.17006,0.24853,1,0
5,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0052065,0.1695,0.19953,1,0
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.040368,0.16942,0.2052,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.050584,0.16882,0.19194,1,0
5,GO CORPUS CALLOSUM DEVELOPMENT,0.040368,0.16835,0.22778,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.045233,0.16831,0.1959,1,0
5,GO CELLULAR RESPONSE TO ALCOHOL,0.0066311,0.1675,0.23658,1,0
5,GO ICOSANOID METABOLIC PROCESS,0.037377,0.16743,0.18255,1,0
5,GO ARTERY DEVELOPMENT,0.016475,0.16681,0.2524,1,0
5,GO INTRACELLULAR STEROL TRANSPORT,0.048745,0.16669,0.18616,1,0
5,GO BLOOD VESSEL REMODELING,0.028348,0.16579,0.27964,1,0
5,GO ERBB2 SIGNALING PATHWAY,0.010101,0.16527,0.23343,1,0
5,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0038653,0.16504,0.31312,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.034576,0.16494,0.22187,1,0
5,GO REGULATION OF PROTEIN SUMOYLATION,0.008797,0.16491,0.23081,1,0
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.048745,0.16427,0.21312,1,0
5,GO MRNA CLEAVAGE,0.0015041,0.16367,0.21163,1,0
5,GO RELAXATION OF CARDIAC MUSCLE,0.02951,0.16325,0.29951,1,0
5,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.013235,0.16264,0.25366,1,0
5,GO FOREBRAIN NEURON DIFFERENTIATION,0.0060238,0.16205,0.25421,1,0
5,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.018736,0.16092,0.21922,1,0
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.012106,0.16053,0.26587,1,0
5,GO SEROTONIN TRANSPORT,0.052482,0.15933,0.205,1,0
5,GO POSITIVE REGULATION OF AUTOPHAGY,0.026142,0.15813,0.19543,1,0
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.054439,0.15804,0.23669,1,0
5,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.016475,0.15786,0.24624,1,0
5,GO CARNITINE SHUTTLE,0.0083971,0.15782,0.25255,1,0
5,GO REGULATION OF RESPONSE TO WOUNDING,0.054439,0.15751,0.18844,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.040368,0.1574,0.19136,1,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.027226,0.15621,0.2164,1,0
5,GO DNA METHYLATION OR DEMETHYLATION,0.0049572,0.15608,0.1885,1,0
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.034576,0.15512,0.21263,1,0
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.021265,0.15434,0.23902,1,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0092139,0.15366,0.21457,1,0
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.010101,0.15347,0.18363,1,0
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.026142,0.15317,0.23142,1,0
5,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.037377,0.15229,0.17908,1,0
5,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.040368,0.15196,0.26234,1,0
5,GO LAMELLIPODIUM ORGANIZATION,0.022172,0.15196,0.19613,1,0
5,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.027226,0.15173,0.14768,1,0
5,GO RESPONSE TO MINERALOCORTICOID,0.035953,0.15158,0.16018,1,0
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0052065,0.15146,0.25838,1,0
5,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.01266,0.1503,0.32168,1,0
5,GO ISOPRENOID METABOLIC PROCESS,0.021265,0.15017,0.13555,1,0
5,GO REGULATION OF AMYLOID BETA FORMATION,0.040368,0.14985,0.19997,1,0
5,GO LATERAL MESODERM DEVELOPMENT,0.052482,0.1498,0.16239,1,0
5,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.046961,0.14943,0.16238,1,0
5,GO ER NUCLEUS SIGNALING PATHWAY,0.010101,0.14943,0.16742,1,0
5,GO DRUG METABOLIC PROCESS,0.045233,0.1492,0.17366,1,0
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.040368,0.14903,0.14661,1,0
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.035953,0.14861,0.15829,1,0
5,GO PROTEIN DEMANNOSYLATION,0.046961,0.14834,0.20484,1,0
5,GO FOREBRAIN GENERATION OF NEURONS,0.0083971,0.148,0.22241,1,0
5,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.054439,0.14782,0.17689,1,0
5,GO TERPENOID METABOLIC PROCESS,0.045233,0.14751,0.13767,1,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.034576,0.14744,0.1997,1,0
5,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.024086,0.14732,0.17107,1,0
5,GO PROTEIN PROCESSING,0.025096,0.14715,0.17192,1,0
5,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.038848,0.14665,0.17412,1,0
5,GO RESPONSE TO ESTROGEN,0.02951,0.1461,0.18506,1,0
5,GO FORMATION OF PRIMARY GERM LAYER,0.028348,0.14563,0.22519,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.048745,0.14537,0.2144,1,0
5,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0040644,0.1452,0.19818,1,0
5,GO CELLULAR RESPONSE TO ATP,0.035953,0.145,0.1852,1,0
5,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.028348,0.14455,0.2136,1,0
5,GO ADIPOSE TISSUE DEVELOPMENT,0.017954,0.14451,0.1893,1,0
5,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.045233,0.14425,0.182,1,0
5,GO PIGMENT GRANULE ORGANIZATION,0.007293,0.14393,0.18779,1,0
5,GO PROTEIN MONOUBIQUITINATION,0.0083971,0.14227,0.19708,1,0
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.027226,0.14223,0.16666,1,0
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.048745,0.14191,0.18377,1,0
5,GO NEGATIVE REGULATION OF DNA REPAIR,0.028348,0.14172,0.16611,1,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.019548,0.14135,0.13369,1,0
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.046961,0.14117,0.21343,1,0
5,GO CELLULAR RESPONSE TO UV,0.037377,0.14056,0.13932,1,0
5,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0042727,0.14032,0.19188,1,0
5,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0172,0.14021,0.1837,1,0
5,GO CEREBELLAR CORTEX MORPHOGENESIS,0.030713,0.13982,0.23025,1,0
5,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.040368,0.13977,0.15734,1,0
5,GO REGULATION OF HISTONE UBIQUITINATION,0.0052065,0.13942,0.18759,1,0
5,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.028348,0.13909,0.22633,1,0
5,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.043559,0.13909,0.19197,1,0
5,GO HINDBRAIN MORPHOGENESIS,0.0172,0.13856,0.23082,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.01266,0.1381,0.20759,1,0
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.033245,0.13802,0.16646,1,0
5,GO ACTIN CYTOSKELETON REORGANIZATION,0.045233,0.13778,0.19361,1,0
5,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.031957,0.1371,0.32191,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.010572,0.13509,0.21181,1,0
5,GO AMELOGENESIS,0.0049572,0.13435,0.23722,1,0
5,GO RESPONSE TO OXIDATIVE STRESS,0.013834,0.13377,0.16394,1,0
5,GO AMYLOID BETA FORMATION,0.043559,0.13109,0.19088,1,0
5,GO TISSUE HOMEOSTASIS,0.016475,0.13095,0.20663,1,0
5,GO RESPONSE TO OSMOTIC STRESS,0.014457,0.13005,0.19597,1,0
5,GO GLYCOPROTEIN CATABOLIC PROCESS,0.052482,0.12989,0.2571,1,0
5,GO MAINTENANCE OF CELL NUMBER,0.01266,0.12963,0.17693,1,0
5,GO REGULATION OF PROTEOLYSIS,0.034576,0.12947,0.15287,1,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.023112,0.12939,0.22107,1,0
5,GO CORONARY VASCULATURE DEVELOPMENT,0.033245,0.12865,0.22803,1,0
5,GO NCRNA TRANSCRIPTION,0.023112,0.12853,0.15143,1,0
5,GO ENDOTHELIAL CELL DEVELOPMENT,0.038848,0.12825,0.23069,1,0
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.037377,0.12808,0.16485,1,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS,0.030713,0.12759,0.15877,1,0
5,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.025096,0.12695,0.1631,1,0
5,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.019548,0.12666,0.1305,1,0
5,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.038848,0.12559,0.16952,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.017954,0.12537,0.16072,1,0
5,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.023112,0.12517,0.12951,1,0
5,GO PROTEIN HOMOTETRAMERIZATION,0.050584,0.12453,0.15458,1,0
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.013834,0.12336,0.19055,1,0
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.054439,0.12332,0.2065,1,0
5,GO REGULATION OF GENE SILENCING,0.010101,0.12284,0.17869,1,0
5,GO LIPID STORAGE,0.037377,0.12199,0.18486,1,0
5,GO REGULATION OF FAT CELL DIFFERENTIATION,0.041938,0.12193,0.193,1,0
5,GO LUNG EPITHELIUM DEVELOPMENT,0.018736,0.12148,0.22507,1,0
5,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.02951,0.12077,0.216,1,0
5,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.037377,0.11966,0.17891,1,0
5,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.038848,0.1195,0.17125,1,0
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0049572,0.11928,0.18609,1,0
5,GO RESPONSE TO GROWTH HORMONE,0.038848,0.11887,0.16804,1,0
5,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.010572,0.11871,0.16584,1,0
5,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.020391,0.11853,0.15488,1,0
5,GO AUTOPHAGY OF NUCLEUS,0.028348,0.11823,0.16994,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.015776,0.11781,0.23159,1,0
5,GO REGULATION OF LIPID METABOLIC PROCESS,0.023112,0.11716,0.16902,1,0
5,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.041938,0.11645,0.16884,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.019548,0.11626,0.13585,1,0
5,GO GASTRULATION,0.011574,0.11564,0.22048,1,0
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.034576,0.1153,0.17897,1,0
5,GO VIRAL RNA GENOME REPLICATION,0.027226,0.115,0.17011,1,0
5,GO RUFFLE ASSEMBLY,0.01266,0.11464,0.21327,1,0
5,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.054439,0.11449,0.17164,1,0
5,GO ESTABLISHMENT OF TISSUE POLARITY,0.013235,0.11394,0.1435,1,0
5,GO UTP METABOLIC PROCESS,0.046961,0.11378,0.164,1,0
5,GO NCRNA CATABOLIC PROCESS,0.010101,0.11375,0.17022,1,0
5,GO METHIONINE BIOSYNTHETIC PROCESS,0.050584,0.11373,0.14194,1,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0092139,0.1136,0.18047,1,0
5,GO PROTEIN SUMOYLATION,0.011063,0.11272,0.1828,1,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.048745,0.11255,0.16996,1,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.02951,0.11229,0.12984,1,0
5,GO NEURAL PRECURSOR CELL PROLIFERATION,0.031957,0.11207,0.18942,1,0
5,GO RESPONSE TO ALCOHOL,0.021265,0.11147,0.17778,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.026142,0.11133,0.12718,1,0
5,GO DNA METABOLIC PROCESS,0.030713,0.11115,0.14773,1,0
5,GO DOUBLE STRAND BREAK REPAIR,0.034576,0.11013,0.17065,1,0
5,GO CELLULAR RESPONSE TO RADIATION,0.028348,0.10988,0.1249,1,0
5,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.037377,0.10947,0.2042,1,0
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.027226,0.10932,0.18438,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.035953,0.10927,0.21617,1,0
5,GO TRNA WOBBLE URIDINE MODIFICATION,0.037377,0.10748,0.1268,1,0
5,GO RIG I SIGNALING PATHWAY,0.048745,0.10706,0.16545,1,0
5,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.020391,0.10589,0.16616,1,0
5,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.030713,0.10582,0.15995,1,0
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.013834,0.10564,0.17109,1,0
5,GO THYMUS DEVELOPMENT,0.013235,0.10451,0.15128,1,0
5,GO STEM CELL DIFFERENTIATION,0.054439,0.10442,0.14112,1,0
5,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.010572,0.10413,0.14616,1,0
5,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.020391,0.10397,0.16862,1,0
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.017954,0.10345,0.16504,1,0
5,GO ESTROGEN METABOLIC PROCESS,0.046961,0.10263,0.18046,1,0
5,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.014457,0.10046,0.15871,1,0
5,GO REGULATION OF TRANSLATIONAL TERMINATION,0.052482,0.099654,0.13902,1,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.012106,0.09962,0.16953,1,0
5,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.035953,0.099545,0.16964,1,0
5,GO BLASTOCYST FORMATION,0.023112,0.099439,0.12402,1,0
5,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.015776,0.09922,0.15574,1,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.024086,0.09811,0.20862,1,0
5,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.041938,0.097858,0.15259,1,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.019548,0.097748,0.29546,1,0
5,GO MISMATCH REPAIR,0.040368,0.094879,0.16984,1,0
5,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.025096,0.092751,0.17303,1,0
5,GO RESPONSE TO OXYGEN LEVELS,0.045233,0.092337,0.12797,1,0
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.028348,0.092333,0.16217,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEUS,0.034576,0.092105,0.14851,1,0
5,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.043559,0.091579,0.24237,1,0
5,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0042727,0.090155,0.14751,1,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.012106,0.088733,0.13414,1,0
5,GO REGULATION OF CELL CYCLE PROCESS,0.035953,0.0864,0.14437,1,0
5,GO ONE CARBON METABOLIC PROCESS,0.054439,0.08518,0.11197,1,0
5,GO RESPONSE TO ETHANOL,0.01266,0.083122,0.16971,1,0
5,GO REGULATION OF MRNA CATABOLIC PROCESS,0.017954,0.082007,0.12729,1,0
5,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.0172,0.081465,0.13005,1,0
5,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.041938,0.081215,0.11927,1,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.046961,0.081148,0.10022,1,0
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0096484,0.080875,0.20629,1,0
5,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.038848,0.080746,0.18135,1,0
5,GO POSITIVE REGULATION OF TRANSLATION,0.025096,0.08073,0.10948,1,0
5,GO APOPTOTIC PROCESS,0.052482,0.079641,0.14743,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.025096,0.078695,0.15623,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.046961,0.076969,0.15051,1,0
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.015104,0.076444,0.15166,1,0
5,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.054439,0.074531,0.15158,1,0
5,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.043559,0.074421,0.12684,1,0
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.043559,0.073323,0.14533,1,0
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.040368,0.072938,0.14429,1,0
5,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.031957,0.071547,0.17474,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.017954,0.069108,0.14071,1,0
5,GO ETHER METABOLIC PROCESS,0.033245,0.068574,0.20447,1,0
5,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.023112,0.058998,0.11348,1,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.035953,0.056023,0.12688,1,0
5,GO CELLULAR AMIDE METABOLIC PROCESS,0.0083971,0.051531,0.099066,1,0
5,GO PEPTIDE METABOLIC PROCESS,0.033245,0.042027,0.075174,1,0
5,GO VIRAL GENE EXPRESSION,0.052482,-0.064805,-0.088303,1,0
5,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.024086,-0.14715,-0.21869,1,0
5,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0172,-0.18656,-0.14243,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0060238,-0.20926,-0.19844,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0038653,-0.27466,-0.23981,1,0
5,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0017696,-0.31328,-0.29861,1,0
5,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.058535,0.48401,0.30259,0,1
5,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.18102,0.48116,0.27619,0,1
5,GO OPSONIZATION,0.29248,0.42083,0.15766,0,1
5,GO REVERSE CHOLESTEROL TRANSPORT,0.08881,0.32034,0.25803,0,1
5,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.10468,0.30607,0.19907,0,1
5,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.067497,0.29331,0.27887,0,1
5,GO LYMPH NODE DEVELOPMENT,0.10134,0.28722,0.21254,0,1
5,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.062884,0.28558,0.23233,0,1
5,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.069906,0.27718,0.28872,0,1
5,GO ELASTIC FIBER ASSEMBLY,0.062884,0.25915,0.35646,0,1
5,GO CARDIOBLAST DIFFERENTIATION,0.062884,0.25865,0.20912,0,1
5,GO NEPHRIC DUCT MORPHOGENESIS,0.060677,0.25827,0.19518,0,1
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.074935,0.25642,0.25634,0,1
5,GO SKIN MORPHOGENESIS,0.11894,0.24379,0.22518,0,1
5,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.08303,0.22644,0.19061,0,1
5,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.23827,0.22546,0.18901,0,1
5,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.11163,0.22261,0.17515,0,1
5,GO SPINAL CORD PATTERNING,0.08588,0.22211,0.21264,0,1
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.098083,0.22133,0.19768,0,1
5,GO MYOBLAST FUSION,0.062884,0.21825,0.21799,0,1
5,GO AORTIC VALVE DEVELOPMENT,0.072385,0.21819,0.21646,0,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.067497,0.21433,0.21203,0,1
5,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.08881,0.21352,0.1565,0,1
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.08588,0.21093,0.17377,0,1
5,GO ETHANOL CATABOLIC PROCESS,0.11163,0.20738,0.12146,0,1
5,GO RESPONSE TO NICOTINE,0.08303,0.20691,0.15471,0,1
5,GO REGULATION OF STEROL TRANSPORT,0.065157,0.20604,0.16338,0,1
5,GO OPTIC NERVE DEVELOPMENT,0.091819,0.20555,0.22269,0,1
5,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.067497,0.20541,0.23845,0,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.067497,0.2052,0.19989,0,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.14312,0.20491,0.18198,0,1
5,GO REGULATION OF GASTRIC ACID SECRETION,0.13467,0.20103,0.089381,0,1
5,GO PLATELET ACTIVATION,0.098083,0.20101,0.19679,0,1
5,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.1306,0.2005,0.137,0,1
5,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.072385,0.19849,0.19039,0,1
5,GO ENDOTHELIAL CELL MIGRATION,0.062884,0.19844,0.20483,0,1
5,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.072385,0.19756,0.19294,0,1
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.10468,0.1964,0.18247,0,1
5,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.067497,0.19528,0.28663,0,1
5,GO COAGULATION,0.065157,0.19455,0.18726,0,1
5,GO DORSAL AORTA DEVELOPMENT,0.13885,0.19339,0.19148,0,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.11163,0.19223,0.17785,0,1
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.091819,0.18991,0.21267,0,1
5,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.056456,0.18826,0.21496,0,1
5,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.094909,0.18552,0.20945,0,1
5,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.056456,0.18483,0.18844,0,1
5,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.065157,0.18445,0.2212,0,1
5,GO MALE MEIOTIC NUCLEAR DIVISION,0.094909,0.18358,0.17067,0,1
5,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.091819,0.18314,0.19437,0,1
5,GO REGULATION OF CELL SUBSTRATE ADHESION,0.069906,0.18194,0.22212,0,1
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.067497,0.18164,0.20523,0,1
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.065157,0.18077,0.16543,0,1
5,GO MEMBRANE DISASSEMBLY,0.072385,0.17832,0.19125,0,1
5,GO GLIAL CELL MIGRATION,0.080256,0.17818,0.1945,0,1
5,GO SULFATION,0.08881,0.17807,0.17084,0,1
5,GO BIOLOGICAL PHASE,0.10811,0.17804,0.19458,0,1
5,GO ENGULFMENT OF APOPTOTIC CELL,0.062884,0.17673,0.23703,0,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.077559,0.17608,0.19106,0,1
5,GO ACYLGLYCEROL HOMEOSTASIS,0.17091,0.17374,0.11945,0,1
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.058535,0.17358,0.16236,0,1
5,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.056456,0.17271,0.20321,0,1
5,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.080256,0.16999,0.16581,0,1
5,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.091819,0.16981,0.15403,0,1
5,GO RESPONSE TO FLUID SHEAR STRESS,0.072385,0.16881,0.20342,0,1
5,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.062884,0.16875,0.15737,0,1
5,GO HEART VALVE DEVELOPMENT,0.062884,0.16766,0.22975,0,1
5,GO PROTEIN KINASE B SIGNALING,0.080256,0.16731,0.17122,0,1
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.1306,0.16595,0.17132,0,1
5,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.056456,0.16565,0.17512,0,1
5,GO MANGANESE ION TRANSPORT,0.10468,0.16528,0.14013,0,1
5,GO KERATINOCYTE PROLIFERATION,0.065157,0.16443,0.17559,0,1
5,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.062884,0.16291,0.15713,0,1
5,GO CALCIUM MEDIATED SIGNALING,0.069906,0.16082,0.17494,0,1
5,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.29248,0.16024,0.15569,0,1
5,GO REGULATION OF CELL MATRIX ADHESION,0.074935,0.15957,0.21836,0,1
5,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.1306,0.15776,0.18032,0,1
5,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.08588,0.15691,0.17173,0,1
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.16123,0.15472,0.1721,0,1
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.062884,0.15256,0.19242,0,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.10134,0.15177,0.15875,0,1
5,GO POSITIVE REGULATION OF MRNA PROCESSING,0.11524,0.15126,0.12032,0,1
5,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.067497,0.15087,0.19992,0,1
5,GO ENDOTHELIAL CELL CHEMOTAXIS,0.058535,0.14954,0.22182,0,1
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.15197,0.14945,0.14382,0,1
5,GO EXOCYTOSIS,0.065157,0.1471,0.16476,0,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.13467,0.1463,0.14676,0,1
5,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.058535,0.14607,0.27178,0,1
5,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.069906,0.14553,0.15321,0,1
5,GO HEART TRABECULA FORMATION,0.10811,0.14445,0.13888,0,1
5,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.080256,0.14428,0.16312,0,1
5,GO ANIMAL ORGAN FORMATION,0.10811,0.1439,0.13552,0,1
5,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.072385,0.14379,0.16218,0,1
5,GO CHONDROCYTE PROLIFERATION,0.12662,0.14148,0.20134,0,1
5,GO ENDOCRINE PROCESS,0.067497,0.1405,0.15371,0,1
5,GO BIOMINERALIZATION,0.056456,0.1403,0.18313,0,1
5,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.23203,0.14008,0.11773,0,1
5,GO VASCULOGENESIS,0.2259,0.13994,0.15495,0,1
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.17091,0.13981,0.16752,0,1
5,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.091819,0.13957,0.15942,0,1
5,GO OSTEOBLAST PROLIFERATION,0.23827,0.13914,0.16117,0,1
5,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.2577,0.13814,0.11698,0,1
5,GO PROSTAGLANDIN TRANSPORT,0.13467,0.1347,0.16297,0,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.11524,0.13441,0.16513,0,1
5,GO CERAMIDE CATABOLIC PROCESS,0.069906,0.13407,0.21071,0,1
5,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.060677,0.13367,0.18544,0,1
5,GO L GLUTAMATE IMPORT,0.080256,0.13276,0.14668,0,1
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.08303,0.13226,0.17664,0,1
5,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.065157,0.1318,0.1147,0,1
5,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.15655,0.13172,0.090908,0,1
5,GO HYPOTHALAMUS DEVELOPMENT,0.067497,0.13052,0.16319,0,1
5,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.062884,0.13045,0.15073,0,1
5,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.11163,0.13025,0.092325,0,1
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.077559,0.1301,0.13668,0,1
5,GO POSITIVE REGULATION OF MAPK CASCADE,0.13467,0.12859,0.15443,0,1
5,GO REGULATION OF MAPK CASCADE,0.069906,0.12766,0.17107,0,1
5,GO REGULATION OF EXOSOMAL SECRETION,0.077559,0.12617,0.14777,0,1
5,GO NEGATIVE REGULATION OF SECRETION,0.074935,0.12582,0.14275,0,1
5,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.091819,0.1257,0.096539,0,1
5,GO PLACENTA DEVELOPMENT,0.067497,0.12498,0.15768,0,1
5,GO RESPONSE TO NUTRIENT,0.067497,0.12495,0.15906,0,1
5,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.098083,0.12395,0.15491,0,1
5,GO MESENCHYME MORPHOGENESIS,0.067497,0.12325,0.18438,0,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.08881,0.12189,0.16991,0,1
5,GO REGULATION OF HEART MORPHOGENESIS,0.13467,0.12147,0.15442,0,1
5,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.14312,0.12023,0.16509,0,1
5,GO MITOCHONDRIAL PROTEIN PROCESSING,0.08588,0.11973,0.12208,0,1
5,GO RESPONSE TO VITAMIN,0.12273,0.11728,0.15156,0,1
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.069906,0.1169,0.15417,0,1
5,GO REGULATION OF TRANSLATIONAL ELONGATION,0.11894,0.11604,0.082589,0,1
5,GO TAXIS,0.072385,0.11479,0.18153,0,1
5,GO INCLUSION BODY ASSEMBLY,0.11163,0.11314,0.17918,0,1
5,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.062884,0.1121,0.18809,0,1
5,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.20256,0.11096,0.096572,0,1
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.056456,0.10918,0.13891,0,1
5,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.08588,0.10904,0.0896,0,1
5,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.08303,0.10885,0.097,0,1
5,GO UROGENITAL SYSTEM DEVELOPMENT,0.056456,0.1085,0.18391,0,1
5,GO EPITHELIAL CELL PROLIFERATION,0.080256,0.10703,0.16461,0,1
5,GO SMOOTH MUSCLE CONTRACTION,0.080256,0.1069,0.15117,0,1
5,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.17591,0.10607,0.10262,0,1
5,GO ENDOTHELIAL CELL PROLIFERATION,0.13467,0.10552,0.15898,0,1
5,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.074935,0.10548,0.16237,0,1
5,GO REGULATION OF ANIMAL ORGAN FORMATION,0.3148,0.10426,0.098646,0,1
5,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.19156,0.10422,0.09588,0,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.16123,0.10333,0.14259,0,1
5,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.17591,0.10074,0.098782,0,1
5,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.056456,0.10027,0.12466,0,1
5,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.077559,0.099267,0.17405,0,1
5,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.12662,0.097346,0.089393,0,1
5,GO CARTILAGE DEVELOPMENT,0.094909,0.0972,0.17477,0,1
5,GO GANGLIOSIDE METABOLIC PROCESS,0.074935,0.096883,0.16137,0,1
5,GO REGULATION OF DNA CATABOLIC PROCESS,0.21989,0.096743,0.091982,0,1
5,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.10811,0.0945,0.17018,0,1
5,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.058535,0.094051,0.13794,0,1
5,GO PEPTIDYL PROLINE MODIFICATION,0.12662,0.090324,0.086772,0,1
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.15655,0.08961,0.14968,0,1
5,GO SLEEP,0.13885,0.089495,0.11419,0,1
5,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.08881,0.086866,0.10556,0,1
5,GO REGULATION OF TELOMERASE ACTIVITY,0.20256,0.086378,0.10762,0,1
5,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.14312,0.083859,0.12341,0,1
5,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.1306,0.083225,0.10802,0,1
5,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.056456,0.080765,0.11327,0,1
5,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.16123,0.07991,0.076641,0,1
5,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.12662,0.072777,0.12377,0,1
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.15655,0.069459,0.13372,0,1
5,GO GTP BIOSYNTHETIC PROCESS,0.28529,0.068978,0.08606,0,1
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.1475,0.062103,0.14421,0,1
5,GO AEROBIC RESPIRATION,0.14312,0.058693,0.051956,0,1
5,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.15655,0.05024,0.052687,0,1
5,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0096484,0.36344,0.39427,0,0
5,GO PARENTAL BEHAVIOR,0.065157,0.34714,0.23399,0,0
5,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0011418,0.319,0.3735,0,0
5,GO INHIBITORY SYNAPSE ASSEMBLY,0.0047188,0.31486,0.4511,0,0
5,GO INTERLEUKIN 13 PRODUCTION,0.23827,0.31031,0.18059,0,0
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.067497,0.30554,0.24392,0,0
5,GO SEX DETERMINATION,0.0083971,0.30328,0.27556,0,0
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.072385,0.29624,0.22072,0,0
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.018736,0.28927,0.2638,0,0
5,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.0044907,0.28538,0.35741,0,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.43329,0.28476,0.11989,0,0
5,GO REGULATION OF TUBULIN DEACETYLATION,0.0029965,0.27954,0.34237,0,0
5,GO INOSITOL METABOLIC PROCESS,0.010572,0.27856,0.24732,0,0
5,GO PROTEIN PALMITOYLATION,0.00018128,0.27691,0.34181,0,0
5,GO NON MOTILE CILIUM ASSEMBLY,0.0036751,0.27538,0.24822,0,0
5,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.0076456,0.27093,0.35124,0,0
5,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.37964,0.26672,0.19092,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.021265,0.26433,0.27692,0,0
5,GO PROTEIN ACTIVATION CASCADE,0.12273,0.26186,0.171,0,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00057531,0.26185,0.30793,0,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.52145,0.25925,0.093397,0,0
5,GO REGULATION OF HIPPO SIGNALING,0.0066311,0.25743,0.2926,0,0
5,GO RESPONSE TO TYPE I INTERFERON,0.62923,0.25408,0.08588,0,0
5,GO REGULATION OF CELL PROJECTION SIZE,0.015104,0.25339,0.28935,0,0
5,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.013235,0.25194,0.22089,0,0
5,GO EPITHELIAL CELL CELL ADHESION,0.058535,0.25132,0.23226,0,0
5,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0054671,0.24953,0.3292,0,0
5,GO MITRAL VALVE DEVELOPMENT,0.11163,0.2463,0.20559,0,0
5,GO LIMB BUD FORMATION,0.094909,0.24545,0.22753,0,0
5,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.018736,0.24369,0.22274,0,0
5,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.026142,0.24175,0.30291,0,0
5,GO SECONDARY PALATE DEVELOPMENT,0.0015041,0.24154,0.38522,0,0
5,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.014457,0.24119,0.35393,0,0
5,GO REGULATION OF RECEPTOR CLUSTERING,0.052482,0.23871,0.24302,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.1306,0.23667,0.20264,0,0
5,GO THYROID HORMONE METABOLIC PROCESS,0.031957,0.23643,0.19524,0,0
5,GO POSITIVE REGULATION OF NEURON MIGRATION,0.098083,0.23592,0.25593,0,0
5,GO CORNIFICATION,0.010101,0.23546,0.1964,0,0
5,GO HISTONE H3 K9 ACETYLATION,0.024086,0.23308,0.21463,0,0
5,GO KERATINOCYTE DEVELOPMENT,0.038848,0.23125,0.24336,0,0
5,GO REGULATION OF GLUTAMATE SECRETION,0.056456,0.231,0.2497,0,0
5,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.00081392,0.22968,0.31078,0,0
5,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.056456,0.22924,0.22965,0,0
5,GO POLYOL TRANSPORT,0.08303,0.22756,0.19238,0,0
5,GO PROTEIN HETEROTETRAMERIZATION,0.019548,0.22686,0.18112,0,0
5,GO MACROPHAGE PROLIFERATION,0.20822,0.22665,0.21797,0,0
5,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.58498,0.22571,0.089305,0,0
5,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.025096,0.22485,0.20181,0,0
5,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.035953,0.22387,0.18895,0,0
5,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.022172,0.21914,0.31594,0,0
5,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.08881,0.21816,0.16096,0,0
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.010101,0.21778,0.315,0,0
5,GO XENOBIOTIC CATABOLIC PROCESS,0.15655,0.21694,0.17468,0,0
5,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.030713,0.21619,0.18532,0,0
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0036751,0.21595,0.29846,0,0
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.2998,0.21586,0.15378,0,0
5,GO CELL DIFFERENTIATION IN SPINAL CORD,0.067497,0.21574,0.169,0,0
5,GO AXONAL FASCICULATION,0.013235,0.21519,0.33247,0,0
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.46168,0.21283,0.10737,0,0
5,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.0083971,0.21188,0.24852,0,0
5,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.00057531,0.21135,0.29232,0,0
5,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.060677,0.2111,0.22864,0,0
5,GO P BODY ASSEMBLY,0.0092139,0.2095,0.25611,0,0
5,GO PROTEIN LOCALIZATION TO AXON,0.12273,0.20781,0.23005,0,0
5,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.40594,0.20777,0.10649,0,0
5,GO SEMI LUNAR VALVE DEVELOPMENT,0.091819,0.20749,0.21972,0,0
5,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.83078,0.20695,0.052449,0,0
5,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.2577,0.20648,0.11015,0,0
5,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.5959,0.20648,0.069097,0,0
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.072385,0.20621,0.24089,0,0
5,GO CGMP METABOLIC PROCESS,0.010572,0.20602,0.30403,0,0
5,GO ASTRAL MICROTUBULE ORGANIZATION,0.012106,0.20545,0.34408,0,0
5,GO CEREBRAL CORTEX DEVELOPMENT,0.0047188,0.20542,0.24466,0,0
5,GO STORE OPERATED CALCIUM ENTRY,0.15197,0.20453,0.15555,0,0
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.47137,0.20438,0.12211,0,0
5,GO OOGENESIS,0.0027019,0.20422,0.20237,0,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.040368,0.20422,0.23358,0,0
5,GO DETECTION OF OTHER ORGANISM,0.64051,0.20364,0.067053,0,0
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0063209,0.20312,0.3333,0,0
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.074935,0.20296,0.18646,0,0
5,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.26442,0.20283,0.16542,0,0
5,GO SCHWANN CELL DEVELOPMENT,0.01266,0.20255,0.25656,0,0
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.54223,0.20148,0.088856,0,0
5,GO REGULATION OF RESPIRATORY BURST,0.043559,0.20135,0.19926,0,0
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.033245,0.20112,0.27806,0,0
5,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.0010798,0.20011,0.26093,0,0
5,GO ASTROCYTE ACTIVATION,0.35442,0.19885,0.12544,0,0
5,GO SINGLE STRAND BREAK REPAIR,0.0076456,0.19849,0.25715,0,0
5,GO PINOCYTOSIS,0.13885,0.19775,0.16631,0,0
5,GO THYMOCYTE APOPTOTIC PROCESS,0.39705,0.19749,0.10413,0,0
5,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.019548,0.19748,0.23124,0,0
5,GO ANTIBACTERIAL HUMORAL RESPONSE,0.2998,0.19732,0.14964,0,0
5,GO MAINTENANCE OF ORGANELLE LOCATION,0.024086,0.19636,0.22741,0,0
5,GO CELL JUNCTION DISASSEMBLY,0.25111,0.19624,0.17274,0,0
5,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.14312,0.19614,0.14145,0,0
5,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.025096,0.19614,0.22695,0,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.00045436,0.19582,0.31176,0,0
5,GO COBALAMIN METABOLIC PROCESS,0.0038653,0.19442,0.22495,0,0
5,GO INSEMINATION,0.1475,0.19421,0.16383,0,0
5,GO LYMPH VESSEL MORPHOGENESIS,0.08303,0.19417,0.23487,0,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.42405,0.19414,0.14153,0,0
5,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.069906,0.19385,0.24087,0,0
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.013235,0.19361,0.22301,0,0
5,GO EPIDERMIS MORPHOGENESIS,0.1475,0.19354,0.16793,0,0
5,GO OOCYTE MATURATION,0.008797,0.19318,0.20852,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.035953,0.19312,0.22808,0,0
5,GO REGULATION OF BONE DEVELOPMENT,0.15655,0.19309,0.18199,0,0
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.072385,0.19275,0.24639,0,0
5,GO NEURAL TUBE DEVELOPMENT,0.011063,0.19257,0.22079,0,0
5,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.091819,0.19248,0.15899,0,0
5,GO OOCYTE DIFFERENTIATION,0.00054254,0.19194,0.25346,0,0
5,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.16602,0.1919,0.18475,0,0
5,GO RESPONSE TO LEUCINE,0.077559,0.19178,0.21277,0,0
5,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.13885,0.19159,0.16735,0,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.080256,0.19157,0.1961,0,0
5,GO MITOCHONDRIAL RNA PROCESSING,0.062884,0.19143,0.16789,0,0
5,GO TRIGEMINAL NERVE DEVELOPMENT,0.49108,0.1911,0.1168,0,0
5,GO SUCKLING BEHAVIOR,0.091819,0.19103,0.18542,0,0
5,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.098083,0.19072,0.15635,0,0
5,GO NEGATIVE REGULATION OF COAGULATION,0.17091,0.19048,0.17039,0,0
5,GO AMYLOID FIBRIL FORMATION,0.077559,0.19034,0.19989,0,0
5,GO CELL PROLIFERATION IN FOREBRAIN,0.11894,0.18975,0.1886,0,0
5,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.11163,0.18951,0.32976,0,0
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.015776,0.18876,0.23594,0,0
5,GO MRNA PROCESSING,0.020391,0.1883,0.15881,0,0
5,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.052482,0.18766,0.27739,0,0
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0012758,0.18719,0.27273,0,0
5,GO PULMONARY VALVE DEVELOPMENT,0.11524,0.18647,0.22725,0,0
5,GO CYTOPLASM ORGANIZATION,0.015104,0.186,0.26457,0,0
5,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.197,0.18586,0.1686,0,0
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.21989,0.18523,0.17186,0,0
5,GO AZOLE TRANSMEMBRANE TRANSPORT,0.062884,0.18467,0.22046,0,0
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.098083,0.18398,0.21926,0,0
5,GO ACTIN FILAMENT BASED TRANSPORT,0.058535,0.18392,0.23511,0,0
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.14312,0.18325,0.17106,0,0
5,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0010798,0.18239,0.27416,0,0
5,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.065157,0.18185,0.18457,0,0
5,GO MACROPHAGE CYTOKINE PRODUCTION,0.17091,0.18066,0.23507,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.66333,0.17998,0.067018,0,0
5,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.42405,0.17935,0.14783,0,0
5,GO BRONCHUS DEVELOPMENT,0.074935,0.17925,0.23627,0,0
5,GO PARAXIAL MESODERM DEVELOPMENT,0.041938,0.17906,0.18794,0,0
5,GO CYTOSOLIC TRANSPORT,0.00020554,0.17869,0.29342,0,0
5,GO POSITIVE REGULATION OF JNK CASCADE,0.056456,0.17832,0.20484,0,0
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.17591,0.17826,0.17629,0,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.37964,0.17823,0.10511,0,0
5,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.021265,0.17807,0.21879,0,0
5,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.11163,0.17768,0.1722,0,0
5,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.023112,0.17726,0.26169,0,0
5,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.20256,0.17715,0.12997,0,0
5,GO MEIOTIC CHROMOSOME SEGREGATION,0.094909,0.17643,0.15952,0,0
5,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.016475,0.17638,0.22368,0,0
5,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.57414,0.17636,0.11384,0,0
5,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.27821,0.1761,0.14662,0,0
5,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.072385,0.17601,0.22733,0,0
5,GO MEIOTIC CHROMOSOME SEPARATION,0.10468,0.17592,0.20443,0,0
5,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0076456,0.17586,0.26039,0,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.023112,0.17583,0.3398,0,0
5,GO METANEPHRIC NEPHRON DEVELOPMENT,0.15655,0.17559,0.18518,0,0
5,GO ARACHIDONIC ACID METABOLIC PROCESS,0.056456,0.17507,0.17716,0,0
5,GO CELLULAR RESPONSE TO STEROL,0.010572,0.17496,0.27854,0,0
5,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.031957,0.17489,0.19701,0,0
5,GO NEGATIVE REGULATION OF TOR SIGNALING,0.007293,0.1745,0.22214,0,0
5,GO LYMPHANGIOGENESIS,0.10468,0.17448,0.2128,0,0
5,GO MAST CELL MEDIATED IMMUNITY,0.37111,0.17412,0.12899,0,0
5,GO CELLULAR RESPONSE TO VITAMIN,0.13467,0.17411,0.17921,0,0
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.08303,0.1738,0.15837,0,0
5,GO HEPARIN METABOLIC PROCESS,0.056456,0.17379,0.2681,0,0
5,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.16602,0.17256,0.15931,0,0
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.67486,0.17242,0.066366,0,0
5,GO NEUTROPHIL EXTRAVASATION,0.54223,0.17214,0.1078,0,0
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.20822,0.17199,0.12426,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.50109,0.17176,0.07816,0,0
5,GO HISTONE H4 K16 ACETYLATION,0.024086,0.17168,0.21516,0,0
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.12662,0.17143,0.25325,0,0
5,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.12662,0.17137,0.19743,0,0
5,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.2577,0.1712,0.1185,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.13467,0.17118,0.16491,0,0
5,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.056456,0.17092,0.14912,0,0
5,GO AMINO ACID IMPORT,0.020391,0.17046,0.18002,0,0
5,GO BRANCHING MORPHOGENESIS OF A NERVE,0.060677,0.1704,0.23715,0,0
5,GO DETECTION OF MECHANICAL STIMULUS,0.0054671,0.17022,0.23551,0,0
5,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.17091,0.17013,0.16323,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.23203,0.17008,0.22661,0,0
5,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.33029,0.17007,0.10443,0,0
5,GO REGULATION OF BONE REMODELING,0.17591,0.16998,0.1715,0,0
5,GO CELLULAR RESPONSE TO ETHANOL,0.214,0.16996,0.18723,0,0
5,GO GAS TRANSPORT,0.14312,0.16964,0.16534,0,0
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.81845,0.16939,0.04171,0,0
5,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.55277,0.16885,0.092844,0,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.67486,0.16871,0.056526,0,0
5,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.14312,0.16865,0.16971,0,0
5,GO MATERNAL PLACENTA DEVELOPMENT,0.12662,0.16856,0.16277,0,0
5,GO MEIOTIC CELL CYCLE,0.019548,0.16856,0.18033,0,0
5,GO DEFINITIVE HEMOPOIESIS,0.041938,0.16821,0.25065,0,0
5,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.062884,0.168,0.19796,0,0
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.072385,0.16787,0.20705,0,0
5,GO VITAMIN D METABOLIC PROCESS,0.38829,0.16751,0.11338,0,0
5,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.11894,0.1675,0.19849,0,0
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.2577,0.16696,0.14646,0,0
5,GO RESPONSE TO INTERLEUKIN 2,0.38829,0.16686,0.16182,0,0
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0080134,0.16651,0.26212,0,0
5,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.11163,0.16647,0.12696,0,0
5,GO NEGATIVE REGULATION OF ANOIKIS,0.11163,0.1664,0.20241,0,0
5,GO RNA SPLICING,0.035953,0.16618,0.14116,0,0
5,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0025648,0.16594,0.18639,0,0
5,GO GANGLION DEVELOPMENT,0.037377,0.16574,0.23948,0,0
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0010798,0.16555,0.25114,0,0
5,GO ENDODERM FORMATION,0.067497,0.16365,0.24108,0,0
5,GO PLATELET DEGRANULATION,0.20822,0.16358,0.15298,0,0
5,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.011063,0.16356,0.15121,0,0
5,GO CHROMATIN SILENCING,0.060677,0.16322,0.16645,0,0
5,GO PROTEIN AUTO ADP RIBOSYLATION,0.026142,0.16292,0.22775,0,0
5,GO NOREPINEPHRINE TRANSPORT,0.08303,0.16286,0.22191,0,0
5,GO MRNA METHYLATION,0.030713,0.16276,0.17514,0,0
5,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.83078,0.16275,0.036857,0,0
5,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.08881,0.1627,0.18814,0,0
5,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.33821,0.16242,0.21133,0,0
5,GO NEGATIVE REGULATION OF GLIOGENESIS,0.019548,0.16241,0.1847,0,0
5,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.1475,0.16237,0.17988,0,0
5,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.037377,0.16227,0.27836,0,0
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.62923,0.16209,0.059568,0,0
5,GO MRNA 3 END PROCESSING,0.043559,0.16182,0.15471,0,0
5,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.25111,0.16171,0.20207,0,0
5,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.08588,0.16169,0.2301,0,0
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.15197,0.16165,0.14865,0,0
5,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.24463,0.16143,0.11314,0,0
5,GO BONE RESORPTION,0.15655,0.16138,0.17339,0,0
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0029965,0.16125,0.23775,0,0
5,GO REGULATION OF PLATELET ACTIVATION,0.40594,0.16104,0.1064,0,0
5,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.038848,0.16062,0.20322,0,0
5,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.15655,0.16053,0.15846,0,0
5,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.045233,0.16052,0.20261,0,0
5,GO REPLICATION FORK PROCESSING,0.27821,0.16049,0.14497,0,0
5,GO GDP METABOLIC PROCESS,0.056456,0.16048,0.1861,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.062884,0.16047,0.14992,0,0
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.10134,0.16023,0.17504,0,0
5,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.44264,0.16015,0.093034,0,0
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.08303,0.15996,0.18627,0,0
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.74555,0.15947,0.031377,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.67486,0.15931,0.069008,0,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.40594,0.15925,0.1142,0,0
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.015776,0.15924,0.23483,0,0
5,GO RENAL FILTRATION,0.12662,0.15921,0.24284,0,0
5,GO METHIONINE METABOLIC PROCESS,0.028348,0.1592,0.16921,0,0
5,GO PEPTIDE CROSS LINKING,0.25111,0.1592,0.15384,0,0
5,GO CONVERGENT EXTENSION,0.035953,0.15864,0.24654,0,0
5,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0060238,0.15774,0.23489,0,0
5,GO HEART VALVE FORMATION,0.074935,0.15754,0.21208,0,0
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.12662,0.15749,0.18138,0,0
5,GO DNA DEALKYLATION,0.0049572,0.15741,0.17782,0,0
5,GO MEMBRANE LIPID CATABOLIC PROCESS,0.080256,0.15714,0.20299,0,0
5,GO MULTICELLULAR ORGANISM AGING,0.054439,0.15708,0.16148,0,0
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.23203,0.15707,0.17113,0,0
5,GO GOLGI TO ENDOSOME TRANSPORT,0.0060238,0.15702,0.30767,0,0
5,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.023112,0.15692,0.23259,0,0
5,GO PROTEIN LOCALIZATION TO ENDOSOME,0.024086,0.15677,0.24499,0,0
5,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.014457,0.15647,0.21133,0,0
5,GO FATTY ACID DERIVATIVE TRANSPORT,0.069906,0.15607,0.15951,0,0
5,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0024341,0.15587,0.21285,0,0
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.026142,0.15578,0.239,0,0
5,GO MEMBRANE PROTEIN PROTEOLYSIS,0.072385,0.15564,0.21,0,0
5,GO OXYGEN TRANSPORT,0.10468,0.15558,0.19308,0,0
5,GO RESPONSE TO INTERFERON ALPHA,0.51122,0.15557,0.11423,0,0
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.55277,0.15531,0.068558,0,0
5,GO ACROSOME ASSEMBLY,0.094909,0.15529,0.15966,0,0
5,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.1475,0.15529,0.13634,0,0
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.93062,0.15513,-0.019231,0,0
5,GO RENAL ABSORPTION,0.11163,0.15488,0.19415,0,0
5,GO EAR MORPHOGENESIS,0.022172,0.15478,0.1655,0,0
5,GO MALE SEX DETERMINATION,0.13885,0.15469,0.19319,0,0
5,GO PRO B CELL DIFFERENTIATION,0.080256,0.15404,0.20943,0,0
5,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.045233,0.15399,0.10753,0,0
5,GO COLLAGEN METABOLIC PROCESS,0.12662,0.15388,0.23204,0,0
5,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.060677,0.15346,0.20346,0,0
5,GO GLUCOSE CATABOLIC PROCESS,0.041938,0.15327,0.18253,0,0
5,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.4521,0.15315,0.11256,0,0
5,GO DIENCEPHALON DEVELOPMENT,0.0076456,0.15313,0.22738,0,0
5,GO SEQUESTERING OF METAL ION,0.79394,0.15308,0.0075311,0,0
5,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.26442,0.15281,0.1455,0,0
5,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.12662,0.1527,0.18516,0,0
5,GO EATING BEHAVIOR,0.0076456,0.15252,0.21048,0,0
5,GO RESPONSE TO MURAMYL DIPEPTIDE,0.14312,0.15251,0.17335,0,0
5,GO TUBE MORPHOGENESIS,0.058535,0.1523,0.19011,0,0
5,GO REGULATION OF RECEPTOR RECYCLING,0.098083,0.1523,0.16978,0,0
5,GO BLOOD VESSEL MORPHOGENESIS,0.13467,0.15229,0.17259,0,0
5,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.025096,0.15227,0.18644,0,0
5,GO MOVEMENT IN HOST ENVIRONMENT,0.18102,0.15211,0.13351,0,0
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.44264,0.15168,0.098731,0,0
5,GO BLASTOCYST GROWTH,0.19156,0.15152,0.10309,0,0
5,GO MAMMARY GLAND MORPHOGENESIS,0.067497,0.15149,0.21848,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.056456,0.15141,0.1462,0,0
5,GO NEURAL CREST CELL DIFFERENTIATION,0.038848,0.15135,0.18965,0,0
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.11163,0.1513,0.19406,0,0
5,GO T CELL CYTOKINE PRODUCTION,0.72171,0.15123,0.041697,0,0
5,GO MALE MEIOSIS I,0.080256,0.1512,0.17589,0,0
5,GO DORSAL SPINAL CORD DEVELOPMENT,0.18102,0.15095,0.19539,0,0
5,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.33029,0.15074,0.1443,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.014457,0.15033,0.2151,0,0
5,GO RESPONSE TO PARATHYROID HORMONE,0.197,0.15029,0.13777,0,0
5,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.040368,0.15017,0.13732,0,0
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.17591,0.15016,0.17307,0,0
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.1306,0.15006,0.18995,0,0
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.008797,0.14986,0.19172,0,0
5,GO REGULATION OF CELLULAR EXTRAVASATION,0.61803,0.14976,0.081271,0,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.031957,0.14941,0.19749,0,0
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.065157,0.14937,0.15277,0,0
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.031957,0.14922,0.20577,0,0
5,GO INTERFERON BETA PRODUCTION,0.27126,0.14898,0.13351,0,0
5,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.1475,0.14875,0.12522,0,0
5,GO MEIOSIS I CELL CYCLE PROCESS,0.091819,0.14872,0.15271,0,0
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.034576,0.14854,0.19363,0,0
5,GO MATING BEHAVIOR,0.20256,0.14846,0.12305,0,0
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.30724,0.14844,0.15036,0,0
5,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.13885,0.14831,0.17175,0,0
5,GO EPIBOLY,0.094909,0.14826,0.20154,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.40594,0.14793,0.10238,0,0
5,GO MEIOTIC CELL CYCLE PROCESS,0.035953,0.1479,0.1722,0,0
5,GO RESPONSE TO PROGESTERONE,0.098083,0.14789,0.18469,0,0
5,GO LAMELLIPODIUM ASSEMBLY,0.023112,0.14774,0.20473,0,0
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.49108,0.14774,0.079976,0,0
5,GO REGULATION OF T CELL MIGRATION,0.51122,0.14759,0.08069,0,0
5,GO HISTONE H2B UBIQUITINATION,0.074935,0.14745,0.14012,0,0
5,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.28529,0.1474,0.11767,0,0
5,GO CELLULAR SODIUM ION HOMEOSTASIS,0.054439,0.14733,0.17554,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.058535,0.14731,0.13068,0,0
5,GO TRANSEPITHELIAL TRANSPORT,0.091819,0.14724,0.17257,0,0
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.24463,0.14699,0.14846,0,0
5,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.21989,0.14693,0.11567,0,0
5,GO ENDOTHELIUM DEVELOPMENT,0.065157,0.14679,0.19999,0,0
5,GO COLLAGEN CATABOLIC PROCESS,0.12273,0.14674,0.23407,0,0
5,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.16123,0.14657,0.13143,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.007293,0.14604,0.2773,0,0
5,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.28529,0.14578,0.17128,0,0
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.08303,0.14572,0.23739,0,0
5,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.062884,0.14568,0.18615,0,0
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.010572,0.14562,0.20484,0,0
5,GO I KAPPAB PHOSPHORYLATION,0.27126,0.1456,0.13869,0,0
5,GO T CELL MEDIATED IMMUNITY,0.83078,0.14522,0.022953,0,0
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.072385,0.14476,0.20023,0,0
5,GO REGULATION OF POSITIVE CHEMOTAXIS,0.19156,0.1447,0.12099,0,0
5,GO KIDNEY MESENCHYME DEVELOPMENT,0.13467,0.14424,0.13936,0,0
5,GO REGULATION OF LIPASE ACTIVITY,0.2998,0.14421,0.096125,0,0
5,GO AMINO SUGAR METABOLIC PROCESS,0.058535,0.14413,0.16136,0,0
5,GO STABILIZATION OF MEMBRANE POTENTIAL,0.060677,0.14406,0.25467,0,0
5,GO TRNA MODIFICATION,0.12273,0.1436,0.11052,0,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.17591,0.14347,0.15504,0,0
5,GO CHROMOSOME ORGANIZATION,0.0172,0.14338,0.18479,0,0
5,GO LEFT RIGHT AXIS SPECIFICATION,0.20822,0.1432,0.14293,0,0
5,GO RNA PROCESSING,0.052482,0.14313,0.11984,0,0
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.072385,0.14305,0.18143,0,0
5,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.74555,0.14288,0.052468,0,0
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.58498,0.14287,0.082066,0,0
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.32248,0.14285,0.1525,0,0
5,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.14312,0.14273,0.14617,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.006955,0.14271,0.17976,0,0
5,GO N GLYCAN PROCESSING,0.050584,0.1427,0.23281,0,0
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.84314,0.14262,0.05441,0,0
5,GO POSITIVE REGULATION OF ANION TRANSPORT,0.08588,0.14241,0.14345,0,0
5,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.074935,0.14199,0.19503,0,0
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0031545,0.14194,0.24343,0,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.0092139,0.14193,0.15378,0,0
5,GO MICROVILLUS ASSEMBLY,0.046961,0.14174,0.1509,0,0
5,GO SERTOLI CELL DIFFERENTIATION,0.18624,0.14159,0.13968,0,0
5,GO GLOMERULUS DEVELOPMENT,0.056456,0.14152,0.25722,0,0
5,GO STEROID HORMONE SECRETION,0.14312,0.14143,0.12467,0,0
5,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.17091,0.14113,0.14183,0,0
5,GO COMPLEMENT ACTIVATION,0.72171,0.141,0.058375,0,0
5,GO RNA 3 END PROCESSING,0.069906,0.14097,0.12977,0,0
5,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.10134,0.14096,0.18669,0,0
5,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.27821,0.14084,0.12011,0,0
5,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.017954,0.1408,0.25708,0,0
5,GO G2 DNA DAMAGE CHECKPOINT,0.08303,0.14028,0.16663,0,0
5,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.28529,0.1402,0.16891,0,0
5,GO CELL FATE SPECIFICATION,0.10134,0.14017,0.14754,0,0
5,GO RENAL VESICLE DEVELOPMENT,0.49108,0.14015,0.081091,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE,0.0092139,0.14009,0.17655,0,0
5,GO REGULATION OF SPINDLE ORGANIZATION,0.020391,0.14008,0.18999,0,0
5,GO MATING,0.091819,0.13966,0.14154,0,0
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.15197,0.13964,0.15054,0,0
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.25111,0.13952,0.11389,0,0
5,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.072385,0.13937,0.17519,0,0
5,GO REGULATION OF TISSUE REMODELING,0.1475,0.1393,0.17391,0,0
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.37111,0.13915,0.11646,0,0
5,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.016475,0.13911,0.19075,0,0
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.27126,0.13902,0.12643,0,0
5,GO REGULATION OF COAGULATION,0.28529,0.13901,0.13821,0,0
5,GO REGULATION OF CELL DIVISION,0.022172,0.13898,0.16414,0,0
5,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.015104,0.1388,0.18276,0,0
5,GO FLUID TRANSPORT,0.27126,0.1385,0.11713,0,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.058535,0.13839,0.20282,0,0
5,GO HEXOSE CATABOLIC PROCESS,0.013235,0.13822,0.17733,0,0
5,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.08303,0.13814,0.18763,0,0
5,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.18624,0.13805,0.18598,0,0
5,GO MALE GENITALIA DEVELOPMENT,0.10811,0.13805,0.15231,0,0
5,GO PARAXIAL MESODERM MORPHOGENESIS,0.13467,0.138,0.16806,0,0
5,GO DIGESTIVE TRACT MORPHOGENESIS,0.048745,0.13752,0.21745,0,0
5,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.16602,0.1375,0.15979,0,0
5,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.27126,0.13743,0.13485,0,0
5,GO DENDRITE SELF AVOIDANCE,0.056456,0.13701,0.25295,0,0
5,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.12662,0.13701,0.13773,0,0
5,GO PEPTIDYL METHIONINE MODIFICATION,0.08588,0.1368,0.13917,0,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.015776,0.13672,0.22416,0,0
5,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.065157,0.13651,0.14927,0,0
5,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.2998,0.13646,0.13233,0,0
5,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.11894,0.13627,0.14647,0,0
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.16123,0.13621,0.18877,0,0
5,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.024086,0.13608,0.18625,0,0
5,GO MATURE B CELL DIFFERENTIATION,0.64051,0.13605,0.065672,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.38829,0.13602,0.10754,0,0
5,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.1306,0.13586,0.16274,0,0
5,GO ENDOCRINE PANCREAS DEVELOPMENT,0.052482,0.13585,0.19906,0,0
5,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.08881,0.13581,0.17889,0,0
5,GO TISSUE REMODELING,0.11524,0.13569,0.20592,0,0
5,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.52145,0.13567,0.07893,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.11163,0.13566,0.16533,0,0
5,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0044907,0.13554,0.23177,0,0
5,GO ETHANOL METABOLIC PROCESS,0.30724,0.13553,0.036849,0,0
5,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.10134,0.13551,0.23063,0,0
5,GO TRNA PROCESSING,0.11894,0.13548,0.10132,0,0
5,GO PROTEIN ADP RIBOSYLATION,0.091819,0.13543,0.12653,0,0
5,GO MACROPHAGE DIFFERENTIATION,0.53179,0.13538,0.084113,0,0
5,GO INTRA S DNA DAMAGE CHECKPOINT,0.065157,0.13527,0.2059,0,0
5,GO COPPER ION TRANSPORT,0.13885,0.13516,0.12733,0,0
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.10468,0.13511,0.17316,0,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.18102,0.13508,0.15997,0,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.007293,0.13499,0.15806,0,0
5,GO PROTEIN K48 LINKED UBIQUITINATION,0.045233,0.13497,0.1483,0,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.13467,0.13496,0.17368,0,0
5,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.062884,0.13461,0.1573,0,0
5,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.11163,0.13453,0.13254,0,0
5,GO VASCULATURE DEVELOPMENT,0.11163,0.13444,0.17871,0,0
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.15655,0.13428,0.14002,0,0
5,GO ANATOMICAL STRUCTURE REGRESSION,0.094909,0.13414,0.21752,0,0
5,GO CORTICOSTEROID HORMONE SECRETION,0.2998,0.13399,0.10184,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.14312,0.13386,0.15447,0,0
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.17591,0.1338,0.12165,0,0
5,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.011063,0.13374,0.28223,0,0
5,GO INTERACTION WITH HOST,0.1475,0.13359,0.13502,0,0
5,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.54223,0.13323,0.099535,0,0
5,GO ZYMOGEN ACTIVATION,0.30724,0.1332,0.11705,0,0
5,GO DNA DEMETHYLATION,0.018736,0.13308,0.16622,0,0
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.052482,0.13295,0.15808,0,0
5,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.26442,0.13295,0.14314,0,0
5,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.56341,0.13295,0.073405,0,0
5,GO REGULATION OF GASTRULATION,0.077559,0.13261,0.17115,0,0
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.13885,0.13252,0.14529,0,0
5,GO CYTOKINE PRODUCTION,0.40594,0.13249,0.098499,0,0
5,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.17591,0.13246,0.14019,0,0
5,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.20822,0.13243,0.14599,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.08303,0.13224,0.14021,0,0
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.072385,0.13212,0.14312,0,0
5,GO BONE MINERALIZATION,0.080256,0.13208,0.17258,0,0
5,GO SIGNAL PEPTIDE PROCESSING,0.060677,0.13202,0.17378,0,0
5,GO SYNCYTIUM FORMATION,0.11163,0.132,0.17537,0,0
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.037377,0.13195,0.18579,0,0
5,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0049572,0.13176,0.21123,0,0
5,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.020391,0.1317,0.15622,0,0
5,GO ENTRY INTO HOST,0.214,0.13166,0.12907,0,0
5,GO RNA MODIFICATION,0.060677,0.1314,0.11751,0,0
5,GO REGULATION OF LIPID KINASE ACTIVITY,0.17591,0.13119,0.14917,0,0
5,GO VIRAL RELEASE FROM HOST CELL,0.0027019,0.13109,0.17266,0,0
5,GO INNER CELL MASS CELL PROLIFERATION,0.1475,0.13108,0.14179,0,0
5,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.062884,0.13105,0.16951,0,0
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.14312,0.13099,0.13478,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.058535,0.13083,0.15677,0,0
5,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.067497,0.13043,0.24749,0,0
5,GO STEROL HOMEOSTASIS,0.13467,0.13042,0.11905,0,0
5,GO MITOTIC CHROMOSOME CONDENSATION,0.32248,0.13024,0.14816,0,0
5,GO ACUTE PHASE RESPONSE,0.41494,0.13021,0.080672,0,0
5,GO REGULATION OF MITOCHONDRIAL FUSION,0.02951,0.13019,0.18991,0,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.55277,0.13009,0.10982,0,0
5,GO POSITIVE REGULATION OF OSSIFICATION,0.10468,0.13008,0.16938,0,0
5,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.40594,0.12986,0.18507,0,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.030713,0.12977,0.14562,0,0
5,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.2259,0.12973,0.10263,0,0
5,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.43329,0.12965,0.077519,0,0
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.50109,0.12961,0.078435,0,0
5,GO POSITIVE REGULATION OF WOUND HEALING,0.18102,0.12949,0.14736,0,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0034935,0.12948,0.17206,0,0
5,GO PROTEIN DEGLYCOSYLATION,0.080256,0.12944,0.18634,0,0
5,GO MRNA EXPORT FROM NUCLEUS,0.030713,0.12927,0.16849,0,0
5,GO CRANIAL NERVE DEVELOPMENT,0.060677,0.12908,0.20186,0,0
5,GO KERATAN SULFATE CATABOLIC PROCESS,0.19156,0.12891,0.22563,0,0
5,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.33029,0.12879,0.08209,0,0
5,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.006955,0.12872,0.21699,0,0
5,GO REGULATION OF PEPTIDASE ACTIVITY,0.12662,0.12853,0.13913,0,0
5,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.10811,0.12842,0.1331,0,0
5,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.18102,0.12838,0.1702,0,0
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.5959,0.12823,0.088021,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.76963,0.12799,0.07265,0,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.094909,0.12791,0.16788,0,0
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.2998,0.12778,0.14246,0,0
5,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.02951,0.1277,0.17819,0,0
5,GO SEQUESTERING OF TRIGLYCERIDE,0.077559,0.12762,0.1922,0,0
5,GO FIBROBLAST MIGRATION,0.069906,0.12751,0.18057,0,0
5,GO SISTER CHROMATID COHESION,0.1306,0.12748,0.14528,0,0
5,GO REGULATION OF MACROPHAGE MIGRATION,0.57414,0.12738,0.087088,0,0
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.14312,0.12736,0.15736,0,0
5,GO NEUROBLAST PROLIFERATION,0.11163,0.12731,0.1774,0,0
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.074935,0.1273,0.14383,0,0
5,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.037377,0.12724,0.17245,0,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.29248,0.12722,0.11302,0,0
5,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.27126,0.12695,0.15635,0,0
5,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.058535,0.12694,0.17839,0,0
5,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.37111,0.12693,0.043723,0,0
5,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.10468,0.12679,0.16056,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.19156,0.12671,0.12338,0,0
5,GO NEGATIVE REGULATION OF CELL DIVISION,0.060677,0.12658,0.20074,0,0
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.99368,0.12637,0.0054567,0,0
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.68646,0.1263,0.057428,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.08881,0.12627,0.19534,0,0
5,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.15197,0.12621,0.14669,0,0
5,GO BICARBONATE TRANSPORT,0.067497,0.1262,0.13868,0,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.214,0.12615,0.14262,0,0
5,GO REGULATION OF STEM CELL DIVISION,0.21989,0.12611,0.18719,0,0
5,GO NEURAL CREST CELL MIGRATION,0.027226,0.1261,0.21231,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.20256,0.12602,0.13189,0,0
5,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.29248,0.12591,0.16043,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.26442,0.12577,0.19148,0,0
5,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.24463,0.12565,0.18152,0,0
5,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.21989,0.12561,0.10006,0,0
5,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.034576,0.12544,0.18947,0,0
5,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.2259,0.12541,0.16276,0,0
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.43329,0.12508,0.085824,0,0
5,GO MAST CELL ACTIVATION,0.4521,0.12497,0.088929,0,0
5,GO REGULATION OF GONAD DEVELOPMENT,0.041938,0.12496,0.19985,0,0
5,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.10811,0.12495,0.20488,0,0
5,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.08588,0.12484,0.19103,0,0
5,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.056456,0.12483,0.16622,0,0
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.060677,0.12478,0.13361,0,0
5,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.037377,0.12475,0.1875,0,0
5,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.080256,0.12434,0.19607,0,0
5,GO VASCULAR WOUND HEALING,0.33821,0.12431,0.14121,0,0
5,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.55277,0.1241,0.078397,0,0
5,GO CELL CELL RECOGNITION,0.11524,0.12382,0.11889,0,0
5,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.15197,0.12359,0.11856,0,0
5,GO PROTEIN AUTOPROCESSING,0.098083,0.12329,0.16666,0,0
5,GO CELLULAR RESPONSE TO VITAMIN D,0.15655,0.12325,0.16023,0,0
5,GO INTRACELLULAR LIPID TRANSPORT,0.031957,0.12323,0.18492,0,0
5,GO ENDOCARDIUM DEVELOPMENT,0.13885,0.12317,0.14273,0,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.048745,0.12297,0.15495,0,0
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.2577,0.12286,0.1152,0,0
5,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.08303,0.12281,0.14363,0,0
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.25111,0.12263,0.14008,0,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.080256,0.12258,0.15211,0,0
5,GO GENITALIA DEVELOPMENT,0.23203,0.12255,0.12314,0,0
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.19156,0.12251,0.13953,0,0
5,GO ROOF OF MOUTH DEVELOPMENT,0.017954,0.12247,0.22742,0,0
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.037377,0.12238,0.15148,0,0
5,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.10134,0.12235,0.17534,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.1475,0.12234,0.15452,0,0
5,GO INTERLEUKIN 6 PRODUCTION,0.5959,0.12222,0.074607,0,0
5,GO MODIFIED AMINO ACID TRANSPORT,0.0054671,0.12222,0.19898,0,0
5,GO SECRETION BY TISSUE,0.060677,0.12215,0.13599,0,0
5,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.11163,0.12213,0.22797,0,0
5,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.10811,0.12196,0.15534,0,0
5,GO REGULATION OF URINE VOLUME,0.041938,0.12164,0.20119,0,0
5,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.021265,0.12163,0.13646,0,0
5,GO SPROUTING ANGIOGENESIS,0.19156,0.12151,0.16868,0,0
5,GO MESENCHYMAL CELL PROLIFERATION,0.1475,0.1215,0.17184,0,0
5,GO CARDIAC CELL DEVELOPMENT,0.0096484,0.12117,0.208,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0052065,0.12108,0.1884,0,0
5,GO MRNA MODIFICATION,0.197,0.12098,0.10487,0,0
5,GO APICAL PROTEIN LOCALIZATION,0.094909,0.12098,0.20847,0,0
5,GO BONE REMODELING,0.16123,0.12093,0.18949,0,0
5,GO PYRUVATE METABOLIC PROCESS,0.012106,0.1209,0.16328,0,0
5,GO INTERLEUKIN 4 PRODUCTION,0.74555,0.12089,0.045689,0,0
5,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.2259,0.12057,0.14945,0,0
5,GO REGULATION OF ANOIKIS,0.091819,0.12031,0.18506,0,0
5,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.14312,0.12028,0.14998,0,0
5,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.10811,0.12021,0.14363,0,0
5,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.08588,0.12009,0.23093,0,0
5,GO VESICLE CARGO LOADING,0.041938,0.12005,0.19272,0,0
5,GO REGULATION OF KIDNEY DEVELOPMENT,0.30724,0.12,0.11092,0,0
5,GO PLATELET AGGREGATION,0.20256,0.11995,0.15904,0,0
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.019548,0.11974,0.2328,0,0
5,GO FIBRINOLYSIS,0.40594,0.11973,0.10046,0,0
5,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.021265,0.11969,0.15405,0,0
5,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.7336,0.11932,0.042269,0,0
5,GO REGULATION OF LYSOSOMAL LUMEN PH,0.27821,0.11919,0.091209,0,0
5,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.045233,0.11914,0.17333,0,0
5,GO NEUROTROPHIN SIGNALING PATHWAY,0.023112,0.11909,0.18709,0,0
5,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.4521,0.11907,0.087617,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.11894,0.11902,0.16438,0,0
5,GO REGULATION OF VASOCONSTRICTION,0.098083,0.11896,0.17619,0,0
5,GO MESODERM MORPHOGENESIS,0.016475,0.11896,0.1968,0,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.20256,0.11895,0.18427,0,0
5,GO THIOESTER METABOLIC PROCESS,0.016475,0.11859,0.13229,0,0
5,GO BASE EXCISION REPAIR,0.018736,0.11842,0.16558,0,0
5,GO ACTIVATED T CELL PROLIFERATION,0.43329,0.11834,0.093848,0,0
5,GO HOMOLOGOUS RECOMBINATION,0.10134,0.1183,0.15837,0,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.48117,0.11828,0.076641,0,0
5,GO REGULATION OF VASCULATURE DEVELOPMENT,0.3148,0.11817,0.1336,0,0
5,GO NEGATIVE REGULATION OF CELL ADHESION,0.13885,0.1179,0.17342,0,0
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.62923,0.11774,0.053823,0,0
5,GO POSITIVE CHEMOTAXIS,0.38829,0.11767,0.10073,0,0
5,GO REGULATION OF SPINDLE ASSEMBLY,0.098083,0.11756,0.14188,0,0
5,GO NOREPINEPHRINE SECRETION,0.12273,0.11752,0.17416,0,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.08303,0.11747,0.19542,0,0
5,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.64051,0.11742,0.082918,0,0
5,GO NEURON FATE COMMITMENT,0.29248,0.1173,0.12492,0,0
5,GO ENDOCARDIAL CUSHION FORMATION,0.08303,0.11715,0.181,0,0
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.12662,0.11708,0.12633,0,0
5,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.077559,0.11697,0.14587,0,0
5,GO REGULATION OF FATTY ACID TRANSPORT,0.11894,0.11695,0.14928,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.38829,0.11687,0.087991,0,0
5,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.11894,0.11681,0.17259,0,0
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.55277,0.11673,0.10698,0,0
5,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.214,0.11666,0.1149,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.30724,0.11665,0.12202,0,0
5,GO ENDODERMAL CELL FATE COMMITMENT,0.10811,0.11653,0.138,0,0
5,GO RETINAL METABOLIC PROCESS,0.20256,0.11644,0.1255,0,0
5,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.11163,0.11636,0.17407,0,0
5,GO LABYRINTHINE LAYER DEVELOPMENT,0.098083,0.11633,0.14503,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.37964,0.11627,0.10993,0,0
5,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.056456,0.1162,0.14179,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.08881,0.11606,0.13234,0,0
5,GO TRABECULA MORPHOGENESIS,0.11524,0.11584,0.1808,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0031545,0.11583,0.17817,0,0
5,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.041938,0.11573,0.18026,0,0
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.2259,0.11557,0.16909,0,0
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.20822,0.11549,0.12886,0,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.197,0.11538,0.17476,0,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.44264,0.11528,0.10446,0,0
5,GO RESPONSE TO HYDROXYUREA,0.12273,0.11527,0.1642,0,0
5,GO REGULATION OF FIBROBLAST MIGRATION,0.077559,0.11525,0.17245,0,0
5,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.062884,0.11519,0.14367,0,0
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.25111,0.1151,0.17604,0,0
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.46168,0.11493,0.07904,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.10468,0.11485,0.13425,0,0
5,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.058535,0.1147,0.19263,0,0
5,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.034576,0.11447,0.17341,0,0
5,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.026142,0.11443,0.16923,0,0
5,GO CELL ADHESION MEDIATED BY INTEGRIN,0.4521,0.11434,0.1433,0,0
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.17091,0.11426,0.16571,0,0
5,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.28529,0.11423,0.15687,0,0
5,GO SKELETAL MUSCLE TISSUE REGENERATION,0.10811,0.11416,0.12237,0,0
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.72171,0.11409,0.040228,0,0
5,GO EMBRYONIC ORGAN DEVELOPMENT,0.035953,0.11398,0.18086,0,0
5,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.44264,0.11388,0.14479,0,0
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.13885,0.11383,0.14641,0,0
5,GO G0 TO G1 TRANSITION,0.10468,0.11381,0.16991,0,0
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.33821,0.1138,0.12413,0,0
5,GO CARDIAC CELL FATE COMMITMENT,0.17591,0.11377,0.14361,0,0
5,GO RESPONSE TO ATP,0.072385,0.1137,0.16203,0,0
5,GO STEM CELL DIVISION,0.21989,0.11367,0.13947,0,0
5,GO RNA STABILIZATION,0.041938,0.11363,0.15918,0,0
5,GO FEVER GENERATION,0.16602,0.11354,0.13472,0,0
5,GO OVULATION,0.24463,0.11351,0.13228,0,0
5,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.1306,0.11331,0.15492,0,0
5,GO REGULATION OF RIBOSOME BIOGENESIS,0.214,0.11327,0.12147,0,0
5,GO CELLULAR IRON ION HOMEOSTASIS,0.10468,0.11325,0.13423,0,0
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.056456,0.11297,0.15487,0,0
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.16123,0.11284,0.187,0,0
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.10811,0.11283,0.19447,0,0
5,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.091819,0.11277,0.12784,0,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.2998,0.11261,0.11229,0,0
5,GO REGIONALIZATION,0.024086,0.1123,0.17677,0,0
5,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.17591,0.1122,0.13904,0,0
5,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.10468,0.11216,0.13567,0,0
5,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.08303,0.11207,0.092007,0,0
5,GO REGULATION OF VASCULOGENESIS,0.2998,0.11206,0.1237,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.091819,0.11191,0.1558,0,0
5,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.074935,0.1119,0.12446,0,0
5,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.4521,0.11184,0.078997,0,0
5,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0054671,0.11182,0.18929,0,0
5,GO RESPONSE TO CORTICOSTEROID,0.12662,0.11174,0.12869,0,0
5,GO BONE GROWTH,0.1306,0.11173,0.17762,0,0
5,GO CELL CYCLE ARREST,0.025096,0.11141,0.15263,0,0
5,GO UBIQUINONE METABOLIC PROCESS,0.008797,0.11128,0.13544,0,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.33029,0.11116,0.11209,0,0
5,GO ZINC ION TRANSPORT,0.006955,0.11104,0.13989,0,0
5,GO ORGANELLE FISSION,0.065157,0.11087,0.14649,0,0
5,GO MEMBRANE INVAGINATION,0.49108,0.11068,0.097097,0,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.214,0.11066,0.1655,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.033245,0.11066,0.14318,0,0
5,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.46168,0.11053,0.10039,0,0
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.2998,0.11049,0.12791,0,0
5,GO REGULATION OF ODONTOGENESIS,0.2259,0.11045,0.10658,0,0
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.11524,0.11037,0.15994,0,0
5,GO RENAL TUBULE DEVELOPMENT,0.019548,0.11024,0.1945,0,0
5,GO RESPONSE TO UV B,0.17591,0.11018,0.12206,0,0
5,GO POSITIVE REGULATION OF CELL DIVISION,0.08588,0.11004,0.12899,0,0
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.47137,0.11001,0.082057,0,0
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.5959,0.10963,0.081157,0,0
5,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.41494,0.10957,0.12859,0,0
5,GO HOMOTYPIC CELL CELL ADHESION,0.17591,0.10952,0.15845,0,0
5,GO MACROPHAGE CHEMOTAXIS,0.61803,0.10935,0.081908,0,0
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16602,0.10931,0.14487,0,0
5,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.091819,0.10929,0.23076,0,0
5,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.012106,0.10924,0.16932,0,0
5,GO SMOOTH MUSCLE CELL PROLIFERATION,0.19156,0.10922,0.15066,0,0
5,GO TYPE I INTERFERON PRODUCTION,0.27126,0.10911,0.11956,0,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.43329,0.1091,0.10152,0,0
5,GO DETERMINATION OF ADULT LIFESPAN,0.20822,0.10899,0.15256,0,0
5,GO BROWN FAT CELL DIFFERENTIATION,0.15655,0.10897,0.11656,0,0
5,GO MUSCLE CELL PROLIFERATION,0.13467,0.10876,0.15108,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.10468,0.10874,0.1354,0,0
5,GO REGULATION OF MEMBRANE PERMEABILITY,0.056456,0.10864,0.12061,0,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.33029,0.1086,0.12174,0,0
5,GO IRON ION HOMEOSTASIS,0.067497,0.10855,0.14437,0,0
5,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.27126,0.1085,0.13046,0,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.080256,0.10829,0.15928,0,0
5,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.41494,0.10817,0.10544,0,0
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.050584,0.10813,0.15677,0,0
5,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.62923,0.10805,0.064064,0,0
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.0038653,0.10799,0.17934,0,0
5,GO REGULATION OF EXCRETION,0.3148,0.10798,0.10886,0,0
5,GO COLLAGEN FIBRIL ORGANIZATION,0.17091,0.10794,0.2376,0,0
5,GO B CELL HOMEOSTASIS,0.37111,0.10786,0.099605,0,0
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.18102,0.10784,0.095605,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.13467,0.1077,0.11413,0,0
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.15197,0.10768,0.15401,0,0
5,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.065157,0.10748,0.087555,0,0
5,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.51122,0.10723,0.08341,0,0
5,GO PERICARDIUM DEVELOPMENT,0.28529,0.10717,0.12564,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.53179,0.10682,0.07574,0,0
5,GO VACUOLAR ACIDIFICATION,0.077559,0.10671,0.13584,0,0
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.23827,0.10651,0.13321,0,0
5,GO REGULATION OF CALCIUM ION IMPORT,0.197,0.10647,0.14007,0,0
5,GO COENZYME A METABOLIC PROCESS,0.017954,0.10615,0.13857,0,0
5,GO PITUITARY GLAND DEVELOPMENT,0.08881,0.10613,0.20855,0,0
5,GO CELLULAR RESPONSE TO LITHIUM ION,0.27126,0.10604,0.077084,0,0
5,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.067497,0.10604,0.22278,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.074935,0.10591,0.1764,0,0
5,GO PROTEIN TARGETING TO LYSOSOME,0.18102,0.1057,0.16327,0,0
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.47137,0.10567,0.065539,0,0
5,GO RESPONSE TO LIPID,0.10468,0.10566,0.14772,0,0
5,GO RESPONSE TO DEXAMETHASONE,0.32248,0.10564,0.089698,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.10468,0.10563,0.11918,0,0
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.13885,0.10563,0.15884,0,0
5,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.5959,0.10559,0.080844,0,0
5,GO COENZYME A BIOSYNTHETIC PROCESS,0.062884,0.10552,0.11932,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.030713,0.10552,0.17016,0,0
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.34626,0.10549,0.12661,0,0
5,GO STRIATED MUSCLE CELL PROLIFERATION,0.052482,0.10542,0.16907,0,0
5,GO SNRNA PROCESSING,0.098083,0.10538,0.088495,0,0
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.15197,0.10532,0.13683,0,0
5,GO PROGRAMMED NECROTIC CELL DEATH,0.30724,0.10518,0.10827,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.30724,0.10514,0.10865,0,0
5,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.060677,0.10504,0.13175,0,0
5,GO REGULATION OF CHROMATIN BINDING,0.091819,0.105,0.16213,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.022172,0.10497,0.16314,0,0
5,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.098083,0.10478,0.15494,0,0
5,GO APPENDAGE MORPHOGENESIS,0.058535,0.10465,0.19371,0,0
5,GO COMMISSURAL NEURON AXON GUIDANCE,0.41494,0.10451,0.10184,0,0
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.08881,0.10446,0.12935,0,0
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.53179,0.10441,0.11513,0,0
5,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.49108,0.10438,0.079198,0,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.08588,0.10435,0.19221,0,0
5,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.41494,0.10431,0.11606,0,0
5,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.11163,0.10427,0.14329,0,0
5,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.058535,0.10407,0.12417,0,0
5,GO PROTEIN OXIDATION,0.1475,0.10404,0.1353,0,0
5,GO EMBRYONIC PLACENTA DEVELOPMENT,0.10811,0.10403,0.16112,0,0
5,GO REGULATION OF BONE MINERALIZATION,0.20256,0.10398,0.15609,0,0
5,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.062884,0.10391,0.12934,0,0
5,GO RETINOL METABOLIC PROCESS,0.13467,0.10382,0.10427,0,0
5,GO MIDGUT DEVELOPMENT,0.16123,0.10381,0.21386,0,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.24463,0.10378,0.16511,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.50109,0.10362,0.088439,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.14312,0.10361,0.14509,0,0
5,GO RESPONSE TO L GLUTAMATE,0.15655,0.10353,0.12414,0,0
5,GO RNA METHYLATION,0.18102,0.10351,0.10059,0,0
5,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.10468,0.10342,0.202,0,0
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.069906,0.10337,0.22076,0,0
5,GO DNA REPAIR,0.021265,0.1033,0.16188,0,0
5,GO P38MAPK CASCADE,0.16602,0.10321,0.15848,0,0
5,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.48117,0.10316,0.16967,0,0
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.214,0.10305,0.159,0,0
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.022172,0.10304,0.16754,0,0
5,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.89296,0.10294,0.024285,0,0
5,GO TRNA METABOLIC PROCESS,0.1475,0.10292,0.093138,0,0
5,GO ASTROCYTE DEVELOPMENT,0.86799,0.10289,0.049734,0,0
5,GO BILE ACID METABOLIC PROCESS,0.080256,0.10284,0.1401,0,0
5,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.16602,0.10281,0.11391,0,0
5,GO ATP DEPENDENT CHROMATIN REMODELING,0.10811,0.10264,0.14782,0,0
5,GO REGULATION OF MYELINATION,0.060677,0.10259,0.1848,0,0
5,GO REGULATION OF DEFENSE RESPONSE,0.42405,0.10257,0.094129,0,0
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.17591,0.10253,0.19408,0,0
5,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.16602,0.1025,0.1457,0,0
5,GO POSITIVE REGULATION OF DNA REPLICATION,0.033245,0.10243,0.18045,0,0
5,GO REGULATION OF MUSCLE HYPERTROPHY,0.10811,0.1022,0.15582,0,0
5,GO REGULATION OF REPRODUCTIVE PROCESS,0.056456,0.10213,0.12414,0,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.78176,0.102,0.041027,0,0
5,GO MESONEPHROS DEVELOPMENT,0.12662,0.102,0.1375,0,0
5,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.027226,0.10194,0.15267,0,0
5,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.041938,0.1018,0.19874,0,0
5,GO REGULATION OF ICOSANOID SECRETION,0.065157,0.10174,0.17502,0,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.12273,0.1017,0.17379,0,0
5,GO RESPONSE TO INTERLEUKIN 6,0.3148,0.10163,0.14881,0,0
5,GO DORSAL VENTRAL PATTERN FORMATION,0.028348,0.10159,0.17444,0,0
5,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.10134,0.10156,0.161,0,0
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.091819,0.10153,0.1221,0,0
5,GO RUFFLE ORGANIZATION,0.08881,0.10153,0.17856,0,0
5,GO REGULATION OF INFLAMMATORY RESPONSE,0.46168,0.10143,0.094341,0,0
5,GO LEUKOTRIENE METABOLIC PROCESS,0.23203,0.10134,0.12032,0,0
5,GO REGULATION OF BINDING,0.026142,0.10125,0.15721,0,0
5,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.13885,0.10118,0.12815,0,0
5,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.30724,0.10112,0.13463,0,0
5,GO REGULATION OF CELL ADHESION,0.21989,0.10106,0.1561,0,0
5,GO MIDDLE EAR MORPHOGENESIS,0.61803,0.10098,0.040464,0,0
5,GO REGULATION OF RECEPTOR BINDING,0.38829,0.10084,0.12045,0,0
5,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.056456,0.10084,0.17083,0,0
5,GO CELLULAR OXIDANT DETOXIFICATION,0.33029,0.10083,0.064508,0,0
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.35442,0.10081,0.12411,0,0
5,GO THIOESTER BIOSYNTHETIC PROCESS,0.012106,0.10078,0.15652,0,0
5,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.15197,0.10061,0.1642,0,0
5,GO EMBRYONIC DIGIT MORPHOGENESIS,0.067497,0.10046,0.17126,0,0
5,GO INFLAMMATORY RESPONSE TO WOUNDING,0.7336,0.10038,0.053981,0,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.065157,0.10032,0.14041,0,0
5,GO REGULATION OF RENAL SYSTEM PROCESS,0.2577,0.10024,0.13104,0,0
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.18102,0.10022,0.15412,0,0
5,GO CELL CYCLE PROCESS,0.023112,0.10019,0.15634,0,0
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.35442,0.099962,0.10668,0,0
5,GO RESPONSE TO UV C,0.197,0.099899,0.13032,0,0
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.18624,0.099895,0.109,0,0
5,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.23203,0.099861,0.13865,0,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.08881,0.099858,0.13206,0,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.42405,0.099366,0.096759,0,0
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.86799,0.099255,0.026162,0,0
5,GO OSTEOBLAST DEVELOPMENT,0.17591,0.099205,0.14197,0,0
5,GO REGULATION OF BIOMINERALIZATION,0.18624,0.099095,0.15575,0,0
5,GO CELL FATE COMMITMENT,0.072385,0.099053,0.15808,0,0
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.11894,0.098711,0.16502,0,0
5,GO APPENDAGE DEVELOPMENT,0.037377,0.098631,0.19257,0,0
5,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.32248,0.098561,0.099056,0,0
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.2998,0.098538,0.1579,0,0
5,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.40594,0.098516,0.083263,0,0
5,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.35442,0.098507,0.13979,0,0
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.47137,0.098461,0.069962,0,0
5,GO POSITIVE REGULATION OF BINDING,0.041938,0.098408,0.13638,0,0
5,GO EMBRYONIC BRAIN DEVELOPMENT,0.19156,0.098325,0.14319,0,0
5,GO SMOOTH MUSCLE CELL MIGRATION,0.067497,0.098275,0.19965,0,0
5,GO TRACHEA DEVELOPMENT,0.37111,0.098027,0.11478,0,0
5,GO COPULATION,0.37111,0.097975,0.091426,0,0
5,GO NEGATIVE REGULATION OF GENE SILENCING,0.1475,0.097829,0.12786,0,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.46168,0.097763,0.099606,0,0
5,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.28529,0.09776,0.16259,0,0
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.41494,0.09776,0.094964,0,0
5,GO SEX DIFFERENTIATION,0.035953,0.097722,0.15643,0,0
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.019548,0.097692,0.18496,0,0
5,GO OTIC VESICLE DEVELOPMENT,0.72171,0.097679,0.031423,0,0
5,GO PROTEIN IMPORT,0.038848,0.097627,0.12909,0,0
5,GO MEMBRANE RAFT ORGANIZATION,0.39705,0.09759,0.1384,0,0
5,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.30724,0.097516,0.11942,0,0
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.43329,0.097497,0.1172,0,0
5,GO VITAMIN CATABOLIC PROCESS,0.15655,0.097464,0.10468,0,0
5,GO REGULATION OF OOGENESIS,0.12662,0.097348,0.11308,0,0
5,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.08588,0.097327,0.24027,0,0
5,GO GABAERGIC NEURON DIFFERENTIATION,0.067497,0.09732,0.34131,0,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.50109,0.09721,0.088082,0,0
5,GO PEPTIDYL TYROSINE MODIFICATION,0.12662,0.097062,0.1703,0,0
5,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.080256,0.096797,0.16283,0,0
5,GO TONGUE MORPHOGENESIS,0.44264,0.096792,0.076784,0,0
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.24463,0.096754,0.11353,0,0
5,GO REGULATION OF RESPONSE TO STRESS,0.060677,0.096637,0.14629,0,0
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.37111,0.09657,0.1137,0,0
5,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.80618,0.096517,0.043469,0,0
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.080256,0.096312,0.14765,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.050584,0.096305,0.12495,0,0
5,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.29248,0.096142,0.15126,0,0
5,GO CHONDROCYTE DIFFERENTIATION,0.091819,0.096093,0.18773,0,0
5,GO VITAMIN D BIOSYNTHETIC PROCESS,0.66333,0.096024,0.049422,0,0
5,GO TRANSPOSITION,0.12662,0.096006,0.11688,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.08588,0.095919,0.19449,0,0
5,GO PROTEIN TRIMERIZATION,0.2577,0.095902,0.13262,0,0
5,GO BLASTOCYST DEVELOPMENT,0.0031545,0.095883,0.14967,0,0
5,GO RESPONSE TO OXYGEN RADICAL,0.14312,0.095864,0.10882,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.34626,0.095835,0.09887,0,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.44264,0.095801,0.11873,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.24463,0.095785,0.11578,0,0
5,GO CELLULAR RESPONSE TO CAMP,0.072385,0.095714,0.15007,0,0
5,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.11163,0.095697,0.20476,0,0
5,GO NEURON FATE SPECIFICATION,0.53179,0.095626,0.097702,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.75756,0.095623,0.028713,0,0
5,GO REGULATION OF SISTER CHROMATID COHESION,0.20822,0.095611,0.13821,0,0
5,GO MITOTIC CELL CYCLE ARREST,0.15655,0.09545,0.13244,0,0
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.18102,0.095391,0.11409,0,0
5,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.2998,0.0953,0.15202,0,0
5,GO COLLAGEN BIOSYNTHETIC PROCESS,0.24463,0.095287,0.19373,0,0
5,GO REGULATION OF LYMPHOCYTE MIGRATION,0.70989,0.095255,0.048084,0,0
5,GO BILE ACID BIOSYNTHETIC PROCESS,0.069906,0.095206,0.13742,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.24463,0.094967,0.15343,0,0
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.069906,0.094869,0.16246,0,0
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.5959,0.094828,0.074796,0,0
5,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.080256,0.094508,0.12445,0,0
5,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.2577,0.094507,0.11728,0,0
5,GO MRNA TRANSPORT,0.050584,0.094469,0.14864,0,0
5,GO DNA REPLICATION CHECKPOINT,0.43329,0.094464,0.12368,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.89296,0.094399,-0.024129,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.074935,0.094283,0.17622,0,0
5,GO ERYTHROCYTE HOMEOSTASIS,0.11163,0.094272,0.13069,0,0
5,GO OSTEOCLAST DIFFERENTIATION,0.33029,0.094214,0.11598,0,0
5,GO NOSE DEVELOPMENT,0.47137,0.094073,0.14897,0,0
5,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.1306,0.094041,0.18357,0,0
5,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.021265,0.094012,0.24413,0,0
5,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.23827,0.093997,0.08181,0,0
5,GO STEM CELL PROLIFERATION,0.043559,0.093985,0.19278,0,0
5,GO NUCLEOSOME ORGANIZATION,0.065157,0.093909,0.1508,0,0
5,GO GLAND MORPHOGENESIS,0.15197,0.093838,0.17431,0,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.021265,0.093751,0.16712,0,0
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.88046,0.093598,0.0038359,0,0
5,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.49108,0.093582,0.080574,0,0
5,GO OSTEOBLAST DIFFERENTIATION,0.10811,0.093475,0.15145,0,0
5,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.077559,0.093309,0.11254,0,0
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.91805,0.093078,0.017026,0,0
5,GO REGULATION OF TRANSLATIONAL FIDELITY,0.10811,0.093071,0.11392,0,0
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.86799,0.093033,0.041704,0,0
5,GO SNRNA TRANSCRIPTION,0.077559,0.09292,0.12691,0,0
5,GO CELLULAR COPPER ION HOMEOSTASIS,0.30724,0.09271,0.085613,0,0
5,GO NEUROBLAST DIVISION,0.1475,0.092622,0.15224,0,0
5,GO NUCLEAR EXPORT,0.040368,0.092502,0.14772,0,0
5,GO DNA CONFORMATION CHANGE,0.10811,0.092461,0.1457,0,0
5,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.23827,0.092338,0.077044,0,0
5,GO CONNECTIVE TISSUE DEVELOPMENT,0.074935,0.092329,0.17956,0,0
5,GO PHOSPHOLIPID HOMEOSTASIS,0.11163,0.092285,0.15664,0,0
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.75756,0.092261,0.044478,0,0
5,GO REGULATION OF NEUTROPHIL ACTIVATION,0.84314,0.092157,0.031834,0,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.89296,0.092136,0.054237,0,0
5,GO REGULATION OF DNA RECOMBINATION,0.060677,0.092136,0.15504,0,0
5,GO NUCLEAR CHROMOSOME SEGREGATION,0.28529,0.091916,0.10603,0,0
5,GO SOMATIC STEM CELL DIVISION,0.38829,0.091826,0.12918,0,0
5,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.21989,0.091701,0.14641,0,0
5,GO POSITIVE REGULATION OF CELL MATURATION,0.13467,0.09169,0.14049,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.11894,0.091645,0.11449,0,0
5,GO RESPONSE TO CYTOKINE,0.37964,0.091518,0.09999,0,0
5,GO TRIPARTITE REGIONAL SUBDIVISION,0.13467,0.091476,0.14003,0,0
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.66333,0.091403,0.053691,0,0
5,GO PEPTIDYL PROLINE HYDROXYLATION,0.43329,0.091216,0.078195,0,0
5,GO REGULATION OF CENTROSOME DUPLICATION,0.12662,0.09113,0.13336,0,0
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.11894,0.091128,0.14445,0,0
5,GO AMYLOID BETA CLEARANCE,0.49108,0.09097,0.094069,0,0
5,GO DORSAL VENTRAL AXIS SPECIFICATION,0.12273,0.090927,0.17194,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.78176,0.090899,0.045383,0,0
5,GO POSITIVE REGULATION OF CELL ADHESION,0.43329,0.090883,0.10812,0,0
5,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.75756,0.090864,0.051801,0,0
5,GO REGULATION OF CELL POPULATION PROLIFERATION,0.10134,0.090768,0.14806,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.58498,0.090574,0.065401,0,0
5,GO REGULATION OF NEURON PROJECTION REGENERATION,0.026142,0.090489,0.2531,0,0
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.67486,0.090448,0.067697,0,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.61803,0.090421,0.076224,0,0
5,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.2998,0.090303,0.093408,0,0
5,GO EMBRYONIC ORGAN MORPHOGENESIS,0.031957,0.090246,0.17756,0,0
5,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.60692,0.090173,0.068024,0,0
5,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.41494,0.090129,0.093795,0,0
5,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.046961,0.090074,0.11822,0,0
5,GO REGULATION OF LIPID LOCALIZATION,0.08588,0.089984,0.1468,0,0
5,GO RECOMBINATIONAL REPAIR,0.10134,0.089976,0.16041,0,0
5,GO POLYSACCHARIDE CATABOLIC PROCESS,0.214,0.089895,0.11125,0,0
5,GO GLUTAMINE METABOLIC PROCESS,0.060677,0.089819,0.13743,0,0
5,GO NEPHRON MORPHOGENESIS,0.10134,0.089628,0.1542,0,0
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.52145,0.089577,0.090864,0,0
5,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.23827,0.089373,0.13285,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.052482,0.08934,0.15087,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.08588,0.089079,0.16607,0,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.1475,0.089015,0.14451,0,0
5,GO CORTICAL CYTOSKELETON ORGANIZATION,0.13467,0.088895,0.14627,0,0
5,GO RENAL SODIUM EXCRETION,0.12662,0.088889,0.15493,0,0
5,GO PSEUDOURIDINE SYNTHESIS,0.33029,0.088786,0.046364,0,0
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.35442,0.088782,0.085256,0,0
5,GO ERK1 AND ERK2 CASCADE,0.43329,0.088775,0.099115,0,0
5,GO POST ANAL TAIL MORPHOGENESIS,0.11894,0.088613,0.18831,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.045233,0.088496,0.13455,0,0
5,GO REGULATION OF TRANSFERASE ACTIVITY,0.013235,0.088488,0.1797,0,0
5,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.53179,0.088257,0.06862,0,0
5,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.010572,0.08821,0.14244,0,0
5,GO SKELETAL SYSTEM MORPHOGENESIS,0.29248,0.088201,0.13119,0,0
5,GO REGULATION OF ISOTYPE SWITCHING,0.33029,0.088168,0.12565,0,0
5,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.60692,0.088142,0.067174,0,0
5,GO CENTRIOLE ASSEMBLY,0.17091,0.088071,0.14539,0,0
5,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.75756,0.088042,0.05136,0,0
5,GO INOSITOL LIPID MEDIATED SIGNALING,0.1306,0.087902,0.16032,0,0
5,GO RESPONSE TO RETINOIC ACID,0.11524,0.087883,0.15926,0,0
5,GO PROTEIN HYDROXYLATION,0.091819,0.087877,0.1654,0,0
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.20256,0.087783,0.14253,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.29248,0.087748,0.11622,0,0
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.10134,0.087731,0.17012,0,0
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.74555,0.087691,0.06433,0,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.23827,0.087672,0.089172,0,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.12662,0.087664,0.16716,0,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.2577,0.087546,0.13478,0,0
5,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.062884,0.087544,0.13597,0,0
5,GO MITOTIC SPINDLE ASSEMBLY,0.40594,0.087512,0.083946,0,0
5,GO DNA PACKAGING,0.098083,0.087489,0.15069,0,0
5,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.15655,0.087444,0.17216,0,0
5,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.33821,0.087412,0.13285,0,0
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.38829,0.087359,0.10325,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.35442,0.087327,0.10736,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.25111,0.087173,0.14541,0,0
5,GO REGULATION OF PROTEIN IMPORT,0.060677,0.087061,0.13841,0,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.0092139,0.086995,0.15292,0,0
5,GO CENTROSOME DUPLICATION,0.1475,0.086993,0.14636,0,0
5,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,1,0.086972,-0.019971,0,0
5,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.30724,0.086963,0.32023,0,0
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.42405,0.086945,0.10106,0,0
5,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.17591,0.086879,0.097709,0,0
5,GO REGULATION OF CELL SHAPE,0.23203,0.08685,0.15736,0,0
5,GO RNA DECAPPING,0.15655,0.086819,0.14882,0,0
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.065157,0.086814,0.17769,0,0
5,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.026142,0.086814,0.11834,0,0
5,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.23203,0.086716,0.13729,0,0
5,GO GLIAL CELL APOPTOTIC PROCESS,0.074935,0.086561,0.16817,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.08588,0.086488,0.091526,0,0
5,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.30724,0.086452,0.1494,0,0
5,GO ANOIKIS,0.10468,0.086362,0.17103,0,0
5,GO FATTY ACID BIOSYNTHETIC PROCESS,0.11524,0.086188,0.10633,0,0
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.48117,0.086133,0.089029,0,0
5,GO NECROTIC CELL DEATH,0.37111,0.086123,0.089525,0,0
5,GO REGULATION OF SENSORY PERCEPTION,0.077559,0.085981,0.15356,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE,0.048745,0.085937,0.13203,0,0
5,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.0172,0.085897,0.16357,0,0
5,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.17591,0.085878,0.18685,0,0
5,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.058535,0.085823,0.14848,0,0
5,GO DETECTION OF BIOTIC STIMULUS,1,0.085772,0.0079812,0,0
5,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.61803,0.085681,0.051959,0,0
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.01266,0.085677,0.16067,0,0
5,GO RESPONSE TO HYDROGEN PEROXIDE,0.067497,0.085633,0.14526,0,0
5,GO NAD METABOLIC PROCESS,0.16123,0.08554,0.12332,0,0
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.08303,0.085518,0.13314,0,0
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.54223,0.085478,0.084325,0,0
5,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.10468,0.085428,0.16216,0,0
5,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.13467,0.085417,0.10947,0,0
5,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.37964,0.085279,0.14623,0,0
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.74555,0.085256,0.061438,0,0
5,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.25111,0.085158,0.11215,0,0
5,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.44264,0.085118,0.11306,0,0
5,GO DEFENSE RESPONSE TO VIRUS,0.51122,0.085068,0.078473,0,0
5,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.28529,0.085031,0.11456,0,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.23203,0.084967,0.11971,0,0
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.25111,0.084902,0.14279,0,0
5,GO BONE TRABECULA MORPHOGENESIS,0.34626,0.084773,0.17012,0,0
5,GO SIALYLATION,0.11163,0.084602,0.19238,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.58498,0.084487,0.040518,0,0
5,GO FOAM CELL DIFFERENTIATION,0.58498,0.08434,0.069935,0,0
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.24463,0.084066,0.10817,0,0
5,GO REGULATION OF MEMBRANE INVAGINATION,0.50109,0.08397,0.10433,0,0
5,GO REGULATION OF OSSIFICATION,0.15197,0.083914,0.16103,0,0
5,GO ASTROCYTE DIFFERENTIATION,0.56341,0.083902,0.08782,0,0
5,GO SKELETAL SYSTEM DEVELOPMENT,0.060677,0.083692,0.18466,0,0
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.58498,0.083623,0.062368,0,0
5,GO DNA GEOMETRIC CHANGE,0.16602,0.083606,0.13017,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.13885,0.083598,0.15127,0,0
5,GO EXIT FROM MITOSIS,0.08881,0.08359,0.1361,0,0
5,GO REGULATION OF AMYLOID BETA CLEARANCE,0.32248,0.083454,0.1334,0,0
5,GO T CELL DIFFERENTIATION IN THYMUS,0.50109,0.083443,0.083777,0,0
5,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.21989,0.083423,0.10393,0,0
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.040368,0.083401,0.15142,0,0
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.11163,0.083171,0.098759,0,0
5,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.19156,0.083146,0.098325,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.29248,0.083105,0.1605,0,0
5,GO TRABECULA FORMATION,0.39705,0.083102,0.11142,0,0
5,GO DENDRITIC SPINE MAINTENANCE,0.11894,0.08309,0.18123,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.86799,0.082919,-0.047071,0,0
5,GO NCRNA METABOLIC PROCESS,0.23827,0.082856,0.07108,0,0
5,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.76963,0.082768,0.041292,0,0
5,GO REPLACEMENT OSSIFICATION,0.24463,0.082633,0.15993,0,0
5,GO NAD BIOSYNTHETIC PROCESS,0.80618,0.082515,0.028295,0,0
5,GO CELL CYCLE G2 M PHASE TRANSITION,0.072385,0.082469,0.12514,0,0
5,GO ACETYL COA METABOLIC PROCESS,0.026142,0.082438,0.14594,0,0
5,GO ATP METABOLIC PROCESS,0.0052065,0.082421,0.10621,0,0
5,GO CELLULAR RESPONSE TO RETINOIC ACID,0.16602,0.082416,0.14409,0,0
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.85555,0.082368,0.03988,0,0
5,GO RNA SURVEILLANCE,0.37964,0.082217,0.058569,0,0
5,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.018736,0.082042,0.15216,0,0
5,GO ATP BIOSYNTHETIC PROCESS,0.17091,0.081996,0.091904,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.197,0.081861,0.15933,0,0
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.32248,0.081781,0.10816,0,0
5,GO PIRNA METABOLIC PROCESS,0.3148,0.081755,0.074419,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.20822,0.081573,0.1137,0,0
5,GO ACTIVATION OF IMMUNE RESPONSE,0.56341,0.081392,0.066392,0,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.1475,0.081338,0.14355,0,0
5,GO KIDNEY MORPHOGENESIS,0.038848,0.081327,0.17926,0,0
5,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.12273,0.08121,0.1456,0,0
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.098083,0.081163,0.16725,0,0
5,GO DNA CATABOLIC PROCESS,0.080256,0.08106,0.11576,0,0
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.10134,0.081008,0.12342,0,0
5,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.64051,0.080795,0.055632,0,0
5,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.2577,0.080782,0.18445,0,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.26442,0.080755,0.099873,0,0
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.14312,0.080738,0.097673,0,0
5,GO CELL DIVISION,0.050584,0.080694,0.14674,0,0
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.7336,0.080605,0.052876,0,0
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.40594,0.080538,0.09227,0,0
5,GO PLASMINOGEN ACTIVATION,0.30724,0.080504,0.094044,0,0
5,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.61803,0.080407,0.10917,0,0
5,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.40594,0.08018,0.043711,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.5959,0.080146,0.068687,0,0
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.19156,0.080137,0.13446,0,0
5,GO CENTROSOME SEPARATION,0.19156,0.079923,0.13093,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.2577,0.079905,0.14856,0,0
5,GO DNA RECOMBINATION,0.15197,0.079744,0.12658,0,0
5,GO BONE DEVELOPMENT,0.094909,0.079667,0.17797,0,0
5,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.3148,0.07961,0.088381,0,0
5,GO NEGATIVE REGULATION OF CELL AGING,0.18102,0.079605,0.10865,0,0
5,GO ANTIMICROBIAL HUMORAL RESPONSE,0.58498,0.079547,0.051612,0,0
5,GO RETINAL ROD CELL DIFFERENTIATION,0.53179,0.079505,0.051815,0,0
5,GO RETINOIC ACID METABOLIC PROCESS,0.33029,0.079443,0.075506,0,0
5,GO APOPTOTIC SIGNALING PATHWAY,0.065157,0.079354,0.13366,0,0
5,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.10134,0.079247,0.12917,0,0
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.197,0.079244,0.14403,0,0
5,GO NUCLEAR TRANSPORT,0.052482,0.079225,0.13412,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.18624,0.079196,0.14308,0,0
5,GO PROSTAGLANDIN SECRETION,0.27821,0.079144,0.11941,0,0
5,GO REGULATION OF GLOMERULAR FILTRATION,0.2259,0.079107,0.18905,0,0
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.12273,0.079097,0.12366,0,0
5,GO IMMUNE EFFECTOR PROCESS,0.52145,0.078957,0.075632,0,0
5,GO MUSCLE FILAMENT SLIDING,0.08881,0.078923,0.14746,0,0
5,GO REGULATION OF CELLULAR RESPIRATION,0.013235,0.078893,0.12709,0,0
5,GO RELAXATION OF MUSCLE,0.072385,0.078883,0.21332,0,0
5,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.33029,0.078826,0.12107,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.56341,0.078745,0.08899,0,0
5,GO FOLIC ACID METABOLIC PROCESS,0.080256,0.078721,0.12421,0,0
5,GO IMMUNOLOGICAL MEMORY PROCESS,0.53179,0.078702,0.10064,0,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.074935,0.0786,0.14482,0,0
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.045233,0.078569,0.15624,0,0
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.25111,0.078566,0.1315,0,0
5,GO ODONTOGENESIS,0.15197,0.07853,0.14875,0,0
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.21989,0.078415,0.20727,0,0
5,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.2259,0.078355,0.098712,0,0
5,GO HEME METABOLIC PROCESS,0.11163,0.078305,0.10337,0,0
5,GO RESPONSE TO KETONE,0.12273,0.078224,0.14162,0,0
5,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.21989,0.078114,0.12375,0,0
5,GO RNA EXPORT FROM NUCLEUS,0.067497,0.078075,0.14049,0,0
5,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.34626,0.077698,0.068388,0,0
5,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.29248,0.07767,0.12502,0,0
5,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.15197,0.077609,0.10276,0,0
5,GO SEQUESTERING OF ACTIN MONOMERS,0.81845,0.077506,-0.0078822,0,0
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.46168,0.077441,0.10965,0,0
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.56341,0.077425,0.066885,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.98106,0.077375,-0.00021596,0,0
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.091819,0.077322,0.13231,0,0
5,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.26442,0.077311,0.078313,0,0
5,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.32248,0.077288,0.14079,0,0
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.15655,0.077287,0.11913,0,0
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.41494,0.077213,0.067336,0,0
5,GO ACUTE INFLAMMATORY RESPONSE,0.67486,0.077199,0.05577,0,0
5,GO HEAT GENERATION,0.27821,0.077163,0.10753,0,0
5,GO ANDROGEN METABOLIC PROCESS,0.18624,0.076981,0.081528,0,0
5,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.72171,0.076958,0.062687,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.23827,0.076931,0.12961,0,0
5,GO RESPONSE TO INTERLEUKIN 15,0.80618,0.076927,0.044367,0,0
5,GO REGULATION OF PROTON TRANSPORT,0.052482,0.0769,0.13668,0,0
5,GO LUNG MORPHOGENESIS,0.19156,0.076798,0.15915,0,0
5,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.1306,0.076672,0.099632,0,0
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.2998,0.076585,0.13081,0,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.10468,0.07658,0.10662,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.7336,0.076464,0.055985,0,0
5,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.069906,0.076449,0.11955,0,0
5,GO NK T CELL DIFFERENTIATION,0.66333,0.076292,0.07324,0,0
5,GO RESPONSE TO HYDROPEROXIDE,0.4521,0.07624,0.10399,0,0
5,GO TUMOR NECROSIS FACTOR SECRETION,0.67486,0.076211,0.061604,0,0
5,GO ASYMMETRIC CELL DIVISION,0.12662,0.076106,0.13948,0,0
5,GO CELL CYCLE G1 S PHASE TRANSITION,0.13885,0.076076,0.11411,0,0
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.50109,0.076056,0.072251,0,0
5,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.43329,0.075984,0.064755,0,0
5,GO AMINO SUGAR CATABOLIC PROCESS,0.68646,0.075945,0.02092,0,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.52145,0.075904,0.10223,0,0
5,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.5959,0.075835,0.08029,0,0
5,GO ESTABLISHMENT OF RNA LOCALIZATION,0.065157,0.075739,0.12882,0,0
5,GO RESPONSE TO SALT STRESS,0.27821,0.075726,0.10599,0,0
5,GO REGULATION OF MITOTIC CELL CYCLE,0.033245,0.075695,0.14144,0,0
5,GO SULFUR AMINO ACID METABOLIC PROCESS,0.072385,0.075524,0.12945,0,0
5,GO REGULATION OF INNATE IMMUNE RESPONSE,0.58498,0.075363,0.052618,0,0
5,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.091819,0.075222,0.11279,0,0
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.197,0.07522,0.12899,0,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.021265,0.074965,0.20004,0,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.2998,0.074946,0.10337,0,0
5,GO DETOXIFICATION,0.67486,0.074939,0.031604,0,0
5,GO DEFENSE RESPONSE,0.41494,0.074874,0.094078,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.067497,0.07482,0.13803,0,0
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.50109,0.074816,0.08335,0,0
5,GO NUCLEAR ENVELOPE REASSEMBLY,0.13885,0.074607,0.10246,0,0
5,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.20256,0.074598,0.11747,0,0
5,GO RESPONSE TO BACTERIUM,0.40594,0.074397,0.083095,0,0
5,GO REGULATION OF STEM CELL DIFFERENTIATION,0.37964,0.074341,0.052996,0,0
5,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.2577,0.074078,0.11207,0,0
5,GO FIBROBLAST PROLIFERATION,0.41494,0.073987,0.11088,0,0
5,GO REGULATION OF SPROUTING ANGIOGENESIS,0.46168,0.073862,0.12138,0,0
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.20256,0.073833,0.096382,0,0
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.91805,0.073713,0.0040516,0,0
5,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.077559,0.073683,0.12532,0,0
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.27821,0.073627,0.13286,0,0
5,GO REGULATION OF LIPID TRANSPORT,0.19156,0.073614,0.1187,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.14312,0.073571,0.090694,0,0
5,GO MYOBLAST PROLIFERATION,0.091819,0.073567,0.21171,0,0
5,GO REGULATION OF PROSTAGLANDIN SECRETION,0.37111,0.073541,0.10746,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.2998,0.073479,0.097783,0,0
5,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0031545,0.073448,0.10797,0,0
5,GO ETHER BIOSYNTHETIC PROCESS,0.51122,0.073447,0.069966,0,0
5,GO MUSCLE CELL MIGRATION,0.20256,0.073412,0.14248,0,0
5,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.21989,0.073363,0.11393,0,0
5,GO REGULATION OF CELL DEATH,0.065157,0.073278,0.1445,0,0
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.17091,0.073238,0.11293,0,0
5,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.056456,0.073231,0.15126,0,0
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.54223,0.07303,0.066514,0,0
5,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.1306,0.072907,0.11676,0,0
5,GO B CELL APOPTOTIC PROCESS,0.35442,0.072902,0.085242,0,0
5,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.69814,0.072869,0.048242,0,0
5,GO MESODERMAL CELL DIFFERENTIATION,0.12273,0.072833,0.16787,0,0
5,GO GLYCOLIPID CATABOLIC PROCESS,0.60692,0.072777,0.094001,0,0
5,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.15197,0.072767,0.074876,0,0
5,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.20256,0.072764,0.088487,0,0
5,GO CELLULAR RESPONSE TO LIPID,0.16123,0.072734,0.133,0,0
5,GO NCRNA PROCESSING,0.37964,0.072656,0.057924,0,0
5,GO REGULATION OF MAST CELL ACTIVATION,0.46168,0.07255,0.085434,0,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.065157,0.072328,0.17618,0,0
5,GO MITOTIC SPINDLE ORGANIZATION,0.27821,0.072279,0.11303,0,0
5,GO REGULATION OF MYOBLAST FUSION,0.51122,0.072111,0.11224,0,0
5,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.1306,0.07177,0.15492,0,0
5,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.50109,0.071699,0.074484,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.79394,0.071695,0.053598,0,0
5,GO TROPHOBLAST CELL MIGRATION,0.27126,0.071623,0.13181,0,0
5,GO MRNA METABOLIC PROCESS,0.08303,0.071494,0.095308,0,0
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.78176,0.071484,0.046938,0,0
5,GO REGULATION OF FIBRINOLYSIS,0.40594,0.071438,0.10648,0,0
5,GO MITOTIC CELL CYCLE,0.038848,0.071417,0.14213,0,0
5,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.08303,0.071355,0.11363,0,0
5,GO SNRNA METABOLIC PROCESS,0.19156,0.071252,0.074394,0,0
5,GO COCHLEA MORPHOGENESIS,0.58498,0.07108,0.062617,0,0
5,GO REGULATION OF EXIT FROM MITOSIS,0.5959,0.071079,0.055816,0,0
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.048745,0.071037,0.16967,0,0
5,GO REGULATION OF PLATELET AGGREGATION,0.41494,0.070858,0.10295,0,0
5,GO INTERSTRAND CROSS LINK REPAIR,0.2998,0.070666,0.11715,0,0
5,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.49108,0.070646,0.092702,0,0
5,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.64051,0.070605,0.055358,0,0
5,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.30724,0.070416,0.10626,0,0
5,GO TONGUE DEVELOPMENT,0.48117,0.07041,0.052801,0,0
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.35442,0.070365,0.11499,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.13467,0.070196,0.16602,0,0
5,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.10134,0.070183,0.15572,0,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.18102,0.07014,0.11871,0,0
5,GO INNATE IMMUNE RESPONSE,0.64051,0.070139,0.056267,0,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.48117,0.070035,0.075631,0,0
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.27126,0.070033,0.10023,0,0
5,GO PROSTANOID METABOLIC PROCESS,0.33821,0.069996,0.086173,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.1475,0.069987,0.19618,0,0
5,GO REGULATION OF CELL AGING,0.11163,0.069951,0.10792,0,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.54223,0.069914,0.09461,0,0
5,GO INTERFERON GAMMA PRODUCTION,0.60692,0.0699,0.047786,0,0
5,GO CHROMOSOME SEGREGATION,0.33029,0.069699,0.099882,0,0
5,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.074935,0.069598,0.14508,0,0
5,GO ER OVERLOAD RESPONSE,0.18102,0.069489,0.11953,0,0
5,GO GMP METABOLIC PROCESS,0.26442,0.069453,0.077611,0,0
5,GO MUCUS SECRETION,0.34626,0.069365,0.10264,0,0
5,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.13467,0.069352,0.14348,0,0
5,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.51122,0.069347,0.079606,0,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.034576,0.069343,0.11972,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.69814,0.069293,0.064274,0,0
5,GO POSITIVE REGULATION OF HEART GROWTH,0.12273,0.069247,0.15044,0,0
5,GO TRANSITION METAL ION HOMEOSTASIS,0.27126,0.069183,0.084523,0,0
5,GO REGULATION OF TRANSPOSITION,0.15655,0.069158,0.11401,0,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.25111,0.069004,0.15911,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.81845,0.0689,0.0034874,0,0
5,GO DECIDUALIZATION,0.56341,0.068857,0.10793,0,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.15655,0.068832,0.11188,0,0
5,GO IMMUNE SYSTEM DEVELOPMENT,0.3148,0.068745,0.10773,0,0
5,GO BASIC AMINO ACID TRANSPORT,0.33029,0.068668,0.11558,0,0
5,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.32248,0.068493,0.093999,0,0
5,GO TRANSLESION SYNTHESIS,0.2259,0.068289,0.074399,0,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.30724,0.068269,0.12401,0,0
5,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.077559,0.068224,0.1486,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.19156,0.068165,0.072632,0,0
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.33029,0.067812,0.12885,0,0
5,GO VITAMIN METABOLIC PROCESS,0.10811,0.067799,0.10465,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.60692,0.067772,0.055436,0,0
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.61803,0.06762,0.05037,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.4521,0.067608,0.07412,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.08881,0.067607,0.11035,0,0
5,GO SUPEROXIDE METABOLIC PROCESS,0.39705,0.067593,0.077484,0,0
5,GO POSITIVE REGULATION OF CELL DEATH,0.065157,0.067309,0.15513,0,0
5,GO STEROID CATABOLIC PROCESS,0.4521,0.06722,0.088305,0,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.72171,0.067217,0.067971,0,0
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.83078,0.06714,0.02806,0,0
5,GO MYELOID CELL DIFFERENTIATION,0.2577,0.067123,0.12084,0,0
5,GO VIRAL LIFE CYCLE,0.20822,0.067094,0.11398,0,0
5,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.65188,0.067085,0.057851,0,0
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.52145,0.067065,0.07425,0,0
5,GO PHAGOCYTOSIS,0.47137,0.067022,0.095041,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.13467,0.06699,0.1373,0,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.11524,0.066984,0.16473,0,0
5,GO CELL ADHESION MOLECULE PRODUCTION,0.36271,0.066939,0.14009,0,0
5,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.53179,0.066903,0.080243,0,0
5,GO REGULATION OF DNA REPLICATION,0.20256,0.066712,0.1126,0,0
5,GO NOTOCHORD DEVELOPMENT,0.60692,0.066708,0.068489,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.08303,0.066697,0.15225,0,0
5,GO APOPTOTIC CELL CLEARANCE,0.53179,0.066688,0.093916,0,0
5,GO NCRNA 3 END PROCESSING,0.2259,0.066679,0.058621,0,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.28529,0.066604,0.15536,0,0
5,GO MITOCHONDRIAL GENOME MAINTENANCE,0.37111,0.066555,0.10386,0,0
5,GO RESPONSE TO VITAMIN A,0.44264,0.0665,0.058715,0,0
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.39705,0.066485,0.10305,0,0
5,GO UTERUS DEVELOPMENT,0.24463,0.066304,0.10356,0,0
5,GO MYELOID CELL HOMEOSTASIS,0.20256,0.066214,0.11687,0,0
5,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.57414,0.066202,0.087671,0,0
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.060677,0.066068,0.11281,0,0
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.57414,0.065939,0.055878,0,0
5,GO GLYCEROL ETHER METABOLIC PROCESS,0.10811,0.065848,0.16818,0,0
5,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.21989,0.065769,0.18963,0,0
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.50109,0.06562,0.072463,0,0
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.48117,0.065544,0.087501,0,0
5,GO RESPONSE TO IONIZING RADIATION,0.17591,0.065527,0.11005,0,0
5,GO SPINDLE ASSEMBLY,0.2259,0.065384,0.12575,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.11524,0.065326,0.18194,0,0
5,GO NEGATIVE REGULATION OF CELL DEATH,0.15197,0.06523,0.12113,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.031957,0.065177,0.11212,0,0
5,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.040368,0.065139,0.19378,0,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.13885,0.065077,0.11513,0,0
5,GO SPINDLE ORGANIZATION,0.18624,0.06498,0.14822,0,0
5,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.7336,0.064951,0.037028,0,0
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.197,0.064936,0.14249,0,0
5,GO RESPONSE TO BIOTIC STIMULUS,0.46168,0.064927,0.081978,0,0
5,GO MYOBLAST DIFFERENTIATION,0.32248,0.064916,0.10129,0,0
5,GO TRNA METHYLATION,0.28529,0.064767,0.08378,0,0
5,GO T CELL RECEPTOR SIGNALING PATHWAY,0.61803,0.064759,0.052803,0,0
5,GO HYPOTONIC RESPONSE,0.23827,0.064687,0.12595,0,0
5,GO TRACHEA MORPHOGENESIS,0.23827,0.064672,0.13509,0,0
5,GO DNA BIOSYNTHETIC PROCESS,0.040368,0.064273,0.13039,0,0
5,GO REGULATION OF CENTROSOME CYCLE,0.13885,0.064217,0.13153,0,0
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.49108,0.064188,0.082087,0,0
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.36271,0.064147,0.11863,0,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.56341,0.06411,0.077148,0,0
5,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.94321,0.064076,-0.042924,0,0
5,GO POSITIVE REGULATION OF ERAD PATHWAY,0.1475,0.064042,0.12364,0,0
5,GO FOREBRAIN REGIONALIZATION,0.61803,0.064041,0.058899,0,0
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.26442,0.06402,0.11928,0,0
5,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.90549,0.063672,-0.011719,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.12273,0.063635,0.10924,0,0
5,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.062884,0.063626,0.12128,0,0
5,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.28529,0.063596,0.15529,0,0
5,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.33029,0.063572,0.11264,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.57414,0.063513,0.054487,0,0
5,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.098083,0.063262,0.12269,0,0
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.65188,0.063256,0.057566,0,0
5,GO REGULATION OF IMMUNE RESPONSE,0.61803,0.063254,0.058894,0,0
5,GO PROTEIN DENEDDYLATION,0.17591,0.063202,0.07921,0,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.41494,0.063136,0.11962,0,0
5,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.57414,0.06311,0.050946,0,0
5,GO BONE MORPHOGENESIS,0.33821,0.062978,0.13677,0,0
5,GO INFLAMMATORY RESPONSE,0.57414,0.062908,0.075449,0,0
5,GO EXTRACELLULAR VESICLE BIOGENESIS,0.08588,0.062894,0.14354,0,0
5,GO CELL CYCLE PHASE TRANSITION,0.11894,0.062829,0.11847,0,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.24463,0.062784,0.15178,0,0
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.4521,0.062707,0.094999,0,0
5,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.50109,0.062504,0.086528,0,0
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.98106,0.062496,0.014189,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.64051,0.062451,0.079757,0,0
5,GO L ASCORBIC ACID METABOLIC PROCESS,0.37964,0.062425,0.072288,0,0
5,GO REGULATION OF NEUROBLAST PROLIFERATION,0.40594,0.062303,0.097747,0,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.58498,0.062285,0.069166,0,0
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.15197,0.062234,0.13764,0,0
5,GO AGING,0.058535,0.062151,0.14632,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.76963,0.061557,0.055398,0,0
5,GO LEUKOCYTE MEDIATED IMMUNITY,0.56341,0.061443,0.0652,0,0
5,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.1306,0.061394,0.11086,0,0
5,GO RESPONSE TO ZINC ION,0.49108,0.061313,0.042935,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.36271,0.061282,0.10429,0,0
5,GO INTEGRIN ACTIVATION,0.61803,0.06099,0.077536,0,0
5,GO RESPONSE TO HEAT,0.046961,0.060965,0.13054,0,0
5,GO INDOLALKYLAMINE METABOLIC PROCESS,0.11524,0.060938,0.17518,0,0
5,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.93062,0.060777,0.043437,0,0
5,GO EPITHELIAL CELL MATURATION,0.24463,0.060676,0.14164,0,0
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.53179,0.060652,0.086046,0,0
5,GO GERMINAL CENTER FORMATION,0.67486,0.060567,0.061314,0,0
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.78176,0.060542,-0.034319,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.27821,0.060538,0.16937,0,0
5,GO CELL AGING,0.038848,0.060513,0.13379,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.033245,0.060383,0.15442,0,0
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.44264,0.060215,0.078341,0,0
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.44264,0.060027,0.11127,0,0
5,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.098083,0.060016,0.13342,0,0
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.3148,0.059924,0.12856,0,0
5,GO REGULATION OF VIRAL TRANSCRIPTION,0.062884,0.059852,0.11469,0,0
5,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.46168,0.059731,0.070334,0,0
5,GO LAMELLIPODIUM MORPHOGENESIS,0.1475,0.059489,0.17451,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.55277,0.059393,0.061928,0,0
5,GO SEROTONIN SECRETION,0.50109,0.059225,0.0705,0,0
5,GO MALE SEX DIFFERENTIATION,0.031957,0.059112,0.17314,0,0
5,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.11163,0.059096,0.11659,0,0
5,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.16602,0.058967,0.09109,0,0
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.12273,0.058916,0.12619,0,0
5,GO MACROPHAGE MIGRATION,0.58498,0.058798,0.056839,0,0
5,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.66333,0.058757,0.056579,0,0
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.60692,0.058587,0.062154,0,0
5,GO REGULATION OF CELL CYCLE ARREST,0.11894,0.058394,0.1335,0,0
5,GO REGULATION OF CENTRIOLE REPLICATION,0.50109,0.058393,0.073768,0,0
5,GO URONIC ACID METABOLIC PROCESS,0.3148,0.057897,0.041809,0,0
5,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.78176,0.057501,0.032297,0,0
5,GO REGULATION OF SULFUR METABOLIC PROCESS,0.26442,0.057474,0.11205,0,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.32248,0.057334,0.1116,0,0
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.64051,0.057296,0.083901,0,0
5,GO HETEROTYPIC CELL CELL ADHESION,0.43329,0.057296,0.10004,0,0
5,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.30724,0.057186,0.13514,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.30724,0.057143,0.1085,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.13885,0.057113,0.14165,0,0
5,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.32248,0.057113,0.10403,0,0
5,GO FRUCTOSE METABOLIC PROCESS,0.15197,0.057097,0.12436,0,0
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.42405,0.057066,0.095955,0,0
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.55277,0.057051,0.073572,0,0
5,GO POSITIVE REGULATION OF ORGAN GROWTH,0.214,0.056875,0.1355,0,0
5,GO GLYCOSIDE METABOLIC PROCESS,0.15655,0.056869,0.079537,0,0
5,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.69814,0.056869,0.11208,0,0
5,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.56341,0.056864,0.052144,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.3148,0.056828,0.099585,0,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.33821,0.056778,0.10981,0,0
5,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.21989,0.056632,0.11196,0,0
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.39705,0.056517,0.080981,0,0
5,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.32248,0.056505,0.10501,0,0
5,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.54223,0.056282,0.070468,0,0
5,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.10811,0.056222,0.11088,0,0
5,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.78176,0.05599,0.048717,0,0
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.55277,0.055901,0.056647,0,0
5,GO DEFENSE RESPONSE TO BACTERIUM,0.51122,0.05588,0.066209,0,0
5,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.95582,0.055745,-0.0073481,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.50109,0.055672,0.14043,0,0
5,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.61803,0.055671,0.094227,0,0
5,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.30724,0.055656,0.1191,0,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.11894,0.055474,0.091517,0,0
5,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.20256,0.055456,0.11335,0,0
5,GO PROTEIN REFOLDING,0.35442,0.055441,0.064847,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.30724,0.055435,0.084706,0,0
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.2577,0.055412,0.14585,0,0
5,GO PROTEIN K11 LINKED UBIQUITINATION,0.54223,0.055406,0.050275,0,0
5,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.0172,0.055384,0.11117,0,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.3148,0.055227,0.073476,0,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.75756,0.055222,0.02261,0,0
5,GO COPPER ION HOMEOSTASIS,0.27126,0.055153,0.09456,0,0
5,GO EMBRYO IMPLANTATION,0.19156,0.054993,0.16437,0,0
5,GO REGULATION OF INTEGRIN ACTIVATION,0.51122,0.05484,0.095385,0,0
5,GO NADPH REGENERATION,0.38829,0.054629,0.064896,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.37964,0.054568,0.10515,0,0
5,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.23203,0.054495,0.20696,0,0
5,GO EPITHELIAL CELL FATE COMMITMENT,0.2998,0.054126,0.13525,0,0
5,GO GLYCINE METABOLIC PROCESS,0.90549,0.054085,-0.037585,0,0
5,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.30724,0.053932,0.12308,0,0
5,GO LEUKOCYTE CHEMOTAXIS,0.96843,0.053831,0.01117,0,0
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.36271,0.053765,0.094603,0,0
5,GO CELL CYCLE CHECKPOINT,0.1475,0.053728,0.14721,0,0
5,GO DNA INTEGRITY CHECKPOINT,0.14312,0.053658,0.15232,0,0
5,GO CELL CHEMOTAXIS,0.76963,0.053492,0.051255,0,0
5,GO REGULATION OF NUCLEAR DIVISION,0.11524,0.053171,0.12449,0,0
5,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.38829,0.053078,0.10056,0,0
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.86799,0.05304,-0.045671,0,0
5,GO TETRAHYDROFOLATE INTERCONVERSION,0.74555,0.052996,0.047505,0,0
5,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.72171,0.052982,0.052028,0,0
5,GO RESPONSE TO ANTIBIOTIC,0.24463,0.052876,0.10194,0,0
5,GO NEGATIVE REGULATION OF CELL KILLING,0.83078,0.052742,-0.029449,0,0
5,GO CHROMOSOME CONDENSATION,0.33821,0.052597,0.127,0,0
5,GO POSITIVE REGULATION OF VASCULOGENESIS,0.43329,0.052554,0.09282,0,0
5,GO MONONUCLEAR CELL DIFFERENTIATION,0.76963,0.052539,0.050364,0,0
5,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.11524,0.052511,0.1299,0,0
5,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.72171,0.052474,0.046028,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.214,0.052364,0.091527,0,0
5,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.214,0.052291,0.15904,0,0
5,GO TELOMERE ORGANIZATION,0.12662,0.052252,0.12646,0,0
5,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.23827,0.052251,0.080284,0,0
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.49108,0.052236,0.073428,0,0
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.29248,0.052229,0.094063,0,0
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.75756,0.052228,0.064564,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.38829,0.052223,0.12566,0,0
5,GO NEGATIVE REGULATION OF OSSIFICATION,0.33029,0.052184,0.14398,0,0
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.42405,0.052087,0.047878,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.11894,0.051983,0.1152,0,0
5,GO LIPID EXPORT FROM CELL,0.27126,0.051957,0.085872,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.27126,0.051941,0.1466,0,0
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.1306,0.051874,0.096193,0,0
5,GO FC RECEPTOR SIGNALING PATHWAY,0.33821,0.05185,0.088793,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.19156,0.05183,0.1015,0,0
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.70989,0.051811,0.044291,0,0
5,GO AMINO ACID ACTIVATION,0.16123,0.05168,0.086119,0,0
5,GO RESPONSE TO TESTOSTERONE,0.68646,0.051606,0.051673,0,0
5,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.37964,0.051439,0.065569,0,0
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.33821,0.051403,0.069675,0,0
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.5959,0.051383,0.062659,0,0
5,GO RNA INTERFERENCE,0.12662,0.051012,0.13578,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.41494,0.050928,0.1125,0,0
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.56341,0.050909,0.061526,0,0
5,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.28529,0.050827,0.082664,0,0
5,GO REGULATION OF STEM CELL PROLIFERATION,0.2577,0.050762,0.12253,0,0
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.66333,0.050754,0.052586,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.098083,0.050731,0.13496,0,0
5,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.43329,0.050596,0.06642,0,0
5,GO HOMOCYSTEINE METABOLIC PROCESS,0.83078,0.050575,0.020545,0,0
5,GO CELL ACTIVATION,0.46168,0.050571,0.083992,0,0
5,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.16602,0.050532,0.14367,0,0
5,GO REGULATION OF PHAGOCYTOSIS,0.72171,0.050422,0.050098,0,0
5,GO REGULATION OF HISTONE PHOSPHORYLATION,0.51122,0.050329,0.074449,0,0
5,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.47137,0.050231,0.06138,0,0
5,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.14312,0.05019,0.11212,0,0
5,GO CYTIDINE TO URIDINE EDITING,0.86799,0.050113,0.022265,0,0
5,GO CELLULAR SENESCENCE,0.098083,0.049834,0.1239,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.056456,0.049754,0.17107,0,0
5,GO REGULATION OF NEUTROPHIL MIGRATION,0.70989,0.049716,0.046078,0,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.37964,0.049527,0.095618,0,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.25111,0.049364,0.10977,0,0
5,GO HYPEROSMOTIC SALINITY RESPONSE,0.19156,0.049324,0.1391,0,0
5,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.65188,0.04927,0.058184,0,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.052482,0.049222,0.11629,0,0
5,GO CELLULAR RESPONSE TO DSRNA,0.67486,0.049185,0.046672,0,0
5,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.23203,0.049049,0.13098,0,0
5,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.23203,0.049032,0.12154,0,0
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.34626,0.049024,0.11004,0,0
5,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.21989,0.048977,0.12841,0,0
5,GO FEMALE GENITALIA DEVELOPMENT,0.40594,0.048565,0.070836,0,0
5,GO RNA LOCALIZATION,0.098083,0.048544,0.11486,0,0
5,GO HUMORAL IMMUNE RESPONSE,0.79394,0.048515,0.03379,0,0
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.16602,0.048381,0.1784,0,0
5,GO LEUKOCYTE TETHERING OR ROLLING,0.62923,0.048361,0.054112,0,0
5,GO CHROMOSOME SEPARATION,0.42405,0.048213,0.089494,0,0
5,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.7336,0.048107,0.015869,0,0
5,GO INTRACELLULAR MRNA LOCALIZATION,0.3148,0.04804,0.097053,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.88046,0.047969,0.042997,0,0
5,GO IMPORT INTO NUCLEUS,0.08588,0.047869,0.1251,0,0
5,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.16123,0.047818,0.12785,0,0
5,GO AMP METABOLIC PROCESS,0.24463,0.047718,0.083594,0,0
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.08588,0.047619,0.12345,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.048745,0.047501,0.08188,0,0
5,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.44264,0.047461,0.093872,0,0
5,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.91805,0.047448,0.01251,0,0
5,GO POSITIVE REGULATION OF CELL AGING,0.67486,0.047404,0.032769,0,0
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.39705,0.047299,0.11039,0,0
5,GO WATER TRANSPORT,0.33821,0.047145,0.12164,0,0
5,GO B CELL DIFFERENTIATION,0.53179,0.047025,0.076588,0,0
5,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.1475,0.046927,0.13567,0,0
5,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.38829,0.046918,0.051861,0,0
5,GO REGULATION OF GLIOGENESIS,0.17091,0.046914,0.11935,0,0
5,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.41494,0.046848,0.07765,0,0
5,GO INTERMEDIATE FILAMENT ORGANIZATION,0.3148,0.046848,0.081141,0,0
5,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.51122,0.046704,0.083226,0,0
5,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.54223,0.046637,0.056233,0,0
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.61803,0.046579,0.076348,0,0
5,GO CELLULAR KETONE METABOLIC PROCESS,0.11894,0.046396,0.084214,0,0
5,GO LYMPHOCYTE HOMEOSTASIS,0.51122,0.046355,0.059532,0,0
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.30724,0.046247,0.13791,0,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.51122,0.046246,0.083839,0,0
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.1475,0.046207,0.13281,0,0
5,GO T CELL HOMEOSTASIS,0.40594,0.046156,0.091765,0,0
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.75756,0.04613,0.054159,0,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.72171,0.046074,0.044947,0,0
5,GO STEROID ESTERIFICATION,0.94321,0.045896,0.039137,0,0
5,GO RESPONSE TO INTERLEUKIN 7,0.61803,0.045895,0.080281,0,0
5,GO RRNA METHYLATION,0.36271,0.045861,0.075487,0,0
5,GO NUCLEOTIDE SALVAGE,0.58498,0.045623,0.038655,0,0
5,GO REGULATION OF GLIAL CELL MIGRATION,0.72171,0.045546,0.04882,0,0
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.64051,0.045407,0.055063,0,0
5,GO REGULATION OF CHEMOTAXIS,0.41494,0.04531,0.11062,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.34626,0.045306,0.059447,0,0
5,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.16602,0.045301,0.16338,0,0
5,GO WHITE FAT CELL DIFFERENTIATION,0.38829,0.045272,0.08687,0,0
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.25111,0.045205,0.12856,0,0
5,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.37111,0.04519,0.10816,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.14312,0.045137,0.073646,0,0
5,GO CELLULAR RESPONSE TO VIRUS,0.28529,0.045129,0.10017,0,0
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.040368,0.044999,0.22584,0,0
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.27821,0.044935,0.18523,0,0
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.58498,0.044925,0.067859,0,0
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.93062,0.044887,0.033624,0,0
5,GO GROOMING BEHAVIOR,0.42405,0.044678,0.10361,0,0
5,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.57414,0.044625,0.053494,0,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.27821,0.044547,0.10308,0,0
5,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.077559,0.044347,0.086898,0,0
5,GO REGULATION OF CELL KILLING,0.96843,0.044329,0.0025157,0,0
5,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.93062,0.044126,0.022282,0,0
5,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.1306,0.044085,0.093564,0,0
5,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.197,0.044037,0.096528,0,0
5,GO TYPE 2 IMMUNE RESPONSE,0.93062,0.043988,-0.023121,0,0
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.54223,0.043903,0.080367,0,0
5,GO MYELIN MAINTENANCE,0.37111,0.043899,0.1258,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.38829,0.043865,0.092163,0,0
5,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.50109,0.043849,0.064864,0,0
5,GO NATURAL KILLER CELL DIFFERENTIATION,0.46168,0.043738,0.10165,0,0
5,GO PRIMARY MIRNA PROCESSING,0.47137,0.043721,0.095727,0,0
5,GO REGULATION OF MRNA BINDING,0.49108,0.043677,0.056924,0,0
5,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.094909,0.043339,0.14544,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.11894,0.043316,0.11296,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.11163,0.043302,0.1306,0,0
5,GO REGULATION OF RNA BINDING,0.35442,0.04317,0.067218,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.74555,0.043099,-0.046463,0,0
5,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.30724,0.043093,0.098598,0,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.27821,0.043072,0.14004,0,0
5,GO HEPATOCYTE DIFFERENTIATION,0.58498,0.043031,0.037959,0,0
5,GO POSTREPLICATION REPAIR,0.44264,0.042594,0.056154,0,0
5,GO CHOLESTEROL STORAGE,0.51122,0.042594,0.095955,0,0
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.51122,0.042482,0.097401,0,0
5,GO ICOSANOID BIOSYNTHETIC PROCESS,0.79394,0.042468,0.024372,0,0
5,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.41494,0.042445,0.1148,0,0
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.39705,0.042315,0.098536,0,0
5,GO LYMPHOCYTE MEDIATED IMMUNITY,0.69814,0.042299,0.041271,0,0
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.96843,0.042294,0.011628,0,0
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.66333,0.042103,0.056927,0,0
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.39705,0.041903,0.12663,0,0
5,GO PROSTATE GLAND MORPHOGENESIS,0.66333,0.041752,0.077857,0,0
5,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.14312,0.041483,0.10582,0,0
5,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.70989,0.041401,0.054079,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.37964,0.04137,0.10302,0,0
5,GO RRNA CATABOLIC PROCESS,0.13885,0.041272,0.13484,0,0
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.70989,0.041268,0.064968,0,0
5,GO MITOTIC NUCLEAR DIVISION,0.2577,0.041249,0.11868,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.51122,0.041232,0.096274,0,0
5,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.51122,0.041146,0.089193,0,0
5,GO SISTER CHROMATID SEGREGATION,0.41494,0.040879,0.091537,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.098083,0.040437,0.11459,0,0
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.95582,0.040291,0.019751,0,0
5,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.70989,0.040259,0.062365,0,0
5,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.67486,0.040011,0.02822,0,0
5,GO HOMEOSTASIS OF NUMBER OF CELLS,0.37111,0.040004,0.094871,0,0
5,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.14312,0.03999,0.1152,0,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.35442,0.039949,0.10476,0,0
5,GO GLIAL CELL ACTIVATION,0.75756,0.039803,0.035007,0,0
5,GO RESPONSE TO ETHER,0.5959,0.039775,0.047955,0,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS,0.2998,0.039605,0.093739,0,0
5,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.214,0.039367,0.060201,0,0
5,GO PENTOSE METABOLIC PROCESS,0.5959,0.039311,0.026345,0,0
5,GO MIDBODY ABSCISSION,0.19156,0.039075,0.092919,0,0
5,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.61803,0.039017,0.10709,0,0
5,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.39705,0.039011,0.094289,0,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.78176,0.038913,0.029203,0,0
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.76963,0.03886,0.031399,0,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.12662,0.038683,0.091021,0,0
5,GO RESPONSE TO HYPEROXIA,0.56341,0.038495,0.079244,0,0
5,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.57414,0.038189,0.08638,0,0
5,GO ARGININE METABOLIC PROCESS,0.55277,0.037919,0.050089,0,0
5,GO SKELETAL MUSCLE CELL PROLIFERATION,0.69814,0.037557,0.034869,0,0
5,GO IMP METABOLIC PROCESS,0.58498,0.037524,0.057569,0,0
5,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.53179,0.037406,0.058011,0,0
5,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.49108,0.037383,0.10636,0,0
5,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.49108,0.037366,0.094407,0,0
5,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.62923,0.037237,0.042945,0,0
5,GO CELLULAR EXTRAVASATION,0.58498,0.037191,0.077491,0,0
5,GO GLIAL CELL PROLIFERATION,0.39705,0.036875,0.10843,0,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.43329,0.036815,0.1264,0,0
5,GO RNA 5 END PROCESSING,0.35442,0.036767,0.047214,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.47137,0.036654,0.082557,0,0
5,GO RESPONSE TO INTERFERON BETA,0.94321,0.036455,0.013318,0,0
5,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.64051,0.036353,0.067523,0,0
5,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.93062,0.036237,-0.010978,0,0
5,GO LYMPHOCYTE APOPTOTIC PROCESS,0.83078,0.036218,0.026384,0,0
5,GO INTERLEUKIN 1 PRODUCTION,0.93062,0.036012,-0.016444,0,0
5,GO POSITIVE REGULATION OF VIRAL PROCESS,0.2577,0.035965,0.097566,0,0
5,GO PROTEIN LOCALIZATION TO CHROMATIN,0.26442,0.035931,0.12984,0,0
5,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.15655,0.035901,0.14632,0,0
5,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.27821,0.035894,0.11178,0,0
5,GO MYELOID LEUKOCYTE ACTIVATION,0.69814,0.035891,0.051714,0,0
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.84314,0.035887,0.045378,0,0
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.61803,0.035873,0.056526,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.51122,0.035727,0.040943,0,0
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.85555,0.035614,0.018803,0,0
5,GO RESPONSE TO VIRUS,0.53179,0.035564,0.064961,0,0
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.78176,0.035438,0.044436,0,0
5,GO RESPONSE TO FATTY ACID,0.23827,0.035372,0.11118,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.197,0.03526,0.083117,0,0
5,GO REGULATION OF PROTEIN MATURATION,0.56341,0.035217,0.077272,0,0
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.54223,0.034997,0.06947,0,0
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.65188,0.034954,0.05554,0,0
5,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.43329,0.034723,0.070185,0,0
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.55277,0.034628,0.08729,0,0
5,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.5959,0.034569,0.043049,0,0
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.55277,0.034433,0.074704,0,0
5,GO VIRAL GENOME REPLICATION,0.51122,0.034381,0.075023,0,0
5,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.51122,0.034246,0.088737,0,0
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.58498,0.034113,0.09066,0,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.15197,0.033986,0.083598,0,0
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.64051,0.033918,0.068748,0,0
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.39705,0.033777,0.084509,0,0
5,GO MITOTIC DNA REPLICATION,0.86799,0.033771,-0.0002425,0,0
5,GO AMIDE BIOSYNTHETIC PROCESS,0.098083,0.033746,0.069988,0,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.69814,0.033549,0.086502,0,0
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.55277,0.033533,0.074525,0,0
5,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.90549,0.033391,0.057245,0,0
5,GO REGULATION OF SYMBIOTIC PROCESS,0.33029,0.03336,0.089774,0,0
5,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.49108,0.032911,0.06787,0,0
5,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.85555,0.0329,0.021442,0,0
5,GO TRNA TRANSPORT,0.21989,0.032876,0.13494,0,0
5,GO REGULATION OF DNA BINDING,0.47137,0.032713,0.083395,0,0
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.41494,0.032503,0.097224,0,0
5,GO REGULATION OF CELL FATE COMMITMENT,0.49108,0.032361,0.08711,0,0
5,GO NUCLEAR PORE ORGANIZATION,0.29248,0.032295,0.1308,0,0
5,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.197,0.032176,0.11349,0,0
5,GO RESPONSE TO VITAMIN D,0.58498,0.032163,0.068342,0,0
5,GO NEGATIVE REGULATION OF RNA SPLICING,0.34626,0.031883,0.093387,0,0
5,GO AXIS ELONGATION,0.44264,0.031869,0.10719,0,0
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.51122,0.031857,0.081374,0,0
5,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.83078,0.031561,0.00053434,0,0
5,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.40594,0.031497,0.039788,0,0
5,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.29248,0.031415,0.073826,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.89296,0.03141,0.0054136,0,0
5,GO ORGAN INDUCTION,0.2998,0.031376,0.078144,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.53179,0.030945,0.054767,0,0
5,GO T CELL DIFFERENTIATION,0.67486,0.030873,0.055314,0,0
5,GO SNORNA METABOLIC PROCESS,0.52145,0.03085,0.060932,0,0
5,GO HISTONE PHOSPHORYLATION,0.38829,0.030794,0.081048,0,0
5,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.39705,0.030749,0.11564,0,0
5,GO BLASTODERM SEGMENTATION,0.23203,0.030603,0.12764,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.32248,0.03058,0.062426,0,0
5,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.67486,0.030467,0.065844,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.1475,0.030459,0.1021,0,0
5,GO SYMBIOTIC PROCESS,0.20256,0.030373,0.089303,0,0
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.53179,0.030313,0.085289,0,0
5,GO PODOSOME ASSEMBLY,0.53179,0.030233,0.11094,0,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.39705,0.030047,0.059494,0,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.56341,0.030008,0.10053,0,0
5,GO GOLGI LOCALIZATION,0.43329,0.029944,0.060432,0,0
5,GO CELLULAR RESPONSE TO HEAT,0.197,0.029862,0.11393,0,0
5,GO NEGATIVE REGULATION OF BEHAVIOR,0.47137,0.029749,0.064501,0,0
5,GO CELLULAR RESPIRATION,0.08881,0.02959,0.056756,0,0
5,GO SUPEROXIDE ANION GENERATION,0.7336,0.029547,0.055363,0,0
5,GO POSITIVE REGULATION OF COAGULATION,0.74555,0.029489,0.056249,0,0
5,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.37964,0.02939,0.10319,0,0
5,GO LEUKOCYTE DIFFERENTIATION,0.58498,0.029257,0.071223,0,0
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.3148,0.02916,0.11686,0,0
5,GO DNA REPLICATION,0.23827,0.029125,0.11158,0,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.52145,0.029112,0.088341,0,0
5,GO ETHANOL OXIDATION,0.93062,0.029013,-0.06229,0,0
5,GO RRNA MODIFICATION,0.38829,0.028951,0.056424,0,0
5,GO DNA STRAND ELONGATION,0.68646,0.028604,0.048536,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.91805,0.028569,-0.011753,0,0
5,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.61803,0.028392,0.060934,0,0
5,GO CELL PROLIFERATION IN HINDBRAIN,0.52145,0.028324,0.07761,0,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.88046,0.02831,0.028423,0,0
5,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.79394,0.028285,-0.010413,0,0
5,GO PROSTATE GLAND DEVELOPMENT,0.65188,0.028185,0.064263,0,0
5,GO PEPTIDYL ASPARAGINE MODIFICATION,0.7336,0.028129,0.022238,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.89296,0.027995,0.0049423,0,0
5,GO LYMPHOCYTE DIFFERENTIATION,0.5959,0.027834,0.064194,0,0
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.16123,0.027786,0.11159,0,0
5,GO VITAMIN BIOSYNTHETIC PROCESS,0.55277,0.027591,0.069957,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.99368,0.027446,-0.0024743,0,0
5,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.46168,0.027438,0.07252,0,0
5,GO REGULATION OF VIRAL LIFE CYCLE,0.42405,0.027433,0.080168,0,0
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.68646,0.027428,0.045998,0,0
5,GO AMINE METABOLIC PROCESS,0.060677,0.027416,0.12451,0,0
5,GO DNA LIGATION,0.70989,0.027402,0.044619,0,0
5,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.11524,0.027262,0.071826,0,0
5,GO NEUTROPHIL HOMEOSTASIS,0.89296,0.027141,0.052709,0,0
5,GO REGULATION OF B CELL DIFFERENTIATION,0.79394,0.027111,0.026368,0,0
5,GO SPINDLE MIDZONE ASSEMBLY,0.96843,0.026976,0.037534,0,0
5,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.98106,0.026801,0.038385,0,0
5,GO RESPONSE TO FUNGUS,0.80618,0.026707,-0.040165,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.46168,0.026615,0.13468,0,0
5,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.98106,0.026417,-0.011592,0,0
5,GO HORMONE CATABOLIC PROCESS,0.47137,0.026252,0.07357,0,0
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.66333,0.026211,0.079011,0,0
5,GO NEPHRON TUBULE FORMATION,0.81845,0.025992,0.000661,0,0
5,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.42405,0.025969,0.05217,0,0
5,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.13885,0.025769,0.12296,0,0
5,GO POSITIVE REGULATION OF CHEMOTAXIS,0.79394,0.025664,0.068309,0,0
5,GO VAGINA DEVELOPMENT,0.81845,0.025644,0.024692,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.11163,0.025627,0.051771,0,0
5,GO CELLULAR RESPONSE TO DRUG,0.1475,0.025562,0.11869,0,0
5,GO DNA REPLICATION INITIATION,0.79394,0.02538,0.020593,0,0
5,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.64051,0.025319,0.086998,0,0
5,GO NCRNA EXPORT FROM NUCLEUS,0.20822,0.025309,0.13572,0,0
5,GO RESPONSE TO SALT,0.94321,0.025106,0.015243,0,0
5,GO MULTI ORGANISM LOCALIZATION,0.16602,0.02503,0.1157,0,0
5,GO ANIMAL ORGAN REGENERATION,0.2577,0.025018,0.10708,0,0
5,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.47137,0.025018,0.10115,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.61803,0.024952,0.071357,0,0
5,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.28529,0.024785,0.06582,0,0
5,GO MITOTIC CELL CYCLE CHECKPOINT,0.18624,0.024749,0.1386,0,0
5,GO CHONDROCYTE DEVELOPMENT,0.33029,0.024585,0.14869,0,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.37111,0.02455,0.088097,0,0
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.89296,0.024534,0.010598,0,0
5,GO CORONARY VASCULATURE MORPHOGENESIS,0.18624,0.024461,0.21068,0,0
5,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.85555,0.024458,0.027113,0,0
5,GO GAMMA DELTA T CELL DIFFERENTIATION,0.2998,0.024147,0.163,0,0
5,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.37111,0.024077,0.089857,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.41494,0.023919,0.10767,0,0
5,GO MATURATION OF SSU RRNA,0.69814,0.023856,0.030396,0,0
5,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.74555,0.023777,0.084035,0,0
5,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.66333,0.023769,-0.053468,0,0
5,GO BLEB ASSEMBLY,0.67486,0.023632,0.060603,0,0
5,GO GAP JUNCTION ASSEMBLY,0.48117,0.02361,0.11725,0,0
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.67486,0.023572,0.053473,0,0
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.83078,0.023536,0.020889,0,0
5,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.55277,0.023466,0.048367,0,0
5,GO LYMPHOCYTE COSTIMULATION,0.61803,0.023403,0.04669,0,0
5,GO POLYAMINE BIOSYNTHETIC PROCESS,0.44264,0.023263,0.049885,0,0
5,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.48117,0.02323,0.084925,0,0
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.51122,0.023153,0.054304,0,0
5,GO MITOCHONDRIAL DNA REPLICATION,0.15655,0.023129,0.11005,0,0
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.93062,0.023103,0.032902,0,0
5,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.85555,0.023009,0.041201,0,0
5,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.47137,0.022778,0.12259,0,0
5,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.51122,0.022751,0.052251,0,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.81845,0.022727,-0.0042101,0,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.80618,0.022346,0.066952,0,0
5,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.25111,0.022246,0.11385,0,0
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.40594,0.022073,0.12886,0,0
5,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.42405,0.022015,0.073272,0,0
5,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.58498,0.022013,0.046693,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.75756,0.022006,0.030654,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.54223,0.021957,0.072249,0,0
5,GO SNORNA 3 END PROCESSING,0.43329,0.021787,0.060981,0,0
5,GO T HELPER 2 CELL DIFFERENTIATION,0.85555,0.021695,-0.036629,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.76963,0.021612,0.045238,0,0
5,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.78176,0.021582,0.021478,0,0
5,GO INTERLEUKIN 8 PRODUCTION,1,0.021573,0.0051653,0,0
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.91805,0.021525,-0.004345,0,0
5,GO FORELIMB MORPHOGENESIS,0.33821,0.021524,0.10948,0,0
5,GO REGULATION OF VIRAL GENOME REPLICATION,0.69814,0.021502,0.060915,0,0
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.27821,0.021385,0.096899,0,0
5,GO PROTEIN INSERTION INTO MEMBRANE,0.077559,0.02135,0.093238,0,0
5,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.2259,0.021335,0.11002,0,0
5,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.44264,0.021097,0.097011,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.60692,0.020923,0.082532,0,0
5,GO NEGATIVE REGULATION OF LIPID STORAGE,0.65188,0.020882,0.086607,0,0
5,GO NEGATIVE REGULATION OF DNA BINDING,0.43329,0.020755,0.076683,0,0
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.72171,0.020722,0.024965,0,0
5,GO RESPONSE TO ACTIVITY,0.36271,0.020708,0.0938,0,0
5,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.67486,0.020647,0.059388,0,0
5,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.17591,0.020639,0.11887,0,0
5,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.56341,0.0206,0.06301,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.99368,0.02037,0.0045085,0,0
5,GO HISTONE SERINE PHOSPHORYLATION,0.95582,0.020123,0.010302,0,0
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.25111,0.020091,0.092785,0,0
5,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.38829,0.019985,0.12677,0,0
5,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.39705,0.019925,0.054482,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.70989,0.01984,0.04492,0,0
5,GO MAST CELL MIGRATION,0.85555,0.019786,0.06446,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.78176,0.019513,0.036638,0,0
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.95582,0.019464,0.015706,0,0
5,GO INTERFERON ALPHA PRODUCTION,0.53179,0.019397,0.074128,0,0
5,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.83078,0.019396,-0.024174,0,0
5,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.74555,0.019394,0.027125,0,0
5,GO INTERACTION WITH SYMBIONT,0.67486,0.019294,0.038695,0,0
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.81845,0.01914,0.014885,0,0
5,GO RESPONSE TO ANGIOTENSIN,0.91805,0.019073,0.04965,0,0
5,GO T CELL ACTIVATION,0.72171,0.019018,0.040605,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.81845,0.018863,-0.011128,0,0
5,GO RESPONSE TO X RAY,0.49108,0.018603,0.077164,0,0
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.79394,0.018589,0.05068,0,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.37964,0.018587,0.086443,0,0
5,GO MITOTIC SISTER CHROMATID COHESION,0.32248,0.018565,0.11777,0,0
5,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.40594,0.018474,0.082148,0,0
5,GO VIRAL TRANSLATION,0.32248,0.018364,0.067854,0,0
5,GO PEPTIDE BIOSYNTHETIC PROCESS,0.36271,0.018279,0.044205,0,0
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.37964,0.018096,0.081044,0,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.3148,0.017995,0.11147,0,0
5,GO ELECTRON TRANSPORT CHAIN,0.7336,0.017927,0.022671,0,0
5,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.79394,0.017799,0.025175,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.83078,0.017671,0.051824,0,0
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.47137,0.017482,0.058904,0,0
5,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.40594,0.017346,0.15333,0,0
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.46168,0.017337,0.07198,0,0
5,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.52145,0.017275,0.054445,0,0
5,GO CELLULAR RESPONSE TO FATTY ACID,0.37111,0.0172,0.09504,0,0
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.58498,0.017185,0.065257,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.51122,0.016876,0.048615,0,0
5,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.35442,0.01652,0.10342,0,0
5,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.33821,0.016311,0.060354,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.197,0.016305,0.12868,0,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.54223,0.016105,0.065689,0,0
5,GO AMINE CATABOLIC PROCESS,0.46168,0.015898,0.080985,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.17091,0.015788,0.1203,0,0
5,GO CYTOKINE METABOLIC PROCESS,0.52145,0.015751,0.05353,0,0
5,GO B CELL MEDIATED IMMUNITY,0.62923,0.01572,0.068298,0,0
5,GO KINETOCHORE ASSEMBLY,0.61803,0.015441,0.087573,0,0
5,GO ERROR FREE TRANSLESION SYNTHESIS,0.76963,0.015389,0.026046,0,0
5,GO REGULATION OF DNA METHYLATION,0.56341,0.01537,0.079025,0,0
5,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.23203,0.015273,0.070197,0,0
5,GO LEUKOCYTE MIGRATION,0.7336,0.015153,0.063851,0,0
5,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.58498,0.015045,0.06952,0,0
5,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.7336,0.015028,0.044682,0,0
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.79394,0.015026,0.018771,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.96843,0.014932,-0.020523,0,0
5,GO ALDITOL METABOLIC PROCESS,0.52145,0.014919,-0.032258,0,0
5,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.75756,0.014814,0.031274,0,0
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.91805,0.014792,0.023885,0,0
5,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.79394,0.014769,0.092379,0,0
5,GO HISTAMINE TRANSPORT,0.43329,0.014706,0.094416,0,0
5,GO GRANULOCYTE CHEMOTAXIS,0.84314,0.014306,-0.025028,0,0
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.83078,0.014242,0.042756,0,0
5,GO MULTI ORGANISM CELLULAR PROCESS,0.62923,0.014172,0.076153,0,0
5,GO DNA DEAMINATION,0.70989,0.014007,0.030392,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.3148,0.013959,0.10117,0,0
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.70989,0.013837,0.050241,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.53179,0.013608,0.045705,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.23827,0.013558,0.092901,0,0
5,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.67486,0.013527,0.068755,0,0
5,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.65188,0.013409,0.033305,0,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.39705,0.013265,0.080186,0,0
5,GO IMP BIOSYNTHETIC PROCESS,0.90549,0.013191,0.025468,0,0
5,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.66333,0.013154,0.060698,0,0
5,GO RESPONSE TO NITROSATIVE STRESS,0.53179,0.013048,0.045295,0,0
5,GO RESPONSE TO INTERLEUKIN 4,0.34626,0.012779,0.11173,0,0
5,GO POSITIVE REGULATION OF T CELL MIGRATION,0.99368,0.012729,-0.00206,0,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.66333,0.012609,0.081528,0,0
5,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.53179,0.012378,0.083302,0,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.74555,0.012367,0.029486,0,0
5,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.86799,0.012132,0.04706,0,0
5,GO PORE COMPLEX ASSEMBLY,0.5959,0.011908,0.058317,0,0
5,GO POSITIVE REGULATION OF GLIOGENESIS,0.57414,0.011817,0.077938,0,0
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.61803,0.011729,0.071671,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.55277,0.011612,0.072095,0,0
5,GO T CELL APOPTOTIC PROCESS,1,0.011043,-0.00090274,0,0
5,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.47137,0.010985,0.050823,0,0
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.79394,0.010748,0.044122,0,0
5,GO REGULATION OF HEMOPOIESIS,0.5959,0.010579,0.070676,0,0
5,GO MACROPHAGE ACTIVATION,0.86799,0.010541,0.035182,0,0
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.7336,0.010487,0.069562,0,0
5,GO SERTOLI CELL DEVELOPMENT,0.66333,0.010145,0.075953,0,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.90549,0.010061,0.036461,0,0
5,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.5959,0.0099841,0.066502,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.75756,0.0098831,0.021568,0,0
5,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.44264,0.0097505,0.098176,0,0
5,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.93062,0.0097352,0.026998,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.3148,0.0097261,0.073951,0,0
5,GO REGULATION OF GLIAL CELL PROLIFERATION,0.68646,0.0095956,0.054711,0,0
5,GO NUCLEOSIDE METABOLIC PROCESS,0.36271,0.0094236,0.061961,0,0
5,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.90549,0.0094112,0.04401,0,0
5,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.35442,0.0092935,0.16929,0,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.3148,0.009243,0.065758,0,0
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.72171,0.0089405,0.038156,0,0
5,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.86799,0.0089046,0.017215,0,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.98106,0.0086865,0.021708,0,0
5,GO REGULATION OF CHROMOSOME SEGREGATION,0.60692,0.0086793,0.068388,0,0
5,GO NUCLEOSOME ASSEMBLY,0.33821,0.0086528,0.083909,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.32248,0.00865,0.10973,0,0
5,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.98106,0.0085935,0.023983,0,0
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.33029,0.008585,0.067863,0,0
5,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.86799,0.0085203,0.030157,0,0
5,GO LIVER REGENERATION,0.37964,0.0080729,0.089477,0,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.86799,0.0079702,0.017077,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.23203,0.0078862,0.074064,0,0
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.93062,0.0078699,0.03312,0,0
5,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.36271,0.0077675,0.13766,0,0
5,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.33821,0.0076988,0.086167,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.89296,0.0076498,0.0094259,0,0
5,GO IMMUNOGLOBULIN SECRETION,0.93062,0.0075421,-0.016783,0,0
5,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.96843,0.0074969,0.020135,0,0
5,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.23827,0.0074934,0.12552,0,0
5,GO T CELL EXTRAVASATION,0.89296,0.0074143,0.032361,0,0
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.75756,0.0073071,0.061042,0,0
5,GO MESODERMAL CELL FATE COMMITMENT,0.91805,0.0070184,0.029811,0,0
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.67486,0.0067552,0.0653,0,0
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.62923,0.0065844,0.079949,0,0
5,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.51122,0.0060367,0.11595,0,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.67486,0.006027,0.061325,0,0
5,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.62923,0.0056533,0.061022,0,0
5,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.88046,0.0056238,0.012845,0,0
5,GO B CELL ACTIVATION,0.5959,0.005513,0.058204,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.74555,0.005441,0.038264,0,0
5,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.34626,0.0051728,0.14526,0,0
5,GO RECEPTOR BIOSYNTHETIC PROCESS,0.39705,0.0048734,0.089002,0,0
5,GO RRNA METABOLIC PROCESS,0.80618,0.0048314,0.031454,0,0
5,GO RESPONSE TO DSRNA,0.75756,0.0048016,0.053525,0,0
5,GO IRON ION TRANSMEMBRANE TRANSPORT,0.93062,0.0044116,0.019648,0,0
5,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.57414,0.0041935,0.069273,0,0
5,GO RESPONSE TO PROTOZOAN,0.98106,0.0039776,-0.0014917,0,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.80618,0.0037145,-0.046477,0,0
5,GO FOREBRAIN NEURON FATE COMMITMENT,0.5959,0.0035908,0.17949,0,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.84314,0.0035206,0.043425,0,0
5,GO REGULATION OF CELL CELL ADHESION,0.56341,0.0034834,0.078554,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.37964,0.0033785,0.088178,0,0
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.62923,0.0029429,0.08955,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION,0.4521,0.0023148,0.072115,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.75756,0.0022584,0.037977,0,0
5,GO RESPONSE TO GAMMA RADIATION,0.62923,0.0021841,0.069239,0,0
5,GO HISTONE EXCHANGE,0.93062,0.001993,0.017418,0,0
5,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.91805,0.0018155,0.00036707,0,0
5,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.80618,0.0018073,0.037864,0,0
5,GO NUCLEOSIDE SALVAGE,0.78176,0.0015683,0.026951,0,0
5,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.47137,0.0015533,0.077814,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.40594,0.0015265,0.077604,0,0
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.80618,0.0012513,0.00049666,0,0
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.91805,0.001235,0.023972,0,0
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.89296,0.00098684,-0.01955,0,0
5,GO DNA DOUBLE STRAND BREAK PROCESSING,0.35442,0.00092214,0.11238,0,0
5,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.7336,0.00088314,0.058385,0,0
5,GO HYPERSENSITIVITY,0.89296,0.000747,-0.053238,0,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.54223,0.00069533,-0.011644,0,0
5,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.79394,0.00063979,0.021113,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.69814,0.0005962,0.049345,0,0
5,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.83078,0.00043996,-0.0020222,0,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.84314,0.00040507,0.032369,0,0
5,GO CELLULAR RESPONSE TO INTERFERON BETA,0.99368,0.00016813,0.017236,0,0
5,GO LACTATE METABOLIC PROCESS,0.69814,4.0711e-05,0.036756,0,0
5,GO INTERLEUKIN 2 PRODUCTION,0.93062,1.0086e-05,-0.0096044,0,0
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.99368,-4.0558e-05,-0.0036072,0,0
5,GO GALACTOSE METABOLIC PROCESS,0.48117,-0.00010272,0.087773,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.98106,-0.00019172,0.0057988,0,0
5,GO DNA DEPENDENT DNA REPLICATION,0.60692,-0.00022187,0.070256,0,0
5,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.60692,-0.00039181,0.062156,0,0
5,GO OXIDATIVE PHOSPHORYLATION,0.70989,-0.0004156,-0.0042871,0,0
5,GO GENITALIA MORPHOGENESIS,0.88046,-0.00056477,0.018359,0,0
5,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.83078,-0.00093441,-0.008465,0,0
5,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.98106,-0.00096014,0.020635,0,0
5,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.61803,-0.0010597,0.088231,0,0
5,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.98106,-0.0010873,-0.017781,0,0
5,GO LYMPHOCYTE ACTIVATION,0.67486,-0.0012314,0.054916,0,0
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.5959,-0.0013178,0.069762,0,0
5,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.61803,-0.0013307,0.038778,0,0
5,GO SYNAPSE PRUNING,0.88046,-0.0015116,0.035757,0,0
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.83078,-0.0016393,0.039365,0,0
5,GO REPLICATIVE SENESCENCE,0.60692,-0.0016786,0.093717,0,0
5,GO NEGATIVE REGULATION OF DNA REPLICATION,0.84314,-0.0017712,0.043738,0,0
5,GO INTERLEUKIN 1 BETA PRODUCTION,0.96843,-0.0018396,-0.0094606,0,0
5,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.80618,-0.0019946,0.040206,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,1,-0.0020096,0.028307,0,0
5,GO MESODERMAL CELL FATE SPECIFICATION,0.99368,-0.0020482,0.024586,0,0
5,GO NIK NF KAPPAB SIGNALING,0.68646,-0.002302,0.041055,0,0
5,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.60692,-0.0023939,0.11171,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.89296,-0.0024816,0.030774,0,0
5,GO MATURATION OF 5 8S RRNA,0.67486,-0.0024938,0.033286,0,0
5,GO MYELOID LEUKOCYTE MIGRATION,0.96843,-0.002519,0.0061567,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.60692,-0.0026895,0.082432,0,0
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.52145,-0.0029431,0.069261,0,0
5,GO REGULATION OF CELL ACTIVATION,0.62923,-0.0029838,0.056217,0,0
5,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.65188,-0.0030537,-0.036002,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.91805,-0.0031274,-0.024116,0,0
5,GO REGULATION OF RELAXATION OF MUSCLE,0.60692,-0.0033428,0.19783,0,0
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.2998,-0.0034327,0.095178,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.44264,-0.0034723,0.071278,0,0
5,GO LABYRINTHINE LAYER MORPHOGENESIS,0.52145,-0.0035043,0.065928,0,0
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.79394,-0.0035142,-0.0027336,0,0
5,GO RNA CATABOLIC PROCESS,0.80618,-0.0036301,0.019331,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.33821,-0.0036747,0.10951,0,0
5,GO NEUROINFLAMMATORY RESPONSE,0.75756,-0.0038792,0.04408,0,0
5,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.89296,-0.0040243,0.020901,0,0
5,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.72171,-0.0040826,0.045934,0,0
5,GO RESPONSE TO PROSTAGLANDIN E,0.79394,-0.0042423,0.059905,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.89296,-0.0042749,0.018356,0,0
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.49108,-0.0042781,0.1021,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.2259,-0.0046042,0.12304,0,0
5,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.64051,-0.0046188,0.03762,0,0
5,GO REGULATION OF HEAT GENERATION,0.75756,-0.0047539,0.064457,0,0
5,GO GRANULOCYTE MIGRATION,0.86799,-0.0050748,-0.017741,0,0
5,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.79394,-0.0052134,-0.0061911,0,0
5,GO RESPONSE TO INTERFERON GAMMA,0.99368,-0.0052269,0.006127,0,0
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.43329,-0.005254,0.07469,0,0
5,GO REGULATION OF SPINDLE CHECKPOINT,0.76963,-0.0052586,0.057894,0,0
5,GO TELENCEPHALON REGIONALIZATION,0.95582,-0.0052759,-0.036129,0,0
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.32248,-0.0055439,0.10259,0,0
5,GO GRANULOCYTE DIFFERENTIATION,0.67486,-0.0056874,0.06826,0,0
5,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.55277,-0.0058101,0.097975,0,0
5,GO ECTODERMAL PLACODE DEVELOPMENT,0.67486,-0.0059637,0.044393,0,0
5,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.94321,-0.0060432,0.046117,0,0
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.53179,-0.0060452,0.11046,0,0
5,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.57414,-0.0073552,-0.026409,0,0
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.91805,-0.0078528,0.031221,0,0
5,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.7336,-0.007979,0.062397,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.81845,-0.0081384,0.042684,0,0
5,GO RESPONSE TO PROSTAGLANDIN,0.62923,-0.0084534,0.055366,0,0
5,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.53179,-0.0087771,-0.034302,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.91805,-0.0094326,0.042469,0,0
5,GO MITOCHONDRIAL GENE EXPRESSION,0.89296,-0.010158,0.0055766,0,0
5,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.72171,-0.010173,0.0002231,0,0
5,GO REGULATION OF LEUKOCYTE MIGRATION,0.94321,-0.010488,0.024294,0,0
5,GO GTP METABOLIC PROCESS,0.93062,-0.010813,0.025833,0,0
5,GO L SERINE METABOLIC PROCESS,0.7336,-0.010814,0.027677,0,0
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.74555,-0.010908,0.046052,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.72171,-0.010953,-0.056881,0,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.75756,-0.011096,0.064823,0,0
5,GO REGULATION OF CELL FATE SPECIFICATION,0.81845,-0.012074,0.055649,0,0
5,GO LYMPHOCYTE MIGRATION,0.95582,-0.012078,-0.0015524,0,0
5,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.90549,-0.012136,0.05164,0,0
5,GO TRANSLATIONAL ELONGATION,0.96843,-0.012971,0.0055801,0,0
5,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.65188,-0.013611,0.074195,0,0
5,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.98106,-0.013813,-0.0033297,0,0
5,GO RESPONSE TO THYROID HORMONE,0.75756,-0.014114,-0.0010066,0,0
5,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.65188,-0.014277,-0.002379,0,0
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.93062,-0.014751,-0.0092702,0,0
5,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.81845,-0.014907,0.012085,0,0
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.76963,-0.014927,0.050153,0,0
5,GO RESPONSE TO TUMOR CELL,0.88046,-0.014949,-0.0083402,0,0
5,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.88046,-0.015244,0.049027,0,0
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.96843,-0.015291,-0.010294,0,0
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.69814,-0.015651,0.073541,0,0
5,GO POSITIVE REGULATION OF HEAT GENERATION,0.60692,-0.01608,0.091289,0,0
5,GO CHROMOSOME LOCALIZATION,0.4521,-0.016467,0.088595,0,0
5,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.79394,-0.016515,-0.063661,0,0
5,GO TELOMERASE RNA LOCALIZATION,0.89296,-0.01653,0.019507,0,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.44264,-0.016769,0.090917,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.91805,-0.016857,0.010906,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.84314,-0.017112,0.028528,0,0
5,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.93062,-0.017161,-0.004624,0,0
5,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.96843,-0.017499,0.0063353,0,0
5,GO T CELL MEDIATED CYTOTOXICITY,0.85555,-0.017955,-0.045349,0,0
5,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.99368,-0.018289,0.0031572,0,0
5,GO LIVER MORPHOGENESIS,0.90549,-0.018515,0.04701,0,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.94321,-0.018591,0.04207,0,0
5,GO T CELL PROLIFERATION,0.85555,-0.018695,0.026475,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE,0.50109,-0.018802,0.074586,0,0
5,GO LEUKOCYTE HOMEOSTASIS,0.68646,-0.019382,0.045427,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.93062,-0.019516,-0.021258,0,0
5,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.54223,-0.019535,-0.10801,0,0
5,GO DE NOVO PROTEIN FOLDING,0.55277,-0.01959,0.068185,0,0
5,GO POSITIVE REGULATION OF HEMOPOIESIS,0.75756,-0.019731,0.053263,0,0
5,GO CELLULAR RESPONSE TO X RAY,0.89296,-0.019758,0.023276,0,0
5,GO EMBRYONIC HEMOPOIESIS,0.52145,-0.019906,0.12534,0,0
5,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.3148,-0.020513,-0.043456,0,0
5,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.89296,-0.020606,0.042998,0,0
5,GO HYALURONAN CATABOLIC PROCESS,0.98106,-0.021032,0.032947,0,0
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.88046,-0.021701,0.016325,0,0
5,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.78176,-0.021743,-0.045208,0,0
5,GO RESPONSE TO LIPOTEICHOIC ACID,0.88046,-0.021813,-0.00026706,0,0
5,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.79394,-0.021853,0.054355,0,0
5,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.94321,-0.02195,-0.0058924,0,0
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.86799,-0.021976,0.0074709,0,0
5,GO CYTOKINE SECRETION,0.94321,-0.022187,0.017567,0,0
5,GO FATTY ACID HOMEOSTASIS,0.96843,-0.022363,0.037082,0,0
5,GO MITOCHONDRIAL TRANSLATION,0.60692,-0.022461,-0.0095767,0,0
5,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.85555,-0.022567,-0.00052572,0,0
5,GO MITOTIC METAPHASE PLATE CONGRESSION,0.62923,-0.0227,0.054552,0,0
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.46168,-0.023048,0.077811,0,0
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.79394,-0.023088,0.050922,0,0
5,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.86799,-0.023189,0.021844,0,0
5,GO REGULATORY T CELL DIFFERENTIATION,0.91805,-0.023234,0.019101,0,0
5,GO RIBOSOME BIOGENESIS,0.81845,-0.023278,0.006463,0,0
5,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.83078,-0.023576,-0.044026,0,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.96843,-0.023656,0.0079767,0,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.84314,-0.023969,0.019883,0,0
5,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.94321,-0.024002,0.0095062,0,0
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.88046,-0.024246,-0.026835,0,0
5,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.96843,-0.024368,0.0012433,0,0
5,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.57414,-0.024399,0.080668,0,0
5,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.86799,-0.024586,0.012059,0,0
5,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.67486,-0.024675,0.058809,0,0
5,GO RRNA 3 END PROCESSING,0.90549,-0.024721,0.016451,0,0
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,1,-0.024757,0.023004,0,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.89296,-0.024767,-0.03786,0,0
5,GO IMMUNE RESPONSE TO TUMOR CELL,0.7336,-0.024972,-0.044769,0,0
5,GO ADAPTIVE IMMUNE RESPONSE,0.84314,-0.025486,0.014207,0,0
5,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.7336,-0.025508,-0.017424,0,0
5,GO POSITIVE REGULATION OF DNA BINDING,0.74555,-0.025767,0.045597,0,0
5,GO PROSTATE GLAND GROWTH,0.55277,-0.025864,0.052169,0,0
5,GO ERROR PRONE TRANSLESION SYNTHESIS,0.94321,-0.025905,0.0078587,0,0
5,GO PROSTATIC BUD FORMATION,0.78176,-0.026475,0.046345,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.7336,-0.026509,-0.0069488,0,0
5,GO REGULATION OF CELL CYCLE CHECKPOINT,0.57414,-0.026543,0.086269,0,0
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.90549,-0.026569,0.035023,0,0
5,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.88046,-0.026665,0.021485,0,0
5,GO CYSTEINE METABOLIC PROCESS,0.47137,-0.026687,0.10755,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.70989,-0.026718,-0.00058123,0,0
5,GO URETER DEVELOPMENT,0.66333,-0.026804,-0.076952,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.88046,-0.026948,0.051258,0,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.58498,-0.027416,0.10279,0,0
5,GO NUCLEOSIDE CATABOLIC PROCESS,0.99368,-0.02743,0.010788,0,0
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.96843,-0.027455,0.0093986,0,0
5,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.91805,-0.027663,0.035681,0,0
5,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.64051,-0.027741,0.071215,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.96843,-0.028152,0.023262,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.89296,-0.028163,0.064688,0,0
5,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.83078,-0.028313,0.02854,0,0
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.91805,-0.028688,-0.04586,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.93062,-0.028733,0.012571,0,0
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.69814,-0.028738,0.0022087,0,0
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.67486,-0.029016,0.070978,0,0
5,GO RESPONSE TO INTERLEUKIN 12,0.55277,-0.029356,-0.04008,0,0
5,GO PROTEIN CONTAINING COMPLEX REMODELING,0.98106,-0.029508,0.0033832,0,0
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.80618,-0.029664,-0.028825,0,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.91805,-0.029891,-0.032591,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.66333,-0.029962,0.054697,0,0
5,GO REGULATION OF PLASMINOGEN ACTIVATION,0.89296,-0.030044,0.01653,0,0
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.74555,-0.030167,0.036578,0,0
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.74555,-0.030174,0.029854,0,0
5,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.95582,-0.03021,0.0054369,0,0
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.70989,-0.030223,0.072473,0,0
5,GO CHEMOKINE PRODUCTION,0.81845,-0.030273,0.037161,0,0
5,GO CENTROMERE COMPLEX ASSEMBLY,0.83078,-0.030769,0.0076447,0,0
5,GO RESPONSE TO INTERLEUKIN 1,0.98106,-0.030915,0.0096155,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.94321,-0.030978,0.01054,0,0
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.94321,-0.031434,0.0032125,0,0
5,GO NEUTROPHIL MIGRATION,0.68646,-0.032067,-0.062288,0,0
5,GO PHAGOCYTOSIS RECOGNITION,0.81845,-0.032638,-0.019606,0,0
5,GO REGULATION OF CHROMOSOME SEPARATION,0.93062,-0.032805,0.040027,0,0
5,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.65188,-0.033105,-0.048986,0,0
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.78176,-0.033124,0.050571,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.12273,-0.033126,-0.066984,0,0
5,GO DEFENSE RESPONSE TO FUNGUS,0.90549,-0.033222,-0.0082997,0,0
5,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.65188,-0.03341,-0.036541,0,0
5,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.85555,-0.033457,-0.013262,0,0
5,GO APOPTOTIC DNA FRAGMENTATION,0.67486,-0.033483,0.048093,0,0
5,GO TRNA 5 LEADER REMOVAL,0.35442,-0.033524,-0.03486,0,0
5,GO BRANCH ELONGATION OF AN EPITHELIUM,1,-0.033775,0.0017794,0,0
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.91805,-0.034504,0.014567,0,0
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.95582,-0.034689,0.0011586,0,0
5,GO METAPHASE PLATE CONGRESSION,0.55277,-0.034756,0.070619,0,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.76963,-0.034952,-0.0047726,0,0
5,GO REGULATION OF HELICASE ACTIVITY,0.94321,-0.035285,0.037295,0,0
5,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.58498,-0.035364,0.083073,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.93062,-0.036595,0.020102,0,0
5,GO POSITIVE REGULATION OF CELL KILLING,0.99368,-0.037256,-0.012823,0,0
5,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.94321,-0.037333,0.012922,0,0
5,GO TRANSLATIONAL TERMINATION,0.44264,-0.037399,-0.021932,0,0
5,GO REGULATION OF LIGASE ACTIVITY,1,-0.037442,0.018043,0,0
5,GO FIBROBLAST APOPTOTIC PROCESS,0.91805,-0.037538,0.030557,0,0
5,GO T CELL MIGRATION,0.85555,-0.037634,0.00083606,0,0
5,GO NEUTROPHIL CHEMOTAXIS,0.64051,-0.037934,-0.077223,0,0
5,GO HISTAMINE SECRETION,0.94321,-0.038222,0.017035,0,0
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.64051,-0.038286,0.050866,0,0
5,GO IMMUNOGLOBULIN PRODUCTION,0.69814,-0.038964,0.040456,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION,0.67486,-0.039042,0.059874,0,0
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.79394,-0.03957,-0.022338,0,0
5,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.42405,-0.040372,-0.023039,0,0
5,GO PROTEIN NEDDYLATION,0.54223,-0.04122,-0.018854,0,0
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.86799,-0.041528,-0.020518,0,0
5,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.47137,-0.041975,-0.055894,0,0
5,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.98106,-0.042368,0.034094,0,0
5,GO POSITIVE REGULATION OF CELL ACTIVATION,0.78176,-0.042551,0.022465,0,0
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.84314,-0.042619,0.033859,0,0
5,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.37111,-0.042642,-0.031434,0,0
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.83078,-0.04353,0.017532,0,0
5,GO RESPONSE TO MUSCLE ACTIVITY,0.95582,-0.044142,0.04345,0,0
5,GO PENILE ERECTION,0.68646,-0.045064,-0.067766,0,0
5,GO NUCLEOBASE METABOLIC PROCESS,0.46168,-0.045703,-0.029497,0,0
5,GO REGULATION OF PODOSOME ASSEMBLY,1,-0.045733,0.037672,0,0
5,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.93062,-0.045798,0.020065,0,0
5,GO VIRAL LATENCY,0.84314,-0.046018,0.01131,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.94321,-0.046045,-0.020311,0,0
5,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.26442,-0.046086,-0.072944,0,0
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.56341,-0.04675,-0.02702,0,0
5,GO MODULATION BY HOST OF VIRAL PROCESS,0.89296,-0.046943,0.025712,0,0
5,GO KILLING OF CELLS OF OTHER ORGANISM,0.90549,-0.047152,-0.019709,0,0
5,GO CELLULAR RESPONSE TO IRON ION,0.91805,-0.047345,0.051273,0,0
5,GO CELL CYCLE DNA REPLICATION,0.95582,-0.047471,0.029055,0,0
5,GO INTERLEUKIN 10 PRODUCTION,0.96843,-0.047665,-0.018493,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.83078,-0.047808,-0.02463,0,0
5,GO ZINC ION HOMEOSTASIS,0.49108,-0.048055,-0.062237,0,0
5,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.58498,-0.048273,-0.010076,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.76963,-0.048655,0.014906,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.83078,-0.048862,-0.0015297,0,0
5,GO PSEUDOPODIUM ORGANIZATION,0.91805,-0.049183,0.04338,0,0
5,GO DENTATE GYRUS DEVELOPMENT,0.72171,-0.049404,-0.049683,0,0
5,GO PYROPTOSIS,0.99368,-0.049538,-0.0083468,0,0
5,GO TRNA 5 END PROCESSING,0.30724,-0.050253,-0.031011,0,0
5,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.93062,-0.050485,-0.023798,0,0
5,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.20256,-0.050516,-0.088057,0,0
5,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.81845,-0.050761,-0.028722,0,0
5,GO RESPONSE TO NITRIC OXIDE,0.93062,-0.050793,0.028141,0,0
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.93062,-0.051139,-0.01009,0,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.57414,-0.051252,-0.048226,0,0
5,GO RESPONSE TO INTERLEUKIN 18,0.72171,-0.051756,0.08275,0,0
5,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.32248,-0.051772,-0.037733,0,0
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.78176,-0.052088,0.059259,0,0
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.56341,-0.052436,0.099131,0,0
5,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.29248,-0.052603,-0.046574,0,0
5,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.91805,-0.052997,0.020854,0,0
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.32248,-0.053318,-0.061557,0,0
5,GO REGULATION OF T CELL ACTIVATION,0.85555,-0.053482,0.021685,0,0
5,GO CELL REDOX HOMEOSTASIS,0.53179,-0.05413,-0.031301,0,0
5,GO SALIVA SECRETION,0.72171,-0.054893,-0.030765,0,0
5,GO LEUKOCYTE PROLIFERATION,0.90549,-0.055127,0.013145,0,0
5,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.7336,-0.055322,0.045478,0,0
5,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.99368,-0.056458,-0.0079238,0,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.74555,-0.056612,0.0048886,0,0
5,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.99368,-0.056769,0.0094735,0,0
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,1,-0.056946,-0.0065445,0,0
5,GO B CELL RECEPTOR SIGNALING PATHWAY,0.89296,-0.057436,-0.01559,0,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.84314,-0.057751,-0.04434,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.86799,-0.058137,0.026524,0,0
5,GO MITOCHONDRIAL TRANSCRIPTION,0.64051,-0.058232,-0.0073517,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.83078,-0.058902,0.020971,0,0
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.98106,-0.060366,0.012198,0,0
5,GO REGULATION OF B CELL ACTIVATION,0.86799,-0.060529,0.027602,0,0
5,GO TRNA CATABOLIC PROCESS,0.89296,-0.060584,0.040277,0,0
5,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.70989,-0.060659,0.11454,0,0
5,GO NATURAL KILLER CELL ACTIVATION,0.81845,-0.061243,0.022837,0,0
5,GO ALPHA BETA T CELL DIFFERENTIATION,1,-0.061411,0.009318,0,0
5,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.44264,-0.061502,-0.043375,0,0
5,GO ALPHA BETA T CELL ACTIVATION,0.94321,-0.061604,0.0032507,0,0
5,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.94321,-0.061664,-0.019199,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.98106,-0.062436,0.014994,0,0
5,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.86799,-0.063094,-0.038454,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.62923,-0.063274,0.0028729,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.84314,-0.064174,-0.060288,0,0
5,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.48117,-0.06421,-0.07673,0,0
5,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.72171,-0.064282,-0.055294,0,0
5,GO CD40 SIGNALING PATHWAY,0.64051,-0.064337,-0.043521,0,0
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.72171,-0.064668,-0.054392,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.54223,-0.06471,-0.045981,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.91805,-0.064998,-0.00015556,0,0
5,GO PROTEIN TARGETING TO MEMBRANE,0.11163,-0.06537,-0.051459,0,0
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.66333,-0.065619,-0.060074,0,0
5,GO PURINE CONTAINING COMPOUND SALVAGE,0.17591,-0.065964,-0.071255,0,0
5,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.98106,-0.066737,-0.028208,0,0
5,GO ALPHA BETA T CELL PROLIFERATION,0.93062,-0.06681,-0.002232,0,0
5,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.85555,-0.066955,-0.04163,0,0
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.84314,-0.067096,-0.023163,0,0
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.85555,-0.067356,-0.030799,0,0
5,GO ZYMOGEN INHIBITION,0.78176,-0.067602,-0.032814,0,0
5,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.50109,-0.067612,-0.043283,0,0
5,GO REGULATION OF RESPONSE TO TUMOR CELL,0.93062,-0.067742,-0.013492,0,0
5,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.80618,-0.067841,-0.035876,0,0
5,GO CARTILAGE MORPHOGENESIS,0.55277,-0.068445,-0.026375,0,0
5,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.29248,-0.068571,-0.04516,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.96843,-0.068975,-0.013876,0,0
5,GO CELLULAR RESPONSE TO ZINC ION,0.69814,-0.070455,-0.059898,0,0
5,GO RESPONSE TO CADMIUM ION,0.37111,-0.070687,-0.0274,0,0
5,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.99368,-0.070809,-0.014785,0,0
5,GO CYTOPLASMIC TRANSLATION,0.033245,-0.071588,-0.090632,0,0
5,GO PROXIMAL DISTAL PATTERN FORMATION,0.65188,-0.071879,-0.050169,0,0
5,GO REGULATION OF MACROPHAGE ACTIVATION,0.95582,-0.072057,0.010717,0,0
5,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.79394,-0.072178,-0.042568,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.54223,-0.072349,-0.11074,0,0
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.88046,-0.072925,-0.02009,0,0
5,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.93062,-0.073384,0.03312,0,0
5,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.23827,-0.073959,-0.047605,0,0
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.84314,-0.074006,0.063909,0,0
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.54223,-0.074054,-0.059531,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.78176,-0.074062,0.020356,0,0
5,GO THYMIC T CELL SELECTION,0.93062,-0.074796,0.01785,0,0
5,GO LEUKOCYTE APOPTOTIC PROCESS,0.94321,-0.074969,0.00024509,0,0
5,GO CELL KILLING,0.96843,-0.075755,-0.017439,0,0
5,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.76963,-0.076002,-0.028286,0,0
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.95582,-0.076383,-0.023538,0,0
5,GO AUTOPHAGIC CELL DEATH,0.32248,-0.07691,-0.040759,0,0
5,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.47137,-0.077061,-0.046469,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.99368,-0.077656,-0.0083231,0,0
5,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.57414,-0.078854,0.0017205,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.96843,-0.078974,-0.0004036,0,0
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.99368,-0.079255,-0.017167,0,0
5,GO LEUKOCYTE CELL CELL ADHESION,0.85555,-0.079293,0.016051,0,0
5,GO CHROMATIN REMODELING AT CENTROMERE,0.52145,-0.079828,-0.055075,0,0
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.99368,-0.080173,-0.0011739,0,0
5,GO REGULATION OF T CELL CHEMOTAXIS,0.68646,-0.080345,-0.047603,0,0
5,GO INTERLEUKIN 17 PRODUCTION,0.93062,-0.080745,-0.033668,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.60692,-0.082038,-0.04614,0,0
5,GO MATURATION OF LSU RRNA,0.15655,-0.082447,-0.05822,0,0
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.36271,-0.08371,-0.073461,0,0
5,GO CHEMOKINE SECRETION,0.94321,-0.084553,-0.0047762,0,0
5,GO KINETOCHORE ORGANIZATION,0.83078,-0.085262,0.053208,0,0
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,1,-0.085861,0.0028171,0,0
5,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.55277,-0.085989,-0.0494,0,0
5,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.067497,-0.086472,-0.14042,0,0
5,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.64051,-0.087045,-0.080256,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.95582,-0.088163,0.0094038,0,0
5,GO REGULATION OF T CELL DIFFERENTIATION,0.83078,-0.088656,0.028521,0,0
5,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.61803,-0.090145,-0.064537,0,0
5,GO PROTEIN NITROSYLATION,0.96843,-0.09166,-0.002354,0,0
5,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.12662,-0.092294,-0.11226,0,0
5,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.19156,-0.092958,-0.17171,0,0
5,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.84314,-0.09299,-0.011571,0,0
5,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.4521,-0.093743,-0.028038,0,0
5,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.47137,-0.094691,-0.09184,0,0
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.99368,-0.09501,0.033604,0,0
5,GO RESPONSE TO COPPER ION,0.38829,-0.095417,-0.053698,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.99368,-0.095926,-0.0044972,0,0
5,GO NEGATIVE REGULATION OF BONE REMODELING,0.7336,-0.096237,-0.031186,0,0
5,GO RESPIRATORY BURST,0.88046,-0.097097,0.0043189,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.72171,-0.097676,-0.028786,0,0
5,GO HISTONE MRNA METABOLIC PROCESS,0.56341,-0.098827,-0.011153,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.72171,-0.099413,-0.067418,0,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.81845,-0.10018,-0.014773,0,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.78176,-0.1007,-0.030498,0,0
5,GO PROSTANOID BIOSYNTHETIC PROCESS,0.33029,-0.10099,-0.089831,0,0
5,GO T CELL LINEAGE COMMITMENT,0.70989,-0.10108,0.075542,0,0
5,GO CELLULAR RESPONSE TO CADMIUM ION,0.37964,-0.10241,-0.061774,0,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.85555,-0.10329,-0.048009,0,0
5,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.12662,-0.10412,-0.07218,0,0
5,GO LEUKOCYTE AGGREGATION,0.44264,-0.10441,-0.12429,0,0
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.50109,-0.1052,-0.077942,0,0
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.79394,-0.10573,-0.064529,0,0
5,GO RESPONSE TO CHEMOKINE,0.7336,-0.10591,-0.073944,0,0
5,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.58498,-0.10636,-0.050413,0,0
5,GO RESPONSE TO PEPTIDOGLYCAN,0.5959,-0.10638,-0.13158,0,0
5,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.95582,-0.10712,-0.013189,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.93062,-0.10751,0.0095335,0,0
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.80618,-0.1082,-0.0035226,0,0
5,GO NEURAL CREST FORMATION,0.91805,-0.10825,-0.0054591,0,0
5,GO CELLULAR RESPONSE TO COPPER ION,0.58498,-0.10831,-0.074862,0,0
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.76963,-0.10843,-0.065229,0,0
5,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.78176,-0.10887,-0.0025428,0,0
5,GO CELLULAR DEFENSE RESPONSE,0.70989,-0.11007,-0.07416,0,0
5,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.95582,-0.1104,0.0033607,0,0
5,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.011063,-0.11044,-0.13424,0,0
5,GO CYCLOOXYGENASE PATHWAY,0.58498,-0.11128,-0.077453,0,0
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.7336,-0.11204,-0.025393,0,0
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.95582,-0.11261,-0.023015,0,0
5,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.80618,-0.11354,-0.086897,0,0
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.64051,-0.11368,-0.0649,0,0
5,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.067497,-0.11462,-0.093263,0,0
5,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.47137,-0.1152,-0.049319,0,0
5,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0092139,-0.11824,-0.11813,0,0
5,GO T CELL SELECTION,0.83078,-0.11839,0.028282,0,0
5,GO MONONUCLEAR CELL MIGRATION,0.56341,-0.12236,-0.10079,0,0
5,GO PROTEASOME ASSEMBLY,0.16602,-0.12252,-0.065463,0,0
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.76963,-0.12409,-0.035198,0,0
5,GO TRANSLATIONAL INITIATION,0.012106,-0.12528,-0.13685,0,0
5,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.069906,-0.12615,-0.12366,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.015776,-0.12658,-0.12273,0,0
5,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.91805,-0.12755,0.00087152,0,0
5,GO T HELPER 1 CELL DIFFERENTIATION,0.55277,-0.12825,-0.11131,0,0
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.67486,-0.12829,0.03462,0,0
5,GO MYOBLAST MIGRATION,0.24463,-0.1288,-0.14337,0,0
5,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.1475,-0.13011,-0.1546,0,0
5,GO RIBOSOME ASSEMBLY,0.026142,-0.13049,-0.10735,0,0
5,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.68646,-0.13158,-0.091223,0,0
5,GO DENDRITIC CELL DIFFERENTIATION,0.7336,-0.13233,-0.044572,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.94321,-0.13366,-0.0087715,0,0
5,GO GAMMA DELTA T CELL ACTIVATION,0.86799,-0.13394,0.025923,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.41494,-0.13463,-0.058454,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.68646,-0.13481,-0.064934,0,0
5,GO MYELOID CELL APOPTOTIC PROCESS,0.75756,-0.13588,-0.018483,0,0
5,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.15197,-0.13624,-0.10681,0,0
5,GO LYMPHOCYTE CHEMOTAXIS,0.5959,-0.13745,-0.11008,0,0
5,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.5959,-0.13775,-0.096003,0,0
5,GO REGULATION OF B CELL PROLIFERATION,0.88046,-0.1378,-0.0098619,0,0
5,GO T HELPER CELL LINEAGE COMMITMENT,0.86799,-0.1403,0.033783,0,0
5,GO TONIC SMOOTH MUSCLE CONTRACTION,0.37964,-0.14459,-0.07975,0,0
5,GO DENDRITIC CELL APOPTOTIC PROCESS,0.70989,-0.14894,-0.1171,0,0
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.70989,-0.14963,-0.083565,0,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.95582,-0.15293,-0.039255,0,0
5,GO INTERLEUKIN 12 PRODUCTION,0.86799,-0.15418,-0.031132,0,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.43329,-0.15539,-0.061601,0,0
5,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.26442,-0.15549,-0.11706,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.72171,-0.15566,-0.076012,0,0
5,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.046961,-0.1582,-0.15695,0,0
5,GO REGULATION OF NUCLEASE ACTIVITY,0.17591,-0.15938,-0.10117,0,0
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.85555,-0.1608,-0.051783,0,0
5,GO V D J RECOMBINATION,0.64051,-0.16219,-0.050328,0,0
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.91805,-0.1628,-0.025917,0,0
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.17091,-0.16873,-0.18104,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.58498,-0.16998,-0.082872,0,0
5,GO POSITIVE T CELL SELECTION,0.96843,-0.17176,0.022952,0,0
5,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.10811,-0.17391,-0.13792,0,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.61803,-0.17417,-0.096603,0,0
5,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.99368,-0.17474,-0.0080183,0,0
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.79394,-0.17553,-0.053427,0,0
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,1,-0.17822,0.01244,0,0
5,GO NEGATIVE T CELL SELECTION,0.78176,-0.18282,-0.063773,0,0
5,GO T CELL CHEMOTAXIS,0.64051,-0.18386,-0.1075,0,0
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.75756,-0.19117,-0.071154,0,0
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.83078,-0.19134,-0.031517,0,0
5,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.08588,-0.1915,-0.16247,0,0
5,GO B CELL PROLIFERATION,0.90549,-0.1935,-0.05064,0,0
5,GO DENDRITIC CELL MIGRATION,0.41494,-0.19421,-0.14649,0,0
5,GO MONOCYTE CHEMOTAXIS,0.37111,-0.20556,-0.16968,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.35442,-0.21146,-0.048608,0,0
5,GO DENDRITIC CELL CHEMOTAXIS,0.4521,-0.21417,-0.15727,0,0
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.84314,-0.21569,-0.022184,0,0
5,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.86799,-0.21974,-0.037379,0,0
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.24463,-0.22586,-0.1563,0,0
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.40594,-0.22721,-0.13724,0,0
5,GO MACROPHAGE APOPTOTIC PROCESS,0.40594,-0.22843,-0.099865,0,0
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.2577,-0.23087,-0.17481,0,0
5,GO REGULATION OF TOLERANCE INDUCTION,0.80618,-0.24384,-0.054691,0,0
5,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.48117,-0.24462,-0.08732,0,0
5,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.57414,-0.25032,-0.14821,0,0
5,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.50109,-0.25177,-0.11613,0,0
5,GO TOLERANCE INDUCTION,0.67486,-0.25386,-0.096937,0,0
5,GO T CELL TOLERANCE INDUCTION,0.90549,-0.25999,-0.045128,0,0
5,GO POSITIVE THYMIC T CELL SELECTION,0.89296,-0.26768,-0.022037,0,0
5,GO MYELOID DENDRITIC CELL ACTIVATION,0.61803,-0.26778,-0.090697,0,0
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.33029,-0.27929,-0.11224,0,0
5,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.70989,-0.28201,-0.064424,0,0
5,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.4521,-0.31443,-0.20693,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.52145,-0.32953,-0.15975,0,0
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.15197,-0.33148,-0.18894,0,0
5,GO CHRONIC INFLAMMATORY RESPONSE,0.24463,-0.33517,-0.25098,0,0
5,GO EOSINOPHIL CHEMOTAXIS,0.15197,-0.33567,-0.27188,0,0
5,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.39705,-0.3558,-0.2012,0,0
5,GO EOSINOPHIL MIGRATION,0.20822,-0.36144,-0.23074,0,0
5,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.48117,-0.38641,-0.20138,0,0
5,GO CYTOLYSIS,0.40594,-0.39576,-0.16406,0,0
5,GO DETOXIFICATION OF INORGANIC COMPOUND,0.074935,-0.42229,-0.35057,0,0
5,GO NATURAL KILLER CELL CHEMOTAXIS,0.15197,-0.64903,-0.38569,0,0
